PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wen, CP; Wai, JPM; Tsai, MK; Yang, YC; Cheng, TYD; Lee, MC; Chan, HT; Tsao, CK; Tsai, SP; Wu, XF				Wen, Chi Pang; Wai, Jackson Pui Man; Tsai, Min Kuang; Yang, Yi Chen; Cheng, Ting Yuan David; Lee, Meng-Chih; Chan, Hui Ting; Tsao, Chwen Keng; Tsai, Shan Pou; Wu, Xifeng			Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study	LANCET			English	Article							CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; DOSE-RESPONSE; RISK; EXERCISE; WALKING; ADULTS; HEALTH; WOMEN; PREVALENCE	Background The health benefits of leisure-time physical activity are well known, but whether less exercise than the recommended 150 min a week can have life expectancy benefits is unclear. We assessed the health benefits of a range of volumes of physical activity in a Taiwanese population. Methods In this prospective cohort study, 416 175 individuals (199 265 men and 216 910 women) participated in a standard medical screening programme in Taiwan between 1996 and 2008, with an average follow-up of 8.05 years (SD 4.21). On the basis of the amount of weekly exercise indicated in a self-administered questionnaire, participants were placed into one of five categories of exercise volumes: inactive, or low, medium, high, or very high activity. We calculated hazard ratios (HR) for mortality risks for every group compared with the inactive group, and calculated life expectancy for every group. Findings Compared with individuals in the inactive group, those in the low-volume activity group, who exercised for an average of 92 min per week (95% CI 71-112) or 15 min a day (SD 1.8), had a 14% reduced risk of all-cause mortality (0.86, 0.81-0.91), and had a 3 year longer life expectancy. Every additional 15 min of daily exercise beyond the minimum amount of 15 min a day further reduced all-cause mortality by 4% (95% CI 2.5-7.0) and all-cancer mortality by 1% (0.3-4.5). These benefits were applicable to all age groups and both sexes, and to those with cardiovascular disease risks. Individuals who were inactive had a 17% (HR 1.17, 95% CI 1.10-1.24) increased risk of mortality compared with individuals in the low-volume group. Interpretation 15 min a day or 90 min a week of moderate-intensity exercise might be of benefit, even for individuals at risk of cardiovascular disease.	[Wen, Chi Pang; Tsai, Min Kuang; Yang, Yi Chen; Chan, Hui Ting] Natl Hlth Res Inst, Inst Populat Sci, 35 Keyan Rd, Zhunan 350, Miaoli County, Taiwan; [Wen, Chi Pang; Tsai, Min Kuang; Yang, Yi Chen] China Med Univ Hosp, Taichung, Taiwan; [Wai, Jackson Pui Man] Natl Taiwan Sport Univ, Inst Sport Sci, Lab Exercise Physiol Res, Tao Yuan, Taiwan; [Cheng, Ting Yuan David] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Lee, Meng-Chih] Chung Shan Med Univ & Hosp, Inst Med, Taichung, Taiwan; [Lee, Meng-Chih] Chung Shan Med Univ & Hosp, Dept Family & Community Med, Taichung, Taiwan; [Tsao, Chwen Keng] MJ Hlth Management Inst, Taipei, Taiwan; [Tsai, Shan Pou] Univ Texas Sch Publ Hlth, Houston, TX USA; [Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	National Health Research Institutes - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; University of Washington; University of Washington Seattle; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; UTMD Anderson Cancer Center	Wen, CP (corresponding author), Natl Hlth Res Inst, Inst Populat Sci, 35 Keyan Rd, Zhunan 350, Miaoli County, Taiwan.	cwengood@nhri.org.tw	Weaver, Marissa/C-4027-2012; Yang, yichen/AAB-5601-2022; Hug, Balthasar L./G-1568-2010		Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH 100-TD-B-111-004]; National Health Research Institutes	Taiwan Department of Health Clinical Trial and Research Center of Excellence; National Health Research Institutes(National Health Research Institutes, Japan)	Taiwan Department of Health Clinical Trial and Research Center of Excellence and National Health Research Institutes.r We thank MJ Health Management Institution for making their large dataset available to us. We thank Nelson Wen for his help in revising the English in this manuscript. This study was supported by Taiwan Department of Health Clinical Trial and Research Centre of Excellence (DOH 100-TD-B-111-004) and the institutional support from National Health Research Institutes.	Adams SA, 2005, AM J EPIDEMIOL, V161, P389, DOI 10.1093/aje/kwi054; American College of Sports Medicine, 2000, ACSMS GUID EX TEST P, P163; Beaglehole R, 2011, LANCET, V378, P449, DOI 10.1016/S0140-6736(11)60879-9; Bijnen FCH, 1998, ARCH INTERN MED, V158, P1499, DOI 10.1001/archinte.158.14.1499; Boecker H, 2008, CEREB CORTEX, V18, P2523, DOI 10.1093/cercor/bhn013; Carlson SA, 2009, J PHYS ACT HEALTH, V6, pS18, DOI 10.1123/jpah.6.s1.s18; Carlsson S, 2006, SCAND J PUBLIC HEALT, V34, P480, DOI 10.1080/14034940600551293; Cerin E., 2009, MENTAL HLTH PHYS ACT, V2, P55, DOI [10.1016/j.mhpa.2009.09.004, DOI 10.1016/J.MHPA.2009.09.004]; Chiang CL, 1984, LIFE TABLE ITS APPL; Department of Health Executive Yuan Taiwan, NAT DEATH FIL NAT CA; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Foundation for Promotion of Cancer Research (FPCR), 2008, CANC STAT JAP 2010; Friedenreich CM, 2002, J NUTR, V132, p3456S, DOI 10.1093/jn/132.11.3456S; Global Advocacy for Physical Activity, TOR CHART PHYS ACT G; Gregg EW, 2003, ARCH INTERN MED, V163, P1440, DOI 10.1001/archinte.163.12.1440; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; Kruger J., 2005, Morbidity and Mortality Weekly Report, V54, P991; Ku PW, 2006, PREV MED, V43, P454, DOI 10.1016/j.ypmed.2006.04.011; Kushi LH, 1997, JAMA-J AM MED ASSOC, V277, P1287, DOI 10.1001/jama.277.16.1287; Lee IM, 2004, AM J EPIDEMIOL, V160, P636, DOI 10.1093/aje/kwh274; Lee IM, 2001, JAMA-J AM MED ASSOC, V285, P1447, DOI 10.1001/jama.285.11.1447; Leitzmann MF, 2007, ARCH INTERN MED, V167, P2453, DOI 10.1001/archinte.167.22.2453; Lollgen H, 2009, INT J SPORTS MED, V30, P213, DOI 10.1055/s-0028-1128150; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; Min Lee I, 2009, EPIDEMIOLOGIC METHOD; National Health Research Institutes, 2005, NAT HLTH INT SURV NH; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Rockhill B, 2001, AM J PUBLIC HEALTH, V91, P578, DOI 10.2105/AJPH.91.4.578; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Schnohr P, 2007, EUR J CARDIOV PREV R, V14, P72, DOI 10.1097/HJR.0b013e3280144470; Schooling CM, 2006, ARCH INTERN MED, V166, P1498, DOI 10.1001/archinte.166.14.1498; Tanasescu M, 2003, CIRCULATION, V107, P2435, DOI 10.1161/01.CIR.0000066906.11109.1F; Thune I, 2001, MED SCI SPORT EXER, V33, pS530, DOI 10.1097/00005768-200106001-00025; Tsai SP, 2010, TAIWAN J PUBLIC HLTH, V29, P261; Wai JPM, 2008, ASIA PAC J CLIN NUTR, V17, P297; Warburton DER, 2006, CAN MED ASSOC J, V174, P961, DOI 10.1503/cmaj.1040750; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; Wen CP, 2009, PUBLIC HEALTH NUTR, V12, P497, DOI 10.1017/S1368980008002802; Wen CP, 2005, TOB CONTROL, V14, pI76, DOI 10.1136/tc.2004.007955; Wisloff U, 2006, EUR J CARDIOV PREV R, V13, P798, DOI 10.1097/01.hjr.0000216548.84560.ac; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104; World Cancer Research Fund/American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organization (WHO), GLOB REC PHYS ACT HL; Ziegelmann JP, 2006, J GERONTOL B-PSYCHOL, V61, pP195, DOI 10.1093/geronb/61.4.P195	47	1106	1129	9	227	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 1	2011	378	9798					1244	1253		10.1016/S0140-6736(11)60749-6	http://dx.doi.org/10.1016/S0140-6736(11)60749-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831IO	21846575				2022-12-01	WOS:000295723600026
J	Pang, PC; Chiu, PCN; Lee, CL; Chang, LY; Panico, M; Morris, HR; Haslam, SM; Khoo, KH; Clark, GF; Yeung, WSB; Dell, A				Pang, Poh-Choo; Chiu, Philip C. N.; Lee, Cheuk-Lun; Chang, Lan-Yi; Panico, Maria; Morris, Howard R.; Haslam, Stuart M.; Khoo, Kay-Hooi; Clark, Gary F.; Yeung, William S. B.; Dell, Anne			Human Sperm Binding Is Mediated by the Sialyl-Lewis(x) Oligosaccharide on the Zona Pellucida	SCIENCE			English	Article							MASS-SPECTROMETRIC ANALYSIS; EXPRESSION; GLYCANS; FUCOSE; SERUM	Human fertilization begins when spermatozoa bind to the extracellular matrix coating of the oocyte, known as the zona pellucida (ZP). One spermatozoan then penetrates this matrix and fuses with the egg cell, generating a zygote. Although carbohydrate sequences on the ZP have been implicated in sperm binding, the nature of the ligand was unknown. Here, ultrasensitive mass spectrometric analyses revealed that the sialyl-Lewis(x) sequence [NeuAc alpha 2-3Gal beta 1-4(Fuc alpha 1-3)GlcNAc], a well-known selectin ligand, is the most abundant terminal sequence on the N- and O-glycans of human ZP. Sperm-ZP binding was largely inhibited by glycoconjugates terminated with sialyl-Lewis(x) sequences or by antibodies directed against this sequence. Thus, the sialyl-Lewis(x) sequence represents the major carbohydrate ligand for human sperm-egg binding.	[Clark, Gary F.] Univ Missouri, Dept Obstet Gynecol & Womens Hlth, Sch Med, Columbia, MO 65201 USA; [Pang, Poh-Choo; Morris, Howard R.; Haslam, Stuart M.; Dell, Anne] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Fac Nat Sci, London SW7 2AZ, England; [Chiu, Philip C. N.; Lee, Cheuk-Lun; Yeung, William S. B.] Univ Hong Kong, Dept Obstet & Gynaecol, Ctr Reprod Dev & Growth, Hong Kong, Hong Kong, Peoples R China; [Chang, Lan-Yi; Khoo, Kay-Hooi] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan	University of Missouri System; University of Missouri Columbia; Imperial College London; University of Hong Kong; Academia Sinica - Taiwan	Clark, GF (corresponding author), Univ Missouri, Dept Obstet Gynecol & Womens Hlth, Sch Med, Columbia, MO 65201 USA.	clarkgf@health.missouri.edu; a.dell@imperial.ac.uk	Lee, Cheuk Lun/AGX-5720-2022; Chiu, Chi Ngong/C-4245-2009; Khoo, Kay-Hooi/E-1989-2019	Chiu, Chi Ngong/0000-0001-6217-1970; Khoo, Kay-Hooi/0000-0003-2906-406X; Dell, Anne/0000-0003-1380-2347; Lee, Cheuk Lun/0000-0003-1553-3478	Biotechnology and Biological Sciences Research Council (BBSRC) [BBF0083091]; Royal Society; Breeden-Adams Foundation; Life Sciences Mission Enhancement Reproductive Biology Program; state of Missouri; University Research Committee, University of Hong Kong; Taiwan National Science Council [NSC99-3112-B-001-025]	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Breeden-Adams Foundation; Life Sciences Mission Enhancement Reproductive Biology Program; state of Missouri; University Research Committee, University of Hong Kong(University of Hong Kong); Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC), grant BBF0083091 (to A. D., H. R. M., and S. M. H.); a Royal Society International Joint Project Award (to A. D. and K-H. K.); the Breeden-Adams Foundation and a Life Sciences Mission Enhancement Reproductive Biology Program funded by the state of Missouri (to G. F. C.); and the University Research Committee, University of Hong Kong (to P.C.N. and W.S.B.Y). The proteomics and sulfoglycomics data were acquired at the National Research Program for Genomic Medicine (NRPGM) Core Facilities for Proteomics and Glycomics funded by the Taiwan National Science Council (NSC99-3112-B-001-025). An intellectual property disclosure has been filed with the University of Missouri that covers technology described in this paper.	Babu P, 2009, GLYCOCONJUGATE J, V26, P975, DOI 10.1007/s10719-008-9146-4; BrinkmanVanderLinden ECM, 1996, GLYCOCONJUGATE J, V13, P27, DOI 10.1007/BF01049676; Chiu PCN, 2008, BIOL REPROD, V79, P869, DOI 10.1095/biolreprod.108.069344; CLARK GF, 1995, HUM REPROD, V10, P31, DOI 10.1093/humrep/10.suppl_1.31; Ferens-Sieczkowska M, 2001, Z NATURFORSCH C, V56, P122; Fukuda M, 1999, J CELL BIOL, V147, P467, DOI 10.1083/jcb.147.3.467; FUKUDA M, 1985, J BIOL CHEM, V260, P2957; HUANG TTF, 1982, GAMETE RES, V5, P355, DOI 10.1002/mrd.1120050406; IMAI Y, 1993, NATURE, V361, P555; Jimenez-Movilla M, 2004, HUM REPROD, V19, P1842, DOI 10.1093/humrep/deh311; Khoo KH, 2010, METHOD ENZYMOL, V478, P3, DOI 10.1016/S0076-6879(10)78001-0; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; LUCAS H, 1994, HUM REPROD, V9, P1532, DOI 10.1093/oxfordjournals.humrep.a138744; MAGNANI J L, 1991, Glycobiology, V1, P318, DOI 10.1093/glycob/1.4.318; Mechref Y, 2009, J PROTEOME RES, V8, P2656, DOI 10.1021/pr8008385; Mengerink KJ, 2001, GLYCOBIOLOGY, V11, p37R, DOI 10.1093/glycob/11.4.37R; North SJ, 2010, METHOD ENZYMOL, V478, P27, DOI 10.1016/S0076-6879(10)78002-2; Pang PC, 2007, J BIOL CHEM, V282, P36593, DOI 10.1074/jbc.M705134200; Patankar MS, 1997, MOL HUM REPROD, V3, P501, DOI 10.1093/molehr/3.6.501; PATANKAR MS, 1993, J BIOL CHEM, V268, P21770; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Schweigert FJ, 2006, HUM REPROD, V21, P2960, DOI 10.1093/humrep/del257; STOOLMAN LM, 1983, J CELL BIOL, V96, P722, DOI 10.1083/jcb.96.3.722; Varki A, 2009, ESSENTIALS GLYCOBIOL; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178	25	240	258	4	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2011	333	6050					1761	1764		10.1126/science.1207438	http://dx.doi.org/10.1126/science.1207438			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21852454	Green Submitted			2022-12-01	WOS:000295121500047
J	Colic, E; Dieperink, H; Titlestad, K; Tepel, M				Colic, Edin; Dieperink, Hans; Titlestad, Kjell; Tepel, Martin			Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: an observational study	LANCET			English	Article							THROMBOTIC THROMBOCYTOPENIC PURPURA; ESCHERICHIA-COLI; SHIGA-TOXIN; RISK	Background Diarrhoea-associated haemolytic uraemic syndrome in adults is a life-threatening, but rare multisystem disorder that is characterised by acute haemolytic anaemia, thrombocytopenia, and renal insufficiency. We aimed to assess the success of management of this disorder with plasma exchange therapy. Methods Patients diagnosed with diarrhoea-associated haemolytic uraemic syndrome in southern Denmark were treated with daily plasma exchange by centrifugation and substitution with fresh frozen plasma. Stool culture and serological testing was done to identify the cause of disease, and the success of management with plasma exchange therapy was assessed from change in platelet count, glomerular filtration rate, and lactate dehydrogenase. Findings During May 25-28, 2011, five patients with a median age of 62 years (range 44-70) presented with diarrhoea-associated haemolytic uraemic syndrome, which was caused by an unusual Shiga-toxin-producing Escherichia coli serotype O104:H4. Strains of E coli showed a high resistance to third-generation cephalosporins because the strains had extended-spectrum beta lactamases. After plasma exchange, median platelet count and glomerular filtration rate increased, median lactate dehydrogenase concentration decreased, and neurological status improved. The time interval from onset of bloody diarrhoea to start of plasma exchange had an inverse correlation with reduction of lactate dehydrogenase concentrations by plasma exchange (p=0.02). All patients were discharged with normal neurological status at 7 days (range 5-8) after starting plasma exchange. Interpretation Early plasma exchange might ameliorate the course of diarrhoea-associated haemolytic uraemic syndrome in adults. However, this finding should be verified in randomised controlled trials	[Colic, Edin; Dieperink, Hans; Tepel, Martin] Odense Univ Hosp, Dept Nephrol, DK-5000 Odense C, Denmark; [Titlestad, Kjell] Odense Univ Hosp, Dept Clin Immunol, DK-5000 Odense C, Denmark; [Tepel, Martin] Univ So Denmark, Inst Mol Med Cardiovasc & Renal Res, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Tepel, M (corresponding author), Odense Univ Hosp, Dept Nephrol, Winslowpk 21-3, DK-5000 Odense C, Denmark.	mtepel@health.sdu.dk	Tepel, Martin/GRS-9581-2022	Tepel, Martin/0000-0002-0086-0997				Bianchi V, 2002, BLOOD, V100, P710, DOI 10.1182/blood-2002-02-0344; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Cohen JA, 1998, J CLIN APHERESIS, V13, P16, DOI 10.1002/(SICI)1098-1101(1998)13:1<16::AID-JCA3>3.0.CO;2-C; Dundas S, 2001, CLIN INFECT DIS, V33, P923, DOI 10.1086/322598; European Centre for Disease Prevention and Control and European Food Safety Authority, 2011, SHIG TOX VER PROD ES; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Garg AX, 2003, JAMA-J AM MED ASSOC, V290, P1360, DOI 10.1001/jama.290.10.1360; Johnson KE, 2006, CLIN INFECT DIS, V43, P1587, DOI 10.1086/509573; Karpac CA, 2008, BRIT J HAEMATOL, V141, P696, DOI 10.1111/j.1365-2141.2008.07116.x; Lapeyraque AL, 2011, NEW ENGL J MED, V364, P2561, DOI 10.1056/NEJMc1100859; Michael M., 2009, COCHRANE DB SYST REV, V1; Piercefield EW, 2010, ARCH INTERN MED, V170, P1656, DOI 10.1001/archinternmed.2010.346; ROCK GA, 1991, NEW ENGL J MED, V325, P393, DOI 10.1056/NEJM199108083250604; Ruggenenti P, 2001, KIDNEY INT, V60, P831, DOI 10.1046/j.1523-1755.2001.060003831.x; Sanchez S, 2010, VET MICROBIOL, V143, P420, DOI 10.1016/j.vetmic.2009.11.016; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601	17	84	88	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 17	2011	378	9796					1089	1093		10.1016/S0140-6736(11)61145-8	http://dx.doi.org/10.1016/S0140-6736(11)61145-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829BE	21871657				2022-12-01	WOS:000295548900025
J	Wogelius, RA; Manning, PL; Barden, HE; Edwards, NP; Webb, SM; Sellers, WI; Taylor, KG; Larson, PL; Dodson, P; You, H; Da-Qing, L; Bergmann, U				Wogelius, R. A.; Manning, P. L.; Barden, H. E.; Edwards, N. P.; Webb, S. M.; Sellers, W. I.; Taylor, K. G.; Larson, P. L.; Dodson, P.; You, H.; Da-Qing, L.; Bergmann, U.			Trace Metals as Biomarkers for Eumelanin Pigment in the Fossil Record	SCIENCE			English	Article							MELANIN; COLOR; FEATHERS; MORPHOLOGY; CHEMISTRY; PRODUCTS; COPPER; EXAFS; BIRDS	Well-preserved fossils of pivotal early bird and nonavian theropod species have provided unequivocal evidence for feathers and/or downlike integuments. Recent studies have reconstructed color on the basis of melanosome structure; however, the chemistry of these proposed melanosomes has remained unknown. We applied synchrotron x-ray techniques to several fossil and extant organisms, including Confuciusornis sanctus, in order to map and characterize possible chemical residues of melanin pigments. Results show that trace metals, such as copper, are present in fossils as organometallic compounds most likely derived from original eumelanin. The distribution of these compounds provides a long-lived biomarker of melanin presence and density within a range of fossilized organisms. Metal zoning patterns may be preserved long after melanosome structures have been destroyed.	[Wogelius, R. A.; Manning, P. L.; Barden, H. E.; Edwards, N. P.; Larson, P. L.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England; [Wogelius, R. A.; Manning, P. L.; Barden, H. E.; Edwards, N. P.] Univ Manchester, Williamson Res Ctr Mol Environm Sci, Manchester M13 9PL, Lancs, England; [Manning, P. L.; You, H.] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA; [Webb, S. M.] SSRL, SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Sellers, W. I.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Taylor, K. G.] Manchester Metropolitan Univ, Sch Sci & Environm, Manchester M1 5GD, Lancs, England; [Larson, P. L.] Black Hills Inst Geol Res, Hill City, SD 57745 USA; [Dodson, P.] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [You, H.] Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China; [Da-Qing, L.] Gansu Geol Museum, Lanzhou 730030, Gansu, Peoples R China; [Bergmann, U.] Linac Coherent Light Source, SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA	University of Manchester; University of Manchester; University of Pennsylvania; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Manchester; Manchester Metropolitan University; University of Pennsylvania; Chinese Academy of Geological Sciences; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Wogelius, RA (corresponding author), Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England.	roy.wogelius@manchester.ac.uk	Wogelius, Roy/C-4917-2008; Manning, Phillip/F-9966-2011; Sellers, William Irvin/Q-3843-2019; Webb, Samuel M/D-4778-2009	Manning, Phillip/0000-0002-7161-6246; Sellers, William Irvin/0000-0002-2913-5406; Webb, Samuel M/0000-0003-1188-0464; Taylor, Kevin/0000-0001-7024-5001; Wogelius, Roy/0000-0002-5781-2152; You, Hai-Lu/0000-0003-2203-6461	Natural Environment Research Council	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Samples were provided by the Black Hills Institute Museum and the Museum fur Naturkunde, Humboldt University, Berlin. We thank D. Schwarz-Wings for making the Archaeopteryx sample available. We also thank Perkin-Elmer, M. George, K. Palmer, E. Kaxiras, V. Vishnyakov, and R. Morton for technical assistance and additional data, and D. Vaughan, G. Brown, and three reviewers for helpful comments on the manuscript. Portions of this research were carried out at SSRL, a national user facility operated by Stanford University on behalf of the U. S. Department of Energy, Office of Basic Energy Sciences. Funding was provided in part by a Natural Environment Research Council Envirosync grant and by an anonymous private donor. R. Hartley provided the artist's drawing of C. sanctus. Data described in this paper are presented within the SOM. R. A. W. wrote the manuscript, analyzed the data, and supervised or assisted in all analyses. P. L. M. cowrote the manuscript and assisted in all analyses. H. E. B., N.P.E., and W. I. S. assisted in all analyses and contributed to the manuscript. S. M. W. performed the EXAFS analyses. K. G. T. provided and supervised VP-FEG-SEM analyses. P. L. L. provided specimen access and identification and also assisted with all x-ray measurements. P. D. consulted on the manuscript, and along with H.Y. and L. D. assisted in field collection, preparation, and identification of samples. U. B. supervised the SRS-XRF program and assisted in manuscript preparation.	Bergmann U, 2010, P NATL ACAD SCI USA, V107, P9060, DOI 10.1073/pnas.1001569107; BOWNESS JM, 1952, BIOCHEM J, V51, P530, DOI 10.1042/bj0510530; Cheah SF, 2000, AM MINERAL, V85, P118, DOI 10.2138/am-2000-0113; Clarke JA, 2010, SCIENCE, V330, P954, DOI 10.1126/science.1193604; EDWARDS NP, P R SOC B, DOI DOI 10.1098/RSPB.2011.0135; Frenkel AI, 1999, J SYNCHROTRON RADIAT, V6, P653, DOI 10.1107/S0909049598015180; HELZ GR, 1993, GEOCHIM COSMOCHIM AC, V57, P15, DOI 10.1016/0016-7037(93)90464-8; Hill G. E., 2006, BIRD COLORATION, VI; Hou LH, 1999, NATURE, V399, P679, DOI 10.1038/21411; Katsikini M, 2009, J PHYS CONF SER, V190, DOI 10.1088/1742-6596/190/1/012204; Kaxiras E, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.218102; LARSSON BS, 1993, PIGM CELL RES, V6, P127, DOI 10.1111/j.1600-0749.1993.tb00591.x; Li QG, 2010, SCIENCE, V327, P1369, DOI 10.1126/science.1186290; Liu Y, 2004, PIGM CELL RES, V17, P262, DOI 10.1111/j.1600-0749.2004.00140.x; Liu Y, 2003, PIGM CELL RES, V16, P72, DOI 10.1034/j.1600-0749.2003.00009.x; McGraw KJ, 2003, OIKOS, V102, P402; Niecke M, 1999, J ORNITHOL, V140, P355, DOI 10.1007/BF01651032; PALUMBO A, 1988, BIOCHIM BIOPHYS ACTA, V964, P193, DOI 10.1016/0304-4165(88)90166-3; RALPH CL, 1969, AM ZOOL, V9, P521; Simon JD, 2009, PIGM CELL MELANOMA R, V22, P563, DOI 10.1111/j.1755-148X.2009.00610.x; Stainsack J, 2003, INORG CHIM ACTA, V356, P243, DOI 10.1016/S0020-1693(03)00474-2; WILLIER B. H., 1940, PHYSIOLOGICAL ZOOLOGY, V13, P177; You HL, 2006, SCIENCE, V312, P1640, DOI 10.1126/science.1126377; Zhang FC, 2010, NATURE, V463, P1075, DOI 10.1038/nature08740	24	117	119	1	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2011	333	6049					1622	1626		10.1126/science.1205748	http://dx.doi.org/10.1126/science.1205748			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21719643				2022-12-01	WOS:000294900900041
J	Joron, M; Frezal, L; Jones, RT; Chamberlain, NL; Lee, SF; Haag, CR; Whibley, A; Becuwe, M; Baxter, SW; Ferguson, L; Wilkinson, PA; Salazar, C; Davidson, C; Clark, R; Quail, MA; Beasley, H; Glithero, R; Lloyd, C; Sims, S; Jones, MC; Rogers, J; Jiggins, CD; Ffrench-Constant, RH				Joron, Mathieu; Frezal, Lise; Jones, Robert T.; Chamberlain, Nicola L.; Lee, Siu F.; Haag, Christoph R.; Whibley, Annabel; Becuwe, Michel; Baxter, Simon W.; Ferguson, Laura; Wilkinson, Paul A.; Salazar, Camilo; Davidson, Claire; Clark, Richard; Quail, Michael A.; Beasley, Helen; Glithero, Rebecca; Lloyd, Christine; Sims, Sarah; Jones, Matthew C.; Rogers, Jane; Jiggins, Chris D.; Ffrench-Constant, Richard H.			Chromosomal rearrangements maintain a polymorphic supergene controlling butterfly mimicry	NATURE			English	Article							GENE FLOW; PAPILIO-DARDANUS; EVOLUTION; SEQUENCE; INVERSIONS; LINKAGE; VISTA	Supergenes are tight clusters of loci that facilitate the co-segregation of adaptive variation, providing integrated control of complex adaptive phenotypes(1). Polymorphic supergenes, in which specific combinations of traits are maintained within a single population, were first described for 'pin' and 'thrum' floral types in Primula(1) and Fagopyrum(2), but classic examples are also found in insect mimicry(3-5) and snail morphology(6). Understanding the evolutionary mechanisms that generate these co-adapted gene sets, as well as the mode of limiting the production of unfit recombinant forms, remains a substantial challenge(7-10). Here we show that individual wing-pattern morphs in the polymorphic mimetic butterfly Heliconius numata are associated with different genomic rearrangements at the supergene locus P. These rearrangements tighten the genetic linkage between at least two colour-pattern loci that are known to recombine in closely related species(9-11), with complete suppression of recombination being observed in experimental crosses across a 400-kilobase interval containing at least 18 genes. In natural populations, notable patterns of linkage disequilibrium (LD) are observed across the entire P region. The resulting divergent haplotype clades and inversion breakpoints are found in complete association with wing-pattern morphs. Our results indicate that allelic combinations at known wing-patterning loci have become locked together in a polymorphic rearrangement at the P locus, forming a supergene that acts as a simple switch between complex adaptive phenotypes found in sympatry. These findings highlight how genomic rearrangements can have a central role in the coexistence of adaptive phenotypes involving several genes acting in concert, by locally limiting recombination and gene flow.	[Joron, Mathieu; Frezal, Lise; Whibley, Annabel] CNRS, Museum Natl Hist Nat, UMR 7205, F-75005 Paris, France; [Joron, Mathieu; Becuwe, Michel] Univ Edinburgh, Inst Evolutionary Biol, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland; [Joron, Mathieu] Leiden Univ, Inst Biol, NL-2300 RA Leiden, Netherlands; [Jones, Robert T.; Chamberlain, Nicola L.; Wilkinson, Paul A.; Ffrench-Constant, Richard H.] Univ Exeter, Sch Biosci, Ctr Ecol & Conservat, Penryn TR10 9EZ, Cornwall, England; [Lee, Siu F.] Univ Melbourne, Inst Bio21, Dept Genet, Parkville, Vic 3010, Australia; [Haag, Christoph R.] Univ Fribourg, Dept Ecol & Evolut Biol, CH-1700 Fribourg, Switzerland; [Baxter, Simon W.; Ferguson, Laura; Jiggins, Chris D.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Salazar, Camilo] NAOS Isl, Smithsonian Trop Res Inst, Panama City, Panama; [Davidson, Claire; Clark, Richard; Quail, Michael A.; Beasley, Helen; Glithero, Rebecca; Lloyd, Christine; Sims, Sarah; Jones, Matthew C.; Rogers, Jane] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of Edinburgh; Leiden University; Leiden University - Excl LUMC; University of Exeter; University of Melbourne; University of Fribourg; University of Cambridge; Smithsonian Institution; Smithsonian Tropical Research Institute; Wellcome Trust Sanger Institute	Joron, M (corresponding author), CNRS, Museum Natl Hist Nat, UMR 7205, CP50,45 Rue Buffon, F-75005 Paris, France.	joron@mnhn.fr	Whibley, Annabel/P-2509-2017; Jiggins, Chris/T-4296-2019; Haag, Christoph/B-6488-2009; Jiggins, Chris D/B-9960-2008; Quail, michael/ABE-6131-2020; GenePool, The/D-8812-2012; Lee, Siu Fai/L-4690-2018; Joron, Mathieu/C-9178-2009; C, Salazar/A-1647-2010; Frezal, Lise Helene/AAC-1783-2020; Whibley, Annabel/G-2836-2011	Whibley, Annabel/0000-0003-1878-7705; Jiggins, Chris/0000-0002-7809-062X; Haag, Christoph/0000-0002-8817-1431; Jiggins, Chris D/0000-0002-7809-062X; Joron, Mathieu/0000-0003-1043-4147; C, Salazar/0000-0001-9217-6588; Frezal, Lise Helene/0000-0002-6518-0423; Baxter, Simon/0000-0001-5773-6578; Lee, Siu Fai/0000-0001-6234-4819; ffrench-Constant, Richard/0000-0001-5385-9888; Jones, Robert/0000-0001-6421-0881; Davidson, Claire/0000-0002-4910-8202	CNRS; EMBO [ALTF-431-2004]; Royal Society [516002.K5917/ROG]; European Research Council; BBSRC [BBE0118451]; Leverhulme Trust [F/00144AY)]; Leverhulme Research Leadership grant; BBSRC [BB/E006191/1, BB/H014268/1, BB/E008836/1] Funding Source: UKRI; MRC [G0900740] Funding Source: UKRI; NERC [NBAF010003] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H014268/1, BB/E006191/1, BB/E008836/1] Funding Source: researchfish; Medical Research Council [G0900740] Funding Source: researchfish; Natural Environment Research Council [NBAF010003, NE/D000114/2] Funding Source: researchfish	CNRS(Centre National de la Recherche Scientifique (CNRS)); EMBO(European Molecular Biology Organization (EMBO)); Royal Society(Royal Society of London); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust(Leverhulme Trust); Leverhulme Research Leadership grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank M. Blaxter and D. Charlesworth for advice throughout the study; The GenePool and S. Humphray for DNA sequencing; S. Kumar and A. Papanicolaou for bioinformatics support; M. Beltran, A. Bulski, M. Veuille and the Botanique-Entomologie-Mycologie molecular facility (BoEM) for laboratory support; S. Johnston for genome-size estimates in H. numata; D. Obbard for providing R scripts; M. Abanto, S. Gallusser, C. Ramirez, L. de Silva, J. Barbut, B. Gilles and G. Lamas for help with butterfly rearing, fieldwork and collecting permits; and the Peruvian National Institute of Natural Resources (INRENA) for granting collecting and export permits (076-2007-INRENA-IFFS-DCB). Fieldwork in French Guiana was supported by a CNRS 'Nouragues Research Grant'. This work was supported by an EMBO long-term fellowship (ALTF-431-2004), EMBO-matching funds from NWO (Netherlands), a Royal Society University Research Fellowship (516002.K5917/ROG), a CNRS grant (ATIP Biodiversite 2008, France) and a European Research Council Starting Grant (ERC-Stg 'MimEvol') to M. J., a BBSRC grant (BBE0118451) to C. D. J. and R.H.ff.-C., a Leverhulme Trust grant (F/00144AY) to R.H.ff.-C., and a Royal Society University Research Fellowship and a Leverhulme Research Leadership grant to C. D. J.	Alvarez G, 1997, GENETICS, V146, P717; Baxter SW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000794; BROWN K S JR, 1974, Biotropica, V6, P205, DOI 10.2307/2989666; BROWN K S JR, 1976, Transactions of the American Entomological Society (Philadelphia), V102, P373; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Chamberlain NL, 2009, SCIENCE, V326, P847, DOI 10.1126/science.1179141; CHARLESWORTH D, 1975, J THEOR BIOL, V55, P305, DOI 10.1016/S0022-5193(75)80082-8; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Clark R, 2008, P R SOC B, V275, P1181, DOI 10.1098/rspb.2007.1762; CLARKE CA, 1968, PHILOS T ROY SOC B, V254, P37, DOI 10.1098/rstb.1968.0013; Counterman BA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000796; DOBZHANSKY T, 1947, GENETICS, V32, P142; Ferguson L, 2010, MOL ECOL, V19, P240, DOI 10.1111/j.1365-294X.2009.04475.x; Forster P, 2001, MOL BIOL EVOL, V18, P1864, DOI 10.1093/oxfordjournals.molbev.a003728; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Garber RJ, 1927, J AGRIC RES, V34, P0181; Hatadani LM, 2004, HEREDITY, V93, P525, DOI 10.1038/sj.hdy.6800544; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; HUDSON RR, 1992, GENETICS, V132, P583; Jones RT, 2012, P ROY SOC B-BIOL SCI, V279, P316, DOI 10.1098/rspb.2011.0882; Joron M, 1999, EVOL ECOL, V13, P721, DOI 10.1023/A:1010875213123; Joron M, 2006, PLOS BIOL, V4, P1831, DOI 10.1371/journal.pbio.0040303; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; Kronforst MR, 2006, P NATL ACAD SCI USA, V103, P6575, DOI 10.1073/pnas.0509685103; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lowry DB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000500; Manfield IW, 2005, J EXP BOT, V56, P1177, DOI 10.1093/jxb/eri110; MATHER K, 1950, EVOLUTION, V4, P340, DOI 10.2307/2405601; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Merrill R. M., 2010, P R SOC B, V278, P511; MURRAY J, 1973, GENETICS, V74, pS188; Nijhout HF, 2003, EVOL DEV, V5, P579, DOI 10.1046/j.1525-142X.2003.03063.x; Papa R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-345; Pinho C, 2010, ANNU REV ECOL EVOL S, V41, P215, DOI 10.1146/annurev-ecolsys-102209-144644; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Pringle EG, 2007, GENETICS, V177, P417, DOI 10.1534/genetics.107.073122; Saenko SV, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-111; Salazar C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-132; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Turner J. R. G., 1984, BIOL BUTTERFLIES, V11, P141; van't Hof AE, 2011, SCIENCE, V332, P958, DOI 10.1126/science.1203043; Zaykin DV, 2008, GENETICS, V180, P533, DOI 10.1534/genetics.108.089409	42	353	357	6	242	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2011	477	7363					203	U102		10.1038/nature10341	http://dx.doi.org/10.1038/nature10341			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816MC	21841803	Green Submitted, Green Published, Green Accepted			2022-12-01	WOS:000294603900034
J	Blaser, M				Blaser, Martin			Stop the killing of beneficial bacteria	NATURE			English	Editorial Material							HELICOBACTER-PYLORI; GUT MICROBIOTA		NYU, Dept Med, Langone Med Ctr, New York, NY 10016 USA	New York University; NYU Langone Medical Center	Blaser, M (corresponding author), NYU, Dept Med, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA.	martin.blaser@med.nyu.edu						Arnold IC, 2011, J CLIN INVEST, V121, P3088, DOI 10.1172/JCI45041; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Chen Y, 2007, ARCH INTERN MED, V167, P821, DOI 10.1001/archinte.167.8.821; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Sharland M, 2007, J ANTIMICROB CHEMOTH, V60, pI15, DOI 10.1093/jac/dkm153; Sjolund M, 2003, ANN INTERN MED, V139, P483, DOI 10.7326/0003-4819-139-6-200309160-00011	9	261	275	2	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 25	2011	476	7361					393	394		10.1038/476393a	http://dx.doi.org/10.1038/476393a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	811KT	21866137				2022-12-01	WOS:000294209400011
J	Shonkoff, JP				Shonkoff, Jack P.			Protecting Brains, Not Simply Stimulating Minds	SCIENCE			English	Editorial Material							STRESS REACTIVITY; SELF-REGULATION; PRESCHOOL; BEHAVIOR; CHILDREN	Curricular enhancements in early childhood education that are guided by the science of learning must be augmented by protective interventions informed by the biology of adversity. The same neuroplasticity that leaves emotional regulation, behavioral adaptation, and executive functioning skills vulnerable to early disruption by stressful environments also enables their successful development through focused interventions during sensitive periods in their maturation. The early childhood field should therefore combine cognitive-linguistic enrichment with greater attention to preventing, reducing, or mitigating the consequences of significant adversity on the developing brain. Guided by this enhanced theory of change, scientists, practitioners, and policy-makers must work together to design, implement, and evaluate innovative strategies to produce substantially greater impacts than those achieved by existing programs.	Harvard Univ, Ctr Dev Child, Cambridge, MA 02138 USA	Harvard University	Shonkoff, JP (corresponding author), Harvard Univ, Ctr Dev Child, 50 Church St, Cambridge, MA 02138 USA.	jack_shonkoff@harvard.edu						[Anonymous], 2009, SOCIAL POLICY REPORT, DOI DOI 10.1002/J.2379-3988.2009.TB00061.X; Barr CS, 2004, ARCH GEN PSYCHIAT, V61, P1146, DOI 10.1001/archpsyc.61.11.1146; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Boutelle K., 2009, LEARNING DISABILITIE, V24, P204, DOI [10.1111/j.1540-5826.2009.00294.x, DOI 10.1111/J.1540-5826.2009.00294.X]; Clements DH, 2007, J RES MATH EDUC, V38, P136, DOI 10.2307/30034954; Diamond A, 2007, SCIENCE, V318, P1387, DOI 10.1126/science.1151148; Fox SE, 2010, CHILD DEV, V81, P28, DOI 10.1111/j.1467-8624.2009.01380.x; Gelman R., 2009, PRESCHOOL PATHWAYS S; Gilliam WS, 2006, INFANT YOUNG CHILD, V19, P228, DOI 10.1097/00001163-200607000-00007; Hamre BK, 2004, EARLY CHILD RES Q, V19, P297, DOI 10.1016/j.ecresq.2004.04.006; Karoly LA., 2005, EARLY CHILDHOOD INTE; Loman MM, 2010, NEUROSCI BIOBEHAV R, V34, P867, DOI 10.1016/j.neubiorev.2009.05.007; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Nachmias M, 1996, CHILD DEV, V67, P508, DOI 10.2307/1131829; Olfson M, 2010, J AM ACAD CHILD PSY, V49, P13, DOI 10.1016/j.jaac.2009.09.003; Pine DS, 1999, BIOL PSYCHIAT, V46, P1555, DOI 10.1016/S0006-3223(99)00115-8; Raver CC, 2011, CHILD DEV, V82, P362, DOI 10.1111/j.1467-8624.2010.01561.x; Raver CC, 2004, CHILD DEV, V75, P346, DOI 10.1111/j.1467-8624.2004.00676.x; Rimm-Kaufman SE, 2000, EARLY CHILD RES Q, V15, P147, DOI 10.1016/S0885-2006(00)00049-1; Shonkoff J., 2000, NEURONS NEIGHBOURHOO; Shonkoff JP, 2010, NEURON, V67, P689, DOI 10.1016/j.neuron.2010.08.032; Shonkoff JP, 2010, CHILD DEV, V81, P357, DOI 10.1111/j.1467-8624.2009.01399.x; Sotres-Bayon F, 2004, LEARN MEMORY, V11, P525, DOI 10.1101/lm.79504	23	156	165	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 19	2011	333	6045					982	983		10.1126/science.1206014	http://dx.doi.org/10.1126/science.1206014			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	808TD	21852492				2022-12-01	WOS:000294000400046
J	Freedman, ND; Silverman, DT; Hollenbeck, AR; Schatzkin, A; Abnet, CC				Freedman, Neal D.; Silverman, Debra T.; Hollenbeck, Albert R.; Schatzkin, Arthur; Abnet, Christian C.			Association Between Smoking and Risk of Bladder Cancer Among Men and Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACTIVE CIGARETTE-SMOKING; LUNG-CANCER; REPRODUCTIVE FACTORS; POOLED ANALYSIS; UNITED-STATES; COHORT; POPULATION; METAANALYSIS; OCCUPATION; MORTALITY	Context Previous studies indicate that the population attributable risk (PAR) of bladder cancer for tobacco smoking is 50% to 65% in men and 20% to 30% in women and that current cigarette smoking triples bladder cancer risk relative to never smoking. During the last 30 years, incidence rates have remained stable in the United States in men (123.8 per 100 000 person-years to 142.2 per 100 000 person-years) and women (32.5 per 100 000 person-years to 33.2 per 100 000 person-years); however, changing smoking prevalence and cigarette composition warrant revisiting risk estimates for smoking and bladder cancer. Objective To evaluate the association between tobacco smoking and bladder cancer. Design, Setting, and Participants Men (n=281 394) and women (n=186 134) of the National Institutes of Health-AARP (NIH-AARP) Diet and Health Study cohort completed a lifestyle questionnaire and were followed up between October 25, 1995, and December 31, 2006. Previous prospective cohort studies of smoking and incident bladder cancer were identified by systematic review and relative risks were estimated from fixed-effects models with heterogeneity assessed by the I-2 statistic. Main Outcome Measures Hazard ratios (HRs), PARs, and number needed to harm (NNH). Results During 4 518 941 person-years of follow-up, incident bladder cancer occurred in 3896 men (144.0 per 100 000 person-years) and 627 women (34.5 per 100 000 person-years). Former smokers (119.8 per 100 000 person-years; HR, 2.22; 95% confidence interval [CI], 2.03-2.44; NNH, 1250) and current smokers (177.3 per 100 000 person-years; HR, 4.06; 95% CI, 3.66-4.50; NNH, 727) had higher risks of bladder cancer than never smokers (39.8 per 100 000 person-years). In contrast, the summary risk estimate for current smoking in 7 previous studies (initiated between 1963 and 1987) was 2.94 (95% CI, 2.45-3.54; I-2=0.0%). The PAR for ever smoking in our study was 0.50 (95% CI, 0.45-0.54) in men and 0.52 (95% CI, 0.45-0.59) in women. Conclusion Compared with a pooled estimate of US data from cohorts initiated between 1963 and 1987, relative risks for smoking in the more recent NIH-AARP Diet and Health Study cohort were higher, with PARs for women comparable with those for men.	[Freedman, Neal D.; Silverman, Debra T.; Schatzkin, Arthur; Abnet, Christian C.] NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Rockville, MD 20852 USA; [Hollenbeck, Albert R.] AARP, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Association of Retired Persons (AARP)	Freedman, ND (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, 6120 Execut Blvd,EPS 320,MSC 7232, Rockville, MD 20852 USA.	freedmanne@mail.nih.gov	Freedman, Neal David/B-9741-2015; Hollenbeck, Albert/AAG-9461-2020; Abnet, Christian C/C-4111-2015	Freedman, Neal David/0000-0003-0074-1098; Abnet, Christian C/0000-0002-3008-7843	National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics; Florida Department of Health; NATIONAL CANCER INSTITUTE [ZIACP010196] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Florida Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics. Cancer incidence data from Arizona were collected by the Arizona Cancer Registry; from Georgia by the Georgia Center for Cancer Statistics; from California by the California Department of Health Services, Cancer Surveillance Section; from Michigan by the Michigan Cancer Surveillance Program; from Florida by the Florida Cancer Data System under contract to the Florida Department of Health; from Louisiana by the Louisiana Tumor Registry; from New Jersey by the New Jersey State Cancer Registry; from North Carolina by the North Carolina Central Cancer Registry; from Pennsylvania by the Division of Health Statistics and Research, Pennsylvania Department of Health; and from Texas by the Texas Cancer Registry.	Alberg AJ, 2007, AM J EPIDEMIOL, V165, P660, DOI 10.1093/aje/kwk047; [Anonymous], INT TOOL ACC SEER CA; Assaf AR, 2002, J WOMEN HEALTH GEN-B, V11, P899, DOI 10.1089/154099902762203731; Baris D, 2009, JNCI-J NATL CANCER I, V101, P1553, DOI 10.1093/jnci/djp361; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Brennan P, 2000, INT J CANCER, V86, P289, DOI 10.1002/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO;2-M; Breslow N E, 1980, IARC Sci Publ, P5; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Butler TL, 2008, INT J EPIDEMIOL, V37, P260, DOI 10.1093/ije/dym165; Cantwell MM, 2006, INT J CANCER, V119, P2398, DOI 10.1002/ijc.22175; Chyou P H, 1993, Ann Epidemiol, V3, P211; Colt JS, 2004, CANCER CAUSE CONTROL, V15, P759, DOI 10.1023/B:CACO.0000043426.28741.a2; Cook MB, 2009, CANCER EPIDEM BIOMAR, V18, P1174, DOI 10.1158/1055-9965.EPI-08-1118; COX DR, 1972, J R STAT SOC B, V34, P187; D'Avanzo Barbara, 1995, Annals of Epidemiology, V5, P427, DOI 10.1016/1047-2797(95)00057-7; Davis-Dao CA, 2011, CANCER EPIDEM BIOMAR, V20, P1156, DOI 10.1158/1055-9965.EPI-11-0017; Devesa SS, 2005, INT J CANCER, V117, P294, DOI 10.1002/ijc.21183; Dryson E, 2008, INT J CANCER, V122, P1340, DOI 10.1002/ijc.23194; Dube S. R., 2010, Morbidity and Mortality Weekly Report, V59, P1135; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Freedman ND, 2008, LANCET ONCOL, V9, P649, DOI 10.1016/S1470-2045(08)70154-2; Fritz A., 2000, INT CLASSIFICATION D; Fuchs CS, 1996, ARCH INTERN MED, V156, P2255, DOI 10.1001/archinte.156.19.2255; Gallicchio L, 2006, PREV MED, V42, P200, DOI 10.1016/j.ypmed.2005.12.014; Garrett Bridgette E., 2011, Morbidity and Mortality Weekly Report, V60, P109; HARTGE P, 1990, J NATL CANCER I, V82, P1636, DOI 10.1093/jnci/82.20.1636; HARTGE P, 1987, J NATL CANCER I, V78, P1119; Hemelt M, 2009, INT J CANCER, V124, P412, DOI 10.1002/ijc.23856; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoffmann D, 2001, CHEM RES TOXICOL, V14, P767, DOI 10.1021/tx000260u; Hotaling J, 2010, J UROLOGY, V183, pE449, DOI 10.1016/j.juro.2010.02.660; IARC, 2004, IARC MON EV CARC RIS, V83; Jemal A, 2003, INT J CANCER, V105, P101, DOI 10.1002/ijc.11020; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.3322/caac.20105]; Limsui D, 2010, JNCI-J NATL CANCER I, V102, P1012, DOI 10.1093/jnci/djq201; McGrath M, 2006, AM J EPIDEMIOL, V163, P236, DOI 10.1093/aje/kwj028; Michaud D., 2005, J REGISTRY MANAGE, V32, P70; Michaud DS, 2001, EPIDEMIOLOGY, V12, P719, DOI 10.1097/00001648-200111000-00022; MILLS PK, 1991, AM J EPIDEMIOL, V133, P230, DOI 10.1093/oxfordjournals.aje.a115867; Moore SC, 2008, INT J OBESITY, V32, P730, DOI 10.1038/sj.ijo.0803801; MUNGER RG, 1992, AM J EPIDEMIOL, V136, P192, DOI 10.1093/oxfordjournals.aje.a116485; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PETITTI DB, 1981, AM J PUBLIC HEALTH, V71, P308, DOI 10.2105/AJPH.71.3.308; Puente D, 2006, CANCER CAUSE CONTROL, V17, P71, DOI 10.1007/s10552-005-0389-0; RIMM EB, 1995, BRIT MED J, V310, P555, DOI 10.1136/bmj.310.6979.555; Rodriguez BL, 1996, CIRCULATION, V94, P952, DOI 10.1161/01.CIR.94.5.952; Rodriguez BL, 2002, STROKE, V33, P230, DOI 10.1161/hs0102.101081; Samanic CM, 2008, OCCUP ENVIRON MED, V65, P347, DOI 10.1136/oem.2007.035816; Samanic C, 2006, CANCER EPIDEM BIOMAR, V15, P1348, DOI 10.1158/1055-9965.EPI-06-0021; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; Silverman DT, 2006, CANC EPIDEMIOLOGY PR, V3, P1101; Spiegelman D, 2007, CANCER CAUSE CONTROL, V18, P571, DOI 10.1007/s10552-006-0090-y; Thun MJ, 1997, JNCI-J NATL CANCER I, V89, P1580, DOI 10.1093/jnci/89.21.1580; Tripathi A, 2002, CANCER-AM CANCER SOC, V95, P2316, DOI 10.1002/cncr.10975; US Department of Health and Human Services, 2004, HLTH CONS SMOK REP S; Warner KE, 2005, AM J PUBLIC HEALTH, V95, P976, DOI 10.2105/AJPH.2004.046904; WYNDER EL, 1994, CANCER RES, V54, P5284	57	547	559	1	39	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 17	2011	306	7					737	745		10.1001/jama.2011.1142	http://dx.doi.org/10.1001/jama.2011.1142			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	807LP	21846855	Green Accepted, Bronze			2022-12-01	WOS:000293900000023
J	Vivante, A; Afek, A; Frenkel-Nir, Y; Tzur, D; Farfel, A; Golan, E; Chaiter, Y; Shohat, T; Skorecki, K; Calderon-Margalit, R				Vivante, Asaf; Afek, Arnon; Frenkel-Nir, Yael; Tzur, Dorit; Farfel, Alon; Golan, Eliezer; Chaiter, Yoram; Shohat, Tamy; Skorecki, Karl; Calderon-Margalit, Ronit			Persistent Asymptomatic Isolated Microscopic Hematuria in Israeli Adolescents and Young Adults and Risk for End-Stage Renal Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC KIDNEY-DISEASE; FOLLOW-UP; CHILDREN; PROTEINURIA; SCHOOLCHILDREN; EPIDEMIOLOGY; POPULATION; EXCRETION	Context Few data are available on long-term outcomes among adolescents and young adults with persistent asymptomatic isolated microscopic hematuria. Objective To evaluate the risk of end-stage renal disease (ESRD) in adolescents and young adults with persistent asymptomatic isolated microscopic hematuria. Design, Setting, and Participants Nationwide, population-based, retrospective cohort study using medical data from 1 203 626 persons aged 16 through 25 years (60% male) examined for fitness for military service between 1975 and 1997 were linked to the Israeli treated ESRD registry. Incident cases of treated ESRD from January 1, 1980, to May 31, 2010, were included. Cox proportional hazards models were used to estimate the hazard ratio (HR) of treated ESRD among those diagnosed as having persistent asymptomatic isolated microscopic hematuria. Main Outcome Measures Treated ESRD onset, defined as the date of initiation of dialysis treatment or the date of renal transplantation, whichever came first. Results Persistent asymptomatic isolated microscopic hematuria was diagnosed in 3690 of 1 203 626 eligible individuals (0.3%). During 21.88 (SD, 6.74) years of follow-up, treated ESRD developed in 26 individuals (0.70%) with and 539 (0.045%) without persistent asymptomatic isolated microscopic hematuria, yielding incidence rates of 34.0 and 2.05 per 100 000 person-years, respectively, and a crude HR of 19.5 (95% confidence interval [CI], 13.1-28.9). A multivariate model adjusted for age, sex, paternal country of origin, year of enrollment, body mass index, and blood pressure at baseline did not substantially alter the risk associated with persistent asymptomatic isolated microscopic hematuria (HR, 18.5 [95% CI, 12.4-27.6]). A substantially increased risk for treated ESRD attributed to primary glomerular disease was found for individuals with persistent asymptomatic isolated microscopic hematuria compared with those without the condition (incidence rates, 19.6 vs 0.55 per 100 000 person-years, respectively; HR, 32.4 [95% CI, 18.9-55.7]). The fraction of treated ESRD attributed to microscopic hematuria was 4.3% (95% CI, 2.9%-6.4%). Conclusion Presence of persistent asymptomatic isolated microscopic hematuria in persons aged 16 through 25 years was associated with significantly increased risk of treated ESRD for a period of 22 years, although the incidence and absolute risk remain quite low.	[Vivante, Asaf; Frenkel-Nir, Yael; Tzur, Dorit; Farfel, Alon; Chaiter, Yoram] Israeli Def Forces Med Corps, IL-52621 Tel Hashomer, Israel; [Vivante, Asaf] Edmond & Lily Safra Childrens Hosp, Talpiot Med Leadership Program, Dept Pediat, Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; [Vivante, Asaf; Afek, Arnon; Golan, Eliezer; Shohat, Tamy] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Skorecki, Karl] Technion Israel Inst Technol, Dept Nephrol, Haifa, Israel; [Skorecki, Karl] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel; [Skorecki, Karl] Technion Israel Inst Technol, Res Inst, Haifa, Israel; [Golan, Eliezer] Meir Med Ctr, Dept Nephrol & Hypertens, Kefar Sava, Israel; [Golan, Eliezer] Israel Renal Registry, Kefar Sava, Israel; [Shohat, Tamy; Calderon-Margalit, Ronit] Minist Hlth, Israel Ctr Dis Control, Jerusalem, Israel; [Calderon-Margalit, Ronit] Hadassah Hebrew Univ, Braun Sch Publ Hlth, Jerusalem, Israel; [Skorecki, Karl] Dept Nephrol, Haifa, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Hadassah University Medical Center	Vivante, A (corresponding author), Israeli Def Forces Med Corps, IL-52621 Tel Hashomer, Israel.	asafvivante@gmail.com	Hug, Balthasar L./G-1568-2010	Chaiter, Yoram/0000-0003-2058-6873				American Academy of Pediatrics, 2000, PEDIATRICS, V105, P645; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Assadi FK, 2005, PEDIATR NEPHROL, V20, P1131, DOI 10.1007/s00467-005-1928-3; Calderon-Margalit R, 2008, NEPHROL DIAL TRANSPL, V23, P659, DOI 10.1093/ndt/gfm597; Chow KM, 2004, QJM-INT J MED, V97, P739, DOI 10.1093/qjmed/hch125; Cohen RA, 2003, NEW ENGL J MED, V348, P2330, DOI 10.1056/NEJMcp012694; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; DODGE WF, 1976, J PEDIATR-US, V88, P327, DOI 10.1016/S0022-3476(76)81012-8; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; Eardley KS, 2004, QJM-INT J MED, V97, P297, DOI 10.1093/qjmed/hch049; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gordon Carrie, 2005, Adolesc Med Clin, V16, P229, DOI 10.1016/j.admecli.2004.09.005; Hogg RJ, 2009, CLIN J AM SOC NEPHRO, V4, P509, DOI 10.2215/CJN.01210308; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Israeli E, 2006, AM J HYPERTENS, V19, P708, DOI 10.1016/j.amjhyper.2006.01.012; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Kelly JD, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3021; Kovacevic Z, 2008, INT J CLIN PRACT, V62, P406, DOI 10.1111/j.1742-1241.2007.01659.x; Kumar P, 2008, CLEV CLIN J MED, V75, P227, DOI 10.3949/ccjm.75.3.227; Lee YM, 2006, ACTA PAEDIATR, V95, P849, DOI 10.1080/08035250600652005; MURAKAMI M, 1991, PEDIATR NEPHROL, V5, P50, DOI 10.1007/BF00852844; Nieuwhof C, 1996, KIDNEY INT, V49, P222, DOI 10.1038/ki.1996.30; Park YH, 2005, PEDIATR NEPHROL, V20, P1126, DOI 10.1007/s00467-005-1915-8; Practice Co Medicine A Committee BFS, 2007, PEDIATRICS, V120, P1376; Shen P, 2007, INT J CLIN PRACT, V61, P789, DOI 10.1111/j.1742-1241.2006.01159.x; SUTTON JM, 1990, JAMA-J AM MED ASSOC, V263, P2475, DOI 10.1001/jama.263.18.2475; TOPHAM PS, 1994, Q J MED, V87, P329; Tryggvason K, 2006, J AM SOC NEPHROL, V17, P813, DOI 10.1681/ASN.2005070737; Tu WH, 2010, NAT REV UROL, V7, P189, DOI 10.1038/nrurol.2010.27; VEHASKARI VM, 1979, J PEDIATR-US, V95, P676, DOI 10.1016/S0022-3476(79)80710-6; Voskarides K, 2007, J AM SOC NEPHROL, V18, P3004, DOI 10.1681/ASN.2007040444; WOOLHANDLER S, 1989, JAMA-J AM MED ASSOC, V262, P1214, DOI 10.1001/jama.262.9.1214; Yamagata K, 1996, CLIN NEPHROL, V45, P281	33	125	137	2	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 17	2011	306	7					729	736		10.1001/jama.2011.1141	http://dx.doi.org/10.1001/jama.2011.1141			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	807LP	21846854	Bronze			2022-12-01	WOS:000293900000022
J	Petersen, JM; Zielinski, FU; Pape, T; Seifert, R; Moraru, C; Amann, R; Hourdez, S; Girguis, PR; Wankel, SD; Barbe, V; Pelletier, E; Fink, D; Borowski, C; Bach, W; Dubilier, N				Petersen, Jillian M.; Zielinski, Frank U.; Pape, Thomas; Seifert, Richard; Moraru, Cristina; Amann, Rudolf; Hourdez, Stephane; Girguis, Peter R.; Wankel, Scott D.; Barbe, Valerie; Pelletier, Eric; Fink, Dennis; Borowski, Christian; Bach, Wolfgang; Dubilier, Nicole			Hydrogen is an energy source for hydrothermal vent symbioses	NATURE			English	Article							MID-ATLANTIC RIDGE; MEMBRANE-BOUND HYDROGENASE; RIFTIA-PACHYPTILA JONES; MOLECULAR-HYDROGEN; DUAL SYMBIOSIS; TUBE WORM; H-2; FLUIDS; 15-DEGREES-N; COMMUNITIES	The discovery of deep-sea hydrothermal vents in 1977 revolutionized our understanding of the energy sources that fuel primary productivity on Earth. Hydrothermal vent ecosystems are dominated by animals that live in symbiosis with chemosynthetic bacteria. So far, only two energy sources have been shown to power chemosynthetic symbioses: reduced sulphur compounds and methane. Using metagenome sequencing, single-gene fluorescence in situ hybridization, immunohistochemistry, shipboard incubations and in situ mass spectrometry, we show here that the symbionts of the hydrothermal vent mussel Bathymodiolus from the Mid-Atlantic Ridge use hydrogen to power primary production. In addition, we show that the symbionts of Bathymodiolus mussels from Pacific vents have hupL, the key gene for hydrogen oxidation. Furthermore, the symbionts of other vent animals such as the tubeworm Riftia pachyptila and the shrimp Rimicaris exoculata also have hupL. We propose that the ability to use hydrogen as an energy source is widespread in hydrothermal vent symbioses, particularly at sites where hydrogen is abundant.	[Petersen, Jillian M.; Zielinski, Frank U.; Moraru, Cristina; Amann, Rudolf; Fink, Dennis; Borowski, Christian; Dubilier, Nicole] Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; [Zielinski, Frank U.] UFZ Helmholtz Ctr Environm Res, D-04318 Leipzig, Germany; [Pape, Thomas] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28334 Bremen, Germany; [Pape, Thomas; Bach, Wolfgang] Univ Bremen, Dept Geosci, D-28334 Bremen, Germany; [Seifert, Richard] Univ Hamburg, Inst Biogeochem & Marine Chem, D-20146 Hamburg, Germany; [Hourdez, Stephane] CNRS UPMC UMR 7144, Biol Stn, Equipe Genet Adaptat Milieux Extremes, F-29682 Roscoff, France; [Girguis, Peter R.; Wankel, Scott D.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Barbe, Valerie; Pelletier, Eric] Commissariat Energie Atom Genoscope, F-91000 Evry, France; [Barbe, Valerie; Pelletier, Eric] CNRS, UMR8030, F-91000 Evry, France; [Barbe, Valerie; Pelletier, Eric] Univ Evry Val dEssone, F-91000 Evry, France	Max Planck Society; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Bremen; University of Bremen; University of Hamburg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Harvard University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Dubilier, N (corresponding author), Max Planck Inst Marine Microbiol, Celsiusstr 1, D-28359 Bremen, Germany.	ndubilie@mpi-bremen.de	Pape, Thomas/A-8138-2018; Dubilier, Nicole/I-8203-2018; Amann, Rudolf I/C-6534-2014; Bach, Wolfgang/D-3713-2017; Petersen, Jillian/K-6066-2015	Pape, Thomas/0000-0002-6872-2144; Dubilier, Nicole/0000-0002-9394-825X; Amann, Rudolf I/0000-0002-0846-7372; Bach, Wolfgang/0000-0002-3099-7142; Petersen, Jillian/0000-0002-9852-3445; Pelletier, Eric/0000-0003-4228-1712; Girguis, Peter/0000-0002-3599-8160	German Science Foundation (DFG) [1144, 60]; DFG Cluster of Excellence "The Ocean in the Earth System" at MARUM (Center for Marine Environmental Sciences); Max Planck Society	German Science Foundation (DFG)(German Research Foundation (DFG)); DFG Cluster of Excellence "The Ocean in the Earth System" at MARUM (Center for Marine Environmental Sciences); Max Planck Society(Max Planck Society)	We thank the chief scientists, and the captains and crews of the research vessels and remotely operated vehicles involved in sampling and analyses at sea. Thank you to D. Garbe-Schonberg, K. van der Heijden and J. Stecher for on-board sampling and analysis, and S. Duperron, M.-A. Cambon-Bonavita and M. Zbinden for providing samples. We acknowledge B. Friedrich and O. Lenz for the antiserum against the C. necator uptake hydrogenase, J. Milucka for help with western blots and T. Holler for culturing C. necator. S. Wetzel provided technical assistance. This work was supported by the German Science Foundation (DFG) Priority Program 1144 "From Mantle to Ocean: Energy-, Material- and Life Cycles at Spreading Axes" (publication number 60), the DFG Cluster of Excellence "The Ocean in the Earth System" at MARUM (Center for Marine Environmental Sciences), and the Max Planck Society.	Amend JP, 2001, FEMS MICROBIOL REV, V25, P175, DOI 10.1016/S0168-6445(00)00062-0; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bernhard M, 1996, J BACTERIOL, V178, P4522, DOI 10.1128/jb.178.15.4522-4529.1996; BOWIEN B, 1981, ANNU REV MICROBIOL, V35, P405, DOI 10.1146/annurev.mi.35.100181.002201; CAVANAUGH CM, 1981, SCIENCE, V213, P340, DOI 10.1126/science.213.4505.340; CAVANAUGH CM, 1987, NATURE, V325, P346, DOI 10.1038/325346a0; CHILDRESS JJ, 1986, SCIENCE, V233, P1306, DOI 10.1126/science.233.4770.1306; Constant P, 2009, SCI TOTAL ENVIRON, V407, P1809, DOI 10.1016/j.scitotenv.2008.10.064; CORLISS JB, 1979, SCIENCE, V203, P1073, DOI 10.1126/science.203.4385.1073; Csaki R, 2001, FEMS MICROBIOL LETT, V205, P203, DOI 10.1111/j.1574-6968.2001.tb10948.x; DiSpirito A. A., 2004, RESP ARCHAEA BACTERI, V2, P149; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Duperron S, 2006, ENVIRON MICROBIOL, V8, P1441, DOI 10.1111/j.1462-2920.2006.01038.x; FELBECK H, 1981, SCIENCE, V213, P336, DOI 10.1126/science.213.4505.336; Fisher CR, 2007, OCEANOGRAPHY, V20, P14, DOI 10.5670/oceanog.2007.75; FRIEDRICH B, 1993, ANNU REV MICROBIOL, V47, P351, DOI 10.1146/annurev.mi.47.100193.002031; Garrity, 2005, BERGEYS MANUAL SYSTE, P119, DOI [10.1007/0-387-28021-9_15, DOI 10.1007/0-387-28021-9_15]; Gebruk AV, 2000, J MAR BIOL ASSOC UK, V80, P383, DOI 10.1017/S0025315499002088; Haase KM, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001509; Haase KM, 2009, MAR GEOL, V266, P52, DOI 10.1016/j.margeo.2009.07.012; Hugler M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016018; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; LEPENNEC M, 1984, OCEANOL ACTA, V7, P517; LILLEY MD, 1982, NATURE, V300, P48, DOI 10.1038/300048a0; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MEYER O, 1978, ARCH MICROBIOL, V118, P35, DOI 10.1007/BF00406071; Moraru C, 2011, ENV MICROBIOL REP, V3, P69, DOI 10.1111/j.1758-2229.2010.00189.x; Moraru C, 2010, ENVIRON MICROBIOL, V12, P3057, DOI 10.1111/j.1462-2920.2010.02281.x; NELSON DC, 1995, MAR BIOL, V121, P487, DOI 10.1007/BF00349457; Ohmura N, 2002, J BACTERIOL, V184, P2081, DOI 10.1128/JB.184.8.2081-2087.2002; Olson JW, 2002, SCIENCE, V298, P1788, DOI 10.1126/science.1077123; Perner M, 2007, FEMS MICROBIOL ECOL, V61, P97, DOI 10.1111/j.1574-6941.2007.00325.x; Perner M, 2010, FEMS MICROBIOL ECOL, V74, P55, DOI 10.1111/j.1574-6941.2010.00940.x; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Petersen JM, 2010, ENVIRON MICROBIOL, V12, P2204, DOI 10.1111/j.1462-2920.2009.02129.x; Petersen JM, 2009, ENV MICROBIOL REP, V1, P319, DOI 10.1111/j.1758-2229.2009.00081.x; Punshon S, 2007, MAR CHEM, V105, P129, DOI 10.1016/j.marchem.2007.01.009; Schmidt K, 2007, CHEM GEOL, V242, P1, DOI 10.1016/j.chemgeo.2007.01.023; Schwartz E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P496, DOI 10.1007/0-387-30742-7_17; Takail K, 2006, GEOPHYS MONOGR SER, V166, P185; Tivey MK, 2007, OCEANOGRAPHY, V20, P50, DOI 10.5670/oceanog.2007.80; Tromp TK, 2003, SCIENCE, V300, P1740, DOI 10.1126/science.1085169; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Wankel SD, 2011, NAT GEOSCI, V4, P461, DOI [10.1038/NGEO1183, 10.1038/ngeo1183]; Welhan J.A., 1983, HYDROTHERMAL PROCESS, P391, DOI [10.1007/978-1-4899-0402-7_17, DOI 10.1007/978-1-4899-0402-7_17]; Wendeberg A, 2012, ISME J, V6, P104, DOI 10.1038/ismej.2011.81; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996; Zielinski FU, 2009, ENVIRON MICROBIOL, V11, P1150, DOI 10.1111/j.1462-2920.2008.01847.x	48	170	177	16	278	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2011	476	7359					176	180		10.1038/nature10325	http://dx.doi.org/10.1038/nature10325			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21833083				2022-12-01	WOS:000293731900029
J	Weber, BN; Chi, AWS; Chavez, A; Yashiro-Ohtani, Y; Yang, Q; Shestova, O; Bhandoola, A				Weber, Brittany Nicole; Chi, Anthony Wei-Shine; Chavez, Alejandro; Yashiro-Ohtani, Yumi; Yang, Qi; Shestova, Olga; Bhandoola, Avinash			A critical role for TCF-1 in T-lineage specification and differentiation	NATURE			English	Article							BETA-CATENIN; TRANSCRIPTION FACTOR; NOTCH1; CELLS; HEMATOPOIESIS; INACTIVATION; CHECKPOINT; EXPRESSION; RECEPTOR; FATE	The vertebrate thymus provides an inductive environment for T-cell development. Within the mouse thymus, Notch signals are indispensable for imposing the T-cell fate on multipotential haematopoietic progenitors, but the downstream effectors that impart T-lineage specification and commitment are not well understood. Here we show that a transcription factor, T-cell factor 1 (TCF-1; also known as transcription factor 7, T-cell specific, TCF7), is a critical regulator in T-cell specification. TCF-1 is highly expressed in the earliest thymic progenitors, and its expression is upregulated by Notch signals. Most importantly, when TCF-1 is forcibly expressed in bone marrow (BM) progenitors, it drives the development of T-lineage cells in the absence of T-inductive Notch1 signals. Further characterization of these TCF-1-induced cells revealed expression of many T-lineage genes, including T-cell-specific transcription factors Gata3 and Bcl11b, and components of the T-cell receptor. Our data suggest a model where Notch signals induce TCF-1, and TCF-1 in turn imprints the T-cell fate by upregulating expression of T-cell essential genes.	[Weber, Brittany Nicole; Chi, Anthony Wei-Shine; Chavez, Alejandro; Yashiro-Ohtani, Yumi; Yang, Qi; Shestova, Olga; Bhandoola, Avinash] Univ Penn, Dept Pathol & Lab Med, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Bhandoola, A (corresponding author), Univ Penn, Dept Pathol & Lab Med, Sch Med, 3620 Hamilton Walk, Philadelphia, PA 19104 USA.	bhandooa@mail.med.upenn.edu			NIH [AI059621]; Leukemia and Lymphoma Society;  [T32AI055428];  [T32CA09140]; NATIONAL CANCER INSTITUTE [T32CA009140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI059621, T32AI055428, R01AI059621] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank H. Clevers for permission to use TCF-1<SUP>-/-</SUP> mice and W. Pear, S. Reiner, C. Bassing, R. Sen and W. Bailis for critical comments. This work was supported by NIH grant AI059621 and a Scholar Award from the Leukemia and Lymphoma Society (A. B.), and institutional training grants T32AI055428 (B.N.W.) and T32CA09140 (A.W.-S.C.).	Brault V, 2001, DEVELOPMENT, V128, P1253; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Goux D, 2005, BLOOD, V106, P1726, DOI 10.1182/blood-2005-01-0337; Hosoya T, 2009, J EXP MED, V206, P2987, DOI 10.1084/jem.20090934; Huang J, 2009, J CLIN INVEST, V119, P3519, DOI 10.1172/JCI40572; Huang JX, 2005, J IMMUNOL, V175, P4858, DOI 10.4049/jimmunol.175.8.4858; Ikawa T, 2010, SCIENCE, V329, P93, DOI 10.1126/science.1188995; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Liu ZY, 2011, J CLIN INVEST, V121, P800, DOI 10.1172/JCI43114; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rothenberg EV, 2010, IMMUNOL REV, V238, P150, DOI 10.1111/j.1600-065X.2010.00964.x; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Schilham MW, 1998, J IMMUNOL, V161, P3984; Schmitt TM, 2006, IMMUNOL REV, V209, P95, DOI 10.1111/j.0105-2896.2006.00353.x; Schwarz BA, 2007, J IMMUNOL, V178, P2008, DOI 10.4049/jimmunol.178.4.2008; SPANGRUDE GJ, 1990, J IMMUNOL, V145, P3661; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Taghon TN, 2005, GENE DEV, V19, P965, DOI 10.1101/gad.1298305; Tago K, 2000, GENE DEV, V14, P1741; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Wendorff AA, 2010, IMMUNITY, V33, P671, DOI 10.1016/j.immuni.2010.11.014; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Yashiro-Ohtani Y, 2009, GENE DEV, V23, P1665, DOI 10.1101/gad.1793709; Yu Q, 2009, NAT IMMUNOL, V10, P992, DOI 10.1038/ni.1762	35	270	274	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2011	476	7358					63	+		10.1038/nature10279	http://dx.doi.org/10.1038/nature10279			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NR	21814277	Green Accepted			2022-12-01	WOS:000293447300029
J	Mrazek, DA; Lerman, C				Mrazek, David A.; Lerman, Caryn			Facilitating Clinical Implementation of Pharmacogenomics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mrazek, David A.] Mayo Clin, Coll Med, Dept Psychiat, Rochester, MN 55905 USA; [Mrazek, David A.] Mayo Clin, Coll Med, Dept Pediat, Rochester, MN 55905 USA; [Lerman, Caryn] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Lerman, Caryn] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA	Mayo Clinic; Mayo Clinic; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Mrazek, DA (corresponding author), Mayo Clin, Coll Med, Dept Psychiat, 200 1st St SW, Rochester, MN 55905 USA.	mrazek.david@mayo.edu	Lerman, Caryn/AHC-5180-2022		NCI NIH HHS [P50 CA143187, P50-CA143187] Funding Source: Medline; NIDA NIH HHS [R01 DA017555, U01 DA020830, U01-DA020830] Funding Source: Medline; NIGMS NIH HHS [U19 GM061388, U19-GM61388] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA143187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U19GM061388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA020830, R01DA017555] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Altman RB, 2011, CLIN PHARMACOL THER, V89, P348, DOI 10.1038/clpt.2010.310; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Kraemer HC, 2009, AM J PSYCHIAT, V166, P1222, DOI 10.1176/appi.ajp.2009.08121809; *NAT AC I MED, 2011, CLIN PRACT GUID WE C; Porcelli S, 2011, J PSYCHIATR NEUROSCI, V36, P87, DOI 10.1503/jpn.100059; Relling MV, 2011, CLIN PHARMACOL THER, V89, P464, DOI 10.1038/clpt.2010.279; Sallee FR, 2000, J CHILD ADOL PSYCHOP, V10, P27, DOI 10.1089/cap.2000.10.27; Shields AE, 2008, CLIN PHARMACOL THER, V83, P635, DOI 10.1038/clpt.2008.4; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Winner JG, 2010, ACAD PSYCHIATR, V34, P115, DOI 10.1176/appi.ap.34.2.115	10	49	49	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2011	306	3					304	305		10.1001/jama.2011.1010	http://dx.doi.org/10.1001/jama.2011.1010			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794BS	21771991	Green Accepted			2022-12-01	WOS:000292870500024
J	Collette, BB; Carpenter, KE; Polidoro, BA; Juan-Jorda, MJ; Boustany, A; Die, DJ; Elfes, C; Fox, W; Graves, J; Harrison, LR; McManus, R; Minte-Vera, CV; Nelson, R; Restrepo, V; Schratwieser, J; Sun, CL; Amorim, A; Peres, MB; Canales, C; Cardenas, G; Chang, SK; Chiang, WC; Leite, ND; Harwell, H; Lessa, R; Fredou, FL; Oxenford, HA; Serra, R; Shao, KT; Sumaila, R; Wang, SP; Watson, R; Yanez, E				Collette, B. B.; Carpenter, K. E.; Polidoro, B. A.; Juan-Jorda, M. J.; Boustany, A.; Die, D. J.; Elfes, C.; Fox, W.; Graves, J.; Harrison, L. R.; McManus, R.; Minte-Vera, C. V.; Nelson, R.; Restrepo, V.; Schratwieser, J.; Sun, C. -L.; Amorim, A.; Brick Peres, M.; Canales, C.; Cardenas, G.; Chang, S. -K.; Chiang, W. -C.; de Oliveira Leite, N., Jr.; Harwell, H.; Lessa, R.; Fredou, F. L.; Oxenford, H. A.; Serra, R.; Shao, K. -T.; Sumaila, R.; Wang, S. -P.; Watson, R.; Yanez, E.			High Value and Long Life-Double Jeopardy for Tunas and Billfishes	SCIENCE			English	Editorial Material							EXTINCTION RISK; SIZE		[Collette, B. B.] NOAA, Natl Marine Fisheries Serv, Systemat Lab, Washington, DC 20230 USA; [Carpenter, K. E.; Polidoro, B. A.; Harwell, H.] Old Dominion Univ, Norfolk, VA 23529 USA; [Juan-Jorda, M. J.] Univ A Coruna, La Coruna, Spain; [Boustany, A.] Duke Univ, Nicholas Sch Environm, Durham, NC 27706 USA; [Die, D. J.] Univ Miami, Coral Gables, FL 33124 USA; [Graves, J.] Coll William & Mary, Virginia Inst Marine Sci, Williamsburg, VA 23187 USA; [Harrison, L. R.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Minte-Vera, C. V.] Univ Estadual Maringa, Maringa, Parana, Brazil; [Sun, C. -L.] Natl Taiwan Univ, Taipei, Taiwan; [Chang, S. -K.] Natl Sun Yat Sen Univ, Kaohsiung, Taiwan; [Lessa, R.; Fredou, F. L.] Univ Fed Rural Pernambuco, Recife, PE, Brazil; [Oxenford, H. A.] Univ W Indies, Ctr Resource Management & Environm Studies, Bridgetown, Barbados; [Shao, K. -T.] Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan; [Sumaila, R.; Watson, R.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Wang, S. -P.] Natl Taiwan Ocean Univ, Chilung, Taiwan; [Yanez, E.] Pontificia Univ Catolica Valparaiso, Valparaiso, Chile	National Oceanic Atmospheric Admin (NOAA) - USA; Old Dominion University; Universidade da Coruna; Duke University; University of Miami; William & Mary; Virginia Institute of Marine Science; Simon Fraser University; Universidade Estadual de Maringa; National Taiwan University; National Sun Yat Sen University; Universidade Federal Rural de Pernambuco (UFRPE); University West Indies Mona Jamaica; University of the West Indies Open Campus; Academia Sinica - Taiwan; University of British Columbia; National Taiwan Ocean University; Pontificia Universidad Catolica de Valparaiso	Collette, BB (corresponding author), NOAA, Natl Marine Fisheries Serv, Systemat Lab, Washington, DC 20230 USA.	collettb@si.edu	Minte-Vera, Carolina/D-6326-2013; Frédou, Flávia Lucena/I-3639-2012; Collette, Bruce B./AAA-9532-2019; Juan-Jordá, Maria José/B-4542-2019; Chang, Shui-Kai/B-5038-2010; LESSA, ROSANGELA PAULA TEIXEIRA/D-5043-2013; Canales, Cristian/AAU-2779-2020; Harrison, Lucy/F-9494-2011; Sumaila, U. Rashid/ABE-6475-2020; Watson, Reg A/F-4850-2012; Minte-Vera, Carolina V/A-5461-2017; CHIANG, WEICHUAN/S-8736-2018	Frédou, Flávia Lucena/0000-0001-5492-7205; Juan-Jordá, Maria José/0000-0002-4586-2400; Chang, Shui-Kai/0000-0003-2929-1510; Watson, Reg A/0000-0001-7201-8865; Minte-Vera, Carolina V/0000-0002-0537-1519; Lessa, Rosangela/0000-0002-9217-1215; Amorim, Alberto/0000-0002-1329-2634; Canales, Cristian/0000-0002-4249-274X; Die, David/0000-0001-6504-8513				Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Cullis-Suzuki S, 2010, MAR POLICY, V34, P1036, DOI 10.1016/j.marpol.2010.03.002; Cyranoski D, 2010, NATURE, V465, P280, DOI 10.1038/465280b; De Roos AM, 2002, P NATL ACAD SCI USA, V99, P12907, DOI 10.1073/pnas.192174199; Fromentin JM, 2010, SCIENCE, V327, P1325, DOI 10.1126/science.327.5971.1325-c; ICCAT, 2010, REP STAND COMM RES S; IUCN Standards and Petitions Subcommittee, 2019, GUID US IUCN RED LIS; Kitchell JF, 2006, B MAR SCI, V79, P669; Losada S, 2010, SCIENCE, V328, P1353, DOI 10.1126/science.328.5984.1353-a; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; MacKenzie BR, 2009, CONSERV LETT, V2, P25, DOI 10.1111/j.1755-263X.2008.00039.x; Majkowski J, 2007, GLOBAL FISHERY RESOU; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Sibert J, 2006, SCIENCE, V314, P1773, DOI 10.1126/science.1135347	15	202	206	0	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2011	333	6040					291	292		10.1126/science.1208730	http://dx.doi.org/10.1126/science.1208730			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21737699				2022-12-01	WOS:000292732000024
J	Carpenter, D; Kesselheim, AS; Joffe, S				Carpenter, Daniel; Kesselheim, Aaron S.; Joffe, Steven			Reputation and Precedent in the Bevacizumab Decision	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Carpenter, Daniel] Harvard Univ, Dept Govt, Cambridge, MA 02138 USA; [Kesselheim, Aaron S.; Joffe, Steven] Harvard Univ, Sch Med, Boston, MA USA; [Kesselheim, Aaron S.] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Joffe, Steven] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Joffe, Steven] Childrens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital	Carpenter, D (corresponding author), Harvard Univ, Dept Govt, Cambridge, MA 02138 USA.		Joffe, Steven/H-3941-2019	Joffe, Steven/0000-0002-0667-7384				Carpenter D, 2010, PRINC STUD AM POLIT, P1; Mckee AE, 2010, ONCOLOGIST, V15, P13, DOI 10.1634/theoncologist.2010-S1-13; Ocana A, 2011, J CLIN ONCOL, V29, P254, DOI 10.1200/JCO.2010.32.0275; OSHAUGHNESSY J, 2010, J CLIN ONCOL S, V28, pS15	4	53	54	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2011	365	2							e3	10.1056/nejmp1107201	http://dx.doi.org/10.1056/nejmp1107201			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	791SP	21707383	Green Published			2022-12-01	WOS:000292685500006
J	Ziogas, A; Horick, NK; Kinney, AY; Lowery, JT; Domchek, SM; Isaacs, C; Griffin, CA; Moorman, PG; Edwards, KL; Hill, DA; Berg, JS; Tomlinson, GE; Anton-Culver, H; Strong, LC; Kasten, CH; Finkelstein, DM; Plon, SE				Ziogas, Argyrios; Horick, Nora K.; Kinney, Anita Y.; Lowery, Jan T.; Domchek, Susan M.; Isaacs, Claudine; Griffin, Constance A.; Moorman, Patricia G.; Edwards, Karen L.; Hill, Deirdre A.; Berg, Jonathan S.; Tomlinson, Gail E.; Anton-Culver, Hoda; Strong, Louise C.; Kasten, Carol H.; Finkelstein, Dianne M.; Plon, Sharon E.			Clinically Relevant Changes in Family History of Cancer Over Time	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BREAST-CANCER; COLORECTAL-CANCER; HIGH-RISK; INHERITANCE; ONSET; WOMEN	Context Knowledge of family cancer history is important for assessing cancer risk and guiding screening recommendations. Objective To quantify how often throughout adulthood clinically significant changes occur in cancer family history that would result in recommendations for earlier or intense screening. Design and Setting Descriptive study examining baseline and follow-up family history data from participants in the Cancer Genetics Network (CGN), a US national population-based cancer registry, between 1999 and 2009. Participants Adults with a personal history, family history, or both of cancer enrolled in the CGN through population-based cancer registries. Retrospective colorectal, breast, and prostate cancer screening-specific analyses included 9861, 2547, and 1817 participants, respectively; prospective analyses included 1533, 617, and 163 participants, respectively. Median follow-up was 8 years (range, 0-11 years). Screening-specific analyses excluded participants with the cancer of interest. Main Outcome Measures Percentage of individuals with clinically significant family histories and rate of change over 2 periods: (1) retrospectively, from birth until CGN enrollment and (2) prospectively, from enrollment to last follow-up. Results Retrospective analysis revealed that the percentages of participants who met criteria for high-risk screening based on family history at ages 30 and 50 years, respectively, were as follows: for colorectal cancer, 2.1% (95% confidence interval [CI], 1.8%-2.4%) and 7.1%(95% CI, 6.5%-7.6%); for breast cancer, 7.2%(95% CI, 6.1%-8.4%) and 11.4% (95% CI, 10.0%-12.8%); and for prostate cancer, 0.9%(95% CI, 0.5%-1.4%) and 2.0% (95% CI, 1.4%-2.7%). In prospective analysis, the numbers of participants who newly met criteria for high-risk screening based on family history per 100 persons followed up for 20 years were 2 (95% CI, 0-7) for colorectal cancer, 6 (95% CI, 2-13) for breast cancer, and 8 (95% CI, 3-16) for prostate cancer. The rate of change in cancer family history was similar for colorectal and breast cancer between the 2 analyses. Conclusion Clinically relevant family history of colorectal, breast, and prostate cancer that would result in recommendations for earlier or intense cancer screening increases between ages 30 and 50 years, although the absolute rate is low for prostate cancer. JAMA. 2011; 306(2): 172-178	[Ziogas, Argyrios; Anton-Culver, Hoda] Univ Calif Irvine, Irvine, CA 92717 USA; [Horick, Nora K.; Finkelstein, Dianne M.] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA; [Finkelstein, Dianne M.] Harvard Univ, Boston, MA 02115 USA; [Kinney, Anita Y.] Huntsman Canc Inst, Salt Lake City, UT USA; [Kinney, Anita Y.] Univ Utah, Salt Lake City, UT USA; [Lowery, Jan T.] Univ Colorado, Aurora, CO USA; [Domchek, Susan M.] Univ Penn, Philadelphia, PA 19104 USA; [Isaacs, Claudine] Georgetown Univ, Washington, DC USA; [Griffin, Constance A.] Johns Hopkins Univ, Baltimore, MD USA; [Moorman, Patricia G.] Duke Univ, Med Ctr, Durham, NC USA; [Edwards, Karen L.] Univ Washington, Seattle, WA 98195 USA; [Hill, Deirdre A.] Univ New Mexico, Albuquerque, NM 87131 USA; [Berg, Jonathan S.] Univ N Carolina, Chapel Hill, NC USA; [Tomlinson, Gail E.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Tomlinson, Gail E.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Strong, Louise C.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Plon, Sharon E.] Baylor Coll Med, Houston, TX 77030 USA; [Kasten, Carol H.] NICHHD, NIH, Bethesda, MD 20892 USA	University of California System; University of California Irvine; Harvard University; Massachusetts General Hospital; Harvard University; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Pennsylvania; Georgetown University; Johns Hopkins University; Duke University; University of Washington; University of Washington Seattle; University of New Mexico; University of North Carolina; University of North Carolina Chapel Hill; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Finkelstein, DM (corresponding author), 50 Staniford St,Ste 560, Boston, MA 02114 USA.	dfinkel-stein@partners.org	Tomlinson, Gail/AAR-9776-2020	Berg, Jonathan/0000-0003-2360-2664; Kinney, Anita/0000-0002-2996-9355	National Cancer Institute [U01CA078284, U24CA078134, U24CA078164, U24CA078156, U24CA078148, U24CA078146, U24CA078174, U24CA078157, U24CA078142, HHSN2612007440000C]; NATIONAL CANCER INSTITUTE [U01CA078284, U24CA078134, U24CA078174, U24CA078157, U24CA078164, U24CA078148, U24CA078146, U24CA078142, U24CA078156, R01CA149051] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The CGN is supported by grants U01CA078284, U24CA078134, U24CA078164, U24CA078156, U24CA078148, U24CA078146, U24CA078174, U24CA078157, and U24CA078142 and contract HHSN2612007440000C from the National Cancer Institute.	Acheson LS, 2000, GENET MED, V2, P180, DOI 10.1097/00125817-200005000-00004; Airewele G, 1998, J NATL CANCER I, V90, P543, DOI 10.1093/jnci/90.7.543; American Cancer Society, PROST CANC EARL DET; American Cancer Society, 2007, CANC FACTS FIG 2007; American Cancer Society, COL CANC EARL DET; Anton-Culver Hoda, 2003, Community Genet, V6, P171, DOI 10.1159/000078165; Bratt O, 2010, JNCI-J NATL CANCER I, V102, P1299; Burke W, 2009, AM J MED GENET A, V149A, P349, DOI 10.1002/ajmg.a.32643; BURT RW, 1995, ANNU REV MED, V46, P371; CLAUS EB, 1994, CANCER, V73, P643, DOI 10.1002/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5; FUCHS CS, 1994, NEW ENGL J MED, V331, P1669, DOI 10.1056/NEJM199412223312501; Hampel H, 2005, GASTROENTEROLOGY, V129, P415, DOI 10.1053/j.gastro.2005.05.011; Kuhl C, 2010, J CLIN ONCOL, V28, P1450, DOI 10.1200/JCO.2009.23.0839; Qureshi N, 2007, AHRQ PUBLICATION, V08-E001; Qureshi Nadeem, 2007, Evid Rep Technol Assess (Full Rep), P1; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Scheuner MT, 2010, GENET MED, V12, P726, DOI 10.1097/GIM.0b013e3181f30e9e; Sifri RD, 2002, J FAM PRACTICE, V51; Sweet KM, 2002, J CLIN ONCOL, V20, P528, DOI 10.1200/JCO.20.2.528; Tyler CV, 2006, J AM BOARD FAM MED, V19, P468, DOI 10.3122/jabfm.19.5.468; Warner E, 2008, ANN INTERN MED, V148, P671, DOI 10.7326/0003-4819-148-9-200805060-00007	21	36	37	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2011	306	2					172	178		10.1001/jama.2011.955	http://dx.doi.org/10.1001/jama.2011.955			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791CO	21750294	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000292639400024
J	Frankel, N; Erezyilmaz, DF; McGregor, AP; Wang, S; Payre, F; Stern, DL				Frankel, Nicolas; Erezyilmaz, Deniz F.; McGregor, Alistair P.; Wang, Shu; Payre, Francois; Stern, David L.			Morphological evolution caused by many subtle-effect substitutions in regulatory DNA	NATURE			English	Article							DROSOPHILA-SECHELLIA; ADAPTIVE EVOLUTION; NATURAL-SELECTION; GENE; PERSPECTIVE; DIVERGENCE; UNDERLIES; EPISTASIS; SEQUENCE; ORIGIN	Morphology evolves often through changes in developmental genes, but the causal mutations, and their effects, remain largely unknown. The evolution of naked cuticle on larvae of Drosophila sechellia resulted from changes in five transcriptional enhancers of shavenbaby (svb), a transcript of the ovo locus that encodes a transcription factor that governs morphogenesis of microtrichiae, hereafter called 'trichomes'. Here we show that the function of one of these enhancers evolved through multiple single-nucleotide substitutions that altered both the timing and level of svb expression. The consequences of these nucleotide substitutions on larval morphology were quantified with a novel functional assay. We found that each substitution had a relatively small phenotypic effect, and that many nucleotide changes account for this large morphological difference. In addition, we observed that the substitutions had non-additive effects. These data provide unprecedented resolution of the phenotypic effects of substitutions and show how individual nucleotide changes in a transcriptional enhancer have caused morphological evolution.	[Frankel, Nicolas; Erezyilmaz, Deniz F.; Wang, Shu; Stern, David L.] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; [Frankel, Nicolas; Erezyilmaz, Deniz F.; Wang, Shu; Stern, David L.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [McGregor, Alistair P.] Vet Med Univ Wien, Inst Populat Genet, A-1210 Vienna, Austria; [Payre, Francois] Univ Toulouse, F-31062 Toulouse, France; [Payre, Francois] Ctr Dev Biol, Ctr Natl Rech Sci, UMR5547, F-31062 Toulouse, France	Howard Hughes Medical Institute; Princeton University; Princeton University; University of Veterinary Medicine Vienna; Universite de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Stern, DL (corresponding author), Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA.	dstern@princeton.edu		McGregor, Alistair/0000-0002-2908-2420; Stern, David/0000-0002-1847-6483; PAYRE, Francois/0000-0002-8144-6711	Pew Charitable Trusts; Ruth L. Kirschstein National Research Service Award [F32 GM 83546-02]; Agence Nationale de la Recherche; NIH [GM063622-06A1]; NSF [IOS-0640339]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM083546, R01GM063622] Funding Source: NIH RePORTER	Pew Charitable Trusts; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de la Recherche(French National Research Agency (ANR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Davis, P. Parikh and P. Valenti for assistance with cloning and the Drosophila Species Stock Center for fly stocks. This work was supported by the Pew Charitable Trusts Latin American Fellows Program in the Biomedical Sciences Fellowship to N.F., a Ruth L. Kirschstein National Research Service Award to D. F. E. (F32 GM 83546-02), Agence Nationale de la Recherche (Blanc 2008, Netoshape) to F. P., and NIH (GM063622-06A1) and NSF (IOS-0640339) grants to D.L.S.	Akam M, 1998, INT J DEV BIOL, V42, P445; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Baines JF, 2002, MOL BIOL EVOL, V19, P989, DOI 10.1093/oxfordjournals.molbev.a004179; CARROLL SB, 1995, NATURE, V376, P479, DOI 10.1038/376479a0; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Casillas S, 2007, MOL BIOL EVOL, V24, P2222, DOI 10.1093/molbev/msm150; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Chanut-Delalande H, 2006, PLOS BIOL, V4, P1549, DOI 10.1371/journal.pbio.0040290; Davidson E. H., 2006, REGULATORY GENOME GE; Endo T, 1996, MOL BIOL EVOL, V13, P685, DOI 10.1093/oxfordjournals.molbev.a025629; Erezyilmaz DF, 2006, P NATL ACAD SCI USA, V103, P6925, DOI 10.1073/pnas.0509983103; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Gerke J, 2009, SCIENCE, V323, P498, DOI 10.1126/science.1166426; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Haygood R, 2010, P NATL ACAD SCI USA, V107, P7853, DOI 10.1073/pnas.0911249107; HOWARD KR, 1990, DEVELOPMENT, V110, P1223; Jeong S, 2008, CELL, V132, P783, DOI 10.1016/j.cell.2008.01.014; Kliman RM, 2000, GENETICS, V156, P1913; Klingler M, 1996, DEV BIOL, V177, P73, DOI 10.1006/dbio.1996.0146; Legrand D, 2009, GENETICS, V182, P1197, DOI 10.1534/genetics.108.092080; Ludwig MZ, 2005, PLOS BIOL, V3, P588, DOI 10.1371/journal.pbio.0030093; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Monterio A, 2009, PLOS BIOL, V7, P209, DOI 10.1371/journal.pbio.1000037; Moses AM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-286; Nadeau NJ, 2010, TRENDS GENET, V26, P484, DOI 10.1016/j.tig.2010.08.004; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Orr HA, 1998, GENETICS, V149, P2099; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Rebeiz M, 2009, SCIENCE, V326, P1663, DOI 10.1126/science.1178357; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; Stern D. L., 2010, EVOLUTION DEV PREDIC; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Sucena E, 2000, P NATL ACAD SCI USA, V97, P4530, DOI 10.1073/pnas.97.9.4530; Swanson CI, 2010, DEV CELL, V18, P359, DOI 10.1016/j.devcel.2009.12.026; TAJIMA F, 1993, GENETICS, V135, P599; Weatherbee, 2001, DNA DIVERSITY MOL GE; Weinreich DM, 2005, EVOLUTION, V59, P1165; Wilkins A.S., 2002, EVOLUTION DEV PATHWA; Williams TM, 2008, CELL, V134, P610, DOI 10.1016/j.cell.2008.06.052; Wittkopp PJ, 2006, HEREDITY, V97, P139, DOI 10.1038/sj.hdy.6800869; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Yuh CH, 1998, SCIENCE, V279, P1896, DOI 10.1126/science.279.5358.1896	44	142	142	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2011	474	7353					598	603		10.1038/nature10200	http://dx.doi.org/10.1038/nature10200			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21720363	Green Accepted, Green Submitted			2022-12-01	WOS:000292204300030
J	Moraes, M				Moraes, Marcia			Lessons from Brazil	NATURE			English	Editorial Material									Univ Sao Paulo, BR-05508 Sao Paulo, Brazil	Universidade de Sao Paulo	Moraes, M (corresponding author), Univ Sao Paulo, BR-05508 Sao Paulo, Brazil.	mafdmora@esalq.usp.br							0	15	15	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S25	S25		10.1038/474S025a	http://dx.doi.org/10.1038/474S025a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697841	Bronze			2022-12-01	WOS:000291939700010
J	Savage, N				Savage, Neil			The ideal biofuel	NATURE			English	Editorial Material																			0	117	119	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S9	S11		10.1038/474S09a	http://dx.doi.org/10.1038/474S09a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697843	Bronze			2022-12-01	WOS:000291939700003
J	Mutreja, A; Kim, DW; Thomson, NR; Connor, TR; Lee, JH; Kariuki, S; Croucher, NJ; Choi, SY; Harris, SR; Lebens, M; Niyogi, SK; Kim, EJ; Ramamurthy, T; Chun, J; Wood, JLN; Clemens, JD; Czerkinsky, C; Nair, GB; Holmgren, J; Parkhill, J; Dougan, G				Mutreja, Ankur; Kim, Dong Wook; Thomson, Nicholas R.; Connor, Thomas R.; Lee, Je Hee; Kariuki, Samuel; Croucher, Nicholas J.; Choi, Seon Young; Harris, Simon R.; Lebens, Michael; Niyogi, Swapan Kumar; Kim, Eun Jin; Ramamurthy, T.; Chun, Jongsik; Wood, James L. N.; Clemens, John D.; Czerkinsky, Cecil; Nair, G. Balakrish; Holmgren, Jan; Parkhill, Julian; Dougan, Gordon			Evidence for several waves of global transmission in the seventh cholera pandemic	NATURE			English	Article							VIBRIO-CHOLERAE; EL-TOR; EVOLUTION; POPULATIONS; SEQUENCES; VIETNAM; STRAINS; ELEMENT; O139	Vibrio cholerae is a globally important pathogen that is endemic in many areas of the world and causes 3-5 million reported cases of cholera every year. Historically, there have been seven acknowledged cholera pandemics; recent outbreaks in Zimbabwe and Haiti are included in the seventh and ongoing pandemic(1). Only isolates in serogroup O1 (consisting of two biotypes known as 'classical' and 'El Tor') and the derivative O139 (refs 2, 3) can cause epidemic cholera(2). It is believed that the first six cholera pandemics were caused by the classical biotype, but El Tor has subsequently spread globally and replaced the classical biotype in the current pandemic(1). Detailed molecular epidemiological mapping of cholera has been compromised by a reliance on sub-genomic regions such as mobile elements to infer relationships, making El Tor isolates associated with the seventh pandemic seem superficially diverse. To understand the underlying phylogeny of the lineage responsible for the current pandemic, we identified high-resolution markers (single nucleotide polymorphisms; SNPs) in 154 whole-genome sequences of globally and temporally representative V. cholerae isolates. Using this phylogeny, we show here that the seventh pandemic has spread from the Bay of Bengal in at least three independent but overlapping waves with a common ancestor in the 1950s, and identify several transcontinental transmission events. Additionally, we show how the acquisition of the SXT family of antibiotic resistance elements has shaped pandemic spread, and show that this family was first acquired at least ten years before its discovery in V. cholerae.	[Mutreja, Ankur; Thomson, Nicholas R.; Connor, Thomas R.; Croucher, Nicholas J.; Harris, Simon R.; Parkhill, Julian; Dougan, Gordon] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Kim, Dong Wook; Lee, Je Hee; Choi, Seon Young; Kim, Eun Jin; Clemens, John D.; Czerkinsky, Cecil] SNU Res Pk, Int Vaccine Inst, Seoul 151919, South Korea; [Kim, Dong Wook] Hanyang Univ, Coll Pharm, Dept Pharm, Kyeonggi Do 426791, South Korea; [Lee, Je Hee; Choi, Seon Young; Chun, Jongsik] Seoul Natl Univ, Seoul 151742, South Korea; [Kariuki, Samuel] KEMRI Kenyatta Hosp Compound, Ctr Microbiol Res, Nairobi, Kenya; [Lebens, Michael; Holmgren, Jan] Univ Gothenburg, Sahlgrenska Acad, Dept Microbiol & Immunol, S-40530 Gothenburg, Sweden; [Lebens, Michael; Holmgren, Jan] Univ Gothenburg, Sahlgrenska Acad, Vaccine Res Inst, S-40530 Gothenburg, Sweden; [Niyogi, Swapan Kumar; Ramamurthy, T.; Nair, G. Balakrish] Natl Inst Cholera & Enter Dis, Kolkata 700010, India; [Wood, James L. N.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England	Wellcome Trust Sanger Institute; International Vaccine Institute; Seoul National University (SNU); Hanyang University; Seoul National University (SNU); University of Gothenburg; University of Gothenburg; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); University of Cambridge	Parkhill, J (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	parkhill@sanger.ac.uk	Weinstock, George M/C-6314-2013; Connor, Thomas/ABD-6533-2021; CZERKINSKY, CECIL/G-6520-2015; Connor, Thomas/ABE-5989-2020; Harris, Simon R/K-1318-2013; Chun, Jongsik/R-8458-2017; Parkhill, Julian/G-4703-2011; Kim, Dong Wook/H-8253-2015; Wood, James/A-1626-2008; Thomson, Nicholas/P-5988-2014	Weinstock, George M/0000-0002-2997-4592; Connor, Thomas/0000-0003-2394-6504; Harris, Simon R/0000-0003-1512-6194; Chun, Jongsik/0000-0003-3385-5171; Parkhill, Julian/0000-0002-7069-5958; Kim, Dong Wook/0000-0001-5351-7597; Wood, James/0000-0002-0258-3188; Holmgren, Jan/0000-0003-1784-5918; Thomson, Nicholas/0000-0002-4432-8505; Lee, Jehee/0000-0001-9144-3648; Croucher, Nicholas/0000-0001-6303-8768; Lebens, Michael/0000-0001-9458-9474	Wellcome Trust [076964]; Government of Korea; Government of Sweden; Government of Kuwait; Ministry of Knowledge and Economy (MKE), Korea [RTI05-01-01]; Korea Science and Engineering Foundation [R01-2006-000-10255-0]; Alborada Trust; Science & Technology Directorate, Department of Homeland Security	Wellcome Trust(Wellcome Trust); Government of Korea(Korean Government); Government of Sweden; Government of Kuwait; Ministry of Knowledge and Economy (MKE), Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Alborada Trust; Science & Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS))	This work was supported by The Wellcome Trust grant 076964. The IVI is supported by the Governments of Korea, Sweden and Kuwait. D. W. K. was partially supported by grant RTI05-01-01 from the Ministry of Knowledge and Economy (MKE), Korea and by R01-2006-000-10255-0 from the Korea Science and Engineering Foundation; and J.L.N.W. was supported by the Alborada Trust and the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security. Thanks to A. Camilli at Tufts University Medical School for providing the corrected N16961 sequence, to B. M. Nguyen at NIHE, Vietnam and M. Ansaruzzaman at ICDDR, Bangladesh for providing strains, and to M. Fookes at WTSI for training support.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2010, MMWR MORB MORTAL WKL, V59, P1473; Assefa S, 2009, BIOINFORMATICS, V25, P1968, DOI 10.1093/bioinformatics/btp347; Bani S, 2007, FEMS MICROBIOL LETT, V266, P42, DOI 10.1111/j.1574-6968.2006.00518.x; Basu A, 2000, EMERG INFECT DIS, V6, P139, DOI 10.3201/eid0602.000206; Binh MN, 2009, J CLIN MICROBIOL, V47, P1568, DOI 10.1128/JCM.02040-08; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Chun J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/pnas.0907787106; Corander J, 2003, GENETICS, V163, P367; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; CVJETANOVIC B, 1972, NATURE, V239, P137, DOI 10.1038/239137a0; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Faruque SM, 2003, TRENDS MICROBIOL, V11, P505, DOI 10.1016/j.tim.2003.09.003; Faruque SM, 2000, J INFECT DIS, V182, P1161, DOI 10.1086/315807; Garriss G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000775; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Hochhut B, 1999, MOL MICROBIOL, V32, P99, DOI 10.1046/j.1365-2958.1999.01330.x; Lam C, 2010, EMERG INFECT DIS, V16, P1130, DOI 10.3201/eid1607.100131; Lee JH, 2009, J MICROBIOL, V47, P783, DOI 10.1007/s12275-009-0292-6; Nair G B, 1994, Indian J Public Health, V38, P33; O'Shea YA, 2004, MICROBIOL-SGM, V150, P4053, DOI 10.1099/mic.0.27172-0; Safa A, 2010, TRENDS MICROBIOL, V18, P46, DOI 10.1016/j.tim.2009.10.003; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Wozniak RAF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000786; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	29	445	461	3	128	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2011	477	7365					462	U111		10.1038/nature10392	http://dx.doi.org/10.1038/nature10392			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21866102	Green Accepted			2022-12-01	WOS:000295080500040
J	Park, HS; Hohn, MJ; Umehara, T; Guo, LT; Osborne, EM; Benner, J; Noren, CJ; Rinehart, J; Soll, D				Park, Hee-Sung; Hohn, Michael J.; Umehara, Takuya; Guo, Li-Tao; Osborne, Edith M.; Benner, Jack; Noren, Christopher J.; Rinehart, Jesse; Soell, Dieter			Expanding the Genetic Code of Escherichia coli with Phosphoserine	SCIENCE			English	Article							ELONGATION-FACTOR TU; DEPENDENT CYSTEINE BIOSYNTHESIS; AMINOACYL-TRANSFER-RNAS; CRYSTAL-STRUCTURE; IN-VIVO; EF-TU; ACID; PHOSPHOPROTEINS; DYNAMICS; AFFINITY	O-Phosphoserine (Sep), the most abundant phosphoamino acid in the eukaryotic phosphoproteome, is not encoded in the genetic code, but synthesized posttranslationally. Here, we present an engineered system for specific cotranslational Sep incorporation (directed by UAG) into any desired position in a protein by an Escherichia coli strain that harbors a Sep-accepting transfer RNA (tRNA(Sep)), its cognate Sep-tRNA synthetase (SepRS), and an engineered EF-Tu (EF-Sep). Expanding the genetic code rested on reengineering EF-Tu to relax its quality-control function and permit Sep-tRNA(Sep) binding. To test our system, we synthesized the activated form of human mitogen-activated ERK activating kinase 1 (MEK1) with either one or two Sep residues cotranslationally inserted in their canonical positions (Sep(218), Sep(222)). This system has general utility in protein engineering, molecular biology, and disease research.	[Osborne, Edith M.; Benner, Jack; Noren, Christopher J.] New England Biolabs Inc, Ipswich, MA 01938 USA; [Park, Hee-Sung; Hohn, Michael J.; Umehara, Takuya; Guo, Li-Tao; Soell, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Rinehart, Jesse] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Rinehart, Jesse] Yale Univ, Syst Biol Inst, West Haven, CT 06516 USA; [Soell, Dieter] Yale Univ, Dept Chem, New Haven, CT 06520 USA	New England Biolabs; Yale University; Yale University; Yale University; Yale University	Noren, CJ (corresponding author), New England Biolabs Inc, Ipswich, MA 01938 USA.	noren@neb.com; jesse.rinehart@yale.edu; dieter.soll@yale.edu	Guo, Li-Tao/C-3126-2014		NSF [MCB-0645283, MCB-0950474]; National Institute of General Medical Sciences [GM 22854]; National Research Foundation of Korea [ABC-20100029737]; National Institute of Diabetes and Digestive and Kidney Diseases [K01DK089006]; Direct For Biological Sciences [0950474] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK089006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022854, R37GM022854] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Research Foundation of Korea(National Research Foundation of Korea); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Dennis, P. O'Donoghue, and J. Ling for enthusiastic discussions. M.J.H. was a Feodor Lynen Postdoctoral Fellow of the Alexander von Humboldt Foundation (Bonn, Germany). H.-S.P. held a postdoctoral fellowship of the Korean Science Foundation. This work was supported by grants from NSF (MCB-0645283 and MCB-0950474) (to D.S.), National Institute of General Medical Sciences (GM 22854) (to D.S.), National Research Foundation of Korea (ABC-20100029737) (to H.-S.P.), and National Institute of Diabetes and Digestive and Kidney Diseases (K01DK089006) (to J.R.). Yale University holds the U.S. Patent 7,723,069 B2: "Site Specific Incorporation of Phosphoserine into Polypeptides Using Phosphoseryl-tRNA Synthetase" by D. Soll and J. Rinehart. Yale University has applied for a patent that covers the engineered EF-Tu described in this manuscript. Reagents are available under a Yale Material Transfer Agreement.	ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; Dale T, 2004, BIOCHEMISTRY-US, V43, P6159, DOI 10.1021/bi036290o; Doi Y, 2007, J AM CHEM SOC, V129, P14458, DOI 10.1021/ja075557u; Eargle J, 2008, J MOL BIOL, V377, P1382, DOI 10.1016/j.jmb.2008.01.073; Fukunaga R, 2007, NAT STRUCT MOL BIOL, V14, P272, DOI 10.1038/nsmb1219; Hohn MJ, 2006, P NATL ACAD SCI USA, V103, P18095, DOI 10.1073/pnas.0608762103; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Kamtekar S, 2007, P NATL ACAD SCI USA, V104, P2620, DOI 10.1073/pnas.0611504104; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; Ling JQ, 2007, P NATL ACAD SCI USA, V104, P15299, DOI 10.1073/pnas.0704441104; Lipmann F, 1933, BIOCHEM Z, V262, P3; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mukai T, 2010, NUCLEIC ACIDS RES, V38, P8188, DOI 10.1093/nar/gkq707; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Nozawa K, 2009, NATURE, V457, P1163, DOI 10.1038/nature07611; Ohtsuki T, 2010, J BIOCHEM, V148, P239, DOI 10.1093/jb/mvq053; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Rothman DM, 2005, J AM CHEM SOC, V127, P846, DOI 10.1021/ja043875c; Sauerwald A, 2005, SCIENCE, V307, P1969, DOI 10.1126/science.1108329; Schrader JM, 2011, P NATL ACAD SCI USA, V108, P5215, DOI 10.1073/pnas.1102128108; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; WANNER BL, 1992, FEMS MICROBIOL LETT, V79, P133; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yoshizawa S, 2009, BBA-GEN SUBJECTS, V1790, P1404, DOI 10.1016/j.bbagen.2009.03.010	26	245	257	8	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 26	2011	333	6046					1151	1154		10.1126/science.1207203	http://dx.doi.org/10.1126/science.1207203			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21868676	Green Accepted			2022-12-01	WOS:000294244300050
J	Idoyaga, J; Steinman, RM				Idoyaga, Juliana; Steinman, Ralph M.			SnapShot: Dendritic Cells	CELL			English	Editorial Material									[Idoyaga, Juliana; Steinman, Ralph M.] Rockefeller Univ, New York, NY 10065 USA	Rockefeller University	Idoyaga, J (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.		Steinman, Ralph/F-7729-2012					Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Henri S, 2010, IMMUNOL CELL BIOL, V88, P366, DOI 10.1038/icb.2010.34; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161	10	28	28	2	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 19	2011	146	4					660	U186	660.e2	10.1016/j.cell.2011.08.010	http://dx.doi.org/10.1016/j.cell.2011.08.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21854989	Green Published, Bronze			2022-12-01	WOS:000294043600020
J	Lowe, CB; Kellis, M; Siepel, A; Raney, BJ; Clamp, M; Salama, SR; Kingsley, DM; Lindblad-Toh, K; Haussler, D				Lowe, Craig B.; Kellis, Manolis; Siepel, Adam; Raney, Brian J.; Clamp, Michele; Salama, Sofie R.; Kingsley, David M.; Lindblad-Toh, Kerstin; Haussler, David			Three Periods of Regulatory Innovation During Vertebrate Evolution	SCIENCE			English	Article							PARALLEL EVOLUTION; BINDING SITES; GENOME; STICKLEBACKS; CHROMATIN; ELEMENTS	The gain, loss, and modification of gene regulatory elements may underlie a substantial proportion of phenotypic changes on animal lineages. To investigate the gain of regulatory elements throughout vertebrate evolution, we identified genome-wide sets of putative regulatory regions for five vertebrates, including humans. These putative regulatory regions are conserved nonexonic elements (CNEEs), which are evolutionarily conserved yet do not overlap any coding or noncoding mature transcript. We then inferred the branch on which each CNEE came under selective constraint. Our analysis identified three extended periods in the evolution of gene regulatory elements. Early vertebrate evolution was characterized by regulatory gains near transcription factors and developmental genes, but this trend was replaced by innovations near extracellular signaling genes, and then innovations near posttranslational protein modifiers.	[Lowe, Craig B.; Raney, Brian J.; Salama, Sofie R.; Haussler, David] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Lowe, Craig B.; Kingsley, David M.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Lowe, Craig B.; Salama, Sofie R.; Kingsley, David M.; Haussler, David] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Kellis, Manolis; Clamp, Michele; Lindblad-Toh, Kerstin] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Siepel, Adam] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden	University of California System; University of California Santa Cruz; Stanford University; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Cornell University; Uppsala University	Haussler, D (corresponding author), Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA.	haussler@soe.ucsc.edu	Kellis, Manolis/ABE-7385-2020; Salama, Sofie/K-6412-2019; Raney, Brian/ABE-6267-2020	Kellis, Manolis/0000-0001-7113-9630; Siepel, Adam/0000-0002-3557-7219; Salama, Sofie/0000-0001-6999-7193	Howard Hughes Medical Institute; NSF [CAREER-0644282, DBI-0644111]; NIH [R01-HG004037, P50- HG02568, U54-HG003067, 1U01-HG004695, 5P41-HG002371]; Sloan Foundation; European Science Foundation (EURYI); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037, P50HG002568, P41HG002371, U01HG004695, U54HG003067] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan Foundation(Alfred P. Sloan Foundation); European Science Foundation (EURYI)(European Science Foundation (ESF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Howard Hughes Medical Institute (C. B. L., S. R. S., D. M. K., D. H.), the NSF (CAREER-0644282 to M. K., DBI-0644111 to A. S.), the NIH (R01-HG004037 to M. K., P50- HG02568 to D. M. K., U54-HG003067 to K.L-T., 1U01-HG004695 to C. B. L., 5P41-HG002371to B.J.R.), the Sloan Foundation (M.K.), and the European Science Foundation (EURYI to K.L-T.).	[Anonymous], 2007, NATURE, V449, P851; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rebeiz M, 2009, SCIENCE, V326, P1663, DOI 10.1126/science.1178357; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Wu P, 2004, INT J DEV BIOL, V48, P249, DOI 10.1387/ijdb.15272390; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104	27	86	88	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2011	333	6045					1019	1024		10.1126/science.1202702	http://dx.doi.org/10.1126/science.1202702			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808TD	21852499	Green Submitted, Green Accepted			2022-12-01	WOS:000294000400056
J	Heath, I				Heath, Iona			LIFE AND DEATH Opt in not out	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIOPULMONARY-RESUSCITATION		Royal Coll Gen Practitioners, London, England		Heath, I (corresponding author), Royal Coll Gen Practitioners, London, England.	iona.heath22@yahoo.co.uk						Conroy SP, 2006, BRIT MED J, V332, P479, DOI 10.1136/bmj.332.7539.479; Guru V, 1999, CAN MED ASSOC J, V161, P1251; Mallery L, 2011, J PALLIAT CARE, V27, P12, DOI 10.1177/082585971102700104; Ramenofsky DH, FAST FACTS CONCEPTS, V179; Schaper J, 2005, CIRCULATION, V112, P6, DOI 10.1161/CIRCULATIONAHA.105.551846	5	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 17	2011	343								d5251	10.1136/bmj.d5251	http://dx.doi.org/10.1136/bmj.d5251			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	811LB	21849380				2022-12-01	WOS:000294210500008
J	Peterson, TR; Sengupta, SS; Harris, TE; Carmack, AE; Kang, SA; Balderas, E; Guertin, DA; Madden, KL; Carpenter, AE; Finck, BN; Sabatini, DM				Peterson, Timothy R.; Sengupta, Shomit S.; Harris, Thurl E.; Carmack, Anne E.; Kang, Seong A.; Balderas, Eric; Guertin, David A.; Madden, Katherine L.; Carpenter, Anne E.; Finck, Brian N.; Sabatini, David M.			mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway	CELL			English	Article							MG2+-DEPENDENT PHOSPHATIDATE PHOSPHATASE; P70 S6 KINASE; MAMMALIAN TARGET; CELL-GROWTH; LAMIN-A; MULTISITE PHOSPHORYLATION; ADIPOCYTE DIFFERENTIATION; PARTIAL LIPODYSTROPHY; BINDING PARTNER; FATTY-ACID	The nutrient-and growth factor-responsive kinase mTOR complex 1 (mTORC1) regulates many processes that control growth, including protein synthesis, autophagy, and lipogenesis. Through unknown mechanisms, mTORC1 promotes the function of SREBP, a master regulator of lipo- and sterolgenic gene transcription. Here, we demonstrate that mTORC1 regulates SREBP by controlling the nuclear entry of lipin 1, a phosphatidic acid phosphatase. Dephosphorylated, nuclear, catalytically active lipin 1 promotes nuclear remodeling and mediates the effects of mTORC1 on SREBP target gene, SREBP promoter activity, and nuclear SREBP protein abundance. Inhibition of mTORC1 in the liver significantly impairs SREBP function and makes mice resistant, in a lipin 1-dependent fashion, to the hepatic steatosis and hypercholesterolemia induced by a high-fat and -cholesterol diet. These findings establish lipin 1 as a key component of the mTORC1-SREBP pathway.	[Sabatini, David M.] MIT, Dept Biol, Koch Ctr Integrat Canc Res, Whitehead Inst Biomed Res,Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Harris, Thurl E.; Carmack, Anne E.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Guertin, David A.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Madden, Katherine L.; Carpenter, Anne E.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Finck, Brian N.] Washington Univ, Sch Med, Div Geriatr & Nutr Sci, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Virginia; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Washington University (WUSTL)	Sabatini, DM (corresponding author), MIT, Dept Biol, Koch Ctr Integrat Canc Res, Whitehead Inst Biomed Res,Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu	Carpenter, Anne/C-4982-2008; Nichols, Anne E.C./J-3150-2019	Carpenter, Anne/0000-0003-1555-8261; Nichols, Anne E.C./0000-0001-8754-7735; /0000-0002-1446-7256; Finck, Brian/0000-0001-5411-3674	National Institutes of Health [R01 AI47389, R01 CA103866]; Keck Foundation; LAM Foundation; American Diabetes Association; Jane Coffin Childs Memorial Fund;  [NIH R01 GM089652-01];  [RO1 DK078187]; NATIONAL CANCER INSTITUTE [R01CA103866, R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389, R37AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); LAM Foundation; American Diabetes Association(American Diabetes Association); Jane Coffin Childs Memorial Fund; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the following for technical assistance: We thank members of the Sabatini lab (in particular, Mathieu Laplante and Peggy Hsu), Ayce Yesilatay, and Monty Krieger for helpful discussions. D. M. S. is an investigator of the Howard Hughes Medical Institute. This work was additionally supported by grants from the National Institutes of Health (R01 AI47389 and R01 CA103866) to D. M. S.; awards from the Keck Foundation and LAM Foundation to D. M. S.; an NIH R01 GM089652-01 to A. E. C.; fellowships from the American Diabetes Association, Ludwig Cancer Fund, and Jane Coffin Childs Memorial Fund to T. R. P; and an RO1 DK078187 to B.N.F.	Abraham RT, 2008, EXPERT OPIN THER TAR, V12, P209, DOI 10.1517/14728222.12.2.209 ; Blum CB, 2002, AM J TRANSPLANT, V2, P551, DOI 10.1034/j.1600-6143.2002.20610.x; Boguslavsky RL, 2006, HUM MOL GENET, V15, P653, DOI 10.1093/hmg/ddi480; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Capanni C, 2005, HUM MOL GENET, V14, P1489, DOI 10.1093/hmg/ddi158; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Caron M, 2003, AIDS, V17, P2437, DOI 10.1097/00002030-200311210-00005; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jiang XY, 2008, AM J PATHOL, V172, P1748, DOI 10.2353/ajpath.2008.070958; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lempiainen H, 2009, MOL CELL, V33, P704, DOI 10.1016/j.molcel.2009.01.034; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Liu QS, 2010, J MED CHEM, V53, P7146, DOI 10.1021/jm101144f; Lloyd DJ, 2002, HUM MOL GENET, V11, P769, DOI 10.1093/hmg/11.7.769; MOULE SK, 1995, BIOCHEM J, V311, P595, DOI 10.1042/bj3110595; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Peterfy M, 2010, J BIOL CHEM, V285, P3857, DOI 10.1074/jbc.M109.072488; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Rehnmark S, 1998, J LIPID RES, V39, P2209; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Sharpe LJ, 2008, BIOCHEM BIOPH RES CO, V373, P670, DOI 10.1016/j.bbrc.2008.06.108; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; SINGH K, 1979, J ANTIBIOT, V32, P630, DOI 10.7164/antibiotics.32.630; Tange Y, 2002, J CELL SCI, V115, P4375, DOI 10.1242/jcs.00135; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Wilson KL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000554; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076	61	773	812	5	114	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 5	2011	146	3					408	420		10.1016/j.cell.2011.06.034	http://dx.doi.org/10.1016/j.cell.2011.06.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	803GT	21816276	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000293570500015
J	Perrachione, TK; Del Tufo, SN; Gabrieli, JDE				Perrachione, Tyler K.; Del Tufo, Stephanie N.; Gabrieli, John D. E.			Human Voice Recognition Depends on Language Ability	SCIENCE			English	Article									[Perrachione, Tyler K.; Del Tufo, Stephanie N.; Gabrieli, John D. E.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Gabrieli, John D. E.] McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Gabrieli, John D. E.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT)	Perrachione, TK (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	tkp@mit.edu; gabrieli@mit.edu	Gabrieli, John/AAJ-2869-2020	Del Tufo, Stephanie/0000-0002-2463-1785	Ellison Medical Foundation; NIH [UL1RR025758]; NSF; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank J. A. Christodoulou, E. S. Norton, B. Levy, C. Cardenas-Iniguez, J. Lymberis, P. Saxler, P. C. M. Wong, C. I. Moore, and S. Shattuck-Hufnagel. This work was supported by the Ellison Medical Foundation and NIH grant UL1RR025758. T. K. P. is supported by an NSF Graduate Research Fellowship.	Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; BRADLEY L, 1983, NATURE, V301, P419, DOI 10.1038/301419a0; Gabrieli JDE, 2009, SCIENCE, V325, P280, DOI 10.1126/science.1171999; HILLENBRAND J, 1995, J ACOUST SOC AM, V97, P3099, DOI 10.1121/1.411872; Perrachione TK, 2007, NEUROPSYCHOLOGIA, V45, P1899, DOI 10.1016/j.neuropsychologia.2006.11.015	5	122	124	33	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2011	333	6042					595	595		10.1126/science.1207327	http://dx.doi.org/10.1126/science.1207327			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21798942	Green Accepted, Green Submitted			2022-12-01	WOS:000293222400052
J	Esplugues, E; Huber, S; Gagliani, N; Hauser, AE; Town, T; Wan, YSY; O'Connor, W; Rongvaux, A; Van Rooijen, N; Haberman, AM; Iwakura, Y; Kuchroo, VK; Kolls, JK; Bluestone, JA; Herold, KC; Flavell, RA				Esplugues, Enric; Huber, Samuel; Gagliani, Nicola; Hauser, Anja E.; Town, Terrence; Wan, Yisong Y.; O'Connor, William, Jr.; Rongvaux, Anthony; Van Rooijen, Nico; Haberman, Ann M.; Iwakura, Yoichiro; Kuchroo, Vijay K.; Kolls, Jay K.; Bluestone, Jeffrey A.; Herold, Kevan C.; Flavell, Richard A.			Control of T(H)17 cells occurs in the small intestine	NATURE			English	Article							GROWTH-FACTOR-BETA; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; T-CELLS; TH17 CELLS; MONOCLONAL-ANTIBODY; T-H-17 CELLS; TGF-BETA; MICE; DIFFERENTIATION; INTERLEUKIN-10	Interleukin (IL)-17-producing T helper cells (T(H)17) are a recently identified CD4(+) T cell subset distinct from T helper type 1 (T(H)1) and T helper type 2 (T(H)2) cells(1). T(H)17 cells can drive antigen-specific autoimmune diseases and are considered the main population of pathogenic T cells driving experimental autoimmune encephalomyelitis (EAE)(2), the mouse model for multiple sclerosis. The factors that are needed for the generation of T(H)17 cells have been well characterized(3-6). However, where and how the immune system controls T(H)17 cells in vivo remains unclear. Here, by using a model of tolerance induced by CD3-specific antibody, a model of sepsis and influenza A viral infection (H1N1), we show that pro-inflammatory T(H)17 cells can be redirected to and controlled in the small intestine. T(H)17-specific IL-17A secretion induced expression of the chemokine CCL20 in the small intestine, facilitating the migration of these cells specifically to the small intestine via the CCR6/CCL20 axis. Moreover, we found that T(H)17 cells are controlled by two different mechanisms in the small intestine: first, they are eliminated via the intestinal lumen; second, pro-inflammatory T(H)17 cells simultaneously acquire a regulatory phenotype within vitro and in vivo immune-suppressive properties (rT(H)17). These results identify mechanisms limiting T(H)17 cell pathogenicity and implicate the gastrointestinal tract as a site for control of T(H)17 cells.	[Esplugues, Enric; Huber, Samuel; O'Connor, William, Jr.; Rongvaux, Anthony; Herold, Kevan C.; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Esplugues, Enric; Hauser, Anja E.] German Rheumatism Res Ctr DRFZ, D-10117 Berlin, Germany; [Esplugues, Enric] Charite, D-10117 Berlin, Germany; [Huber, Samuel] Univ Klinikum Hamburg Eppendorf, Med Klin 1, D-20246 Hamburg, Germany; [Gagliani, Nicola] San Raffaele Diabet Res Inst HSR DRI, I-20132 Milan, Italy; [Town, Terrence] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Town, Terrence] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA; [Town, Terrence] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA 90048 USA; [Wan, Yisong Y.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Van Rooijen, Nico] Vrije Univ Amsterdam, Fac Med, Dept Mol Cell Biol, NL-1081 BT Amsterdam, Netherlands; [Haberman, Ann M.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; [Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Med Expt, Tokyo 1088639, Japan; [Kuchroo, Vijay K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Kolls, Jay K.] LSU Hlth Sci Ctr, Dept Genet, New Orleans, LA 70112 USA; [Bluestone, Jeffrey A.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Flavell, Richard A.] Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Vrije Universiteit Amsterdam; Yale University; University of Tokyo; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of California System; University of California San Francisco; Howard Hughes Medical Institute	Esplugues, E (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	enric.esplugues@yale.edu; richard.flavell@yale.edu	Kolls, Jay/AAH-1829-2019; Wan, Yisong/ABE-1200-2021; Esplugues, Enric/AAD-4245-2020; Iwakura, Yoichiro/E-5457-2011; Van Rooijen, Nico/Z-1578-2019	Kolls, Jay/0000-0001-5151-6304; Wan, Yisong/0000-0003-4346-9717; Iwakura, Yoichiro/0000-0002-9934-5775; Huber, Samuel/0000-0001-9325-8227; Esplugues, Enric/0000-0002-8130-0413; Esplugues, Enric/0000-0002-9733-8707; Hauser, Anja Erika/0000-0002-7725-9526; Gagliani, Nicola/0000-0001-8514-1395	National Multiple Sclerosis Society; DFG [HU 1714/1-1]; James Hudson Brown-Alexander B. Coxe Fellowship; Spanish Ministry of Science; Transgenic Core of the Yale DERC [DK45735]; JDRF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL104601, R01HL061271, R37HL079142, R01HL062052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); DFG(German Research Foundation (DFG)); James Hudson Brown-Alexander B. Coxe Fellowship; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Transgenic Core of the Yale DERC; JDRF(Juvenile Diabetes Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank F. Manzo for expert administrative assistance, L. Evangelisti and C. Hughes for generating embryonic stem cells and chimaeric mice, respectively, J. Stein for initial screening of knock-in mice, T. Ferrandino for assistance with the mouse colony, E. Eynon and J. Alderman for managing the mouse program and A. Lin for assistance with Gene Array analysis. We also thank T. Taylor and G. Tokmoulina for expert help with the FACS sorting and D. Gonzalez for help with the multiphoton microscopy. We would like to thank J. P. Allison for providing the anti-CTLA-4 antibody, F. Waldron-Lynch and J. S. Pober for providing peripheral blood mononuclear cells, and the NIH Tetramer core facility for providing the tetramers. W.O. was supported by a fellowship from the National Multiple Sclerosis Society. S. H. was supported by the DFG (HU 1714/1-1) and by a James Hudson Brown-Alexander B. Coxe Fellowship. E. E. was supported by the Spanish Ministry of Science postdoctoral fellowship and by a James Hudson Brown-Alexander B. Coxe Fellowship. R. A. F. is an Investigator of the Howard Hughes Medical Institute. The generation of mice for this work was supported by the Transgenic Core of the Yale DERC DK45735 and some of the work supported by a Pilot project from DK45735. This work was also supported by the JDRF.	ALEGRE ML, 1995, J IMMUNOL, V155, P1544; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brown SJ, 2007, AM J GASTROENTEROL, V102, P2058, DOI 10.1111/j.1572-0241.2007.01343.x; Carpenter PA, 2000, J IMMUNOL, V165, P6205, DOI 10.4049/jimmunol.165.11.6205; Chatenoud L, 1997, J IMMUNOL, V158, P2947; Chatenoud L, 2007, NAT REV IMMUNOL, V7, P622, DOI 10.1038/nri2134; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Herold KC, 2009, CLIN IMMUNOL, V132, P166, DOI 10.1016/j.clim.2009.04.007; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Kohm AP, 2005, J IMMUNOL, V174, P4525, DOI 10.4049/jimmunol.174.8.4525; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Merger M, 2002, GUT, V51, P155, DOI 10.1136/gut.51.2.155; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Ochi A, 1993, Semin Immunol, V5, P57, DOI 10.1006/smim.1993.1008; Perruche S, 2008, NAT MED, V14, P528, DOI 10.1038/nm1749; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Petitto JM, 2000, NEUROSCI LETT, V285, P66, DOI 10.1016/S0304-3940(00)00996-4; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Rodriguez-Creixems M, 2008, MEDICINE, V87, P234, DOI 10.1097/MD.0b013e318182119b; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; SOOS JM, 1993, J NEUROIMMUNOL, V43, P39, DOI 10.1016/0165-5728(93)90073-8; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519	33	458	474	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2011	475	7357					514	U114		10.1038/nature10228	http://dx.doi.org/10.1038/nature10228			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21765430	Green Accepted, Green Submitted			2022-12-01	WOS:000293167900044
J	Xu, X; You, HL; Du, K; Han, FL				Xu, Xing; You, Hailu; Du, Kai; Han, Fenglu			An Archaeopteryx-like theropod from China and the origin of Avialae	NATURE			English	Article							EARLY EVOLUTION; BIRDS; DINOSAURS; SPECIMEN	Archaeopteryx is widely accepted as being the most basal bird, and accordingly it is regarded as central to understanding avialan origins; however, recent discoveries of derived maniraptorans have weakened the avialan status of Archaeopteryx. Here we report a new Archaeopteryx-like theropod from China. This find further demonstrates that many features formerly regarded as being diagnostic of Avialae, including long and robust forelimbs, actually characterize the more inclusive group Paraves (composed of the avialans and the deinonychosaurs). Notably, adding the new taxon into a comprehensive phylogenetic analysis shifts Archaeopteryx to the Deinonychosauria. Despite only tentative statistical support, this result challenges the centrality of Archaeopteryx in the transition to birds. If this new phylogenetic hypothesis can be confirmed by further investigation, current assumptions regarding the avialan ancestral condition will need to be re-evaluated.	[Xu, Xing] Linyi Univ, Coll Life Sci, Linyi 276005, Shandong, Peoples R China; [Xu, Xing; Han, Fenglu] Chinese Acad Sci, Key Lab Evolutionary Systemat Vertebrates, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; [You, Hailu] Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China; [Du, Kai] Capital Normal Univ, Dept Biol, Beijing 100037, Peoples R China	Linyi University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Geological Sciences; Capital Normal University	Xu, X (corresponding author), Linyi Univ, Coll Life Sci, Shuangling Rd, Linyi 276005, Shandong, Peoples R China.	xingxu@vip.sina.com		You, Hai-Lu/0000-0003-2203-6461	National Natural Science Foundation of China; Chinese Academy of Sciences; Special Funds for Major State Basic Research Projects of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Special Funds for Major State Basic Research Projects of China	The authors thank X. Zheng for permission to study the holotype specimen of Xiaotingia zhengi and for discussions; P. Chen, L. Hou and Z. Zhou for coordinating the project; C. Sullivan for editing and commenting on the manuscript; R. Li for illustrations; T. Yu for preparing the specimen; X. Ding for editing the illustrations; D. Pol for help in using the TNT software package; P. Barrett, O. Rauhut, M. Kolbl-Ebert and M. Roper for facilitating access to the Archaeopteryx specimens under their care; and G. Mayr for discussions. This work was supported by grants from the National Natural Science Foundation of China, Chinese Academy of Sciences, and Special Funds for Major State Basic Research Projects of China.	Chiappe Luis M., 1999, Bulletin of the American Museum of Natural History, V242, P1; Choiniere JN, 2010, SCIENCE, V327, P571, DOI 10.1126/science.1182143; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Feduccia A., 1999, ORIGIN EVOLUTION BIR, V2nd; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Frobisch J, 2009, P ROY SOC B-BIOL SCI, V276, P3611, DOI 10.1098/rspb.2009.0911; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Holtz Jr T. R., 2000, GAIA, V15, P5; Holtz TR, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P99; Hu DY, 2010, ACTA GEOL SIN-ENGL, V84, P472, DOI 10.1111/j.1755-6724.2010.00188.x; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Hwang SH, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)381<0001:NSOMZT>2.0.CO;2; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Makovicky PJ, 2004, DINOSAURIA, 2ND EDITION, P184; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; Maryanska T, 2002, ACTA PALAEONTOL POL, V47, P97; Mayr G, 2005, SCIENCE, V310, P1483, DOI 10.1126/science.1120331; Mayr G, 2007, ZOOL J LINN SOC-LOND, V149, P97, DOI 10.1111/j.1096-3642.2006.00245.x; Norell MA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P49; Norell MA, 2004, DINOSAURIA, 2ND EDITION, P196; Novas FE, 2004, LIFE O PAST, P150; Novas FE, 1997, NATURE, V387, P390, DOI 10.1038/387390a0; Osmolska H, 2004, DINOSAURIA, 2ND EDITION, P165; Paul G., 1988, PREDATORY DINOSAURS; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; Senter P, 2007, J SYST PALAEONTOL, V5, P429, DOI 10.1017/S1477201907002143; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Tamura K, 2011, SCIENCE, V331, P753, DOI 10.1126/science.1198229; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Wellnhofer P., 2008, ARCHAEOPTERYX URVOGE; Witmer Lawrence M., 2002, P3; Xu K., 2003, JURASSIC SYSTEM N CH, VVII; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 2002, NATURE, V415, P780, DOI 10.1038/415780a; Xu X., 2002, THESIS CHINESE ACAD; Xu X, 2009, CHINESE SCI BULL, V54, P430, DOI 10.1007/s11434-009-0009-6; Xu X, 2010, CHINESE SCI BULL, V55, P3971, DOI 10.1007/s11434-010-4150-z; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108; Zanno LE, 2009, P ROY SOC B-BIOL SCI, V276, P3505, DOI 10.1098/rspb.2009.1029; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447; Zheng X. T., 2009, ORIGIN BIRDS; Zhou ZH, 2003, CAN J EARTH SCI, V40, P731, DOI 10.1139/E03-011; Zhou ZH, 2004, NATURWISSENSCHAFTEN, V91, P455, DOI 10.1007/s00114-004-0570-4	44	175	197	2	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2011	475	7357					465	470		10.1038/nature10288	http://dx.doi.org/10.1038/nature10288			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21796204				2022-12-01	WOS:000293167900033
J	Zhou, RB; Kozlov, AG; Roy, R; Zhang, JC; Korolev, S; Lohman, TM; Ha, T				Zhou, Ruobo; Kozlov, Alexander G.; Roy, Rahul; Zhang, Jichuan; Korolev, Sergey; Lohman, Timothy M.; Ha, Taekjip			SSB Functions as a Sliding Platform that Migrates on DNA via Reptation	CELL			English	Article							SINGLE-STRANDED-DNA; COLI RECO PROTEIN; ESCHERICHIA-COLI; BINDING-PROTEIN; GENETIC-RECOMBINATION; POLYMER-CHAIN; COMPLEXES; MULTIPLE; DYNAMICS; KINETICS	SSB proteins bind to and control the accessibility of single-stranded DNA (ssDNA), likely facilitated by their ability to diffuse on ssDNA. Using a hybrid single-molecule method combining fluorescence and force, we probed how proteins with large binding site sizes can migrate rapidly on DNA and how protein-protein interactions and tension may modulate the motion. Weobserved force-induced progressive unraveling of ssDNA from the SSB surface between 1 and 6 pN, followed by SSB dissociation at similar to 10 pN, and obtained experimental evidence of a reptation mechanism for protein movement along DNA wherein a protein slides via DNA bulge formation and propagation. SSB diffusion persists even when bound with RecO and at forces under which the fully wrapped state is perturbed, suggesting that even in crowded cellular conditions SSB can act as a sliding platform to recruit and carry its interacting proteins for use in DNA replication, recombination and repair.	[Kozlov, Alexander G.; Lohman, Timothy M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Zhou, Ruobo; Roy, Rahul; Zhang, Jichuan; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Zhou, Ruobo; Roy, Rahul; Zhang, Jichuan; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Zhang, Jichuan] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Korolev, Sergey] St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA	Washington University (WUSTL); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Saint Louis University; Howard Hughes Medical Institute	Lohman, TM (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	lohman@biochem.wustl.edu; tjha@illinois.edu	Roy, Rahul/Y-5878-2019; Korolev, Sergey/ABA-7517-2020; Roy, Rahul/D-5329-2009; Ha, Taekjip/B-9506-2009	Roy, Rahul/0000-0003-3329-8803; Roy, Rahul/0000-0003-3329-8803; Ha, Taekjip/0000-0003-2195-6258; Korolev, Sergey/0000-0001-9313-7126; Zhou, Ruobo/0000-0001-8628-0282	National Institutes of Health [GM030498, GM073837, RR025341, GM065367]; National Science Foundation [0822613, 0646550]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367, R01GM073837, R01GM030498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all the members of Ha laboratory for experimental help and discussion. These studies were supported by grants from the National Institutes of Health (GM030498 to T.M.L., GM073837 to S.K., and RR025341 and GM065367 to T.H.) and the National Science Foundation (0822613 and 0646550 to T.H.). T.H. is an employee of the Howard Hughes Medical Institute.	BEARD P, 1978, CELL, V15, P955, DOI 10.1016/0092-8674(78)90279-9; Brower-Toland BD, 2002, P NATL ACAD SCI USA, V99, P1960, DOI 10.1073/pnas.022638399; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; CHRYSOGELOS S, 1982, P NATL ACAD SCI-BIOL, V79, P5803, DOI 10.1073/pnas.79.19.5803; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; DEGENNES PG, 1971, J CHEM PHYS, V55, P572, DOI 10.1063/1.1675789; Dudko OK, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.108101; Dudko OK, 2008, P NATL ACAD SCI USA, V105, P15755, DOI 10.1073/pnas.0806085105; Gorman J, 2008, NAT STRUCT MOL BIOL, V15, P768, DOI 10.1038/nsmb.1441; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Hohng S, 2007, SCIENCE, V318, P279, DOI 10.1126/science.1146113; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; Kim HD, 2002, P NATL ACAD SCI USA, V99, P4284, DOI 10.1073/pnas.032077799; Kozlov AG, 2002, BIOCHEMISTRY-US, V41, P6032, DOI 10.1021/bi020122z; Kozlov AG, 2010, J BIOL CHEM, V285, P17246, DOI 10.1074/jbc.M110.118273; Kulic IM, 2003, BIOPHYS J, V84, P3197, DOI 10.1016/S0006-3495(03)70044-7; Kulic IM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.148103; Kumaran S, 2006, BIOCHEMISTRY-US, V45, P11958, DOI 10.1021/bi060994r; Kuznetsov SV, 2006, J MOL BIOL, V359, P55, DOI 10.1016/j.jmb.2006.02.070; Lang MJ, 2002, BIOPHYS J, V83, P491, DOI 10.1016/S0006-3495(02)75185-0; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; LOHMAN TM, 1984, BIOCHEMISTRY-US, V23, P4656, DOI 10.1021/bi00315a022; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.bi.63.070194.002523; LOHMAN TM, 1986, BIOCHEMISTRY-US, V25, P21, DOI 10.1021/bi00349a004; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; LUISIDELUCA C, 1994, J MOL BIOL, V236, P124, DOI 10.1006/jmbi.1994.1123; Makharashvili N, 2004, STRUCTURE, V12, P1881, DOI 10.1016/j.str.2004.08.006; Makharashvili N, 2009, J BIOL CHEM, V284, P1425, DOI 10.1074/jbc.M806378200; Manfredi C, 2008, J BIOL CHEM, V283, P24837, DOI 10.1074/jbc.M802002200; Mihardja S, 2006, P NATL ACAD SCI USA, V103, P15871, DOI 10.1073/pnas.0607526103; Murphy MC, 2004, BIOPHYS J, V86, P2530, DOI 10.1016/S0006-3495(04)74308-8; PERKINS TT, 1994, SCIENCE, V264, P819, DOI 10.1126/science.8171335; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Ranjith P, 2007, P NATL ACAD SCI USA, V104, P13649, DOI 10.1073/pnas.0701459104; Richard DJ, 2009, CRIT REV BIOCHEM MOL, V44, P98, DOI 10.1080/10409230902849180; ROMER R, 1984, BIOCHEMISTRY-US, V23, P6132; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Roy R, 2007, J MOL BIOL, V369, P1244, DOI 10.1016/j.jmb.2007.03.079; Roy R, 2009, NATURE, V461, P1092, DOI 10.1038/nature08442; Ryzhikov M., 2011, NUCL ACIDS IN PRESS; Sakai A, 2009, J BIOL CHEM, V284, P3264, DOI 10.1074/jbc.M807220200; Schiessel H, 2001, PHYS REV LETT, V86, P4414, DOI 10.1103/PhysRevLett.86.4414; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Sukhishvili SA, 2000, NATURE, V406, P146, DOI 10.1038/35018166; UMEZU K, 1994, J BIOL CHEM, V269, P30005	51	130	133	1	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 22	2011	146	2					222	232		10.1016/j.cell.2011.06.036	http://dx.doi.org/10.1016/j.cell.2011.06.036			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	795XS	21784244	Bronze, Green Accepted			2022-12-01	WOS:000293013000006
J	Redig, AJ				Redig, Amanda J.			The Patient's Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Redig, AJ (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	aredig@partners.org							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2011	306	3					247	248		10.1001/jama.2011.934	http://dx.doi.org/10.1001/jama.2011.934			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794BS	21771979				2022-12-01	WOS:000292870500001
J	Devaraneni, PK; Conti, B; Matsumura, Y; Yang, ZY; Johnson, AE; Skach, WR				Devaraneni, Prasanna K.; Conti, Brian; Matsumura, Yoshihiro; Yang, Zhongying; Johnson, Arthur E.; Skach, William R.			Stepwise Insertion and Inversion of a Type II Signal Anchor Sequence in the Ribosome-Sec61 Translocon Complex	CELL			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; ER MEMBRANE; PROTEIN TRANSLOCATION; TRANSMEMBRANE SEGMENTS; SECRETORY PROTEINS; TOPOGENESIS; RECOGNITION; INTEGRATION; REVEALS; CHANNEL	In eukaryotic cells, the ribosome-Sec61 translocon complex (RTC) establishes membrane protein topology by cotranslationally partitioning nascent polypeptides into the cytosol, ER lumen, and lipid bilayer. Using photocrosslinking, collisional quenching, cysteine accessibility, and protease protection, we show that a canonical type II signal anchor (SA) acquires its topology through four tightly coupled and mechanistically distinct steps: (1) head-first insertion into Sec61 alpha, (2) nascent chain accumulation within the RTC, (3) inversion from type I to type II topology, and (4) stable translocation of C-terminal flanking residues. Progression through each stage is induced by incremental increases in chain length and involves abrupt changes in the molecular environment of the SA. Importantly, type II SA inversion deviates from a type I SA at an unstable intermediate whose topology is controlled by dynamic interactions between the ribosome and translocon. Thus, the RTC coordinates SA topogenesis within a protected environment via sequential energetic transitions of the TM segment.	[Devaraneni, Prasanna K.; Conti, Brian; Matsumura, Yoshihiro; Yang, Zhongying; Skach, William R.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Johnson, Arthur E.] Texas A&M Univ, Texas A&M Univ Syst Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Johnson, Arthur E.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Johnson, Arthur E.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Oregon Health & Science University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Skach, WR (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.	skachw@ohsu.edu	Johnson, Arthur E/G-3457-2012	Matsumura, Yoshihiro/0000-0002-3108-0440	US National Institutes of Health [GM53457, DK51818, GM26494, GM083568, HL083808]; NSF [EF-0623664]; Robert A. Welch Foundation Chair [BE-0017]; Manpei Suzuki Diabetes Foundation; American Heart Association; Cystic Fibrosis Foundation Therapeutics Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL083808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026494, R01GM053457, F32GM083568] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Robert A. Welch Foundation Chair(The Welch Foundation); Manpei Suzuki Diabetes Foundation; American Heart Association(American Heart Association); Cystic Fibrosis Foundation Therapeutics Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. N. Alder for valuable assistance and advice with fluorescence quenching, K. Rusterholtz and B. Leighton for technical assistance, Drs. Soo Kim and Amardeep Khushoo for critically reading the manuscript, and Dr. R. Hegde for generously providing TRAM antisera. This work was supported by US National Institutes of Health grants GM53457 (W.R.S.), DK51818 (W.R.S.), GM26494 (A.E.J.), GM083568 (B.C.), HL083808 (B.C.), NSF grant EF-0623664 (A.E.J.), Robert A. Welch Foundation Chair grant BE-0017 (A.E.J.), the Manpei Suzuki Diabetes Foundation (Y.M.), the American Heart Association (W.R.S.), and the Cystic Fibrosis Foundation Therapeutics Inc. (W.R.S.).	Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; Cheng ZL, 2005, J CELL BIOL, V168, P67, DOI 10.1083/jcb.200408188; CROWLEY KS, 1993, CELL, V73, P1101, DOI 10.1016/0092-8674(93)90640-C; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; Denzer AJ, 1995, EMBO J, V14, P6311, DOI 10.1002/j.1460-2075.1995.tb00321.x; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Foster W, 2000, J BIOL CHEM, V275, P34157, DOI 10.1074/jbc.M000165200; Garrison JL, 2005, NATURE, V436, P285, DOI 10.1038/nature03821; Goder V, 1999, J CELL BIOL, V147, P257, DOI 10.1083/jcb.147.2.257; Goder V, 2003, EMBO J, V22, P3645, DOI 10.1093/emboj/cdg361; HEGDE K, 1996, CELL, V85, P217; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; HIGH S, 1993, J BIOL CHEM, V268, P26745; Higy M, 2004, BIOCHEMISTRY-US, V43, P12716, DOI 10.1021/bi048368m; Ismail N, 2008, BIOCHEM J, V411, P495, DOI 10.1042/BJ20071597; Johnson AE, 2005, TRAFFIC, V6, P1078, DOI 10.1111/j.1600-0854.2005.00340.x; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Junne T, 2010, MOL BIOL CELL, V21, P1662, DOI 10.1091/mbc.E10-01-0060; KALIES KU, 1994, J CELL BIOL, V126, P925, DOI 10.1083/jcb.126.4.925; Kida Y, 2007, J CELL BIOL, V179, P1441, DOI 10.1083/jcb.200707050; Kida Y, 2010, MOL BIOL CELL, V21, P418, DOI 10.1091/mbc.E09-08-0738; Kim SJ, 2002, DEV CELL, V2, P207, DOI 10.1016/S1534-5807(01)00120-4; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; Lu JL, 2005, BIOCHEMISTRY-US, V44, P8230, DOI 10.1021/bi050372q; MATLACK KES, 1995, J BIOL CHEM, V270, P6170, DOI 10.1074/jbc.270.11.6170; McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6; Mingarro I, 2000, BMC Cell Biol, V1, P3, DOI 10.1186/1471-2121-1-3; MOTHES W, 1994, EMBO J, V13, P3973, DOI 10.1002/j.1460-2075.1994.tb06713.x; Pitonzo D, 2009, MOL BIOL CELL, V20, P685, DOI 10.1091/mbc.E08-09-0902; Plath K, 2004, MOL BIOL CELL, V15, P1, DOI 10.1091/mbc.E03-06-0390; Pool MR, 2009, J CELL BIOL, V185, P889, DOI 10.1083/jcb.200807066; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; ROTHMAN RE, 1988, J BIOL CHEM, V263, P10470; Rutkowski DT, 2001, P NATL ACAD SCI USA, V98, P7823, DOI 10.1073/pnas.141125098; Sadlish H, 2005, NAT STRUCT MOL BIOL, V12, P870, DOI 10.1038/nsmb994; SHAW AS, 1988, P NATL ACAD SCI USA, V85, P7592, DOI 10.1073/pnas.85.20.7592; Shibatani T, 2005, BIOCHEMISTRY-US, V44, P5982, DOI 10.1021/bi047328f; Skach WR, 2009, NAT STRUCT MOL BIOL, V16, P606, DOI 10.1038/nsmb.1600; Song WQ, 2000, CELL, V100, P333, DOI 10.1016/S0092-8674(00)80669-8; THRIFT RN, 1991, J CELL BIOL, V112, P809, DOI 10.1083/jcb.112.5.809; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063	46	77	78	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 8	2011	146	1					134	147		10.1016/j.cell.2011.06.004	http://dx.doi.org/10.1016/j.cell.2011.06.004			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729785	Green Accepted, Bronze			2022-12-01	WOS:000292539300012
J	Long, DT; Raschle, M; Joukov, V; Walter, JC				Long, David T.; Raeschle, Markus; Joukov, Vladimir; Walter, Johannes C.			Mechanism of RAD51-Dependent DNA Interstrand Cross-Link Repair	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; FANCONI-ANEMIA; HOMOLOGOUS RECOMBINATION; JUNCTIONS; PROTEIN	DNA interstrand cross-links (ICLs) are toxic DNA lesions whose repair in S phase of eukaryotic cells is incompletely understood. In Xenopus egg extracts, ICL repair is initiated when two replication forks converge on the lesion. Dual incisions then create a DNA double-strand break (DSB) in one sister chromatid, whereas lesion bypass restores the other sister. We report that the broken sister chromatid is repaired via RAD51-dependent strand invasion into the regenerated sister. Recombination acts downstream of FANCI-FANCD2, yet RAD51 binds ICL-stalled replication forks independently of FANCI-FANCD2 and before DSB formation. Our results elucidate the functional link between the Fanconi anemia pathway and the recombination machinery during ICL repair. In addition, they demonstrate the complete repair of a DSB via homologous recombination in vitro.	[Long, David T.; Walter, Johannes C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Raeschle, Markus] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Joukov, Vladimir] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Max Planck Society; Harvard University; Dana-Farber Cancer Institute	Walter, JC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	johannes_walter@hms.harvard.edu	Joukov, Vladimir/K-3525-2019	Walter, Johannes/0000-0002-4186-7570; Long, David/0000-0001-9232-0316	NIH [GM GM80676, HL098316]; Department of Defense Breast Cancer Research [W81XWH-04-1-0524]; American Cancer Society [PF-10-146-01-DMC]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080676] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research(United States Department of Defense); American Cancer Society(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank V. Costanzo for the BRC<SUP>WT</SUP> expression construct; T. V. Ho and O. Scharer for instruction on pICL preparation; P. Knipscheer for reagents and helpful discussions; and A. D'Andrea, K. J. Patel, R. Scully, and P. Knipscheer for critical reading of the manuscript. This work was supported by NIH grants GM GM80676 and HL098316 and a John and Virginia Kaneb award to J.C.W., Department of Defense Breast Cancer Research Program Award W81XWH-04-1-0524 to V. J., and American Cancer Society postdoctoral fellowship PF-10-146-01-DMC to D.T.L. M. R. made initial observation of X-arcs; V. J. generated x.l.RAD51 antibodies; D.T.L. and J.C.W. designed and analyzed experiments; D.T.L. performed experiments; and D.T.L. and J.C.W. prepared the manuscript.	Bzymek M, 2010, NATURE, V464, P937, DOI 10.1038/nature08868; Carreira A, 2009, CELL, V136, P1032, DOI 10.1016/j.cell.2009.02.019; Deans AJ, 2009, MOL CELL, V36, P943, DOI 10.1016/j.molcel.2009.12.006; Hashimoto Y, 2010, NAT STRUCT MOL BIOL, V17, P1305, DOI 10.1038/nsmb.1927; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Lambert S, 2007, DNA REPAIR, V6, P1042, DOI 10.1016/j.dnarep.2007.02.024; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Nakanishi K, 2011, NAT STRUCT MOL BIOL, V18, P500, DOI 10.1038/nsmb.2029; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Robinson NP, 2007, EMBO J, V26, P816, DOI 10.1038/sj.emboj.7601529; Thompson LH, 2009, MUTAT RES-FUND MOL M, V668, P54, DOI 10.1016/j.mrfmmm.2009.02.003; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Yamamoto K, 2003, MOL CELL BIOL, V23, P5421, DOI 10.1128/MCB.23.15.5421-5430.2003; Yang YG, 2005, CARCINOGENESIS, V26, P1731, DOI 10.1093/carcin/bgi134; Zhang NX, 2007, DNA REPAIR, V6, P1670, DOI 10.1016/j.dnarep.2007.06.002	17	165	165	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2011	333	6038					84	87		10.1126/science.1204258	http://dx.doi.org/10.1126/science.1204258			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719678	Green Accepted			2022-12-01	WOS:000292255400054
J	Ma, DH; Taneja, TK; Hagen, BM; Kim, BY; Ortega, B; Lederer, WJ; Welling, PA				Ma, Donghui; Taneja, Tarvinder Kaur; Hagen, Brian M.; Kim, Bo-Young; Ortega, Bernardo; Lederer, W. Jonathan; Welling, Paul A.			Golgi Export of the Kir2.1 Channel Is Driven by a Trafficking Signal Located within Its Tertiary Structure	CELL			English	Article							ANDERSEN-TAWIL-SYNDROME; RECTIFIER POTASSIUM CHANNELS; CLATHRIN-COATED VESICLES; ENDOPLASMIC-RETICULUM; SORTING SIGNALS; CELL-SURFACE; TRANSMEMBRANE PROTEINS; PROTEOMIC ANALYSIS; MEMBRANE-PROTEINS; PLASMA-MEMBRANE	Mechanisms that are responsible for sorting newly synthesized proteins for traffic to the cell surface from the Golgi are poorly understood. Here, we show that the potassium channel Kir2.1, mutations in which are associated with Andersen-Tawil syndrome, is selected as cargo into Golgi export carriers in an unusual signal-dependent manner. Unlike conventional trafficking signals, which are typically comprised of short linear peptide sequences, Golgi exit of Kir2.1 is dictated by residues that are embedded within the confluence of two separate domains. This signal patch forms a recognition site for interaction with the AP1 adaptor complex, thereby marking Kir2.1 for incorporation into clathrin-coated vesicles at the trans-Golgi. The identification of a trafficking signal in the tertiary structure of Kir2.1 reveals a quality control step that couples protein conformation to Golgi export and provides molecular insight into how mutations in Kir2.1 arrest the channels at the Golgi.	[Ma, Donghui; Taneja, Tarvinder Kaur; Hagen, Brian M.; Kim, Bo-Young; Ortega, Bernardo; Lederer, W. Jonathan; Welling, Paul A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Welling, PA (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	pwelling@umaryland.edu			NIH [P01 HL70709, R01 DK54231, R01 DK 63049, T32-HL-072751]; American Heart Association [0855321E]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070709, T32HL072751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054231, R01DK063049] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by funds from the NIH (P01 HL70709, R01 DK54231, R01 DK 63049, and T32-HL-072751) and the American Heart Association (0855321E). We thank Drs. Ora Weisz and S. Kornberg for reagents, Dr. Terry Rogers for support and advice, and Dr. William R. Randall for help with adenovirus production.	ANDERSEN ED, 1971, ACTA PAEDIATR SCAND, V60, P559, DOI 10.1111/j.1651-2227.1971.tb06990.x; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Baust T, 2006, P NATL ACAD SCI USA, V103, P3159, DOI 10.1073/pnas.0511062103; Bendahhou S, 2003, J BIOL CHEM, V278, P51779, DOI 10.1074/jbc.M310278200; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Campo C, 2005, REV PHYSIOL BIOCH P, V153, P47, DOI 10.1007/s10254-004-0037-1; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Crump CM, 2001, EMBO J, V20, P2191, DOI 10.1093/emboj/20.9.2191; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Deborde S, 2008, NATURE, V452, P719, DOI 10.1038/nature06828; Donaldson MR, 2004, ANN MED, V36, P92, DOI 10.1080/17431380410032490; Doray B, 2002, SCIENCE, V297, P1700, DOI 10.1126/science.1075327; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fischer-Lougheed J, 2001, J CELL BIOL, V153, P677, DOI 10.1083/jcb.153.4.677; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; GRIFFITHS G, 1985, J CELL BIOL, V101, P949, DOI 10.1083/jcb.101.3.949; Habuchi S, 2005, P NATL ACAD SCI USA, V102, P9511, DOI 10.1073/pnas.0500489102; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; Janvier K, 2003, J CELL BIOL, V163, P1281, DOI 10.1083/jcb.200307157; Kohout TA, 1996, CIRC RES, V78, P971, DOI 10.1161/01.RES.78.6.971; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; LeBorgne R, 1996, J BIOL CHEM, V271, P2162; Lee I, 2008, J CELL BIOL, V180, P467, DOI 10.1083/jcb.200709037; LeMaout S, 1997, P NATL ACAD SCI USA, V94, P13329, DOI 10.1073/pnas.94.24.13329; Leonoudakis D, 2004, J BIOL CHEM, V279, P22331, DOI 10.1074/jbc.M400285200; Leonoudakis D, 2004, J BIOL CHEM, V279, P19051, DOI 10.1074/jbc.M400284200; LITTMAN DR, 1985, CELL, V40, P237, DOI 10.1016/0092-8674(85)90138-2; Liu YW, 2001, J CELL BIOL, V155, P27, DOI 10.1083/jcb.200103020; Lock JG, 2005, TRAFFIC, V6, P1142, DOI 10.1111/j.1600-0854.2005.00349.x; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Lui WWY, 2003, MOL BIOL CELL, V14, P2385, DOI 10.1091/mbc.E02-11-0735; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Ma DH, 2007, J BIOL CHEM, V282, P5781, DOI 10.1074/jbc.M608776200; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; MANDERS EMM, 1992, J CELL SCI, V103, P857; Melnyk P, 2002, AM J PHYSIOL-HEART C, V283, pH1123, DOI 10.1152/ajpheart.00934.2001; Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; O'Connell AD, 2005, P NATL ACAD SCI USA, V102, P9954, DOI 10.1073/pnas.0504332102; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Orzech E, 1999, J BIOL CHEM, V274, P2201, DOI 10.1074/jbc.274.4.2201; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Pogwizd SM, 2004, TRENDS CARDIOVAS MED, V14, P61, DOI 10.1016/j.tcm.2003.12.002; Prescott AR, 1997, EUR J CELL BIOL, V72, P238; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Rahkila P, 1997, EXP CELL RES, V234, P452, DOI 10.1006/excr.1997.3633; RALSTON E, 1993, J CELL BIOL, V120, P399, DOI 10.1083/jcb.120.2.399; Rodriguez-Boulan E, 2005, BBA-MOL CELL RES, V1744, P455, DOI 10.1016/j.bbamcr.2005.04.007; Sampson LJ, 2003, J BIOL CHEM, V278, P41988, DOI 10.1074/jbc.M307479200; Sansone V, 1997, ANN NEUROL, V42, P305, DOI 10.1002/ana.410420306; SARASTE J, 1984, CELL, V38, P535, DOI 10.1016/0092-8674(84)90508-7; Shih W, 1995, J BIOL CHEM, V270, P31083, DOI 10.1074/jbc.270.52.31083; Stockklausner C, 2003, J BIOL CHEM, V278, P17000, DOI 10.1074/jbc.M212243200; Tristani-Firouzi M, 2002, J CLIN INVEST, V110, P381, DOI 10.1172/JCI200215183; Wang CW, 2006, J CELL BIOL, V174, P973, DOI 10.1083/jcb.200605106; Yoo D, 2005, J BIOL CHEM, V280, P35281, DOI 10.1074/jbc.M504836200; Yoo D, 2003, J BIOL CHEM, V278, P23066, DOI 10.1074/jbc.M212301200; Zaritsky JJ, 2001, J PHYSIOL-LONDON, V533, P697, DOI 10.1111/j.1469-7793.2001.t01-1-00697.x; Zerangue N, 2001, P NATL ACAD SCI USA, V98, P2431, DOI 10.1073/pnas.051630198	68	76	76	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 24	2011	145	7					1102	1115		10.1016/j.cell.2011.06.007	http://dx.doi.org/10.1016/j.cell.2011.06.007			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703452	Green Submitted, Green Accepted, Bronze			2022-12-01	WOS:000292025700016
J	Robbins, M				Robbins, Martin			Fuelling politics	NATURE			English	Editorial Material																			0	21	23	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S22	S24		10.1038/474S022a	http://dx.doi.org/10.1038/474S022a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697840	Bronze			2022-12-01	WOS:000291939700009
J	Hara, MR; Kovacs, JJ; Whalen, EJ; Rajagopal, S; Strachan, RT; Grant, W; Towers, AJ; Williams, B; Lam, CM; Xiao, KH; Shenoy, SK; Gregory, SG; Ahn, S; Duckett, DR; Lefkowitz, RJ				Hara, Makoto R.; Kovacs, Jeffrey J.; Whalen, Erin J.; Rajagopal, Sudarshan; Strachan, Ryan T.; Grant, Wayne; Towers, Aaron J.; Williams, Barbara; Lam, Christopher M.; Xiao, Kunhong; Shenoy, Sudha K.; Gregory, Simon G.; Ahn, Seungkirl; Duckett, Derek R.; Lefkowitz, Robert J.			A stress response pathway regulates DNA damage through beta(2)-adrenoreceptors and beta-arrestin-1	NATURE			English	Article							SHORT-INTERFERING RNAS; NUCLEAR EXPORT SIGNAL; BETA-ARRESTINS; ADENYLYL-CYCLASE; N-DOMAIN; RECEPTOR; ACTIVATION; EXPRESSION; GROWTH; P53	The human mind and body respond to stress(1), a state of perceived threat to homeostasis, by activating the sympathetic nervous system and secreting the catecholamines adrenaline and noradrenaline in the 'fight-or-flight' response. The stress response is generally transient because its accompanying effects (for example, immunosuppression, growth inhibition and enhanced catabolism) can be harmful in the long term(2). When chronic, the stress response can be associated with disease symptoms such as peptic ulcers or cardiovascular disorders(3), and epidemiological studies strongly indicate that chronic stress leads to DNA damage(4,5). This stress-induced DNA damage may promote ageing(6), tumorigenesis(4,7), neuropsychiatric conditions(8,9) and miscarriages(10). However, the mechanisms by which these DNA-damage events occur in response to stress are unknown. The stress hormone adrenaline stimulates beta(2)-adrenoreceptors that are expressed throughout the body, including in germline cells and zygotic embryos(11). Activated beta(2)-adrenoreceptors promote Gs-protein-dependent activation of protein kinase A (PKA), followed by the recruitment of beta-arrestins, which desensitize G-protein signalling and function as signal transducers in their own right(12). Here we elucidate a molecular mechanism by which beta-adrenergic catecholamines, acting through both Gs-PKA and beta-arrestin-mediated signalling pathways, trigger DNA damage and suppress p53 levels respectively, thus synergistically leading to the accumulation of DNA damage. In mice and in human cell lines, beta-arrestin-1 (ARRB1), activated via beta(2)-adrenoreceptors, facilitates AKT-mediated activation of MDM2 and also promotes MDM2 binding to, and degradation of, p53, by acting as a molecular scaffold. Catecholamine-induced DNA damage is abrogated in Arrb1-knockout (Arrb1(-/-)) mice, which show preserved p53 levels in both the thymus, an organ that responds prominently to acute or chronic stress(1), and in the testes, in which paternal stress may affect the offspring's genome. Our results highlight the emerging role of ARRB1 as an E3-ligase adaptor in the nucleus, and reveal how DNA damage may accumulate in response to chronic stress.	[Hara, Makoto R.; Kovacs, Jeffrey J.; Whalen, Erin J.; Rajagopal, Sudarshan; Strachan, Ryan T.; Towers, Aaron J.; Williams, Barbara; Lam, Christopher M.; Xiao, Kunhong; Shenoy, Sudha K.; Gregory, Simon G.; Ahn, Seungkirl; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Grant, Wayne; Duckett, Derek R.] Scripps Res Inst, Translat Res Inst, Jupiter, FL 33458 USA; [Towers, Aaron J.; Gregory, Simon G.] Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Scripps Research Institute; Duke University; Duke University; Howard Hughes Medical Institute	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	lefko001@receptor-biol.duke.edu	Lefkowitz, Robert/AAW-2649-2021; Xiao, Kunhong/AAG-4275-2020; Shenoy, Sudha/AAN-4075-2021; Rajagopal, Sudarshan/G-8975-2013	Xiao, Kunhong/0000-0002-1069-1226; Shenoy, Sudha/0000-0002-2565-4663; Rajagopal, Sudarshan/0000-0002-3443-5040; Gregory, Simon/0000-0002-7805-1743	 [HL16037];  [HL70631]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070631, R01HL016037, R37HL016037] Funding Source: NIH RePORTER	; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	R.J.L. is a Howard Hughes Medical Institute investigator. This work was supported by HL16037 and HL70631 (R.J.L.). We thank D. Addison and Q. Lennon for secretarial assistance; S. H. Snyder and M. A. Koldobskiy for providing p53 deletion constructs; B. K. Kobilka and H. A. Rockman for providing Adrb2<SUP>-/-</SUP> mice; M. C. Hung for providing the MDM2-S166D plasmid; A. K. Shukla, A. Kahsai, J. Kim, J. Sun, S. M. DeWire and N. Odajima for discussion and comments.	Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Boularan C, 2007, P NATL ACAD SCI USA, V104, P18061, DOI 10.1073/pnas.0705550104; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chruscinski AJ, 1999, J BIOL CHEM, V274, P16694, DOI 10.1074/jbc.274.24.16694; Cikos S, 2005, MOL REPROD DEV, V71, P145, DOI 10.1002/mrd.20256; Conner DA, 1997, CIRC RES, V81, P1021; De Gregorio G, 2007, ONCOGENE, V26, P2039, DOI 10.1038/sj.onc.1210011; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Flint MS, 2007, PSYCHONEUROENDOCRINO, V32, P470, DOI 10.1016/j.psyneuen.2007.02.013; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Goel R, 2002, J BIOL CHEM, V277, P18640, DOI 10.1074/jbc.M108995200; Goldstein David S, 2003, Endocr Regul, V37, P69; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; HAUSDORFF WP, 1990, J BIOL CHEM, V265, P1388; Khachaturian AS, 2006, ARCH NEUROL-CHICAGO, V63, P686, DOI 10.1001/archneur.63.5.noc60013; Kinney DK, 2008, NEUROSCI BIOBEHAV R, V32, P1519, DOI 10.1016/j.neubiorev.2008.06.004; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Koldobskiy MA, 2010, P NATL ACAD SCI USA, V107, P20947, DOI 10.1073/pnas.1015671107; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Lista F, 1997, CANCER RES, V57, P4408; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Nepomnaschy PA, 2006, P NATL ACAD SCI USA, V103, P3938, DOI 10.1073/pnas.0511183103; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Nobles KN, 2007, J BIOL CHEM, V282, P21370, DOI 10.1074/jbc.M611483200; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; RAINBOW TC, 1984, P NATL ACAD SCI-BIOL, V81, P1585, DOI 10.1073/pnas.81.5.1585; Schuller HM, 2002, NAT REV CANCER, V2, P455, DOI 10.1038/nrc824; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Selye H, 1936, NATURE, V138, P32, DOI 10.1038/138032a0; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; SESHADRI T, 1990, SCIENCE, V247, P205, DOI 10.1126/science.2104680; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Wang P, 2003, J BIOL CHEM, V278, P11648, DOI 10.1074/jbc.M208109200; Wang P, 2003, J BIOL CHEM, V278, P6363, DOI 10.1074/jbc.M210350200; Xiao KH, 2004, J BIOL CHEM, V279, P55744, DOI 10.1074/jbc.M409785200; Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	49	277	288	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2011	477	7364					349	U129		10.1038/nature10368	http://dx.doi.org/10.1038/nature10368			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819TD	21857681	Green Accepted			2022-12-01	WOS:000294852400035
J	Frezza, C; Zheng, L; Folger, O; Rajagopalan, KN; MacKenzie, ED; Jerby, L; Micaroni, M; Chaneton, B; Adam, J; Hedley, A; Kalna, G; Tomlinson, IPM; Pollard, PJ; Watson, DG; Deberardinis, RJ; Shlomi, T; Ruppin, E; Gottlieb, E				Frezza, Christian; Zheng, Liang; Folger, Ori; Rajagopalan, Kartik N.; MacKenzie, Elaine D.; Jerby, Livnat; Micaroni, Massimo; Chaneton, Barbara; Adam, Julie; Hedley, Ann; Kalna, Gabriela; Tomlinson, Ian P. M.; Pollard, Patrick J.; Watson, Dave G.; Deberardinis, Ralph J.; Shlomi, Tomer; Ruppin, Eytan; Gottlieb, Eyal			Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase	NATURE			English	Article							RENAL-CANCER; MODELS; CELLS; RECONSTRUCTION; PROTEIN; ASSAY	Fumarate hydratase (FH) is an enzyme of the tricarboxylic acid cycle (TCA cycle) that catalyses the hydration of fumarate into malate. Germline mutations of FH are responsible for hereditary leiomyomatosis and renal-cell cancer (HLRCC)(1). It has previously been demonstrated that the absence of FH leads to the accumulation of fumarate, which activates hypoxia-inducible factors (HIFs) at normal oxygen tensions(2-4). However, so far no mechanism that explains the ability of cells to survive without a functional TCA cycle has been provided. Here we use newly characterized genetically modified kidney mouse cells in which Fh1 has been deleted, and apply a newly developed computer model of the metabolism of these cells to predict and experimentally validate a linear metabolic pathway beginning with glutamine uptake and ending with bilirubin excretion from Fh1-deficient cells. This pathway, which involves the biosynthesis and degradation of haem, enables Fh1-deficient cells to use the accumulated TCA cycle metabolites and permits partial mitochondrial NADH production. We predicted and confirmed that targeting this pathway would render Fh1-deficient cells nonviable, while sparing wild-type Fh1-containing cells. This work goes beyond identifying a metabolic pathway that is induced in Fh1-deficient cells to demonstrate that inhibition of haem oxygenation is synthetically lethal when combined with Fh1 deficiency, providing a new potential target for treating HLRCC patients.	[Frezza, Christian; Zheng, Liang; MacKenzie, Elaine D.; Chaneton, Barbara; Hedley, Ann; Kalna, Gabriela; Gottlieb, Eyal] Beatson Inst Canc Res, Canc Res UK, Glasgow G61 1BD, Lanark, Scotland; [Folger, Ori; Jerby, Livnat; Ruppin, Eytan] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Rajagopalan, Kartik N.; Deberardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Rajagopalan, Kartik N.; Deberardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Micaroni, Massimo] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Tomlinson, Ian P. M.] Univ Oxford, Wellcome Trust Ctr Human Genet, Mol & Populat Genet Lab, Oxford OX3 7BN, England; [Watson, Dave G.] Univ Strathclyde, Strathclyde Inst Pharmaceut & Biomed Sci, Glasgow G4 0NR, Lanark, Scotland; [Shlomi, Tomer] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel; [Ruppin, Eytan] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Beatson Institute; Cancer Research UK; Tel Aviv University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Queensland; University of Oxford; Wellcome Centre for Human Genetics; University of Strathclyde; Technion Israel Institute of Technology; Tel Aviv University; Sackler Faculty of Medicine	Gottlieb, E (corresponding author), Beatson Inst Canc Res, Canc Res UK, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	e.gottlieb@beatson.gla.ac.uk	Ruppin, Eytan/R-9698-2017; Pollard, Patrick/F-7516-2012; Gottlieb, Eyal/G-6450-2010; Frezza, Christian/G-2174-2010	Ruppin, Eytan/0000-0002-7862-3940; Pollard, Patrick/0000-0002-4459-4993; Gottlieb, Eyal/0000-0002-9770-0956; Frezza, Christian/0000-0002-3293-7397; Zheng, Liang/0000-0002-5346-4111; Micaroni, Massimo/0000-0001-6405-0451; Adam, Julie/0000-0002-7980-7151	Cancer Research UK; EMBO [ALTF330]; Wellcome Trust [WT091112MA]; NIH [DK072565-05]; Cancer Prevention and Research Institute of Texas [HIRP100437-01]; Israel Science Foundation (ISF); Israel Cancer Research Foundation; Edmond J. Safra Bioinformatics program at TAU; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK072565] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); EMBO(European Molecular Biology Organization (EMBO)); Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Israel Science Foundation (ISF)(Israel Science Foundation); Israel Cancer Research Foundation; Edmond J. Safra Bioinformatics program at TAU; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Cancer Research UK. We would like to acknowledge the Patterson Institute for Cancer Research for the Exon Array analysis. C. F. is supported by an EMBO long term fellowship (ALTF330). P.J.P. is in receipt of a Beit Memorial Fellowship funded by the Wellcome Trust (WT091112MA). D. G. W. and L.Z. would like to acknowledge SULSA (Scottish Universities Life Science Alliance). R.J.D. and K.N.R. are supported by the NIH (DK072565-05) and the Cancer Prevention and Research Institute of Texas (HIRP100437-01). O.F., T. S. and E. R. are supported by the Israel Science Foundation (ISF) and the Israel Cancer Research Foundation. L.J. is supported by the Edmond J. Safra Bioinformatics program at TAU. We thank UOB Tumor Cell Line Repository and W. Marston Linehan for providing us with the UOK262 cell lines, and A. King for editorial work.	Anderson KE, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2006.05.026; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Folger O, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.35; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Frezza C, 2011, J MOL MED, V89, P213, DOI 10.1007/s00109-011-0728-4; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Jerby L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.56; Labbe RF, 1999, CLIN CHEM, V45, P2060; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281; Mathew R, 2008, METHOD ENZYMOL, V446, P77, DOI 10.1016/S0076-6879(08)01605-4; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Pollard PJ, 2007, CANCER CELL, V11, P311, DOI 10.1016/j.ccr.2007.02.005; Price ND, 2003, TRENDS BIOTECHNOL, V21, P162, DOI 10.1016/S0167-7799(03)00030-1; SCHOENFELD N, 1984, BIOCHEM PHARMACOL, V33, P2783, DOI 10.1016/0006-2952(84)90696-8; Sudarshan S, 2009, MOL CELL BIOL, V29, P4080, DOI 10.1128/MCB.00483-09; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Uc A, 2004, AM J PHYSIOL-GASTR L, V287, pG1150, DOI 10.1152/ajpgi.00157.2004; Vanharanta S, 2006, HUM MOL GENET, V15, P97, DOI 10.1093/hmg/ddi431; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Yang Y, 2010, CANCER GENET CYTOGEN, V196, P45, DOI 10.1016/j.cancergencyto.2009.08.018	24	346	349	3	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2011	477	7363					225	U132		10.1038/nature10363	http://dx.doi.org/10.1038/nature10363			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816MC	21849978				2022-12-01	WOS:000294603900039
J	Chao, LH; Stratton, MM; Lee, IH; Rosenberg, OS; Levitz, J; Mandell, DJ; Kortemme, T; Groves, JT; Schulman, H; Kuriyan, J				Chao, Luke H.; Stratton, Margaret M.; Lee, Il-Hyung; Rosenberg, Oren S.; Levitz, Joshua; Mandell, Daniel J.; Kortemme, Tanja; Groves, Jay T.; Schulman, Howard; Kuriyan, John			A Mechanism for Tunable Autoinhibition in the Structure of a Human Ca2+/Calmodulin-Dependent Kinase II Holoenzyme	CELL			English	Article							DEPENDENT PROTEIN-KINASE; RAY SOLUTION SCATTERING; CAM KINASE; INHIBITORY AUTOPHOSPHORYLATION; CA2+ OSCILLATIONS; IN-VITRO; CALMODULIN; ACTIVATION; ALPHA; BRAIN	Calcium/calmodulin-dependent kinase II (CaMKII) forms a highly conserved dodecameric assembly that is sensitive to the frequency of calcium pulse trains. Neither the structure of the dodecameric assembly nor how it regulates CaMKII are known. We present the crystal structure of an autoinhibited full-length human CaMKII holoenzyme, revealing an unexpected compact arrangement of kinase domains docked against a central hub, with the calmodulin-binding sites completely inaccessible. We show that this compact docking is important for the autoinhibition of the kinase domains and for setting the calcium response of the holoenzyme. Comparison of CaMKII isoforms, which differ in the length of the linker between the kinase domain and the hub, demonstrates that these interactions can be strengthened or weakened by changes in linker length. This equilibrium between autoinhibited states provides a simple mechanism for tuning the calcium response without changes in either the hub or the kinase domains.	[Chao, Luke H.; Stratton, Margaret M.; Rosenberg, Oren S.; Kuriyan, John] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Chao, Luke H.; Stratton, Margaret M.; Lee, Il-Hyung; Rosenberg, Oren S.; Groves, Jay T.; Kuriyan, John] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Chao, Luke H.; Stratton, Margaret M.; Lee, Il-Hyung; Rosenberg, Oren S.; Groves, Jay T.; Kuriyan, John] Univ Calif Berkeley, Calif Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA; [Chao, Luke H.; Stratton, Margaret M.; Lee, Il-Hyung; Rosenberg, Oren S.; Groves, Jay T.; Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Levitz, Joshua; Groves, Jay T.; Kuriyan, John] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Mandell, Daniel J.; Kortemme, Tanja] Univ Calif San Francisco, Calif Inst Quantitat Biosci QB3, San Francisco, CA 94143 USA; [Mandell, Daniel J.; Kortemme, Tanja] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Schulman, Howard] Allosteros Therapeut, Sunnyvale, CA 94089 USA; [Groves, Jay T.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Groves, Jay T.; Kuriyan, John] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kuriyan, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	kuriyan@berkeley.edu	Chao, Luke/R-4627-2019; Kortemme, Tanja/AAN-3180-2021	Chao, Luke/0000-0002-4849-4148; Kortemme, Tanja/0000-0002-8494-680X; Lee, Il-Hyung/0000-0001-6755-3257	Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045547] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Angus Nairn, Andre Hoelz, Sebastian Deindl, Patricia Pellicena, Paul De Koninck, Jonathan Winger, and the members of the Kuriyan Lab for many discussions and insights. We thank Giulio Superi-Furga for bosutinib, David King for peptide synthesis and mass spectrometry, Alice Ting for the BirA vector, Tony lavarone for mass spectrometry support, and Greg Hura for SAXS data collection. We thank Tiago Barros and Joel Guenther for review of the manuscript. We acknowledge Corie Ralston and the staff at Advanced Light Source beamlines 8.2.2 and 8.2.1 for assistance with data collection. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BARKER SC, 1995, BIOCHEMISTRY-US, V34, P14843, DOI 10.1021/bi00045a027; Bayer KU, 2002, EMBO J, V21, P3590, DOI 10.1093/emboj/cdf360; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chao LH, 2010, NAT STRUCT MOL BIOL, V17, P264, DOI 10.1038/nsmb.1751; Chiba H, 2008, BIOPHYS J, V95, P2139, DOI 10.1529/biophysj.107.118505; COLBRAN RJ, 1993, J BIOL CHEM, V268, P7163; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HANSON PI, 1992, J BIOL CHEM, V267, P17216; HANSON PI, 1989, NEURON, V3, P59, DOI 10.1016/0896-6273(89)90115-3; Hoelz A, 2003, MOL CELL, V11, P1241, DOI 10.1016/S1097-2765(03)00171-0; Hoffman L, 2011, EMBO J, V30, P1251, DOI 10.1038/emboj.2011.40; Howarth M, 2008, NAT PROTOC, V3, P534, DOI 10.1038/nprot.2008.20; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KENNEDY MB, 1983, J NEUROSCI, V3, P818; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kolodziej SJ, 2000, J BIOL CHEM, V275, P14354, DOI 10.1074/jbc.275.19.14354; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; LeBoeuf B, 2007, PLOS GENET, V3, P1622, DOI 10.1371/journal.pgen.0030156; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Morris EP, 2001, J MOL BIOL, V308, P1, DOI 10.1006/jmbi.2001.4584; NAIRN AC, 1985, ANNU REV BIOCHEM, V54, P931, DOI 10.1146/annurev.biochem.54.1.931; Pepke S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000675; Putkey JA, 1996, J BIOL CHEM, V271, P29619, DOI 10.1074/jbc.271.47.29619; Puttini M, 2006, CANCER RES, V66, P11314, DOI 10.1158/0008-5472.CAN-06-1199; Rellos P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000426; Rix U, 2010, LEUKEMIA, V24, P44, DOI 10.1038/leu.2009.228; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Ryan TJ, 2009, NAT REV NEUROSCI, V10, P701, DOI 10.1038/nrn2717; SCHULMAN H, 1978, NATURE, V271, P478, DOI 10.1038/271478a0; Shen K, 1998, J NEUROCHEM, V70, P96; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Thaler C, 2009, P NATL ACAD SCI USA, V106, P6369, DOI 10.1073/pnas.0901913106; Tombes RM, 2003, GENE, V322, P17, DOI 10.1016/j.gene.2003.08.023; Wang P, 2000, FEBS LETT, V475, P107, DOI 10.1016/S0014-5793(00)01634-3; WOODGETT JR, 1984, FEBS LETT, V170, P49, DOI 10.1016/0014-5793(84)81366-6	50	164	167	2	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 2	2011	146	5					732	745		10.1016/j.cell.2011.07.038	http://dx.doi.org/10.1016/j.cell.2011.07.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21884935	Green Accepted, Bronze			2022-12-01	WOS:000294477500014
J	Snyder, JS; Soumier, A; Brewer, M; Pickel, J; Cameron, HA				Snyder, Jason S.; Soumier, Amelie; Brewer, Michelle; Pickel, James; Cameron, Heather A.			Adult hippocampal neurogenesis buffers stress responses and depressive behaviour	NATURE			English	Article							GLUCOCORTICOID-RECEPTOR; TRANSGENIC MICE; ANIMAL-MODEL; ASTROCYTES; NEURONS; ANTIDEPRESSANTS; FOREBRAIN; LESIONS; BRAIN; RATS	Glucocorticoids are released in response to stressful experiences and serve many beneficial homeostatic functions. However, dysregulation of glucocorticoids is associated with cognitive impairments and depressive illness(1,2). In the hippocampus, a brain region densely populated with receptors for stress hormones, stress and glucocorticoids strongly inhibit adult neurogenesis(3). Decreased neurogenesis has been implicated in the pathogenesis of anxiety and depression, but direct evidence for this role is lacking(4,5). Here we show that adult-born hippocampal neurons are required for normal expression of the endocrine and behavioural components of the stress response. Using either transgenic or radiation methods to inhibit adult neurogenesis specifically, we find that glucocorticoid levels are slower to recover after moderate stress and are less suppressed by dexamethasone in neurogenesis-deficient mice than intact mice, consistent with a role for the hippocampus in regulation of the hypothalamic-pituitary-adrenal (HPA) axis(6,7). Relative to controls, neurogenesis-deficient mice also showed increased food avoidance in a novel environment after acute stress, increased behavioural despair in the forced swim test, and decreased sucrose preference, a measure of anhedonia. These findings identify a small subset of neurons within the dentate gyrus that are critical for hippocampal negative control of the HPA axis and support a direct role for adult neurogenesis in depressive illness.	[Snyder, Jason S.; Soumier, Amelie; Brewer, Michelle; Pickel, James; Cameron, Heather A.] NIMH, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Cameron, HA (corresponding author), NIMH, NIH, Bethesda, MD 20892 USA.	heathercameron@mail.nih.gov	Cameron, Heather/E-6221-2011; Snyder, Jason/F-3435-2011	Cameron, Heather/0000-0002-3245-5777; Snyder, Jason/0000-0002-5509-0272	National Institute of Mental Health, National Institutes of Health, USA [ZIA MH002784]; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002784, ZICMH002901, Z01MH002784] Funding Source: NIH RePORTER	National Institute of Mental Health, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. Sowers and J. Mitchell for help with irradiation, M. Brenner for providing the plasmid construct, GlaxoSmithKline for providing the antibody against HSV-TK, and K. Sanzone, F. Kamhi, L. Glover, S. Ferrante and L. Grigereit for assisting with mouse breeding and treatment. This research was supported by the Intramural Program of the National Institute of Mental Health, National Institutes of Health, USA, ZIA MH002784 (to H.A.C.).	Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Anacker C, 2011, PSYCHONEUROENDOCRINO, V36, P415, DOI 10.1016/j.psyneuen.2010.03.007; Barkus C, 2010, EUR J PHARMACOL, V626, P49, DOI 10.1016/j.ejphar.2009.10.014; BORRELLI E, 1989, NATURE, V339, P538, DOI 10.1038/339538a0; BROWN TS, 1973, PHYSIOL BEHAV, V11, P833, DOI 10.1016/0031-9384(73)90278-3; Buccafusco JJ, 2009, METHODS BEHAV ANAL N; Burns KA, 2009, GLIA, V57, P1115, DOI 10.1002/glia.20835; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Delaney CL, 1996, J NEUROSCI, V16, P6908; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Drew Michael R., 2007, CNS & Neurological Disorders-Drug Targets, V6, P205, DOI 10.2174/187152707780619353; Duman CH, 2010, VITAM HORM, V82, P1, DOI 10.1016/S0083-6729(10)82001-1; Furay AR, 2008, ENDOCRINOLOGY, V149, P5482, DOI 10.1210/en.2008-0642; Holsboer F, 2010, ANNU REV PSYCHOL, V61, P81, DOI 10.1146/annurev.psych.093008.100321; Jankord R, 2008, ANN NY ACAD SCI, V1148, P64, DOI 10.1196/annals.1410.012; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; Oomen CA, 2010, J NEUROSCI, V30, P6635, DOI 10.1523/JNEUROSCI.0247-10.2010; Revest JM, 2009, MOL PSYCHIATR, V14, P959, DOI 10.1038/mp.2009.15; Ridder S, 2005, J NEUROSCI, V25, P6243, DOI 10.1523/JNEUROSCI.0736-05.2005; Roozendaal B, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn766; Sandi Carmen, 2007, Neural Plasticity, V2007, DOI 10.1055/2007/78970; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sapolsky RM, 2004, BIOL PSYCHIAT, V56, P137, DOI 10.1016/j.biopsych.2004.04.012; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; Surget A, 2011, MOL PSYCHIATR, V16, P1177, DOI 10.1038/mp.2011.48; Treadway MT, 2011, NEUROSCI BIOBEHAV R, V35, P537, DOI 10.1016/j.neubiorev.2010.06.006; Wojtowicz JM, 2006, HIPPOCAMPUS, V16, P261, DOI 10.1002/hipo.20158	30	967	1007	9	330	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 25	2011	476	7361					458	U112		10.1038/nature10287	http://dx.doi.org/10.1038/nature10287			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811KT	21814201	Green Accepted			2022-12-01	WOS:000294209400038
J	Sato, Y; Iketani, M; Kurihara, Y; Yamaguchi, M; Yamashita, N; Nakamura, F; Arie, Y; Kawasaki, T; Hirata, T; Abe, T; Kiyonari, H; Strittmatter, SM; Goshima, Y; Takei, K				Sato, Yasufumi; Iketani, Masumi; Kurihara, Yuji; Yamaguchi, Megumi; Yamashita, Naoya; Nakamura, Fumio; Arie, Yuko; Kawasaki, Takahiko; Hirata, Tatsumi; Abe, Takaya; Kiyonari, Hiroshi; Strittmatter, Stephen M.; Goshima, Yoshio; Takei, Kohtaro			Cartilage Acidic Protein-1B (LOTUS), an Endogenous Nogo Receptor Antagonist for Axon Tract Formation	SCIENCE			English	Article							LATERAL OLFACTORY TRACT; MITRAL CELL AXONS; NERVOUS-SYSTEM; IDENTIFICATION; REGENERATION; INHIBITION; EXPRESSION; GROWTH	Neural circuitry formation depends on the molecular control of axonal projection during development. By screening with fluorophore-assisted light inactivation in the developing mouse brain, we identified cartilage acidic protein-1B as a key molecule for lateral olfactory tract (LOT) formation and named it LOT usher substance (LOTUS). We further identified Nogo receptor-1 (NgR1) as a LOTUS-binding protein. NgR1 is a receptor of myelin-derived axon growth inhibitors, such as Nogo, which prevent neural regeneration in the adult. LOTUS suppressed Nogo-NgR1 binding and Nogo-induced growth cone collapse. A defasciculated LOT was present in lotus-deficient mice but not in mice lacking both lotus- and ngr1. These findings suggest that endogenous antagonism of NgR1 by LOTUS is crucial for normal LOT formation.	[Sato, Yasufumi; Iketani, Masumi; Kurihara, Yuji; Yamaguchi, Megumi; Yamashita, Naoya; Nakamura, Fumio; Arie, Yuko; Goshima, Yoshio; Takei, Kohtaro] Yokohama City Univ, Grad Sch Med, Dept Mol Pharmacol & Neurobiol, Yokohama, Kanagawa 2360004, Japan; [Kawasaki, Takahiko; Hirata, Tatsumi] Natl Inst Genet, Grad Sch Adv Studies, Div Brain Funct, Mishima, Shizuoka 4118540, Japan; [Abe, Takaya; Kiyonari, Hiroshi] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo 6500047, Japan; [Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; [Strittmatter, Stephen M.] Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA; [Goshima, Yoshio; Takei, Kohtaro] Yokohama City Univ, Grad Sch Med, Adv Med Res Ctr, Yokohama, Kanagawa 2360004, Japan	Yokohama City University; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; RIKEN; Yale University; Yale University; Yokohama City University	Goshima, Y (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Mol Pharmacol & Neurobiol, Yokohama, Kanagawa 2360004, Japan.	goshima@med.yokohama-cu.ac.jp; kohtaro@med.yokohama-cu.ac.jp	Kiyonari, Hiroshi/N-7936-2015; Strittmatter, Stephen/F-5739-2011	Strittmatter, Stephen/0000-0001-8188-3092; Kawasaki, Takahiko/0000-0001-9939-8407	Core Research for Evolutionary Science Technology (CREST) of the Japan Science and Technology Agency; Ministry of Education, Culture, Sport, Science, and Technology of Japan; Dr. Ralph and Marion Falk Medical Research Trust; NIH; Yokohama City University, Japan [S2107]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033020] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23657151, 21700387, 23500452] Funding Source: KAKEN	Core Research for Evolutionary Science Technology (CREST) of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sport, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Dr. Ralph and Marion Falk Medical Research Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yokohama City University, Japan; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Supported by grants from the Core Research for Evolutionary Science Technology (CREST) of the Japan Science and Technology Agency (to Y.S., T.H., Y.G., and K.T.); grants-in-aid from the Ministry of Education, Culture, Sport, Science, and Technology of Japan (to T.H. and K.T.); grants from the Dr. Ralph and Marion Falk Medical Research Trust and the NIH (to S.M.S.); and a grant for Research and Development Project II (No. S2107) of Yokohama City University, Japan (to Y.G. and K.T.). The authors thank T. Takeyama and Y. Saito at the Olympus Corporation (Tokyo, Japan) for technical assistance with FALI; H. Sekiguchi-Kaneko, T. Okada, M. Ogawara, and S. Chen for technical assistance; and Y. Sasaki, K. Ogura, K. Nishiyama, H. Ito, and T. Takahashi for helpful discussions and comments. K.T. and Y.S. designed the study, and K.T. and Y.G. supervised the experiments, data analysis, and interpretation. The experiments were carried out by Y.S., M.I., Y.K., M.Y., N.Y., F.N., Y.A., and K.T. T.K. and T.H. generated the mouse cDNA expression library of the olfactory bulb and collaborated on the production of monoclonal antibodies. T.A. and H.K. collaborated on the generation of crtac1B (lotus)-deficient mice. S.M.S. collaborated on experiments using ngr1-deficient mice and NgR2-3. K.T. wrote the paper, and Y.S., F.N., N.Y., and Y.G. edited the manuscript. S.M.S. is a cofounder and consultant of Axerion Therapeutics. Yale University holds a patent licensed to Axerion Therapeutics related to Ngr1 receptor blockers for recovery from central nervous system damage. Yokohama City University has a patent pending on Crtac 1B(LOTUS) function in neuronal cell growth. Materials transfer agreements restrict the use of Crtac1B(LOTUS) knockout mice and NgR1 knockout mice and expression constructs of NgR1, NgR2, and NgR3 proteins.	Beck S, 2002, PROTEOMICS, V2, P247, DOI 10.1002/1615-9861(200203)2:3<247::AID-PROT247>3.0.CO;2-K; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Hirata T, 1999, J NEUROBIOL, V38, P93; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; Kawasaki T, 2005, J NEUROBIOL, V62, P330, DOI 10.1002/neu.20105; Liu BP, 2006, PHILOS T R SOC B, V361, P1593, DOI 10.1098/rstb.2006.1891; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; LOFTUS JC, 1994, J BIOL CHEM, V269, P25235; LopezMascaraque L, 1996, NEUROSCIENCE, V70, P255, DOI 10.1016/0306-4522(95)00360-U; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Sato Y, 1998, J NEUROSCI, V18, P7800; SCHWOB JE, 1984, J COMP NEUROL, V223, P177, DOI 10.1002/cne.902230204; Shipley MT, 1996, J NEUROBIOL, V30, P123; Steck E, 2001, BIOCHEM J, V353, P169, DOI 10.1042/0264-6021:3530169; Steck E, 2007, MATRIX BIOL, V26, P30, DOI 10.1016/j.matbio.2006.09.006; Sugisaki N, 1996, J NEUROBIOL, V29, P127, DOI 10.1002/(SICI)1097-4695(199602)29:2<127::AID-NEU1>3.0.CO;2-C; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tozaki H, 2002, MOL BRAIN RES, V104, P111, DOI 10.1016/S0169-328X(02)00172-9; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956	22	59	61	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 5	2011	333	6043					769	773		10.1126/science.1204144	http://dx.doi.org/10.1126/science.1204144			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817055	Green Accepted			2022-12-01	WOS:000293512100047
J	Funk, C				Funk, Chris			We thought trouble was coming	NATURE			English	Editorial Material									Univ Calif Santa Barbara, Dept Geog, Climate Hazard Grp, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Funk, C (corresponding author), Univ Calif Santa Barbara, Dept Geog, Climate Hazard Grp, Santa Barbara, CA 93106 USA.	cfunk@usgs.gov		Funk, Chris/0000-0002-9254-6718					0	42	43	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 4	2011	476	7358					7	7		10.1038/476007a	http://dx.doi.org/10.1038/476007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	801NR	21814237	Bronze			2022-12-01	WOS:000293447300003
J	Rutter, H				Rutter, Harry			Where next for obesity?	LANCET			English	Editorial Material									Natl Obes Observ, Oxford OX4 2GX, England		Rutter, H (corresponding author), Natl Obes Observ, Oxford OX4 2GX, England.	harry.rutter@dph.ox.ac.uk	Rutter, Harry/HCI-8765-2022	Rutter, Harry/0000-0002-9322-0656				Berlin Isaiah, 1953, HEDGEHOG FOX ESSAY T; Bhopal R, 2011, LANCET, V378, P464, DOI 10.1016/S0140-6736(11)61147-1; Butland B., 2007, FORESIGHT TACKLING O; Chapman J., 2004, SYSTEM FAILURE; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Lang T, 2007, OBES REV, V8, P165, DOI 10.1111/j.1467-789X.2007.00338.x; RITTEL HWJ, 1973, POLICY SCI, V4, P155, DOI 10.1007/BF01405730; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1	8	34	34	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG-SEP	2011	378	9793					746	747		10.1016/S0140-6736(11)61272-5	http://dx.doi.org/10.1016/S0140-6736(11)61272-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816FY	21872736				2022-12-01	WOS:000294585300006
J	Abubakar, I; Lipman, M; Anderson, C; Davies, P; Zumla, A				Abubakar, Ibrahim; Lipman, Marc; Anderson, Charlotte; Davies, Peter; Zumla, Alimuddin			Tuberculosis in the UK-time to regain control	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NEW-YORK-CITY; ASYLUM SEEKERS; IMMIGRATION; EPIDEMIOLOGY; POLITICS; ENGLAND; IMPACT; ENTRY; CARE		[Abubakar, Ibrahim] Hlth Protect Agcy, Hlth Protect Serv Colindale, TB Sect, London NW9 5EQ, England; [Abubakar, Ibrahim] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Lipman, Marc] UCL, Sch Med, Royal Free Hosp, Ctr Resp Med, London W1N 8AA, England; [Anderson, Charlotte] Hlth Protect Agcy, London Reg Epidemiol Unit, London, England; [Davies, Peter] Liverpool Heart & Chest Hosp, TB Unit, Liverpool, Merseyside, England; [Zumla, Alimuddin] UCL, Sch Med, Div Infect & Immun, London WC1E 6BT, England	Health Protection Agency; University of East Anglia; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Health Protection Agency; Liverpool Heart & Chest Hospital; University of London; University College London; UCL Medical School	Abubakar, I (corresponding author), Hlth Protect Agcy, Hlth Protect Serv Colindale, TB Sect, London NW9 5EQ, England.	ibrahim.abubakar@hpa.org.uk	ZUMLA, Alimuddin/ABA-8208-2020	ZUMLA, Alimuddin/0000-0002-5111-5735; Abubakar, Ibrahim/0000-0002-0370-1430; Lipman, Marc/0000-0001-7501-4448				Abubakar I, 2010, COST EFFECTIVENESS F; Ahmed AB, 2007, THORAX, V62, P672, DOI 10.1136/thx.2006.072611; Anderson C, 2011, EVALUATION IMPLEMENT; Anderson C, 2010, J EPIDEMIOL COMMUN H, V64, P373, DOI 10.1136/jech.2009.094375; Borgdorff MW, 2010, EUR RESPIR J, V36, P339, DOI 10.1183/09031936.00155409; *BRIT THOR SOC ALL, 2008, PUTT TUB LOC AG; Erkens C, 2008, EUR RESPIR J, V32, P153, DOI 10.1183/09031936.00137907; [European Centre for Disease Prevention and Control WHO], 2003, TUB SURV REP; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; GEITER L, 2000, ENDING NEGLECT ELIMI; Gilbert RL, 2009, INT J TUBERC LUNG D, V13, P645; Griffiths C, 2007, LANCET, V369, P1528, DOI 10.1016/S0140-6736(07)60707-7; Harstad I, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-670; Hayward J, 2010, LONDON TB SERVICE RE; Health Protection Agency, ENH TB SURV; Health Protection Agency, 2010, TUB UK ANN REP TUB S; Hollo V, 2009, EUROSURVEILLANCE, V14; Love J, 2009, INT J TUBERC LUNG D, V13, P201; Lowenthal P, 2011, INT J TUBERC LUNG D, V15, P761, DOI 10.5588/ijtld.10.0370; Moore-Gillon J, 2010, THORAX, V65, P663, DOI 10.1136/thx.2009.132373; New York Health Department, 2008, CLIN POL PROT; NICE, 2011, TUB CG117 CLIN DIAGN; Paolo WF, 2004, LANCET INFECT DIS, V4, P287, DOI 10.1016/S1473-3099(04)01004-7; Pareek M, 2011, EUR RESPIR J, V37, P1175, DOI 10.1183/09031936.00105810; Pareek M, 2011, LANCET INFECT DIS, V11, P435, DOI 10.1016/S1473-3099(11)70069-X; Story A, 2007, THORAX, V62, P667, DOI 10.1136/thx.2006.065409; Story A, 2006, BRIT MED J, V333, P57, DOI 10.1136/bmj.333.7558.57; Taylor K, 2009, BRIT J GEN PRACT, V59, P765, DOI 10.3399/bjgp09X472539; Watson J, 2007, MOBILE TARGETED DIGI	29	42	42	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2011	343								d4281	10.1136/bmj.d4281	http://dx.doi.org/10.1136/bmj.d4281			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801LY	21804155				2022-12-01	WOS:000293441600001
J	Zhang, K; Ding, S				Zhang, Kang; Ding, Sheng			Stem Cells and Eye Development	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zhang, Kang] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Mol Med Res Ctr, Chengdu 610064, Peoples R China; [Zhang, Kang] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Dept Ophthalmol, Chengdu 610064, Peoples R China; [Zhang, Kang] Univ Calif San Diego, Shiley Eye Ctr, La Jolla, CA 92093 USA; [Zhang, Kang] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Ding, Sheng] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94143 USA; [Ding, Sheng] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	Sichuan University; Sichuan University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Zhang, K (corresponding author), Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Mol Med Res Ctr, Chengdu 610064, Peoples R China.		Zhang, Kang/Y-2740-2019	Zhang, Kang/0000-0002-4549-1697	NATIONAL EYE INSTITUTE [R01EY021374, R01EY018660] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY018660, R01 EY021374] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691	4	14	16	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2011	365	4					370	372		10.1056/NEJMcibr1105280	http://dx.doi.org/10.1056/NEJMcibr1105280			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798AJ	21793749	Green Accepted			2022-12-01	WOS:000293172200018
J	Woo, WM; Oro, AE				Woo, Wei-Meng; Oro, Anthony E.			SnapShot: Hair Follicle Stem Cells	CELL			English	Editorial Material							REGENERATION; NICHE; ACTIVATION; LINEAGES; SKIN		[Woo, Wei-Meng; Oro, Anthony E.] Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA	Stanford University	Woo, WM (corresponding author), Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA.		Woo, Wei Meng/M-5856-2013; Woo, Wei Meng/H-6594-2015	Oro, Anthony/0000-0002-6261-138X	NIAMS NIH HHS [R01 AR052785, R01 AR054780] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052785, R01AR054780] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; Fuchs E, 2008, COLD SH Q B, V73, P333, DOI 10.1101/sqb.2008.73.032; Fujiwara H, 2011, CELL, V144, P577, DOI 10.1016/j.cell.2011.01.014; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Legue E, 2010, DEVELOPMENT, V137, P569, DOI 10.1242/dev.044123; Plikus MV, 2011, SCIENCE, V332, P586, DOI 10.1126/science.1201647; Rabbani P, 2011, CELL, V145, P941, DOI 10.1016/j.cell.2011.05.004; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733	10	35	37	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 22	2011	146	2					334	U159		10.1016/j.cell.2011.07.001	http://dx.doi.org/10.1016/j.cell.2011.07.001			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	795XS	21784251	Green Accepted, Bronze			2022-12-01	WOS:000293013000015
J	Polak, JF; Pencina, MJ; Pencina, KM; O'Donnell, CJ; Wolf, PA; D'Agostino, RB				Polak, Joseph F.; Pencina, Michael J.; Pencina, Karol M.; O'Donnell, Christopher J.; Wolf, Philip A.; D'Agostino, Ralph B., Sr.			Carotid-Wall Intima-Media Thickness and Cardiovascular Events	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; ATHEROSCLEROSIS RISK; ARTERIAL-WALL; MYOCARDIAL-INFARCTION; FRAMINGHAM RISK; PREDICTION; STROKE; COMMUNITIES; POPULATION; PLAQUE	Background Intima-media thickness of the walls of the common carotid artery and internal carotid artery may add to the Framingham risk score for predicting cardiovascular events. Methods We measured the mean intima-media thickness of the common carotid artery and the maximum intima-media thickness of the internal carotid artery in 2965 members of the Framingham Offspring Study cohort. Cardiovascular-disease outcomes were evaluated for an average follow-up of 7.2 years. Multivariable Cox proportional-hazards models were generated for intima-media thickness and risk factors. We evaluated the reclassification of cardiovascular disease on the basis of the 8-year Framingham risk score category (low, intermediate, or high) after adding intima-media thickness values. Results A total of 296 participants had a cardiovascular event. The risk factors of the Framingham risk score predicted these events, with a C statistic of 0.748 (95% confidence interval [CI], 0.719 to 0.776). The adjusted hazard ratio for cardiovascular disease with a 1-SD increase in the mean intima-media thickness of the common carotid artery was 1.13 (95% CI, 1.02 to 1.24), with a nonsignificant change in the C statistic of 0.003 (95% CI, 0.000 to 0.007); the corresponding hazard ratio for the maximum intima-media thickness of the internal carotid artery was 1.21 (95% CI, 1.13 to 1.29), with a modest increase in the C statistic of 0.009 (95% CI, 0.003 to 0.016). The net reclassification index increased significantly after addition of intima-media thickness of the internal carotid artery (7.6%, P<0.001) but not intima-media thickness of the common carotid artery (0.0%, P = 0.99). With the presence of plaque, defined as intima-media thickness of the internal carotid artery of more than 1.5 mm, the net reclassification index was 7.3% (P = 0.01), with an increase in the C statistic of 0.014 (95% CI, 0.003 to 0.025). Conclusions The maximum internal and mean common carotid-artery intima-media thicknesses both predict cardiovascular outcomes, but only the maximum intima-media thickness of (and presence of plaque in) the internal carotid artery significantly (albeit modestly) improves the classification of risk of cardiovascular disease in the Framingham Offspring Study cohort.	[Polak, Joseph F.] Tufts Med Ctr, Dept Radiol, Boston, MA 02111 USA; [Pencina, Michael J.] Boston Univ, Dept Biostat, Boston, MA 02215 USA; [Pencina, Karol M.; D'Agostino, Ralph B., Sr.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Wolf, Philip A.] Boston Univ, Dept Med & Neurol, Boston, MA 02215 USA; [O'Donnell, Christopher J.] NHLBI, Div Intramural Res, Framingham, MA USA	Tufts Medical Center; Boston University; Boston University; Boston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Polak, JF (corresponding author), Tufts Med Ctr, Dept Radiol, 800 Washington St,Box 299, Boston, MA 02111 USA.	jpolak@tuftsmedicalcenter.org		Wolf, Philip/0000-0002-3628-301X; Pencina, Michael/0000-0001-5798-8855	National Heart, Lung, and Blood Institute [R01 HL069003, HL081352, N01-HC-25195]; Abbott; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006002, R01HL081352, R01HL069003] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Abbott(Abbott Laboratories); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Heart, Lung, and Blood Institute (R01 HL069003 and HL081352, to Dr. Polak) and its Framingham Heart Study (N01-HC-25195).; Dr. Pencina reports receiving fees for board membership from Abbott. No other potential conflict of interest relevant to this article was reported.	Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; Chambless LE, 2000, AM J EPIDEMIOL, V151, P478; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Dalager S, 2007, STROKE, V38, P2698, DOI 10.1161/STROKEAHA.107.486480; del Sol AI, 2001, STROKE, V32, P1532, DOI 10.1161/01.STR.32.7.1532; Expert Panel on Detection E Treatment of High Blood Cholesterol in A, 2001, JAMA, V285, P2486; Folsom AR, 2008, ARCH INTERN MED, V168, P1333, DOI 10.1001/archinte.168.12.1333; Greenland P, 2010, CIRCULATION, V122, P2748, DOI 10.1161/CIR.0b013e3182051bab; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; Hodis HN, 1996, ANN INTERN MED, V124, P548, DOI 10.7326/0003-4819-124-6-199603150-00002; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; LI RL, 1994, STROKE, V25, P2377, DOI 10.1161/01.STR.25.12.2377; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Lorenz MW, 2006, STROKE, V37, P87, DOI 10.1161/01.STR.0000196964.24024.ea; MCNAMARA JR, 1987, CLIN CHIM ACTA, V166, P1, DOI 10.1016/0009-8981(87)90188-4; Naghavi M., 2006, AM J CARDIOL, V98, P2, DOI DOI 10.1016/J.AMJCARD.2006.03.002; Nambi V, 2010, J AM COLL CARDIOL, V55, P1600, DOI 10.1016/j.jacc.2009.11.075; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; OLeary DH, 1996, STROKE, V27, P224, DOI 10.1161/01.STR.27.2.224; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; PIGNOLI P, 1986, CIRCULATION, V74, P1399, DOI 10.1161/01.CIR.74.6.1399; POLAK JF, 1993, RADIOLOGY, V188, P363, DOI 10.1148/radiology.188.2.8327679; Polak JF, 2010, J ULTRAS MED, V29, P1759, DOI 10.7863/jum.2010.29.12.1759; Rosvall M, 2005, J INTERN MED, V257, P430, DOI 10.1111/j.1365-2796.2005.01485.x; Rundek T, 2008, NEUROLOGY, V70, P1200, DOI 10.1212/01.wnl.0000303969.63165.34; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P376; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Touboul PJ, 2005, STROKE, V36, P1741, DOI 10.1161/01.STR.0000174490.23495.57; Touboul PJ, 2004, CEREBROVASC DIS, V18, P346, DOI 10.1159/000081812; Tzoulaki I, 2009, JAMA-J AM MED ASSOC, V302, P2345, DOI 10.1001/jama.2009.1757; WARWICK GR, 1982, CLIN CHEM, V28, P1379; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	36	564	588	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2011	365	3					213	221		10.1056/NEJMoa1012592	http://dx.doi.org/10.1056/NEJMoa1012592			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794QI	21774709	Green Accepted			2022-12-01	WOS:000292915500005
J	Isaacs, FJ; Carr, PA; Wang, HH; Lajoie, MJ; Sterling, B; Kraal, L; Tolonen, AC; Gianoulis, TA; Goodman, DB; Reppas, NB; Emig, CJ; Bang, D; Hwang, SJ; Jewett, MC; Jacobson, JM; Church, GM				Isaacs, Farren J.; Carr, Peter A.; Wang, Harris H.; Lajoie, Marc J.; Sterling, Bram; Kraal, Laurens; Tolonen, Andrew C.; Gianoulis, Tara A.; Goodman, Daniel B.; Reppas, Nikos B.; Emig, Christopher J.; Bang, Duhee; Hwang, Samuel J.; Jewett, Michael C.; Jacobson, Joseph M.; Church, George M.			Precise Manipulation of Chromosomes in Vivo Enables Genome-Wide Codon Replacement	SCIENCE			English	Article							ESCHERICHIA-COLI; GENETIC-CODE; AMINO-ACIDS; RECOMBINATION; CONSEQUENCES; EVOLUTION; CLONING; SYSTEM; REPAIR; CELL	We present genome engineering technologies that are capable of fundamentally reengineering genomes from the nucleotide to the megabase scale. We used multiplex automated genome engineering (MAGE) to site-specifically replace all 314 TAG stop codons with synonymous TAA codons in parallel across 32 Escherichia coli strains. This approach allowed us to measure individual recombination frequencies, confirm viability for each modification, and identify associated phenotypes. We developed hierarchical conjugative assembly genome engineering (CAGE) to merge these sets of codon modifications into genomes with 80 precise changes, which demonstrate that these synonymous codon substitutions can be combined into higher-order strains without synthetic lethal effects. Our methods treat the chromosome as both an editable and an evolvable template, permitting the exploration of vast genetic landscapes.	[Isaacs, Farren J.; Wang, Harris H.; Lajoie, Marc J.; Kraal, Laurens; Tolonen, Andrew C.; Gianoulis, Tara A.; Goodman, Daniel B.; Jewett, Michael C.; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Carr, Peter A.; Sterling, Bram; Jacobson, Joseph M.] MIT, Ctr Bits & Atoms, Cambridge, MA 02139 USA; [Carr, Peter A.; Sterling, Bram; Jacobson, Joseph M.] MIT, Media Lab, Cambridge, MA 02139 USA; [Wang, Harris H.] Harvard Univ, Program Biophys, Cambridge, MA 02138 USA; [Wang, Harris H.; Goodman, Daniel B.] Harvard Mit Div Hlth Sci & Technol, Program Med Engn & Med Phys, Cambridge, MA 02139 USA; [Wang, Harris H.; Gianoulis, Tara A.; Church, George M.] Harvard Univ, Wyss Inst, Boston, MA 02115 USA; [Lajoie, Marc J.] Harvard Univ, Program Chem Biol, Cambridge, MA 02138 USA; [Reppas, Nikos B.] Jould Unltd, Cambridge, MA 02139 USA; [Emig, Christopher J.] Stanford Univ, Dept Bioengn, Palo Alto, CA 94305 USA; [Bang, Duhee] Yonsei Univ, Dept Chem, Seoul 120749, South Korea; [Hwang, Samuel J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Jewett, Michael C.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Jewett, Michael C.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Harvard University; Harvard University; Stanford University; Yonsei University; Massachusetts Institute of Technology (MIT); Northwestern University; Northwestern University	Isaacs, FJ (corresponding author), Yale Univ, Syst Biol Inst, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	farren.isaacs@yale.edu; carr@mit.edu	Jewett, Michael C/E-3506-2010	Jewett, Michael/0000-0003-2948-6211; church, george/0000-0001-6232-9969; Goodman, Daniel/0000-0003-3759-6883; Tolonen, Andrew/0000-0001-5907-4504; Jacobson, Joseph/0000-0002-1332-3197	NSF (SynBERC, Center for Bits and Atoms, and Genes and Genomes Systems Cluster); U.S. Department of Energy; NSF; National Defense Science and Engineering Graduate Fellowship; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM081450, K99GM081450] Funding Source: NIH RePORTER	NSF (SynBERC, Center for Bits and Atoms, and Genes and Genomes Systems Cluster); U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); National Defense Science and Engineering Graduate Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Zhang for helpful discussions and extensive use of laboratory resources, R. Kolter for the JC411 strain, and members of the Church and Jacobson labs for helpful discussions. Supported by the NSF (SynBERC, Center for Bits and Atoms, and Genes and Genomes Systems Cluster), the U.S. Department of Energy, an NSF graduate fellowship (H. H. W.), a National Defense Science and Engineering Graduate Fellowship (M.J.L.), and an NIH K99/R00 award (M.C.J.).	Ambrogelly A, 2007, NAT CHEM BIOL, V3, P29, DOI 10.1038/nchembio847; Carr PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh160; Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Cha R S, 1992, PCR Methods Appl, V2, P14; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; Costantino N, 2003, P NATL ACAD SCI USA, V100, P15748, DOI 10.1073/pnas.2434959100; DeVito JA, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1084; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Funchain P, 2000, GENETICS, V154, P959; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; GUTMAN GA, 1989, P NATL ACAD SCI USA, V86, P3699, DOI 10.1073/pnas.86.10.3699; Hemm MR, 2010, J BACTERIOL, V192, P46, DOI 10.1128/JB.00872-09; IRWIN B, 1995, J BIOL CHEM, V270, P22801, DOI 10.1074/jbc.270.39.22801; Itaya M, 2005, P NATL ACAD SCI USA, V102, P15971, DOI 10.1073/pnas.0503868102; Jacinto-Loeza E, 2008, NUCLEIC ACIDS RES, V36, P4233, DOI 10.1093/nar/gkn395; Knight RD, 2001, NAT REV GENET, V2, P49, DOI 10.1038/35047500; Lartigue C, 2007, SCIENCE, V317, P632, DOI 10.1126/science.1144622; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Masi M, 2007, J BACTERIOL, V189, P2667, DOI 10.1128/JB.01448-06; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mukai T, 2010, NUCLEIC ACIDS RES, V38, P8188, DOI 10.1093/nar/gkq707; Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Oppenheim AB, 2004, VIROLOGY, V319, P185, DOI 10.1016/j.virol.2003.11.007; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; SCHAAPER RM, 1987, P NATL ACAD SCI USA, V84, P6220, DOI 10.1073/pnas.84.17.6220; SMITH GR, 1991, CELL, V64, P19, DOI 10.1016/0092-8674(91)90205-D; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Young TS, 2010, J BIOL CHEM, V285, P11039, DOI 10.1074/jbc.R109.091306; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	35	392	436	5	215	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2011	333	6040					348	353		10.1126/science.1205822	http://dx.doi.org/10.1126/science.1205822			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21764749	Green Accepted, Green Submitted, Green Published			2022-12-01	WOS:000292732000045
J	Luo, AH; Tahsili-Fahadan, P; Wise, RA; Lupica, CR; Aston-Jones, G				Luo, Alice H.; Tahsili-Fahadan, Pouya; Wise, Roy A.; Lupica, Carl R.; Aston-Jones, Gary			Linking Context with Reward: A Functional Circuit from Hippocampal CA3 to Ventral Tegmental Area	SCIENCE			English	Article							DOPAMINE NEURONS; COCAINE-SEEKING; NUCLEUS; RAT; REPRESENTATIONS; STIMULATION; PROJECTIONS; AFFERENTS; RELAPSE; MEMORY	Reward-motivated behavior is strongly influenced by the learned significance of contextual stimuli in the environment. However, the neural pathways that mediate context-reward relations are not well understood. We have identified a circuit from area CA3 of dorsal hippocampus to ventral tegmental area (VTA) that uses lateral septum (LS) as a relay. Theta frequency stimulation of CA3 excited VTA dopamine (DA) neurons and inhibited non-DA neurons. DA neuron excitation was likely mediated by disinhibition because local antagonism of g-aminobutyric acid receptors blocked responses to CA3 stimulation. Inactivating components of the CA3-LS-VTA pathway blocked evoked responses in VTA and also reinstatement of cocaine-seeking by contextual stimuli. This transsynaptic link between hippocampus and VTA appears to be an important substrate by which environmental context regulates goal-directed behavior.	[Luo, Alice H.; Wise, Roy A.] Natl Inst Drug Abuse, Behav Neurosci Sect, Behav Neurosci Res Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Tahsili-Fahadan, Pouya; Aston-Jones, Gary] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Lupica, Carl R.] Natl Inst Drug Abuse, Electrophysiol Res Sect, Cellular Neurobiol Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Luo, AH (corresponding author), Natl Inst Drug Abuse, Behav Neurosci Sect, Behav Neurosci Res Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA.	alice_luo@hotmail.com	Lupica, Carl/AAY-3193-2021; Wise, Roy A/A-6465-2012	Lupica, Carl/0000-0002-5375-3263; 	U.S. Public Health Service [R37-DA006214, F31-MH071093]; National Institute on Drug Abuse; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH071093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA006214, ZIADA000471, ZIADA000588, ZIADA000457] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B. Bingham and J. See for assistance with the initial anatomical experiments; R. Fallon, G. Sartor, L. Zhang, S. Mahler, K. Moussawi, R. Smith, and T. Smith for assistance with behavioral studies; C. Backman and W. Freed for use of their microscopy equipment; and C. Mejias-Aponte for his programming expertise and thoughtful comments. This work was supported by U.S. Public Health Service grant awards R37-DA006214 and F31-MH071093, and the National Institute on Drug Abuse Intramural Research Program. The anatomical data were gathered at the University of Pennsylvania.	Alvernhe A, 2008, J NEUROSCI, V28, P7324, DOI 10.1523/JNEUROSCI.1909-08.2008; Bossert JM, 2005, EUR J PHARMACOL, V526, P36, DOI 10.1016/j.ejphar.2005.09.030; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; CARD JP, 1993, J NEUROSCI, V13, P2515, DOI 10.1523/JNEUROSCI.13-06-02515.1993; DEFRANCE JF, 1973, EXP BRAIN RES, V17, P447; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Floresco SB, 2001, J NEUROSCI, V21, P4915, DOI 10.1523/JNEUROSCI.21-13-04915.2001; Fuchs RA, 2007, EUR J NEUROSCI, V26, P487, DOI 10.1111/j.1460-9568.2007.05674.x; Geisler S, 2005, J COMP NEUROL, V490, P270, DOI 10.1002/cne.20668; Hasselmo ME, 2005, HIPPOCAMPUS, V15, P936, DOI 10.1002/hipo.20116; JOHNSON SW, 1992, J NEUROSCI, V12, P483; Legault M, 2000, J NEUROSCI, V20, P1635; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Luo AH, 2009, EUR J NEUROSCI, V29, P748, DOI 10.1111/j.1460-9568.2008.06606.x; SWANSON LW, 1981, J NEUROSCI, V1, P548; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Vorel SR, 2001, SCIENCE, V292, P1175, DOI 10.1126/science.1058043	17	269	277	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2011	333	6040					353	357		10.1126/science.1204622	http://dx.doi.org/10.1126/science.1204622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21764750	Green Accepted			2022-12-01	WOS:000292732000046
J	Gravitz, L				Gravitz, Lauren			DRUGS A tangled web of targets	NATURE			English	Editorial Material							ALZHEIMERS-DISEASE											Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Mazanetz MP, 2007, NAT REV DRUG DISCOV, V6, P464, DOI 10.1038/nrd2111; Medina DX, 2011, BRAIN PATHOL, V21, P140, DOI 10.1111/j.1750-3639.2010.00430.x; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0	5	62	64	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2011	475	7355					S9	S11		10.1038/475S9a	http://dx.doi.org/10.1038/475S9a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	791UA	21760583				2022-12-01	WOS:000292690500005
J	Shimamura, T; Shiroishi, M; Weyand, S; Tsujimoto, H; Winter, G; Katritch, V; Abagyan, R; Cherezov, V; Liu, W; Han, GW; Kobayashi, T; Stevens, RC; Iwata, S				Shimamura, Tatsuro; Shiroishi, Mitsunori; Weyand, Simone; Tsujimoto, Hirokazu; Winter, Graeme; Katritch, Vsevolod; Abagyan, Ruben; Cherezov, Vadim; Liu, Wei; Han, Gye Won; Kobayashi, Takuya; Stevens, Raymond C.; Iwata, So			Structure of the human histamine H-1 receptor complex with doxepin	NATURE			English	Article							SITE-DIRECTED MUTAGENESIS; STRUCTURE-BASED DISCOVERY; CRYSTAL-STRUCTURE; BINDING-SITE; MUTATIONAL ANALYSIS; ANTIDEPRESSANTS; PURIFICATION; MEMBRANE; AFFINITY; MODELS	The biogenic amine histamine is an important pharmacological mediator involved in pathophysiological processes such as allergies and inflammations. Histamine H-1 receptor (H1R) antagonists are very effective drugs alleviating the symptoms of allergic reactions. Here we show the crystal structure of the H1R complex with. doxepin, a first-generation H1R antagonist. Doxepin sits deep in the ligand-binding pocket and directly interacts with Trp 428(6,48), a highly conserved key residue G -protein-coupled-receptor activation. This well-conserved pocket with mostly hydrophobic nature contributes to the low selectivity of the first-generation compounds. The pocket is associated with an anion-binding region occupied by a phosphate ion. Docking of various second-generation H1R antagonists reveals that the unique carboxyl group present in this class of compounds interacts with Lys191(5.39) and/or Lys 179(ECL2), both of which form part of the anion-binding region. This region is not conserved in other aminergic receptors, demonstrating how minor differences in receptors lead to pronounced selectivity differences with small molecules. Our study sheds light on the molecular basis of H1R antagonist specificity against H1R.	[Shimamura, Tatsuro; Cherezov, Vadim; Liu, Wei; Han, Gye Won; Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Shimamura, Tatsuro; Shiroishi, Mitsunori; Weyand, Simone; Tsujimoto, Hirokazu; Kobayashi, Takuya; Iwata, So] Japan Sci & Technol Agcy, ERATO, Human Receptor Crystallog Project, Sakyo Ku, Kyoto 6068501, Japan; [Shimamura, Tatsuro; Shiroishi, Mitsunori; Tsujimoto, Hirokazu; Kobayashi, Takuya; Iwata, So] Kyoto Univ, Grad Sch Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Shiroishi, Mitsunori] Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, Fukuoka 8128582, Japan; [Weyand, Simone; Iwata, So] Univ London Imperial Coll Sci Technol & Med, Membrane Prot Crystallog Grp, Div Mol Biosci, London SW7 2AZ, England; [Weyand, Simone; Winter, Graeme; Iwata, So] Diamond Light Source, Didcot OX11 0DE, Oxon, England; [Katritch, Vsevolod; Abagyan, Ruben] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Katritch, Vsevolod; Abagyan, Ruben] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; [Iwata, So] RIKEN, Syst & Struct Biol Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Scripps Research Institute; Japan Science & Technology Agency (JST); Kyoto University; Kyushu University; Imperial College London; Diamond Light Source; University of California System; University of California San Diego; University of California System; University of California San Diego; RIKEN	Stevens, RC (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	t-coba@mfour.med.kyoto-u.ac.jp; stevens@scripps.edu; so_iwata@me.com	soler, martha maricel m gomez/L-6025-2014; Cherezov, Vadim/L-9812-2013; Katritch, Vsevolod/Q-8357-2016; Stevens, Raymond/K-7272-2015; Han, Gye Won/GLT-1531-2022; Liu, Wei/F-1820-2011; Han, Gye Won/GLQ-8673-2022; Han, Gye Won/GLQ-8724-2022; Katritch, Vsevolod/Y-2721-2019	soler, martha maricel m gomez/0000-0002-4412-8108; Cherezov, Vadim/0000-0002-5265-3914; Katritch, Vsevolod/0000-0003-3883-4505; Stevens, Raymond/0000-0002-4522-8725; Han, Gye Won/0000-0003-4107-835X; Shiroishi, Mitsunori/0000-0002-3133-157X	Japan Science and Technology Agency; MEXT, Japan; NIH [P50 GM073197, R01 GM071872, GM075915]; NIH PSI [U54 GM094618]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G023425/1]; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Scientific Foundation; Sumitomo Foundation; Wellcome Trust at the Diamond Light Source Limited [062164/7/00/Z]; Scripps Research Institute; National Science Foundation [HS0308078]; Science Foundation Ireland [02-IN1-B266]; Biotechnology and Biological Sciences Research Council [BB/G023425/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073197, R01GM089857, R01GM071872, U54GM094618] Funding Source: NIH RePORTER; BBSRC [BB/G023425/1] Funding Source: UKRI	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH PSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Scientific Foundation(Takeda Science Foundation (TSF)); Sumitomo Foundation; Wellcome Trust at the Diamond Light Source Limited(Wellcome Trust); Scripps Research Institute; National Science Foundation(National Science Foundation (NSF)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the ERATO Human Receptor Crystallography Project from the Japan Science and Technology Agency and by the Targeted Proteins Research Program of MEXT (S.I.), Japan; the NIH Common Fund grant P50 GM073197 for technology development (R.C.S.) and NIH PSI:Biology grant U54 GM094618 (R.C.S., V.C., V.K. and R.A.); R.A. was also partly funded by NIH R01 GM071872. The work was also partly funded by the Biotechnology and Biological Sciences Research Council (BBSRC) BB/G023425/1 (SI), Grant-in-Aid for challenging Exploratory Research (T.S.), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (T.S. and T.K.), Takeda Scientific Foundation (M.S.) and the Sumitomo Foundation (T K.). A part of the work was performed in the Membrane Protein Laboratory funded by the Wellcome Trust (grant 062164/7/00/Z) at the Diamond Light Source Limited and at The Scripps Research Institute. We thank D. Axford, R. Owen and G. Evans for help with data collection at 124 of the Diamond Light Source Limited, H. Wu for help with the preparation of Supplementary Fig. 1 and Q. Xu for help on validation of data processing and A. Walker for assistance with manuscript preparation. The authors acknowledge Y. Zheng (The Ohio State University) and M. Caffrey, Trinity College (Dublin, Ireland), for the loan of the in meso robot (built with support from the NIH (GM075915), the National Science Foundation (HS0308078), and Science Foundation Ireland (02-IN1-B266)). S.I. is thankful for the help of L E Johnson, a co-founder of the Diamond-MPL Project and R. Tanaka, the technical coordinator of the ERATO Human Receptor Crystallography Project.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Abagyan R., 2011, ICM MANUAL V 3 0; Aishima J, 2010, ACTA CRYSTALLOGR D, V66, P1032, DOI 10.1107/S0907444910028192; [Anonymous], [No title captured], DOI DOI 10.1145/299432.299509; Bakker RA, 2004, MOL PHARMACOL, V65, P538, DOI 10.1124/mol.65.3.538; Bakker RA, 2000, EUR J PHARMACOL, V387, pR5, DOI 10.1016/S0014-2999(99)00803-1; Bakker RA, 2001, MOL PHARMACOL, V60, P1133, DOI 10.1124/mol.60.5.1133; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI DOI 10.1016/S1043-9471(05)80049-7; Bruysters M, 2004, EUR J PHARMACOL, V487, P55, DOI 10.1016/j.ejphar.2004.01.028; Cherezov V, 2004, ACTA CRYSTALLOGR D, V60, P1795, DOI 10.1107/S0907444904019109; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; CUSACK B, 1994, PSYCHOPHARMACOLOGY, V114, P559, DOI 10.1007/BF02244985; de Graaf C, 2009, CURR PHARM DESIGN, V15, P4026, DOI 10.2174/138161209789824786; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gillard M, 2003, INFLAMM RES, V52, pS49, DOI 10.1007/s000110300050; Gillard M, 2002, MOL PHARMACOL, V61, P391, DOI 10.1124/mol.61.2.391; Hill SJ, 1997, PHARMACOL REV, V49, P253; HILL SJ, 1990, PHARMACOL REV, V42, P45; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jongejan A, 2005, ARCH PHARM, V338, P248, DOI 10.1002/ardp.200400998; Katritch V, 2011, NEUROPHARMACOLOGY, V60, P108, DOI 10.1016/j.neuropharm.2010.07.009; Katritch V, 2010, J MED CHEM, V53, P1799, DOI 10.1021/jm901647p; Katritch V, 2009, J MOL RECOGNIT, V22, P307, DOI 10.1002/jmr.949; Kiss R, 2004, EUR J MED CHEM, V39, P959, DOI 10.1016/j.ejmech.2004.07.009; Klabunde T, 2002, CHEMBIOCHEM, V3, P929, DOI 10.1002/1439-7633(20021004)3:10<928::AID-CBIC928>3.0.CO;2-5; Kolb P, 2009, P NATL ACAD SCI USA, V106, P6843, DOI 10.1073/pnas.0812657106; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; LEURS R, 1995, BIOCHEM BIOPH RES CO, V214, P110, DOI 10.1006/bbrc.1995.2263; Matsumoto Y, 2008, PHARMACOLOGY, V81, P266, DOI 10.1159/000115970; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; Nonaka H, 1998, EUR J PHARMACOL, V345, P111, DOI 10.1016/S0014-2999(97)01620-8; OHTA K, 1994, BIOCHEM BIOPH RES CO, V203, P1096, DOI 10.1006/bbrc.1994.2295; Okamura N, 2000, BRIT J PHARMACOL, V129, P115, DOI 10.1038/sj.bjp.0702994; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; Qanbar R, 2003, PHARMACOL THERAPEUT, V97, P1, DOI 10.1016/S0163-7258(02)00300-5; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Ratnala VRP, 2004, EUR J BIOCHEM, V271, P2636, DOI 10.1111/j.1432-1033.2004.04192.x; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Sarker S, 2010, MOL PHARMACOL, V78, P1026, DOI 10.1124/mol.110.067538; SCHWARTZ JC, 1991, PHYSIOL REV, V71, P1, DOI 10.1152/physrev.1991.71.1.1; Simons FER, 2004, NEW ENGL J MED, V351, P2203, DOI 10.1056/NEJMra033121; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; Tashiro M, 2009, HUM PSYCHOPHARM CLIN, V24, P540, DOI 10.1002/hup.1051; Totrov M, 1997, PROTEINS, P215; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wieland K, 1999, J BIOL CHEM, V274, P29994, DOI 10.1074/jbc.274.42.29994; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; WOOSLEY RL, 1993, JAMA-J AM MED ASSOC, V269, P1532, DOI 10.1001/jama.269.12.1532; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; YAMASHITA M, 1991, P NATL ACAD SCI USA, V88, P11515, DOI 10.1073/pnas.88.24.11515; Yap Yee Guan, 2002, Clin Allergy Immunol, V17, P389	59	594	606	6	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					65	U82		10.1038/nature10236	http://dx.doi.org/10.1038/nature10236			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21697825	Green Accepted, Green Published			2022-12-01	WOS:000292461300045
J	Hart, CL; Gruer, L; Watt, GCM				Hart, Carole L.; Gruer, Laurence; Watt, Graham C. M.			Cause specific mortality, social position, and obesity among women who had never smoked: 28 year cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LUNG-FUNCTION; BODY-MASS; SMOKING; MEN; DISEASE; HEALTH; RISK; INEQUALITIES; OVERWEIGHT; SCOTLAND	Objective To investigate the relations between causes of death, social position, and obesity in women who had never smoked. Design Prospective cohort study. Setting Renfrew and Paisley, Scotland. Participants 8353 women and 7049 men aged 45-64 were recruited to the Renfrew and Paisley Study in 1972-6. Of these, 3613 women had never smoked and were the focus of this study. They were categorised by occupational class (I and II, III non-manual, III manual, and IV and V) and body mass index groups (normal weight, overweight, moderately obese, and severely obese). Main outcome measures All cause and cause specific mortality during 28 years of follow-up by occupational class and body mass index, using Cox proportional hazards models adjusted for age and other confounders. Results The women in lower occupational classes who had never smoked were on average shorter and had poorer lung function and higher systolic blood pressure than women in the higher occupational classes. Overall, 43% (n=1555) were overweight, 14% (n=515) moderately obese, and 5% (n=194) severely obese. Obesity rates were higher in lower occupational classes and much higher in all occupational classes than in current smokers in the full cohort. Half the women died, 51% (n=916) from cardiovascular disease and 27% (n=487) from cancer. Relative to occupational class I and II, all cause mortality rates were more than a third higher in occupational classes III manual (relative rate 1.35, 95% confidence interval 1.16 to 1.57) and IV and V (1.34, 1.17 to 1.55) and largely explained by differences in obesity, systolic blood pressure, and lung function. Similar upward gradients were seen for cardiovascular disease and respiratory disease but not for cancer. Mortality rates were highest in severely obese women in the lowest occupational classes. Conclusions Women who had never smoked and were not obese had the lowest mortality rates, regardless of their social position. Where obesity is socially patterned as in this cohort, it may contribute to health inequalities and increase pressure on health and social services serving more disadvantaged populations.	[Hart, Carole L.; Watt, Graham C. M.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow G12 8RZ, Lanark, Scotland; [Gruer, Laurence] NHS Hlth Scotland, Glasgow, Lanark, Scotland	University of Glasgow	Hart, CL (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Glasgow G12 8RZ, Lanark, Scotland.	carole.hart@glasgow.ac.uk		Gruer, Laurence/0000-0002-1089-2896	NHS Health Scotland; University of Glasgow	NHS Health Scotland; University of Glasgow	This research was supported by NHS Health Scotland. CLH and LG were funded by NHS Health Scotland and GCMW by the University of Glasgow. They had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. The researchers were independent of the funders. All decisions relating to the study were made by the authors alone. The views expressed in the paper may not reflect those of the funding organisations.	Aekplakorn Wichai, 2004, Journal of the Medical Association of Thailand, V87, P685; [Anonymous], 1965, LANCET, V1, P775; Cavelaars AEJM, 2000, BRIT MED J, V320, P1102, DOI 10.1136/bmj.320.7242.1102; Corbett J, 2009, SCOTTISH HLTH SURVEY; DALLOSSO HM, 1984, INT J OBESITY, V8, P365; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; General Register Office, 1966, CLASS OCC 1966, P1; Gruer L, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b480; Hart CL, 2005, INT J EPIDEMIOL, V34, P28, DOI 10.1093/ije/dyh348; Haslam D, 2006, BMJ-BRIT MED J, V333, P640, DOI 10.1136/bmj.333.7569.640; HAWTHORNE VM, 1995, SCOT MED J, V40, P102, DOI 10.1177/003693309504000402; Hole DJ, 1996, BRIT MED J, V313, P711; Hotchkiss JW, 2010, J EPIDEMIOL COMMUN H, V64, pA12, DOI 10.1136/jech.2010.120956.31; Huisman M, 2005, TOB CONTROL, V14, P106, DOI 10.1136/tc.2004.008573; Law MR, 1998, J EPIDEMIOL COMMUN H, V52, P344, DOI 10.1136/jech.52.6.344; Lawlor DA, 2006, OBESITY, V14, P2294, DOI 10.1038/oby.2006.269; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mannino DM, 2006, EUR RESPIR J, V27, P627, DOI 10.1183/09031936.06.00024605; Meyer HE, 2002, MED SCI SPORT EXER, V34, P1065, DOI 10.1097/00005768-200207000-00002; Nechuta SJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000339; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Sabia S, 2010, AM J EPIDEMIOL, V172, P1415, DOI 10.1093/aje/kwq294; Singh PN, 1998, EPIDEMIOLOGY, V9, P246, DOI 10.1097/00001648-199805000-00007; Stringhini S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000419; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; World Health Organization Commission on Social Inequalities in Health, 2007, ACH HLTH EQ ROOT CAU	26	19	19	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 28	2011	342								d3785	10.1136/bmj.d3785	http://dx.doi.org/10.1136/bmj.d3785			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	788PY	21712337	Green Submitted, Green Accepted, hybrid, Green Published			2022-12-01	WOS:000292458100003
J	Gardner, BM; Walter, P				Gardner, Brooke M.; Walter, Peter			Unfolded Proteins Are Ire1-Activating Ligands That Directly Induce the Unfolded Protein Response	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; MESSENGER-RNA; TRANSCRIPTION FACTOR; REVEALS; SPECIFICITY; IRE1P; BIP; MECHANISM; PATHWAY; BINDING	The unfolded protein response (UPR) detects the accumulation of unfolded proteins in the endoplasmic reticulum (ER) and adjusts the protein-folding capacity to the needs of the cell. Under conditions of ER stress, the transmembrane protein Ire1 oligomerizes to activate its cytoplasmic kinase and ribonuclease domains. It is unclear what feature of ER stress Ire1 detects. We found that the core ER-lumenal domain (cLD) of yeast Ire1 binds to unfolded proteins in yeast cells and to peptides primarily composed of basic and hydrophobic residues in vitro. Mutation of amino acid side chains exposed in a putative peptide-binding groove of Ire1 cLD impaired peptide binding. Peptide binding caused Ire1 cLD oligomerization in vitro, suggesting that direct binding to unfolded proteins activates the UPR.	[Gardner, Brooke M.; Walter, Peter] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Walter, Peter] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Walter, P (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	peter@walterlab.ucsf.edu		Gardner, Brooke/0000-0001-7999-8827	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	We thank J. Weissman, G. Narlikar, and D. Mullins for insightful comments; S. Neher and A. Korennykh for their invaluable guidance; and the Walter Lab, especially H. Li, E. van Anken, D. Pincus, C. Gallagher, and M. Diaz for their assistance and scientific discussions. Purified Kar2 was a generous gift from J. Brodsky. We are grateful to the Massachussetts Institute of Technology Biopolymers Institute for synthesizing the peptide arrays. B. G. was supported by a National Science Foundation predoctoral fellowship. P. W. is an investigator of the Howard Hughes Medical Institute.	Aragon T, 2009, NATURE, V457, P736, DOI 10.1038/nature07641; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; deCrouyChanel A, 1996, J BIOL CHEM, V271, P15486, DOI 10.1074/jbc.271.26.15486; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; ISHIWATAKIMATA Y, MOL BIOL CELL, DOI DOI 10.1091/MBC.E11-04-0295; Kawahara T, 1997, MOL BIOL CELL, V8, P1845, DOI 10.1091/mbc.8.10.1845; Kimata Y, 2004, J CELL BIOL, V167, P445, DOI 10.1083/jcb.200405153; Kimata Y, 2007, J CELL BIOL, V179, P75, DOI 10.1083/jcb.200704166; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Okamura K, 2000, BIOCHEM BIOPH RES CO, V279, P445, DOI 10.1006/bbrc.2000.3987; Peterson JH, 2003, J BIOL CHEM, V278, P46155, DOI 10.1074/jbc.M309082200; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	24	477	498	6	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 30	2011	333	6051					1891	1894		10.1126/science.1209126	http://dx.doi.org/10.1126/science.1209126			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21852455	Green Accepted, Bronze			2022-12-01	WOS:000295365800057
J	Wu, XL; Zhou, TQ; Zhu, J; Zhang, BS; Georgiev, I; Wang, C; Chen, XJ; Longo, NS; Louder, M; McKee, K; O'Dell, S; Perfetto, S; Schmidt, SD; Shi, W; Wu, L; Yang, YP; Yang, ZY; Yang, ZJ; Zhang, ZH; Bonsignori, M; Crump, JA; Kapiga, SH; Sam, NE; Haynes, BF; Simek, M; Burton, DR; Koff, WC; Doria-Rose, NA; Connors, M; Mullikin, JC; Nabel, GJ; Roederer, M; Shapiro, L; Kwong, PD; Mascola, JR				Wu, Xueling; Zhou, Tongqing; Zhu, Jiang; Zhang, Baoshan; Georgiev, Ivelin; Wang, Charlene; Chen, Xuejun; Longo, Nancy S.; Louder, Mark; McKee, Krisha; O'Dell, Sijy; Perfetto, Stephen; Schmidt, Stephen D.; Shi, Wei; Wu, Lan; Yang, Yongping; Yang, Zhi-Yong; Yang, Zhongjia; Zhang, Zhenhai; Bonsignori, Mattia; Crump, John A.; Kapiga, Saidi H.; Sam, Noel E.; Haynes, Barton F.; Simek, Melissa; Burton, Dennis R.; Koff, Wayne C.; Doria-Rose, Nicole A.; Connors, Mark; Mullikin, James C.; Nabel, Gary J.; Roederer, Mario; Shapiro, Lawrence; Kwong, Peter D.; Mascola, John R.		NISC Comparative Sequencing Progra	Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing	SCIENCE			English	Article							MONOCLONAL-ANTIBODIES; BROAD; SELECTION; BREADTH; EPITOPE; GLYCOPROTEIN; DIVERSITY; DESIGN; DOMAIN; GP120	Antibody VRC01 is a human immunoglobulin that neutralizes about 90% of HIV-1 isolates. To understand how such broadly neutralizing antibodies develop, we used x-ray crystallography and 454 pyrosequencing to characterize additional VRC01-like antibodies from HIV-1-infected individuals. Crystal structures revealed a convergent mode of binding for diverse antibodies to the same CD4-binding-site epitope. A functional genomics analysis of expressed heavy and light chains revealed common pathways of antibody-heavy chain maturation, confined to the IGHV1-2*02 lineage, involving dozens of somatic changes, and capable of pairing with different light chains. Broadly neutralizing HIV-1 immunity associated with VRC01-like antibodies thus involves the evolution of antibodies to a highly affinity-matured state required to recognize an invariant viral structure, with lineages defined from thousands of sequences providing a genetic roadmap of their development.	[Wu, Xueling; Zhou, Tongqing; Zhu, Jiang; Zhang, Baoshan; Georgiev, Ivelin; Wang, Charlene; Chen, Xuejun; Longo, Nancy S.; Louder, Mark; McKee, Krisha; O'Dell, Sijy; Perfetto, Stephen; Schmidt, Stephen D.; Shi, Wei; Wu, Lan; Yang, Yongping; Yang, Zhi-Yong; Yang, Zhongjia; Zhang, Zhenhai; Nabel, Gary J.; Roederer, Mario; Shapiro, Lawrence; Kwong, Peter D.; Mascola, John R.] NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA; [Zhang, Zhenhai; Shapiro, Lawrence] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Bonsignori, Mattia; Haynes, Barton F.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Crump, John A.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Crump, John A.] Duke Univ, Med Ctr, Div Infect Dis & Int Hlth, Dept Med, Durham, NC 27710 USA; [Crump, John A.; Sam, Noel E.] Tumaini Univ, Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Crump, John A.; Sam, Noel E.] Tumaini Univ, Kilimanjaro Christian Med Coll, Moshi, Tanzania; [Kapiga, Saidi H.; Sam, Noel E.] Kilimanjaro Reprod Hlth Programme, Moshi, Tanzania; [Simek, Melissa; Koff, Wayne C.] Int AIDS Vaccine Initiat IAVI, New York, NY 10038 USA; [Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbiol Sci, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Burton, Dennis R.] Massachusetts Gen Hosp, Massachusetts Inst Technol & Harvard, Ragon Inst, Cambridge, MA 02129 USA; [Doria-Rose, Nicole A.; Connors, Mark] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Mullikin, James C.; NISC Comparative Sequencing Progra] NHGRI, NIH Intramural Sequencing Ctr NISC, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; Columbia University; Duke University; Duke University; Duke University; Kilimanjaro Christian Medical Centre; International AIDS Vaccine Initiative; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Kwong, PD (corresponding author), NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA.	pdkwong@nih.gov; jmascola@nih.gov	Crump, John A./AAZ-6412-2020; Mascola, John/AAI-7193-2021; Schmidt, Stephen/AAC-6967-2019; Shapiro, Lawrence/AAE-7172-2019; Zhou, Tongqing/A-6880-2010; Zhang, Zhenhai/GRX-5887-2022; Roederer, Mario/G-1887-2011; Bonsignori, Mattia/AAE-7678-2019; Crump, John A./AAZ-6289-2020; Schmidt, Stephen/B-5398-2012	Crump, John A./0000-0002-4529-102X; Zhou, Tongqing/0000-0002-3935-4637; Zhang, Zhenhai/0000-0002-4310-0525; Bonsignori, Mattia/0000-0003-2973-2101; Crump, John A./0000-0002-4529-102X; Kapiga, Saidi/0000-0003-1753-4060	Vaccine Research Center, National Institute of Allergy and Infectious Diseases; National Human Genome Research Institute, NIH; International AIDS Vaccine Initiative's Neutralizing Antibody Consortium; NIH [AI 5U19 AI 067854-06]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196, ZIAHG200330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033292, ZIAAI005095, U19AI067854, ZIAAI005022] Funding Source: NIH RePORTER	Vaccine Research Center, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); International AIDS Vaccine Initiative's Neutralizing Antibody Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	X.W., T.Z., J.Z., G.J.N., M. R., L. S., P. D. K., and J.R.M. designed research; B.Z., C. W., X. C., M. L., K. M., S.O.D., S. P., S. D. S., W. S., L. W., Y.Y., Z.Y.Y., Z.Y., NISC, and J.M. performed experiments; X. W. isolated and characterized VRC01-like antibodies by RSC3 probe, devised and prepared samples for 454 pyrosequencing, and assisted with functional characterization; T.Z. determined and analyzed structures of VRC-PG04 and VRC03 with gp120 and assisted with functional characterization; J.Z. devised and carried out computational bioinformatics on the antibodyome; M. B., J.A.C, S. H. K, N.E.S., and B. F. H. contributed donor 0219 materials; M. S., D. R. B., and W. C. K contributed Protocol G materials, including donor 74; N.D.R. and M. C. contributed donor 45 materials; X. W., T.Z., J.Z, I. G., N.S.L., Z.Z., L. S., P. D. K., and J. R. M. analyzed the data; and L. S., G.J.N., P. D. K., and J. R. M. wrote the paper, on which all authors commented. We thank J. Almeida and D. Douek for protocols of PBMC cDNA preparation and for helpful discussions; J. Stuckey for assistance with figures; T. Wrin for sequence information on the donor 74 virus; J. Binley, D. Montefiori, L. Morris, and G. Tomaras for donor 0219 serum characterization; and all of the IAVI Protocol G team members and the Protocol G clinical investigators, specifically, G. Miiro, A. Pozniak, D. McPhee, O. Manigart, E. Karita, A. Inwoley, W. Jaoko, J. DeHovitz, L.-G. Bekker, P. Pitisuttithum, R. Paris, J. Serwanga, and S. Allen. We also thank H. Sato, I. Wilson, and members of the Structural Biology Section and Structural Bioinformatics Core, Vaccine Research Center, for discussions or comments on the manuscript. Support for this work was provided by the Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, and the National Human Genome Research Institute, NIH; by grants from the International AIDS Vaccine Initiative's Neutralizing Antibody Consortium; and by the Center for HIV AIDS Vaccine Immunology grant AI 5U19 AI 067854-06 from NIH. Use of sector 22 (Southeast Region Collaborative Access Team) at the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract W-31-109-Eng-38. Structure factors and coordinates for antibodies VRC03 and VRC-PG04 in complex with HIV-1 gp120 have been deposited with the Protein Data Bank under accession codes 3SE8 and 3SE9, respectively. We have also deposited deep sequencing data for donors 45 and 74 (Appendices 1 to 4) used in this study to National Center for Biotechnology Information Short Reads Archives (SRA) under accession no. SRP006992. Information deposited with GenBank includes the heavy-and light-chain variable region sequences of probe-identified antibodies VRC-PG04 and VRC-PG04b (accession nos. JN159464 to JN159467), VRC-CH30, VRC-CH31, and VRC-CH32 (JN159434 to JN159439), and VRC-CH33 and VRC-CH34 (JN159470 to 159473), as well as the sequences of genomically identified neutralizers: 24 heavy chains from donor 74, 2008 (JN159440 to JN159463), two heavy chains from donor 45, 2008 (JN159474 and JN159475), two light chains from donor 45, 2001 (JN159468 and JN159469), and 1561 unique sequences associated with neutralizing CDR H3 distributions with at least one low divergent member shown in Fig. 6B and fig. S16 (JN157873 to JN159433).	Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Breden F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016857; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Edry E, 2004, J IMMUNOL, V173, P4265, DOI 10.4049/jimmunol.173.7.4265; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; Gnanakaran S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000955; Gorny MK, 2009, MOL IMMUNOL, V46, P917, DOI 10.1016/j.molimm.2008.09.005; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Huber M, 2010, J VIROL, V84, P10700, DOI 10.1128/JVI.01111-10; Kabat EA, 1991, SEQUENCES PROTEINS I, V5th; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Lerner RA, 2011, MOL BIOSYST, V7, P1004, DOI 10.1039/c0mb00310g; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nemazee D, 2000, J EXP MED, V191, P1813, DOI 10.1084/jem.191.11.1813; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Sabin C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001195; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	37	650	711	3	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2011	333	6049					1593	1602		10.1126/science.1207532	http://dx.doi.org/10.1126/science.1207532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21835983	Green Accepted			2022-12-01	WOS:000294900900034
J	Cote, M; Misasi, J; Ren, T; Bruchez, A; Lee, K; Filone, CM; Hensley, L; Li, Q; Ory, D; Chandran, K; Cunningham, J				Cote, Marceline; Misasi, John; Ren, Tao; Bruchez, Anna; Lee, Kyungae; Filone, Claire Marie; Hensley, Lisa; Li, Qi; Ory, Daniel; Chandran, Kartik; Cunningham, James			Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection	NATURE			English	Article							STEROL-SENSING DOMAIN; CHOLESTEROL ACCUMULATION; ZAIRE EBOLAVIRUS; VIRAL ENTRY; BINDING; GLYCOPROTEIN; PROTEIN; TRAFFICKING; EVENTS; IDENTIFICATION	Ebola virus (EboV) is a highly pathogenic enveloped virus that causes outbreaks of zoonotic infection in Africa. The clinical symptoms are manifestations of the massive production of pro-inflammatory cytokines in response to infection(1) and in many outbreaks, mortality exceeds 75%. The unpredictable onset, ease of transmission, rapid progression of disease, high mortality and lack of effective vaccine or therapy have created a high level of public concern about EboV(2). Here we report the identification of a novel benzylpiperazine adamantane diamide-derived compound that inhibits EboV infection. Using mutant cell lines and informative derivatives of the lead compound, we show that the target of the inhibitor is the endosomal membrane protein Niemann-Pick C1 (NPC1). We find that NPC1 is essential for infection, that it binds to the virus glycoprotein (GP), and that antiviral compounds interfere with GP binding to NPC1. Combined with the results of previous studies of GP structure and function, our findings support a model of EboV infection in which cleavage of the GP1 subunit by endosomal cathepsin proteases removes heavily glycosylated domains to expose the amino-terminal domain(3-7), which is a ligand for NPC1 and regulates membrane fusion by the GP2 subunit(8). Thus, NPC1 is essential for EboV entry and a target for antiviral therapy.	[Cote, Marceline; Misasi, John; Bruchez, Anna; Filone, Claire Marie; Li, Qi; Chandran, Kartik; Cunningham, James] Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA; [Misasi, John] Childrens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA; [Ren, Tao; Lee, Kyungae] Harvard Univ, Sch Med, New England Reg Ctr Excellence Biodefense & Emerg, Boston, MA 02115 USA; [Filone, Claire Marie; Hensley, Lisa] USA, Med Res Inst Infect Dis, Div Virol, Frederick, MD 21702 USA; [Ory, Daniel] Washington Univ, Sch Med, Diabet Cardiovasc Dis Ctr, St Louis, MO 63110 USA; [Cunningham, James] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Washington University (WUSTL); Harvard University; Harvard Medical School	Cunningham, J (corresponding author), Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA.	jcunningham@rics.bwh.harvard.edu	Cote, Marceline/AAA-6386-2021	Hensley, Lisa/0000-0003-1188-4342; Misasi, John/0000-0001-7169-2639; Bruchez, Anna/0000-0003-1695-5349; Filone, Claire Marie/0000-0002-4041-3948	PIDS-Sanofi-Pasteur Fellowship [K12-HD052896, 5K08AI079381, 5-T32-HL007623]; Fonds de la Recherche en Sante du Quebec; US Army Medical Research and Material Command;  [U54 AI057159];  [R01 CA104266]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052896] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA104266] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, K08AI079381, R01AI088027] Funding Source: NIH RePORTER	PIDS-Sanofi-Pasteur Fellowship; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); US Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Considine, A. Nilsson and S. Wilkes for assistance, S. Chiang for critical reading of the manuscript, G. Beltz, N. Gray, S. Grinstein, Y. Iannou, R. Infante, J. Kornhuber, F. Sharom and S. Whelan for discussion. This work was supported by grants from U54 AI057159, R01 CA104266 to J. C., PIDS-Sanofi-Pasteur Fellowship, K12-HD052896 and 5K08AI079381 to J. M., 5-T32-HL007623 to A.B., and fellowship from Fonds de la Recherche en Sante du Quebec to M. C.; C. M. F. was supported by the Postgraduate Research Participation Program at the US Army Medical Research and Material Command administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the US Department of Energy and USAMRMC.	Ban HS, 2010, J AM CHEM SOC, V132, P11870, DOI 10.1021/ja104739t; Brindley MA, 2007, J VIROL, V81, P7702, DOI 10.1128/JVI.02433-06; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Chevallier J, 2008, J BIOL CHEM, V283, P27871, DOI 10.1074/jbc.M801463200; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; Dube D, 2010, P NATL ACAD SCI USA, V107, P16637, DOI 10.1073/pnas.1008509107; Dube D, 2009, J VIROL, V83, P2883, DOI 10.1128/JVI.01956-08; Geisbert TW, 2004, NAT MED, V10, pS110, DOI 10.1038/nm1142; Gelsthorpe ME, 2008, J BIOL CHEM, V283, P8229, DOI 10.1074/jbc.M708735200; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hood CL, 2010, J VIROL, V84, P2972, DOI 10.1128/JVI.02151-09; Huynh KK, 2008, J BIOL CHEM, V283, P35745, DOI 10.1074/jbc.M806232200; Kaletsky RL, 2007, J VIROL, V81, P13378, DOI 10.1128/JVI.01170-07; Ko DC, 2001, MOL BIOL CELL, V12, P601, DOI 10.1091/mbc.12.3.601; Kolter T, 2010, FEBS LETT, V584, P1700, DOI 10.1016/j.febslet.2009.10.021; Kuhn JH, 2006, J BIOL CHEM, V281, P15951, DOI 10.1074/jbc.M601796200; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Millard EE, 2000, J BIOL CHEM, V275, P38445, DOI 10.1074/jbc.M003180200; Millard EE, 2005, J BIOL CHEM, V280, P28581, DOI 10.1074/jbc.M414024200; Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Saeed MF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001110; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Towner JS, 2005, VIROLOGY, V332, P20, DOI 10.1016/j.virol.2004.10.048; Weidmann M, 2004, J CLIN VIROL, V30, P94, DOI 10.1016/j.jcv.2003.09.004; Wong AC, 2010, J VIROL, V84, P163, DOI 10.1128/JVI.01832-09; Zampieri CA, 2007, NAT IMMUNOL, V8, P1159, DOI 10.1038/ni1519	30	489	524	1	172	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 15	2011	477	7364					344	U122		10.1038/nature10380	http://dx.doi.org/10.1038/nature10380			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819TD	21866101	Green Accepted			2022-12-01	WOS:000294852400034
J	Park, D; Han, CZ; Elliott, MR; Kinchen, JM; Trampont, PC; Das, S; Collins, S; Lysiak, JJ; Hoehn, KL; Ravichandran, KS				Park, Daeho; Han, Claudia Z.; Elliott, Michael R.; Kinchen, Jason M.; Trampont, Paul C.; Das, Soumita; Collins, Sheila; Lysiak, Jeffrey J.; Hoehn, Kyle L.; Ravichandran, Kodi S.			Continued clearance of apoptotic cells critically depends on the phagocyte Ucp2 protein	NATURE			English	Article							MITOCHONDRIAL UNCOUPLING-PROTEIN; PHOSPHATIDYLSERINE RECEPTOR; PROTON LEAK; ENGULFMENT; OBESITY; GENE	Rapid and efficient removal of apoptotic cells by phagocytes is important during development, tissue homeostasis and in immune responses(1-5). Efficient clearance depends on the capacity of a single phagocyte to ingest multiple apoptotic cells successively, and to process the corpse-derived cellular material(6). However, the factors that influence continued clearance by phagocytes are not known. Here we show that the mitochondrial membrane potential of the phagocyte critically controls engulfment capacity, with lower potential enhancing engulfment and vice versa. The mitochondrial membrane protein Ucp2, which acts to lower the mitochondrial membrane potential(7-9), was upregulated in phagocytes engulfing apoptotic cells. Loss of Ucp2 reduced phagocytic capacity, whereas Ucp2 overexpression enhanced engulfment. Mutational and pharmacological studies indicated a direct role for Ucp2-mediated mitochondrial function in phagocytosis. Macrophages from Ucp2-deficient mice(10,11) were impaired in phagocytosis in vitro, and Ucp2-deficient mice showed profound in vivo defects in clearing dying cells in the thymus and testes. Collectively, these data indicate that mitochondrial membrane potential and Ucp2 are key molecular determinants of apoptotic cell clearance. As Ucp2 is linked to metabolic diseases and atherosclerosis(11,12), this newly discovered role for Ucp2 in apoptotic cell clearance has implications for the complex aetiology and pathogenesis of these diseases.	[Park, Daeho; Han, Claudia Z.; Elliott, Michael R.; Kinchen, Jason M.; Trampont, Paul C.; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA; [Park, Daeho; Han, Claudia Z.; Elliott, Michael R.; Kinchen, Jason M.; Trampont, Paul C.; Ravichandran, Kodi S.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Han, Claudia Z.; Kinchen, Jason M.; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Das, Soumita] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA; [Collins, Sheila] Sanford Burnham Med Res Inst, Diabet & Obes Res Ctr, Orlando, FL 32827 USA; [Lysiak, Jeffrey J.] Univ Virginia, Dept Urol, Charlottesville, VA 22908 USA; [Hoehn, Kyle L.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Hoehn, Kyle L.] Univ Virginia, CVRC, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; Sanford Burnham Prebys Medical Discovery Institute; University of Virginia; University of Virginia; University of Virginia	Ravichandran, KS (corresponding author), Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA.	ravi@virginia.edu	Kinchen, Jason/ABC-5663-2021	Trampont, Paul/0000-0002-3643-8472; Hoehn, Kyle/0000-0002-0214-3238; Kinchen, Jason/0000-0001-8430-2265; Ravichandran, Kodi/0000-0001-9049-1410; Elliott, Michael/0000-0002-0642-482X	National Institute of General Medical Sciences; National Institute of Child Health and Development; American Heart Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD057242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064709, T32GM008136] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Schwartz and members of the K. S. R. laboratory for discussions. This work was supported by grants from the National Institute of General Medical Sciences (to K. S. R.), and ARRA funding from National Institute of Child Health and Development (to J.J.L. and K. S. R.). K. S. R. is a Bill Benter Senior Fellow of the American Asthma Foundation. J.M.K. is supported by an American Heart Association Award.	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Blanc J, 2003, CIRCULATION, V107, P388, DOI 10.1161/01.CIR.0000051722.66074.60; Echtay KS, 2000, BIOCHEMISTRY-US, V39, P3311, DOI 10.1021/bi992448m; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gregory CD, 2011, J PATHOL, V223, P177, DOI 10.1002/path.2792; Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Krauss S, 2002, P NATL ACAD SCI USA, V99, P118, DOI 10.1073/pnas.012410699; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Lugli E, 2005, CYTOM PART A, V68A, P28, DOI 10.1002/cyto.a.20188; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Moukdar F, 2009, J LIPID RES, V50, P59, DOI 10.1194/jlr.M800273-JLR200; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park D, 2009, CURR BIOL, V19, P346, DOI 10.1016/j.cub.2009.01.042; Pi J, 2010, DIABETES OBES METAB, V12, P141, DOI 10.1111/j.1463-1326.2010.01269.x; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Sokal A, 1998, ARCH BIOCHEM BIOPHYS, V349, P113, DOI 10.1006/abbi.1997.0445; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Urbankova E, 2003, INT J BIOCHEM CELL B, V35, P212, DOI 10.1016/S1357-2725(02)00131-0; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010	28	146	151	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 8	2011	477	7363					220	U126		10.1038/nature10340	http://dx.doi.org/10.1038/nature10340			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816MC	21857682	Green Accepted			2022-12-01	WOS:000294603900038
J	Dang, EV; Barbi, J; Yang, HY; Jinasena, D; Yu, H; Zheng, Y; Bordman, Z; Fu, J; Kim, Y; Yen, HR; Luo, WB; Zeller, K; Shimoda, L; Topalian, SL; Semenza, GL; Dang, CV; Pardoll, DM; Pan, F				Dang, Eric V.; Barbi, Joseph; Yang, Huang-Yu; Jinasena, Dilini; Yu, Hong; Zheng, Ying; Bordman, Zachary; Fu, Juan; Kim, Young; Yen, Hung-Rong; Luo, Weibo; Zeller, Karen; Shimoda, Larissa; Topalian, Suzanne L.; Semenza, Gregg L.; Dang, Chi V.; Pardoll, Drew M.; Pan, Fan			Control of T(H)17/T-reg Balance by Hypoxia-Inducible Factor 1	CELL			English	Article							REGULATORY T-CELLS; TGF-BETA; CUTTING EDGE; DIFFERENTIATION; EFFECTOR; ACTIVATION; TH17; INDUCTION; MTOR; AUTOIMMUNITY	T cell differentiation into distinct functional effector and inhibitory subsets is regulated, in part, by the cytokine environment present at the time of antigen recognition. Here, we show that hypoxia-inducible factor 1 (HIF-1), a key metabolic sensor, regulates the balance between regulatory T cell (T-reg) and T(H)17 differentiation. HIF-1 enhances T(H)17 development through direct transcriptional activation of ROR gamma t and via tertiary complex formation with ROR gamma t and p300 recruitment to the IL-17 promoter, thereby regulating T(H)17 signature genes. Concurrently, HIF-1 attenuates T-reg development by binding Foxp3 and targeting it for proteasomal degradation. Importantly, this regulation occurs under both normoxic and hypoxic conditions. Mice with HIF-1 alpha-deficient T cells are resistant to induction of T(H)17-dependent experimental autoimmune encephalitis associated with diminished T(H)17 and increased T-reg cells. These findings highlight the importance of metabolic cues in T cell fate determination and suggest that metabolic modulation could ameliorate certain T cell-based immune pathologies.	[Dang, Eric V.; Barbi, Joseph; Yang, Huang-Yu; Jinasena, Dilini; Yu, Hong; Zheng, Ying; Bordman, Zachary; Yen, Hung-Rong; Pardoll, Drew M.; Pan, Fan] Johns Hopkins Univ, Sch Med, Immunol & Hematopoiesis Div, Dept Oncol & Med,Sidney Kimmel Comprehens Canc Ct, Baltimore, MD 21231 USA; [Fu, Juan; Kim, Young] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21231 USA; [Luo, Weibo; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Vasc Program, Inst Cell Engn,Dept Pediat, Baltimore, MD 21231 USA; [Luo, Weibo; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Vasc Program, Inst Cell Engn,Dept Med, Baltimore, MD 21231 USA; [Luo, Weibo; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Vasc Program, Inst Cell Engn,Dept Oncol, Baltimore, MD 21231 USA; [Luo, Weibo; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Vasc Program, Inst Cell Engn,Dept Radiat Oncol, Baltimore, MD 21231 USA; [Luo, Weibo; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Vasc Program, Inst Cell Engn,Dept Biol Chem, Baltimore, MD 21231 USA; [Luo, Weibo; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21231 USA; [Zeller, Karen; Dang, Chi V.] Johns Hopkins Univ, Sch Med, Div Hematol, Dept Med, Baltimore, MD 21231 USA; [Shimoda, Larissa] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Dept Med, Baltimore, MD 21231 USA; [Topalian, Suzanne L.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21231 USA; [Yang, Huang-Yu] Chang Gung Univ, Coll Med, Dept Nephrol, Chang Gung Mem Hosp, Tao Yuan 333, Taiwan; [Yen, Hung-Rong] Chang Gung Univ, Coll Med, Dept Pediat, Chang Gung Mem Hosp,Ctr Tradit Chinese Med, Tao Yuan 333, Taiwan	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Pardoll, DM (corresponding author), Johns Hopkins Univ, Sch Med, Immunol & Hematopoiesis Div, Dept Oncol & Med,Sidney Kimmel Comprehens Canc Ct, Baltimore, MD 21231 USA.	dmpardol@jhmi.edu; fpan1@jhmi.edu	Dang, Chi/Y-3375-2019; Yen, Hung-Rong/M-1373-2013	Luo, Weibo/0000-0002-1992-0320; Yen, Hung-Rong/0000-0002-0131-1658; Dang, Eric/0000-0002-2389-6167; Dang, Chi/0000-0002-4031-2522; YANG, HUANG-YU/0000-0001-6826-9717	NIH; Melanoma Research Alliance; Janey Fund and Seraph Foundation; Stewart Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089830] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; Janey Fund and Seraph Foundation; Stewart Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the members of the D. Pardoll, F. Pan, J. Powell, and C. Drake laboratories for helpful discussions. We are grateful to Drs. J. Liu (Department of Pharmacology at Johns Hopkins), A. Rudensky (Memorial Sloan Kettering Cancer Center), and D. Littman (NYU) for helpful suggestions and/or reagent contribution. We thank Dr. H. Wei (Dr. Semenza's laboratory) for the HIF1<SUP>fl/fl</SUP> mice and genotyping primer sequences. This work was supported by grants from NIH and the Melanoma Research Alliance, the Janey Fund and Seraph Foundation, and gifts from Bill and Betty Topecer and Dorothy Needle. F.P. is a recipient of the Stewart Trust Scholar Award.	Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNOLOGY, V127, P459, DOI 10.1111/j.1365-2567.2009.03125.x; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Getnet D, 2010, MOL IMMUNOL, V47, P1595, DOI 10.1016/j.molimm.2010.02.001; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Hot A, 2011, ANN RHEUM DIS, V70, P727, DOI 10.1136/ard.2010.143768; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Koch CJ, 2002, METHOD ENZYMOL, V352, P3; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Lukashev D, 2006, J IMMUNOL, V177, P4962, DOI 10.4049/jimmunol.177.8.4962; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; O'Quinn DB, 2008, ADV IMMUNOL, V99, P115, DOI 10.1016/S0065-2776(08)00605-6; Pan F, 2005, EMBO J, V24, P2104, DOI 10.1038/sj.emboj.7600685; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Pouyssegur J, 2006, BIOL CHEM, V387, P1337, DOI 10.1515/BC.2006.167; Rajewsky K, 2008, CURR OPIN IMMUNOL, V20, P127, DOI 10.1016/j.coi.2008.04.005; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Semenza G. L., 2007, SCI STKE, pcm8, DOI DOI 10.1126/STKE.4072007CM8; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Youn HD, 2000, EMBO J, V19, P4323, DOI 10.1093/emboj/19.16.4323; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	48	1004	1065	8	97	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 2	2011	146	5					772	784		10.1016/j.cell.2011.07.033	http://dx.doi.org/10.1016/j.cell.2011.07.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21871655	Bronze, Green Accepted			2022-12-01	WOS:000294477500017
J	He, YF; Li, BZ; Li, Z; Liu, P; Wang, Y; Tang, QY; Ding, JP; Jia, YY; Chen, ZC; Li, L; Sun, Y; Li, XX; Dai, Q; Song, CX; Zhang, KL; He, C; Xu, GL				He, Yu-Fei; Li, Bin-Zhong; Li, Zheng; Liu, Peng; Wang, Yang; Tang, Qingyu; Ding, Jianping; Jia, Yingying; Chen, Zhangcheng; Li, Lin; Sun, Yan; Li, Xiuxue; Dai, Qing; Song, Chun-Xiao; Zhang, Kangling; He, Chuan; Xu, Guo-Liang			Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; GLYCOSYLASE ACTIVITY; GENE-EXPRESSION; 5-HYDROXYMETHYLCYTOSINE; DEMETHYLATION; METHYLATION; REPAIR; DEAMINATION	The prevalent DNA modification in higher organisms is the methylation of cytosine to 5-methylcytosine (5mC), which is partially converted to 5-hydroxymethylcytosine (5hmC) by the Tet (ten eleven translocation) family of dioxygenases. Despite their importance in epigenetic regulation, it is unclear how these cytosine modifications are reversed. Here, we demonstrate that 5mC and 5hmC in DNA are oxidized to 5-carboxylcytosine (5caC) by Tet dioxygenases in vitro and in cultured cells. 5caC is specifically recognized and excised by thymine-DNA glycosylase (TDG). Depletion of TDG in mouse embyronic stem cells leads to accumulation of 5caC to a readily detectable level. These data suggest that oxidation of 5mC by Tet proteins followed by TDG-mediated base excision of 5caC constitutes a pathway for active DNA demethylation.	[He, Yu-Fei; Li, Bin-Zhong; Li, Zheng; Liu, Peng; Wang, Yang; Xu, Guo-Liang] Chinese Acad Sci, Grp DNA Metab, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Sun, Yan; Li, Xiuxue] Chinese Acad Sci, Inst Mat Med, Shanghai 201203, Peoples R China; [Dai, Qing; Song, Chun-Xiao; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Dai, Qing; Song, Chun-Xiao; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Zhang, Kangling] Loma Linda Univ, Sch Med, Dept Biochem, Loma Linda, CA 92350 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; University of Chicago; University of Chicago; Loma Linda University	Xu, GL (corresponding author), Chinese Acad Sci, Grp DNA Metab, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China.	glxu@sibs.ac.cn	li, zheng/AAI-1750-2020; Dai, Qing/ABD-8444-2021; Tang, Qingyu/W-4530-2018; Li, Binzhong/I-2307-2013	li, zheng/0000-0002-4987-0205; Tang, Qingyu/0000-0002-5554-6540; Song, Chun-Xiao/0000-0002-7781-6521; ding, jian ping/0000-0001-7029-7346; Liu, Peng/0000-0002-6469-6460; He, Yu-Fei/0000-0002-0648-6430	Ministry of Science and Technology China [2007CB947503, 2009CB941101, 2010CB912100]; National Science Foundation of China [30730059, 30930052, 30821065]; Chinese Academy of Sciences [XDA01010301]; NIH [GM071440, 1S10RR027643-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071440] Funding Source: NIH RePORTER	Ministry of Science and Technology China(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Walsh for critical reading of the manuscript, G. Shi and S. Klimasauskas for discussions, J. Ju for providing Tet cDNA clones, T. Carell for 2'-deoxy-5-carboxylcytidine and Z. Hua for the TDG antibody. This study was supported by grants from the Ministry of Science and Technology China (2007CB947503 and 2009CB941101 to G.-L. X., 2010CB912100 to L. L.), National Science Foundation of China (30730059 to G.-L. X., 30930052 and 30821065 to L. L.), and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA01010301 to G.-L. X.) and by the NIH (GM071440 to C. H.) and (1S10RR027643-01 to K.Z.).	Bennett MT, 2006, J AM CHEM SOC, V128, P12510, DOI 10.1021/ja0634829; Boorstein RJ, 2001, J BIOL CHEM, V276, P41991, DOI 10.1074/jbc.M106953200; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Dahl C, 2011, CLIN CHIM ACTA, V412, P831, DOI 10.1016/j.cca.2011.02.013; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; He XJ, 2011, CELL RES, V21, P442, DOI 10.1038/cr.2011.23; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Krokan HE, 1997, BIOCHEM J, V325, P1; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Liutkeviciute Z, 2009, NAT CHEM BIOL, V5, P400, DOI 10.1038/nchembio.172; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Walsh CP, 2006, CURR TOP MICROBIOL, V301, P283; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Zhu B, 2000, P NATL ACAD SCI USA, V97, P5135, DOI 10.1073/pnas.100107597	26	1880	1991	7	364	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2011	333	6047					1303	1307		10.1126/science.1210944	http://dx.doi.org/10.1126/science.1210944			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21817016	Green Accepted			2022-12-01	WOS:000294406400058
J	Glantz, LH; Annas, GJ				Glantz, Leonard H.; Annas, George J.			Impossible? Outlawing State Safety Laws for Generic Drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PREEMPTION; FDA		[Glantz, Leonard H.; Annas, George J.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Glantz, LH (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831; Glantz, Leonard/0000-0003-4591-2305				Annas GJ, 2009, NEW ENGL J MED, V361, P1206, DOI 10.1056/NEJMhle0902889; Glantz LH, 2008, NEW ENGL J MED, V358, P1883, DOI 10.1056/NEJMp0802108; *US DRUG SAF SYST, 2007, FUT DRUG SAF PROM PR	3	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2011	365	8					681	683		10.1056/NEJMp1107832	http://dx.doi.org/10.1056/NEJMp1107832			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	811JM	21830958				2022-12-01	WOS:000294205300001
J	Dutta, D; Shatalin, K; Epshtein, V; Gottesman, ME; Nudler, E				Dutta, Dipak; Shatalin, Konstantin; Epshtein, Vitaly; Gottesman, Max E.; Nudler, Evgeny			Linking RNA Polymerase Backtracking to Genome Instability in E. coli	CELL			English	Article							REPLICATION FORK PROGRESSION; TERMINATION FACTOR-RHO; COUPLING FACTOR MFD; UNITS IN-VIVO; ESCHERICHIA-COLI; DNA-REPLICATION; TRANSCRIPTION TERMINATION; ELONGATION-FACTORS; BACILLUS-SUBTILIS; REPAIR	Frequent codirectional collisions between the replisome and RNA polymerase (RNAP) are inevitable because the rate of replication is much faster than that of transcription. Here we show that, in E. coli, the outcome of such collisions depends on the productive state of transcription elongation complexes (ECs). Codirectional collisions with backtracked (arrested) ECs lead to DNA double-strand breaks (DSBs), whereas head-on collisions do not. A mechanistic model is proposed to explain backtracking-mediated DSBs. We further show that bacteria employ various strategies to avoid replisome collisions with backtracked RNAP, the most general of which is translation that prevents RNAP backtracking. If translation is abrogated, DSBs are suppressed by elongation factors that either prevent backtracking or reactivate backtracked ECs. Finally, termination factors also contribute to genomic stability by removing arrested ECs. Our results establish RNAP backtracking as the intrinsic hazard to chromosomal integrity and implicate active ribosomes and other anti-backtracking mechanisms in genome maintenance.	[Dutta, Dipak; Shatalin, Konstantin; Epshtein, Vitaly; Nudler, Evgeny] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Gottesman, Max E.] Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Gottesman, Max E.] Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA	New York University; Columbia University; Columbia University	Nudler, E (corresponding author), NYU, Sch Med, Dept Biochem, New York, NY 10016 USA.	evgeny.nudler@nyumc.org		Nudler, Evgeny/0000-0002-8811-3071	NIH [R01 GM58750, R01 GM32719]; BGRF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058750] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BGRF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Yuri Nedyalkov, Linqi Wang, Catherine Potenski, Grigory Mogilnitskiy, and Robert Washburn for technical assistance, Lynn Thomason for plasmid pCODIR (pHW27), Susan Rosenberg for SMR8476 strain, and Hanna Klein and Danny Reinberg for critical reading of the manuscript. This work was supported by grants from the NIH, R01 GM58750 (E.N.) and R01 GM32719 (M. E. G.). We also thank Timur Artemyev and BGRF for their support.	Alff-Steinberger C, 2000, J THEOR BIOL, V206, P307, DOI 10.1006/jtbi.2000.2126; Azvolinsky A, 2006, GENE DEV, V20, P3104, DOI 10.1101/gad.1478906; Birren B, 1993, PULSE FIELD GEL ELEC; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Borukhov S, 2005, MOL MICROBIOL, V55, P1315, DOI 10.1111/j.1365-2958.2004.04481.x; Boubakri H, 2010, EMBO J, V29, P145, DOI 10.1038/emboj.2009.308; BREWER BJ, 1988, CELL, V53, P679, DOI 10.1016/0092-8674(88)90086-4; Cardinale CJ, 2008, SCIENCE, V320, P935, DOI 10.1126/science.1152763; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; CONDON C, 1995, MICROBIOL REV, V59, P623, DOI 10.1128/MMBR.59.4.623-645.1995; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; Epshtein V, 2010, NATURE, V463, P245, DOI 10.1038/nature08669; FRENCH S, 1992, SCIENCE, V258, P1362, DOI 10.1126/science.1455232; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Greive SJ, 2005, J BIOL CHEM, V280, P36397, DOI 10.1074/jbc.M507146200; Gusarov I, 2005, P NATL ACAD SCI USA, V102, P13855, DOI 10.1073/pnas.0504307102; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Kornberg A., 1992, DNA REPLICATION; Kostrzynska M, 2002, J MICROBIOL METH, V48, P43, DOI 10.1016/S0167-7012(01)00335-9; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; KUZMINOV A, 1995, MOL MICROBIOL, V16, P373, DOI 10.1111/j.1365-2958.1995.tb02403.x; McGlynn P, 2000, CELL, V101, P35, DOI 10.1016/S0092-8674(00)80621-2; Merrikh H, 2011, NATURE, V470, P554, DOI 10.1038/nature09758; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Nudler E, 2003, METHOD ENZYMOL, V371, P160; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Nudler E, 2009, ANNU REV BIOCHEM, V78, P335, DOI 10.1146/annurev.biochem.76.052705.164655; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Park S, 2003, J BACTERIOL, V185, P1942, DOI 10.1128/JB.185.6.1942-1950.2003; Pennington JM, 2007, NAT GENET, V39, P797, DOI 10.1038/ng2051; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; Pomerantz RT, 2010, SCIENCE, V327, P590, DOI 10.1126/science.1179595; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; Prado F, 2005, EMBO J, V24, P1267, DOI 10.1038/sj.emboj.7600602; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Rees WA, 1997, J MOL BIOL, V273, P797, DOI 10.1006/jmbi.1997.1327; RICHARDSON JP, 1991, CELL, V64, P1047, DOI 10.1016/0092-8674(91)90257-Y; Roberts JW, 2008, ANNU REV MICROBIOL, V62, P211, DOI 10.1146/annurev.micro.61.080706.093422; Rocha EPC, 2003, NAT GENET, V34, P377, DOI 10.1038/ng1209; Rudolph CJ, 2007, DNA REPAIR, V6, P981, DOI 10.1016/j.dnarep.2007.02.017; SELBY CP, 1994, MICROBIOL REV, V58, P317, DOI 10.1128/MMBR.58.3.317-329.1994; Sigurdsson S, 2010, MOL CELL, V38, P202, DOI 10.1016/j.molcel.2010.02.026; Tehranchi AK, 2010, CELL, V141, P595, DOI 10.1016/j.cell.2010.03.036; Torres M, 2001, EMBO J, V20, P3811, DOI 10.1093/emboj/20.14.3811; Trautinger BW, 2005, MOL CELL, V19, P247, DOI 10.1016/j.molcel.2005.06.004; Trautinger BW, 2002, EMBO J, V21, P6944, DOI 10.1093/emboj/cdf654; Vilette D, 1996, MOL GEN GENET, V252, P398, DOI 10.1007/BF02173004; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729; Wang JD, 2007, P NATL ACAD SCI USA, V104, P5608, DOI 10.1073/pnas.0608999104; Washburn RS, 2011, P NATL ACAD SCI USA, V108, P792, DOI 10.1073/pnas.1009564108; Washburn RS, 2003, J MOL BIOL, V329, P655, DOI 10.1016/S0022-2836(03)00465-0; Yao NY, 2010, CELL, V141, P1088, DOI 10.1016/j.cell.2010.05.042; ZWIEFKA A, 1993, BIOCHEMISTRY-US, V32, P3564, DOI 10.1021/bi00065a007	57	234	237	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 19	2011	146	4					533	543		10.1016/j.cell.2011.07.034	http://dx.doi.org/10.1016/j.cell.2011.07.034			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21854980	Green Accepted, Bronze			2022-12-01	WOS:000294043600009
J	Morin, RD; Mendez-Lago, M; Mungall, AJ; Goya, R; Mungall, KL; Corbett, RD; Johnson, NA; Severson, TM; Chiu, R; Field, M; Jackman, S; Krzywinski, M; Scott, DW; Trinh, DL; Tamura-Wells, J; Li, S; Firme, MR; Rogic, S; Griffith, M; Chan, S; Yakovenko, O; Meyer, IM; Zhao, EY; Smailus, D; Moksa, M; Chittaranjan, S; Rimsza, L; Brooks-Wilson, A; Spinelli, JJ; Ben-Neriah, S; Meissner, B; Woolcock, B; Boyle, M; McDonald, H; Tam, A; Zhao, YJ; Delaney, A; Zeng, T; Tse, K; Butterfield, Y; Birol, I; Holt, R; Schein, J; Horsman, DE; Moore, R; Jones, SJM; Connors, JM; Hirst, M; Gascoyne, RD; Marra, MA				Morin, Ryan D.; Mendez-Lago, Maria; Mungall, Andrew J.; Goya, Rodrigo; Mungall, Karen L.; Corbett, Richard D.; Johnson, Nathalie A.; Severson, Tesa M.; Chiu, Readman; Field, Matthew; Jackman, Shaun; Krzywinski, Martin; Scott, David W.; Trinh, Diane L.; Tamura-Wells, Jessica; Li, Sa; Firme, Marlo R.; Rogic, Sanja; Griffith, Malachi; Chan, Susanna; Yakovenko, Oleksandr; Meyer, Irmtraud M.; Zhao, Eric Y.; Smailus, Duane; Moksa, Michelle; Chittaranjan, Suganthi; Rimsza, Lisa; Brooks-Wilson, Angela; Spinelli, John J.; Ben-Neriah, Susana; Meissner, Barbara; Woolcock, Bruce; Boyle, Merrill; McDonald, Helen; Tam, Angela; Zhao, Yongjun; Delaney, Allen; Zeng, Thomas; Tse, Kane; Butterfield, Yaron; Birol, Inanc; Holt, Rob; Schein, Jacqueline; Horsman, Douglas E.; Moore, Richard; Jones, Steven J. M.; Connors, Joseph M.; Hirst, Martin; Gascoyne, Randy D.; Marra, Marco A.			Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma	NATURE			English	Article							B-CELL LYMPHOMA; NF-KAPPA-B; FOLLICULAR LYMPHOMA; SOMATIC MUTATIONS; RNA-SEQ; INACTIVATION; CANCER; EXPRESSION; SUBTYPES; PHOSPHORYLATION	Follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) are the two most common non-Hodgkin lymphomas (NHLs). Here we sequenced tumour and matched normal DNA from 13 DLBCL cases and one FL case to identify genes with mutations in B-cell NHL. We analysed RNA-seq data from these and another 113 NHLs to identify genes with candidate mutations, and then re-sequenced tumour and matched normal DNA from these cases to confirm 109 genes with multiple somatic mutations. Genes with roles in histone modification were frequent targets of somatic mutation. For example, 32% of DLBCL and 89% of FL cases had somatic mutations in MLL2, which encodes a histone methyltransferase, and 11.4% and 13.4% of DLBCL and FL cases, respectively, had mutations in MEF2B, a calcium-regulated gene that cooperates with CREBBP and EP300 in acetylating histones. Our analysis suggests a previously unappreciated disruption of chromatin biology in lymphomagenesis.	[Morin, Ryan D.; Mendez-Lago, Maria; Mungall, Andrew J.; Goya, Rodrigo; Mungall, Karen L.; Corbett, Richard D.; Severson, Tesa M.; Chiu, Readman; Field, Matthew; Jackman, Shaun; Krzywinski, Martin; Trinh, Diane L.; Tamura-Wells, Jessica; Li, Sa; Firme, Marlo R.; Griffith, Malachi; Chan, Susanna; Yakovenko, Oleksandr; Zhao, Eric Y.; Smailus, Duane; Moksa, Michelle; Chittaranjan, Suganthi; Brooks-Wilson, Angela; McDonald, Helen; Tam, Angela; Zhao, Yongjun; Delaney, Allen; Zeng, Thomas; Tse, Kane; Butterfield, Yaron; Birol, Inanc; Holt, Rob; Schein, Jacqueline; Moore, Richard; Jones, Steven J. M.; Hirst, Martin; Marra, Marco A.] BC Canc Agcy Vancouver, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Johnson, Nathalie A.; Scott, David W.; Rogic, Sanja; Ben-Neriah, Susana; Meissner, Barbara; Woolcock, Bruce; Boyle, Merrill; Horsman, Douglas E.; Connors, Joseph M.; Gascoyne, Randy D.] BC Canc Agcy, Ctr Lymphoid Canc, Vancouver, BC V5Z 1L3, Canada; [Meyer, Irmtraud M.] Centre High Throughput Biol, Dept Comp Sci, Vancouver, BC V6T 1Z4, Canada; [Rimsza, Lisa] Univ Arizona, Dept Pathol, Tucson, AZ 85724 USA; [Brooks-Wilson, Angela] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada; [Connors, Joseph M.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V6T 1Z3, Canada; [Gascoyne, Randy D.] Univ British Columbia, Dept Pathol, Vancouver, BC V6T 2B5, Canada; [Marra, Marco A.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada	British Columbia Cancer Agency; British Columbia Cancer Agency; University of Arizona; Simon Fraser University; University of British Columbia; University of British Columbia; University of British Columbia	Marra, MA (corresponding author), BC Canc Agcy Vancouver, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada.	mmarra@bcgsc.ca	Marra, Marco A/B-5987-2008; Griffith, Malachi/P-1285-2014; Hirst, Martin/B-7684-2016; Schein, Jacquie E/G-3674-2015; Birol, Inanc/G-5440-2011; Spinelli, John J./B-6210-2013; Connors, Joseph/AAF-5284-2019; Gascoyne, Randy D/A-6009-2013; Brooks-Wilson, Angela/E-9399-2012; Mungall, Andrew J./U-7067-2018; Jones, Steven J/C-3621-2009; Holt, Robert A/C-3303-2009; Morin, Ryan/AAE-7824-2019; Jackman, Shaun/G-9622-2013	Marra, Marco A/0000-0001-7146-7175; Griffith, Malachi/0000-0002-6388-446X; Birol, Inanc/0000-0003-0950-7839; Spinelli, John J./0000-0002-9119-3287; Connors, Joseph/0000-0002-1361-7531; Gascoyne, Randy D/0000-0002-2610-5690; Brooks-Wilson, Angela/0000-0003-1009-6408; Mungall, Andrew J./0000-0002-0905-2742; Jones, Steven J/0000-0003-3394-2208; Holt, Robert A/0000-0002-7259-1247; Morin, Ryan/0000-0003-2932-7800; Rogic, Sanja/0000-0002-9988-3661; Stutheit-Zhao, Eric/0000-0003-1277-6335; Field, Matthew/0000-0003-0788-6513; Jackman, Shaun/0000-0002-9275-5966	National Cancer Institute Office of Cancer Genomics [HHSN261200800001E]; Terry Fox Foundation [019001, NCIC 019005]; Genome Canada/Genome British Columbia; NIH [P50CA130805-01, 1U01CA114778]; Michael Smith Foundation for Health Research [ST-PDF-01793]; MSFHR; Spanish Ministry of Education; Terry Fox Foundation at Canadian Institutes of Health Research [TGT-53912]; Canadian Cancer Society; Canadian Institutes of Health Research; UBC Four Year Fellowship; Canadian Foundation for Innovation; NATIONAL CANCER INSTITUTE [P50CA130805, U01CA114778, U24CA143866] Funding Source: NIH RePORTER	National Cancer Institute Office of Cancer Genomics; Terry Fox Foundation; Genome Canada/Genome British Columbia(Genome Canada); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); MSFHR(Michael Smith Foundation for Health Research); Spanish Ministry of Education(Spanish Government); Terry Fox Foundation at Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); UBC Four Year Fellowship; Canadian Foundation for Innovation(Canada Foundation for Innovation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded in part by funding from the National Cancer Institute Office of Cancer Genomics (Contract No. HHSN261200800001E), the Terry Fox Foundation (grant 019001, Biology of Cancer: Insights from Genomic Analyses of Lymphoid Neoplasms) and Genome Canada/Genome British Columbia Grant Competition III (Project Title: High Resolution Analysis of Follicular Lymphoma Genomes) to J.M.C., R. D. G. and M. A. M. We acknowledge support from NIH grants P50CA130805-01 "SPORE in Lymphoma, Tissue Resource Core (PI Fisher)" and 1U01CA114778 "Molecular Signatures to Improve Diagnosis and Outcome in Lymphoma (PIChan)". A.J.M. is a Career Development Program Fellow of the Leukemia and Lymphoma Society. N.A.J. was a research fellow of the Terry Fox Foundation(award NCIC 019005) and the Michael Smith Foundation for Health Research (ST-PDF-01793). M. A. M. is a Terry Fox Young Investigator and a Michael Smith Senior Research Scholar. R. D. M. is a Vanier Scholar (CIHR) and holds a MSFHR senior graduate studentship. M.M.-L. acknowledges support from a Postdoctoral Fellowship from the Spanish Ministry of Education, under the "Programa Nacional de Movilidad de Recursos Humanos del Plan Nacional de I-D+i 2008-2011". D. W. S. was supported by the Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at Canadian Institutes of Health Research (Grant No. TGT-53912). J.J.S. acknowledges funding from The Canadian Cancer Society and the Canadian Institutes of Health Research. R. G. is supported by a UBC Four Year Fellowship. I. M. M. acknowledges the Canadian Foundation for Innovation for a Leaders Opportunity Fund. The laboratory work for this study was undertaken at the Genome Sciences Centre, British Columbia Cancer Research Centre and the Centre for Translational and Applied Genomics, a program of the Provincial Health Services Authority Laboratories. The authors would like to thank C. Greenman for supplying his software and also acknowledge D. Gerhard and S. Aparicio for discussions and guidance. Special thanks to C. Suragh, R. Roscoe, A. Troussard and A. Drobnies for expert project management assistance, and to the Library Construction, Sequencing and Bioinformatics teams at the Genome Sciences Centre. The content of this publication does not necessarily reflect the views of policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Anderson JR, 1998, ANN ONCOL, V9, P717, DOI 10.1023/A:1008265532487; Bhattacharyya R, 2000, J BIOL CHEM, V275, P14992, DOI 10.1074/jbc.M000415200; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Canaani E, 2004, BRIT J CANCER, V90, P756, DOI 10.1038/sj.bjc.6601639; Cheung KJJ, 2010, CANCER RES, V70, P9166, DOI 10.1158/0008-5472.CAN-10-2460; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Du MQ, 2000, BLOOD, V95, P3885; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; Goya R, 2010, BIOINFORMATICS, V26, P730, DOI 10.1093/bioinformatics/btq040; Greenman C, 2006, GENETICS, V173, P2187, DOI 10.1534/genetics.105.044677; Han AD, 2005, J MOL BIOL, V345, P91, DOI 10.1016/j.jmb.2004.10.033; HE J, 2011, NUCL ACIDS RES; Iqbal J, 2007, LEUKEMIA, V21, P2332, DOI 10.1038/sj.leu.2404856; Iqbal J, 2004, AM J PATHOL, V165, P159, DOI 10.1016/S0002-9440(10)63284-1; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Kreutz B, 2007, CELL SIGNAL, V19, P1681, DOI 10.1016/j.cellsig.2007.03.004; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Manganello JM, 2003, J BIOL CHEM, V278, P124, DOI 10.1074/jbc.M209219200; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Mo JS, 2011, J CELL SCI, V124, P100, DOI 10.1242/jcs.073924; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; PASINI D, 2010, NUCL ACIDS RES; Pasqualucci L, 2006, J EXP MED, V203, P311, DOI 10.1084/jem.20052204; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Saito M, 2009, P NATL ACAD SCI USA, V106, P11294, DOI 10.1073/pnas.0903854106; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Tai DJC, 2009, J BIOL CHEM, V284, P4073, DOI 10.1074/jbc.M805055200; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Youn HD, 2000, IMMUNITY, V13, P85, DOI 10.1016/S1074-7613(00)00010-8; Young KH, 2008, BLOOD, V112, P3088, DOI 10.1182/blood-2008-01-129783; Yusuf I, 2004, BLOOD, V104, P784, DOI 10.1182/blood-2003-09-3071	50	1125	1168	1	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 18	2011	476	7360					298	303		10.1038/nature10351	http://dx.doi.org/10.1038/nature10351			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21796119	Green Accepted, hybrid			2022-12-01	WOS:000294206500031
J	Yang, JJ; Plenge, RM				Yang, Jun J.; Plenge, Robert M.			Genomic Technology Applied to Pharmacological Traits	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ASSOCIATION		[Yang, Jun J.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Plenge, Robert M.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Plenge, Robert M.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Yang, JJ (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 262 Danny Thomas Pl,MS313, Memphis, TN 38105 USA.	jun.yang@stjude.org; rplenge@partners.org	Yang, Jun/B-6976-2008; Yang, Jun J./ABG-5646-2020	Yang, Jun/0000-0002-0770-9659; Yang, Jun J./0000-0002-0770-9659	NCI NIH HHS [R21 CA158568, R21 CA158568-02, R21-CA158568, RC4 CA156449, RC4 CA156449-01, RC4-CA156449] Funding Source: Medline; NIAMS NIH HHS [R01-AR059648, R01 AR059648-02, R01 AR056768, R01-AR056768, R01 AR057108-02, R01 AR056768-04, R01 AR059648, R01-AR057108, R01 AR057108] Funding Source: Medline; NIGMS NIH HHS [U01 GM092691, U01-GM092691, U01-GM92666, U01 GM092666-03, U01 GM092691-03, U01 GM092666] Funding Source: Medline; NATIONAL CANCER INSTITUTE [RC4CA156449, R21CA158568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059648, R01AR056768, R01AR057108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092691, U01GM092666] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Fellay J, 2010, NATURE, V464, P405, DOI 10.1038/nature08825; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mardis ER, 2011, NATURE, V470, P198, DOI 10.1038/nature09796; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Wang LW, 2011, NEW ENGL J MED, V364, P1144, DOI 10.1056/NEJMra1010600; Wilke RA, 2011, CLIN PHARMACOL THER, V89, P379, DOI 10.1038/clpt.2010.260; Zhou KX, 2011, NAT GENET, V43, P117, DOI 10.1038/ng.735	10	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 10	2011	306	6					652	653		10.1001/jama.2011.1125	http://dx.doi.org/10.1001/jama.2011.1125			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	804XD	21828330	Green Accepted			2022-12-01	WOS:000293687300030
J	Eastwood, DC; Floudas, D; Binder, M; Majcherczyk, A; Schneider, P; Aerts, A; Asiegbu, FO; Baker, SE; Barry, K; Bendiksby, M; Blumentritt, M; Coutinho, PM; Cullen, D; de Vries, RP; Gathman, A; Goodell, B; Henrissat, B; Ihrmark, K; Kauserud, H; Kohler, A; LaButti, K; Lapidus, A; Lavin, JL; Lee, YH; Lindquist, E; Lilly, W; Lucas, S; Morin, E; Murat, C; Oguiza, JA; Park, J; Pisabarro, AG; Riley, R; Rosling, A; Salamov, A; Schmidt, O; Schmutz, J; Skrede, I; Stenlid, J; Wiebenga, A; Xie, XF; Kues, U; Hibbett, DS; Hoffmeister, D; Hogberg, N; Martin, F; Grigoriev, IV; Watkinson, SC				Eastwood, Daniel C.; Floudas, Dimitrios; Binder, Manfred; Majcherczyk, Andrzej; Schneider, Patrick; Aerts, Andrea; Asiegbu, Fred O.; Baker, Scott E.; Barry, Kerrie; Bendiksby, Mika; Blumentritt, Melanie; Coutinho, Pedro M.; Cullen, Dan; de Vries, Ronald P.; Gathman, Allen; Goodell, Barry; Henrissat, Bernard; Ihrmark, Katarina; Kauserud, Havard; Kohler, Annegret; LaButti, Kurt; Lapidus, Alla; Lavin, Jose L.; Lee, Yong-Hwan; Lindquist, Erika; Lilly, Walt; Lucas, Susan; Morin, Emmanuelle; Murat, Claude; Oguiza, Jose A.; Park, Jongsun; Pisabarro, Antonio G.; Riley, Robert; Rosling, Anna; Salamov, Asaf; Schmidt, Olaf; Schmutz, Jeremy; Skrede, Inger; Stenlid, Jan; Wiebenga, Ad; Xie, Xinfeng; Kuees, Ursula; Hibbett, David S.; Hoffmeister, Dirk; Hogberg, Nils; Martin, Francis; Grigoriev, Igor V.; Watkinson, Sarah C.			The Plant Cell Wall-Decomposing Machinery Underlies the Functional Diversity of Forest Fungi	SCIENCE			English	Article							SERPULA-LACRYMANS; DECAY FUNGI; WOOD; GENOME; MECHANISMS; DIVERSIFICATION; CONVERSION; SYMBIOSIS; LITTER	Brown rot decay removes cellulose and hemicellulose from wood-residual lignin contributing up to 30% of forest soil carbon-and is derived from an ancestral white rot saprotrophy in which both lignin and cellulose are decomposed. Comparative and functional genomics of the "dry rot" fungus Serpula lacrymans, derived from forest ancestors, demonstrated that the evolution of both ectomycorrhizal biotrophy and brown rot saprotrophy were accompanied by reductions and losses in specific protein families, suggesting adaptation to an intercellular interaction with plant tissue. Transcriptome and proteome analysis also identified differences in wood decomposition in S. lacrymans relative to the brown rot Postia placenta. Furthermore, fungal nutritional mode diversification suggests that the boreal forest biome originated via genetic coevolution of above- and below-ground biota.	[Eastwood, Daniel C.] Univ Swansea, Coll Sci, Swansea SA2 8PP, W Glam, Wales; [Floudas, Dimitrios; Binder, Manfred; Hibbett, David S.] Clark Univ, Dept Biol, Worcester, MA 01610 USA; [Majcherczyk, Andrzej; Kuees, Ursula] Univ Gottingen, Busgen Inst, D-37077 Gottingen, Germany; [Schneider, Patrick; Hoffmeister, Dirk] Univ Jena, Hans Knoll Inst, D-07745 Jena, Germany; [Aerts, Andrea; Baker, Scott E.; LaButti, Kurt; Lapidus, Alla; Lindquist, Erika; Lucas, Susan; Riley, Robert; Salamov, Asaf; Schmutz, Jeremy; Grigoriev, Igor V.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Asiegbu, Fred O.] Univ Helsinki, Dept Forest Sci, FIN-00014 Helsinki, Finland; [Baker, Scott E.] Pacific NW Natl Lab, Richland, WA 99352 USA; [Bendiksby, Mika] Univ Oslo, Nat Hist Museum, NO-0138 Blindern, Norway; [Blumentritt, Melanie; Goodell, Barry; Xie, Xinfeng] Univ Maine, Orono, ME 04469 USA; [Coutinho, Pedro M.; Henrissat, Bernard] Univ Aix Marseille 1, UMR CNRS 6098, F-13288 Marseille 9, France; [Coutinho, Pedro M.; Henrissat, Bernard] Univ Aix Marseille 2, UMR CNRS 6098, F-13288 Marseille 9, France; [Cullen, Dan] Forest Prod Lab, Madison, WI 53726 USA; [de Vries, Ronald P.; Wiebenga, Ad] Royal Netherlands Acad Arts & Sci, Fungal Biodivers Ctr, Cent Bur Schimmelcultures, NL-3584 CT Utrecht, Netherlands; [Gathman, Allen; Lilly, Walt] SE Missouri State Univ, Dept Biol, Cape Girardeau, MO 63701 USA; [Goodell, Barry] Virginia Tech, Dept Wood Sci & Forest Prod, Blacksburg, VA 24061 USA; [Ihrmark, Katarina; Rosling, Anna; Stenlid, Jan; Hogberg, Nils] Swedish Univ Agr Sci, Dept Forest Mycol & Pathol, S-75007 Uppsala, Sweden; [Kauserud, Havard; Skrede, Inger] Univ Oslo, Dept Biol, NO-0316 Oslo, Norway; [Kohler, Annegret; Morin, Emmanuelle; Murat, Claude; Martin, Francis] Inst Natl Rech Agron INRA Nancy Univ, INRA Nancy, UMR 1136, F-54280 Champenoux, France; [Lavin, Jose L.; Oguiza, Jose A.; Pisabarro, Antonio G.] Univ Publ Navarra, Dept Agr Prod, Pamplona 31006, Spain; [Lee, Yong-Hwan; Park, Jongsun] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea; [Schmidt, Olaf] Univ Hamburg, Dept Wood Biol, D-21031 Hamburg, Germany; [Watkinson, Sarah C.] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England	Swansea University; Clark University; University of Gottingen; Friedrich Schiller University of Jena; Hans Knoll Institute (HKI); United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Helsinki; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Oslo; University of Maine System; University of Maine Orono; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; United States Department of Agriculture (USDA); United States Forest Service; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); Virginia Polytechnic Institute & State University; Swedish University of Agricultural Sciences; University of Oslo; INRAE; Universite de Lorraine; Universidad Publica de Navarra; Seoul National University (SNU); University of Hamburg; University of Oxford	Eastwood, DC (corresponding author), Univ Swansea, Coll Sci, Singleton Pk, Swansea SA2 8PP, W Glam, Wales.	d.c.eastwood@swansea.ac.uk	JL, Lavín/J-7892-2013; Pisabarro, Antonio G./K-3622-2014; Lapidus, Alla L/I-4348-2013; Baker, Scott E./ABB-1635-2020; Cullen, Daniel/AAN-5484-2020; de Vries, Ronald P./F-8125-2011; Baker, Scott E/X-2065-2018; Oguiza, Jose A/K-5147-2014; Stenlid, Jan/K-5909-2019; morin, emmanuelle/AAA-1246-2019; Riley, Robert/AAA-4531-2020; Schmutz, Jeremy/N-3173-2013; Henrissat, Bernard/J-2475-2012; Kohler, Annegret/AAD-1876-2019; Murat, Claude/AAA-5226-2020; Goodell, Barry/CAI-6720-2022; Binder, Manfred/C-8571-2013; Kües, Ursula/B-8280-2008; Rosling, Anna/D-1984-2012; Barry, Kerrie Whitelaw/AAA-5500-2020; Majcherczyk, Andrzej/B-8267-2008	JL, Lavín/0000-0003-0914-3211; Pisabarro, Antonio G./0000-0001-6987-5794; Lapidus, Alla L/0000-0003-0427-8731; Baker, Scott E./0000-0001-5085-3106; de Vries, Ronald P./0000-0002-4363-1123; Baker, Scott E/0000-0001-5085-3106; morin, emmanuelle/0000-0002-7268-972X; Riley, Robert/0000-0003-0224-0975; Schmutz, Jeremy/0000-0001-8062-9172; Henrissat, Bernard/0000-0002-3434-8588; Murat, Claude/0000-0003-0685-7307; Goodell, Barry/0000-0002-7798-7419; Kües, Ursula/0000-0001-9180-4079; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Majcherczyk, Andrzej/0000-0002-1616-6983; Eastwood, Daniel/0000-0002-7015-0739; Blumentritt, Melanie/0000-0003-2172-5599; Rosling, Anna/0000-0002-7003-5941; Grigoriev, Igor/0000-0002-3136-8903; Skrede, Inger/0000-0002-1113-7403; Asiegbu, Fred O/0000-0003-0223-7194; Park, Jongsun/0000-0003-0786-4701; Stenlid, Jan/0000-0002-5344-2094	Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; NERC [NE/F01449X/1] Funding Source: UKRI; Natural Environment Research Council [NE/F01449X/1] Funding Source: researchfish	Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	J. Schilling, University of Minnesota, and D. Barbara, University of Warwick, critically reviewed the manuscript; T. Marks designed graphics; and B. Wackler and M. Zomorrodi gave technical assistance. Assembly and annotations of S. lacrymans genomes are available at www.jgi.doe.gov/Serpula and DNA Data Bank of Japan/European Molecular Biology Laboratory/GenBank, accessions nos. AECQB00000000 and AEQC00000000. The complete microarray expression data set is available at the Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo/) accession no. GSE27839. The work was conducted by the U.S. Department of Energy Joint Genome Institute and supported by the Office of Science of the U.S. Department of Energy under contract DE-AC02-05CH11231. Further financial support is acknowledged in the supporting online material on Science Online.	Arantes V, 2011, J IND MICROBIOL BIOT, V38, P541, DOI 10.1007/s10295-010-0798-2; Binder M, 2006, MYCOLOGIA, V98, P971, DOI 10.3852/mycologia.98.6.971; Binder M, 2010, MYCOLOGIA, V102, P865, DOI 10.3852/09-288; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Curling SF, 2002, INT BIODETER BIODEGR, V49, P13, DOI 10.1016/S0964-8305(01)00101-9; Eckert AJ, 2006, MOL PHYLOGENET EVOL, V40, P166, DOI 10.1016/j.ympev.2006.03.009; Eriksson K.-E., 1990, MICROBIAL ENZYMATIC; GILBERTSON RL, 1980, MYCOLOGIA, V72, P1, DOI 10.2307/3759417; Goodell B, 1997, J BIOTECHNOL, V53, P133, DOI 10.1016/S0168-1656(97)01681-7; Hibbett DS, 2001, SYST BIOL, V50, P215, DOI 10.1080/10635150151125879; Kauserud H, 2007, MOL ECOL, V16, P3350, DOI 10.1111/j.1365-294X.2007.03387.x; Lindahl BD, 2007, NEW PHYTOL, V173, P611, DOI 10.1111/j.1469-8137.2006.01936.x; Lindahl BO, 2002, PLANT SOIL, V242, P123, DOI 10.1023/A:1019650226585; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martin F, 2011, NEW PHYTOL, V190, P818, DOI 10.1111/j.1469-8137.2011.03688.x; MARTIN F, 2007, BIOL FUNGAL CELL MYC, V8, P291; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; NILSSON T, 1979, MYCOLOGIA, V71, P170, DOI 10.2307/3759230; NORTHUP RR, 1995, NATURE, V377, P227, DOI 10.1038/377227a0; Schmidt O, 2000, HOLZFORSCHUNG, V54, P221, DOI 10.1515/HF.2000.038; Schneider P, 2008, FUNGAL GENET BIOL, V45, P1487, DOI 10.1016/j.fgb.2008.08.009; Shimokawa T, 2004, HOLZFORSCHUNG, V58, P305, DOI 10.1515/HF.2004.047; Tlalka M, 2008, APPL ENVIRON MICROB, V74, P2700, DOI 10.1128/AEM.02765-07; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Vasiliauskas R, 2007, NEW PHYTOL, V174, P441, DOI 10.1111/j.1469-8137.2007.02014.x; Wymelenberg AV, 2010, APPL ENVIRON MICROB, V76, P3599, DOI 10.1128/AEM.00058-10	28	384	406	6	468	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2011	333	6043					762	765		10.1126/science.1205411	http://dx.doi.org/10.1126/science.1205411			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21764756	Green Submitted			2022-12-01	WOS:000293512100045
J	Cerling, TE; Wynn, JG; Andanje, SA; Bird, MI; Korir, DK; Levin, NE; Mace, W; Macharia, AN; Quade, J; Remien, CH				Cerling, Thure E.; Wynn, Jonathan G.; Andanje, Samuel A.; Bird, Michael I.; Korir, David Kimutai; Levin, Naomi E.; Mace, William; Macharia, Anthony N.; Quade, Jay; Remien, Christopher H.			Woody cover and hominin environments in the past 6 million years	NATURE			English	Article							HUMAN-EVOLUTION; ARDIPITHECUS-RAMIDUS; CLIMATE-CHANGE; STABLE CARBON; ISOTOPIC COMPOSITION; TURKANA BASIN; EAST-AFRICA; C-4 PLANTS; VEGETATION; DELTA-C-13	The role of African savannahs in the evolution of early hominins has been debated for nearly a century. Resolution of this issue has been hindered by difficulty in quantifying the fraction of woody cover in the fossil record. Here we show that the fraction of woody cover in tropical ecosystems can be quantified using stable carbon isotopes in soils. Furthermore, we use fossil soils from hominin sites in the Awash and Omo-Turkana basins in eastern Africa to reconstruct the fraction of woody cover since the Late Miocene epoch (about 7 million years ago). C-13/C-12 ratio data from 1,300 palaeosols at or adjacent to hominin sites dating to at least 6 million years ago show that woody cover was predominantly less than similar to 40% at most sites. These data point to the prevalence of open environments at the majority of hominin fossil sites in eastern Africa over the past 6 million years.	[Cerling, Thure E.; Mace, William; Macharia, Anthony N.; Remien, Christopher H.] Univ Utah, Salt Lake City, UT 84112 USA; [Wynn, Jonathan G.] Univ S Florida, Tampa, FL 33620 USA; [Andanje, Samuel A.; Korir, David Kimutai] Kenya Wildlife Serv, Nairobi, Kenya; [Bird, Michael I.] James Cook Univ, Cairns, Qld 4870, Australia; [Levin, Naomi E.] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Quade, Jay] Univ Arizona, Tucson, AZ 85721 USA	Utah System of Higher Education; University of Utah; State University System of Florida; University of South Florida; James Cook University; Johns Hopkins University; University of Arizona	Cerling, TE (corresponding author), Univ Utah, Salt Lake City, UT 84112 USA.	thure.cerling@utah.edu	Bird, Michael/G-5364-2010; Levin, Naomi E/B-4124-2010; Wynn, Jonathan/C-1646-2010	Bird, Michael/0000-0003-1801-8703; Levin, Naomi E/0000-0001-5703-3717; Cerling, Thure/0000-0002-3590-294X	LSB Leakey Foundation; NSF [BCS 0621542, EAR-0617010, EAR-0937819, BCS-0321893]	LSB Leakey Foundation; NSF(National Science Foundation (NSF))	We thank the governments of Kenya and Ethiopia for permission to conduct this research, and F. H. Brown for discussions. The authors thank Kenya Wildlife Service and members of the Dikika and Gona Research Projects for support in the field, and Z. Bedaso for aid with analyses. This research was supported by funding from the LSB Leakey Foundation and NSF grants BCS 0621542, EAR-0617010, EAR-0937819 and BCS-0321893.	Aronson JL, 2008, J HUM EVOL, V55, P532, DOI 10.1016/j.jhevol.2008.04.004; Behrensmeyer AK, 2006, SCIENCE, V311, P476, DOI 10.1126/science.1116051; Bird MI, 2004, GLOBAL CHANGE BIOL, V10, P342, DOI 10.1046/j.1365-2486.2003.00695.x; Bird MI, 1996, NATURE, V381, P143, DOI 10.1038/381143a0; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Cane MA, 2001, NATURE, V411, P157, DOI 10.1038/35075500; Cerling TE, 1992, PALAEOGEOGR PALAEOCL, V97, P241, DOI 10.1016/0031-0182(92)90211-M; Cerling TE, 2010, SCIENCE, V328, DOI 10.1126/science.1185274; Dart RA, 1925, NATURE, V115, P195, DOI 10.1038/115195a0; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; deMenocal PB, 2011, SCIENCE, V331, P540, DOI 10.1126/science.1190683; Feakins SJ, 2005, GEOLOGY, V33, P977, DOI 10.1130/G21814.1; Feibel C.S., 1991, P321; Francey RJ, 1999, TELLUS B, V51, P170, DOI 10.1034/j.1600-0889.1999.t01-1-00005.x; Gibbons A, 2009, SCIENCE, V326, P36, DOI 10.1126/science.326_36; Good SP, 2011, P NATL ACAD SCI USA, V108, P4902, DOI 10.1073/pnas.1013100108; Keeling R.F., 2010, TRENDS COMPENDIUM DA; KLEIN RG, 1999, HUMAN CAREER HUMAN B; Levin NE, 2011, PALAEOGEOGR PALAEOCL, V307, P75, DOI 10.1016/j.palaeo.2011.04.026; Levin NE, 2004, EARTH PLANET SC LETT, V219, P93, DOI 10.1016/S0012-821X(03)00707-6; Lloyd J, 2008, TREE PHYSIOL, V28, P451, DOI 10.1093/treephys/28.3.451; Lovejoy C.O., 1978, EARLY HOMINIDAFRIC, P433; Ometto JPHB, 2006, BIOGEOCHEMISTRY, V79, P251, DOI 10.1007/s10533-006-9008-8; Passey BH, 2010, P NATL ACAD SCI USA, V107, P11245, DOI 10.1073/pnas.1001824107; PEARCY RW, 1984, PLANT CELL ENVIRON, V7, P1, DOI 10.1111/j.1365-3040.1984.tb01194.x; Pickering TR, 2007, J HUM EVOL, V53, P434, DOI 10.1016/j.jhevol.2007.01.012; Plummer TW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007199; Potts R, 1998, YEARB PHYS ANTHROPOL, V41, P93; Quade J., 2008, GEOLOGICAL SOC AM SP, V446; Quinn RL, 2007, J HUM EVOL, V53, P560, DOI 10.1016/j.jhevol.2007.01.013; Ratnam J, 2011, GLOBAL ECOL BIOGEOGR, V20, P653, DOI 10.1111/j.1466-8238.2010.00634.x; Richmond BG, 2001, YEARB PHYS ANTHROPOL, V44, P70, DOI 10.1002/ajpa.10019; ROGERS MJ, 1994, J HUM EVOL, V27, P139, DOI 10.1006/jhev.1994.1039; Salzmann U, 2008, GLOBAL ECOL BIOGEOGR, V17, P432, DOI 10.1111/j.1466-8238.2008.00381.x; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Sept J, 1998, AM J PRIMATOL, V46, P85, DOI 10.1002/(SICI)1098-2345(1998)46:1<85::AID-AJP7>3.3.CO;2-1; Sikes NE, 2007, J HUM EVOL, V53, P574, DOI 10.1016/j.jhevol.2006.12.008; Teaford MF, 2000, P NATL ACAD SCI USA, V97, P13506, DOI 10.1073/pnas.260368897; Vrba E. S., 1995, PALEOCLIMATE EVOLUTI; WHEELER PE, 1994, J HUM EVOL, V26, P339, DOI 10.1006/jhev.1994.1021; White F., 1983, VEGETATION AFRICA, V20; White TD, 2006, NATURE, V440, P883, DOI 10.1038/nature04629; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; WoldeGabriel G, 2009, SCIENCE, V326, DOI 10.1126/science.1175817; Wood B, 2008, J ANAT, V212, P354, DOI 10.1111/j.1469-7580.2008.00871.x; Wood B, 2011, NATURE, V470, P347, DOI 10.1038/nature09709; Wynn JG, 2004, AM J PHYS ANTHROPOL, V123, P106, DOI 10.1002/ajpa.10317; Wynn JG, 2000, J HUM EVOL, V39, P411, DOI 10.1006/jhev.2000.0431; Wynn JG, 2008, TELLUS B, V60, P604, DOI 10.1111/j.1600-0889.2008.00361.x; Zar J.H., 1999, BIOSTAT ANAL	50	323	327	4	172	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2011	476	7358					51	56		10.1038/nature10306	http://dx.doi.org/10.1038/nature10306			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	801NR	21814275				2022-12-01	WOS:000293447300027
J	Ewer, AK; Middleton, LJ; Furmston, AT; Bhoyar, A; Daniels, JP; Thangaratinam, S; Deeks, JJ; Khan, KS				Ewer, Andrew K.; Middleton, Lee J.; Furmston, Alexandra T.; Bhoyar, Abhay; Daniels, Jane P.; Thangaratinam, Shakila; Deeks, Jonathan J.; Khan, Khalid S.		PulseOx Study Grp	Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): a test accuracy study	LANCET			English	Article							FETAL DIAGNOSIS; DISEASE; PREVALENCE; SURVIVAL; IMPACT	Background Screening for congenital heart defects relies on antenatal ultrasonography and postnatal clinical examination; however, life-threatening defects often are not detected. We prospectively assessed the accuracy of pulse oximetry as a screening test for congenital heart defects. Methods In six maternity units in the UK, asymptomatic newborn babies (gestation >34 weeks) were screened with pulse oximetry before discharge. Infants who did not achieve predetermined oxygen saturation thresholds underwent echocardiography. All other infants were followed up to 12 months of age by use of regional and national registries and clinical follow-up. The main outcome was the sensitivity and specificity of pulse oximetry for detection of critical congenital heart defects (causing death or requiring invasive intervention before 28 days) or major congenital heart disease (causing death or requiring invasive intervention within 12 months of age). Findings 20055 newborn babies were screened and 53 had major congenital heart disease (24 critical), a prevalence of 2.6 per 1000 livebirths. Analyses were done on all babies for whom a pulse oximetry reading was obtained. Sensitivity of pulse oximetry was 75.00% (95%. CI 53.29-90.23) for critical cases and 49.06% (35.06-63.16) for all major congenital heart defects. In 35 cases, congenital heart defects were already suspected after antenatal ultrasonography, and exclusion of these reduced the sensitivity to 58.33% (27.67-84.83) for critical cases and 28.57% (14.64-46.30) for all cases of major congenital heart defects. False-positive results were noted for 169 (0.8%) babies (specificity 99.16%, 99.02-99.28), of which six cases were significant, but not major, congenital heart defects, and 40 were other illnesses that required urgent medical intervention. Interpretation Pulse oximetry is a safe, feasible test that adds value to existing screening. It identifies cases of critical congenital heart defects that go undetected with antenatal ultrasonography. The early detection of other diseases is an additional advantage.	[Ewer, Andrew K.] Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Ewer, Andrew K.] Birmingham Womens Healthcare NHS Fdn Trust, Birmingham, W Midlands, England; [Middleton, Lee J.] Univ Birmingham, Birmingham Clin Trials Unit, Birmingham, W Midlands, England; [Daniels, Jane P.] Birmingham Childrens Hosp NHS Fdn Trust, Birmingham, W Midlands, England; [Bhoyar, Abhay] Queen Mary Univ London, Birmingham, W Midlands, England; [Bhoyar, Abhay] Barts & London Queen Marys Sch Med & Dent, London, England; [Thangaratinam, Shakila; Deeks, Jonathan J.; Khan, Khalid S.] Univ Birmingham, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of London; Queen Mary University London; University of London; Queen Mary University London; University of Birmingham	Ewer, AK (corresponding author), Birmingham Womens Hosp, Neonatal Unit, Birmingham B15 2TG, W Midlands, England.	a.k.ewer@bham.ac.uk	Khan, Khalid S/AAT-8824-2020; Ewer, Andrew K/B-1050-2013; Thangaratinam, Shakila/AAP-3724-2021; Deeks, Jon/AAV-5745-2020	Khan, Khalid S/0000-0001-5084-7312; Thangaratinam, Shakila/0000-0002-4254-460X; Deeks, Jon/0000-0002-8850-1971; Ewer, Andrew/0000-0002-3825-4781; Middleton, Lee/0000-0003-4621-1922	National Institute for Health Research; National Institute for Health Research (NIHR) [06/06/03]; Medical Research Council [G0800808] Funding Source: researchfish; MRC [G0800808] Funding Source: UKRI	National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme (project number 06/06/03) and will be published this year in full in Health Technology Assessment. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA programme, NIHR, National Health Service, or Department of Health. We thank the members of the joint steering and data monitoring committee for their assistance throughout the project-Gerben ter Riet (chair, Academisch Medisch Centrum, Universiteit van Amsterdam), Suzie Hutchinson (Little Hearts Matter), Carole Cummins (University of Birmingham), Sam Richmond (Sunderland Royal Hospital), and Stavros Petrou (University of Oxford). The PulseOx study was coordinated by Birmingham Clinical Trials Unit at the University of Birmingham and we acknowledge the work of all the staff involved in the study, especially Leanne Fulcher, who was the data manager, and Edward Tyler who designed and developed the study database. We thank John Wright and Tarak Desai (Birmingham Children's Hospital) for their advice with the assessments of echocardiograms and grading echocardiographic findings; all the echocardiographers who helped with the additional echocardiography required by the study, particularly Vishna Rasiah, David Roden, Mrinalini Rajimwale, and Askar Kukkadi; David Cunningham who searched the Central Cardiac Audit Database; and all the midwives and midwifery assistants who worked so hard with recruitment and screening and use women who consented to take part in the study.	ABUHARB M, 1994, ARCH DIS CHILD-FETAL, V71, pF179, DOI 10.1136/fn.71.3.F179; [Anonymous], 2003, HLTH STAT Q, V18, P57; Arlettaz R, 2006, EUR J PEDIATR, V165, P94, DOI 10.1007/s00431-005-0006-y; Bakr AF, 2005, PEDIATR CARDIOL, V26, P832, DOI 10.1007/s00246-005-0981-9; Botto LD, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e32; Brown JW, 2001, ANN THORAC SURG, V71, P1978, DOI 10.1016/S0003-4975(01)02529-2; Brown KL, 2006, HEART, V92, P1298, DOI 10.1136/hrt.2005.078097; Bull C, 1999, LANCET, V354, P1242, DOI 10.1016/S0140-6736(99)01167-8; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.1093/biomet/26.4.404; de Wahl Granelli Anne, 2005, Acta Paediatr, V94, P1590, DOI 10.1080/08035250510039900; de-Wahl GA, 2009, BMJ-BRIT MED J, V338, pa3037, DOI DOI 10.1136/BMJ.A3037; Franklin O, 2002, HEART, V87, P67, DOI 10.1136/heart.87.1.67; Garne E, 2001, ULTRASOUND OBST GYN, V17, P386, DOI 10.1046/j.1469-0705.2001.00385.x; Hoke TR, 2002, PEDIATR CARDIOL, V23, P403, DOI 10.1007/s00246-002-1482-8; Koppel RI, 2003, PEDIATRICS, V111, P451, DOI 10.1542/peds.111.3.451; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Mahle WT, 2009, CIRCULATION, V120, P447, DOI 10.1161/CIRCULATIONAHA.109.192576; Meberg A, 2008, J PEDIATR-US, V152, P761, DOI 10.1016/j.jpeds.2007.12.043; Reich JD, 2003, J PEDIATR-US, V142, P268, DOI 10.1067/mpd.2003.87; Richmond S, 2002, ARCH DIS CHILD-FETAL, V87, pF83, DOI 10.1136/fn.87.2.F83; Riede FT, 2010, EUR J PEDIATR, V169, P975, DOI 10.1007/s00431-010-1160-4; Rosati E, 2005, J PERINAT MED, V33, P455, DOI 10.1515/JPM.2005.080; Sendelbach DM, 2008, PEDIATRICS, V122, pE815, DOI 10.1542/peds.2008-0781; Tegnander E, 2006, ULTRASOUND OBST GYN, V27, P252, DOI 10.1002/uog.2710; Thangaratinam S, 2007, ARCH DIS CHILD-FETAL, V92, pF176, DOI 10.1136/adc.2006.107656; Tworetzky W, 2001, CIRCULATION, V103, P1269, DOI 10.1161/01.cir.103.9.1269; Wren C, 2008, ARCH DIS CHILD-FETAL, V93, pF33, DOI 10.1136/adc.2007.119032; Wren C, 1999, ARCH DIS CHILD-FETAL, V80, pF49, DOI 10.1136/fn.80.1.F49	28	192	207	0	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2011	378	9793					785	794		10.1016/S0140-6736(11)60753-8	http://dx.doi.org/10.1016/S0140-6736(11)60753-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816FY	21820732				2022-12-01	WOS:000294585300034
J	Braun, P; Carvunis, AR; Charloteaux, B; Dreze, M; Ecker, JR; Hill, DE; Roth, FP; Vidal, M; Galli, M; Balumuri, P; Bautista, V; Chesnut, JD; Kim, RC; de los Reyes, C; Gilles, P; Kim, CJ; Matrubutham, U; Mirchandani, J; Olivares, E; Patnaik, S; Quan, R; Ramaswamy, G; Shinn, P; Swamilingiah, GM; Wu, S; Ecker, JR; Dreze, M; Byrdsong, D; Dricot, A; Duarte, M; Gebreab, F; Gutierrez, BJ; MacWilliams, A; Monachello, D; Mukhtar, MS; Poulin, MM; Reichert, P; Romero, V; Tam, S; Waaijers, S; Weiner, EM; Vidal, M; Hill, DE; Braun, P; Galli, M; Carvunis, AR; Cusick, ME; Dreze, M; Romero, V; Roth, FP; Tasan, M; Yazaki, J; Braun, P; Ecker, JR; Carvunis, AR; Ahn, YY; Barabasi, AL; Charloteaux, B; Chen, HM; Cusick, ME; Dangl, JL; Dreze, M; Ecker, JR; Fan, CY; Gai, LT; Galli, M; Ghoshal, G; Hao, T; Hill, DE; Lurin, C; Milenkovic, T; Moore, J; Mukhtar, MS; Pevzner, SJ; Przulj, N; Rabello, S; Rietman, EA; Rolland, T; Roth, FP; Santhanam, B; Schmitz, RJ; Spooner, W; Stein, J; Tasan, M; Vandenhaute, J; Ware, D; Braun, P; Vidal, M; Braun, P; Carvunis, AR; Charloteaux, B; Dreze, M; Galli, M; Vidal, M				Braun, Pascal; Carvunis, Anne-Ruxandra; Charloteaux, Benoit; Dreze, Matija; Ecker, Joseph R.; Hill, David E.; Roth, Frederick P.; Vidal, Marc; Galli, Mary; Balumuri, Padmavathi; Bautista, Vanessa; Chesnut, Jonathan D.; Kim, Rosa Cheuk; de los Reyes, Chris; Gilles, Patrick, II; Kim, Christopher J.; Matrubutham, Uday; Mirchandani, Jyotika; Olivares, Eric; Patnaik, Suswapna; Quan, Rosa; Ramaswamy, Gopalakrishna; Shinn, Paul; Swamilingiah, Geetha M.; Wu, Stacy; Ecker, Joseph R.; Dreze, Matija; Byrdsong, Danielle; Dricot, Amelie; Duarte, Melissa; Gebreab, Fana; Gutierrez, Bryan J.; MacWilliams, Andrew; Monachello, Dario; Mukhtar, M. Shahid; Poulin, Matthew M.; Reichert, Patrick; Romero, Viviana; Tam, Stanley; Waaijers, Selma; Weiner, Evan M.; Vidal, Marc; Hill, David E.; Braun, Pascal; Galli, Mary; Carvunis, Anne-Ruxandra; Cusick, Michael E.; Dreze, Matija; Romero, Viviana; Roth, Frederick P.; Tasan, Murat; Yazaki, Junshi; Braun, Pascal; Ecker, Joseph R.; Carvunis, Anne-Ruxandra; Ahn, Yong-Yeol; Barabasi, Albert-Laszlo; Charloteaux, Benoit; Chen, Huaming; Cusick, Michael E.; Dangl, Jeffery L.; Dreze, Matija; Ecker, Joseph R.; Fan, Changyu; Gai, Lantian; Galli, Mary; Ghoshal, Gourab; Hao, Tong; Hill, David E.; Lurin, Claire; Milenkovic, Tijana; Moore, Jonathan; Mukhtar, M. Shahid; Pevzner, Samuel J.; Przulj, Natasa; Rabello, Sabrina; Rietman, Edward A.; Rolland, Thomas; Roth, Frederick P.; Santhanam, Balaji; Schmitz, Robert J.; Spooner, William; Stein, Joshua; Tasan, Murat; Vandenhaute, Jean; Ware, Doreen; Braun, Pascal; Vidal, Marc; Braun, Pascal; Carvunis, Anne-Ruxandra; Charloteaux, Benoit; Dreze, Matija; Galli, Mary; Vidal, Marc		Arabidopsis Interactome Mapping Co	Evidence for Network Evolution in an Arabidopsis Interactome Map	SCIENCE			English	Article							PROTEIN-INTERACTION NETWORKS; DUPLICATED GENES; GENOME; DIVERGENCE; EXPRESSION; PLASTICITY; BINDING; EVOLVES; PLANTS; FATE	Plants have unique features that evolved in response to their environments and ecosystems. A full account of the complex cellular networks that underlie plant-specific functions is still missing. We describe a proteome-wide binary protein-protein interaction map for the interactome network of the plant Arabidopsis thaliana containing about 6200 highly reliable interactions between about 2700 proteins. A global organization of plant biological processes emerges from community analyses of the resulting network, together with large numbers of novel hypothetical functional links between proteins and pathways. We observe a dynamic rewiring of interactions following gene duplication events, providing evidence for a model of evolution acting upon interactome networks. This and future plant interactome maps should facilitate systems approaches to better understand plant biology and improve crops.	[Carvunis, Anne-Ruxandra; Charloteaux, Benoit; Dricot, Amelie; Gutierrez, Bryan J.; MacWilliams, Andrew; Carvunis, Anne-Ruxandra; Barabasi, Albert-Laszlo; Fan, Changyu; Santhanam, Balaji] Dana Farber Canc Inst, Ctr Canc Syst Biol CCSB, Boston, MA 02215 USA; [Carvunis, Anne-Ruxandra; Dricot, Amelie; MacWilliams, Andrew; Carvunis, Anne-Ruxandra; Barabasi, Albert-Laszlo] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Carvunis, Anne-Ruxandra; Dricot, Amelie; MacWilliams, Andrew; Carvunis, Anne-Ruxandra] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Carvunis, Anne-Ruxandra] CNRS, Computat & Math Biol Grp, UMR5525, F-38706 La Tronche, France; [Carvunis, Anne-Ruxandra] Univ Grenoble, Fac Med, F-38706 La Tronche, France; [Charloteaux, Benoit] Univ Liege, GIGA R, Unit Anim Genom, B-4000 Liege, Wallonia Brusse, Belgium; [Charloteaux, Benoit] Univ Liege, Fac Vet Med, B-4000 Liege, Wallonia Brusse, Belgium; [Dreze, Matija; Vandenhaute, Jean] Fac Univ Notre Dame Paix, Unite Rech Biol Mol, B-5000 Namur, Wallonia Brusse, Belgium; [Ecker, Joseph R.; de los Reyes, Chris; Kim, Christopher J.; Chen, Huaming] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Ecker, Joseph R.] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Balumuri, Padmavathi; Chesnut, Jonathan D.; Gilles, Patrick, II; Matrubutham, Uday; Mirchandani, Jyotika; Olivares, Eric; Patnaik, Suswapna; Ramaswamy, Gopalakrishna; Swamilingiah, Geetha M.] Harvard Univ, Sch Med, Dept Biol Chem, Boston, MA 02115 USA; [Balumuri, Padmavathi; Chesnut, Jonathan D.; Gilles, Patrick, II; Matrubutham, Uday; Mirchandani, Jyotika; Olivares, Eric; Patnaik, Suswapna; Ramaswamy, Gopalakrishna; Swamilingiah, Geetha M.] Harvard Univ, Sch Med, Dept Mol Pharmacol, Boston, MA 02115 USA; [Ahn, Yong-Yeol; Barabasi, Albert-Laszlo; Ghoshal, Gourab; Rabello, Sabrina] Northeastern Univ, Dept Phys, Ctr Complex Network Res CCNR, Boston, MA 02115 USA; [Mukhtar, M. Shahid; Dangl, Jeffery L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Monachello, Dario; Lurin, Claire] Univ Evry Val Essonne, Unite Rech Genom Vegetale, Inst Natl Rech Agron, Unite Mixtes Rech,ERL Ctr Natl Rech Sci, F-91057 Evry, France; [Milenkovic, Tijana] Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA; [Moore, Jonathan] Univ Warwick, Warwick Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England; [Pevzner, Samuel J.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Pevzner, Samuel J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Przulj, Natasa] Univ London Imperial Coll Sci Technol & Med, Dept Comp, London SW7 2AZ, England; [Spooner, William; Stein, Joshua; Ware, Doreen] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Spooner, William] Eagle Genom Ltd, Cambridge CB4 1JD, England; [Ware, Doreen] Cornell Univ, USDA, ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite de Franche-Comte; University of Liege; University of Liege; University of Namur; Salk Institute; Salk Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Northeastern University; University of North Carolina; University of North Carolina Chapel Hill; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Notre Dame; University of Warwick; Boston University; Boston University; Imperial College London; Cold Spring Harbor Laboratory; Cornell University; United States Department of Agriculture (USDA)	Vidal, M (corresponding author), Dana Farber Canc Inst, Ctr Canc Syst Biol CCSB, Boston, MA 02215 USA.	ecker@salk.edu; david_hill@dfci.harvard.edu; marc_vidal@dfci.harvard.edu; pascal_braun@dfci.harvard.edu	Moore, Jonathan D/D-1796-2013; Hill, David E/B-6617-2011; Ecker, Joseph R/B-9144-2008; Przulj, Natasa/AAO-2850-2020; Braun, Pascal/B-9669-2013; Vidal, Marc/Y-2466-2019; Ahn, Yong-Yeol/C-6334-2011; Barabasi, Albert-Laszlo/S-6474-2017; Schmitz, Robert/AAY-7659-2020; /AAD-1735-2020; Dreze, Matija/AAZ-3293-2020; Yazaki, Junshi/B-1557-2012; Roth, Frederick P/H-6308-2011	Moore, Jonathan D/0000-0002-5486-0407; Ecker, Joseph R/0000-0001-5799-5895; Braun, Pascal/0000-0003-2012-6746; Vidal, Marc/0000-0003-3391-5410; Ahn, Yong-Yeol/0000-0002-4352-4301; Schmitz, Robert/0000-0001-7538-6663; /0000-0003-3516-4438; Barabasi, Albert/0000-0002-4028-3522; Przulj, Natasa/0000-0002-1290-853X; Mukhtar, Shahid/0000-0002-1104-6931; Carvunis, Anne-Ruxandra/0000-0002-6474-6413; /0000-0001-7002-8488; Rolland, Thomas/0000-0001-6468-8391	NSF [0703905, 0520253, 0313578, 0703908]; National Human Genome Research Institute [R01HG001715]; Canada Excellence Research Chairs Program; Canadian Institute for Advanced Research Fellowship; James S. McDonnell Foundation [220020084]; Sixth Framework Programme [LSHG-CT-2006-037704]; National Institute of General Medical Sciences [R01GM066025]; U.S. Department of Agriculture, Agricultural Research Service [1907-21000-030]; NIH [F32HG004098, F32HG004830]; Biotechnology and Biological Sciences Research Council [F005806]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001715, F32HG004830, F32HG004098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066025] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Canada Excellence Research Chairs Program(Canada Research Chairs); Canadian Institute for Advanced Research Fellowship(Canadian Institute for Advanced Research (CIFAR)); James S. McDonnell Foundation; Sixth Framework Programme(European Commission); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Benfey, H. Yu, M. Nordborg, P. Ronald, M Snyder, and R. Wing as well as members of the Dana-Farber Cancer Institute Center for Cancer Systems Biology, for helpful discussions. This work was supported by the following grants: NSF 0703905 to M. V., J.R.E., and D. E. H.; National Human Genome Research Institute R01HG001715 to M. V., D. E. H., and F. P. R.; NSF 0520253 and NSF 0313578 to J.R.E.; Canada Excellence Research Chairs Program and Canadian Institute for Advanced Research Fellowship to F. P. R.; James S. McDonnell Foundation 220020084 to A.-L. B; Sixth Framework Programme LSHG-CT-2006-037704 (AGRON-OMICS) to C. L.; National Institute of General Medical Sciences R01GM066025 to J.L.D.; U.S. Department of Agriculture, Agricultural Research Service 1907-21000-030 to D. W.; NIH National Research Service Award fellowships F32HG004098 to M. T. and F32HG004830 to R.J.S.; Biotechnology and Biological Sciences Research Council grant F005806 to Jim Beynon in support of J.M.; and NSF 0703908 to D. W. in support of J.S. and W. S. M. V. is a Chercheur Qualifie Honoraire from the Fonds de la Recherche Scientifique (FRS-FNRS, Wallonia- Brussels Federation, Belgium). Data reported here are available at the Web site http://interactome.dfci.harvard.edu/A_thaliana	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Amoutzias GD, 2010, P NATL ACAD SCI USA, V107, P2967, DOI 10.1073/pnas.0911603107; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Casneuf T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r13; Cusick ME, 2009, NAT METHODS, V6, P39, DOI [10.1038/NMETH.1284, 10.1038/nmeth.1284]; Dreze M, 2010, METHOD ENZYMOL, V470, P281, DOI 10.1016/S0076-6879(10)70012-4; Dreze M, 2009, NAT METHODS, V6, P843, DOI [10.1038/NMETH.1394, 10.1038/nmeth.1394]; Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Ganko EW, 2007, MOL BIOL EVOL, V24, P2298, DOI 10.1093/molbev/msm158; Guan YF, 2007, GENETICS, V175, P933, DOI 10.1534/genetics.106.064329; Hanada K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000781; Hou XL, 2010, DEV CELL, V19, P884, DOI 10.1016/j.devcel.2010.10.024; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Kagale S, 2010, PLANT PHYSIOL, V152, P1109, DOI 10.1104/pp.109.151704; Kieffer M, 2006, PLANT CELL, V18, P560, DOI 10.1105/tpc.105.039107; Krogan NT, 2009, CURR OPIN PLANT BIOL, V12, P628, DOI 10.1016/j.pbi.2009.07.011; Levy ED, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.260pe11; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maslov S, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-9; Mayo AE, 2006, PLOS BIOL, V4, P555, DOI 10.1371/journal.pbio.0040045; Mazzucotelli E, 2006, CURR GENOMICS, V7, P509, DOI 10.2174/138920206779315728; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Pastor-Satorras R, 2003, J THEOR BIOL, V222, P199, DOI 10.1016/S0022-5193(03)00028-6; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schoonheim PJ, 2007, PLANT J, V49, P289, DOI 10.1111/j.1365-313X.2006.02955.x; Seo PJ, 2008, TRENDS PLANT SCI, V13, P550, DOI 10.1016/j.tplants.2008.06.008; Shou C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001050; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Vazquez Alexei, 2003, ComPlexUs, V1, P38, DOI 10.1159/000067642; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wagner A, 2003, P ROY SOC B-BIOL SCI, V270, P457, DOI 10.1098/rspb.2002.2269; Wagner A, 2001, MOL BIOL EVOL, V18, P1283, DOI 10.1093/oxfordjournals.molbev.a003913; Wen R, 2008, PLANT CELL, V20, P213, DOI 10.1105/tpc.107.051862; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	42	653	1041	13	260	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2011	333	6042					601	607		10.1126/science.1203877	http://dx.doi.org/10.1126/science.1203877			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21798944	Green Accepted			2022-12-01	WOS:000293222400054
J	Ranasinghe, AM; Strong, D; Boland, B; Bonser, RS				Ranasinghe, Aaron M.; Strong, Daniel; Boland, Barry; Bonser, Robert S.			EASILY MISSED? Acute aortic dissection	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTERNATIONAL REGISTRY; D-DIMER; DIAGNOSIS; OUTCOMES; IRAD		[Ranasinghe, Aaron M.; Bonser, Robert S.] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp, Dept Cardiac Surg, Birmingham B15 2TH, W Midlands, England; [Ranasinghe, Aaron M.; Bonser, Robert S.] Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England; [Strong, Daniel] Royal Wolverhampton Hosp NHS Trust, New Cross Hosp, Wolverhampton WV10 0QP, W Midlands, England; [Boland, Barry] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp, Emergency Dept, Birmingham B15 2TH, W Midlands, England	University of Birmingham; University of Birmingham; New Cross Hospital; University of Birmingham	Bonser, RS (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp, Dept Cardiac Surg, Birmingham B15 2TH, W Midlands, England.	robert.bonser@uhb.nhs.uk						Bossone E, 2002, AM J CARDIOL, V89, P851, DOI 10.1016/S0002-9149(02)02198-7; Collins JS, 2004, CIRCULATION, V110, pII237, DOI 10.1161/01.CIR.0000138219.67028.2a; Estrera AL, 2006, J THORAC CARDIOV SUR, V132, P1404, DOI 10.1016/j.jtcvs.2006.07.026; Fattori R, 2008, JACC-CARDIOVASC INTE, V1, P395, DOI 10.1016/j.jcin.2008.04.009; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; Meszaros I, 2000, CHEST, V117, P1271, DOI 10.1378/chest.117.5.1271; National Institute for Health and Clinical Excellence, 2010, CHEST PAIN REC ONS A; Nienaber CA, 2003, CIRCULATION, V108, P628, DOI 10.1161/01.CIR.0000087009.16755.E4; Olsson C, 2006, CIRCULATION, V114, P2611, DOI 10.1161/CIRCULATIONAHA.106.630400; Raghupathy A, 2008, AM J CARDIOL, V102, P1562, DOI 10.1016/j.amjcard.2008.07.049; Sabik JF, 2000, J THORAC CARDIOV SUR, V119, P946, DOI 10.1016/S0022-5223(00)70090-0; Sodeck G, 2007, EUR HEART J, V28, P3067, DOI 10.1093/eurheartj/ehm484; Suzuki T, 2009, CIRCULATION, V119, P2702, DOI 10.1161/CIRCULATIONAHA.108.833004; von Kodolitsch Y, 2000, ARCH INTERN MED, V160, P2977, DOI 10.1001/archinte.160.19.2977	14	8	10	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2011	343								d4487	10.1136/bmj.d4487	http://dx.doi.org/10.1136/bmj.d4487			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801LU	21803810				2022-12-01	WOS:000293441200001
J	Nusinow, DA; Helfer, A; Hamilton, EE; King, JJ; Imaizumi, T; Schultz, TF; Farre, EM; Kay, SA				Nusinow, Dmitri A.; Helfer, Anne; Hamilton, Elizabeth E.; King, Jasmine J.; Imaizumi, Takato; Schultz, Thomas F.; Farre, Eva M.; Kay, Steve A.			The ELF4-ELF3-LUX complex links the circadian clock to diurnal control of hypocotyl growth	NATURE			English	Article							QUANTITATIVE-ANALYSIS; ARTIFICIAL MICRORNAS; FUNCTIONAL GENOMICS; PROTEIN; ELF3; TRANSCRIPTION; COMPONENT; ENCODES; TIME; COINCIDENCE	The circadian clock is required for adaptive responses to daily and seasonal changes in environmental conditions(1-3). Light and the circadian clock interact to consolidate the phase of hypocotyl cell elongation to peak at dawn under diurnal cycles in Arabidopsis thaliana(4-7). Here we identify a protein complex (called the evening complex)-composed of the proteins encoded by EARLY FLOWERING 3 (ELF3), ELF4 and the transcription-factor-encoding gene LUX ARRHYTHMO (LUX; also known as PHYTOCLOCK 1)-that directly regulates plant growth(8-12). ELF3 is both necessary and sufficient to form a complex between ELF4 and LUX, and the complex is diurnally regulated, peaking at dusk. ELF3, ELF4 and LUX are required for the proper expression of the growth-promoting transcription factors encoded by PHYTOCHROME INTERACTING FACTOR 4 (PIF4) and PIF5 (also known as PHYTOCHROME INTERACTING FACTOR 3-LIKE 6) under diurnal conditions(4,6,13). LUX targets the complex to the promoters of PIF4 and PIF5 in vivo. Mutations in PIF4 and/or PIF5 are epistatic to the loss of the ELF4-ELF3-LUX complex, suggesting that regulation of PIF4 and PIF5 is a crucial function of the complex. Therefore, the evening complex underlies the molecular basis for circadian gating of hypocotyl growth in the early evening.	[Nusinow, Dmitri A.; Helfer, Anne; Hamilton, Elizabeth E.; King, Jasmine J.; Imaizumi, Takato; Schultz, Thomas F.; Farre, Eva M.; Kay, Steve A.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Nusinow, Dmitri A.; Helfer, Anne; Hamilton, Elizabeth E.; King, Jasmine J.; Kay, Steve A.] Univ Calif San Diego, Ctr Chronobiol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Kay, SA (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	skay@ucsd.edu	Kay, Steve A/F-6025-2011; Nusinow, Dmitri A/K-9129-2013	Kay, Steve A/0000-0002-0402-2878; Nusinow, Dmitri A/0000-0002-0497-1723; Schultz, Thomas/0000-0001-9694-9920; Farre, Eva M./0000-0003-1566-7572	University of California, San Diego; Chancellor's Undergraduate Research Scholarship; European Molecular Biology Organization [ALTF 236-2005]; National Science Foundation [IBN-0416762]; National Institutes of Health [NRSA GM083585, NRSA GM080930, R01 GM79712, R01 GM50006, GM67837]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056006, F32GM083585, R01GM050006, R01GM067837, R01GM079712, F32GM080930, RC2GM092412] Funding Source: NIH RePORTER	University of California, San Diego(University of California System); Chancellor's Undergraduate Research Scholarship; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	P. Y. Pongsawakul illustrated the model in Fig. 4c. We thank G. Breton, T. Hirota, J. Pruneda-Paz, D. Nagel, E. Kolmos and B. J. Cole for critical reading of the manuscript. We also thank J. Halverson, A. L. Quiroz and C. Valdivia for excellent technical assistance. pif4-101 pif5-1 seedlings were a generous gift from S. Lorrain and C. Fankhauser. F. Harmon originally identified the nature of the elf4-3 mutation and designed the dCAPS strategy. This work was supported by a University of California, San Diego, Chancellor's Undergraduate Research Scholarship (to J. J. K.), grants from the European Molecular Biology Organization (ALTF 236-2005 to A. H.), the National Science Foundation (IBN-0416762 to T. F. S.) and the National Institutes of Health (NRSA GM083585 to D.A.N., NRSA GM080930 to E. E. H., R01 GM79712 to T. I., and R01 GM50006 and GM67837 to S.A.K.).	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; de Montaigu A, 2010, TRENDS GENET, V26, P296, DOI 10.1016/j.tig.2010.04.003; Dixon LE, 2011, CURR BIOL, V21, P120, DOI 10.1016/j.cub.2010.12.013; Doyle MR, 2002, NATURE, V419, P74, DOI 10.1038/nature00954; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; Harlow, 1999, USING ANTIBODIES LAB; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; Hazen SP, 2005, P NATL ACAD SCI USA, V102, P10387, DOI 10.1073/pnas.0503029102; Hazen SP, 2005, PLANT PHYSIOL, V138, P990, DOI 10.1104/pp.105.061408; Helfer A, 2011, CURR BIOL, V21, P126, DOI 10.1016/j.cub.2010.12.021; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; Hicks KA, 2001, PLANT CELL, V13, P1281, DOI 10.1105/tpc.13.6.1281; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Khanna R, 2003, PLANT PHYSIOL, V133, P1530, DOI 10.1104/pp.103.030007; Kikis EA, 2005, PLANT J, V44, P300, DOI 10.1111/j.1365-313X.2005.02531.x; Liu XL, 2001, PLANT CELL, V13, P1293, DOI 10.1105/tpc.13.6.1293; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Lorrain S, 2008, PLANT J, V53, P312, DOI 10.1111/j.1365-313X.2007.03341.x; Lu SX, 2009, PLANT PHYSIOL, V150, P834, DOI 10.1104/pp.108.133272; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Michael TP, 2008, PLOS BIOL, V6, P1887, DOI 10.1371/journal.pbio.0060225; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Mockler TC, 2007, COLD SPRING HARB SYM, V72, P353, DOI 10.1101/sqb.2007.72.006; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; Niwa Y, 2009, PLANT CELL PHYSIOL, V50, P838, DOI 10.1093/pcp/pcp028; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Onai K, 2005, GENES CELLS, V10, P963, DOI 10.1111/j.1365-2443.2005.00892.x; Ossowski S, 2008, PLANT J, V53, P674, DOI 10.1111/j.1365-313X.2007.03328.x; Para A, 2007, PLANT CELL, V19, P3462, DOI 10.1105/tpc.107.054775; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Pruneda-Paz JL, 2009, SCIENCE, V323, P1481, DOI 10.1126/science.1167206; Rozen S, 2000, Methods Mol Biol, V132, P365; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Thines B, 2010, P NATL ACAD SCI USA, V107, P3257, DOI 10.1073/pnas.0911006107; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Yakir E, 2007, FEBS J, V274, P335, DOI 10.1111/j.1742-4658.2006.05616.x; Yu JW, 2008, MOL CELL, V32, P617, DOI 10.1016/j.molcel.2008.09.026; Zagotta MT, 1996, PLANT J, V10, P691, DOI 10.1046/j.1365-313X.1996.10040691.x	43	521	557	14	179	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 21	2011	475	7356					398	U161		10.1038/nature10182	http://dx.doi.org/10.1038/nature10182			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21753751	Green Accepted			2022-12-01	WOS:000292911200047
J	Stuber, GD; Sparta, DR; Stamatakis, AM; van Leeuwen, WA; Hardjoprajitno, JE; Cho, S; Tye, KM; Kempadoo, KA; Zhang, F; Deisseroth, K; Bonci, A				Stuber, Garret D.; Sparta, Dennis R.; Stamatakis, Alice M.; van Leeuwen, Wieke A.; Hardjoprajitno, Juanita E.; Cho, Saemi; Tye, Kay M.; Kempadoo, Kimberly A.; Zhang, Feng; Deisseroth, Karl; Bonci, Antonello			Excitatory transmission from the amygdala to nucleus accumbens facilitates reward seeking	NATURE			English	Article							MIDBRAIN DOPAMINE NEURONS; BASOLATERAL AMYGDALA; COCAINE-SEEKING; BEHAVIOR; CORE; RELEASE; DISCONNECTION; INVOLVEMENT; MOTIVATION; INTERFACE	The basolateral amygdala (BLA) has a crucial role in emotional learning irrespective of valence(1-5,21-23). The BLA projection to the nucleus accumbens (NAc) is thought to modulate cue-triggered motivated behaviours(4,6,7,24,25), but our understanding of the interaction between these two brain regions has been limited by the inability to manipulate neural-circuit elements of this pathway selectively during behaviour. To circumvent this limitation, we used in vivo optogenetic stimulation or inhibition of glutamatergic fibres from the BLA to the NAc, coupled with intracranial pharmacology and ex vivo electrophysiology. Here we show that optical stimulation of the pathway from the BLA to the NAc in mice reinforces behavioural responding to earn additional optical stimulation of these synaptic inputs. Optical stimulation of these glutamatergic fibres required intra-NAc dopamine D1-type receptor signalling, but not D2-type receptor signalling. Brief optical inhibition of fibres from the BLA to the NAc reduced cue-evoked intake of sucrose, demonstrating an important role of this specific pathway in controlling naturally occurring reward-related behaviour. Moreover, although optical stimulation of glutamatergic fibres from the medial prefrontal cortex to the NAc also elicited reliable excitatory synaptic responses, optical self-stimulation behaviour was not observed by activation of this pathway. These data indicate that whereas the BLA is important for processing both positive and negative affect, the glutamatergic pathway from the BLA to the NAc, in conjunction with dopamine signalling in the NAc, promotes motivated behavioural responding. Thus, optogenetic manipulation of anatomically distinct synaptic inputs to the NAc reveals functionally distinct properties of these inputs in controlling reward-seeking behaviours.	[Stuber, Garret D.; Sparta, Dennis R.; Stamatakis, Alice M.] Univ N Carolina, UNC Neurosci Ctr, Dept Psychiat, Chapel Hill, NC 27599 USA; [Stuber, Garret D.; Sparta, Dennis R.; Stamatakis, Alice M.] Univ N Carolina, UNC Neurosci Ctr, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Stuber, Garret D.; Sparta, Dennis R.; van Leeuwen, Wieke A.; Hardjoprajitno, Juanita E.; Cho, Saemi; Tye, Kay M.; Kempadoo, Kimberly A.; Bonci, Antonello] Univ Calif San Francisco, Wheeler Ctr Neurobiol Drug Addict, Dept Neurol, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94608 USA; [Tye, Kay M.; Zhang, Feng; Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Tye, Kay M.; Zhang, Feng; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Bonci, Antonello] NIDA, Intramural Res Program, Baltimore, MD 21224 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Stuber, GD (corresponding author), Univ N Carolina, UNC Neurosci Ctr, Dept Psychiat, Chapel Hill, NC 27599 USA.	gstuber@med.unc.edu	Core, Vector/CAF-4832-2022; Macrae, Rhiannon/AAX-1536-2020; , UNC Neuroscience Microscopy Core/AAE-8305-2022; Stuber, Garret/E-1160-2011; Tye, Kay/J-6158-2013	Tye, Kay/0000-0002-2435-0182; Stuber, Garret/0000-0003-1730-4855	NARSAD; ABMRF; Foundation of Hope; NIDA [DA029325]; Psychiatry Department at UNC Chapel Hill; State of California through the University of California at San Francisco;  [F32AA018610]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F32AA018610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA029325, R01DA032750] Funding Source: NIH RePORTER	NARSAD(NARSAD); ABMRF; Foundation of Hope; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Psychiatry Department at UNC Chapel Hill; State of California through the University of California at San Francisco; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Phillips, V. Kharazia, A. Adamantidis and H.-C. Tsai for assistance and advice. We also thank V. Gukassyan and the UNC Neuroscience Center microscopy core facility. This study was supported by funds from NARSAD, ABMRF, The Foundation of Hope, and NIDA (DA029325), by startup funds provided by the Psychiatry Department at UNC Chapel Hill (G. D. S.) and by the State of California through the University of California at San Francisco (A. B.). D. R. S. was supported by F32AA018610.	Ambroggi F, 2008, NEURON, V59, P648, DOI 10.1016/j.neuron.2008.07.004; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; Bromberg-Martin ES, 2009, NEURON, V63, P119, DOI 10.1016/j.neuron.2009.06.009; CADOR M, 1989, NEUROSCIENCE, V30, P77, DOI 10.1016/0306-4522(89)90354-0; Di Ciano P, 2004, J NEUROSCI, V24, P7167, DOI 10.1523/JNEUROSCI.1581-04.2004; Di Ciano P, 2001, J NEUROSCI, V21, P9471, DOI 10.1523/JNEUROSCI.21-23-09471.2001; Floresco SB, 1998, EUR J NEUROSCI, V10, P1241, DOI 10.1046/j.1460-9568.1998.00133.x; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Jones JL, 2010, BIOL PSYCHIAT, V67, P737, DOI 10.1016/j.biopsych.2009.11.006; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; McFarland K, 2003, J NEUROSCI, V23, P3531; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Setlow B, 2002, BEHAV NEUROSCI, V116, P267, DOI 10.1037//0735-7044.116.2.267; Shabel SJ, 2009, P NATL ACAD SCI USA, V106, P15031, DOI 10.1073/pnas.0905580106; Shiflett MW, 2010, EUR J NEUROSCI, V32, P1735, DOI 10.1111/j.1460-9568.2010.07439.x; Stuber GD, 2008, SCIENCE, V321, P1690, DOI 10.1126/science.1160873; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tye KM, 2008, NATURE, V453, P1253, DOI 10.1038/nature06963; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; WRIGHT CI, 1995, J COMP NEUROL, V361, P383, DOI 10.1002/cne.903610304; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	26	562	578	2	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 21	2011	475	7356					377	U129		10.1038/nature10194	http://dx.doi.org/10.1038/nature10194			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21716290	Green Submitted, Green Accepted			2022-12-01	WOS:000292911200042
J	Kralj, JM; Hochbaum, DR; Douglass, AD; Cohen, AE				Kralj, Joel M.; Hochbaum, Daniel R.; Douglass, Adam D.; Cohen, Adam E.			Electrical Spiking in Escherichia coli Probed with a Fluorescent Voltage-Indicating Protein	SCIENCE			English	Article							FLAGELLAR MOTOR; TRANSPORT; PHOTOTROPHY	Bacteria have many voltage-and ligand-gated ion channels, and population-level measurements indicate that membrane potential is important for bacterial survival. However, it has not been possible to probe voltage dynamics in an intact bacterium. Here we developed a method to reveal electrical spiking in Escherichia coli. To probe bacterial membrane potential, we engineered a voltage-sensitive fluorescent protein based on green-absorbing proteorhodopsin. Expression of the proteorhodopsin optical proton sensor (PROPS) in E. coli revealed electrical spiking at up to 1 hertz. Spiking was sensitive to chemical and physical perturbations and coincided with rapid efflux of a small-molecule fluorophore, suggesting that bacterial efflux machinery may be electrically regulated.	[Kralj, Joel M.; Cohen, Adam E.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Hochbaum, Daniel R.] Harvard Univ, Sch Engn & Appl Sci, Appl Phys Program, Cambridge, MA 02138 USA; [Douglass, Adam D.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Cohen, Adam E.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Harvard University	Cohen, AE (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	cohen@chemistry.harvard.edu		Hochbaum, Daniel/0000-0001-6220-6651	Harvard Center for Brain Science; Intelligence Community Postdoctoral Fellowship; National Science Foundation; Helen Hay Whitney Postdoctoral Fellowship; Charles A. King Trust	Harvard Center for Brain Science; Intelligence Community Postdoctoral Fellowship; National Science Foundation(National Science Foundation (NSF)); Helen Hay Whitney Postdoctoral Fellowship; Charles A. King Trust	We thank K. Rothschild for helpful discussions and for the GPR plasmid. We also thank H. Berg, R. Losick, J. Yuan, H. Inada, A. Garner, and D. Kahne for helpful discussions. G. Miesenbock provided the pHluorin plasmid. A. Fields, H. Bayraktar, V. Venkatachalam, and L. Bane helped with measurements. This work was supported by the Harvard Center for Brain Science, an Intelligence Community Postdoctoral Fellowship (J. M. K.), a National Science Foundation Graduate Fellowship (D. R. H.), a Helen Hay Whitney Postdoctoral Fellowship (A. D. D.), and a Charles A. King Trust Postdoctoral Fellowship (A. D. D). J. M. K., A. D. D., and A. E. C. have applied for a patent on PROPS as a sensor of membrane potential.	Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Bohnert JA, 2010, ANTIMICROB AGENTS CH, V54, P3770, DOI 10.1128/AAC.00620-10; Dioumaev AK, 2003, BIOCHEMISTRY-US, V42, P6582, DOI 10.1021/bi034253r; FUNG DC, 1995, NATURE, V375, P809, DOI 10.1038/375809a0; INGLEDEW WJ, 1984, MICROBIOL REV, V48, P222, DOI 10.1128/MMBR.48.3.222-271.1984; JOSHI AK, 1989, J BIOL CHEM, V264, P2126; Kolodner P, 1996, P NATL ACAD SCI USA, V93, P11618, DOI 10.1073/pnas.93.21.11618; Lo CJ, 2007, BIOPHYS J, V93, P294, DOI 10.1529/biophysj.106.095265; Martinac B, 2008, PHYSIOL REV, V88, P1449, DOI 10.1152/physrev.00005.2008; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; NOUMI T, 1987, FEBS LETT, V213, P381, DOI 10.1016/0014-5793(87)81526-0; Novo D, 1999, CYTOMETRY, V35, P55, DOI 10.1002/(SICI)1097-0320(19990101)35:1<55::AID-CYTO8>3.0.CO;2-2; Pucihar G., 2009, JOVE-J VIS EXP, V1659, DOI [10.3791/1659, DOI 10.3791/1659]; SPROTT GD, 1976, PHOTOCHEM PHOTOBIOL, V24, P21, DOI 10.1111/j.1751-1097.1976.tb06793.x; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365	16	228	235	4	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2011	333	6040					345	348		10.1126/science.1204763	http://dx.doi.org/10.1126/science.1204763			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21764748				2022-12-01	WOS:000292732000044
J	Park, JE; Heo, I; Tian, Y; Simanshu, DK; Chang, H; Jee, D; Patel, DJ; Kim, VN				Park, Jong-Eun; Heo, Inha; Tian, Yuan; Simanshu, Dhirendra K.; Chang, Hyeshik; Jee, David; Patel, Dinshaw J.; Kim, V. Narry			Dicer recognizes the 5 ' end of RNA for efficient and accurate processing	NATURE			English	Article							C-ELEGANS; MICRORNA BIOGENESIS; BINDING-PROTEIN; INTERFERENCE; DROSOPHILA; CELLS; MATURATION; URIDYLATION; MECHANISMS; PATHWAYS	A hallmark of RNA silencing is a class of approximately 22-nucleotide RNAs that are processed from double-stranded RNA precursors by Dicer. Accurate processing by Dicer is crucial for the functionality of microRNAs (miRNAs). The current model posits that Dicer selects cleavage sites by measuring a set distance from the 3' overhang of the double-stranded RNA terminus. Here we report that human Dicer anchors not only the 3' end but also the 5' end, with the cleavage site determined mainly by the distance (similar to 2 nucleotides) from the 5' end (5' counting rule). This cleavage requires a 5'-terminal phosphate group. Further, we identify a novel basic motif (5' pocket) in human Dicer that recognizes the 5'-phosphorylated end. The 5' counting rule and the 5' anchoring residues are conserved in Drosophila Dicer-1, but not in Giardia Dicer. Mutations in the 5' pocket reduce processing efficiency and alter cleavage sites in vitro. Consistently, miRNA biogenesis is perturbed in vivo when Dicer-null embryonic stem cells are replenished with the 5'-pocket mutant. Thus, 5'-end recognition by Dicer is important for precise and effective biogenesis of miRNAs. Insights from this study should also afford practical benefits to the design of small hairpin RNAs.	[Park, Jong-Eun; Heo, Inha; Chang, Hyeshik; Jee, David; Kim, V. Narry] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Tian, Yuan; Simanshu, Dhirendra K.; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Seoul National University (SNU); Memorial Sloan Kettering Cancer Center	Kim, VN (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	narrykim@snu.ac.kr	Simanshu, Dhirendra/B-3361-2008; PARK, JONGEUN/AAG-9677-2019	PARK, JONGEUN/0000-0002-1687-2423; Simanshu, Dhirendra/0000-0002-9717-4618; Chang, Hyeshik/0000-0002-9812-8015	National Research Foundation [2010000021, 20100020415]; Ministry of Education, Science and Technology; National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068776] Funding Source: NIH RePORTER	National Research Foundation; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to G. Hannon for Dicer-null mouse ES cells; J. Doudna for Giardia Dicer cDNA; and M. Siomi for Drosophila Dicer-1, Dicer-2, Loqs-PB and R2D2 constructs. We also thank the members of the V.N.K. laboratory, particularly C. Joo, M.-J. Yoon, K.-H. Yeom and A. Cho for discussions and technical help. The V.N.K. laboratory was supported by the Creative Research Initiatives Program (2010000021) and National Honor Scientist Program (20100020415) through the National Research Foundation and the BK21 Fellowships (J.-E.P. and H. C.) from the Ministry of Education, Science and Technology. Research in the D. J. P. laboratory was supported by the National Institutes of Health.	Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Gunther T, 2006, MAGNESIUM RES, V19, P225; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han KH, 1996, NUCLEIC ACIDS RES, V24, P4362, DOI 10.1093/nar/24.21.4362; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MacRae IJ, 2007, NAT STRUCT MOL BIOL, V14, P934, DOI 10.1038/nsmb1293; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Miyoshi K, 2010, RNA, V16, P506, DOI 10.1261/rna.1952110; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Serra MJ, 2002, RNA, V8, P307, DOI 10.1017/S1355838202024226; Silva J, 2004, ONCOGENE, V23, P8401, DOI 10.1038/sj.onc.1208176; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; Wu HQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007566; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	41	335	353	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2011	475	7355					201	U107		10.1038/nature10198	http://dx.doi.org/10.1038/nature10198			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21753850	Green Accepted			2022-12-01	WOS:000292690500044
J	Tadmor, AD; Ottesen, EA; Leadbetter, JR; Phillips, R				Tadmor, Arbel D.; Ottesen, Elizabeth A.; Leadbetter, Jared R.; Phillips, Rob			Probing Individual Environmental Bacteria for Viruses by Using Microfluidic Digital PCR	SCIENCE			English	Article							DNA PACKAGING MOTOR; MICROBIAL COMMUNITIES; MOLECULAR ANALYSIS; SEQUENCE; DYNAMICS; TERMITE; ACETOGENESIS; DIVERSITY; SAMPLE; GUT	Viruses may very well be the most abundant biological entities on the planet. Yet neither metagenomic studies nor classical phage isolation techniques have shed much light on the identity of the hosts of most viruses. We used a microfluidic digital polymerase chain reaction (PCR) approach to physically link single bacterial cells harvested from a natural environment with a viral marker gene. When we implemented this technique on the microbial community residing in the termite hindgut, we found genus-wide infection patterns displaying remarkable intragenus selectivity. Viral marker allelic diversity revealed restricted mixing of alleles between hosts, indicating limited lateral gene transfer of these alleles despite host proximity. Our approach does not require culturing hosts or viruses and provides a method for examining virus-bacterium interactions in many environments.	[Tadmor, Arbel D.] CALTECH, Dept Biochem & Mol Biophys, Pasadena, CA 91125 USA; [Ottesen, Elizabeth A.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Leadbetter, Jared R.] CALTECH, Ronald & Maxine Linde Ctr Global Environm Sci, Pasadena, CA 91125 USA; [Phillips, Rob] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [Phillips, Rob] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA	California Institute of Technology; Massachusetts Institute of Technology (MIT); California Institute of Technology; California Institute of Technology; California Institute of Technology	Tadmor, AD (corresponding author), CALTECH, Dept Biochem & Mol Biophys, Pasadena, CA 91125 USA.	arbel@caltech.edu; phillips@pboc.caltech.edu		Leadbetter, Jared/0000-0002-7033-0844	NIH [R01 GM085286-01S]; U.S. Department of Energy [DE-FG02-07ER64484]; NSF [EF-0523267, CMMI-0758343]; Davidow Family Research Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098465, R01GM085286] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000217] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Davidow Family Research Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We wish to thank D. Baltimore, S. Casjens, D. S. Fisher, R. W. Hendrix, H. J. Lee, M. Linden, E. G. Matson, R. Milo, V. J. Orphan, S. R. Quake, A. Z. Rosenthal, E. M. Rubin and colleagues at JGI, D. Z. Soghoian, N. D. Wolfe, D. Wu, X. Zhang, and the anonymous referees for their advice and feedback. We also wish to thank E. G. M. and A. Z. R for their assistance in collection of specimens and E. G. M. for ZAS genomic DNA. This project was supported by the NIH Director's Pioneer Award, NIH American Recovery and Reinvestment Act grant number R01 GM085286-01S, U.S. Department of Energy grant no. DE-FG02-07ER64484, and NSF grant nos. EF-0523267 and CMMI-0758343 and by the Davidow Family Research Fund. GenBank accession numbers are given in table S10.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; [Anonymous], 2000, GLOBAL CHANGE HUM HL, DOI [DOI 10.1023/A:1011519513354, 10.1023/A:1011519513354.]; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Casjens SR, 2005, J BACTERIOL, V187, P1091, DOI 10.1128/JB.187.3.1091-1104.2005; CHAI S, 1992, J MOL BIOL, V224, P87, DOI 10.1016/0022-2836(92)90578-8; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dube S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002876; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; EPPLER K, 1991, VIROLOGY, V183, P519, DOI 10.1016/0042-6822(91)90981-G; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hongoh Y, 2003, FEMS MICROBIOL ECOL, V44, P231, DOI 10.1016/S0168-6496(03)00026-6; Hugenholtz P, 2002, GENOME BIOL, V3; Kristensen DM, 2010, TRENDS MICROBIOL, V18, P11, DOI 10.1016/j.tim.2009.11.003; Leadbetter JR, 1999, SCIENCE, V283, P686, DOI 10.1126/science.283.5402.686; Lilburn TC, 2001, SCIENCE, V292, P2495, DOI 10.1126/science.1060281; Lindell D, 2007, NATURE, V449, P83, DOI 10.1038/nature06130; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Mitchell MS, 2002, NUCLEIC ACIDS RES, V30, P4009, DOI 10.1093/nar/gkf524; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Moore SD, 2002, CURR BIOL, V12, pR96, DOI 10.1016/S0960-9822(02)00670-X; Ottesen EA, 2006, SCIENCE, V314, P1464, DOI 10.1126/science.1131370; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Rohwer F, 2002, J BACTERIOL, V184, P4529, DOI 10.1128/JB.184.16.4529-4535.2002; Rose TM, 1998, NUCLEIC ACIDS RES, V26, P1628, DOI 10.1093/nar/26.7.1628; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Sun S, 2008, CELL, V135, P1251, DOI 10.1016/j.cell.2008.11.015; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Tholen A, 1997, FEMS MICROBIOL ECOL, V24, P137, DOI 10.1111/j.1574-6941.1997.tb00430.x; Thompson JR, 2004, APPL ENVIRON MICROB, V70, P4103, DOI 10.1128/AEM.70.7.4103-4110.2004; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456; Zare RN, 2010, ANNU REV BIOMED ENG, V12, P187, DOI 10.1146/annurev-bioeng-070909-105238	38	160	175	1	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2011	333	6038					58	62		10.1126/science.1200758	http://dx.doi.org/10.1126/science.1200758			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719670	Green Accepted			2022-12-01	WOS:000292255400046
J	Avrani, S; Wurtzel, O; Sharon, I; Sorek, R; Lindell, D				Avrani, Sarit; Wurtzel, Omri; Sharon, Itai; Sorek, Rotem; Lindell, Debbie			Genomic island variability facilitates Prochlorococcus-virus coexistence	NATURE			English	Article							PHAGE; EVOLUTION; BACTERIAL; ATLANTIC; ECOTYPES; COMMUNITIES; RESISTANCE; ELEMENTS	Prochlorococcus cyanobacteria are extremely abundant in the oceans, as are the viruses that infect them. How hosts and viruses coexist in nature remains unclear, although the presence of both susceptible and resistant cells may allow this coexistence. Combined whole-genome sequencing and PCR screening technology now enables us to investigate the effect of resistance on genome evolution and the genomic mechanisms behind the long-term coexistence of Prochlorococcus and their viruses. Here we present a genome analysis of 77 substrains selected for resistance to ten viruses, revealing mutations primarily in non-conserved, horizontally transferred genes that localize to a single hypervariable genomic island. Mutations affected viral attachment to the cell surface and imposed a fitness cost to the host, manifested by significantly lower growth rates or a previously unknown mechanism of more rapid infection by other viruses. The mutant genes are generally uncommon in nature yet some carry polymorphisms matching those found experimentally. These data are empirical evidence indicating that viral-attachment genes are preferentially located in genomic islands and that viruses are a selective pressure enhancing the diversity of both island genes and island gene content. This diversity emerges as a genomic mechanism that reduces the effective host population size for infection by a given virus, thus facilitating long-term coexistence between viruses and their hosts in nature.	[Avrani, Sarit; Sharon, Itai; Lindell, Debbie] Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel; [Wurtzel, Omri; Sorek, Rotem] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Technion Israel Institute of Technology; Weizmann Institute of Science	Lindell, D (corresponding author), Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel.	dlindell@tx.technion.ac.il	Sharon, Itai/M-4472-2019; Wurtzel, Omri/AAG-3985-2019	Sharon, Itai/0000-0003-0705-2316; Wurtzel, Omri/0000-0002-6865-5914; Lindell, Debbie/0000-0003-0612-4517	European Commission ERC [203406]; ISF [1504/06]; Technion Russell Berrie Nanotechnology Institute; ISF-FIRST [1615/09]; ERC; Azrieli fellowship	European Commission ERC(European CommissionEuropean Commission Joint Research CentreEuropean Research Council (ERC)); ISF(Israel Science Foundation); Technion Russell Berrie Nanotechnology Institute; ISF-FIRST; ERC(European Research Council (ERC)European Commission); Azrieli fellowship	We thank E. Zinser for the bacterial helper strain; I. Pekarsky for help with adsorption assays; I. Izhaki for advice on statistical analyses; O. Beja, Y. Mandel-Gutfreund, K. Kozek, U. Qimron and Lindell lab members for comments on the manuscript; and T. Dagan for coining the term 'susceptibility region'. Genome sequencing was carried out at the genome sequencing units at the Weizmann Institute of Science and the Technion - Israel Institute of Technology. This work was supported by a European Commission ERC Starting Grant (no. 203406), an ISF Morasha grant (no. 1504/06) and the Technion Russell Berrie Nanotechnology Institute (D. L.); and by an ISF-FIRST grant (no. 1615/09) and an ERC Starting Grant (R. S.). O. W. was supported by an Azrieli fellowship and D. L. is a Shillman fellow.	Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x; Bouman HA, 2006, SCIENCE, V312, P918, DOI 10.1126/science.1122692; Charlebois RL, 2004, GENOME RES, V14, P2469, DOI 10.1101/gr.3024704; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Comeau AM, 2005, CURR OPIN MICROBIOL, V8, P488, DOI 10.1016/j.mib.2005.06.004; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Dufresne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r90; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; Hsiao WWL, 2005, PLOS GENET, V1, P540, DOI 10.1371/journal.pgen.0010062; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Langille MGI, 2010, NAT REV MICROBIOL, V8, P372, DOI 10.1038/nrmicro2350; LENSKI RE, 1985, AM NAT, V125, P585, DOI 10.1086/284364; Luria SE, 1943, GENETICS, V28, P491; Lythgoe KA, 2003, ECOL LETT, V6, P326, DOI 10.1046/j.1461-0248.2003.00433.x; Malmstrom RR, 2010, ISME J, V4, P1252, DOI 10.1038/ismej.2010.60; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Palenik B, 2003, NATURE, V424, P1037, DOI 10.1038/nature01943; Parsons YN, 2003, ARCH MICROBIOL, V179, P214, DOI 10.1007/s00203-003-0518-7; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Somova A G, 1966, Biull Eksp Biol Med, V31, P99; Stern A, 2011, BIOESSAYS, V33, P43, DOI 10.1002/bies.201000071; Stoddard LI, 2007, APPL ENVIRON MICROB, V73, P5516, DOI 10.1128/AEM.00356-07; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Walker CB, 2009, ENVIRON MICROBIOL, V11, P2244, DOI 10.1111/j.1462-2920.2009.01946.x; WATERBURY JB, 1993, APPL ENVIRON MICROB, V59, P3393, DOI 10.1128/AEM.59.10.3393-3399.1993; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zwirglmaier K, 2007, ENVIRON MICROBIOL, V9, P1278, DOI 10.1111/j.1462-2920.2007.01246.x	34	192	197	6	90	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 30	2011	474	7353					604	608		10.1038/nature10172	http://dx.doi.org/10.1038/nature10172			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21720364				2022-12-01	WOS:000292204300031
J	Refojo, D; Schweizer, M; Kuehne, C; Ehrenberg, S; Thoeringer, C; Vogl, AM; Dedic, N; Schumacher, M; von Wolff, G; Avrabos, C; Touma, C; Engblom, D; Schutz, G; Nave, KA; Eder, M; Wotjak, CT; Sillaber, I; Holsboer, F; Wurst, W; Deussing, JM				Refojo, Damian; Schweizer, Martin; Kuehne, Claudia; Ehrenberg, Stefanie; Thoeringer, Christoph; Vogl, Annette M.; Dedic, Nina; Schumacher, Marion; von Wolff, Gregor; Avrabos, Charilaos; Touma, Chadi; Engblom, David; Schuetz, Guenther; Nave, Klaus-Armin; Eder, Matthias; Wotjak, Carsten T.; Sillaber, Inge; Holsboer, Florian; Wurst, Wolfgang; Deussing, Jan M.			Glutamatergic and Dopaminergic Neurons Mediate Anxiogenic and Anxiolytic Effects of CRHR1	SCIENCE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; FACTOR RECEPTOR 1-DEFICIENT; IMPAIRED STRESS-RESPONSE; MICE LACKING; I-H; HORMONE; ANXIETY; BRAIN; BEHAVIOR; CRF	The corticotropin-releasing hormone receptor 1 (CRHR1) critically controls behavioral adaptation to stress and is causally linked to emotional disorders. Using neurochemical and genetic tools, we determined that CRHR1 is expressed in forebrain glutamatergic and gamma-aminobutyric acid-containing (GABAergic) neurons as well as in midbrain dopaminergic neurons. Via specific CRHR1 deletions in glutamatergic, GABAergic, dopaminergic, and serotonergic cells, we found that the lack of CRHR1 in forebrain glutamatergic circuits reduces anxiety and impairs neurotransmission in the amygdala and hippocampus. Selective deletion of CRHR1 in midbrain dopaminergic neurons increases anxiety-like behavior and reduces dopamine release in the prefrontal cortex. These results define a bidirectional model for the role of CRHR1 in anxiety and suggest that an imbalance between CRHR1-controlled anxiogenic glutamatergic and anxiolytic dopaminergic systems might lead to emotional disorders.	[Refojo, Damian; Schweizer, Martin; Kuehne, Claudia; Ehrenberg, Stefanie; Thoeringer, Christoph; Vogl, Annette M.; Dedic, Nina; Schumacher, Marion; von Wolff, Gregor; Avrabos, Charilaos; Touma, Chadi; Eder, Matthias; Wotjak, Carsten T.; Sillaber, Inge; Holsboer, Florian; Wurst, Wolfgang; Deussing, Jan M.] Max Planck Inst Psychiat, Munich, Germany; [Schweizer, Martin; Sillaber, Inge] Affectis Pharmaceut, Munich, Germany; [Engblom, David; Schuetz, Guenther] German Canc Res Ctr, Div Mol Biol Cell 1, D-6900 Heidelberg, Germany; [Nave, Klaus-Armin] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Wurst, Wolfgang] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Dev Genet, Neuherberg, Germany; [Wurst, Wolfgang] Tech Univ Weihenstephan, Inst Entwicklungsgenet, Neuherberg, Germany; [Wurst, Wolfgang] DZNE Demenzzentrum, Munich, Germany	Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Deussing, JM (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	deussing@mpipsykl.mpg.de	Touma, Chadi/G-4677-2011; Deussing, Jan M/ABB-5993-2021; Wotjak, Carsten T./S-3200-2019	Vogl, Annette/0000-0001-6283-2521; Refojo, Damian/0000-0002-9798-6413; Eder, Matthias/0000-0002-2579-2628; Wurst, Wolfgang/0000-0003-4422-7410; Deussing, Jan/0000-0002-9329-5252	Max Planck Society; Bundesministerium fur Bildung und Forschung [01GS08151, 01GS08155]; Helmholtz Association [HA-215]; Deutsche Forschungsgemeinschaft center for Molecular Physiology of the brain; European Molecular Biology Organization; NARSAD Young Investigator Award	Max Planck Society(Max Planck Society); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Helmholtz Association(Helmholtz Association); Deutsche Forschungsgemeinschaft center for Molecular Physiology of the brain; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); NARSAD Young Investigator Award(NARSAD)	We thank W. Zieglgansberger for his valuable suggestions and critical reading of the manuscript; S. Meyr, M. Schieven, U. Habersetzer, C. Flachskamm, S. Bourier, S. Weidemann, and A. Tasdemir for their excellent technical assistance; A. Chen for sharing unpublished data; S. Silberstein and E. Arzt for the CRHR1-HT22 stable-cell line; N. Singewald for his support with microdyalysis studies; J. Rubinstein and M. Ekker for providing Dlx5/6-cre mice; E. Deneris for providing the ePet-cre mouse line; and F. Stewart for providing hACTB::Flpe mice. This work was supported by the Max Planck Society; the Bundesministerium fur Bildung und Forschung within the framework of NGFN-Plus (grants 01GS08151 and 01GS08155; J. D. and W. W.); the Initiative and Networking Fund of the Helmholtz Association in the framework of the Helmholtz Alliance for Mental Health in an Aging Society (grant HA-215, J. D. and W. W.); the Deutsche Forschungsgemeinschaft center for Molecular Physiology of the brain (K. A. N.); the European Molecular Biology Organization (D. R.),; a NARSAD Young Investigator Award (D. R.); and the Max Planck Society (D. R., as a Max Planck Research Scientist).	Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; ALDENHOFF JB, 1983, SCIENCE, V221, P875, DOI 10.1126/science.6603658; Arborelius L, 1999, J ENDOCRINOL, V160, P1, DOI 10.1677/joe.0.1600001; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Borgland SL, 2010, BRAIN RES, V1314, P139, DOI 10.1016/j.brainres.2009.10.068; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Giesbrecht CJ, 2010, J NEUROSCI, V30, P16970, DOI 10.1523/JNEUROSCI.2306-10.2010; Hollrigel GS, 1998, NEUROSCIENCE, V84, P71, DOI 10.1016/S0306-4522(97)00499-5; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lu A, 2008, MOL PSYCHIATR, V13, P1028, DOI 10.1038/mp.2008.51; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Magalhaes AC, 2010, NAT NEUROSCI, V13, P622, DOI 10.1038/nn.2529; Maier SF, 2005, NEUROSCI BIOBEHAV R, V29, P829, DOI 10.1016/j.neubiorev.2005.03.021; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Muller MB, 2003, NAT NEUROSCI, V6, P1100, DOI 10.1038/nn1123; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Refojo D, 2005, P NATL ACAD SCI USA, V102, P6183, DOI 10.1073/pnas.0502070102; Sanacora G, 2008, NAT REV DRUG DISCOV, V7, P426, DOI 10.1038/nrd2462; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Sillaber I, 2002, SCIENCE, V296, P931, DOI 10.1126/science.1069836; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; SWANSON LW, 1983, NEUROENDOCRINOLOGY, V36, P165, DOI 10.1159/000123454; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; Tovote P, 2005, NEUROSCIENCE, V134, P1113, DOI 10.1016/j.neuroscience.2005.05.027; Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U; von Wolff G, 2011, J PSYCHIATR RES, V45, P256, DOI 10.1016/j.jpsychires.2010.06.007; Wanat MJ, 2008, J PHYSIOL-LONDON, V586, P2157, DOI 10.1113/jphysiol.2007.150078; Wise RA, 2010, BRAIN RES, V1314, P38, DOI 10.1016/j.brainres.2009.09.101	29	210	218	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 30	2011	333	6051					1903	1907		10.1126/science.1202107	http://dx.doi.org/10.1126/science.1202107			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21885734				2022-12-01	WOS:000295365800060
J	Walker, T; Johnson, PH; Moreira, LA; Iturbe-Ormaetxe, I; Frentiu, FD; McMeniman, CJ; Leong, YS; Dong, Y; Axford, J; Kriesner, P; Lloyd, AL; Ritchie, SA; O'Neill, SL; Hoffmann, AA				Walker, T.; Johnson, P. H.; Moreira, L. A.; Iturbe-Ormaetxe, I.; Frentiu, F. D.; McMeniman, C. J.; Leong, Y. S.; Dong, Y.; Axford, J.; Kriesner, P.; Lloyd, A. L.; Ritchie, S. A.; O'Neill, S. L.; Hoffmann, A. A.			The wMel Wolbachia strain blocks dengue and invades caged Aedes aegypti populations	NATURE			English	Article							VIRUS; INFECTION; CULICIDAE; DIPTERA; MODELS; SPREAD	Dengue fever is the most important mosquito-borne viral disease of humans with more than 50 million cases estimated annually in more than 100 countries(1,2). Disturbingly, the geographic range of dengue is currently expanding and the severity of outbreaks is increasing(2-4). Control options for dengue are very limited and currently focus on reducing population abundance of the major mosquito vector, Aedes aegypti(5,6). These strategies are failing to reduce dengue incidence in tropical communities and there is an urgent need for effective alternatives. It has been proposed that endosymbiotic bacterial Wolbachia infections of insects might be used in novel strategies for dengue control(7-9). For example, the wMelPop-CLA Wolbachia strain reduces the lifespan of adult A. aegypti mosquitoes in stably transinfected lines(8). This life-shortening phenotype was predicted to reduce the potential for dengue transmission. The recent discovery that several Wolbachia infections, including wMelPop-CLA, can also directly influence the susceptibility of insects to infection with a range of insect and human pathogens(9-11) has markedly changed the potential for Wolbachia infections to control human diseases. Here we describe the successful transinfection of A. aegypti with the avirulent wMel strain of Wolbachia, which induces the reproductive phenotype cytoplasmic incompatibility with minimal apparent fitness costs and high maternal transmission, providing optimal phenotypic effects for invasion. Under semi-field conditions, the wMel strain increased from an initial starting frequency of 0.65 to near fixation within a few generations, invading A. aegypti populations at an accelerated rate relative to trials with the wMelPop-CLA strain. We also show that wMel and wMelPop-CLA strains block transmission of dengue serotype 2 (DENV-2) in A. aegypti, forming the basis of a practical approach to dengue suppression(12).	[Walker, T.; Moreira, L. A.; Iturbe-Ormaetxe, I.; Frentiu, F. D.; McMeniman, C. J.; Leong, Y. S.; Dong, Y.; O'Neill, S. L.] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Axford, J.; Kriesner, P.; Hoffmann, A. A.] Univ Melbourne, Dept Genet, Inst Bio21, Melbourne, Vic 3010, Australia; [Johnson, P. H.; Ritchie, S. A.] James Cook Univ, Sch Publ Hlth & Trop Med & Rehabil Sci, Cairns, Qld 4870, Australia; [Lloyd, A. L.] N Carolina State Univ, Biomath Grad Program, Raleigh, NC 27695 USA; [Lloyd, A. L.] N Carolina State Univ, Dept Math, Raleigh, NC 27695 USA; [Lloyd, A. L.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [O'Neill, S. L.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia	University of Queensland; University of Melbourne; James Cook University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Monash University	O'Neill, SL (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia.	scott.oneill@monash.edu	Kriesner, Peter/L-7595-2013; Hoffmann, Ary/C-2961-2011; Lloyd, Alun L/H-4944-2012; Lloyd, Alun/AAN-6639-2020; Walker, Thomas/B-9198-2014; Frentiu, Francesca D/K-4561-2012; Hoffmann, Ary/R-2972-2019; O'Neill, Scott L/B-3568-2009; Walker, Thomas/F-6572-2013; O'Neill, Scott/R-9560-2019	Kriesner, Peter/0000-0002-2382-7006; Lloyd, Alun/0000-0002-6389-6321; Walker, Thomas/0000-0002-3545-012X; Hoffmann, Ary/0000-0001-9497-7645; O'Neill, Scott L/0000-0002-4131-3615; Walker, Thomas/0000-0003-4475-5395; O'Neill, Scott/0000-0002-4131-3615; McMeniman, Conor/0000-0001-8502-8712; Frentiu, Francesca/0000-0001-8628-4216	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation; National Health and Medical Research Council, Australia; NIH; Climate and Health Cluster of the CSIRO; Australian Research Council	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Climate and Health Cluster of the CSIRO; Australian Research Council(Australian Research Council)	We are grateful to N. Kenny for technical support and to members of the O'Neill laboratory for critical reading of the manuscript. We thank R. Silcock, M. Janes, S. Long, C. Paton and C. Omodei for their assistance in the semi-field cages and laboratory at James Cook University. We are very grateful for all of our volunteers who helped to blood-feed the mosquitoes in the cages and to P. Young for providing the anti-dengue antibodies. This research was supported by a grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation, The National Health and Medical Research Council, Australia, the RAPIDD program of the NIH, the Climate and Health Cluster of the CSIRO Flagship collaboration Fund and fellowships from the Australian Research Council.	Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Calisher CH, 2005, EMERG INFECT DIS, V11, P738; Cook PE, 2008, ADV EXP MED BIOL, V627, P126, DOI 10.1007/978-0-387-78225-6_11; Dobson SL, 2002, APPL ENVIRON MICROB, V68, P656, DOI 10.1128/AEM.68.2.656-660.2002; Franco C, 2010, BIOSECUR BIOTERROR, V8, P273, DOI 10.1089/bsp.2010.0032; Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398; Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977; GUBLER DJ, 1979, AM J TROP MED HYG, V28, P1045, DOI 10.4269/ajtmh.1979.28.1045; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Hancock PA, 2011, AM NAT, V177, P323, DOI 10.1086/658121; Harrington LC, 2001, J MED ENTOMOL, V38, P537, DOI 10.1603/0022-2585-38.4.537; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007; Hoffmann AA, 1997, INFLUENTIAL PASSENGERS, P42; Kearney M, 2009, FUNCT ECOL, V23, P528, DOI 10.1111/j.1365-2435.2008.01538.x; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Macia A, 2006, J VECTOR ECOL, V31, P371, DOI 10.3376/1081-1710(2006)31[371:DIPOAA]2.0.CO;2; McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08; McMeniman CJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000748; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Montgomery BL, 2002, AM J TROP MED HYG, V67, P244, DOI 10.4269/ajtmh.2002.67.244; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Richardson J, 2006, AM J TROP MED HYG, V74, P132, DOI 10.4269/ajtmh.2006.74.132; Riegler M, 2005, CURR BIOL, V15, P1428, DOI 10.1016/j.cub.2005.06.069; Ritchie Scott A, 2011, PLoS Negl Trop Dis, V5, pe988, DOI 10.1371/journal.pntd.0000988; Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Telang A, 2004, J INSECT PHYSIOL, V50, P677, DOI 10.1016/j.jinsphys.2004.05.001; TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0; Turelli M, 2010, EVOLUTION, V64, P232, DOI 10.1111/j.1558-5646.2009.00822.x; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Williams CR, 2008, J MED ENTOMOL, V45, P1173, DOI 10.1603/0022-2585(2008)45[1173:REOAAP]2.0.CO;2; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Yeap HL, 2011, GENETICS, V187, P583, DOI 10.1534/genetics.110.122390	36	805	834	7	285	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2011	476	7361					450	U101		10.1038/nature10355	http://dx.doi.org/10.1038/nature10355			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811KT	21866159				2022-12-01	WOS:000294209400036
J	Gerrienne, P; Gensel, PG; Strullu-Derrien, C; Lardeux, H; Steemans, P; Prestianni, C				Gerrienne, Philippe; Gensel, Patricia G.; Strullu-Derrien, Christine; Lardeux, Hubert; Steemans, Philippe; Prestianni, Cyrille			A Simple Type of Wood in Two Early Devonian Plants	SCIENCE			English	Article									[Gerrienne, Philippe; Steemans, Philippe] Univ Liege U Lg, Dept Geol, B-4000 Liege 1, Belgium; [Gensel, Patricia G.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Strullu-Derrien, Christine] Univ Angers, Lab Mycorhizes, Fac Sci, F-49045 Angers, France; [Lardeux, Hubert] Univ Catholique Ouest, Inst Rech Fondamentale & Appl, Lab Geol, F-49008 Angers 1, France; [Prestianni, Cyrille] Inst Royal Sci Nat Belgique, B-1000 Brussels, Belgium	University of North Carolina; University of North Carolina Chapel Hill; Universite d'Angers	Gerrienne, P (corresponding author), Univ Liege U Lg, Dept Geol, B18 Sart Tilman, B-4000 Liege 1, Belgium.	P.Gerrienne@ulg.ac.be	Strullu-Derrien, Christine/P-4543-2019	Strullu-Derrien, Christine/0000-0003-1131-9546; Steemans, Philippe/0000-0003-1183-6324				Bannan MW, 1934, BOT GAZ, V96, P260, DOI 10.1086/334470; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; Dannenhoffer JM, 2003, INT J PLANT SCI, V164, P429, DOI 10.1086/374198; Donoghue MJ, 2005, PALEOBIOLOGY, V31, P77, DOI 10.1666/0094-8373(2005)031[0077:KICASM]2.0.CO;2; ROWE NP, 2003, EVOLUTION PLANT PHYS, P297	5	68	72	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 12	2011	333	6044					837	837		10.1126/science.1208882	http://dx.doi.org/10.1126/science.1208882			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21836008				2022-12-01	WOS:000293785400030
J	Altman, DG; Bland, JM				Altman, Douglas G.; Bland, J. Martin			How to obtain the confidence interval from a P value	BMJ-BRITISH MEDICAL JOURNAL			English	Article									[Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford OX2 6UD, England; [Bland, J. Martin] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	University of Oxford; University of York - UK	Altman, DG (corresponding author), Univ Oxford, Ctr Stat Med, Oxford OX2 6UD, England.	doug.altman@csm.ox.ac.uk						Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Bland JM, 1996, BRIT MED J, V312, P700; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; LIN JT, 1989, APPL STAT-J ROY ST C, V38, P69; LINDBLAD U, 1994, BRIT MED J, V308, P681, DOI 10.1136/bmj.308.6930.681; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Roy SK, 2008, BMJ-BRIT MED J, V336, P266, DOI 10.1136/bmj.39416.646250.AE	7	96	98	1	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 8	2011	343								d2090	10.1136/bmj.d2090	http://dx.doi.org/10.1136/bmj.d2090			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V41KQ	21824904	Green Submitted, Bronze			2022-12-01	WOS:000209545500001
J	Harrington, AW; St Hillaire, C; Zweifel, LS; Glebova, NO; Philippidou, P; Halegoua, S; Ginty, DD				Harrington, Anthony W.; St Hillaire, Coryse; Zweifel, Larry S.; Glebova, Natalia O.; Philippidou, Polyxeni; Halegoua, Simon; Ginty, David D.			Recruitment of Actin Modifiers to TrkA Endosomes Governs Retrograde NGF Signaling and Survival	CELL			English	Article							NERVE GROWTH-FACTOR; SYMPATHETIC NEURONS; RHO-GTPASES; VESICULAR TRAFFICKING; IN-VIVO; PATHWAYS; RECEPTOR; NEUROTROPHIN-3; ORGANIZATION; ENDOCYTOSIS	The neurotrophins NGF and NT3 collaborate to support development of sympathetic neurons. Although both promote axonal extension via the TrkA receptor, only NGF activates retrograde transport of TrkA endosomes to support neuronal survival. Here, we report that actin depolymerization is essential for initiation of NGF/TrkA endosome trafficking and that a Rac1-cofilin signaling module associated with TrkA early endosomes supports their maturation to retrograde transport-competent endosomes. These actin-regulatory endosomal components are absent from NT3/TrkA endosomes, explaining the failure of NT3 to support retrograde TrkA transport and survival. The inability of NT3 to activate Rac1-GTP-cofilin signaling is likely due to the labile nature of NT3/TrkA complexes within the acidic environment of TrkA early endosomes. Thus, TrkA endosomes associate with actin-modulatory proteins to promote F-actin disassembly, enabling their maturation into transport-competent signaling endosomes. Differential control of this process explains how NGF but not NT3 supports retrograde survival of sympathetic neurons.	[Harrington, Anthony W.; St Hillaire, Coryse; Zweifel, Larry S.; Glebova, Natalia O.; Ginty, David D.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Harrington, Anthony W.; St Hillaire, Coryse; Zweifel, Larry S.; Glebova, Natalia O.; Ginty, David D.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Philippidou, Polyxeni; Halegoua, Simon] SUNY Stony Brook, Ctr Nervous Syst Disorders, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [Philippidou, Polyxeni; Halegoua, Simon] SUNY Stony Brook, Program Neurosci, Stony Brook, NY 11794 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	dginty@jhmi.edu	Zweifel, Larry/O-3284-2017	Zweifel, Larry/0000-0003-3465-5331; Philippidou, Polyxeni/0000-0002-0733-3591	NIH [NS34814, NS18218]; Silvio Conte Center for Neuroscience Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034814, R37NS034814, R29NS034814, R01NS018218] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Silvio Conte Center for Neuroscience Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Alex Kolodkin, Christopher Deppmann, and members of the Ginty laboratory for comments on this manuscript. We thank William Mobley and Janice Valletta for advice about cell fractionation, Robert Cole and Marjan Gucek at the JHU Mass Spectroscopy and Proteomics Facility for performing the mass spectroscopy proteomic analysis, Ann Taylor and Huy Vo for advice and help with microfluidic chamber devices, and Douglas Robinson for advice on actin depolymerization assays. This work was supported by NIH grants NS34814 (D.D.G.), NS18218 (S.H.) and The Silvio Conte Center for Neuroscience Research (D. D. G.). D. D. G. is an investigator of the Howard Hughes Medical Institute.	Andres R, 2008, NEUROSCI LETT, V431, P241, DOI 10.1016/j.neulet.2007.11.045; Barker PA, 2002, TRENDS NEUROSCI, V25, P379, DOI 10.1016/S0166-2236(02)02199-9; Belliveau DJ, 1997, J CELL BIOL, V136, P375, DOI 10.1083/jcb.136.2.375; Cosker KE, 2008, CURR OPIN NEUROBIOL, V18, P270, DOI 10.1016/j.conb.2008.08.005; DAVIES AM, 1995, EMBO J, V14, P4482, DOI 10.1002/j.1460-2075.1995.tb00127.x; Deppmann CD, 2008, SCIENCE, V320, P369, DOI 10.1126/science.1152677; Devon RS, 2006, P NATL ACAD SCI USA, V103, P9595, DOI 10.1073/pnas.0510197103; Francis N, 1999, DEV BIOL, V210, P411, DOI 10.1006/dbio.1999.9269; Fujimoto LM, 2000, TRAFFIC, V1, P161, DOI 10.1034/j.1600-0854.2000.010208.x; Glebova NO, 2004, J NEUROSCI, V24, P743, DOI 10.1523/JNEUROSCI.4523-03.2004; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Howe CL, 2005, CURR OPIN NEUROBIOL, V15, P40, DOI 10.1016/j.conb.2005.01.010; Kligys K, 2007, J BIOL CHEM, V282, P32520, DOI 10.1074/jbc.M707041200; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; LEVIMONTALCINI R, 1960, P NATL ACAD SCI USA, V46, P384, DOI 10.1073/pnas.46.3.384; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Miller FD, 2001, CELL MOL LIFE SCI, V58, P1045, DOI 10.1007/PL00000919; Overly CC, 1996, J NEUROSCI, V16, P6056; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Pandey D, 2009, BLOOD, V114, P415, DOI 10.1182/blood-2008-10-183582; Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316; Pazyra-Murphy MF, 2009, J NEUROSCI, V29, P6700, DOI 10.1523/JNEUROSCI.0233-09.2009; Philippidou P, 2011, P NATL ACAD SCI USA, V108, P852, DOI 10.1073/pnas.1015981108; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Robertson AS, 2009, CELL MOL LIFE SCI, V66, P2049, DOI 10.1007/s00018-009-0001-y; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Shao YF, 2002, J CELL BIOL, V157, P679, DOI 10.1083/jcb.200201063; Sharma N, 2010, NEURON, V67, P422, DOI 10.1016/j.neuron.2010.07.018; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Sun CX, 2007, J CELL BIOL, V179, P239, DOI 10.1083/jcb.200705122; Sun YJ, 2006, MOL CELL BIOL, V26, P6923, DOI 10.1128/MCB.02474-05; Symons M, 2003, CURR BIOL, V13, pR409, DOI 10.1016/S0960-9822(03)00324-5; Valdez G, 2007, P NATL ACAD SCI USA, V104, P12270, DOI 10.1073/pnas.0702819104; Wan J, 2008, J NEUROSCI, V28, P9002, DOI 10.1523/JNEUROSCI.0767-08.2008; Wu CB, 2007, TRAFFIC, V8, P1503, DOI 10.1111/j.1600-0854.2007.00636.x	38	92	96	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 5	2011	146	3					421	434		10.1016/j.cell.2011.07.008	http://dx.doi.org/10.1016/j.cell.2011.07.008			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	803GT	21816277	Bronze, Green Accepted			2022-12-01	WOS:000293570500016
J	Giuliano, AE; Hawes, D; Ballman, KV; Whitworth, PW; Blumencranz, PW; Reintgen, DS; Morrow, M; Leitch, AM; Hunt, KK; McCall, LM; Abati, A; Cote, R				Giuliano, Armando E.; Hawes, Debra; Ballman, Karla V.; Whitworth, Pat W.; Blumencranz, Peter W.; Reintgen, Douglas S.; Morrow, Monica; Leitch, A. Marilyn; Hunt, Kelly K.; McCall, Linda M.; Abati, Andrea; Cote, Richard			Association of Occult Metastases in Sentinel Lymph Nodes and Bone Marrow With Survival Among Women With Early-Stage Invasive Breast Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CIRCULATING TUMOR-CELLS; PROGNOSTIC-SIGNIFICANCE; CLINICAL-TRIAL; MICROMETASTASES; DISSECTION; CARCINOMA	Context Immunochemical staining of sentinel lymph nodes (SLNs) and bone marrow identifies breast cancer metastases not seen with routine pathological or clinical examination. Objective To determine the association between survival and metastases detected by immunochemical staining of SLNs and bone marrow specimens from patients with early-stage breast cancer. Design, Setting, and Patients From May 1999 to May 2003, 126 sites in the American College of Surgeons Oncology Group Z0010 trial enrolled women with clinical T1 to T2N0M0 invasive breast carcinoma in a prospective observational study. Interventions All 5210 patients underwent breast-conserving surgery and SLN dissection. Bone marrow aspiration at the time of operation was initially optional and subsequently mandatory (March 2001). Sentinel lymph node specimens (hematoxylineosin negative) and bone marrow specimens were sent to a central laboratory for immunochemical staining; treating clinicians were blinded to results. Main Outcome Measures Overall survival (primary end point) and disease-free survival (a secondary end point). Results Of 5119 SLN specimens (98.3%), 3904 (76.3%) were tumor-negative by hematoxylin-eosin staining. Of 3326 SLN specimens examined by immunohistochemistry, 349 (10.5%) were positive for tumor. Of 3413 bone marrow specimens examined by immunocytochemistry, 104 (3.0%) were positive for tumors. At a median follow-up of 6.3 years (through April 2010), 435 patients had died and 376 had disease recurrence. Immunohistochemical evidence of SLN metastases was not significantly associated with overall survival (5-year rates: 95.7%; 95% confidence interval [CI], 95.0%-96.5% for immunohistochemical negative and 95.1%; 95% CI, 92.7%-97.5% for immunohistochemical positive disease; P=.64; unadjusted hazard ratio [HR], 0.90; 95% CI, 0.59-1.39; P=.64). Bone marrow metastases were associated with decreased overall survival (unadjusted HR for mortality, 1.94; 95% CI, 1.02-3.67; P=.04), but neither immunohistochemical evidence of tumor in SLNs (adjusted HR, 0.88; 95% CI, 0.45-1.71; P=.70) nor immunocytochemical evidence of tumor in bone marrow (adjusted HR, 1.83; 95% CI, 0.79-4.26; P=.15) was statistically significant on multivariable analysis. Conclusion Among women receiving breast-conserving therapy and SLN dissection, immunohistochemical evidence of SLN metastasis was not associated with overall survival over a median of 6.3 years, whereas occult bone marrow metastasis, although rare, was associated with decreased survival.	[Giuliano, Armando E.] St Johns Hlth Ctr, John Wayne Canc Inst, Div Surg Oncol, Santa Monica, CA USA; [Hawes, Debra] Univ So Calif, Dept Pathol, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Ballman, Karla V.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Whitworth, Pat W.] Nashville Breast Ctr, Nashville, TN USA; [Blumencranz, Peter W.] Morton Plant Hosp, Clearwater, FL USA; [Reintgen, Douglas S.] Lakeland Reg Canc Ctr, Lakeland, FL USA; [Morrow, Monica] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Leitch, A. Marilyn] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Hunt, Kelly K.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [McCall, Linda M.] Amer Coll Surg Oncol Grp, Durham, NC USA; [Abati, Andrea] NCI, Cytopathol Sect, Pathol Lab, Bethesda, MD 20892 USA; [Cote, Richard] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA	John Wayne Cancer Institute; University of Southern California; Mayo Clinic; Memorial Sloan Kettering Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Miami	Giuliano, AE (corresponding author), Cedars Sinai Med Ctr, 310 N San Vicente Blvd,3rd Floor, Los Angeles, CA 90048 USA.	armando.giuliano@cshs.org		Ballman, Karla/0000-0002-4492-0357	NIH [NCI R01 CA 85840]; US Department of Defense; California Breast Cancer Research; Whittier Foundation; V-Force; American College of Surgeons Oncology Group [NCI U10 CA076001]; NATIONAL CANCER INSTITUTE [R01CA085840, U10CA076001, P30CA016672] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); California Breast Cancer Research; Whittier Foundation; V-Force; American College of Surgeons Oncology Group; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Giuliano reported that he has received support from ACOSOG for travel to ACOSOG meetings. Dr Hawes reported receiving grant support from the NIH and travel support from ACOSOG and has personal and institutional grants pending from the NIH, the US Department of Defense, California Breast Cancer Research, Whittier Foundation, and V-Force. Dr Ballman reported institutional support from the National Institute of Cancer and other support from AstraZeneca, Lilly, and Novartis. Dr Whitworth reported travel support from ACOSOG. Dr Blumencranz reported institutional support from Morton Plant Hospital, serving on the Florida Society of General Surgeons board of directors; and institutional payment for lectures from Hologic. Dr Morrow reported grant support from ACOSOG. Dr Leitch reported travel support from ACOSOG and institutional support from ACOSOG for capitation payments for patients enrolled in a study.; This study was supported by funds from the National Institutes of Health, under the grants entitled "Bone Marrow and Sentinel Node Micrometastases in Breast Cancer" (NCI R01 CA 85840; R. Cote, principal investigator) and American College of Surgeons Oncology Group (NCI U10 CA076001).	Balic M, 2006, CLIN CANCER RES, V12, P5615, DOI 10.1158/1078-0432.CCR-06-0169; Braun S, 2000, NEW ENGL J MED, V342, P525, DOI 10.1056/NEJM200002243420801; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Chen SL, 2007, ANN SURG ONCOL, V14, P3378, DOI 10.1245/s10434-007-9513-6; COTE RJ, 1991, J CLIN ONCOL, V9, P1749, DOI 10.1200/JCO.1991.9.10.1749; Cote RJ, 1999, LANCET, V354, P896, DOI 10.1016/S0140-6736(98)11104-2; Cristofanilli M, 2010, JAMA-J AM MED ASSOC, V303, P1092, DOI 10.1001/jama.2010.292; de Boer M, 2009, NEW ENGL J MED, V361, P653, DOI 10.1056/NEJMoa0904832; DEMASCAREL I, 1992, BRIT J CANCER, V66, P523, DOI 10.1038/bjc.1992.306; Diel IJ, 1996, JNCI-J NATL CANCER I, V88, P1652, DOI 10.1093/jnci/88.22.1652; FISHER ER, 1978, CANCER, V42, P2025, DOI 10.1002/1097-0142(197810)42:4<2025::AID-CNCR2820420452>3.0.CO;2-J; GIULIANO AE, 1995, ANN SURG, V222, P394, DOI 10.1097/00000658-199509000-00016; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Hansen NM, 2009, J CLIN ONCOL, V27, P4679, DOI 10.1200/JCO.2008.19.0686; Lin HK, 2010, CLIN CANCER RES, V16, P5011, DOI 10.1158/1078-0432.CCR-10-1105; MOLINO A, 1991, CANCER, V67, P1033, DOI 10.1002/1097-0142(19910215)67:4<1033::AID-CNCR2820670428>3.0.CO;2-H; NASSER IA, 1993, HUM PATHOL, V24, P950, DOI 10.1016/0046-8177(93)90108-S; Oakman C, 2010, NAT REV CLIN ONCOL, V7, P725, DOI 10.1038/nrclinonc.2010.170; OSBORNE MP, 1991, CANCER RES, V51, P2706; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Posther KE, 2005, ANN SURG, V242, P593, DOI 10.1097/01.sla.0000184210.68646.77; TROJANI M, 1987, BRIT J CANCER, V55, P303, DOI 10.1038/bjc.1987.59; Tvedskov TF, 2011, EUR J CANCER, V47, P872, DOI 10.1016/j.ejca.2010.11.022; Weaver DL, 2011, NEW ENGL J MED, V364, P412, DOI 10.1056/NEJMoa1008108	24	185	188	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2011	306	4					385	393		10.1001/jama.2011.1034	http://dx.doi.org/10.1001/jama.2011.1034			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	797KL	21791687	Green Accepted			2022-12-01	WOS:000293125800024
J	Sekiya, S; Suzuki, A				Sekiya, Sayaka; Suzuki, Atsushi			Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors	NATURE			English	Article							HEPATIC PROGENITOR CELLS; CLONAL IDENTIFICATION; STEM-CELLS; IN-VIVO; LIVER; DIFFERENTIATION; CARDIOMYOCYTES; NORMALIZATION; EXPRESSION; NEURONS	The location and timing of cellular differentiation must be stringently controlled for proper organ formation. Normally, hepatocytes differentiate from hepatic progenitor cells to form the liver during development(1,2). However, previous studies have shown that the hepatic program can also be activated in non-hepatic lineage cells after exposure to particular stimuli or fusion with hepatocytes(3-9). These unexpected findings suggest that factors critical to hepatocyte differentiation exist and become activated to induce hepatocyte-specific properties in different cell types. Here, by screening the effects of twelve candidate factors, we identify three specific combinations of two transcription factors, comprising Hnf4 alpha plus Foxa1, Foxa2 or Foxa3, that can convert mouse embryonic and adult fibroblasts into cells that closely resemble hepatocytes in vitro. The induced hepatocyte-like (iHep) cells have multiple hepatocyte-specific features and reconstitute damaged hepatic tissues after transplantation. The generation of iHep cells may provide insights into the molecular nature of hepatocyte differentiation and potential therapies for liver diseases.	[Sekiya, Sayaka; Suzuki, Atsushi] Kyushu Univ, Div Organogenesis & Regenerat, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan; [Suzuki, Atsushi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	Kyushu University; Japan Science & Technology Agency (JST)	Suzuki, A (corresponding author), Kyushu Univ, Div Organogenesis & Regenerat, Med Inst Bioregulat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	suzukicks@bioreg.kyushu-u.ac.jp		Suzuki, Atsushi/0000-0002-6347-5498	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	We thank A. Iwama, H. Miyoshi and R. M. Tanguay for sharing reagents, F. Costantini for providing the R26R<SUP>YFP</SUP> mice and E. Gunshima, A. Kaneyuki and H. Kuboyama for excellent technical assistance. This work was supported in part by the Program for Improvement of the Research Environment for Young Researchers from the Special Coordination Funds for Promoting Science and Technology commissioned by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, a Grant-in-Aid for Scientific Research from the MEXT of Japan and the Precursory Research for Embryonic Science and Technology Program of the Japan Science and Technology Agency.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Banas A, 2007, HEPATOLOGY, V46, P219, DOI 10.1002/hep.21704; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kaneko S, 2001, HUM GENE THER, V12, P35, DOI 10.1089/104303401450942; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; REDDY JK, 1984, J CELL BIOL, V98, P2082, DOI 10.1083/jcb.98.6.2082; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SCARPELLI DG, 1981, P NATL ACAD SCI-BIOL, V78, P2577, DOI 10.1073/pnas.78.4.2577; SEGLEN PO, 1979, J TOXICOL ENV HEALTH, V5, P551, DOI 10.1080/15287397909529766; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Suzuki A, 2000, HEPATOLOGY, V32, P1230, DOI 10.1053/jhep.2000.20349; Suzuki A, 2003, P NATL ACAD SCI USA, V100, P5034, DOI 10.1073/pnas.0936260100; Suzuki A, 2002, J CELL BIOL, V156, P173, DOI 10.1083/jcb.200108066; Suzuki A, 2003, DEVELOPMENT, V130, P2513, DOI 10.1242/dev.00459; Suzuki A, 2008, HEPATOLOGY, V48, P1964, DOI 10.1002/hep.22558; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Wang X, 2001, AM J PATHOL, V158, P571, DOI 10.1016/S0002-9440(10)63999-5; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	31	591	643	4	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2011	475	7356					390	U148		10.1038/nature10263	http://dx.doi.org/10.1038/nature10263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21716291				2022-12-01	WOS:000292911200045
J	Robinson, JK; Bigby, M				Robinson, June K.; Bigby, Michael			Prevention of Melanoma With Regular Sunscreen Use	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK; SKIN; CELL		[Robinson, June K.] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA; [Bigby, Michael] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Bigby, Michael] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Northwestern University; Feinberg School of Medicine; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Robinson, JK (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Dermatol, 132 E Delaware Pl 5806, Chicago, IL 60611 USA.	june-robinson@northwestern.edu						[Anonymous], MEL SKIN CANC; Chang YM, 2009, INT J EPIDEMIOL, V38, P814, DOI 10.1093/ije/dyp166; Dennis LK, 2003, ANN INTERN MED, V139, P966, DOI 10.7326/0003-4819-139-12-200312160-00006; Green A, 1999, LANCET, V354, P723, DOI 10.1016/S0140-6736(98)12168-2; Green AC, 2011, J CLIN ONCOL, V29, P257, DOI 10.1200/JCO.2010.28.7078; Huncharek M, 2002, AM J PUBLIC HEALTH, V92, P1173, DOI 10.2105/AJPH.92.7.1173; IARC, 2001, IARC HDB CANC PREV, V5; *IARC, 1992, IARC MON EV CARC RIS, V55; Lin JS, 2011, ANN INTERN MED, V154, P190, DOI 10.7326/0003-4819-154-3-201102010-00009; van der Pols JC, 2006, CANCER EPIDEM BIOMAR, V15, P2546, DOI 10.1158/1055-9965.EPI-06-0352	10	10	10	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2011	306	3					302	303		10.1001/jama.2011.990	http://dx.doi.org/10.1001/jama.2011.990			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794BS	21712528				2022-12-01	WOS:000292870500023
J	Kabrhel, C; Varraso, R; Goldhaber, SZ; Rimm, E; Camargo, CA				Kabrhel, Christopher; Varraso, Raphaelle; Goldhaber, Samuel Z.; Rimm, Eric; Camargo, Carlos A., Jr.			Physical inactivity and idiopathic pulmonary embolism in women: prospective study	BRITISH MEDICAL JOURNAL			English	Article							DEEP-VEIN THROMBOSIS; CARDIOVASCULAR RISK-FACTORS; VENOUS-BLOOD FLOW; THROMBOEMBOLISM; EXERCISE; DISEASE; POPULATION; FIBRINOLYSIS; HEMOSTASIS; FIBRINOGEN	Objectives To determine the association between physical inactivity (that is, a sedentary lifestyle) and incident idiopathic pulmonary embolism. Design Prospective cohort study. Setting Nurses' Health Study. Participants 69 950 female nurses who completed biennial questionnaires from 1990 to 2008. Main outcome measures The primary outcome was idiopathic pulmonary embolism confirmed in medical records. Multivariable Cox proportional hazards models controlled for age, body mass index (BMI), energy intake, smoking, pack years, race, spouse's educational attainment, parity, menopause, non-aspirin non-steroidal anti-inflammatory drugs, warfarin, multivitamin supplements, hypertension, coronary heart disease, rheumatological disease, and dietary patterns. The primary exposure was physical inactivity, measured in hours of sitting each day. The secondary exposure was physical activity, measured in metabolic equivalents a day. Results Over the 18 year study period, there were 268 cases of incident idiopathic pulmonary embolism. There was an association between time of sitting and risk of idiopathic pulmonary embolism (41/104 720 v 16/14 565 cases in most inactive v least inactive in combined data; P<0.001 for trend). The risk of pulmonary embolism was more than twofold in women who spent the most time sitting compared with those who spent the least time sitting (multivariable hazard ratio 2.34, 95% confidence interval 1.30 to 4.20). There was no association between physical activity and pulmonary embolism (P=0.53 for trend). Conclusions Physical inactivity is associated with incident pulmonary embolism in women. Interventions that decrease time sitting could lower the risk of pulmonary embolism.	[Kabrhel, Christopher; Camargo, Carlos A., Jr.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Goldhaber, Samuel Z.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc,Dept Med, Boston, MA 02115 USA; [Varraso, Raphaelle] INSERM, CESP Ctr Res Epidemiol & Populat Hlth, U1018, Resp & Environm Epidemiol Team, F-94807 Villejuif, France; [Varraso, Raphaelle] Univ Paris 11, UMRS 1018, F-94807 Villejuif, France; [Rimm, Eric] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Rimm, Eric] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Rimm, Eric; Camargo, Carlos A., Jr.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab,Dept Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kabrhel, C (corresponding author), Massachusetts Gen Hosp, Dept Emergency Med, Zero Emerson Pl,Suite 3B, Boston, MA 02114 USA.	ckabrhel@partners.org	Camargo, Carlos A./C-2145-2008; Varraso, Raphaelle/R-8740-2016	Camargo, Carlos A./0000-0002-5071-7654; Varraso, Raphaelle/0000-0002-3338-7825; Kabrhel, Christopher/0000-0002-8699-7176	National Institute on Aging, National Institutes of Health, Bethesda, MD [R21AG031079, P01CA87969, R01HL034594]; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG031079] Funding Source: NIH RePORTER	National Institute on Aging, National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the National Institute on Aging, National Institutes of Health, Bethesda, MD (R21AG031079, P01CA87969, and R01HL034594). The funding source had no role in design or conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript.	Arterburn DE, 2004, J AM GERIATR SOC, V52, P1907, DOI 10.1111/j.1532-5415.2004.52517.x; Bassett DR, 2010, MED SCI SPORT EXER, V42, P1819, DOI 10.1249/MSS.0b013e3181dc2e54; Centers for Disease Control and Prevention, 2007, US PHYS ACT STAT; Cushman M, 2004, JAMA-J AM MED ASSOC, V292, P1573, DOI 10.1001/jama.292.13.1573; El-Sayed MS, 2004, SPORTS MED, V34, P181, DOI 10.2165/00007256-200434030-00004; El-Sayed MS, 2000, MED SCI SPORT EXER, V32, P918; Eliasson M, 1996, INT J EPIDEMIOL, V25, P1182, DOI 10.1093/ije/25.6.1182; ElSayed MS, 1996, SPORTS MED, V22, P282, DOI 10.2165/00007256-199622050-00002; ElSayed MS, 1996, BLOOD COAGUL FIBRIN, V7, P484, DOI 10.1097/00001721-199606000-00009; Everett BM, 2009, J THROMB HAEMOST, V7, P588, DOI 10.1111/j.1538-7836.2009.03302.x; FOLSOM AR, 1991, ATHEROSCLEROSIS, V91, P191, DOI 10.1016/0021-9150(91)90167-2; Glynn RJ, 2005, AM J EPIDEMIOL, V162, P975, DOI 10.1093/aje/kwi309; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Goldhaber SZ, 1997, JAMA-J AM MED ASSOC, V277, P642, DOI 10.1001/jama.277.8.642; GOLDHABER SZ, 1983, AM J MED, V74, P1023, DOI 10.1016/0002-9343(83)90805-7; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; Heit JA, 2005, J THROMB HAEMOST, V3, P1611, DOI 10.1111/j.1538-7836.2005.01415.x; Heit JA, 2003, CLIN CHEST MED, V24, P1, DOI 10.1016/S0272-5231(02)00077-1; Hitos K, 2007, J THROMB HAEMOST, V5, P1890, DOI 10.1111/j.1538-7836.2007.02664.x; Jackson AS, 2009, ARCH INTERN MED, V169, P1781, DOI 10.1001/archinternmed.2009.312; Kabrhel C, 2009, OBESITY, V17, P2040, DOI 10.1038/oby.2009.92; Kline JA, 2004, J THROMB HAEMOST, V2, P1247, DOI 10.1111/j.1538-7836.2004.00790.x; Kucher N, 2005, THROMB HAEMOSTASIS, V93, P494, DOI 10.1160/TH04-09-0587; Kurkciyan I, 2000, ARCH INTERN MED, V160, P1529, DOI 10.1001/archinte.160.10.1529; McNally MA, 1997, J BONE JOINT SURG AM, V79A, P1198, DOI 10.2106/00004623-199708000-00012; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Sochart DH, 1999, J BONE JOINT SURG BR, V81B, P700, DOI 10.1302/0301-620X.81B4.8909; STRATTON JR, 1991, CIRCULATION, V83, P1692, DOI 10.1161/01.CIR.83.5.1692; TROY LM, 1995, INT J OBESITY, V19, P570; Tsai AW, 2002, ARCH INTERN MED, V162, P1182, DOI 10.1001/archinte.162.10.1182; van Stralen KJ, 2007, J THROMB HAEMOST, V5, P2186, DOI 10.1111/j.1538-7836.2007.02732.x; van Stralen KJ, 2008, J AM GERIATR SOC, V56, P517, DOI 10.1111/j.1532-5415.2007.01588.x; van Stralen KJ, 2008, ARCH INTERN MED, V168, P21, DOI 10.1001/archinternmed.2007.5; Van Stralen KJ, 2005, J THROMB HAEMOST, V3, P2110, DOI 10.1111/j.1538-7836.2005.01482.x; Varraso R, 2007, AM J CLIN NUTR, V86, P488, DOI 10.1093/ajcn/86.2.488; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; WILSON PWF, 1986, AM HEART J, V111, P1177, DOI 10.1016/0002-8703(86)90022-0; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	40	50	51	0	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 4	2011	343								d3867	10.1136/bmj.d3867	http://dx.doi.org/10.1136/bmj.d3867			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791RR	21727169	Green Submitted, Green Published, hybrid			2022-12-01	WOS:000292682800005
J	Lee, MSY; Jago, JB; Garcia-Bellido, DC; Edgecombe, GD; Gehling, JG; Paterson, JR				Lee, Michael S. Y.; Jago, James B.; Garcia-Bellido, Diego C.; Edgecombe, Gregory D.; Gehling, James G.; Paterson, John R.			Modern optics in exceptionally preserved eyes of Early Cambrian arthropods from Australia	NATURE			English	Article							EMU BAY SHALE; SOUTH-AUSTRALIA; KANGAROO ISLAND; VISUAL-SYSTEM; LAGERSTATTE; TRILOBITES; EVOLUTION; TUZOIA	Despite the status of the eye as an "organ of extreme perfection"(1), theory suggests that complex eyes can evolve very rapidly(2). The fossil record has, until now, been inadequate in providing insight into the early evolution of eyes during the initial radiation of many animal groups known as the Cambrian explosion. This is surprising because Cambrian Burgess-Shale-type deposits are replete with exquisitely preserved animals, especially arthropods, that possess eyes(3-5). However, with the exception of biomineralized trilobite eyes, virtually nothing is known about the details of their optical design. Here we report exceptionally preserved fossil eyes from the Early Cambrian (similar to 515 million years ago) Emu Bay Shale of South Australia, revealing that some of the earliest arthropods possessed highly advanced compound eyes, each with over 3,000 large ommatidial lenses and a specialized 'bright zone'. These are the oldest non-biomineralized eyes known in such detail, with preservation quality exceeding that found in the Burgess Shale and Chengjiang deposits. Non-biomineralized eyes of similar complexity are otherwise unknown until about 85 million years later(6,7). The arrangement and size of the lenses indicate that these eyes belonged to an active predator that was capable of seeing in low light. The eyes are more complex than those known from contemporaneous trilobites and are as advanced as those of many living forms. They provide further evidence that the Cambrian explosion involved rapid innovation in fine-scale anatomy as well as gross morphology, and are consistent with the concept that the development of advanced vision helped to drive this great evolutionary event(8).	[Lee, Michael S. Y.; Jago, James B.; Gehling, James G.] S Australian Museum, Adelaide, SA 5000, Australia; [Lee, Michael S. Y.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [Jago, James B.] Univ S Australia, Sch Nat & Built Environm, Mawson Lakes, SA 5095, Australia; [Garcia-Bellido, Diego C.] Inst Geociencias CSIC UCM, Inst Geol Econ, Dept Paleontol, Madrid 28040, Spain; [Edgecombe, Gregory D.] Nat Hist Museum, Dept Paleontol, London SW7 5BD, England; [Paterson, John R.] Univ New England, Sch Environm & Rural Sci, Div Earth Sci, Armidale, NSW 2351, Australia	University of Adelaide; University of South Australia; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UCM - Instituto de Geociencias (IGEO); CSIC-UCM - Instituto de Geologia Economica (IGE); Natural History Museum London; University of New England	Lee, MSY (corresponding author), S Australian Museum, Adelaide, SA 5000, Australia.	mike.lee@samuseum.sa.gov.au; jpater20@une.edu.au	Garcia-Bellido, Diego/AAF-9043-2021	Paterson, John/0000-0003-2947-3912; Garcia-Bellido, Diego/0000-0003-1922-9836; Edgecombe, Gregory/0000-0002-9591-8011; Jago, James/0000-0002-3059-1572	Australian Research Council [LP0774959]; South Australian Museum; Spanish Ministry of Science [RYC2007-00090, CGL2009-07073]; Beach Energy and Sealink Pty Ltd	Australian Research Council(Australian Research Council); South Australian Museum; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Beach Energy and Sealink Pty Ltd	We thank P. and C. Buck for access to and assistance at the fossil site; N. Schroeder, M. Gemmell, R. Atkinson, M. A. Binnie and numerous others (Supplementary Table 3) for help with excavations and curatorial assistance; A. Netting, P. Hudson and Adelaide Microscopy for imaging; D. Birch and G. Brock for SEM-EDS analysis; A. Baonza and J. F. de Celis for discussions on arthropod eye development; R. Fortey and A. Parker for comments and the Australian Research Council (grant LP0774959), South Australian Museum, Spanish Ministry of Science (RYC2007-00090 and grant CGL2009-07073), Beach Energy and Sealink Pty Ltd for funding.	[Anonymous], 1994, FOSSILS BURGESS SHAL; Briggs DEG, 1997, J PALEONTOL, V71, P22, DOI 10.1017/S0022336000038919; Clarkson E, 2006, ARTHROPOD STRUCT DEV, V35, P247, DOI 10.1016/j.asd.2006.08.002; Conway-Morris Simon., 1998, CRUCIBLE CREATION BU; Daley AC, 2009, SCIENCE, V323, P1597, DOI 10.1126/science.1169514; Darwin C., 1859, ORIGIN SPECIES MEANS; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Garcia-Bellido DC, 2009, PALAEONTOLOGY, V52, P1221, DOI 10.1111/j.1475-4983.2009.00914.x; Gehling JG, 2011, AUST J EARTH SCI, V58, P243, DOI 10.1080/08120099.2011.555487; Harzsch S, 2007, ORG DIVERS EVOL, V7, P20, DOI 10.1016/j.ode.2006.02.004; Harzsch S, 2006, ARTHROPOD STRUCT DEV, V35, P319, DOI 10.1016/j.asd.2006.08.009; Haug JT, 2009, PALAEONTOGR ABT A, V289, P1; Hou X. -G., 2004, CAMBRIAN FOSSILS CHE; Land M.F., 2002, ANIMAL EYES; McCormick T, 1998, PALEOBIOLOGY, V24, P235; NILSSON DE, 1994, P ROY SOC B-BIOL SCI, V256, P53, DOI 10.1098/rspb.1994.0048; Oldham S, 2002, DEVELOPMENT, V129, P4103; Parker A., 2003, BLINK EYE CAUSE MOST; Parker AR, 2011, OPT LASER TECHNOL, V43, P323, DOI 10.1016/j.optlastec.2008.12.020; Paterson JR, 2010, PALAEONTOLOGY, V53, P377, DOI 10.1111/j.1475-4983.2010.00932.x; Plotnick RE, 2010, PALEOBIOLOGY, V36, P303, DOI 10.1666/08062.1; Ritchie A., 1985, Alcheringa, V9, P117, DOI 10.1080/03115518508618961; SCHOENEMANN B, 2010, LETHAIA         0930, DOI DOI 10.1111/J.1502-3931.2010.00239.X; Schoenemann B, 2008, ENTOMOL GEN, V31, P287; Snyder A. W., 1979, COMP PHYSL EVOLUTION, P225, DOI DOI 10.1007/978-3-642-66999-6_5; vanderBrugghen W, 1997, NATURE, V385, P589, DOI 10.1038/385589a0; Vannier J, 2007, J PALEONTOL, V81, P445, DOI 10.1666/pleo05070.1; Warrant E, 2006, INVERTEBRATE VISION, pXIX; WEHNER R, 1981, COMP PHYSL EVOLUTION, P287; ZHANG XG, 1990, PALAEONTOLOGY, V33, P911	30	58	60	1	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 30	2011	474	7353					631	634		10.1038/nature10097	http://dx.doi.org/10.1038/nature10097			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21720369				2022-12-01	WOS:000292204300037
J	O'Brian, S; Onslow, M				O'Brian, Susan; Onslow, Mark			Clinical management of stuttering in children and adults	BRITISH MEDICAL JOURNAL			English	Review							LIDCOMBE PROGRAM; SOCIAL PHOBIA; TRIAL; ATTITUDES; IMPACT; INTERVENTION; ETIOLOGY; STAMMER; ONSET; AGE		[O'Brian, Susan; Onslow, Mark] Univ Sydney, Australian Stuttering Res Ctr, Lidcombe, NSW 2060, Australia	University of Sydney	Onslow, M (corresponding author), Univ Sydney, Australian Stuttering Res Ctr, Lidcombe, NSW 2060, Australia.	mark.onslow@sydney.edu.au		Onslow, Mark/0000-0003-2629-2390; O'Brian, Susan/0000-0002-0882-1909	University of Sydney	University of Sydney(University of Sydney)	Both authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: SO and MO have support from the University of Sydney for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	Blumgart E, 2010, DEPRESS ANXIETY, V27, P687, DOI 10.1002/da.20657; Carey B, 2010, INT J LANG COMM DIS, V45, P108, DOI 10.3109/13682820902763944; Chang SE, 2008, NEUROIMAGE, V39, P1333, DOI 10.1016/j.neuroimage.2007.09.067; CONTURE EG, 1991, J SPEECH HEAR RES, V34, P1041, DOI 10.1044/jshr.3405.1041; Craig A, 2009, J FLUENCY DISORD, V34, P61, DOI 10.1016/j.jfludis.2009.05.002; Cream A, 2010, J SPEECH LANG HEAR R, V53, P887, DOI 10.1044/1092-4388(2009/09-0080); Cykowski MD, 2010, NEUROIMAGE, V52, P1495, DOI 10.1016/j.neuroimage.2010.05.011; Davis S, 2002, J CHILD PSYCHOL PSYC, V43, P939, DOI 10.1111/1469-7610.00093; DeCarle AJ, 1996, AM J PSYCHIAT, V153, P1367; DENIL LF, 1991, J SPEECH HEAR RES, V34, P60; Ezrati-Vinacour R, 2001, J SPEECH LANG HEAR R, V44, P368, DOI 10.1044/1092-4388(2001/030); Felsenfeld S, 2000, BEHAV GENET, V30, P359, DOI 10.1023/A:1002765620208; Hayhow R, 2002, J FLUENCY DISORD, V27, P1, DOI 10.1016/S0094-730X(01)00102-4; Hugh-Jones S, 1999, BRIT J EDUC PSYCHOL, V69, P141, DOI 10.1348/000709999157626; HURST MI, 1983, J FLUENCY DISORD, V8, P1, DOI 10.1016/0094-730X(83)90017-7; Iverach L, 2010, J SPEECH LANG HEAR R, V53, P1178, DOI 10.1044/1092-4388(2010/09-0166); Iverach L, 2009, J FLUENCY DISORD, V34, P173, DOI 10.1016/j.jfludis.2009.09.001; Iverach L, 2009, J ANXIETY DISORD, V23, P928, DOI 10.1016/j.janxdis.2009.06.003; Iverach L, 2009, J FLUENCY DISORD, V34, P29, DOI 10.1016/j.jfludis.2009.02.002; Jones M, 2005, BMJ-BRIT MED J, V331, P659, DOI 10.1136/bmj.38520.451840.E0; Kingston M, 2003, INT J LANG COMM DIS, V38, P165, DOI 10.1080/1368282031000062882; Klein JF, 2004, J FLUENCY DISORD, V29, P255, DOI 10.1016/j.jfludis.2004.08.001; Langevin M., 1998, CONT ISSUES COMMUNIC, V25, P8, DOI 10.1044/cicsd_25_S_8; Langevin M, 2009, J FLUENCY DISORD, V34, P72, DOI 10.1016/j.jfludis.2009.05.001; Langevin M, 2009, AM J SPEECH-LANG PAT, V18, P264, DOI 10.1044/1058-0360(2009/07-0087); Lattermann C, 2008, J FLUENCY DISORD, V33, P52, DOI 10.1016/j.jfludis.2007.12.002; Lewis C, 2008, AM J SPEECH-LANG PAT, V17, P139, DOI 10.1044/1058-0360(2008/014); Menzies RG, 2008, J SPEECH LANG HEAR R, V51, P1451, DOI 10.1044/1092-4388(2008/07-0070); Onslow M., HDB EVIDENC IN PRESS; Reilly S, 2009, PEDIATRICS, V123, P270, DOI 10.1542/peds.2007-3219; Sommer M, 2002, LANCET, V360, P380, DOI 10.1016/S0140-6736(02)09610-1; Stein MB, 1996, AM J PSYCHIAT, V153, P278; Yairi E, 1999, J SPEECH LANG HEAR R, V42, P1097, DOI 10.1044/jslhr.4205.1097; YAIRI E, 1983, J SPEECH HEAR DISORD, V48, P171, DOI 10.1044/jshd.4802.171	34	5	5	0	27	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 24	2011	342								d3742	10.1136/bmj.d3742	http://dx.doi.org/10.1136/bmj.d3742			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AW	21705407				2022-12-01	WOS:000292200800002
J	Tocheva, EI; Matson, EG; Morris, DM; Moussavi, F; Leadbetter, JR; Jensen, GJ				Tocheva, Elitza I.; Matson, Eric G.; Morris, Dylan M.; Moussavi, Farshid; Leadbetter, Jared R.; Jensen, Grant J.			Peptidoglycan Remodeling and Conversion of an Inner Membrane into an Outer Membrane during Sporulation	CELL			English	Article							BACILLUS-SUBTILIS; SPORE COAT; ELECTRON CRYOTOMOGRAPHY; CRYOELECTRON TOMOGRAPHY; PROTEIN LOCALIZATION; GENE-EXPRESSION; CELL-DIVISION; SP-NOV; MORPHOGENESIS; ULTRASTRUCTURE	Two hallmarks of the Firmicute phylum, which includes the Bacilli and Clostridia classes, are their ability to form endospores and their "Gram-positive'' single-membraned, thick-cell-wall envelope structure. Acetonema longum is part of a lesser-known family (the Veillonellaceae) of Clostridia that form endospores but that are surprisingly "Gram negative,'' possessing both an inner and outer membrane and a thin cell wall. Here, we present macromolecular resolution, 3D electron cryotomographic images of vegetative, sporulating, and germinating A. longum cells showing that during the sporulation process, the inner membrane of the mother cell is inverted and transformed to become the outer membrane of the germinating cell. Peptidoglycan persists throughout, leading to a revised, "continuous'' model of its role in the process. Coupled with genomic analyses, these results point to sporulation as a mechanism by which the bacterial outer membrane may have arisen and A. longum as a potential "missing link'' between single- and double-membraned bacteria.	[Tocheva, Elitza I.; Morris, Dylan M.; Jensen, Grant J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Matson, Eric G.; Leadbetter, Jared R.] CALTECH, Ronald & Maxine Linde Ctr Global Environm Sci, Pasadena, CA 91125 USA; [Jensen, Grant J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Moussavi, Farshid] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Stanford University	Jensen, GJ (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	jensen@caltech.edu		Leadbetter, Jared/0000-0002-7033-0844	DOE [DE-FG02-09ER20097, DE-FG02-07ER64484]; Natural Sciences and Engineering Research Council of Canada; Howard Hughes Medical Foundation; Gordon and Betty Moore Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094800] Funding Source: NIH RePORTER	DOE(United States Department of Energy (DOE)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Howard Hughes Medical Foundation(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Alasdair McDowall and Mark Ladinsky for their help with the preparation of mature spores by traditional EM methods and Dr. Martin Pilhofer for helping with the immunofluorescence and western blotting experiments. The GC-MS analysis of LPS was performed at the Complex Carbohydrate Research Center and was supported by DOE grant DE-FG02-09ER20097. We thank Everett Kane for the generation of Movie S2 and Jane H. Ding for helping with the generation of Movie S1 and Movie S2. We thank Ivan Tochev for generating Figure 4B. We thank Dr. Stephen Quake and Richard White at Stanford University for performing the shotgun genome sequencing of A. longum. The authors gratefully acknowledge the IGS annotation engine. This work was supported by a Natural Sciences and Engineering Research Council of Canada Postdoctorate Fellowship (to E.I.T.), the Howard Hughes Medical Foundation, and gifts to Caltech from the Gordon and Betty Moore Foundation, including support for the Caltech Center for Integrative Study of Cell Regulation. E.G.M was supported by the Department of Energy (award DE-FG02-07ER64484 to J.R.L).	Atrih A, 1996, J BACTERIOL, V178, P6173, DOI 10.1128/jb.178.21.6173-6183.1996; BECHTEL DB, 1976, J BACTERIOL, V127, P1472, DOI 10.1128/JB.127.3.1472-1481.1976; Ben-Harush K, 2010, J CELL SCI, V123, P7, DOI 10.1242/jcs.060111; BLADEN HA, 1964, J BACTERIOL, V88, P1482, DOI 10.1128/JB.88.5.1482-1492.1964; Blaylock B, 2004, GENE DEV, V18, P2916, DOI 10.1101/gad.1252704; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Briegel A, 2006, MOL MICROBIOL, V62, P5, DOI 10.1111/j.1365-2958.2006.05355.x; Briegel A, 2009, P NATL ACAD SCI USA, V106, P17181, DOI 10.1073/pnas.0905181106; Buchanan C.E., 1994, BACTERIAL CELL WALL, V1; CAVALIERSMITH T, 2004, ORGANELLES GENOMES E; CHART H, 1992, EPIDEMIOL INFECT, V108, P77, DOI 10.1017/S0950268800049529; Chen SY, 2011, EMBO J, V30, P2972, DOI 10.1038/emboj.2011.186; Dmitriev BA, 2003, J BACTERIOL, V185, P3458, DOI 10.1128/JB.185.11.3458-3468.2003; Dowd MM, 2008, J BACTERIOL, V190, P4541, DOI 10.1128/JB.00249-08; Driks A, 2002, TRENDS MICROBIOL, V10, P251, DOI 10.1016/S0966-842X(02)02373-9; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; ERRINGTON J, 1993, MICROBIOL REV, V57, P1; Gan L, 2008, P NATL ACAD SCI USA, V105, P18953, DOI 10.1073/pnas.0808035105; Gueiros-Filho F., 2007, BACILLUS CELULAR MOL, V1; Gutierrez J, 2010, J BACTERIOL, V192, P3174, DOI 10.1128/JB.00127-10; Harwood C.R., 1989, BIOTECHNOLOGY HDB, P169; Hayhurst EJ, 2008, P NATL ACAD SCI USA, V105, P14603, DOI 10.1073/pnas.0804138105; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; Hilbert DW, 2004, MICROBIOL MOL BIOL R, V68, P234, DOI 10.1128/MMBR.68.2.234-262.2004; HOFSTAD T, 1970, Acta Pathologica et Microbiologica Scandinavica Section B Microbiology and Immunology, V78, P760; HOFSTAD T, 1978, ACTA PATH MICRO IM B, V86, P47; Iancu CV, 2006, NAT PROTOC, V1, P2813, DOI 10.1038/nprot.2006.432; ILLING N, 1991, J BACTERIOL, V173, P3159, DOI 10.1128/JB.173.10.3159-3169.1991; Joseleau-Petit D, 2007, J BACTERIOL, V189, P6512, DOI 10.1128/JB.00273-07; KANE MD, 1991, ARCH MICROBIOL, V156, P91, DOI 10.1007/BF00290979; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kuo CH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001050; Lake JA, 2009, NATURE, V460, P967, DOI 10.1038/nature08183; Leadbetter JR, 1996, APPL ENVIRON MICROB, V62, P3620, DOI 10.1128/AEM.62.10.3620-3631.1996; Li Z, 2009, CURR OPIN MICROBIOL, V12, P333, DOI 10.1016/j.mib.2009.03.007; Liu J, 2009, J BACTERIOL, V191, P5026, DOI 10.1128/JB.00340-09; Margolin W, 2002, CURR BIOL, V12, pR391, DOI 10.1016/S0960-9822(02)00882-5; MERGENHAGEN SE, 1965, J BACTERIOL, V90, P1730, DOI 10.1128/JB.90.6.1730-1734.1965; Meyer P, 2010, MOL MICROBIOL, V76, P956, DOI 10.1111/j.1365-2958.2010.07155.x; NICHOLSON WL, 1990, J BACTERIOL, V172, P7, DOI 10.1128/JB.172.1.7-14.1990; Onyenwoke RU, 2004, ARCH MICROBIOL, V182, P182, DOI 10.1007/s00203-004-0696-y; Perez AR, 2000, J BACTERIOL, V182, P1096, DOI 10.1128/JB.182.4.1096-1108.2000; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Pilhofer M., 2010, ELECT MICROSCOPY MOD; POINDEXTER JS, 1981, CAN J MICROBIOL, V27, P704, DOI 10.1139/m81-109; Popham DL, 1996, J BACTERIOL, V178, P6451, DOI 10.1128/jb.178.22.6451-6458.1996; Prajapati RS, 2000, BBA-GEN SUBJECTS, V1475, P353, DOI 10.1016/S0304-4165(00)00089-1; Rainey F. A., 2009, BERGEYS MANUAL SYSTE, V3; Ramamurthi KS, 2008, MOL CELL, V31, P406, DOI 10.1016/j.molcel.2008.05.030; Ramamurthi KS, 2006, MOL MICROBIOL, V62, P1547, DOI 10.1111/j.1365-2958.2006.05468.x; Ramamurthi KS, 2009, P NATL ACAD SCI USA, V106, P13541, DOI 10.1073/pnas.0906851106; Ramamurthi KS, 2009, SCIENCE, V323, P1354, DOI 10.1126/science.1169218; ROELS S, 1992, J BACTERIOL, V174, P575, DOI 10.1128/jb.174.2.575-585.1992; SABATINI DD, 1963, J CELL BIOL, V17, P19, DOI 10.1083/jcb.17.1.19; Setlow P, 2008, CELL, V135, P410, DOI 10.1016/j.cell.2008.10.006; Setlow P, 2007, TRENDS MICROBIOL, V15, P172, DOI 10.1016/j.tim.2007.02.004; Smith TJ, 2000, MICROBIOL-UK, V146, P249, DOI 10.1099/00221287-146-2-249; Steichen CT, 2007, MOL MICROBIOL, V64, P359, DOI 10.1111/j.1365-2958.2007.05658.x; STEVENS CM, 1992, J BACTERIOL, V174, P586, DOI 10.1128/jb.174.2.586-594.1992; TIPPER DJ, 1976, J BACTERIOL, V126, P213, DOI 10.1128/JB.126.1.213-221.1976; YANOURI A, 1993, J BACTERIOL, V175, P7604, DOI 10.1128/JB.175.23.7604-7616.1993	64	68	68	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 2	2011	146	5					799	812		10.1016/j.cell.2011.07.029	http://dx.doi.org/10.1016/j.cell.2011.07.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21884938	Green Accepted, Bronze			2022-12-01	WOS:000294477500019
J	Togashi, H; Kominami, K; Waseda, M; Komura, H; Miyoshi, J; Takeichi, M; Takai, Y				Togashi, Hideru; Kominami, Kanoko; Waseda, Masazumi; Komura, Hitomi; Miyoshi, Jun; Takeichi, Masatoshi; Takai, Yoshimi			Nectins Establish a Checkerboard-Like Cellular Pattern in the Auditory Epithelium	SCIENCE			English	Article							INTERCELLULAR-JUNCTIONS; SIGNALING PATHWAY; MAMMALIAN COCHLEA; DROSOPHILA EYE; ADHESION; AFADIN; CORTI; MORPHOGENESIS; MOLECULES; PLANAR	In the auditory epithelium of the cochlea, the sensory hair cells and supporting cells are arranged in a checkerboard-like fashion, but the mechanism underlying this cellular patterning is unclear. We found that mouse hair cells and supporting cells express the immunoglobulin-like adhesion molecules nectin-1 and -3, respectively, and that their interaction mediates the heterotypic adhesion between these two cell types. Genetic removal of nectin-1 or -3 disrupted the checkerboard-like pattern, inducing aberrant attachment between hair cells. When cells expressing either nectin-1 or -3 were cocultured, they arranged themselves into a mosaic pattern. Thus, nectin-1 and -3 promote the formation of the checkerboard-like pattern of the auditory epithelia.	[Togashi, Hideru; Kominami, Kanoko; Waseda, Masazumi; Komura, Hitomi; Takai, Yoshimi] Kobe Univ, Div Mol & Cellular Biol, Dept Biochem & Mol Biol, Grad Sch Med, Kobe, Hyogo 6500017, Japan; [Miyoshi, Jun] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Mol Biol, Osaka 5378511, Japan; [Takeichi, Masatoshi] RIKEN Ctr Dev Biol, Lab Cell Adhes & Tissue Patterning, Kobe, Hyogo 6500047, Japan	Kobe University; Osaka Medical Center for Cancer & Cardiovascular Diseases; RIKEN	Takai, Y (corresponding author), Kobe Univ, Div Mol & Cellular Biol, Dept Biochem & Mol Biol, Grad Sch Med, Kobe, Hyogo 6500017, Japan.	ytakai@med.kobe-u.ac.jp	Takeichi, Masatoshi/G-5903-2012	Takeichi, Masatoshi/0000-0002-9931-3378; Togashi, Hideru/0000-0002-3967-5940; Waseda, Masazumi/0000-0001-7179-5945	Global Center for Education and Research in Integrative Membrane Biology; Ministry of Education, Culture, Sports, Science and Technology in Japan; Japan Society for the Promotion of Science; Japanese Science and Technology Agency	Global Center for Education and Research in Integrative Membrane Biology; Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by the Global Centers of Excellence Program "Global Center for Education and Research in Integrative Membrane Biology" and the Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science and Technology in Japan; by Grants-in-Aid from the Japan Society for the Promotion of Science; and by the Core Research for Evolutional Science and Technology from the Japanese Science and Technology Agency.	Bao SJ, 2005, DEV CELL, V8, P925, DOI 10.1016/j.devcel.2005.03.011; Bao SJ, 2010, DEV BIOL, V344, P948, DOI 10.1016/j.ydbio.2010.06.013; Chen P, 2002, DEVELOPMENT, V129, P2495; GULLEY RL, 1976, J NEUROCYTOL, V5, P479, DOI 10.1007/BF01181652; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; HONDA H, 1986, J EMBRYOL EXP MORPH, V98, P1; KELLEY MW, 1995, J NEUROSCI, V15, P3013; Kimble J, 1997, ANNU REV CELL DEV BI, V13, P333, DOI 10.1146/annurev.cellbio.13.1.333; Kopan R, 1997, TRENDS GENET, V13, P465, DOI 10.1016/S0168-9525(97)01318-8; Lanford PJ, 1999, NAT GENET, V21, P289, DOI 10.1038/6804; Lewis J, 1996, CURR OPIN NEUROBIOL, V6, P3, DOI 10.1016/S0959-4388(96)80002-X; McKenzie E, 2004, DEV DYNAM, V229, P802, DOI 10.1002/dvdy.10500; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Montcouquiol M, 2003, J NEUROSCI, V23, P9469; Nunes FD, 2006, J CELL SCI, V119, P4819, DOI 10.1242/jcs.03233; Okabe N, 2004, DEV DYNAM, V230, P174, DOI 10.1002/dvdy.20033; Satoh-Horikawa K, 2000, J BIOL CHEM, V275, P10291, DOI 10.1074/jbc.275.14.10291; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Togashi H, 2006, J CELL BIOL, V174, P141, DOI 10.1083/jcb.200601089; YAMANAKA H I, 1990, International Journal of Developmental Biology, V34, P377	24	81	85	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 26	2011	333	6046					1144	1147		10.1126/science.1208467	http://dx.doi.org/10.1126/science.1208467			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21798896				2022-12-01	WOS:000294244300048
J	Barreira, TV; Harrington, DM; Staiano, AE; Heymsfield, SB; Katzmarzyk, PT				Barreira, Tiago V.; Harrington, Deirdre M.; Staiano, Amanda E.; Heymsfield, Steven B.; Katzmarzyk, Peter T.			Body Adiposity Index, Body Mass Index, and Body Fat in White and Black Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							RACE; BMI; SEX		[Barreira, Tiago V.; Harrington, Deirdre M.; Staiano, Amanda E.; Heymsfield, Steven B.; Katzmarzyk, Peter T.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Barreira, TV (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.	peter.katzmarzyk@pbrc.edu	Heymsfield, Steven B/N-1968-2017; Staiano, Amanda E/H-3956-2017; Katzmarzyk, Peter T/N-1974-2017; Barreira, Tiago/AAD-9429-2021	Heymsfield, Steven B/0000-0003-1127-9425; Staiano, Amanda E/0000-0001-7846-046X; Katzmarzyk, Peter T/0000-0002-9280-6022; Barreira, Tiago/0000-0001-7108-3374; Harrington, Deirdre/0000-0003-0278-6812	NIDDK NIH HHS [2P30-DK072476-06, P30 DK072476] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; Bouchard C, 2007, INT J OBESITY, V31, P1552, DOI 10.1038/sj.ijo.0803653; Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248; Jackson AS, 2002, INT J OBESITY, V26, P789, DOI 10.1038/sj.ijo.0802006; Katzmarzyk PT, 2010, AM J CLIN NUTR, V91, P7, DOI 10.3945/ajcn.2009.28136	5	61	66	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 24	2011	306	8					828	830		10.1001/jama.2011.1189	http://dx.doi.org/10.1001/jama.2011.1189			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	810VY	21862743	Bronze, Green Accepted			2022-12-01	WOS:000294157300019
J	Warriner, DR				Warriner, David R.			PERSONAL VIEW Patients who discharge themselves need further thought	BRITISH MEDICAL JOURNAL			English	Editorial Material												D.R.Warriner@sheffield.ac.uk							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 10	2011	343								d5054	10.1136/bmj.d5054	http://dx.doi.org/10.1136/bmj.d5054			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	808DL	21831946				2022-12-01	WOS:000293956300015
J	Beaufort, L; Probert, I; de Garidel-Thoron, T; Bendif, EM; Ruiz-Pino, D; Metzl, N; Goyet, C; Buchet, N; Coupel, P; Grelaud, M; Rost, B; Rickaby, REM; de Vargas, C				Beaufort, L.; Probert, I.; de Garidel-Thoron, T.; Bendif, E. M.; Ruiz-Pino, D.; Metzl, N.; Goyet, C.; Buchet, N.; Coupel, P.; Grelaud, M.; Rost, B.; Rickaby, R. E. M.; de Vargas, C.			Sensitivity of coccolithophores to carbonate chemistry and ocean acidification	NATURE			English	Article							EMILIANIA-HUXLEYI PRYMNESIOPHYCEAE; ATMOSPHERIC CO2; REDUCED CALCIFICATION; CALCIUM-CARBONATE; SEA; PHOTOSYNTHESIS; PCO(2); LIGHT	About one-third of the carbon dioxide (CO(2)) released into the atmosphere as a result of human activity has been absorbed by the oceans(1), where it partitions into the constituent ions of carbonic acid. This leads to ocean acidification, one of the major threats to marine ecosystems(2) and particularly to calcifying organisms such as corals(3,4), foraminifera(5-7) and coccolithophores(8). Coccolithophores are abundant phytoplankton that are responsible for a large part of modern oceanic carbonate production. Culture experiments investigating the physiological response of coccolithophore calcification to increased CO(2) have yielded contradictory results between and even within species(8-11). Here we quantified the calcite mass of dominant coccolithophores in the present ocean and over the past forty thousand years, and found a marked pattern of decreasing calcification with increasing partial pressure of CO(2) and concomitant decreasing concentrations of CO(3)(2-). Our analyses revealed that differentially calcified species and morphotypes are distributed in the ocean according to carbonate chemistry. A substantial impact on the marine carbon cycle might be expected upon extrapolation of this correlation to predicted ocean acidification in the future. However, our discovery of a heavily calcified Emiliania huxleyi morphotype in modern waters with low pH highlights the complexity of assemblage-level responses to environmental forcing factors.	[Beaufort, L.; de Garidel-Thoron, T.; Buchet, N.; Grelaud, M.] Univ Aix Marseille, CNRS, CEREGE, F-13545 Aix En Provence 4, France; [Probert, I.; Bendif, E. M.; de Vargas, C.] Univ Paris 06, Stn Biol Roscoff, CNRS, F-29680 Roscoff, France; [Ruiz-Pino, D.; Metzl, N.; Coupel, P.] Univ Paris 06, LOCEAN IPSL, CNRS, F-75252 Paris 5, France; [Goyet, C.] Univ Perpignan, F-66860 Perpignan 9, France; [Rost, B.] Alfred Wegener Inst, D-27570 Bremerhaven, Germany; [Rickaby, R. E. M.] Univ Oxford, Dept Earth Sci, Oxford OX1 30R, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Perpignan Via Domitia; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Oxford	Beaufort, L (corresponding author), Univ Aix Marseille, CNRS, CEREGE, Ave L Philibert,BP80, F-13545 Aix En Provence 4, France.	beaufort@cerege.fr	Rost, Bjoern/B-4447-2015; Probert, Ian/M-9807-2019; Beaufort, Luc/AAH-5305-2021; Beaufort, Luc/ABG-2289-2021; de Garidel-Thoron, Thibault/B-1204-2008	Rost, Bjoern/0000-0001-5452-5505; Beaufort, Luc/0000-0001-6055-9373; de Garidel-Thoron, Thibault/0000-0001-8983-9571; Grelaud, Michael/0000-0001-8649-9743; Rickaby, Rosalind/0000-0002-6095-8419; metzl, nicolas/0000-0002-1165-1074	INSU (Institut National des Sciences de l'Univers); IPSL (Institut Pierre-Simon Laplace); IPEV (Institut Paul-Emile Victor); Agence National de la Recherche [ANR-06-JCJC-0142]; European Research Council [205150]; European Funding Agencies from the ERA-net program Biodiversa; Biomarks project; European Community [211384]	INSU (Institut National des Sciences de l'Univers); IPSL (Institut Pierre-Simon Laplace); IPEV (Institut Paul-Emile Victor); Agence National de la Recherche(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); European Funding Agencies from the ERA-net program Biodiversa; Biomarks project; European Community(European Commission)	We thank the crew from Puerto Deseado, Atalante, Suroit and Marion-Dufresne, and D. Vaulot, L. Garczarek, M.-A. Sicre and H. Claustre for their help in collecting material for this work. The long-term OISO observational programme is supported by INSU (Institut National des Sciences de l'Univers), IPSL (Institut Pierre-Simon Laplace) and IPEV (Institut Paul-Emile Victor). We thank F. C. Bassinot for help in estimating palaeosalinities. The IMAGES programme is acknowledged for collection and curation of the cores. This work was funded by the 'Agence National de la Recherche' project PALEO-CTD (grant ANR-06-JCJC-0142), by the European Research Council under grant agreement 205150, by the European Funding Agencies from the ERA-net program Biodiversa, under the Biomarks project, and by the European Community's Seventh Framework Program EPOCA (European Project on Ocean Acidification) under grant agreement 211384.	Anderson DM, 2002, NATURE, V416, P70, DOI 10.1038/416070a; Barker S, 2002, SCIENCE, V297, P833, DOI 10.1126/science.1072815; Berry L, 2002, FUNCT PLANT BIOL, V29, P289, DOI 10.1071/PP01218; Bollmann J, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000742; Bollmann J, 2007, EARTH PLANET SC LETT, V255, P273, DOI 10.1016/j.epsl.2006.12.029; Buitenhuis ET, 1999, J PHYCOL, V35, P949, DOI 10.1046/j.1529-8817.1999.3550949.x; Colmenero-Hidalgo E, 2002, MAR MICROPALEONTOL, V46, P247, DOI 10.1016/S0377-8398(02)00065-8; de Moel H, 2009, BIOGEOSCIENCES, V6, P1917, DOI 10.5194/bg-6-1917-2009; De Vargas Colomban, 2007, P251, DOI 10.1016/B978-012370518-1/50013-8; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Feng Y, 2008, EUR J PHYCOL, V43, P87, DOI 10.1080/09670260701664674; Gattuso JP, 1998, GLOBAL PLANET CHANGE, V18, P37, DOI 10.1016/S0921-8181(98)00035-6; Gibbs SJ, 2006, SCIENCE, V314, P1770, DOI 10.1126/science.1133902; HAGINO K, J PHYCOL IN PRESS, P97654; Honisch B, 2005, EARTH PLANET SC LETT, V236, P305, DOI 10.1016/j.epsl.2005.04.027; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Langer G., 2009, BIOGEOSCI DISCUSS, V6, P4361, DOI DOI 10.5194/BGD-6-4361-2009; Langer G, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001227; Lewis E., 1998, ORNLCDIAC105; Mackinder L, 2010, GEOMICROBIOL J, V27, P585, DOI 10.1080/01490451003703014; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Moy AD, 2009, NAT GEOSCI, V2, P276, DOI 10.1038/NGEO460; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Young J.R., 2003, J NANNOPLANKT RES, P1; Zondervan I, 2002, J EXP MAR BIOL ECOL, V272, P55, DOI 10.1016/S0022-0981(02)00037-0; Zondervan I, 2007, DEEP-SEA RES PT II, V54, P521, DOI 10.1016/j.dsr2.2006.12.004	30	317	337	9	406	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 4	2011	476	7358					80	83		10.1038/nature10295	http://dx.doi.org/10.1038/nature10295			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NR	21814280				2022-12-01	WOS:000293447300033
J	Cormican, M; Murphy, AW; Vellinga, A				Cormican, Martin; Murphy, Andrew W.; Vellinga, Akke			RATIONAL TESTING Interpreting asymptomatic bacteriuria	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							URINARY-TRACT-INFECTION; MANAGEMENT		[Cormican, Martin] NUI Galway, Antimicrobial Resistance & Microbial Ecol Lab, Sch Med, Inst Clin Sci, Galway, Ireland; [Cormican, Martin] NUI Galway, Ctr Hlth Environm, Ryan Inst, Galway, Ireland; [Murphy, Andrew W.; Vellinga, Akke] NUI Galway, Discipline Gen Practice, Sch Med, Inst Clin Sci, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Cormican, M (corresponding author), NUI Galway, Antimicrobial Resistance & Microbial Ecol Lab, Sch Med, Inst Clin Sci, Newcastle Rd, Galway, Ireland.	martin.cormican@hse.ie	Cormican, Martin/T-8323-2019; Vellinga, Akke/H-2130-2011	Cormican, Martin/0000-0002-8023-1882; Vellinga, Akke/0000-0002-6583-4300; Murphy, Andrew/0000-0001-5549-8246				Al-Hasan MN, 2010, J INFECTION, V60, P278, DOI 10.1016/j.jinf.2010.01.007; BAERHEIM A, 1990, Scandinavian Journal of Primary Health Care, V8, P207, DOI 10.3109/02813439008994960; Bent S, 2002, JAMA-J AM MED ASSOC, V287, P2701, DOI 10.1001/jama.287.20.2701; Costelloe C, 2010, BMJ-BRIT MED J, V340, P1; Ducharme James, 2007, CJEM, V9, P87; Fry AC, 2006, POSTGRAD MED J, V82, P106, DOI 10.1136/pgmj.2005.038588; Giesen LGM, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-78; Grabe M, 2010, GUIDELINE UROLOGICAL; John AS, 2006, AM J CLIN PATHOL, V126, P428, DOI DOI 10.1309/C69RW1BT7E4QAFPV; Lifshitz E, 2000, ARCH INTERN MED, V160, P2537, DOI 10.1001/archinte.160.16.2537; Little P, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13190; *NAT I HLTH CLIN E, 2008, CLIN GUID NAT I HLTH, V62; National Institute for Health and Clinical Excellence, 2007, CLIN GUID NAT I HLTH; Nicolle LE, 2005, CLIN INFECT DIS, V40, P643, DOI 10.1086/427507; NielWeise BS, 2009, URINARY CATHETER POL; Patrick DM, 2009, CAN MED ASSOC J, V180, P416, DOI 10.1503/cmaj.080626; Renko M, 2011, DIABETES CARE, V34, P230, DOI 10.2337/dc10-0421; Rodhe N, 2008, SCAND J INFECT DIS, V40, P804, DOI 10.1080/00365540802195242; Rodhe N, 2008, SCAND J PRIM HEALTH, V26, P35, DOI 10.1080/02813430701878250; SAVAGE DCL, 1973, ARCH DIS CHILD, V48, P8, DOI 10.1136/adc.48.1.8; Smaill FM, 2009, ANTIBIOTICS ASYMPTOM; Tenke P, 2008, INT J ANTIMICROB AG, V31, pS68, DOI 10.1016/j.ijantimicag.2007.07.033; Trautner BW, 2010, CURR OPIN INFECT DIS, V23, P76, DOI 10.1097/QCO.0b013e328334dda8; Whiting P, 2006, HEALTH TECHNOL ASSES, V10, P1; WHITING P, 2006, HEALTH TECHNOL ASSES, V10, pR11; WHITING P, 2006, HEALTH TECHNOL ASSES, V10, pR3	26	16	16	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 4	2011	343								d4780	10.1136/bmj.d4780	http://dx.doi.org/10.1136/bmj.d4780			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805NO	21816734	Green Submitted			2022-12-01	WOS:000293734800004
J	Heathcote, E				Heathcote, Edwin			OLDER PEOPLE Old age and the city	BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, London, England		Heathcote, E (corresponding author), Financial Times, London, England.	edwinheathcote@hotmail.com							0	2	2	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 25	2011	343								d4418	10.1136/bmj.d4418	http://dx.doi.org/10.1136/bmj.d4418			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	801LM	21788259				2022-12-01	WOS:000293440400004
J	Shetty, P				Shetty, Priya			Kamiar and Arash Alaei: championing HIV/AIDS initiatives in Iran	LANCET			English	Editorial Material																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 16	2011	378	9787					219	219		10.1016/S0140-6736(11)61113-6	http://dx.doi.org/10.1016/S0140-6736(11)61113-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	798JD	21763927				2022-12-01	WOS:000293201100015
J	Gourdon, P; Liu, XY; Skjorringe, T; Morth, JP; Moller, LB; Pedersen, BP; Nissen, P				Gourdon, Pontus; Liu, Xiang-Yu; Skjorringe, Tina; Morth, J. Preben; Moller, Lisbeth Birk; Pedersen, Bjorn Panyella; Nissen, Poul			Crystal structure of a copper-transporting PIB-type ATPase	NATURE			English	Article							P-TYPE-ATPASE; MENKES DISEASE; METAL-BINDING; CANDIDATE GENE; ACTUATOR DOMAIN; PUMP; CU+; MECHANISM; SODIUM; ORGANIZATION	Heavy-metal homeostasis and detoxification is crucial for cell viability. P-type ATPases of the class IB (PIB) are essential in these processes, actively extruding heavy metals from the cytoplasm of cells. Here we present the structure of a PIB-ATPase, a Legionella pneumophila CopA Cu+-ATPase, in a copper-free form, as determined by X-ray crystallography at 3.2 angstrom resolution. The structure indicates a three-stage copper transport pathway involving several conserved residues. A PIB-specific transmembrane helix kinks at a double-glycine motif displaying an amphipathic helix that lines a putative copper entry point at the intracellular interface. Comparisons to Ca2+-ATPase suggest an ATPase-coupled copper release mechanism from the binding sites in the membrane via an extracellular exit site. The structure also provides a framework to analyse missense mutations in the human ATP7A and ATP7B proteins associated with Menkes' and Wilson's diseases.	[Skjorringe, Tina; Moller, Lisbeth Birk] Kennedy Ctr, Ctr Appl Human Mol Genet, DK-2600 Glostrup, Denmark; [Gourdon, Pontus; Liu, Xiang-Yu; Morth, J. Preben; Pedersen, Bjorn Panyella; Nissen, Poul] Aarhus Univ, Ctr Membrane Pumps Cells & Dis PUMPKIN, Danish Natl Res Fdn, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Liu, Xiang-Yu] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China	Aarhus University; Danmarks Grundforskningsfond; Peking University	Moller, LB (corresponding author), Kennedy Ctr, Ctr Appl Human Mol Genet, GI Landevej 7, DK-2600 Glostrup, Denmark.	lbm@kennedy.dk; pn@mb.au.dk	Morth, Jens Preben/AAP-7834-2021; Pedersen, Bjørn/H-4128-2017; Nissen, Poul/D-5774-2014; Pedersen, Bjørn/AAT-2409-2021; Gourdon, Pontus/E-1076-2014; Gourdon, Pontus/HCI-8898-2022; Morth, Jens Preben/G-4450-2013	Morth, Jens Preben/0000-0003-4077-0192; Pedersen, Bjørn/0000-0001-7860-7230; Pedersen, Bjørn/0000-0001-7860-7230; Gourdon, Pontus/0000-0002-8631-3539; Morth, Jens Preben/0000-0003-4077-0192; Nissen, Poul/0000-0003-0948-6628; Moller, Lisbeth/0000-0002-9524-4301	Danish Natural Science Research Council; Swedish Research Council; China Scholarship Council; Carlsberg Foundation; European Research Council; Novo Nordisk Foundation	Danish Natural Science Research Council(Danish Natural Science Research Council); Swedish Research Council(Swedish Research CouncilEuropean Commission); China Scholarship Council(China Scholarship Council); Carlsberg Foundation(Carlsberg Foundation); European Research Council(European Research Council (ERC)European Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	We thank A. Pauluhn, C. Schulze-Briese,T. Tomizaki and V. Olieric (SLS), T. Ursby, M. Thunnissen, J. Unge and D. Haase (MAXLAB), and U. Muller, M. Weiss and K. Paithankar (BESSY) for assistance with synchrotron data collection. Support was provided by the Danscatt program of the Danish Natural Science Research Council. We also thank C. Buchrieser for supplying the L. pneumophila Philadelphia genome; X. D. Su for discussions, A. M. Nielsen for technical assistance and J. L. Karlsen for support on crystallographic computing. We are thankful to T. Deva and K. Faxen for preliminary functional analysis of the protein. P.G. was supported by the Swedish Research Council, X.-Y.L. by the China Scholarship Council and J.P.M. and B.P.P. by the Carlsberg Foundation. P.N. was supported by an advanced research grant (Biomemos) of the European Research Council and at earlier stages by a Hallas-Moller stipend of the Novo Nordisk Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Arnesano F, 2001, BIOCHEMISTRY-US, V40, P1528, DOI 10.1021/bi0014711; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Banci L, 2001, J BIOL CHEM, V276, P8415, DOI 10.1074/jbc.M008389200; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Banci L, 2009, BIOCHEM J, V422, P37, DOI 10.1042/BJ20090422; Boal AK, 2009, J AM CHEM SOC, V131, P14196, DOI 10.1021/ja906363t; Cariani L, 2004, ANAL BIOCHEM, V324, P79, DOI 10.1016/j.ab.2003.09.008; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chintalapati S, 2008, J MOL BIOL, V378, P581, DOI 10.1016/j.jmb.2008.01.094; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; de Bie P, 2007, J MED GENET, V44, P673, DOI 10.1136/jmg.2007.052746; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forbes JR, 1999, J BIOL CHEM, V274, P12408, DOI 10.1074/jbc.274.18.12408; Gonzalez-Guerrero M, 2008, J BIOL CHEM, V283, P29753, DOI 10.1074/jbc.M803248200; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Gonzalez-Guerrero M, 2009, J BIOL CHEM, V284, P20804, DOI 10.1074/jbc.M109.016329; Gordon E, 2008, PROTEIN EXPRES PURIF, V62, P1, DOI 10.1016/j.pep.2008.07.005; Gourdon P, 2011, CRYST GROWTH DES, V11, P2098, DOI 10.1021/cg101360d; Guerrero SA, 2001, APPL MICROBIOL BIOT, V56, P718, DOI 10.1007/s002530100690; Hatori Y, 2007, J BIOL CHEM, V282, P25213, DOI 10.1074/jbc.M703520200; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; Jones CE, 2003, J STRUCT BIOL, V143, P209, DOI 10.1016/j.jsb.2003.08.008; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim EH, 2009, FEMS MICROBIOL LETT, V301, P164, DOI 10.1111/j.1574-6968.2009.01813.x; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Leonhardt K, 2009, J BIOL CHEM, V284, P7793, DOI 10.1074/jbc.M805145200; Long F, 2010, NATURE, V467, P484, DOI 10.1038/nature09395; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; Moller AB, 2008, MOL PHYLOGENET EVOL, V46, P619, DOI 10.1016/j.ympev.2007.10.023; Morin I, 2009, FEBS J, V276, P4483, DOI 10.1111/j.1742-4658.2009.07155.x; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Pedersen BP, 2010, ACTA CRYSTALLOGR D, V66, P309, DOI 10.1107/S0907444909053244; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; POST RL, 1972, J BIOL CHEM, V247, P6530; Sazinsky MH, 2006, BIOCHEMISTRY-US, V45, P9949, DOI 10.1021/bi0610045; Sazinsky MH, 2006, J BIOL CHEM, V281, P11161, DOI 10.1074/jbc.M510708200; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SILVER S, 1989, TRENDS BIOCHEM SCI, V14, P76, DOI 10.1016/0968-0004(89)90048-0; Solioz M, 2010, J BIOL INORG CHEM, V15, P3, DOI 10.1007/s00775-009-0588-3; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; TOYOSHIMA C, 1993, NATURE, V362, P469, DOI 10.1038/362469a0; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Tsuda T, 2009, EMBO J, V28, P1782, DOI 10.1038/emboj.2009.143; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Williams LE, 2005, TRENDS PLANT SCI, V10, P491, DOI 10.1016/j.tplants.2005.08.008; Wu CC, 2008, STRUCTURE, V16, P976, DOI 10.1016/j.str.2008.02.025; Zheng ZQ, 2010, J NEUROCHEM, V114, P1630, DOI 10.1111/j.1471-4159.2010.06888.x	63	234	240	3	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					59	U74		10.1038/nature10191	http://dx.doi.org/10.1038/nature10191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21716286				2022-12-01	WOS:000292461300044
J	Unal, E; Kinde, B; Amon, A				Unal, Elcin; Kinde, Benyam; Amon, Angelika			Gametogenesis Eliminates Age-Induced Cellular Damage and Resets Life Span in Yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; MEIOSIS-I; PROTEIN; GENE; MUTANTS; SEGREGATION; DIVISION; NDT80; RDNA	Eukaryotic organisms age, yet detrimental age-associated traits are not passed on to progeny. How life span is reset from one generation to the next is not known. We show that in budding yeast resetting of life span occurs during gametogenesis. Gametes (spores) generated by aged cells show the same replicative potential as gametes generated by young cells. Age-associated damage is no longer detectable in mature gametes. Furthermore, transient induction of a transcription factor essential for later stages of gametogenesis extends the replicative life span of aged cells. Our results indicate that gamete formation brings about rejuvenation by eliminating age-induced cellular damage.	[Unal, Elcin; Amon, Angelika] MIT, David H Koch Inst Integrat Canc Res, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, David H Koch Inst Integrat Canc Res, Howard Hughes Med Inst, E76-543,500 Main St, Cambridge, MA 02139 USA.	angelika@mit.edu		Unal, Elcin/0000-0002-6768-609X; Amon, Angelika/0000-0001-9837-0314	NIH [GM62207]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062207, R01GM056800] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Alpert, M. Boselli, A. Thompson, and J. Chen for technical help; D. Koshland for reagents; and T. Orr-Weaver, F. Solomon, and members of the Amon laboratory for comments on the manuscript. Research was supported by NIH grant GM62207 to A.A. A.A. is also an HHMI investigator. E.U. is a fellow of the Jane Coffin Childs Memorial Fund. The authors declare no competing financial interests.	Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Boselli M, 2009, DEV CELL, V16, P844, DOI 10.1016/j.devcel.2009.05.013; Carlile TM, 2008, CELL, V133, P280, DOI 10.1016/j.cell.2008.02.032; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Curran SP, 2009, NATURE, V459, P1079, DOI 10.1038/nature08106; Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307; Fuchs J, 2004, CHROMOSOME RES, V12, P427, DOI 10.1023/B:CHRO.0000034726.05374.db; Ganley ARD, 2009, MOL CELL, V35, P683, DOI 10.1016/j.molcel.2009.07.012; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; KASSIR Y, 1988, CELL, V52, P853, DOI 10.1016/0092-8674(88)90427-8; KLAPHOLZ S, 1980, GENETICS, V96, P567; Kobayashi T, 1996, GENES CELLS, V1, P465, DOI 10.1046/j.1365-2443.1996.d01-256.x; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; LENZ AG, 1984, ARCH MICROBIOL, V137, P104, DOI 10.1007/BF00414448; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Neiman AM, 2005, MICROBIOL MOL BIOL R, V69, P565, DOI 10.1128/MMBR.69.4.565-584.2005; Scherthan H, 2007, P NATL ACAD SCI USA, V104, P16934, DOI 10.1073/pnas.0704860104; Sinclair D, 1998, ANNU REV MICROBIOL, V52, P533, DOI 10.1146/annurev.micro.52.1.533; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Sinclair DA, 1997, SCIENCE, V277, P1313, DOI 10.1126/science.277.5330.1313; Smeal T, 1996, CELL, V84, P633, DOI 10.1016/S0092-8674(00)81038-7; XU LZ, 1995, MOL CELL BIOL, V15, P6572	25	83	85	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 24	2011	332	6037					1554	1557		10.1126/science.1204349	http://dx.doi.org/10.1126/science.1204349			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700873	Green Submitted, Green Accepted			2022-12-01	WOS:000291990000044
J	Payne, D				Payne, David			RISK COMMUNICATION Watching the detectives: tracking the source of Europe's latest E coli outbreak	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Payne, D (corresponding author), BMJ, London WC1H 9JR, England.	dpayne@bmj.com						[Anonymous], 2011, LANCET, V377, P1978; EVANS S, 2011, BBC NEWS        0607; *R KOCH I, 2011, INF UPD EHEC REC BAS	3	0	0	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 22	2011	342								d3884	10.1136/bmj.d3884	http://dx.doi.org/10.1136/bmj.d3884			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AT	21697228	Bronze, Green Submitted			2022-12-01	WOS:000292200500010
J	Festa, E; Fretz, J; Berry, R; Schmidt, B; Rodeheffer, M; Horowitz, M; Horsley, V				Festa, Eric; Fretz, Jackie; Berry, Ryan; Schmidt, Barbara; Rodeheffer, Matthew; Horowitz, Mark; Horsley, Valerie			Adipocyte Lineage Cells Contribute to the Skin Stem Cell Niche to Drive Hair Cycling	CELL			English	Article							SCARRING ALOPECIA; ADIPOSE-TISSUE; IN-VIVO; DIFFERENTIATION; MICE; ACTIVATION; PRECURSORS; FOLLICLE; MOUSE; GLAND	In mammalian skin, multiple types of resident cells are required to create a functional tissue and support tissue homeostasis and regeneration. The cells that compose the epithelial stem cell niche for skin homeostasis and regeneration are not well defined. Here, we identify adipose precursor cells within the skin and demonstrate that their dynamic regeneration parallels the activation of skin stem cells. Functional analysis of adipocyte lineage cells in mice with defects in adipogenesis and in transplantation experiments revealed that intradermal adipocyte lineage cells are necessary and sufficient to drive follicular stem cell activation. Furthermore, we implicate PDGF expression by immature adipocyte cells in the regulation of follicular stem cell activity. These data highlight adipogenic cells as skin niche cells that positively regulate skin stem cell activity, and suggest that adipocyte lineage cells may alter epithelial stem cell function clinically.	[Festa, Eric; Rodeheffer, Matthew; Horsley, Valerie] Yale Univ, Dept Mol Cell & Dev Biol, New Haven, CT 06520 USA; [Fretz, Jackie; Horowitz, Mark] Yale Univ, Dept Orthopaed & Rehabil, New Haven, CT 06520 USA; [Rodeheffer, Matthew] Yale Univ, Comparat Med Sect, New Haven, CT 06520 USA; [Rodeheffer, Matthew; Horsley, Valerie] Yale Univ, Yale Stem Cell Ctr, New Haven, CT 06520 USA; [Berry, Ryan; Schmidt, Barbara] Yale Univ, Mol Cell Biol Genet & Dev Program, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Yale University	Horsley, V (corresponding author), Yale Univ, Dept Mol Cell & Dev Biol, 219 Prospect St, New Haven, CT 06520 USA.	valerie.horsley@yale.edu		Fretz, Jackie/0000-0002-6605-869X	NIH [AR054775, AR060295]; Connecticut Department of Public Health [09SCAYALE30]; NIH (NIDDK) [AR052690, AR046032, DK084970]; NIH (NIAMS) [AR052690, AR046032, DK084970]; NIDDK/NIH [5P30DK045735-18, DK090489]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K99AR054775, P30AR046032, R01AR060295, R01AR052690, R00AR054775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK092759, P30DK045735, R01DK090489, R24DK084970] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Connecticut Department of Public Health; NIH (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Mengqing Xiang for the vector encoding the Ebf1 in situ hybridization probe and Drs. Ana Tadeu and Natalie Roberts for assistance with experiments. Horsley lab members and Drs. Michael Rendl and Tudorita Tumbar provided critical reading of the manuscript and valuable discussions. V.H. is a Pew Scholar in Biomedical Research and is funded by the NIH (AR054775 and AR060295) and the Connecticut Department of Public Health (09SCAYALE30). M.H. is funded by AR052690, AR046032 and DK084970 from NIH (NIDDK and NIAMS). M.R. is supported by 5P30DK045735-18 and DK090489 from NIDDK/NIH.	Bendixen AC, 2001, P NATL ACAD SCI USA, V98, P2443, DOI 10.1073/pnas.041493198; Biernaskie J, 2009, CELL STEM CELL, V5, P610, DOI 10.1016/j.stem.2009.10.019; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Butcher EO, 1934, ANAT REC, V61, P5, DOI 10.1002/ar.1090610103; CHASE HB, 1953, ANAT REC, V116, P75, DOI 10.1002/ar.1091160107; Chen HC, 2002, J CLIN INVEST, V109, P175, DOI 10.1172/JCI0213880; Couldrey C, 2002, DEV DYNAM, V223, P459, DOI 10.1002/dvdy.10065; Fukumoto D, 2009, J DERMATOL, V36, P499, DOI 10.1111/j.1346-8138.2009.00685.x; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; HANSEN LS, 1984, ANAT REC, V210, P569, DOI 10.1002/ar.1092100404; Herrmann T, 2003, J CELL BIOL, V161, P1105, DOI 10.1083/jcb.200207080; Hesslein DGT, 2009, BONE, V44, P537, DOI 10.1016/j.bone.2008.11.021; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Jin KX, 2010, J NEUROSCI, V30, P11902, DOI 10.1523/JNEUROSCI.2187-10.2010; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Jong MC, 1998, J CLIN INVEST, V101, P145, DOI 10.1172/JCI791; Karlsson L, 1999, DEVELOPMENT, V126, P2611; Karnik P, 2009, J INVEST DERMATOL, V129, P1243, DOI 10.1038/jid.2008.369; Landskroner-Eiger S, 2010, DEV BIOL, V344, P968, DOI 10.1016/j.ydbio.2010.06.019; Le Lay S, 2010, AUTOPHAGY, V6, P754, DOI 10.4161/auto.6.6.12574; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lurie R, 1996, CUTIS, V57, P151; Mao-Qiang M, 2004, J INVEST DERMATOL, V123, P305, DOI 10.1111/j.0022-202X.2004.23235.x; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; OCHI M, 1988, AM J PHYSIOL, V254, pR740, DOI 10.1152/ajpregu.1988.254.5.R740; Park BS, 2010, BIOMED RES-TOKYO, V31, P27, DOI 10.2220/biomedres.31.27; PIACQUADIO DJ, 1994, J AM ACAD DERMATOL, V30, P1028, DOI 10.1016/S0190-9622(09)80150-3; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Sundberg JP, 2000, AM J PATHOL, V156, P2067, DOI 10.1016/S0002-9440(10)65078-X; Tomita Y, 2006, J DERMATOL SCI, V43, P105, DOI 10.1016/j.jdermsci.2006.03.012; Tsai SY, 2010, STEM CELLS, V28, P221, DOI 10.1002/stem.281; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011; Wright HM, 2000, J BIOL CHEM, V275, P1873, DOI 10.1074/jbc.275.3.1873; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004	43	377	389	7	50	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 2	2011	146	5					761	771		10.1016/j.cell.2011.07.019	http://dx.doi.org/10.1016/j.cell.2011.07.019			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21884937	Green Accepted, Bronze			2022-12-01	WOS:000294477500016
J	Merikangas, KR; Cui, LH; Richardson, AK; Isler, H; Khoromi, S; Nakamura, E; Lamers, F; Rossler, W; Ajdacic-Gross, V; Gamma, A; Angst, J				Merikangas, Kathleen R.; Cui, Lihong; Richardson, Amanda Kalaydjian; Isler, Hansruedi; Khoromi, Suzan; Nakamura, Erin; Lamers, Femke; Roessler, Wulf; Ajdacic-Gross, Vladeta; Gamma, Alex; Angst, Jules			Magnitude, impact, and stability of primary headache subtypes: 30 year prospective Swiss cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TENSION-TYPE HEADACHE; FOLLOW-UP; ZURICH COHORT; MENTAL-DISORDERS; UNITED-STATES; MIGRAINE; PREVALENCE; EPIDEMIOLOGY; COMORBIDITY; CLASSIFICATION	Objective To determine the prevalence, impact, and stability of different subtypes of headache in a 30 year prospective follow-up study of a general population sample. Design Prospective cohort study. Setting Canton of Zurich, Switzerland. Participants 591 people aged 19-20 from a cohort of 4547 residents of Zurich, Switzerland, interviewed seven times across 30 years of follow-up. Main outcome measures Prevalence of headache; stability of the predominant subtype of headache over time; and age of onset, severity, impact, family history, use of healthcare services, and drugs for headache subtypes. Results The average one year prevalences of subtypes of headache were 0.9% (female: male ratio of 2.8) for migraine with aura, 10.9% (female: male ratio of 2.2) for migraine without aura, and 11.5% (female: male ratio of 1.2) for tension-type headache. Cumulative 30 year prevalences of headache subtypes were 3.0% for migraine with aura, 36.0% for migraine without aura, and 29.3% for tension-type headache. Despite the high prevalence of migraine without aura, most cases were transient and only about 20% continued to have migraine for more than half of the follow-up period. 69% of participants with migraine and 58% of those with tension-type headache manifested the same predominant subtype over time. However, the prospective stability of the predominant headache subtypes was quite low, with substantial crossover among the subtypes and no specific ordinal pattern of progression. A gradient of severity of clinical correlates and service use was present across headache subtypes; the greatest effect was for migraine with aura followed by migraine without aura, and then tension-type headache and unclassified headaches. Conclusions These findings highlight the importance of prospective follow-up of people with headache. The substantial longitudinal overlap among subtypes of headache shows the developmental heterogeneity of headache syndromes. Studies of the causes of headache that apply diagnostic nomenclature based on distinctions between discrete headache subtypes may not capture the true nature of headache in the general population.	[Merikangas, Kathleen R.; Cui, Lihong; Richardson, Amanda Kalaydjian; Khoromi, Suzan; Nakamura, Erin; Lamers, Femke] NIMH, NIH, Intramural Res Program, Genet Epidemiol Res Branch, Bethesda, MD 20892 USA; [Isler, Hansruedi] Hochhaus Schanze, CH-8032 Zurich, Switzerland; [Roessler, Wulf; Ajdacic-Gross, Vladeta; Gamma, Alex; Angst, Jules] Univ Zurich, Hosp Psychiat, Zurich, Switzerland	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Zurich	Merikangas, KR (corresponding author), NIMH, NIH, Intramural Res Program, Genet Epidemiol Res Branch, Bethesda, MD 20892 USA.	Kathleen.Merikangas@nih.gov	Lamers, Femke/G-5161-2012	Lamers, Femke/0000-0003-4344-5766; Ajdacic-Gross, Vladeta/0000-0002-7032-9237; Merikangas, Kathkeen/0000-0002-4667-2414; Rossler, Wulf/0000-0003-0049-4533	Swiss National Science Foundation [3200-050881.97/1]; National Institute of Mental Health [ZIAMH002807-07]; Netherlands Organisation for Scientific Research (NWO); NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002807] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grant 3200-050881.97/1 of the Swiss National Science Foundation and National Institute of Mental Health, Intramural Research Program grant No ZIAMH002807-07 for collaborative analyses of the Zurich Cohort Study. FL is supported by a Rubicon fellowship from the Netherlands Organisation for Scientific Research (NWO). The views and opinions expressed in this report are those of the authors and should not be construed to represent the views of any of the sponsoring organisations, agencies, or US government.	American Psychiatric Association, 1987, DIAGNOSTIC STAT MANU, V3rd; American Psychiatric Association, 1980, DIAGN STAT MAN 3; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Angst J, 2005, EPIDEMIOL PSICHIAT S, V14, P68, DOI 10.1017/S1121189X00006278; Angst J, 2010, AM J PSYCHIAT, V167, P1194, DOI 10.1176/appi.ajp.2010.09071011; Anttila P, 2006, PEDIATRICS, V117, pE1197, DOI 10.1542/peds.2005-2274; Bille B, 1997, CEPHALALGIA, V17, P488, DOI 10.1046/j.1468-2982.1997.1704488.x; BINDER J, 1982, PSYCHOTHER PSYCHOSOM, V38, P128, DOI 10.1159/000287621; BRESLAU N, 1993, J PSYCHIAT RES, V27, P211, DOI 10.1016/0022-3956(93)90009-Q; Cady R, 2002, HEADACHE, V42, P204, DOI 10.1046/j.1526-4610.2002.02053.x; Derogatis L.R., 1977, CLIN PSYCHOM RES; Dunn G, 1999, BRIT J PSYCHIAT, V174, P95, DOI 10.1192/bjp.174.2.95; Eich D, 2003, ACTA PSYCHIAT SCAND, V108, P11, DOI 10.1034/j.1600-0447.108.s418.3.x; Guidetti V, 1998, CEPHALALGIA, V18, P449, DOI 10.1046/j.1468-2982.1998.1807449.x; HONKASALO ML, 1995, HEADACHE, V35, P70, DOI 10.1111/j.1526-4610.1995.hed3502070.x; Jensen R, 2008, LANCET NEUROL, V7, P354, DOI 10.1016/S1474-4422(08)70062-0; Kallela M, 1999, CEPHALALGIA, V19, P151, DOI 10.1046/j.1468-2982.1999.1903151.x; Kienbacher C, 2006, CEPHALALGIA, V26, P820, DOI 10.1111/j.1468-2982.2006.01108.x; LARSSON B, 1995, HEADACHE, V35, P513, DOI 10.1111/j.1526-4610.1995.hed3509513.x; Ligthart L, 2006, TWIN RES HUM GENET, V9, P54, DOI 10.1375/twin.9.1.54; Lipton RB, 2005, AM J MED, V118, p3S, DOI 10.1016/j.amjmed.2005.01.014; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; Lipton RB, 2002, NEUROLOGY, V58, pS27, DOI 10.1212/WNL.58.9_suppl_6.S27; Lyngberg AC, 2005, EUR J EPIDEMIOL, V20, P1007, DOI 10.1007/s10654-005-3778-5; Lyngberg AC, 2005, NEUROLOGY, V65, P580, DOI 10.1212/01.wnl.0000172918.74999.8a; Lyngberg AC, 2005, AM J EPIDEMIOL, V161, P1066, DOI 10.1093/aje/kwi139; Manzoni GC, 2004, NEUROL SCI, V25, pS67, DOI 10.1007/s10072-004-0255-y; MERIKANGAS KR, 1994, EUR ARCH PSY CLIN N, V244, P145, DOI 10.1007/BF02191890; MERIKANGAS KR, 1990, ARCH GEN PSYCHIAT, V47, P849; RASMUSSEN BK, 1994, CURR OPIN NEUROL, V7, P264, DOI 10.1097/00019052-199406000-00015; Rasmussen BK, 1997, CEPHALALGIA, V17, P487, DOI 10.1046/j.1468-2982.1997.1704487.x; Rossler W, 2011, EUR ARCH PSY CLIN N, V261, P11, DOI 10.1007/s00406-010-0123-0; Russell MB, 2002, HEADACHE, V42, P332, DOI 10.1046/j.1526-4610.2002.02102.x; Russell MB, 2007, AM J MED GENET B, V144B, P982, DOI 10.1002/ajmg.b.30497; Saunders K, 2008, NEUROLOGY, V70, P538, DOI 10.1212/01.wnl.0000297192.84581.21; Shapiro RE, 2007, CEPHALALGIA, V27, P991, DOI 10.1111/j.1468-2982.2007.01396.x; Stang P, 1998, J GEN INTERN MED, V13, P296, DOI 10.1046/j.1525-1497.1998.00094.x; Stewart WF, 2008, J OCCUP ENVIRON MED, V50, P736, DOI 10.1097/JOM.0b013e31818180cb; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Swartz KL, 2000, ARCH GEN PSYCHIAT, V57, P945, DOI 10.1001/archpsyc.57.10.945; Wessman M, 2007, LANCET NEUROL, V6, P521, DOI 10.1016/S1474-4422(07)70126-6	42	27	27	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 25	2011	343								d5076	10.1136/bmj.d5076	http://dx.doi.org/10.1136/bmj.d5076			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813ZQ	21868455	hybrid, Green Published, Green Accepted, Green Submitted			2022-12-01	WOS:000294410400003
J	Sedzinski, J; Biro, M; Oswald, A; Tinevez, JY; Salbreux, G; Paluch, E				Sedzinski, Jakub; Biro, Mate; Oswald, Annelie; Tinevez, Jean-Yves; Salbreux, Guillaume; Paluch, Ewa			Polar actomyosin contractility destabilizes the position of the cytokinetic furrow	NATURE			English	Article							CLEAVAGE FURROW; CELL-SHAPE; MYOSIN-II; DYNAMICS; ANILLIN; ACTIN; RECRUITMENT; SIGNALS; TENSION; MITOSIS	Cytokinesis, the physical separation of daughter cells at the end of mitosis, requires precise regulation of the mechanical properties of the cell periphery(1,2). Although studies of cytokinetic mechanics mostly focus on the equatorial constriction ring(3), a contractile actomyosin cortex is also present at the poles of dividing cells(2,4). Whether polar forces influence cytokinetic cell shape and furrow positioning remains an open question. Here we demonstrate that the polar cortex makes cytokinesis inherently unstable. We show that limited asymmetric polar contractions occur during cytokinesis, and that perturbing the polar cortex leads to cell shape oscillations, resulting in furrow displacement and aneuploidy. A theoretical model based on a competition between cortex turnover and contraction dynamics accurately accounts for the oscillations. We further propose that membrane blebs, which commonly form at the poles of dividing cells(5) and whose role in cytokinesis has long been enigmatic, stabilize cell shape by acting as valves releasing cortical contractility. Our findings reveal an inherent instability in the shape of the dividing cell and unveil a novel, spindle-independent mechanism ensuring the stability of cleavage furrow positioning.	[Sedzinski, Jakub; Biro, Mate; Oswald, Annelie; Tinevez, Jean-Yves; Paluch, Ewa] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Sedzinski, Jakub; Biro, Mate; Tinevez, Jean-Yves; Paluch, Ewa] Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland; [Salbreux, Guillaume] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany	Max Planck Society; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Max Planck Society	Paluch, E (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	paluch@mpi-cbg.de	Tinevez, Jean-Yves/L-7581-2015; Tinevez, Jean-Yves/O-4551-2019; Biro, Maté/H-6292-2014; Tinevez, Jean-Yves/E-8398-2012	Tinevez, Jean-Yves/0000-0002-0998-4718; Tinevez, Jean-Yves/0000-0002-0998-4718; Biro, Maté/0000-0001-5852-3726; Tinevez, Jean-Yves/0000-0002-0998-4718; Salbreux, Guillaume/0000-0001-7041-1292; Sedzinski, Jakub/0000-0002-1788-0329; Paluch, Ewa/0000-0003-4691-2323	Polish Ministry of Science and Higher Education; Max Planck Society	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Max Planck Society(Max Planck Society)	We thank J. S. Bois, A. G. Clark, S. W. Grill, C. P. Heisenberg, J. Howard, A. A. Hyman, J. F. Joanny, D. K. Lubensky, A. Oates, M. Piel, I. M. Tolic-Norrelykke, W. Zachariae and M. Zerial for discussions and comments on the manuscript, and J. Roensch and the Max Planck Institute of Molecular Cell Biology and Genetics Light Microscopy Facility for technical assistance. This work was supported by the Polish Ministry of Science and Higher Education and by the Max Planck Society.	Blanchard GB, 2010, DEVELOPMENT, V137, P2743, DOI 10.1242/dev.045872; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Bringmann H, 2005, NATURE, V436, P731, DOI 10.1038/nature03823; Burgess DR, 2005, TRENDS CELL BIOL, V15, P156, DOI 10.1016/j.tcb.2005.01.006; Cabernard C, 2010, NATURE, V467, P91, DOI 10.1038/nature09334; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Dean SO, 2005, P NATL ACAD SCI USA, V102, P13473, DOI 10.1073/pnas.0506810102; Effler JC, 2007, CELL CYCLE, V6, P30, DOI 10.4161/cc.6.1.3674; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Hickson GRX, 2008, J CELL BIOL, V180, P285, DOI 10.1083/jcb.200709005; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Mitchison TJ, 2008, SEMIN CELL DEV BIOL, V19, P215, DOI 10.1016/j.semcdb.2008.01.008; O'Connell CB, 2001, CURR BIOL, V11, P702, DOI 10.1016/S0960-9822(01)00181-6; Ou GS, 2010, SCIENCE, V330, P677, DOI 10.1126/science.1196112; Piekny AJ, 2008, CURR BIOL, V18, P30, DOI 10.1016/j.cub.2007.11.068; PLATEAU JAF, 1873, STAT EXPT THEORIQUE, V2, pCH7; Pollard TD, 2010, CURR OPIN CELL BIOL, V22, P50, DOI 10.1016/j.ceb.2009.11.010; Raffel M, 2007, EXP FLUID MECH, P1, DOI 10.1007/978-3-540-72308-0; Rankin KE, 2010, J CELL BIOL, V190, P35, DOI 10.1083/jcb.201004017; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Robinson DN, 2004, CURR OPIN CELL BIOL, V16, P182, DOI 10.1016/j.ceb.2004.02.002; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; Smith TC, 2010, CYTOSKELETON, V67, P346, DOI 10.1002/cm.20449; Straight AF, 2005, MOL BIOL CELL, V16, P193, DOI 10.1091/mbc.E04-08-0758; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Wang YL, 2005, TRENDS CELL BIOL, V15, P581, DOI 10.1016/j.tcb.2005.09.006; Werner M, 2008, BIOCHEM SOC T, V36, P371, DOI 10.1042/BST0360371; Werner M, 2007, CURR BIOL, V17, P1286, DOI 10.1016/j.cub.2007.06.070; YONEDA M, 1972, J EXP BIOL, V57, P575; Zhang WD, 2005, P NATL ACAD SCI USA, V102, P7186, DOI 10.1073/pnas.0502545102	33	237	239	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 25	2011	476	7361					462	U119		10.1038/nature10286	http://dx.doi.org/10.1038/nature10286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811KT	21822289				2022-12-01	WOS:000294209400039
J	Stuckler, D; Basu, S; McKee, M				Stuckler, David; Basu, Sanjay; McKee, Martin			Commentary: UN high level meeting on non-communicable diseases: an opportunity for whom?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NONCOMMUNICABLE DISEASES; ALCOHOL TAX; HEALTH; MORTALITY		[Stuckler, David] Univ Cambridge, Dept Sociol, Cambridge CB23RQ, England; [Basu, Sanjay] Univ Calif San Francisco, Dept Sociol, San Francisco, CA USA; [McKee, Martin] London Sch Hyg & Trop Med, London, England	University of Cambridge; University of California System; University of California San Francisco; University of London; London School of Hygiene & Tropical Medicine	Stuckler, D (corresponding author), Univ Cambridge, Dept Sociol, Cambridge CB23RQ, England.	ds450@cam.ac.uk	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018; Stuckler, David/H-2261-2012	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Stuckler, David/0000-0002-1288-8401				Alwan AD, 2011, B WORLD HEALTH ORGAN, V89, P546, DOI 10.2471/BLT.11.091074; Barnes PJ, 2007, PLOS MED, V4, P779, DOI 10.1371/journal.pmed.0040112; BEAGLEHOLE R, UNPUB LANCET; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; BOSELEY S, 2010, GUARDIAN        1221; CAPEWELL S, UNPUB RAPID MORTALIT; Delamothe T, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2102; FREUDENBERG N, 2011, CORP HLTH WATCH 0727; Geneau R, 2010, LANCET, V376, P1689, DOI 10.1016/S0140-6736(10)61414-6; Horton R, 2005, LANCET, V366, P1514, DOI 10.1016/S0140-6736(05)67454-5; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; KOSTOVA D, 2010, 15781 NBER WORKING P; Labonte R, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-21; LAYTON L, 2011, WASHINTON POST  0709; Mccoy D, 2009, LANCET, V373, P1645, DOI 10.1016/S0140-6736(09)60571-7; McDaniel PA, 2006, TOB CONTROL, V15, P215, DOI 10.1136/tc.2005.014977; MCNEIL D, 2009, NY TIMES        0216; Narayan KMV, 2010, NEW ENGL J MED, V363, P1196, DOI 10.1056/NEJMp1002024; Nugent R, 2010, SCARCE DONOR FUNDING; Ooms G, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-17; POKHAREL K, 2011, WALL ST J; Siegel K., 2011, SICK SOC RESPONDING; Stuckler D, 2008, LANCET, V372, P1563, DOI 10.1016/S0140-6736(08)61656-6; Stuckler D, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001020; *UN, 2010, PREV CONTR NONC DIS; Wagenaar AC, 2010, AM J PUBLIC HEALTH, V100, P2270, DOI 10.2105/AJPH.2009.186007; Wagenaar AC, 2009, AM J PUBLIC HEALTH, V99, P1464, DOI 10.2105/AJPH.2007.131326; World Health Organization, 2009, GLOB HLTH RISKS MORT; World Health Organization, 2009, MORT BURD DIS EST WH, P2009; YACH D, 2004, TOWARDS WHO LONG TER; Zhang B, 2006, AM J PREV MED, V30, P474, DOI 10.1016/j.amepre.2006.02.001	33	29	29	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 23	2011	343								d5336	10.1136/bmj.d5336	http://dx.doi.org/10.1136/bmj.d5336			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813ZK	21865280	Green Accepted			2022-12-01	WOS:000294409600022
J	Haymart, MR; Banerjee, M; Stewart, AK; Koenig, RJ; Birkmeyer, JD; Griggs, JJ				Haymart, Megan R.; Banerjee, Mousumi; Stewart, Andrew K.; Koenig, Ronald J.; Birkmeyer, John D.; Griggs, Jennifer J.			Use of Radioactive Iodine for Thyroid Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							2ND PRIMARY MALIGNANCIES; REMNANT ABLATION; PROGNOSTIC-FACTORS; PAPILLARY MICROCARCINOMA; INCREASING INCIDENCE; RADIOIODINE THERAPY; UNITED-STATES; CARCINOMA; I-131; SURVIVAL	Context Substantial uncertainty persists about the indications for radioactive iodine for thyroid cancer. Use of radioactive iodine over time and the correlates of its use remain unknown. Objective To determine practice patterns, the degree to which hospitals vary in their use of radioactive iodine, and factors that contribute to this variation. Design, Setting, and Patients Time trend analysis of radioactive iodine use in a cohort of 189 219 patients with well-differentiated thyroid cancer treated at 981 hospitals associated with the US National Cancer Database between 1990 and 2008. We used multilevel analysis to assess the correlates of patient and hospital characteristics on radioactive iodine use in the cohort treated from 2004 to 2008. Main Outcome Measure Use of radioactive iodine after total thyroidectomy. Results Between 1990 and 2008, across all tumor sizes, there was a significant increase in the proportion of patients with well-differentiated thyroid cancer receiving radioactive iodine (1373/3397 [40.4%] vs 11 539/20 620 [56.0%]; P<.001). Multivariable analysis of patients treated from 2004 to 2008 found that there was a statistical difference in radioactive iodine use between American Joint Committee on Cancer stages I and IV (odds ratio [OR], 0.34; 95% confidence interval [CI], 0.31-0.37) but not between stages II/III and IV (for stage II vs stage IV, OR, 0.97; 95% CI, 0.88-1.07 and for stage III vs stage IV, OR, 1.06; 95% CI, 0.95-1.17). In addition to patient and tumor characteristics, hospital volume was associated with radioactive iodine use. Wide variation in radioactive iodine use existed, and only 21.1% of this variation was accounted for by patient and tumor characteristics. Hospital type and case volume accounted for 17.1% of the variation. After adjusting for available patient, tumor, and hospital characteristics, 29.1% of the variance was attributable to unexplained hospital characteristics. Conclusion Among patients treated for well-differentiated thyroid cancer at hospitals in the National Cancer Database, there was an increase in the proportion receiving radioactive iodine between 1990 and 2008; much of the variation in use was associated with hospital characteristics.	[Haymart, Megan R.; Koenig, Ronald J.] Univ Michigan, Dept Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Haymart, Megan R.; Griggs, Jennifer J.] Univ Michigan, Dept Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA; [Banerjee, Mousumi] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Birkmeyer, John D.] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; [Griggs, Jennifer J.] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Stewart, Andrew K.] Amer Coll Surg Commiss Canc, Chicago, IL USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Haymart, MR (corresponding author), Univ Michigan Hlth Syst, Dept Med, Div Metab Endocrinol & Diabet, 300 N Ingalls Bldg,NI 3A17, Ann Arbor, MI 48109 USA.	meganhay@umich.edu		Haymart, Megan/0000-0002-1083-1575	National Institutes of Health [1K07CA154595-01]; NATIONAL CANCER INSTITUTE [K07CA154595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr Haymart is funded by grant 1K07CA154595-01 from the National Institutes of Health.	[Anonymous], 2003, MULTILEVEL METHODS P; Birkmeyer JD, 1998, SURGERY, V124, P917, DOI 10.1067/msy.1998.90268; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; BLACK WC, 1993, NEW ENGL J MED, V328, P1237, DOI 10.1056/NEJM199304293281706; Bonnet S, 2009, J CLIN ENDOCR METAB, V94, P1162, DOI 10.1210/jc.2008-1931; Brierley J, 2005, CLIN ENDOCRINOL, V63, P418, DOI 10.1111/j.1365-2265.2005.02358.x; Brown AP, 2008, J CLIN ENDOCR METAB, V93, P504, DOI 10.1210/jc.2007-1154; Burns JA, 2004, OPHTHAL PLAST RECONS, V20, P126, DOI 10.1097/01.IOP.0000117340.41849.81; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen AY, 2009, CANCER-AM CANCER SOC, V115, P3801, DOI 10.1002/cncr.24416; Chow SM, 2006, ENDOCR-RELAT CANCER, V13, P1159, DOI 10.1677/erc.1.01320; Chow SM, 2006, LARYNGOSCOPE, V116, P2060, DOI 10.1097/01.mlg.0000240287.57704.01; Cobin R H, 2001, Endocr Pract, V7, P202; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Gilliland FD, 1997, CANCER-AM CANCER SOC, V79, P564, DOI 10.1002/(SICI)1097-0142(19970201)79:3<564::AID-CNCR20>3.0.CO;2-0; Greenberg CC, 2011, ARCH SURG-CHICAGO, V146, P1128, DOI 10.1001/archsurg.2011.141; Greene FL., 2002, AJCC CANC STAGING MA, V6, DOI DOI 10.1007/978-1-4757-3656-4; Griggs JJ, 2009, MED CARE, V47, P749, DOI 10.1097/MLR.0b013e31819748b3; HARACH HR, 1985, CANCER-AM CANCER SOC, V56, P531, DOI 10.1002/1097-0142(19850801)56:3<531::AID-CNCR2820560321>3.0.CO;2-3; Hay ID, 2008, J NUCL MED, V49, P1395, DOI 10.2967/jnumed.108.052654; Hay ID, 2006, J SURG ONCOL, V94, P692, DOI 10.1002/jso.20696; Hay Ian D, 2002, Trans Am Clin Climatol Assoc, V113, P241; Hay ID, 2010, WORLD J SURG, V34, P1291, DOI 10.1007/s00268-010-0469-5; Hay ID, 2002, WORLD J SURG, V26, P879, DOI 10.1007/s00268-002-6612-1; Hughes DT, 2011, THYROID, V21, P231, DOI 10.1089/thy.2010.0137; Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1; Hyer S, 2002, CLIN ENDOCRINOL, V56, P755, DOI 10.1046/j.1365-2265.2002.t01-1-01545.x; Ito Y, 2010, WORLD J SURG, V34, P1285, DOI 10.1007/s00268-009-0356-0; Iyer NG, 2011, CANCER-AM CANCER SOC, V117, P4439, DOI 10.1002/cncr.26070; Jonklaas J, 2006, THYROID, V16, P1229, DOI 10.1089/thy.2006.16.1229; Jonklaas J, 2010, THYROID, V20, P1423, DOI 10.1089/thy.2010.0308; Jung TS, 2007, ENDOCR J, V54, P265, DOI 10.1507/endocrj.K06-166; Kloos RT, 2009, THYROID, V19, P925, DOI 10.1089/thy.2009.0236; Lin HW, 2009, LARYNGOSCOPE, V119, P1983, DOI 10.1002/lary.20617; Luster M, 2008, EUR J NUCL MED MOL I, V35, P1941, DOI 10.1007/s00259-008-0883-1; Malpani BL, 1996, INT J RADIAT ONCOL, V35, P535, DOI 10.1016/0360-3016(95)02138-8; MARTINEZTELLO FJ, 1993, CANCER-AM CANCER SOC, V71, P4022, DOI 10.1002/1097-0142(19930615)71:12<4022::AID-CNCR2820711236>3.0.CO;2-O; Mazzaferri EL, 2009, ONCOLOGY-NY, V23, P579; Molinaro E, 2009, THYROID, V19, P1035, DOI 10.1089/thy.2008.0430; Morgenstern KE, 2005, OPHTHAL PLAST RECONS, V21, P337, DOI 10.1097/01.iop.0000179369.75569.a8; National Cancer Institute, SURV EP END RES; Normand SLT, 1997, J AM STAT ASSOC, V92, P803, DOI 10.2307/2965545; Pace-Asciak PZ, 2007, ARCH OTOLARYNGOL, V133, P870, DOI 10.1001/archotol.133.9.870; Percy C, 2000, INT CLASSIFICATION D; Phillips JK, 2006, FACILITY ONCOLOGY DA; Podnos YD, 2007, J SURG ONCOL, V96, P3, DOI 10.1002/jso.20656; Raval MV, 2009, J SURG ONCOL, V99, P488, DOI 10.1002/jso.21173; RAYMOND JP, 1989, J CLIN ENDOCR METAB, V69, P186, DOI 10.1210/jcem-69-1-186; Rosario PW, 2008, J NUCL MED, V49, P1776, DOI 10.2967/jnumed.108.050591; Roti E, 2008, EUR J ENDOCRINOL, V159, P659, DOI 10.1530/EJE-07-0896; Rubino C, 2003, BRIT J CANCER, V89, P1638, DOI 10.1038/sj.bjc.6601319; Sandeep TC, 2006, J CLIN ENDOCR METAB, V91, P1819, DOI 10.1210/jc.2005-2009; Sawka AM, 2004, J CLIN ENDOCR METAB, V89, P3668, DOI 10.1210/jc.2003-031167; Sawka AM, 2009, THYROID, V19, P451, DOI 10.1089/thy.2008.0392; Sawka AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004191; Sherman Steven I, 2007, J Natl Compr Canc Netw, V5, P568; Sherman Steven I, 2005, J Natl Compr Canc Netw, V3, P404; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sirovich B, 2008, HEALTH AFFAIR, V27, P813, DOI 10.1377/hlthaff.27.3.813; Sisson JC, 2011, THYROID, V21, P335, DOI 10.1089/thy.2010.0403; SISSON JC, 1983, J NUCL MED, V24, P743; Smedley BD, 2003, INTERVENTIONS CROSS, DOI DOI 10.17226/12875; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; Snijders T. A. B., 1999, MULTILEVEL ANAL; Solans R, 2001, J NUCL MED, V42, P738; Tuttle RM, 2010, J NATL COMPR CANC NE, V8, P1228, DOI 10.6004/jnccn.2010.0093; VANNOSTRAND D, 1986, J NUCL MED, V27, P1519; VARMA VM, 1970, J AMER MED ASSOC, V214, P1437, DOI 10.1001/jama.214.8.1437; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Wennberg JE, 1999, NEW ENGL J MED, V340, P52, DOI 10.1056/NEJM199901073400111; WENNBERG JE, 1982, SOC SCI MED, V16, P811, DOI 10.1016/0277-9536(82)90234-9	73	144	151	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 17	2011	306	7					721	728		10.1001/jama.2011.1139	http://dx.doi.org/10.1001/jama.2011.1139			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	807LP	21846853	Green Accepted			2022-12-01	WOS:000293900000021
J	Kuo, YF; Goodwin, JS				Kuo, Yong-Fang; Goodwin, James S.			Association of Hospitalist Care With Medical Utilization After Discharge: Evidence of Cost Shift From a Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							PATIENT SAFETY; OUTPATIENT; SERVICE; CONTINUITY; PHYSICIANS; INPATIENT; OUTCOMES; COMMUNICATION; TRANSITIONS; RISK	Background: Hospitalist care has grown rapidly, in part because it is associated with decreased length of stay and hospital costs. No national studies examining the effect of hospitalist care on hospital costs or on medical utilization and costs after discharge have been done. Objective: To assess the relationship of hospitalist care with hospital length of stay, hospital charges, and medical utilization and Medicare costs after discharge. Design: Population-based national cohort study. Setting: Hospital care of Medicare patients. Patients: A 5% national sample of enrollees in Medicare parts A and B with a primary care physician who were cared for by their primary care physician or a hospitalist during medical hospitalizations from 2001 to 2006. Measurements: Length of stay, hospital charges, discharge location and physician visits, emergency department visits, rehospitalization, and Medicare spending within 30 days after discharge. Results: In propensity score analysis, hospital length of stay was 0.64 day less among patients receiving hospitalist care. Hospital charges were $282 lower, whereas Medicare costs in the 30 days after discharge were $332 higher (P < 0.001 for both). Patients cared for by hospitalists were less likely to be discharged to home (odds ratio, 0.82 [95% CI, 0.78 to 0.86]) and were more likely to have emergency department visits (odds ratio, 1.18 [CI, 1.12 to 1.24]) and readmissions (odds ratio, 1.08 [CI, 1.02 to 1.14]) after discharge. They also had fewer visits with their primary care physician and more nursing facility visits after discharge. Limitation: Observational studies are subject to selection bias. Conclusion: Decreased length of stay and hospital costs associated with hospitalist care are offset by higher medical utilization and costs after discharge.	[Kuo, Yong-Fang] Univ Texas Med Branch, Dept Internal Med, Sealy Ctr Aging, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Kuo, YF (corresponding author), Univ Texas Med Branch, Dept Internal Med, Sealy Ctr Aging, 301 Univ Blvd, Galveston, TX 77555 USA.	yokuo@utmb.edu			National Institute on Aging [1R01-AG033134, P30AG024832]; National Cancer Institute [K05-CA134923]; NATIONAL CANCER INSTITUTE [K05CA134923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033134, P30AG024832] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By the National Institute on Aging (grants 1R01-AG033134 and P30AG024832) and the National Cancer Institute (grant K05-CA134923).	Anderson GF, 1999, ARCH FAM MED, V8, P149, DOI 10.1001/archfami.8.2.149; Center for Medicare and Medicaid Services, 100 MEDPAR INP HOSP; Coleman EA, 2004, HEALTH SERV RES, V39, P1449, DOI 10.1111/j.1475-6773.2004.00298.x; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Donini-Lenhoff F, 2005, GUIDEBOOK GME PROGRA, P59; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Forster AJ, 2005, J GEN INTERN MED, V20, P317, DOI 10.1111/j.1525-1497.2005.30390.x; Frakt AB, 2005, HEALTH CARE FINANC R, V26, P21; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Go JT, 2010, J HOSP MED, V5, P133, DOI 10.1002/jhm.612; Griswold ME, 2010, ANN INTERN MED, V152, P393, DOI 10.7326/0003-4819-152-6-201003160-00010; Hinami K, 2009, J HOSP MED, V4, P535, DOI 10.1002/jhm.523; Howrey B, MED CARE IN PRESS; Kearns PJ, 2001, ARCH INTERN MED, V161, P235, DOI 10.1001/archinte.161.2.235; Koroukian SM, 2008, MED CARE, V46, P1184, DOI 10.1097/MLR.0b013e31817925d2; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Kuo YF, 2010, J AM GERIATR SOC, V58, P1649, DOI 10.1111/j.1532-5415.2010.03007.x; Kuo Y, 2009, NEW ENGL J MED, V360, P1102, DOI 10.1056/NEJMsa0802381; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Lindenauer PK, 2007, NEW ENGL J MED, V357, P2589, DOI 10.1056/NEJMsa067735; McWilliams JM, 2009, ANN INTERN MED, V151, P757, DOI [10.7326/0000605-200912010-00149, 10.7326/0003-4819-151-11-200912010-00149]; Meltzer D, 2002, ANN INTERN MED, V137, P866, DOI 10.7326/0003-4819-137-11-200212030-00007; Moore C, 2003, J GEN INTERN MED, V18, P646, DOI 10.1046/j.1525-1497.2003.20722.x; Mullahy J, 1998, J HEALTH ECON, V17, P247, DOI 10.1016/S0167-6296(98)00030-7; Palmer HC, 2001, AM J MED, V111, P627, DOI 10.1016/S0002-9343(01)00976-7; Pham HH, 2008, HEALTH AFFAIR, V27, P1315, DOI 10.1377/hlthaff.27.5.1315; Rabe-Hesketh S., 2005, MULTILEVEL LONGITUDI; Roy CL, 2005, ANN INTERN MED, V143, P121, DOI 10.7326/0003-4819-143-2-200507190-00011; Shah BR, 2007, HEALTH SERV RES, V42, P1783, DOI 10.1111/j.1475-6773.2006.00681.x; Sharma G, 2010, ARCH INTERN MED, V170, P1664, DOI 10.1001/archinternmed.2010.345; Sharma G, 2009, JAMA-J AM MED ASSOC, V301, P1671, DOI 10.1001/jama.2009.517; Sharma G, 2009, ARCH INTERN MED, V169, P81, DOI 10.1001/archinternmed.2008.514; Wachter RM, 1998, JAMA-J AM MED ASSOC, V279, P1560, DOI 10.1001/jama.279.19.1560; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103	35	81	82	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 2	2011	155	3					152	+		10.7326/0003-4819-155-3-201108020-00005	http://dx.doi.org/10.7326/0003-4819-155-3-201108020-00005			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	800DJ	21810708	Green Accepted			2022-12-01	WOS:000293339600003
J	Bobrow, M				Bobrow, Martin			Regulate research at the animal-human interface	NATURE			English	Editorial Material									[Bobrow, Martin] Univ Cambridge, Cambridge CB2 1TN, England	University of Cambridge	Bobrow, M (corresponding author), Univ Cambridge, Cambridge CB2 1TN, England.	Laura.Boothman@acmedsci.ac.uk						Academy of Medical Sciences, 2011, AN CONT HUM MAT, V4; Greely HT, 2007, AM J BIOETHICS, V7, P27, DOI 10.1080/15265160701290371; *IPSOS MORI, 2010, EXPL BOUND REP PUBL; Zeng FY, 2006, P NATL ACAD SCI USA, V103, P7801, DOI 10.1073/pnas.0602646103	4	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2011	475	7357					448	448		10.1038/475448a	http://dx.doi.org/10.1038/475448a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	797ZA	21796184				2022-12-01	WOS:000293167900015
J	Bermejo, R; Capra, T; Jossen, R; Colosio, A; Frattini, C; Carotenuto, W; Cocito, A; Doksani, Y; Klein, H; Gomez-Gonzalez, B; Aguilera, A; Katou, Y; Shirahige, K; Foiani, M				Bermejo, Rodrigo; Capra, Thelma; Jossen, Rachel; Colosio, Arianna; Frattini, Camilla; Carotenuto, Walter; Cocito, Andrea; Doksani, Ylli; Klein, Hannah; Gomez-Gonzalez, Belen; Aguilera, Andres; Katou, Yuki; Shirahige, Katsuhiko; Foiani, Marco			The Replication Checkpoint Protects Fork Stability by Releasing Transcribed Genes from Nuclear Pores	CELL			English	Article							HEAD-ON COLLISION; DNA-DAMAGE; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; GENOME STABILITY; ORIGINS; RECOMBINATION; PROGRESSION; LOCALIZATION; ORGANIZATION	Transcription hinders replication fork progression and stability, and the Mec1/ATR checkpoint protects fork integrity. Examining checkpoint-dependent mechanisms controlling fork stability, we find that fork reversal and dormant origin firing due to checkpoint defects are rescued in checkpoint mutants lacking THO, TREX-2, or inner-basket nucleoporins. Gene gating tethers transcribed genes to the nuclear periphery and is counteracted by checkpoint kinases through phosphorylation of nucleoporins such as Mlp1. Checkpoint mutants fail to detach transcribed genes from nuclear pores, thus generating topological impediments for incoming forks. Releasing this topological complexity by introducing a doublestrand break between a fork and a transcribed unit prevents fork collapse. Mlp1 mutants mimicking constitutive checkpoint-dependent phosphorylation also alleviate checkpoint defects. We propose that the checkpoint assists fork progression and stability at transcribed genes by phosphorylating key nucleoporins and counteracting gene gating, thus neutralizing the topological tension generated at nuclear pore gated genes.	[Bermejo, Rodrigo; Capra, Thelma; Jossen, Rachel; Colosio, Arianna; Frattini, Camilla; Carotenuto, Walter; Cocito, Andrea; Doksani, Ylli; Foiani, Marco] Fdn Ist FIRC Oncol Mol IFOM, I-20139 Milan, Italy; [Doksani, Ylli] Rockefeller Univ, New York, NY 10065 USA; [Klein, Hannah] NYU, Sch Med, New York, NY 10016 USA; [Gomez-Gonzalez, Belen; Aguilera, Andres] Univ Seville, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Seville 41004, Spain; [Katou, Yuki] Tokyo Inst Technol, Yokohama, Kanagawa 2268503, Japan; [Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Bunkyo Ku, Tokyo 1088639, Japan; [Foiani, Marco] Univ Milan, DSBB, I-20139 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS Istituti Fisioterapici Ospitalieri (IFO); Rockefeller University; New York University; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Tokyo Institute of Technology; University of Tokyo; University of Milan	Bermejo, R (corresponding author), Fdn Ist FIRC Oncol Mol IFOM, IFOM IEO Campus,Via Adamello 16, I-20139 Milan, Italy.	rodrigo.bermejo@ifom-ieo-campus.it; marco.foiani@ifom-ieo-campus.it	Bermejo, Rodrigo/K-6613-2014; Gonzalez, Belen Gomez/B-2365-2014; Capra, Thelma/AAN-4064-2020; Aguilera, Andres/L-1825-2014; Bermejo, Rodrigo/S-2445-2019; Bermejo, Rodrigo/AAG-7830-2019; Foiani, Marco/M-8234-2014	Bermejo, Rodrigo/0000-0002-2692-7045; Gonzalez, Belen Gomez/0000-0003-1655-8407; Aguilera, Andres/0000-0003-4782-1714; Shirahige, Katsuhiko/0000-0002-7862-1144; Foiani, Marco/0000-0003-4795-834X; Doksani, Ylli/0000-0002-2392-5722; Klein, Hannah/0000-0003-4228-8535	FIRC; AIRC; AICR; Telethon-Italy; E.U.; Italian Ministry of Health; Spanish Ministry of Science and Innovation [BFU2006-05260, CSD2007-0015]; NIH [GM053738]; UICC Yamagiwa-Yoshida Memorial International Cancer Study; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053738] Funding Source: NIH RePORTER	FIRC(Fondazione AIRC per la ricerca sul cancro); AIRC(Fondazione AIRC per la ricerca sul cancro); AICR; Telethon-Italy(Fondazione Telethon); E.U.(European Commission); Italian Ministry of Health(Ministry of Health, Italy); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UICC Yamagiwa-Yoshida Memorial International Cancer Study; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Markus Smolka, Nancy Kleckner, Ed Hurt, Massimo Lopes, Giordano Liberi, Dana Branzei, and all members of our laboratories for discussions and Robert Crouch, Francesca Storici, Arta Ajazi, Giulia Bastianello, Dario Parazzoli, Amanda Oldani, and Maria Garcia-Rubio for reagents, advice, and technical support. M.F. was supported by grants from FIRC, AIRC, AICR, Telethon-Italy, E.U. GENICA-project, and Italian Ministry of Health. A.A. was supported by the Spanish Ministry of Science and Innovation (grants BFU2006-05260 and Consolider Ingenio 2010 CSD2007-0015); H.K. by NIH grant GM053738; and R.B. by a UICC Yamagiwa-Yoshida Memorial International Cancer Study. T.C. and A.C. were supported by FIRC fellowships.	Aguilera A, 2005, CURR OPIN CELL BIOL, V17, P242, DOI 10.1016/j.ceb.2005.03.001; AGUILERA A, 1990, MOL CELL BIOL, V10, P1439, DOI 10.1128/MCB.10.4.1439; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; Azvolinsky A, 2009, MOL CELL, V34, P722, DOI 10.1016/j.molcel.2009.05.022; Berger AB, 2008, NAT METHODS, V5, P1031, DOI 10.1038/nmeth.1266; Bermejo R, 2008, GENE DEV, V22, P2297, DOI 10.1101/gad.1719308; Bermejo R, 2009, CELL, V138, P870, DOI 10.1016/j.cell.2009.06.022; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BREWER BJ, 1988, CELL, V53, P679, DOI 10.1016/0092-8674(88)90086-4; Brickner DG, 2007, PLOS BIOL, V5, P704, DOI 10.1371/journal.pbio.0050081; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Casolari JM, 2005, GENE DEV, V19, P1188, DOI 10.1101/gad.1307205; Chavez S, 1997, GENE DEV, V11, P3459, DOI 10.1101/gad.11.24.3459; Chen SH, 2010, J BIOL CHEM, V285, P12803, DOI 10.1074/jbc.M110.106989; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Conti E, 2009, CURR OPIN STRUC BIOL, V19, P62, DOI 10.1016/j.sbi.2009.01.003; Cotta-Ramusino C, 2005, MOL CELL, V17, P153, DOI 10.1016/j.molcel.2004.11.032; Decourty L, 2008, P NATL ACAD SCI USA, V105, P5821, DOI 10.1073/pnas.0710533105; Doksani Y, 2009, CELL, V137, P247, DOI 10.1016/j.cell.2009.02.016; Drubin DA, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-19; EliasArnanz M, 1997, EMBO J, V16, P5775, DOI 10.1093/emboj/16.18.5775; Fachinetti D, 2010, MOL CELL, V39, P595, DOI 10.1016/j.molcel.2010.07.024; Fay DS, 1997, CURR GENET, V31, P97, DOI 10.1007/s002940050181; Feng WY, 2006, NAT CELL BIOL, V8, P148, DOI 10.1038/ncb1358; Ghavidel A, 2007, CELL, V131, P915, DOI 10.1016/j.cell.2007.09.042; Gomez-Gonzalez B, 2011, EMBO J, V30, P3106, DOI 10.1038/emboj.2011.206; Gomez-Gonzalez B, 2009, MOL CELL BIOL, V29, P5203, DOI 10.1128/MCB.00402-09; Gonzalez-Aguilera C, 2008, MOL BIOL CELL, V19, P4310, DOI 10.1091/mbc.E08-04-0355; Grinthal A, 2010, P NATL ACAD SCI USA, V107, P2467, DOI 10.1073/pnas.0914073107; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Jani DY, 2009, MOL CELL, V33, P727, DOI 10.1016/j.molcel.2009.01.033; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kohler A, 2010, MOL CELL, V38, P6, DOI 10.1016/j.molcel.2010.01.040; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Koster DA, 2007, NATURE, V448, P213, DOI 10.1038/nature05938; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lee SE, 2000, COLD SPRING HARB SYM, V65, P303, DOI 10.1101/sqb.2000.65.303; Lee YD, 2006, GENE DEV, V20, P334, DOI 10.1101/gad.1380506; Light WH, 2010, MOL CELL, V40, P112, DOI 10.1016/j.molcel.2010.09.007; LIU B, 1995, SCIENCE, V267, P1131, DOI 10.1126/science.7855590; Loeillet S, 2005, DNA REPAIR, V4, P459, DOI 10.1016/j.dnarep.2004.11.010; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lopes M, 2003, MOL CELL, V12, P1499, DOI 10.1016/S1097-2765(03)00473-8; Lucca C, 2004, ONCOGENE, V23, P1206, DOI 10.1038/sj.onc.1207199; Luna R, 2008, CHROMOSOMA, V117, P319, DOI 10.1007/s00412-008-0158-4; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; NEWLON CS, 1993, COLD SPRING HARB SYM, V58, P415, DOI 10.1101/SQB.1993.058.01.048; Nguyen VC, 2010, NAT STRUCT MOL BIOL, V17, P976, DOI 10.1038/nsmb.1857; Olavarrieta L, 2002, J MOL BIOL, V322, P1, DOI 10.1016/S0022-2836(02)00740-4; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Petermann E, 2010, P NATL ACAD SCI USA, V107, P16090, DOI 10.1073/pnas.1005031107; Poloumienko A, 2001, MOL BIOL CELL, V12, P3317, DOI 10.1091/mbc.12.11.3317; Pomerantz RT, 2010, SCIENCE, V327, P590, DOI 10.1126/science.1179595; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; Postow L, 2004, GENE DEV, V18, P1766, DOI 10.1101/gad.1207504; Postow L, 2001, P NATL ACAD SCI USA, V98, P8219, DOI 10.1073/pnas.111006998; Postow L, 2001, J BIOL CHEM, V276, P2790, DOI 10.1074/jbc.M006736200; Prado F, 2005, EMBO J, V24, P1267, DOI 10.1038/sj.emboj.7600602; Rocha EPC, 2004, MICROBIOL-SGM, V150, P1609, DOI 10.1099/mic.0.26974-0; Rougemaille M, 2008, CELL, V135, P308, DOI 10.1016/j.cell.2008.08.005; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Schvartzman JB, 2004, EMBO REP, V5, P256, DOI 10.1038/sj.embor.7400101; Segurado M, 2008, GENE DEV, V22, P1816, DOI 10.1101/gad.477208; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Smolka MB, 2005, MOL CELL PROTEOMICS, V4, P1358, DOI 10.1074/mcp.M500115-MCP200; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Tan-Wong SM, 2009, GENE DEV, V23, P2610, DOI 10.1101/gad.1823209; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WANG JC, 1990, CELL, V62, P403, DOI 10.1016/0092-8674(90)90002-V; Wellinger RE, 2006, MOL CELL BIOL, V26, P3327, DOI 10.1128/MCB.26.8.3327-3334.2006; Zhao XL, 2002, P NATL ACAD SCI USA, V99, P3746, DOI 10.1073/pnas.062502299; ZHENG P, 1993, MOL CELL BIOL, V13, P5829, DOI 10.1128/MCB.13.9.5829; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	85	166	169	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 22	2011	146	2					233	246		10.1016/j.cell.2011.06.033	http://dx.doi.org/10.1016/j.cell.2011.06.033			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	795XS	21784245	Green Submitted, Green Published, hybrid			2022-12-01	WOS:000293013000007
J	Minemawari, H; Yamada, T; Matsui, H; Tsutsumi, J; Haas, S; Chiba, R; Kumai, R; Hasegawa, T				Minemawari, Hiromi; Yamada, Toshikazu; Matsui, Hiroyuki; Tsutsumi, Jun'ya; Haas, Simon; Chiba, Ryosuke; Kumai, Reiji; Hasegawa, Tatsuo			Inkjet printing of single-crystal films	NATURE			English	Article							HIGH-PERFORMANCE; TRANSISTOR; MOBILITY; POLYMER; TRANSPORT	The use of single crystals has been fundamental to the development of semiconductor microelectronics and solid-state science(1). Whether based on inorganic(2-5) or organic(6-8) materials, the devices that show the highest performance rely on single-crystal interfaces, with their nearly perfect translational symmetry and exceptionally high chemical purity. Attention has recently been focused on developing simple ways of producing electronic devices by means of printing technologies. 'Printed electronics' is being explored for the manufacture of large-area and flexible electronic devices by the patterned application of functional inks containing soluble or dispersed semiconducting materials(9-11). However, because of the strong self-organizing tendency of the deposited materials(12,13), the production of semiconducting thin films of high crystallinity (indispensable for realizing high carrier mobility) may be incompatible with conventional printing processes. Here we develop a method that combines the technique of antisolvent crystallization(14) with inkjet printing to produce organic semiconducting thin films of high crystallinity. Specifically, we show that mixing fine droplets of an antisolvent and a solution of an active semiconducting component within a confined area on an amorphous substrate can trigger the controlled formation of exceptionally uniform single-crystal or polycrystalline thin films that grow at the liquid-air interfaces. Using this approach, we have printed single crystals of the organic semiconductor 2,7-dioctyl[1] benzothieno[3,2-b][1] benzothiophene (C-8-BTBT) (ref. 15), yielding thin-film transistors with average carrier mobilities as high as 16.4 cm(2) V-1 s(-1). This printing technique constitutes a major step towards the use of high-performance single-crystal semiconductor devices for large-area and flexible electronics applications.	[Minemawari, Hiromi; Yamada, Toshikazu; Matsui, Hiroyuki; Tsutsumi, Jun'ya; Haas, Simon; Chiba, Ryosuke; Kumai, Reiji; Hasegawa, Tatsuo] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058562, Japan; [Chiba, Ryosuke] Univ Tokyo, Dept Appl Phys, Hongo 1138656, Japan; [Kumai, Reiji] High Energy Accelerator Res Org KEK, Inst Mat Struct Sci, CMRC, Tsukuba, Ibaraki 3050801, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; High Energy Accelerator Research Organization (KEK)	Hasegawa, T (corresponding author), Natl Inst Adv Ind Sci & Technol, AIST Tsukuba Cent 4, Tsukuba, Ibaraki 3058562, Japan.	t-hasegawa@aist.go.jp	Tsutsumi, Jun'ya/O-6490-2016; Matsui, Hiroyuki/G-4616-2018; Kumai, Reiji/R-2453-2017; Minemawari, Hiromi/K-9776-2018; Yamada, Toshikazu/C-7533-2017; Hasegawa, Tatsuo/M-4775-2018	Tsutsumi, Jun'ya/0000-0002-0910-1188; Matsui, Hiroyuki/0000-0003-1956-9603; Kumai, Reiji/0000-0002-5320-0028; Minemawari, Hiromi/0000-0003-3157-7905; Yamada, Toshikazu/0000-0002-8322-2391; Hasegawa, Tatsuo/0000-0001-5187-7433	New Energy and Industrial Technology Development Organization (NEDO); Japan Society for the Promotion of Science (JSPS)	New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We are grateful to Nippon Kayaku for providing C<INF>8</INF>-BTBT. We thank K. Takimiya and S. Horiuchi for discussions, H. Okamoto and H. Matsuzaki for help with optical measurements, K. Kobayashi for help with the X-ray measurements, and T. Iwadate for help with atomic-force microscopy and measurements of device characteristics. The synchrotron X-ray study was performed with the approval of the Photon Factory Program Advisory Committee (no. 2009S2-003). This work was supported by the New Energy and Industrial Technology Development Organization (NEDO) through a Grant for Industrial Technology Research and also by the Japan Society for the Promotion of Science (JSPS) through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program).	Briseno AL, 2006, NATURE, V444, P913, DOI 10.1038/nature05427; Chen ZG, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3269930; De Poortere EP, 2002, APPL PHYS LETT, V80, P1583, DOI 10.1063/1.1456265; Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827; deMello AJ, 2006, NATURE, V442, P394, DOI 10.1038/nature05062; Ebata H, 2007, J AM CHEM SOC, V129, P15732, DOI 10.1021/ja074841i; Faltermeier D, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.125416; Hasegawa T, 2010, THIN SOLID FILMS, V518, P3988, DOI 10.1016/j.tsf.2009.11.024; Hiraoka M, 2007, ADV MATER, V19, P3248, DOI 10.1002/adma.200701162; Izawa T, 2008, ADV MATER, V20, P3388, DOI 10.1002/adma.200800799; Lim JA, 2009, ADV FUNCT MATER, V19, P1515, DOI 10.1002/adfm.200801135; Noh YY, 2007, NAT NANOTECHNOL, V2, P784, DOI 10.1038/nnano.2007.365; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; Pope M., 1999, ELECT PROCESSES ORGA, V2nd ed., P59; Rivnay J, 2009, NAT MATER, V8, P952, DOI [10.1038/NMAT2570, 10.1038/nmat2570]; Sirringhaus H, 2000, SCIENCE, V290, P2123, DOI 10.1126/science.290.5499.2123; Sundar VC, 2004, SCIENCE, V303, P1644, DOI 10.1126/science.1094196; Takeya J, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2711393; TEAL GK, 1976, IEEE T ELECTRON DEV, V23, P621, DOI 10.1109/T-ED.1976.18464; TSUI DC, 1982, PHYS REV LETT, V48, P1559, DOI 10.1103/PhysRevLett.48.1559; Tsukazaki A, 2010, NAT MATER, V9, P889, DOI [10.1038/nmat2874, 10.1038/NMAT2874]; Tung H.H., 2009, CRYSTALLIZATION ORGA, P179; Uemura T, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.111501; Ulman A., 1991, INTRO ULTRATHIN ORGA; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Yan H, 2009, NATURE, V457, P679, DOI 10.1038/nature07727	26	1368	1393	33	1322	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2011	475	7356					364	367		10.1038/nature10313	http://dx.doi.org/10.1038/nature10313			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21753752				2022-12-01	WOS:000292911200039
J	Arbabi, EM; Arshad, FA; Holden, K; Carrim, ZI				Arbabi, Esmaeil M.; Arshad, Faisal A.; Holden, Kate; Carrim, Zia I.			10-MINUTE CONSULTATION The Watery Eye	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Arbabi, Esmaeil M.; Carrim, Zia I.] St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England; [Arshad, Faisal A.] Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England; [Holden, Kate] Haxby & Wigginton Hlth Ctr, York, N Yorkshire, England	Saint James's University Hospital; University of Sheffield	Arbabi, EM (corresponding author), St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England.	esarbabi@gmail.com						Kanski J. K., 2007, CLIN OPHTHALMOLOGY S, P151; KUSHNER BJ, 1982, ARCH OPHTHALMOL-CHIC, V100, P597	2	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 19	2011	343								d4029	10.1136/bmj.d4029	http://dx.doi.org/10.1136/bmj.d4029			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	797ZG	21771824				2022-12-01	WOS:000293168500006
J	Williams, R				Williams, Ruth			BIOMARKERS Warning signs	NATURE			English	Editorial Material							NEUROIMAGING INITIATIVE SUBJECTS; ALZHEIMERS-DISEASE											Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Reddy MM, 2011, CELL, V144, P132, DOI 10.1016/j.cell.2010.11.054; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Trojanowski JQ, 2010, ALZHEIMERS DEMENT, V6, P230, DOI 10.1016/j.jalz.2010.03.008	6	15	15	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					S5	S7		10.1038/475S5a	http://dx.doi.org/10.1038/475S5a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21760581	Bronze			2022-12-01	WOS:000292690500003
J	Murtagh, L; Ludwig, DS				Murtagh, Lindsey; Ludwig, David S.			State Intervention in Life-Threatening Childhood Obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BARIATRIC SURGERY; CHILDREN; ADOLESCENTS		[Ludwig, David S.] Childrens Hosp, Dept Med, Optimal Weight Life Program, Boston, MA 02115 USA; [Murtagh, Lindsey] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Ludwig, DS (corresponding author), Childrens Hosp, Dept Med, Optimal Weight Life Program, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544	NIDDK NIH HHS [K24DK082730] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		DePanfilis D, 2006, CHILD NEGLECT GUIDE; Murtagh L, 2007, J LAW MED ETHICS, V35, P497; Pinhas-Hamiel O, 2007, LANCET, V369, P1823, DOI 10.1016/S0140-6736(07)60821-6; Skelton JA, 2009, ACAD PEDIATR, V9, P322, DOI 10.1016/j.acap.2009.04.005; Treadwell JR, 2008, ANN SURG, V248, P763, DOI 10.1097/SLA.0b013e31818702f4; Varness T, 2009, PEDIATRICS, V123, P399, DOI 10.1542/peds.2008-0712; Viner RM, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3074; Wang YC, 2006, PEDIATRICS, V118, pE1721, DOI 10.1542/peds.2006-0682; Weiss R, 2010, NAT REV ENDOCRINOL, V6, P125, DOI 10.1038/nrendo.2010.1	9	33	34	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2011	306	2					206	207		10.1001/jama.2011.903	http://dx.doi.org/10.1001/jama.2011.903			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791CO	21750301				2022-12-01	WOS:000292639400031
J	Detsky, AS; Baerlocher, MO				Detsky, Allan S.; Baerlocher, Mark O.			Do Nice Patients Receive Better Care?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHYSICIANS		[Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada; [Baerlocher, Mark O.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of California System; University of California San Diego	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 600 Univ Ave,Room 429, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca						Atzema CL, 2011, CAN MED ASSOC J, V183, P663, DOI 10.1503/cmaj.100685; AYANIAN JZ, 1991, NEW ENGL J MED, V325, P221, DOI 10.1056/NEJM199107253250401; Bach PB, 1999, NEW ENGL J MED, V341, P1198, DOI 10.1056/NEJM199910143411606; Cain DM, 2008, JAMA-J AM MED ASSOC, V299, P2893, DOI 10.1001/jama.299.24.2893; Chapman KR, 2001, CHEST, V119, P1691, DOI 10.1378/chest.119.6.1691; GORLIN R, 1983, NEW ENGL J MED, V308, P1059, DOI 10.1056/NEJM198305053081804; Hahn SR, 1996, J GEN INTERN MED, V11, P1, DOI 10.1007/BF02603477; LEVINSON W, 1993, MED CARE, V31, P285, DOI 10.1097/00005650-199304000-00001; Lutfey K, 2005, AM J SOCIOL, V110, P1326, DOI 10.1086/428914; Pomm HA, 2004, FAM MED, V36, P467	10	6	6	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2011	306	1					94	95		10.1001/jama.2011.883	http://dx.doi.org/10.1001/jama.2011.883			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	787LV	21730247				2022-12-01	WOS:000292378700028
J	Spence, D				Spence, Des			FROM THE FRONTLINE Assisted dying: are doctors in denial?	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 22	2011	342								d3891	10.1136/bmj.d3891	http://dx.doi.org/10.1136/bmj.d3891			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AT	21697230				2022-12-01	WOS:000292200500012
J	Xu, XM; Wang, J; Xuan, ZY; Goldshmidt, A; Borrill, PGM; Hariharan, N; Kim, JY; Jackson, D				Xu, Xianfeng Morgan; Wang, Jing; Xuan, Zhenyu; Goldshmidt, Alexander; Borrill, Philippa G. M.; Hariharan, Nisha; Kim, Jae Yean; Jackson, David			Chaperonins Facilitate KNOTTED1 Cell-to-Cell Trafficking and Stem Cell Function	SCIENCE			English	Article							INTERCELLULAR MOVEMENT; HOMEODOMAIN PROTEIN; MESSENGER-RNA; ARABIDOPSIS; PLASMODESMATA; GENE; PREFOLDIN; TRANSPORT; REQUIRES	Cell-to-cell communication in plants includes the selective trafficking of transcription factors and other signals through plasmodesmata. The KNOTTED1 (KN1) homeobox (KNOX) family transcription factors, which use this pathway, are essential for stem cell establishment and/or maintenance. Here we show that KN1 trafficking requires the chaperonin complex, which belongs to a group of cytosolic chaperones that fold specific substrate proteins. Genetic and physical interaction data show a functional relevance for chaperonins in KNOX family-dependent stem cell maintenance. Furthermore, tissue-specific complementation assays indicate a mechanistic basis for chaperonin function during the posttranslocational refolding process. Our study shows that chaperonins are essential for the cell-to-cell trafficking of a subset of mobile transcription factors and demonstrates the importance of chaperonin-dependent protein trafficking for plant stem cell function.	[Xu, Xianfeng Morgan; Wang, Jing; Xuan, Zhenyu; Goldshmidt, Alexander; Borrill, Philippa G. M.; Hariharan, Nisha; Kim, Jae Yean; Jackson, David] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Jackson, D (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	jacksond@cshl.edu	Borrill, Philippa/B-3199-2012	Xuan, Zhenyu/0000-0001-9344-8493; Borrill, Philippa/0000-0002-7623-8256; Goldshmidt, Alexander/0000-0001-7468-6779	Vaadia-Binational Agricultural Research and Development [FI-413]; Cold Spring Harbor Laboratory; Rural Development Administration, Korea [PJ008109]; NSF [1027003]; Division Of Integrative Organismal Systems [1027003] Funding Source: National Science Foundation	Vaadia-Binational Agricultural Research and Development; Cold Spring Harbor Laboratory; Rural Development Administration, Korea(Rural Development Administration (RDA), Republic of Korea); NSF(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank the Arabidopsis Biological Resource Center, K. Barton, P. Benfey, Y. Gu, J.-Y. Lee, and D. Chitwood for seeds and plasmids. We also thank M. Regulski for assisting with the Illumina sequencing library; T. Mulligan for plant care; and R. Martienssen, Z. Lippman, F Kragler, and members of the Jackson lab for discussion and comments on the manuscript. X. M. X. is a LSRF Fellow of the Life Sciences Research Foundation and a Chapman Fellow of the Chapman Foundation. A.G. is supported by the Vaadia-Binational Agricultural Research and Development Postdoctoral Fellowship Award FI-413. P.G.M.B. and N.H. were supported by the Cold Spring Harbor Laboratory's Undergraduate Research Program. J.Y.K. is currently supported by the Next-Generation BioGreen 21 Program (SSAC grant PJ008109), Rural Development Administration, Korea. This research is supported by the NSF (award 1027003). Author contributions: X.M.X. performed the imaging, RT-PCRs, immunoprecipitations (Ips), and genetic and transgenic analyses. J.W. started the screen and performed mutant cloning. Z.X. processed the Illumina sequencing data. P.G.M.B. assisted with the IP assays. N.H. analyzed the cct3-1 embryos. A.G. took the scanning electron microscopy images. J.Y.K. generated the starting line for mutagenesis. X.M.X. and D.J. analyzed the data and wrote the manuscript. All of the authors read and approved the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Aoki K, 2002, P NATL ACAD SCI USA, V99, P16342, DOI 10.1073/pnas.252427999; Bouyer D, 2008, PLOS BIOL, V6, P1166, DOI 10.1371/journal.pbio.0060141; Carlsbecker A, 2010, NATURE, V465, P316, DOI 10.1038/nature08977; CRONSHAW J, 1980, J HISTOCHEM CYTOCHEM, V28, P375, DOI 10.1177/28.4.6445380; Dunoyer P, 2010, SCIENCE, V328, P912, DOI 10.1126/science.1185880; Fernandez-Calvino L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018880; Gu Y, 2008, P NATL ACAD SCI USA, V105, P18064, DOI 10.1073/pnas.0808652105; HAKE S, 1986, NATURE, V320, P621, DOI 10.1038/320621a0; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Kanrar S, 2006, PLANTA, V224, P1163, DOI 10.1007/s00425-006-0298-9; Kim I, 2005, CURR OPIN PLANT BIOL, V8, P593, DOI 10.1016/j.pbi.2005.09.013; Kim JY, 2005, GENE DEV, V19, P788, DOI 10.1101/gad.332805; Kim JY, 2003, DEVELOPMENT, V130, P4351, DOI 10.1242/dev.00618; Kragler F, 1998, PLANT J, V15, P367, DOI 10.1046/j.1365-313X.1998.00219.x; Kurata T, 2005, CURR OPIN PLANT BIOL, V8, P600, DOI 10.1016/j.pbi.2005.09.005; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; Lucas WJ, 2009, TRENDS CELL BIOL, V19, P495, DOI 10.1016/j.tcb.2009.07.003; LUCAS WJ, 1995, SCIENCE, V270, P1980, DOI 10.1126/science.270.5244.1980; Martin-Benito J, 2002, EMBO J, V21, P6377, DOI 10.1093/emboj/cdf640; Maule AJ, 2008, CURR OPIN PLANT BIOL, V11, P680, DOI 10.1016/j.pbi.2008.08.002; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; OPPENHEIMER DG, 1991, CELL, V67, P483, DOI 10.1016/0092-8674(91)90523-2; Peremyslov VV, 1999, P NATL ACAD SCI USA, V96, P14771, DOI 10.1073/pnas.96.26.14771; Plath K, 2000, J CELL BIOL, V151, P167, DOI 10.1083/jcb.151.1.167; Vollbrecht E, 2000, DEVELOPMENT, V127, P3161; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; Winter N, 2007, PLANT CELL, V19, P3001, DOI 10.1105/tpc.107.044354; Wright KM, 2007, TRAFFIC, V8, P21, DOI 10.1111/j.1600-0854.2006.00510.x; Xu XM, 2010, CURR OPIN PLANT BIOL, V13, P684, DOI 10.1016/j.pbi.2010.09.003	31	100	114	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 26	2011	333	6046					1141	1144		10.1126/science.1205727	http://dx.doi.org/10.1126/science.1205727			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21868675				2022-12-01	WOS:000294244300047
J	Mercer, TR; Neph, S; Dinger, ME; Crawford, J; Smith, MA; Shearwood, AMJ; Haugen, E; Bracken, CP; Rackham, O; Stamatoyannopoulos, JA; Filipovska, A; Mattick, JS				Mercer, Tim R.; Neph, Shane; Dinger, Marcel E.; Crawford, Joanna; Smith, Martin A.; Shearwood, Anne-Marie J.; Haugen, Eric; Bracken, Cameron P.; Rackham, Oliver; Stamatoyannopoulos, John A.; Filipovska, Aleksandra; Mattick, John S.			The Human Mitochondrial Transcriptome	CELL			English	Article							MESSENGER-RNAS; HUMAN GENOME; IN-VIVO; DNA; PROTEIN; POLYADENYLATION; SEQUENCE; REVEALS; IMPORT; ORIGIN	The human mitochondrial genome comprises a distinct genetic system transcribed as precursor poly-cistronic transcripts that are subsequently cleaved to generate individual mRNAs, tRNAs, and rRNAs. Here, we provide a comprehensive analysis of the human mitochondrial transcriptome across multiple cell lines and tissues. Using directional deep sequencing and parallel analysis of RNA ends, we demonstrate wide variation in mitochondrial transcript abundance and precisely resolve transcript processing and maturation events. We identify previously undescribed transcripts, including small RNAs, and observe the enrichment of several nuclear RNAs in mitochondria. Using high-throughput in vivo DNaseI footprinting, we establish the global profile of DNA-binding protein occupancy across the mitochondrial genome at single-nucleotide resolution, revealing regulatory features at mitochondrial transcription initiation sites and functional insights into disease-associated variants. This integrated analysis of the mitochondrial transcriptome reveals unexpected complexity in the regulation, expression, and processing of mitochondrial RNA and provides a resource for future studies of mitochondrial function (accessed at http://mitochondria.matticklab.com).	[Neph, Shane; Haugen, Eric; Stamatoyannopoulos, John A.] Univ Washington, Sch Med, Dept Genome Sci & Med, Seattle, WA 98195 USA; [Mercer, Tim R.; Dinger, Marcel E.; Crawford, Joanna; Smith, Martin A.; Mattick, John S.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Shearwood, Anne-Marie J.; Rackham, Oliver; Filipovska, Aleksandra] Univ Western Australia, Med Res Ctr, Perth, WA 6000, Australia; [Shearwood, Anne-Marie J.; Rackham, Oliver; Filipovska, Aleksandra] Univ Western Australia, Western Australian Inst Med Res, Perth, WA 6000, Australia; [Bracken, Cameron P.] SA Pathol, Ctr Canc Biol, Div Human Immunol, Adelaide, SA 5000, Australia	University of Washington; University of Washington Seattle; University of Queensland; University of Western Australia; University of Western Australia; Centre for Cancer Biology; SA Pathology	Stamatoyannopoulos, JA (corresponding author), Univ Washington, Sch Med, Dept Genome Sci & Med, Seattle, WA 98195 USA.	jstam@u.washington.edu; afilipov@waimr.uwa.edu.au; j.mattick@uq.edu.au	Rackham, Oliver/AGO-0005-2022; Crawford, Joanna/F-9135-2013; Smith, Martin A./L-5265-2019; Mattick, John/ABH-6130-2020; Dinger, Marcel/N-1398-2019; Mercer, Tim/AAK-5060-2020; Mattick, John S/I-7789-2012; Rackham, Oliver/E-1264-2013	Rackham, Oliver/0000-0002-5301-9624; Crawford, Joanna/0000-0003-0786-6889; Smith, Martin A./0000-0003-2259-1713; Mattick, John/0000-0002-7680-7527; Mercer, Tim/0000-0001-8780-894X; Mattick, John S/0000-0002-7680-7527; Rackham, Oliver/0000-0002-5301-9624; Dinger, Marcel/0000-0003-4423-934X; Bracken, Cameron/0000-0001-7722-625X; Filipovska, Aleksandra/0000-0002-6998-8403; Haugen, Eric/0000-0001-7444-8981	Australian Research Council; National Health and Medical Research Council of Australia; Queensland Government Department of Employment, Economic Development and Innovation; Australian Stem Cell Centre; NIH [U54HG004592, U54HG004592-S1]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004592] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Queensland Government Department of Employment, Economic Development and Innovation; Australian Stem Cell Centre; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grants and fellowships from the Australian Research Council, the National Health and Medical Research Council of Australia, the Queensland Government Department of Employment, Economic Development and Innovation, the Australian Stem Cell Centre, and NIH Grants U54HG004592 and U54HG004592-S1. We thank Rob King from GeneWorks (Adelaide, SA) for advice with RNA sequencing; Andreas Gruber from the Institute for Theoretical Chemistry in Vienna for providing his software for merging and fragmenting alignment files; Robert Thurman, Alex Reynolds, and Dave Shechner for help with DNaseI hypersensitivity analysis; and Illumina (Hayward, CA) for providing early access to thehuman "Body Map" RNA sequencing atlas.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bhat A, 2007, HUM GENET, V120, P821, DOI 10.1007/s00439-006-0272-4; Cannino G, 2007, MITOCHONDRION, V7, P359, DOI 10.1016/j.mito.2007.07.001; Crimi M, 2003, EUR J HUM GENET, V11, P896, DOI 10.1038/sj.ejhg.5201056; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Entelis NS, 2001, ADV DRUG DELIVER REV, V49, P199, DOI 10.1016/S0169-409X(01)00135-1; Entelis NS, 1998, P NATL ACAD SCI USA, V95, P2838, DOI 10.1073/pnas.95.6.2838; FISHER RP, 1992, J BIOL CHEM, V267, P3358; FISHER RP, 1987, CELL, V50, P247, DOI 10.1016/0092-8674(87)90220-0; Fuste JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Gesell T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-248; GHIVIZZANI SC, 1994, MOL CELL BIOL, V14, P7717, DOI 10.1128/MCB.14.12.7717; Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868; HANCOCK K, 1992, J BIOL CHEM, V267, P23963; Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810; HAUSWIRTH WW, 1985, NUCLEIC ACIDS RES, V13, P8093, DOI 10.1093/nar/13.22.8093; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/nmeth.1313, 10.1038/NMETH.1313]; Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Karginov FV, 2010, MOL CELL, V38, P781, DOI 10.1016/j.molcel.2010.06.001; Khogali SS, 2001, LANCET, V357, P1265, DOI 10.1016/S0140-6736(00)04422-6; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Lin H, 2008, BIOINFORMATICS, V24, P2431, DOI 10.1093/bioinformatics/btn416; Lu JX, 2010, MITOCHONDRION, V10, P69, DOI 10.1016/j.mito.2009.09.007; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nagaike T, 2005, J BIOL CHEM, V280, P19721, DOI 10.1074/jbc.M500804200; NOLL M, 1974, NUCLEIC ACIDS RES, V1, P1573, DOI 10.1093/nar/1.11.1573; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Percival D. B., 1993, MULTITAPER CONVENTIO; Piechota J, 2006, ACTA BIOCHIM POL, V53, P157; Rossmanith W, 2009, CELL CYCLE, V8, P1650, DOI 10.4161/cc.8.11.8502; Rubio MAT, 2008, P NATL ACAD SCI USA, V105, P9186, DOI 10.1073/pnas.0804283105; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; SBISA E, 1992, FEBS LETT, V296, P311, DOI 10.1016/0014-5793(92)80311-4; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Slomovic S, 2005, MOL CELL BIOL, V25, P6427, DOI 10.1128/MCB.25.15.6427-6435.2005; Suissa S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000474; Sylvestre J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r44; Szczesny RJ, 2010, NUCLEIC ACIDS RES, V38, P279, DOI 10.1093/nar/gkp903; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Temperley R, 2010, SCIENCE, V327, P301, DOI 10.1126/science.1180674; Temperley RJ, 2010, BBA-BIOENERGETICS, V1797, P1081, DOI 10.1016/j.bbabio.2010.02.036; Temperley RJ, 2003, HUM MOL GENET, V12, P2341, DOI 10.1093/hmg/ddg238; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Yakubovskaya E, 2010, CELL, V141, P982, DOI 10.1016/j.cell.2010.05.018; Zhang CX, 2009, CURR OPIN MOL THER, V11, P641	58	520	537	1	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 19	2011	146	4					645	658		10.1016/j.cell.2011.06.051	http://dx.doi.org/10.1016/j.cell.2011.06.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21854988	Green Accepted, Bronze			2022-12-01	WOS:000294043600018
J	Solomon, DA; Kim, T; Diaz-Martinez, LA; Fair, J; Elkahloun, AG; Harris, BT; Toretsky, JA; Rosenberg, SA; Shukla, N; Ladanyi, M; Samuels, Y; James, CD; Yu, HT; Kim, JS; Waldman, T				Solomon, David A.; Kim, Taeyeon; Diaz-Martinez, Laura A.; Fair, Joshlean; Elkahloun, Abdel G.; Harris, Brent T.; Toretsky, Jeffrey A.; Rosenberg, Steven A.; Shukla, Neerav; Ladanyi, Marc; Samuels, Yardena; James, C. David; Yu, Hongtao; Kim, Jung-Sik; Waldman, Todd			Mutational Inactivation of STAG2 Causes Aneuploidy in Human Cancer	SCIENCE			English	Article							TUMOR-SUPPRESSOR GENE; CHROMOSOME INSTABILITY; COPY NUMBER; COHESIN; OVEREXPRESSION; HETEROZYGOSITY; TUMORIGENESIS; EXPRESSION	Most cancer cells are characterized by aneuploidy, an abnormal number of chromosomes. We have identified a clue to the mechanistic origins of aneuploidy through integrative genomic analyses of human tumors. A diverse range of tumor types were found to harbor deletions or inactivating mutations of STAG2, a gene encoding a subunit of the cohesin complex, which regulates the separation of sister chromatids during cell division. Because STAG2 is on the X chromosome, its inactivation requires only a single mutational event. Studying a near-diploid human cell line with a stable karyotype, we found that targeted inactivation of STAG2 led to chromatid cohesion defects and aneuploidy, whereas in two aneuploid human glioblastoma cell lines, targeted correction of the endogenous mutant alleles of STAG2 led to enhanced chromosomal stability. Thus, genetic disruption of cohesin is a cause of aneuploidy in human cancer.	[Solomon, David A.; Kim, Taeyeon; Fair, Joshlean; Toretsky, Jeffrey A.; Kim, Jung-Sik; Waldman, Todd] Georgetown Univ, Sch Med, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Diaz-Martinez, Laura A.; Yu, Hongtao] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Diaz-Martinez, Laura A.; Yu, Hongtao] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Elkahloun, Abdel G.; Samuels, Yardena] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Harris, Brent T.] Georgetown Univ, Sch Med, Dept Neurol, Washington, DC 20057 USA; [Harris, Brent T.] Georgetown Univ, Sch Med, Dept Pathol, Washington, DC 20057 USA; [Rosenberg, Steven A.] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA; [Shukla, Neerav; Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [James, C. David] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, Brain Tumor Res Ctr, Dept Neurol Surg, San Francisco, CA 94143 USA	Georgetown University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Georgetown University; Georgetown University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Waldman, T (corresponding author), Georgetown Univ, Sch Med, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA.	waldmant@georgetown.edu	Ladanyi, Marc/AAG-8585-2019; James, Charles D/E-2721-2012	James, Charles D/0000-0002-1027-203X; Diaz-Martinez, Laura/0000-0002-7226-7068; Samuels, Yardena/0000-0002-3349-7266; Yu, Hongtao/0000-0002-8861-049X	NIH [R01CA115699, R21CA143282]; SPORE grant [CA097257]; American Cancer Society [RSG0619101]; National Human Genome Research Institute, NIH; NATIONAL CANCER INSTITUTE [R01CA169345, R01CA133662, ZIABC010984, P50CA097257, R21CA143282, R01CA138212] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200337, ZICHG200365] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SPORE grant; American Cancer Society(American Cancer Society); National Human Genome Research Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank K. Creswell, S. Sen, and Applied Genetics Laboratories for technical assistance; and M. White and the Brain Tumor Tissue Bank of Canada, S. Baker, F. Bunz, J.-M. Peters, and the Children's Oncology Group for reagents and tumor samples. This research was supported by NIH grants R01CA115699 (T. W.), R21CA143282 (T. W.), SPORE grant CA097257 (C.D.J.), and American Cancer Society grant RSG0619101 (T. W.). Georgetown University has filed a patent application relating to the application of the mutations described in this work to the diagnosis and treatment of cancer. Y.S. is supported by the Intramural Research Programs of the National Human Genome Research Institute, NIH. Primer sequences are in table S6. For copy number arrays: the scanned array images and processed data sets have been deposited in the Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo, dataset GSE13021). For expression microarrays: the scanned array images and processed data sets have been deposited in the Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo, dataset GSE28214)	Baker DJ, 2009, CANCER CELL, V16, P475, DOI 10.1016/j.ccr.2009.10.023; Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Gorringe KL, 2009, GENE CHROMOSOME CANC, V48, P931, DOI 10.1002/gcc.20694; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim JS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn566; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Lara-Pezzi E, 2004, J BIOL CHEM, V279, P6553, DOI 10.1074/jbc.M307663200; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; LOEB LA, 1991, CANCER RES, V51, P3075; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Rocquain J, 2010, AM J HEMATOL, V85, P717, DOI 10.1002/ajh.21798; Solomon DA, 2008, CANCER RES, V68, P2564, DOI 10.1158/0008-5472.CAN-07-6388; Solomon DA, 2008, CANCER RES, V68, P10300, DOI 10.1158/0008-5472.CAN-08-3272; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Sumara I, 2000, J CELL BIOL, V151, P749, DOI 10.1083/jcb.151.4.749; Walter MJ, 2009, P NATL ACAD SCI USA, V106, P12950, DOI 10.1073/pnas.0903091106; Wang ZGC, 2004, CANCER RES, V64, P64, DOI 10.1158/0008-5472.CAN-03-2570; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Zhang NG, 2008, P NATL ACAD SCI USA, V105, P13033, DOI 10.1073/pnas.0801610105	24	324	326	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2011	333	6045					1039	1043		10.1126/science.1203619	http://dx.doi.org/10.1126/science.1203619			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808TD	21852505	Green Accepted			2022-12-01	WOS:000294000400062
J	Wang, M; Gamo, NJ; Yang, Y; Jin, LE; Wang, XJ; Laubach, M; Mazer, JA; Lee, D; Arnsten, AFT				Wang, Min; Gamo, Nao J.; Yang, Yang; Jin, Lu E.; Wang, Xiao-Jing; Laubach, Mark; Mazer, James A.; Lee, Daeyeol; Arnsten, Amy F. T.			Neuronal basis of age-related working memory decline	NATURE			English	Article							MONKEY PREFRONTAL-CORTEX; COGNITIVE DECLINE; RHESUS-MONKEY; EXECUTIVE FUNCTION; IMPAIRMENT; DYSFUNCTION; NETWORK; MACAQUE	Many of the cognitive deficits of normal ageing (forgetfulness, distractibility, inflexibility and impaired executive functions) involve prefrontal cortex (PFC) dysfunction(1-4). The PFC guides behaviour and thought using working memory(5), which are essential functions in the information age. Many PFC neurons hold information in working memory through excitatory networks that can maintain persistent neuronal firing in the absence of external stimulation(6). This fragile process is highly dependent on the neurochemical environment(7). For example, elevated cyclic-AMP signalling reduces persistent firing by opening HCN and KCNQ potassium channels(8,9). It is not known if molecular changes associated with normal ageing alter the physiological properties of PFC neurons during working memory, as there have been no in vivo recordings, to our knowledge, from PFC neurons of aged monkeys. Here we characterize the first recordings of this kind, revealing a marked loss of PFC persistent firing with advancing age that can be rescued by restoring an optimal neurochemical environment. Recordings showed an age-related decline in the firing rate of DELAY neurons, whereas the firing of CUE neurons remained unchanged with age. The memory-related firing of aged DELAY neurons was partially restored to more youthful levels by inhibiting cAMP signalling, or by blocking HCN or KCNQ channels. These findings reveal the cellular basis of age-related cognitive decline in dorsolateral PFC, and demonstrate that physiological integrity can be rescued by addressing the molecular needs of PFC circuits.	[Wang, Min; Gamo, Nao J.; Yang, Yang; Jin, Lu E.; Wang, Xiao-Jing; Laubach, Mark; Mazer, James A.; Lee, Daeyeol; Arnsten, Amy F. T.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Laubach, Mark] John B Pierce Lab, New Haven, CT 06510 USA	Yale University; Yale University; The John B Pierce Laboratory, Inc	Arnsten, AFT (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	amy.arnsten@yale.edu	Lee, Daeyeol/A-6794-2008; Wang, Xiao-Jing/D-2722-2009	Lee, Daeyeol/0000-0003-3474-019X; Yang, Yang/0000-0001-6612-8865; Laubach, Mark/0000-0002-2403-4497	PHS, National Institute on Aging [PO1AG030004]; NATIONAL INSTITUTE ON AGING [P01AG030004] Funding Source: NIH RePORTER	PHS, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)United States Public Health Service); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by PHS grant PO1AG030004 from the National Institute on Aging. The authors would like to thank J. Thomas, L. Ciavarella, S. Johnson, B. Brunson and M. Horn for their assistance in making this work possible.	Alexander GE, 2008, J NEUROSCI, V28, P2710, DOI 10.1523/JNEUROSCI.1852-07.2008; Arnsten AFT, 2010, TRENDS COGN SCI, V14, P365, DOI 10.1016/j.tics.2010.05.003; Bowles RP, 2003, PSYCHOL AGING, V18, P608, DOI 10.1037/0882-7974.18.3.608; Bucur B, 2010, EXP AGING RES, V36, P153, DOI 10.1080/03610731003613482; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P197, DOI 10.1162/089892900561832; Cappell KA, 2010, CORTEX, V46, P462, DOI 10.1016/j.cortex.2009.11.009; DAVIS HP, 1990, BEHAV NEUROSCI, V104, P288, DOI 10.1037/0735-7044.104.2.288; Downs JL, 2007, NEUROBIOL AGING, V28, P1286, DOI 10.1016/j.neurobiolaging.2006.05.025; Dumitriu D, 2010, J NEUROSCI, V30, P7507, DOI 10.1523/JNEUROSCI.6410-09.2010; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; George MS, 2009, NAT NEUROSCI, V12, P577, DOI 10.1038/nn.2307; Goldman-Rakic P. S., 1987, HDB PHYSL, V5, P373, DOI DOI 10.1002/CPHY.CP010509; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Herndon JG, 1997, BEHAV BRAIN RES, V87, P25, DOI 10.1016/S0166-4328(96)02256-5; Luebke JI, 2007, NEUROSCIENCE, V150, P556, DOI 10.1016/j.neuroscience.2007.09.042; Luebke J, 2010, BRAIN RES REV, V62, P212, DOI 10.1016/j.brainresrev.2009.12.002; Moore TL, 2006, NEUROBIOL AGING, V27, P1484, DOI 10.1016/j.neurobiolaging.2005.08.004; Moore TL, 2005, BEHAV BRAIN RES, V160, P208, DOI 10.1016/j.bbr.2004.12.003; Peters A, 1996, J NEUROPATH EXP NEUR, V55, P861, DOI 10.1097/00005072-199608000-00001; Prakash RS, 2009, BRAIN COGNITION, V71, P328, DOI 10.1016/j.bandc.2009.07.005; Ramos BP, 2003, NEURON, V40, P835, DOI 10.1016/S0896-6273(03)00694-9; RAPP PR, 1989, J NEUROSCI, V9, P3568; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Royall DR, 2005, J INT NEUROPSYCH SOC, V11, P899, DOI 10.1017/S135561770505109X; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Schoenbaum G, 2006, J NEUROPHYSIOL, V95, P1509, DOI 10.1152/jn.01052.2005; Sisodia S S, 1995, Neuroimaging Clin N Am, V5, P59; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272	30	267	280	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 11	2011	476	7359					210	U110		10.1038/nature10243	http://dx.doi.org/10.1038/nature10243			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21796118	Green Accepted			2022-12-01	WOS:000293731900037
J	Uchihashi, T; Iino, R; Ando, T; Noji, H				Uchihashi, Takayuki; Iino, Ryota; Ando, Toshio; Noji, Hiroyuki			High-Speed Atomic Force Microscopy Reveals Rotary Catalysis of Rotorless F-1-ATPase	SCIENCE			English	Article							ATP SYNTHESIS; ROTATION; F1-ATPASE; SUBUNIT; PS3	F-1 is an adenosine triphosphate (ATP)-driven motor in which three torque-generating beta subunits in the alpha(3)beta(3) stator ring sequentially undergo conformational changes upon ATP hydrolysis to rotate the central shaft gamma unidirectionally. Although extensive experimental and theoretical work has been done, the structural basis of cooperative torque generation to realize the unidirectional rotation remains elusive. We used high-speed atomic force microscopy to show that the rotorless F-1 still "rotates"; in the isolated alpha(3)beta(3) stator ring, the three beta subunits cyclically propagate conformational states in the counterclockwise direction, similar to the rotary shaft rotation in F-1. The structural basis of unidirectionality is programmed in the stator ring. These findings have implications for cooperative interplay between subunits in other hexameric ATPases.	[Uchihashi, Takayuki; Ando, Toshio] Kanazawa Univ, Dept Phys, Kanazawa, Ishikawa 9201192, Japan; [Uchihashi, Takayuki; Ando, Toshio] Kanazawa Univ, BioAFM Frontier Res Ctr, Coll Sci & Engn, Kanazawa, Ishikawa 9201192, Japan; [Uchihashi, Takayuki; Iino, Ryota; Ando, Toshio; Noji, Hiroyuki] Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1020075, Japan; [Iino, Ryota; Noji, Hiroyuki] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan; [Iino, Ryota; Noji, Hiroyuki] Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan	Kanazawa University; Kanazawa University; Japan Science & Technology Agency (JST); Osaka University; University of Tokyo	Ando, T (corresponding author), Kanazawa Univ, Dept Phys, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	tando@staff.kanazawa-u.ac.jp; hnoji@appchem.t.u-tokyo.ac.jp	ANDO, Toshio/E-7054-2015; Iino, Ryota/B-7746-2011; Uchihashi, Takayuki/D-5209-2011	ANDO, Toshio/0000-0001-8819-154X; Iino, Ryota/0000-0003-0110-5704; Uchihashi, Takayuki/0000-0002-0263-5312	Ministry of Education, Culture, Sports, Science and Technology [18074005, 18201025, 21770168, 21681017, 2102301, 21107517, 22247025, 20221006]; Knowledge Cluster Initiative; Japan Science and Technology Agency for Core Research for Evolutional Science and Technology; Grants-in-Aid for Scientific Research [21681017] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Knowledge Cluster Initiative(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency for Core Research for Evolutional Science and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Tanigawara, H. Yamashita, R. Hasegawa, and D. Okuno for technical help and members of the Noji and Ando laboratories for valuable comments. This work was supported by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology project ID nos. 18074005, 18201025, 21770168, 21681017, 2102301, 21107517, 22247025, and 20221006); the Knowledge Cluster Initiative; and the Japan Science and Technology Agency for Core Research for Evolutional Science and Technology.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; ALOISE P, 1991, J BIOL CHEM, V266, P10368; Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Ando T, 2008, PROG SURF SCI, V83, P337, DOI 10.1016/j.progsurf.2008.09.001; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Furuike S, 2008, SCIENCE, V319, P955, DOI 10.1126/science.1151343; Garcia JJ, 1998, J BIOL CHEM, V273, P15940, DOI 10.1074/jbc.273.26.15940; GRESSER MJ, 1982, J BIOL CHEM, V257, P2030; Iko Y, 2009, FEBS LETT, V583, P3187, DOI 10.1016/j.febslet.2009.08.042; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Kaibara C, 1996, J BIOL CHEM, V271, P2433, DOI 10.1074/jbc.271.5.2433; Kodera N, 2010, NATURE, V468, P72, DOI 10.1038/nature09450; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Mnatsakanyan N, 2009, J BIOL CHEM, V284, P11336, DOI 10.1074/jbc.M900374200; Nakamoto RK, 1999, ANNU REV BIOPH BIOM, V28, P205, DOI 10.1146/annurev.biophys.28.1.205; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Rondelez Y, 2005, NATURE, V433, P773, DOI 10.1038/nature03277; Shibata M, 2010, NAT NANOTECHNOL, V5, P208, DOI [10.1038/NNANO.2010.7, 10.1038/nnano.2010.7]; Shirakihara Y, 1997, STRUCTURE, V5, P825, DOI 10.1016/S0969-2126(97)00236-0; Wang HY, 1998, NATURE, V396, P279, DOI 10.1038/24409; Watanabe R, 2010, NAT CHEM BIOL, V6, P814, DOI 10.1038/NCHEMBIO.443; YOSHIDA M, 1990, J BIOL CHEM, V265, P2483	25	304	311	3	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2011	333	6043					755	758		10.1126/science.1205510	http://dx.doi.org/10.1126/science.1205510			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817054	Green Submitted			2022-12-01	WOS:000293512100043
J	Nair, U; Jotwani, A; Geng, JF; Gammoh, N; Richerson, D; Yen, WL; Griffith, J; Nag, S; Wang, K; Moss, T; Baba, M; Mcnew, JA; Jiang, XJ; Reggiori, F; Melia, TJ; Klionsky, DJ				Nair, Usha; Jotwani, Anjali; Geng, Jiefei; Gammoh, Noor; Richerson, Diana; Yen, Wei-Lien; Griffith, Janice; Nag, Shanta; Wang, Ke; Moss, Tyler; Baba, Misuzu; Mcnew, James A.; Jiang, Xuejun; Reggiori, Fulvio; Melia, Thomas J.; Klionsky, Daniel J.			SNARE Proteins Are Required for Macroautophagy	CELL			English	Article							PRE-AUTOPHAGOSOMAL STRUCTURE; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; VESICLE FORMATION; SEC PROTEINS; YEAST; FUSION; TRANSPORT; COMPLEX	Macroautophagy mediates the degradation of long-lived proteins and organelles via the de novo formation of double-membrane autophagosomes that sequester cytoplasm and deliver it to the vacuole/lysosome; however, relatively little is known about autophagosome biogenesis. Atg8, a phosphatidylethanolamine-conjugated protein, was previously proposed to function in autophagosome membrane expansion, based on the observation that it mediates liposome tethering and hemifusion in vitro. We show here that with physiological concentrations of phosphatidylethanolamine, Atg8 does not act as a fusogen. Rather, we provide evidence for the involvement of exocytic Q/t-SNAREs in autophagosome formation, acting in the recruitment of key autophagy components to the site of autophagosome formation, and in regulating the organization of Atg9 into tubulovesicular clusters. Additionally, we found that the endosomal Q/t-SNARE Tlg2 and the R/v-SNAREs Sec22 and Ykt6 interact with Sso1-Sec9, and are required for normal Atg9 transport. Thus, multiple SNARE-mediated fusion events are likely to be involved in autophagosome biogenesis.	[Griffith, Janice; Reggiori, Fulvio] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; [Griffith, Janice; Reggiori, Fulvio] Univ Med Ctr Utrecht, Inst Biomembranes, NL-3584 CX Utrecht, Netherlands; [Nair, Usha; Geng, Jiefei; Yen, Wei-Lien; Wang, Ke; Klionsky, Daniel J.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Jotwani, Anjali; Nag, Shanta] Yale Coll, New Haven, CT 06520 USA; [Gammoh, Noor; Jiang, Xuejun] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY USA; [Richerson, Diana; Melia, Thomas J.] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA; [Moss, Tyler; Mcnew, James A.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; [Baba, Misuzu] Kogakuin Univ, Collaborat Open Res Ctr, Tokyo 1920015, Japan	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Michigan System; University of Michigan; Yale University; Memorial Sloan Kettering Cancer Center; Yale University; Rice University; Kogakuin University	Reggiori, F (corresponding author), Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands.	f.reggiori@umcutrecht.nl; thomas.melia@yale.edu; klionsky@umich.edu	Geng, Jiefei/G-1536-2013; McNew, James/AAV-4911-2020; McNew, James/ABD-8081-2020; Reggiori, Fulvio/U-8327-2019	McNew, James/0000-0001-8459-3664; Reggiori, Fulvio/0000-0003-2652-2686; Moss, Tyler/0000-0001-7140-9987	National Institutes of Health [GM53396, NS063973, CA113890, GM071832]; Netherlands Organization for Health Research and Development [ZonMW-VIDI-917.76.329]; Netherlands Organization for Scientific Research [700.59.003]; NATIONAL CANCER INSTITUTE [R01CA113890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071832, R01GM053396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Hans Ronne (Uppsala University) for providing strain H603, Charlie Boone and Zhijian Li for providing the sec mutants, Phil Hieter for providing the ykt6 mutant, Zhifen Yang for the pCUP1-PA-SEC22 and pCUP1-PA-YKT6 constructs, Midori Umekawa for pMU1 (pATG8 under the control of its endogenous promoter, with the hygromycin resistance marker) and Clinton Bartholomew (University of Michigan) and Ai Yamamoto (Columbia University) for helpful discussions. This work was supported by National Institutes of Health grants GM53396 (to D.J.K.), NS063973 (to T.J.M.), CA113890 (to X.J.; also supported by the Geoffrey Beene Cancer Research Fund) and GM071832 (to J.A.M.), as well as the Netherlands Organization for Health Research and Development (ZonMW-VIDI-917.76.329) and the Netherlands Organization for Scientific Research (Chemical Sciences, ECHO grant 700.59.003 to F.R.).	AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; Abeliovich H, 1999, EMBO J, V18, P6005, DOI 10.1093/emboj/18.21.6005; BRENNWALD P, 1994, CELL, V79, P245, DOI 10.1016/0092-8674(94)90194-5; Brugger B, 2000, EMBO J, V19, P1272, DOI 10.1093/emboj/19.6.1272; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Fukasawa M, 2004, P NATL ACAD SCI USA, V101, P4815, DOI 10.1073/pnas.0401183101; Geng JF, 2010, MOL BIOL CELL, V21, P2257, DOI 10.1091/mbc.E09-11-0969; Grote E, 2000, J CELL BIOL, V151, P439, DOI 10.1083/jcb.151.2.439; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; HARSAY E, 1995, J CELL BIOL, V131, P297, DOI 10.1083/jcb.131.2.297; Holthuis JCM, 1998, EMBO J, V17, P113, DOI 10.1093/emboj/17.1.113; Isahara K, 1999, NEUROSCIENCE, V91, P233, DOI 10.1016/S0306-4522(98)00566-1; Ishihara N, 2001, MOL BIOL CELL, V12, P3690, DOI 10.1091/mbc.12.11.3690; Jantti J, 2002, J CELL SCI, V115, P409; Liu YT, 2004, J BIOL CHEM, V279, P27225, DOI 10.1074/jbc.M312122200; Liu YT, 2002, MOL BIOL CELL, V13, P3314, DOI 10.1091/mbc.E02-04-0204; Lynch-Day MA, 2010, P NATL ACAD SCI USA, V107, P7811, DOI 10.1073/pnas.1000063107; Mari M, 2010, J CELL BIOL, V190, P1005, DOI 10.1083/jcb.200912089; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; McNew JA, 1997, J BIOL CHEM, V272, P17776, DOI 10.1074/jbc.272.28.17776; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Noda T, 2000, J CELL BIOL, V148, P465, DOI 10.1083/jcb.148.3.465; Paumet F, 2001, J CELL BIOL, V155, P961, DOI 10.1083/jcb.200104092; PROTOPOPOV V, 1993, CELL, V74, P855, DOI 10.1016/0092-8674(93)90465-3; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Reggiori F, 2004, DEV CELL, V6, P79, DOI 10.1016/S1534-5807(03)00402-7; Reggiori F, 2004, MOL BIOL CELL, V15, P2189, DOI 10.1091/mbc.E03-07-0479; Reggiori F, 2005, AUTOPHAGY, V1, P101, DOI 10.4161/auto.1.2.1840; Scott BL, 2004, J CELL BIOL, V167, P75, DOI 10.1083/jcb.200405018; Ungermann C, 1999, J CELL BIOL, V145, P1435, DOI 10.1083/jcb.145.7.1435; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Weidberg H, 2011, DEV CELL, V20, P444, DOI 10.1016/j.devcel.2011.02.006; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yen WL, 2010, J CELL BIOL, V188, P101, DOI 10.1083/jcb.200904075	36	322	331	2	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 22	2011	146	2					290	302		10.1016/j.cell.2011.06.022	http://dx.doi.org/10.1016/j.cell.2011.06.022			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	795XS	21784249	Bronze, Green Accepted			2022-12-01	WOS:000293013000011
J	Sanchez, T; Welch, D; Nicastro, D; Dogic, Z				Sanchez, Timothy; Welch, David; Nicastro, Daniela; Dogic, Zvonimir			Cilia-Like Beating of Active Microtubule Bundles	SCIENCE			English	Article							SEA-URCHIN SPERM; SELF-ORGANIZATION; MOTORS; FILAMENTS; MOLECULE; FLAGELLA; COMPLEX; DRIVEN; FLOW	The mechanism that drives the regular beating of individual cilia and flagella, as well as dense ciliary fields, remains unclear. We describe a minimal model system, composed of microtubules and molecular motors, which self-assemble into active bundles exhibiting beating patterns reminiscent of those found in eukaryotic cilia and flagella. These observations suggest that hundreds of molecular motors, acting within an elastic microtubule bundle, spontaneously synchronize their activity to generate large-scale oscillations. Furthermore, we also demonstrate that densely packed, actively bending bundles spontaneously synchronize their beating patterns to produce collective behavior similar to metachronal waves observed in ciliary fields. The simple in vitro system described here could provide insights into beating of isolated eukaryotic cilia and flagella, as well as their synchronization in dense ciliary fields.	[Sanchez, Timothy; Dogic, Zvonimir] Brandeis Univ, Dept Phys, Waltham, MA 02454 USA; [Welch, David] Brandeis Univ, Grad Program Biophys & Struct Biol, Waltham, MA 02454 USA; [Nicastro, Daniela] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Brandeis University; Brandeis University	Dogic, Z (corresponding author), Brandeis Univ, Dept Phys, 415 South St, Waltham, MA 02454 USA.	zdogic@brandeis.edu	Sanchez, Tim/H-6339-2013	Nicastro, Daniela/0000-0002-0122-7173	W. M. Keck Foundation; National Science Foundation [DMR-MRSEC-0820492]; National Institutes of Health [5K25GM85613, 5R01GM083122]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007596, K25GM085613, R01GM083122] Funding Source: NIH RePORTER	W. M. Keck Foundation(W.M. Keck Foundation); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge useful discussions with S. Fraden and M. Hagan. We are grateful to J. Chung and J. Gelles for their help in purification of microtubules and kinesin and also acknowledge D. Chen and E. Peck for images of beating Chlamydomonas reinhardtii. We are thankful to the IWF for their permission to use images of Opalina ranarum (Fig. 3C). This work was supported by funding from the W. M. Keck Foundation, National Science Foundation (DMR-MRSEC-0820492), and National Institutes of Health (5K25GM85613 to Z.D. and 5R01GM083122 to D.N.).	Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; Bormuth V, 2009, SCIENCE, V325, P870, DOI 10.1126/science.1174923; Brangwynne CP, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118104; Bray D., 2000, CELL MOVEMENTS MOL M; Brokaw CJ, 2009, CELL MOTIL CYTOSKEL, V66, P425, DOI 10.1002/cm.20313; Camalet S, 1999, PHYS REV LETT, V82, P1590, DOI 10.1103/PhysRevLett.82.1590; Claessens MMAE, 2006, NAT MATER, V5, P748, DOI 10.1038/nmat1718; Dreyfus R, 2005, NATURE, V437, P862, DOI 10.1038/nature04090; Dymek EE, 2007, J CELL BIOL, V179, P515, DOI 10.1083/jcb.200703107; GIBBONS BH, 1972, J CELL BIOL, V54, P75, DOI 10.1083/jcb.54.1.75; Gittes F, 1996, BIOPHYS J, V70, P418, DOI 10.1016/S0006-3495(96)79585-1; Guerin T, 2010, CURR OPIN CELL BIOL, V22, P14, DOI 10.1016/j.ceb.2009.12.012; Gueron S, 1999, P NATL ACAD SCI USA, V96, P12240, DOI 10.1073/pnas.96.22.12240; Guirao B, 2007, BIOPHYS J, V92, P1900, DOI 10.1529/biophysj.106.084897; Hentrich C, 2010, J CELL BIOL, V189, P465, DOI 10.1083/jcb.200910125; Heuser T, 2009, J CELL BIOL, V187, P921, DOI 10.1083/jcb.200908067; Horstmann E., 1964, IWF MOVIE C792 1959; Julicher F, 1997, PHYS REV LETT, V78, P4510, DOI 10.1103/PhysRevLett.78.4510; Lau AWC, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/48006; Minoura I, 1999, CELL STRUCT FUNCT, V24, P27, DOI 10.1247/csf.24.27; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; Needleman DJ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.198104; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Placais PY, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.158102; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; SATIR P, 1968, J CELL BIOL, V39, P77, DOI 10.1083/jcb.39.1.77; Stolc V, 2005, P NATL ACAD SCI USA, V102, P3703, DOI 10.1073/pnas.0408358102; SUMMERS KE, 1971, P NATL ACAD SCI USA, V68, P3092, DOI 10.1073/pnas.68.12.3092; Surrey T, 2001, SCIENCE, V292, P1167, DOI 10.1126/science.1059758; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vilfan M, 2010, P NATL ACAD SCI USA, V107, P1844, DOI 10.1073/pnas.0906819106	32	166	168	1	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2011	333	6041					456	459		10.1126/science.1203963	http://dx.doi.org/10.1126/science.1203963			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21778400	Green Accepted			2022-12-01	WOS:000292959600047
J	Weinberg, DE; Nakanishi, K; Patel, DJ; Bartel, DP				Weinberg, David E.; Nakanishi, Kotaro; Patel, Dinshaw J.; Bartel, David P.			The Inside-Out Mechanism of Dicers from Budding Yeasts	CELL			English	Article							DOUBLE-STRANDED-RNA; COLI RIBONUCLEASE-III; STRUCTURAL BASIS; NUCLEASE DOMAIN; IN-VITRO; CLEAVAGE; RECOGNITION; DROSOPHILA; INSIGHTS; DSRNA	The Dicer ribonuclease III (RNase III) enzymes process long double-stranded RNA (dsRNA) into small interfering RNAs (siRNAs) that direct RNA interference. Here, we describe the structure and activity of a catalytically active fragment of Kluyveromyces polysporus Dcr1, which represents the noncanonical Dicers found in budding yeasts. The crystal structure revealed a homodimer resembling that of bacterial RNase III but extended by a unique N-terminal domain, and it identified additional catalytic residues conserved throughout eukaryotic RNase III enzymes. Biochemical analyses showed that Dcr1 dimers bind cooperatively along the dsRNA substrate such that the distance between consecutive active sites determines the length of the siRNA products. Thus, unlike canonical Dicers, which successively remove siRNA duplexes from the dsRNA termini, budding-yeast Dicers initiate processing in the interior and work outward. The distinct mechanism of budding-yeast Dicers establishes a paradigm for natural molecular rulers and imparts substrate preferences with ramifications for biological function.	[Nakanishi, Kotaro; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Weinberg, David E.; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; [Weinberg, David E.; Bartel, David P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Weinberg, David E.; Bartel, David P.] MIT, Dept Biol, Cambridge, MA 02139 USA	Memorial Sloan Kettering Cancer Center; Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pateld@mskcc.org; dbartel@wi.mit.edu		Nakanishi, Kotaro/0000-0002-9857-6010	National Institutes of Health [GM061835, AI121493]; National Science Foundation; Human Frontier Science Program Long-term Fellowship; Japan Society for the Promotion of Science for Research Abroad; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061835, R37GM061835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Human Frontier Science Program Long-term Fellowship(Human Frontier Science Program); Japan Society for the Promotion of Science for Research Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank I. A. Drinnenberg, G. Fink, R. Fukunaga, C. Jan, R. Sauer, and D. Shechner for helpful discussions, D. Koppstein for performing mammalian gene knockdown experiments, the Whitehead Genome Technology Core for high-throughput sequencing, P. Zamore for providing DmDcr-2 enzyme, F. Roth for providing pAG416Gal-Dicer plasmid, Q. Yin in the H. Wu laboratory for assistance with light scattering experiments, the X29 beamline at Brookhaven National Laboratory, and the NE-CAT beamline at the Advanced Photon Source, Argonne National Laboratory. This work was supported by National Institutes of Health grants GM061835 (D.P.B.) and AI121493 (D.J.P.), a National Science Foundation graduate research fellowship (D.E.W.), a Human Frontier Science Program Long-term Fellowship (K.N.), and a fellowship from the Japan Society for the Promotion of Science for Research Abroad (K.N.). D.P.B. is an Investigator of the Howard Hughes Medical Institute.	Akey DL, 2005, PROTEIN SCI, V14, P2744, DOI 10.1110/ps.051665905; Blaszczyk J, 2004, STRUCTURE, V12, P457, DOI 10.1016/j.str.2004.02.004; Blaszczyk J, 2001, STRUCTURE, V9, P1225, DOI 10.1016/S0969-2126(01)00685-2; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Cenik ES, 2011, MOL CELL, V42, P172, DOI 10.1016/j.molcel.2011.03.002; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Du Z, 2008, P NATL ACAD SCI USA, V105, P2391, DOI 10.1073/pnas.0711506105; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Gan JH, 2006, CELL, V124, P355, DOI 10.1016/j.cell.2005.11.034; Gan J, 2008, MOL MICROBIOL, V67, P143, DOI 10.1111/j.1365-2958.2007.06032.x; Halic M, 2010, CELL, V140, P504, DOI 10.1016/j.cell.2010.01.019; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HOPWOOD D, 1975, HISTOCHEM J, V7, P267, DOI 10.1007/BF01003595; Lamontagne B, 2000, MOL CELL BIOL, V20, P1104, DOI 10.1128/MCB.20.4.1104-1115.2000; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Leulliot N, 2004, EMBO J, V23, P2468, DOI 10.1038/sj.emboj.7600260; MacRae IJ, 2007, NAT STRUCT MOL BIOL, V14, P934, DOI 10.1038/nsmb1293; MacRae IJ, 2007, CURR OPIN STRUC BIOL, V17, P138, DOI 10.1016/j.sbi.2006.12.002; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Meng WZ, 2008, BIOCHEM J, V410, P39, DOI 10.1042/BJ20071047; Nussbaum AK, 1998, P NATL ACAD SCI USA, V95, P12504, DOI 10.1073/pnas.95.21.12504; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Sun WM, 2004, BIOCHEMISTRY-US, V43, P13054, DOI 10.1021/bi049258i; Sun WM, 2001, BIOCHEMISTRY-US, V40, P5102, DOI 10.1021/bi010022d; Takeshita D, 2007, J MOL BIOL, V374, P106, DOI 10.1016/j.jmb.2007.08.069; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; VAUCHERET H, 2005, SCI STKE, pPE43, DOI DOI 10.1126/STKE.3002005PE42; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Welker NC, 2011, MOL CELL, V41, P589, DOI 10.1016/j.molcel.2011.02.005; WENZEL T, 1994, FEBS LETT, V349, P205, DOI 10.1016/0014-5793(94)00665-2; Wu HH, 2004, P NATL ACAD SCI USA, V101, P8307, DOI 10.1073/pnas.0402627101; Xiao JP, 2009, RNA, V15, P984, DOI 10.1261/rna.1196509; Yang D, 2002, P NATL ACAD SCI USA, V99, P9942, DOI 10.1073/pnas.152327299; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	39	50	52	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 22	2011	146	2					262	276		10.1016/j.cell.2011.06.021	http://dx.doi.org/10.1016/j.cell.2011.06.021			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	795XS	21784247	Green Submitted, Green Accepted, Bronze			2022-12-01	WOS:000293013000009
J	Karim, SSA; Kashuba, ADM; Werner, L; Karim, QA				Karim, Salim S. Abdool; Kashuba, Angela D. M.; Werner, Lise; Karim, Quarraisha Abdool			Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women	LANCET			English	Editorial Material									[Karim, Salim S. Abdool; Werner, Lise; Karim, Quarraisha Abdool] Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa, ZA-4013 Durban, Kwazulu Natal, South Africa; [Karim, Salim S. Abdool; Karim, Quarraisha Abdool] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Kashuba, Angela D. M.] Univ N Carolina, Div Pharmacotherapy & Expt Therapeut, Eshelman Sch Pharm, Chapel Hill, NC USA	University of Kwazulu Natal; Columbia University; University of North Carolina; University of North Carolina Chapel Hill	Karim, SSA (corresponding author), Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa, ZA-4013 Durban, Kwazulu Natal, South Africa.	karims1@ukzn.ac.za	Karim, Salim Abdool/AAE-7118-2019; Karim, Salim Safurdeen Abdool/N-5947-2013; Karim, Salim Abdool/P-3117-2019; Abdool Karim, Quarraisha/GVS-1160-2022	Karim, Salim Safurdeen Abdool/0000-0002-4986-2133; Karim, Salim Abdool/0000-0002-4986-2133; Abdool Karim, Quarraisha/0000-0002-0985-477X	NIAID NIH HHS [U01 AI095031, P30 AI050410] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095031, P30AI050410] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2011, FHI STAT FEM PREP HI; [Anonymous], 18 C RETR OPP INF BO; Dumond JB, 2007, AIDS, V21, P1899, DOI 10.1097/QAD.0b013e328270385a; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; HENDRIX C, 2011, 18 C OPP INF RETR BO; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2010, INDIAN J MED RES, V132, P656; Kashuba AD, 2010, 18 INT AIDS C VIENN; Patterson K. P. H., 2010, 18 INT AIDS C VIENN, P18; SCHWARTZ J, 2009, 5 IAS C HIV PATH TRE; UNAIDS Report on the Global AIDS Epidemic 2010, 2010, UNAIDS REP GLOB AIDS	11	179	179	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2011	378	9787					279	281		10.1016/S0140-6736(11)60878-7	http://dx.doi.org/10.1016/S0140-6736(11)60878-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798JD	21763939	Green Submitted, Green Accepted			2022-12-01	WOS:000293201100035
J	Alilain, WJ; Horn, KP; Hu, HM; Dick, TE; Silver, J				Alilain, Warren J.; Horn, Kevin P.; Hu, Hongmei; Dick, Thomas E.; Silver, Jerry			Functional regeneration of respiratory pathways after spinal cord injury	NATURE			English	Article							CROSSED PHRENIC PHENOMENON; INTERMITTENT HYPOXIA; AXONAL REGENERATION; PLASTICITY; RECOVERY; ABNORMALITIES; MOTONEURONS; AGONISTS; BRIDGES; GRAFTS	Spinal cord injuries often occur at the cervical level above the phrenic motor pools, which innervate the diaphragm. The effects of impaired breathing are a leading cause of death from spinal cord injuries, underscoring the importance of developing strategies to restore respiratory activity. Here we show that, after cervical spinal cord injury, the expression of chondroitin sulphate proteoglycans (CSPGs) associated with the perineuronal net (PNN) is upregulated around the phrenic motor neurons. Digestion of these potently inhibitory extracellular matrix molecules with chondroitinase ABC (denoted ChABC) could, by itself, promote the plasticity of tracts that were spared and restore limited activity to the paralysed diaphragm. However, when combined with a peripheral nerve autograft, ChABC treatment resulted in lengthy regeneration of serotonin-containing axons and other bulbospinal fibres and remarkable recovery of diaphragmatic function. After recovery and initial transection of the graft bridge, there was an unusual, overall increase in tonic electromyographic activity of the diaphragm, suggesting that considerable remodelling of the spinal cord circuitry occurs after regeneration. This increase was followed by complete elimination of the restored activity, proving that regeneration is crucial for the return of function. Overall, these experiments present a way to markedly restore the function of a single muscle after debilitating trauma to the central nervous system, through both promoting the plasticity of spared tracts and regenerating essential pathways.	[Alilain, Warren J.; Horn, Kevin P.; Hu, Hongmei; Dick, Thomas E.; Silver, Jerry] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [Dick, Thomas E.] Case Western Reserve Univ, Sch Med, Div Pulm Crit Care & Sleep Med, Dept Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Silver, J (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, 2109 Adelbert Rd, Cleveland, OH 44106 USA.	wja4@case.edu; jxs10@case.edu			Christopher and Dana Reeve Foundation; International Spinal Research Trust; National Institute of Neurological Disorders and Stroke [NS25713, NS060767]; National Heart, Lung and Blood Institute [HL080318]; Brumagin Memorial Fund; Ellen Becker Neuroscience Regenerative Medicine Research Fund; International Spinal Research Trust [STR106] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060767, R01NS025713, R37NS025713] Funding Source: NIH RePORTER	Christopher and Dana Reeve Foundation; International Spinal Research Trust; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Brumagin Memorial Fund; Ellen Becker Neuroscience Regenerative Medicine Research Fund; International Spinal Research Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was funded by The Christopher and Dana Reeve Foundation (W.J.A.), the International Spinal Research Trust (W.J.A.), the National Institute of Neurological Disorders and Stroke, grants NS25713 and NS060767 (J.S.), and the National Heart, Lung and Blood Institute, grant HL080318 (T. E. D.). We offer special thanks to the Brumagin Memorial Fund (J.S.) and the Ellen Becker Neuroscience Regenerative Medicine Research Fund (J.S.). We also thank J. D. Houle and V. J. Tom for teaching us the peripheral nerve grafting technique.	Alilain WJ, 2008, J NEUROSCI, V28, P11862, DOI 10.1523/JNEUROSCI.3378-08.2008; Alto LT, 2009, NAT NEUROSCI, V12, P1106, DOI 10.1038/nn.2365; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Choi H, 2005, J NEUROSCI, V25, P4550, DOI 10.1523/JNEUROSCI.5135-04.2005; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005; Fuller DD, 2005, J NEUROTRAUM, V22, P203, DOI 10.1089/neu.2005.22.203; Fuller DD, 2003, J NEUROSCI, V23, P2993; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; GAUTHIER P, 1988, BRAIN RES, V438, P225, DOI 10.1016/0006-8993(88)91341-8; Gauthier P, 2002, J NEUROSCI RES, V70, P65, DOI 10.1002/jnr.10379; Golder FJ, 2005, J NEUROSCI, V25, P2925, DOI 10.1523/JNEUROSCI.0148-05.2005; Goshgarian HG, 2003, J APPL PHYSIOL, V94, P795, DOI 10.1152/japplphysiol.00847.2002; Hadley SD, 1999, EXP NEUROL, V160, P479, DOI 10.1006/exnr.1999.7240; Hayashi F, 2003, J APPL PHYSIOL, V94, P1421, DOI 10.1152/japplphysiol.00599.2002; Hodges MR, 2008, J NEUROSCI, V28, P2495, DOI 10.1523/JNEUROSCI.4729-07.2008; Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006; Houle John D, 2009, J Vis Exp, DOI 10.3791/1324; Hunanyan AS, 2010, J NEUROSCI, V30, P7761, DOI 10.1523/JNEUROSCI.4659-09.2010; Lane MA, 2008, J COMP NEUROL, V511, P692, DOI 10.1002/cne.21864; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; McPhail LT, 2005, EUR J NEUROSCI, V21, P267, DOI 10.1111/j.1460-9568.2004.03837.x; MUNZ M, 1985, BRAIN RES, V340, P115, DOI 10.1016/0006-8993(85)90780-2; Nantwi KD, 1996, EXP NEUROL, V140, P53, DOI 10.1006/exnr.1996.0114; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Teng YD, 2003, J NEUROSCI, V23, P4182; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Yang LJS, 2006, P NATL ACAD SCI USA, V103, P11057, DOI 10.1073/pnas.0604613103; Zhou LJ, 2003, J NEUROSCI, V23, P1424, DOI 10.1523/JNEUROSCI.23-04-01424.2003	33	283	290	1	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					196	U95		10.1038/nature10199	http://dx.doi.org/10.1038/nature10199			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21753849	Green Accepted			2022-12-01	WOS:000292690500043
J	Deweerdt, S				DeWeerdt, Sarah			PREVENTION Activity is the best medicine	NATURE			English	Editorial Material							COGNITIVE DECLINE; ALZHEIMER-DISEASE; PHYSICAL-ACTIVITY; OLDER-ADULTS; RISK; DEMENTIA; DIET											Barnes LL, 2004, NEUROLOGY, V63, P2322, DOI 10.1212/01.WNL.0000147473.04043.B3; Belleville S, 2011, BRAIN, V134, P1623, DOI 10.1093/brain/awr037; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Feart C, 2009, JAMA-J AM MED ASSOC, V302, P638, DOI 10.1001/jama.2009.1146; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Savica R, 2011, PSYCHIAT CLIN N AM, V34, P127, DOI 10.1016/j.psc.2010.11.006; Scarmeas N, 2009, JAMA-J AM MED ASSOC, V302, P627, DOI 10.1001/jama.2009.1144; Tangney CC, 2011, AM J CLIN NUTR, V93, P601, DOI 10.3945/ajcn.110.007369; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805	9	32	33	3	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					S16	S17		10.1038/475S16a	http://dx.doi.org/10.1038/475S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	791UA	21760577	Bronze			2022-12-01	WOS:000292690500008
J	Schmidt, M; Christiansen, CF; Mehnert, F; Rothman, KJ; Sorensen, HT				Schmidt, Morten; Christiansen, Christian F.; Mehnert, Frank; Rothman, Kenneth J.; Sorensen, Henrik Toft			Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CYCLOOXYGENASE-2 INHIBITORS; METAANALYSIS; COHORT; NSAIDS	Objectives To examine the risk of atrial fibrillation or flutter associated with use of non-selective non-steroidal anti-inflammatory drugs (NSAIDs) or selective cyclo-oxygenase (COX) 2 inhibitors. Design Population based case-control study using data from medical databases. Setting Northern Denmark (population 1.7 million). Participants 32 602 patients with a first inpatient or outpatient hospital diagnosis of atrial fibrillation or flutter between 1999 and 2008; 325 918 age matched and sex matched controls based on risk-set sampling. Main outcome measures Exposure to NSAID use at the time of admission (current use) or before (recent use). Current use was further classified as new use (first ever prescription redemption within 60 days before diagnosis date) or long term use. We used conditional logistic regression to compute odds ratios as unbiased estimates of the incidence rate ratios. Results 2925 cases (9%) and 21 871 controls (7%) were current users of either non-selective NSAIDs or COX 2 inhibitors. Compared with no use, the incidence rate ratio associating current drug use with atrial fibrillation or flutter was 1.33 (95% confidence interval 1.26 to 1.41) for non-selective NSAIDs and 1.50 (1.42 to 1.59) for COX 2 inhibitors. Adjustments for age, sex, and risk factors for atrial fibrillation or flutter reduced the incidence rate ratio to 1.17 (1.10 to 1.24) for non-selective NSAIDs and 1.27 (1.20 to 1.34) for COX 2 inhibitors. Among new users, the adjusted incidence rate ratio was 1.46 (1.33 to 1.62) for non-selective NSAIDs and 1.71 (1.56 to 1.88) for COX 2 inhibitors. Results for individual NSAIDs were similar. Conclusions Use of non-aspirin NSAIDs was associated with an increased risk of atrial fibrillation or flutter. Compared with non-users, the association was strongest for new users, with a 40-70% increase in relative risk (lowest for non-selective NSAIDs and highest for COX 2 inhibitors). Our study thus adds evidence that atrial fibrillation or flutter needs to be added to the cardiovascular risks to be considered when prescribing NSAIDs.	[Schmidt, Morten; Christiansen, Christian F.; Mehnert, Frank; Sorensen, Henrik Toft] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8200 Aarhus N, Denmark; [Rothman, Kenneth J.] Res Triangle Inst, RTI Hlth Solut, Res Triangle Pk, NC 27709 USA; [Rothman, Kenneth J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Aarhus University; Research Triangle Institute; Boston University	Schmidt, M (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8200 Aarhus N, Denmark.	msc@dce.au.dk	Schmidt, Morten/F-5048-2013; Sorensen, Henrik Toft/Z-6181-2019; Christiansen, Christian Fynbo/B-5870-2014; Christiansen, Christian/ABE-9423-2021	Sorensen, Henrik Toft/0000-0003-4299-7040; Christiansen, Christian Fynbo/0000-0002-0727-953X; Christiansen, Christian/0000-0002-0727-953X; Schmidt, Morten/0000-0002-4935-4059; Mehnert, Frank/0000-0001-7639-7356; Rothman, Kenneth/0000-0003-2398-1705	Danish Medical Research Council [271-05-0511]; Clinical Epidemiological Research Foundation, Denmark; Danish Heart Association; Aarhus University; Department of Clinical Epidemiology collaborates within the EU	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Clinical Epidemiological Research Foundation, Denmark; Danish Heart Association; Aarhus University; Department of Clinical Epidemiology collaborates within the EU	The study was supported by the Danish Medical Research Council (grant 271-05-0511), the Clinical Epidemiological Research Foundation, Denmark, the Danish Heart Association, and an Aarhus University scholarship. Department of Clinical Epidemiology collaborates within the EU Seventh Framework Programme: Arrhythmogenic potential of drugs (ARITMO). None of the funding sources had a role in the study design, conduct, analysis, or reporting.	Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], GUIDELINES TREATMENT; Aw TJ, 2005, ARCH INTERN MED, V165, P490, DOI 10.1001/archinte.165.5.IOI50013; Badhwar N, 2008, J CARDIOVASC ELECTR, V19, P1151, DOI 10.1111/j.1540-8167.2008.01238.x; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Capone ML, 2007, PROSTAG OTH LIPID M, V82, P85, DOI 10.1016/j.prostaglandins.2006.05.019; Christiansen CF, 2009, ARCH INTERN MED, V169, P1677, DOI 10.1001/archinternmed.2009.297; Cryer B, 1998, AM J MED, V104, P413, DOI 10.1016/S0002-9343(98)00091-6; *DAN MED AG, REIMB MED; De Caterina R, 2010, ARCH INTERN MED, V170, P1450, DOI 10.1001/archinternmed.2010.305; Ehrenstein Vera, 2010, Clin Epidemiol, V2, P273, DOI 10.2147/CLEP.S13458; Engelmann MDM, 2005, EUR HEART J, V26, P2083, DOI 10.1093/eurheartj/ehi350; Frost L, 2004, ARCH INTERN MED, V164, P1993, DOI 10.1001/archinte.164.18.1993; Greenland S, 2000, AM J EPIDEMIOL, V151, P531; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Laine L, 2002, SEMIN ARTHRITIS RHEU, V32, P25, DOI 10.1053/sarh.2002.37217; Pedersen CB, 2006, DAN MED BULL, V53, P441; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Stevenson WG, 2004, NEW ENGL J MED, V351, P2437, DOI 10.1056/NEJMe048248; Thomsen RW, 2006, AM J GASTROENTEROL, V101, P2704, DOI 10.1111/j.1572-0241.2006.00825.x; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; van der Hooft CS, 2004, J AM COLL CARDIOL, V44, P2117, DOI 10.1016/j.jacc.2004.08.053; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1019, DOI 10.1093/oxfordjournals.aje.a116396; Waldo AL, 2008, J AM COLL CARDIOL, V51, P779, DOI 10.1016/j.jacc.2007.08.066; Whelton A., 2001, AM J MED S1, V110, P33; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Zhang JJ, 2006, JAMA-J AM MED ASSOC, V296, P1619, DOI 10.1001/jama.296.13.jrv60015	30	80	87	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 4	2011	343								d3450	10.1136/bmj.d3450	http://dx.doi.org/10.1136/bmj.d3450			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791RR	21727167	hybrid			2022-12-01	WOS:000292682800003
J	Laurance, J				Laurance, Jeremy			On Reflection A bug's life	LANCET			English	Editorial Material												j.laurance@independent.co.uk							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL-AUG	2011	378	9789					392	392		10.1016/S0140-6736(11)61198-7	http://dx.doi.org/10.1016/S0140-6736(11)61198-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	803XM	21803193				2022-12-01	WOS:000293615900015
J	Graham-Rowe, D				Graham-Rowe, Duncan			Beyond food versus fuel	NATURE			English	Editorial Material																			0	155	159	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S6	S8		10.1038/474S06a	http://dx.doi.org/10.1038/474S06a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697842	Bronze			2022-12-01	WOS:000291939700002
J	Gong, R; Ding, C; Hu, J; Lu, Y; Liu, F; Mann, E; Xu, FQ; Cohen, MB; Luo, MM				Gong, Rong; Ding, Cheng; Hu, Ji; Lu, Yao; Liu, Fei; Mann, Elizabeth; Xu, Fuqiang; Cohen, Mitchell B.; Luo, Minmin			Role for the Membrane Receptor Guanylyl Cyclase-C in Attention Deficiency and Hyperactive Behavior	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; MICE LACKING; DOPAMINE; AMPHETAMINE; UROGUANYLIN; RESISTANT; PATHWAY	Midbrain dopamine neurons regulate many important behavioral processes, and their dysfunctions are associated with several human neuropsychiatric disorders such as attention deficit hyperactivity disorder (ADHD) and schizophrenia. Here, we report that these neurons in mice selectively express guanylyl cyclase-C (GC-C), a membrane receptor previously thought to be expressed mainly in the intestine. GC-C activation potentiates the excitatory responses mediated by glutamate and acetylcholine receptors via the activity of guanosine 3',5'-monophosphate-dependent protein kinase (PKG). Mice in which GC-C has been knocked out exhibit hyperactivity and attention deficits. Moreover, their behavioral phenotypes are reversed by ADHD therapeutics and a PKG activator. These results indicate important behavioral and physiological functions for the GC-C/PKG signaling pathway within the brain and suggest new therapeutic targets for neuropsychiatric disorders related to the malfunctions of midbrain dopamine neurons.	[Gong, Rong; Ding, Cheng; Hu, Ji; Lu, Yao; Luo, Minmin] NIBS, Beijing 102206, Peoples R China; [Gong, Rong] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China; [Gong, Rong] Peking Union Med Coll, Beijing 100730, Peoples R China; [Ding, Cheng] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Liu, Fei; Xu, Fuqiang] Chinese Acad Sci, Wuhan Inst Phys & Math, Wuhan 430071, Peoples R China; [Mann, Elizabeth; Cohen, Mitchell B.] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA; [Luo, Minmin] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Normal University; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; Cincinnati Children's Hospital Medical Center; Tsinghua University	Luo, MM (corresponding author), NIBS, Beijing 102206, Peoples R China.	luominmin@nibs.ac.cn	xu, fuqiang/AAI-1571-2019; Ding, Cheng/N-6735-2016; Hu, Ji/H-2293-2011; Gong, Rong/A-6358-2017	Gong, Rong/0000-0002-9775-118X; xu, fu qiang/0000-0002-4382-9797; Luo, Minmin/0000-0003-3535-6624; Cohen, Mitchell/0000-0002-4412-350X	China Ministry of Science and Technology	China Ministry of Science and Technology(Ministry of Science and Technology, China)	We thank K. Kobayashi (Fukushima Medical University, Japan) for TH-GFP transgenic mice, X. Lei (NIBS) for behavioral reagents, and J. Zhang (Chinese Academy of Medical Sciences) for high-pressure liquid chromatography/electrochemical detection service. We also thank D. Perkel and Y. Rao for comments on the manuscript. M. L. is supported by China Ministry of Science and Technology 973 Grants. In situ hybridization and immunostaining was performed by R. G. and J. H.; slice recording was performed by R. G. and J. H.; behavioral assays were performed by C. D., Y. L., and J. H.; in vivo microdialysis was performed by C. D., F. L., and F. X.; in vivo drug delivery was performed by C. D.; GC-C KO generation was performed by E. M. and M. B. C.; and experimental design and manuscript writing were performed by M. L. The authors declare no conflicts of interest. Cincinnati Children's Hospital requires a materials transfer agreement for use of the GC-C KO mice.	Bengtson CP, 2004, J PHYSIOL-LONDON, V555, P323, DOI 10.1113/jphysiol.2003.060061; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; BUTT E, 1994, EUR J PHARM-MOLEC PH, V269, P265, DOI 10.1016/0922-4106(94)90095-7; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; CURRIE MG, 1992, P NATL ACAD SCI USA, V89, P947, DOI 10.1073/pnas.89.3.947; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; Emilien G, 1999, PHARMACOL THERAPEUT, V84, P133, DOI 10.1016/S0163-7258(99)00029-7; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; HAMRA FK, 1993, P NATL ACAD SCI USA, V90, P10464, DOI 10.1073/pnas.90.22.10464; Hess EJ, 1996, J NEUROSCI, V16, P3104, DOI 10.1523/jneurosci.16-09-03104.1996; Kinoshita H, 1997, KIDNEY INT, V52, P1028, DOI 10.1038/ki.1997.424; KRAUSE WJ, 1994, J ANAT, V184, P407; Kwan HY, 2004, P NATL ACAD SCI USA, V101, P2625, DOI 10.1073/pnas.0304471101; LACEY MG, 1990, J PHARMACOL EXP THER, V253, P395; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lucas KA, 2000, PHARMACOL REV, V52, P375; Mann EA, 1997, BIOCHEM BIOPH RES CO, V239, P463, DOI 10.1006/bbrc.1997.7487; Matsushita N, 2002, J NEUROCHEM, V82, P295, DOI 10.1046/j.1471-4159.2002.00972.x; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Nugent FS, 2007, NATURE, V446, P1086, DOI 10.1038/nature05726; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; Reaume Christopher J., 2009, V191, P423, DOI 10.1007/978-3-540-68964-5_18; Sagvolden T, 2005, BIOL PSYCHIAT, V57, P1239, DOI 10.1016/j.biopsych.2005.02.002; Scheving LA, 1999, AM J PHYSIOL-CELL PH, V277, pC1177, DOI 10.1152/ajpcell.1999.277.6.C1177; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; SCHULZ S, 1990, CELL, V63, P941, DOI 10.1016/0092-8674(90)90497-3; Schulz S, 1997, J CLIN INVEST, V100, P1590, DOI 10.1172/JCI119683; Spencer T, 2001, ARCH GEN PSYCHIAT, V58, P775, DOI 10.1001/archpsyc.58.8.775; TIPPER SP, 1989, J EXP CHILD PSYCHOL, V48, P353, DOI 10.1016/0022-0965(89)90047-7; Volkow ND, 2009, JAMA-J AM MED ASSOC, V302, P1084, DOI 10.1001/jama.2009.1308; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	31	81	84	5	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2011	333	6049					1642	1646		10.1126/science.1207675	http://dx.doi.org/10.1126/science.1207675			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21835979				2022-12-01	WOS:000294900900047
J	Schwille, P				Schwille, Petra			Bottom-Up Synthetic Biology: Engineering in a Tinkerer's World	SCIENCE			English	Editorial Material							ORGANIZATION; LESSONS	How synthetic can "synthetic biology" be? A literal interpretation of the name of this new life science discipline invokes expectations of the systematic construction of biological systems with cells being built module by module-from the bottom up. But can this possibly be achieved, taking into account the enormous complexity and redundancy of living systems, which distinguish them quite remarkably from design features that characterize human inventions? There are several recent developments in biology, in tight conjunction with quantitative disciplines, that may bring this literal perspective into the realm of the possible. However, such bottom-up engineering requires tools that were originally designed by nature's greatest tinkerer: evolution.	Tech Univ Dresden, Biophys BIOTEC, D-01307 Dresden, Germany	Technische Universitat Dresden	Schwille, P (corresponding author), Tech Univ Dresden, Biophys BIOTEC, Tatzberg 47-51, D-01307 Dresden, Germany.	schwille@biotec.tu-dresden.de	Schwille, Petra/A-4983-2010					Bashor CJ, 2010, ANNU REV BIOPHYS, V39, P515, DOI 10.1146/annurev.biophys.050708.133652; Choi HJ, 2005, NANO LETT, V5, P2538, DOI 10.1021/nl051896e; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Loose M, 2011, ANNU REV BIOPHYS, V40, P315, DOI 10.1146/annurev-biophys-042910-155332; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nandagopal N, 2011, SCIENCE, V333, P1244, DOI 10.1126/science.1207084; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Ruder WC, 2011, SCIENCE, V333, P1248, DOI 10.1126/science.1206843; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; Taubes G, 2000, SCIENCE, V288, P80, DOI 10.1126/science.288.5463.80; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Yeh BJ, 2007, NAT CHEM BIOL, V3, P521, DOI 10.1038/nchembio0907-521	16	146	153	2	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2011	333	6047					1252	1254		10.1126/science.1211701	http://dx.doi.org/10.1126/science.1211701			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21885774				2022-12-01	WOS:000294406400042
J	Pan, YD; Birdsey, RA; Fang, JY; Houghton, R; Kauppi, PE; Kurz, WA; Phillips, OL; Shvidenko, A; Lewis, SL; Canadell, JG; Ciais, P; Jackson, RB; Pacala, SW; McGuire, AD; Piao, SL; Rautiainen, A; Sitch, S; Hayes, D				Pan, Yude; Birdsey, Richard A.; Fang, Jingyun; Houghton, Richard; Kauppi, Pekka E.; Kurz, Werner A.; Phillips, Oliver L.; Shvidenko, Anatoly; Lewis, Simon L.; Canadell, Josep G.; Ciais, Philippe; Jackson, Robert B.; Pacala, Stephen W.; McGuire, A. David; Piao, Shilong; Rautiainen, Aapo; Sitch, Stephen; Hayes, Daniel			A Large and Persistent Carbon Sink in the World's Forests	SCIENCE			English	Article							TROPICAL FORESTS; UNITED-STATES; CO2 EMISSIONS; DROUGHT; LAND; SENSITIVITY; MANAGEMENT; ATMOSPHERE; INCREASE; BALANCE	The terrestrial carbon sink has been large in recent decades, but its size and location remain uncertain. Using forest inventory data and long-term ecosystem carbon studies, we estimate a total forest sink of 2.4 +/- 0.4 petagrams of carbon per year (Pg C year(-1)) globally for 1990 to 2007. We also estimate a source of 1.3 +/- 0.7 Pg C year(-1) from tropical land-use change, consisting of a gross tropical deforestation emission of 2.9 +/- 0.5 Pg C year(-1) partially compensated by a carbon sink in tropical forest regrowth of 1.6 +/- 0.5 Pg C year(-1). Together, the fluxes comprise a net global forest sink of 1.1 +/- 0.8 Pg C year(-1), with tropical estimates having the largest uncertainties. Our total forest sink estimate is equivalent in magnitude to the terrestrial sink deduced from fossil fuel emissions and land-use change sources minus ocean and atmospheric sinks.	[Pan, Yude; Birdsey, Richard A.] US Forest Serv, USDA, Newtown Sq, PA 19073 USA; [Fang, Jingyun; Piao, Shilong] Peking Univ, Minist Educ, Key Lab Earth Surface Proc, Beijing 100871, Peoples R China; [Fang, Jingyun] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing 100093, Peoples R China; [Houghton, Richard] Woods Hole Res Ctr, Falmouth, MA 02543 USA; [Kauppi, Pekka E.; Rautiainen, Aapo] Univ Helsinki, Helsinki, Finland; [Kurz, Werner A.] Nat Resources Canada, Canadian Forest Serv, Victoria, BC V8Z 1M5, Canada; [Phillips, Oliver L.; Lewis, Simon L.; Sitch, Stephen] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Shvidenko, Anatoly] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Canadell, Josep G.] Commonwealth Sci & Ind Res Org Marine & Atmospher, Global Carbon Project, Canberra, ACT, Australia; [Ciais, Philippe] Lab Sci Climat & Environm CEA UVSQ CNRS, Gif Sur Yvette, France; [Jackson, Robert B.] Duke Univ, Durham, NC 27708 USA; [Pacala, Stephen W.] Princeton Univ, Princeton, NJ 08544 USA; [McGuire, A. David] Univ Alaska, US Geol Survey, Alaska Cooperat Fish & Wildlife Res Unit, Fairbanks, AK 99775 USA; [Hayes, Daniel] Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA	United States Department of Agriculture (USDA); United States Forest Service; Peking University; Chinese Academy of Sciences; Institute of Botany, CAS; Woods Hole Research Center; University of Helsinki; Natural Resources Canada; Canadian Forest Service; University of Leeds; International Institute for Applied Systems Analysis (IIASA); Commonwealth Scientific & Industrial Research Organisation (CSIRO); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Duke University; Princeton University; United States Department of the Interior; United States Geological Survey; University of Alaska System; University of Alaska Fairbanks; United States Department of Energy (DOE); Oak Ridge National Laboratory	Pan, YD (corresponding author), US Forest Serv, USDA, Newtown Sq, PA 19073 USA.	ypan@fs.fed.us	Noojipady, Praveen/B-2511-2010; Pan, Yude/F-6145-2015; Ciais, Philippe M/A-6840-2011; Phillips, Oliver L/A-1523-2011; Sitch, Stephen A/F-8034-2015; Canadell, Pep/E-9419-2010; Shvidenko, Anatoly/I-1505-2016; Hayes, Daniel/B-8968-2012	Ciais, Philippe M/0000-0001-8560-4943; Phillips, Oliver L/0000-0002-8993-6168; Sitch, Stephen A/0000-0003-1821-8561; Canadell, Pep/0000-0002-8788-3218; Shvidenko, Anatoly/0000-0001-7640-2151; Jackson, Robert/0000-0001-8846-7147; Kurz, Werner/0000-0003-4576-7849; Rautiainen, Aapo/0000-0002-6885-215X; Lewis, Simon/0000-0002-8066-6851; Hayes, Daniel/0000-0002-3011-7934	U.S. Forest Service, NASA [31021001]; National Basic Research Program of China on Global Change [2010CB50600]; Gordon and Betty Moore Foundation; Peking Univ.; Princeton Univ.; Natural Environment Research Council [NE/D000300/1, NE/B504630/1, NE/B503384/1] Funding Source: researchfish	U.S. Forest Service, NASA(United States Department of Agriculture (USDA)United States Forest ServiceNational Aeronautics & Space Administration (NASA)); National Basic Research Program of China on Global Change(National Basic Research Program of China); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Peking Univ.(Peking University); Princeton Univ.(Princeton University); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study is the major output of two workshops at Peking Univ. and Princeton Univ. Y.P., R.A.B., and J.F. were lead authors and workshop organizers; Y.P., R.A.B., J.F., R.H., P.E.K., W.A.K., O.L.P., A.S., and S.L.L. contributed primary data sets and analyses; J.G.C., P.C., R.B.J., and S.W.P. contributed noteworthy ideas to improve the study; A.D.M., S.P., A.R., S.S., and D.H. provided results of modeling or data analysis relevant to the study; and all authors contributed in writing, discussions, or comments. We thank K. McCullough for helping to make the map in Fig. 1 and C. Wayson for helping to develop a Monte-Carlo analysis. This work was supported in part by the U.S. Forest Service, NASA (grant 31021001), the National Basic Research Program of China on Global Change (2010CB50600), the Gordon and Betty Moore Foundation, Peking Univ., and Princeton Univ. This work is a contribution toward the Global Carbon Project's aim of fostering an international framework to study the global carbon cycle.	Birdsey R, 2006, J ENVIRON QUAL, V35, P1461, DOI 10.2134/jeq2005.0162; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Ciais P, 2008, NAT GEOSCI, V1, P425, DOI 10.1038/ngeo233; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; FAO: Global Forest Resources Assessment, 2010, 163 FAO; Friedlingstein P, 2010, NAT GEOSCI, V3, P811, DOI 10.1038/ngeo1022; Gloor M, 2009, GLOBAL CHANGE BIOL, V15, P2418, DOI 10.1111/j.1365-2486.2009.01891.x; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.1890/1051-0761(2002)012[0891:FCSITN]2.0.CO;2; Hooijer A, 2010, BIOGEOSCIENCES, V7, P1505, DOI 10.5194/bg-7-1505-2010; Houghton RA, 2007, ANNU REV EARTH PL SC, V35, P313, DOI 10.1146/annurev.earth.35.031306.140057; Houghton RA, 2003, TELLUS B, V55, P378, DOI 10.1034/j.1600-0889.2003.01450.x; Intergovernamental Panel on Climate Change, 2006, IPCC GUID NAT GREENH; Kauppi PE, 2006, P NATL ACAD SCI USA, V103, P17574, DOI 10.1073/pnas.0608343103; Kauppi PE, 2010, FOREST ECOL MANAG, V259, P1239, DOI 10.1016/j.foreco.2009.07.044; Khatiwala S, 2009, NATURE, V462, P346, DOI 10.1038/nature08526; Kurz WA, 2008, P NATL ACAD SCI USA, V105, P1551, DOI 10.1073/pnas.0708133105; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Lewis SL, 2009, ANNU REV ECOL EVOL S, V40, P529, DOI 10.1146/annurev.ecolsys.39.110707.173345; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; McGuire AD, 2009, ECOL MONOGR, V79, P523, DOI 10.1890/08-2025.1; Metsaranta JM, 2010, TELLUS B, V62, P719, DOI 10.1111/j.1600-0889.2010.00487.x; Nabuurs G. J., 2007, CLIMATE CHANGE 2007, P542; Pacala SW, 2001, SCIENCE, V292, P2316, DOI 10.1126/science.1057320; Page SE, 2011, GLOBAL CHANGE BIOL, V17, P798, DOI 10.1111/j.1365-2486.2010.02279.x; Pan Y, 2011, BIOGEOSCIENCES, V8, P715, DOI 10.5194/bg-8-715-2011; Pan YD, 2009, FOREST ECOL MANAG, V259, P151, DOI 10.1016/j.foreco.2009.09.049; Phillips OL, 2004, PHILOS T R SOC B, V359, P381, DOI 10.1098/rstb.2003.1438; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Sarmiento JL, 2010, BIOGEOSCIENCES, V7, P2351, DOI 10.5194/bg-7-2351-2010; Schulze ED, 2009, NAT GEOSCI, V2, P842, DOI 10.1038/ngeo686; Shvidenko A.Z., 2007, BASIC PROBLEMS TRANS, P5; Stinson G, 2011, GLOBAL CHANGE BIOL, V17, P2227, DOI 10.1111/j.1365-2486.2010.02369.x; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Zhao MS, 2010, SCIENCE, V329, P940, DOI 10.1126/science.1189590	37	3937	4289	322	3396	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 19	2011	333	6045					988	993		10.1126/science.1201609	http://dx.doi.org/10.1126/science.1201609			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808TD	21764754				2022-12-01	WOS:000294000400048
J	Gai, ZK; Donoghue, PCJ; Zhu, M; Janvier, P; Stampanoni, M				Gai, Zhikun; Donoghue, Philip C. J.; Zhu, Min; Janvier, Philippe; Stampanoni, Marco			Fossil jawless fish from China foreshadows early jawed vertebrate anatomy	NATURE			English	Article							TOMOGRAPHIC MICROSCOPY; INTERNAL ANATOMY; NEURAL CREST; ORIGIN; EVOLUTION; AGNATHANS; PHYLOGENY; LAMPREY; HEAD	Most living vertebrates are jawed vertebrates (gnathostomes), and the living jawless vertebrates (cyclostomes), hagfishes and lampreys, provide scarce information about the profound reorganization of the vertebrate skull during the evolutionary origin of jaws(1-9). The extinct bony jawless vertebrates, or 'ostracoderms', are regarded as precursors of jawed vertebrates and provide insight into this formative episode in vertebrate evolution(8-14). Here, using synchrotron radiation X-ray tomography(15,16), we describe the cranial anatomy of galeaspids, a 435-370-million-year-old 'ostracoderm' group from China and Vietnam(17). The paired nasal sacs of galeaspids are located anterolaterally in the braincase, and the hypophyseal duct opens anteriorly towards the oral cavity. These three structures (the paired nasal sacs and the hypophyseal duct) were thus already independent of each other, like in gnathostomes and unlike in cyclostomes and osteostracans (another 'ostracoderm' group), and therefore have the condition that current developmental models regard as prerequisites for the development of jaws(1-3). This indicates that the reorganization of vertebrate cranial anatomy was not driven deterministically by the evolutionary origin of jaws but occurred stepwise, ultimately allowing the rostral growth of ectomesenchyme that now characterizes gnathostome head development(1-3).	[Gai, Zhikun; Donoghue, Philip C. J.] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England; [Gai, Zhikun; Zhu, Min] Chinese Acad Sci, Lab Evolutionary Systemat Vertebrates, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; [Janvier, Philippe] Museum Natl Hist Nat, CNRS, UMR 7207, F-75231 Paris 05, France; [Stampanoni, Marco] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Stampanoni, Marco] Univ & ETH Zurich, Inst Biomed Engn, CH-8092 Zurich, Switzerland	University of Bristol; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Donoghue, PCJ (corresponding author), Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England.	phil.donoghue@bristol.ac.uk; zhumin@ivpp.ac.cn	min, zhu/AAL-6712-2021; Janvier, Philippe/Q-5268-2019; Donoghue, Philip/A-3873-2008; Stampanoni, Marco/AAZ-3033-2021; Stampanoni, Marco/J-4099-2013; Stampanoni, Marco/GRR-9695-2022; Zhu, Min/E-8728-2012	Donoghue, Philip/0000-0003-3116-7463; Stampanoni, Marco/0000-0001-7486-6681; Stampanoni, Marco/0000-0001-7486-6681; Stampanoni, Marco/0000-0001-7486-6681; Zhu, Min/0000-0002-4786-0898	Chinese Academy of Sciences [KZCX2-YW-156]; Chinese Foundation of Natural Sciences [40872020, 40930208]; Major Basic Research Projects of MST of China [2006CB806400]; Paul Scherrer Institut; European Union; Leverhulme Trust; Natural Environmental Research Council; SYNTHESYS Project; Royal Society; NERC [NE/G016623/1] Funding Source: UKRI; Natural Environment Research Council [NE/G016623/1] Funding Source: researchfish	Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Foundation of Natural Sciences; Major Basic Research Projects of MST of China; Paul Scherrer Institut; European Union(European Commission); Leverhulme Trust(Leverhulme Trust); Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); SYNTHESYS Project; Royal Society(Royal Society of London); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank F. Marone, S. Bengtson, E.-M. Friis, N. J. Gostling, T. Huldtgren, M. Pawlowska and C.-W. Thomas for assistance in retrieving synchrotron radiation X-ray tomographic microscopy data; Q.-S. Chen and W.-J. Zhao for field work; and S. Powell, F.-X. Wu, B. Choo and R.-D. Zhao for illustrations. This work was supported by the Chinese Academy of Sciences (KZCX2-YW-156), the Chinese Foundation of Natural Sciences (40872020, 40930208), the Major Basic Research Projects (2006CB806400) of MST of China, the Paul Scherrer Institut (P. C. J. D.), European Union FP6 (P. C. J. D.), the Leverhulme Trust (P. C. J. D.), the Natural Environmental Research Council (P. C. J. D.), the SYNTHESYS Project (Z.G.) and a Dorothy Hodgkin studentship from the Royal Society (Z.G.).	Baker CVH, 2005, J EXP ZOOL PART B, V304B, P269, DOI 10.1002/jez.b.21060; Donoghue PCJ, 2001, T ROY SOC EDIN-EARTH, V92, P15, DOI 10.1017/S026359330000002X; Donoghue PCJ, 2005, TRENDS ECOL EVOL, V20, P312, DOI 10.1016/j.tree.2005.04.008; Donoghue PCJ, 2006, NATURE, V442, P680, DOI 10.1038/nature04890; FOREY P, 1993, NATURE, V361, P129, DOI 10.1038/361129a0; FOREY PL, 1995, REV FISH BIOL FISHER, V5, P267, DOI 10.1007/BF00043003; Gai Zhi-Kun, 2005, Vertebrata Palasiatica, V43, P61; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; HALSTEAD LB, 1979, NATURE, V282, P833, DOI 10.1038/282833a0; HALSTEAD LB, 1979, NATURE, V282, P831, DOI 10.1038/282831a0; Heimberg AM, 2010, P NATL ACAD SCI USA, V107, P19379, DOI 10.1073/pnas.1010350107; Janvier P, 1996, PALAEONTOLOGY, V39, P259; Janvier P, 2001, SYST ASSOC SPEC VOL, V61, P172; JANVIER P, 1979, ZOOL SCR, V8, P287, DOI 10.1111/j.1463-6409.1979.tb00640.x; JANVIER P., 1996, EARLY VERTEBRATES; Janvier Philippe, 2007, P57; Khonsari RH, 2009, ACTA ZOOL-STOCKHOLM, V90, P52, DOI 10.1111/j.1463-6395.2008.00388.x; Kuratani S, 2001, PHILOS T ROY SOC B, V356, P1615, DOI 10.1098/rstb.2001.0976; Kuratani S, 2008, J EXP ZOOL PART B, V310B, P294, DOI 10.1002/jez.b.21190; Mazan S, 2000, EVOL DEV, V2, P186, DOI 10.1046/j.1525-142x.2000.00062.x; PAN J, 1986, YOH SS, P67; Shigetani Y, 2002, SCIENCE, V296, P1316, DOI 10.1126/science.1068310; Smeets W.J.A.J., 1998, P551; Stampanoni M, 2007, AIP CONF PROC, V879, P848; Stensio E.A., 1927, SKRIFTER SVALBARD NO, DOI DOI 10.3402/POLAR.V14I1.6649; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Uchida K, 2003, J EXP ZOOL PART B, V300B, P32, DOI 10.1002/jez.b.00044; von Kupffer C., 1900, STUDIEN VERGLEICHEND; Wang Nian-zhong, 1991, P41; Zhu Min, 2006, Vertebrata Palasiatica, V44, P1	30	84	102	3	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 18	2011	476	7360					324	327		10.1038/nature10276	http://dx.doi.org/10.1038/nature10276			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21850106				2022-12-01	WOS:000294206500036
J	Leadbeater, E; Carruthers, JM; Green, JP; Rosser, NS; Field, J				Leadbeater, Ellouise; Carruthers, Jonathan M.; Green, Jonathan P.; Rosser, Neil S.; Field, Jeremy			Nest Inheritance Is the Missing Source of Direct Fitness in a Primitively Eusocial Insect	SCIENCE			English	Article							POLISTES-DOMINULUS; FUTURE FITNESS; KIN SELECTION; MODELS FAIL; SKEW	Animals that cooperate with nonrelatives represent a challenge to inclusive fitness theory, unless cooperative behavior is shown to provide direct fitness benefits. Inheritance of breeding resources could provide such benefits, but this route to cooperation has been little investigated in the social insects. We show that nest inheritance can explain the presence of unrelated helpers in a classic social insect model, the primitively eusocial wasp Polistes dominulus. We found that subordinate helpers produced more direct offspring than lone breeders, some while still subordinate but most after inheriting the dominant position. Thus, while indirect fitness obtained through helping relatives has been the dominant paradigm for understanding eusociality in insects, direct fitness is vital to explain cooperation in P. dominulus.	[Leadbeater, Ellouise; Carruthers, Jonathan M.; Green, Jonathan P.; Field, Jeremy] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; [Carruthers, Jonathan M.] Univ Sheffield, NERC, Biomol Anal Facil, Sheffield S10 2TN, S Yorkshire, England; [Rosser, Neil S.] UCL, Dept Genet Evolut & Environm, London NW1 2HE, England	University of Sussex; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Sheffield; University of London; University College London	Leadbeater, E (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW4 4RY, England.	ellouise.leadbeater@ioz.ac.uk		Rosser, Neil/0000-0001-7796-2548	NERC [NE/E017894/1]; NERC [NBAF010001] Funding Source: UKRI; Natural Environment Research Council [NBAF010001] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We are grateful to J. M. Mancera Romero for facilities in Spain and to P. Nonacs and N. Raihani for comments on an earlier version of the manuscript. Primer design and genotyping was carried out at the NERC Biomolecular Analysis Facility, Sheffield, for which we thank T. Burke, D. Dawson, and A. Krupa. Funded by NERC grant NE/E017894/1 (J.F.). Data have been deposited in the Dryad Digital Repository, 10.5061/dryad.85g00.	[Anonymous], 1991, SOCIAL BIOL WASPS; Boomsma JJ, 2007, CURR BIOL, V17, pR673, DOI 10.1016/j.cub.2007.06.033; Bourke AFG, 2011, OX ECOL EV, P1, DOI 10.1093/acprof:oso/9780199231157.001.0001; Cant MA, 2006, P ROY SOC B-BIOL SCI, V273, P2977, DOI 10.1098/rspb.2006.3669; Cant MA, 2001, P ROY SOC B-BIOL SCI, V268, P1959, DOI 10.1098/rspb.2001.1754; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Field J, 2006, NATURE, V441, P214, DOI 10.1038/nature04560; Field J., 2009, REPROD SKEW VERTEBRA; Karsai I, 1996, BEHAV ECOL SOCIOBIOL, V39, P97, DOI 10.1007/s002650050271; Kokko H, 1999, P ROY SOC B-BIOL SCI, V266, P571, DOI 10.1098/rspb.1999.0674; Leadbeater E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011997; Liebert AE, 2006, ANIM BEHAV, V71, P913, DOI 10.1016/j.anbehav.2005.09.005; Liebert AE, 2005, BEHAV ECOL SOCIOBIOL, V57, P445, DOI 10.1007/s00265-004-0875-5; Nonacs P, 2006, AM NAT, V167, P467, DOI 10.1086/501168; PETERS JM, 1995, P ROY SOC B-BIOL SCI, V260, P7, DOI 10.1098/rspb.1995.0052; Queller DC, 2000, NATURE, V405, P784, DOI 10.1038/35015552; Ragsdale JE, 1999, EVOL ECOL RES, V1, P859; Reeve Hudson K., 1993, P45; Shreeves G, 2003, P ROY SOC B-BIOL SCI, V270, P1617, DOI 10.1098/rspb.2003.2409; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; Zanette LRS, 2008, MOL ECOL, V17, P2590, DOI 10.1111/j.1365-294X.2008.03785.x	21	127	128	2	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2011	333	6044					874	876		10.1126/science.1205140	http://dx.doi.org/10.1126/science.1205140			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21836014				2022-12-01	WOS:000293785400039
J	Yoo, AS; Sun, AX; Li, L; Shcheglovitov, A; Portmann, T; Li, YL; Lee-Messer, C; Dolmetsch, RE; Tsien, RW; Crabtree, GR				Yoo, Andrew S.; Sun, Alfred X.; Li, Li; Shcheglovitov, Aleksandr; Portmann, Thomas; Li, Yulong; Lee-Messer, Chris; Dolmetsch, Ricardo E.; Tsien, Richard W.; Crabtree, Gerald R.			MicroRNA-mediated conversion of human fibroblasts to neurons	NATURE			English	Article							CHROMATIN-REMODELING COMPLEXES; SUBVENTRICULAR ZONE; NEURAL DEVELOPMENT; GENE-EXPRESSION; MIR-124; REST; DIFFERENTIATION; NEUROGENESIS; NEOCORTEX; NETWORK	Neurogenic transcription factors and evolutionarily conserved signalling pathways have been found to be instrumental in the formation of neurons(1,2). However, the instructive role of microRNAs (miRNAs) in neurogenesis remains unexplored. We recently discovered that miR-9* and miR-124 instruct compositional changes of SWI/SNF-like BAF chromatin-remodelling complexes, a process important for neuronal differentiation and function(3-6). Nearing mitotic exit of neural progenitors, miR-9* and miR-124 repress the BAF53a subunit of the neural-progenitor (np)BAF chromatin-remodelling complex. After mitotic exit, BAF53a is replaced by BAF53b, and BAF45a by BAF45b and BAF45c, which are then incorporated into neuron-specific (n)BAF complexes essential for post-mitotic functions(4). Because miR-9/9* and miR-124 also control multiple genes regulating neuronal differentiation and function(5,7-13), we proposed that these miRNAs might contribute to neuronal fates. Here we show that expression of miR-9/9* and miR-124 (miR-9/9*-124) in human fibroblasts induces their conversion into neurons, a process facilitated by NEUROD2. Further addition of neurogenic transcription factors ASCL1 and MYT1L enhances the rate of conversion and the maturation of the converted neurons, whereas expression of these transcription factors alone without miR-9/9*-124 was ineffective. These studies indicate that the genetic circuitry involving miR-9/9*-124 can have an instructive role in neural fate determination.	[Yoo, Andrew S.; Crabtree, Gerald R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Yoo, Andrew S.; Crabtree, Gerald R.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Yoo, Andrew S.; Crabtree, Gerald R.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Sun, Alfred X.] Stanford Univ, Program Canc Biol, Stanford, CA 94305 USA; [Li, Li; Li, Yulong; Tsien, Richard W.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Li, Li] Stanford Univ, Med Scientist Training Program, Stanford, CA 94305 USA; [Li, Li] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Shcheglovitov, Aleksandr; Portmann, Thomas; Dolmetsch, Ricardo E.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Lee-Messer, Chris] Stanford Univ, Dept Neurol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Crabtree, GR (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	yooa@wustl.edu; crabtree@stanford.edu	Li, Li/B-9514-2015	Yoo, Andrew/0000-0002-0304-3247; Li, Li/0000-0001-6131-4394; Li, Yulong/0000-0002-9166-9919; Sun, Alfred Xuyang/0000-0002-7893-2006	Agency of Science, Technology and Research of Singapore (A*STAR); Stanford Medical Scientist Training Program; National Institutes of Mental Health (NIMH) [F30MH093125]; Frances B. Nelson predoctoral fellowship; CIRM; Swiss National Science Foundation SNSF [PA00P3_134196]; NIH [HD55391, AI060037, NS046789, NS24067, GM58234, MH064070]; Simon's Foundation; Simons Family Foundation; Mathers Family Foundation; Burnett Family Foundation; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064070, R56MH064070, F30MH093125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024067, R01NS046789, R37NS046789] Funding Source: NIH RePORTER	Agency of Science, Technology and Research of Singapore (A*STAR)(Agency for Science Technology & Research (A*STAR)); Stanford Medical Scientist Training Program; National Institutes of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Frances B. Nelson predoctoral fellowship; CIRM(California Institute for Regenerative Medicine); Swiss National Science Foundation SNSF(Swiss National Science Foundation (SNSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simon's Foundation; Simons Family Foundation; Mathers Family Foundation; Burnett Family Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank I. Graef and A. Cho for helpful suggestions and reagents, A. Kuo and W. Ho for technical help, and X. Bao and P. Khavari for their generous gift of reagents. A.S.Y. is a fellow of the Helen Hay Whitney Foundation. A. X. S. is funded by the Agency of Science, Technology and Research of Singapore (A*STAR). L. L. is supported by the Stanford Medical Scientist Training Program, National Institutes of Mental Health (NIMH) F30MH093125, and the Frances B. Nelson predoctoral fellowship. A. S. is supported by the CIRM post-doctoral fellowship. T. P. is supported by a Swiss National Science Foundation SNSF fellowship for advanced researchers (PA00P3_134196). R. E. D. is supported by the NIH Director's Award, and awards from the Simon's Foundation and the CIRM. R. E. D. is also grateful for funding from B. and F. Horowitz, M. McCafferey, B. and J. Packard, P. Kwan and K. Wang. R. W. T. is supported by grants from the Simons, Mathers and Burnett Family Foundations. This work was supported by grants from the Howard Hughes Medical Institute (G. R. C.) and the NIH (HD55391, AI060037 and NS046789 to G. R. C., and NS24067, GM58234 and MH064070 to R.W.T.).	Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Coolen M, 2009, CURR OPIN NEUROBIOL, V19, P461, DOI 10.1016/j.conb.2009.09.006; Hansen DV, 2011, NEURON, V70, P645, DOI 10.1016/j.neuron.2011.05.006; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; HO L, NATURE CELL IN PRESS; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Ince-Dunn G, 2006, NEURON, V49, P683, DOI 10.1016/j.neuron.2006.01.031; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Laneve P, 2010, NUCLEIC ACIDS RES, V38, P6895, DOI 10.1093/nar/gkq604; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lin CH, 2005, P NATL ACAD SCI USA, V102, P14877, DOI 10.1073/pnas.0506785102; Maiorano NA, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-40; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; McCormick MB, 1996, MOL CELL BIOL, V16, P5792; Olson JM, 2001, DEV BIOL, V234, P174, DOI 10.1006/dbio.2001.0245; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Tang XQ, 2007, RNA, V13, P1803, DOI 10.1261/rna.498607; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Wu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r85; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139	27	692	741	0	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 11	2011	476	7359					228	U123		10.1038/nature10323	http://dx.doi.org/10.1038/nature10323			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21753754	Green Accepted			2022-12-01	WOS:000293731900041
J	Akre, KL; Farris, HE; Lea, AM; Page, RA; Ryan, MJ				Akre, Karin L.; Farris, Hamilton E.; Lea, Amanda M.; Page, Rachel A.; Ryan, Michael J.			Signal Perception in Frogs and Bats and the Evolution of Mating Signals	SCIENCE			English	Article							TUNGARA FROGS; SEXUAL SELECTION; MATE CHOICE; FEMALE PREFERENCES; CALL DURATION; ADVERTISEMENT; PSYCHOPHYSICS; COMPLEXITY; CUES	Psychophysics measures the relationship between a stimulus's physical magnitude and its perceived magnitude. Because decisions are based on perception of stimuli, this relationship is critical to understanding decision-making. We tested whether psychophysical laws explain how female tungara frogs (Physalaemus pustulosus) and frog-eating bats (Trachops cirrhosus) compare male frog calls, and how this imposes selection on call evolution. Although both frogs and bats prefer more elaborate calls, they are less selective as call elaboration increases, because preference is based on stimulus ratios. Thus, as call elaboration increases, both relative attractiveness and relative predation risk decrease because of how receivers perceive and compare stimuli. Our data show that female cognition can limit the evolution of sexual signal elaboration.	[Akre, Karin L.; Lea, Amanda M.; Ryan, Michael J.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Farris, Hamilton E.] Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA 70112 USA; [Farris, Hamilton E.] Louisiana State Univ, Hlth Sci Ctr, Kresge Hearing Labs, New Orleans, LA 70112 USA; [Page, Rachel A.; Ryan, Michael J.] Smithsonian Trop Res Inst, Balboa, Panama	University of Texas System; University of Texas Austin; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Smithsonian Institution; Smithsonian Tropical Research Institute	Akre, KL (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	kakre@mail.utexas.edu	Page, Rachel/AAE-4816-2021; Page, Rachel A/GQQ-2818-2022	Page, Rachel A/0000-0001-7072-0669	NSF [IBN0078150]; NIH [P20RR016816]; STRI, NSF [0608131]; American Association of University Women; P.E.O. Scholar award; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016816] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); STRI, NSF(Smithsonian InstitutionSmithsonian Tropical Research InstituteNational Science Foundation (NSF)); American Association of University Women; P.E.O. Scholar award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank J. Saunders, S. Ozeroff, A. Shah, K. Miller, K. Loukes, S. Troxell, S. Griffin, M. Moscoso, V. Fugere, and W. Wohlwend for help conducting experiments. A. Mason and WABC 2011 participants gave helpful suggestions. STRI provided excellent logistical support. Supported by an NSF graduate research fellowship (K.L.A.), NIH grant P20RR016816 (H.E.F.), NSF grant IBN0078150 (M.J.R.), STRI, NSF grant 0608131, the American Association of University Women, and a P.E.O. Scholar award (R.A.P.).	Akre KL, 2010, ETHOLOGY, V116, P1138, DOI 10.1111/j.1439-0310.2010.01825.x; Andersson Malte, 1994; Bateson M, 2005, TRENDS ECOL EVOL, V20, P659, DOI 10.1016/j.tree.2005.08.013; Bee MA, 2008, ANIM BEHAV, V76, P845, DOI 10.1016/j.anbehav.2008.01.029; Bernal XE, 2007, AM NAT, V169, P409, DOI 10.1086/510729; Bernal XE, 2009, BEHAV ECOL SOCIOBIOL, V63, P1269, DOI 10.1007/s00265-009-0795-5; Bonachea LA, 2011, ETHOLOGY, V117, P56, DOI 10.1111/j.1439-0310.2010.01843.x; COHEN JA, 1984, Z TIERPSYCHOL, V64, P1; Endler JA, 2005, EVOLUTION, V59, P1795, DOI 10.1111/j.0014-3820.2005.tb01827.x; Fechner G.T., 1912, CLASSICAL PSYCHOLOGI, P562; Gerhardt HC, 2000, BEHAV ECOL, V11, P663, DOI 10.1093/beheco/11.6.663; GREEN DM, 1989, J ACOUST SOC AM, V86, P629, DOI 10.1121/1.398759; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Page RA, 2005, P ROY SOC B-BIOL SCI, V272, P841, DOI 10.1098/rspb.2004.2998; Page RA, 2008, ANIM BEHAV, V76, P761, DOI 10.1016/j.anbehav.2008.05.006; Popper A. N., 1995, SPRINGER HDB AUDITOR; PRICE DK, 1994, AM NAT, V144, P908, DOI 10.1086/285718; Prum RO, 2010, EVOLUTION, V64, P3085, DOI 10.1111/j.1558-5646.2010.01054.x; Pryke SR, 2008, BEHAV ECOL, V19, P1116, DOI 10.1093/beheco/arn100; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; Ryan M.J., 1990, Oxford Surveys in Evolutionary Biology, V7, P157; Ryan MJ, 2010, CURR ZOOL, V56, P343, DOI 10.1093/czoolo/56.3.343; RYAN MJ, 1982, AM NAT, V119, P136, DOI 10.1086/283899; Ryan MJ., 1985, TUNGARA FROG STUDY S; Shettleworth S., 2009, COGNITION EVOLUTION; Stevens S. S., 2017, PSYCHOPHYSICS INTRO; Wyttenbach RA, 2004, MICROSC RES TECHNIQ, V63, P375, DOI 10.1002/jemt.20054	29	104	106	3	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2011	333	6043					751	752		10.1126/science.1205623	http://dx.doi.org/10.1126/science.1205623			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817052				2022-12-01	WOS:000293512100041
J	Alvania, R				Alvania, Rebecca			Slick Science: Will New BP Funds Keep Gulf Genomics Afloat?	CELL			English	Editorial Material									Trends Cell Biol, Cambridge, MA USA		Alvania, R (corresponding author), Trends Cell Biol, Cambridge, MA USA.	ralvania@cell.com		Alvania, Rebecca/0000-0002-3846-0702					0	0	0	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 5	2011	146	3					343	345		10.1016/j.cell.2011.07.017	http://dx.doi.org/10.1016/j.cell.2011.07.017			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	803GT	21816268	Bronze			2022-12-01	WOS:000293570500006
J	Chen, SK; Badea, TC; Hattar, S				Chen, S. -K.; Badea, T. C.; Hattar, S.			Photoentrainment and pupillary light reflex are mediated by distinct populations of ipRGCs	NATURE			English	Article							RETINAL GANGLION-CELLS; MELANOPSIN; MORPHOLOGY; RESPONSES; PROJECTIONS; DIVERSITY	Intrinsically photosensitive retinal ganglion cells (ipRGCs) express the photopigment melanopsin and regulate a wide array of light-dependent physiological processes(1-11). Genetic ablation of ipRGCs eliminates circadian photoentrainment and severely disrupts the pupillary light reflex (PLR)(12,13). Here we show that ipRGCs consist of distinct subpopulations that differentially express the Brn3b transcription factor, and can be functionally distinguished. Brn3b-negative M1 ipRGCs innervate the suprachiasmatic nucleus (SCN) of the hypothalamus, whereas Brn3b-positive ipRGCs innervate all other known brain targets, including the olivary pre-tectal nucleus. Consistent with these innervation patterns, selective ablation of Brn3b-positive ipRGCs severely disrupts the PLR, but does not impair circadian photoentrainment. Thus, we find that molecularly distinct subpopulations of M1 ipRGCs, which are morphologically and electrophysiologically similar, innervate different brain regions to execute specific light-induced functions.	[Chen, S. -K.; Hattar, S.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Badea, T. C.] NEI, Retinal Circuit Dev & Genet Unit, N NRL, NIH, Bethesda, MD 20892 USA; [Hattar, S.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21218 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Johns Hopkins University	Hattar, S (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	tudor.badea@nih.gov; shattar@jhu.edu	Badea, Tudor Constantin/B-1654-2018; Hattar, Samer/W-6927-2019	Badea, Tudor Constantin/0000-0003-3086-6713; CHEN, SHIH-KUO/0000-0002-7921-1358	Johns Hopkins University Mouse Tri-Lab; National Institutes of Health [GM076430]; David and Lucile Packard Foundation; Alfred P. Sloan Foundation; NATIONAL EYE INSTITUTE [ZIAEY000504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076430] Funding Source: NIH RePORTER	Johns Hopkins University Mouse Tri-Lab; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Nathans for providing several animal lines (Brn3b<SUP>CKOAP</SUP>, R26<SUP>IAP</SUP> and Z/AP) that were crucial for the completion of this study. We thank J. L. Ecker, who created the inducible cre line (Opn4<SUP>CreERT2</SUP>) we used in this study. We thank Z. Yang in D. Zack's laboratory for providing the Brn3b<SUP>Z-dta</SUP> mouse line, which was generously provided by the original laboratory that created this line: W. Klein. We also thank R. Kuruvilla, H. Zhao, M. Halpern, A. P. Sampath and T. Schmidt for their careful reading of the manuscript and helpful suggestions and the Johns Hopkins University Mouse Tri-Lab for support. This work was supported by the National Institutes of Health grant GM076430 (S. H.), the David and Lucile Packard Foundation (S. H.), and the Alfred P. Sloan Foundation (S.H.).	Badea TC, 2003, J NEUROSCI, V23, P2314; Badea TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007859; Badea TC, 2009, NEURON, V61, P852, DOI 10.1016/j.neuron.2009.01.020; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brown TM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000558; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Gan L, 1999, DEV BIOL, V210, P469, DOI 10.1006/dbio.1999.9280; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hannibal J, 2004, NEUROREPORT, V15, P2317, DOI 10.1097/00001756-200410250-00003; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; Mu XQ, 2005, CURR BIOL, V15, P525, DOI 10.1016/j.cub.2005.01.043; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751	28	273	278	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2011	476	7358					92	+		10.1038/nature10206	http://dx.doi.org/10.1038/nature10206			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NR	21765429	Green Accepted			2022-12-01	WOS:000293447300036
J	Tonkin, ML; Roques, M; Lamarque, MH; Pugniere, M; Douguet, D; Crawford, J; Lebrun, M; Boulanger, MJ				Tonkin, Michelle L.; Roques, Magali; Lamarque, Mauld H.; Pugniere, Martine; Douguet, Dominique; Crawford, Joanna; Lebrun, Maryse; Boulanger, Martin J.			Host Cell Invasion by Apicomplexan Parasites: Insights from the Co-Structure of AMA1 with a RON2 Peptide	SCIENCE			English	Article							APICAL MEMBRANE ANTIGEN-1; TOXOPLASMA-GONDII; MOVING JUNCTION; INHIBITORY ANTIBODY; COMPLEX; ERYTHROCYTE	Apicomplexan parasites such as Toxoplasma gondii and Plasmodium species actively invade host cells through a moving junction (MJ) complex assembled at the parasite-host cell interface. MJ assembly is initiated by injection of parasite rhoptry neck proteins (RONs) into the host cell, where RON2 spans the membrane and functions as a receptor for apical membrane antigen 1 (AMA1) on the parasite. We have determined the structure of TgAMA1 complexed with a RON2 peptide at 1.95 angstrom resolution. A stepwise assembly mechanism results in an extensive buried surface area, enabling the MJ complex to resist the mechanical forces encountered during host cell invasion. Besides providing insights into host cell invasion by apicomplexan parasites, the structure offers a basis for designing therapeutics targeting these global pathogens.	[Roques, Magali; Lamarque, Mauld H.; Lebrun, Maryse] Univ Montpellier 2, CNRS, UMR 5235, F-34095 Montpellier, France; [Tonkin, Michelle L.; Crawford, Joanna; Boulanger, Martin J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Pugniere, Martine] INSERM, U896, Inst Rech Cancerol Montpellier, F-34298 Montpellier, France; [Douguet, Dominique] Univ Nice Sophia Antipolis, CNRS, UMR6097, F-06560 Valbonne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of Victoria; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Lebrun, M (corresponding author), Univ Montpellier 2, CNRS, UMR 5235, F-34095 Montpellier, France.	mylebrun@univ-montp2.fr; mboulang@uvic.ca	Pugniere, Martine/T-1355-2017; PUGNIERE, Martine/AAD-4315-2020; Lebrun, Maryse/I-7728-2016; Crawford, Joanna/F-9135-2013; douguet, dominique/D-5644-2017	Pugniere, Martine/0000-0002-2049-2909; PUGNIERE, Martine/0000-0002-2049-2909; Crawford, Joanna/0000-0003-0786-6889; Lebrun, Maryse/0000-0002-0962-0156	Canadian Institutes of Health Research (CIHR) [MOP82915]; Julie Payette Natural Sciences and Engineering Research Council;  [ANR-MIE-2009]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Julie Payette Natural Sciences and Engineering Research Council; 	This work was supported by Canadian Institutes of Health Research (CIHR) grant MOP82915 to M.J.B. and ANR-MIE-2009 grant to M. L. M.J.B. is a CIHR New Investigator and a Michael Smith Foundation for Health Research scholar. M. L. T. is supported by a Julie Payette Natural Sciences and Engineering Research Council Research Scholarship. M. H. L. is supported by ANR-MIE-2009. We are grateful to G. Labesse and R. Cerdan for helpful discussions and to J.-F. Dubremetz and M. Murphy for critical reading of the manuscript. Structure factors and coordinates have been deposited in the Protein Data Bank (PDB) under accession nos.: 2y8t, r2y8tsf (TgAMA1-TgRON2sp), 2y8r, r2y8rsf (TgAMA1 Y230A) and 2y8s, r2y8ssf (TgAMA1 Y230A-TgRON2sp). The CNRS and the University of Victoria Innovation and Development Corporation have filed a European Patent Application (application number EP 11305540.4) on the identification of a region of RON2 involved in AMA1 binding and its potential targeting by vaccines and drugs.	AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; Alexander DL, 2006, EUKARYOT CELL, V5, P1169, DOI 10.1128/EC.00040-06; Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Cao J, 2009, PARASITOL INT, V58, P29, DOI 10.1016/j.parint.2008.09.005; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Carruthers VB, 2007, CURR OPIN MICROBIOL, V10, P82; Chesne-Seck ML, 2005, MOL BIOCHEM PARASIT, V144, P55, DOI 10.1016/j.molbiopara.2005.07.007; Coley AM, 2006, INFECT IMMUN, V74, P2628, DOI 10.1128/IAI.74.5.2628-2636.2006; Coley AM, 2007, PLOS PATHOG, V3, P1308, DOI 10.1371/journal.ppat.0030138; Collins CR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000273; Crawford J, 2010, J BIOL CHEM, V285, P15644, DOI 10.1074/jbc.M109.092619; Henderson KA, 2007, STRUCTURE, V15, P1452, DOI 10.1016/j.str.2007.09.011; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Lebrun M, 2005, CELL MICROBIOL, V7, P1823, DOI 10.1111/j.1462-5822.2005.00646.x; Mital J, 2005, MOL BIOL CELL, V16, P4341, DOI 10.1091/mbc.E05-04-0281; Mordue DG, 1999, J EXP MED, V190, P1783, DOI 10.1084/jem.190.12.1783; MORISAKI JH, 1995, J CELL SCI, V108, P2457; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Santos JM, 2011, SCIENCE, V331, P473, DOI 10.1126/science.1199284; Treeck M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000322; Tyler JS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001282	26	143	155	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2011	333	6041					463	467		10.1126/science.1204988	http://dx.doi.org/10.1126/science.1204988			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21778402				2022-12-01	WOS:000292959600049
J	Eyerich, S; Onken, AT; Weidinger, S; Franke, A; Nasorri, F; Pennino, D; Grosber, M; Pfab, F; Schmidt-Weber, CB; Mempel, M; Hein, R; Ring, J; Cavani, A; Eyerich, K				Eyerich, Stefanie; Onken, Anna T.; Weidinger, Stephan; Franke, Andre; Nasorri, Francesca; Pennino, Davide; Grosber, Martine; Pfab, Florian; Schmidt-Weber, Carsten B.; Mempel, Martin; Hein, Ruediger; Ring, Johannes; Cavani, Andrea; Eyerich, Kilian			Mutual Antagonism of T Cells Causing Psoriasis and Atopic Eczema	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PATCH TEST; DISEASE; MECHANISMS; EXPRESSION; IL-17	The simultaneous occurrence of psoriasis driven by type 1 helper T (Th1) cells and type 17 helper T (Th17) cells and atopic eczema dominated by type 2 helper T (Th2) cells is rare. Here, we describe three patients with co-occurring psoriasis and atopic eczema with an antagonistic course and distinct T-cell infiltrates in lesions from psoriasis and those from atopic eczema. Sensitized patients with psoriasis had a reaction to epicutaneous allergen challenge, with clinically and histologically verified eczema lesions containing a large number of allergen-reactive T cells. These findings support a causative role for T cells triggered by specific antigens in both psoriasis and atopic eczema.	[Onken, Anna T.; Grosber, Martine; Pfab, Florian; Hein, Ruediger; Ring, Johannes; Eyerich, Kilian] Tech Univ Munich, Dept Dermatol & Allergy, D-80802 Munich, Germany; [Eyerich, Stefanie; Pennino, Davide; Schmidt-Weber, Carsten B.] Tech Univ, Ctr Allergy & Environm ZAUM, Munich, Germany; [Eyerich, Stefanie; Pennino, Davide; Schmidt-Weber, Carsten B.] Helmholtz Ctr Munich, Munich, Germany; [Weidinger, Stephan] Univ Hosp Schleswig Holstein, Dept Dermatol Allergol & Venerol, Kiel, Germany; [Franke, Andre] Univ Hosp Schleswig Holstein, Inst Clin Mol Biol, Kiel, Germany; [Mempel, Martin] Univ Med Gottingen, Dept Dermatol Venereol & Allergol, Gottingen, Germany; [Nasorri, Francesca; Cavani, Andrea] Ist Dermopat Immacolata, Expt Immunol Lab, Rome, Italy	Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Gottingen; IRCCS Istituto Dermopatico dell'Immacolata (IDI)	Eyerich, K (corresponding author), Tech Univ Munich, Dept Dermatol & Allergy, Biedersteiner Str 29, D-80802 Munich, Germany.	kilian.eyerich@lrz.tum.de	Schmidt-Weber, Carsten B./AAU-1621-2021; Pennino, Davide/D-7519-2013; Franke, Andre/B-2151-2010; Ring, Johannes/GLN-4341-2022; Weidinger, Stephan/C-8461-2011	Schmidt-Weber, Carsten B./0000-0002-3203-8084; Pennino, Davide/0000-0002-5834-1049; Franke, Andre/0000-0003-1530-5811; Ring, Johannes/0000-0001-8236-3152; Weidinger, Stephan/0000-0003-3944-252X	German Research Foundation [EY97/1-2, WE2678/4-1]; Kommission Klinische Forschung of the Klinikum Rechts der Isar Munich; Hochschulwissen-schaftsprogramm of the Technische Universitat Munich; Bayerische Forschungsstiftung; National Genome Research Network [01GS0809, 01GS0818]; Christine Kuhne Center of Allergy Research and Education	German Research Foundation(German Research Foundation (DFG)); Kommission Klinische Forschung of the Klinikum Rechts der Isar Munich; Hochschulwissen-schaftsprogramm of the Technische Universitat Munich; Bayerische Forschungsstiftung; National Genome Research Network; Christine Kuhne Center of Allergy Research and Education	Supported by the German Research Foundation and others.; Supported by grants from Deutsche Forschungsgemeinschaft (EY97/1-2 and WE2678/4-1), Kommission Klinische Forschung of the Klinikum Rechts der Isar Munich, Hochschulwissen-schaftsprogramm of the Technische Universitat Munich, Bayerische Forschungsstiftung, the National Genome Research Network (01GS0809 and 01GS0818), and the Christine Kuhne Center of Allergy Research and Education.	Albanesi C, 2007, J IMMUNOL, V179, P984, DOI 10.4049/jimmunol.179.2.984; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; DARSOW U, 1995, J ALLERGY CLIN IMMUN, V95, P677, DOI 10.1016/S0091-6749(95)70172-9; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Eyerich K, 2008, J INVEST DERMATOL, V128, P2640, DOI 10.1038/jid.2008.139; Eyerich K, 2008, INT ARCH ALLERGY IMM, V145, P213, DOI 10.1159/000109290; Eyerich K, 2009, J ALLERGY CLIN IMMUN, V123, P59, DOI 10.1016/j.jaci.2008.10.031; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Ghoreschi K, 2003, NAT MED, V9, P40, DOI 10.1038/nm804; GREWE M, 1995, J INVEST DERMATOL, V105, P407, DOI 10.1111/1523-1747.ep12321078; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; HENSELER T, 1995, J AM ACAD DERMATOL, V32, P982, DOI 10.1016/0190-9622(95)91336-X; Howell MD, 2009, J ALLERGY CLIN IMMUN, V124, pR7, DOI 10.1016/j.jaci.2009.07.012; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nograles KE, 2009, J ALLERGY CLIN IMMUN, V123, P1244, DOI 10.1016/j.jaci.2009.03.041; Pennino D, 2010, J IMMUNOL, V184, P4880, DOI 10.4049/jimmunol.0901767; Weidinger S, 2008, J ALLERGY CLIN IMMUN, V121, P1203, DOI 10.1016/j.jaci.2008.02.014; Weiss G, 2002, J EUR ACAD DERMATOL, V16, P241, DOI 10.1046/j.1473-2165.2002.00406.x	18	142	147	2	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2011	365	3					231	238		10.1056/NEJMoa1104200	http://dx.doi.org/10.1056/NEJMoa1104200			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794QI	21774711	Green Submitted, Green Published			2022-12-01	WOS:000292915500007
J	Rothberg, JM; Hinz, W; Rearick, TM; Schultz, J; Mileski, W; Davey, M; Leamon, JH; Johnson, K; Milgrew, MJ; Edwards, M; Hoon, J; Simons, JF; Marran, D; Myers, JW; Davidson, JF; Branting, A; Nobile, JR; Puc, BP; Light, D; Clark, TA; Huber, M; Branciforte, JT; Stoner, IB; Cawley, SE; Lyons, M; Fu, YT; Homer, N; Sedova, M; Miao, X; Reed, B; Sabina, J; Feierstein, E; Schorn, M; Alanjary, M; Dimalanta, E; Dressman, D; Kasinskas, R; Sokolsky, T; Fidanza, JA; Namsaraev, E; McKernan, KJ; Williams, A; Roth, GT; Bustillo, J				Rothberg, Jonathan M.; Hinz, Wolfgang; Rearick, Todd M.; Schultz, Jonathan; Mileski, William; Davey, Mel; Leamon, John H.; Johnson, Kim; Milgrew, Mark J.; Edwards, Matthew; Hoon, Jeremy; Simons, Jan F.; Marran, David; Myers, Jason W.; Davidson, John F.; Branting, Annika; Nobile, John R.; Puc, Bernard P.; Light, David; Clark, Travis A.; Huber, Martin; Branciforte, Jeffrey T.; Stoner, Isaac B.; Cawley, Simon E.; Lyons, Michael; Fu, Yutao; Homer, Nils; Sedova, Marina; Miao, Xin; Reed, Brian; Sabina, Jeffrey; Feierstein, Erika; Schorn, Michelle; Alanjary, Mohammad; Dimalanta, Eileen; Dressman, Devin; Kasinskas, Rachel; Sokolsky, Tanya; Fidanza, Jacqueline A.; Namsaraev, Eugeni; McKernan, Kevin J.; Williams, Alan; Roth, G. Thomas; Bustillo, James			An integrated semiconductor device enabling non-optical genome sequencing	NATURE			English	Article							SENSOR ARRAY CHIP; CMOS TECHNOLOGY; DNA; CHARGE; TRANSISTOR; SEA	The seminal importance of DNA sequencing to the life sciences, biotechnology and medicine has driven the search for more scalable and lower-cost solutions. Here we describe a DNA sequencing technology in which scalable, low-cost semiconductor manufacturing techniques are used to make an integrated circuit able to directly perform non-optical DNA sequencing of genomes. Sequence data are obtained by directly sensing the ions produced by template-directed DNA polymerase synthesis using all-natural nucleotides on this massively parallel semiconductor-sensing device or ion chip. The ion chip contains ion-sensitive, field-effect transistor-based sensors in perfect register with 1.2 million wells, which provide confinement and allow parallel, simultaneous detection of independent sequencing reactions. Use of the most widely used technology for constructing integrated circuits, the complementary metal-oxide semiconductor (CMOS) process, allows for low-cost, large-scale production and scaling of the device to higher densities and larger array sizes. We show the performance of the system by sequencing three bacterial genomes, its robustness and scalability by producing ion chips with up to 10 times as many sensors and sequencing a human genome.	[Rothberg, Jonathan M.; Hinz, Wolfgang; Rearick, Todd M.; Schultz, Jonathan; Mileski, William; Davey, Mel; Leamon, John H.; Johnson, Kim; Milgrew, Mark J.; Edwards, Matthew; Hoon, Jeremy; Simons, Jan F.; Marran, David; Myers, Jason W.; Davidson, John F.; Branting, Annika; Nobile, John R.; Puc, Bernard P.; Light, David; Clark, Travis A.; Huber, Martin; Branciforte, Jeffrey T.; Stoner, Isaac B.; Cawley, Simon E.; Lyons, Michael; Fu, Yutao; Homer, Nils; Sedova, Marina; Miao, Xin; Reed, Brian; Sabina, Jeffrey; Feierstein, Erika; Schorn, Michelle; Alanjary, Mohammad; Dimalanta, Eileen; Dressman, Devin; Kasinskas, Rachel; Sokolsky, Tanya; Fidanza, Jacqueline A.; Namsaraev, Eugeni; McKernan, Kevin J.; Williams, Alan; Roth, G. Thomas; Bustillo, James] Ion Torrent Life Technol, Guilford, CT 06437 USA	Thermo Fisher Scientific	Rothberg, JM (corresponding author), Ion Torrent Life Technol, Suite 100,246 Goose Lane, Guilford, CT 06437 USA.	Jonathan.Rothberg@Lifetech.com	schorn, michelle/AAD-6284-2020; Alanjary, Mohammad/D-3896-2016	Alanjary, Mohammad/0000-0001-8420-1325; McKernan, Kevin/0000-0002-3908-1122	National Human Genome Research Institute (NHGRI) [RFA-HG-08-008];  [R01 HG005094]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005094] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We want to thank G. Moore for his willingness to participate in this study. We thank G. Fergus, M. Jain, J. Kole, L. Stevens and the ION team for supporting our efforts, and H. Peckman, V. Tadigotla, D. Holloway and S. Mclaughlin for help on the variant analysis, and M. Ross of the Broad Institute for help on quality scores. This research was supported, in part, by a grant from the National Human Genome Research Institute (NHGRI), RFA-HG-08-008, Revolutionary Genome Sequencing Technologies-The $1000 Genome. Grant number: R01 HG005094.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Bausells J, 1999, SENSOR ACTUAT B-CHEM, V57, P56, DOI 10.1016/S0925-4005(99)00135-5; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bergveld P, 2003, SENSOR ACTUAT B-CHEM, V88, P1, DOI 10.1016/S0925-4005(02)00301-5; BERGVELD P, 1970, IEEE T BIO-MED ENG, VBM17, P70, DOI 10.1109/TBME.1970.4502688; BRANDSTATTER AK, 2011, HUM MUTAT, V32, P25; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; DAVIES K, 2010, 1000 GENOME; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Drummond TG, 2003, NAT BIOTECHNOL, V21, P1192, DOI 10.1038/nbt873; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fritz J, 2002, P NATL ACAD SCI USA, V99, P14142, DOI 10.1073/pnas.232276699; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Hammond PA, 2004, MICROELECTRON ENG, V73-4, P893, DOI 10.1016/j.mee.2004.03.071; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hizawa T, 2006, SENSOR ACTUAT B-CHEM, V117, P509, DOI 10.1016/j.snb.2006.01.056; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mikolajick T, 1997, SENSOR ACTUAT B-CHEM, V44, P262, DOI 10.1016/S0925-4005(97)00166-4; Milgrew MJ, 2008, IEEE T ELECTRON DEV, V55, P1074, DOI 10.1109/TED.2008.916680; Milgrew MJ, 2005, SENSOR ACTUAT B-CHEM, V111, P347, DOI 10.1016/j.snb.2005.01.020; Milgrew MJ, 2004, SENSOR ACTUAT B-CHEM, V103, P37, DOI 10.1016/j.snb.2004.03.004; Moore GE, 1965, ELECTRONICS, V38, P114; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Noonan JP, 2005, SCIENCE, V309, P597, DOI 10.1126/science.1113485; Pourmand N, 2006, P NATL ACAD SCI USA, V103, P6466, DOI 10.1073/pnas.0601184103; Purushothaman S, 2006, SENSOR ACTUAT B-CHEM, V114, P964, DOI 10.1016/j.snb.2005.06.069; SAKATA T, 2006, ANGEW CHEM, V118, P2283; SAKURAI T, 1992, ANAL CHEM, V64, P1996, DOI 10.1021/ac00041a040; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Themissen AJP, 2008, SOLID STATE ELECTRON, V52, P1401, DOI 10.1016/j.sse.2008.04.012; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wanlass F. M., 1967, US Pat., Patent No. [3,356,858, 3356858]; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Yeow TCW, 1997, SENSOR ACTUAT B-CHEM, V44, P434, DOI 10.1016/S0925-4005(97)00207-4	46	1380	1629	13	469	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2011	475	7356					348	352		10.1038/nature10242	http://dx.doi.org/10.1038/nature10242			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21776081	hybrid			2022-12-01	WOS:000292911200036
J	Abbott, A				Abbott, Alison			DEMENTIA A problem for our age	NATURE			English	Editorial Material																			0	165	176	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2011	475	7355					S2	S4		10.1038/475S2a	http://dx.doi.org/10.1038/475S2a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	791UA	21760579	Bronze			2022-12-01	WOS:000292690500002
J	Eisenstein, M				Eisenstein, Michael			GENETICS Finding risk factors	NATURE			English	Editorial Material							ALZHEIMER-DISEASE; COMMON VARIANTS; CD2AP; EPHA1; CD33											Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Peila R, 2002, DIABETES, V51, P1256, DOI 10.2337/diabetes.51.4.1256; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Zhang J, 2008, AM J CLIN PATHOL, V129, P526, DOI 10.1309/W01Y0B808EMEH12L	8	46	47	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2011	475	7355					S20	S22		10.1038/475S20a	http://dx.doi.org/10.1038/475S20a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	791UA	21760580	Bronze			2022-12-01	WOS:000292690500010
J	Schnabel, J				Schnabel, Jim			VACCINES Chasing the dream	NATURE			English	Editorial Material																		Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Goni F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013391; Hughes RAC, 2009, CLIN EXP IMMUNOL, V158, P34, DOI [10.1111/j.1365-2249.2009.04025.x, 10.1111/j.1365-2249.2009.04025.X]; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808	6	14	14	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					S18	S19		10.1038/475S18a	http://dx.doi.org/10.1038/475S18a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	791UA	21760578				2022-12-01	WOS:000292690500009
J	Schnabel, J				Schnabel, Jim			AMYLOID Little proteins, big clues	NATURE			English	Editorial Material																			0	50	50	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2011	475	7355					S12	S14		10.1038/475S12a	http://dx.doi.org/10.1038/475S12a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21760575	Bronze			2022-12-01	WOS:000292690500006
J	van de Veerdonk, FL; Plantinga, TS; Hoischen, A; Smeekens, SP; Joosten, LAB; Gilissen, C; Arts, P; Rosentul, DC; Carmichael, AJ; Smits-van der Graaf, CAA; Kullberg, BJ; van der Meer, JWM; Lilic, D; Veltman, JA; Netea, MG				van de Veerdonk, Frank L.; Plantinga, Theo S.; Hoischen, Alexander; Smeekens, Sanne P.; Joosten, Leo A. B.; Gilissen, Christian; Arts, Peer; Rosentul, Diana C.; Carmichael, Andrew J.; Smits-van der Graaf, Chantal A. A.; Kullberg, Bart Jan; van der Meer, Jos W. M.; Lilic, Desa; Veltman, Joris A.; Netea, Mihai G.			STAT1 Mutations in Autosomal Dominant Chronic Mucocutaneous Candidiasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEFICIENCY; IMMUNITY; AUTOANTIBODIES; INFLAMMATION; RECOGNITION; CARCINOMA; ALBICANS; CELLS; IL-17	Background Chronic mucocutaneous candidiasis (CMC) is characterized by susceptibility to candida infection of skin, nails, and mucous membranes. Patients with recessive CMC and autoimmunity have mutations in the autoimmune regulator AIRE. The cause of autosomal dominant CMC is unknown. Methods We evaluated 14 patients from five families with autosomal dominant CMC. We incubated their peripheral-blood mononuclear cells with different combinations of stimuli to test the integrity of pathways that mediate immunity, which led to the selection of 100 genes that were most likely to contain the genetic defect. We used an array-based sequence-capture assay, followed by next-generation sequencing, to identify mutations. Results The mononuclear cells from the affected patients were characterized by poor production of interferon-gamma, interleukin-17, and interleukin-22, suggesting that the defect lay within the interleukin-12 receptor and interleukin-23 receptor signaling pathways. We identified heterozygous missense mutations in the DNA sequence encoding the coiled-coil (CC) domain of signal transducer and activator of transcription 1 (STAT1) in the patients. These mutations lead to defective responses in type 1 and type 17 helper T cells (Th1 and Th17). The interferon-gamma receptor pathway was intact in these patients. Conclusions Mutations in the CC domain of STAT1 underlie autosomal dominant CMC and lead to defective Th1 and Th17 responses, which may explain the increased susceptibility to fungal infection.	[van de Veerdonk, Frank L.; Plantinga, Theo S.; Smeekens, Sanne P.; Joosten, Leo A. B.; Rosentul, Diana C.; Smits-van der Graaf, Chantal A. A.; Kullberg, Bart Jan; van der Meer, Jos W. M.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6500 HB Nijmegen, Netherlands; [Hoischen, Alexander; Gilissen, Christian; Arts, Peer; Veltman, Joris A.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Smits-van der Graaf, Chantal A. A.] Radboud Univ Nijmegen, Med Ctr, Dept Pulm Dis, NL-6500 HB Nijmegen, Netherlands; [van de Veerdonk, Frank L.; Plantinga, Theo S.; Smeekens, Sanne P.; Joosten, Leo A. B.; Rosentul, Diana C.; Smits-van der Graaf, Chantal A. A.; Kullberg, Bart Jan; van der Meer, Jos W. M.; Netea, Mihai G.] Nijmegen Inst Infect Inflammat & Immun, Nijmegen, Netherlands; [Carmichael, Andrew J.] James Cook Univ Hosp, Dept Dermatol, Middlesbrough, Cleveland, England; [Lilic, Desa] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; James Cook University Hospital; Newcastle University - UK	van der Meer, JWM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med, POB 9101, NL-6500 HB Nijmegen, Netherlands.	j.vandermeer@aig.umcn.nl	Gilissen, Christian/E-5246-2012; Hoischen, Alexander/AGF-7293-2022; Kullberg, BJ/C-8520-2013; Veltman, Joris A/F-5128-2010; Hoischen, Alexander/D-1282-2013; Plantinga, Theo S./A-6895-2015; Smits-van der Graaf, Chantal/E-8652-2018; van der Meer, Jos W.M./C-8521-2013; Smeekens, Sanne/AAZ-2061-2021; Smeekens, Sanne/G-8307-2011; Arts, Peer/Q-4139-2019; Netea, Mihai/N-5155-2014; Joosten, Leo AB/H-3138-2015; van de Veerdonk, Frank L/C-7256-2008	Gilissen, Christian/0000-0003-1693-9699; Hoischen, Alexander/0000-0002-8072-4476; Kullberg, BJ/0000-0002-6813-8167; Veltman, Joris A/0000-0002-3218-8250; Hoischen, Alexander/0000-0002-8072-4476; Plantinga, Theo S./0000-0003-4990-6084; van der Meer, Jos W.M./0000-0001-5120-3690; Smeekens, Sanne/0000-0002-7835-914X; Smeekens, Sanne/0000-0002-7835-914X; Arts, Peer/0000-0002-6742-6239; Joosten, Leo AB/0000-0001-6166-9830; van de Veerdonk, Frank L/0000-0002-1121-4894	Netherlands Organization for Scientific Research; Primary Immunodeficiency Association UK; European Union [Health-F5-2009-223143]; Aneuploidy Project [LSHG-CT-2006-37627]; Netherlands Organization for Health Research and Development (ZonMW) [917.66.36]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Primary Immunodeficiency Association UK; European Union(European Commission); Aneuploidy Project; Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	Supported by grants from the Netherlands Organization for Scientific Research (to Dr. Netea), the Primary Immunodeficiency Association UK (to Dr. Lilic), the Techgene Project funded by the European Union (Health-F5-2009-223143, to Drs. Veltman and Arts), the Aneuploidy Project (LSHG-CT-2006-37627, to Drs. Hoischen and Veltman), and the Netherlands Organization for Health Research and Development (ZonMW grant 917.66.36, to Dr. Veltman).	Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Cetani F, 2001, J CLIN ENDOCR METAB, V86, P4747, DOI 10.1210/jc.86.10.4747; Chapgier A, 2006, PLOS GENET, V2, P1193, DOI 10.1371/journal.pgen.0020131; Chapgier A, 2006, J IMMUNOL, V176, P5078, DOI 10.4049/jimmunol.176.8.5078; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Dupuis S, 2001, SCIENCE, V293, P300, DOI 10.1126/science.1061154; Eyerich K, 2008, J INVEST DERMATOL, V128, P2640, DOI 10.1038/jid.2008.139; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Hoshino A, 2006, BIOCHEM BIOPH RES CO, V346, P1062, DOI 10.1016/j.bbrc.2006.06.026; Kaganoi J, 2007, ANN SURG ONCOL, V14, P1405, DOI 10.1245/s10434-006-9274-7; Kimura HJ, 2009, ENDOCRINOLOGY, V150, P3409, DOI 10.1210/en.2008-1769; KIRKPATRICK CH, 1994, J AM ACAD DERMATOL, V31, pS14, DOI 10.1016/S0190-9622(08)81260-1; Koch D, 2009, CLIN EXP DERMATOL, V34, pE818, DOI 10.1111/j.1365-2230.2009.03561.x; Meloni A, 2008, J CLIN ENDOCR METAB, V93, P4389, DOI 10.1210/jc.2008-0935; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Ng WF, 2010, J ALLERGY CLIN IMMUN, V126, P1006, DOI 10.1016/j.jaci.2010.08.027; Park ES, 2000, MOL ENDOCRINOL, V14, P440, DOI 10.1210/me.14.3.440; Pfitzner E, 2004, CURR PHARM DESIGN, V10, P2839; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; van der Graaf CAA, 2003, NETH J MED, V61, P365; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Watanabe G, 2001, CANCER J, V7, P132; Xing JC, 2008, GENOMICS, V92, P452, DOI 10.1016/j.ygeno.2008.08.007; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhong MH, 2005, P NATL ACAD SCI USA, V102, P3966, DOI 10.1073/pnas.0501063102	31	440	445	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2011	365	1					54	61		10.1056/NEJMoa1100102	http://dx.doi.org/10.1056/NEJMoa1100102			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	788QL	21714643				2022-12-01	WOS:000292459400009
J	Ye, HF; Daoud-El Baba, M; Peng, RW; Fussenegger, M				Ye, Haifeng; Daoud-El Baba, Marie; Peng, Ren-Wang; Fussenegger, Martin			A Synthetic Optogenetic Transcription Device Enhances Blood-Glucose Homeostasis in Mice	SCIENCE			English	Article							GLUCAGON-LIKE PEPTIDE-1; ECTOPIC EXPRESSION; VISUAL FUNCTION; MELANOPSIN; LIGHT; CELLS; RESPONSES; ROD; SYSTEMS	Synthetic biology has advanced the design of genetic devices that can be used to reprogram metabolic activities in mammalian cells. By functionally linking the signal transduction of melanopsin to the control circuit of the nuclear factor of activated T cells, we have designed a synthetic signaling cascade enabling light-inducible transgene expression in different cell lines grown in culture or bioreactors or implanted into mice. In animals harboring intraperitoneal hollow-fiber or subcutaneous implants containing light-inducible transgenic cells, the serum levels of the human glycoprotein secreted alkaline phosphatase could be remote-controlled with fiber optics or transdermally regulated through direct illumination. Light-controlled expression of the glucagon-like peptide 1 was able to attenuate glycemic excursions in type II diabetic mice. Synthetic light-pulse-transcription converters may have applications in therapeutics and protein expression technology.	[Ye, Haifeng; Peng, Ren-Wang; Fussenegger, Martin] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Daoud-El Baba, Marie] IUT, Dept Genie Biol, F-69622 Villeurbanne, France; [Fussenegger, Martin] Univ Basel, Fac Sci, CH-4058 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel	Fussenegger, M (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland.	fussenegger@bsse.ethz.ch	Peng, Ren-Wang/AAM-8542-2021	Peng, Ren-Wang/0000-0003-1199-6520; Ye, Haifeng/0000-0002-5482-8116	Swiss National Science Foundation [31003A-126022]; EC	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EC(European CommissionEuropean Commission Joint Research Centre)	We thank I. Provencio for providing pIRES<INF>2</INF>-OPN<INF>4</INF>AI and G. Charpin for skillful assistance with the animal study. This work was supported by the Swiss National Science Foundation (grant 31003A-126022) and in part by the EC Framework 7 (Persist).	Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Crabtree GR, 2009, CELL, V138, DOI 10.1016/j.cell.2009.06.026; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Do MTH, 2009, NATURE, V457, P281, DOI 10.1038/nature07682; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Fu YB, 2005, P NATL ACAD SCI USA, V102, P10339, DOI 10.1073/pnas.0501866102; Fussenegger M, 1998, NAT BIOTECHNOL, V16, P468, DOI 10.1038/nbt0598-468; Greber D, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn443; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hankins MW, 2008, TRENDS NEUROSCI, V31, P27, DOI 10.1016/j.tins.2007.11.002; Hartwick ATE, 2007, J NEUROSCI, V27, P13468, DOI 10.1523/JNEUROSCI.3626-07.2007; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hockberger PE, 1999, P NATL ACAD SCI USA, V96, P6255, DOI 10.1073/pnas.96.11.6255; HOLZ GG, 1993, NATURE, V361, P362, DOI 10.1038/361362a0; Kemmer C, 2010, NAT BIOTECHNOL, V28, P355, DOI 10.1038/nbt.1617; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kielgast U, 2009, CURR DIABETES REV, V5, P266, DOI 10.2174/157339909789804413; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Lin B, 2008, P NATL ACAD SCI USA, V105, P16009, DOI 10.1073/pnas.0806114105; Lupi D, 2008, NAT NEUROSCI, V11, P1068, DOI 10.1038/nn.2179; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; NELSON DE, 1991, BRAIN RES, V554, P272, DOI 10.1016/0006-8993(91)90200-F; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; O'Shaughnessy EC, 2011, CELL, V144, P119, DOI 10.1016/j.cell.2010.12.014; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Parsons GB, 2007, GENE THER, V14, P38, DOI 10.1038/sj.gt.3302842; Peisajovich SG, 2010, SCIENCE, V328, P368, DOI 10.1126/science.1182376; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; Weber W, 2007, CURR OPIN BIOTECH, V18, P399, DOI 10.1016/j.copbio.2007.09.002; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026	35	315	341	3	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2011	332	6037					1565	1568		10.1126/science.1203535	http://dx.doi.org/10.1126/science.1203535			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700876				2022-12-01	WOS:000291990000047
J	Snyder, SA; Gollner, A; Chiriac, MI				Snyder, Scott A.; Gollner, Andreas; Chiriac, Maria I.			Regioselective reactions for programmable resveratrol oligomer synthesis	NATURE			English	Article							CARAGANA-SINICA; STEM BARK; 4-HYDROXYSTILBENES; OLIGOSTILBENES; PRODUCTS; DIMERS; PLANTS	Although much attention has been devoted to resveratrol, a unique polyphenol produced by plants and credited as potentially being responsible for the 'French paradox'-the observation that French people have a relatively low incidence of coronary heart disease, even though their diet is high in saturated fats-the oligomers of resveratrol have been largely ignored despite their high biological activity. Challenges in achieving their isolation in sufficient quantity from natural sources, coupled with an inability to prepare them easily synthetically, are seen as the main obstacles. Here we report a programmable, controlled and potentially scalable synthesis of the resveratrol family via a three-stage design. The synthetic approach requires strategy- and reagent-guided chemical functionalizations to differentiate two distinct cores possessing multiple sites with the same or similar reactivity, ultimately leading to five higher-order natural products. This work demonstrates that challenging, positionally selective functionalizations of complex materials are possible where biosynthetic studies have indicated otherwise, it provides materials and tools with which to unlock the full biochemical potential of this family of natural products, and it affords an intellectual framework within which other oligomeric families could potentially be accessed.	[Snyder, Scott A.; Gollner, Andreas; Chiriac, Maria I.] Columbia Univ, Dept Chem, New York, NY 10027 USA	Columbia University	Snyder, SA (corresponding author), Columbia Univ, Dept Chem, Havemeyer Hall,3000 Broadway, New York, NY 10027 USA.	sas2197@columbia.edu		Gollner, Andreas/0000-0002-4347-8296; Snyder, Scott/0000-0003-3594-8769	Columbia University; National Institutes of Health [R01-GM84994]; Bristol-Myers Squibb; Eli Lilly; Research Corporation for Science Advancement; Austrian Science Fund (FWF) [J2986-N19]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084994] Funding Source: NIH RePORTER	Columbia University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bristol-Myers Squibb(Bristol-Myers Squibb); Eli Lilly(Eli Lilly); Research Corporation for Science Advancement(Research Corporation for Science Advancement); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Sukenick of The Memorial Sloan Kettering Cancer Research Institute and J. Decatur of Columbia University for NMR assistance, Y. Itagaki for mass spectrometric assistance, C. Stathakis for preliminary attempts to form dihydrofuran units on the pallidol core, A. ElSohly for theoretical calculations and discussions, and K. Shaw and J. Boyce for preparing some starting materials. Financial support was provided by Columbia University, the National Institutes of Health (R01-GM84994), Bristol-Myers Squibb, Eli Lilly, the Research Corporation for Science Advancement (Cottrell Scholar Award to S.A.S.), and the Austrian Science Fund (FWF, Schrodinger postdoctoral fellowship J2986-N19 to A.G.).	Abe N, 2010, J NAT PROD, V73, P1499, DOI 10.1021/np1002675; Atun S., 2008, J PHYS SCI, V19, P7; BACH NJ, 1980, J MED CHEM, V23, P481, DOI 10.1021/jm00179a003; BAKER R, 1987, CHEM COMMUN, P1102; Bertolini F, 2009, ORG PREP PROCED INT, V41, P385, DOI 10.1080/00304940903240836; BOGER DL, 1984, J ORG CHEM, V49, P4050, DOI 10.1021/jo00195a035; Burke MD, 2004, ANGEW CHEM INT EDIT, V43, P46, DOI 10.1002/anie.200300626; Chen K, 2009, NATURE, V459, P824, DOI 10.1038/nature08043; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Corey E.J., 1995, LOGIC CHEM SYNTHESIS; COREY EJ, 1965, J AM CHEM SOC, V87, P1353, DOI 10.1021/ja01084a034; Fischbach MA, 2007, NAT CHEM BIOL, V3, P353, DOI 10.1038/nchembio0707-353; Gustafson JL, 2010, SCIENCE, V328, P1251, DOI 10.1126/science.1188403; He YH, 2006, HETEROCYCLES, V68, P93; Ito T, 2003, CARCINOGENESIS, V24, P1489, DOI 10.1093/carcin/bgg105; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jeffrey JL, 2009, ORG LETT, V11, P5450, DOI 10.1021/ol902141z; Kim I, 2009, ORG BIOMOL CHEM, V7, P2788, DOI 10.1039/b901911a; Kraus GA, 2009, TETRAHEDRON LETT, V50, P7180, DOI 10.1016/j.tetlet.2009.10.040; Kurosawa W, 2004, TETRAHEDRON, V60, P9615, DOI 10.1016/j.tet.2004.06.144; LANGCAKE P, 1977, J CHEM SOC CHEM COMM, P208, DOI 10.1039/c39770000208; Lewis CA, 2006, ANGEW CHEM INT EDIT, V45, P5616, DOI 10.1002/anie.200601490; Li WL, 2006, ANGEW CHEM INT EDIT, V45, P7609, DOI 10.1002/anie.200603097; Li WL, 2010, SYNLETT, P1247, DOI 10.1055/s-0029-1219787; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Nicolaou KC, 2010, J AM CHEM SOC, V132, P7540, DOI 10.1021/ja102623j; OSHIMA Y, 1993, TETRAHEDRON, V49, P5801, DOI 10.1016/S0040-4020(01)87946-1; Quideau S, 2011, ANGEW CHEM INT EDIT, V50, P586, DOI 10.1002/anie.201000044; Sako M, 2004, J ORG CHEM, V69, P2598, DOI 10.1021/jo035791c; Sculimbrene BR, 2002, J AM CHEM SOC, V124, P11653, DOI 10.1021/ja027402m; Snyder SA, 2007, ANGEW CHEM INT EDIT, V46, P8186, DOI 10.1002/anie.200703333; Snyder SA, 2011, NAT PROD REP, V28, P897, DOI 10.1039/c1np00001b; Snyder SA, 2010, J AM CHEM SOC, V132, P14303, DOI 10.1021/ja106813s; Snyder SA, 2009, J AM CHEM SOC, V131, P1753, DOI 10.1021/ja806183r; SOTHEESWARAN S, 1993, PHYTOCHEMISTRY, V32, P1083, DOI 10.1016/S0031-9422(00)95070-2; Takaya Y, 2005, TETRAHEDRON, V61, P10285, DOI 10.1016/j.tet.2005.08.023; Takaya Y, 2002, TETRAHEDRON, V58, P9265, DOI 10.1016/S0040-4020(02)01191-2; Takaya Y, 2002, TETRAHEDRON, V58, P7259, DOI 10.1016/S0040-4020(02)00785-8; Tanaka T, 2000, PHYTOCHEMISTRY, V54, P63, DOI 10.1016/S0031-9422(00)00026-1; Tanaka T, 2001, HETEROCYCLES, V55, P729, DOI 10.3987/COM-01-9166; Tsukamoto T, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-46; Velu SS, 2008, CHEM-EUR J, V14, P11376, DOI 10.1002/chem.200801575; Wang SG, 2005, HELV CHIM ACTA, V88, P2315, DOI 10.1002/hlca.200590166; Wang SG, 2004, J ASIAN NAT PROD RES, V6, P241, DOI 10.1080/10286020310001653309; Yamada M, 2006, PHYTOCHEMISTRY, V67, P307, DOI 10.1016/j.phytochem.2005.11.001	45	158	159	1	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					461	466		10.1038/nature10197	http://dx.doi.org/10.1038/nature10197			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21697944	Green Accepted			2022-12-01	WOS:000291939700038
J	Lyu, SY; Su, LW; Chen, YMA				Lyu, Shu-Yu; Su, Lien-Wen; Chen, Yi-Ming Arthur			Effects of education on harm-reduction programmes	LANCET			English	Editorial Material							DRUG-USERS; INFECTION; TAIWAN; HIV-1		[Lyu, Shu-Yu; Chen, Yi-Ming Arthur] Natl Yang Ming Univ, AIDS Prevent & Res Ctr, Taipei 112, Taiwan; [Lyu, Shu-Yu] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan; [Su, Lien-Wen] Taipei City Hosp, Dept Addict Sci, Songde Branch, Taipei, Taiwan; [Chen, Yi-Ming Arthur] Natl Yang Ming Univ, Sch Med, Dept Microbiol, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Taipei Medical University; Taipei City Hospital; National Yang Ming Chiao Tung University	Chen, YMA (corresponding author), Natl Yang Ming Univ, AIDS Prevent & Res Ctr, Taipei 112, Taiwan.	arthur@ym.edu.tw						Beyrer C, 2010, LANCET, V376, P551, DOI 10.1016/S0140-6736(10)60928-2; Chen YJ, 2010, JAIDS-J ACQ IMM DEF, V53, P425, DOI 10.1097/QAI.0b013e3181ccba1a; Chen YMA, 2007, LANCET, V369, P623, DOI 10.1016/S0140-6736(07)60291-8; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Lan YC, 2008, 17 INT AIDS C MEX CI; Morisky Donald E, 2009, Prospects (Paris), V39, P335; Peng EY, 2007, AM PUBL HLTH ASS 135; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Taiwan Centers for Disease Control Department of Health Executive Yuan, 2011, HIV AIDS STAT DRUG S; Taiwan Ministry of Justice, 2011, STAT JUST; Tsai TI, 2010, AIDS EDUC PREV, V22, P546, DOI 10.1521/aeap.2010.22.6.546; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X	12	18	18	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2012	379	9814					E28	E30		10.1016/S0140-6736(11)60786-1	http://dx.doi.org/10.1016/S0140-6736(11)60786-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	891AF	21851974	Green Published, Bronze			2022-12-01	WOS:000300187800002
J	Yusuf, S; Islam, S; Chow, CK; Rangarajan, S; Dagenais, G; Diaz, R; Gupta, R; Kelishadi, R; Iqbal, R; Avezum, A; Kruger, A; Kutty, R; Lanas, F; Liu, LS; Wei, L; Lopez-Jaramillo, P; Oguz, A; Rahman, O; Swidan, H; Yusoff, K; Zatonski, W; Rosengren, A; Teo, KK				Yusuf, Salim; Islam, Shofiqul; Chow, Clara K.; Rangarajan, Sumathy; Dagenais, Gilles; Diaz, Rafael; Gupta, Rajeev; Kelishadi, Roya; Iqbal, Romaina; Avezum, Alvaro; Kruger, Annamarie; Kutty, Raman; Lanas, Fernando; Liu Lisheng; Wei, Li; Lopez-Jaramillo, Patricio; Oguz, Aytekin; Rahman, Omar; Swidan, Hany; Yusoff, Khalid; Zatonski, Witold; Rosengren, Annika; Teo, Koon K.		PURE Study Investigators	Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey	LANCET			English	Article							ACUTE CORONARY SYNDROMES; MYOCARDIAL-INFARCTION; RISK-FACTORS; HEART-FAILURE; SELF-REPORT; STROKE; AVAILABILITY; MEDICINES; VALIDITY; IMPACT	Background Although most cardiovascular disease occurs in low-income and middle-income countries, little is known about the use of effective secondary prevention medications in these communities. We aimed to assess use of proven effective secondary preventive drugs (antiplatelet drugs, beta blockers, angiotensin-converting-enzyme [ACE] inhibitors or angiotensin-receptor blockers [ARBs], and statins) in individuals with a history of coronary heart disease or stroke. Methods In the Prospective Urban Rural Epidemiological (PURE) study, we recruited individuals aged 35-70 years from rural and urban communities in countries at various stages of economic development. We assessed rates of previous cardiovascular disease (coronary heart disease or stroke) and use of proven effective secondary preventive drugs and blood-pressure-lowering drugs with standardised questionnaires, which were completed by telephone interviews, household visits, or on patient's presentation to clinics. We report estimates of drug use at national, community, and individual levels. Findings We enrolled 153 996 adults from 628 urban and rural communities in countries with incomes classified as high (three countries), upper-middle (seven), lower-middle (three), or low (four) between January, 2003, and December, 2009. 5650 participants had a self-reported coronary heart disease event (median 5.0 years previously [IQR 2.0-10.0]) and 2292 had stroke (4.0 years previously [2.0-8.0]). Overall, few individuals with cardiovascular disease took antiplatelet drugs (25.3%), beta blockers (17.4%), ACE inhibitors or ARBs (19.5%), or statins (14.6%). Use was highest in high-income countries (antiplatelet drugs 62.0%, beta blockers 40.0%, ACE inhibitors or ARBs 49.8%, and statins 66.5%), lowest in low-income countries (8.8%, 9.7%, 5.2%, and 3.3%, respectively), and decreased in line with reduction of country economic status (p(trend)<0.0001 for every drug type). Fewest patients received no drugs in high-income countries (11.2%), compared with 45.1% in upper middle-income countries, 69.3% in lower middle-income countries, and 80.2% in low-income countries. Drug use was higher in urban than rural areas (antiplatelet drugs 28.7% urban vs 21.3% rural, beta blockers 23.5% vs 15.6%, ACE inhibitors or ARBs 22.8% vs 15.5%, and statins 19.9% vs 11.6%; all p<0.0001), with greatest variation in poorest countries (p(interaction)<0.0001 for urban vs rural differences by country economic status). Country-level factors (eg, economic status) affected rates of drug use more than did individual-level factors (eg, age, sex, education, smoking status, body-mass index, and hypertension and diabetes statuses). Interpretation Because use of secondary prevention medications is low worldwide-especially in low-income countries and rural areas-systematic approaches are needed to improve the long-term use of basic, inexpensive, and effective drugs.	[Yusuf, Salim; Islam, Shofiqul; Chow, Clara K.; Rangarajan, Sumathy; Teo, Koon K.] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Yusuf, Salim; Islam, Shofiqul; Chow, Clara K.; Rangarajan, Sumathy; Teo, Koon K.] McMaster Univ, Hamilton, ON, Canada; [Dagenais, Gilles] Hosp Laval, Quebec Heart Inst, Ste Foy, PQ, Canada; [Diaz, Rafael] Estudios Clin Latinoamer, Rosario, Argentina; [Gupta, Rajeev] Fortis Escorts Hosp, Jaipur, Rajasthan, India; [Kelishadi, Roya] Isfahan Univ Med Sci, Isfahan Cardiovasc Res Ctr, Esfahan, Iran; [Iqbal, Romaina] Aga Khan Univ, Dept Community Hlth Sci & Med, Karachi, Pakistan; [Avezum, Alvaro] Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; [Kutty, Raman] Hlth Act People, Trivandrum, Kerala, India; [Lanas, Fernando] Univ La Frontera, Temuco, Chile; [Liu Lisheng; Wei, Li] Chinese Acad Med Sci, Cardiovasc Inst, Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Liu Lisheng; Wei, Li] Chinese Acad Med Sci, FuWai Hosp, Beijing 100730, Peoples R China; [Lopez-Jaramillo, Patricio] Fdn Oftalmol Santander FOSCAL, Floridablanca Santander, Colombia; [Oguz, Aytekin] Goztepe Training & Res Hosp, Istanbul, Turkey; [Rahman, Omar] Independent Univ, Dhaka, Bangladesh; [Swidan, Hany] Dubai Hlth Author, Dubai, U Arab Emirates; [Yusoff, Khalid] Univ Teknol MARA Sungai Buloh, Fac Med, Selangor, Malaysia; [Zatonski, Witold] Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland; [Zatonski, Witold] Inst Oncol, Warsaw, Poland; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden	McMaster University; Population Health Research Institute; McMaster University; Laval University; Fortis Escorts Hospital; Isfahan University Medical Science; Aga Khan University; Instituto Dante Pazzanese de Cardiologia; Universidad de La Frontera; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Istanbul Goztepe Training and Research Hospital; Independent University Bangladesh (IUB); Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; University of Gothenburg	Yusuf, S (corresponding author), Hamilton Gen Hosp, DBCVSRI, Populat Hlth Res Inst, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	yusufs@mcmaster.ca	Ramli, Anis Safura/K-3322-2014; Nawawi, Hapizah/N-7446-2019; Oguz, Aytekin/AAJ-2732-2021; Ramli, Anis Safura/U-3548-2018; Yusoff, Khalid/I-7029-2019; Igumbor, Ehimario U/B-2652-2012; Avezum, Alvaro/AAP-7687-2020; Lanas, Fernando/AAE-8842-2022; Nawawi, Hapizah Mohd/J-8873-2019; Nor-Ashikin, Mohamed Noor Khan/P-2055-2015; Kelishadi, Roya/E-6154-2012; Rahman, Omar/E-1329-2019; Avezum, Alvaro AA/K-6137-2016; Qorbani, Mostafa/M-8171-2017; Gomez-Arbelaez, Diego/K-1883-2013; Corsi, Daniel J/S-4689-2018	Ramli, Anis Safura/0000-0002-9517-1413; Nawawi, Hapizah/0000-0003-4462-8484; Oguz, Aytekin/0000-0002-2595-5167; Ramli, Anis Safura/0000-0002-9517-1413; Yusoff, Khalid/0000-0001-5669-5188; Igumbor, Ehimario U/0000-0002-6313-6031; Nawawi, Hapizah Mohd/0000-0003-4462-8484; Nor-Ashikin, Mohamed Noor Khan/0000-0002-1325-9236; Kelishadi, Roya/0000-0001-7455-1495; Rahman, Omar/0000-0002-0606-2507; Avezum, Alvaro AA/0000-0002-3073-6890; Lanas, Fernando/0000-0003-3595-9759; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Jerling, Johann/0000-0003-2600-3536; Teo, Koon/0000-0002-3731-0956; Gomez-Arbelaez, Diego/0000-0001-6150-0066; Yusuf, Salim/0000-0003-4776-5601; Iqbal, Romaina/0000-0002-5364-4366; Gulec, Sadi/0000-0002-2685-2522; Levitt, Naomi/0000-0001-6480-8066; Corsi, Daniel J/0000-0001-7063-3354	Marion W Burke endowed chair of the Heart and Stroke Foundation of Ontario, ON, Canada; National Heart and Medical Research Council of Australia; National Heart Foundation of Australia; Sydney Medical School Foundation; Population Health Research Institute; Canadian Institutes of Health Research; Heart and Stroke Foundation of Ontario; AstraZeneca [Sweden]; AstraZeneca [Canada]; Sanofi-Aventis [France]; Sanofi-Aventis [Canada]; Boehringer Ingelheim [Germany]; Boehringer Ingelheim [Canada]; Servier; GlaxoSmithKline; Bangladesh Independent University; Mitra and Associates in Bangladesh; Unilever Health Institute in Brazil; Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network in Canada; Universidad de la Frontera in Chile; National Center for Cardiovascular Diseases in China; Colciencias in Colombia [6566-04-18062]; Indian Council of Medical Research in India; Ministry of Science, Technology and Innovation of Malaysia [07-05-IFN-MEB010]; Universiti Teknologi MARA, Universiti Kebangsaan Malaysia in Malaysia [UKM-Hejim-Komuniti-15-2010]; Polish Ministry of Science and Higher Education [290/W-PURE/2008/0]; Wroclaw Medical University in Poland; North-West University; South Africa and Netherlands Programme for Alternative Development (SANPAD); National Research Foundation; Medical Research Council of South Africa; South Africa Sugar Association (SASA); Faculty of Community and Health Sciences (UWC) in South Africa; Swedish Council for Working Life and Social Research; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; Swedish Heart and Lung Foundation; Swedish Research Council; Swedish State; Vastra Gotaland Region (FOUU) in Sweden; Metabolic Syndrome Society; Astra Zeneca; Sanofi-Aventis in Turkey; Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences; Dubai Health Authority, Dubai, in the United Arab Emirates	Marion W Burke endowed chair of the Heart and Stroke Foundation of Ontario, ON, Canada; National Heart and Medical Research Council of Australia; National Heart Foundation of Australia(National Heart Foundation of Australia); Sydney Medical School Foundation; Population Health Research Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); AstraZeneca [Sweden](AstraZeneca); AstraZeneca [Canada](AstraZeneca); Sanofi-Aventis [France](Sanofi-Aventis); Sanofi-Aventis [Canada](Sanofi-Aventis); Boehringer Ingelheim [Germany](Boehringer Ingelheim); Boehringer Ingelheim [Canada](Boehringer Ingelheim); Servier(Servier); GlaxoSmithKline(GlaxoSmithKline); Bangladesh Independent University; Mitra and Associates in Bangladesh; Unilever Health Institute in Brazil(Unilever); Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network in Canada; Universidad de la Frontera in Chile; National Center for Cardiovascular Diseases in China; Colciencias in Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Indian Council of Medical Research in India; Ministry of Science, Technology and Innovation of Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Universiti Teknologi MARA, Universiti Kebangsaan Malaysia in Malaysia; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Wroclaw Medical University in Poland; North-West University; South Africa and Netherlands Programme for Alternative Development (SANPAD); National Research Foundation; Medical Research Council of South Africa(South African Medical Research Council); South Africa Sugar Association (SASA); Faculty of Community and Health Sciences (UWC) in South Africa; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish State; Vastra Gotaland Region (FOUU) in Sweden; Metabolic Syndrome Society; Astra Zeneca(AstraZeneca); Sanofi-Aventis in Turkey; Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences; Dubai Health Authority, Dubai, in the United Arab Emirates	SY is supported by the Marion W Burke endowed chair of the Heart and Stroke Foundation of Ontario, ON, Canada. CKC is supported by a fellowship co-funded by the National Heart and Medical Research Council of Australia, National Heart Foundation of Australia and Sydney Medical School Foundation. The main PURE study and its components are funded by the Population Health Research Institute, the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, and through unrestricted grants from several pharmaceutical companies (major contributions from AstraZeneca [Sweden and Canada], Sanofi-Aventis [France and Canada], Boehringer Ingelheim [Germany and Canada], Servier, and GlaxoSmithKline), and additional contributions from Novartis and King Pharma and from various national or local organisations in participating countries. These contributions were from the Bangladesh Independent University and Mitra and Associates in Bangladesh; Unilever Health Institute in Brazil; Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network in Canada; Universidad de la Frontera in Chile; National Center for Cardiovascular Diseases in China; Colciencias in Colombia (grant number 6566-04-18062); Indian Council of Medical Research in India; Ministry of Science, Technology and Innovation of Malaysia (grant number 07-05-IFN-MEB010) and Universiti Teknologi MARA, Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010) in Malaysia; Polish Ministry of Science and Higher Education (grant number 290/W-PURE/2008/0) and Wroclaw Medical University in Poland; The North-West University, South Africa and Netherlands Programme for Alternative Development (SANPAD), National Research Foundation, Medical Research Council of South Africa, The South Africa Sugar Association (SASA), and Faculty of Community and Health Sciences (UWC) in South Africa; Swedish Council for Working Life and Social Research, Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, Swedish Heart and Lung Foundation, Swedish Research Council, Grant from the Swedish State under LUA (LakarUtbildningsAvtalet) agreement, and grant from the Vastra Gotaland Region (FOUU) in Sweden; Metabolic Syndrome Society, Astra Zeneca, and Sanofi-Aventis in Turkey; Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences, Dubai Health Authority, Dubai, in the United Arab Emirates.	ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bergmann MM, 1998, AM J EPIDEMIOL, V147, P969; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Cameron A, 2011, B WORLD HEALTH ORGAN, V89, P412, DOI 10.2471/BLT.10.084327; Dagenais GR, 2006, LANCET, V368, P581, DOI 10.1016/S0140-6736(06)69201-5; Fox KAA, 2007, JAMA-J AM MED ASSOC, V297, P1892, DOI 10.1001/jama.297.17.1892; Haynes RB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub3; HEALY B, 1991, NEW ENGL J MED, V325, P274, DOI 10.1056/NEJM199107253250408; Heckbert SR, 2004, AM J EPIDEMIOL, V160, P1152, DOI 10.1093/aje/kwh314; John RM, 2008, SOC SCI MED, V66, P1356, DOI 10.1016/j.socscimed.2007.11.020; Joshi R, 2009, CIRCULATION, V119, P1950, DOI 10.1161/CIRCULATIONAHA.108.819201; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; Lampe FC, 1999, J CLIN EPIDEMIOL, V52, P73, DOI 10.1016/S0895-4356(98)00146-2; Lonn E, 2010, CIRCULATION, V122, P2078, DOI 10.1161/CIRCULATIONAHA.109.873232; MacQueen KM, 2001, AM J PUBLIC HEALTH, V91, P1929, DOI 10.2105/AJPH.91.12.1929; Mendis S, 2005, B WORLD HEALTH ORGAN, V83, P820; Niens LM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000333; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Ramsey F.L., 2002, STAT SLEUTH COURSE M; Sacco RL, 2006, STROKE, V37, P577, DOI 10.1161/01.STR.0000199147.30016.74; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; van Mourik MSM, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-25; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; World Bank, WE CLASS COUNTR; Xavier D, 2008, LANCET, V371, P1435, DOI 10.1016/S0140-6736(08)60623-6; Yamagishi K, 2009, J CLIN EPIDEMIOL, V62, P667, DOI 10.1016/j.jclinepi.2008.07.016; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5; Yusuf S, 2002, LANCET, V360, P2, DOI 10.1016/S0140-6736(02)09358-3; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2000, NEW ENGL J MED, V342, P145	35	649	698	2	105	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 1	2011	378	9798					1231	1243		10.1016/S0140-6736(11)61215-4	http://dx.doi.org/10.1016/S0140-6736(11)61215-4			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831IO	21872920				2022-12-01	WOS:000295723600025
J	Furumoto, T; Yamaguchi, T; Ohshima-Ichie, Y; Nakamura, M; Tsuchida-Iwata, Y; Shimamura, M; Ohnishi, J; Hata, S; Gowik, U; Westhoff, P; Brautigam, A; Weber, APM; Izui, K				Furumoto, Tsuyoshi; Yamaguchi, Teppei; Ohshima-Ichie, Yumiko; Nakamura, Masayoshi; Tsuchida-Iwata, Yoshiko; Shimamura, Masaki; Ohnishi, Junichi; Hata, Shingo; Gowik, Udo; Westhoff, Peter; Braeutigam, Andrea; Weber, Andreas P. M.; Izui, Katsura			A plastidial sodium-dependent pyruvate transporter	NATURE			English	Article							MESOPHYLL CHLOROPLASTS; C-4 PHOTOSYNTHESIS; MAIZE; PLANT; EXPRESSION; ENVELOPE; REVEALS; FAMILY; DRIVEN; TAF10	Pyruvate serves as a metabolic precursor for many plastid-localized biosynthetic pathways, such as those for fatty acids(1), terpenoids(2) and branched-chainamino acids(3). In spite of the importance of pyruvate uptake into plastids (organelles within cells of plants and algae), the molecular mechanisms of this uptake have not yet been explored. This is mainly because pyruvate is a relatively small compound that is able to passively permeate lipid bilayers(4), which precludes accurate measurement of pyruvate transport activity in reconstituted liposomes. Using differential transcriptome analyses of C-3 and C-4 plants of the genera Flaveria and Cleome, here we have identified a novel gene that is abundant in C-4 species, named BASS2 (BILE ACID:SODIUM SYMPORTER FAMILY PROTEIN 2). The BASS2 protein is localized at the chloroplast envelope membrane, and is highly abundant in C-4 plants that have the sodium-dependent pyruvate transporter. Recombinant BASS2 shows sodium-dependent pyruvate uptake activity. Sodium influx is balanced by a sodium: proton antiporter (NHD1), which was mimicked in recombinant Escherichia coli cells expressing both BASS2 and NHD1. Arabidopsis thaliana bass2 mutants lack pyruvate uptake into chloroplasts, which affects plastid-localized isopentenyl diphosphate synthesis, as evidenced by increased sensitivity of such mutants to mevastatin, an inhibitor of cytosolic isopentenyl diphosphate biosynthesis. We thus provide molecular evidence for a sodium-coupled metabolite transporter in plastid envelopes. Orthologues of BASS2 can be detected in all the genomes of land plants that have been characterized so far, thus indicating the widespread importance of sodium-coupled pyruvate import into plastids.	[Furumoto, Tsuyoshi; Shimamura, Masaki] Hiroshima Univ, Grad Sch Sci, Higashihiroshima 7398526, Japan; [Furumoto, Tsuyoshi; Yamaguchi, Teppei; Ohshima-Ichie, Yumiko; Nakamura, Masayoshi; Tsuchida-Iwata, Yoshiko; Hata, Shingo; Izui, Katsura] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; [Ohnishi, Junichi] Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, Saitama 3388570, Japan; [Hata, Shingo] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Gowik, Udo; Westhoff, Peter] Univ Dusseldorf, Inst Entwicklungs & Mol Biol Pflanzen, D-40225 Dusseldorf, Germany; [Braeutigam, Andrea; Weber, Andreas P. M.] Univ Dusseldorf, Inst Biochem Pflanzen, D-40225 Dusseldorf, Germany; [Izui, Katsura] Kinki Univ, Fac Biol Oriented Sci & Technol, Wakayama 6496493, Japan	Hiroshima University; Kyoto University; Saitama University; Nagoya University; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Kindai University (Kinki University)	Furumoto, T (corresponding author), Hiroshima Univ, Grad Sch Sci, 1-3-1 Kagamiyama, Higashihiroshima 7398526, Japan.	tfurumoto@hiroshima-u.ac.jp	Weber, Andreas Paul Michael/O-3043-2019; Bräutigam, Andrea/H-2685-2012; Weber, Andreas PM/A-6250-2011; Nakamura, Masayoshi/D-1979-2017	Weber, Andreas Paul Michael/0000-0003-0970-4672; Bräutigam, Andrea/0000-0002-5309-0527; Weber, Andreas PM/0000-0003-0970-4672; Nakamura, Masayoshi/0000-0002-7107-4942; Gowik, Udo/0000-0002-8986-7318; Shimamura, Masaki/0000-0002-5665-5116	Ministry of Education, Science and Culture of Japan; Japan Science Society; German Research Foundation [CRC-TR1, IRTG 1525/1, CRC 590]	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science Society; German Research Foundation(German Research Foundation (DFG))	We thank G. Schonknecht, S. Yamaguchi and Y. Kamiya for discussions; N. Das, S. von Caemmerer and R. T. Furbank for critical reading of the manuscript; R. F. Sage, T. Endo, M. Munekage, J. Hibberd and M. Ku for gifts of seeds; T. Kinoshita for technical advice on the BASS2 immunoblot analysis; N. Aoki and S. Koreeda for technical advice on the pyruvate-uptake measurements; A. Izumida for preparation of the F. trinervia cDNA library; and Y. Takahashi for suggesting the dual expression system. This work was supported in part by the Ministry of Education, Science and Culture of Japan (Grants-in-Aid for Scientific Research to T.F. and K.I.), by a Sasakawa Scientific Research Grant from the Japan Science Society to T.F., and by the German Research Foundation (CRC-TR1 and IRTG 1525/1 to A.P.M.W., and CRC 590 to P.W.).	Aoki N, 1997, PLANT CELL PHYSIOL, V38, P1217, DOI 10.1093/oxfordjournals.pcp.a029108; AOKI N, 1992, PLANT CELL PHYSIOL, V33, P805; Brautigam A, 2008, PLANT PHYSIOL, V148, P568, DOI 10.1104/pp.108.121012; Brautigam A, 2011, PLANT PHYSIOL, V155, P142, DOI 10.1104/pp.110.159442; Cellier F, 2004, PLANT J, V39, P834, DOI 10.1111/j.1365-313X.2004.02177.x; FLUGGE UI, 1985, FEBS LETT, V183, P335, DOI 10.1016/0014-5793(85)80805-X; Furumoto T, 2005, PLANT CELL PHYSIOL, V46, P108, DOI 10.1093/pcp/pci006; Furumoto T, 1999, PLANT MOL BIOL, V41, P301, DOI 10.1023/A:1006317120460; Furumoto T, 2007, PLANT PHYSIOL, V144, P1936, DOI 10.1104/pp.107.102541; Gigolashvili T, 2009, PLANT CELL, V21, P1813, DOI 10.1105/tpc.109.066399; Hemmerlin A, 2003, J BIOL CHEM, V278, P26666, DOI 10.1074/jbc.M302526200; HUBER SC, 1977, BIOCHIM BIOPHYS ACTA, V462, P583, DOI 10.1016/0005-2728(77)90103-7; Majeran W, 2008, MOL CELL PROTEOMICS, V7, P1609, DOI 10.1074/mcp.M800016-MCP200; McKown AD, 2005, AM J BOT, V92, P1911, DOI 10.3732/ajb.92.11.1911; OHNISHI J, 1990, FEBS LETT, V269, P122, DOI 10.1016/0014-5793(90)81134-A; OHNISHI JI, 1987, FEBS LETT, V219, P347, DOI 10.1016/0014-5793(87)80250-8; PADAN E, 1989, J BIOL CHEM, V264, P20297; Pavon LR, 2008, J BIOL CHEM, V283, P13520, DOI 10.1074/jbc.M709371200; PROUDLOVE MO, 1981, NEW PHYTOL, V88, P255, DOI 10.1111/j.1469-8137.1981.tb01722.x; Sawada Y, 2009, PLANT CELL PHYSIOL, V50, P1579, DOI 10.1093/pcp/pcp110; SCHULZESIEBERT D, 1984, PLANT PHYSIOL, V76, P465, DOI 10.1104/pp.76.2.465; Schwender J, 2004, CURR OPIN PLANT BIOL, V7, P309, DOI 10.1016/j.pbi.2004.03.016; Sugden Mary C, 2003, Biochem J, V374, pe1, DOI 10.1042/BJ20031105; Suzuki M, 2004, PLANT J, V37, P750, DOI 10.1111/j.1365-313X.2004.02003.x; Tamada Y, 2007, PLANT CELL PHYSIOL, V48, P134, DOI 10.1093/pcp/pcl048; TSUCHIYA T, 1977, J BACTERIOL, V131, P848, DOI 10.1128/JB.131.3.848-853.1977; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; Weber APM, 2010, CURR OPIN PLANT BIOL, V13, P257, DOI 10.1016/j.pbi.2010.01.007; Weber APM, 2005, ANNU REV PLANT BIOL, V56, P133, DOI 10.1146/annurev.arplant.56.032604.144228	29	176	181	3	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2011	476	7361					472	U131		10.1038/nature10250	http://dx.doi.org/10.1038/nature10250			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811KT	21866161	Green Published			2022-12-01	WOS:000294209400041
J	Gupta, PB; Fillmore, CM; Jiang, GZ; Shapira, SD; Tao, K; Kuperwasser, C; Lander, ES				Gupta, Piyush B.; Fillmore, Christine M.; Jiang, Guozhi; Shapira, Sagi D.; Tao, Kai; Kuperwasser, Charlotte; Lander, Eric S.			Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells	CELL			English	Article							EMBRYONIC STEM-CELLS; HUMAN BREAST-CANCER; BASAL-LIKE TUMORS; GENE-EXPRESSION; MAMMARY-GLAND; SELF-RENEWAL; IN-VITRO; FLUCTUATING ENVIRONMENTS; STEM/PROGENITOR CELLS; PROGENITOR CELLS	Cancer cells within individual tumors often exist in distinct phenotypic states that differ in functional attributes. While cancer cell populations typically display distinctive equilibria in the proportion of cells in various states, the mechanisms by which this occurs are poorly understood. Here, we study the dynamics of phenotypic proportions in human breast cancer cell lines. We show that subpopulations of cells purified for a given phenotypic state return towards equilibrium proportions over time. These observations can be explained by a Markov model in which cells transition stochastically between states. A prediction of this model is that, given certain conditions, any subpopulation of cells will return to equilibrium phenotypic proportions over time. A second prediction is that breast cancer stem-like cells arise de novo from non-stem-like cells. These findings contribute to our understanding of cancer heterogeneity and reveal how stochasticity in single-cell behaviors promotes phenotypic equilibrium in populations of cancer cells.	[Gupta, Piyush B.; Jiang, Guozhi; Shapira, Sagi D.; Lander, Eric S.] Broad Inst, Cambridge, MA 02142 USA; [Fillmore, Christine M.; Kuperwasser, Charlotte] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Dept Anat & Cellular Biol, Boston, MA 02111 USA; [Tao, Kai; Kuperwasser, Charlotte] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; [Gupta, Piyush B.; Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Tufts University; Tufts Medical Center; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Gupta, PB (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	pgupta@wi.mit.edu; lander@broadinstitute.org	Brainson, Christine/AAG-4688-2020	Brainson, Christine/0000-0002-0854-5043	Breast Cancer Research Foundation; Raymond and Beverly Sackler Foundation; Broad Institute	Breast Cancer Research Foundation; Raymond and Beverly Sackler Foundation; Broad Institute	We thank Aviv Regev, Robert Weinberg, Todd Golub, and Gaorav Gupta for valuable discussions and criticism of the manuscript, Supriya Gupta for assistance with gene-expression profiling, and Tom DiCesare for assistance with graphical design. This work was supported by the Breast Cancer Research Foundation, the Raymond and Beverly Sackler Foundation, and the Broad Institute.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Blackman B, 2005, BREAST CANCER RES, V7, pR248, DOI 10.1186/bcr988; Bocker W, 2002, LAB INVEST, V82, P737, DOI 10.1097/01.LAB.0000017371.72714.C5; Bonnet D, 1999, BONE MARROW TRANSPL, V23, P203, DOI 10.1038/sj.bmt.1701564; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Bussolati G, 1996, AM J PATHOL, V148, P1895; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Deng H, 2011, MED HYPOTHESES, V76, P809, DOI 10.1016/j.mehy.2011.02.024; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Diehn M, 2006, J NATL CANCER I, V98, P1755, DOI 10.1093/jnci/djj505; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Drabsch Y, 2007, P NATL ACAD SCI USA, V104, P13762, DOI 10.1073/pnas.0700104104; Dressman M. A., 2001, Pharmacogenomics Journal, V1, P135; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107; Frobenius G., 1912, MATRIZEN NICHT NEGAT, P456; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gill S, 2001, J CLIN PATHOL, V54, P956, DOI 10.1136/jcp.54.12.956; Govoni KE, 2009, J CELL BIOCHEM, V106, P482, DOI 10.1002/jcb.22035; Gudjonsson T, 2002, GENE DEV, V16, P693, DOI 10.1101/gad.952602; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Gutierrez GM, 2008, P NATL ACAD SCI USA, V105, P18402, DOI 10.1073/pnas.0805925105; Harris MA, 2008, CANCER RES, V68, P10051, DOI 10.1158/0008-5472.CAN-08-0786; Howard B, 2006, PLOS GENET, V2, P1121, DOI 10.1371/journal.pgen.0020112; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jones C, 2004, CANCER RES, V64, P3037, DOI 10.1158/0008-5472.CAN-03-2028; Kariagina A, 2007, ENDOCRINOLOGY, V148, P2723, DOI 10.1210/en.2006-1493; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lee HS, 2007, MOL CELL BIOCHEM, V296, P129, DOI 10.1007/s11010-006-9306-4; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Lu S, 2008, CLIN CANCER RES, V14, P1050, DOI 10.1158/1078-0432.CCR-07-4116; Monaghan P, 1995, EPITHELIAL CELL BIOL, V4, P52; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Parisi S, 2008, J CELL SCI, V121, P2629, DOI 10.1242/jcs.027599; Perron O, 1907, MATH ANN, V64, P248, DOI 10.1007/BF01449896; Perry SS, 2007, BLOOD, V110, P2351, DOI 10.1182/blood-2007-01-069914; Phinney DG, 2005, BIOCHEM BIOPH RES CO, V338, P1759, DOI 10.1016/j.bbrc.2005.10.140; RASBRIDGE SA, 1993, J PATHOL, V169, P245, DOI 10.1002/path.1711690211; Reis JS, 2006, HISTOPATHOLOGY, V49, P10, DOI 10.1111/j.1365-2559.2006.02467.x; Richard JP, 2011, DEVELOPMENT, V138, P1483, DOI 10.1242/dev.063115; Sansone P, 2007, STEM CELLS, V25, P807, DOI 10.1634/stemcells.2006-0442; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Smyth G.K., 2004, STAT APPL GENET MOL, V3, pArticl, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Sorlie T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-127; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Wolf DM, 2005, J THEOR BIOL, V234, P227, DOI 10.1016/j.jtbi.2004.11.020; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Yarosh W, 2008, CANCER RES, V68, P693, DOI 10.1158/0008-5472.CAN-07-5012; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	68	999	1024	0	87	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 19	2011	146	4					633	644		10.1016/j.cell.2011.07.026	http://dx.doi.org/10.1016/j.cell.2011.07.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21854987	Bronze, Green Published			2022-12-01	WOS:000294043600017
J	Sheltzer, JM; Blank, HM; Pfau, SJ; Tange, Y; George, BM; Humpton, TJ; Brito, IL; Hiraoka, Y; Niwa, O; Amon, A				Sheltzer, Jason M.; Blank, Heidi M.; Pfau, Sarah J.; Tange, Yoshie; George, Benson M.; Humpton, Timothy J.; Brito, Ilana L.; Hiraoka, Yasushi; Niwa, Osami; Amon, Angelika			Aneuploidy Drives Genomic Instability in Yeast	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; RECOMBINATION; CELLS; PROLIFERATION; EVOLUTION; REPAIR	Aneuploidy decreases cellular fitness, yet it is also associated with cancer, a disease of enhanced proliferative capacity. To investigate one mechanism by which aneuploidy could contribute to tumorigenesis, we examined the effects of aneuploidy on genomic stability. We analyzed 13 budding yeast strains that carry extra copies of single chromosomes and found that all aneuploid strains exhibited one or more forms of genomic instability. Most strains displayed increased chromosome loss and mitotic recombination, as well as defective DNA damage repair. Aneuploid fission yeast strains also exhibited defects in mitotic recombination. Aneuploidy-induced genomic instability could facilitate the development of genetic alterations that drive malignant growth in cancer.	[Sheltzer, Jason M.; Blank, Heidi M.; Pfau, Sarah J.; George, Benson M.; Humpton, Timothy J.; Amon, Angelika] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sheltzer, Jason M.; Blank, Heidi M.; Pfau, Sarah J.; George, Benson M.; Humpton, Timothy J.; Amon, Angelika] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Tange, Yoshie; Hiraoka, Yasushi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Brito, Ilana L.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Hiraoka, Yasushi] Natl Inst Informat & Commun Technol, Kobe Adv ICT Res Ctr, Nishi Ku, Kobe, Hyogo 6512492, Japan; [Niwa, Osami] Rockefeller Univ, New York, NY 10065 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Osaka University; Columbia University; National Institute of Information & Communications Technology (NICT) - Japan; Rockefeller University	Amon, A (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	angelika@mit.edu	Hiraoka, Yasushi/B-5111-2009; Humpton, Timothy/AAV-5501-2020; Brito, Ilana/W-1827-2017	Hiraoka, Yasushi/0000-0001-9407-8228; Humpton, Timothy/0000-0002-8030-9539; Amon, Angelika/0000-0001-9837-0314; Brito, Ilana/0000-0002-2250-3480; Pfau, Sarah/0000-0001-7528-0666	NSF;  [GM056800]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056800, R29GM056800] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Koshland, T. Petes, R. Li, L. Symington, D. Page, T. Matsumoto, and J. Takeda for reagents, and I. Cheeseman, J. Haber, M. Rose, F. Solomon, and the Amon lab for comments on the manuscript. J. M. S. and S. J. P. are supported by NSF Graduate Fellowships and A. A by grant GM056800. A.A. is an HHMI investigator.	Charles JS, 2010, GENETICS, V186, P537, DOI 10.1534/genetics.110.121533; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Duesberg P, 1998, P NATL ACAD SCI USA, V95, P13692, DOI 10.1073/pnas.95.23.13692; Harfe BD, 2000, MOL CELL, V6, P1491, DOI 10.1016/S1097-2765(00)00145-3; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Matzke MA, 2003, TRENDS GENET, V19, P253, DOI 10.1016/S0168-9525(03)00057-X; Meister P, 2003, NUCLEIC ACIDS RES, V31, P5064, DOI 10.1093/nar/gkg719; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Natarajan AT, 2006, MED INTELL UNIT, P61; Niwa O, 2006, YEAST, V23, P937, DOI 10.1002/yea.1411; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Rattray AJ, 2002, GENETICS, V162, P1063; Shaver AC, 2002, GENETICS, V162, P557; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Takeda J, 2008, DNA REPAIR, V7, P1250, DOI 10.1016/j.dnarep.2008.04.006; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Torres EM, 2010, CELL, V143, P71, DOI 10.1016/j.cell.2010.08.038; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058	23	273	280	3	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2011	333	6045					1026	1030		10.1126/science.1206412	http://dx.doi.org/10.1126/science.1206412			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808TD	21852501	Green Submitted, Green Accepted			2022-12-01	WOS:000294000400058
J	Lindhurst, MJ; Sapp, JC; Teer, JK; Johnston, JJ; Finn, EM; Peters, K; Turner, J; Cannons, JL; Bick, D; Blakemore, L; Blumhorst, C; Brockmann, K; Calder, P; Cherman, N; Deardorff, MA; Everman, DB; Golas, G; Greenstein, RM; Kato, BM; Keppler-Noreuil, KM; Kuznetsov, SA; Miyamoto, RT; Newman, K; Ng, D; O'Brien, K; Rothenberg, S; Schwartzentruber, DJ; Singhal, V; Tirabosco, R; Upton, J; Wientroub, S; Zackai, EH; Hoag, K; Whitewood-Neal, T; Robey, PG; Schwartzberg, PL; Darling, TN; Tosi, LL; Mullikin, JC; Biesecker, LG				Lindhurst, Marjorie J.; Sapp, Julie C.; Teer, Jamie K.; Johnston, Jennifer J.; Finn, Erin M.; Peters, Kathryn; Turner, Joyce; Cannons, Jennifer L.; Bick, David; Blakemore, Laurel; Blumhorst, Catherine; Brockmann, Knut; Calder, Peter; Cherman, Natasha; Deardorff, Matthew A.; Everman, David B.; Golas, Gretchen; Greenstein, Robert M.; Kato, B. Maya; Keppler-Noreuil, Kim M.; Kuznetsov, Sergei A.; Miyamoto, Richard T.; Newman, Kurt; Ng, David; O'Brien, Kevin; Rothenberg, Steven; Schwartzentruber, Douglas J.; Singhal, Virender; Tirabosco, Roberto; Upton, Joseph; Wientroub, Shlomo; Zackai, Elaine H.; Hoag, Kimberly; Whitewood-Neal, Tracey; Robey, Pamela G.; Schwartzberg, Pamela L.; Darling, Thomas N.; Tosi, Laura L.; Mullikin, James C.; Biesecker, Leslie G.			A Mosaic Activating Mutation in AKT1 Associated with the Proteus Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TUMOR-SUPPRESSOR PTEN; GERMLINE MUTATION; GENE; CELLS; CHALLENGES; DEFECTS; GROWTH	BACKGROUND The Proteus syndrome is characterized by the overgrowth of skin, connective tissue, brain, and other tissues. It has been hypothesized that the syndrome is caused by somatic mosaicism for a mutation that is lethal in the nonmosaic state. METHODS We performed exome sequencing of DNA from biopsy samples obtained from patients with the Proteus syndrome and compared the resultant DNA sequences with those of unaffected tissues obtained from the same patients. We confirmed and extended an observed association, using a custom restriction-enzyme assay to analyze the DNA in 158 samples from 29 patients with the Proteus syndrome. We then assayed activation of the AKT protein in affected tissues, using phosphorylation-specific antibodies on Western blots. RESULTS Of 29 patients with the Proteus syndrome, 26 had a somatic activating mutation (c.49G -> A, p.Glu17Lys) in the oncogene AKT1, encoding the AKT1 kinase, an enzyme known to mediate processes such as cell proliferation and apoptosis. Tissues and cell lines from patients with the Proteus syndrome harbored admixtures of mutant alleles that ranged from 1% to approximately 50%. Mutant cell lines showed greater AKT phosphorylation than did control cell lines. A pair of single-cell clones that were established from the same starting culture and differed with respect to their mutation status had different levels of AKT phosphorylation. CONCLUSIONS The Proteus syndrome is caused by a somatic activating mutation in AKT1, proving the hypothesis of somatic mosaicism and implicating activation of the PI3K-AKT pathway in the characteristic clinical findings of overgrowth and tumor susceptibility in this disorder. (Funded by the Intramural Research Program of the National Human Genome Research Institute.)	[Biesecker, Leslie G.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Cherman, Natasha; Kuznetsov, Sergei A.; Robey, Pamela G.] Natl Inst Dent & Craniofacial Res, Bethesda, MD USA; [Schwartzentruber, Douglas J.] NCI, Bethesda, MD 20892 USA; [Darling, Thomas N.] Uniformed Serv Univ Hlth Sci, Dept Dermatol, Bethesda, MD 20814 USA; [Mullikin, James C.; Biesecker, Leslie G.] Natl Inst Hlth Intramural Sequencing Ctr, Rockville, MD USA; [Bick, David] Med Coll Wisconsin, Dept Pediat, Div Genet, Milwaukee, WI 53226 USA; [Blakemore, Laurel; Tosi, Laura L.] Childrens Natl Med Ctr, Div Orthopaed & Sports Med, Washington, DC 20010 USA; [Newman, Kurt] Childrens Natl Med Ctr, Dept Surg, Washington, DC 20010 USA; [Brockmann, Knut] Univ Gottingen, Dept Pediat & Pediat Neurol, Gottingen, Germany; [Calder, Peter; Tirabosco, Roberto] Royal Natl Orthopaed Hosp, Stanmore HA7 4LP, Middx, England; [Deardorff, Matthew A.; Zackai, Elaine H.] Childrens Hosp Philadelphia, Div Genet, Philadelphia, PA 19104 USA; [Everman, David B.] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Greenstein, Robert M.] Univ Connecticut, Dept Genet & Dev Biol, Hartford, CT USA; [Kato, B. Maya] Ear Inst, Palm Desert, CA USA; [Keppler-Noreuil, Kim M.] Univ Iowa, Dept Pediat, Div Genet, Iowa City, IA 52242 USA; [Miyamoto, Richard T.] Indiana Univ Purdue Univ, Dept Otolaryngol, Indianapolis, IN 46202 USA; [Rothenberg, Steven] Rocky Mt Hosp Children, Dept Pediat Surg, Denver, CO USA; [Singhal, Virender] Childrens Mercy Hosp & Clin, Dept Pediat Plast & Craniofacial Surg, Kansas City, MO USA; [Upton, Joseph] Childrens Hosp, Div Plast Surg, Boston, MA 02115 USA; [Wientroub, Shlomo] Tel Aviv Univ, Tel Aviv Med Ctr, Dana Childrens Hosp, Dept Pediat Orthopaed, IL-69978 Tel Aviv, Israel; [Hoag, Kimberly] Proteus Syndrome Fdn, Colorado Springs, CO USA; [Whitewood-Neal, Tracey] Proteus Syndrome Fdn UK, Bexhill On Sea, England	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; Medical College of Wisconsin; Children's National Health System; Children's National Health System; University of Gottingen; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Greenwood Genetic Center; University of Connecticut; University of Iowa; Indiana University System; Indiana University-Purdue University Indianapolis; Children's Mercy Hospital; Harvard University; Boston Children's Hospital; Tel Aviv University; Sackler Faculty of Medicine	Biesecker, LG (corresponding author), NHGRI, Genet Dis Res Branch, NIH, Bldg 49,Rm 4A56, Bethesda, MD 20892 USA.	leslieb@helix.nih.gov	Robey, Pamela Gehron/H-1429-2011; Lindhurst, Marjorie/AHD-3412-2022	Robey, Pamela Gehron/0000-0002-5316-5576; Sapp, Julie/0000-0002-4003-258X; Darling, Thomas/0000-0002-5161-1974	National Human Genome Research Institute; Proteus Syndrome Foundation in the United States; Proteus Syndrome Foundation in the United Kingdom; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200328, ZIAHG200330, ZIAHG000123, ZIBHG000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000380] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Proteus Syndrome Foundation in the United States; Proteus Syndrome Foundation in the United Kingdom; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Supported by the Intramural Research Program of the National Human Genome Research Institute. The Proteus Syndrome Foundations in the United States and the United Kingdom contributed financial support for the sequencing.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barker K, 2001, J MED GENET, V38, P480, DOI 10.1136/jmg.38.7.480; Biesecker L. G., 2005, MANAGEMENT GENETIC S, P449; Biesecker L, 2006, EUR J HUM GENET, V14, P1151, DOI 10.1038/sj.ejhg.5201638; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; Biesecker LG, 2001, LANCET, V358, P2079, DOI 10.1016/S0140-6736(01)07109-4; Biesecker LG, 2001, JAMA-J AM MED ASSOC, V285, P2240, DOI 10.1001/jama.285.17.2240; Brasier JL, 1997, J CLIN INVEST, V99, P194, DOI 10.1172/JCI119147; Brockmann K, 2008, AM J MED GENET A, V146A, P2122, DOI 10.1002/ajmg.a.32417; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Caux F, 2007, EUR J HUM GENET, V15, P767, DOI 10.1038/sj.ejhg.5201823; Chen JH, 2004, BLOOD, V104, P1703, DOI 10.1182/blood-2003-10-3428; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fukai A, 2010, ARTHRITIS RHEUM-US, V62, P826, DOI 10.1002/art.27296; Happle R, 2007, BRIT J DERMATOL, V156, P1089, DOI 10.1111/j.1365-2133.2007.07818.x; HAPPLE R, 1986, HUM GENET, V72, P280, DOI 10.1007/BF00291899; HAPPLE R, 1987, J AM ACAD DERMATOL, V16, P899, DOI 10.1016/S0190-9622(87)80249-9; HAPPLE R, 1986, CLIN GENET, V29, P321; Kharas MG, 2010, BLOOD, V115, P1406, DOI 10.1182/blood-2009-06-229443; Segrelles C, 2008, MOL BIOL CELL, V19, P137, DOI 10.1091/mbc.E07-08-0764; Segrelles C, 2007, CANCER RES, V67, P10879, DOI 10.1158/0008-5472.CAN-07-2564; Slavotinek AM, 2000, CLIN GENET, V58, P386, DOI 10.1034/j.1399-0004.2000.580509.x; Smith JM, 2002, J MED GENET, V39, P937, DOI 10.1136/jmg.39.12.937; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Thiffault I, 2004, AM J MED GENET A, V130A, P123, DOI 10.1002/ajmg.a.30335; Vandoorne K, 2010, MAGN RESON MED, V64, P54, DOI 10.1002/mrm.22395; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; WEINSTEIN LS, 1992, NEW ENGL J MED, V326, P1648; Xue W, 2011, NATURE, V473, P544, DOI 10.1038/nature09909; Zhou F, 2010, AM J PATHOL, V177, P2124, DOI 10.2353/ajpath.2010.091301; Zhou XP, 2000, HUM MOL GENET, V9, P765, DOI 10.1093/hmg/9.5.765; Zhou XP, 2001, LANCET, V358, P210, DOI 10.1016/S0140-6736(01)05412-5	35	555	574	1	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2011	365	7					611	619		10.1056/NEJMoa1104017	http://dx.doi.org/10.1056/NEJMoa1104017			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808ER	21793738	Green Accepted			2022-12-01	WOS:000293960500008
J	Kim, DH; Lu, NS; Ma, R; Kim, YS; Kim, RH; Wang, SD; Wu, J; Won, SM; Tao, H; Islam, A; Yu, KJ; Kim, TI; Chowdhury, R; Ying, M; Xu, LZ; Li, M; Chung, HJ; Keum, H; McCormick, M; Liu, P; Zhang, YW; Omenetto, FG; Huang, YG; Coleman, T; Rogers, JA				Kim, Dae-Hyeong; Lu, Nanshu; Ma, Rui; Kim, Yun-Soung; Kim, Rak-Hwan; Wang, Shuodao; Wu, Jian; Won, Sang Min; Tao, Hu; Islam, Ahmad; Yu, Ki Jun; Kim, Tae-il; Chowdhury, Raeed; Ying, Ming; Xu, Lizhi; Li, Ming; Chung, Hyun-Joong; Keum, Hohyun; McCormick, Martin; Liu, Ping; Zhang, Yong-Wei; Omenetto, Fiorenzo G.; Huang, Yonggang; Coleman, Todd; Rogers, John A.			Epidermal Electronics	SCIENCE			English	Article							MECHANICAL-PROPERTIES; INTEGRATED-CIRCUITS; SKIN; INTERCONNECTS; INDENTATION	We report classes of electronic systems that achieve thicknesses, effective elastic moduli, bending stiffnesses, and areal mass densities matched to the epidermis. Unlike traditional wafer-based technologies, laminating such devices onto the skin leads to conformal contact and adequate adhesion based on van der Waals interactions alone, in a manner that is mechanically invisible to the user. We describe systems incorporating electrophysiological, temperature, and strain sensors, as well as transistors, light-emitting diodes, photodetectors, radio frequency inductors, capacitors, oscillators, and rectifying diodes. Solar cells and wireless coils provide options for power supply. We used this type of technology to measure electrical activity produced by the heart, brain, and skeletal muscles and show that the resulting data contain sufficient information for an unusual type of computer game controller.	[Kim, Dae-Hyeong; Lu, Nanshu; Kim, Yun-Soung; Kim, Rak-Hwan; Won, Sang Min; Islam, Ahmad; Yu, Ki Jun; Kim, Tae-il; Ying, Ming; Xu, Lizhi; Chung, Hyun-Joong; Keum, Hohyun; Rogers, John A.] Univ Illinois, Dept Mat Sci & Engn, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Kim, Dae-Hyeong; Lu, Nanshu; Kim, Yun-Soung; Kim, Rak-Hwan; Won, Sang Min; Islam, Ahmad; Yu, Ki Jun; Kim, Tae-il; Ying, Ming; Xu, Lizhi; Chung, Hyun-Joong; Keum, Hohyun; Rogers, John A.] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA; [Ma, Rui; Chowdhury, Raeed; McCormick, Martin; Coleman, Todd] Univ Illinois, Dept Elect & Comp Engn, Coordinated Sci Lab, Urbana, IL 61801 USA; [Wang, Shuodao; Wu, Jian; Li, Ming; Huang, Yonggang] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA; [Wang, Shuodao; Wu, Jian; Li, Ming; Huang, Yonggang] Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL 60208 USA; [Tao, Hu; Omenetto, Fiorenzo G.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Liu, Ping; Zhang, Yong-Wei] Inst High Performance Comp, Singapore 138632, Singapore; [Li, Ming] Dalian Univ Technol, State Key Lab Struct Anal Ind Equipment, Dalian 116024, Peoples R China	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University; Northwestern University; Tufts University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC); Dalian University of Technology	Rogers, JA (corresponding author), Univ Illinois, Dept Mat Sci & Engn, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA.	jrogers@uiuc.edu	Zhang, Yong-Wei/D-5191-2012; Lu, Nanshu/B-1611-2008; huang, yonggang/O-6236-2019; Kim, Tae-il/C-4769-2015; Wu, Jian/I-3466-2012; Wang, Shuodao/H-6014-2011; Huang, Yonggang/B-6998-2009; Rogers, John/L-2798-2016; Tao, Hu/C-1528-2013; Kim, Rak-Hwan/A-6155-2012; Chung, Hyun-Joong/H-6208-2011; Chung, Hyun-Joong/D-5383-2013; Xu, Lizhi/D-8143-2016; Islam, Ahmad Ehteshamul/A-6569-2008; Chowdhury, Raeed Hasan/J-4443-2019; li, ming/F-6060-2010	Zhang, Yong-Wei/0000-0001-7255-1678; Lu, Nanshu/0000-0002-3595-3851; Kim, Tae-il/0000-0002-6667-5356; Wu, Jian/0000-0003-2295-6815; Wang, Shuodao/0000-0002-0481-7902; Chung, Hyun-Joong/0000-0003-0569-6951; Xu, Lizhi/0000-0001-6888-0524; Islam, Ahmad Ehteshamul/0000-0002-4233-1233; Chowdhury, Raeed Hasan/0000-0002-5934-919X; Coleman, Todd/0000-0002-2144-2495; Kim, Dae-Hyeong/0000-0002-4722-1893	National Security Science and Engineering Faculty; Air Force Research Laboratory; National Science Foundation (NSF) [CMMI 07-49028, ECCS-0824129, OISE-1043143]; U.S. Department of Energy, Division of Materials Sciences [DE-FG02-07ER46471, DE-FG02-07ER46453]; Beckman Institute postdoctoral fellowship	National Security Science and Engineering Faculty; Air Force Research Laboratory; National Science Foundation (NSF)(National Science Foundation (NSF)); U.S. Department of Energy, Division of Materials Sciences(United States Department of Energy (DOE)); Beckman Institute postdoctoral fellowship	This material is based on work supported by a National Security Science and Engineering Faculty Fellowship and a grant from the Air Force Research Laboratory. The manufacturing techniques were developed with support from the National Science Foundation (NSF) under grant CMMI 07-49028 and used facilities at the Materials Research Laboratory and Center for Microanalysis of Materials at the University of Illinois at Urbana-Champaign, supported by the U.S. Department of Energy, Division of Materials Sciences under awards DE-FG02-07ER46471 and DE-FG02-07ER46453. N.L. acknowledges support from a Beckman Institute postdoctoral fellowship. Y.H. acknowledges NSF grants ECCS-0824129 and OISE-1043143. We thank K. Shenoy and R. Nuzzo for useful discussions. One or more provisional patents are being filed on this work. J.A.R. is a co-founder and equity holder in the company MC10, which pursues the commercialization of biointegrated devices.	ARUMUGAM V, 1994, J BIOSCIENCE, V19, P307, DOI 10.1007/BF02716820; Barbir F., 2005, PEM FUEL CELLS, DOI [10.1016/B978-0-12-078142-3.X5000-9, DOI 10.1016/B978-0-12-078142-3.X5000-9, DOI 10.1016/B978-0-12-437552-9.X5000-4]; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Cheung KC, 2007, BIOSENS BIOELECTRON, V22, P1783, DOI 10.1016/j.bios.2006.08.035; FOX EJ, 1976, PAIN, V2, P141, DOI 10.1016/0304-3959(76)90109-3; Geerligs M, 2011, J BIOMECH, V44, P1176, DOI 10.1016/j.jbiomech.2011.01.015; GERDLE B, 1999, MODERN TECHNIQUES NE, P705; Gonzalez M, 2008, MICROELECTRON RELIAB, V48, P825, DOI 10.1016/j.microrel.2008.03.025; Griss P, 2002, IEEE T BIO-MED ENG, V49, P597, DOI 10.1109/TBME.2002.1001974; HARDYCK CD, 1966, SCIENCE, V154, P1467, DOI 10.1126/science.154.3755.1467; Hu LB, 2010, NANO LETT, V10, P708, DOI 10.1021/nl903949m; Irimia-Vladu M, 2010, ADV FUNCT MATER, V20, P4069, DOI 10.1002/adfm.201001031; Ives JR, 2007, CLIN NEUROPHYSIOL, V118, P1633, DOI 10.1016/j.clinph.2007.03.013; Kaneko A, 2005, J HAND THER, V18; Kaneko Atsushi, 2005, J Hand Ther, V18, P421, DOI 10.1197/j.jht.2005.09.010; Keplinger C, 2010, P NATL ACAD SCI USA, V107, P4505, DOI 10.1073/pnas.0913461107; Kim DH, 2008, SCIENCE, V320, P507, DOI 10.1126/science.1154367; Kim DH, 2008, P NATL ACAD SCI USA, V105, P18675, DOI 10.1073/pnas.0807476105; Kim RH, 2010, NAT MATER, V9, P929, DOI [10.1038/NMAT2879, 10.1038/nmat2879]; Kubo M, 2010, ADV MATER, V22, P2749, DOI 10.1002/adma.200904201; Kuwazuru O, 2008, MED ENG PHYS, V30, P516, DOI 10.1016/j.medengphy.2007.06.001; Lacour SP, 2005, P IEEE, V93, P1459, DOI 10.1109/JPROC.2005.851502; Mannsfeld SCB, 2010, NAT MATER, V9, P859, DOI [10.1038/nmat2834, 10.1038/NMAT2834]; Pailler-Mattei C, 2008, MED ENG PHYS, V30, P599, DOI 10.1016/j.medengphy.2007.06.011; Searle A, 2000, PHYSIOL MEAS, V21, P271, DOI 10.1088/0967-3334/21/2/307; Sekitani T, 2008, SCIENCE, V321, P1468, DOI 10.1126/science.1160309; Spreen O., 2006, COMPENDIUM NEUROPSYC; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Takei K, 2010, NAT MATER, V9, P821, DOI [10.1038/nmat2835, 10.1038/NMAT2835]; Tchvialeva  L., 2010, SKIN ROUGHNESS ASSES; Webster J G, 2009, MED INSTRUM, P189; Wilhelm K. P., 1997, BIOENGINEERING SKIN; Yu LM, 2009, SENSOR ACTUAT A-PHYS, V151, P17, DOI 10.1016/j.sna.2009.01.020	33	3187	3320	134	2225	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 12	2011	333	6044					838	843		10.1126/science.1206157	http://dx.doi.org/10.1126/science.1206157			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21836009	Green Submitted			2022-12-01	WOS:000293785400031
J	Naya, Y; Suzuki, WA				Naya, Yuji; Suzuki, Wendy A.			Integrating What and When Across the Primate Medial Temporal Lobe	SCIENCE			English	Article							INFEROTEMPORAL CORTEX; EPISODIC MEMORY; HIPPOCAMPUS; REPRESENTATION; CONTEXT; MONKEY; ORDER; OBJECTS; EVENTS	Episodic memory or memory for the detailed events in our lives is critically dependent on structures of the medial temporal lobe (MTL). A fundamental component of episodic memory is memory for the temporal order of items within an episode. To understand the contribution of individual MTL structures to temporal-order memory, we recorded single-unit activity and local field potential from three MTL areas (hippocampus and entorhinal and perirhinal cortex) and visual area TE as monkeys performed a temporal-order memory task. Hippocampus provided incremental timing signals from one item presentation to the next, whereas perirhinal cortex signaled the conjunction of items and their relative temporal order. Thus, perirhinal cortex appeared to integrate timing information from hippocampus with item information from visual sensory area TE.	[Naya, Yuji; Suzuki, Wendy A.] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Naya, Y (corresponding author), NYU, Ctr Neural Sci, 4 Washington Pl, New York, NY 10003 USA.	yujin@cns.nyu.edu			NIH [RO1 MH086563, RO1 MH058847]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086563, R01MH058847] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The present study was funded by NIH grants RO1 MH086563 to W.A.S. and Y.N. and RO1 MH058847 to W.A.S. We thank E. Wang, A. Shang, and N. Nystrom for expert animal care and E. Hargreaves, M. Yanike, and M. Shapiro for helpful comments. The authors declare no competing financial interests. Y.N. and W.A.S. designed the experiments and wrote the manuscript. Y.N. performed the experiment and analyzed the data.	Barak O, 2010, J NEUROSCI, V30, P9424, DOI 10.1523/JNEUROSCI.1875-10.2010; Downes JJ, 2002, NEUROPSYCHOLOGIA, V40, P853, DOI 10.1016/S0028-3932(01)00172-5; Eichenbaum H, 2003, CURR DIR PSYCHOL SCI, V12, P53, DOI 10.1111/1467-8721.01225; Gill PR, 2011, HIPPOCAMPUS, V21, P1240, DOI 10.1002/hipo.20832; Howard MW, 2005, PSYCHOL REV, V112, P75, DOI 10.1037/0033-295X.112.1.75; Howard MW, 2002, J MATH PSYCHOL, V46, P269, DOI 10.1006/jmps.2001.1388; Jenkins LJ, 2010, J NEUROSCI, V30, P15558, DOI 10.1523/JNEUROSCI.1337-10.2010; Lehky SR, 2005, VISION RES, V45, P57, DOI 10.1016/j.visres.2004.07.021; Manns JR, 2007, NEURON, V56, P530, DOI 10.1016/j.neuron.2007.08.017; Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013; Naya Y, 2003, J NEUROSCI, V23, P2861; Naya Y, 2001, SCIENCE, V291, P661, DOI 10.1126/science.291.5504.661; Ninokura Y, 2003, J NEUROPHYSIOL, V89, P2868, DOI 10.1152/jn.00647.2002; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Paz R, 2010, P NATL ACAD SCI USA, V107, P6046, DOI 10.1073/pnas.0910834107; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tubridy S, 2011, CEREB CORTEX, V21, P272, DOI 10.1093/cercor/bhq092; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Warden MR, 2007, CEREB CORTEX, V17, pI41, DOI 10.1093/cercor/bhm070; Wirth S, 2003, SCIENCE, V300, P1578, DOI 10.1126/science.1084324	22	155	157	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 5	2011	333	6043					773	776		10.1126/science.1206773	http://dx.doi.org/10.1126/science.1206773			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817056				2022-12-01	WOS:000293512100048
J	Alter, G; Heckerman, D; Schneidewind, A; Fadda, L; Kadie, CM; Carlson, JM; Oniangue-Ndza, C; Martin, M; Li, B; Khakoo, SI; Carrington, M; Allen, TM; Altfeld, M				Alter, Galit; Heckerman, David; Schneidewind, Arne; Fadda, Lena; Kadie, Carl M.; Carlson, Jonathan M.; Oniangue-Ndza, Cesar; Martin, Maureen; Li, Bin; Khakoo, Salim I.; Carrington, Mary; Allen, Todd M.; Altfeld, Marcus			HIV-1 adaptation to NK-cell-mediated immune pressure	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NATURAL-KILLER-CELLS; MHC CLASS-I; HLA-B; INHIBITORY RECEPTOR; VIRAL PEPTIDES; BINDING-SITE; RECOGNITION; KIR3DL1; RESPONSES	Natural killer (NK) cells have an important role in the control of viral infections, recognizing virally infected cells through a variety of activating and inhibitory receptors(1-3). Epidemiological and functional studies have recently suggested that NK cells can also contribute to the control of HIV-1 infection through recognition of virally infected cells by both activating and inhibitory killer immunoglobulin-like receptors (KIRs)(4-7). However, it remains unknown whether NK cells can directly mediate antiviral immune pressure in vivo in humans. Here we describe KIR-associated amino-acid polymorphisms in the HIV-1 sequence of chronically infected individuals, on a population level. We show that these KIR-associated HIV-1 sequence polymorphisms can enhance the binding of inhibitory KIRs to HIV-1-infected CD4(+) T cells, and reduce the antiviral activity of KIR-positive NK cells. These data demonstrate that KIR-positive NK cells can place immunological pressure on HIV-1, and that the virus can evade such NK-cell-mediated immune pressure by selecting for sequence polymorphisms, as was previously described for virus-specific T cells and neutralizing antibodies(8). NK cells might therefore have a previously underappreciated role in contributing to viral evolution.	[Alter, Galit; Schneidewind, Arne; Fadda, Lena; Oniangue-Ndza, Cesar; Li, Bin; Carrington, Mary; Allen, Todd M.; Altfeld, Marcus] Harvard Univ, Ragon Inst MGH MIT & Harvard, Massachusetts Gen Hosp, Sch Med, Boston, MA 02129 USA; [Heckerman, David; Kadie, Carl M.; Carlson, Jonathan M.] Microsoft Res, Redmond, WA 98053 USA; [Martin, Maureen; Carrington, Mary] NCI, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick Inc, Frederick, MD 21702 USA; [Khakoo, Salim I.] Univ London Imperial Coll Sci Technol & Med, Div Med, London W2 1PG, England	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Microsoft; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Imperial College London	Altfeld, M (corresponding author), Harvard Univ, Ragon Inst MGH MIT & Harvard, Massachusetts Gen Hosp, Sch Med, Boston, MA 02129 USA.	maltfeld@partners.org	Allen, Todd/F-5473-2011; Altfeld, Marcus/AAE-7306-2019	Allen, Todd/0000-0002-6609-1318; Altfeld, Marcus/0000-0001-5972-2997; Li, Bin/0000-0003-2248-4002; Khakoo, Salim/0000-0002-4057-9091	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases [R01 AI067031, PO1 AI074415]; Doris Duke Charitable Foundation; National Cancer Institute (NIH) [HHSN261200800001E]; NIH, National Cancer Institute, Center for Cancer Research; Wellcome Trust; Microsoft Research; Bill & Melinda Gates Foundation; Mark and Lisa Schwartz Foundation; Phillip T. and Susan M. Ragon Foundation; NATIONAL CANCER INSTITUTE [ZIABC010791] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Cancer Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome Trust); Microsoft Research(Microsoft); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Mark and Lisa Schwartz Foundation; Phillip T. and Susan M. Ragon Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported by National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases grants R01 AI067031 (M. A.) and PO1 AI074415 (M. A. and T. M. A.), and by the Doris Duke Charitable Foundation (M. A.). This project was funded in whole or in part with federal funds from the National Cancer Institute (NIH) under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US government. This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. S. I. K. is a recipient of a Wellcome Trust Senior Clinical Fellowship and M. A. is a Distinguished Clinical Scientist of the Doris Duke Charitable Foundation. We thank Microsoft Research, the Bill & Melinda Gates Foundation, the Mark and Lisa Schwartz Foundation and the Phillip T. and Susan M. Ragon Foundation for their support.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Altfeld M, 2007, NAT GENET, V39, P708, DOI 10.1038/ng0607-708; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Carlson JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000225; Fadda L, 2011, J VIROL, V85, P5970, DOI 10.1128/JVI.00412-11; Fadda L, 2010, P NATL ACAD SCI USA, V107, P10160, DOI 10.1073/pnas.0913745107; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Le Gall S, 2007, J CLIN INVEST, V117, P3563, DOI 10.1172/JCI32047; MALNATI MS, 1995, SCIENCE, V267, P1016, DOI 10.1126/science.7863326; Mandelboim O, 1997, P NATL ACAD SCI USA, V94, P4604, DOI 10.1073/pnas.94.9.4604; Mandelboim O, 1997, IMMUNITY, V6, P341, DOI 10.1016/S1074-7613(00)80336-2; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Moesta AK, 2008, J IMMUNOL, V180, P3969, DOI 10.4049/jimmunol.180.6.3969; Peruzzi M, 1996, J IMMUNOL, V157, P3350; Rajagopalan S, 1997, J EXP MED, V185, P1523, DOI 10.1084/jem.185.8.1523; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Stewart CA, 2005, P NATL ACAD SCI USA, V102, P13224, DOI 10.1073/pnas.0503594102; Stewart-Jones GBE, 2005, EUR J IMMUNOL, V35, P341, DOI 10.1002/eji.200425724; Thananchai H, 2007, J IMMUNOL, V178, P33, DOI 10.4049/jimmunol.178.1.33; Wang YYE, 2009, J VIROL, V83, P1845, DOI 10.1128/JVI.01061-08; Ward J, 2007, BLOOD, V110, P1207, DOI 10.1182/blood-2006-06-028175; Ward J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000613; Yokoyama WM, 2005, ADV EXP MED BIOL, V560, P57	29	256	262	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 4	2011	476	7358					96	+		10.1038/nature10237	http://dx.doi.org/10.1038/nature10237			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NR	21814282	Green Accepted, Green Published			2022-12-01	WOS:000293447300037
J	Wintemute, GJ; Claire, B; McHenry, V; Wright, MA				Wintemute, Garen J.; Claire, Barbara; McHenry, Vanessa; Wright, Mona A.			Stray Bullet Shootings in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							VIOLENCE		[Wintemute, Garen J.; Claire, Barbara; McHenry, Vanessa; Wright, Mona A.] Univ Calif Davis, Violence Prevent Res Program, Sacramento, CA 95817 USA	University of California System; University of California Davis	Wintemute, GJ (corresponding author), Univ Calif Davis, Violence Prevent Res Program, Sacramento, CA 95817 USA.	gjwintemute@ucdavis.edu						Centers for Disease Control and Prevention, WISQARS WEB BAS INJ; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P1174; Horowitz K, 2005, AM J ORTHOPSYCHIAT, V75, P356, DOI 10.1037/0002-9432.75.3.356; Howard DE, 2003, AM J HEALTH BEHAV, V27, P483, DOI 10.5993/AJHB.27.5.1; Sorenson SB, 1998, AM J PUBLIC HEALTH, V88, P1510, DOI 10.2105/AJPH.88.10.1510; Wolfer T A, 2000, Violence Vict, V15, P283	6	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 3	2011	306	5					491	492		10.1001/jama.2011.1066	http://dx.doi.org/10.1001/jama.2011.1066			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	800SH	21813426	Bronze			2022-12-01	WOS:000293386500015
J	Coupland, C; Dhiman, P; Morriss, R; Arthur, A; Barton, G; Hippisley-Cox, J				Coupland, Carol; Dhiman, Paula; Morriss, Richard; Arthur, Antony; Barton, Garry; Hippisley-Cox, Julia			Antidepressant use and risk of adverse outcomes in older people: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEROTONIN-REUPTAKE INHIBITORS; ISCHEMIC-HEART-DISEASE; MYOCARDIAL-INFARCTION; DRUG-USE; DEPRESSION; HYPONATREMIA; ASSOCIATION; MORTALITY; HEALTH; FALLS	Objectives To investigate the association between antidepressant treatment and risk of several potential adverse outcomes in older people with depression and to examine risks by class of antidepressant, duration of use, and dose. Design Cohort study of people aged 65 and over diagnosed as having depression. Setting 570 general practices in the United Kingdom supplying data to the QResearch primary care database. Participants 60 746 patients diagnosed as having a new episode of depression between the ages of 65 and 100 years from 1 January 1996 to 31 December 2007 and followed up until 31 December 2008. Main outcome measures Hazard ratios associated with antidepressant use for all cause mortality, attempted suicide/self harm, myocardial infarction, stroke/transient ischaemic attack, falls, fractures, upper gastrointestinal bleeding, epilepsy/seizures, road traffic accidents, adverse drug reactions, and hyponatraemia, adjusted for a range of potential confounding variables. Hazard ratios were calculated for antidepressant class (tricyclic and related antidepressants, selective serotonin reuptake inhibitors, other antidepressants), dose, and duration of use and for commonly prescribed individual drugs. Results 54 038 (89.0%) patients received at least one prescription for an antidepressant during follow-up. A total of 1 398 359 antidepressant prescriptions were issued: 764 659 (54.7%) for selective serotonin reuptake inhibitors, 442 192 (31.6%) for tricyclic antidepressants, 2203 (0.2%) for monoamine oxidase inhibitors, and 189 305 (13.5%) for the group of other antidepressants. The associations with the adverse outcomes differed significantly between the antidepressant classes for seven outcomes. Selective serotonin reuptake inhibitors were associated with the highest adjusted hazard ratios for falls (1.66, 95% confidence interval 1.58 to 1.73) and hyponatraemia (1.52, 1.33 to 1.75) compared with when antidepressants were not being used. The group of other antidepressants was associated with the highest adjusted hazard ratios for all cause mortality (1.66, 1.56 to 1.77), attempted suicide/self harm (5.16, 3.90 to 6.83), stroke/transient ischaemic attack (1.37, 1.22 to 1.55), fracture (1.64, 1.46 to 1.84), and epilepsy/seizures (2.24, 1.60 to 3.15), compared with when antidepressants were not being used. Tricyclic antidepressants did not have the highest hazard ratio for any of the outcomes. Significantly different associations also existed between the individual drugs for the same seven outcomes; trazodone (tricyclic antidepressant), mirtazapine, and venlafaxine (both in the group of other antidepressants) were associated with the highest rates for some of these outcomes. Absolute risks over 1 year for all cause mortality were 7.04% for patients while not taking antidepressants, 8.12% for those taking tricyclic antidepressants, 10.61% for selective serotonin reuptake inhibitors, and 11.43% for other antidepressants. Conclusions Selective serotonin reuptake inhibitors and drugs in the group of other antidepressants were associated with an increased risk of several adverse outcomes compared with tricyclic antidepressants. Among individual drugs, trazodone, mirtazapine, and venlafaxine were associated with the highest risks for some outcomes. As this is an observational study, it is susceptible to confounding by indication, channelling bias, and residual confounding, so differences in characteristics between patients prescribed different antidepressant drugs that could account for some of the associations between the drugs and the adverse outcomes may remain. Further research is needed to confirm these findings, but the risks and benefits of different antidepressants should be carefully evaluated when these drugs are prescribed to older people.	[Coupland, Carol; Dhiman, Paula; Hippisley-Cox, Julia] Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England; [Morriss, Richard] Univ Nottingham, Div Psychiat, Nottingham NG7 2RD, England; [Arthur, Antony] Univ Nottingham, Div Nursing, Nottingham NG7 2RD, England; [Barton, Garry] Univ E Anglia, Sch Med Hlth Policy & Practice, HEG, Norwich NR4 7TJ, Norfolk, England	University of Nottingham; University of Nottingham; University of Nottingham; University of East Anglia	Coupland, C (corresponding author), Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England.	carol.coupland@nottingham.ac.uk	Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Morriss, Richard/0000-0003-2910-4121; Coupland, Carol/0000-0002-2327-3306; Arthur, Antony/0000-0001-8617-5714	NIHR [06/42/01]; National Institute for Health Research [06/42/01] Funding Source: researchfish	NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by the NIHR Health Technology Assessment Programme (project number 06/42/01). The views and opinions expressed are those of the authors and do not necessarily reflect those of the Department of Health.	Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Arfken CL, 2001, INT PSYCHOGERIATR, V13, P85, DOI 10.1017/S1041610201007487; Barbui C, 2009, CAN MED ASSOC J, V180, P291, DOI 10.1503/cmaj.081514; Beekman ATF, 1999, BRIT J PSYCHIAT, V174, P307, DOI 10.1192/bjp.174.4.307; Bingefors K, 1996, BRIT J PSYCHIAT, V169, P647, DOI 10.1192/bjp.169.5.647; Blanchette CM, 2008, ANN EPIDEMIOL, V18, P316, DOI 10.1016/j.annepidem.2007.11.004; [British Medical Association Royal Pharmaceutical Society of Great Britain], 2007, BRIT NAT FORM; Cadieux RJ, 1999, POSTGRAD MED, V106, P231, DOI 10.3810/pgm.1999.11.780; Cassano P, 2002, J PSYCHOSOM RES, V53, P849, DOI 10.1016/S0022-3999(02)00304-5; Cohen HW, 2000, AM J MED, V108, P2, DOI 10.1016/S0002-9343(99)00301-0; Coupland C, 2011, HLTH TECHNO IN PRESS; Darowski A, 2009, DRUG AGING, V26, P381, DOI 10.2165/00002512-200926050-00002; de Abajo FJ, 1999, BRIT MED J, V319, P1106, DOI 10.1136/bmj.319.7217.1106; de Abajo FJ, 2006, BASIC CLIN PHARMACOL, V98, P304, DOI 10.1111/j.1742-7843.2006.pto_303.x; de Abajo FJ, 2008, ARCH GEN PSYCHIAT, V65, P795, DOI 10.1001/archpsyc.65.7.795; Diem SJ, 2007, J AM GERIATR SOC, V55, P824, DOI 10.1111/j.1532-5415.2007.01194.x; FURUKAWA T, 2003, COCHRANE DB SYST REV, V3; Giron MST, 2005, INT J GERIATR PSYCH, V20, P201, DOI 10.1002/gps.1273; Haney EM, 2007, ARCH INTERN MED, V167, P1246, DOI 10.1001/archinte.167.12.1246; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hippisley-Cox J, 2001, BRIT MED J, V323, P666, DOI 10.1136/bmj.323.7314.666; Hippisley-Cox J, 1998, BMJ-BRIT MED J, V316, P1714, DOI 10.1136/bmj.316.7146.1714; Hippisley- Cox J., 2005, COMP KEY PRACTICE CH; Hubbard R, 2003, AM J EPIDEMIOL, V158, P77, DOI 10.1093/aje/kwg114; Jacob S, 2006, ANN PHARMACOTHER, V40, P1618, DOI 10.1345/aph.1G293; Kallin K, 2004, AGING CLIN EXP RES, V16, P270; Kerse N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002423; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Kirby D, 2001, INT J GERIATR PSYCH, V16, P484, DOI 10.1002/gps.367; Kirby D, 2002, INT J GERIATR PSYCH, V17, P231, DOI 10.1002/gps.591; LEVEILLE SG, 1994, EPIDEMIOLOGY, V5, P591, DOI 10.1097/00001648-199411000-00006; Martinez C, 2005, BRIT MED J, V330, P389, DOI 10.1136/bmj.330.7488.389; Mcdougall FA, 2007, AGE AGEING, V36, P562, DOI 10.1093/ageing/afm111; Monster TBM, 2004, AM J MED, V117, P732, DOI 10.1016/j.amjmed.2004.06.027; Mottram P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003491.pub2; Movig KLL, 2002, BRIT J CLIN PHARMACO, V53, P363, DOI 10.1046/j.1365-2125.2002.01550.x; National Institute for Health and Clinical Excellence, 2009, DEPR TREATM MAN DEPR; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Opatrny L, 2008, BRIT J CLIN PHARMACO, V66, P76, DOI 10.1111/j.1365-2125.2008.03154.x; Parikh C, 2000, BRIT J CLIN PHARMACO, V49, P539, DOI 10.1046/j.1365-2125.2000.00201.x; Pollock BG, 1999, J CLIN PSYCHIAT, V60, P4; RAY WA, 1992, AM J EPIDEMIOL, V136, P873, DOI 10.1093/aje/136.7.873; Reid S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1468; Richards JB, 2007, ARCH INTERN MED, V167, P188, DOI 10.1001/archinte.167.2.188; ROSENSTEIN DL, 1993, J CLIN PSYCHIAT, V54, P289; Ryan J, 2008, BRIT J PSYCHIAT, V192, P12, DOI 10.1192/bjp.bp.107.039164; Sauer WH, 2003, CIRCULATION, V108, P32, DOI 10.1161/01.CIR.0000079172.43229.CD; Schlienger Raymond G, 2003, Am J Cardiovasc Drugs, V3, P149, DOI 10.2165/00129784-200303030-00001; Schlienger RG, 2004, DRUG SAFETY, V27, P1157, DOI 10.2165/00002018-200427140-00006; Skop BP, 1996, PSYCHOSOMATICS, V37, P12, DOI 10.1016/S0033-3182(96)71592-X; Smoller JW, 2009, ARCH INTERN MED, V169, P2128, DOI 10.1001/archinternmed.2009.436; Spigset O, 1997, PHARMACOTHERAPY, V17, P348; Stone M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2880; Tata LJ, 2005, HEART, V91, P465, DOI 10.1136/hrt.2004.037457; The NHS Information Centre Prescribing Support Unit, 2010, PRESCR COST AN ENGL; The NHS Information Centre Prescribing Support Unit, 2010, PRESCR DISP COMM STA; The NHS Information Centre Prescribing Support Unit, 2005, PRESCR COST AN ENGL; Tiihonen J, 2006, ARCH GEN PSYCHIAT, V63, P1358, DOI 10.1001/archpsyc.63.12.1358; Townsend P, 1988, HLTH DEPRIVATION INE; Trifiro G, 2010, J CLIN PSYCHOPHARM, V30, P252, DOI 10.1097/JCP.0b013e3181dca10a; van Walraven C, 2001, BMJ-BRIT MED J, V323, P655, DOI 10.1136/bmj.323.7314.655; Vassilev ZP, 2009, AM J HEALTH-SYST PH, V66, P481, DOI 10.2146/ajhp080267; Vestergaard P, 2008, CALCIFIED TISSUE INT, V82, P92, DOI 10.1007/s00223-007-9099-9; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Ziere G, 2008, J CLIN PSYCHOPHARM, V28, P411, DOI 10.1097/JCP.0b013e31817e0ecb	65	480	488	8	87	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 2	2011	343								d4551	10.1136/bmj.d4551	http://dx.doi.org/10.1136/bmj.d4551			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	805NM	21810886	Green Submitted, hybrid, Green Published			2022-12-01	WOS:000293734600003
J	Simon, R; Holderied, MW; Koch, CU; von Helversen, O				Simon, Ralph; Holderied, Marc W.; Koch, Corinna U.; von Helversen, Otto			Floral Acoustics: Conspicuous Echoes of a Dish-Shaped Leaf Attract Bat Pollinators	SCIENCE			English	Article							OBJECT RECOGNITION; ECHOLOCATION; SIZE; FLOWERS	The visual splendor of many diurnal flowers serves to attract visually guided pollinators such as bees and birds, but it remains to be seen whether bat-pollinated flowers have evolved analogous echo-acoustic signals to lure their echolocating pollinators. Here, we demonstrate how an unusual dish-shaped leaf displayed above the inflorescences of the vine Marcgravia evenia attracts bat pollinators. Specifically, this leaf's echoes fulfilled requirements for an effective beacon, that is, they were strong, multidirectional, and had a recognizable invariant echo signature. In behavioral experiments, presence of the leaves halved foraging time for flower-visiting bats.	[Simon, Ralph] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Holderied, Marc W.] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; [Koch, Corinna U.; von Helversen, Otto] Univ Erlangen Nurnberg, Inst Zool 2, D-91058 Erlangen, Germany	Ulm University; University of Bristol; University of Erlangen Nuremberg	Simon, R (corresponding author), Univ Ulm, Inst Expt Ecol, Albert Einstein Allee 11, D-89069 Ulm, Germany.	ralph.simon@uni-ulm.de	Holderied, Marc/M-9382-2013	Holderied, Marc/0000-0002-1573-7908; Simon, Ralph/0000-0002-6083-0394	Deutsche Forschungsgemeinschaft [HE 1180/15, HE 1180/13, HO 3914/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We are grateful to S. Dressler and M. Tschapka for information on pollination biology of Marcgravia and S. Dressler and J. Gutierrez for providing localities of M. evenia in Cuba. We thank E. K. V. Kalko, G. Jones, M. Knornschild, D. Kelm, H. Baldwin, N. Muchhala, and two anonymous reviewers for helpful comments on this manuscript. This work was supported by Deutsche Forschungsgemeinschaft (HE 1180/15, HE 1180/13, and HO 3914/1-1).	Armbruster WS, 2005, ECOLOGY, V86, P3323, DOI 10.1890/04-1873; Dressler S, 2000, WILLDENOWIA, V30, P369; Fleming TH, 2009, ANN BOT-LONDON, V104, P1017, DOI 10.1093/aob/mcp197; Forrest J, 2009, NATURWISSENSCHAFTEN, V96, P921, DOI 10.1007/s00114-009-0549-2; Herrera J, 1997, ECOLOGY, V78, P494, DOI 10.1890/0012-9658(1997)078[0494:TROCAB]2.0.CO;2; Heywood V. H., 1993, FLOWERING PLANTS WOR; Holderied MW, 2006, J EXP BIOL, V209, P3457, DOI 10.1242/jeb.02386; Johnson SD, 2000, TRENDS ECOL EVOL, V15, P140, DOI 10.1016/S0169-5347(99)01811-X; Kalko EKV, 1998, FUNCT ECOL, V12, P364, DOI 10.1046/j.1365-2435.1998.00198.x; Muller R, 2000, J ACOUST SOC AM, V108, P836, DOI 10.1121/1.429617; Simon R, 2006, J EXP BIOL, V209, P3599, DOI 10.1242/jeb.02398; Smith WK, 1997, BIOSCIENCE, V47, P785, DOI 10.2307/1313100; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098; TERASHIMA I, 1995, PLANT CELL ENVIRON, V18, P1111, DOI 10.1111/j.1365-3040.1995.tb00623.x; Tschapka M, 2006, FLORA, V201, P383, DOI 10.1016/j.flora.2005.07.014; von Helversen D, 2004, J COMP PHYSIOL A, V190, P515, DOI 10.1007/s00359-004-0492-9; Von Helversen D, 2003, J EXP BIOL, V206, P1025, DOI 10.1242/jeb.00203; von Helversen D, 2003, J COMP PHYSIOL A, V189, P327, DOI 10.1007/s00359-003-0405-3; von Helversen D, 1999, NATURE, V398, P759, DOI 10.1038/19648; von Helversen O, 2003, BAT ECOLOGY, P346; von Helversen O., 1993, ANIMAL PLANT INTERAC, P41; Weberling F., 1992, MORPHOLOGY FLOWERS I; Winter Y, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P148, DOI 10.1017/CBO9780511542268.009; Yovel Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000429	24	66	68	3	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2011	333	6042					631	633		10.1126/science.1204210	http://dx.doi.org/10.1126/science.1204210			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21798950				2022-12-01	WOS:000293222400062
J	Mele, C; Iatropoulos, P; Donadelli, R; Calabria, A; Maranta, R; Cassis, P; Buelli, S; Tomasoni, S; Piras, R; Krendel, M; Bettoni, S; Morigi, M; Delledonne, M; Pecoraro, C; Abbate, I; Capobianchi, MR; Hildebrandt, F; Otto, E; Schaefer, F; Macciardi, F; Ozaltin, F; Emre, S; Ibsirlioglu, T; Benigni, A; Remuzzi, G; Noris, M				Mele, Caterina; Iatropoulos, Paraskevas; Donadelli, Roberta; Calabria, Andrea; Maranta, Ramona; Cassis, Paola; Buelli, Simona; Tomasoni, Susanna; Piras, Rossella; Krendel, Mira; Bettoni, Serena; Morigi, Marina; Delledonne, Massimo; Pecoraro, Carmine; Abbate, Isabella; Capobianchi, Maria Rosaria; Hildebrandt, Friedhelm; Otto, Edgar; Schaefer, Franz; Macciardi, Fabio; Ozaltin, Fatih; Emre, Sevinc; Ibsirlioglu, Tulin; Benigni, Ariela; Remuzzi, Giuseppe; Noris, Marina		PodoNet Consortium	MYO1E Mutations and Childhood Familial Focal Segmental Glomerulosclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESISTANT NEPHROTIC SYNDROME; ACTIN CYTOSKELETON; GLOMERULAR PODOCYTES; GENE; DISEASES; PROTEIN; IDENTIFICATION; CYCLOSPORINE; ORGANIZATION; ENDOCYTOSIS	BACKGROUND Focal segmental glomerulosclerosis is a kidney disease that is manifested as the nephrotic syndrome. It is often resistant to glucocorticoid therapy and progresses to end-stage renal disease in 50 to 70% of patients. Genetic studies have shown that familial focal segmental glomerulosclerosis is a disease of the podocytes, which are major components of the glomerular filtration barrier. However, the molecular cause in over half the cases of primary focal segmental glomerulosclerosis is unknown, and effective treatments have been elusive. METHODS We performed whole-genome linkage analysis followed by high-throughput sequencing of the positive-linkage area in a family with autosomal recessive focal segmental glomerulosclerosis (index family) and sequenced a newly discovered gene in 52 unrelated patients with focal segmental glomerulosclerosis. Immunohistochemical studies were performed on human kidney-biopsy specimens and cultured podocytes. Expression studies in vitro were performed to characterize the functional consequences of the mutations identified. RESULTS We identified two mutations (A159P and Y695X) in MYO1E, which encodes a nonmuscle class I myosin, myosin 1E (Myo1E). The mutations in MYO1E segregated with focal segmental glomerulosclerosis in two independent pedigrees (the index family and Family 2). Patients were homozygous for the mutations and did not have a response to glucocorticoid therapy. Electron microscopy showed thickening and disorganization of the glomerular basement membrane. Normal expression of Myo1E was documented in control human kidney-biopsy specimens in vivo and in glomerular podocytes in vitro. Transfection studies revealed abnormal subcellular localization and function of the A159P-Myo1E mutant. The Y695X mutation causes loss of calmodulin binding and of the tail domains of Myo1E. CONCLUSIONS MYO1E mutations are associated with childhood-onset, glucocorticoid-resistant focal segmental glomerulosclerosis. Our data provide evidence of a role of Myo1E in podocyte function and the consequent integrity of the glomerular filtration barrier.	[Buelli, Simona; Tomasoni, Susanna; Morigi, Marina; Benigni, Ariela; Remuzzi, Giuseppe] Mario Negri Inst Pharmacol Res, Ctr Anna Maria Astori, I-24126 Bergamo, Italy; [Mele, Caterina; Iatropoulos, Paraskevas; Donadelli, Roberta; Maranta, Ramona; Cassis, Paola; Piras, Rossella; Bettoni, Serena; Remuzzi, Giuseppe; Noris, Marina] Mario Negri Inst Pharmacol Res, Clin Res Ctr Rare Dis Aldo & Cele Dacco Ranica, I-24126 Bergamo, Italy; [Remuzzi, Giuseppe] Osped Riuniti Bergamo, Unit Nephrol & Dialysis, I-24100 Bergamo, Italy; [Calabria, Andrea; Macciardi, Fabio] Univ Milan, Dept Med Surg & Dent, Milan, Italy; [Delledonne, Massimo] Univ Verona, Dept Biotechnol, Ctr Funct Genom, I-37100 Verona, Italy; [Pecoraro, Carmine] Santobono Hosp, Dept Nephrol & Dialysis, Naples, Italy; [Abbate, Isabella; Capobianchi, Maria Rosaria] Ist Nazl Malattie Infett Lazzaro Spallanzani, Virol Lab, Rome, Italy; [Krendel, Mira] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY USA; [Hildebrandt, Friedhelm; Otto, Edgar] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Hildebrandt, Friedhelm] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Schaefer, Franz] Ctr Pediat & Adolescent Med, Pediat Nephrol Div, Heidelberg, Germany; [Ozaltin, Fatih; Ibsirlioglu, Tulin] Hacettepe Univ, Fac Med, Dept Pediat Nephrol, TR-06100 Ankara, Turkey; [Emre, Sevinc] Istanbul Univ, Istanbul Fac Med, Dept Pediat Nephrol, Istanbul, Turkey	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Ospedali Riuniti di Bergamo; University of Milan; University of Verona; IRCCS Lazzaro Spallanzani; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Hacettepe University; Istanbul University	Remuzzi, G (corresponding author), Mario Negri Inst Pharmacol Res, Ctr Anna Maria Astori, Via Stezzano 87, I-24126 Bergamo, Italy.	giuseppe.remuzzi@marionegri.it	Calabria, Andrea/AAA-3349-2019; Tomasoni, Susanna/ABF-5747-2020; Bettoni, Serena/G-9469-2012; Schaefer, Franz/G-4365-2010; Delledonne, Massimo/O-8685-2017; Abbate, Isabella/K-6434-2016; NORIS, MARINA/ABG-2219-2020; Piras, Rossella/AAZ-1122-2020; Ariela, Benigni/ABH-3492-2020; Mele, Caterina/ABF-3728-2020; Donadelli, Roberta/ABG-8930-2020; Macciardi, Fabio/N-3768-2014; Buelli, Simona/AAB-1847-2020; Morigi, Marina/ABH-3131-2020; Remuzzi, Giuseppe/V-9766-2017	Calabria, Andrea/0000-0003-3515-3384; Tomasoni, Susanna/0000-0002-7212-2512; NORIS, MARINA/0000-0001-7651-5033; Piras, Rossella/0000-0002-0218-0901; Ariela, Benigni/0000-0002-4721-5485; Mele, Caterina/0000-0002-9536-3474; Macciardi, Fabio/0000-0003-0537-4266; Buelli, Simona/0000-0002-2508-7793; Morigi, Marina/0000-0001-8029-7382; Remuzzi, Giuseppe/0000-0002-6194-3446; Krendel, Mira/0000-0002-7008-9069; Delledonne, Massimo/0000-0002-7100-4581; Iatropoulos, Paraskevas/0000-0001-9406-5734; Bettoni, Serena/0000-0002-7840-4596; Donadelli, Roberta/0000-0003-1472-1143; Capobianchi, Maria Rosaria/0000-0003-3465-0071; Otto, Edgar/0000-0002-2387-9973	E-Rare program (PodoNet); Fondazione La Nuova Speranza Organizzazione Non Lucrativa di Utilita' Sociale (Onlus) (Milan); Fondazione Aiuti per la Ricerca sulle Malattie Rare Onlus (Bergamo, Italy); Fondazione ART per la Ricerca sui Trapianti Onlus (Milan); NephCure Foundation; National Institutes of Health [R01-DK076683, RC1-DK086542]; Fondazione ART per la Ricerca sui Trapianti Onlus; Scientific and Research Council of Turkey [108S417]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076683, RC1DK086542] Funding Source: NIH RePORTER	E-Rare program (PodoNet); Fondazione La Nuova Speranza Organizzazione Non Lucrativa di Utilita' Sociale (Onlus) (Milan); Fondazione Aiuti per la Ricerca sulle Malattie Rare Onlus (Bergamo, Italy); Fondazione ART per la Ricerca sui Trapianti Onlus (Milan); NephCure Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondazione ART per la Ricerca sui Trapianti Onlus; Scientific and Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported in part by grants from the E-Rare program (PodoNet), Fondazione La Nuova Speranza Organizzazione Non Lucrativa di Utilita' Sociale (Onlus) (Milan), Fondazione Aiuti per la Ricerca sulle Malattie Rare Onlus (Bergamo, Italy), Fondazione ART per la Ricerca sui Trapianti Onlus (Milan), and the NephCure Foundation; grants from the National Institutes of Health (R01-DK076683 and RC1-DK086542, to Dr. Hildebrandt); fellowships from Fondazione ART per la Ricerca sui Trapianti Onlus (to Drs. Piras and Mele); and a grant from the Scientific and Research Council of Turkey (108S417, to Dr. Ozaltin).	Adamek N, 2008, P NATL ACAD SCI USA, V105, P5710, DOI 10.1073/pnas.0710520105; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Barisoni L, 2007, CLIN J AM SOC NEPHRO, V2, P529, DOI 10.2215/CJN.04121206; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Braden GL, 2000, AM J KIDNEY DIS, V35, P878, DOI 10.1016/S0272-6386(00)70258-7; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Cattran DC, 1999, KIDNEY INT, V56, P2220, DOI 10.1046/j.1523-1755.1999.00778.x; Chiang CK, 2010, NAT REV NEPHROL, V6, P539, DOI 10.1038/nrneph.2010.103; D'Agati VD, 2004, AM J KIDNEY DIS, V43, P368, DOI 10.1053/j.ajkd.2003.10.024; DRENCKHAHN D, 1988, LAB INVEST, V59, P673; El Mezgueldi M, 2002, J BIOL CHEM, V277, P21514, DOI 10.1074/jbc.M200713200; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Filler G, 2003, AM J KIDNEY DIS, V42, P1107, DOI 10.1053/j.ajkd.2003.08.010; Forgacs E, 2009, J BIOL CHEM, V284, P2138, DOI 10.1074/jbc.M805530200; Friedrich C, 2006, AM J PHYSIOL-RENAL, V291, pF856, DOI 10.1152/ajprenal.00196.2005; Genin E, 1998, ANN HUM GENET, V62, P419, DOI 10.1046/j.1469-1809.1998.6250419.x; Genovese G, 2010, KIDNEY INT, V78, P698, DOI 10.1038/ki.2010.251; HAAS M, 1995, AM J KIDNEY DIS, V26, P740, DOI 10.1016/0272-6386(95)90437-9; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kerjaschki D, 2001, J CLIN INVEST, V108, P1583, DOI 10.1172/JCI200114629; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068; Kitiyakara C, 2004, AM J KIDNEY DIS, V44, P815, DOI [10.1053/j.ajkd.2004.07.008, 10.1016/S0272-6386(04)01081-9]; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Krendel M, 2007, FEBS LETT, V581, P644, DOI 10.1016/j.febslet.2007.01.021; Krendel M, 2009, J AM SOC NEPHROL, V20, P86, DOI 10.1681/ASN.2007111172; Lowik MM, 2009, EUR J PEDIATR, V168, P1291, DOI 10.1007/s00431-009-1017-x; Machuca E, 2009, HUM MOL GENET, V18, pR185, DOI 10.1093/hmg/ddp328; Mathieson PW, 2008, NEW ENGL J MED, V359, P2492, DOI 10.1056/NEJMcibr0806881; Meyrier AY, 2009, KIDNEY INT, V76, P487, DOI 10.1038/ki.2009.204; Mucha B, 2006, PEDIATR RES, V59, P325, DOI 10.1203/01.pdr.0000196717.94518.f0; Nabet B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006491; Pollak MR, 2008, CURR OPIN NEPHROL HY, V17, P138, DOI 10.1097/MNH.0b013e3282f5dbe4; Roux AF, 2006, J MED GENET, V43, P763, DOI 10.1136/jmg.2006.041954; Singh N, 2009, AM J KIDNEY DIS, V54, P732, DOI 10.1053/j.ajkd.2009.06.023; Takeda T, 2001, J CLIN INVEST, V108, P289, DOI 10.1172/JCI200112539; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yu HYE, 2007, MOL BIOL CELL, V18, P4096, DOI 10.1091/mbc.E06-11-0993	40	167	172	1	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2011	365	4					295	306		10.1056/NEJMoa1101273	http://dx.doi.org/10.1056/NEJMoa1101273			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798AJ	21756023	Green Accepted			2022-12-01	WOS:000293172200008
J	Orloff, M; Peterson, C; He, X; Ganapathi, S; Heald, B; Yang, YR; Bebek, G; Romigh, T; Song, JH; Wu, WJ; David, S; Cheng, YL; Meltzer, SJ; Eng, C				Orloff, Mohammed; Peterson, Charissa; He, Xin; Ganapathi, Shireen; Heald, Brandie; Yang, Yi-ran; Bebek, Gurkan; Romigh, Todd; Song, Jee Hoon; Wu, Wenjing; David, Stefan; Cheng, Yulan; Meltzer, Stephen J.; Eng, Charis			Germline Mutations in MSR1, ASCC1, and CTHRC1 in Patients With Barrett Esophagus and Esophageal Adenocarcinoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLOBAL SEARCH DESIGNS; SCAVENGER RECEPTOR-1 GENE; PROSTATE-CANCER; LINKAGE ANALYSIS; EXPRESSION ANALYSIS; SEQUENCE VARIANTS; MOUSE MODEL; CELL-CYCLE; ASSOCIATION; POPULATION	Context Barrett esophagus (BE) occurs in 1% to 10% of the general population and is believed to be the precursor of esophageal adenocarcinoma (EAC). The incidence of EAC has increased 350% in the last 3 decades without clear etiology. Finding predisposition genes may improve premorbid risk assessment, genetic counseling, and management. Genome-wide multiplatform approaches may lead to the identification of genes important in BE/EAC development. Objective To identify risk alleles or mutated genes associated with BE/EAC. Design, Setting, and Patients Model-free linkage analyses of 21 concordant-affected sibling pairs with BE/EAC and 11 discordant sibling pairs (2005-2006). Significant germline genomic regions in independent prospectively accrued series of 176 white patients with BE/EAC and 200 ancestry-matched controls (2007-2010) were validated and fine mapped. Integrating data from these significant genomic regions with somatic gene expression data from 19 BE/EAC tissues yielded 12 "priority" candidate genes for mutation analysis (2010). Genes that showed mutations in cases but not in controls were further screened in an independent prospectively accrued validation series of 58 cases (2010). Main Outcome Measures Identification of germline mutations in genes associated with BE/EAC cases. Functional interrogation of the most commonly mutated gene. Results Three major genes, MSR1, ASCC1, and CTHRC1 were associated with BE/EAC (all P<.001). In addition, 13 patients (11.2%) with BE/EAC carried germline mutations in MSR1, ASCC1, or CTHRC1. MSR1 was the most frequently mutated, with 8 of 116 (proportion, 0.069; 95% confidence interval [CI], 0.030-0.130; P<.001) cases with c.877C>T (p.R293X). An independent validation series confirmed germline MSR1 mutations in 2 of 58 cases (proportion, 0.035; 95% CI, 0.004-0.120; P=.09). MSR1 mutation resulted in CCND1 up-regulation in peripheral-protein lysate. Immunohistochemistry of BE tissues in MSR1-mutation carriers showed increased nuclear expression of CCND1. Conclusion MSR1 was significantly associated with the presence of BE/EAC in derivation and validation samples, although it was only present in a small percentage of the cases. JAMA. 2011; 306(4): 410-419	[Orloff, Mohammed; Peterson, Charissa; He, Xin; Ganapathi, Shireen; Heald, Brandie; Yang, Yi-ran; Bebek, Gurkan; Romigh, Todd; Eng, Charis] Cleveland Clin, Genom Med Inst, Cleveland, OH 44195 USA; [Orloff, Mohammed; Heald, Brandie; Eng, Charis] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44195 USA; [Eng, Charis] Cleveland Clin, Stanley Shalom Zielony Inst Nursing Excellence, Cleveland, OH 44195 USA; [Bebek, Gurkan] Case Western Reserve Univ, Sch Med, Ctr Prote & Bioinformat, Cleveland, OH USA; [Eng, Charis] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [Bebek, Gurkan; Eng, Charis] Case Western Reserve Univ, Sch Med, CASE Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Song, Jee Hoon; Wu, Wenjing; David, Stefan; Cheng, Yulan; Meltzer, Stephen J.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Song, Jee Hoon; Wu, Wenjing; David, Stefan; Cheng, Yulan; Meltzer, Stephen J.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Eng, C (corresponding author), Cleveland Clin, Genom Med Inst, 9500 Euclid Ave,Mailstop NE-50, Cleveland, OH 44195 USA.	engc@ccf.org	he, xin/C-3122-2011	Eng, Charis/0000-0002-3693-5145; Heald, Brandie/0000-0003-4227-3675	National Institutes of Health (NIH); National Cancer Institute (NCI); National Institute of Diabetes and Digestive and Kidney Diseases; Hong Kong University; Rudy Endowment; NCI/NIH [CA30722, DK087454, CA146799, CA133012]; Johns Hopkins University School of Medicine; Doris Duke Distinguished Clinical Scientist Award; M. Kirby Foundation; NATIONAL CANCER INSTITUTE [R01CA146799, R21CA030722, R01CA133012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087454] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Hong Kong University(University of Hong Kong); Rudy Endowment; NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Johns Hopkins University School of Medicine(Johns Hopkins University); Doris Duke Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); M. Kirby Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Bebek reported receiving grant funding from the National Institutes of Health (NIH). Dr Meltzer reported receiving grants from the National Cancer Institute (NCI) and the National Institute of Diabetes and Digestive and Kidney Diseases; and travel, accommodations, and meeting expenses from Hong Kong University. Dr Eng reported receiving grants from the NCI and Rudy Endowment. All other authors reported no financial disclosures.; This work was funded in part by the M. Frank and Margaret Domiter Rudy Endowment of the Cleveland Clinic Taussig Cancer Institute and grants CA30722, DK087454, CA146799, and CA133012 from the NCI/NIH (S.J.M. and C. E.). Dr Meltzer is the Harry & Betty Myerberg/Thomas R. Hendrix Professor of Gastroenterology and was funded in part by the Esophageal Cancer Research Fund at the Johns Hopkins University School of Medicine. Dr Eng was a recipient of the Doris Duke Distinguished Clinical Scientist Award, is an American Cancer Society Clinical Research Professor generously funded in part by the F. M. Kirby Foundation, holds the Sondra J. & Stephen R. Hardis Chair in Cancer Genomic Medicine at the Cleveland Clinic, and is an honorary fellow of the Cancer Research UK Human Cancer Genetics Research Group, University of Cambridge, Cambridge, England.	[Anonymous], 2003, SAGE STAT AN GEN EP; Arber N, 1996, CANCER EPIDEM BIOMAR, V5, P457; Cameron AJ, 1997, GASTROENTEROL CLIN N, V26, P487, DOI 10.1016/S0889-8553(05)70308-3; Chak A, 2006, CANCER EPIDEM BIOMAR, V15, P1668, DOI 10.1158/1055-9965.EPI-06-0293; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.3.CO;2-U; Drovdlic CM, 2003, J MED GENET, V40, P651, DOI 10.1136/jmg.40.9.651; Durmus T, 2006, GENE EXPR PATTERNS, V6, P935, DOI 10.1016/j.modgep.2006.03.008; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elston RC, 1996, GENET EPIDEMIOL, V13, P535, DOI 10.1002/(SICI)1098-2272(1996)13:6<535::AID-GEPI2>3.3.CO;2-R; EMI M, 1993, J BIOL CHEM, V268, P2120; Engel LS, 2003, J NATL CANCER I, V95, P1404, DOI 10.1093/jnci/djg047; Fitzgerald RC, 2005, CLIN GASTROENTEROL H, V3, P529, DOI 10.1016/S1542-3565(05)00248-X; Goddard KAB, 2001, AM J HUM GENET, V68, P1197, DOI 10.1086/320103; Groopman JD, 2005, TOXICOL APPL PHARM, V206, P131, DOI 10.1016/j.taap.2004.09.020; Guo XQ, 2000, GENET EPIDEMIOL, V18, P97, DOI 10.1002/(SICI)1098-2272(200002)18:2<97::AID-GEPI1>3.0.CO;2-J; Guo XQ, 2000, GENET EPIDEMIOL, V18, P111, DOI 10.1002/(SICI)1098-2272(200002)18:2<111::AID-GEPI2>3.0.CO;2-M; Hampel H, 2005, ANN INTERN MED, V143, P199, DOI 10.7326/0003-4819-143-3-200508020-00006; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Jung DJ, 2002, MOL CELL BIOL, V22, P5203, DOI 10.1128/MCB.22.14.5203-5211.2002; Kimchi ET, 2005, CANCER RES, V65, P3146, DOI 10.1158/0008-5472.CAN-04-2490; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lee YS, 2002, BIOL REPROD, V67, P1580, DOI 10.1095/biolreprod.102.006155; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Maier C, 2006, HUM MUTAT, V27, P98, DOI 10.1002/humu.20271; Maier C, 2005, EUR J HUM GENET, V13, P352, DOI 10.1038/sj.ejhg.5201333; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Mueller A, 1997, CANCER RES, V57, P5542; Murray L, 2003, BRIT MED J, V327, P534, DOI 10.1136/bmj.327.7414.534; Nakou M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013351; Opitz OG, 2002, J CLIN INVEST, V110, P761, DOI 10.1172/JCI200215324; Osterheld MC, 2002, AM J CLIN PATHOL, V117, P451; Pakakasama S, 2002, PEDIATR CLIN N AM, V49, P1393, DOI 10.1016/S0031-3955(02)00095-0; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reich D, 2008, NAT GENET, V40, P491, DOI 10.1038/ng0508-491; REID BJ, 1993, GASTROENTEROLOGY, V105, P119, DOI 10.1016/0016-5085(93)90017-7; Ronkainen J, 2005, GASTROENTEROLOGY, V129, P1825, DOI 10.1053/j.gastro.2005.08.053; SPECHLER SJ, 1986, NEW ENGL J MED, V315, P362, DOI 10.1056/NEJM198608073150605; Stairs DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003534; Sugar Linda M, 2006, Can J Urol, V13 Suppl 1, P46; van Dekken H, 2006, CANCER GENET CYTOGEN, V166, P157, DOI 10.1016/j.cancergencyto.2005.11.002; von Holzen U, 2010, TRANSL ONCOL, V3, P33, DOI 10.1593/tlo.09187; Wang L, 2003, NAT GENET, V35, P128, DOI 10.1038/ng1239; Winters C, 1987, GASTROENTEROLOGY, V92, P118, DOI 10.1016/0016-5085(87)90847-X; Xu JF, 2002, NAT GENET, V32, P321, DOI 10.1038/ng994; Xu JF, 2003, AM J HUM GENET, V72, P208, DOI 10.1086/345802; Xu JY, 2006, PROSTATE, V66, P1082, DOI 10.1002/pros.20430; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Ziegler A, 2001, GENET EPIDEMIOL, V20, P397, DOI 10.1002/gepi.9	53	73	80	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2011	306	4					410	419		10.1001/jama.2011.1029	http://dx.doi.org/10.1001/jama.2011.1029			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	797KL	21791690	Green Accepted, Bronze			2022-12-01	WOS:000293125800027
J	Carson, C; Kelly, Y; Kurinczuk, JJ; Sacker, A; Redshaw, M; Quigley, MA				Carson, C.; Kelly, Y.; Kurinczuk, J. J.; Sacker, A.; Redshaw, M.; Quigley, M. A.			Effect of pregnancy planning and fertility treatment on cognitive outcomes in children at ages 3 and 5: longitudinal cohort study	BRITISH MEDICAL JOURNAL			English	Article							INTRACYTOPLASMIC SPERM INJECTION; IN-VITRO FERTILIZATION; UNINTENDED PREGNANCIES; INFERTILITY TREATMENT; CONTRACEPTION; CONCEPTION; WOMEN; RISK; BORN; CARE	Objective To investigate how pregnancy planning, time to conception, and infertility treatment influence cognitive development at ages 3 and 5. Design Prospective population based cohort study. Setting Millennium Cohort Study in the United Kingdom. Participants 18 818 children recruited at 9 months and followed up at 3 and 5 years. 11 790 singletons with available data on pregnancy, cognitive outcomes, and confounders were included in analyses at age 3 and 12 136 at age 5. Exposure measures Mothers reported whether the pregnancy was planned, and their feelings when first pregnant; those in whom the pregnancy was planned provided time to conception, and details of any assisted reproductive technologies. The population was divided into "unplanned" (unplanned and unhappy), "mistimed" (unplanned but happy), "planned" (planned, time to conception <12 months), "subfertile" (planned, time to conception >= 12 months), "induced ovulation" (received clomiphene citrate), and "assisted reproduction" (in vitro fertilisation or intracytoplasmic sperm injection). The "planned" group was the comparison group in all analyses. Outcome measures Three components of the British Ability Scales (BAS II). Naming vocabulary assessed verbal ability at age 3; this test was repeated at age 5 with the picture similarities and pattern construction subscales, which measure non-verbal and spatial abilities. Results In unadjusted analyses, the scores on all scales in children from unplanned pregnancies were significantly lower than in those from planned pregnancies-for example, the difference in mean verbal ability score at age 3 was -4.8 (95% confidence interval -6.0 to -3.7; P<0.05), equivalent to an average delay of four months. After adjustment for sociodemographic factors these differences were attenuated: -0.3 (-1.3 to 0.7), equivalent to no delay. Children born after assisted reproduction age 3 and 3.5 (0.2 to 6.8) at age 5), which suggests that on average these children are three to four months ahead; this difference did not completely disappear with adjustment for confounders. Children born after infertility treatment had lower mean scores in non-verbal tests (-1.2 (-4.1 to 1.6) after assisted reproduction and -1.5 (-3.5 to 0.4) after induced ovulation) and in spatial ability tests (-2.7 (-6.9 to 1.6) after assisted reproduction), though the differences were not significant. Conclusions Pregnancy planning, subfertility, or assisted reproduction do not adversely affect children's cognitive development at age 3 or 5. The differences observed in the unadjusted analyses are almost entirely explained by marked inequalities in socioeconomic circumstances between the groups.	[Carson, C.; Kurinczuk, J. J.; Redshaw, M.; Quigley, M. A.] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England; [Kelly, Y.] Univ Essex, Inst Social & Econ Res, Colchester CO4 3SQ, Essex, England; [Kelly, Y.; Sacker, A.] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	University of Oxford; University of Essex; University of London; University College London	Carson, C (corresponding author), Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England.	claire.carson@npeu.ox.ac.uk	Carson, Claire/F-1662-2011	Sacker, Amanda/0000-0001-8796-5398; Quigley, Maria/0000-0002-8058-6181; Kelly, Yvonne/0000-0002-2936-3994	Medical Research Council; ESRC [ES/H00811X/1, ES/G002452/1] Funding Source: UKRI; MRC [G0701009] Funding Source: UKRI; Economic and Social Research Council [ES/G002452/1, ES/H00811X/1] Funding Source: researchfish; Medical Research Council [G0701009] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a grant from the Medical Research Council.	Agarwal P, 2005, BJOG-INT J OBSTET GY, V112, P1376, DOI 10.1111/j.1471-0528.2005.00663.x; [Anonymous], 2007, STAT STAT SOFTW REL; Bachrach CA, 1999, FAM PLANN PERSPECT, V31, P251, DOI 10.2307/2991577; Barrett G, 2002, SOC SCI MED, V55, P545, DOI 10.1016/S0277-9536(01)00187-3; Baydar N, 1995, FAM PLANN PERSPECT, V27, P228, DOI 10.2307/2136174; Bowen JR, 1998, LANCET, V351, P1529, DOI 10.1016/S0140-6736(98)10168-X; Condon JT, 1998, J REPROD INFANT PSYC, V16, P57, DOI DOI 10.1080/02646839808404558; D'Angelo DV, 2004, PERSPECT SEX REPRO H, V36, P192, DOI 10.1111/j.1931-2393.2004.tb00022.x; Earle Sarah, 2004, Hum Fertil (Camb), V7, P39, DOI 10.1080/1464727042000198078; Elliott C.D., 1997, BRIT ABILITY SCALES; Ermisch J, 2008, NATL INST ECON REV, V205, P62, DOI 10.1177/0027950108096589; Farrow A, 2002, HUM REPROD, V17, P2754, DOI 10.1093/humrep/17.10.2754; FLEISSIG A, 1991, BRIT MED J, V302, P147, DOI 10.1136/bmj.302.6769.147; Gibson FL, 1998, HUM REPROD, V13, P1727, DOI 10.1093/humrep/13.6.1727; Gipson JD, 2008, STUD FAMILY PLANN, V39, P18, DOI 10.1111/j.1728-4465.2008.00148.x; Hansen K., 2008, MILLENNIUM COHORT ST; Hansen M, 2005, HUM REPROD, V20, P328, DOI 10.1093/humrep/deh593; Hellerstedt WL, 1998, AM J PUBLIC HEALTH, V88, P663, DOI 10.2105/AJPH.88.4.663; Helmerhorst FM, 2004, BRIT MED J, V328, P261, DOI 10.1136/bmj.37957.560278.EE; Hill Vivian, 2005, Child Adolesc Ment Health, V10, P87, DOI 10.1111/j.1475-3588.2004.00123.x; JAYAWEERA H, 2005, CHILDREN 21 CENTURY, P109; Jones E, 2010, CHILDREN OF THE 21ST CENTURY: THE FIRST FIVE YEARS, P53; Joyce T, 2002, DEMOGRAPHY, V39, P199, DOI 10.1353/dem.2002.0006; Joyce TJ, 2000, DEMOGRAPHY, V37, P83, DOI 10.2307/2648098; Kelly Y, 2009, INT J EPIDEMIOL, V38, P129, DOI 10.1093/ije/dyn230; Ketende S, 2008, MILLENNIUM COHORT ST; Kiernan KE, 2008, BRIT J SOCIOL, V59, P783, DOI 10.1111/j.1468-4446.2008.00219.x; Knoester M, 2008, FERTIL STERIL, V90, P289, DOI 10.1016/j.fertnstert.2007.06.090; Kost K, 1998, FAM PLANN PERSPECT, V30, P223, DOI 10.2307/2991608; Lakha F, 2006, LANCET, V368, P1782, DOI 10.1016/S0140-6736(06)69737-7; Ludwig AK, 2006, EUR J OBSTET GYN R B, V127, P3, DOI 10.1016/j.ejogrb.2006.02.009; Lugo-Gil J, 2008, CHILD DEV, V79, P1065, DOI 10.1111/j.1467-8624.2008.01176.x; Middelburg KJ, 2008, HUM REPROD UPDATE, V14, P219, DOI 10.1093/humupd/dmn005; Oakley L, 2008, HUM REPROD, V23, P447, DOI 10.1093/humrep/dem369; *OFF NAT STAT, 2004, INF PER MORT 2004 HL; PIANTA RC, 1995, CHILD PARENT R UNPUB; Plewis I., 2007, INT J SOC RES METHOD, V10, P325, DOI DOI 10.1080/13645570701676955; Plewis I., 2007, MILLENNIUM COHORT ST; Ponjaert-Kristoffersen I, 2005, PEDIATRICS, V115, pE283, DOI 10.1542/peds.2004-1445; Rosenberg KD, 2003, PEDIATRICS, V111, P1142; Rutter Michael, 1970, ED HLTH BEHAV; Wang PS, 2007, JAMA-J AM MED ASSOC, V298, P1401, DOI 10.1001/jama.298.12.1401; Zhu JL, 2009, PAEDIATR PERINAT EP, V23, P98, DOI 10.1111/j.1365-3016.2008.00989.x	43	46	47	0	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2011	343								d4473	10.1136/bmj.d4473	http://dx.doi.org/10.1136/bmj.d4473			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	801LP	21791498	Green Published, Green Submitted, hybrid			2022-12-01	WOS:000293440700008
J	Caplan, A				Caplan, Arthur			The art of medicine Time to mandate influenza vaccination in health-care workers	LANCET			English	Editorial Material									Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Caplan, A (corresponding author), Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA.	caplan@mail.med.upenn.edu						Caplan A., 2011, HEALTH AFFAIR, V30, P1205, DOI [https://doi.org/10.1377/hlthaff.2011.0472, DOI 10.1377/HLTHAFF.2011.0472]; Carman WF, 2000, LANCET, V355, P93, DOI 10.1016/S0140-6736(99)05190-9; deSante JE, 2010, VACCINE, V28, P2517, DOI 10.1016/j.vaccine.2010.01.042; Feemster KA, 2011, VACCINE, V29, P1762, DOI 10.1016/j.vaccine.2010.12.115; Field RI, 2008, KENNEDY INST ETHIC J, V18, P111; Lantos JD, 2010, CURR PROB PEDIATR AD, V40, P38, DOI 10.1016/j.cppeds.2010.01.003; Poland GA, 2010, VACCINE, V28, P5757, DOI 10.1016/j.vaccine.2010.07.057; Talbot TR, 2010, INFECT CONT HOSP EP, V31, P987, DOI 10.1086/656558	8	35	35	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 23	2011	378	9788					310	311		10.1016/S0140-6736(11)61156-2	http://dx.doi.org/10.1016/S0140-6736(11)61156-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	803XL	21789789				2022-12-01	WOS:000293615800013
J	Wilke, RA; Dolan, ME				Wilke, Russell A.; Dolan, M. Eileen			Genetics and Variable Drug Response	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GENOTYPE		[Wilke, Russell A.] Vanderbilt Univ, Med Ctr, Oates Inst Expt Therapeut, Div Clin Pharmacol, Nashville, TN 37232 USA; [Wilke, Russell A.] Vanderbilt Univ, Dept Med, Div Gen Internal Med, Nashville, TN 37232 USA; [Dolan, M. Eileen] Univ Chicago, Dept Med, Comprehens Canc Res Ctr, Comm Clin Pharmacol & Pharmacogen, Chicago, IL 60637 USA	Vanderbilt University; Vanderbilt University; University of Chicago	Wilke, RA (corresponding author), Vanderbilt Univ, Med Ctr, Oates Inst Expt Therapeut, Div Clin Pharmacol, 23rd Ave S & Pierce Ave,550 RRB, Nashville, TN 37232 USA.	russell.a.wilke@vanderbilt.edu			NCI NIH HHS [R01 CA136765, P50 CA125183, CA136765] Funding Source: Medline; NHLBI NIH HHS [U01HL069757, U19 HL069757, U19 HL065962, U01 HL069757, U19HL065962] Funding Source: Medline; NIDDK NIH HHS [R01 DK080007, R01DK080007] Funding Source: Medline; NIGMS NIH HHS [U01GM61393, U01 GM061393] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA125183, R01CA136765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U19HL069757, U19HL065962, U01HL069757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chen P, 2011, NEW ENGL J MED, V364, P1126, DOI 10.1056/NEJMoa1009717; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Epstein RS, 2010, J AM COLL CARDIOL, V55, P2804, DOI 10.1016/j.jacc.2010.03.009; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; Relling MV, 2011, CLIN PHARMACOL THER, V89, P387, DOI 10.1038/clpt.2010.320; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; US Food and Drug Administration (FDA), TABL PHARM BIOM DRUG	10	41	41	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2011	306	3					306	307		10.1001/jama.2011.998	http://dx.doi.org/10.1001/jama.2011.998			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794BS	21771992	Green Accepted			2022-12-01	WOS:000292870500025
J	Kuhn, L; Susser, I; Stein, Z				Kuhn, Louise; Susser, Ida; Stein, Zena			Can further placebo-controlled trials of antiretroviral drugs to prevent sexual transmission of HIV be justified?	LANCET			English	Editorial Material									[Kuhn, Louise] Columbia Univ, Gertrude H Sergievsky Ctr, Coll Phys & Surg, New York, NY 10032 USA; [Kuhn, Louise] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10032 USA; [Susser, Ida] CUNY Hunter Coll, Dept Anthropol, New York, NY 10021 USA; [Susser, Ida] CUNY, Grad Ctr, New York, NY USA; [Susser, Ida] Columbia Univ, Dept Sociomed Sci, Mailman Sch Publ Hlth, New York, NY 10032 USA; [Stein, Zena] New York State Psychiat Inst & Hosp, HIV Ctr Clin & Behav Studies, New York, NY 10032 USA	Columbia University; Columbia University; City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Columbia University; New York State Psychiatry Institute	Kuhn, L (corresponding author), Columbia Univ, Gertrude H Sergievsky Ctr, Coll Phys & Surg, New York, NY 10032 USA.	lk24@coloumbia.edu			NIMH NIH HHS [P30-MH433520] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Aldrovandi GM, 2010, J INFECT DIS, V202, pS366, DOI 10.1086/655972; *CDC, 1995, MMWR-MORBID MORTAL W, V44, P929; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; FHI, 2011, FHI IN ORD CLOS FEM; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Lurie P, 1999, LANCET, V353, P1878; Mofenson LM, 2010, ANTIVIR THER, V15, P537, DOI 10.3851/IMP1574; *NAT AIDS TREATM A, 2010, CONRAD FDA CONRAD CH; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Roland ME, 2007, CURR OPIN INFECT DIS, V20, P39, DOI 10.1097/QCO.0b013e328012c5e0; Stein Z., 2010, TRANSPARENCY ACCOUNT; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; UNICEF UNAIDS WHO & UNFPA, 2010, 5 UNICEF UNAIDS WHO; WILLIAMS BG, 2010, 18 INT AIDS C VIENN; Young TN, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002835.pub3	16	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2011	378	9787					285	287		10.1016/S0140-6736(11)60134-7	http://dx.doi.org/10.1016/S0140-6736(11)60134-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	798JD	21763941				2022-12-01	WOS:000293201100037
J	Wood, AJ; Lo, TW; Zeitler, B; Pickle, CS; Ralston, EJ; Lee, AH; Amora, R; Miller, JC; Leung, E; Meng, XD; Zhang, L; Rebar, EJ; Gregory, PD; Urnov, FD; Meyer, BJ				Wood, Andrew J.; Lo, Te-Wen; Zeitler, Bryan; Pickle, Catherine S.; Ralston, Edward J.; Lee, Andrew H.; Amora, Rainier; Miller, Jeffrey C.; Leung, Elo; Meng, Xiangdong; Zhang, Lei; Rebar, Edward J.; Gregory, Philip D.; Urnov, Fyodor D.; Meyer, Barbara J.			Targeted Genome Editing Across Species Using ZFNs and TALENs	SCIENCE			English	Article									[Wood, Andrew J.; Lo, Te-Wen; Pickle, Catherine S.; Ralston, Edward J.; Meyer, Barbara J.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Zeitler, Bryan; Lee, Andrew H.; Amora, Rainier; Miller, Jeffrey C.; Leung, Elo; Meng, Xiangdong; Zhang, Lei; Rebar, Edward J.; Gregory, Philip D.; Urnov, Fyodor D.] Sangamo BioSci Inc, Richmond, CA 94804 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; Sangamo Therapeutics, Inc.	Meyer, BJ (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	bjmeyer@berkeley.edu		Meyer, Barbara/0000-0002-6530-4588; Wood, Andrew/0000-0002-0653-2070; Gregory, Philip/0000-0001-9249-2468	NIH [GM30702]; HHMI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030702, R01GM030702] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.J.W. is a Sir Henry Wellcome Post-Doctoral Fellow. NIH (GM30702) and HHMI funded these studies.	Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Meyer BJ, 2010, CURR OPIN GENET DEV, V20, P179, DOI 10.1016/j.gde.2010.03.008; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Morton J, 2006, P NATL ACAD SCI USA, V103, P16370, DOI 10.1073/pnas.0605633103; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842	5	440	612	1	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2011	333	6040					307	307		10.1126/science.1207773	http://dx.doi.org/10.1126/science.1207773			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21700836	Green Accepted			2022-12-01	WOS:000292732000032
J	Bustamante, CD; Burchard, EG; De La Vega, FM				Bustamante, Carlos D.; Burchard, Esteban Gonzalez; De La Vega, Francisco M.			Genomics for the world	NATURE			English	Editorial Material							ANCESTRY		[Bustamante, Carlos D.; De La Vega, Francisco M.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Burchard, Esteban Gonzalez] Univ Calif San Francisco, San Francisco, CA 94143 USA	Stanford University; University of California System; University of California San Francisco	Bustamante, CD (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	cdbustam@stanford.edu	De La Vega, Francisco/H-3832-2011	Bustamante, Carlos D./0000-0002-4187-7920	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG005715, R01HG003229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007546] Funding Source: NIH RePORTER; NHGRI NIH HHS [U01 HG005715, R01 HG003229] Funding Source: Medline; NIEHS NIH HHS [R01 ES015794] Funding Source: Medline; NIGMS NIH HHS [T32 GM007546] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acuna-Alonzo V, 2010, HUM MOL GENET, V19, P2877, DOI 10.1093/hmg/ddq173; Adeyemo A, 2010, PUBLIC HEALTH GENOMI, V13, P72, DOI 10.1159/000218711; [Anonymous], 2010, Nature, V467, P1026, DOI 10.1038/4671026a; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Kumar R, 2010, NEW ENGL J MED, V363, P321, DOI 10.1056/NEJMoa0907897; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Need AC, 2009, TRENDS GENET, V25, P489, DOI 10.1016/j.tig.2009.09.012; Waters KM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001078; Yang JJ, 2011, NAT GENET, V43, P237, DOI 10.1038/ng.763	10	364	367	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					163	165		10.1038/475163a	http://dx.doi.org/10.1038/475163a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	791UA	21753830	Green Accepted, Bronze			2022-12-01	WOS:000292690500024
J	Langevin, F; Crossan, GP; Rosado, IV; Arends, MJ; Patel, KJ				Langevin, Frederic; Crossan, Gerry P.; Rosado, Ivan V.; Arends, Mark J.; Patel, Ketan J.			Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice	NATURE			English	Article							FETAL ALCOHOL SYNDROME; FANCONI-ANEMIA; DNA-ADDUCTS; CHILDHOOD LEUKEMIA; KNOCKOUT MICE; BONE-MARROW; ACETALDEHYDE; ETHANOL; CONSUMPTION; METABOLISM	Reactive aldehydes are common carcinogens. They are also by-products of several metabolic pathways and, without enzymatic catabolism, may accumulate and cause DNA damage. Ethanol, which is metabolished to acetaldehyde, is both carcinogenic and teratogenic in humans. Here we find that the Fanconi anaemia DNA repair pathway counteracts acetaldehyde-induced genotoxicity in mice. Our results show that the acetaldehyde-catabolising enzyme Aldh2 is essential for the development of Fancd2(-/-) embryos. Nevertheless, acetaldehyde-catabolism-competent mothers (Aldh2(+/-)) can support the development of double-mutant (Aldh2(-/-)Fancd2(-/-)) mice. However, these embryos are usually sensitive to ethanol exposure in utero, and ethanol consumption by postnatal double-deficient mice rapidly precipitates bone marrow failure. Lastly, Aldh2(-/-)Fancd2(-/-) mice spontaneously develop acute leukaemia. Acetaldehyde-mediated DNA damage may critically contribute to the genesis of fetal alcohol syndrome in fetuses, as well as to abnormal development, haematopoietic failure and cancer predisposition in Fanconi anaemia patients.	[Langevin, Frederic; Crossan, Gerry P.; Rosado, Ivan V.; Patel, Ketan J.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Arends, Mark J.] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Cambridge CB2 2QQ, England; [Patel, Ketan J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England	MRC Laboratory Molecular Biology; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Patel, KJ (corresponding author), MRC Lab Mol Biol, Hills Rd, Cambridge CB2 0QH, England.	kjp@mrc-lmb.cam.ac.uk	Rosado, Ivan/AAZ-9068-2020	Rosado, Ivan/0000-0001-7409-7341; Crossan, Gerry/0000-0002-7974-009X	Children's Leukaemia Trust; Fanconi Anaemia Research Fund; Medical Research Council [MC_U105178811] Funding Source: researchfish; MRC [MC_U105178811] Funding Source: UKRI	Children's Leukaemia Trust; Fanconi Anaemia Research Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Grompe for Fancd2 knockout mice, J. Sale and S. Takeda for DT40 strains, N. Sugimura and F. Gergely for comments on the manuscript. We are grateful to T. Langford, R. Berks, V. Smith, J. Wiles, C. Shepherd, M. Kidd, M. Brown, A. Mead, R. Pannell, J. Garaycoechea and A. Shortland for their assistance with animal experiments and husbandry. We thank N. Grant and P. Banks from the Visual Aids department for photographic images and W. Zhao of the Human Research Tissue Bank (NIHR Cambridge Biomedical Research Centre) for processing histology. F.L. and I.V.R. are funded by the Children's Leukaemia Trust and Fanconi Anaemia Research Fund, respectively. K.J.P. acknowledges M. Neuberger, N. McIntyre and C. Decal for support.	ABEL EL, 1991, ALCOHOL CLIN EXP RES, V15, P514, DOI 10.1111/j.1530-0277.1991.tb00553.x; Alpi A, 2007, MOL CELL BIOL, V27, P8421, DOI 10.1128/MCB.00504-07; Alter BP, 2005, ARCH OTOLARYNGOL, V131, P635, DOI 10.1001/archotol.131.7.635; Brooks PJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000050; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Chen L, 2007, CHEM RES TOXICOL, V20, P108, DOI 10.1021/tx060232x; Cheng G, 2003, CHEM RES TOXICOL, V16, P145, DOI 10.1021/tx025614r; Crossan GP, 2011, NAT GENET, V43, P147, DOI 10.1038/ng.752; Hazen SL, 1998, BIOCHEMISTRY-US, V37, P6864, DOI 10.1021/bi972449j; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; King G, 1998, J EXP ZOOL, V282, P12; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kunitoh S, 1997, J PHARMACOL EXP THER, V280, P527; Latino-Martel P, 2010, CANCER EPIDEM BIOMAR, V19, P1238, DOI 10.1158/1055-9965.EPI-09-1110; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; MacArthur AC, 2008, CANCER CAUSE CONTROL, V19, P283, DOI 10.1007/s10552-007-9091-8; Marc N, 2000, BIOCHEM GENET, V38, P297, DOI 10.1023/A:1002057000788; Marietta C, 2009, MUTAT RES-FUND MOL M, V664, P77, DOI 10.1016/j.mrfmmm.2009.03.011; Matsuda T, 2007, CARCINOGENESIS, V28, P2363, DOI 10.1093/carcin/bgm057; McKay JD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001333; MEAGHER RC, 1982, NEW ENGL J MED, V307, P845, DOI 10.1056/NEJM198209303071402; MICHOT F, 1987, ACTA HAEMATOL-BASEL, V78, P252, DOI 10.1159/000205888; Nagayoshi H, 2009, MUTAT RES-GEN TOX EN, V673, P74, DOI 10.1016/j.mrgentox.2008.11.009; NAKAO S, 1991, AM J HEMATOL, V37, P120, DOI 10.1002/ajh.2830370210; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; O'Brien PJ, 2005, CRIT REV TOXICOL, V35, P609, DOI 10.1080/10408440591002183; OSHEA KS, 1979, J ANAT, V128, P65; Pappa A, 2003, BIOCHEM J, V376, P615, DOI 10.1042/BJ20030810; Parmar K, 2009, MUTAT RES-FUND MOL M, V668, P133, DOI 10.1016/j.mrfmmm.2009.03.015; Patel KJ, 2007, DNA REPAIR, V6, P885, DOI 10.1016/j.dnarep.2007.02.002; Perez-Miller S, 2010, NAT STRUCT MOL BIOL, V17, P159, DOI 10.1038/nsmb.1737; Ridpath JR, 2007, CANCER RES, V67, P11117, DOI 10.1158/0008-5472.CAN-07-3028; Riveros-Rosas H, 1997, ARCH MED RES, V28, P453; Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191; Stein S, 2006, MUTAT RES-GEN TOX EN, V608, P1, DOI 10.1016/j.mrgentox.2006.01.009; SULIK KK, 1981, SCIENCE, V214, P936, DOI 10.1126/science.6795717; Vasiliou V, 2004, DRUG METAB REV, V36, P279, DOI 10.1081/DMR-120034001; VASILIOU V, 1989, COMP BIOCHEM PHYS C, V94, P671, DOI 10.1016/0742-8413(89)90130-8; Wang M, 2000, CHEM RES TOXICOL, V13, P1149, DOI 10.1021/tx000118t; WEBSTER WS, 1983, TERATOLOGY, V27, P231, DOI 10.1002/tera.1420270211; Yu HS, 2009, TOXICOL MECH METHOD, V19, P535, DOI 10.3109/15376510903401708	41	357	364	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 7	2011	475	7354					53	U67		10.1038/nature10192	http://dx.doi.org/10.1038/nature10192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21734703				2022-12-01	WOS:000292461300043
J	de Jager, M; Weissing, FJ; Herman, PMJ; Nolet, BA; van de Koppel, J				de Jager, Monique; Weissing, Franz J.; Herman, Peter M. J.; Nolet, Bart A.; van de Koppel, Johan			Levy Walks Evolve Through Interaction Between Movement and Environmental Complexity	SCIENCE			English	Article							RANDOM SEARCHES; PATTERNS; ANIMALS; STRATEGIES; FLIGHTS; SUCCESS	Ecological theory predicts that animal movement is shaped by its efficiency of resource acquisition. Focusing solely on efficiency, however, ignores the fact that animal activity can affect resource availability and distribution. Here, we show that feedback between individual behavior and environmental complexity can explain movement strategies in mussels. Specifically, experiments show that mussels use a Levy walk during the formation of spatially patterned beds, and models reveal that this Levy movement accelerates pattern formation. The emergent patterning in mussel beds, in turn, improves individual fitness. These results suggest that Levy walks evolved as a result of the selective advantage conferred by autonomously generated, emergent spatial patterns in mussel beds. Our results emphasize that an interaction between individual selection and habitat complexity shapes animal movement in natural systems.	[de Jager, Monique; Herman, Peter M. J.; van de Koppel, Johan] Netherlands Inst Ecol NIOO KNAW, Spatial Ecol Dept, NL-4400 AC Yerseke, Netherlands; [Weissing, Franz J.] Univ Groningen, Theoret Biol Grp, Ctr Ecol & Evolutionary Studies, NL-9747 AG Groningen, Netherlands; [Nolet, Bart A.] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, NL-6700 AB Wageningen, Netherlands; [Nolet, Bart A.; van de Koppel, Johan] Netherlands Inst Ecol NIOO KNAW, Project Grp Movement Ecol, NL-6700 AB Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); University of Groningen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	de Jager, M (corresponding author), Netherlands Inst Ecol NIOO KNAW, Spatial Ecol Dept, POB 140, NL-4400 AC Yerseke, Netherlands.	m.dejager@nioo.knaw.nl	Nolet, Bart A/C-1416-2008; Van de Koppel, Johan/E-7266-2010; de Jager, Monique/ABC-8594-2020; Herman, Peter M.J./A-9018-2011	Nolet, Bart A/0000-0002-7437-4879; Herman, Peter M.J./0000-0003-2188-6341; de Jager, Monique/0000-0001-5271-6957; Weissing, Franz J./0000-0003-3281-663X	Netherlands Organization of Scientific Research-Earth and Life Sciences (NWO-ALW); KNAW	Netherlands Organization of Scientific Research-Earth and Life Sciences (NWO-ALW)(Netherlands Organization for Scientific Research (NWO)); KNAW	For assistance, we thank S. Benhamou, A. Kolzsch, J. Powell, G. Theraulaz, W. Mooij, A. van den Berg, and J. van Soelen. We thank S. Kefi, F. Bartumeus, B. Silliman, and M. Rietkerk for comments on manuscript drafts. M.d.J. and J.v.d.K. designed the study. Experimental data were collected by M.d.J. and J.v.d.K. B.A.N. introduced the topic of Levy walks, and F.J.W. suggested the evolutionary invasion analysis. All analyses and modeling were done by M.d.J., assisted by J.v.d.K., P.M.J.H., and F.J.W. The paper was written by M.d.J. and J.v.d.K., and all authors contributed to the subsequent drafts. The authors declare no competing financial interests. M.d.J. is supported by a grant from the Netherlands Organization of Scientific Research-Earth and Life Sciences (NWO-ALW), and Project Group Movement Ecology by the KNAW Strategic Fund. This is publication 5033 of the Netherlands Institute of Ecology (NIOO-KNAW).	Adler PB, 2001, OECOLOGIA, V128, P465, DOI 10.1007/s004420100737; Bartumeus F, 2005, ECOLOGY, V86, P3078, DOI 10.1890/04-1806; Bartumeus F, 2009, OIKOS, V118, P488, DOI 10.1111/j.1600-0706.2009.17313.x; Benhamou S, 2008, ECOLOGY, V89, P2351, DOI 10.1890/08-0313.1; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Boyer D, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434014; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Dercole F, 2008, PRINC SER THEOR COMP, P1; Geesteranus R. A. M., 1942, Archives Neerlandaises de Zoologie, V6, P283; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Hauert C, 2006, ADV COMPLEX SYST, V9, P315, DOI 10.1142/S0219525906000847; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Nolet BA, 2002, J ANIM ECOL, V71, P451, DOI 10.1046/j.1365-2656.2002.00610.x; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; Reynolds AM, 2009, J THEOR BIOL, V260, P98, DOI 10.1016/j.jtbi.2009.05.033; Reynolds AM, 2009, ECOLOGY, V90, P877, DOI 10.1890/08-0153.1; Reynolds AM, 2007, ECOLOGY, V88, P1955, DOI 10.1890/06-1916.1; Reynolds A, 2008, ECOLOGY, V89, P2347, DOI 10.1890/07-1688.1; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; van de Koppel J, 2005, AM NAT, V165, pE66; van de Koppel J, 2008, SCIENCE, V322, P739, DOI 10.1126/science.1163952; Viswanathan GM, 2010, NATURE, V465, P1018, DOI 10.1038/4651018a; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Viswanathan GM, 2000, PHYSICA A, V282, P1, DOI 10.1016/S0378-4371(00)00071-6	25	193	194	3	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2011	332	6037					1551	1553		10.1126/science.1201187	http://dx.doi.org/10.1126/science.1201187			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700872	Green Submitted, Green Published			2022-12-01	WOS:000291990000043
J	Karim, SSA; Karim, QA				Karim, Salim S. Abdool; Karim, Quarraisha Abdool			Antiretroviral prophylaxis: a defining moment in HIV control	LANCET			English	Editorial Material							PREVENTION; INFECTION		[Karim, Salim S. Abdool] Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa CAPRISA, ZA-4013 Durban, South Africa; Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	University of Kwazulu Natal; Columbia University	Karim, SSA (corresponding author), Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa CAPRISA, ZA-4013 Durban, South Africa.	karims1@ukzn.ac.za	Abdool Karim, Quarraisha/GVS-1160-2022; Karim, Salim Abdool/P-3117-2019; Karim, Salim Abdool/AAE-7118-2019; Karim, Salim Safurdeen Abdool/N-5947-2013	Abdool Karim, Quarraisha/0000-0002-0985-477X; Karim, Salim Abdool/0000-0002-4986-2133; Karim, Salim Safurdeen Abdool/0000-0002-4986-2133	NIAID NIH HHS [U01 AI069469, U01 AI069469-06, UM1 AI068619, UM1 AI068619-07] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068619, U01AI069469] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; FHI statement on the FEM-PrEP HIV Prevention Study, 2011, FHI STATEMENT FEM PR; Gilead Sciences Inc, 2011, GIL EXP ACC PROGR ME; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, LANCET, V378, P279, DOI 10.1016/S0140-6736(11)60878-7; Karim SSA, 2011, NATURE, V474, P29, DOI 10.1038/474029a; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Siegfried N., 2009, COCHRANE DB SYST REV, V15	12	73	76	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 17	2011	378	9809					E23	E25		10.1016/S0140-6736(11)61136-7	http://dx.doi.org/10.1016/S0140-6736(11)61136-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	865EL	21771566	Green Submitted, Green Accepted			2022-12-01	WOS:000298293600002
J	Hansen, SB; Tao, X; MacKinnon, R				Hansen, Scott B.; Tao, Xiao; MacKinnon, Roderick			Structural basis of PIP2 activation of the classical inward rectifier K+ channel Kir2.2	NATURE			English	Article							POTASSIUM CHANNELS; PROTEINS	The regulation of ion channel activity by specific lipid molecules is widely recognized as an integral component of electrical signalling in cells(1,2). In particular, phosphatidylinositol 4,5-bisphosphate (PIP2), a minor yet dynamic phospholipid component of cell membranes, is known to regulate many different ion channels(2-8). PIP2 is the primary agonist for classical inward rectifier (Kir2) channels, through which this lipid can regulate a cell's resting membrane potential(2,7-9). However, the molecular mechanism by which PIP2 exerts its action is unknown. Here we present the X-ray crystal structure of a Kir2.2 channel in complex with a short-chain (dioctanoyl) derivative of PIP2. We found that PIP2 binds at an interface between the transmembrane domain (TMD) and the cytoplasmic domain (CTD). The PIP2-binding site consists of a conserved non-specific phospholipid-binding region in the TMD and a specific phosphatidylinositol-binding region in the CTD. On PIP2 binding, a flexible expansion linker contracts to a compact helical structure, the CTD translates 6 angstrom and becomes tethered to the TMD and the inner helix gate begins to open. In contrast, the small anionic lipid dioctanoyl glycerol pyrophosphatidic acid (PPA) also binds to the non-specific TMD region, but not to the specific phosphatidylinositol region, and thus fails to engage the CTD or open the channel. Our results show how PIP2 can control the resting membrane potential through a specific ion-channel-receptor-ligand interaction that brings about a large conformational change, analogous to neurotransmitter activation of ion channels at synapses.	[Hansen, Scott B.; Tao, Xiao; MacKinnon, Roderick] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10065 USA.	mackinn@rockefeller.edu			Howard Hughes Medical Institute Funding Source: Medline; NIBIB NIH HHS [P30 EB009998] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Cheng WWL, 2011, BIOPHYS J, V100, P620, DOI 10.1016/j.bpj.2010.12.3724; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Cohen SX, 2004, ACTA CRYSTALLOGR D, V60, P2222, DOI 10.1107/S0907444904027556; Dart C, 2010, J PHYSIOL-LONDON, V588, P3169, DOI 10.1113/jphysiol.2010.191585; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enkvetchakul D, 2005, J BIOL CHEM, V280, P35785, DOI 10.1074/jbc.C500355200; Fujiwara Y, 2006, J PHYSIOL-LONDON, V576, P135, DOI 10.1113/jphysiol.2006.115246; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; Monserrate JP, 2010, CURR OPIN CELL BIOL, V22, P365, DOI 10.1016/j.ceb.2010.03.006; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Stanfield PR, 2002, REV PHYSIOL BIOCH P, V145, P47, DOI 10.1007/BFb0116431; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vaithianathan T, 2008, J GEN PHYSIOL, V132, P13, DOI 10.1085/jgp.200709913; Xie LH, 2007, PROG BIOPHYS MOL BIO, V94, P320, DOI 10.1016/j.pbiomolbio.2006.04.001; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	30	414	419	1	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2011	477	7365					495	U152		10.1038/nature10370	http://dx.doi.org/10.1038/nature10370			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21874019	Green Accepted			2022-12-01	WOS:000295080500047
J	Guse, A; Carroll, CW; Moree, B; Fuller, CJ; Straight, AF				Guse, Annika; Carroll, Christopher W.; Moree, Ben; Fuller, Colin J.; Straight, Aaron F.			In vitro centromere and kinetochore assembly on defined chromatin templates	NATURE			English	Article							XENOPUS EGG EXTRACTS; CENP-A NUCLEOSOMES; AURORA B; HISTONE; COMPLEX; PHOSPHORYLATION; CHECKPOINT; HJURP; DNA; ORGANIZATION	During cell division, chromosomes are segregated to nascent daughter cells by attaching to the microtubules of the mitotic spindle through the kinetochore. Kinetochores are assembled on a specialized chromatin domain called the centromere, which is characterized by the replacement of nucleosomal histone H3 with the histone H3 variant centromere protein A(CENP-A). CENP-A is essential for centromere and kinetochore formation in all eukaryotes but it is unknown how CENP-A chromatin directs centromere and kinetochore assembly(1). Here we generate synthetic CENP-A chromatin that recapitulates essential steps of centromere and kinetochore assembly in vitro. We show that reconstituted CENP-A chromatin when added to cell-free extracts is sufficient for the assembly of centromere and kinetochore proteins, microtubule binding and stabilization, and mitotic checkpoint function. Using chromatin assembled from histone H3/CENP-A chimaeras, we demonstrate that the conserved carboxy terminus of CENP-A is necessary and sufficient for centromere and kinetochore protein recruitment and function but that the CENP-A targeting domain-required for new CENP-A histone assembly(2)-is not. These data show that two of the primary requirements for accurate chromosome segregation, the assembly of the kinetochore and the propagation of CENP-A chromatin, are specified by different elements in the CENP-A histone. Our unique cell-free system enables complete control and manipulation of the chromatin substrate and thus presents a powerful tool to study centromere and kinetochore assembly.	[Guse, Annika; Carroll, Christopher W.; Moree, Ben; Fuller, Colin J.; Straight, Aaron F.] Stanford Med Sch, Dept Biochem, Stanford, CA 94305 USA	Stanford University	Straight, AF (corresponding author), Stanford Med Sch, Dept Biochem, Beckman 409A, Stanford, CA 94305 USA.	astraigh@stanford.edu	Guse, Annika/I-1183-2013	Guse, Annika/0000-0002-8737-9206; Straight, Aaron/0000-0001-5885-7881; Moree, Ben/0000-0002-8811-7400	German Research Foundation (DFG); Helen Hay Whitney Foundation; American Heart Association (AHA); Stanford Graduate Fellowship; National Institutes of Health (NIH) [R01GM074728];  [T32GM007276]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074728, T32GM007276] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); Helen Hay Whitney Foundation; American Heart Association (AHA)(American Heart Association); Stanford Graduate Fellowship(Stanford University); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank A. F. S. laboratory members for support and comments, J. E. Ferrell, A. Murray, R.-H. Chen, G. Kops and P. T. Stukenberg for providing antibodies. D. Rhodes, P. Robinson, K. Luger, J. Hansen, G. Narlikar and J. Yang for providing reagents and advice. A. G. was supported by a postdoctoral fellowship from the German Research Foundation (DFG). C. W. C. was supported by a postdoctoral fellowship from the Helen Hay Whitney Foundation and the American Heart Association (AHA). B. M. was supported by T32GM007276, C. J. F. was supported by a Stanford Graduate Fellowship and this work was supported by National Institutes of Health (NIH) R01GM074728 to A.F.S.	Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2008, CURR OPIN CELL BIOL, V20, P91, DOI 10.1016/j.ceb.2007.11.007; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Budde PP, 2001, J CELL BIOL, V153, P149, DOI 10.1083/jcb.153.1.149; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Desai A, 1999, METHOD CELL BIOL, V61, P385; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Field CM, 1998, METHOD ENZYMOL, V298, P525, DOI 10.1016/S0076-6879(98)98043-0; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Hannak E, 2006, NAT PROTOC, V1, P2305, DOI 10.1038/nprot.2006.396; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Hu H, 2011, GENE DEV, V25, P901, DOI 10.1101/gad.2045111; Huynh VAT, 2005, J MOL BIOL, V345, P957, DOI 10.1016/j.jmb.2004.10.075; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Kim SY, 2005, MOL CELL BIOL, V25, P10580, DOI 10.1128/MCB.25.23.10580-10590.2005; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; McClelland SE, 2007, EMBO J, V26, P5033, DOI 10.1038/sj.emboj.7601927; Milks KJ, 2009, MOL BIOL CELL, V20, P4246, DOI 10.1091/mbc.E09-05-0378; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; NICKLAS RB, 1995, J CELL BIOL, V130, P929, DOI 10.1083/jcb.130.4.929; Osborne J.W., 2008, BEST PRACT QUANT MET, DOI DOI 10.4135/9781412995627.D18; Ribeiro SA, 2010, P NATL ACAD SCI USA, V107, P10484, DOI 10.1073/pnas.1002325107; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; ZINKOWSKI RP, 1991, J CELL BIOL, V113, P1091, DOI 10.1083/jcb.113.5.1091	37	170	170	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2011	477	7364					354	U136		10.1038/nature10379	http://dx.doi.org/10.1038/nature10379			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819TD	21874020	Green Accepted			2022-12-01	WOS:000294852400036
J	Strunk, BS; Loucks, CR; Su, M; Vashisth, H; Cheng, SS; Schilling, J; Brooks, CL; Karbstein, K; Skiniotis, G				Strunk, Bethany S.; Loucks, Cherisse R.; Su, Min; Vashisth, Harish; Cheng, Shanshan; Schilling, Justin; Brooks, Charles L., III; Karbstein, Katrin; Skiniotis, Georgios			Ribosome Assembly Factors Prevent Premature Translation Initiation by 40S Assembly Intermediates	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; MOLECULAR-DYNAMICS; TRANSFER-RNA; 30S SUBUNIT; CRYOELECTRON MICROSCOPY; EUKARYOTIC RIBOSOME; PROTEIN-SYNTHESIS; CRYSTAL-STRUCTURE; 80S RIBOSOME; BIOGENESIS	Ribosome assembly in eukaryotes requires approximately 200 essential assembly factors (AFs) and occurs through ordered events that initiate in the nucleolus and culminate in the cytoplasm. Here, we present the electron cryo-microscopy (cryo-EM) structure of a late cytoplasmic 40S ribosome assembly intermediate from Saccharomyces cerevisiae at 18 angstrom resolution. We obtained cryo-EM reconstructions of preribosomal complexes lacking individual components to define the positions of all seven AFs bound to this intermediate. These late-binding AFs are positioned to prevent each step in the translation initiation pathway. Together, they obstruct the binding sites for initiation factors, prevent the opening of the messenger RNA channel, block 60S subunit joining, and disrupt the decoding site. These redundant mechanisms probably ensure that pre-40S particles do not enter the translation pathway, which would result in their rapid degradation.	[Strunk, Bethany S.; Karbstein, Katrin] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Strunk, Bethany S.] Univ Michigan, Chem Biol Doctoral Program, Ann Arbor, MI 48109 USA; [Loucks, Cherisse R.; Su, Min; Schilling, Justin; Skiniotis, Georgios] Univ Michigan, Inst Life Sci, Sch Med, Ann Arbor, MI 48109 USA; [Loucks, Cherisse R.; Su, Min; Schilling, Justin; Skiniotis, Georgios] Univ Michigan, Dept Biol Chem, Sch Med, Ann Arbor, MI 48109 USA; [Vashisth, Harish; Brooks, Charles L., III] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Vashisth, Harish; Brooks, Charles L., III; Skiniotis, Georgios] Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA; [Cheng, Shanshan; Brooks, Charles L., III] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	Scripps Research Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Karbstein, K (corresponding author), Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA.	kkarbst@scripps.edu; skinioti@umich.edu	Vashisth, Harish/E-5651-2011	Vashisth, Harish/0000-0002-2087-2880; Karbstein, Katrin/0000-0002-4034-1331; Skiniotis, Georgios/0000-0003-0238-7846; Strunk, Bethany/0000-0003-2337-4614; Cheng, Shanshan/0000-0003-2676-7341	NSF; NIH [R01-GM086451, RR12255]; Univ. of Michigan; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086451] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Univ. of Michigan; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Campbell for the gift of recombinant Tsr1 and (MBP)Tsr1; J. P. Gelugne for yeast strains; J. Doudna for making eIF3 maps available; H. Remmers (Univ. of Michigan) and M. Chalmers (The Scripps Research Institute-Florida) for performing mass spectrometry experiments; S. Ludtke, J. Zhang, and L. Passmore for EMAN scripts to generate variance maps; and J. Doudna, J. Cleveland, K. Nettles, T. Walz, and members of the Karbstein and Skiniotis labs for comments. B.S.S. is supported by a NSF predoctoral fellowship. This work is supported by NIH grant R01-GM086451 (to K.K.), the NIH-supported resource Multiscale Modeling Tools for Structural Biology (grant RR12255 to C.L.B.), and the Univ. of Michigan Biological Sciences Scholars Program (G.S.). EM maps have been deposited in the Electron Microscopy Data Bank with accession codes EMD-1922, -1923, -1924, -1925, -1926, and -1927.	Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Campbell MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016194; Carron C, 2011, NUCLEIC ACIDS RES, V39, P280, DOI 10.1093/nar/gkq734; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Datta PP, 2007, MOL CELL, V28, P434, DOI 10.1016/j.molcel.2007.08.026; Desai PM, 2006, ARCH BIOCHEM BIOPHYS, V449, P57, DOI 10.1016/j.abb.2006.02.028; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Granneman S, 2005, MOL CELL BIOL, V25, P10352, DOI 10.1128/MCB.25.23.10352-10364.2005; Granneman S, 2010, EMBO J, V29, P2026, DOI 10.1038/emboj.2010.86; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Ho JHN, 1999, MOL CELL BIOL, V19, P2389; Jakovljevic J, 2004, MOL CELL, V14, P331, DOI 10.1016/S1097-2765(04)00215-1; Lamanna AC, 2011, J MOL BIOL, V405, P3, DOI 10.1016/j.jmb.2010.09.064; Lamanna AC, 2009, P NATL ACAD SCI USA, V106, P14259, DOI 10.1073/pnas.0905403106; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Mulder AM, 2010, SCIENCE, V330, P673, DOI 10.1126/science.1193220; Neueder A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010194; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Roy-Chaudhuri B, 2010, P NATL ACAD SCI USA, V107, P4567, DOI 10.1073/pnas.0912305107; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Sengupta J, 2010, J CELL BIOL, V189, P1079, DOI 10.1083/jcb.201001124; Sharma MR, 2005, MOL CELL, V18, P319, DOI 10.1016/j.molcel.2005.03.028; Si K, 1999, MOL CELL BIOL, V19, P1416; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Soudet J, 2010, EMBO J, V29, P80, DOI 10.1038/emboj.2009.307; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Strunk BS, 2009, RNA, V15, P2083, DOI 10.1261/rna.1792109; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Trabuco LG, 2011, J STRUCT BIOL, V173, P420, DOI 10.1016/j.jsb.2010.09.024; Trabuco LG, 2010, J MOL BIOL, V402, P741, DOI 10.1016/j.jmb.2010.07.056; Trabuco LG, 2009, METHODS, V49, P174, DOI 10.1016/j.ymeth.2009.04.005; Vanrobays E, 2004, RNA, V10, P645, DOI 10.1261/rna.5162204; VERSCHOOR A, 1989, J MOL BIOL, V209, P115, DOI 10.1016/0022-2836(89)90175-7; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Woolls HA, 2011, J BIOL CHEM, V286, P2578, DOI 10.1074/jbc.M110.191494; Xu Z, 2008, NAT STRUCT MOL BIOL, V15, P534, DOI 10.1038/nsmb.1408; Yu YP, 2009, NUCLEIC ACIDS RES, V37, P5167, DOI 10.1093/nar/gkp519	46	157	157	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 9	2011	333	6048					1449	1453		10.1126/science.1208245	http://dx.doi.org/10.1126/science.1208245			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817KU	21835981	Green Accepted			2022-12-01	WOS:000294672200043
J	Pomowski, A; Zumft, WG; Kroneck, PMH; Einsle, O				Pomowski, Anja; Zumft, Walter G.; Kroneck, Peter M. H.; Einsle, Oliver			N2O binding at a [4Cu:2S] copper-sulphur cluster in nitrous oxide reductase	NATURE			English	Article							CU-Z CLUSTER; ACHROMOBACTER-CYCLOCLASTES; PSEUDOMONAS-STUTZERI; ANGSTROM RESOLUTION; MULTICOPPER ENZYME; CUPRIC SITE; DENITRIFICATION; PURIFICATION; ACTIVATION; DINITROGEN	Nitrous oxide (N2O) is generated by natural and anthropogenic processes and has a critical role in environmental chemistry. It has an ozone-depleting potential similar to that of hydrochlorofluorocarbons as well as a global warming potential exceeding that of CO2 300-fold(1,2). In bacterial denitrification, N2O is reduced to N-2 by the copper-dependent nitrous oxide reductase (N2OR)(3). This enzyme carries the mixed-valent Cu-A centre and the unique, tetranuclear Cu-Z site. Previous structural data were obtained with enzyme isolated in the presence of air that is catalytically inactive without prior reduction. Its Cu-Z site was described as a [4Cu:S] centre, and the substrate-binding mode and reduction mechanism remained elusive. Here we report the structure of purple N2OR from Pseudomonas stutzeri, handled under the exclusion of dioxygen, and locate the substrate in N2O-pressurized crystals. The active Cu-Z cluster contains two sulphur atoms, yielding a [4Cu:2S] stoichiometry; and N2O bound side-on at Cu-Z, in close proximity to Cu-A. With the substrate located between the two clusters, electrons are transferred directly from Cu-A to N2O, which is activated by side-on binding in a specific binding pocket on the face of the [4Cu:2S] centre. These results reconcile a multitude of available biochemical data on N2OR that could not be explained by earlier structures, and outline a mechanistic pathway in which both metal centres and the intervening protein act in concert to achieve catalysis. This structure represents the first direct observation, to our knowledge, of N2O bound to its reductase, and sheds light on the functionality of metalloenzymes that activate inert small-molecule substrates. The principle of using distinct clusters for substrate activation and for reduction may be relevant for similar systems, in particular nitrogen-fixing nitrogenase(4).	[Pomowski, Anja; Einsle, Oliver] Univ Freiburg, Inst Organ Chem & Biochem, Lehrstuhl Biochem, D-79104 Freiburg, Germany; [Zumft, Walter G.] Karlsruher Inst Technol, Abt Mol Mikrobiol, Inst Angew Biowissensch, D-76187 Karlsruhe, Germany; [Kroneck, Peter M. H.] Univ Konstanz, Fachbereich Biol, D-78457 Constance, Germany; [Einsle, Oliver] Univ Freiburg, Ctr Biol Signalling Studies Bioss, D-79104 Freiburg, Germany	University of Freiburg; Helmholtz Association; Karlsruhe Institute of Technology; University of Konstanz; University of Freiburg	Einsle, O (corresponding author), Univ Freiburg, Inst Organ Chem & Biochem, Lehrstuhl Biochem, Albertstr 21, D-79104 Freiburg, Germany.	einsle@biochemie.uni-freiburg.de		Einsle, Oliver/0000-0001-8722-2893	Deutsche Forschungsgemeinschaft [IRTG 1422]; Center for Biological Signalling Studies [EXC 294]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Biological Signalling Studies	This work was supported by the Deutsche Forschungsgemeinschaft (IRTG 1422) and the Center for Biological Signalling Studies (bioss, EXC 294). We thank the beam line staff at the Swiss Light Source for their assistance with data collection, T. Spatzal, K. Dorner and T. Friedrich for recording EPR spectra and F. Neese for discussions.	Atkins, 2001, INORG CHEM, P227; Brown K, 2000, NAT STRUCT BIOL, V7, P191; Brown K, 2000, J BIOL CHEM, V275, P41133, DOI 10.1074/jbc.M008617200; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; COYLE CL, 1985, EUR J BIOCHEM, V153, P459, DOI 10.1111/j.1432-1033.1985.tb09324.x; Crutzen PJ, 2008, ATMOS CHEM PHYS, V8, P389, DOI 10.5194/acp-8-389-2008; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Dell'Acqua S, 2010, J BIOL INORG CHEM, V15, P967, DOI 10.1007/s00775-010-0658-6; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Einsle O, 2004, BIOL CHEM, V385, P875, DOI 10.1515/BC.2004.115; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujita K, 2007, J INORG BIOCHEM, V101, P1836, DOI 10.1016/j.jinorgbio.2007.06.029; Ghosh S, 2003, J AM CHEM SOC, V125, P15708, DOI 10.1021/ja038344n; Gorelsky SI, 2006, J AM CHEM SOC, V128, P278, DOI 10.1021/ja055856o; Haltia T, 2003, BIOCHEM J, V369, P77, DOI 10.1042/BJ20020782; KRONECK PMH, 1989, FEBS LETT, V248, P212, DOI 10.1016/0014-5793(89)80464-8; KRONECK PMH, 1988, FEBS LETT, V242, P70, DOI 10.1016/0014-5793(88)80987-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Paraskevopoulos K, 2006, J MOL BIOL, V362, P55, DOI 10.1016/j.jmb.2006.06.064; Paulat F, 2004, INORG CHEM, V43, P6979, DOI 10.1021/ic049302i; Pomowski A, 2010, ACTA CRYSTALLOGR F, V66, P1541, DOI 10.1107/S1744309110038832; Rasmussen T, 2005, DALTON T, P3501, DOI 10.1039/b501846c; Rasmussen T, 2000, BIOCHEMISTRY-US, V39, P12753, DOI 10.1021/bi001811i; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; RIESTER J, 1989, EUR J BIOCHEM, V178, P751, DOI 10.1111/j.1432-1033.1989.tb14506.x; Samarkin VA, 2010, NAT GEOSCI, V3, P341, DOI 10.1038/NGEO847; Savelieff MG, 2010, J BIOL INORG CHEM, V15, P461, DOI 10.1007/s00775-010-0625-2; Schmittner A, 2008, NATURE, V456, P373, DOI 10.1038/nature07531; Solomon EI, 2006, INORG CHEM, V45, P8012, DOI 10.1021/ic060450d; Tolman WB, 2010, ANGEW CHEM INT EDIT, V49, P1018, DOI 10.1002/anie.200905364; Zumft WG, 2007, ADV MICROB PHYSIOL, V52, P107, DOI 10.1016/S0065-2911(06)52003-X; ZUMFT WG, 1982, FEBS LETT, V148, P107, DOI 10.1016/0014-5793(82)81253-2; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	33	142	144	3	179	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 8	2011	477	7363					234	U143		10.1038/nature10332	http://dx.doi.org/10.1038/nature10332			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816MC	21841804				2022-12-01	WOS:000294603900041
J	Siracusa, MC; Saenz, SA; Hill, DA; Kim, BS; Headley, MB; Doering, TA; Wherry, EJ; Jessup, HK; Siegel, LA; Kambayashi, T; Dudek, EC; Kubo, M; Cianferoni, A; Spergel, JM; Ziegler, SF; Comeau, MR; Artis, D				Siracusa, Mark C.; Saenz, Steven A.; Hill, David A.; Kim, Brian S.; Headley, Mark B.; Doering, Travis A.; Wherry, E. John; Jessup, Heidi K.; Siegel, Lori A.; Kambayashi, Taku; Dudek, Emily C.; Kubo, Masato; Cianferoni, Antonella; Spergel, Jonathan M.; Ziegler, Steven F.; Comeau, Michael R.; Artis, David			TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation	NATURE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; CELL; EXPRESSION; IMMUNITY; SUFFICIENT; INDUCTION; INFECTION; ASSOCIATE; VARIANTS; ASTHMA	CD4(+) T-helper type 2 (T(H)2) cells, characterized by their expression of interleukin (IL)-4, IL-5, IL-9 and IL-13, are required for immunity to helminth parasites(1) and promote the pathological inflammation associated with asthma and allergic diseases(2). Polymorphisms in the gene encoding the cytokine thymic stromal lymphopoietin (TSLP) are associated with the development of multiple allergic disorders in humans, indicating that TSLP is a critical regulator of T(H)2 cytokine-associated inflammatory diseases(3-6). In support of genetic analyses, exaggerated TSLP production is associated with asthma, atopic dermatitis and food allergies in patients, and studies in murine systems demonstrated that TSLP promotes T(H)2 cytokine-mediated immunity and inflammation(5,7-12). However, the mechanisms through which TSLP induces T(H)2 cytokine responses remain poorly defined. Here we demonstrate that TSLP promotes systemic basophilia, that disruption of TSLP-TSLPR interactions results in defective basophil responses, and that TSLPR-sufficient basophils can restore T(H)2-cell-dependent immunity in vivo. TSLP acted directly on bone-marrow-resident progenitors to promote basophil responses selectively. Critically, TSLP could elicit basophil responses in both IL-3-IL-3R-sufficient and -deficient environments, and genome-wide transcriptional profiling and functional analyses identified heterogeneity between TSLP-elicited versus IL-3-elicited basophils. Furthermore, activated human basophils expressed TSLPR, and basophils isolated from eosinophilic oesophagitis patients were distinct from classical basophils. Collectively, these studies identify previously unrecognized heterogeneity within the basophil cell lineage and indicate that expression of TSLP may influence susceptibility to multiple allergic diseases by regulating basophil haematopoiesis and eliciting a population of functionally distinct basophils that promote T(H)2 cytokine-mediated inflammation.	[Siracusa, Mark C.; Saenz, Steven A.; Hill, David A.; Kim, Brian S.; Doering, Travis A.; Wherry, E. John; Artis, David] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Siracusa, Mark C.; Saenz, Steven A.; Hill, David A.; Kim, Brian S.; Doering, Travis A.; Wherry, E. John; Artis, David] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Headley, Mark B.; Ziegler, Steven F.] Benaroya Res Inst, Program Immunol, Seattle, WA 98101 USA; [Headley, Mark B.; Ziegler, Steven F.] Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA; [Jessup, Heidi K.; Siegel, Lori A.; Comeau, Michael R.] Amgen Inc, Inflammat Res, Seattle, WA 98119 USA; [Kambayashi, Taku] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Dudek, Emily C.; Cianferoni, Antonella; Spergel, Jonathan M.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Div Allergy & Immunol,Dept Pediat, Philadelphia, PA 19104 USA; [Kubo, Masato] RIKEN, Yokohama Inst, Res Ctr Allergy & Immunol, Lab Signal Network, Yokohama, Kanagawa 2300045, Japan; [Kubo, Masato] Tokyo Univ Sci, Res Inst Biol Sci, Div Mol Pathol, Chiba 2780022, Japan; [Artis, David] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Benaroya Research Institute; University of Washington; University of Washington Seattle; Amgen; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; RIKEN; Tokyo University of Science; University of Pennsylvania	Artis, D (corresponding author), Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA.	dartis@mail.med.upenn.edu	Kubo, Masato/A-5918-2016; Kim, Brian/GZK-6649-2022; Wherry, John/ABI-1280-2020	Kim, Brian/0000-0002-8100-7161; Hill, David/0000-0001-9286-4268; Headley, Mark/0000-0002-0924-9326; Spergel, Jonathan/0000-0002-4658-5353; Artis, David/0000-0002-1753-4100	National Institutes of Health [AI61570, AI74878, AI87990, AI083480, AI085828, GM082187, AI060516]; Burroughs Wellcome Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060516, U01AI095608, F32AI085828, R01AI074878, R21AI087990, R01AI095466, R21AI083480, R01AI061570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM082187] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Artis laboratory for critical reading of the manuscript, A. Budelsky, T. Martin, B.-R. Park Yoon, J. Bigler and M. Timour (Amgen) for assistance with experiments and microarrays and the University of Pennsylvania flow cytometry core for assistance with sorting. Work in the Artis laboratory is supported by the National Institutes of Health (AI61570, AI74878, AI87990 and AI083480 (to D. A.), F32 fellowship AI085828 (to M. C. S.), F31 training grant GM082187 (to S. A. S), T32 training grant AI060516 (to D. A. H.)) and the Burroughs Wellcome Fund (to D.A.).	Al-Shami A, 2004, J EXP MED, V200, P159, DOI 10.1084/jem.20031975; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063; Haining WN, 2010, IMMUNITY, V32, P152, DOI 10.1016/j.immuni.2010.02.001; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Harada M, 2011, AM J RESP CELL MOL, V44, P787, DOI 10.1165/rcmb.2009-0418OC; Hunninghake GM, 2010, ALLERGY, V65, P1566, DOI 10.1111/j.1398-9995.2010.02415.x; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; Lenox LE, 2009, J ALLERGY CLIN IMMUN, V124, P1088, DOI 10.1016/j.jaci.2009.08.038; Li M, 2009, J INVEST DERMATOL, V129, P498, DOI 10.1038/jid.2008.232; Mou ZL, 2009, ACTA OTO-LARYNGOL, V129, P297, DOI 10.1080/00016480802225884; Nair MG, 2008, J IMMUNOL, V181, P4709, DOI 10.4049/jimmunol.181.7.4709; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Rothenberg ME, 2010, NAT GENET, V42, P289, DOI 10.1038/ng.547; Sawaguchi M., 2011, INT C IMM; Scott CL, 2000, BLOOD, V96, P1588, DOI 10.1182/blood.V96.4.1588.h8001588_1588_1590; Sebestyen MG, 2006, J GENE MED, V8, P852, DOI 10.1002/jgm.921; Sherrill JD, 2010, J ALLERGY CLIN IMMUN, V126, P160, DOI 10.1016/j.jaci.2010.04.037; Siracusa MC, 2010, IMMUNOL CELL BIOL, V88, P275, DOI 10.1038/icb.2010.1; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Taylor BC, 2009, J EXP MED, V206, P655, DOI 10.1084/jem.20081499; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	32	339	350	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2011	477	7363					229	U138		10.1038/nature10329	http://dx.doi.org/10.1038/nature10329			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816MC	21841801	Green Accepted			2022-12-01	WOS:000294603900040
J	Yizhar, O; Fenno, LE; Prigge, M; Schneider, F; Davidson, TJ; O'Shea, DJ; Sohal, VS; Goshen, I; Finkelstein, J; Paz, JT; Stehfest, K; Fudim, R; Ramakrishnan, C; Huguenard, JR; Hegemann, P; Deisseroth, K				Yizhar, Ofer; Fenno, Lief E.; Prigge, Matthias; Schneider, Franziska; Davidson, Thomas J.; O'Shea, Daniel J.; Sohal, Vikaas S.; Goshen, Inbal; Finkelstein, Joel; Paz, Jeanne T.; Stehfest, Katja; Fudim, Roman; Ramakrishnan, Charu; Huguenard, John R.; Hegemann, Peter; Deisseroth, Karl			Neocortical excitation/inhibition balance in information processing and social dysfunction	NATURE			English	Article							RETT-SYNDROME; OPTOGENETIC CONTROL; PREFRONTAL CORTEX; NEURAL SYSTEMS; MOUSE MODEL; AUTISM; SCHIZOPHRENIA; NEURONS; CHILDREN; MEMORY	Severe behavioural deficits in psychiatric diseases such as autism and schizophrenia have been hypothesized to arise from elevations in the cellular balance of excitation and inhibition (E/I balance) within neural microcircuitry. This hypothesis could unify diverse streams of pathophysiological and genetic evidence, but has not been susceptible to direct testing. Here we design and use several novel optogenetic tools to causally investigate the cellular E/I balance hypothesis in freely moving mammals, and explore the associated circuit physiology. Elevation, but not reduction, of cellular E/I balance within the mouse medial prefrontal cortex was found to elicit a profound impairment in cellular information processing, associated with specific behavioural impairments and increased high-frequency power in the 30-80 Hz range, which have both been observed in clinical conditions in humans. Consistent with the E/I balance hypothesis, compensatory elevation of inhibitory cell excitability partially rescued social deficits caused by E/I balance elevation. These results provide support for the elevated cellular E/I balance hypothesis of severe neuropsychiatric disease-related symptoms.	[Yizhar, Ofer; Fenno, Lief E.; Davidson, Thomas J.; O'Shea, Daniel J.; Sohal, Vikaas S.; Goshen, Inbal; Finkelstein, Joel; Ramakrishnan, Charu; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Clark Ctr W083, Stanford, CA 94305 USA; [Yizhar, Ofer] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Fenno, Lief E.; O'Shea, Daniel J.] Stanford Univ, Neurosci Program, Clark Ctr W083, Stanford, CA 94305 USA; [Prigge, Matthias; Schneider, Franziska; Stehfest, Katja; Fudim, Roman; Hegemann, Peter] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Sohal, Vikaas S.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Paz, Jeanne T.; Huguenard, John R.] Stanford Univ, Dept Neurol & Neurol Sci, Clark Ctr W083, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Clark Ctr W083, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Clark Ctr W083, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, CNC Program, Clark Ctr W083, Stanford, CA 94305 USA	Stanford University; Weizmann Institute of Science; Stanford University; Humboldt University of Berlin; University of California System; University of California San Francisco; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Yizhar, O (corresponding author), Stanford Univ, Dept Bioengn, Clark Ctr W083, 318 Campus Dr W, Stanford, CA 94305 USA.	ofer.yizhar@weizmann.ac.il; hegemape@rz.hu-berlin.de; deissero@stanford.edu	Goshen, Inbal/GQI-2230-2022; O'Shea, Daniel J/AAK-6525-2020; Fenno, Lief/AAK-2924-2020; Huguenard, John/K-6429-2019; Fenno, Lief/AAF-9638-2019; Sohal, Vikaas/M-9327-2016; YIZHAR, OFER/AAV-8497-2021; Huguenard, John/I-5016-2012	Goshen, Inbal/0000-0001-7578-2615; Huguenard, John/0000-0002-6950-1191; Sohal, Vikaas/0000-0002-2238-4186; Huguenard, John/0000-0002-6950-1191; O'Shea, Daniel/0000-0002-1366-1743; Yizhar, Ofer/0000-0003-4228-1448; Ramakrishnan, Charu/0000-0002-3474-6332; Davidson, Thomas/0000-0003-0836-6333	Human Frontier Science Program; Stanford MSTP program; DFG [HE3824/9-1, 17-1]; NIMH; NIDA; NINDS; DARPA; CIRM; Yu Foundation; Woo Foundation; Snyder Foundation; Keck Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075957, R01MH086373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034774, R01NS006477] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000616] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); Stanford MSTP program; DFG(German Research Foundation (DFG)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); CIRM(California Institute for Regenerative Medicine); Yu Foundation; Woo Foundation; Snyder Foundation; Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the K. D., P. H. and J.R.H. laboratories for discussions on the manuscript. We are grateful to S. Pak, Z. Chen and C. Perry for technical assistance. O.Y. is supported by the Human Frontier Science Program. L. E. F. is supported by the Stanford MSTP program. P. H. is supported by the DFG (HE3824/9-1 and 17-1, Cluster of Excellence: Unifying Concepts in Catalysis), and K. D. by NIMH, NIDA, NINDS, the DARPA REPAIR program, CIRM and the Yu, Woo, Snyder and Keck Foundations.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Belmonte MK, 2010, J CHILD PSYCHOL PSYC, V51, P259, DOI 10.1111/j.1469-7610.2009.02153.x; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Blatt GJ, 2001, J AUTISM DEV DISORD, V31, P537, DOI 10.1023/A:1013238809666; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Canitano R, 2007, EUR CHILD ADOLES PSY, V16, P61, DOI 10.1007/s00787-006-0563-2; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; D'Argembeau A, 2008, J ABNORM PSYCHOL, V117, P247, DOI 10.1037/0021-843X.117.1.247; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Dichter GS, 2009, SOC COGN AFFECT NEUR, V4, P215, DOI 10.1093/scan/nsp017; Diester I, 2011, NAT NEUROSCI, V14, P387, DOI 10.1038/nn.2749; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Gillberg C, 2000, ACTA PSYCHIAT SCAND, V102, P321, DOI 10.1034/j.1600-0447.2000.102005321.x; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Gomot M, 2008, BRAIN, V131, P2479, DOI 10.1093/brain/awn172; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Hashimoto T, 2008, AM J PSYCHIAT, V165, P479, DOI 10.1176/appi.ajp.2007.07081223; Kehrer C, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02/006.2008; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2004, PSYCHOPHARMACOLOGY, V174, P143, DOI 10.1007/s00213-003-1673-x; Lind SE, 2010, J ABNORM PSYCHOL, V119, P896, DOI 10.1037/a0020631; Lisman JE, 2008, TRENDS NEUROSCI, V31, P234, DOI 10.1016/j.tins.2008.02.005; Markram K, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00224; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Ni AM, 2010, CURR BIOL, V20, P824, DOI 10.1016/j.cub.2010.02.065; O'Donovan MC, 2009, HUM GENET, V126, P3, DOI 10.1007/s00439-009-0703-0; Orekhova EV, 2007, BIOL PSYCHIAT, V62, P1022, DOI 10.1016/j.biopsych.2006.12.029; Pardo CA, 2007, BRAIN PATHOL, V17, P434, DOI 10.1111/j.1750-3639.2007.00102.x; Patterson PH, 2011, PEDIATR RES, V69, p34R, DOI 10.1203/PDR.0b013e318212b80f; Rinaldi T, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.004.2008; Rippon G, 2007, INT J PSYCHOPHYSIOL, V63, P164, DOI 10.1016/j.ijpsycho.2006.03.012; Rojas DC, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-66; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rubenstein JLR, 2010, CURR OPIN NEUROL, V23, P118, DOI 10.1097/WCO.0b013e328336eb13; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Vattikuti S, 2010, BIOL PSYCHIAT, V67, P672, DOI 10.1016/j.biopsych.2009.09.008; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012893; Wilson TW, 2007, BIOL PSYCHIAT, V62, P192, DOI 10.1016/j.biopsych.2006.07.002; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120	50	1474	1535	7	274	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2011	477	7363					171	178		10.1038/nature10360	http://dx.doi.org/10.1038/nature10360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	816MC	21796121	Green Accepted			2022-12-01	WOS:000294603900027
J	Moynihan, R				Moynihan, Ray			REALITY CHECK Is your mum on drugs?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Newcastle, Callaghan, NSW 2308, Australia	University of Newcastle	Moynihan, R (corresponding author), Univ Newcastle, Callaghan, NSW 2308, Australia.	Ray.Moynihan@newcastle.edu.au	Moynihan, Ray/ABC-3010-2020					Garfinkel D, 2010, ARCH INTERN MED, V170, P1648, DOI 10.1001/archinternmed.2010.355; Mangin D, 2007, BMJ-BRIT MED J, V335, P285, DOI 10.1136/bmj.39241.630741.BE1; TRIMBLE J, IS YOUR MOM DRUGS FI; TRIMBLE J, IS YOUR MOM DRUGS OU	4	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 24	2011	343								d5184	10.1136/bmj.d5184	http://dx.doi.org/10.1136/bmj.d5184			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	813ZN	21865271				2022-12-01	WOS:000294409900001
J	Voss, TC; Schiltz, RL; Sung, MH; Yen, PM; Stamatoyannopoulos, JA; Biddie, SC; Johnson, TA; Miranda, TB; John, S; Hager, GL				Voss, Ty C.; Schiltz, R. Louis; Sung, Myong-Hee; Yen, Paul M.; Stamatoyannopoulos, John A.; Biddie, Simon C.; Johnson, Thomas A.; Miranda, Tina B.; John, Sam; Hager, Gordon L.			Dynamic Exchange at Regulatory Elements during Chromatin Remodeling Underlies Assisted Loading Mechanism	CELL			English	Article							TRANSCRIPTION-FACTOR-BINDING; PROTEIN-DNA INTERACTIONS; CHIP-SEQ DATA; GLUCOCORTICOID-RECEPTOR; IN-VIVO; LIVING CELLS; ESTROGEN-RECEPTOR; GENE-EXPRESSION; SITES; ASSOCIATION	The glucocorticoid receptor (GR), like other eukaryotic transcription factors, regulates gene expression by interacting with chromatinized DNA response elements. Photobleaching experiments in living cells indicate that receptors transiently interact with DNA on the time scale of seconds and predict that the response elements may be sparsely occupied on average. Here, we show that the binding of one receptor at the glucocorticoid response element (GRE) does not reduce the steady-state binding of another receptor variant to the same GRE. Mathematical simulations reproduce this noncompetitive state using short GR/GRE residency times and relatively long times between DNA binding events. At many genomic sites where GR binding causes increased chromatin accessibility, concurrent steady-state binding levels for the variant receptor are actually increased, a phenomenon termed assisted loading. Temporally sparse transcription factor-DNA interactions induce local chromatin reorganization, resulting in transient access for binding of secondary regulatory factors.	[Voss, Ty C.; Schiltz, R. Louis; Sung, Myong-Hee; Biddie, Simon C.; Johnson, Thomas A.; Miranda, Tina B.; John, Sam; Hager, Gordon L.] NCI, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA; [Yen, Paul M.] Duke Natl Univ Singapore, Cardiovasc & Metab Disorders Program, Lab Hormonal Regulat, Singapore 169857, Singapore; [Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National University of Singapore; University of Washington; University of Washington Seattle	Hager, GL (corresponding author), NCI, Lab Receptor Biol & Gene Express, NIH, Bldg 41,B602,41 Lib Dr, Bethesda, MD 20892 USA.	hagerg@exchange.nih.gov	Yen, Paul M/V-9857-2019; Sung, Myong-Hee/AAC-7316-2020	Sung, Myong-Hee/0000-0002-9739-8558; Yen, Paul/0000-0002-3790-8114; Biddie, Simon/0000-0002-8253-0253	NIH, National Cancer Institute, Center for Cancer Research; D.O.D.'s U.S. [W81XWH-06-1-0776]; NATIONAL CANCER INSTITUTE [ZIABC005450] Funding Source: NIH RePORTER	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); D.O.D.'s U.S.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Anindya Indrawan for general technical support of these experiments. Tatiana Karpova, manager of the NCI Fluorescence Imaging Core Facility), provided expert assistance for epifluorescence microscopy experiments. The resources of the NCI High-Throughput Imaging Facility (HiTIF) were also essential for the rapid completion of this study. This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, and by the D.O.D.'s U.S. Congressionally Directed Medical Research Programs Grant W81XWH-06-1-0776.	Becker M, 2002, EMBO REP, V3, P1188, DOI 10.1093/embo-reports/kvf244; Boeger H, 2008, CELL, V133, P716, DOI 10.1016/j.cell.2008.02.051; BURGHAUS U, 2006, PRACTICAL GUIDE KINE, P1; CANN JR, 1989, J BIOL CHEM, V264, P17032; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; Fletcher TM, 2002, MOL CELL BIOL, V22, P3255, DOI 10.1128/MCB.22.10.3255-3263.2002; Granek JA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r87; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Hager GL, 2002, CURR OPIN GENET DEV, V12, P137, DOI 10.1016/S0959-437X(02)00278-2; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/nmeth.1313, 10.1038/NMETH.1313]; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kaufmann BB, 2007, CURR OPIN GENET DEV, V17, P107, DOI 10.1016/j.gde.2007.02.007; Kim HD, 2008, NAT STRUCT MOL BIOL, V15, P1192, DOI 10.1038/nsmb.1500; Kraus WL, 1995, P NATL ACAD SCI USA, V92, P12314, DOI 10.1073/pnas.92.26.12314; Krum SA, 2008, MOL ENDOCRINOL, V22, P2393, DOI 10.1210/me.2008-0100; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li Q, 1997, METHODS, V12, P96, DOI 10.1006/meth.1997.0451; MADER S, 1989, NATURE, V338, P271, DOI 10.1038/338271a0; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; MEYER ME, 1989, CELL, V57, P433, DOI 10.1016/0092-8674(89)90918-5; Nagaich AK, 2004, MOL CELL, V14, P163, DOI 10.1016/S1097-2765(04)00178-9; Nalley K, 2006, NATURE, V442, P1054, DOI 10.1038/nature05067; OSTROWSKI MC, 1984, EMBO J, V3, P1891, DOI 10.1002/j.1460-2075.1984.tb02064.x; PAYVAR F, 1983, CELL, V35, P381, DOI 10.1016/0092-8674(83)90171-X; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Stavreva DA, 2009, NAT CELL BIOL, V11, P1093, DOI 10.1038/ncb1922; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Voss TC, 2009, J CELL SCI, V122, P345, DOI 10.1242/jcs.035865; Walker D, 1999, METHODS, V19, P386, DOI 10.1006/meth.1999.0874; Wasson T, 2009, GENOME RES, V19, P2101, DOI 10.1101/gr.093450.109	38	237	238	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 19	2011	146	4					544	554		10.1016/j.cell.2011.07.006	http://dx.doi.org/10.1016/j.cell.2011.07.006			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21835447	Green Accepted, Bronze			2022-12-01	WOS:000294043600010
J	Abou-Setta, AM; Beaupre, LA; Rashiq, S; Dryden, DM; Hamm, MP; Sadowski, CA; Menon, MRG; Majumdar, SR; Wilson, DM; Karkhaneh, M; Mousavi, SS; Wong, K; Tjosvold, L; Jones, CA				Abou-Setta, Ahmed M.; Beaupre, Lauren A.; Rashiq, Saifee; Dryden, Donna M.; Hamm, Michele P.; Sadowski, Cheryl A.; Menon, Matthew R. G.; Majumdar, Sumit R.; Wilson, Donna M.; Karkhaneh, Mohammad; Mousavi, Shima S.; Wong, Kai; Tjosvold, Lisa; Jones, C. Allyson			Comparative Effectiveness of Pain Management Interventions for Hip Fracture: A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							FEMORAL NERVE BLOCK; PREOPERATIVE SKIN TRACTION; PSOAS COMPARTMENT BLOCK; PERIOPERATIVE MYOCARDIAL-ISCHEMIA; SPINAL-ANESTHESIA; ELDERLY-PATIENTS; POSTOPERATIVE ANALGESIA; EMERGENCY-DEPARTMENT; ONSET TIME; DOSE BUPIVACAINE	Background: Pain management is integral to the management of hip fracture. Purpose: To review the benefits and harms of pharmacologic and nonpharmacologic interventions for managing pain after hip fracture. Data Sources: 25 electronic databases (January 1990 to December 2010), gray literature, trial registries, and reference lists, with no language restrictions. Study Selection: Multiple reviewers independently and in duplicate screened 9357 citations to identify randomized, controlled trials (RCTs); nonrandomized, controlled trials (non-RCTs); and cohort studies of pain management techniques in older adults after acute hip fracture. Data Extraction: Independent, duplicate data extraction and quality assessment were conducted, with discrepancies resolved by consensus or a third reviewer. Data extracted included study characteristics, inclusion and exclusion criteria, participant characteristics, interventions, and outcomes. Data Synthesis: 83 unique studies (64 RCTs, 5 non-RCTs, and 14 cohort studies) were included that addressed nerve blockade (n = 32), spinal anesthesia (n = 30), systemic analgesia (n = 3), traction (n = 11), multimodal pain management (n = 2), neurostimulation (n = 2), rehabilitation (n = 1), and complementary and alternative medicine (n = 2). Overall, moderate evidence suggests that nerve blockades are effective for relieving acute pain and reducing delirium. Low-level evidence suggests that preoperative traction does not reduce acute pain. Evidence was insufficient on the benefits and harms of most interventions, including spinal anesthesia, systemic analgesia, multimodal pain management, acupressure, relaxation therapy, transcutaneous electrical neurostimulation, and physical therapy regimens, in managing acute pain. Limitations: No studies evaluated outcomes of chronic pain or exclusively examined participants from nursing homes or with cognitive impairment. Systemic analgesics (narcotics, nonsteroidal anti-inflammatory drugs) were understudied during the search period. Conclusion: Nerve blockade seems to be effective in reducing acute pain after hip fracture. Sparse data preclude firm conclusions about the relative benefits or harms of many other pain management interventions for patients with hip fracture.	[Abou-Setta, Ahmed M.] Univ Alberta, Fac Med & Dent, Dept Pediat, Alberta Res Ctr Hlth Evidence,Univ Alberta Eviden, Edmonton, AB T6G 2J3, Canada	University of Alberta	Abou-Setta, AM (corresponding author), Univ Alberta, Fac Med & Dent, Dept Pediat, Alberta Res Ctr Hlth Evidence,Univ Alberta Eviden, Aberhart Ctr 1,Room 8412,11402 Univ Ave, Edmonton, AB T6G 2J3, Canada.	ahmedabou-setta@med.ualberta.ca	Sadowski, Cheryl/X-4663-2019	Tjosvold, Lisa/0000-0002-5667-6312	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services [HHSA 290 2007 10021 I]; Alberta Innovates-Health Solutions (formerly Alberta Heritage Foundation for Medical Research); Canadian Institutes of Health Research; Agency for Healthcare Research and Quality; University of Alberta Evidence-based Practice Center; Edmonton Civic Employees Charitable Fund	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Alberta Innovates-Health Solutions (formerly Alberta Heritage Foundation for Medical Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); University of Alberta Evidence-based Practice Center; Edmonton Civic Employees Charitable Fund	This project was funded under contract HHSA 290 2007 10021 I from the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services. Drs. Beaupre, Jones, and Majumdar receive salary support from Alberta Innovates-Health Solutions (formerly Alberta Heritage Foundation for Medical Research), and Dr. Jones receives new investigator salary support from the Canadian Institutes of Health Research.r Drs. Abou-Setta, Rashiq, and Dryden: Grant (money to institution): Agency for Healthcare Research and Quality. Drs. Beaupre and Jones: Grant (money to institution): Agency for Healthcare Research and Quality; Other (money to institution): University of Alberta Evidence-based Practice Center. Dr. Sadowski: Grants/grants pending (money to institution): Pfizer Canada; Payment for lectures including service on speakers bureaus: Pfizer Canada. Dr. Menon: Employment: University of Alberta; Grants/grants pending: Edmonton Civic Employees Charitable Fund. Dr. Karkhaneh: Grant (money to institution): Agency for Healthcare Research and Quality. Mr. Wong: Grant (money to institution): Agency for Healthcare Research and Quality. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M11-0328.	Abbey Jennifer, 2004, Int J Palliat Nurs, V10, P6; Abou-Setta AM, 2011, AHRQ PUBLICATION; Adams H A, 1990, Anasth Intensivther Notfallmed, V25, P263, DOI 10.1055/s-2007-1001062; Alonso Chico A, 2003, Rev Esp Anestesiol Reanim, V50, P17; Amador LF, 2005, J AM COLL SURGEONS, V200, P767, DOI 10.1016/j.jamcollsurg.2004.08.031; ANDERSON GH, 1993, J BONE JOINT SURG BR, V75, P794, DOI 10.1302/0301-620X.75B5.8376442; Antonopoulo E, 2006, REGIONAL ANESTHES S1, V31, P92; Apostolopoulos A, 2006, J BONE JOINT SURG S1, p[88, 186]; Baker A, 2004, ANESTH ANALG, V99, P128, DOI 10.1213/01.ANE.0000114549.17864.36; Barker R, 2006, ACAD EMERG MED, V13, P19, DOI 10.1197/j.aem.2005.07.014; Beaupre LA, 2007, J GERONTOL A-BIOL, V62, P1127, DOI 10.1093/gerona/62.10.1127; Ben-David B, 2000, ANESTHESIOLOGY, V92, P6, DOI 10.1097/00000542-200001000-00007; Bitsch MS, 2004, ACTA ORTHOP SCAND, V75, P378, DOI 10.1080/00016470410001123; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; BREDAHL C, 1991, ACTA ANAESTH SCAND, V35, P548, DOI 10.1111/j.1399-6576.1991.tb03346.x; Casati A, 2003, EUR J ANAESTH, V20, P640, DOI 10.1097/00003643-200308000-00009; Chudinov A, 1999, REGION ANESTH PAIN M, V24, P563, DOI 10.1016/S1098-7339(99)90050-0; Cleeland CS, 1998, JAMA-J AM MED ASSOC, V279, P1914, DOI 10.1001/jama.279.23.1914; CLOSS SJ, 1990, J ADV NURS, V15, P42, DOI 10.1111/j.1365-2648.1990.tb01671.x; COAD NR, 1991, EUR J ANAESTH, V8, P287; Cuvillon P, 2007, ANN FR ANESTH, V26, P2, DOI 10.1016/j.annfar.2006.06.025; Danelli G, 2008, CAN J ANAESTH, V55, P501, DOI 10.1007/BF03016669; de Visme V, 2000, REGION ANESTH PAIN M, V25, P158, DOI 10.1053/rapm.2000.0250158; Del Rosario E., 2008, ACUTE PAIN, V10, P59, DOI [10.1016/j.acpain.2008.02.001, DOI 10.1016/J.ACPAIN.2008.02.001]; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Lorenzo L, 2007, Eura Medicophys, V43, P349; Ehret B, 2006, J EUROPEEN URGENCES, V19, P9; Eyrolle L, 1998, BRIT J ANAESTHESI S1, V80, P112; FavarelGarrigues JF, 1996, ANESTH ANALG, V82, P312, DOI 10.1097/00000539-199602000-00017; Ferrell BA, 1998, J AM GERIATR SOC, V46, P635, DOI 10.1111/j.1532-5415.1998.tb01084.x; FERRELL BA, 1991, J AM GERIATR SOC, V39, P64, DOI 10.1111/j.1532-5415.1991.tb05908.x; Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; FINSEN V, 1992, INJURY, V23, P242, DOI 10.1016/S0020-1383(05)80007-5; Fletcher AK, 2003, ANN EMERG MED, V41, P227, DOI 10.1067/mem.2003.51; Foss NB, 2005, ANESTHESIOLOGY, V102, P1197, DOI 10.1097/00000542-200506000-00020; Foss NB, 2007, ANESTHESIOLOGY, V106, P773, DOI 10.1097/01.anes.0000264764.56544.d2; Fuchs-Lacelle S, 2004, PAIN MANAG NURS, V5, P37, DOI 10.1016/j.pmn.2003.10.001; Ghnaimat M, 2005, J BAHRAIN MED SOC, V17, P240; Gille J, 2006, ANAESTHESIST, V55, P414, DOI 10.1007/s00101-005-0949-4; Monzon DG, 2010, INT J EMERG MED, V3, P321, DOI 10.1007/s12245-010-0234-4; Gorodetskyi IG, 2007, J BONE JOINT SURG BR, V89B, P1488, DOI 10.1302/0301-620X.89B11.19352; Gotzsche PC, 2007, JAMA-J AM MED ASSOC, V298, P430, DOI 10.1001/jama.298.4.430; Graham CA, 2008, HONG KONG J EMERG ME, V15, P205, DOI 10.1177/102490790801500403; HADDAD FS, 1995, J BONE JOINT SURG BR, V77B, P922, DOI 10.1302/0301-620X.77B6.7593107; Henderson K, 2008, ANN EMERG MED, V52, pS164, DOI 10.1016/j.annemergmed.2008.06.426; Herrick C, 2004, J AM GERIATR SOC, V52, P2062, DOI 10.1111/j.1532-5415.2004.52566.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2008, COCHRANE HDB SYSTEMA; Hoda Mohammad Qamarul, 2007, J Pak Med Assoc, V57, P245; HOOD G, 1991, ANAESTHESIA, V46, P138, DOI 10.1111/j.1365-2044.1991.tb09361.x; Hooda S, 2006, J ANAESTHESIOLOGY CL, V22, P267; Jerre R, 2000, CLIN ORTHOP RELAT R, P169; Juelsgaard P, 1998, EUR J ANAESTH, V15, P656, DOI 10.1097/00003643-199811000-00006; KLIMSCHA W, 1995, ANESTH ANALG, V80, P322, DOI 10.1097/00000539-199502000-00020; Kocum A, 2007, ANAESTH INTENS CARE, V35, P510, DOI 10.1177/0310057X0703500408; Koval KJ, 1999, ORTHOPEDICS, V22, P31; Krobot R, 2006, REG ANESTH PAIN M S1, V31, P33; Kwan A. S. K., 1997, Hong Kong Medical Journal, V3, P250; LABAILLE T, 1992, REGION ANESTH, V17, P193; Lane A, 2008, CAN J ANAESTH, V55, P190, DOI 10.1007/BF03016097; Lang T, 2007, J TRAUMA, V62, P184, DOI 10.1097/01.ta.0000197176.75598.fc; Mak JCS, 2010, MED J AUSTRALIA, V192, P37, DOI 10.5694/j.1326-5377.2010.tb03400.x; Malchow RJ, 2008, CRIT CARE MED, V36, pS346, DOI 10.1097/CCM.0b013e31817e2fc9; Malcolmson SE, 2009, CRITICAL CARE SHOCK, V12, P144; Malek J, 2004, ACUTE PAIN, V6, P53; Mannion S, 2005, ANESTH ANALG, V100, P873, DOI 10.1213/01.ANE.0000143950.13939.7A; Marhofer P, 1997, ANESTH ANALG, V85, P854, DOI 10.1097/00000539-199710000-00026; Marhofer P, 1998, REGION ANESTH PAIN M, V23, P584, DOI 10.1016/S1098-7339(98)90086-4; Marhofer P, 2000, ANESTH ANALG, V90, P125, DOI 10.1097/00000539-200001000-00028; Martin KR, 1991, RELAXATION POSTOPERA; Martyr JW, 2005, ANAESTH INTENS CARE, V33, P64, DOI 10.1177/0310057X0503300110; Martyr JW, 2001, ANAESTH INTENS CARE, V29, P501, DOI 10.1177/0310057X0102900509; Matot I, 2003, ANESTHESIOLOGY, V98, P156, DOI 10.1097/00000542-200301000-00025; MAURETTE P, 1993, REGION ANESTH, V18, P290; Milisen K, 2001, J AM GERIATR SOC, V49, P523, DOI 10.1046/j.1532-5415.2001.49109.x; MILLER K, 1990, ANAESTHESIST, V39, P83; Minville V, 2006, ANESTH ANALG, V102, P1559, DOI 10.1213/01.ane.0000218421.18723.cf; Minville V, 2008, MINERVA ANESTESIOL, V74, P691; Morrison RS, 2003, J GERONTOL A-BIOL, V58, P76; Morrison RS, 2003, PAIN, V103, P303, DOI 10.1016/S0304-3959(02)00458-X; Mouzopoulos G, 2009, J ORTHOP TRAUMATOL, V10, P127, DOI 10.1007/s10195-009-0062-6; Navas Martinez A, 2008, REG ANESTH PAIN M S1, V33, pe30; NEEDOFF M, 1993, INJURY, V24, P317, DOI 10.1016/0020-1383(93)90054-A; OGILVIEHARRIS DJ, 1993, J ORTHOP TRAUMA, V7, P428, DOI 10.1097/00005131-199310000-00005; Olofsson C, 2004, ACTA ANAESTH SCAND, V48, P1240, DOI 10.1111/j.1399-6576.2004.00504.x; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Parker MJ, 2006, COCHRANE DB SYST REV, V3; Pasero CL, 1997, AM J NURS, V97, P20; Pedersen SJ, 2008, J AM GERIATR SOC, V56, P1831, DOI 10.1111/j.1532-5415.2008.01945.x; Penrod JD, 2004, J AM GERIATR SOC, V52, P1114, DOI 10.1111/j.1532-5415.2004.52309.x; Pergolizzi Joseph, 2008, Pain Pract, V8, P287, DOI 10.1111/j.1533-2500.2008.00204.x; Poitevin Luciano Augusto, 1999, Prensa Medica Argentina, V86, P913; Rais K, 2008, EUR 2008 EUR SOC AN; Resch S, 2005, DISABIL REHABIL, V27, P1191, DOI 10.1080/09638280500055800; Resch S, 1998, ACTA ORTHOP SCAND, V69, P277; Ronald LA, 2008, CAN J AGING, V27, P109, DOI 10.3138/cja.27.1.109; Roofthooft E, 2008, CURR OPIN ANESTHESIO, V21, P259, DOI 10.1097/ACO.0b013e3282ff5e41; Rosen JE, 2001, J ORTHOP TRAUMA, V15, P81, DOI 10.1097/00005131-200102000-00001; Said-Ahmed HA, 2006, ACTA ANAESTHESIOL IT, V57, P198; Saygi B, 2010, BULL HOSP JT DIS, V68, P15; Scheinin H, 2000, ACTA ANAESTH SCAND, V44, P1061, DOI 10.1034/j.1399-6576.2000.440905.x; Jimenez MIS, 2009, REV ESP ANEST REANIM, V56, P590, DOI 10.1016/S0034-9356(09)70474-8; Segado Jimnez MI., 2010, REV SOC ESPA OLA DOL, V17, P259; Sen Selda, 2007, J Clin Monit Comput, V21, P103, DOI 10.1007/s10877-006-9062-8; Shih YJ, 2010, INT J GERONTOL, V4, P37, DOI 10.1016/S1873-9598(10)70020-X; Spansberg NLM, 1996, EUR J ANAESTH, V13, P410, DOI 10.1046/j.1365-2346.1996.00958.x; SUTCLIFFE AJ, 1994, ANAESTHESIA, V49, P237; Tuncer S, 2003, ACUTE PAIN, V4, P105; Turker G, 2003, ACTA ANAESTH SCAND, V47, P30, DOI 10.1034/j.1399-6576.2003.470106.x; Van Balen R, 2003, DISABIL REHABIL, V25, P507, DOI 10.1080/0963828031000090443; Vermeiren J, 1995, Acta Orthop Belg, V61, P122; Warden Victoria, 2003, J Am Med Dir Assoc, V4, P9, DOI 10.1097/00130535-200301000-00002; Wells G, 2000, NEWCASTLE OTTAWA SCA; Yip DKH, 2002, INT ORTHOP, V26, P361, DOI 10.1007/s00264-002-0387-8; Yun MJ, 2009, ACTA ANAESTH SCAND, V53, P1282, DOI 10.1111/j.1399-6576.2009.02052.x	115	125	134	5	55	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2011	155	4					234	+		10.7326/0003-4819-155-4-201108160-00346	http://dx.doi.org/10.7326/0003-4819-155-4-201108160-00346			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	807KN	21844549				2022-12-01	WOS:000293896400004
J	Hippisley-Cox, J; Coupland, C				Hippisley-Cox, Julia; Coupland, Carol			Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DEEP-VEIN THROMBOSIS; WALES PROSPECTIVE DERIVATION; PULMONARY-EMBOLISM; CARDIOVASCULAR RISK; HOSPITALIZED-PATIENTS; ORAL-CONTRACEPTIVES; GENERAL-PRACTICE; UNITED-KINGDOM; MISSING DATA; ENGLAND	Objectives To derive and validate a new clinical risk prediction algorithm (QThrombosis, www.qthrombosis.org) to estimate individual patients' risk of venous thromboembolism. Design Prospective open cohort study using routinely collected data from general practices. Cox proportional hazards models used in derivation cohort to derive risk equations evaluated at 1 and 5 years. Measures of calibration and discrimination undertaken in validation cohort. Setting 564 general practices in England and Wales contributing to the QResearch database. Participants Patients aged 25-84 years, with no record of pregnancy in the preceding 12 months or any previous venous thromboembolism, and not prescribed oral anticoagulation at baseline: 2 314 701 in derivation cohort and 1 240 602 in validation cohort. Outcomes Incident cases of venous thromboembolism, either deep vein thrombosis or pulmonary embolism, recorded in primary care records or linked cause of death records. Results The derivation cohort included 14 756 incident cases of venous thromboembolism from 10 095 199 person years of observation (rate of 14.6 per 10 000 person years). The validation cohort included 6913 incident cases from 4 632 694 person years of observation (14.9 per 10 000 person years). Independent predictors included in the final model for men and women were age, body mass index, smoking status, varicose veins, congestive cardiac failure, chronic renal disease, cancer, chronic obstructive pulmonary disease, inflammatory bowel disease, hospital admission in past six months, and current prescriptions for antipsychotic drugs. We also included oral contraceptives, tamoxifen, and hormone replacement therapy in the final model for women. The risk prediction equation explained 33% of the variation in women and 34% in men in the validation cohort evaluated at 5 years The D statistic was 1.43 for women and 1.45 for men. The receiver operating curve statistic was 0.75 for both sexes. The model was well calibrated. Conclusions We have developed and validated a new risk prediction model that quantifies absolute risk of thrombosis at 1 and 5 years. It can help identify patients at high risk of venous thromboembolism for prevention. The algorithm is based on simple clinical variables which the patient is likely to know or which are routinely recorded in general practice records. The algorithm could be integrated into general practice clinical computer systems and used to risk assess patients before hospital admission or starting medication which might increase the risk of venous thromboembolism.	[Hippisley-Cox, Julia; Coupland, Carol] Div Primary Care, Nottingham NG2 7RD, England		Hippisley-Cox, J (corresponding author), Div Primary Care, Univ Pk, Nottingham NG2 7RD, England.	juliahippisleycox@gmail.com	Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Coupland, Carol/0000-0002-2327-3306	EMIS	EMIS	There was no external funding for the majority of the work undertaken on this project, which JHC and CC undertook in their ClinRisk roles. This analysis arose from a study of risks and benefits of hormone replacement therapy which was originally funded by David Stables (medical director of EMIS) in 2008, since venous thromboembolism was one of the outcomes.	Alikhan R, 2004, ARCH INTERN MED, V164, P963, DOI 10.1001/archinte.164.9.963; Canonico M, 2008, BMJ-BRIT MED J, V336, P1227, DOI 10.1136/bmj.39555.441944.BE; Collins GS, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2584; Committee HoCH, 2005, PREV THROMB HOSP PAT, P112; Couturaud F, 2009, CHEST, V136, P1537, DOI 10.1378/chest.09-0757; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Galanter WL, 2010, AM J HEALTH-SYST PH, V67, P1265, DOI 10.2146/ajhp090575; Geerts WH, 2001, CHEST, V119, p132S, DOI 10.1378/chest.119.1_suppl.132S; Grainge MJ, 2010, LANCET, V375, P657, DOI 10.1016/S0140-6736(09)61963-2; Health NIf, 2010, VEN THROMB RED RISK, P50, DOI [DOI 10.1056/NEJMOA011327, 10.1056/NEJMoa011327]; Heinemann LAJ, 2005, THROMB J, V3, DOI 10.1186/1477-9560-3-5; Heinemann LAJ, 2007, CONTRACEPTION, V75, P328, DOI 10.1016/j.contraception.2006.12.018; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; Heit JA, 2006, J THROMB THROMBOLYS, V21, P23, DOI 10.1007/s11239-006-5572-y; Heit JA, 2002, ARCH INTERN MED, V162, P1245, DOI 10.1001/archinte.162.11.1245; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V338, pb880, DOI DOI 10.1136/bmj.b880; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2197; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4229; HOFFENBERG R, 1989, BRIT MED J, V298, P573; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick SS, 2006, CONTRACEPTION, V73, P566, DOI 10.1016/j.contraception.2006.02.002; Khorana AA, 2008, BLOOD, V111, P4902, DOI 10.1182/blood-2007-10-116327; KOELEMAN BPC, 1994, BLOOD, V84, P1031; Kyrle PA, 2005, LANCET, V365, P1163, DOI 10.1016/S0140-6736(05)71880-8; Lawrenson R, 2000, BRIT J CLIN PHARMACO, V49, P591, DOI 10.1046/j.1365-2125.2000.00199.x; Lee AYY, 2003, CIRCULATION, V107, pI17, DOI 10.1161/01.CIR.0000078466.72504.AC; Lidegaard O, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2890; Lutsey PL, 2010, AM J PUBLIC HEALTH, V100, P1506, DOI 10.2105/AJPH.2008.157776; Majeed Azeem, 2004, Health Stat Q, P5; Miehsler W, 2004, GUT, V53, P542, DOI 10.1136/gut.2003.025411; Mohr DN, 2000, MAYO CLIN PROC, V75, P1249, DOI 10.4065/75.12.1249; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Ng TMH, 2010, CIRC-HEART FAIL, V3, P165, DOI 10.1161/CIRCHEARTFAILURE.109.892349; Parker C, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4245; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Roberts H, 2008, BRIT MED J, V336, P1203, DOI 10.1136/bmj.39556.666944.80; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Royston P, 2006, STATA J, V6, P83, DOI 10.1177/1536867X0600600105; Rubin D.B., 1987, MULTIPLE IMPUTATION, P1; Samama MM, 2003, HAEMATOLOGICA, V88, P1410; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Smith NL, 2004, JAMA-J AM MED ASSOC, V292, P1581, DOI 10.1001/jama.292.13.1581; Steyerberg EW, 2007, J CLIN EPIDEMIOL, V60, P979, DOI 10.1016/j.jclinepi.2007.03.003; Vlieg AV, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2921	50	88	96	2	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2011	343								d4656	10.1136/bmj.d4656	http://dx.doi.org/10.1136/bmj.d4656			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811KU	21846713	Green Submitted, hybrid, Green Published			2022-12-01	WOS:000294209500001
J	Gracheva, EO; Cordero-Morales, JF; Gonzalez-Carcacia, JA; Ingolia, NT; Manno, C; Aranguren, CI; Weissman, JS; Julius, D				Gracheva, Elena O.; Cordero-Morales, Julio F.; Gonzalez-Carcacia, Jose A.; Ingolia, Nicholas T.; Manno, Carlo; Aranguren, Carla I.; Weissman, Jonathan S.; Julius, David			Ganglion-specific splicing of TRPV1 underlies infrared sensation in vampire bats	NATURE			English	Article							DESMODUS-ROTUNDUS; CAPSAICIN RECEPTOR; PHYLOGENETICS; SENSITIVITY; MAMMALS; CHANNEL; SNAKES; COLD; WARM	Vampire bats (Desmodus rotundus) are obligate blood feeders that have evolved specialized systems to suit their sanguinary lifestyle(1-3). Chief among such adaptations is the ability to detect infrared radiation as a means of locating hotspots on warm-blooded prey. Among vertebrates, only vampire bats, boas, pythons and pit vipers are capable of detecting infrared radiation(1,4). In each case, infrared signals are detected by trigeminal nerve fibres that innervate specialized pit organs on the animal's face(5-10). Thus, vampire bats and snakes have taken thermosensation to the extreme by developing specialized systems for detecting infrared radiation. As such, these creatures provide a window into the molecular and genetic mechanisms underlying evolutionary tuning of thermoreceptors in a species-specific or cell-type-specific manner. Previously, we have shown that snakes co-opt a non-heat-sensitive channel, vertebrate TRPA1 (transient receptor potential cation channel A1), to produce an infrared detector(6). Here we show that vampire bats tune a channel that is already heat-sensitive, TRPV1, by lowering its thermal activation threshold to about 30 degrees C. This is achieved through alternative splicing of TRPV1 transcripts to produce a channel with a truncated carboxy-terminal cytoplasmic domain. These splicing events occur exclusively in trigeminal ganglia, and not in dorsal root ganglia, thereby maintaining a role for TRPV1 as a detector of noxious heat in somatic afferents. This reflects a unique organization of the bat Trpv1 gene that we show to be characteristic of Laurasiatheria mammals (cows, dogs and moles), supporting a close phylogenetic relationship with bats. These findings reveal a novel molecular mechanism for physiological tuning of thermosensory nerve fibres.	[Gracheva, Elena O.; Cordero-Morales, Julio F.; Julius, David] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Gonzalez-Carcacia, Jose A.; Aranguren, Carla I.] Inst Venezolano Invest Cient, Ctr Ecol, Lab Biol Organismos, Caracas 1020A, Venezuela; [Ingolia, Nicholas T.] Carnegie Inst, Dept Embryol, Baltimore, MD 21218 USA; [Manno, Carlo] Inst Venezolano Invest Cient, Ctr Biofis & Bioquim, Lab Fisiol Celular, Caracas 1020A, Venezuela; [Weissman, Jonathan S.; Julius, David] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Weissman, Jonathan S.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Venezuelan Institute Science Research; Carnegie Institution for Science; Venezuelan Institute Science Research; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.	ingolia@ciwemb.edu; david.julius@ucsf.edu		Weissman, Jonathan/0000-0003-2445-670X; Cordero Morales, Julio/0000-0002-6505-5403; Gracheva, Elena O/0000-0002-0846-3427; Manno, Carlo/0000-0002-1120-9606	Ruth L. Kirschstein National Research Service Award [GM080853]; UCSF CVRI; Howard Hughes Medical Institute; NIH [P01 AG010770, NS047723, NS055299]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047723, R01NS055299, R37NS047723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010770] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF CVRI; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Y. Kelly and J. Poblete for technical assistance, C. Sehnert for help with bovine tissue collection, M. Suzawa and H. Ingraham for providing zebrafish mRNA, A. Walsh for providing megabat blood samples, the Centro Tecnico de Produccion Socialista Florentino for providing access to Hato Pinero (Cojedes, Venezuela) for animal collection and J. Nassar for providing access to laboratory material required for specimen collection. This work was supported by a Ruth L. Kirschstein National Research Service Award (GM080853; N.T.I.), a Pathway to Independence Fellowship from the UCSF CVRI (E.O.G.), the Howard Hughes Medical Institute (J. S. W.), and grants from NIH, including P01 AG010770 (J. S. W.) and NS047723 and NS055299 (D.J.).	Asher RJ, 2009, BIOESSAYS, V31, P853, DOI 10.1002/bies.200900053; Bakken GS, 2007, J EXP BIOL, V210, P2801, DOI 10.1242/jeb.006965; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BULLOCK TH, 1952, SCIENCE, V115, P541, DOI 10.1126/science.115.2994.541-a; Campbell AL, 2002, MICRON, V33, P211, DOI 10.1016/S0968-4328(01)00010-5; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; DeCoursey TE, 1998, J GEN PHYSIOL, V112, P503, DOI 10.1085/jgp.112.4.503; Grabowski PJ, 2001, PROG NEUROBIOL, V65, P289, DOI 10.1016/S0301-0082(01)00007-7; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; KISHIDA R, 1984, BRAIN RES, V322, P351, DOI 10.1016/0006-8993(84)90132-X; KURTEN L, 1984, NATURWISSENSCHAFTEN, V71, P327, DOI 10.1007/BF00396621; KURTEN L, 1982, J COMP PHYSIOL, V146, P223; MOLENAAR GJ, 1978, J COMP NEUROL, V179, P137, DOI 10.1002/cne.901790109; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Nishihara H, 2006, P NATL ACAD SCI USA, V103, P9929, DOI 10.1073/pnas.0603797103; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; PETTIGREW JD, 1989, PHILOS T ROY SOC B, V325, P489, DOI 10.1098/rstb.1989.0102; Prasad AB, 2008, MOL BIOL EVOL, V25, P1795, DOI 10.1093/molbev/msn104; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Safer AB, 2004, BEHAV BRAIN RES, V154, P55, DOI 10.1016/j.bbr.2004.01.020; SCHAFER K, 1988, PFLUG ARCH EUR J PHY, V412, P188, DOI 10.1007/BF00583749; Schutt B., 2008, DARK BANQUET BLOOD C; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; Tellgren-Roth A, 2009, NATURWISSENSCHAFTEN, V96, P39, DOI 10.1007/s00114-008-0446-0; Will CL, 2005, BIOL CHEM, V386, P713, DOI 10.1515/BC.2005.084	30	150	154	1	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 4	2011	476	7358					88	+		10.1038/nature10245	http://dx.doi.org/10.1038/nature10245			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NR	21814281	Green Accepted, Green Submitted			2022-12-01	WOS:000293447300035
J	Mack, MC; Bret-Harte, MS; Hollingsworth, TN; Jandt, RR; Schuur, EAG; Shaver, GR; Verbyla, DL				Mack, Michelle C.; Bret-Harte, M. Syndonia; Hollingsworth, Teresa N.; Jandt, Randi R.; Schuur, Edward A. G.; Shaver, Gaius R.; Verbyla, David L.			Carbon loss from an unprecedented Arctic tundra wildfire	NATURE			English	Article							CLIMATE-CHANGE; NORTH-AMERICA; FIRE; VEGETATION; SOILS; VULNERABILITY; ECOSYSTEMS; SEVERITY; STORAGE; FORESTS	Arctic tundra soils store large amounts of carbon (C) in organic soil layers hundreds to thousands of years old that insulate, and in some cases maintain, permafrost soils(1,2). Fire has been largely absent from most of this biome since the early Holocene epoch(3), but its frequency and extent are increasing, probably in response to climate warming(4). The effect of fires on the C balance of tundra landscapes, however, remains largely unknown. The Anaktuvuk River fire in 2007 burned 1,039 square kilometres of Alaska's Arctic slope, making it the largest fire on record for the tundra biome and doubling the cumulative area burned since 1950 (ref. 5). Here we report that tundra ecosystems lost 2,016 +/- 435 g C m(-2) in the fire, an amount two orders of magnitude larger than annual net C exchange in undisturbed tundra(6). Sixty per cent of this C loss was from soil organic matter, and radiocarbon dating of residual soil layers revealed that the maximum age of soil C lost was 50 years. Scaled to the entire burned area, the fire released approximately 2.1 teragrams of C to the atmosphere, an amount similar in magnitude to the annual net C sink for the entire Arctic tundra biome averaged over the last quarter of the twentieth century(7). The magnitude of ecosystem C lost by fire, relative to both ecosystem and biome-scale fluxes, demonstrates that a climate-driven increase in tundra fire disturbance may represent a positive feedback, potentially offsetting Arctic greening(8) and influencing the net C balance of the tundra biome.	[Mack, Michelle C.; Schuur, Edward A. G.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Bret-Harte, M. Syndonia] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA; [Hollingsworth, Teresa N.] Univ Alaska Fairbanks, Boreal Ecol Cooperat Res Unit, PNW Res Stn USDA Forest Serv, Fairbanks, AK 99775 USA; [Jandt, Randi R.] Bur Land Management, Alaska Fire Serv, Ft Wainwright, AK 99703 USA; [Shaver, Gaius R.] Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; [Verbyla, David L.] Univ Alaska Fairbanks, Dept Forest Sci, Fairbanks, AK USA	State University System of Florida; University of Florida; University of Alaska System; University of Alaska Fairbanks; United States Department of Agriculture (USDA); United States Forest Service; University of Alaska System; University of Alaska Fairbanks; Marine Biological Laboratory - Woods Hole; University of Alaska System; University of Alaska Fairbanks	Mack, MC (corresponding author), Univ Florida, Dept Biol, POB 118525, Gainesville, FL 32611 USA.	mcmack@ufl.edu	Jandt, Randi/E-9018-2013	Jandt, Randi/0000-0001-8471-792X	US NSF Division of Environmental Biology; Division of Biological Infrastructure and Office of Polar Programs; US National Center for Ecological Analysis and Synthesis; US Bureau of Land Management Alaska Fire Service and Arctic Field Office	US NSF Division of Environmental Biology; Division of Biological Infrastructure and Office of Polar Programs; US National Center for Ecological Analysis and Synthesis; US Bureau of Land Management Alaska Fire Service and Arctic Field Office	We thank J. Ahgook Jr, L. Boby, M. Cahill, E. Miya, E. Miller, J. Oyler, C. Roberts, E. Suronen, C. Wachs, C. Wasykowski and D. Yokel for their contributions to fieldwork, C. Apodaca, G. Blohm, E. Brown, G. Crummer and D. Nossov for their contributions to laboratory work and sample analyses, H. Alexander for contributing to data analyses, and P. Ray for insights into tussock morphology. This research was supported by the US NSF Division of Environmental Biology, the Division of Biological Infrastructure and Office of Polar Programs, by the US National Center for Ecological Analysis and Synthesis and by the US Bureau of Land Management Alaska Fire Service and Arctic Field Office.	Balshi MS, 2009, GLOBAL CHANGE BIOL, V15, P1491, DOI 10.1111/j.1365-2486.2009.01877.x; Boby LA, 2010, ECOL APPL, V20, P1633, DOI 10.1890/08-2295.1; Chapin FS, 2005, SCIENCE, V310, P657, DOI 10.1126/science.1117368; Chapin FS, 2000, GLOBAL CHANGE BIOL, V6, P211, DOI 10.1046/j.1365-2486.2000.06022.x; Field CB, 2007, ANNU REV ENV RESOUR, V32, P1, DOI 10.1146/annurev.energy.32.053006.141119; Goetz SJ, 2005, P NATL ACAD SCI USA, V102, P13521, DOI 10.1073/pnas.0506179102; HARDEN JW, 1992, SCIENCE, V258, P1921, DOI 10.1126/science.258.5090.1921; Higuera PE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001744; Hobara S, 2006, ARCT ANTARCT ALP RES, V38, P363, DOI 10.1657/1523-0430(2006)38[363:NFISSA]2.0.CO;2; Hu FS, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001270; Jones BM, 2009, ARCT ANTARCT ALP RES, V41, P309, DOI 10.1657/1938-4246-41.3.309; Kasischke ES, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025677; Krawchuk MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005102; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Mack MC, 2004, NATURE, V431, P440, DOI 10.1038/nature02887; McGuire AD, 2009, ECOL MONOGR, V79, P523, DOI 10.1890/08-2025.1; Oechel WC, 2000, GLOB CHANGE BIOL, V6, P160, DOI 10.1046/j.1365-2486.2000.06018.x; Ping CL, 2008, NAT GEOSCI, V1, P615, DOI 10.1038/ngeo284; Ping CL, 1998, J GEOPHYS RES-ATMOS, V103, P28917, DOI 10.1029/98JD02024; Randerson JT, 2006, SCIENCE, V314, P1130, DOI 10.1126/science.1132075; Rocha AV, 2009, AGR FOREST METEOROL, V149, P1560, DOI 10.1016/j.agrformet.2009.03.016; Schell D., 1989, PEAT CORES TOOLIK LA; Schuur EAG, 2008, BIOSCIENCE, V58, P701, DOI 10.1641/B580807; Schuur EAG, 2009, NATURE, V459, P556, DOI 10.1038/nature08031; SHAVER GR, 1991, ECOL MONOGR, V61, P1, DOI 10.2307/1942997; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; The Intergovernmental Panel on Climate Change (IPCC), 2007, CHANG 2007 PHYS SCI; Trumbore SE, 1997, J GEOPHYS RES-ATMOS, V102, P28817, DOI 10.1029/97JD02231; Turetsky MR, 2011, NAT GEOSCI, V4, P27, DOI 10.1038/NGEO1027; Walker DA, 2005, J VEG SCI, V16, P267, DOI 10.1111/j.1654-1103.2005.tb02365.x; Zimov SA, 1999, SCIENCE, V284, P1973, DOI 10.1126/science.284.5422.1973	32	286	292	6	306	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2011	475	7357					489	492		10.1038/nature10283	http://dx.doi.org/10.1038/nature10283			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21796209				2022-12-01	WOS:000293167900038
J	Maslin, M; Scott, J				Maslin, Mark; Scott, Joanne			Carbon trading needs a multi-level approach	NATURE			English	Editorial Material									[Maslin, Mark] UCL, Dept Geog, London WC1E 6BT, England; [Scott, Joanne] UCL, Fac Laws, London WC1H 0EG, England	University of London; University College London; University of London; University College London	Maslin, M (corresponding author), UCL, Dept Geog, Pearson Bldg,Gower St, London WC1E 6BT, England.	mmaslin@geog.ucl.ac.uk		Maslin, Mark/0000-0001-9957-3463				Eggleston S., 2006, 2006 IPCC GUIDELINES; Friedlingstein P, 2010, NAT GEOSCI, V3, P811, DOI 10.1038/ngeo1022; Levin K., 2010, COMPARABILITY ANNEX; Linacre N., 2011, STATE TRENDS CARBON; Penman J., 2003, GOOD PRACTICE GUIDAN; Phelps J, 2010, SCIENCE, V328, P312, DOI 10.1126/science.1187774; POESSINOUW M, 2010, KNOWLEDGE MATRIX LTD; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Wara M, 2007, NATURE, V445, P595, DOI 10.1038/445595a	9	17	18	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2011	475	7357					445	447		10.1038/475445a	http://dx.doi.org/10.1038/475445a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	797ZA	21796183	Bronze			2022-12-01	WOS:000293167900014
J	Ladabaum, U; Wang, G; Terdiman, J; Blanco, A; Kuppermann, M; Boland, CR; Ford, J; Elkin, E; Phillips, KA				Ladabaum, Uri; Wang, Grace; Terdiman, Jonathan; Blanco, Amie; Kuppermann, Miriam; Boland, C. Richard; Ford, James; Elkin, Elena; Phillips, Kathryn A.			Strategies to Identify the Lynch Syndrome Among Patients With Colorectal Cancer A Cost-Effectiveness Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							DNA-MISMATCH-REPAIR; SERVICES TASK-FORCE; REVISED BETHESDA GUIDELINES; GENETIC TESTING STRATEGIES; NONPOLYPOSIS COLON-CANCER; POPULATION-BASED COHORT; AT-RISK RELATIVES; MICROSATELLITE INSTABILITY; ENDOMETRIAL CANCER; RANDOMIZED-TRIAL	Background: Testing has been advocated for all persons with newly diagnosed colorectal cancer to identify families with the Lynch syndrome, an autosomal dominant cancer-predisposition syndrome that is a paradigm for personalized medicine. Objective: To estimate the effectiveness and cost-effectiveness of strategies to identify the Lynch syndrome, with attention to sex, age at screening, and differential effects for probands and relatives. Design: Markov model that incorporated risk for colorectal, endometrial, and ovarian cancers. Data Sources: Published literature. Target Population: All persons with newly diagnosed colorectal cancer and their relatives. Time Horizon: Lifetime. Perspective: Third-party payer. Intervention: Strategies based on clinical criteria, prediction algorithms, tumor testing, or up-front germline mutation testing, followed by tailored screening and risk-reducing surgery. Outcome Measures: Life-years, cancer cases and deaths, costs, and incremental cost-effectiveness ratios. Results of Base-Case Analysis: The benefit of all strategies accrued primarily to relatives with a mutation associated with the Lynch syndrome, particularly women, whose life expectancy could increase by approximately 4 years with hysterectomy and salpingo-oophorectomy and adherence to colorectal cancer screening recommendations. At current rates of germline testing, screening, and prophylactic surgery, the strategies reduced deaths from colorectal cancer by 7% to 42% and deaths from endometrial and ovarian cancer by 1% to 6%. Among tumor-testing strategies, immunohistochemistry followed by BRAF mutation testing was preferred, with an incremental cost-effectiveness ratio of $36 200 per life-year gained. Results of Sensitivity Analysis: The number of relatives tested per proband was a critical determinant of both effectiveness and cost-effectiveness, with testing of 3 to 4 relatives required for most strategies to meet a threshold of $50 000 per life-year gained. Immunohistochemistry followed by BRAF mutation testing was preferred in 59% of iterations in probabilistic sensitivity analysis at a threshold of $100 000 per life-year gained. Screening for the Lynch syndrome with immunohistochemistry followed by BRAF mutation testing only up to age 70 years cost $44 000 per incremental life-year gained compared with screening only up to age 60 years, and screening without an upper age limit cost $88 700 per incremental life-year gained compared with screening only up to age 70 years. Limitation: Other types of cancer, uncertain family pedigrees, and genetic variants of unknown significance were not considered. Conclusion: Widespread colorectal tumor testing to identify families with the Lynch syndrome could yield substantial benefits at acceptable costs, particularly for women with a mutation associated with the Lynch syndrome who begin regular screening and have risk-reducing surgery. The cost-effectiveness of such testing depends on the participation rate among relatives at risk for the Lynch syndrome.	[Ladabaum, Uri] Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Redwood City, CA 94063 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Baylor Univ, Med Ctr, Dallas, TX USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Stanford University; University of California System; University of California San Francisco; Baylor University; Baylor University Medical Center; Memorial Sloan Kettering Cancer Center	Ladabaum, U (corresponding author), Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, 450 Broadway St,Pavil C,4th Floor,MC 6341, Redwood City, CA 94063 USA.	uri.ladabaum@stanford.edu		Ford, James/0000-0002-2513-7025	National Institutes of Health [NIH 1 P01 CA130818, R01 CA72851]; National Cancer Institute; NATIONAL CANCER INSTITUTE [P01CA130818, R01CA072851] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By grants NIH 1 P01 CA130818 and R01 CA72851 from the National Institutes of Health.r Grants/grants pending: National Cancer Institute.		0	254	259	0	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2011	155	2					69	+		10.7326/0003-4819-155-2-201107190-00002	http://dx.doi.org/10.7326/0003-4819-155-2-201107190-00002			26	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	793KW	21768580	Green Accepted			2022-12-01	WOS:000292822000013
J	Joo, W; Xu, GZ; Persky, NS; Smogorzewska, A; Rudge, DG; Buzovetsky, O; Elledge, SJ; Pavletich, NP				Joo, Woo; Xu, Guozhou; Persky, Nicole S.; Smogorzewska, Agata; Rudge, Derek G.; Buzovetsky, Olga; Elledge, Stephen J.; Pavletich, Nikola P.			Structure of the FANCI-FANCD2 Complex: Insights into the Fanconi Anemia DNA Repair Pathway	SCIENCE			English	Article							INTERSTRAND CROSS-LINK; PROTEIN; REPLICATION; FANCD2; IDENTIFICATION; SCREEN; BINDS; GENE	Fanconi anemia is a cancer predisposition syndrome caused by defects in the repair of DNA interstrand cross-links (ICLs). Central to this pathway is the Fanconi anemia I-Fanconi anemia D2 (FANCI-FANCD2) (ID) complex, which is activated by DNA damage-induced phosphorylation and monoubiquitination. The 3.4 angstrom crystal structure of the similar to 300 kilodalton ID complex reveals that monoubiquitination and regulatory phosphorylation sites map to the I-D interface, suggesting that they occur on monomeric proteins or an opened-up complex and that they may serve to stabilize I-D heterodimerization. The 7.8 angstrom electron-density map of FANCI-DNA crystals and in vitro data show that each protein has binding sites for both single-and double-stranded DNA, suggesting that the ID complex recognizes DNA structures that result from the encounter of replication forks with an ICL.	[Joo, Woo; Persky, Nicole S.; Rudge, Derek G.; Buzovetsky, Olga; Pavletich, Nikola P.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Xu, Guozhou] Cornell Univ, Sloan Kettering Div, Joan & Sanford I Weill Grad Sch Med Sci, New York, NY 10065 USA; [Persky, Nicole S.; Rudge, Derek G.; Buzovetsky, Olga; Elledge, Stephen J.; Pavletich, Nikola P.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Smogorzewska, Agata; Elledge, Stephen J.] Harvard Univ, Brigham & Womens Hosp, Dept Genet, Div Genet,Sch Med, Boston, MA 02115 USA; [Smogorzewska, Agata] Rockefeller Univ, Lab Genome Maintenance, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Rockefeller University	Pavletich, NP (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pavletin@mskcc.org		Smogorzewska, Agata/0000-0001-6285-1562	NIH; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [T32CA009216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM044664, R01GM044664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D. King for mass spectroscopy analysis and the staff of the Advanced Photon Source Northeast Collaborative Access Team and National Synchrotron Light Source X29 beamlines for help with data collection. This work was supported by the NIH and the Howard Hughes Medical Institute. Coordinates and structure factors have been deposited with the Protein Data Bank (accession codes 3S51 for FANCI, 3S4W for FANCI-FANCD2, and 3S4Z for Y DNA-FANCI).	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ben-Yehoyada M, 2009, MOL CELL, V35, P704, DOI 10.1016/j.molcel.2009.08.014; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Dorsman JC, 2007, CELL ONCOL, V29, P211; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Ishiai M, 2008, NAT STRUCT MOL BIOL, V15, P1138, DOI 10.1038/nsmb.1504; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Longerich S, 2009, J BIOL CHEM, V284, P23182, DOI 10.1074/jbc.C109.038075; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Park WH, 2005, J BIOL CHEM, V280, P23593, DOI 10.1074/jbc.M503730200; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Shen X, 2009, MOL CELL, V35, P716, DOI 10.1016/j.molcel.2009.06.034; Shimamura A, 2002, BLOOD, V100, P4649, DOI 10.1182/blood-2002-05-1399; Sims AE, 2007, NAT STRUCT MOL BIOL, V14, P564, DOI 10.1038/nsmb1252; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Timmers C, 2001, MOL CELL, V7, P241, DOI 10.1016/S1097-2765(01)00172-1; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Winget JM, 2010, MOL CELL, V38, P627, DOI 10.1016/j.molcel.2010.05.003; Yamamoto KN, 2011, P NATL ACAD SCI USA, V108, P6492, DOI 10.1073/pnas.1018487108; Yuan FH, 2009, J BIOL CHEM, V284, P24443, DOI 10.1074/jbc.M109.016006	23	118	118	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2011	333	6040					312	316		10.1126/science.1205805	http://dx.doi.org/10.1126/science.1205805			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21764741	Green Accepted			2022-12-01	WOS:000292732000034
J	Buckholtz, NS				Buckholtz, Neil S.			PERSPECTIVE In search of biomarkers	NATURE			English	Editorial Material							ALZHEIMERS ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; RECOMMENDATIONS; DISEASE		NIA, Dementias Aging Branch, Div Neurosci, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Buckholtz, NS (corresponding author), NIA, Dementias Aging Branch, Div Neurosci, Bethesda, MD 20892 USA.	buckholn@nia.nih.gov						Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003	3	16	16	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2011	475	7355					S8	S8		10.1038/475S8a	http://dx.doi.org/10.1038/475S8a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21760582	Bronze			2022-12-01	WOS:000292690500004
J	Luther, S; Fenton, FH; Kornreich, BG; Squires, A; Bittihn, P; Hornung, D; Zabel, M; Flanders, J; Gladuli, A; Campoy, L; Cherry, EM; Luther, G; Hasenfuss, G; Krinsky, VI; Pumir, A; Gilmour, RF; Bodenschatz, E				Luther, Stefan; Fenton, Flavio H.; Kornreich, Bruce G.; Squires, Amgad; Bittihn, Philip; Hornung, Daniel; Zabel, Markus; Flanders, James; Gladuli, Andrea; Campoy, Luis; Cherry, Elizabeth M.; Luther, Gisa; Hasenfuss, Gerd; Krinsky, Valentin I.; Pumir, Alain; Gilmour, Robert F., Jr.; Bodenschatz, Eberhard			Low-energy control of electrical turbulence in the heart	NATURE			English	Article							CARDIAC TISSUE; SPIRAL WAVES; DEFIBRILLATION; FIBRILLATION; TERMINATION; FIELD; PROPAGATION; ACTIVATION; MECHANISMS; SHOCKS	Controlling the complex spatio-temporal dynamics underlying life-threatening cardiac arrhythmias such as fibrillation is extremely difficult, because of the nonlinear interaction of excitation waves in a heterogeneous anatomical substrate(1-4). In the absence of a better strategy, strong, globally resetting electrical shocks remain the only reliable treatment for cardiac fibrillation(5-7). Here we establish the relationship between the response of the tissue to an electric field and the spatial distribution of heterogeneities in the scale-free coronary vascular structure. We show that in response to a pulsed electric field, E, these heterogeneities serve as nucleation sites for the generation of intramural electrical waves with a source density rho(E) and a characteristic time, tau, for tissue depolarization that obeys the power law tau proportional to E-alpha. These intramural wave sources permit targeting of electrical turbulence near the cores of the vortices of electrical activity that drive complex fibrillatory dynamics. Weshow in vitro that simultaneous and direct access to multiple vortex cores results in rapid synchronization of cardiac tissue and therefore, efficient termination of fibrillation. Using this control strategy, we demonstrate low-energy termination of fibrillation in vivo. Our results give new insights into the mechanisms and dynamics underlying the control of spatio-temporal chaos in heterogeneous excitable media and provide new research perspectives towards alternative, life-saving low-energy defibrillation techniques.	[Luther, Stefan; Fenton, Flavio H.; Squires, Amgad; Bittihn, Philip; Hornung, Daniel; Cherry, Elizabeth M.; Luther, Gisa; Krinsky, Valentin I.; Bodenschatz, Eberhard] Max Planck Inst Dynam & Self Org, D-37077 Gottingen, Germany; [Luther, Stefan; Fenton, Flavio H.; Cherry, Elizabeth M.; Gilmour, Robert F., Jr.] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA; [Luther, Stefan; Bittihn, Philip; Hornung, Daniel; Luther, Gisa; Bodenschatz, Eberhard] Georg August Univ, Inst Nonlinear Dynam, D-37077 Gottingen, Germany; [Luther, Stefan; Zabel, Markus; Hasenfuss, Gerd; Bodenschatz, Eberhard] Heart Res Ctr Gottingen HRCG, D-37075 Gottingen, Germany; [Kornreich, Bruce G.; Flanders, James; Gladuli, Andrea; Campoy, Luis] Cornell Univ, Dept Clin Sci, Ithaca, NY 14853 USA; [Squires, Amgad; Bodenschatz, Eberhard] Cornell Univ, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA; [Zabel, Markus; Hasenfuss, Gerd] Univ Med Ctr UMG, Dept Cardiol & Pneumol, D-37075 Gottingen, Germany; [Cherry, Elizabeth M.] Rochester Inst Technol, Sch Math Sci, Rochester, NY 14623 USA; [Krinsky, Valentin I.] Inst Nonlineaire Nice, F-06560 Valbonne, France; [Pumir, Alain] Univ Lyon 1, Lab Phys, Ecole Normale Super Lyon, F-69007 Lyon, France; [Pumir, Alain] CNRS, F-69007 Lyon, France; [Bodenschatz, Eberhard] Cornell Univ, Dept Mech & Aerosp Engn, Ithaca, NY 14853 USA	Max Planck Society; Cornell University; University of Gottingen; Cornell University; Cornell University; Rochester Institute of Technology; Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Cornell University	Luther, S (corresponding author), Max Planck Inst Dynam & Self Org, Fassberg 17, D-37077 Gottingen, Germany.	stefan.luther@ds.mpg.de; flavio.h.fenton@cornell.edu	Luther, Stefan/C-7226-2009; Squires, Amgad Andrew/E-7414-2010; Bittihn, Philip/E-2078-2011; Pumir, Alain/AAH-6566-2020	Hornung, Daniel/0000-0002-7846-6375; Bodenschatz, Eberhard/0000-0002-2901-0144; Bittihn, Philip/0000-0002-1276-9381	National Science Foundation (NSF) [0800793, 0926190]; National Institutes of Health (NIH) [HL075515-S04, HL075515, HL073644]; IFCPAR Project [3404-4]; German Ministry for Education and Research [FKZ 01EZ0905/6]; Kavli Institute for Theoretical Physics [NSFPHY05-51164]; Pittsburgh Supercomputing Center (NSF TeraGrid); Pittsburgh NMR Center for Biomedical Research [NIH P41-EB001977]; European Community [HEALTH-F2-2009-241526]; Max Planck Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075515, R01HL073644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001977] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IFCPAR Project; German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Kavli Institute for Theoretical Physics; Pittsburgh Supercomputing Center (NSF TeraGrid)(National Science Foundation (NSF)); Pittsburgh NMR Center for Biomedical Research; European Community(European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank M. L. Riccio and the Cornell University mu CT Facility for Imaging and Preclinical Research for performing the micro-CT scanning, and T. K. Hitchens for technical assistance with cardiac structural imaging. M. W. Enyeart and J. Boesch assisted with the experiments and N. F. Otani provided insights from computer simulations. G. Hooker conducted the statistical analysis. This work was supported by National Science Foundation (NSF) grants 0800793 (F.H.F. and E.M.C.) and 0926190 (F.H.F.); by National Institutes of Health (NIH) grants HL075515-S04 (F.H.F.), HL075515 (R.F.G.) and HL073644 (R.F.G. and E.B.); by IFCPAR Project no. 3404-4 (A.P.); by the German Ministry for Education and Research through FKZ 01EZ0905/6 (S.L., M.Z., E.B. and G.H.); by the Kavli Institute for Theoretical Physics through NSFPHY05-51164; by the Pittsburgh Supercomputing Center (NSF TeraGrid); by the Pittsburgh NMR Center for Biomedical Research (NIH P41-EB001977); by the European Community's Seventh Framework Programme FP7/2007-2013 agreement HEALTH-F2-2009-241526 (EUTrigTreat) and by the Max Planck Society.	BABBS CF, 1980, AM HEART J, V99, P734, DOI 10.1016/0002-8703(80)90623-7; BIKTASHEV VN, 1994, PHILOS T R SOC A, V347, P611, DOI 10.1098/rsta.1994.0070; Cherry EM, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/12/125016; DAVIDENKO JM, 1992, NATURE, V355, P349, DOI 10.1038/355349a0; Fast VG, 1998, CIRC RES, V82, P375, DOI 10.1161/01.RES.82.3.375; Fenton F, 1998, CHAOS, V8, P20, DOI 10.1063/1.166311; Fenton FH, 2002, CHAOS, V12, P852, DOI 10.1063/1.1504242; Fenton FH, 2009, CIRCULATION, V120, P467, DOI 10.1161/CIRCULATIONAHA.108.825091; Gray RA, 2005, P NATL ACAD SCI USA, V102, P4672, DOI 10.1073/pnas.0407860102; Gray RA, 1998, NATURE, V392, P75, DOI 10.1038/32164; Hooks DA, 2002, CIRC RES, V91, P331, DOI 10.1161/01.RES.0000031957.70034.89; Kassab GS, 2006, AM J PHYSIOL-HEART C, V290, pH894, DOI 10.1152/ajpheart.00579.2005; KIRCHHOF C, 1993, CIRCULATION, V88, P736, DOI 10.1161/01.CIR.88.2.736; Koster RW, 2004, AM HEART J, V147, DOI 10.1016/j.ahj.2003.10.049; Mackenzie D, 2004, SCIENCE, V303, P786, DOI 10.1126/science.303.5659.786; Maleckar MM, 2008, AM J PHYSIOL-HEART C, V295, pH1626, DOI 10.1152/ajpheart.00706.2008; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; PLONSEY R, 1982, BIOPHYS J, V39, P309, DOI 10.1016/S0006-3495(82)84521-9; Pumir A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.208101; Pumir A, 1999, J THEOR BIOL, V199, P311, DOI 10.1006/jtbi.1999.0957; Rappel WJ, 1999, PHYS REV LETT, V83, P456, DOI 10.1103/PhysRevLett.83.456; Ripplinger CM, 2006, AM J PHYSIOL-HEART C, V291, pH184, DOI 10.1152/ajpheart.01300.2005; ROTH BJ, 1986, IEEE T BIO-MED ENG, V33, P467, DOI 10.1109/TBME.1986.325804; Sakurai T, 2002, SCIENCE, V296, P2009, DOI 10.1126/science.1071265; Sambelashvili AT, 2004, AM J PHYSIOL-HEART C, V286, pH2183, DOI 10.1152/ajpheart.00637.2003; Santini M, 1999, J INTERV CARD ELECTR, V3, P45, DOI 10.1023/A:1009871422517; Takagi S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.058101; Trayanova N, 1998, J ELECTROCARDIOL, V31, P23, DOI 10.1016/S0022-0736(98)90274-6; Walcott GP, 2003, RESUSCITATION, V59, P59, DOI 10.1016/S0300-9572(03)00161-8; Witkowski FX, 1998, NATURE, V392, P78, DOI 10.1038/32170	30	218	221	2	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					235	U152		10.1038/nature10216	http://dx.doi.org/10.1038/nature10216			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21753855	Green Accepted			2022-12-01	WOS:000292690500052
J	Eyler, CE; Wu, QL; Yan, K; MacSwords, JM; Chandler-Militello, D; Misuraca, KL; Lathia, JD; Forrester, MT; Lee, J; Stamler, JS; Goldman, SA; Bredel, M; McLendon, RE; Sloan, AE; Hjelmeland, AB; Rich, JN				Eyler, Christine E.; Wu, Qiulian; Yan, Kenneth; MacSwords, Jennifer M.; Chandler-Militello, Devin; Misuraca, Katherine L.; Lathia, Justin D.; Forrester, Michael T.; Lee, Jeongwu; Stamler, Jonathan S.; Goldman, Steven A.; Bredel, Markus; McLendon, Roger E.; Sloan, Andrew E.; Hjelmeland, Anita B.; Rich, Jeremy N.			Glioma Stem Cell Proliferation and Tumor Growth Are Promoted by Nitric Oxide Synthase-2	CELL			English	Article							LYMPHOCYTIC-LEUKEMIA CELLS; HIGHLY SELECTIVE INHIBITOR; ACUTE MYELOID-LEUKEMIA; ISCHEMIC BRAIN-INJURY; MICE LACKING; IN-VIVO; HUMAN GLIOBLASTOMA; INITIATING CELLS; SEPTIC SHOCK; SELF-RENEWAL	Malignant gliomas are aggressive brain tumors with limited therapeutic options, and improvements in treatment require a deeper molecular understanding of this disease. As in other cancers, recent studies have identified highly tumorigenic subpopulations within malignant gliomas, known generally as cancer stem cells. Here, we demonstrate that glioma stem cells (GSCs) produce nitric oxide via elevated nitric oxide synthase-2 (NOS2) expression. GSCs depend on NOS2 activity for growth and tumorigenicity, distinguishing them from non-GSCs and normal neural progenitors. Gene expression profiling identified many NOS2-regulated genes, including the cell-cycle inhibitor cell division autoantigen-1 (CDA1). Further, high NOS2 expression correlates with decreased survival in human glioma patients, and NOS2 inhibition slows glioma growth in a murine intracranial model. These data provide insight into how GSCs are mechanistically distinct from their less tumorigenic counterparts and suggest that NOS2 inhibition may be an efficacious approach to treating this devastating disease.	[Eyler, Christine E.; Wu, Qiulian; Yan, Kenneth; MacSwords, Jennifer M.; Lathia, Justin D.; Lee, Jeongwu; Hjelmeland, Anita B.; Rich, Jeremy N.] Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44195 USA; [Eyler, Christine E.; Misuraca, Katherine L.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Eyler, Christine E.] Duke Univ, Med Ctr, Med Scientist Training Program, Durham, NC 27710 USA; [McLendon, Roger E.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Chandler-Militello, Devin; Goldman, Steven A.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Forrester, Michael T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Stamler, Jonathan S.] Case Western Reserve Univ, Sch Med, Inst Transformat Mol Med, Cleveland, OH 44106 USA; [Stamler, Jonathan S.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Sloan, Andrew E.] Case Western Reserve Univ, Sch Med, Dept Neurol Surg, Cleveland, OH 44106 USA; [Sloan, Andrew E.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Sloan, Andrew E.] Case Western Reserve Univ, Sch Med, Dept Translat Neurosci, Cleveland, OH 44106 USA; [Rich, Jeremy N.] Case Western Reserve Univ, Sch Med, Cleveland Clin Lerner Coll Med, Dept Mol Med, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; [Bredel, Markus] Univ Alabama, Ctr Comprehens Canc, Dept Radiat Oncol, Birmingham, AL 35249 USA; [Bredel, Markus] Univ Freiburg, Neuroctr, Dept Neurosurg, D-79106 Freiburg, Germany; [Bredel, Markus] Univ Freiburg, Ctr Comprehens Canc, D-79106 Freiburg, Germany	Cleveland Clinic Foundation; Duke University; Duke University; Duke University; University of Rochester; Harvard University; Harvard Medical School; Massachusetts General Hospital; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation; University Hospitals of Cleveland; University of Alabama System; University of Alabama Birmingham; University of Freiburg; University of Freiburg	Hjelmeland, AB (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44195 USA.	hjelmea@ccf.org; richj@ccf.org	Eyler, Christine E/A-2921-2010; Sloan, Andrew/AAE-9842-2020; Rich, Jeremy/AAM-1445-2021; Lathia, Justin/AHB-8296-2022	Goldman, Steven/0000-0002-5498-4303; Stamler, Jonathan/0000-0002-6866-1572	National Institutes of Health [F30NS063496, CA112958, CA116659, CA154130, CA151522, CA137443, NS063971, CA128269, CA101954, CA116257, CA142159, HL059130, HL091876,, HLO95463, CA108786, NS20023]; German Cancer Aid Grant Award [107714]; NATIONAL CANCER INSTITUTE [K08CA101954, R42CA128269, R01CA154130, R01CA116659, R01CA151522, P50CA108786, R01CA116257, UM1CA137443, R01CA129958, U01CA137443, F32CA142159] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059130, R01HL091876, R01HL095463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075345, R01NS052534, F30NS063496, P50NS020023, R01NS063971, R01NS054276] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Cancer Aid Grant Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the sources of our funding, including National Institutes of Health grant F30NS063496 for C.E.E.; CA112958, CA116659, and CA154130 for J.N.R.; CA151522 for A.B.H.; CA137443, NS063971, CA128269, CA101954, and CA116257 for A.E.S.; CA142159 for J.D.L.; HL059130, HL091876, and HLO95463 for J.S.S.; and CA108786 and NS20023 for R.E.M. We also thank the Adelson Medical Research Foundation (S.A.G.), American Brain Tumor Association (J.D.L.), National Brain Tumor Society (A.B.H.), Ben and Catherine Ivy Foundation (A. E. S.), Damon Runyon Cancer Research Foundation (J.N.R.), German Cancer Aid Grant Award 107714 (M.B.), Goldhirsh Foundation (J.N.R.), James S. McDonnell Foundation (J.N.R. and S.A.G.), New York State Stem Cell Science Board (S. A. G.), Ohio Department of Development Tech 09-071 (A.E.S.), and Pediatric Brain Tumor Foundation of the United States (R.E.M.). We appreciate critical manuscript review by H. Suh; animal support provided by T. Myshrall, Y. Parker, and D. Lindner; M. Cook, B. Harvat, C. Shemo, and S. O'Bryant for flow cytometry assistance; D. Satterfield, L. Ehinger, J. Funkhouser, and J. Faison for technical assistance; the tissue provided by the Cleveland Clinic Foundation Tissue Procurement Service and S. Staugatis, R. Weil, and M. McGraw; and microarray analysis completed by P. Faber and W. Jones.	Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Avontuur JAM, 1998, CRIT CARE MED, V26, P660, DOI 10.1097/00003246-199804000-00012; Bakshi A, 1998, J NEUROL SCI, V155, P196, DOI 10.1016/S0022-510X(97)00315-8; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brindicci C, 2009, CHEST, V135, P353, DOI 10.1378/chest.08-0964; Broadley KWR, 2011, STEM CELLS, V29, P452, DOI 10.1002/stem.582; Chai ZL, 2001, J BIOL CHEM, V276, P33665, DOI 10.1074/jbc.M007681200; Charles NA, 2010, CELL STEM CELL, V6, P6, DOI 10.1016/j.stem.2009.12.005; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; COBBS CS, 1995, CANCER RES, V55, P727; Dover AR, 2006, CLIN SCI, V111, P275, DOI 10.1042/CS20060104; Eissa NT, 1998, P NATL ACAD SCI USA, V95, P7625, DOI 10.1073/pnas.95.13.7625; Eissa NT, 1996, J BIOL CHEM, V271, P27184, DOI 10.1074/jbc.271.43.27184; Engels K, 2008, CANCER RES, V68, P5159, DOI 10.1158/0008-5472.CAN-08-0406; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Fetz V, 2009, INT J CANCER, V124, P2033, DOI 10.1002/ijc.24182; Forrester MT, 2011, BIOTECHNIQUES, V50, P41, DOI 10.2144/000113586; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Hausladen A, 2001, P NATL ACAD SCI USA, V98, P10108, DOI 10.1073/pnas.181199698; Hausladen A, 1998, P NATL ACAD SCI USA, V95, P14100, DOI 10.1073/pnas.95.24.14100; Hochman JS, 2007, JAMA-J AM MED ASSOC, V297, P1657; Iadecola C, 1997, J NEUROSCI, V17, P9157; Kandalaft LE, 2008, CARCINOGENESIS, V29, P1282, DOI 10.1093/carcin/bgn087; Kashiwagi S, 2008, NAT MED, V14, P255, DOI 10.1038/nm1730; Keyoung HM, 2001, NAT BIOTECHNOL, V19, P843, DOI 10.1038/nbt0901-843; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Lam-Himlin D, 2006, NEUROCHEM INT, V49, P764, DOI 10.1016/j.neuint.2006.07.001; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Levesque MC, 2003, LEUKEMIA, V17, P442, DOI 10.1038/sj.leu.2402783; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lopez A, 2004, CRIT CARE MED, V32, P21, DOI 10.1097/01.CCM.0000105581.01815.C6; Luo CX, 2007, J NEUROCHEM, V103, P1872, DOI 10.1111/j.1471-4159.2007.04915.x; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Martinez-Diaz H, 2003, ARCH PATHOL LAB MED, V127, P1187; Nakatsubo N, 1998, FEBS LETT, V427, P263, DOI 10.1016/S0014-5793(98)00440-2; Perry A, 2009, BRAIN PATHOL, V19, P81, DOI 10.1111/j.1750-3639.2008.00167.x; Rai RM, 1998, P NATL ACAD SCI USA, V95, P13829, DOI 10.1073/pnas.95.23.13829; REBELLO SS, 2002, AAPS PHARMSCI, V4; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Singh D, 2007, AM J RESP CRIT CARE, V176, P988, DOI 10.1164/rccm.200704-588OC; Singh SK, 2003, CANCER RES, V63, P5821; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Strub A, 2006, MOL PHARMACOL, V69, P328, DOI 10.1124/mol.105.017087; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Thomsen LL, 1997, CANCER RES, V57, P3300; Tiscornia AC, 2004, LEUKEMIA, V18, P48, DOI 10.1038/sj.leu.2403169; Tu YG, 2007, J BIOL CHEM, V282, P11722, DOI 10.1074/jbc.M609623200; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; WEI XQ, 1995, NATURE, V375, P408, DOI 10.1038/375408a0; Williams EL, 2005, BIOESSAYS, V27, P1228, DOI 10.1002/bies.20324; Yamaguchi S, 2002, BRIT J NEUROSURG, V16, P567; Yang DI, 2002, ANN NY ACAD SCI, V962, P8, DOI 10.1111/j.1749-6632.2002.tb04052.x; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311; Zhao HX, 1998, BLOOD, V92, P1031; Zhao XR, 2000, BRAIN RES, V872, P215, DOI 10.1016/S0006-8993(00)02459-8	72	228	235	1	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 8	2011	146	1					53	66		10.1016/j.cell.2011.06.006	http://dx.doi.org/10.1016/j.cell.2011.06.006			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729780	Green Accepted, Bronze			2022-12-01	WOS:000292539300006
J	Jeon, Y; Lee, JT				Jeon, Yesu; Lee, Jeannie T.			YY1 Tethers Xist RNA to the Inactive X Nucleation Center	CELL			English	Article							CHROMOSOME INACTIVATION; DOSAGE COMPENSATION; IN-VIVO; CELL-DIFFERENTIATION; BINDING PROTEIN; POLYMERASE-II; CTCF BINDING; POLYCOMB; GENE; MOUSE	The long noncoding Xist RNA inactivates one X chromosome in the female mammal. Current models posit that Xist induces silencing as it spreads along X and recruits Polycomb complexes. However, the mechanisms for Xist loading and spreading are currently unknown. Here, we define the nucleation center for Xist RNA and show that YY1 docks Xist particles onto the X chromosome. YY1 is a "bivalent'' protein, capable of binding both RNA and DNA through different sequence motifs. Xist's exclusive attachment to the inactive X is determined by an epigenetically regulated trio of YY1 sites as well as allelic origin. Specific YY1-to-RNA and YY1-to-DNA contacts are required to load Xist particles onto X. YY1 interacts with Xist RNA through Repeat C. We propose that YY1 acts as adaptor between regulatory RNA and chromatin targets.	[Jeon, Yesu; Lee, Jeannie T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Howard Hughes Med Inst,Dept Mol Biol, Boston, MA 02114 USA; [Jeon, Yesu; Lee, Jeannie T.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Lee, JT (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Howard Hughes Med Inst,Dept Mol Biol, Boston, MA 02114 USA.	lee@molbio.mgh.harvard.edu			Korean Research Foundation; MGH ECOR Fund; NIH [RO1-GM090278]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090278] Funding Source: NIH RePORTER	Korean Research Foundation(National Research Foundation of Korea); MGH ECOR Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	lWe thank K. Sarma, B. Del Rosario, and B. Payer for reading of the manuscript and all lab members for many helpful suggestions. We acknowledge K. Hochedlinger for Rosa26-M2rtTA mice, Y. Shi for His-YY1, and B. Del Rosario for purified His-GFP. This work was supported by a Korean Research Foundation grant and the MGH ECOR Fund to Y.J. and NIH RO1-GM090278 to J.T.L. J.T.L. is an Investigator of the Howard Hughes Medical Institute.	Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Bhadra MP, 2006, GENETICS, V174, P1151, DOI 10.1534/genetics.106.060541; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Chow JC, 2007, P NATL ACAD SCI USA, V104, P10104, DOI 10.1073/pnas.0610946104; Chureau C, 2002, GENOME RES, V12, P894, DOI 10.1101/gr.152902; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Clemson CM, 1998, J CELL BIOL, V142, P13, DOI 10.1083/jcb.142.1.13; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Do Kim J, 2006, GENOME RES, V16, P901, DOI 10.1101/gr.5091406; Do Kim J, 2009, NUCLEIC ACIDS RES, V37, P5656, DOI 10.1093/nar/gkp613; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Essien K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r131; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; HARIHARAN N, 1991, P NATL ACAD SCI USA, V88, P9799, DOI 10.1073/pnas.88.21.9799; HENDRICH BD, 1993, HUM MOL GENET, V2, P663, DOI 10.1093/hmg/2.6.663; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Iuchi S, 2001, CELL MOL LIFE SCI, V58, P625, DOI 10.1007/PL00000885; Johnston CM, 1998, CELL, V94, P809, DOI 10.1016/S0092-8674(00)81739-0; Jonkers I, 2008, MOL CELL BIOL, V28, P5583, DOI 10.1128/MCB.02269-07; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Laverty C, 2010, CURR OPIN GENET DEV, V20, P171, DOI 10.1016/j.gde.2010.01.007; Lee JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003749; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; Lee JT, 1999, P NATL ACAD SCI USA, V96, P3836, DOI 10.1073/pnas.96.7.3836; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Meyer BJ, 2010, CURR OPIN GENET DEV, V20, P179, DOI 10.1016/j.gde.2010.03.008; Nesterova TB, 2001, GENOME RES, V11, P833, DOI 10.1101/gr.174901; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676; PARK K, 1991, P NATL ACAD SCI USA, V88, P9804, DOI 10.1073/pnas.88.21.9804; Park Y, 2003, MOL CELL, V11, P977, DOI 10.1016/S1097-2765(03)00147-3; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Pillet N, 1995, P NATL ACAD SCI USA, V92, P12515, DOI 10.1073/pnas.92.26.12515; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Pugacheva EM, 2005, HUM MOL GENET, V14, P953, DOI 10.1093/hmg/ddi089; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Sado T, 2001, DEVELOPMENT, V128, P1275; Sarma Kavitha, 2010, Proc Natl Acad Sci U S A, V107, P22196, DOI 10.1073/pnas.1009785107; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; SETO E, 1991, NATURE, V354, P241, DOI 10.1038/354241a0; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Stavropoulos N, 2005, MOL CELL BIOL, V25, P2757, DOI 10.1128/MCB.25.7.2757-2769.2005; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Takahashi Y, 2000, GENE DEV, V14, P804; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Wutz A, 2007, CURR OPIN GENET DEV, V17, P387, DOI 10.1016/j.gde.2007.08.001; Xu N, 2007, NAT GENET, V39, P1390, DOI 10.1038/ng.2007.5; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	70	359	391	1	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 8	2011	146	1					119	133		10.1016/j.cell.2011.06.026	http://dx.doi.org/10.1016/j.cell.2011.06.026			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729784	Green Accepted, Bronze			2022-12-01	WOS:000292539300011
J	Mazzulli, JR; Xu, YH; Sun, Y; Knight, AL; McLean, PJ; Caldwell, GA; Sidransky, E; Grabowski, GA; Krainc, D				Mazzulli, Joseph R.; Xu, You-Hai; Sun, Ying; Knight, Adam L.; McLean, Pamela J.; Caldwell, Guy A.; Sidransky, Ellen; Grabowski, Gregory A.; Krainc, Dimitri			Gaucher Disease Glucocerebrosidase and alpha-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies	CELL			English	Article							PARKINSONS-DISEASE; MOUSE MODELS; MUTATIONS; DEFICIENCY; MECHANISM; OLIGOMERS; CATECHOLS; ENZYME	Parkinson's disease (PD), an adult neurodegenerative disorder, has been clinically linked to the lysosomal storage disorder Gaucher disease (GD), but the mechanistic connection is not known. Here, we show that functional loss of GD-linked glucocerebrosidase (GCase) in primary cultures or human iPS neurons compromises lysosomal protein degradation, causes accumulation of alpha-synuclein (alpha-syn), and results in neurotoxicity through aggregation-dependent mechanisms. Glucosylceramide (GlcCer), the GCase substrate, directly influenced amyloid formation of purified alpha-syn by stabilizing soluble oligomeric intermediates. We further demonstrate that alpha-syn inhibits the lysosomal activity of normal GCase in neurons and idiopathic PD brain, suggesting that GCase depletion contributes to the pathogenesis of sporadic synucleinopathies. These findings suggest that the bidirectional effect of alpha-syn and GCase forms a positive feedback loop that may lead to a self-propagating disease. Therefore, improved targeting of GCase to lysosomes may represent a specific therapeutic approach for PD and other synucleinopathies.	[Mazzulli, Joseph R.; McLean, Pamela J.; Krainc, Dimitri] Harvard Univ, Sch Med, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis,Dept Neurol, Charlestown, MA 02129 USA; [Xu, You-Hai; Sun, Ying; Grabowski, Gregory A.] Cincinnati Childrens Hosp, Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Xu, You-Hai; Sun, Ying; Grabowski, Gregory A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA; [Knight, Adam L.; Caldwell, Guy A.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Caldwell, Guy A.] Univ Alabama Birmingham, Ctr Neurodegenerat & Expt Therapeut, Dept Neurol, Birmingham, AL 35294 USA; [Caldwell, Guy A.] Univ Alabama Birmingham, Ctr Neurodegenerat & Expt Therapeut, Dept Neurobiol, Birmingham, AL 35294 USA; [Sidransky, Ellen] NHGRI, Sect Mol Neurogenet, Med Genet Branch, NIH, Bethesda, MD 20892 USA	Harvard University; Massachusetts General Hospital; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Alabama System; University of Alabama Tuscaloosa; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Krainc, D (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis,Dept Neurol, Charlestown, MA 02129 USA.	krainc@mgh.helix.harvard.edu	Mazzulli, joseph/AAS-4480-2020	Caldwell, Guy/0000-0002-8283-9090; McLean, Pamela/0000-0003-4870-5715	National Institutes of Health [R01NS051303, F32NS066730]; National Institute of Neurological Disorders and Stroke [R01DK36729]; National Human Genome Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070168, R01NS051303, F32NS066730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Harry Ischiropoulos for pCDNA3.1 human alpha-syn plasmids and syn303 antibody, Benoit I. Giasson for the SNL-1 antibody, and Kimberly Kegel for technical advice on liposome formation. This work was supported by National Institutes of Health grants R01NS051303 (D.K.) and F32NS066730 (J.R.M.) from the National Institute of Neurological Disorders and Stroke, R01DK36729 (G.A.G.), and the Intramural Programs of the National Human Genome Research Institute and the National Institutes of Health (E.S.).	Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; BRADY RO, 1965, J BIOL CHEM, V240, P39; Bultron G, 2010, J INHERIT METAB DIS, V33, P167, DOI 10.1007/s10545-010-9055-0; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Duda JE, 2002, ANN NEUROL, V52, P205, DOI 10.1002/ana.10279; ERICKSON AH, 1985, J BIOL CHEM, V260, P4319; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Goker-Alpan O, 2004, J MED GENET, V41, P937, DOI 10.1136/jmg.2004.024455; GOKERALPAN O, 2008, LANCET, V372, P1263; Hodara R, 2004, J BIOL CHEM, V279, P47746, DOI 10.1074/jbc.M408906200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; LEE RE, 1968, P NATL ACAD SCI USA, V61, P484, DOI 10.1073/pnas.61.2.484; LILL CM, 2008, PDGENE DATABASE ALZH; Manning-Bog AB, 2009, NEUROTOXICOLOGY, V30, P1127, DOI 10.1016/j.neuro.2009.06.009; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Martinez Z, 2007, BIOCHEMISTRY-US, V46, P1868, DOI 10.1021/bi061749a; Mazzulli JR, 2007, J BIOL CHEM, V282, P31621, DOI 10.1074/jbc.M704737200; Mazzulli JR, 2006, J NEUROSCI, V26, P10068, DOI 10.1523/JNEUROSCI.0896-06.2006; Neudorfer O, 1996, QJM-MON J ASSOC PHYS, V89, P691; Neumann J, 2009, BRAIN, V132, P1783, DOI 10.1093/brain/awp044; Seibler P, 2011, J NEUROSCI, V31, P5970, DOI 10.1523/JNEUROSCI.4441-10.2011; Sidransky E, 2005, MOL GENET METAB, V84, P302, DOI 10.1016/j.ymgme.2004.11.007; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Sun Y, 2005, J LIPID RES, V46, P2102, DOI 10.1194/jlr.M500202-JLR200; Tayebi N, 2003, MOL GENET METAB, V79, P104, DOI 10.1016/S1096-7192(03)00071-4; Tayebi N, 2001, MOL GENET METAB, V73, P313, DOI 10.1006/mgme.2001.3201; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; Trojanowski JQ, 2002, NEUROTOXICOLOGY, V23, P457, DOI 10.1016/S0161-813X(02)00065-7; Tsika E, 2010, J NEUROSCI, V30, P3409, DOI 10.1523/JNEUROSCI.4977-09.2010; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Wong KD, 2004, MOL GENET METAB, V82, P192, DOI 10.1016/j.ymgme.2004.04.011; Xu YH, 2011, MOL GENET METAB, V102, P436, DOI 10.1016/j.ymgme.2010.12.014; Xu YH, 2003, AM J PATHOL, V163, P2093, DOI 10.1016/S0002-9440(10)63566-3; Zala D, 2005, NEUROBIOL DIS, V20, P785, DOI 10.1016/j.nbd.2005.05.017	38	884	913	1	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 8	2011	146	1					37	52		10.1016/j.cell.2011.06.001	http://dx.doi.org/10.1016/j.cell.2011.06.001			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21700325	Bronze, Green Accepted			2022-12-01	WOS:000292539300005
J	De Nicola, GM; Karreth, FA; Humpton, TJ; Gopinathan, A; Wei, C; Frese, K; Mangal, D; Yu, KH; Yeo, CJ; Calhoun, ES; Scrimieri, F; Winter, JM; Hruban, RH; Iacobuzio-Donahue, C; Kern, SE; Blair, IA; Tuveson, DA				De Nicola, Gina M.; Karreth, Florian A.; Humpton, Timothy J.; Gopinathan, Aarthi; Wei, Cong; Frese, Kristopher; Mangal, Dipti; Yu, Kenneth H.; Yeo, Charles J.; Calhoun, Eric S.; Scrimieri, Francesca; Winter, Jordan M.; Hruban, Ralph H.; Iacobuzio-Donahue, Christine; Kern, Scott E.; Blair, Ian A.; Tuveson, David A.			Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis	NATURE			English	Article							PANCREATIC-CANCER; HEME OXYGENASE-1; K-RAS; ACTIVATION; EXPRESSION; PATHWAY; INHIBITION; MUTATIONS; INDUCTION; ELEMENTS	Reactive oxygen species (ROS) are mutagenic and may thereby promote cancer(1). Normally, ROS levels are tightly controlled by an inducible antioxidant program that responds to cellular stressors and is predominantly regulated by the transcription factor Nrf2 (also known as Nfe212) and its repressor protein Keap1 (refs 2-5). In contrast to the acute physiological regulation of Nrf2, in neoplasia there is evidence for increased basal activation of Nrf2. Indeed, somatic mutations that disrupt the Nrf2-Keap1 interaction to stabilize Nrf2 and increase the constitutive transcription of Nrf2 target genes were recently identified, indicating that enhanced ROS detoxification and additional Nrf2 functions may in fact be pro-tumorigenic(6). Here, we investigated ROS metabolism in primary murine cells following the expression of endogenous oncogenic alleles of Kras, Braf and Myc, and found that ROS are actively suppressed by these oncogenes. K-Ras(G12D), B-Raf(V619E) and Myc(ERT2) each increased the transcription of Nrf2 to stably elevate the basal Nrf2, antioxidant program and thereby lower intracellular ROS and confer a more reduced intracellular environment. Oncogene-directed increased expression of Nrf2 is a new mechanism for the activation of the Nrf2 antioxidant program, and is evident in primary cells and tissues of mice expressing K-Ras(G12D) up and B-Raf(V619E), and in human pancreatic cancer. Furthermore, genetic targeting of the Nrf2 pathway impairs K-Ras(G12D)-induced proliferation and tumorigenesis in vivo. Thus, the Nrf2 antioxidant and cellular detoxification program represents a previously unappreciated mediator of oncogenesis.	[De Nicola, Gina M.; Karreth, Florian A.; Humpton, Timothy J.; Gopinathan, Aarthi; Frese, Kristopher; Tuveson, David A.] Cancer Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [De Nicola, Gina M.; Gopinathan, Aarthi] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Karreth, Florian A.] Univ Vienna, A-1030 Vienna, Austria; [Wei, Cong; Mangal, Dipti; Yu, Kenneth H.; Blair, Ian A.] Univ Penn, Ctr Canc Pharmacol, Philadelphia, PA 19104 USA; [Yeo, Charles J.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Surg, Philadelphia, PA 19107 USA; [Calhoun, Eric S.] Alma Coll, Dept Biol, Alma, MI 48801 USA; [Scrimieri, Francesca; Hruban, Ralph H.; Iacobuzio-Donahue, Christine; Kern, Scott E.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Oncol, Baltimore, MD 21287 USA; [Winter, Jordan M.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Surg, Baltimore, MD 21287 USA; [Hruban, Ralph H.; Iacobuzio-Donahue, Christine; Kern, Scott E.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Pathol, Baltimore, MD 21287 USA	Cancer Research UK; CRUK Cambridge Institute; University of Pennsylvania; Pennsylvania Medicine; University of Vienna; University of Pennsylvania; Pennsylvania Medicine; Jefferson University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Tuveson, DA (corresponding author), Cancer Res UK Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England.	david.tuveson@cancer.org.uk	Humpton, Timothy/AAV-5501-2020; Iacobuzio-Donahue, Christine/ABF-1295-2020	Humpton, Timothy/0000-0002-8030-9539; Iacobuzio-Donahue, Christine/0000-0002-4672-3023; DeNicola, Gina/0000-0001-6611-6696; Wei, Cong/0000-0003-2310-9255	University of Cambridge; Cancer Research UK; The Li Ka Shing Foundation; Hutchison Whampoa Limited; NIHR Cambridge Biomedical Research Centre; NIH [CA101973, CA111294, CA084291, CA105490, CA62924, CA128920, CA106610]; Abramson Cancer Center of the University of Pennsylvania [IRG 78-002-26]; Emerald Foundation; Marjorie Kovler Fund; Ruth L. Kirschstein National Research Service Award [F32CA123887-01]; NATIONAL CANCER INSTITUTE [R01CA128920, R01CA101973, U01CA105490, F32CA123887, P50CA062924, U01CA084291, K08CA106610, U01CA111294] Funding Source: NIH RePORTER	University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK); The Li Ka Shing Foundation; Hutchison Whampoa Limited; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abramson Cancer Center of the University of Pennsylvania; Emerald Foundation; Marjorie Kovler Fund; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Johnson for providing the Nrf2<SUP>-/-</SUP> mice; G. Evan, O. Sansom, C. Murtaugh, J.-J. Ventura and E. Wagner for MEFs; E Schmidt for Nrf2 antiserum; E. Jaffee,A. Maitra and A. Hors for human PDAcell lines; B. Haynes, S. Davies and N. Cook for human PDA tissue samples; C. Ross-Innes, K Holmes and J. Carroll for advice with the ChIP assay; and the ENCODE Consortium for ChIP-seq studies. We thank F. Connor, C. Martins arid other members of the Tuveson lab for assistance arid advice, and the animal carestaff and histology core at CRI. This research was supported by the University of Cambridge and Cancer Research UK, The Li Ka Shing Foundation and Hutchison Whampoa Limited, the NIHR Cambridge Biomedical Research Centre, arid the NIH (grants CA101973, CA111294, CA084291 and CA105490 to D.A.T.: CA62924 and CA128920 to S.E.K. and C.I.-D.; and CA106610 to C.I.-D.). Additional support was obtained from the Abramson Cancer Center of the University of Pennsylvania Pilot Grant IRG 78-002-26 (D.A.T.), Emerald Foundation (E.S.C.), the Marjorie Kovler Fund (S.E.K) and the Ruth L. Kirschstein National Research Service Award F32CA123887-01 (K.F) We regret that many primary references have been omitted due to space limitations.	Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cakir Y, 2005, ANTIOXID REDOX SIGN, V7, P726, DOI 10.1089/ars.2005.7.726; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; HAHN SA, 1995, CANCER RES, V55, P4670; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; He XQ, 2006, J BIOL CHEM, V281, P23620, DOI 10.1074/jbc.M604120200; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Karreth FA, 2009, MOL CELL, V36, P477, DOI 10.1016/j.molcel.2009.10.017; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Keum YS, 2006, CANCER RES, V66, P8804, DOI 10.1158/0008-5472.CAN-05-3513; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Park JH, 2008, P NATL ACAD SCI USA, V105, P6846, DOI 10.1073/pnas.0802776105; Rasband W.S., 1997, IMAGEJ; Recktenwald CV, 2008, CANCER RES, V68, P10086, DOI 10.1158/0008-5472.CAN-08-0360; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Sun CL, 2001, ONCOL REP, V8, P89; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Suvorova ES, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006158; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Zhu PJ, 2008, RAPID COMMUN MASS SP, V22, P432, DOI 10.1002/rcm.3380	31	1429	1477	13	328	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					106	U128		10.1038/nature10189	http://dx.doi.org/10.1038/nature10189			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21734707	Green Accepted, Green Submitted			2022-12-01	WOS:000292461300054
J	Shattock, RJ; Warren, M; McCormack, S; Hankins, CA				Shattock, Robin J.; Warren, Mitchell; McCormack, Sheena; Hankins, Catherine A.			Turning the Tide Against HIV	SCIENCE			English	Editorial Material							TRANSMISSION; PREVENTION		[Shattock, Robin J.; McCormack, Sheena] Univ London Imperial Coll Sci Technol & Med, London W2 1PG, England; [Warren, Mitchell] AVAC Global Advocacy HIV Prevent, New York, NY 10027 USA; [McCormack, Sheena] MRC, Clin Trials Unit, London NW1 2DA, England; [Hankins, Catherine A.] Joint United Nations Programme HIV AIDS, Programme Branch, Off Deputy Execut Director, CH-1211 Geneva, Switzerland	Imperial College London; Medical Research Council Clinical Trials Unit	Shattock, RJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, London W2 1PG, England.	r.shattock@imperial.ac.uk		Hankins, Catherine/0000-0002-1642-8592	MRC [MC_U122861322] Funding Source: UKRI; Medical Research Council [MC_U122861322] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Cranage M, 2008, PLOS MED, V5, P1238, DOI 10.1371/journal.pmed.0050157; Excler JL, 2011, AIDS RES HUM RETROV, V27, P669, DOI [10.1089/aid.2010.0206, 10.1089/AID.2010.0206]; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hankins CA, 2010, AIDS, V24, pS70, DOI 10.1097/01.aids.0000390709.04255.fd; Hecht R, 2010, LANCET, V376, P1254, DOI 10.1016/S0140-6736(10)61255-X; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Keele BF, 2011, BLOOD, V118, P839, DOI 10.1182/blood-2010-12-325860; Kersh EN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019295; Matthews LT, 2010, AIDS, V24, P1975, DOI 10.1097/QAD.0b013e32833bedeb; Patterson K. P. H., 2010, 18 INT AIDS C VIENN, P18; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Roehr B., 2011, BRIT MED J, V342, pd2613; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; UNAIDS, 2011, AIDS 30 NAT CROSSR; van't Klooster G, 2008, 15 C RETR OPP INF CR; Whaley KJ, 2010, ANTIVIR RES, V88, pS55, DOI 10.1016/j.antiviral.2010.09.006	17	63	63	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 1	2011	333	6038					42	43		10.1126/science.1206399	http://dx.doi.org/10.1126/science.1206399			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	785UF	21719662				2022-12-01	WOS:000292255400037
J	Sanderson, K				Sanderson, Katharine			A chewy problem	NATURE			English	Editorial Material																		Binder JB, 2009, J AM CHEM SOC, V131, P1979, DOI 10.1021/ja808537j; Sergeev AG, 2011, SCIENCE, V332, P439, DOI 10.1126/science.1200437; Zhong SH, 2010, ENERG FUEL, V24, P2891, DOI 10.1021/ef901575a	3	250	265	4	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S12	S14		10.1038/474S012a	http://dx.doi.org/10.1038/474S012a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697834				2022-12-01	WOS:000291939700004
J	Mayrose, I; Zhan, SH; Rothfels, CJ; Magnuson-Ford, K; Barker, MS; Rieseberg, LH; Otto, SP				Mayrose, Itay; Zhan, Shing H.; Rothfels, Carl J.; Magnuson-Ford, Karen; Barker, Michael S.; Rieseberg, Loren H.; Otto, Sarah P.			Recently Formed Polyploid Plants Diversify at Lower Rates	SCIENCE			English	Article							SPECIATION		[Mayrose, Itay; Zhan, Shing H.; Magnuson-Ford, Karen; Rieseberg, Loren H.; Otto, Sarah P.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; [Rothfels, Carl J.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Barker, Michael S.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Rieseberg, Loren H.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	University of British Columbia; Duke University; University of Arizona; Indiana University System; Indiana University Bloomington	Mayrose, I (corresponding author), Tel Aviv Univ, Fac Life Sci, Dept Mol Biol & Ecol Plants, IL-69978 Tel Aviv, Israel.	itaymay@post.tau.ac.il	Barker, Mike/AAE-7891-2019; Otto, Sarah Perin/K-5625-2012; Rieseberg, Loren H/B-3591-2013	Barker, Mike/0000-0001-7173-1319; Otto, Sarah Perin/0000-0003-3042-0818; Rieseberg, Loren H/0000-0002-2712-2417; Zhan, Shing/0000-0002-6351-8873; Rothfels, Carl/0000-0002-6605-1770	Natural Sciences and Engineering Research Council	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank R. FitzJohn for instrumental help in using diversitree. Funded by Natural Sciences and Engineering Research Council Discovery grants to L. H. R. and S.P.O. Data have been deposited at Dryad (10.5061/dryad.6hf21).	Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Maddison WP, 2007, SYST BIOL, V56, P701, DOI 10.1080/10635150701607033; Mayrose I, 2010, SYST BIOL, V59, P132, DOI 10.1093/sysbio/syp083; STEBBINS G. L., 1971, Chromosomal evolution in higher plants.; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106	5	302	314	3	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2011	333	6047					1257	1257		10.1126/science.1207205	http://dx.doi.org/10.1126/science.1207205			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21852456				2022-12-01	WOS:000294406400044
J	Mariappan, M; Mateja, A; Dobosz, M; Bove, E; Hegde, RS; Keenan, RJ				Mariappan, Malaiyalam; Mateja, Agnieszka; Dobosz, Malgorzata; Bove, Elia; Hegde, Ramanujan S.; Keenan, Robert J.			The mechanism of membrane-associated steps in tail-anchored protein insertion	NATURE			English	Article							ENDOPLASMIC-RETICULUM; TRANSLOCATION; YEAST; COMPLEX; BINDING; MODEL; GET3	Tail-anchored (TA) membrane proteins destined for the endoplasmic reticulum are chaperoned by cytosolic targeting factors that deliver them to a membrane receptor for insertion. Although a basic framework for TA protein recognition is now emerging, the decisive targeting and membrane insertion steps are not understood. Here we reconstitute the TA protein insertion cycle with purified components, present crystal structures of key complexes between these components and perform mutational analyses based on the structures. We show that a committed targeting complex, formed by a TA protein bound to the chaperone ATPase Get3, is initially recruited to the membrane through an interaction with Get2. Once the targeting complex has been recruited, Get1 interacts with Get3 to drive TA protein release in an ATPase-dependent reaction. After releasing its TA protein cargo, the now-vacant Get3 recycles back to the cytosol concomitant with ATP binding. This work provides a detailed structural and mechanistic framework for the minimal TA protein insertion cycle.	[Mateja, Agnieszka; Dobosz, Malgorzata; Bove, Elia; Keenan, Robert J.] Univ Chicago, Dept Biochem & Mol Biol, Gordon Ctr Integrat Sci, Chicago, IL 60637 USA; [Mariappan, Malaiyalam; Hegde, Ramanujan S.] NICHHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA	University of Chicago; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Keenan, RJ (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, Gordon Ctr Integrat Sci, Room W238,929 E 57th St, Chicago, IL 60637 USA.	hegde.science@gmail.com; bkeenan@uchicago.edu	mariappan, malaiyalam/K-9024-2012	Dobosz-Bartoszek, Malgorzata/0000-0001-7773-596X; Keenan, Robert/0000-0003-1466-0889; Hegde, Ramanujan/0000-0001-8338-852X	US DOE [DE-AC02-06CH11357]; NIH [R01 GM086487]; Camille and Henry Dreyfus Postdoctoral Program in Environmental Chemistry; Edward Mallinckrodt, Jr. Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD008862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086487] Funding Source: NIH RePORTER	US DOE(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Camille and Henry Dreyfus Postdoctoral Program in Environmental Chemistry; Edward Mallinckrodt, Jr. Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Data were collected at beamline 21-IDG at the Advanced Photon Source (APS), Argonne National Laboratory, and we thank the beamline staff for support. We thank T. Dever for yeast strains, T. Rapoport for the Sec61 alpha antibody, M. Downing for technical assistance, members of the Hegde, Keenan and E. Perozo labs and D. Freymann for advice, and A. Shiau and S. Shao for discussions and comments on the manuscript. Use of the APS, an Office of Science User Facility operated for the US Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the US DOE under contract no. DE-AC02-06CH11357. This work was supported by the Intramural Research Program of the NIH (to R.S.H.), the Camille and Henry Dreyfus Postdoctoral Program in Environmental Chemistry (to R.J.K. and E.B.), an Edward Mallinckrodt, Jr. Foundation Grant (to R.J.K.) and NIH Grant R01 GM086487 (to R.J.K.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Auld KL, 2006, GENETICS, V174, P215, DOI 10.1534/genetics.106.058362; Beilharz T, 2003, J BIOL CHEM, V278, P8219, DOI 10.1074/jbc.M212725200; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; Borgese N, 2010, TRAFFIC, V11, P877, DOI 10.1111/j.1600-0854.2010.01068.x; Bozkurt G, 2009, P NATL ACAD SCI USA, V106, P21131, DOI 10.1073/pnas.0910223106; Brambillasca S, 2005, EMBO J, V24, P2533, DOI 10.1038/sj.emboj.7600730; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; Chang YW, 2010, J BIOL CHEM, V285, P9962, DOI 10.1074/jbc.M109.087098; Chartron JW, 2010, P NATL ACAD SCI USA, V107, P12127, DOI 10.1073/pnas.1006036107; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; DeLano W.L., 2002, PYMOL MOL VIEWER; DESHAIES RJ, 1989, J CELL BIOL, V109, P2653, DOI 10.1083/jcb.109.6.2653; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Favaloro V, 2010, J CELL SCI, V123, P1522, DOI 10.1242/jcs.055970; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; HANSEN W, 1986, CELL, V45, P397, DOI 10.1016/0092-8674(86)90325-9; Hu JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008061; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kalbfleisch T, 2007, TRAFFIC, V8, P1687, DOI 10.1111/j.1600-0854.2007.00661.x; Kriechbaumer V, 2009, TRAFFIC, V10, P1753, DOI 10.1111/j.1600-0854.2009.00991.x; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Renthal R, 2010, CELL MOL LIFE SCI, V67, P1077, DOI 10.1007/s00018-009-0234-9; ROTHBLATT JA, 1986, CELL, V44, P619, DOI 10.1016/0092-8674(86)90271-0; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Sharma A, 2010, METHODS MOL BIOL, V619, P339, DOI 10.1007/978-1-60327-412-8_20; Sherrill J, 2011, TRAFFIC, V12, P1119, DOI 10.1111/j.1600-0854.2011.01229.x; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Suloway CJM, 2009, P NATL ACAD SCI USA, V106, P14849, DOI 10.1073/pnas.0907522106; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038; Yamagata A, 2010, GENES CELLS, V15, P29, DOI 10.1111/j.1365-2443.2009.01362.x	39	110	111	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2011	477	7362					61	U69		10.1038/nature10362	http://dx.doi.org/10.1038/nature10362			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813XT	21866104	Green Accepted			2022-12-01	WOS:000294404300030
J	Stransky, N; Egloff, AM; Tward, AD; Kostic, AD; Cibulskis, K; Sivachenko, A; Kryukov, GV; Lawrence, MS; Sougnez, C; McKenna, A; Shefler, E; Ramos, AH; Stojanov, P; Carter, SL; Voet, D; Cortes, ML; Auclair, D; Berger, MF; Saksena, G; Guiducci, C; Onofrio, RC; Parkin, M; Romkes, M; Weissfeld, JL; Seethala, RR; Wang, L; Rangel-Escareno, C; Fernandez-Lopez, JC; Hidalgo-Miranda, A; Melendez-Zajgla, J; Winckler, W; Ardlie, K; Gabriel, SB; Meyerson, M; Lander, ES; Getz, G; Golub, TR; Garraway, LA; Grandis, JR				Stransky, Nicolas; Egloff, Ann Marie; Tward, Aaron D.; Kostic, Aleksandar D.; Cibulskis, Kristian; Sivachenko, Andrey; Kryukov, Gregory V.; Lawrence, Michael S.; Sougnez, Carrie; McKenna, Aaron; Shefler, Erica; Ramos, Alex H.; Stojanov, Petar; Carter, Scott L.; Voet, Douglas; Cortes, Maria L.; Auclair, Daniel; Berger, Michael F.; Saksena, Gordon; Guiducci, Candace; Onofrio, Robert C.; Parkin, Melissa; Romkes, Marjorie; Weissfeld, Joel L.; Seethala, Raja R.; Wang, Lin; Rangel-Escareno, Claudia; Carlos Fernandez-Lopez, Juan; Hidalgo-Miranda, Alfredo; Melendez-Zajgla, Jorge; Winckler, Wendy; Ardlie, Kristin; Gabriel, Stacey B.; Meyerson, Matthew; Lander, Eric S.; Getz, Gad; Golub, Todd R.; Garraway, Levi A.; Grandis, Jennifer R.			The Mutational Landscape of Head and Neck Squamous Cell Carcinoma	SCIENCE			English	Article							TUMOR-SUPPRESSOR; STEM-CELLS; E-CADHERIN; CANCER; NOTCH; SKIN; DIFFERENTIATION; GENOME; KERATINOCYTES; INACTIVATION	Head and neck squamous cell carcinoma (HNSCC) is a common, morbid, and frequently lethal malignancy. To uncover its mutational spectrum, we analyzed whole-exome sequencing data from 74 tumor-normal pairs. The majority exhibited a mutational profile consistent with tobacco exposure; human papillomavirus was detectable by sequencing DNA from infected tumors. In addition to identifying previously known HNSCC genes (TP53, CDKN2A, PTEN, PIK3CA, and HRAS), our analysis revealed many genes not previously implicated in this malignancy. At least 30% of cases harbored mutations in genes that regulate squamous differentiation (for example, NOTCH1, IRF6, and TP63), implicating its dysregulation as a major driver of HNSCC carcinogenesis. More generally, the results indicate the ability of large-scale sequencing to reveal fundamental tumorigenic mechanisms.	[Stransky, Nicolas; Tward, Aaron D.; Kostic, Aleksandar D.; Cibulskis, Kristian; Sivachenko, Andrey; Kryukov, Gregory V.; Lawrence, Michael S.; Sougnez, Carrie; McKenna, Aaron; Shefler, Erica; Ramos, Alex H.; Stojanov, Petar; Carter, Scott L.; Voet, Douglas; Cortes, Maria L.; Auclair, Daniel; Berger, Michael F.; Saksena, Gordon; Guiducci, Candace; Onofrio, Robert C.; Parkin, Melissa; Winckler, Wendy; Ardlie, Kristin; Gabriel, Stacey B.; Meyerson, Matthew; Lander, Eric S.; Getz, Gad; Golub, Todd R.; Garraway, Levi A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Egloff, Ann Marie; Grandis, Jennifer R.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15213 USA; [Egloff, Ann Marie; Seethala, Raja R.; Wang, Lin; Grandis, Jennifer R.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA; [Tward, Aaron D.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02114 USA; [Tward, Aaron D.] Massachusetts Eye & Ear Infirm, Dept Otolaryngol, Boston, MA 02114 USA; [Kostic, Aleksandar D.; Kryukov, Gregory V.; Meyerson, Matthew; Lander, Eric S.; Golub, Todd R.; Garraway, Levi A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Romkes, Marjorie] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA; [Romkes, Marjorie] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15261 USA; [Weissfeld, Joel L.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15232 USA; [Weissfeld, Joel L.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15232 USA; [Seethala, Raja R.; Wang, Lin] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; [Rangel-Escareno, Claudia; Carlos Fernandez-Lopez, Juan; Hidalgo-Miranda, Alfredo; Melendez-Zajgla, Jorge] Inst Nacl Med Genom, Mexico City 01900, DF, Mexico; [Meyerson, Matthew; Garraway, Levi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Meyerson, Matthew; Golub, Todd R.; Garraway, Levi A.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Lander, Eric S.] MIT, Cambridge, MA 02142 USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Grandis, Jennifer R.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Instituto Nacional de Medicina Genomica; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Garraway, LA (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	levi_garraway@dfci.harvard.edu; grandisjr@upmc.edu	Cibulskis, Kristian/AAC-7380-2019; Melendez-Zajgla, Jorge/A-5708-2008; Lawrence, Michael/AAC-8202-2020; Hidalgo-Miranda, Alfredo/B-2123-2010; Rangel-Escareno, Claudia/F-4587-2012; Meyerson, Matthew L/E-7123-2012; Fernandez, Juan Carlos/C-4976-2013; Stojanov, Petar/GQI-4462-2022; Kryukov, Gregory V/A-9592-2008	Hidalgo-Miranda, Alfredo/0000-0003-2315-3977; Rangel-Escareno, Claudia/0000-0003-1303-0834; Fernandez, Juan Carlos/0000-0003-3680-4193; Stojanov, Petar/0000-0001-7815-776X; Kostic, Aleksandar/0000-0002-0837-4360; Cibulskis, Kristian/0000-0003-1343-1582; Meyerson, Matthew/0000-0002-9133-8108; Kryukov, Gregory/0000-0002-6131-9483	Carlos Slim Health Institute; International Cancer Genome Consortium; National Human Genome Research Institute; National Cancer Institute; Starr Cancer Consortium; Novartis Institutes for BioMedical Research; Howard Hughes Medical Institute; American Cancer Society; NIH; NATIONAL CANCER INSTITUTE [P50CA097190, R01CA077308, R01CA098372] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	Carlos Slim Health Institute; International Cancer Genome Consortium; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Starr Cancer Consortium; Novartis Institutes for BioMedical Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the Broad Institute Sequencing Platform for the generation of sequencing data, the staff of the Biological Samples Platform and the Genetic Analysis Platform at the Broad Institute, and J. Aster for helpful discussions. This work was conducted as part of the Slim Initiative for Genomic Medicine, a joint U.S.-Mexico project funded by the Carlos Slim Health Institute, and is part of a global effort in collaboration with the International Cancer Genome Consortium. The work was also supported by grants from the National Human Genome Research Institute (S.B.G., E.S.L.), the National Cancer Institute (M.M., S.B.G., L.A.G., J.R.G., A.M.E.), the Starr Cancer Consortium (L.A.G.), the Novartis Institutes for BioMedical Research (N.S.), the Howard Hughes Medical Institute (T.R.G.), the American Cancer Society (J.R.G.), and the NIH Director's New Innovator Award (L.A.G.). L.A.G. and M.M. are paid consultants for and equity holders in Foundation Medicine, a genomics-based oncology diagnostics company, and are also paid consultants for Novartis. M.F.B. is a paid consultant for Foundation Medicine. E.S.L. is an equity holder in Foundation Medicine. The compressed binary Sequence Alignment/Map files (BAM) and SNP array data are available in dbGaP under accession no. phs000370.v1.p1.	Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chidgey M, 2001, J CELL BIOL, V155, P821, DOI 10.1083/jcb.200105009; Dumortier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009258; Extance A, 2010, NAT REV DRUG DISCOV, V9, P749, DOI 10.1038/nrd3288; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fujimoto K, 2002, J BIOL CHEM, V277, P50497, DOI 10.1074/jbc.M210146200; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Gupta S, 2009, INT J CANCER, V125, P2159, DOI 10.1002/ijc.24533; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Koch U, 2010, CURR TOP DEV BIOL, V92, P411, DOI 10.1016/S0070-2153(10)92013-9; Kostic AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/nbt.1868; Kovall RA, 2010, CURR TOP DEV BIOL, V92, P31, DOI 10.1016/S0070-2153(10)92002-4; Lee SY, 2009, CANCER SCI, V100, P920, DOI 10.1111/j.1349-7006.2009.01130.x; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Luke Y, 2008, J CELL SCI, V121, P1887, DOI 10.1242/jcs.019075; Moretti F, 2010, J CLIN INVEST, V120, P1570, DOI 10.1172/JCI40267; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Okuyama R, 2007, ONCOGENE, V26, P4478, DOI 10.1038/sj.onc.1210235; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Sok JC, 2006, CLIN CANCER RES, V12, P5064, DOI 10.1158/1078-0432.CCR-06-0913; Su XH, 2009, EMBO J, V28, P1904, DOI 10.1038/emboj.2009.151; Tinkle CL, 2004, P NATL ACAD SCI USA, V101, P552, DOI 10.1073/pnas.0307437100; Tu CL, 2008, J BIOL CHEM, V283, P3519, DOI 10.1074/jbc.M708318200; Westra WH, 2008, CLIN CANCER RES, V14, P366, DOI 10.1158/1078-0432.CCR-07-1402; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Yugawa T, 2010, CANCER RES, V70, P4034, DOI 10.1158/0008-5472.CAN-09-4063	33	1761	1788	3	194	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 26	2011	333	6046					1157	1160		10.1126/science.1208130	http://dx.doi.org/10.1126/science.1208130			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21798893	Green Accepted, Green Submitted			2022-12-01	WOS:000294244300052
J	Fairchild, AL; Bayer, R				Fairchild, Amy L.; Bayer, Ronald			HIV Surveillance, Public Health, and Clinical Medicine - Will the Walls Come Tumbling Down?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE		[Fairchild, Amy L.; Bayer, Ronald] Columbia Univ, Mailman Sch Publ Hlth, Ctr Hist & Eth Publ Hlth, Dept Sociomed Sci, New York, NY 10027 USA	Columbia University	Fairchild, AL (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Ctr Hist & Eth Publ Hlth, Dept Sociomed Sci, New York, NY 10027 USA.		Fairchild, Amy/F-1811-2018	Fairchild, Amy/0000-0002-1292-7212				COLE J, 2010, 2010 RYAN WHIT GRANT; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Torian LV, 2011, AIDS PATIENT CARE ST, V25, P79, DOI 10.1089/apc.2010.0151; Torian LV, 2011, MEASURING NAS OUTCOM; 2010, HRSA CAREACTION  FEB, P4	5	25	25	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2011	365	8					685	687		10.1056/NEJMp1107294	http://dx.doi.org/10.1056/NEJMp1107294			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	811JM	21864165	Bronze			2022-12-01	WOS:000294205300003
J	Hayashi, K; Ohta, H; Kurimoto, K; Aramaki, S; Saitou, M				Hayashi, Katsuhiko; Ohta, Hiroshi; Kurimoto, Kazuki; Aramaki, Shinya; Saitou, Mitinori			Reconstitution of the Mouse Germ Cell Specification Pathway in Culture by Pluripotent Stem Cells	CELL			English	Article							GROUND-STATE; MICE; GENERATION; EPIBLAST; LINEAGE; EMBRYOS; TRANSPLANTATION; ESTABLISHMENT; BLIMP1; TESTIS	The generation of properly functioning gametes in vitro requires reconstitution of the multistepped pathway of germ cell development. We demonstrate here the generation of primordial germ cell-like cells (PGCLCs) in mice with robust capacity for spermatogenesis. PGCLCs were generated from embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) through epiblast-like cells (EpiLCs), a cellular state highly similar to pregastrulating epiblasts but distinct from epiblast stem cells (EpiSCs). Reflecting epiblast development, EpiLC induction from ESCs/iPSCs is a progressive process, and EpiLCs highly competent for the PGC fate are a transient entity. The global transcription profiles, epigenetic reprogramming, and cellular dynamics during PGCLC induction from EpiLCs meticulously capture those associated with PGC specification from the epiblasts. Furthermore, we identify Integrin-beta 3 and SSEA1 as markers that allow the isolation of PGCLCs with spermatogenic capacity from tumorigenic undifferentiated cells. Our findings provide a paradigm for the first step of in vitro gametogenesis.	[Hayashi, Katsuhiko; Ohta, Hiroshi; Kurimoto, Kazuki; Aramaki, Shinya; Saitou, Mitinori] Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Saitou, Mitinori] Kyoto Univ, Inst Integrated Cell Mat Sci, Sakyo Ku, Kyoto 6068501, Japan; [Hayashi, Katsuhiko; Ohta, Hiroshi; Kurimoto, Kazuki; Saitou, Mitinori] CREST, JST, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST)	Saitou, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	saitou@anat2.med.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; JST-CREST; Takeda Science Foundation; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [19061001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST-CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J. Nichols for her advice on the ground state ESC culture. We are grateful to K. Okita and S. Yamanaka for the information on germline transmission of the three iPSC lines. We also thank K. Kabashima, H. Tanizaki, K. Takakura, S. Chuma, and N. Nakatsuji for their support with the FACS analysis; A. Fukunaga for her help with bisulfate sequence analysis; and Y. Toda for his help with the histology. S. A. is a JSPS research fellow. This study was supported, in part, by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; by JST-CREST; by the Takeda Science Foundation; and by the Uehara Memorial Foundation.	Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Chuma S, 2005, DEVELOPMENT, V132, P117, DOI 10.1242/dev.01555; Daley GQ, 2007, SCIENCE, V316, P409, DOI 10.1126/science.1138772; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hayashi K, 2009, DEVELOPMENT, V136, P3549, DOI 10.1242/dev.037747; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Lee J, 2002, DEVELOPMENT, V129, P1807; MINTZ B, 1957, J EXP ZOOL, V134, P207, DOI 10.1002/jez.1401340202; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Nayernia K, 2006, DEV CELL, V11, P125, DOI 10.1016/j.devcel.2006.05.010; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Ohinata Y, 2008, REPRODUCTION, V136, P503, DOI 10.1530/REP-08-0053; Ohinata Y, 2009, CELL, V137, P571, DOI 10.1016/j.cell.2009.03.014; Ohta H, 2000, DEV GROWTH DIFFER, V42, P105; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; Rathjen J, 1999, J CELL SCI, V112, P601; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Saitou M, 2010, REPRODUCTION, V139, P931, DOI 10.1530/REP-10-0043; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	41	822	880	6	152	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 19	2011	146	4					519	532		10.1016/j.cell.2011.06.052	http://dx.doi.org/10.1016/j.cell.2011.06.052			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21820164	Bronze			2022-12-01	WOS:000294043600008
J	Yi, CH; Pan, HL; Seebacher, J; Jang, IH; Hyberts, SG; Heffron, GJ; Vander Heiden, MG; Yang, RL; Li, FP; Locasale, JW; Sharfi, H; Zhai, B; Rodriguez-Mias, R; Luithardt, H; Cantley, LC; Daley, GQ; Asara, JM; Gygi, SP; Wagner, G; Liu, CF; Yuan, JY				Yi, Caroline H.; Pan, Heling; Seebacher, Jan; Jang, Il-Ho; Hyberts, Sven G.; Heffron, Gregory J.; Vander Heiden, Matthew G.; Yang, Renliang; Li, Fupeng; Locasale, Jason W.; Sharfi, Hadar; Zhai, Bo; Rodriguez-Mias, Ricard; Luithardt, Harry; Cantley, Lewis C.; Daley, George Q.; Asara, John M.; Gygi, Steven P.; Wagner, Gerhard; Liu, Chuan-Fa; Yuan, Junying			Metabolic Regulation of Protein N-Alpha-Acetylation by Bcl-xL Promotes Cell Survival	CELL			English	Article							BCL-X(L) PREVENTS; APOPTOSIS; DEATH; CYCLE; (-)-HYDROXYCITRATE; ACCUMULATION; SUBTILISIN; CLONING; SWITCH; YEAST	Previous experiments suggest a connection between the N-alpha-acetylation of proteins and sensitivity of cells to apoptotic signals. Here, we describe a biochemical assay to detect the acetylation status of proteins and demonstrate that protein N-alpha-acetylation is regulated by the availability of acetylCoA. Because the antiapoptotic protein Bcl-xL is known to influence mitochondrial metabolism, we reasoned that Bcl-xL may provide a link between protein N-alpha-acetylation and apoptosis. Indeed, Bcl-xL overexpression leads to a reduction in levels of acetyl-CoA and N-alpha-acetylated proteins in the cell. This effect is independent of Bax and Bak, the known binding partners of Bcl-xL. Increasing cellular levels of acetyl-CoA by addition of acetate or citrate restores protein N-alpha-acetylation in Bcl-xL-expressing cells and confers sensitivity to apoptotic stimuli. We propose that acetyl-CoA serves as a signaling molecule that couples apoptotic sensitivity to metabolism by regulating protein N-alpha-acetylation.	[Yi, Caroline H.; Pan, Heling; Seebacher, Jan; Zhai, Bo; Gygi, Steven P.; Yuan, Junying] Beth Israel Deaconess Med Ctr, Dept Cell Biol, Boston, MA 02115 USA; [Hyberts, Sven G.; Heffron, Gregory J.; Rodriguez-Mias, Ricard; Wagner, Gerhard] Beth Israel Deaconess Med Ctr, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Vander Heiden, Matthew G.; Locasale, Jason W.; Sharfi, Hadar; Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Dept Syst Biol, Boston, MA 02115 USA; [Jang, Il-Ho; Daley, George Q.] Beth Israel Deaconess Med Ctr, Childrens Hosp Boston, Boston, MA 02115 USA; [Cantley, Lewis C.; Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Cantley, Lewis C.; Asara, John M.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Vander Heiden, Matthew G.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Vander Heiden, Matthew G.] MIT, Koch Inst, Cambridge, MA 02142 USA; [Yang, Renliang; Li, Fupeng; Liu, Chuan-Fa] Nanyang Technol Univ, Sch Biol Sci, Div Chem Biol & Biotechnol, Singapore 637551, Singapore; [Luithardt, Harry] Solut Labs, Cambridge, MA 02139 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Yuan, JY (corresponding author), Beth Israel Deaconess Med Ctr, Dept Cell Biol, Boston, MA 02115 USA.	jyuan@hms.harvard.edu	Cantley, Lewis C/D-1800-2014; Liu, Chuan Fa/A-2190-2011; Locasale, Jason W/ABE-6505-2020	Cantley, Lewis C/0000-0002-1298-7653; Liu, Chuan Fa/0000-0001-7433-2081; Locasale, Jason W/0000-0002-7766-3502; Jang, Il Ho/0000-0002-0820-3035	U.S. Army [DAMD17-02-1-0403]; National Institute of Aging [R37-012859]; National Institutes of Health (NIH) [DK070299, GM47467, 5P01CA120964-03]; National Institute of Neurological Disorders and Stroke [1F31NS057872-01]; NATIONAL CANCER INSTITUTE [P01CA120964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070299, R21DK070299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS057872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG012859] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000580] Funding Source: NIH RePORTER	U.S. Army(United States Department of DefenseUnited States Army); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are indebted to Alfred Goldberg, Tom Rapoport, Andrew Steele, Marta Lipinski, and Benedicte Py for critical reading of the manuscript, to Pere Puigserver, Harvey Lodish, Kristin White, and Danny Chou for helpful discussions, and to Xuemei Yang for help in acquiring mass spectrometry metabolomics data. We thank Thomas Arnesen and Johan Lillehaug (University of Bergen) for anti-NATH and for help in designing caspase-2 N-alpha-acetylation mutants. We also thank Tullia Lindsten and Craig Thompson (University of Pennsylvania) for providing anti-Bcl-xL as well as Bcl-xL<SUP>+/+</SUP> and Bcl-xL<SUP>-/-</SUP> MEFs. VSV-RAIDD and Bcl-xL mutant constructs were generously provided by Jurg Tschopp (University of Lausanne) and Emily Cheng (Washington University), respectively. This work was supported in part by an Innovator's Award from the U.S. Army Breast Cancer Research Program (grant DAMD17-02-1-0403), a grant from the National Institute of Aging (R37-012859) and a National Institutes of Health (NIH) Director's Pioneer Award to J.Y., NIH grants (DK070299 and GM47467) to G. W., a NIH grant (5P01CA120964-03) to J.M.A., and a Kirchstein National Research Service Award from the National Institute of Neurological Disorders and Stroke (grant 1F31NS057872-01) to C.H.Y.	ABRAHMSEN L, 1991, BIOCHEMISTRY-US, V30, P4151, DOI 10.1021/bi00231a007; Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Ametzazurra A, 2008, ONCOGENE, V27, P7296, DOI 10.1038/onc.2008.332; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Arnesen T, 2008, CURR CANCER DRUG TAR, V8, P545, DOI 10.2174/156800908786241113; Bajad SU, 2006, J CHROMATOGR A, V1125, P76, DOI 10.1016/j.chroma.2006.05.019; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Gnoni GV, 2009, IUBMB LIFE, V61, P987, DOI 10.1002/iub.249; Goetze S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000236; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; Hsu JL, 2003, ANAL CHEM, V75, P6843, DOI 10.1021/ac0348625; KAPLAN RS, 1993, J BIOL CHEM, V268, P13682; Khidekel N, 2007, NAT CHEM BIOL, V3, P339, DOI 10.1038/nchembio881; Lu W, 2008, J CHROMATOGR B, V871, P236, DOI 10.1016/j.jchromb.2008.04.031; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; MARTIN H, 1993, FEBS LETT, V331, P296, DOI 10.1016/0014-5793(93)80356-Y; Martinez A, 2008, PROTEOMICS, V8, P2809, DOI 10.1002/pmic.200701191; Morrish F, 2009, ONCOGENE, V28, P2485, DOI 10.1038/onc.2009.112; Nutt LK, 2009, DEV CELL, V16, P856, DOI 10.1016/j.devcel.2009.04.005; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Polevoda B, 2003, BIOCHEM BIOPH RES CO, V308, P1, DOI 10.1016/S0006-291X(03)01316-0; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Starheim KK, 2008, BIOCHEM J, V415, P325, DOI 10.1042/BJ20080658; Starheim Kristian K, 2009, BMC Proc, V3 Suppl 6, pS3, DOI 10.1186/1753-6561-3-S6-S3; SULLIVAN AC, 1974, LIPIDS, V9, P129, DOI 10.1007/BF02532137; SULLIVAN AC, 1974, LIPIDS, V9, P121, DOI 10.1007/BF02532136; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Tan XH, 2007, CHEMBIOCHEM, V8, P1512, DOI 10.1002/cbic.200700284; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Vander Heiden MG, 1999, MOL CELL, V3, P159; Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; WELLS JA, 1983, NUCLEIC ACIDS RES, V11, P7911, DOI 10.1093/nar/11.22.7911; WHITEWAY M, 1985, CELL, V43, P483, DOI 10.1016/0092-8674(85)90178-3; Yi CH, 2007, J CELL BIOL, V179, P619, DOI 10.1083/jcb.200708090; Yoshihara HAI, 2008, BIOORG MED CHEM LETT, V18, P6000, DOI 10.1016/j.bmcl.2008.08.044	43	142	145	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 19	2011	146	4					607	620		10.1016/j.cell.2011.06.050	http://dx.doi.org/10.1016/j.cell.2011.06.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21854985	Bronze, Green Published, Green Accepted			2022-12-01	WOS:000294043600015
J	Lallemant, M; Chang, S; Cohen, R; Pecoul, B				Lallemant, Marc; Chang, Shing; Cohen, Rachel; Pecoul, Bernard			GLOBAL HEALTH Pediatric HIV - A Neglected Disease?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lallemant, Marc; Chang, Shing; Pecoul, Bernard] Drugs Neglected Dis initiat, Geneva, Switzerland; [Cohen, Rachel] Drugs Neglected Dis initiat, New York, NY USA; [Lallemant, Marc] Inst Rech Dev, Program HIV Prevent, Chiang Mai, Thailand; [Lallemant, Marc] Inst Rech Dev, Program HIV Treatment, Chiang Mai, Thailand	Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD)	Lallemant, M (corresponding author), Drugs Neglected Dis initiat, Geneva, Switzerland.							Coovadia A, 2010, JAMA-J AM MED ASSOC, V304, P1082, DOI 10.1001/jama.2010.1278; *NAT I ALL INF DIS, 2011, TREAT HIV INF PEOPL; Palumbo P, 2011, 18 C RETR OPP INF BO; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; World Health Organization, 2010, ANT THER HIV INF INF	5	36	36	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2011	365	7					581	583		10.1056/NEJMp1107275	http://dx.doi.org/10.1056/NEJMp1107275			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	808ER	21848457				2022-12-01	WOS:000293960500001
J	Hoyle, E				Hoyle, Ewan			PERSONAL VIEW It's time for the UK government to fully review drug policy	BRITISH MEDICAL JOURNAL			English	Editorial Material												ewanhoyle@gmail.com							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 17	2011	343								d5235	10.1136/bmj.d5235	http://dx.doi.org/10.1136/bmj.d5235			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	811LB	21849391				2022-12-01	WOS:000294210500006
J	Hiller, DA; Singh, V; Zhong, MH; Strobel, SA				Hiller, David A.; Singh, Vipender; Zhong, Minghong; Strobel, Scott A.			A two-step chemical mechanism for ribosome-catalysed peptide bond formation	NATURE			English	Article							TRANSITION-STATE; TRANSFERASE REACTION; TRANSFER-RNA; HYDRAZINOLYSIS; INTERMEDIATE; 2'-HYDROXYL; AMINOLYSIS; REVEALS; 2'-OH; WATER	The chemical step of natural protein synthesis, peptide bond formation, is catalysed by the large subunit of the ribosome. Crystal structures have shown that the active site for peptide bond formation is composed entirely of RNA(1). Recent work has focused on how an RNA active site is able to catalyse this fundamental biological reaction at a suitable rate for protein synthesis. On the basis of the absence of important ribosomal functional groups(2), lack of a dependence on pH(3), and the dominant contribution of entropy to catalysis(4), it has been suggested that the role of the ribosome is limited to bringing the substrates into close proximity. Alternatively, the importance of the 2'-hydroxyl of the peptidyl-transfer RNA(5) and a Bronsted coefficient near zero(6) have been taken as evidence that the ribosome coordinates a proton-transfer network. Here we report the transition state of peptide bond formation, based on analysis of the kinetic isotope effect at five positions within the reaction centre of a peptidyl-transfer RNA mimic. Our results indicate that in contrast to the uncatalysed reaction, formation of the tetrahedral intermediate and proton transfer from the nucleophilic nitrogen both occur in the rate-limiting step. Unlike in previous proposals, the reaction is not fully concerted; instead, breakdown of the tetrahedral intermediate occurs in a separate fast step. This suggests that in addition to substrate positioning, the ribosome is contributing to chemical catalysis by changing the rate-limiting transition state.	[Hiller, David A.; Singh, Vipender; Zhong, Minghong; Strobel, Scott A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Strobel, SA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	scott.strobel@yale.edu			NIH [GM54839]; Brown-Coxe fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054839] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brown-Coxe fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Klinman and D. Singleton for critical reading of the manuscript, and members of the S. A. S. laboratory for discussion. This work was supported by an NIH postdoctoral fellowship (D. A. H.), a Brown-Coxe fellowship (V. S.) and an NIH grant (GM54839).	Anisimov V, 1999, J MATH CHEM, V26, P75, DOI 10.1023/A:1019173509273; Bieling P, 2006, NAT STRUCT MOL BIOL, V13, P423, DOI 10.1038/nsmb1091; CLELAND WW, 1995, METHOD ENZYMOL, V249, P341; Dorner S, 2003, NUCLEIC ACIDS RES, V31, P6536, DOI 10.1093/nar/gkg842; Erlacher MD, 2005, NUCLEIC ACIDS RES, V33, P1618, DOI 10.1093/nar/gki308; Gawlita E, 2000, J AM CHEM SOC, V122, P11660, DOI 10.1021/ja001891d; Hiller DA, 2010, BIOCHEMISTRY-US, V49, P3868, DOI 10.1021/bi901458x; HOGG JL, 1980, J AM CHEM SOC, V102, P79, DOI 10.1021/ja00521a014; Huang KS, 2008, BIOCHEMISTRY-US, V47, P8822, DOI 10.1021/bi800299u; INWARD PW, 1965, J BIOL CHEM, V240, P1986; Kingery DA, 2008, CHEM BIOL, V15, P493, DOI 10.1016/j.chembiol.2008.04.005; Marlier JF, 1997, J AM CHEM SOC, V119, P8838, DOI 10.1021/ja970993+; MONRO RE, 1967, J MOL BIOL, V25, P347, DOI 10.1016/0022-2836(67)90146-5; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; OLEARY MH, 1979, J AM CHEM SOC, V101, P3300, DOI 10.1021/ja00506a027; Ranelov MA, 2010, J ORG CHEM, V75, P6782, DOI 10.1021/jo100886p; SATTERTH.AC, 1974, J AM CHEM SOC, V96, P7018, DOI 10.1021/ja00829a034; SAWYER CB, 1973, J AM CHEM SOC, V95, P7375, DOI 10.1021/ja00803a027; Schmeing TM, 2005, MOL CELL, V20, P437, DOI 10.1016/j.molcel.2005.09.006; Seila AC, 2005, BIOCHEMISTRY-US, V44, P4018, DOI 10.1021/bi047742f; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sievers A, 2004, P NATL ACAD SCI USA, V101, P7897, DOI 10.1073/pnas.0402488101; Singleton DA, 2000, J AM CHEM SOC, V122, P11035, DOI 10.1021/ja005519+; Unrau PJ, 2003, P NATL ACAD SCI USA, V100, P15393, DOI 10.1073/pnas.2433147100; Wallin G, 2010, P NATL ACAD SCI USA, V107, P1888, DOI 10.1073/pnas.0914192107; Wang QA, 2010, CHEM PHYS LETT, V501, P113, DOI 10.1016/j.cplett.2010.10.048; Zaher HS, 2011, EMBO J, V30, P2445, DOI 10.1038/emboj.2011.142; ZEEBERG B, 1973, J BIOL CHEM, V248, P5887; Zhong MH, 2006, ORG LETT, V8, P55, DOI 10.1021/ol052484f; Zhong MH, 2008, J ORG CHEM, V73, P603, DOI 10.1021/jo702070m	30	56	56	3	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2011	476	7359					236	U143		10.1038/nature10248	http://dx.doi.org/10.1038/nature10248			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21765427	Green Accepted			2022-12-01	WOS:000293731900043
J	Ramkumar, N; Anderson, KV				Ramkumar, Nitya; Anderson, Kathryn V.			SnapShot: Mouse Primitive Streak	CELL			English	Editorial Material									[Ramkumar, Nitya; Anderson, Kathryn V.] Sloan Kettering Inst, New York, NY 10065 USA; [Ramkumar, Nitya] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Ramkumar, N (corresponding author), Sloan Kettering Inst, New York, NY 10065 USA.			Anderson, Kathryn/0000-0003-1657-2161; Ramkumar, Nitya/0000-0002-4086-4562	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD035455, R37HD035455] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD035455] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; AULEHLA A, 2010, COLD SPRING HARB PER, V2; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Lee JD, 2007, DEVELOPMENT, V134, P2007, DOI 10.1242/dev.000885; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; Qian LH, 2011, P NATL ACAD SCI USA, V108, P8692, DOI 10.1073/pnas.1100328108; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; Takemoto T, 2011, NATURE, V470, P394, DOI 10.1038/nature09729; Wardle FC, 2008, CURR OPIN GENET DEV, V18, P418, DOI 10.1016/j.gde.2008.07.017	10	24	24	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 5	2011	146	3							488.e1	10.1016/j.cell.2011.07.028	http://dx.doi.org/10.1016/j.cell.2011.07.028			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	803GT	21816280	Bronze			2022-12-01	WOS:000293570500023
J	Stefer, S; Reitz, S; Wang, F; Wild, K; Pang, YY; Schwarz, D; Bomke, J; Hein, C; Lohr, F; Bernhard, F; Denic, V; Dotsch, V; Sinning, I				Stefer, Susanne; Reitz, Simon; Wang, Fei; Wild, Klemens; Pang, Yin-Yuin; Schwarz, Daniel; Bomke, Joerg; Hein, Christopher; Loehr, Frank; Bernhard, Frank; Denic, Vladimir; Doetsch, Volker; Sinning, Irmgard			Structural Basis for Tail-Anchored Membrane Protein Biogenesis by the Get3-Receptor Complex	SCIENCE			English	Article							SIGNAL RECOGNITION PARTICLE; PHOSPHOLIPID-BILAYERS; ER MEMBRANE; INSERTION; GET3; TRANSLOCATION; MECHANISM; PATHWAY; BINDING	Tail-anchored (TA) proteins are involved in cellular processes including trafficking, degradation, and apoptosis. They contain a C-terminal membrane anchor and are posttranslationally delivered to the endoplasmic reticulum (ER) membrane by the Get3 adenosine triphosphatase interacting with the hetero-oligomeric Get1/2 receptor. We have determined crystal structures of Get3 in complex with the cytosolic domains of Get1 and Get2 in different functional states at 3.0, 3.2, and 4.6 angstrom resolution. The structural data, together with biochemical experiments, show that Get1 and Get2 use adjacent, partially overlapping binding sites and that both can bind simultaneously to Get3. Docking to the Get1/2 complex allows for conformational changes in Get3 that are required for TA protein insertion. These data suggest a molecular mechanism for nucleotide-regulated delivery of TA proteins.	[Wang, Fei; Denic, Vladimir] Harvard Univ, Dept Mol & Cellular Biol, Northwest Labs, Cambridge, MA 02138 USA; [Stefer, Susanne; Hein, Christopher; Loehr, Frank; Bernhard, Frank; Doetsch, Volker] Goethe Univ Frankfurt, Inst Biophys Chem, Ctr Biomol Magnet Resonance, D-60325 Frankfurt, Germany; [Reitz, Simon; Wild, Klemens; Pang, Yin-Yuin; Sinning, Irmgard] Univ Heidelberg, Biochem Ctr BZH, D-69120 Heidelberg, Germany; [Schwarz, Daniel; Bomke, Joerg] Merck KGaA, Merck Serono, Mol Interact & Biophys, D-64293 Darmstadt, Germany	Harvard University; Goethe University Frankfurt; Ruprecht Karls University Heidelberg; Merck KGaA; EMD Serono Inc.	Denic, V (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Northwest Labs, Cambridge, MA 02138 USA.	vdenic@mcb.harvard.edu; vdoetsch@em.uni-frankfurt.de; irmi.sinning@bzh.uni-heidelberg.de		Dotsch, Volker/0000-0001-5720-212X; Bernhard, Frank/0000-0002-4860-1783	Deutsche Forschungsgemeinschaft (DFG) [SFB 807, SFB 638]; Centre for Biomolecular Magnetic Resonance (BMRZ); Cluster of Excellence Frankfurt (Macromolecular Complexes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099943] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Centre for Biomolecular Magnetic Resonance (BMRZ); Cluster of Excellence Frankfurt (Macromolecular Complexes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	V.D. would like to thank M. Frech for his support of the project and acknowledges funding by the Deutsche Forschungsgemeinschaft (DFG) (SFB 807), the Centre for Biomolecular Magnetic Resonance (BMRZ), and the Cluster of Excellence Frankfurt (Macromolecular Complexes). I. S. thanks J. Kopp und C. Siegmann from the crystallization platform of the Biochemiezentrum and the Cluster of Excellence Heidelberg (CellNetworks), the European Synchrotron Radiation Facility for access to data collection, B. Dobberstein for generous support and stimulating discussions, and acknowledges funding by the DFG (SFB 638). Coordinates and structure factors have been deposited in the Research Collaboratory for Structural Bioinformatics Protein Data Bank (PDB) with accession nos. 3SJA, 3SJB, 3SJC, and 3SJD.	Abell BM, 2007, J CELL SCI, V120, P1743, DOI 10.1242/jcs.002410; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; Bozkurt G, 2009, P NATL ACAD SCI USA, V106, P21131, DOI 10.1073/pnas.0910223106; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; Colombo SF, 2009, J CELL SCI, V122, P2383, DOI 10.1242/jcs.049460; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Favaloro V, 2010, J CELL SCI, V123, P1522, DOI 10.1242/jcs.055970; High S, 2004, BIOCHEM SOC T, V32, P659, DOI 10.1042/BST0320659; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Hu JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008061; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; Meineke B, 2008, FEBS LETT, V582, P855, DOI 10.1016/j.febslet.2008.02.009; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Shan SO, 2005, FEBS LETT, V579, P921, DOI 10.1016/j.febslet.2004.11.049; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Suloway CJM, 2009, P NATL ACAD SCI USA, V106, P14849, DOI 10.1073/pnas.0907522106; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Vilardi F, 2011, J CELL SCI, V124, P1301, DOI 10.1242/jcs.084277; Wattenberg B, 2001, TRAFFIC, V2, P66, DOI 10.1034/j.1600-0854.2001.20108.x; Yamagata A, 2010, GENES CELLS, V15, P29, DOI 10.1111/j.1365-2443.2009.01362.x; Zaitseva J, 2006, EMBO J, V25, P3432, DOI 10.1038/sj.emboj.7601208	28	78	82	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 5	2011	333	6043					758	762		10.1126/science.1207125	http://dx.doi.org/10.1126/science.1207125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21719644	Green Accepted			2022-12-01	WOS:000293512100044
J	Bates, ME; Simmons, JA; Zorikov, TV				Bates, Mary E.; Simmons, James A.; Zorikov, Tengiz V.			Bats Use Echo Harmonic Structure to Distinguish Their Targets from Background Clutter	SCIENCE			English	Article							BIG BROWN BATS; EPTESICUS-FUSCUS; ECHOLOCATING BAT; ACOUSTIC IMAGES; PERCEPTION; DELAY; DISCRIMINATION; INFORMATION; MODULATION; PATTERN	When echolocating big brown bats fly in complex surroundings, echoes arriving from irrelevant objects (clutter) located to the sides of their sonar beam can mask perception of relevant objects located to the front (targets), causing "blind spots." Because the second harmonic is beamed more weakly to the sides than the first harmonic, these clutter echoes have a weaker second harmonic. In psychophysical experiments, we found that electronically misaligning first and second harmonics in echoes (to mimic the misalignment of corresponding neural responses to harmonics in clutter echoes) disrupts the bat's echo-delay perception but also prevents clutter masking. Electronically offsetting harmonics to realign their neural responses restores delay perception but also clutter interference. Thus, bats exploit harmonics to distinguish clutter echoes from target echoes, sacrificing delay acuity to suppress masking.	[Bates, Mary E.] Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA; [Simmons, James A.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Simmons, James A.] Doshisha Univ, Bionav Res Ctr, Kyoto 6100321, Japan; [Zorikov, Tengiz V.] Inst Cybernet, GE-0186 Tbilisi, Georgia	Brown University; Brown University; Doshisha University	Bates, ME (corresponding author), Brown Univ, Dept Cognit Linguist & Psychol Sci, Box 1853, Providence, RI 02912 USA.	maryebates@gmail.com			Office of Naval Research (ONR) [N00014-04-1-0415, N00014-09-1-0691, N00014-07-1-0857]; NSF [IOS-0843522]; National Institute of Mental Health [R01-MH069633]; Brown University; RI Space Grant; Brown Institute for Brain Science; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069633] Funding Source: NIH RePORTER	Office of Naval Research (ONR)(Office of Naval Research); NSF(National Science Foundation (NSF)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Brown University; RI Space Grant; Brown Institute for Brain Science; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support for this research came from Office of Naval Research (ONR) grants N00014-04-1-0415 and N00014-09-1-0691, NSF grant IOS-0843522, and National Institute of Mental Health grant R01-MH069633 to J.A.S.; from a Brown University dissertation fellowship to M. E. B.; from ONR-Global grant N00014-07-1-0857 to T.V.Z.; and from the RI Space Grant and from the Brown Institute for Brain Science. We thank A. M. Simmons for editorial advice.	Acoustical Society of America, S1261995 ANSI AC SOC; Bates ME, 2011, J EXP BIOL, V214, P394, DOI 10.1242/jeb.048983; Bates ME, 2010, J ACOUST SOC AM, V128, P936, DOI 10.1121/1.3459823; BODENHAMER RD, 1981, HEARING RES, V5, P317, DOI 10.1016/0378-5955(81)90055-1; BURKARD R, 1994, J ACOUST SOC AM, V96, P801, DOI 10.1121/1.410318; Ghose K, 2003, J ACOUST SOC AM, V114, P1120, DOI 10.1121/1.1589754; HARTLEY DJ, 1989, J ACOUST SOC AM, V85, P1348, DOI 10.1121/1.397466; Hiryu S, 2010, P NATL ACAD SCI USA, V107, P7048, DOI 10.1073/pnas.1000429107; Ma XF, 2008, J NEUROPHYSIOL, V100, P1127, DOI 10.1152/jn.90508.2008; MASTERS WM, 1985, SCIENCE, V228, P1331, DOI 10.1126/science.4001947; MOSS CF, 1994, J ACOUST SOC AM, V95, P2745, DOI 10.1121/1.409843; Muller R, 2000, J ACOUST SOC AM, V108, P836, DOI 10.1121/1.429617; Petrites AE, 2009, J COMP PHYSIOL A, V195, P603, DOI 10.1007/s00359-009-0435-6; Saillant PA, 2007, J ACOUST SOC AM, V121, P3001, DOI 10.1121/1.2714920; Simmons J. A., 2001, Acoustics Research Letters Online, V2, P43, DOI 10.1121/1.1352717; Simmons JA, 2005, ACOUST RES LETT ONL, V6, P238, DOI 10.1121/1.1985957; SIMMONS JA, 1989, COGNITION, V33, P155, DOI 10.1016/0010-0277(89)90009-7; SIMMONS JA, 1973, J ACOUST SOC AM, V54, P157, DOI 10.1121/1.1913559; SIMMONS JA, 1989, J ACOUST SOC AM, V86, P1333, DOI 10.1121/1.398694; SIMMONS JA, 1990, J COMP PHYSIOL A, V167, P589; SIMMONS JA, 1990, J COMP PHYSIOL A, V166, P449; Stamper SA, 2009, J COMP PHYSIOL A, V195, P79, DOI 10.1007/s00359-008-0384-5; Sumer S, 2009, J COMP PHYSIOL A, V195, P463, DOI 10.1007/s00359-009-0424-9; Surlykke A, 2000, J ACOUST SOC AM, V108, P2419, DOI 10.1121/1.1315295; Surlykke A, 2009, J EXP BIOL, V212, P1011, DOI 10.1242/jeb.024620; Yovel Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000032	26	81	86	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2011	333	6042					627	630		10.1126/science.1202065	http://dx.doi.org/10.1126/science.1202065			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21798949				2022-12-01	WOS:000293222400061
J	Pope, PB; Smith, W; Denman, SE; Tringe, SG; Barry, K; Hugenholtz, P; McSweeney, CS; McHardy, AC; Morrison, M				Pope, P. B.; Smith, W.; Denman, S. E.; Tringe, S. G.; Barry, K.; Hugenholtz, P.; McSweeney, C. S.; McHardy, A. C.; Morrison, M.			Isolation of Succinivibrionaceae Implicated in Low Methane Emissions from Tammar Wallabies	SCIENCE			English	Article							ANAEROBIOSPIRILLUM-SUCCINICIPRODUCENS; MACROPUS-EUGENII; BOVINE RUMEN; FERMENTATION; FORESTOMACH; COMMUNITY; NITROGEN	The Tammar wallaby (Macropus eugenii) harbors unique gut bacteria and produces only one-fifth the amount of methane produced by ruminants per unit of digestible energy intake. We have isolated a dominant bacterial species (WG-1) from the wallaby microbiota affiliated with the family Succinivibrionaceae and implicated in lower methane emissions from starch-containing diets. This was achieved by using a partial reconstruction of the bacterium's metabolism from binned metagenomic data (nitrogen and carbohydrate utilization pathways and antibiotic resistance) to devise cultivation-based strategies that produced axenic WG-1 cultures. Pure-culture studies confirm that the bacterium is capnophilic and produces succinate, further explaining a microbiological basis for lower methane emissions from macropodids. This knowledge also provides new strategic targets for redirecting fermentation and reducing methane production in livestock.	[Pope, P. B.; Smith, W.; Denman, S. E.; McSweeney, C. S.; Morrison, M.] CSIRO Livestock Ind, Queensland Biosci Precinct, St Lucia, Qld 4067, Australia; [Pope, P. B.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway; [Tringe, S. G.; Barry, K.; Hugenholtz, P.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Hugenholtz, P.] Australian Ctr Ecogenom, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Hugenholtz, P.] Australian Ctr Ecogenom, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [McHardy, A. C.] Max Planck Inst Informat, Max Planck Res Grp Computat Genom & Epidemiol, D-66123 Saarbrucken, Germany; [McHardy, A. C.] Univ Dusseldorf, Dept Algorithm Bioinformat, D-40225 Dusseldorf, Germany; [Morrison, M.] Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Norwegian University of Life Sciences; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Queensland; University of Queensland; Max Planck Society; Heinrich Heine University Dusseldorf; University System of Ohio; Ohio State University	Morrison, M (corresponding author), CSIRO Livestock Ind, Queensland Biosci Precinct, St Lucia, Qld 4067, Australia.	mark.morrison@csiro.au	Pope, Phillip/AAQ-2251-2021; McHardy, Alice/ABF-2322-2020; Morrison, Mark/C-9707-2013; Hugenholtz, Philip/AAD-9138-2019; Hugenholtz, Philip/G-9608-2011; McHardy, Alice C/K-9377-2018; McSweeney, Chris S/C-3688-2012; Denman, Stuart E/A-5823-2011	Pope, Phillip/0000-0002-2067-4059; McHardy, Alice/0000-0003-2370-3430; Morrison, Mark/0000-0001-9257-9133; Hugenholtz, Philip/0000-0001-5386-7925; Hugenholtz, Philip/0000-0001-5386-7925; McHardy, Alice C/0000-0003-2370-3430; Denman, Stuart E/0000-0002-9910-3709; McSweeney, Chris/0000-0002-0114-5151	Commonwealth Scientific and Industrial Research Organisation's (CSIRO's) Office of the Chief Executive (OCE); U.S. Department of Energy-Joint Genome Institute Community Sequencing Program; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]	Commonwealth Scientific and Industrial Research Organisation's (CSIRO's) Office of the Chief Executive (OCE); U.S. Department of Energy-Joint Genome Institute Community Sequencing Program; Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE))	The Tammar wallaby project is partially supported by the Commonwealth Scientific and Industrial Research Organisation's (CSIRO's) Office of the Chief Executive (OCE) Science Leader and Transformational Biology Capability Platform grant programs (awarded to M. M.), a CSIRO OCE Postdoctoral Fellowship (awarded to P. B. P.), and the U.S. Department of Energy-Joint Genome Institute Community Sequencing Program. We are especially grateful for the support from L. Hinds (CSIRO Ecosystem Sciences), A.-D. Wright (University of Vermont), and P. Evans (CSIRO Livestock Industries), who assisted in sample collections. The work conducted by the U.S. Department of Energy-Joint Genome Institute is supported by the Office of Science of the U.S. Department of Energy under contract no. DE-AC02-05CH11231. The whole-metagenome shotgun project and whole-genome shotgun project (for the WG-1 isolate) has been deposited at DDBJ/EMBL/GenBank under accession numbers ADGC00000000 and AFAK00000000, respectively. 16S rRNA gene sequences are deposited under accession numbers GQ358225 to GQ358517.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Evans PN, 2009, APPL ENVIRON MICROB, V75, P2598, DOI 10.1128/AEM.02436-08; Gagen EJ, 2010, APPL ENVIRON MICROB, V76, P7785, DOI 10.1128/AEM.01679-10; HAMLIN LJ, 1956, J BACTERIOL, V72, P548, DOI 10.1128/JB.72.4.548-554.1956; HUME ID, 1984, BIOSCIENCE, V34, P435, DOI 10.2307/1309633; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KEMPTON TJ, 1976, AUST J BIOL SCI, V29, P209, DOI 10.1071/BI9760209; KENNEDY PM, 1978, COMP BIOCHEM PHYS A, V61, P117, DOI 10.1016/0300-9629(78)90286-4; Lee PC, 1999, ENZYME MICROB TECH, V24, P549, DOI 10.1016/S0141-0229(98)00156-2; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; McKinlay JB, 2007, METAB ENG, V9, P177, DOI 10.1016/j.ymben.2006.10.006; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Ouwerkerk D, 2009, ANIM PROD SCI, V49, P1043, DOI 10.1071/EA08294; Patil KR, 2011, NAT METHODS, V8, P191, DOI 10.1038/nmeth0311-191; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; RUSSELL JB, 1989, APPL ENVIRON MICROB, V55, P1; Samuelov NS, 1999, APPL ENVIRON MICROB, V65, P2260; Tyson GW, 2005, APPL ENVIRON MICROB, V71, P6319, DOI 10.1128/AEM.71.10.6319-6324.2005; von Engelhardt W., 1978, Comparative Biochemistry and Physiology A, V60, P309, DOI 10.1016/0300-9629(78)90254-2	21	118	127	4	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2011	333	6042					646	648		10.1126/science.1205760	http://dx.doi.org/10.1126/science.1205760			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21719642				2022-12-01	WOS:000293222400066
J	Chen, XW; Leischner, U; Rochefort, NL; Nelken, I; Konnerth, A				Chen, Xiaowei; Leischner, Ulrich; Rochefort, Nathalie L.; Nelken, Israel; Konnerth, Arthur			Functional mapping of single spines in cortical neurons in vivo	NATURE			English	Article							MOUSE AUDITORY-CORTEX; PYRAMIDAL NEURONS; DENDRITIC SPINES; FLUORESCENCE MICROSCOPY; VISUAL-CORTEX; ORGANIZATION; EXCITATION; DYNAMICS; SIGNALS; SPIKES	The individual functional properties and spatial arrangement of afferent synaptic inputs on dendrites have a critical role in the processing of information by neurons in the mammalian brain(1-4). Although recent work has identified visually-evoked local dendritic calcium signals in the rodent visual cortex(5), sensory-evoked signalling on the level of dendritic spines, corresponding to individual afferent excitatory synapses, remains unexplored(6). Here we used a new variant of high-resolution two-photon imaging(7) to detect sensory-evoked calcium transients in single dendritic spines of mouse cortical neurons in vivo. Calcium signals evoked by sound stimulation required the activation of NMDA (N-methyl-D-aspartate) receptors. Active spines are widely distributed on basal and apical dendrites and pure-tone stimulation at different frequencies revealed both narrowly and widely tuned spines. Notably, spines tuned for different frequencies were highly interspersed on the same dendrites: even neighbouring spines were mostly tuned to different frequencies. Thus, our results demonstrate that NMDA-receptor-dependent single-spine synaptic inputs to the same dendrite are highly heterogeneous. Furthermore, our study opens the way for in vivo mapping of functionally defined afferent sensory inputs with single-synapse resolution.	[Chen, Xiaowei; Leischner, Ulrich; Rochefort, Nathalie L.; Konnerth, Arthur] Tech Univ Munich, Inst Neurosci, D-80802 Munich, Germany; [Chen, Xiaowei; Leischner, Ulrich; Rochefort, Nathalie L.; Konnerth, Arthur] Tech Univ Munich, Ctr Integrated Prot Sci, D-80802 Munich, Germany; [Nelken, Israel] Hebrew Univ Jerusalem, Dept Neurobiol, Silberman Inst Life Sci, IL-91904 Jerusalem, Israel; [Nelken, Israel] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, IL-91904 Jerusalem, Israel	Technical University of Munich; Technical University of Munich; University of Munich; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Konnerth, A (corresponding author), Tech Univ Munich, Inst Neurosci, Biedersteinerstr 29, D-80802 Munich, Germany.	arthur.konnerth@lrz.tum.de	Leischner, Ulrich/H-9936-2012; Nelken, Israel/B-7753-2011	Nelken, Israel/0000-0002-6645-107X; Leischner, Ulrich/0000-0001-7771-2135; Rochefort, Nathalie/0000-0002-3498-6221	Schiedel Foundation; German-Israeli Foundation (GIF) [1002/2008]; Deutsche Forschungsgemeinschaft [IRTG 1373]; Bundesministerium fur Bildung und Forschung (BMBF)	Schiedel Foundation; German-Israeli Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	We thank J. Lou for technical assistance, D. Bayer, F. Bayer and W. Zeitz for building the scanning device, A. Fohr for software support and Y. Kovalchuk and H. Adelsberger for help during the initial experiments. This work was supported by the Schiedel Foundation, the German-Israeli Foundation (GIF grant 1002/2008 to I.N. and A. K.), the Deutsche Forschungsgemeinschaft (IRTG 1373) and the Bundesministerium fur Bildung und Forschung (BMBF) in the frame of ERA-NET NEURON. A. K. is a Carl-von-Linde senior fellow of the Institute for Advanced Study of the Technische Universitat Munchen.	Bandyopadhyay S, 2010, NAT NEUROSCI, V13, P361, DOI 10.1038/nn.2490; Berretta N, 1996, NEUROSCIENCE, V75, P339, DOI 10.1016/0306-4522(96)00301-6; Bloodgood BL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000190; Branco T, 2010, CURR OPIN NEUROBIOL, V20, P494, DOI 10.1016/j.conb.2010.07.009; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Chadderton P, 2009, J NEUROSCI, V29, P14127, DOI 10.1523/JNEUROSCI.2061-09.2009; de Kock CPJ, 2008, J PHYSIOL-LONDON, V586, P3353, DOI 10.1113/jphysiol.2008.155580; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Donnert G, 2007, NAT METHODS, V4, P81, DOI 10.1038/NMETH986; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; GERIG JS, 1964, P IEEE, V52, P1753, DOI 10.1109/PROC.1964.3500; Holthoff K, 2004, J PHYSIOL-LONDON, V560, P27, DOI 10.1113/jphysiol.2004.072678; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Ji N, 2008, NAT METHODS, V5, P197, DOI 10.1038/NMETH.1175; Jia HB, 2011, NAT PROTOC, V6, P28, DOI 10.1038/nprot.2010.169; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Kawaguchi Y, 2006, CEREB CORTEX, V16, P696, DOI 10.1093/cercor/bhj015; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Kremer Y, 2008, OPT EXPRESS, V16, P10066, DOI 10.1364/OE.16.010066; Larkum ME, 2008, CURR OPIN NEUROBIOL, V18, P321, DOI 10.1016/j.conb.2008.08.013; Lechleiter JD, 2002, BIOPHYS J, V83, P2292, DOI 10.1016/S0006-3495(02)73989-1; Linden JF, 2003, J NEUROPHYSIOL, V90, P2660, DOI 10.1152/jn.00751.2002; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Peters A., 1984, CEREBRAL CORTEX FUNC, P107, DOI [10.1007/978-3-662-03733-1_15, DOI 10.1007/978-3-662-03733-1_15]; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Roorda RD, 2004, J NEUROPHYSIOL, V92, P609, DOI 10.1152/jn.00087.2004; Rothschild G, 2010, NAT NEUROSCI, V13, P353, DOI 10.1038/nn.2484; Sabatini BL, 2001, CURR OPIN NEUROBIOL, V11, P349, DOI 10.1016/S0959-4388(00)00218-X; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Scholl B, 2010, NEURON, V65, P412, DOI 10.1016/j.neuron.2010.01.020; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Waters J, 2003, J NEUROSCI, V23, P8558; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; Wu GY, 2006, NEURON, V52, P705, DOI 10.1016/j.neuron.2006.10.009; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	43	260	266	2	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2011	475	7357					501	U97		10.1038/nature10193	http://dx.doi.org/10.1038/nature10193			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21706031				2022-12-01	WOS:000293167900041
J	Knoepfler, P				Knoepfler, Paul			My year as a stem-cell blogger	NATURE			English	Editorial Material									Univ Calif Davis, Sch Med, Davis, CA 95616 USA	University of California System; University of California Davis	Knoepfler, P (corresponding author), Univ Calif Davis, Sch Med, Davis, CA 95616 USA.	knoepfler@ucdavis.edu		Knoepfler, Paul/0000-0001-5444-334X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100782] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM100782] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2011	475	7357					425	425		10.1038/475425a	http://dx.doi.org/10.1038/475425a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	797ZA	21796162	Bronze, Green Accepted			2022-12-01	WOS:000293167900004
J	Morran, LT; Schmidt, OG; Gelarden, IA; Parrish, RC; Lively, CM				Morran, Levi T.; Schmidt, Olivia G.; Gelarden, Ian A.; Parrish, Raymond C., II; Lively, Curtis M.			Running with the Red Queen: Host-Parasite Coevolution Selects for Biparental Sex	SCIENCE			English	Article							INBREEDING DEPRESSION; SELF-FERTILIZATION; EVOLUTION; SNAIL; GENE	Most organisms reproduce through outcrossing, even though it comes with substantial costs. The Red Queen hypothesis proposes that selection from coevolving pathogens facilitates the persistence of outcrossing despite these costs. We used experimental coevolution to test the Red Queen hypothesis and found that coevolution with a bacterial pathogen (Serratia marcescens) resulted in significantly more outcrossing in mixed mating experimental populations of the nematode Caenorhabditis elegans. Furthermore, we found that coevolution with the pathogen rapidly drove obligately selfing populations to extinction, whereas outcrossing populations persisted through reciprocal coevolution. Thus, consistent with the Red Queen hypothesis, coevolving pathogens can select for biparental sex.	[Morran, Levi T.; Schmidt, Olivia G.; Gelarden, Ian A.; Parrish, Raymond C., II; Lively, Curtis M.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Morran, LT (corresponding author), Indiana Univ, Dept Biol, 1001 E 3rd St, Bloomington, IN 47405 USA.	lmorran@indiana.edu	Lively, Curtis M/A-8057-2011	Gelarden, Ian/0000-0002-7599-050X	Wissenschaftskolleg zu Berlin; NSF [DEB-0640639]; NIH [1F32GM096482-01]; NIH National Center for Research Resources (NCRR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM096482] Funding Source: NIH RePORTER	Wissenschaftskolleg zu Berlin(Austrian Science Fund (FWF)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Hundley and R. Matteson for logistical assistance. We also thank F. Bashey, L. Delph, P. Phillips, M. Parmenter, the Lively and Hall laboratories, and two reviewers for helpful comments and discussion, as well as the Wissenschaftskolleg zu Berlin for a fellowship to C.M.L. during the preparation of the manuscript. Funding was provided by the NSF (DEB-0640639 to C.M.L) and the NIH (1F32GM096482-01 to L.T.M). Nematode strains were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR). Data deposited at Dryad, 10.5061/dryad.c0q0h.	Agrawal AF, 2001, EVOLUTION, V55, P869, DOI 10.1554/0014-3820(2001)055[0869:PATEOS]2.0.CO;2; Bell G., 1982, MASTERPIECE NATURE E; BRENNER S, 1974, GENETICS, V77, P71; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.ecolsys.18.1.237; Decaestecker E, 2007, NATURE, V450, P870, DOI 10.1038/nature06291; Fisher R.A., 1930, GENETICAL THEORY NAT; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; JAENIKE J, 1978, Evolutionary Theory, V3, P191; Jokela J, 2009, AM NAT, V174, pS43, DOI 10.1086/599080; King KC, 2009, CURR BIOL, V19, P1438, DOI 10.1016/j.cub.2009.06.062; Koskella B, 2009, EVOLUTION, V63, P2213, DOI 10.1111/j.1558-5646.2009.00711.x; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; LIVELY CM, 1990, NATURE, V344, P864, DOI 10.1038/344864a0; LIVELY CM, 1987, NATURE, V328, P519, DOI 10.1038/328519a0; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Maynard-Smith J., 1978, MODELS ECOLOGY; MILLER LM, 1988, CELL, V55, P167, DOI 10.1016/0092-8674(88)90019-0; Morran LT, 2009, NATURE, V462, P350, DOI 10.1038/nature08496; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; Paterson S, 2010, NATURE, V464, P275, DOI 10.1038/nature08798; SCHEDL T, 1988, GENETICS, V119, P43; Schulte RD, 2010, P NATL ACAD SCI USA, V107, P7359, DOI 10.1073/pnas.1003113107; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Teotonio H, 2006, EVOLUTION, V60, P1300, DOI 10.1111/j.0014-3820.2006.tb01207.x; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi	28	255	258	7	402	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2011	333	6039					216	218		10.1126/science.1206360	http://dx.doi.org/10.1126/science.1206360			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21737739	Green Accepted			2022-12-01	WOS:000292502700048
J	Yong, E				Yong, Ed			EMERGING DISEASES Disease trackers	BRITISH MEDICAL JOURNAL			English	Editorial Material												edyong209@googlemail.com						KARESH WB, 2005, EMERG INFECT DIS JUL	1	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 5	2011	343								d4117	10.1136/bmj.d4117	http://dx.doi.org/10.1136/bmj.d4117			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791RV	21729998				2022-12-01	WOS:000292683200003
J	[Anonymous]				[Anonymous]			Global response to non-communicable disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIOVASCULAR-DISEASE						Prabhakaran, Dorairaj/B-4147-2011; Miranda, J. Jaime/A-8482-2008; Niessen, Louis/F-6254-2015	Prabhakaran, Dorairaj/0000-0002-3172-834X; Miranda, J. Jaime/0000-0002-4738-5468; Niessen, Louis/0000-0002-8639-5191; Levitt, Naomi/0000-0001-6480-8066; Ghannem, Hassen/0000-0002-9417-6837				American Cancer Society, 2010, GLOB EC COST CANC; [Anonymous], 2008, ACT PLAN GLOB STRAT; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; First Global Ministerial Conference on Healthy Lifestyles and Noncommunicable Disease Control, 2011, 1 GLOBAL MINISTERIAL; NCD Alliance, 2011, PROP OUTC DOC UN HIG; Nugent RA, 2010, 228 CTR GLOB DEV; Rodgers A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019857; Smith R, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2796; SRIDHAR D, 2011, GETTING POLITICS RIG; Wald NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018742; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2011, GLOB STAT REP NONC D; *WHO, 2008, GLOB STRAT HARMF US; World Health Organization, 2011, PRIOR RES AG PREV CO; World Health Organization, 2003, FRAM CONV TOB CONTR; World Health Organization, 2005, PREVENTING CHRONIC D; World Health Organization, 2004, GLOB STRAT DIET PHYS; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5; GLOBAL ALLIANCE CHRO	20	21	22	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2011	342								d3823	10.1136/bmj.d3823	http://dx.doi.org/10.1136/bmj.d3823			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	788QB	21724543				2022-12-01	WOS:000292458400002
J	Bettegowda, C; Agrawal, N; Jiao, YC; Sausen, M; Wood, LD; Hruban, RH; Rodriguez, FJ; Cahill, DP; McLendon, R; Riggins, G; Velculescu, VE; Oba-Shinjo, SM; Marie, SKN; Vogelstein, B; Bigner, D; Yan, H; Papadopoulos, N; Kinzler, KW				Bettegowda, Chetan; Agrawal, Nishant; Jiao, Yuchen; Sausen, Mark; Wood, Laura D.; Hruban, Ralph H.; Rodriguez, Fausto J.; Cahill, Daniel P.; McLendon, Roger; Riggins, Gregory; Velculescu, Victor E.; Oba-Shinjo, Sueli Mieko; Marie, Suely Kazue Nagahashi; Vogelstein, Bert; Bigner, Darell; Yan, Hai; Papadopoulos, Nickolas; Kinzler, Kenneth W.			Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma	SCIENCE			English	Article							C-MYC; GLIOMAS; CAPICUA; CANCER; 19Q; 1P; OLIGOASTROCYTOMAS; REPRESSION; DELETIONS; GENES	Oligodendrogliomas are the second most common malignant brain tumor in adults and exhibit characteristic losses of chromosomes 1p and 19q. To identify the molecular genetic basis for this alteration, we performed exomic sequencing of seven tumors. Among other changes, we found that the CIC gene (homolog of the Drosophila gene capicua) on chromosome 19q was somatically mutated in six cases and that the FUBP1 gene [encoding far-upstream element (FUSE) binding protein] on chromosome 1p was somatically mutated in two tumors. Examination of 27 additional oligodendrogliomas revealed 12 and 3 more tumors with mutations of CIC and FUBP1, respectively, 58% of which were predicted to result in truncations of the encoded proteins. These results suggest a critical role for these genes in the biology and pathology of oligodendrocytes.	[Bettegowda, Chetan; Agrawal, Nishant; Jiao, Yuchen; Sausen, Mark; Riggins, Gregory; Velculescu, Victor E.; Vogelstein, Bert; Papadopoulos, Nickolas; Kinzler, Kenneth W.] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet, Baltimore, MD 21287 USA; [Bettegowda, Chetan; Agrawal, Nishant; Jiao, Yuchen; Sausen, Mark; Riggins, Gregory; Velculescu, Victor E.; Vogelstein, Bert; Papadopoulos, Nickolas; Kinzler, Kenneth W.] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21287 USA; [Bettegowda, Chetan; Riggins, Gregory] Johns Hopkins Med Inst, Dept Neurosurg, Baltimore, MD 21287 USA; [Agrawal, Nishant] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21287 USA; [Wood, Laura D.; Hruban, Ralph H.; Rodriguez, Fausto J.] Johns Hopkins Med Inst, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21287 USA; [Cahill, Daniel P.] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Cahill, Daniel P.] Baylor Coll Med, Houston, TX 77030 USA; [McLendon, Roger; Bigner, Darell; Yan, Hai] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr Duke, Pediat Brain Tumor Fdn Inst, Durham, NC 27710 USA; [McLendon, Roger; Bigner, Darell; Yan, Hai] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Oba-Shinjo, Sueli Mieko; Marie, Suely Kazue Nagahashi] Univ Sao Paulo, Sch Med, Dept Neurol, Sao Paulo, Brazil	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Duke University; Duke University; Universidade de Sao Paulo	Vogelstein, B (corresponding author), Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet, Baltimore, MD 21287 USA.	vogelbe@jhmi.edu; yan00002@mc.duke.edu; npapado1@jhmi.edu; kinzlke@jhmi.edu	Marie, Suely Kazue Nagahashi/D-1870-2012; Velculescu, Victor/ABF-4846-2020; Papadopoulos, Nickolas/K-7272-2012; jiao, yuchen/H-6313-2011; Wood, Laura/ABF-1531-2020; Oba-Shinjo, Sueli M./C-4017-2012	Marie, Suely Kazue Nagahashi/0000-0003-4419-7928; Velculescu, Victor/0000-0003-1195-438X; Oba-Shinjo, Sueli M./0000-0002-1650-5973; Cahill, Daniel/0000-0003-2552-6546; Sausen, Mark/0000-0002-2916-5269; Jiao, Yuchen/0000-0001-7917-8810	Virginia; D. K. Ludwig Fund for Cancer Research; Pediatric Brain Tumor Foundation; Duke Comprehensive Cancer Center Core; Burroughs Wellcome Fund; James S. McDonnell Foundation; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [04/12433-6, 01/12898-4]; National Cancer Institute Division of Cancer Prevention [N01-CN-43302]; National Institutes of Health [CA43460, CA57345, CA11898, CA121113, CA62924, RC2DE020957, NS20023]; NIH/NCI Institutional National Research Service [T32 CA009574]; NATIONAL CANCER INSTITUTE [R37CA057345, R01CA140316, R01CA043460, P50CA062924, R01CA121113, T32CA009574, R01CA057345, R37CA011898, R01CA011898, R37CA043460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS020023] Funding Source: NIH RePORTER	Virginia; D. K. Ludwig Fund for Cancer Research; Pediatric Brain Tumor Foundation; Duke Comprehensive Cancer Center Core; Burroughs Wellcome Fund(Burroughs Wellcome Fund); James S. McDonnell Foundation; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Cancer Institute Division of Cancer Prevention(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI Institutional National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Whalen, N. Silliman, J. Ptak, L. Dobbyn, and J. Schaeffer for expert technical assistance. This work was supported by the Virginia and D. K. Ludwig Fund for Cancer Research, Pediatric Brain Tumor Foundation, Duke Comprehensive Cancer Center Core, Burroughs Wellcome Fund, James S. McDonnell Foundation, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) grants 04/12433-6, 01/12898-4, the National Cancer Institute Division of Cancer Prevention contract N01-CN-43302, and National Institutes of Health grants CA43460, CA57345, CA11898, CA121113, CA62924, RC2DE020957, and NS20023. C.B. is a recipient of T32 CA009574 NIH/NCI Institutional National Research Service Award. Johns Hopkins University has filed a patent relating to the application of the mutations described in this work to the diagnosis and treatment of cancer. Under agreements between the Johns Hopkins University, Genzyme, Exact Sciences, Inostics, Qiagen, Invitrogen, and Personal Genome Diagnostics, N.P., B.V., K.W.K., and V.E.V are entitled to a share of the royalties received by the university on sales of products related to genes and technologies described in this manuscript. N.P., B.V., K.W.K., and V.E.V are co-founders of Inostics and Personal Genome Diagnostics, are members of their Scientific Advisory Boards, and own Inostics and Personal Genome Diagnostics stock, which is subject to certain restrictions under Johns Hopkins University policy. The sequence data reported in this manuscript are deposited in www.sanger.ac.uk/perl/genetics/CGP/cosmic.	Ajuria L, 2011, DEVELOPMENT, V138, P915, DOI 10.1242/dev.057729; Astigarraga S, 2007, EMBO J, V26, P668, DOI 10.1038/sj.emboj.7601532; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Bromberg JEC, 2009, ONCOLOGIST, V14, P155, DOI 10.1634/theoncologist.2008-0248; Cairncross G, 2008, CANCER J, V14, P352, DOI 10.1097/PPO.0b013e31818d8178; Coons SW, 1997, CANCER, V79, P1381, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W; Dang L, 2010, NATURE, V465, P966, DOI 10.1038/nature09132; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; Griffin CA, 2006, J NEUROPATH EXP NEUR, V65, P988, DOI 10.1097/01.jnen.0000235122.98052.8f; Hsiao HH, 2010, BIOCHEMISTRY-US, V49, P4620, DOI 10.1021/bi9021445; Jenkins RB, 2006, CANCER RES, V66, P9852, DOI 10.1158/0008-5472.CAN-06-1796; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Jimenez G, 2000, GENE DEV, V14, P224; Kawamura-Saito M, 2006, HUM MOL GENET, V15, P2125, DOI 10.1093/hmg/ddl136; Knudson AG, 1996, J CANCER RES CLIN, V122, P135, DOI 10.1007/BF01366952; KNUDSON AG, 1975, CANCER, V35, P1022, DOI 10.1002/1097-0142(197503)35:3+<1022::AID-CNCR2820350726>3.0.CO;2-A; Lee CJ, 2005, J NEURO-ONCOL, V73, P101, DOI 10.1007/s11060-004-4598-2; Maintz D, 1997, J NEUROPATH EXP NEUR, V56, P1098, DOI 10.1097/00005072-199710000-00003; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Parmigiani G, 2009, GENOMICS, V93, P17, DOI 10.1016/j.ygeno.2008.07.005; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Roch F, 2002, DEVELOPMENT, V129, P993; Smith JS, 2000, J CLIN ONCOL, V18, P636, DOI 10.1200/JCO.2000.18.3.636; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	25	380	395	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2011	333	6048					1453	1455		10.1126/science.1210557	http://dx.doi.org/10.1126/science.1210557			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817KU	21817013	Green Accepted			2022-12-01	WOS:000294672200044
J	Taylor, MR				Taylor, Michael R.			Will the Food Safety Modernization Act Help Prevent Outbreaks of Foodborne Illness?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									US FDA, Off Deputy Commissioner Foods, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Taylor, MR (corresponding author), US FDA, Off Deputy Commissioner Foods, Silver Spring, MD 20993 USA.							Cavallaro E, 2011, NEW ENGL J MED, V365, P601, DOI 10.1056/NEJMoa1011208; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483	2	19	19	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2011	365	9							e18	10.1056/NEJMp1109388	http://dx.doi.org/10.1056/NEJMp1109388			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	813YC	21848454				2022-12-01	WOS:000294405200004
J	Hashimoto, S; Boissel, S; Zarhrate, M; Rio, M; Munnich, A; Egly, JM; Colleaux, L				Hashimoto, Satoru; Boissel, Sarah; Zarhrate, Mohammed; Rio, Marlene; Munnich, Arnold; Egly, Jean-Marc; Colleaux, Laurence			MED23 Mutation Links Intellectual Disability to Dysregulation of Immediate Early Gene Expression	SCIENCE			English	Article							PREINITIATION COMPLEX; TRANSCRIPTIONAL REGULATION; CHROMATIN MODIFICATION; MEDIATOR COMPLEX; ACTIVATION; MECHANISM; TFIIH; RECRUITMENT; PATHWAY; JUN	MED23 is a subunit of the Mediator complex, a key regulator of protein-coding gene expression. Here, we report a missense mutation (p. R617Q) in MED23 that cosegregates with nonsyndromic autosomal recessive intellectual disability. This mutation specifically impaired the response of JUN and FOS immediate early genes (IEGs) to serum mitogens by altering the interaction between enhancer-bound transcription factors (TCF4 and ELK1, respectively) and Mediator. Transcriptional dysregulation of these genes was also observed in cells derived from patients presenting with other neurological disorders linked to mutations in other Mediator subunits or proteins interacting with MED. These findings highlight the crucial role of Mediator in brain development and functioning and suggest that altered IEG expression might be a common molecular hallmark of cognitive deficit.	[Hashimoto, Satoru; Egly, Jean-Marc] Univ Strasbourg, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, Cu Strasbourg, France; [Boissel, Sarah; Zarhrate, Mohammed; Rio, Marlene; Munnich, Arnold; Colleaux, Laurence] Univ Paris 05, Hop Necker Enfants Malad, INSERM U781, F-75015 Paris, France; [Boissel, Sarah; Zarhrate, Mohammed; Rio, Marlene; Munnich, Arnold; Colleaux, Laurence] Univ Paris 05, Hop Necker Enfants Malad, Fdn IMAGINE, Dept Genet, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Egly, JM (corresponding author), Univ Strasbourg, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, BP 163, F-67404 Illkirch Graffenstaden, Cu Strasbourg, France.	egly@igbmc.fr; laurence.colleaux@inserm.fr	COLLEAUX, LAURENCE/AAA-8144-2022; COLLEAUX, Laurence/H-6455-2017	COLLEAUX, LAURENCE/0000-0002-0987-7648; Rio, Marlene/0000-0003-2049-5058	European Research Council [2009]; French National Research Agency [ANR-08-GENOPAT-042, ANR-08-MNP-010]; Association pour la Recherche sur le Cancer [SL220100601335]; Centre National de la Recherche Scientifique; INSERM; Region Ile-de France; Fondation pour la Recherche Medicale; Fondation Jerome Lejeune	European Research Council(European Research Council (ERC)European Commission); French National Research Agency(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Ile-de France(Region Ile-de-France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation Jerome Lejeune	We are grateful to the patients and their families for their participation in the study. We thank J. P. Jais for LOD-score calculation. Work in the J.-M. Egly's laboratory was supported by a European Research Council Advanced Grant 2009, the French National Research Agency (no. ANR-08-GENOPAT-042), and the Association pour la Recherche sur le Cancer (SL220100601335). L. Colleaux's laboratory was supported in part by the Centre National de la Recherche Scientifique and the French National Research Agency (no. ANR-08-MNP-010). S.H. was supported by an INSERM young investigator grant. S.B. was supported by the Region Ile-de France, the Fondation pour la Recherche Medicale, and the Fondation Jerome Lejeune. The authors declare that they have no conflicts of interest.	Akoulitchev S, 2000, NATURE, V407, P102, DOI 10.1038/35024111; Balamotis MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.1164302; Black JC, 2006, MOL CELL, V23, P809, DOI 10.1016/j.molcel.2006.07.018; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Cai G, 2009, STRUCTURE, V17, P559, DOI 10.1016/j.str.2009.01.016; Cantin GT, 2003, P NATL ACAD SCI USA, V100, P12003, DOI 10.1073/pnas.2035253100; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; Compe E, 2007, NAT NEUROSCI, V10, P1414, DOI 10.1038/nn1990; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Le May N, 2010, MOL CELL, V38, P54, DOI 10.1016/j.molcel.2010.03.004; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; Sanyal S, 2002, NATURE, V416, P870, DOI 10.1038/416870a; Schwartz CE, 2007, J MED GENET, V44, P472, DOI 10.1136/jmg.2006.048637; SINGH N, 1995, GENE DEV, V9, P2251, DOI 10.1101/gad.9.18.2251; Soutourina J, 2011, SCIENCE, V331, P1451, DOI 10.1126/science.1200188; Stevens JL, 2002, SCIENCE, V296, P755, DOI 10.1126/science.1068943; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Tischmeyer W, 1999, CELL MOL LIFE SCI, V55, P564, DOI 10.1007/s000180050315; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010	28	82	90	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 26	2011	333	6046					1161	1163		10.1126/science.1206638	http://dx.doi.org/10.1126/science.1206638			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21868677				2022-12-01	WOS:000294244300053
J	Reed, RD; Papa, R; Martin, A; Hines, HM; Counterman, BA; Pardo-Diaz, C; Jiggins, CD; Chamberlain, NL; Kronforst, MR; Chen, R; Halder, G; Nijhout, HF; McMillan, WO				Reed, Robert D.; Papa, Riccardo; Martin, Arnaud; Hines, Heather M.; Counterman, Brian A.; Pardo-Diaz, Carolina; Jiggins, Chris D.; Chamberlain, Nicola L.; Kronforst, Marcus R.; Chen, Rui; Halder, Georg; Nijhout, H. Frederik; McMillan, W. Owen			optix Drives the Repeated Convergent Evolution of Butterfly Wing Pattern Mimicry	SCIENCE			English	Article							GENETICS	Mimicry-whereby warning signals in different species evolve to look similar-has long served as a paradigm of convergent evolution. Little is known, however, about the genes that underlie the evolution of mimetic phenotypes or to what extent the same or different genes drive such convergence. Here, we characterize one of the major genes responsible for mimetic wing pattern evolution in Heliconius butterflies. Mapping, gene expression, and population genetic work all identify a single gene, optix, that controls extreme red wing pattern variation across multiple species of Heliconius. Our results show that the cis-regulatory evolution of a single transcription factor can repeatedly drive the convergent evolution of complex color patterns in distantly related species, thus blurring the distinction between convergence and homology.	[Reed, Robert D.; Papa, Riccardo; Martin, Arnaud] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; [Papa, Riccardo] Univ Puerto Rico, Dept Biol, Rio Piedras, PR 00931 USA; [Papa, Riccardo] Univ Puerto Rico, Ctr Appl Trop Ecol & Conservat, Rio Piedras, PR 00931 USA; [Hines, Heather M.; McMillan, W. Owen] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Counterman, Brian A.] Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA; [Pardo-Diaz, Carolina; Jiggins, Chris D.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Chamberlain, Nicola L.; Kronforst, Marcus R.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Chen, Rui] Baylor Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Halder, Georg] Univ Texas Houston, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Nijhout, H. Frederik] Duke Univ, Dept Biol, Durham, NC 27708 USA; [McMillan, W. Owen] Smithsonian Trop Res Inst, Panama City, Panama	University of California System; University of California Irvine; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras; University of Puerto Rico; University of Puerto Rico Rio Piedras; University of North Carolina; North Carolina State University; Mississippi State University; University of Cambridge; Harvard University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Duke University; Smithsonian Institution; Smithsonian Tropical Research Institute	Reed, RD (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA.	rreed@uci.edu; rpapa.lab@gmail.com	Reed, Robert D/A-2419-2008; Jiggins, Chris/T-4296-2019; Pardo-Diaz, Carolina/C-7936-2016; Halder, Georg/F-2966-2015; Jiggins, Chris D/B-9960-2008	Jiggins, Chris/0000-0002-7809-062X; Pardo-Diaz, Carolina/0000-0002-7259-1183; Halder, Georg/0000-0001-7580-3236; Jiggins, Chris D/0000-0002-7809-062X; Martin, Arnaud/0000-0002-5980-2249; Reed, Robert/0000-0002-6065-6728; McMillan, W. Owen/0000-0003-2805-2745; Counterman, Brian/0000-0003-2724-071X	NSF; NIH; Centre National de la Recherche Scientifique-Guyane; Peruvian Ministerio de Agricultura and Instituto Nacional De Recursos Naturales [004-2008-INRENA-IFFS-DCB, 011756-AG-INRENA]; French Guiana Ministere de L'Ecologie, de L'Energie, du Developpemet Durable et de la Mar [BIODAD-2010-0433]; Ecuadorian Ministerio del Ambiente Ecuadorian [013-09 IC-FAU-DNB/MA]; Panamanian Autoridad Nacional del Ambiente [SC/A-7-11]	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centre National de la Recherche Scientifique-Guyane; Peruvian Ministerio de Agricultura and Instituto Nacional De Recursos Naturales; French Guiana Ministere de L'Ecologie, de L'Energie, du Developpemet Durable et de la Mar; Ecuadorian Ministerio del Ambiente Ecuadorian; Panamanian Autoridad Nacional del Ambiente	We thank M. A. Flores and A. Portugal for help rearing butterflies, M.-J. Sung for help with electron microscopy, J. Miller for help with microarray analysis, and J. Mallet for sharing samples. Supported by funding from NSF (R.D.R., W.O.M., M.R.K.), NIH (H.M.H., M.R.K.), and Centre National de la Recherche Scientifique-Guyane (B.A.C.) Sequences are available on GenBank (JN102349-JN102354). Microarray data are available on Gene Expression Omnibus (GSE30221). Permission to collect and export butterfly tissue was provided by the Peruvian Ministerio de Agricultura and Instituto Nacional De Recursos Naturales (004-2008-INRENA-IFFS-DCB and 011756-AG-INRENA); the French Guiana Ministere de L'Ecologie, de L'Energie, du Developpemet Durable et de la Mar (BIODAD-2010-0433); the Ecuadorian Ministerio del Ambiente Ecuadorian (013-09 IC-FAU-DNB/MA); and the Panamanian Autoridad Nacional del Ambiente (SC/A-7-11). W.O.M., F.N, and R.D.R. designed experiments and conducted initial work. R.P. produced butterfly crosses and generated and analyzed the microarray data with H.M.H. A.M. generated in situ hybridization data. B.A.C., C.P.-D., C.D.J., N.L.C, and M.R.K. contributed nucleotide association data. R.C. and G.H. assisted with positional cloning. R.P., A.M., B.A.C., and R.D.R. prepared figures and R.D.R. wrote the manuscript with support from R.P., A.M., and W.O.M. The authors declare that they have no competing financial interests.	Arendt J, 2008, TRENDS ECOL EVOL, V23, P26, DOI 10.1016/j.tree.2007.09.011; Baxter SW, 2008, GENETICS, V180, P1567, DOI 10.1534/genetics.107.082982; Baxter SW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000794; BROWN K.S., 1979, THESIS U ESTADUAL CA; Chamberlain NL, 2011, HEREDITY, V107, P200, DOI 10.1038/hdy.2011.3; Counterman BA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000796; MALLET J, 1995, BIOL J LINN SOC, V55, P159, DOI 10.1111/j.1095-8312.1995.tb01057.x; Papa R, 2008, CURR OPIN GENET DEV, V18, P559, DOI 10.1016/j.gde.2008.11.007; Papa R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-345; Pohl N, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-99; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; SHEPPARD PM, 1985, PHILOS T R SOC B, V308, P433, DOI 10.1098/rstb.1985.0066; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; Wagner GP, 2007, NAT REV GENET, V8, P473, DOI 10.1038/nrg2099; Werner T, 2010, NATURE, V464, P1143, DOI 10.1038/nature08896	15	283	287	5	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2011	333	6046					1137	1141		10.1126/science.1208227	http://dx.doi.org/10.1126/science.1208227			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21778360				2022-12-01	WOS:000294244300046
J	Goldfine, AB; Kaul, S; Hiatt, WR				Goldfine, Allison B.; Kaul, Sanjay; Hiatt, William R.			Fibrates in the Treatment of Dyslipidemias - Time for a Reassessment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GEMFIBROZIL; PREVENTION; THERAPY; MEN		[Goldfine, Allison B.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Goldfine, Allison B.] Harvard Univ, Sch Med, Boston, MA USA; [Kaul, Sanjay] Univ Calif Los Angeles, Los Angeles, CA USA; [Kaul, Sanjay] Cedars Sinai Med Ctr, Div Cardiol, Los Angeles, CA 90048 USA; [Hiatt, William R.] Univ Colorado, Div Cardiol, Sch Med, Aurora, CO USA; [Hiatt, William R.] CPC Clin Res, Aurora, CO USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; Cedars Sinai Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus	Goldfine, AB (corresponding author), Joslin Diabet Ctr, Boston, MA 02215 USA.			Goldfine, Allison/0000-0002-0345-1048				FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1748; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Keech A, 2005, LANCET; Keech A, 2005, LANCET; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Schlesinger Z, 2000, CIRCULATION, V102, P21, DOI 10.1161/01.CIR.102.1.21	8	42	44	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2011	365	6					481	484		10.1056/NEJMp1106688	http://dx.doi.org/10.1056/NEJMp1106688			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805MW	21830963				2022-12-01	WOS:000293732100001
J	Hinch, AG; Tandon, A; Patterson, N; Song, YL; Rohland, N; Palmer, CD; Chen, GK; Wang, K; Buxbaum, SG; Akylbekova, EL; Aldrich, MC; Ambrosone, CB; Amos, C; Bandera, EV; Berndt, SI; Bernstein, L; Blot, WJ; Bock, CH; Boerwinkle, E; Cai, QY; Caporaso, N; Casey, G; Cupples, LA; Deming, SL; Diver, WR; Divers, J; Fornage, M; Gillanders, EM; Glessner, J; Harris, CC; Hu, JJ; Ingles, SA; Isaacs, W; John, EM; Kao, WHL; Keating, B; Kittles, RA; Kolonel, LN; Larkin, E; Le Marchand, L; McNeill, LH; Millikan, RC; Murphy, A; Musani, S; Neslund-Dudas, C; Nyante, S; Papanicolaou, GJ; Press, MF; Psaty, BM; Reiner, AP; Rich, SS; Rodriguez-Gil, JL; Rotter, JI; Rybicki, BA; Schwartz, AG; Signorello, LB; Spitz, M; Strom, SS; Thun, MJ; Tucker, MA; Wang, ZM; Wiencke, JK; Witte, JS; Wrensch, M; Wu, XF; Yamamura, Y; Zanetti, KA; Zheng, W; Ziegler, RG; Zhu, XF; Redline, S; Hirschhorn, JN; Henderson, BE; Taylor, HA; Price, AL; Hakonarson, H; Chanock, SJ; Haiman, CA; Wilson, JG; Reich, D; Myers, SR				Hinch, Anjali G.; Tandon, Arti; Patterson, Nick; Song, Yunli; Rohland, Nadin; Palmer, Cameron D.; Chen, Gary K.; Wang, Kai; Buxbaum, Sarah G.; Akylbekova, Ermeg L.; Aldrich, Melinda C.; Ambrosone, Christine B.; Amos, Christopher; Bandera, Elisa V.; Berndt, Sonja I.; Bernstein, Leslie; Blot, William J.; Bock, Cathryn H.; Boerwinkle, Eric; Cai, Qiuyin; Caporaso, Neil; Casey, Graham; Cupples, L. Adrienne; Deming, Sandra L.; Diver, W. Ryan; Divers, Jasmin; Fornage, Myriam; Gillanders, Elizabeth M.; Glessner, Joseph; Harris, Curtis C.; Hu, Jennifer J.; Ingles, Sue A.; Isaacs, William; John, Esther M.; Kao, W. H. Linda; Keating, Brendan; Kittles, Rick A.; Kolonel, Laurence N.; Larkin, Emma; Le Marchand, Loic; McNeill, Lorna H.; Millikan, Robert C.; Murphy, Adam; Musani, Solomon; Neslund-Dudas, Christine; Nyante, Sarah; Papanicolaou, George J.; Press, Michael F.; Psaty, Bruce M.; Reiner, Alex P.; Rich, Stephen S.; Rodriguez-Gil, Jorge L.; Rotter, Jerome I.; Rybicki, Benjamin A.; Schwartz, Ann G.; Signorello, Lisa B.; Spitz, Margaret; Strom, Sara S.; Thun, Michael J.; Tucker, Margaret A.; Wang, Zhaoming; Wiencke, John K.; Witte, John S.; Wrensch, Margaret; Wu, Xifeng; Yamamura, Yuko; Zanetti, Krista A.; Zheng, Wei; Ziegler, Regina G.; Zhu, Xiaofeng; Redline, Susan; Hirschhorn, Joel N.; Henderson, Brian E.; Taylor, Herman A., Jr.; Price, Alkes L.; Hakonarson, Hakon; Chanock, Stephen J.; Haiman, Christopher A.; Wilson, James G.; Reich, David; Myers, Simon R.			The landscape of recombination in African Americans	NATURE			English	Article							HUMAN GENOME; MEIOTIC RECOMBINATION; MAP; HUMANS; PRDM9; POPULATIONS; SEQUENCE; HOTSPOTS; GENE; INSTABILITY	Recombination, together with mutation, gives rise to genetic variation in populations. Here we leverage the recent mixture of people of African and European ancestry in the Americas to build a genetic map measuring the probability of crossing over at each position in the genome, based on about 2.1 million crossovers in 30,000 unrelated African Americans. At intervals of more than three megabases it is nearly identical to a map built in Europeans. At finer scales it differs significantly, and we identify about 2,500 recombination hotspots that are active in people of West African ancestry but nearly inactive in Europeans. The probability of a crossover at these hotspots is almost fully controlled by the alleles an individual carries at PRDM9(P value <10(-245)). We identify a 17-base-pair DNA sequence motif that is enriched in these hotspots, and is an excellent match to the predicted binding target of PRDM9 alleles common in West Africans and rare in Europeans. Sites of this motif are predicted to be risk loci for disease-causing genomic rearrangements in individuals carrying these alleles. More generally, this map provides a resource for research in human genetic variation and evolution.	[Tandon, Arti; Patterson, Nick; Rohland, Nadin; Reich, David] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Hinch, Anjali G.; Myers, Simon R.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Tandon, Arti; Rohland, Nadin; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Song, Yunli; Myers, Simon R.] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Palmer, Cameron D.; Hirschhorn, Joel N.] Broad Inst, Program Med & Populat Genet, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Palmer, Cameron D.; Hirschhorn, Joel N.] Childrens Hosp Boston, Div Endocrinol, Boston, MA 02115 USA; [Palmer, Cameron D.; Hirschhorn, Joel N.] Childrens Hosp Boston, Div Genet, Boston, MA 02115 USA; [Palmer, Cameron D.; Hirschhorn, Joel N.] Childrens Hosp Boston, Program Genom, Boston, MA 02115 USA; [Chen, Gary K.; Casey, Graham; Ingles, Sue A.; Press, Michael F.; Henderson, Brian E.; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA; [Chen, Gary K.; Casey, Graham; Ingles, Sue A.; Press, Michael F.; Henderson, Brian E.; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90033 USA; [Wang, Kai] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Wang, Kai; Glessner, Joseph; Keating, Brendan; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Buxbaum, Sarah G.; Akylbekova, Ermeg L.] Jackson State Univ, Jackson Heart Study Coordinating Ctr, Jackson, MS 39213 USA; [Akylbekova, Ermeg L.; Musani, Solomon; Taylor, Herman A., Jr.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Aldrich, Melinda C.] Vanderbilt Univ, Sch Med, Dept Thorac Surg, Nashville, TN 37203 USA; [Aldrich, Melinda C.; Blot, William J.; Cai, Qiuyin; Deming, Sandra L.; Signorello, Lisa B.; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Div Epidemiol,Dept Med, Nashville, TN 37203 USA; [Aldrich, Melinda C.; Blot, William J.; Cai, Qiuyin; Deming, Sandra L.; Signorello, Lisa B.; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37203 USA; [Ambrosone, Christine B.] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Amos, Christopher; Spitz, Margaret; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Div Canc Prevent & Populat Sci, Houston, TX 77030 USA; [Bandera, Elisa V.] Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Berndt, Sonja I.; Caporaso, Neil; Tucker, Margaret A.; Ziegler, Regina G.; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Bernstein, Leslie] City Hope Natl Med Ctr, Div Canc Etiol, Dept Populat Sci, Beckman Res Inst, Duarte, CA 91010 USA; [Blot, William J.; Signorello, Lisa B.] Int Epidemiol Inst, Rockville, MD 20850 USA; [Bock, Cathryn H.; Schwartz, Ann G.] Wayne State Univ Med, Karmanos Canc Inst, Detroit, MI 48201 USA; [Bock, Cathryn H.; Schwartz, Ann G.] Wayne State Univ Med, Dept Oncol, Detroit, MI 48201 USA; [Boerwinkle, Eric] Univ Texas Houston, Ctr Human Genet, Houston, TX 77030 USA; [Boerwinkle, Eric] Univ Texas Houston, Div Epidemiol, Houston, TX 77030 USA; [Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Cupples, L. Adrienne] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; [Diver, W. Ryan; Thun, Michael J.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30303 USA; [Divers, Jasmin] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Winston Salem, NC 27157 USA; [Fornage, Myriam; Gillanders, Elizabeth M.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Inst Mol Med, Houston, TX 77030 USA; [Fornage, Myriam; Gillanders, Elizabeth M.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Epidemiol, Houston, TX 77030 USA; [Zanetti, Krista A.] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; [Harris, Curtis C.; Zanetti, Krista A.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Hu, Jennifer J.; Rodriguez-Gil, Jorge L.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Hu, Jennifer J.; Rodriguez-Gil, Jorge L.] Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Miami, FL 33136 USA; [Isaacs, William] Johns Hopkins Hosp & Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21287 USA; [John, Esther M.] Canc Prevent Inst Calif, Fremont, CA 94538 USA; [John, Esther M.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [John, Esther M.] Stanford Canc Ctr, Stanford, CA 94305 USA; [Kao, W. H. Linda] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Kittles, Rick A.] Univ Illinois, Dept Med, Chicago, IL 60607 USA; [Kolonel, Laurence N.; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96813 USA; [Larkin, Emma] Vanderbilt Univ, Med Ctr, Div Allergy Pulm & Crit Care, Dept Med,Med Ctr E, Nashville, TN 37232 USA; [McNeill, Lorna H.] Univ Texas MD Anderson Canc Ctr, Dept Hlth Dispar Res, Div OVP Canc Prevent & Populat Sci, Houston, TX 77030 USA; [McNeill, Lorna H.] Univ Texas MD Anderson Canc Ctr, Ctr Community Implementat & Disseminat Res, Duncan Family Inst, Houston, TX 77030 USA; [Millikan, Robert C.; Nyante, Sarah] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Millikan, Robert C.; Nyante, Sarah] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Murphy, Adam] Northwestern Univ, Dept Urol, Chicago, IL 60611 USA; [Neslund-Dudas, Christine; Rybicki, Benjamin A.] Henry Ford Hosp, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Papanicolaou, George J.] NHLBI, Div Cardiovasc Sci, Bethesda, MD 20892 USA; [Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Res Inst, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Seattle, WA 98101 USA; [Reiner, Alex P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Wang, Zhaoming] Natl Canc Inst Frederick, Core Genotype Facil, SAIC Frederick Inc, Frederick, MD 20877 USA; [Witte, John S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, Inst Human Genet, San Francisco, CA 94158 USA; [Witte, John S.] Univ Calif San Francisco, Dept Urol, Inst Human Genet, San Francisco, CA 94158 USA; [Zhu, Xiaofeng] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Redline, Susan] Brigham & Womens Hosp, Dept Med, Div Sleep Med, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Taylor, Herman A., Jr.] Jackson State Univ, Jackson, MS 39217 USA; [Taylor, Herman A., Jr.] Tougaloo Coll, Tougaloo, MS 39174 USA; [Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Hakonarson, Hakon] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Oxford; Wellcome Centre for Human Genetics; Harvard University; Harvard Medical School; University of Oxford; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Southern California; University of Southern California; University of Southern California; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Jackson State University; University of Mississippi; University of Mississippi Medical Center; Vanderbilt University; Vanderbilt University; Vanderbilt University; Roswell Park Cancer Institute; University of Texas System; UTMD Anderson Cancer Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); City of Hope; Beckman Research Institute of City of Hope; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Boston University; Framingham Heart Study; American Cancer Society; Wake Forest University; Wake Forest Baptist Medical Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Miami; University of Miami; Johns Hopkins University; Johns Hopkins Medicine; Cancer Prevention Institute of California; Stanford University; Stanford Cancer Institute; Stanford University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Cancer Research Center of Hawaii; University of Hawaii System; Vanderbilt University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Northwestern University; Henry Ford Health System; Henry Ford Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Washington; University of Washington Seattle; University of Virginia; Cedars Sinai Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Case Western Reserve University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Jackson State University; Tougaloo College; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Pennsylvania; University of Mississippi; University of Mississippi Medical Center	Reich, D (corresponding author), Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA.	reich@genetics.med.harvard.edu; myers@stats.ox.ac.uk	Diver, Ryan/AAG-3469-2019; Tucker, Margaret A/B-4297-2015; Rybicki, Benjamin/L-4614-2019; Aldrich, Melinda/C-7783-2013; Zheng, Wei/O-3351-2013; Rotter, Jerome/AAY-6598-2021; Jorge L. Rodriguez-Gil, D.Phil/AAD-3523-2020; Myers, Simon R/A-6792-2015; zhang, weihua/GXV-1334-2022; Buxbaum, Sarah G./E-1970-2013; Berndt, Sonja I/J-8423-2016; Bandera, Elisa V/M-4169-2014; Zhu, Xiaofeng/O-6874-2019; Wang, Zhaoming/R-5527-2018	Diver, Ryan/0000-0002-5418-9000; Rybicki, Benjamin/0000-0003-3190-3467; Zheng, Wei/0000-0003-1226-070X; Jorge L. Rodriguez-Gil, D.Phil/0000-0002-1125-1281; Myers, Simon R/0000-0002-2585-9626; Buxbaum, Sarah G./0000-0002-4886-3564; Bandera, Elisa V/0000-0002-8789-2755; Wang, Zhaoming/0000-0001-7556-3869; Nyante, Sarah/0000-0002-1770-5993; Zhu, Xiaofeng/0000-0003-0037-411X; Cupples, L. Adrienne/0000-0003-0273-7965; Glessner, Joseph/0000-0001-5131-2811; Rich, Stephen/0000-0003-3872-7793	Wellcome Trust; NIH [HL084107, GM091332]; National Heart, Lung and Blood Institute [HHSN268200960009C]; Children's Hospital of Philadelphia; Landenberger Foundation; Cotswold Foundation; DoD; Norris Foundation; MEC [CA63464, CA54281]; CARE [HD33175]; WCHS [CA100598]; DAMD [170100334, 17966071, W81XWH0710645, W81XWH0710203, W81XWH0610066]; Breast Cancer Research Foundation; SFBC [CA77305]; CBCS [CA58223, ES10126]; PLCO; NHBS [CA100374]; WFBC [R01-CA73629]; CPS-II (the American Cancer Society); LAAPC [99-00524V-10258, PC35139, DP000807]; MEC; MDA [CA68578, CA140388, ES007784]; GECAP [ES011126]; CaP Genes [CA88164]; IPCG [W81XWH0710122]; DCPC [GM08016]; SCCS [CA092447, CA68485]; University Cancer Foundation; Duncan Family institute; Center for Community; Implementation and Dissemination Research Core; Maryland Studies;  [CA1326792];  [CA148085];  [HG004726];  [CA060691];  [CA87895];  [PC35145];  [CA22453];  [ES06717];  [CA55769];  [CA127219];  [CA1116460S1];  [CA1116460];  [CA121197];  [CA141716];  [CA121197S2];  [CPRIT RP100443];  [CA148127];  [DAMD W81XWH0710645]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD033175] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA088164, R01CA100598, R01CA127219, R01CA052689, R01CA087895, P50CA140388, R01CA077305, R01CA054281, R01CA073629, R01CA068578, RC2CA148085, R01CA063464, R01CA141716, R37CA054281, U01CA063464, U19CA148127, R01CA100374, R01CA060691, P30CA068485, P30CA022453, R01CA092447, P50CA058223, R01CA055769, R01CA121197] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U58DP000807] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084107, R01HL065226] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004726, R01HG006399, U01HG004168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126, R01ES011126, R01ES006717, P30ES007784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC1GM091332, S06GM008016] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Children's Hospital of Philadelphia; Landenberger Foundation; Cotswold Foundation; DoD(United States Department of Defense); Norris Foundation; MEC(European Commission); CARE; WCHS; DAMD; Breast Cancer Research Foundation; SFBC; CBCS; PLCO; NHBS; WFBC; CPS-II (the American Cancer Society)(American Cancer Society); LAAPC; MEC(European Commission); MDA(Muscular Dystrophy Association); GECAP; CaP Genes; IPCG; DCPC; SCCS; University Cancer Foundation; Duncan Family institute; Center for Community; Implementation and Dissemination Research Core; Maryland Studies; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the participants who donated DNA samples, to D. Altshuler, J. Buard, K. Bryc, J. Kovacs, B. de Massy, G. McVean, B. Pasaniuc and S. Sankararaman for conversations and critiques, and to A. Auton for facilitating analysis of the 1000 Genomes Project data. Analysis was supported by the Wellcome Trust and NIH grants HL084107 and GM091332. CARe was supported by a contract from the National Heart, Lung and Blood Institute (HHSN268200960009C) to create a phenotype and genotype database for dissemination to the biomedical research community. Eight parent studies contributed phenotypic data and DNA samples through the Broad Institute (N01-HC-65226): the Atherosclerosis Risk in Communities study (ARIC), the Cleveland Family Study (CFS), the Coronary Artery Risk Development in Young Adults study (CARDIA), the Jackson Heart Study (JHS), the Multi-Ethnic Study of Atherosclerosis (MESA) study, the Cardiovascular Health Study (CHS), the Framingham Heart Study (FHS) and the Sleep Heart Health Study (SHHS). Support for CARe also came from the individual research institutions, investigators, field staff and study participants. Individual funding information is available at http://public.nhlbi.nih.gov/GeneticsGenomics/home/care.aspx. All genome-wide genotyping of samples from the Children's Hospital of Pennsylvania (CHOP) was supported by an Institutional Development Award to the Center for Applied Genomics from the Children's Hospital of Philadelphia, a research award from the Landenberger Foundation and the Cotswold Foundation. We thank all study participants and the staff at the Center for Applied Genomics for performing the genotyping. The African American Breast Cancer Consortium (AABCC) was supported by a DoD Breast Cancer Research Program Era of Hope Scholar Award to C. A. H. and the Norris Foundation, and by grants to the component studies: MEC (CA63464, CA54281); CARE (HD33175); WCHS (CA100598, DAMD 170100334, Breast Cancer Research Foundation); SFBC (CA77305, DAMD 17966071); CBCS (CA58223, ES10126), PLCO (NCI Intramural Research Program); NHBS (CA100374); WFBC (R01-CA73629); and CPS-II (the American Cancer Society). The African American Prostate Cancer Consortium(AAPCC) was supported by grants CA63464, CA54281, CA1326792, CA148085 and HG004726, and by grants to the component studies: PLCO (NCI Intramural Research Program), LAAPC (Cancer Research Fund 99-00524V-10258), both MEC and LAAPC (PC35139, DP000807); MDA (CA68578, CA140388, ES007784, DAMD W81XWH0710645); GECAP (ES011126); CaP Genes (CA88164); IPCG (W81XWH0710122); DCPC (GM08016, DAMD W81XWH0710203, DAMD W81XWH0610066); and SCCS (CA092447, CA68485). The African American Lung Cancer Consortium(AALCC) was supported by grants CA060691, CA87895, PC35145 and CA22453, CA68578, CA140388, ES007784, ES06717, CA55769, CA127219, CA1116460S1, CA1116460, CA121197, CA141716, CA121197S2, CPRIT RP100443, CA148127, DAMD W81XWH0710645, University Cancer Foundation, Duncan Family institute, Center for Community, Implementation and Dissemination Research Core, and by grants to the component studies: PLCO and the Maryland Studies (NCI Intramural Research Program), LAAPC (Cancer Research Fund 99-00524V-10258), and both MEC and LAAPC (PC35139, DP000807).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; De Raedt T, 2006, NAT GENET, V38, P1419, DOI 10.1038/ng1920; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; GRIFFITHS RC, 1995, MATH BIOSCI, V127, P77, DOI 10.1016/0025-5564(94)00044-Z; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jorgenson E, 2005, AM J HUM GENET, V76, P276, DOI 10.1086/427926; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2008, SCIENCE, V319, P1398, DOI 10.1126/science.1152422; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Matise TC, 2007, GENOME RES, V17, P1783, DOI 10.1101/gr.7156307; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Sankararaman S, 2008, AM J HUM GENET, V82, P290, DOI 10.1016/j.ajhg.2007.09.022; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; WEITKAMP LR, 1974, CYTOGENET CELL GENET, V13, P179, DOI 10.1159/000130267	29	208	211	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2011	476	7359					170	U67		10.1038/nature10336	http://dx.doi.org/10.1038/nature10336			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21775986	Green Accepted, Green Submitted			2022-12-01	WOS:000293731900028
J	Barker, MK				Barker, Mary Kavanagh			A Great Case	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Harvard Vanguard Med Associates, Wellesley, MA 02481 USA	Harvard Vanguard Medical Associates	Barker, MK (corresponding author), Harvard Vanguard Med Associates, Wellesley, MA 02481 USA.	mary_barker@vmed.org							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 10	2011	306	6					588	589		10.1001/jama.2011.905	http://dx.doi.org/10.1001/jama.2011.905			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	804XD	21828314				2022-12-01	WOS:000293687300001
J	Spence, D				Spence, Des			FROM THE FRONTLINE Inactivity and obesity	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						2008, OBESITY, V16, P654, DOI DOI 10.1038/0BY.2007.103	1	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 10	2011	343								d5093	10.1136/bmj.d5093	http://dx.doi.org/10.1136/bmj.d5093			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	808DL	21831949				2022-12-01	WOS:000293956300020
J	Wiener, RS; Schwartz, LM; Woloshin, S; Welch, HG				Wiener, Renda Soylemez; Schwartz, Lisa M.; Woloshin, Steven; Welch, H. Gilbert			Population-Based Risk for Complications After Transthoracic Needle Lung Biopsy of a Pulmonary Nodule: An Analysis of Discharge Records	ANNALS OF INTERNAL MEDICINE			English	Article							PNEUMOTHORAX; ASPIRATION; ICD-9-CM; LESIONS; HEMORRHAGE; CANCER	Background: Because pulmonary nodules are found in up to 25% of patients undergoing computed tomography of the chest, the question of whether to perform biopsy is becoming increasingly common. Data on complications after transthoracic needle lung biopsy are limited to case series from selected institutions. Objective: To determine population-based estimates of risks for complications after transthoracic needle biopsy of a pulmonary nodule. Design: Cross-sectional analysis. Setting: The 2006 State Ambulatory Surgery Databases and State Inpatient Databases for California, Florida, Michigan, and New York from the Healthcare Cost and Utilization Project. Patients: 15 865 adults who had transthoracic needle biopsy of a pulmonary nodule. Measurements: Percentage of biopsies complicated by hemorrhage, any pneumothorax, or pneumothorax requiring a chest tube, and adjusted odds ratios for these complications associated with various biopsy characteristics, calculated by using multivariate, population-averaged generalized estimating equations. Results: Although hemorrhage was rare, complicating 1.0% (95% CI, 0.9% to 1.2%) of biopsies, 17.8% (CI, 11.8% to 23.8%) of patients with hemorrhage required a blood transfusion. In contrast, the risk for any pneumothorax was 15.0% (CI, 14.0% to 16.0%), and 6.6% (CI, 6.0% to 7.2%) of all biopsies resulted in pneumothorax requiring a chest tube. Compared with patients without complications, those who experienced hemorrhage or pneumothorax requiring a chest tube had longer lengths of stay (P < 0.001) and were more likely to develop respiratory failure requiring mechanical ventilation (P = 0.020). Patients aged 60 to 69 years (as opposed to younger or older patients), smokers, and those with chronic obstructive pulmonary disease had higher risk for complications. Limitations: Estimated risks may be inaccurate if coding of complications is incomplete. The analyzed databases contain little clinical detail (such as information on nodule characteristics or biopsy pathology) and cannot indicate whether performing the biopsy produced useful information. Conclusion: Whereas hemorrhage is an infrequent complication of transthoracic needle lung biopsy, pneumothorax is common and often necessitates chest tube placement. These population-based data should help patients and physicians make more informed choices about whether to perform biopsy of a pulmonary nodule.	[Wiener, Renda Soylemez] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; Edith Nourse Rogers Mem Vet Adm Hosp, Ctr Hlth Qual Outcomes & Econ Res, Bedford, MA 01730 USA; Dept Vet Affairs, Vet Affairs Outcomes Grp, White River Jct, VT USA; Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA	Boston University; Dartmouth College	Wiener, RS (corresponding author), Boston Univ, Sch Med, Ctr Pulm, 72 E Concord St,R-304, Boston, MA 02118 USA.	rwiener@bu.edu	Wiener, Renda/AAO-1557-2020	Wiener, Renda/0000-0001-7712-2135	National Cancer Institute [K07 CA138772]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [K07CA138772] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By career development award K07 CA138772 from the National Cancer Institute (Dr. Wiener) and by the Department of Veterans Affairs.	[Anonymous], 2010, LUNG CANC TRIAL RES; Chakrabarti B, 2009, RESP MED, V103, P449, DOI 10.1016/j.rmed.2008.09.010; Covey AM, 2004, J VASC INTERV RADIOL, V15, P479; Croswell JM, 2010, ANN INTERN MED, V152, P505, DOI 10.7326/0003-4819-152-8-201004200-00007; De Coster C, 2008, MED CARE, V46, P627, DOI 10.1097/MLR.0b013e3181649439; Geraghty PR, 2003, RADIOLOGY, V229, P475, DOI 10.1148/radiol.2291020499; Gould MK, 2007, CHEST, V132, p108S, DOI 10.1378/chest.07-1353; Healthcare Cost and Utilization Project (HCUP), 2006, HCUP STAT AMB SURG D; Healthcare Cost and Utilization Project (HCUP), 2006, HCUP STAT INP DAT SI; Heyer CM, 2008, ACAD RADIOL, V15, P1017, DOI 10.1016/j.acra.2008.02.018; Hiraki T, 2010, AM J ROENTGENOL, V194, P809, DOI 10.2214/AJR.09.3224; Hodges A, 2009, CODING Q A ASK EXPER; Khan MF, 2008, EUR RADIOL, V18, P1356, DOI 10.1007/s00330-008-0893-1; Laspas F, 2008, J MED IMAG RADIAT ON, V52, P458, DOI 10.1111/j.1440-1673.2008.01990.x; Lawthers AG, 2000, MED CARE, V38, P785, DOI 10.1097/00005650-200008000-00003; Mazza E, 2005, RADIOL MED, V110, P141; McCarthy EP, 2000, MED CARE, V38, P868, DOI 10.1097/00005650-200008000-00010; Ost D, 2003, NEW ENGL J MED, V348, P2535, DOI 10.1056/NEJMcp012290; Romano Maurizio, 2004, Radiol Med, V108, P275; Sadeghi B, 2010, AM J MED QUAL, V25, P218, DOI 10.1177/1062860609359534; United States Bureau of the Census, 2010, POP EST; Yamagami T, 2006, Australas Radiol, V50, P435, DOI 10.1111/j.1440-1673.2006.01619.x; Yeow KM, 2004, CHEST, V126, P748, DOI 10.1378/chest.126.3.748	23	324	346	1	29	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 2	2011	155	3					137	+		10.7326/0003-4819-155-3-201108020-00003	http://dx.doi.org/10.7326/0003-4819-155-3-201108020-00003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	800DJ	21810706	Green Accepted			2022-12-01	WOS:000293339600001
J	Lioy, DT; Garg, SK; Monaghan, CE; Raber, J; Foust, KD; Kaspar, BK; Hirrlinger, PG; Kirchhoff, F; Bissonnette, JM; Ballas, N; Mandel, G				Lioy, Daniel T.; Garg, Saurabh K.; Monaghan, Caitlin E.; Raber, Jacob; Foust, Kevin D.; Kaspar, Brian K.; Hirrlinger, Petra G.; Kirchhoff, Frank; Bissonnette, John M.; Ballas, Nurit; Mandel, Gail			A role for glia in the progression of Rett's syndrome	NATURE			English	Article							MECP2 DEFICIENCY; MOUSE MODEL; NEURONS; EXPRESSION; ASTROCYTES; ABNORMALITIES; DEFECTS; RELEASE	Rett's syndrome (RTT) is an X-chromosome-linked autism spectrum disorder caused by loss of function of the transcription factor methyl-CpG-binding protein 2 (MeCP2)(1). Although MeCP2 is expressed in most tissues(2), loss of MeCP2 expression results primarily in neurological symptoms(1,3,4). Earlier studies suggested the idea that RTT is due exclusively to loss of MeCP2 function in neurons(2,4-10). Although defective neurons clearly underlie the aberrant behaviours, we and others showed recently that the loss of MECP2 from glia negatively influences neurons in a non-cell-autonomous fashion(11-13). Here we show that in globally MeCP2-deficient mice, re-expression of Mecp2 preferentially in astrocytes significantly improved locomotion and anxiety levels, restored respiratory abnormalities to a normal pattern, and greatly prolonged lifespan compared to globally null mice. Furthermore, restoration of MeCP2 in the mutant astrocytes exerted a non-cell-autonomous positive effect on mutant neurons in vivo, restoring normal dendritic morphology and increasing levels of the excitatory glutamate transporter VGLUT1. Our study shows that glia, like neurons, are integral components of the neuropathology of RTT, and supports the targeting of glia as a strategy for improving the associated symptoms.	[Lioy, Daniel T.; Garg, Saurabh K.; Monaghan, Caitlin E.; Mandel, Gail] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Lioy, Daniel T.; Garg, Saurabh K.; Monaghan, Caitlin E.; Mandel, Gail] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97239 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Div Neurosci, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Foust, Kevin D.; Kaspar, Brian K.] Ohio State Univ, Dept Pediat, Ctr Gene Therapy, Nationwide Childrens Hosp, Columbus, OH 43205 USA; [Hirrlinger, Petra G.] Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany; [Kirchhoff, Frank] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Kirchhoff, Frank] Univ Saarland, Inst Pathol, D-37075 Homburg, Germany; [Bissonnette, John M.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97202 USA; [Bissonnette, John M.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97202 USA; [Ballas, Nurit] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Max Planck Society; Saarland University; Oregon Health & Science University; Oregon Health & Science University; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Mandel, G (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA.	mandelg@ohsu.edu	Kirchhoff, Frank/B-9335-2008; Kaspar, Brian/E-3349-2011	Kirchhoff, Frank/0000-0002-2324-2761; Monaghan, Caitlin/0000-0001-7055-3610	National Institutes of Health; International Rett Syndrome Foundation; Rett Syndrome Research Trust; Oregon Brain Institute; OHSU; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061800] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Rett Syndrome Foundation; Rett Syndrome Research Trust; Oregon Brain Institute; OHSU; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Brehm, R. H. Goodman, C. Bond, M. McGinley and C. Mandel-Brehm for discussions; P. Micha, J. Eng, S. Knopp and T. Shaffer for technical support; and M. Murtha for generating the CBA/CMV-MECP2 construct. ViraPur, LLC generated the AAV9 virus. The work was supported by grants from the National Institutes of Health (G. M. and N.B.), International Rett Syndrome Foundation (N.B. and J. M. B.), Rett Syndrome Research Trust (G. M. and B. K. K.), Oregon Brain Institute (D. T. L.), and OHSU Cell and Developmental Biology Training Program (D. T. L.). G. M. is an Investigator of the Howard Hughes Medical Institute.	Armstrong DD, 2005, J CHILD NEUROL, V20, P747, DOI 10.1177/08830738050200082401; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; BAUMAN ML, 1995, NEUROLOGY, V45, P1581, DOI 10.1212/WNL.45.8.1581; BRENNER M, 1994, J NEUROSCI, V14, P1030, DOI 10.1523/JNEUROSCI.14-03-01030.1994; Casper KB, 2007, GENESIS, V45, P292, DOI 10.1002/dvg.20287; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chow LML, 2008, TRANSGENIC RES, V17, P919, DOI 10.1007/s11248-008-9185-4; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Gemelli T, 2006, BIOL PSYCHIAT, V59, P468, DOI 10.1016/j.biopsych.2005.07.025; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hirrlinger PG, 2006, GLIA, V54, P11, DOI 10.1002/glia.20342; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Maezawa I, 2010, J NEUROSCI, V30, P5346, DOI 10.1523/JNEUROSCI.5966-09.2010; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; McGill BE, 2006, P NATL ACAD SCI USA, V103, P18267, DOI 10.1073/pnas.0608702103; Pelka GJ, 2006, BRAIN, V129, P887, DOI 10.1093/brain/awl022; Samaco RC, 2009, P NATL ACAD SCI USA, V106, P21966, DOI 10.1073/pnas.0912257106; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Stearns NA, 2007, NEUROSCIENCE, V146, P907, DOI 10.1016/j.neuroscience.2007.02.009; Viemari JC, 2005, J NEUROSCI, V25, P11521, DOI 10.1523/JNEUROSCI.4373-05.2005; Weese-Mayer DE, 2006, PEDIATR RES, V60, P443, DOI 10.1203/01.pdr.0000238302.84552.d0	29	338	351	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2011	475	7357					497	U90		10.1038/nature10214	http://dx.doi.org/10.1038/nature10214			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21716289	Green Accepted			2022-12-01	WOS:000293167900040
J	Morrison, D; Aitchison, M; Connelly, DT; Mair, FS				Morrison, Deborah; Aitchison, Michael; Connelly, Derek T.; Mair, Frances S.			10-MINUTE CONSULTATION Sexual dysfunction in cardiovascular disease	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Morrison, Deborah; Mair, Frances S.] Univ Glasgow, Inst Hlth & WellBeing, Acad Unit Gen Practice & Primary Care, Glasgow, Lanark, Scotland; [Aitchison, Michael] Gartnavel Royal Hosp, Glasgow, Lanark, Scotland; [Connelly, Derek T.] Glasgow Royal Infirm, Glasgow G4 0SF, Lanark, Scotland; [Connelly, Derek T.] Golden Jubilee Natl Hosp, Glasgow, Lanark, Scotland	University of Glasgow; Gartnavel Royal Hospital; University of Glasgow; Golden Jubilee Hospital	Mair, FS (corresponding author), Univ Glasgow, Inst Hlth & WellBeing, Acad Unit Gen Practice & Primary Care, Glasgow, Lanark, Scotland.	Frances.Mair@glasgow.ac.uk		Mair, Frances/0000-0001-9780-1135				Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Hackett G., 2007, BRIT SOC SEXUAL MED; Hatzimouratidis K, 2010, EUR UROL, V57, P804, DOI 10.1016/j.eururo.2010.02.020; Kostis JB, 2005, AM J CARDIOL, V96, P313, DOI 10.1016/j.amjcard.2005.03.065	4	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2011	343								d4437	10.1136/bmj.d4437	http://dx.doi.org/10.1136/bmj.d4437			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	801LP	21791492	Green Accepted			2022-12-01	WOS:000293440700005
J	Liu, C; Sage, JC; Miller, MR; Verhaak, RGW; Hippenmeyer, S; Vogel, H; Foreman, O; Bronson, RT; Nishiyama, A; Luo, LQ; Zong, H				Liu, Chong; Sage, Jonathan C.; Miller, Michael R.; Verhaak, Roel G. W.; Hippenmeyer, Simon; Vogel, Hannes; Foreman, Oded; Bronson, Roderick T.; Nishiyama, Akiko; Luo, Liqun; Zong, Hui			Mosaic Analysis with Double Markers Reveals Tumor Cell of Origin in Glioma	CELL			English	Article							NEURAL STEM-CELLS; INTEGRATED GENOMIC ANALYSIS; PROGENITOR CELLS; SUBVENTRICULAR ZONE; SUPPRESSOR GENE; WHITE-MATTER; HUMAN BRAIN; NG2 CELLS; GROWTH; GLIOBLASTOMA	Cancer cell of origin is difficult to identify by analyzing cells within terminal stage tumors, whose identity could be concealed by the acquired plasticity. Thus, an ideal approach to identify the cell of origin is to analyze proliferative abnormalities in distinct lineages prior to malignancy. Here, we use mosaic analysis with double markers (MADM) in mice to model gliomagenesis by initiating concurrent p53/Nf1 mutations sporadically in neural stem cells (NSCs). Surprisingly, MADM-based lineage tracing revealed significant aberrant growth prior to malignancy only in oligodendrocyte precursor cells (OPCs), but not in any other NSC-derived lineages or NSCs themselves. Upon tumor formation, phenotypic and transcriptome analyses of tumor cells revealed salient OPC features. Finally, introducing the same p53/Nf1 mutations directly into OPCs consistently led to gliomagenesis. Our findings suggest OPCs as the cell of origin in this model, even when initial mutations occur in NSCs, and highlight the importance of analyzing premalignant stages to identify the cancer cell of origin.	[Liu, Chong; Sage, Jonathan C.; Miller, Michael R.; Zong, Hui] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Verhaak, Roel G. W.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Hippenmeyer, Simon; Luo, Liqun] Stanford Univ, HHMI, Stanford, CA 94305 USA; [Hippenmeyer, Simon; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Vogel, Hannes] Stanford Univ, Sch Med, Dept Neuropathol, Stanford, CA 94305 USA; [Foreman, Oded] Jackson Lab, Sacramento, CA 95838 USA; [Bronson, Roderick T.] Tufts Cummings Sch Vet Med, Dept Biomed Sci, North Grafton, MA 01536 USA; [Nishiyama, Akiko] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA	University of Oregon; University of Texas System; UTMD Anderson Cancer Center; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Jackson Laboratory; University of Connecticut	Zong, H (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	hzong@uoregon.edu	Messier, Claude/A-2322-2008; Liu, Chong/J-4826-2014; Liu, Chong/G-3514-2011; Verhaak, Roel/ABE-7058-2020	Messier, Claude/0000-0002-4791-1763; Vogel, Otto Hannes/0000-0002-0960-3508; Luo, Liqun/0000-0001-5467-9264; Liu, Chong/0000-0001-6578-5919; Hippenmeyer, Simon/0000-0003-2279-1061	NIH [R55-CA136495, R01-CA136495]; NSF; European Molecular Biology Organization [ALTF 851-2005]; Human Frontier Science Program Organization [LT00805/2006-L]; Swiss National Science Foundation [PA00P3_124160]; Pew Charitable Trusts; NATIONAL CANCER INSTITUTE [R01CA136495, R55CA136495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050835] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program Organization(Human Frontier Science Program); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Pew Charitable Trusts; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Henner and M. Valle for technical support; J. Dugas for his help with the immunopanning method; and B. Bowerman, C. Doe, R. Galvao, W. Hong, M. Kohwi, M. Raff, R. Read, B. Tasic, X. Wu, and Y. Zhu for critical comments on the manuscript. This work is supported by NIH grants (R55-CA136495, R01-CA136495). M.R.M was supported by an NSF predoctoral fellowship. S.H. was supported by postdoctoral fellowships from the European Molecular Biology Organization (ALTF 851-2005), Human Frontier Science Program Organization (LT00805/2006-L), and Swiss National Science Foundation (PA00P3_124160). H.Z. is a Pew Scholar in Biomedical Sciences, supported by The Pew Charitable Trusts.	Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Bennett MR, 2003, J NEUROSCI, V23, P7207, DOI 10.1523/JNEUROSCI.23-18-07207.2003; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Geha S, 2010, BRAIN PATHOL, V20, P399, DOI 10.1111/j.1750-3639.2009.00295.x; Genove G, 2005, NAT MED, V11, P450, DOI 10.1038/nm1208; Hippenmeyer S, 2010, NEURON, V68, P695, DOI 10.1016/j.neuron.2010.09.027; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Komitova M, 2009, J COMP NEUROL, V512, P702, DOI 10.1002/cne.21917; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Lee JS, 2010, HUM MOL GENET, V19, P4643, DOI 10.1093/hmg/ddq395; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Lindberg N, 2009, ONCOGENE, V28, P2266, DOI 10.1038/onc.2009.76; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Louis D. N., 2007, WHO CLASSIFICATION T; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Persson AI, 2010, CANCER CELL, V18, P669, DOI 10.1016/j.ccr.2010.10.033; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Reilly KM, 2000, NAT GENET, V26, P109, DOI 10.1038/79075; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wang Y, 2009, CANCER CELL, V15, P514, DOI 10.1016/j.ccr.2009.04.001; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	38	421	432	5	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 22	2011	146	2					209	221		10.1016/j.cell.2011.06.014	http://dx.doi.org/10.1016/j.cell.2011.06.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	795XS	21737130	Green Accepted, Bronze			2022-12-01	WOS:000293013000005
J	MacDonald, ME				MacDonald, Margaret E.			The art of medicine The cultural evolution of natural birth	LANCET			English	Editorial Material							HOME BIRTH; BODIES		York Univ, Dept Anthropol, N York, ON M3J 1P3, Canada	York University - Canada	MacDonald, ME (corresponding author), York Univ, Dept Anthropol, N York, ON M3J 1P3, Canada.	maggie@yorku.ca						Bernike Pasveer, 2001, BIRTH DESIGN PREGNAN, P229; BOURGEAULT IL, 2002, CAN J MIDWIFERY RES, V1, P4; Klassen PE, 2001, SIGNS, V26, P775, DOI 10.1086/495628; Macdonald M, 2006, MED ANTHROPOL Q, V20, P235, DOI 10.1525/maq.2006.20.2.235; Margaret, 2007, WORK FIELD BIRTH; MICHIE H, 2000, GENDER HLTH, P44; Viisainen K, 2001, SOC SCI MED, V52, P1109, DOI 10.1016/S0277-9536(00)00206-9	7	5	5	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL-AUG	2011	378	9789					394	395		10.1016/S0140-6736(11)61200-2	http://dx.doi.org/10.1016/S0140-6736(11)61200-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	803XM	21809497	Bronze			2022-12-01	WOS:000293615900017
J	Guilbaud, R; Butler, IB; Ellam, RM				Guilbaud, Romain; Butler, Ian B.; Ellam, Rob M.			Abiotic Pyrite Formation Produces a Large Fe Isotope Fractionation	SCIENCE			English	Article							IRON; REDOX; CONSTRAINTS; SEDIMENTS; MINERALS; OCEAN; REDUCTION; CHEMISTRY; FE(III); OXYGEN	The iron isotope composition of sedimentary pyrite has been proposed as a potential proxy to trace microbial metabolism and the redox evolution of the oceans. We demonstrate that Fe isotope fractionation accompanies abiotic pyrite formation in the absence of Fe(II) redox change. Combined fractionation factors between Fe(II)(aq), mackinawite, and pyrite permit the generation of pyrite with Fe isotope signatures that nearly encapsulate the full range of sedimentary delta(56)Fe(pyrite) recorded in Archean to modern sediments. We propose that Archean negative Fe isotope excursions reflect partial Fe(II)(aq) utilization during abiotic pyrite formation rather than microbial dissimilatory Fe(III) reduction. Late Proterozoic to modern sediments may reflect greater Fe(II)(aq) utilization and variations in source composition.	[Guilbaud, Romain; Butler, Ian B.] Univ Edinburgh, Sch Geosci, Grant Inst, Edinburgh EH9 3JW, Midlothian, Scotland; [Guilbaud, Romain; Butler, Ian B.; Ellam, Rob M.] Scottish Univ Environm Res Ctr, E Kilbride G75 0QF, Lanark, Scotland; [Ellam, Rob M.] ECOSSE, Edinburgh EH9 3JW, Midlothian, Scotland	University of Edinburgh; Scottish Universities Research & Reactor Center	Guilbaud, R (corresponding author), Univ Edinburgh, Sch Geosci, Grant Inst, Edinburgh EH9 3JW, Midlothian, Scotland.	R.Guilbaud@sms.ed.ac.uk	Guilbaud, Romain/R-1428-2017; Ellam, Rob M/B-7878-2009	Guilbaud, Romain/0000-0001-9701-9522; Ellam, Rob M/0000-0001-8159-4864	ECOSSE; Natural Environment Research Council [NE/E003958/1]; NERC [NE/E003958/1] Funding Source: UKRI	ECOSSE; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by an ECOSSE Ph.D. studentship to R.G. and Natural Environment Research Council research grant NE/E003958/1 to I.B.B. We are thankful to K. Keefe, V. Gallagher, N. Odling, B. D. Roach, S. Mowbray, and C. Fricke for technical support and B. Ngwenya, A. Matthews, D. Rickard, A. McAnena, and M. Pekala for constructive discussions.	Anbar AD, 2000, SCIENCE, V288, P126, DOI 10.1126/science.288.5463.126; Anbar AD, 2007, ANNU REV EARTH PL SC, V35, P717, DOI 10.1146/annurev.earth.34.031405.125029; Archer C, 2006, GEOLOGY, V34, P153, DOI 10.1130/G22067.1; Butler IB, 2005, EARTH PLANET SC LETT, V236, P430, DOI 10.1016/j.epsl.2005.05.022; Butler IB, 2004, EARTH PLANET SC LETT, V228, P495, DOI 10.1016/j.epsl.2004.10.005; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Czaja AD, 2010, EARTH PLANET SC LETT, V292, P170, DOI 10.1016/j.epsl.2010.01.032; Duan Y, 2010, EARTH PLANET SC LETT, V290, P244, DOI 10.1016/j.epsl.2009.11.052; Guilbaud R, 2011, GEOCHIM COSMOCHIM AC, V75, P2721, DOI 10.1016/j.gca.2011.02.023; ISLEY AE, 1995, J GEOL, V103, P169, DOI 10.1086/629734; Johnson CM, 2008, ANNU REV EARTH PL SC, V36, P457, DOI 10.1146/annurev.earth.36.031207.124139; Johnson CM, 2005, GEOCHIM COSMOCHIM AC, V69, P963, DOI 10.1016/j.gca.2004.06.043; Li C, 2010, SCIENCE, V328, P80, DOI 10.1126/science.1182369; Luther GW, 2005, J NANOPART RES, V7, P389, DOI 10.1007/s11051-005-4272-4; Matthews A, 2004, GEOCHIM COSMOCHIM AC, V68, P3107, DOI 10.1016/j.gca.2004.01.019; McAnena A, 2009, GEOCHIM COSMOCHIM AC, V73, pA854; Polyakov VB, 2007, GEOCHIM COSMOCHIM AC, V71, P3833, DOI 10.1016/j.gca.2007.05.019; Poulton SW, 2010, NAT GEOSCI, V3, P486, DOI 10.1038/NGEO889; Raiswell R, 1998, AM J SCI, V298, P219, DOI 10.2475/ajs.298.3.219; Rickard D, 1997, GEOCHIM COSMOCHIM AC, V61, P135, DOI 10.1016/S0016-7037(96)00322-5; Rickard D, 2007, CHEM REV, V107, P514, DOI 10.1021/cr0503658; Rouxel OJ, 2005, SCIENCE, V307, P1088, DOI 10.1126/science.1105692; Rouxel OJ, 2010, GEOSTAND GEOANAL RES, V34, P135, DOI 10.1111/j.1751-908X.2010.00063.x; Schauble EA, 2004, REV MINERAL GEOCHEM, V55, P65, DOI 10.2138/gsrmg.55.1.65; Severmann S, 2006, GEOCHIM COSMOCHIM AC, V70, P2006, DOI 10.1016/j.gca.2006.01.007; Severmann S, 2008, GEOLOGY, V36, P487, DOI 10.1130/G24670A.1; Skulan JL, 2002, GEOCHIM COSMOCHIM AC, V66, P2995, DOI 10.1016/S0016-7037(02)00902-X; Yamaguchi KE, 2005, CHEM GEOL, V218, P135, DOI 10.1016/j.chemgeo.2005.01.020	29	103	112	4	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 24	2011	332	6037					1548	1551		10.1126/science.1202924	http://dx.doi.org/10.1126/science.1202924			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700871	Green Accepted			2022-12-01	WOS:000291990000042
J	Walker, LM; Huber, M; Doores, KJ; Falkowska, E; Pejchal, R; Julien, JP; Wang, SK; Ramos, A; Chan-Hui, PY; Moyle, M; Mitcham, JL; Hammond, PW; Olsen, OA; Phung, P; Fling, S; Wong, CH; Phogat, S; Wrin, T; Simek, MD; Koff, WC; Wilson, IA; Burton, DR; Poignard, P				Walker, Laura M.; Huber, Michael; Doores, Katie J.; Falkowska, Emilia; Pejchal, Robert; Julien, Jean-Philippe; Wang, Sheng-Kai; Ramos, Alejandra; Chan-Hui, Po-Ying; Moyle, Matthew; Mitcham, Jennifer L.; Hammond, Phillip W.; Olsen, Ole A.; Pham Phung; Fling, Steven; Wong, Chi-Huey; Phogat, Sanjay; Wrin, Terri; Simek, Melissa D.; Koff, Wayne C.; Wilson, Ian A.; Burton, Dennis R.; Poignard, Pascal		Protocol G Principal Investigators	Broad neutralization coverage of HIV by multiple highly potent antibodies	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; CROSS-CLADE NEUTRALIZATION; VACCINE; PROTECTION; CHALLENGE; MACAQUES; TRIAL; TITER; ASSAY	Broadly neutralizing antibodies against highly variable viral pathogens are much sought after to treat or protect against global circulating viruses. Here we probed the neutralizing antibody repertoires of four human immunodeficiency virus (HIV)-infected donors with remarkably broad and potent neutralizing responses and rescued 17 new monoclonal antibodies that neutralize broadly across clades. Many of the new monoclonal antibodies are almost tenfold more potent than the recently described PG9, PG16 and VRC01 broadly neutralizing monoclonal antibodies and 100-fold more potent than the original prototype HIV broadly neutralizing monoclonal antibodies(1-3). The monoclonal antibodies largely recapitulate the neutralization breadth found in the corresponding donor serum and many recognize novel epitopes on envelope (Env) glycoprotein gp120, illuminating new targets for vaccine design. Analysis of neutralization by the full complement of anti-HIV broadly neutralizing monoclonal antibodies now available reveals that certain combinations of antibodies should offer markedly more favourable coverage of the enormous diversity of global circulating viruses than others and these combinations might be sought in active or passive immunization regimes. Overall, the isolation of multiple HIV broadly neutralizing monoclonal antibodies from several donors that, in aggregate, provide broad coverage at low concentrations is a highly positive indicator for the eventual design of an effective antibody-based HIV vaccine.	[Walker, Laura M.; Huber, Michael; Doores, Katie J.; Falkowska, Emilia; Ramos, Alejandra; Burton, Dennis R.; Poignard, Pascal] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Walker, Laura M.; Huber, Michael; Doores, Katie J.; Falkowska, Emilia; Pejchal, Robert; Julien, Jean-Philippe; Ramos, Alejandra; Wilson, Ian A.; Burton, Dennis R.; Poignard, Pascal] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Huber, Michael; Doores, Katie J.; Falkowska, Emilia; Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Boston, MA 02129 USA; [Pejchal, Robert; Julien, Jean-Philippe; Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, Dept Mol Biol, La Jolla, CA 92037 USA; [Wang, Sheng-Kai; Wong, Chi-Huey] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Chan-Hui, Po-Ying; Moyle, Matthew; Mitcham, Jennifer L.; Hammond, Phillip W.; Olsen, Ole A.] Theraclone Sci Inc, Seattle, WA 98104 USA; [Pham Phung; Wrin, Terri] Monogram Biosci Inc, San Francisco, CA 94080 USA; [Fling, Steven; Phogat, Sanjay; Simek, Melissa D.; Koff, Wayne C.; Poignard, Pascal] Int AIDS Vaccine Initiat, New York, NY 10038 USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Scripps Research Institute; Scripps Research Institute; International AIDS Vaccine Initiative	Burton, DR (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	burton@scripps.edu; poignard@scripps.edu	Huber, Michael/B-8509-2015; poignard, pascal/AAB-4613-2020; poignard, pascal/N-6678-2013	Huber, Michael/0000-0002-0384-0000; Doores, Katie/0000-0002-5507-1725; Julien, Jean-Philippe/0000-0001-7602-3995; Poignard, Pascal/0000-0002-0021-7192; Wang, Sheng-Kai/0000-0002-3827-7983	IAVI; NIAID; Ragon Institute; United States for International Development (USAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084817, R01AI033292] Funding Source: NIH RePORTER	IAVI; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ragon Institute; United States for International Development (USAID)(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank N. Schultz, K. Le and V. Thaney for technical assistance at The Scripps Research Institute. We also thank C. Corbaci, S. M. Eagol and C. Williams for assistance with Fig. 3. We would also like to thank the research staff members of the Theraclone I-STAR Discovery and Antibody Purification Team, and K. Limoli, S. Jauregui, K. Tran, P. Sitou, J. Perea, B. Huang and P. Guinto at Monogram BioSciences. We thank R. McBride for assistance with the glycan array and are grateful to W. Olson for providing purified KNH1144 SOSIP trimer, R. Wyatt for providing the YU2 Foldon trimer and J. Mascola for providing monoclonal antibody VRC01. In addition, we would like to thank all of the International AIDS Vaccine Initiative (IAVI) Protocol G project, clinical and site team members, the IAVI Human Immunology Laboratory (HIL) and all of the Protocol G clinical investigators, specifically, G. Miiro, A. Pozniak, D. McPhee, O. Manigart, E. Karita, A. Inwoley, W. Jaoko, J. DeHovitz, L.-G. Bekker, P. Pitisuttithum, R. Paris, J. Serwanga and S. Allen. This work was supported by IAVI, NIAID, the Ragon Institute and the United States for International Development (USAID). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government.	Amanna IJ, 2008, HUM VACCINES, V4, P316, DOI 10.4161/hv.4.4.5751; [Anonymous], 2013, VACCINES-BASEL; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Herrera GA, 2007, VACCINE, V25, P154, DOI 10.1016/j.vaccine.2006.05.129; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Martell BA, 2009, ARCH GEN PSYCHIAT, V66, P1116, DOI 10.1001/archgenpsychiatry.2009.128; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Munshaw S, 2010, BIOINFORMATICS, V26, P867, DOI 10.1093/bioinformatics/btq056; Nishimura Y, 2002, J VIROL, V76, P2123, DOI 10.1128/jvi.76.5.2123-2130.2002; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Plotkin SA, 2001, PEDIATR INFECT DIS J, V20, P63, DOI 10.1097/00006454-200101000-00013; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Schief WR, 2009, CURR OPIN HIV AIDS, V4, P431, DOI 10.1097/COH.0b013e32832e6184; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; TRKOLA A, 1995, J VIROL, V69, P6609, DOI 10.1128/JVI.69.11.6609-6617.1995; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang SK, 2008, P NATL ACAD SCI USA, V105, P3690, DOI 10.1073/pnas.0712326105; Willey R, 2010, AIDS RES HUM RETROV, V26, P89, DOI 10.1089/aid.2009.0144; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659	33	1118	1208	5	179	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2011	477	7365					466	U117		10.1038/nature10373	http://dx.doi.org/10.1038/nature10373			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21849977	Green Accepted			2022-12-01	WOS:000295080500041
J	Shi, WL; Zhang, XL; Jiang, X; Yuan, HM; Lee, JS; Barry, CE; Wang, HH; Zhang, WH; Zhang, Y				Shi, Wanliang; Zhang, Xuelian; Jiang, Xin; Yuan, Haiming; Lee, Jong Seok; Barry, Clifton E., III; Wang, Honghai; Zhang, Wenhong; Zhang, Ying			Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis	SCIENCE			English	Article							RIBOSOMAL-PROTEIN S1; ESCHERICHIA-COLI; PYRAZINOIC ACID; PNCA MUTATIONS; MESSENGER-RNA; BINDING; RESISTANCE; TMRNA; SUSCEPTIBILITY; SYNTHASE	Pyrazinamide (PZA) is a first-line tuberculosis drug that plays a unique role in shortening the duration of tuberculosis chemotherapy. PZA is hydrolyzed intracellularly to pyrazinoic acid (POA) by pyrazinamidase (PZase, encoded by pncA), an enzyme frequently lost in PZA-resistant strains, but the target of POA in Mycobacterium tuberculosis has remained elusive. Here, we identify a previously unknown target of POA as the ribosomal protein S1 (RpsA), a vital protein involved in protein translation and the ribosome-sparing process of trans-translation. Three PZA-resistant clinical isolates without pncA mutation harbored RpsA mutations. RpsA overexpression conferred increased PZA resistance, and we confirmed that POA bound to RpsA (but not a clinically identified DAla mutant) and subsequently inhibited trans-translation rather than canonical translation. Trans-translation is essential for freeing scarce ribosomes in nonreplicating organisms, and its inhibition may explain the ability of PZA to eradicate persisting organisms.	[Shi, Wanliang; Zhang, Ying] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Zhang, Xuelian; Yuan, Haiming; Wang, Honghai] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Jiang, Xin] Shanghai Univ Tradit Chinese Med, Dept Med Microbiol & Immunol, Shanghai 201203, Peoples R China; [Lee, Jong Seok] Int TB Res Ctr, Chang Won 4751, South Korea; [Barry, Clifton E., III] NIAID, TB Res Sect, NIH, Bethesda, MD 20892 USA; [Zhang, Wenhong; Zhang, Ying] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200040, Peoples R China	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Fudan University; Shanghai University of Traditional Chinese Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fudan University	Zhang, Y (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.	yzhang@jhsph.edu	吴, 晶/D-3782-2013; Barry, Clifton E/ABE-7992-2020; Barry, Clifton E/H-3839-2012	Barry, Clifton E/0000-0002-2927-270X; Barry, Clifton E/0000-0002-2927-270X; Jiang, Xin/0000-0001-7007-0483	NIH [AI44063]; NIAID, NIH; National Key Technologies Research and Development Program of China [2008ZX10003003]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001067, R01AI044063, ZIAAI000783] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Key Technologies Research and Development Program of China(National Key Technology R&D Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH grant AI44063, in part by the intramural research program of the NIAID, NIH, and by National Key Technologies Research and Development Program of China (2008ZX10003003). We thank D. E. Griffin and M. J. Klag for encouragement and support. Johns Hopkins University has filed a patent on detection of RpsA mutation as a marker for pyrazinamide resistance and use of trans-translation pathway as a target for development of new antibiotics against TB persister bacteria.	Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Barends S, 2001, J MOL BIOL, V314, P9, DOI 10.1006/jmbi.2001.5114; Boni IV, 2000, J BACTERIOL, V182, P5872, DOI 10.1128/JB.182.20.5872-5879.2000; Boshoff HI, 2002, J BACTERIOL, V184, P2167, DOI 10.1128/JB.184.8.2167-2172.2002; Bycroft M, 1997, CELL, V88, P235, DOI 10.1016/S0092-8674(00)81844-9; Cheng SJ, 2000, ANTIMICROB AGENTS CH, V44, P528, DOI 10.1128/AAC.44.3.528-532.2000; Ibrahim M, 2007, ANTIMICROB AGENTS CH, V51, P1011, DOI 10.1128/AAC.00898-06; Junop MS, 2000, EMBO J, V19, P5962, DOI 10.1093/emboj/19.22.5962; Keiler KC, 2008, ANNU REV MICROBIOL, V62, P133, DOI 10.1146/annurev.micro.62.081307.162948; LAMBERT JM, 1983, J BACTERIOL, V154, P1323, DOI 10.1128/JB.154.3.1323-1328.1983; Li X, 2006, RNA, V12, P248, DOI 10.1261/rna.2212606; MCCUNE RM, 1966, J EXP MED, V123, P445, DOI 10.1084/jem.123.3.445; MCDERMOTT W, 1954, AM REV TUBERC PULM, V70, P748; Mikulik K, 2008, PROTEOMICS, V8, P1429, DOI 10.1002/pmic.200700560; MITCHISON DA, 1985, TUBERCLE, V66, P219, DOI 10.1016/0041-3879(85)90040-6; Muto A, 2000, GENES CELLS, V5, P627, DOI 10.1046/j.1365-2443.2000.00356.x; Nuermberger E, 2008, ANTIMICROB AGENTS CH, V52, P1522, DOI 10.1128/AAC.00074-08; Saguy M, 2007, NUCLEIC ACIDS RES, V35, P2368, DOI 10.1093/nar/gkm100; Scorpio A, 1996, NAT MED, V2, P662, DOI 10.1038/nm0696-662; Scorpio A, 1997, ANTIMICROB AGENTS CH, V41, P540, DOI 10.1128/AAC.41.3.540; TARSHIS MS, 1953, AM REV TUBERC PULM, V67, P391; Thibonnier M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003810; World Health Organization, 2010, WHO REP 2010 GLOB TU; Wower IK, 2000, EMBO J, V19, P6612, DOI 10.1093/emboj/19.23.6612; Yew WW, 2011, EXPERT OPIN EMERG DR, V16, P1, DOI 10.1517/14728214.2011.521497; Zhang Y, 2003, J ANTIMICROB CHEMOTH, V52, P790, DOI 10.1093/jac/dkg446; Zhang Y, 2003, INT J TUBERC LUNG D, V7, P6; Zhang Y, 2002, J MED MICROBIOL, V51, P42, DOI 10.1099/0022-1317-51-1-42; Zhang Y, 1999, J BACTERIOL, V181, P2044, DOI 10.1128/JB.181.7.2044-2049.1999; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; Zimhony O, 2000, NAT MED, V6, P1043, DOI 10.1038/79558	31	367	391	2	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2011	333	6049					1630	1632		10.1126/science.1208813	http://dx.doi.org/10.1126/science.1208813			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21835980	Green Accepted, Green Published			2022-12-01	WOS:000294900900043
J	Wake, H; Lee, PR; Fields, D				Wake, Hiroaki; Lee, Philip R.; Fields, Douglas			Control of Local Protein Synthesis and Initial Events in Myelination by Action Potentials	SCIENCE			English	Article							WHITE-MATTER; OLIGODENDROCYTE LINEAGE; FYN KINASE; CELLS; DIFFERENTIATION; COMMUNICATION; PROGRESSION; ACTIVATION; RELEASE; NEURONS	Formation of myelin, the electrical insulation on axons produced by oligodendrocytes, is controlled by complex cell-cell signaling that regulates oligodendrocyte development and myelin formation on appropriate axons. If electrical activity could stimulate myelin induction, then neurodevelopment and the speed of information transmission through circuits could be modified by neural activity. We find that release of glutamate from synaptic vesicles along axons of mouse dorsal root ganglion neurons in culture promotes myelin induction by stimulating formation of cholesterol-rich signaling domains between oligodendrocytes and axons, and increasing local synthesis of the major protein in the myelin sheath, myelin basic protein, through Fyn kinase-dependent signaling. This axon-oligodendrocyte signaling would promote myelination of electrically active axons to regulate neural development and function according to environmental experience.	[Wake, Hiroaki; Lee, Philip R.; Fields, Douglas] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Nervous Syst Dev & Plast Sect, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Fields, D (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Nervous Syst Dev & Plast Sect, Bethesda, MD 20892 USA.	fieldsd@mail.nih.gov		WAKE, Hiroaki/0000-0002-8543-4590	National Institute of Child Health and Human Development; Japan Society for the Promotion of Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000713] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank M. D. Ehlers for the TfR construct; J. Lippincott-Schwartz for the photoactivatable GFP; E. A. Johnson for BnTX; D. Abebe for assistance with experimental animals; and J. Chan, R. Chittajallu, and J. Ou for critical comments on an earlier draft of this manuscript. This work was supported by the intramural research program at the National Institute of Child Health and Human Development and by a Japan Society for the Promotion of Science fellowship for H. Wake.	AINGER K, 1993, J CELL BIOL, V123, P431, DOI 10.1083/jcb.123.2.431; Back SA, 2002, J NEUROPATH EXP NEUR, V61, P197, DOI 10.1093/jnen/61.2.197; Bakiri Y, 2009, NEURON GLIA BIOL, V5, P3, DOI 10.1017/S1740925X09990202; De Biase LM, 2010, J NEUROSCI, V30, P3600, DOI 10.1523/JNEUROSCI.6000-09.2010; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Fields RD, 2010, SCIENCE, V330, P768, DOI 10.1126/science.1199139; Fields RD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001128; FIELDS RD, 1992, PRACTICAL ELECTROPHY; Gallo V, 1996, J NEUROSCI, V16, P2659, DOI 10.1523/jneurosci.16-08-02659.1996; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Kennedy MJ, 2010, CELL, V141, P524, DOI 10.1016/j.cell.2010.02.042; Kramer EM, 1999, J BIOL CHEM, V274, P29042, DOI 10.1074/jbc.274.41.29042; Kukley M, 2010, J NEUROSCI, V30, P8320, DOI 10.1523/JNEUROSCI.0854-10.2010; Laursen LS, 2011, J CELL BIOL, V192, P797, DOI 10.1083/jcb.201007014; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Simons M, 2000, J CELL BIOL, V151, P143, DOI 10.1083/jcb.151.1.143; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Stevens B, 2000, SCIENCE, V287, P2267, DOI 10.1126/science.287.5461.2267; Wacker SA, 2007, DEV DYNAM, V236, P473, DOI 10.1002/dvdy.20955; Welch MJ, 2000, TOXICON, V38, P245, DOI 10.1016/S0041-0101(99)00153-1; White R, 2008, J CELL BIOL, V181, P579, DOI 10.1083/jcb.200706164	25	418	427	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2011	333	6049					1647	1651		10.1126/science.1206998	http://dx.doi.org/10.1126/science.1206998			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21817014	Green Accepted			2022-12-01	WOS:000294900900048
J	Deng, HX; Chen, WJ; Hong, ST; Boycott, KM; Gorrie, GH; Siddique, N; Yang, Y; Fecto, F; Shi, Y; Zhai, H; Jiang, HJ; Hirano, M; Rampersaud, E; Jansen, GH; Donkervoort, S; Bigio, EH; Brooks, BR; Ajroud, K; Sufit, RL; Haines, JL; Mugnaini, E; Pericak-Vance, MA; Siddique, T				Deng, Han-Xiang; Chen, Wenjie; Hong, Seong-Tshool; Boycott, Kym M.; Gorrie, George H.; Siddique, Nailah; Yang, Yi; Fecto, Faisal; Shi, Yong; Zhai, Hong; Jiang, Hujun; Hirano, Makito; Rampersaud, Evadnie; Jansen, Gerard H.; Donkervoort, Sandra; Bigio, Eileen H.; Brooks, Benjamin R.; Ajroud, Kaouther; Sufit, Robert L.; Haines, Jonathan L.; Mugnaini, Enrico; Pericak-Vance, Margaret A.; Siddique, Teepu			Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia	NATURE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; PROTEIN AGGREGATION; SUPEROXIDE-DISMUTASE; GENE-MUTATIONS; TDP-43; CRITERIA; DOMAINS; FUS; PROTEASOME	Amyotrophic lateral sclerosis (ALS) is a paralytic and usually fatal disorder caused by motor-neuron degeneration in the brain and spinal cord. Most cases of ALS are sporadic but about 5-10% are familial. Mutations in superoxide dismutase 1 (SOD1)(1,2), TAR DNA-binding protein (TARDBP, also known as TDP43)(3,4) and fused in sarcoma (FUS, also known as translocated in liposarcoma (TLS))(5,6) account for approximately 30% of classic familial ALS. Mutations in several other genes have also been reported as rare causes of ALS or ALS-like syndromes(7-15). The causes of the remaining cases of familial ALS and of the vast majority of sporadic ALS are unknown. Despite extensive studies of previously identified ALS-causing genes, the pathogenic mechanism underlying motor-neuron degeneration in ALS remains largely obscure. Dementia, usually of the frontotemporal lobar type, may occur in some ALS cases. It is unclear whether ALS and dementia share common aetiology and pathogenesis in ALS/dementia. Here we show that mutations in UBQLN2, which encodes the ubiquitin-like protein ubiquilin 2, cause dominantly inherited, chromosome-X-linked ALS and ALS/dementia. We describe novel ubiquilin 2 pathology in the spinal cords of ALS cases and in the brains of ALS/dementia cases with or without UBQLN2 mutations. Ubiquilin 2 is a member of the ubiquilin family, which regulates the degradation of ubiquitinated proteins. Functional analysis showed that mutations in UBQLN2 lead to an impairment of protein degradation. Therefore, our findings link abnormalities in ubiquilin 2 to defects in the protein degradation pathway, abnormal protein aggregation and neurodegeneration, indicating a common pathogenic mechanism that can be exploited for therapeutic intervention.	[Deng, Han-Xiang; Chen, Wenjie; Hong, Seong-Tshool; Gorrie, George H.; Siddique, Nailah; Yang, Yi; Fecto, Faisal; Shi, Yong; Zhai, Hong; Jiang, Hujun; Hirano, Makito; Donkervoort, Sandra; Ajroud, Kaouther; Sufit, Robert L.; Siddique, Teepu] Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol & Clin Neurosci, Div Neuromuscular Med, Chicago, IL 60611 USA; [Boycott, Kym M.] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Boycott, Kym M.] Univ Ottawa, Dept Pediat, Ottawa, ON K1H 8L1, Canada; [Fecto, Faisal; Mugnaini, Enrico; Siddique, Teepu] Northwestern Univ, Feinberg Sch Med, Interdept Neurosci Program, Chicago, IL 60611 USA; [Rampersaud, Evadnie; Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Jansen, Gerard H.] Ottawa Hosp, Div Anat Pathol, Ottawa, ON K1Y 4E9, Canada; [Bigio, Eileen H.] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Div Neuropathol, Chicago, IL 60611 USA; [Brooks, Benjamin R.] Carolinas Med Ctr, Dept Neurol, Neurosci & Spine Inst, Charlotte, NC 28207 USA; [Haines, Jonathan L.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37232 USA; [Mugnaini, Enrico; Siddique, Teepu] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Northwestern University; Feinberg School of Medicine; University of Miami; University of Ottawa; Ottawa Hospital Research Institute; Northwestern University; Feinberg School of Medicine; Carolinas Medical Center; Vanderbilt University; Northwestern University; Feinberg School of Medicine	Siddique, T (corresponding author), Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol & Clin Neurosci, Div Neuromuscular Med, Chicago, IL 60611 USA.	t-siddique@northwestern.edu	Siddique, Teepu/AAT-8166-2021; Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728; Fecto, Faisal/0000-0002-7587-8024; Siddique, Teepu/0000-0001-7293-9146; Hong, Seong-Tshool/0000-0001-8254-6581; Deng, Han-Xiang/0000-0002-0030-8465	National Institute of Neurological Disorders and Stroke [NS050641]; Les Turner ALS Foundation; Vena E. Schaff ALS Research Fund; Herbert and Florence C. Wenske Foundation; David C. Asselin MD Memorial Fund; Help America Foundation; Les Turner ALS Foundation/Herbert C. Wenske Foundation; NIH [T32AG20506]; MND Scotland; NCI [CCSG P30 CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037912, R01NS050641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020506] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Les Turner ALS Foundation; Vena E. Schaff ALS Research Fund; Herbert and Florence C. Wenske Foundation; David C. Asselin MD Memorial Fund; Help America Foundation; Les Turner ALS Foundation/Herbert C. Wenske Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MND Scotland; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institute of Neurological Disorders and Stroke (NS050641), the Les Turner ALS Foundation, the Vena E. Schaff ALS Research Fund, the Harold Post Research Professorship, the Herbert and Florence C. Wenske Foundation, the David C. Asselin MD Memorial Fund, the Help America Foundation and the Les Turner ALS Foundation/Herbert C. Wenske Foundation Professorship. F. F. has support from NIH (T32AG20506). K. A. is a postdoctoral fellow of the Blazeman Foundation for ALS. G. H. G. received travel funds from MND Scotland. We thank N. Dantuma for the UPS reporter plasmid (through Addgene) and the staff of the Northwestern University Robert H. Lurie Comprehensive Cancer Center flow cytometry core facility for technical assistance. Imaging work was performed at the Northwestern University Cell Imaging Facility, supported by NCI CCSG P30 CA060553 awarded to the Robert H Lurie Comprehensive Cancer Center.	Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Aitio O, 2010, P NATL ACAD SCI USA, V107, P21743, DOI 10.1073/pnas.1010243107; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Chow CY, 2009, AM J HUM GENET, V84, P85, DOI 10.1016/j.ajhg.2008.12.010; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Deng HX, 2010, ANN NEUROL, V67, P739, DOI 10.1002/ana.22051; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Fecto F, 2011, J BIOL CHEM, V286, P17281, DOI 10.1074/jbc.M111.237685; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Haapasalo A, 2010, BIOCHEM SOC T, V38, P150, DOI 10.1042/BST0380150; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kim SH, 2009, J BIOL CHEM, V284, P8083, DOI 10.1074/jbc.M808064200; Ko HS, 2004, FEBS LETT, V566, P110, DOI 10.1016/j.febslet.2004.04.031; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Mackenzie IRA, 2006, ACTA NEUROPATHOL, V112, P539, DOI 10.1007/s00401-006-0138-9; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Mitchell J, 2010, P NATL ACAD SCI USA, V107, P7556, DOI 10.1073/pnas.0914128107; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Shibata N, 1996, J NEUROPATH EXP NEUR, V55, P481, DOI 10.1097/00005072-199604000-00011; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Ticozzi N, 2010, ANN NEUROL, V68, P102, DOI 10.1002/ana.21993; Urwin H, 2010, ACTA NEUROPATHOL, V120, P33, DOI 10.1007/s00401-010-0698-6; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160	36	813	841	3	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 8	2011	477	7363					211	U113		10.1038/nature10353	http://dx.doi.org/10.1038/nature10353			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816MC	21857683	Green Accepted			2022-12-01	WOS:000294603900036
J	Frank, KT; Petrie, B; Fisher, JAD; Leggett, WC				Frank, Kenneth T.; Petrie, Brian; Fisher, Jonathan A. D.; Leggett, William C.			Transient dynamics of an altered large marine ecosystem	NATURE			English	Article							SCOTIAN-SHELF; TROPHIC CASCADES; CONTINENTAL-SHELF; REGIME SHIFTS; GADUS-MORHUA; ATLANTIC COD; FISH; CANADA; RECOVERY; COLLAPSE	Overfishing of large-bodied benthic fishes and their subsequent population collapses on the Scotian Shelf of Canada's east coast(1,2) and elsewhere(3,4) resulted in restructuring of entire food webs now dominated by planktivorous, forage fish species and macroinvertebrates. Despite the imposition of strict management measures in force since the early 1990s, the Scotian Shelf ecosystem has not reverted back to its former structure. Here we provide evidence of the transient nature of this ecosystem and its current return path towards benthic fish species domination. The prolonged duration of the altered food web, and its current recovery, was and is being governed by the oscillatory, runaway consumption dynamics of the forage fish complex. These erupting forage species, which reached biomass levels 900% greater than those prevalent during the pre-collapse years of large benthic predators, are now in decline, having outstripped their zooplankton food supply. This dampening, and the associated reduction in the intensity of predation, was accompanied by lagged increases in species abundances at both lower and higher trophic levels, first witnessed in zooplankton and then in large-bodied predators, all consistent with a return towards the earlier ecosystem structure. We conclude that the reversibility of perturbed ecosystems can occur and that this bodes well for other collapsed fisheries.	[Frank, Kenneth T.; Petrie, Brian] Bedford Inst Oceanog, Ocean Sci Div, Dartmouth, NS B2Y 4A2, Canada; [Fisher, Jonathan A. D.; Leggett, William C.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	Bedford Institute of Oceanography; Fisheries & Oceans Canada; Queens University - Canada	Frank, KT (corresponding author), Bedford Inst Oceanog, Ocean Sci Div, POB 1006, Dartmouth, NS B2Y 4A2, Canada.	kenneth.frank@dfo-mpo.gc.ca	Leggett, William C/F-6009-2011	Frank, Kenneth T/0000-0001-6939-9724	Fisheries and Oceans Canada; Natural Sciences and Engineering Research Council of Canada; NERC [SAH01001] Funding Source: UKRI; Natural Environment Research Council [SAH01001] Funding Source: researchfish	Fisheries and Oceans Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the Department of Fisheries and Oceans staff who collected and maintained the multi-trophic level and biogeochemical monitoring data, J. Black for assistance with computing and database issues, and A. Bundy and D. R. Strong for helpful criticisms. Symbols for Fig. 2b are courtesy of the Integration and Application Network (http://www.ian.umces.edu/symbols). This research was supported by Fisheries and Oceans Canada and Discovery grants from the Natural Sciences and Engineering Research Council of Canada (to K.T.F. and W.C.L.).	Anderson SC, 2008, CAN J FISH AQUAT SCI, V65, P2553, DOI 10.1139/F08-156; Benoit H., 2008, AZMP B, V8, P19; Bundy A., 2004, Canadian Technical Report of Fisheries and Aquatic Sciences, V2520, P1; Bundy A, 2009, PROG OCEANOGR, V81, P188, DOI 10.1016/j.pocean.2009.04.010; Casini M, 2008, P ROY SOC B-BIOL SCI, V275, P1793, DOI 10.1098/rspb.2007.1752; Cauffope Genevieve, 2005, University of British Columbia Fisheries Centre Research Reports, V13, P225; Chadwick E.M.P., 2007, AZMP B, V6, P25; Choi JS, 2005, OCEANOGR MAR BIOL, V43, P47; COCHLAN WP, 1986, CONT SHELF RES, V5, P555, DOI 10.1016/0278-4343(86)90076-2; Daskalov GM, 2007, P NATL ACAD SCI USA, V104, P10518, DOI 10.1073/pnas.0701100104; Doubleday W.G., 1981, Canadian Special Publication of Fisheries and Aquatic Sciences, V58, P1; Doubleday W. G., 1981, STUDIES 2 MANUAL GRO; Fauchald P, 2010, ECOLOGY, V91, P2191, DOI 10.1890/09-1500.1; Fisher JAD, 2008, ECOL LETT, V11, P883, DOI 10.1111/j.1461-0248.2008.01216.x; Fisher JAD, 2010, ECOLOGY, V91, P2499, DOI 10.1890/09-1914.1; Forsyth DM, 2006, ECOLOGY, V87, P297, DOI 10.1890/05-0709; FOURNIER RO, 1977, J FISH RES BOARD CAN, V34, P1004, DOI 10.1139/f77-153; Fowler G. W., 2000, DFO CAN SCI ADVIS SE, V2000, P1; Frank KT, 2006, ECOL LETT, V9, P1096, DOI 10.1111/j.1461-0248.2006.00961.x; Frank KT, 2000, ICES J MAR SCI, V57, P1023, DOI 10.1006/jmsc.2000.0587; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Harrison G., 2009, DFO CAN SCI ADVIS SE, V2009, P1; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Litzow MA, 2008, ECOL APPL, V18, P1331, DOI 10.1890/07-0998.1; MAYO R K, 1981, Journal of Northwest Atlantic Fishery Science, V2, P13; MILLS EL, 1979, MAR BIOL, V54, P101, DOI 10.1007/BF00386589; Mousseau L, 1998, ICES J MAR SCI, V55, P44, DOI 10.1006/jmsc.1997.0224; Murawski SA, 2010, ICES J MAR SCI, V67, P1830, DOI 10.1093/icesjms/fsq125; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; Myers RA, 1997, FISH B-NOAA, V95, P762; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; Persson L, 2007, SCIENCE, V316, P1743, DOI 10.1126/science.1141412; PETERSON RO, 1984, SCIENCE, V224, P1350, DOI 10.1126/science.224.4655.1350; Petrie B, 2007, ATMOS OCEAN, V45, P141, DOI 10.3137/ao.450302; Petrie B, 2009, FISH OCEANOGR, V18, P83, DOI 10.1111/j.1365-2419.2009.00500.x; Richardson AJ, 2006, PROG OCEANOGR, V68, P27, DOI 10.1016/j.pocean.2005.09.011; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Rodionov SN, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019448; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Savenkoff C, 2007, ECOL MODEL, V204, P115, DOI 10.1016/j.ecolmodel.2006.12.029; Shackell NL, 2010, P ROY SOC B-BIOL SCI, V277, P1353, DOI 10.1098/rspb.2009.1020; Shackell NL, 2003, AQUAT CONSERV, V13, P305, DOI 10.1002/aqc.554; Shelton PA, 2006, CAN J FISH AQUAT SCI, V63, P235, DOI 10.1139/F05-253; Smith Stephen J., 1996, Northwest Atlantic Fisheries Organization Scientific Council Studies, V28, P25; Steele J. H., 2004, GLOBAL COASTAL OCEAN, V13; STRONG DR, 1992, ECOLOGY, V73, P747, DOI 10.2307/1940154; Terborgh J., 2010, TROPHIC CASCADES PRE; TREMBLAY MJ, 1983, CAN J FISH AQUAT SCI, V40, P749, DOI 10.1139/f83-097; Yodzis P, 2001, TRENDS ECOL EVOL, V16, P78, DOI 10.1016/S0169-5347(00)02062-0	50	194	202	0	233	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2011	477	7362					86	U98		10.1038/nature10285	http://dx.doi.org/10.1038/nature10285			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813XT	21796120				2022-12-01	WOS:000294404300036
J	Rasko, DA; Webster, DR; Sahl, JW; Bashir, A; Boisen, N; Scheutz, F; Paxinos, EE; Sebra, R; Chin, CS; Iliopoulos, D; Klammer, A; Peluso, P; Lee, L; Kislyuk, AO; Bullard, J; Kasarskis, A; Wang, S; Eid, J; Rank, D; Redman, JC; Steyert, SR; Frimodt-Moller, J; Struve, C; Petersen, AM; Krogfelt, KA; Nataro, JP; Schadt, EE; Waldor, MK				Rasko, David A.; Webster, Dale R.; Sahl, Jason W.; Bashir, Ali; Boisen, Nadia; Scheutz, Flemming; Paxinos, Ellen E.; Sebra, Robert; Chin, Chen-Shan; Iliopoulos, Dimitris; Klammer, Aaron; Peluso, Paul; Lee, Lawrence; Kislyuk, Andrey O.; Bullard, James; Kasarskis, Andrew; Wang, Susanna; Eid, John; Rank, David; Redman, Julia C.; Steyert, Susan R.; Frimodt-Moller, Jakob; Struve, Carsten; Petersen, Andreas M.; Krogfelt, Karen A.; Nataro, James P.; Schadt, Eric E.; Waldor, Matthew K.			Origins of the E. coli Strain Causing an Outbreak of Hemolytic-Uremic Syndrome in Germany	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENTEROAGGREGATIVE ESCHERICHIA-COLI; AGGREGATIVE ADHERENCE; GENOMIC ANALYSIS; DIARRHEA; FIMBRIAE; CHILDREN; PROTEASE; AGENT; CELLS	Background A large outbreak of diarrhea and the hemolytic-uremic syndrome caused by an unusual serotype of Shiga-toxin-producing Escherichia coli (O104:H4) began in Germany in May 2011. As of July 22, a large number of cases of diarrhea caused by Shiga-toxinproducing E. coli have been reported - 3167 without the hemolytic-uremic syndrome (16 deaths) and 908 with the hemolytic-uremic syndrome (34 deaths) - indicating that this strain is notably more virulent than most of the Shiga-toxin-producing E. coli strains. Preliminary genetic characterization of the outbreak strain suggested that, unlike most of these strains, it should be classified within the enteroaggregative pathotype of E. coli. Methods We used third-generation, single-molecule, real-time DNA sequencing to determine the complete genome sequence of the German outbreak strain, as well as the genome sequences of seven diarrhea-associated enteroaggregative E. coli serotype O104: H4 strains from Africa and four enteroaggregative E. coli reference strains belonging to other serotypes. Genomewide comparisons were performed with the use of these enteroaggregative E. coli genomes, as well as those of 40 previously sequenced E. coli isolates. Results The enteroaggregative E. coli O104: H4 strains are closely related and form a distinct clade among E. coli and enteroaggregative E. coli strains. However, the genome of the German outbreak strain can be distinguished from those of other O104: H4 strains because it contains a prophage encoding Shiga toxin 2 and a distinct set of additional virulence and antibiotic-resistance factors. Conclusions Our findings suggest that horizontal genetic exchange allowed for the emergence of the highly virulent Shiga-toxin-producing enteroaggregative E. coli O104: H4 strain that caused the German outbreak. More broadly, these findings highlight the way in which the plasticity of bacterial genomes facilitates the emergence of new pathogens.	[Rasko, David A.; Sahl, Jason W.; Redman, Julia C.; Steyert, Susan R.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Rasko, David A.; Sahl, Jason W.; Redman, Julia C.; Steyert, Susan R.] Univ Maryland, Sch Dent, Dept Microbiol, Baltimore, MD 21201 USA; [Webster, Dale R.; Bashir, Ali; Paxinos, Ellen E.; Sebra, Robert; Chin, Chen-Shan; Iliopoulos, Dimitris; Klammer, Aaron; Peluso, Paul; Lee, Lawrence; Kislyuk, Andrey O.; Bullard, James; Kasarskis, Andrew; Wang, Susanna; Eid, John; Rank, David; Schadt, Eric E.] Pacific Biosci, Menlo Pk, CA USA; [Boisen, Nadia; Nataro, James P.] Univ Virginia, Sch Med, Dept Pediat, Charlottesville, VA 22908 USA; [Boisen, Nadia; Scheutz, Flemming] World Hlth Org Collaborating Ctr Reference & Res, Copenhagen, Denmark; [Boisen, Nadia; Scheutz, Flemming; Frimodt-Moller, Jakob; Struve, Carsten; Petersen, Andreas M.; Krogfelt, Karen A.] Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark; [Frimodt-Moller, Jakob] Hillerod Sygehus, Dept Clin Microbiol, Hillerod, Denmark; [Petersen, Andreas M.] Hvidovre Univ Hosp, Dept Gastroenterol, DK-2650 Hvidovre, Denmark; [Waldor, Matthew K.] Harvard Univ, Sch Med, Channing Lab, Brigham & Womens Hosp, Boston, MA 02115 USA; [Waldor, Matthew K.] Howard Hughes Med Inst, Boston, MA 02115 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Virginia; World Health Organization; Statens Serum Institut; University of Copenhagen; University of Copenhagen; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Schadt, EE (corresponding author), 1380 Willow Rd, Menlo Pk, CA 94025 USA.	eschadt@pacificbiosciences.com	Paxinos, Ellen/AAG-2907-2019; Krogfelt, Karen Angeliki/P-2430-2018; Krogfelt, Karen Angeliki A/O-8145-2016	Paxinos, Ellen/0000-0002-1710-8064; Krogfelt, Karen Angeliki A/0000-0001-7536-3453; David, Rasko/0000-0002-7337-7154; Frimodt-Moller, Jakob/0000-0002-7585-636X; Petersen, Andreas Munk/0000-0003-0531-0553; , Jason/0000-0002-2497-0138; Eid, John/0000-0002-2099-8344; Scheutz, Flemming/0000-0002-3931-4846; Rank, David/0000-0001-9213-6965; Waldor, Matthew/0000-0003-1843-7000	University of Maryland; National Institutes of Health (NIH) [AI090873, R37-AI-42347, AI-033096]; Howard Hughes Medical Institute; Danish Council for Strategic Research [09-063070]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090873, R29AI033096, R01AI033096, R37AI042347] Funding Source: NIH RePORTER	University of Maryland; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the University of Maryland Internal Funds and by grants from the National Institutes of Health (NIH) (AI090873, to the University of Maryland School of Medicine), the Howard Hughes Medical Institute and the NIH (R37-AI-42347, to Dr. Waldor), the NIH (AI-033096, to Drs. Nataro and Boisen), and the Danish Council for Strategic Research (09-063070, to Dr. Krogfelt).	Adachi JA, 2001, CLIN INFECT DIS, V32, P1706, DOI 10.1086/320756; Al-Hasani K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008223; Bae WK, 2006, YONSEI MED J, V47, P437, DOI 10.3349/ymj.2006.47.3.437; Behrman R. E., 2002, NELSON ESSENTIALS PE; Bernier C, 2002, INFECT IMMUN, V70, P4302, DOI 10.1128/IAI.70.8.4302-4311.2002; Bielaszewska M, 2011, LANCET INFECT D 0622; Boisen N, 2008, INFECT IMMUN, V76, P3281, DOI 10.1128/IAI.01646-07; Boisen N, 2009, AM J TROP MED HYG, V80, P294, DOI 10.4269/ajtmh.2009.80.294; Chaudhuri RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008801; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Cobeljic M, 1996, EPIDEMIOL INFECT, V117, P11, DOI 10.1017/S0950268800001072; Czeczulin JR, 1997, INFECT IMMUN, V65, P4135, DOI 10.1128/IAI.65.10.4135-4145.1997; Dudley EG, 2006, MOL MICROBIOL, V61, P1267, DOI 10.1111/j.1365-2958.2006.05281.x; Dutta PR, 2002, INFECT IMMUN, V70, P7105, DOI 10.1128/IAI.70.12.7105-7113.2002; Eslava C, 1993, 93 GEN M AM SOC MICR; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Harrington SM, 2005, CELL MICROBIOL, V7, P1565, DOI 10.1111/j.1462-5822.2005.00588.x; Harrington SM, 2009, INFECT IMMUN, V77, P2465, DOI 10.1128/IAI.01494-08; Huang DB, 2004, AM J GASTROENTEROL, V99, P383, DOI 10.1111/j.1572-0241.2004.04041.x; Itoh Y, 1997, J CLIN MICROBIOL, V35, P2546, DOI 10.1128/JCM.35.10.2546-2550.1997; Iyoda S, 2000, FEMS MICROBIOL LETT, V191, P7, DOI 10.1016/S0378-1097(00)00360-8; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kupferschmidt K, 2011, SCIENCE, V332, P1249, DOI 10.1126/science.332.6035.1249; MATHEWSON JJ, 1987, J CLIN MICROBIOL, V25, P1917, DOI 10.1128/JCM.25.10.1917-1919.1987; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Morabito S, 1998, J CLIN MICROBIOL, V36, P840, DOI 10.1128/JCM.36.3.840-842.1998; NATARO JP, 1985, J INFECT DIS, V152, P560, DOI 10.1093/infdis/152.3.560; NATARO JP, 1992, INFECT IMMUN, V60, P2297, DOI 10.1128/IAI.60.6.2297-2304.1992; Okeke IN, 2000, J INFECT DIS, V181, P252, DOI 10.1086/315204; Olesen B, 2005, J CLIN MICROBIOL, V43, P3636, DOI 10.1128/JCM.43.8.3636-3641.2005; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Ruiz-Perez F, P NATL ACAD IN PRESS; Sahl JW, 2011, INFECT IMMUN, V79, P950, DOI 10.1128/IAI.00932-10; Scheutz F, 2011, EURO SURVEILL, V16; Sheikh J, 2002, J CLIN INVEST, V110, P1329, DOI 10.1172/JCI200216172; Smet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011202; Tompkins D S, 1999, Commun Dis Public Health, V2, P108; TOMPKINS DS, 1999, COMMUN DIS PUBLIC HL, V2, P222; Torres AG, 2009, J CLIN MICROBIOL, V47, P2442, DOI 10.1128/JCM.00566-09; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Travers KJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq543; VIAL PA, 1988, J INFECT DIS, V158, P70, DOI 10.1093/infdis/158.1.70; Wanke CA, 1998, J INFECT DIS, V178, P185, DOI 10.1086/515595; Wieser A, 2010, INFECT IMMUN, V78, P3432, DOI 10.1128/IAI.00174-10; Zhang XP, 2000, J INFECT DIS, V181, P664, DOI 10.1086/315239	46	600	630	2	119	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2011	365	8					709	717		10.1056/NEJMoa1106920	http://dx.doi.org/10.1056/NEJMoa1106920			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811JM	21793740	Green Accepted, Bronze			2022-12-01	WOS:000294205300006
J	Murff, HJ; FitzHenry, F; Matheny, ME; Gentry, N; Kotter, KL; Crimin, K; Dittus, RS; Rosen, AK; Elkin, PL; Brown, SH; Speroff, T				Murff, Harvey J.; FitzHenry, Fern; Matheny, Michael E.; Gentry, Nancy; Kotter, Kristen L.; Crimin, Kimberly; Dittus, Robert S.; Rosen, Amy K.; Elkin, Peter L.; Brown, Steven H.; Speroff, Theodore			Automated Identification of Postoperative Complications Within an Electronic Medical Record Using Natural Language Processing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PATIENT-SAFETY-INDICATORS; QUALITY IMPROVEMENT PROGRAM; ADMINISTRATIVE DATA; ADVERSE EVENTS; TIME; CARE	Context Currently most automated methods to identify patient safety occurrences rely on administrative data codes; however, free-text searches of electronic medical records could represent an additional surveillance approach. Objective To evaluate a natural language processing search-approach to identify postoperative surgical complications within a comprehensive electronic medical record. Design, Setting, and Patients Cross-sectional study involving 2974 patients undergoing inpatient surgical procedures at 6 Veterans Health Administration (VHA) medical centers from 1999 to 2006. Main Outcome Measures Postoperative occurrences of acute renal failure requiring dialysis, deep vein thrombosis, pulmonary embolism, sepsis, pneumonia, or myocardial infarction identified through medical record review as part of the VA Surgical Quality Improvement Program. We determined the sensitivity and specificity of the natural language processing approach to identify these complications and compared its performance with patient safety indicators that use discharge coding information. Results The proportion of postoperative events for each sample was 2% (39 of 1924) for acute renal failure requiring dialysis, 0.7% (18 of 2327) for pulmonary embolism, 1% (29 of 2327) for deep vein thrombosis, 7% (61 of 866) for sepsis, 16% (222 of 1405) for pneumonia, and 2% (35 of 1822) for myocardial infarction. Natural language processing correctly identified 82% (95% confidence interval [CI], 67%-91%) of acute renal failure cases compared with 38% (95% CI, 25%-54%) for patient safety indicators. Similar results were obtained for venous thromboembolism (59%, 95% CI, 44%-72% vs 46%, 95% CI, 32%-60%), pneumonia (64%, 95% CI, 58%-70% vs 5%, 95% CI, 3%-9%), sepsis (89%, 95% CI, 78%-94% vs 34%, 95% CI, 24%-47%), and postoperative myocardial infarction (91%, 95% CI, 78%-97%) vs 89%, 95% CI, 74%-96%). Both natural language processing and patient safety indicators were highly specific for these diagnoses. Conclusion Among patients undergoing inpatient surgical procedures at VA medical centers, natural language processing analysis of electronic medical records to identify postoperative complications had higher sensitivity and lower specificity compared with patient safety indicators based on discharge coding. JAMA. 2011;306(8):848-855 www.jama.com	[Murff, Harvey J.; FitzHenry, Fern; Matheny, Michael E.; Gentry, Nancy; Dittus, Robert S.; Brown, Steven H.; Speroff, Theodore] Vet Affairs Med Ctr, Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA; [Murff, Harvey J.; Matheny, Michael E.; Dittus, Robert S.; Speroff, Theodore] Vanderbilt Univ, Div Gen Internal Med & Publ Hlth, Nashville, TN USA; [FitzHenry, Fern; Matheny, Michael E.; Brown, Steven H.] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN USA; [Kotter, Kristen L.; Crimin, Kimberly; Speroff, Theodore] Vanderbilt Univ, Dept Biostat, Nashville, TN USA; [Rosen, Amy K.] Boston Univ, Sch Publ Hlth, Ctr Org Leadership & Management Res, VA Boston Healthcare Syst, Boston, MA USA; [Rosen, Amy K.] Boston Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [Elkin, Peter L.] Mt Sinai Sch Med, New York, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; Icahn School of Medicine at Mount Sinai	Murff, HJ (corresponding author), Vanderbilt Epidemiol Ctr, Inst Med & Publ Hlth, 2525 W End Ave,Ste 600,6th Floor, Nashville, TN 37203 USA.	harvey.j.murff@vanderbilt.edu	Hug, Balthasar L./G-1568-2010; Matheny, Michael E/B-3541-2008	Matheny, Michael E/0000-0003-3217-4147	Veterans Health Administration [CDA-08-020]; Veterans Health Consortium for Health Informatics Research (CHIR) [HIR 09-001, HIR 09-003]; National Institutes of Health; Department of Veterans Affairs [SAF-03-223]	Veterans Health Administration(US Department of Veterans Affairs); Veterans Health Consortium for Health Informatics Research (CHIR)(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interests. Dr Matheny reported that he is supported by the Veterans Health Administration HSR&D Career Development Award CDA-08-020. Drs Matheny and Speroff reported that they are supported by the Veterans Health Consortium for Health Informatics Research (CHIR) awards HIR 09-001 and HIR 09-003. Dr Elkins reported that a pending grant gfrom the National Institutes of Health. No other disclosures were made.; This study was supported by grant SAF-03-223 from the Department of Veterans Affairs.	[Anonymous], 2003, AHRQ QUID PAT SAF IN; Bahl V, 2008, MED CARE, V46, P516, DOI 10.1097/MLR.0b013e31815f537f; Blumenthal D, 2010, NEW ENGL J MED, V362, P382, DOI 10.1056/NEJMp0912825; Brown SH, 2006, MAYO CLIN PROC, V81, P1472, DOI 10.4065/81.11.1472; Brown Steven H, 2008, AMIA Annu Symp Proc, P71; Centers for Medicare and Medicaid Services, MED QUAL MON SYST; Davis CL, 2007, J AM COLL SURGEONS, V204, P550, DOI 10.1016/j.jamcollsurg.2007.01.012; Elkin PL, 2006, MAYO CLIN PROC, V81, P741, DOI 10.4065/81.6.741; HealthGrades, 2010, HEALTHGRADES 7 ANN P; Houchens RL, 2008, JT COMM J QUAL PATIE, V34, P154, DOI 10.1016/S1553-7250(08)34018-5; Hripcsak G, 2003, J BIOMED INFORM, V36, P120, DOI 10.1016/j.jbi.2003.08.001; IEZZONI LI, 1994, MED CARE, V32, P700, DOI 10.1097/00005650-199407000-00004; International Health Terminology Standards Development Organisation, SNOMED CT; Itani KMF, 2009, AM J SURG, V198, pS9, DOI 10.1016/j.amjsurg.2009.08.003; Jha AK, 2009, NEW ENGL J MED, V360, P1628, DOI 10.1056/NEJMsa0900592; Kaafarani HMA, 2009, AM J SURG, V198, pS63, DOI 10.1016/j.amjsurg.2009.08.008; Khuri SF, 1998, ANN SURG, V228, P491, DOI 10.1097/00000658-199810000-00006; Melton CB, 2005, J AM MED INFORM ASSN, V12, P448, DOI 10.1197/jamia.M1794; Meystre S M, 2008, Yearb Med Inform, P128; Penz JFE, 2007, J BIOMED INFORM, V40, P174, DOI 10.1016/j.jbi.2006.06.003; Premier I, 2010, CMS PREM HOSP QUAL I; Rivard P, 2005, ADV PATIENT SAFETY R, V2, P7; Romano PS, 2009, HEALTH SERV RES, V44, P182, DOI 10.1111/j.1475-6773.2008.00905.x; Rosen AK, 2005, MED CARE, V43, P873, DOI 10.1097/01.mlr.0000173561.79742.fb; Rosen AK, 2006, MED CARE, V44, P850, DOI 10.1097/01.mlr.0000220686.82472.9c; White RH, 2009, MED CARE, V47, P1237, DOI 10.1097/MLR.0b013e3181b58940; Zhan C, 2003, QUAL SAF HEALTH CARE, V12, pII58, DOI 10.1136/qhc.12.suppl_2.ii58	27	275	277	0	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 24	2011	306	8					848	855		10.1001/jama.2011.1204	http://dx.doi.org/10.1001/jama.2011.1204			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	810VY	21862746	Bronze			2022-12-01	WOS:000294157300022
J	Jaqaman, K; Kuwata, H; Touret, N; Collins, R; Trimble, WS; Danuser, G; Grinstein, S				Jaqaman, Khuloud; Kuwata, Hirotaka; Touret, Nicolas; Collins, Richard; Trimble, William S.; Danuser, Gaudenz; Grinstein, Sergio			Cytoskeletal Control of CD36 Diffusion Promotes Its Receptor and Signaling Function	CELL			English	Article							GPI-ANCHORED PROTEINS; SINGLE-PARTICLE TRACKING; PLASMA-MEMBRANE MICRODOMAINS; LOW-DENSITY-LIPOPROTEIN; LIVING CELL-MEMBRANES; MOLECULE TRACKING; LIPID RAFTS; ACTIN CYTOSKELETON; ENDOTHELIAL-CELLS; T-CELLS	The mechanisms that govern receptor coalescence into functional clusters-often a critical step in their stimulation by ligand-are poorly understood. We used single-molecule tracking to investigate the dynamics of CD36, a clustering-responsive receptor that mediates oxidized LDL uptake by macrophages. We found that CD36 motion in the membrane was spatially structured by the cortical cytoskeleton. A subpopulation of receptors diffused within linear confinement regions whose unique geometry simultaneously facilitated freedom of movement along one axis while increasing the effective receptor density. Co-confinement within troughs enhanced the probability of collisions between unligated receptors and promoted their clustering. Cytoskeleton perturbations that inhibited diffusion in linear confinement regions reduced receptor clustering in the absence of ligand and, following ligand addition, suppressed CD36-mediated signaling and internalization. These observations demonstrate a role for the cytoskeleton in controlling signal transduction by structuring receptor diffusion within membrane regions that increase their collision frequency.	[Jaqaman, Khuloud; Danuser, Gaudenz] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Jaqaman, Khuloud] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Kuwata, Hirotaka; Collins, Richard; Trimble, William S.; Grinstein, Sergio] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Touret, Nicolas] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2E1, Canada; [Danuser, Gaudenz] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Scripps Research Institute; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Alberta; Harvard University; Harvard Medical School	Danuser, G (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	gaudenz_danuser@hms.harvard.edu; sergio.grinstein@sickkids.ca	Kuwata, Hiro/N-2023-2019	Kuwata, Hiro/0000-0002-5023-1777; Jaqaman, Khuloud/0000-0003-3471-1911; Danuser, Gaudenz/0000-0001-8583-2014	Heart and Stroke Foundation of Ontario; Canadian Institutes of Health Research [MOP-102474]; NIH [U01 GM67230]; Uehara Memorial Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kanae Foundation for the Promotion of Medical Science; Alberta Heritage Foundation for Medical Research Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762, U01GM067230] Funding Source: NIH RePORTER	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kanae Foundation for the Promotion of Medical Science; Alberta Heritage Foundation for Medical Research Scholarship(Alberta Heritage Foundation for Medical Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the Grinstein lab was supported by the Heart and Stroke Foundation of Ontario and by Canadian Institutes of Health Research Grant MOP-102474. Work in the Danuser lab was supported by NIH grant U01 GM67230. K.J. is an investigator in the Center for Cell Decision Processes (NIH P50 GM068762). HK was supported in part by the Uehara Memorial Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research and the Kanae Foundation for the Promotion of Medical Science. N.T. is supported by an Alberta Heritage Foundation for Medical Research Scholarship. S. G. is the current holder of the Pitblado Chair in Cell Biology.	Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; Berg, 2018, RANDOM WALKS BIOL; Bouzigues C, 2007, P NATL ACAD SCI USA, V104, P11251, DOI 10.1073/pnas.0702536104; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Cambi A, 2006, MOL BIOL CELL, V17, P4270, DOI 10.1091/mbc.E05-12-1098; Cebecauer M, 2010, J CELL SCI, V123, P309, DOI 10.1242/jcs.061739; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Collins RF, 2009, J BIOL CHEM, V284, P30288, DOI 10.1074/jbc.M109.045104; Daviet L, 1997, THROMB HAEMOSTASIS, V78, P897; de Keijzer S, 2011, BBA-BIOMEMBRANES, V1808, P1701, DOI 10.1016/j.bbamem.2011.02.009; Dorahy DJ, 1996, BIOCHEM J, V319, P67, DOI 10.1042/bj3190067; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Espenel C, 2008, J CELL BIOL, V182, P765, DOI 10.1083/jcb.200803010; Ewers H, 2005, P NATL ACAD SCI USA, V102, P15110, DOI 10.1073/pnas.0504407102; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI14006; Ferrari R, 2001, PHYSICA D, V154, P111, DOI 10.1016/S0167-2789(01)00234-2; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; Gambin Y, 2006, P NATL ACAD SCI USA, V103, P2098, DOI 10.1073/pnas.0511026103; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Harder T, 1997, MOL BIOL CELL, V8, P533, DOI 10.1091/mbc.8.3.533; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Huet S, 2006, BIOPHYS J, V91, P3542, DOI 10.1529/biophysj.105.080622; Iino R, 2001, BIOPHYS J, V80, P2667, DOI 10.1016/S0006-3495(01)76236-4; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Kaizuka Y, 2009, J CELL BIOL, V185, P521, DOI 10.1083/jcb.200809136; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Kennedy DJ, 2011, CARDIOVASC RES, V89, P604, DOI 10.1093/cvr/cvq360; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kusumi A, 2005, SEMIN IMMUNOL, V17, P3, DOI 10.1016/j.smim.2004.09.004; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Long BR, 2010, BIOPHYS J, V98, P1712, DOI 10.1016/j.bpj.2009.12.4299; Manneville JB, 2003, J CELL SCI, V116, P3927, DOI 10.1242/jcs.00672; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; McGrath JL, 1998, BIOPHYS J, V75, P2070, DOI 10.1016/S0006-3495(98)77649-0; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Ponti A, 2005, BIOPHYS J, V89, P3456, DOI 10.1529/biophysj.104.058701; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Savill J, 1997, BRIT MED BULL, V53, P491; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Serge A, 2003, J CELL SCI, V116, P5015, DOI 10.1242/jcs.00822; Sethna J., 2006, STAT MECH ENTROPY OR, V2nd; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Subbaramaiah K, 2000, J BIOL CHEM, V275, P14838, DOI 10.1074/jbc.275.20.14838; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Thorne RF, 2000, J BIOL CHEM, V275, P35264, DOI 10.1074/jbc.M003969200; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Viola A, 2007, NAT REV IMMUNOL, V7, P889, DOI 10.1038/nri2193; Yang G, 2007, NAT CELL BIOL, V9, P1233, DOI 10.1038/ncb1643; Yujiri T, 1999, J BIOL CHEM, V274, P12605, DOI 10.1074/jbc.274.18.12605; Zeng YC, 2003, J BIOL CHEM, V278, P45931, DOI 10.1074/jbc.M307722200	62	173	173	0	60	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 19	2011	146	4					593	606		10.1016/j.cell.2011.06.049	http://dx.doi.org/10.1016/j.cell.2011.06.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21854984	Green Accepted, Bronze			2022-12-01	WOS:000294043600014
J	Ekiert, DC; Friesen, RHE; Bhabha, G; Kwaks, T; Jongeneelen, M; Yu, WL; Ophorst, C; Cox, F; Korse, HJWM; Brandenburg, B; Vogels, R; Brakenhoff, JPJ; Kompier, R; Koldijk, MH; Cornelissen, LAHM; Poon, LLM; Peiris, M; Koudstaal, W; Wilson, IA; Goudsmit, J				Ekiert, Damian C.; Friesen, Robert H. E.; Bhabha, Gira; Kwaks, Ted; Jongeneelen, Mandy; Yu, Wenli; Ophorst, Carla; Cox, Freek; Korse, Hans J. W. M.; Brandenburg, Boerries; Vogels, Ronald; Brakenhoff, Just P. J.; Kompier, Ronald; Koldijk, Martin H.; Cornelissen, Lisette A. H. M.; Poon, Leo L. M.; Peiris, Malik; Koudstaal, Wouter; Wilson, Ian A.; Goudsmit, Jaap			A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses	SCIENCE			English	Article							MONOCLONAL-ANTIBODIES; HEMAGGLUTININ; PH; RECOGNITION; PEPTIDE; H5N1; HA2	Current flu vaccines provide only limited coverage against seasonal strains of influenza viruses. The identification of V(H)1-69 antibodies that broadly neutralize almost all influenza A group 1 viruses constituted a breakthrough in the influenza field. Here, we report the isolation and characterization of a human monoclonal antibody CR8020 with broad neutralizing activity against most group 2 viruses, including H3N2 and H7N7, which cause severe human infection. The crystal structure of Fab CR8020 with the 1968 pandemic H3 hemagglutinin (HA) reveals a highly conserved epitope in the HA stalk distinct from the epitope recognized by the V(H)1-69 group 1 antibodies. Thus, a cocktail of two antibodies may be sufficient to neutralize most influenza A subtypes and, hence, enable development of a universal flu vaccine and broad-spectrum antibody therapies.	[Friesen, Robert H. E.; Kwaks, Ted; Jongeneelen, Mandy; Ophorst, Carla; Cox, Freek; Korse, Hans J. W. M.; Brandenburg, Boerries; Vogels, Ronald; Brakenhoff, Just P. J.; Kompier, Ronald; Koldijk, Martin H.; Koudstaal, Wouter; Goudsmit, Jaap] Crucell Holland BV, NL-2301 CA Leiden, Netherlands; [Ekiert, Damian C.; Bhabha, Gira; Yu, Wenli; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Cornelissen, Lisette A. H. M.] Wageningen Univ, Cent Vet Inst, NL-8221 RA Lelystad, Netherlands; [Poon, Leo L. M.; Peiris, Malik] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Emerging Infect Dis, Pokfulam, Hong Kong, Peoples R China; [Poon, Leo L. M.; Peiris, Malik] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Johnson & Johnson; Scripps Research Institute; Wageningen University & Research; University of Hong Kong; University of Hong Kong; Scripps Research Institute	Koudstaal, W (corresponding author), Crucell Holland BV, Archimedesweg 4-6, NL-2301 CA Leiden, Netherlands.	wouter.koudstaal@crucell.com; wilson@scripps.edu	Poon, Leo Lit Man/C-4382-2009; Poon, Leo/AAP-6887-2020; Peiris, Joseph Sriyal Malik/C-4380-2009	Poon, Leo Lit Man/0000-0002-9101-7953; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Brandenburg, Boerries/0000-0002-5025-3802; Kwaks, Ted/0000-0003-1608-9372; Ekiert, Damian/0000-0002-2570-0404	National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services, USA [HHSN272200900060C]; University Grants Committee, Hong Kong [AoE/M-12/06]; NIH [GM080209]; Skaggs Institute; DOE Office of Biological and Environmental Research; NIH, National Center for Research Resources; National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080209] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University Grants Committee, Hong Kong; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute; DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Tien and D. Marciano of the Robotics Core at the Joint Center for Structural Genomics for automated crystal screening; T. Doukov and the staff of the SSRL BL9-2 for beamline support; X. Dai and R. Stanfield for excellent assistance with data collection, processing, and analyses; R. Lerner, J. Paulson, and D. Burton for valuable comments and insightful discussion; E. Geelen, D. Spek, and V. Klaren for excellent assistance and advice; K. Hegmans, A. Lourbakos, J. Meijer, and A. Apetri and their teams for producing the mAbs and Fabs; C. Y. H. Leung for providing the A/WF/Hong Kong/MPA892/06 virus; E. de Boer-Luijtze and technicians in the groups of P. van Rossum and S. Riemersma for assistance with the animal experiments; E. Brown from Ottawa University, Canada for the mouse-adapted A/Hong Kong/1/68 strain; and A. Dingemans for critical review of the manuscript. This project has been funded in part by the National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services, USA, under contract HHSN272200900060C; the Area of Excellence Scheme of the University Grants Committee, Hong Kong (grant AoE/M-12/06); a predoctoral fellowship from the Achievement Rewards for College Scientists Foundation (D. C. E.); grant GM080209 from the NIH Molecular Evolution Training Program (D. C. E.); and the Skaggs Institute (I. A. W.). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a national user facility operated by Stanford University on behalf of the U.S. Department of Energy (DOE), Office of Basic Energy Sciences. The Stanford Synchrotron Radiation Lightsource (SSRL) Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by NIH, National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences. This is publication 20951 from the Scripps Research Institute. Coordinates and structure factors have been deposited in the Protein Data Bank (PDB code 3SDY). Nucleotide sequences for the CR8020 variable regions have been deposited in GenBank (accession nos. JN093122, JN093123). A patent application relating to antibody CR8020 has been filed (International Publication Number WO2010/130636). Sharing of materials will be subject to standard material transfer agreements.	Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Barbey-Martin C, 2002, VIROLOGY, V294, P70, DOI 10.1006/viro.2001.1320; Beigel J, 2008, ANTIVIR RES, V78, P91, DOI 10.1016/j.antiviral.2008.01.003; Belongia E., 2008, Morbidity and Mortality Weekly Report, V57, P393; Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Chen GL, 2009, NAT MED, V15, P1251, DOI 10.1038/nm1109-1251; Chen J, 1999, P NATL ACAD SCI USA, V96, P8967, DOI 10.1073/pnas.96.16.8967; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fleury D, 1999, NAT STRUCT BIOL, V6, P530, DOI 10.1038/9299; Fleury D, 1998, NAT STRUCT BIOL, V5, P119, DOI 10.1038/nsb0298-119; Fleury D, 2000, PROTEINS, V40, P572; Hashem AM, 2010, BIOCHEM BIOPH RES CO, V403, P247, DOI 10.1016/j.bbrc.2010.11.030; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Lorieau JL, 2010, P NATL ACAD SCI USA, V107, P11341, DOI 10.1073/pnas.1006142107; Lowen Anice C., 2007, Infectious Disorders - Drug Targets, V7, P318; RUSS G, 1987, ACTA VIROL, V31, P374; Salzberg S, 2008, NATURE, V454, P160, DOI 10.1038/454160a; Skehel JJ, 2002, VACCINE, V20, pS51, DOI 10.1016/S0264-410X(02)00131-7; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Stropkovska A, 2009, ACTA VIROL, V53, P15, DOI 10.4149/av_2009_01_15; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Vareckova E, 2003, ARCH VIROL, V148, P469, DOI 10.1007/s00705-002-0932-1; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; Wang TT, 2009, NAT STRUCT MOL BIOL, V16, P233, DOI 10.1038/nsmb.1574; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Xu R, 2011, J VIROL, V85, P5172, DOI 10.1128/JVI.02430-10; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350	37	630	713	3	173	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2011	333	6044					843	850		10.1126/science.1204839	http://dx.doi.org/10.1126/science.1204839			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21737702	Green Accepted			2022-12-01	WOS:000293785400032
J	Kiers, ET; Duhamel, M; Beesetty, Y; Mensah, JA; Franken, O; Verbruggen, E; Fellbaum, CR; Kowalchuk, GA; Hart, MM; Bago, A; Palmer, TM; West, SA; Vandenkoornhuyse, P; Jansa, J; Bucking, H				Kiers, E. Toby; Duhamel, Marie; Beesetty, Yugandhar; Mensah, Jerry A.; Franken, Oscar; Verbruggen, Erik; Fellbaum, Carl R.; Kowalchuk, George A.; Hart, Miranda M.; Bago, Alberto; Palmer, Todd M.; West, Stuart A.; Vandenkoornhuyse, Philippe; Jansa, Jan; Buecking, Heike			Reciprocal Rewards Stabilize Cooperation in the Mycorrhizal Symbiosis	SCIENCE			English	Article							HOST SANCTIONS; MUTUALISM; EVOLUTION; CARBON; PERSISTENCE; HYPOTHESIS; ALLOCATION; CONFLICT; NETWORKS; TRADE	Plants and their arbuscular mycorrhizal fungal symbionts interact in complex underground networks involving multiple partners. This increases the potential for exploitation and defection by individuals, raising the question of how partners maintain a fair, two-way transfer of resources. We manipulated cooperation in plants and fungal partners to show that plants can detect, discriminate, and reward the best fungal partners with more carbohydrates. In turn, their fungal partners enforce cooperation by increasing nutrient transfer only to those roots providing more carbohydrates. On the basis of these observations we conclude that, unlike many other mutualisms, the symbiont cannot be "enslaved." Rather, the mutualism is evolutionarily stable because control is bidirectional, and partners offering the best rate of exchange are rewarded.	[Kiers, E. Toby; Duhamel, Marie; Franken, Oscar; Verbruggen, Erik; Kowalchuk, George A.] Vrije Univ Amsterdam, Inst Ecol Sci, NL-1081 HV Amsterdam, Netherlands; [Duhamel, Marie; Vandenkoornhuyse, Philippe] Univ Rennes 1, CNRS, EcoBio UMR6553, F-35042 Rennes, France; [Beesetty, Yugandhar] Rutgers State Univ, Dept Biol, Camden, NJ 08102 USA; [Beesetty, Yugandhar; Mensah, Jerry A.; Fellbaum, Carl R.; Buecking, Heike] S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA; [Kowalchuk, George A.] Netherlands Inst Ecol, Dept Microbial Ecol, NL-6708 PB Wageningen, Netherlands; [Hart, Miranda M.] Univ British Columbia, Kelowna, BC, Canada; [Bago, Alberto] CSIC, Estn Expt Zaidin, E-18008 Granada, Spain; [Palmer, Todd M.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [West, Stuart A.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Jansa, Jan] Swiss Fed Inst Technol, Inst Agr Sci, CH-8315 Lindau, Switzerland	Vrije Universiteit Amsterdam; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Rennes 1; Rutgers State University Camden; Rutgers State University New Brunswick; South Dakota State University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research; University of British Columbia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); State University System of Florida; University of Florida; University of Oxford; Swiss Federal Institutes of Technology Domain; ETH Zurich	Kiers, ET (corresponding author), Vrije Univ Amsterdam, Inst Ecol Sci, NL-1081 HV Amsterdam, Netherlands.	toby.kiers@vu.nl	West, Stuart A/M-3608-2014; Jansa, Jan/H-3161-2014; Verbruggen, Erik/AAF-1018-2019; Palmer, Todd/GRS-0639-2022; Kowalchuk, George A/C-4298-2011; Hart, Miranda m/D-1562-2011; Toby, Kiers/H-4819-2017; Drigo, Barbara/AAJ-9484-2021; Pijl, A/D-4220-2012; Verbruggen, Erik/A-5351-2012	West, Stuart A/0000-0003-2152-3153; Jansa, Jan/0000-0002-0331-1774; Verbruggen, Erik/0000-0001-7015-1515; Toby, Kiers/0000-0002-0597-1653; Drigo, Barbara/0000-0002-3301-0470; Kowalchuk, George/0000-0003-3866-0832; Palmer, Todd/0000-0001-5710-9750; Bucking, Heike/0000-0002-4040-0944; Franken, Oscar/0000-0001-8361-3117	Netherlands Organisation for Scientific Research (NWO);  [NSF-IOS 0943338/1051397];  [NSF-DEB-0827610];  [ANR-10-STRA-002]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ; ; 	We thank R. F. Denison, J. Ellers, and N. M. van Straalen for useful discussion; Isolife, A. S. Pijl, and B. Drigo for technical assistance; B. Hause for seeds; and NSF-IOS 0943338/1051397, NSF-DEB-0827610, ANR-10-STRA-002, and the Netherlands Organisation for Scientific Research (NWO) for financial support. A. B. is one of the cofounders of Mycovitro S. L. (Granada, Spain), a company providing AM fungal inoculum for research and biotechnology purposes. Fungal cultures provided by Mycovitro are available for purchase. Plasmids containing mitochondrial DNA fragments of fungal species (provided by ETH Zurich, Switzerland) are freely available under a material transfer agreement for noncommercial use. AM fungal sequences were deposited in GenBank, accession nos. HQ706096 to HQ706103.	Bever JD, 2009, ECOL LETT, V12, P13, DOI 10.1111/j.1461-0248.2008.01254.x; Bonfante P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1046; Bshary R, 2003, DAHL WS ENV, P167; Cowden CC, 2009, ECOL MODEL, V220, P1522, DOI 10.1016/j.ecolmodel.2009.03.028; de Mazancourt C, 2010, ECOL LETT, V13, P349, DOI 10.1111/j.1461-0248.2009.01431.x; Douglas AE, 2008, NEW PHYTOL, V177, P849, DOI 10.1111/j.1469-8137.2007.02326.x; Fitter AH, 2006, NEW PHYTOL, V172, P3, DOI 10.1111/j.1469-8137.2006.01861.x; Frank SA, 1996, P ROY SOC B-BIOL SCI, V263, P339, DOI 10.1098/rspb.1996.0052; Goto R, 2010, ECOL LETT, V13, P321, DOI 10.1111/j.1461-0248.2009.01425.x; Hoeksema JD, 2003, AM NAT, V162, pS40, DOI 10.1086/378644; Jander KC, 2010, P ROY SOC B-BIOL SCI, V277, P1481, DOI 10.1098/rspb.2009.2157; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Kiers ET, 2006, ECOLOGY, V87, P1627, DOI 10.1890/0012-9658(2006)87[1627:MSITAM]2.0.CO;2; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; Leigh EG, 2010, J EVOLUTION BIOL, V23, P2507, DOI 10.1111/j.1420-9101.2010.02114.x; Manefield M, 2002, APPL ENVIRON MICROB, V68, P5367, DOI 10.1128/AEM.68.11.5367-5373.2002; Mikkelsen BL, 2008, NEW PHYTOL, V180, P890, DOI 10.1111/j.1469-8137.2008.02623.x; NOE R, 1995, TRENDS ECOL EVOL, V10, P336, DOI 10.1016/S0169-5347(00)89123-5; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; PELLMYR O, 1994, NATURE, V372, P257, DOI 10.1038/372257a0; Pfeffer PE, 1999, PLANT PHYSIOL, V120, P587, DOI 10.1104/pp.120.2.587; Poulsen M, 2005, SCIENCE, V307, P741, DOI 10.1126/science.1106688; Powell JR, 2009, P ROY SOC B-BIOL SCI, V276, P4237, DOI 10.1098/rspb.2009.1015; Schwartz MW, 1998, ECOLOGY, V79, P1029, DOI 10.2307/176598; Selosse MA, 2006, TRENDS ECOL EVOL, V21, P621, DOI 10.1016/j.tree.2006.07.003; Smith SE, 2010, PLANT SOIL, V326, P3, DOI 10.1007/s11104-009-9981-5; Takanishi I, 2009, SOIL BIOL BIOCHEM, V41, P1571, DOI 10.1016/j.soilbio.2009.04.002; Vandenkoornhuyse P, 2007, P NATL ACAD SCI USA, V104, P16970, DOI 10.1073/pnas.0705902104; WEST SA, 1994, P ROY SOC B-BIOL SCI, V258, P67, DOI 10.1098/rspb.1994.0143	29	981	1046	38	1083	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2011	333	6044					880	882		10.1126/science.1208473	http://dx.doi.org/10.1126/science.1208473			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21836016				2022-12-01	WOS:000293785400041
J	Fearon, KCH				Fearon, Kenneth C. H.			Cancer Cachexia and Fat-Muscle Physiology	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Edinburgh, Royal Infirm, Dept Clin Surg, Sch Clin Sci & Community Hlth, Edinburgh EH3 9YW, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh	Fearon, KCH (corresponding author), Univ Edinburgh, Royal Infirm, Dept Clin Surg, Sch Clin Sci & Community Hlth, Edinburgh EH3 9YW, Midlothian, Scotland.							DAS SK, 2011, SCIENCE         0616; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Tan BHL, 2009, CLIN CANCER RES, V15, P6973, DOI 10.1158/1078-0432.CCR-09-1525; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	5	93	98	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2011	365	6					565	567		10.1056/NEJMcibr1106880	http://dx.doi.org/10.1056/NEJMcibr1106880			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805MW	21830971				2022-12-01	WOS:000293732100015
J	Tachiwana, H; Kagawa, W; Shiga, T; Osakabe, A; Miya, Y; Saito, K; Hayashi-Takanaka, Y; Oda, T; Sato, M; Park, SY; Kimura, H; Kurumizaka, H				Tachiwana, Hiroaki; Kagawa, Wataru; Shiga, Tatsuya; Osakabe, Akihisa; Miya, Yuta; Saito, Kengo; Hayashi-Takanaka, Yoko; Oda, Takashi; Sato, Mamoru; Park, Sam-Yong; Kimura, Hiroshi; Kurumizaka, Hitoshi			Crystal structure of the human centromeric nucleosome containing CENP-A	NATURE			English	Article							HISTONE H3; PROTEIN; DNA; FEATURES; VARIANT; CSE4	In eukaryotes, accurate chromosome segregation during mitosis and meiosis is coordinated by kinetochores, which are unique chromosomal sites for microtubule attachment(1,2). Centromeres specify the kinetochore formation sites on individual chromosomes, and are epigenetically marked by the assembly of nucleosomes containing the centromere-specific histone H3 variant, CENP-A(3-12). Although the underlying mechanism is unclear, centromere inheritance is probably dictated by the architecture of the centromeric nucleosome. Here we report the crystal structure of the human centromeric nucleosome containing CENP-A and its cognate alpha-satellite DNA derivative (147 base pairs). In the human CENP-A nucleosome, the DNA is wrapped around the histone octamer, consisting of two each of histones H2A, H2B, H4 and CENP-A, in a left-handed orientation. However, unlike the canonical H3 nucleosome, only the central 121 base pairs of the DNA are visible. The thirteen base pairs from both ends of the DNA are invisible in the crystal structure, and the alpha N helix of CENP-A is shorter than that of H3, which is known to be important for the orientation of the DNA ends in the canonical H3 nucleosome(13). A structural comparison of the CENP-A and H3 nucleosomes revealed that CENP-A contains two extra amino acid residues (Arg 80 and Gly 81) in the loop 1 region, which is completely exposed to the solvent. Mutations of the CENP-A loop 1 residues reduced CENP-A retention at the centromeres in human cells. Therefore, the CENP-A loop 1 may function in stabilizing the centromeric chromatin containing CENP-A, possibly by providing a binding site for trans-acting factors. The structure provides the first atomic-resolution picture of the centromere-specific nucleosome.	[Tachiwana, Hiroaki; Kagawa, Wataru; Shiga, Tatsuya; Osakabe, Akihisa; Miya, Yuta; Saito, Kengo; Kurumizaka, Hitoshi] Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Shinjuku Ku, Tokyo 1628480, Japan; [Hayashi-Takanaka, Yoko; Kimura, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Oda, Takashi; Sato, Mamoru] Yokohama City Univ, Grad Sch Nanobiosci, Dept Supramol Biol, Div Macromol Crystallog, Yokohama, Kanagawa 2300045, Japan; [Park, Sam-Yong] Yokohama City Univ, Grad Sch Nanobiosci, Dept Supramol Biol, Prot Design Lab, Yokohama, Kanagawa 2300045, Japan	Waseda University; Osaka University; Yokohama City University; Yokohama City University	Kurumizaka, H (corresponding author), Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Shinjuku Ku, 2-2 Wakamatsu Cho, Tokyo 1628480, Japan.	kurumizaka@waseda.jp	Tachiwana, Hiroaki/AHB-3091-2022; Kimura, Hiroshi/B-9524-2015; Hayashi, Yoko/GPT-4159-2022	Tachiwana, Hiroaki/0000-0001-9227-7653; Kimura, Hiroshi/0000-0003-0854-083X; Kagawa, Wataru/0000-0002-8801-6589; Kurumizaka, Hitoshi/0000-0001-7412-3722; SAITO, Kengo/0000-0002-8714-6285; HAYASHI, Yoko/0000-0002-0556-6738; Osakabe, Akihisa/0000-0002-2526-3398	Japanese Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Waseda Research Institute for Science and Engineering; Grants-in-Aid for Scientific Research [23770008] Funding Source: KAKEN	Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Waseda Research Institute for Science and Engineering; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the beamline scientists, N. Shimizu, Y. Kawano, M. Makino and T. Hikima, for their assistance with data collection at the BL41XU and BL45XU beamlines of SPring-8. We also thank R. Matsumoto for technical assistance, K. Yoda for anti-CENP-C, and T. Fukagawa and Y. Hiraoka for discussions. This work was supported in part by Grants-in-Aid from the Japanese Society for the Promotion of Science (JSPS), and the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. H.Ku. was also supported by the Waseda Research Institute for Science and Engineering.	Ando S, 2002, MOL CELL BIOL, V22, P2229, DOI 10.1128/MCB.22.7.2229-2241.2002; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchwitz BJ, 1999, NATURE, V401, P547, DOI 10.1038/44062; Camahort R, 2009, MOL CELL, V35, P794, DOI 10.1016/j.molcel.2009.07.022; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Dalai Y, 2007, P NATL ACAD SCI USA, V104, P15974, DOI 10.1073/pnas.0707648104; Dalal Y, 2007, PLOS BIOL, V5, P1798, DOI 10.1371/journal.pbio.0050218; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujisawa T, 2000, J APPL CRYSTALLOGR, V33, P797, DOI 10.1107/S002188980000131X; Furuyama T, 2009, CELL, V138, P104, DOI 10.1016/j.cell.2009.04.049; Glatter O., 1982, SMALL ANGLE XRAY SCA; Henikoff S, 2000, P NATL ACAD SCI USA, V97, P716, DOI 10.1073/pnas.97.2.716; Howman EV, 2000, P NATL ACAD SCI USA, V97, P1148, DOI 10.1073/pnas.97.3.1148; Kingston IJ, 2011, J BIOL CHEM, V286, P4021, DOI 10.1074/jbc.M110.189340; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Osakabe A, 2010, J BIOL CHEM, V285, P11913, DOI 10.1074/jbc.M109.083238; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALMER DK, 1987, J CELL BIOL, V104, P805, DOI 10.1083/jcb.104.4.805; Regnier V, 2005, MOL CELL BIOL, V25, P3967, DOI 10.1128/MCB.25.10.3967-3981.2005; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Silva NCE, 2007, J MOL BIOL, V370, P555, DOI 10.1016/j.jmb.2007.04.064; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tachiwana H, 2008, NUCLEIC ACIDS RES, V36, P2208, DOI 10.1093/nar/gkn060; Tachiwana H, 2010, P NATL ACAD SCI USA, V107, P10454, DOI 10.1073/pnas.1003064107; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Tanaka Y, 2005, J BIOL CHEM, V280, P41609, DOI 10.1074/jbc.M509666200; Tanaka Y, 2004, METHODS, V33, P3, DOI 10.1016/j.ymeth.2003.10.024; Tsunaka Y, 2005, NUCLEIC ACIDS RES, V33, P3424, DOI 10.1093/nar/gki663; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yoda K, 2000, P NATL ACAD SCI USA, V97, P7266, DOI 10.1073/pnas.130189697	40	279	282	1	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2011	476	7359					232	U135		10.1038/nature10258	http://dx.doi.org/10.1038/nature10258			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21743476				2022-12-01	WOS:000293731900042
J	Zhang, RD; So, BR; Li, PL; Yong, J; Glisovic, T; Wan, LL; Dreyfuss, G				Zhang, Rundong; So, Byung Ran; Li, Pilong; Yong, Jeongsik; Glisovic, Tina; Wan, Lili; Dreyfuss, Gideon			Structure of a Key Intermediate of the SMN Complex Reveals Gemin2's Crucial Function in snRNP Assembly	CELL			English	Article							SPINAL MUSCULAR-ATROPHY; MOTOR-NEURON COMPLEX; CRYSTAL-STRUCTURE; RNA-BINDING; U1 SNRNP; X-RAY; SPLICEOSOMAL SNRNPS; ARGININE RESIDUES; PROTEIN COMPLEXES; GENE-PRODUCT	The SMN complex mediates the assembly of heptameric Sm protein rings on small nuclear RNAs (snRNAs), which are essential for snRNP function. Specific Sm core assembly depends on Sm proteins and snRNA recognition by SMN/Gemin2- and Gemin5-containing subunits, respectively. The mechanism by which the Sm proteins are gathered while preventing illicit Sm assembly on non-snRNAs is unknown. Here, we describe the 2.5 angstrom crystal structure of Gemin2 bound to SmD1/D2/F/E/G pentamer and SMN's Gemin2-binding domain, a key assembly intermediate. Remarkably, through its extended conformation, Gemin2 wraps around the crescent-shaped pentamer, interacting with all five Sm proteins, and gripping its bottom and top sides and outer perimeter. Gemin2 reaches into the RNA-binding pocket, preventing RNA binding. Interestingly, SMN-Gemin2 interaction is abrogated by a spinal muscular atrophy (SMA)-causing mutation in an SMN helix that mediates Gemin2 binding. These findings provide insight into SMN complex assembly and specificity, linking snRNP biogenesis and SMA pathogenesis.	[Zhang, Rundong; So, Byung Ran; Li, Pilong; Yong, Jeongsik; Glisovic, Tina; Wan, Lili; Dreyfuss, Gideon] Univ Penn, Howard Hughes Med Inst, Sch Med, Philadelphia, PA 19104 USA; [Zhang, Rundong; So, Byung Ran; Li, Pilong; Yong, Jeongsik; Glisovic, Tina; Wan, Lili; Dreyfuss, Gideon] Univ Penn, Dept Biochem & Biophys, Sch Med, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania	Dreyfuss, G (corresponding author), Univ Penn, Howard Hughes Med Inst, Sch Med, Philadelphia, PA 19104 USA.	gdreyfuss@hhmi.upenn.edu	wan, li/GRY-7634-2022; ZHANG, RUNDONG/AAD-1161-2019; Zhang, Rundong/F-5946-2012; Dreyfuss, Gideon/D-1218-2013	ZHANG, RUNDONG/0000-0002-1719-1961; Dreyfuss, Gideon/0000-0001-8129-8774	Association Francaise Contre les Myopathies	Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies)	We thank Corie Ralston and Christy Bertoldo for their assistance with X-ray data collection at the Advanced Light Source (ALS, Berkeley, CA) synchrotron beamlines 8.2.1 and 8.2.2. We thank Emily Anna Bridges for help with bacterial cell culture. We are grateful to the members of our laboratory for helpful discussions and comments on this manuscript. This work was supported by the Association Francaise Contre les Myopathies. G. D. is an Investigator of the Howard Hughes Medical Institute.	Baccon J, 2002, J BIOL CHEM, V277, P31957, DOI 10.1074/jbc.M203478200; Battle DJ, 2007, J BIOL CHEM, V282, P27953, DOI 10.1074/jbc.M702317200; Battle DJ, 2006, MOL CELL, V23, P273, DOI 10.1016/j.molcel.2006.05.036; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carissimi C, 2006, J BIOL CHEM, V281, P8126, DOI 10.1074/jbc.M512243200; Carissimi C, 2005, FEBS LETT, V579, P2348, DOI 10.1016/j.febslet.2005.03.034; Cauchi RJ, 2010, BIOESSAYS, V32, P1077, DOI 10.1002/bies.201000088; Chari A, 2008, CELL, V135, P497, DOI 10.1016/j.cell.2008.09.020; Charroux B, 2000, J CELL BIOL, V148, P1177, DOI 10.1083/jcb.148.6.1177; Charroux B, 1999, J CELL BIOL, V147, P1181, DOI 10.1083/jcb.147.6.1181; Collins BM, 2003, J BIOL CHEM, V278, P17291, DOI 10.1074/jbc.M211826200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng WQ, 2005, HUM MOL GENET, V14, P1605, DOI 10.1093/hmg/ddi168; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Friesen MJ, 2000, J BIOL CHEM, V275, P26370, DOI 10.1074/jbc.M003299200; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Golembe TJ, 2005, MOL CELL BIOL, V25, P10989, DOI 10.1128/MCB.25.24.10989-11004.2005; Grimmler M, 2005, HUM MOL GENET, V14, P3099, DOI 10.1093/hmg/ddi343; Gubitz AK, 2002, J BIOL CHEM, V277, P5631, DOI 10.1074/jbc.M109448200; Jablonka S, 2002, P NATL ACAD SCI USA, V99, P10126, DOI 10.1073/pnas.152318699; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Krummel DAP, 2009, NATURE, V458, P475, DOI 10.1038/nature07851; Lau CK, 2009, NAT STRUCT MOL BIOL, V16, P486, DOI 10.1038/nsmb.1584; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Ma YL, 2005, STRUCTURE, V13, P883, DOI 10.1016/j.str.2005.03.014; MATTAJ IW, 1993, MOL BIOL REP, V18, P79, DOI 10.1007/BF00986760; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Neuenkirchen N, 2008, FEBS LETT, V582, P1997, DOI 10.1016/j.febslet.2008.03.009; Newman AJ, 2010, CURR OPIN STRUC BIOL, V20, P82, DOI 10.1016/j.sbi.2009.12.003; Ogawa C, 2007, J BIOL CHEM, V282, P11122, DOI 10.1074/jbc.M609297200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owen N, 2000, HUM MOL GENET, V9, P675, DOI 10.1093/hmg/9.5.675; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; Paushkin S, 2000, J BIOL CHEM, V275, P23841, DOI 10.1074/jbc.M001441200; Pellizzoni L, 1999, P NATL ACAD SCI USA, V96, P11167, DOI 10.1073/pnas.96.20.11167; Pellizzoni L, 2002, J BIOL CHEM, V277, P7540, DOI 10.1074/jbc.M110141200; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pesiridis GS, 2009, J BIOL CHEM, V284, P21347, DOI 10.1074/jbc.M109.015578; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Pu WT, 1999, MOL CELL BIOL, V19, P4113; Raker VA, 1999, MOL CELL BIOL, V19, P6554; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; Sauter C, 2003, NUCLEIC ACIDS RES, V31, P4091, DOI 10.1093/nar/gkg480; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Selenko P, 2001, NAT STRUCT BIOL, V8, P27; Shpargel KB, 2005, P NATL ACAD SCI USA, V102, P17372, DOI 10.1073/pnas.0508947102; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Sprangers R, 2003, J MOL BIOL, V327, P507, DOI 10.1016/S0022-2836(03)00148-7; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Sun Y, 2005, HUM MUTAT, V25, P64, DOI 10.1002/humu.20111; Talbot K, 2001, SEMIN NEUROL, V21, P189, DOI 10.1055/s-2001-15264; Thore S, 2003, J BIOL CHEM, V278, P1239, DOI 10.1074/jbc.M207685200; Toro I, 2001, EMBO J, V20, P2293, DOI 10.1093/emboj/20.9.2293; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wan LL, 2008, MOL CELL, V31, P244, DOI 10.1016/j.molcel.2008.06.004; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; Wang J, 2001, J BIOL CHEM, V276, P45387, DOI 10.1074/jbc.M105059200; Weber G, 2010, EMBO J, V29, P4172, DOI 10.1038/emboj.2010.295; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wirth Brunhilde, 2006, Semin Pediatr Neurol, V13, P121, DOI 10.1016/j.spen.2006.06.008; Yong J, 2004, MOL CELL BIOL, V24, P2747, DOI 10.1128/MCB.24.7.2747-2756.2004; Yong J, 2010, MOL CELL, V38, P551, DOI 10.1016/j.molcel.2010.03.014; Yong JS, 2004, TRENDS CELL BIOL, V14, P226, DOI 10.1016/j.tcb.2004.03.010	73	76	76	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 5	2011	146	3					384	395		10.1016/j.cell.2011.06.043	http://dx.doi.org/10.1016/j.cell.2011.06.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	803GT	21816274	Green Accepted, Bronze			2022-12-01	WOS:000293570500013
J	Hu, J; Xue, Y; Lee, S; Ha, Y				Hu, Jian; Xue, Yi; Lee, Sangwon; Ha, Ya			The crystal structure of GXGD membrane protease FlaK	NATURE			English	Article							SIGNAL PEPTIDE PEPTIDASE; GAMMA-SECRETASE; PSEUDOMONAS-AERUGINOSA; CATALYTIC PORE; II SECRETION; PRESENILIN; DOMAIN; IDENTIFICATION; CONFORMATION; TOPOLOGY	The GXGD proteases are polytopic membrane proteins with catalytic activities against membrane-spanning substrates that require a pair of aspartyl residues(1-4). Representative members of the family include preflagellin peptidase, type 4 prepilin peptidase, presenilin and signal peptide peptidase. Many GXGD proteases are important in medicine. For example, type 4 prepilin peptidase may contribute to bacterial pathogenesis(5-7), and mutations in presenilin are associated with Alzheimer's disease(8-10). As yet, there is no atomic-resolution structure in this protease family. Here we report the crystal structure of FlaK, a preflagellin peptidase from Methanococcus maripaludis, solved at 3.6 angstrom resolution. The structure contains six transmembrane helices. The GXGD motif and a short transmembrane helix, helix 4, are positioned at the centre, surrounded by other transmembrane helices. The crystal structure indicates that the protease must undergo conformational changes to bring the GXGD motif and a second essential aspartyl residue from transmembrane helix 1 into close proximity for catalysis. A comparison of the crystal structure with models of presenilin derived from biochemical analysis reveals three common transmembrane segments that are similarly arranged around the active site. This observation reinforces the idea that the prokaryotic and human proteases are evolutionarily related(11,12). The crystal structure presented here provides a framework for understanding the mechanism of the GXGD proteases, and may facilitate the rational design of inhibitors that target specific members of the family.	[Hu, Jian; Xue, Yi; Lee, Sangwon; Ha, Ya] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Ha, Y (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	ya.ha@yale.edu		Lee, Sangwon/0000-0002-9441-6546	US Department of Energy; National Institutes of Health; Ellison Medical Foundation; Yale's programme in Cellular Neuroscience, Neurodegeneration, and Repair (CNNR); NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301, P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082839, R01GM101136] Funding Source: NIH RePORTER	US Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Yale's programme in Cellular Neuroscience, Neurodegeneration, and Repair (CNNR); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Heroux, H. Robinson and A. Soares at NSLS, and J. Schuermann at APS NE-CAT for their help during data collection. X-ray diffraction data were measured at beamlines X25 and X29 at NSLS, and at 24-ID-C and 24-ID-E at APS. Financial support was principally from the US Department of Energy and from the National Institutes of Health. This work was supported by a New Scholar Award in Aging from the Ellison Medical Foundation (to Y.H.), a gift from the Neuroscience Education and Research Foundation (to Y.H.) and a pilot grant from Yale's programme in Cellular Neuroscience, Neurodegeneration, and Repair (CNNR) (to Y.H.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bardy SL, 2003, MOL MICROBIOL, V50, P1339, DOI 10.1046/j.1365-2958.2003.03758.x; Bardy SL, 2002, FEMS MICROBIOL LETT, V208, P53, DOI 10.1111/j.1574-6968.2002.tb11060.x; Bayley DP, 1999, J BACTERIOL, V181, P4146, DOI 10.1128/JB.181.14.4146-4153.1999; Bondar AN, 2009, STRUCTURE, V17, P395, DOI 10.1016/j.str.2008.12.017; Brouwers N, 2008, ANN MED, V40, P562, DOI 10.1080/07853890802186905; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; DAVIES DR, 1990, ANNU REV BIOPHYS BIO, V19, P189, DOI 10.1146/annurev.bb.19.060190.001201; Francetic O, 2007, J BACTERIOL, V189, P1783, DOI 10.1128/JB.01230-06; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Ha Y, 2009, SEMIN CELL DEV BIOL, V20, P240, DOI 10.1016/j.semcdb.2008.11.006; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jorissen E, 2010, CURR TOP DEV BIOL, V92, P201, DOI 10.1016/S0070-2153(10)92006-1; KABACK HR, 1966, P NATL ACAD SCI USA, V55, P920, DOI 10.1073/pnas.55.4.920; KALMOKOFF ML, 1990, BIOCHEM BIOPH RES CO, V167, P154, DOI 10.1016/0006-291X(90)91744-D; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; LaPointe CF, 2000, J BIOL CHEM, V275, P1502, DOI 10.1074/jbc.275.2.1502; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; Lory S, 1997, GENE, V192, P117, DOI 10.1016/S0378-1119(96)00830-X; Narayanan S, 2007, J BIOL CHEM, V282, P20172, DOI 10.1074/jbc.M701536200; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Spasic D, 2006, J BIOL CHEM, V281, P26569, DOI 10.1074/jbc.M600592200; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Wang YC, 2007, J MOL BIOL, V374, P1104, DOI 10.1016/j.jmb.2007.10.014; Wang YC, 2007, P NATL ACAD SCI USA, V104, P2098, DOI 10.1073/pnas.0611080104; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077	41	58	60	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2011	475	7357					528	U130		10.1038/nature10218	http://dx.doi.org/10.1038/nature10218			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21765428	Green Accepted			2022-12-01	WOS:000293167900047
J	Ferron, SR; Charalambous, M; Radford, E; McEwen, K; Wildner, H; Hind, E; Morante-Redolat, JM; Laborda, J; Guillemot, F; Bauer, SR; Farinas, I; Ferguson-Smith, AC				Ferron, Sacri R.; Charalambous, Marika; Radford, Elizabeth; McEwen, Kirsten; Wildner, Hendrik; Hind, Eleanor; Manuel Morante-Redolat, Jose; Laborda, Jorge; Guillemot, Francois; Bauer, Steven R.; Farinas, Isabel; Ferguson-Smith, Anne C.			Postnatal loss of Dlk1 imprinting in stem cells and niche astrocytes regulates neurogenesis	NATURE			English	Article							DIFFERENTIATION; EXPRESSION; GENES; ZONE; MOUSE-CHROMOSOME-12; PROLIFERATION; GTL2; GLIA	The gene for the atypical NOTCH ligand delta-like homologue 1 (Dlk1) encodes membrane-bound and secreted isoforms that function in several developmental processes in vitro and in vivo. Dlk1, a member of a cluster of imprinted genes, is expressed from the paternally inherited chromosome(1,2). Here we show that mice that are deficient in Dlk1 have defects in postnatal neurogenesis in the subventricular zone: a developmental continuum that results in depletion of mature neurons in the olfactory bulb. We show that DLK1 is secreted by niche astrocytes, whereas its membrane-bound isoform is present in neural stem cells (NSCs) and is required for the inductive effect of secreted DLK1 on self-renewal. Notably, we find that there is a requirement for Dlk1 to be expressed from both maternally and paternally inherited chromosomes. Selective absence of Dlk1 imprinting in both NSCs and niche astrocytes is associated with postnatal acquisition of DNA methylation at the germ-line-derived imprinting control region. The results emphasize molecular relationships between NSCs and the niche astrocyte cells of the microenvironment, identifying a signalling system encoded by a single gene that functions coordinately in both cell types. The modulation of genomic imprinting in a stem-cell environment adds a new level of epigenetic regulation to the establishment and maintenance of the niche, raising wider questions about the adaptability, function and evolution of imprinting in specific developmental contexts.	[Ferron, Sacri R.; Charalambous, Marika; Radford, Elizabeth; McEwen, Kirsten; Hind, Eleanor; Ferguson-Smith, Anne C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Wildner, Hendrik; Guillemot, Francois] Natl Inst Med Res, MRC, Dept Mol Neurobiol, London NW7 1AA, England; [Manuel Morante-Redolat, Jose; Farinas, Isabel] Univ Valencia, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Dept Biol Celular, E-46100 Burjassot, Spain; [Laborda, Jorge] Univ Castilla La Mancha, Reg Ctr Biomed Res, Sch Med, Dept Inorgan & Organ Chem & Biochem, Albacete 02006, Spain; [Bauer, Steven R.] US FDA, Cellular & Tissue Therapies Branch, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA	University of Cambridge; MRC National Institute for Medical Research; CIBERNED; University of Valencia; Universidad de Castilla-La Mancha; US Food & Drug Administration (FDA)	Ferguson-Smith, AC (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England.	afsmith@mole.bio.cam.ac.uk	Ferguson-Smith, Anne C/G-7534-2011; Bauer, Steven/G-5559-2012; Ferrón, Sacri R./I-2958-2015; Laborda, Jorge/L-5726-2014; Guillemot, Francois/AAV-1482-2021; Morante-Redolat, Jose Manuel/L-9397-2014; Farinas, Isabel/L-7118-2014	Ferrón, Sacri R./0000-0003-0854-8575; Laborda, Jorge/0000-0002-9210-838X; Charalambous, Marika/0000-0002-1684-5783; McEwen, Kirsten/0000-0002-9173-5664; Ferguson-Smith, Anne/0000-0002-7608-5894; Bauer, Steven/0000-0003-2831-846X; Morante-Redolat, Jose Manuel/0000-0003-0610-1665; Radford, Elizabeth/0000-0002-7829-5422; Farinas, Isabel/0000-0003-2903-4960	Medical Research Council; Wellcome Trust; Ministerio de Ciencia e Innovacion [SAF2008-01006, CB06/05/0086, RD06/0010/0010]; Generalitat Valenciana (Prometeo); University of Cambridge; Medical Research Council [G0800784, G0701196, MC_U117570528, G0800784B] Funding Source: researchfish; MRC [G0800784, MC_U117570528, G0701196] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat Valenciana (Prometeo)(Center for Forestry Research & Experimentation (CIEF)); University of Cambridge(University of Cambridge); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to J. Herbert and E. B. Keverne for sharing expertise during the course of this work. We thank members of the Ferguson-Smith laboratory for discussions and B. Sun, D. Gray, S. Curran, I. Gutteridge, R. Rancourt and X. d'Anglemont de Tassigny for technical assistance. The work was funded by grants from the Medical Research Council and Wellcome Trust to A.C.F.-S. and by grants from Ministerio de Ciencia e Innovacion (SAF2008-01006, CB06/05/0086, RD06/0010/0010) and Generalitat Valenciana (Prometeo) to I. F. S. R. F. is a recipient of a University of Cambridge Herchel-Smith Fellowship.	Abdallah BM, 2004, J BONE MINER RES, V19, P841, DOI 10.1359/JBMR.040118; Andreu-Agullo C, 2009, NAT NEUROSCI, V12, P1514, DOI 10.1038/nn.2437; Bauer M, 2008, J NEUROCHEM, V104, P1101, DOI 10.1111/j.1471-4159.2007.05037.x; Bray SJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-11; Christophersen NS, 2007, EXP NEUROL, V204, P791, DOI 10.1016/j.expneurol.2007.01.014; da Rocha ST, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000392; Davis E, 2004, CURR BIOL, V14, P1858, DOI 10.1016/j.cub.2004.09.079; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Ferron SR, 2007, NAT PROTOC, V2, P849, DOI 10.1038/nprot.2007.104; Garcia-Marques J, 2010, GLIA, V58, P218, DOI 10.1002/glia.20918; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Kornyei Z, 2005, GLIA, V49, P430, DOI 10.1002/glia.20123; Li L, 2005, ONCOGENE, V24, P4472, DOI 10.1038/sj.onc.1208637; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; Ma DK, 2009, CELL RES, V19, P672, DOI 10.1038/cr.2009.56; Mirzadeh Zaman, 2010, J Vis Exp, DOI 10.3791/1938; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Nyfeler Y, 2005, EMBO J, V24, P3504, DOI 10.1038/sj.emboj.7600816; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Raghunandan R, 2008, STEM CELLS DEV, V17, P495, DOI 10.1089/scd.2007.0102; Riquelme PA, 2008, PHILOS T R SOC B, V363, P123, DOI 10.1098/rstb.2006.2016; Schmidt JV, 2000, GENE DEV, V14, P1997; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Takada S, 2000, CURR BIOL, V10, P1135, DOI 10.1016/S0960-9822(00)00704-1; Tramontin AD, 2003, CEREB CORTEX, V13, P580, DOI 10.1093/cercor/13.6.580	30	191	198	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2011	475	7356					381	U136		10.1038/nature10229	http://dx.doi.org/10.1038/nature10229			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21776083	Green Submitted, Green Accepted			2022-12-01	WOS:000292911200043
J	Mackereth, CD; Madl, T; Bonnal, S; Simon, B; Zanier, K; Gasch, A; Rybin, V; Valcarcel, J; Sattler, M				Mackereth, Cameron D.; Madl, Tobias; Bonnal, Sophie; Simon, Bernd; Zanier, Katia; Gasch, Alexander; Rybin, Vladimir; Valcarcel, Juan; Sattler, Michael			Multi-domain conformational selection underlies pre-mRNA splicing regulation by U2AF	NATURE			English	Article							AUXILIARY FACTOR U2AF(65); POLYPYRIMIDINE TRACT; RECOGNITION; DYNAMICS; BINDING; RELAXATION; DOMAIN; RESTRAINTS; SEQUENCES; MECHANISM	Many cellular functions involve multi-domain proteins, which are composed of structurally independent modules connected by flexible linkers. Although it is often well understood how a given domain recognizes a cognate oligonucleotide or peptide motif, the dynamic interaction of multiple domains in the recognition of these ligands remains to be characterized. Here we have studied the molecular mechanisms of the recognition of the 3'-splice-site-associated polypyrimidine tract RNA by the large subunit of the human U2 snRNP auxiliary factor (U2AF65)(1-3) as a key early step in pre-mRNA splicing(4). We show that the tandem RNA recognition motif domains of U2AF65 adopt two remarkably distinct domain arrangements in the absence or presence of a strong (that is, high affinity) polypyrimidine tract. Recognition of sequence variations in the polypyrimidine tract RNA involves a population shift between these closed and open conformations. The equilibrium between the two conformations functions as a molecular rheostat that quantitatively correlates the natural variations in polypyrimidine tract nucleotide composition, length and functional strength to the efficiency to recruit U2 snRNP to the intron during spliceosome assembly(1,5-8). Mutations that shift the conformational equilibrium without directly affecting RNA binding modulate splicing activity accordingly. Similar mechanisms of cooperative multi-domain conformational selection may operate more generally in the recognition of degenerate nucleotide or amino acid motifs by multi-domain proteins(9,10).	[Mackereth, Cameron D.; Madl, Tobias; Sattler, Michael] Helmholtz Zentrum Munchen, Inst Struct Biol, D-85764 Neuherberg, Germany; [Mackereth, Cameron D.] Univ Bordeaux, F-33607 Pessac, France; [Mackereth, Cameron D.] Inst Europe Chim & Biol, F-33607 Pessac, France; [Mackereth, Cameron D.; Simon, Bernd; Zanier, Katia; Gasch, Alexander; Rybin, Vladimir; Sattler, Michael] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Madl, Tobias; Sattler, Michael] Tech Univ Munich, Dept Chem, Munich Ctr Integrated Prot Sci, D-85747 Garching, Germany; [Bonnal, Sophie; Valcarcel, Juan] Univ Pompeu Fabra, Ctr Regulacio Genom, Barcelona 08003, Spain; [Valcarcel, Juan] Inst Catalana Recerca & Estudis Avancats, Barcelona 08003, Spain; [Madl, Tobias; Sattler, Michael] Tech Univ Munich, Chair Biomol NMR, Dept Chem, D-85747 Garching, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; UDICE-French Research Universities; Universite de Bordeaux; European Molecular Biology Laboratory (EMBL); Technical University of Munich; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA; Technical University of Munich	Sattler, M (corresponding author), Helmholtz Zentrum Munchen, Inst Struct Biol, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	sattler@helmholtz-muenchen.de	Mackereth, Cameron D./F-7946-2013; Madl, Tobias/B-1682-2012; Sattler, Michael/A-2407-2012; Valcarcel, Juan/O-9814-2014	Mackereth, Cameron D./0000-0002-0776-7947; Madl, Tobias/0000-0002-9725-5231; Sattler, Michael/0000-0002-1594-0527; Valcarcel, Juan/0000-0001-5398-3571; Simon, Bernd/0000-0003-0164-5516	EMBO Long Term Fellowship; ICSN; Aquitaine regional government; Austrian Science Fund (FWF); EMBO; European Commission [226507]; EURASNET; AICR; Fundacion Marcelino Botin; ICREA Funding Source: Custom	EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); ICSN; Aquitaine regional government(Region Nouvelle-Aquitaine); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); EMBO(European Molecular Biology Organization (EMBO)); European Commission(European CommissionEuropean Commission Joint Research Centre); EURASNET; AICR; Fundacion Marcelino Botin; ICREA(ICREA)	We thank F. Gabel, M. Nilges, C. Griesinger, J. Muller and K. Scheffzek for discussions, and H. Tilgner for analysis of natural Py tract sequences. C. D. M. acknowledges support by EMBO Long Term Fellowship, ICSN and Aquitaine regional government. T. M. thanks the Austrian Science Fund (FWF) and EMBO for postdoctoral fellowships. We thank the EU NMR LSF in Frankfurt and the Bavarian NMR Centre (BNMRZ) in Munich for NMR measurement time. This work was supported by the European Commission, grants 3D Repertoire, FSG-V-RNA and NIM3 No. 226507 (M. S.), EURASNET, AICR and Fundacion Marcelino Botin (J.V.).	Banerjee H, 2003, RNA, V9, P88, DOI 10.1261/rna.2131603; Banerjee H, 2004, RNA, V10, P240, DOI 10.1261/rna.5153204; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUCKLE PE, 1993, BIOSENS BIOELECTRON, V8, P355, DOI 10.1016/0956-5663(93)80074-Y; Coolidge CJ, 1997, NUCLEIC ACIDS RES, V25, P888, DOI 10.1093/nar/25.4.888; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Guth S, 2001, MOL CELL BIOL, V21, P7673, DOI 10.1128/MCB.21.22.7673-7681.2001; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Ito T, 1999, EMBO J, V18, P4523, DOI 10.1093/emboj/18.16.4523; Iwahara J, 2004, J AM CHEM SOC, V126, P5879, DOI 10.1021/ja031580d; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; Soares LMM, 2006, SCIENCE, V312, P1961, DOI 10.1126/science.1128659; NILGES M, 1995, J MOL BIOL, V245, P645, DOI 10.1006/jmbi.1994.0053; Ramos A, 1998, J AM CHEM SOC, V120, P10992, DOI 10.1021/ja982496e; REED R, 1989, GENE DEV, V3, P2113, DOI 10.1101/gad.3.12b.2113; ROSCIGNO RF, 1993, J BIOL CHEM, V268, P11222; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Sickmier EA, 2006, MOL CELL, V23, P49, DOI 10.1016/j.molcel.2006.05.025; Simon B, 2010, ANGEW CHEM INT EDIT, V49, P1967, DOI 10.1002/anie.200906147; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; VALCARCEL J, 1997, MRNA FORMATION FUNCT, P31; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Yang DW, 1999, J BIOMOL NMR, V14, P333, DOI 10.1023/A:1008314803561; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0; Zhang Q, 2007, NATURE, V450, P1263, DOI 10.1038/nature06389	36	157	156	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 21	2011	475	7356					408	U174		10.1038/nature10171	http://dx.doi.org/10.1038/nature10171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21753750				2022-12-01	WOS:000292911200049
J	Tanser, F; Barnighausen, T; Hund, L; Garnett, GP; McGrath, N; Newell, ML				Tanser, Frank; Baernighausen, Till; Hund, Lauren; Garnett, Geoffrey P.; McGrath, Nuala; Newell, Marie-Louise			Effect of concurrent sexual partnerships on rate of new HIV infections in a high-prevalence, rural South African population: a cohort study	LANCET			English	Article							SUB-SAHARAN AFRICA; PUBLIC-HEALTH; COMMUNITY; DYNAMICS; LESSONS; EXPLAIN; SPREAD	Background Concurrent sexual partnerships are widely believed to be one of the main drivers of the HIV epidemic in sub-Saharan Africa. This view is supported by theoretical models predicting that increases in prevalence of concurrent partnerships could substantially increase the rate of spread of the disease. However, the effect of concurrent partnerships on HIV incidence has not been appropriately tested in a sub-Saharan African setting. Methods For this population-based cohort study, we used data from the Africa Centre demographic surveillance site in KwaZulu-Natal, South Africa, to try to find support for the concurrency hypothesis. We used a moving-window approach to construct estimates of the geographical variation in reported concurrent and lifetime partners in sexually active men aged 15-55 years (n=2153) across the study area. We then followed up 7284 HIV-negative women (>= 15 years of age) in the population and quantified the effect of the sexual behaviour profiles of men in the surrounding local community on a woman's hazard of HIV acquisition. Findings During 5 years' follow-up, 693 new female HIV infections occurred (incidence 3.60 cases per 100 person-years). We identified substantial intercommunity heterogeneity in the estimated point-prevalence of partnership concurrency (range 4.0-76.3%; mean 31.5%) and mean number of lifetime sexual partners (3.4-12.9; mean 6.3) in sexually active men in this population. After adjustment for individual-level sexual behaviour and demographic, socioeconomic, and environmental factors associated with HIV acquisition, mean lifetime number of partners of men in the immediate local community was predictive of hazard of HIV acquisition in women (adjusted hazard ratio [HR] 1.08, 95% CI 1.03-1.14, p=0.004), whereas a high prevalence of partnership concurrency in the same local community was not associated with any increase in risk of HIV acquisition (adjusted HR 1.02, 95% CI 0.95-1.09, p=0.556). Interpretation We find no evidence to suggest that concurrent partnerships are an important driver of HIV incidence in this typical high-prevalence rural African population. Our findings suggest that in similar hyperendemic sub-Saharan African settings, there is a need for straightforward, unambiguous messages aimed at the reduction of multiple partnerships, irrespective of whether those partnerships overlap in time.	[Tanser, Frank; Baernighausen, Till; McGrath, Nuala; Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, ZA-3935 Mtubatuba, South Africa; [Baernighausen, Till] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Hund, Lauren] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Garnett, Geoffrey P.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [McGrath, Nuala] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Newell, Marie-Louise] UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England	University of Kwazulu Natal; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Tanser, F (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, ZA-3935 Mtubatuba, South Africa.	tanserf@africacentre.ac.za	Tanser, Frank/ABE-8326-2021; Garnett, Geoffrey P/A-9312-2008; Newell, Marie-Louise/AAE-8222-2019; Bärnighausen, Till/Y-2388-2019	Newell, Marie-Louise/0000-0002-1074-7699; McGrath, Nuala/0000-0002-1039-0159; Tanser, Frank/0000-0001-9797-0000	US National Institute of Child Health and Human Development; Wellcome Trust [WT083495MA]; National Institute of Child Health and Human Development [1R01-HD058482-01]; Wellcome Trust, UK [082384/Z/07/Z]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058482] Funding Source: NIH RePORTER	US National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust, UK(Wellcome Trust); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	US National Institute of Child Health and Human Development; Wellcome Trust.; This research was supported by grant 1R01-HD058482-01 from the National Institute of Child Health and Human Development. Funding for the Africa Centre's Demographic Surveillance Information System and Population-based HIV Survey was received from the Wellcome Trust, UK (grant 082384/Z/07/Z). NM was supported by a Wellcome Trust fellowship (grant WT083495MA).	ANDERSON R M, 1991; Barnighausen T, 2009, AIDS RES HUM RETROV, V25, P405, DOI 10.1089/aid.2008.0211; Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Barnighausen T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003640; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Cleland J, 2004, SEX TRANSM INFECT, V80, P1, DOI 10.1136/sti.2004.013151; Epstein H, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2638; Ferguson NM, 2000, SEX TRANSM DIS, V27, P600, DOI 10.1097/00007435-200011000-00008; Halperin DT, 2004, LANCET, V364, P4, DOI 10.1016/S0140-6736(04)16606-3; Helleringer S, 2009, AIDS, V23, P1285, DOI 10.1097/QAD.0b013e32832aa85c; Hosegood V, 2009, DEMOGR RES, V20, P279, DOI 10.4054/DemRes.2009.20.13; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Lagarde E, 2001, AIDS, V15, P877, DOI 10.1097/00002030-200105040-00008; Lurie MN, 2010, AIDS BEHAV, V14, P34, DOI 10.1007/s10461-009-9640-0; Mah TL, 2010, AIDS BEHAV, V14, P25, DOI 10.1007/s10461-009-9617-z; MISHRA V, 2009, CONCURRENT SEXUAL PA; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Morris M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014092; Morris M, 2010, AIDS BEHAV, V14, P31, DOI 10.1007/s10461-009-9639-6; Ng BE, 2011, COCHRANE DB SYST REV, V3; Potts M, 2008, SCIENCE, V320, P749, DOI 10.1126/science.1153843; Randolph W, 2004, ANNU REV PUBL HEALTH, V25, P419, DOI 10.1146/annurev.publhealth.25.101802.123046; Reniers G, 2010, AIDS, V24, P299, DOI 10.1097/QAD.0b013e328333af03; Roux AVD, 2005, J INFECT DIS, V191, pS25, DOI 10.1086/425288; Royston P, 2001, STATA J, V1, P1, DOI 10.1177/1536867X0100100101; Sawers L, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-34; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Shelton JD, 2007, LANCET, V370, P1809, DOI 10.1016/S0140-6736(07)61755-3; Shelton JD, 2010, LANCET, V375, P964, DOI 10.1016/S0140-6736(10)60416-3; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; Tanser F, 2009, INT J EPIDEMIOL, V38, P1008, DOI 10.1093/ije/dyp148; *UNAIDS, 2008, 2008 REP GLOB AIDS E; *UNAIDS, 2008, STRAT CONS COMM MULT; UNAIDS Reference Group On Estimates Modelling & Projections, 2009, LANCET, V375, P621; *UNAIDS WHO, 2001, GUID US HIV TEST TEC; Waller L.A., 2004, APPL SPATIAL STAT PU; WATTS CH, 1992, MATH BIOSCI, V108, P89, DOI 10.1016/0025-5564(92)90006-I; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; *WORLD BANK, 2009, GLOB EC CRIS HIV PRE	39	123	124	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2011	378	9787					247	255		10.1016/S0140-6736(11)60779-4	http://dx.doi.org/10.1016/S0140-6736(11)60779-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798JD	21763937	Green Published, Green Accepted			2022-12-01	WOS:000293201100032
J	Fry, AM; Perez, A; Finelli, L				Fry, Alicia M.; Perez, Alejandro; Finelli, Lyn			Use of Intravenous Neuraminidase Inhibitors During the 2009 Pandemic: Results From Population-Based Surveillance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							INFLUENZA		[Fry, Alicia M.; Perez, Alejandro; Finelli, Lyn] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Fry, AM (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA.	afry@cdc.gov	Finelli, Lyn/AAK-2360-2020					[Anonymous], UPD INT REC US ANT M; [Anonymous], EM US AUTH PER 4 FAC; Birnkrant D, 2009, NEW ENGL J MED, V361, P2204, DOI 10.1056/NEJMp0910479; Dao CN, 2010, J INFECT DIS, V202, P881, DOI 10.1086/655904; Dawood FS, 2010, J PEDIATR-US, V157, P808, DOI 10.1016/j.jpeds.2010.05.012	5	7	7	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2011	306	2					160	162		10.1001/jama.2011.950	http://dx.doi.org/10.1001/jama.2011.950			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791CO	21750292				2022-12-01	WOS:000292639400019
J	Notta, F; Doulatov, S; Laurenti, E; Poeppl, A; Jurisica, I; Dick, JE				Notta, Faiyaz; Doulatov, Sergei; Laurenti, Elisa; Poeppl, Armando; Jurisica, Igor; Dick, John E.			Isolation of Single Human Hematopoietic Stem Cells Capable of Long-Term Multilineage Engraftment	SCIENCE			English	Article							CORD-BLOOD; PROGENITOR CELLS; MICE; RECONSTITUTION; PURIFICATION; POPULATION; RECIPIENTS; HIERARCHY; MAP	Lifelong blood cell production is dependent on rare hematopoietic stem cells (HSCs) to perpetually replenish mature cells via a series of lineage-restricted intermediates. Investigating the molecular state of HSCs is contingent on the ability to purify HSCs away from transiently engrafting cells. We demonstrated that human HSCs remain infrequent, using current purification strategies based on Thy1 (CD90) expression. By tracking the expression of several adhesion molecules in HSC-enriched subsets, we revealed CD49f as a specific HSC marker. Single CD49f(+) cells were highly efficient in generating long-term multilineage grafts, and the loss of CD49f expression identified transiently engrafting multipotent progenitors (MPPs). The demarcation of human HSCs and MPPs will enable the investigation of the molecular determinants of HSCs, with a goal of developing stem cell-based therapeutics.	[Notta, Faiyaz; Doulatov, Sergei; Laurenti, Elisa; Poeppl, Armando; Dick, John E.] Ontario Canc Inst, Campbell Family Inst Canc Res, Div Stem Cell & Dev Biol, Toronto, ON M4X 1K9, Canada; [Notta, Faiyaz; Doulatov, Sergei; Laurenti, Elisa; Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Jurisica, Igor] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Jurisica, Igor] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto	Dick, JE (corresponding author), Toronto Med Discovery Tower,Room 8-301,101 Coll S, Toronto, ON M5G 1L7, Canada.	jdick@uhnres.utoronto.ca		Dick, John/0000-0002-9527-8317; Laurenti, Elisa/0000-0002-9917-9092	Canadian Institutes for Health Research (CIHR); Swiss National Science Foundation; Roche; Canadian Cancer Society; Terry Fox Foundation; Genome Canada through the Ontario Genomics Institute; Ontario Institute for Cancer Research with province of Ontario; Ontario Ministry of Health and Long Term Care (OMOHLTC)	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Roche(Roche Holding); Canadian Cancer Society(Canadian Cancer Society (CCS)); Terry Fox Foundation; Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Institute for Cancer Research with province of Ontario; Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario)	We thank K. Moore and the obstetrics unit of Trillium Hospital (Mississauga, Ontario) for providing CB, the Dick Lab and M. Cooper for critical manuscript review, C. Nostro from the Keller lab for assistance with immunofluorescence, and P. A. Penttila and the University Health Network/Sickkids flow cytometry facility. This work was supported by Canadian Institutes for Health Research (CIHR) studentships (F.N. and S.D.) and Swiss National Science Foundation and Roche fellowships (E.L.). Grants were received from the CIHR, Canadian Cancer Society, Terry Fox Foundation, Genome Canada through the Ontario Genomics Institute, Ontario Institute for Cancer Research with funds from the province of Ontario, and a Canada Research Chair. This research was funded in part by the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC. Microarray data are available online at the Gene Expression Omnibus Web page (accession code GSE29105). F.N., S.D., and J.E.D. designed the study; F.N., S.D., and A.P. performed experiments; E.L., S.D., and I.J. analyzed gene expression data; F.N. prepared the manuscript; S.D. and J.E.D. edited the manuscript; and J.E.D supervised the study.	Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]; BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; CRAIG W, 1993, J EXP MED, V177, P1331, DOI 10.1084/jem.177.5.1331; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Goren A, 2010, NAT METHODS, V7, P47, DOI [10.1038/nmeth.1404, 10.1038/NMETH.1404]; HAO QL, 1995, BLOOD, V86, P3745, DOI 10.1182/blood.V86.10.3745.bloodjournal86103745; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; MAYANI H, 1993, BLOOD, V82, P2664; McKenzie JL, 2005, BLOOD, V106, P1259, DOI 10.1182/blood-2005-03-1081; McKenzie JL, 2007, BLOOD, V109, P543, DOI 10.1182/blood-2006-06-030270; Notta F, 2010, BLOOD, V115, P3704, DOI 10.1182/blood-2009-10-249326; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Ueno H, 2003, NAT IMMUNOL, V4, P457, DOI 10.1038/ni916	21	541	571	1	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					218	221		10.1126/science.1201219	http://dx.doi.org/10.1126/science.1201219			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21737740				2022-12-01	WOS:000292502700049
J	Bushey, D; Tononi, G; Cirelli, C				Bushey, Daniel; Tononi, Giulio; Cirelli, Chiara			Sleep and Synaptic Homeostasis: Structural Evidence in Drosophila	SCIENCE			English	Article							MENTAL-RETARDATION PROTEIN; MUSHROOM BODIES; DENDRITIC SPINES; CIRCADIAN CLOCK; PLASTICITY; INCREASES; NEURONS; NEED; WAKE; MICROSCOPY	The functions of sleep remain elusive, but a strong link exists between sleep need and neuronal plasticity. We tested the hypothesis that plastic processes during wake lead to a net increase in synaptic strength and sleep is necessary for synaptic renormalization. We found that, in three Drosophila neuronal circuits, synapse size or number increases after a few hours of wake and decreases only if flies are allowed to sleep. A richer wake experience resulted in both larger synaptic growth and greater sleep need. Finally, we demonstrate that the gene Fmr1 (fragile X mental retardation 1) plays an important role in sleep-dependent synaptic renormalization.	[Bushey, Daniel; Tononi, Giulio; Cirelli, Chiara] Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA	University of Wisconsin System; University of Wisconsin Madison	Cirelli, C (corresponding author), Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA.	ccirelli@wisc.edu			National Institute of General Medical Sciences [R01 GM075315]; NIH; Army Research Office [W911NF-08-1-0169]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075315] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000579] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was supported by National Institute of General Medical Sciences (R01 GM075315 to C.C.), NIH Director's Pioneer award (to G.T.), Army Research Office (DURIP award W911NF-08-1-0169 to C.C.), and Canadian Institutes of Health Research (to D.B.). We thank G. Tavosanis for technical advice.	Appelbaum L, 2010, NEURON, V68, P87, DOI 10.1016/j.neuron.2010.09.006; BALLING A, 1987, J NEUROGENET, V4, P65, DOI 10.3109/01677068709102334; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Bushey D, 2009, J NEUROSCI, V29, P1948, DOI 10.1523/JNEUROSCI.4830-08.2009; Cirelli C, 2008, PLOS BIOL, V6, P1605, DOI 10.1371/journal.pbio.0060216; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Gatto CL, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.008.2009; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Helfrich-Forster C, 2005, GENES BRAIN BEHAV, V4, P65, DOI 10.1111/j.1601-183X.2004.00092.X; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Irwin SA, 2005, NEUROBIOL LEARN MEM, V83, P180, DOI 10.1016/j.nlm.2004.11.004; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Lee T, 1999, DEVELOPMENT, V126, P4065; Leiss F, 2009, DEV NEUROBIOL, V69, P221, DOI 10.1002/dneu.20699; Liu ZW, 2010, J NEUROSCI, V30, P8671, DOI 10.1523/JNEUROSCI.1409-10.2010; Maimon G, 2010, NAT NEUROSCI, V13, P393, DOI 10.1038/nn.2492; Mignot E, 2008, PLOS BIOL, V6, P661, DOI 10.1371/journal.pbio.0060106; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Pan LY, 2004, CURR BIOL, V14, P1863, DOI 10.1016/j.cub.2004.09.085; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Redondo RL, 2011, NAT REV NEUROSCI, V12, P17, DOI 10.1038/nrn2963; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Sigrist SJ, 2003, J NEUROSCI, V23, P6546; Tessier CR, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.008.2009; Todd PK, 2000, MOL BRAIN RES, V80, P17, DOI 10.1016/S0169-328X(00)00098-X; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	36	230	235	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 24	2011	332	6037					1576	1581		10.1126/science.1202839	http://dx.doi.org/10.1126/science.1202839			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700878	Green Accepted			2022-12-01	WOS:000291990000050
J	Isbell, F; Calcagno, V; Hector, A; Connolly, J; Harpole, WS; Reich, PB; Scherer-Lorenzen, M; Schmid, B; Tilman, D; van Ruijven, J; Weigelt, A; Wilsey, BJ; Zavaleta, ES; Loreau, M				Isbell, Forest; Calcagno, Vincent; Hector, Andy; Connolly, John; Harpole, W. Stanley; Reich, Peter B.; Scherer-Lorenzen, Michael; Schmid, Bernhard; Tilman, David; van Ruijven, Jasper; Weigelt, Alexandra; Wilsey, Brian J.; Zavaleta, Erika S.; Loreau, Michel			High plant diversity is needed to maintain ecosystem services	NATURE			English	Article							GRASSLAND EXPERIMENT; BIOMASS PRODUCTION; CURRENT KNOWLEDGE; ELEVATED CO2; BIODIVERSITY; PRODUCTIVITY; COMMUNITIES; ECOLOGY; INSURANCE; STABILITY	Biodiversity is rapidly declining worldwide(1), and there is consensus that this can decrease ecosystem functioning and services(2-7). It remains unclear, though, whether few(8) or many(9) of the species in an ecosystem are needed to sustain the provisioning of ecosystem services. It has been hypothesized that most species would promote ecosystem services if many times, places, functions and environmental changes were considered(9); however, no previous study has considered all of these factors together. Here we show that 84% of the 147 grassland plant species studied in 17 biodiversity experiments promoted ecosystem functioning at least once. Different species promoted ecosystem functioning during different years, at different places, for different functions and under different environmental change scenarios. Furthermore, the species needed to provide one function during multiple years were not the same as those needed to provide multiple functions within one year. Our results indicate that even more species will be needed to maintain ecosystem functioning and services than previously suggested by studies that have either (1) considered only the number of species needed to promote one function under one set of environmental conditions, or (2) separately considered the importance of biodiversity for providing ecosystem functioning across multiple years(10-14), places(15,16), functions(14,17,18) or environmental change scenarios(12,19-22). Therefore, although species may appear functionally redundant when one function is considered under one set of environmental conditions(7), many species are needed to maintain multiple functions at multiple times and places in a changing world.	[Isbell, Forest; Calcagno, Vincent; Loreau, Michel] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Hector, Andy; Schmid, Bernhard] Univ Zurich, Inst Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland; [Connolly, John] Univ Coll Dublin, UCD Sch Math Sci, Dublin 4, Ireland; [Harpole, W. Stanley; Wilsey, Brian J.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Reich, Peter B.] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Reich, Peter B.] Univ Western Sydney, Hawkesbury Inst Environm, Richmond, NSW 2753, Australia; [Scherer-Lorenzen, Michael] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Tilman, David] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [van Ruijven, Jasper] Wageningen Univ, NL-6700 AA Wageningen, Netherlands; [Weigelt, Alexandra] Univ Leipzig, Inst Biol 1, D-04103 Leipzig, Germany; [Zavaleta, Erika S.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA	McGill University; University of Zurich; University College Dublin; Iowa State University; University of Minnesota System; University of Minnesota Twin Cities; Western Sydney University; University of Freiburg; University of Minnesota System; University of Minnesota Twin Cities; Wageningen University & Research; Leipzig University; University of California System; University of California Santa Cruz	Isbell, F (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	forest.isbell@gmail.com	Schmid, Bernhard/C-8625-2009; calcagno, vincent/B-1456-2015; Isbell, Forest/C-6915-2012; Tilman, David/ABD-5309-2021; Harpole, William S/C-2814-2013; van Ruijven, Jasper/ABE-7791-2020; van Ruijven, Jasper/D-9848-2011; Hector, Andrew/H-4199-2011; Scherer-Lorenzen, Michael/AGB-4140-2022	Schmid, Bernhard/0000-0002-8430-3214; calcagno, vincent/0000-0002-5781-967X; Isbell, Forest/0000-0001-9689-769X; Harpole, William S/0000-0002-3404-9174; van Ruijven, Jasper/0000-0003-0003-2363; Hector, Andrew/0000-0002-1309-7716; Scherer-Lorenzen, Michael/0000-0001-9566-590X; Wilsey, Brian J./0000-0002-0628-5006; Reich, Peter/0000-0003-4424-662X	Swiss SystemsX.ch initiative [IPP-2008/23]; European Commission [ENV-CT95-0008]; Swiss Federal Office for Education and Science [EU-1311]; Deutsche Forschungsgemeinschaft (DFG) [FOR 456]; Friedrich Schiller University of Jena; Max Planck Society; University of Zurich; Swiss National Science Foundation [3100AO-107531]; ETH Zurich; Dutch Organisation for Scientific Research (NWO); EU Commission [852]; Science Foundation Ireland [09/RFP/EOB2546]; US Department of Energy [DOE/DE-FG02-96ER62291]; US National Science Foundation [0322057, LTER DEB 9411972, DEB 0080382, DEB 0620652, LTREB DEB 0716587, DEB 0639417]; Natural Sciences and Engineering Research Council of Canada; Canada Research Chair program	Swiss SystemsX.ch initiative; European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss Federal Office for Education and Science; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Friedrich Schiller University of Jena; Max Planck Society(Max Planck SocietyFoundation CELLEX); University of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich); Dutch Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); EU Commission(European CommissionEuropean Commission Joint Research Centre); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); US Department of Energy(United States Department of Energy (DOE)); US National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair program(Canada Research Chairs)	We thank J. Byrnes, L. Gamfeldt and M. Emmerson for comments on an earlier version of this manuscript. We thank the Swiss SystemsX.ch initiative (IPP-2008/23) for supporting this project. The BIODEPTH project was funded by the European Commission within the Framework IV Environment and Climate Programme (ENV-CT95-0008) and by the Swiss Federal Office for Education and Science (Project EU-1311). The Jena Experiment was funded by the Deutsche Forschungsgemeinschaft (DFG, FOR 456), Friedrich Schiller University of Jena, Max Planck Society, University of Zurich, Swiss National Science Foundation (3100AO-107531) and ETH Zurich. The Wageningen experiment was funded by the Dutch Organisation for Scientific Research (NWO) within the framework of the Biodiversity Programme. Work on the Agrodiversity experiment was funded by the EU Commission through COST Action 852 and Science Foundation Ireland (09/RFP/EOB2546). The BioCON experiment was funded by the US Department of Energy (DOE/DE-FG02-96ER62291) and the US National Science Foundation (Biocomplexity 0322057, LTER DEB 9411972, DEB 0080382, DEB 0620652 and LTREB DEB 0716587). The MEND Irrigation, BioGEN and Rarity-Extinction experiments were funded by the US National Science Foundation (DEB 0639417). The Cedar Creek Biodiversity experiment was funded by the US National Science Foundation. M. L. was supported by The Natural Sciences and Engineering Research Council of Canada (Discovery Grant) and the Canada Research Chair program.	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Calcagno V, 2010, J STAT SOFTW, V34, P1; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Craine JM, 2003, ECOL LETT, V6, P623, DOI 10.1046/j.1461-0248.2003.00467.x; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Efron B., 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; EHRLICH P, 1982, EXTINCTION CAUSES CO; Gamfeldt L, 2008, ECOLOGY, V89, P1223, DOI 10.1890/06-2091.1; Griffin JN, 2009, OIKOS, V118, P1335, DOI 10.1111/j.1600-0706.2009.17572.x; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Isbell FI, 2008, OIKOS, V117, P996, DOI 10.1111/j.0030-1299.2008.16692.x; Isbell FI, 2011, OECOLOGIA, V165, P771, DOI 10.1007/s00442-010-1877-9; Kirwan L, 2007, J ECOL, V95, P530, DOI 10.1111/j.1365-2745.2007.01225.x; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Manly B. F., 1997, RANDOMIZATION BOOTST; MCNAUGHTON SJ, 1977, AM NAT, V111, P515, DOI 10.1086/283181; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Naeem S., 2009, BIODIVERSITY ECOSYST; Nyfeler D, 2009, J APPL ECOL, V46, P683, DOI 10.1111/j.1365-2664.2009.01653.x; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Ridder B, 2008, BIODIVERS CONSERV, V17, P781, DOI 10.1007/s10531-008-9316-5; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; van Ruijven J, 2009, OIKOS, V118, P101, DOI 10.1111/j.1600-0706.2008.17119.x; Weigelt A, 2009, BIOGEOSCIENCES, V6, P1695, DOI 10.5194/bg-6-1695-2009; Wilsey BJ, 2009, ECOL LETT, V12, P432, DOI 10.1111/j.1461-0248.2009.01298.x; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Zavaleta ES, 2010, P NATL ACAD SCI USA, V107, P1443, DOI 10.1073/pnas.0906829107	34	910	970	44	1454	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 8	2011	477	7363					199	U96		10.1038/nature10282	http://dx.doi.org/10.1038/nature10282			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816MC	21832994	Green Accepted, Green Published			2022-12-01	WOS:000294603900033
J	Karisch, R; Fernandez, M; Taylor, P; Virtanen, C; St-Germain, JR; Jin, LL; Harris, IS; Mori, J; Mak, TW; Senis, YA; Ostman, A; Moran, MF; Neel, BG				Karisch, Robert; Fernandez, Minerva; Taylor, Paul; Virtanen, Carl; St-Germain, Jonathan R.; Jin, Lily L.; Harris, Isaac S.; Mori, Jun; Mak, Tak W.; Senis, Yotis A.; Ostman, Arne; Moran, Michael F.; Neel, Benjamin G.			Global Proteomic Assessment of the Classical Protein-Tyrosine Phosphatome and "Redoxome''	CELL			English	Article							SPECTROMETRY-BASED PROTEOMICS; EPIDERMAL-GROWTH-FACTOR; MASS-SPECTROMETRY; REVERSIBLE OXIDATION; IN-VIVO; CANCER; CELLS; 1B; INACTIVATION; CYSTEINE	Protein-tyrosine phosphatases (PTPs), along with protein-tyrosine kinases, play key roles in cellular signaling. All Class I PTPs contain an essential active site cysteinyl residue, which executes a nucleophilic attack on substrate phosphotyrosyl residues. The high reactivity of the catalytic cysteine also predisposes PTPs to oxidation by reactive oxygen species, such as H2O2. Reversible PTP oxidation is emerging as an important cellular regulatory mechanism and might contribute to diseases such as cancer. We exploited these unique features of PTP enzymology to develop proteomic methods, broadly applicable to cell and tissue samples, that enable the comprehensive identification and quantification of expressed classical PTPs (PTPome) and the oxidized subset of the PTPome (oxPTPome). We find that mouse and human cells and tissues, including cancer cells, display distinctive PTPomes and oxPTPomes, revealing additional levels of complexity in the regulation of protein-tyrosine phosphorylation in normal and malignant cells.	[Karisch, Robert; Neel, Benjamin G.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Karisch, Robert; Fernandez, Minerva; Virtanen, Carl; Harris, Isaac S.; Mak, Tak W.; Neel, Benjamin G.] Univ Hlth Network, Campbell Family Canc Res Inst, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [Karisch, Robert; Fernandez, Minerva; Virtanen, Carl; Harris, Isaac S.; Mak, Tak W.; Neel, Benjamin G.] Univ Hlth Network, Princess Margaret Hosp, Toronto, ON M5G 1L7, Canada; [Taylor, Paul; St-Germain, Jonathan R.; Jin, Lily L.; Moran, Michael F.] Univ Toronto, Program Mol Struct & Funct, Hosp Sick Children, Toronto, ON M5G 1L7, Canada; [Taylor, Paul; St-Germain, Jonathan R.; Jin, Lily L.; Moran, Michael F.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1L7, Canada; [Taylor, Paul; St-Germain, Jonathan R.; Jin, Lily L.; Moran, Michael F.] Univ Toronto, McLaughlin Ctr Mol Med, Toronto, ON M5G 1L7, Canada; [Taylor, Paul; St-Germain, Jonathan R.; Jin, Lily L.; Moran, Michael F.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L7, Canada; [Mori, Jun; Senis, Yotis A.] Univ Birmingham, Ctr Cardiovasc Sci, Inst Biomed Res, Sch Clin & Expt Med,Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Ostman, Arne] Karolinska Inst, Canc Ctr Karolinska, Dept Pathol & Oncol, S-17176 Stockholm, Sweden	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of Birmingham; Karolinska Institutet	Karisch, R (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada.	rkarisch@uhnresearch.ca	Senis, Yotis/AAD-7183-2021; Moran, Michael/GYD-3631-2022	Senis, Yotis/0000-0002-0947-9957; Harris, Isaac/0000-0002-6855-2763	National Institutes of Health [R37CA49152]; Human Frontiers of Science Program [RGP0039/2009-C]; Canadian Institutes of Health Research (CIHR); Canadian Cancer Society Research Institute; Swedish Research Council; EU; Ontario Ministry of Health and Long Term Care; Princess Margaret Hospital Foundation; Natural Sciences and Engineering Council of Canada; NATIONAL CANCER INSTITUTE [R37CA049152] Funding Source: NIH RePORTER; British Heart Foundation [FS/08/034/25085] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers of Science Program(Human Frontier Science Program); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Swedish Research Council(Swedish Research CouncilEuropean Commission); EU(European Commission); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Princess Margaret Hospital Foundation; Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); British Heart Foundation(British Heart Foundation)	We thank Dr. Petr Heneberg for qPCR and Dr. Suzanne Trudel (Ontario Cancer Institute/Princess Margaret Hospital) for the MM cell lines. This work was supported by National Institutes of Health Grant R37CA49152 (B.G.N.), the Human Frontiers of Science Program Grant RGP0039/2009-C (B.G.N.), the Canadian Institutes of Health Research (CIHR; M.F.M.), the Canadian Cancer Society Research Institute (M.F.M.), the Swedish Research Council (A.O.), and the EU-funded PTPNET Research Training Network (A.O.). Additional support was provided by the Ontario Ministry of Health and Long Term Care and the Princess Margaret Hospital Foundation. B.G.N. and M.F.M. are Canada Research Chairs, Tier 1. Y.A.S. is a British Heart Foundation (BHF) Intermediate Research Fellow (FS/08/034/25085) and J.M. is a BHF Post Doctoral Fellow (PG/07/034/22775). R.K. and I.S.H. are the recipients of graduate fellowships from the CIHR and the Natural Sciences and Engineering Council of Canada, respectively. A.O. is a coinventor of the monoclonal oxidized PTP active site antibody and receives royalties for sales of the antibody.	Agazie YM, 2003, ONCOGENE, V22, P6909, DOI 10.1038/sj.onc.1206798; Ahn NG, 2007, ACS CHEM BIOL, V2, P39, DOI 10.1021/cb600357d; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Arnold RS, 2001, P NATL ACAD SCI USA, V98, P5550, DOI 10.1073/pnas.101505898; Boivin B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3137pl2; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; BURRIDGE K, 1995, ANAL BIOCHEM, V232, P56, DOI 10.1006/abio.1995.9961; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chen CY, 2009, BIOCHEMISTRY-US, V48, P1399, DOI 10.1021/bi801973z; den Hertog J, 2005, ARCH BIOCHEM BIOPHYS, V434, P11, DOI 10.1016/j.abb.2004.05.024; Denu JM, 1998, CURR OPIN CHEM BIOL, V2, P633, DOI 10.1016/S1367-5931(98)80095-1; Elschenbroich S, 2011, MOL BIOSYST, V7, P292, DOI 10.1039/c0mb00159g; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Gianni D, 2008, MOL BIOL CELL, V19, P2984, DOI 10.1091/mbc.E08-02-0138; Gingras MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005105; Groen A, 2005, J BIOL CHEM, V280, P10298, DOI 10.1074/jbc.M412424200; Gross S, 2002, J BIOL CHEM, V277, P48139, DOI 10.1074/jbc.M208228200; Gstaiger M, 2009, NAT REV GENET, V10, P617, DOI 10.1038/nrg2633; Hsu MF, 2010, J BIOL CHEM, V285, P7919, DOI 10.1074/jbc.M109.057513; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; Kumar S, 2004, P NATL ACAD SCI USA, V101, P7943, DOI 10.1073/pnas.0402323101; Lahiry P, 2010, NAT REV GENET, V11, P60, DOI 10.1038/nrg2707; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Li S, 2003, ARCH BIOCHEM BIOPHYS, V410, P269, DOI 10.1016/S0003-9861(02)00696-3; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Lou YW, 2008, FEBS J, V275, P69, DOI 10.1111/j.1742-4658.2007.06173.x; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; MIZUNO K, 1993, MOL CELL BIOL, V13, P5513, DOI 10.1128/MCB.13.9.5513; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Nelson KJ, 2010, METHOD ENZYMOL, V473, P95, DOI 10.1016/S0076-6879(10)73004-4; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Pandey A, 2002, ONCOGENE, V21, P8029, DOI 10.1038/sj.onc.1205988; Pearce AC, 2004, J BIOL CHEM, V279, P53955, DOI 10.1074/jbc.M410355200; Persson C, 2005, METHODS, V35, P37, DOI 10.1016/j.ymeth.2004.07.006; Persson C, 2004, P NATL ACAD SCI USA, V101, P1886, DOI 10.1073/pnas.0304403101; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Rhee S G, 2000, Sci STKE, V2000, ppe1; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Salmeen A, 2005, ANTIOXID REDOX SIGN, V7, P560, DOI 10.1089/ars.2005.7.560; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Sattler M, 2000, J BIOL CHEM, V275, P24273, DOI 10.1074/jbc.M002094200; Seo YH, 2009, P NATL ACAD SCI USA, V106, P16163, DOI 10.1073/pnas.0903015106; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; St-Germain JR, 2009, P NATL ACAD SCI USA, V106, P20127, DOI 10.1073/pnas.0910957106; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tanner JJ, 2011, ANTIOXID REDOX SIGN, V15, P77, DOI 10.1089/ars.2010.3611; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Walther TC, 2010, J CELL BIOL, V190, P491, DOI 10.1083/jcb.201004052; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Weibrecht I, 2007, FREE RADICAL BIO MED, V43, P100, DOI 10.1016/j.freeradbiomed.2007.03.021; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200; ZHANG ZY, 1994, P NATL ACAD SCI USA, V91, P1624, DOI 10.1073/pnas.91.5.1624	65	130	131	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 2	2011	146	5					826	840		10.1016/j.cell.2011.07.020	http://dx.doi.org/10.1016/j.cell.2011.07.020			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21884940	Green Accepted, Bronze			2022-12-01	WOS:000294477500021
J	Liu, Z; Scannell, DR; Eisen, MB; Tjian, R				Liu, Zhe; Scannell, Devin R.; Eisen, Michael B.; Tjian, Robert			Control of Embryonic Stem Cell Lineage Commitment by Core Promoter Factor, TAF3	CELL			English	Article							TRANSCRIPTION FACTORS; ENDODERM DIFFERENTIATION; PLURIPOTENCY; EXPRESSION; THOUSANDS; PATHWAY; REGIONS; GENOME; ROLES; MODEL	Deciphering the molecular basis of pluripotency is fundamental to our understanding of development and embryonic stem cell function. Here, we report that TAF3, a TBP-associated core promoter factor, is highly enriched in ES cells. In this context, TAF3 is required for endoderm lineage differentiation and prevents premature specification of neuroectoderm and mesoderm. In addition to its role in the core promoter recognition complex TFIID, genome-wide binding studies reveal that TAF3 localizes to a subset of chromosomal regions bound by CTCF/cohesin that are selectively associated with genes upregulated by TAF3. Notably, CTCF directly recruits TAF3 to promoter distal sites and TAF3-dependent DNA looping is observed between the promoter distal sites and core promoters occupied by TAF3/CTCF/cohesin. Together, our findings support a new role of TAF3 in mediating long-range chromatin regulatory interactions that safeguard the finely-balanced transcriptional programs underlying pluripotency.	[Liu, Zhe; Scannell, Devin R.; Eisen, Michael B.; Tjian, Robert] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Tjian, Robert] Univ Calif Berkeley, LKS Biomed & Hlth Sci Ctr, CIRM Ctr Excellence, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Tjian, R (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	jmlim@berkeley.edu		Eisen, Michael/0000-0002-7528-738X; Scannell, Devin/0000-0002-8188-5992	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R37 CA025417-34, R37 CA025417] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA025417] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Daley GQ, 2008, CELL, V132, P544, DOI 10.1016/j.cell.2008.02.009; Deato MDE, 2008, MOL CELL, V32, P96, DOI 10.1016/j.molcel.2008.09.009; Deato MDE, 2007, GENE DEV, V21, P2137, DOI 10.1101/gad.1583407; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Gangloff YG, 2001, MOL CELL BIOL, V21, P5109, DOI 10.1128/MCB.21.15.5109-5121.2001; Goodrich JA, 2010, NAT REV GENET, V11, P549, DOI 10.1038/nrg2847; Grapin-Botton A, 2007, MECH DEVELOP, V124, P253, DOI 10.1016/j.mod.2007.01.001; Hart DO, 2009, DEV DYNAM, V238, P2540, DOI 10.1002/dvdy.22083; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Khattra J, 2007, GENOME RES, V17, P108, DOI 10.1101/gr.5488207; Li LJ, 2010, P NATL ACAD SCI USA, V107, P1402, DOI 10.1073/pnas.0905657107; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; Verheijen MHG, 1999, J BIOL CHEM, V274, P1487, DOI 10.1074/jbc.274.3.1487; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Yao J, 2011, GENE DEV, V25, P569, DOI 10.1101/gad.2021411; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	30	128	130	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 2	2011	146	5					720	731		10.1016/j.cell.2011.08.005	http://dx.doi.org/10.1016/j.cell.2011.08.005			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21884934	Green Accepted, Bronze			2022-12-01	WOS:000294477500013
J	Herrera, AF; Soriano, G; Bellizzi, AM; Hornick, JL; Ho, VT; Ballen, KK; Baden, LR; Cutler, CS; Antin, JH; Soiffer, RJ; Marty, FM				Herrera, Alex F.; Soriano, Gabriela; Bellizzi, Andrew M.; Hornick, Jason L.; Ho, Vincent T.; Ballen, Karen K.; Baden, Lindsey R.; Cutler, Corey S.; Antin, Joseph H.; Soiffer, Robert J.; Marty, Francisco M.			Cord Colitis Syndrome in Cord-Blood Stem-Cell Transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; UNRELATED DONORS; CHRONIC GRAFT; HEMATOLOGIC MALIGNANCIES; MYCOPHENOLATE-MOFETIL; HEPATIC COMPLICATIONS; PERIPHERAL-BLOOD; ADULT PATIENTS; RECIPIENTS	Background Diarrhea is a frequent complication of hematopoietic stem-cell transplantation (HSCT). Important causes of diarrhea after HSCT include acute graft-versus-host disease (GVHD), infections, and medications. After the transplantation and engraftment of hematopoietic stem cells from umbilical-cord blood, we observed a new syndrome of culture-negative, antibiotic-responsive diarrhea not attributable to any known cause. Methods We conducted a retrospective cohort study of all patients undergoing cord-blood HSCT at our center between March 2003 and March 2010. The cord colitis syndrome was defined as a persistent diarrheal illness in such patients that was not due to acute GVHD, viral or bacterial infection, or another identifiable cause. Clinical and histopathological features of patients meeting the case definition were further analyzed. Results Among 104 patients who underwent cord-blood HSCT at our center, the cord colitis syndrome developed in 11 (10.6%). The 1-year Kaplan-Meier cumulative probability of meeting the case definition for the syndrome was 0.16. The median time to onset after transplantation was 131 days (range, 88 to 314). All patients had a response to a 10-to-14-day course of empirical therapy with metronidazole, alone or in combination with a fluoroquinolone. Five of the 11 patients (45%) had recurrent diarrhea shortly after discontinuation of antibiotics, and all patients who had a relapse had a response to reinitiation of antibiotic therapy. On histologic examination, all patients with the cord colitis syndrome had chronic active colitis, with granulomatous inflammation present in 7 of 11 patients (64%). Conclusions The cord colitis syndrome is clinically and histopathologically distinct from acute GVHD and other causes of diarrhea in patients who have undergone cord-blood HSCT and is relatively common in this patient population. The syndrome should be considered in such patients who have diarrhea that is not attributable to other causes.	[Herrera, Alex F.; Soriano, Gabriela] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Bellizzi, Andrew M.; Hornick, Jason L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Baden, Lindsey R.; Marty, Francisco M.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Ho, Vincent T.; Cutler, Corey S.; Antin, Joseph H.; Soiffer, Robert J.] Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA; [Ballen, Karen K.] Massachusetts Gen Hosp, Bone Marrow Transplant Unit, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital	Herrera, AF (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	afherrera@partners.org	Marty, Francisco M./H-7088-2019	Marty, Francisco M./0000-0002-3708-8734; Bellizzi, Andrew/0000-0002-8264-6379; Hornick, Jason/0000-0001-6475-8345; Hobbs, Gabriela/0000-0002-0199-9333				Asplund S, 1998, MODERN PATHOL, V11, P513; Ballen KK, 2007, BIOL BLOOD MARROW TR, V13, P82, DOI 10.1016/j.bbmt.2006.08.041; Baudard M, 2002, BONE MARROW TRANSPL, V30, P287, DOI 10.1038/sj.bmt.1703633; Boeckh M, 2003, BIOL BLOOD MARROW TR, V9, P543, DOI 10.1016/S1083-8791(03)00287-8; Bow EJ, 1997, J CLIN ONCOL, V15, P2254, DOI 10.1200/JCO.1997.15.6.2254; Brunstein CG, 2007, BLOOD, V110, P3064, DOI 10.1182/blood-2007-04-067215; Cutler C, 2011, BONE MARROW TRANSPL, V46, P659, DOI 10.1038/bmt.2010.192; Davila ML, 2006, CURR OPIN GASTROEN, V22, P44; Deeg HJ, 1998, BLOOD, V91, P1833, DOI 10.1182/blood.V91.6.1833.1833_1833_1844; Dubberke ER, 2010, CLIN TRANSPLANT, V24, P192, DOI 10.1111/j.1399-0012.2009.01035.x; Jalal H, 2005, J CLIN MICROBIOL, V43, P2575, DOI 10.1128/JCM.43.6.2575-2580.2005; KEEVER CA, 1995, BONE MARROW TRANSPL, V15, P407; Klein AK, 2001, BIOL BLOOD MARROW TR, V7, P454, DOI 10.1016/S1083-8791(01)80013-6; Laughlin MJ, 2004, NEW ENGL J MED, V351, P2265, DOI 10.1056/NEJMoa041276; Legrand F, 2011, BONE MARROW TRANSPL, V46, P858, DOI 10.1038/bmt.2010.200; Liakopoulou E, 2005, BONE MARROW TRANSPL, V36, P691, DOI 10.1038/sj.bmt.1705127; Marty FM, 2007, BLOOD, V110, P490, DOI 10.1182/blood-2007-01-069294; MCDONALD GB, 1986, GASTROENTEROLOGY, V90, P770, DOI 10.1016/0016-5085(86)91137-6; MCDONALD GB, 1986, GASTROENTEROLOGY, V90, P460, DOI 10.1016/0016-5085(86)90949-2; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; Roddie C, 2009, CLIN INFECT DIS, V49, P1061, DOI 10.1086/605557; Rubin David T, 2005, Rev Gastroenterol Disord, V5 Suppl 3, pS10; SALE GE, 1979, AM J SURG PATHOL, V3, P291, DOI 10.1097/00000478-197908000-00001; Shafran I, 2010, DIGEST DIS SCI, V55, P1079, DOI 10.1007/s10620-009-1111-y; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; SULLIVAN KM, 1981, BLOOD, V57, P267, DOI 10.1182/blood.V57.2.267.267; Szabolcs P, 2003, EXP HEMATOL, V31, P708, DOI 10.1016/S0301-472X(03)00160-7; Takahashi S, 2004, BLOOD, V104, P3813, DOI 10.1182/blood-2004-03-1001; Takahashi S, 2007, BLOOD, V109, P1322, DOI 10.1182/blood-2006-04-020172; Takami A, 2006, INT J HEMATOL, V83, P80, DOI 10.1532/IJH97.05111; van Kraaij MGJ, 2000, BONE MARROW TRANSPL, V26, P299, DOI 10.1038/sj.bmt.1702484; WARREN S, 1954, JAMA-J AM MED ASSOC, V154, P189, DOI 10.1001/jama.1954.02940370001001; WILLIAMS WJ, 1964, GUT, V5, P510, DOI 10.1136/gut.5.6.510	34	44	44	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2011	365	9					815	824		10.1056/NEJMoa1104959	http://dx.doi.org/10.1056/NEJMoa1104959			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813YC	21879899				2022-12-01	WOS:000294405200008
J	Spence, D				Spence, Des			FROM THE FRONTLINE Bad medicine: melanoma	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						*CANC RES UK, 2011, SURV HIGHL NEED BETT; Cancer Research UK, 2011, SKIN CANC UK INC STA; Holick MF, 2008, BRIT MED J, V336, P1318, DOI 10.1136/bmj.39581.411424.80; Levell NJ, 2009, BRIT J DERMATOL, V161, P630, DOI 10.1111/j.1365-2133.2009.09299.x; Sondak VK, 2011, NAT REV CLIN ONCOL, V8, P513, DOI 10.1038/nrclinonc.2011.119; *UK NAT STAT, UPD CANC TRENDS ENGL; Welch HG, 2005, BRIT MED J, V331, P481, DOI 10.1136/bmj.38516.649537.E0	7	5	5	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 31	2011	343								d5477	10.1136/bmj.d5477	http://dx.doi.org/10.1136/bmj.d5477			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816LE	21880678				2022-12-01	WOS:000294600400006
J	Barr, HL; Britton, J; Smyth, AR; Fogarty, AW				Barr, Helen L.; Britton, John; Smyth, Alan R.; Fogarty, Andrew W.			Association between socioeconomic status, sex, and age at death from cystic fibrosis in England and Wales (1959 to 2008): cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PSEUDOMONAS-AERUGINOSA; GENDER-DIFFERENCES; PULMONARY-FUNCTION; UNITED-KINGDOM; SURVIVAL; MORTALITY; CHILDREN; ADULTS; CARE; OUTCOMES	Objective To determine the trend in the association between socioeconomic status and sex and median age at death from cystic fibrosis in England and Wales, over the past 50 years. Design Series of annual cross sectional studies of all registered deaths with a diagnosis of cystic fibrosis in England and Wales, from 1959 to 2008. Methods We obtained national mortality data for cystic fibrosis from the Office for National Statistics. From 1959 to 2000, the Registrar General's Social Class coded socioeconomic status as manual or non-manual. From 2001 onwards, the National Statistics Socioeconomic Classification was implemented and socioeconomic status was split into three groups: professional and managerial, intermediate, and routine and manual. We calculated median age at death for every study year. We calculated the effects of sex and socioeconomic status on the odds of death above the median age at death for every study decade using logistic regression. Results From 1959 to 2008, 6750 deaths were attributed to cystic fibrosis in England and Wales. Males were more likely to die above the annual median age at death than females (from 1959 to 1999, adjusted odds ratio for socioeconomic status 1.28, 95% confidence intervals 1.13 to 1.45; from 2000 to 2008, 1.57, 1.18 to 2.08). Individuals in the highest socioeconomic class were also more likely to die above the median age of death than those in the lowest socioeconomic class (from 1959 to 2000, adjusted odds ratio for sex 2.50, 2.16 to 2.90; from 2001 to 2008, 1.89, 1.20 to 2.97). Conclusions Socioeconomic status and sex remain strong determinants of survival from cystic fibrosis in England and Wales, and the magnitude of these effects does not appear to have substantially reduced over time.	[Barr, Helen L.] Univ Nottingham, Div Resp Med, Nottingham Resp Biomed Res Unit, Nottingham NG5 1PB, England; [Britton, John; Fogarty, Andrew W.] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham Resp Biomed Res Unit, Nottingham NG5 1PB, England; [Smyth, Alan R.] Univ Nottingham, Nottingham Univ Hosp NHS Trust, Nottingham Resp Biomed Res Unit, Div Child Hlth,Queens Med Ctr, Nottingham NG5 1PB, England	University of Nottingham; University of Nottingham; Nottingham University Hospital NHS Trust; University of Nottingham	Barr, HL (corresponding author), Univ Nottingham, Div Resp Med, Nottingham Resp Biomed Res Unit, City Hosp Campus, Nottingham NG5 1PB, England.	helen.barr@nottingham.ac.uk	Britton, John R/G-9705-2011	Smyth, Alan/0000-0001-5494-5438	Medical Research Council; University of Nottingham; National Institute for Health Research [CL-2011-12-501] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Nottingham; National Institute for Health Research(National Institute for Health Research (NIHR))	This research was funded by the Medical Research Council and the University of Nottingham.	Adler AI, 2008, DIABETES CARE, V31, P1789, DOI 10.2337/dc08-0466; Armstrong D, 2003, J CLIN MICROBIOL, V41, P2266, DOI 10.1128/JCM.41.5.2266-2267.2003; Arrington-Sanders R, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-5; Balmer DF, 2008, J CYST FIBROS, V7, P543, DOI 10.1016/j.jcf.2008.06.004; Bell SC, 2008, CYSTIC FIBROSIS STAN; Borowitz D, 2009, J PEDIATR-US, V155, pS73, DOI 10.1016/j.jpeds.2009.09.001; BRITTON JR, 1989, BRIT MED J, V298, P483, DOI 10.1136/bmj.298.6672.483; Cheng K, 1996, LANCET, V348, P639, DOI 10.1016/S0140-6736(96)05169-0; Coakley RD, 2008, J CLIN INVEST, V118, P4025, DOI 10.1172/JCI33893; Collins CE, 1999, ARCH DIS CHILD, V81, P241, DOI 10.1136/adc.81.3.241; Corey M, 1997, J PEDIATR-US, V131, P809, DOI 10.1016/S0022-3476(97)70025-8; COREY M, 1988, J CLIN EPIDEMIOL, V41, P583, DOI 10.1016/0895-4356(88)90063-7; Cystic Fibrosis Trust, 2008, UK CF REG ANN REP 20; DEMKO CA, 1995, J CLIN EPIDEMIOL, V48, P1041, DOI 10.1016/0895-4356(94)00230-N; Dodge JA, 2007, EUR RESPIR J, V29, P522, DOI 10.1183/09031936.00099506; Dodge J A, 1993, Paediatr Perinat Epidemiol, V7, P157, DOI 10.1111/j.1365-3016.1993.tb00390.x; DODGE JA, 1988, BRIT MED J, V297, P1599; Elborn JS, 2009, J CYST FIBROS, V8, P348, DOI 10.1016/j.jcf.2009.05.004; ELBORN JS, 1991, THORAX, V46, P881, DOI 10.1136/thx.46.12.881; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; Farrell PM, 2005, J PEDIATR-US, V147, pS30, DOI 10.1016/j.jpeds.2005.08.012; FITZSIMMONS SC, 1993, J PEDIATR-US, V122, P1, DOI 10.1016/S0022-3476(05)83478-X; Frederiksen B, 1996, PEDIATR PULM, V21, P153, DOI 10.1002/(SICI)1099-0496(199603)21:3<153::AID-PPUL1>3.0.CO;2-R; George PM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1008; HENLEY LD, 1990, PEDIATRICS, V85, P1008; HENRY RL, 1992, PEDIATR PULM, V12, P158, DOI 10.1002/ppul.1950120306; HILL DJS, 1985, MED J AUSTRALIA, V143, P230, DOI 10.5694/j.1326-5377.1985.tb122953.x; HUANG NN, 1987, AM J MED, V82, P871, DOI 10.1016/0002-9343(87)90147-1; Jackson Anthony, 1996, Journal of the Royal College of Physicians of London, V30, P305; JOHANSEN HK, 1991, LANCET, V337, P631, DOI 10.1016/0140-6736(91)92449-C; Jones AM, 2001, LANCET, V358, P557, DOI 10.1016/S0140-6736(01)05714-2; KEREM E, 1992, NEW ENGL J MED, V326, P1187, DOI 10.1056/NEJM199204303261804; Lebecque P, 2009, J CYST FIBROS, V8, P26, DOI 10.1016/j.jcf.2008.07.005; Mahadeva R, 1998, BMJ-BRIT MED J, V316, P1771, DOI 10.1136/bmj.316.7147.1771; Merelle ME, 2001, EUR RESPIR J, V18, P306, DOI 10.1183/09031936.01.00080101; NOLAN T, 1986, PEDIATRICS, V77, P229; O'Connor GT, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e333; OPCS, 1966, CLASS OCC; PENKETH ARL, 1987, THORAX, V42, P526, DOI 10.1136/thx.42.7.526; PHELAN P, 1984, ARCH DIS CHILD, V59, P71, DOI 10.1136/adc.59.1.71; Rose D, 2003, RES GUIDE NATL STAT; Rose David, 1998, ESRC REV GOVT SOCIAL; Rosenfeld M, 1997, AM J EPIDEMIOL, V145, P794; Royal College of Physicians, 1991, J R COLL PHYSICIANS, V25, P12; RUBIN BK, 1990, NEW ENGL J MED, V323, P782, DOI 10.1056/NEJM199009203231203; Saiman L, 2003, JAMA-J AM MED ASSOC, V290, P1749, DOI 10.1001/jama.290.13.1749; Schaedel C, 2002, PEDIATR PULM, V33, P483, DOI 10.1002/ppul.10100; Schechter MS, 2009, J PEDIATR-US, V155, P634, DOI 10.1016/j.jpeds.2009.04.059; Schechter MS, 1998, J PEDIATR-US, V132, P260, DOI 10.1016/S0022-3476(98)70442-1; Schechter MS, 2001, AM J RESP CRIT CARE, V163, P1331, DOI 10.1164/ajrccm.163.6.9912100; Schechter MS, 2009, J PEDIAT, V155, p[634, e1]; Selvadurai HC, 2004, ARCH DIS CHILD, V89, P928, DOI 10.1136/adc.2003.034249; VALERIUS NH, 1991, LANCET, V338, P725, DOI 10.1016/0140-6736(91)91446-2; van Koolwijk LME, 2002, ACTA PAEDIATR, V91, P972, DOI 10.1080/080352502760272687; WALTERS S, 1993, BRIT MED J, V306, P549, DOI 10.1136/bmj.306.6877.549; WALTERS S, 1994, THORAX, V49, P300, DOI 10.1136/thx.49.4.300; Walters S, 2002, J ROY SOC MED, V95, P32; World Health Organization, 1965, MAN INT STAT CLASS D; World Health Organization, 1994, INT STAT CLASS DIS R; World Health Organization, 1957, MAN INT STAT CLASS D; World Health Organization, 1975, MAN INT STAT CLASS D, V1, P9; Yankaskas JR, 2004, CHEST, V125, p1S, DOI 10.1378/chest.125.1_suppl.1S; Zeitlin PL, 2008, J CLIN INVEST, V118, P3841, DOI 10.1172/JCI37778	63	65	65	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 23	2011	343								d4662	10.1136/bmj.d4662	http://dx.doi.org/10.1136/bmj.d4662			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813ZK	21862532	Green Published, Green Submitted, hybrid			2022-12-01	WOS:000294409600001
J	Dellomonaco, C; Clomburg, JM; Miller, EN; Gonzalez, R				Dellomonaco, Clementina; Clomburg, James M.; Miller, Elliot N.; Gonzalez, Ramon			Engineered reversal of the beta-oxidation cycle for the synthesis of fuels and chemicals	NATURE			English	Article							ESCHERICHIA-COLI; FATTY-ACIDS; CLOSTRIDIUM-ACETOBUTYLICUM; MOLECULAR CHARACTERIZATION; GLYCOLYTIC FLUX; METABOLISM; ENZYME; GENES; THIOLASE; GROWTH	Advanced (long-chain) fuels and chemicals are generated from short-chain metabolic intermediates through pathways that require carbon-chain elongation. The condensation reactions mediating this carbon-carbon bond formation can be catalysed by enzymes from the thiolase superfamily, including beta-ketoacyl-acyl-carrier protein (ACP) synthases, polyketide synthases, 3-hydroxy-3-methylglutaryl-CoA synthases, and biosynthetic thiolases(1). Pathways involving these enzymes have been exploited for fuel and chemical production, with fatty-acid biosynthesis (beta-ketoacyl-ACP synthases) attracting the most attention in recent years(2-4). Degradative thiolases, which are part of the thiolase superfamily and naturally function in the beta-oxidation of fatty acids(5,6), can also operate in the synthetic direction and thus enable carbon-chain elongation. Here we demonstrate that a functional reversal of the beta-oxidation cycle can be used as a metabolic platform for the synthesis of alcohols and carboxylic acids with various chain lengths and functionalities. This pathway operates with coenzyme A (CoA) thioester intermediates and directly uses acetylCoA for acyl-chain elongation (rather than first requiring ATP-dependent activation to malonyl-CoA), characteristics that enable product synthesis at maximum carbon and energy efficiency. The reversal of the beta-oxidation cycle was engineered in Escherichia coli and used in combination with endogenous dehydrogenases and thioesterases to synthesize n-alcohols, fatty acids and 3-hydroxy-, 3-keto- and trans-Delta(2)-carboxylic acids. The superior nature of the engineered pathway was demonstrated by producing higher-chain linear n-alcohols (C >= 4) and extracellular long-chain fatty acids (C > 10) at higher efficiency than previously reported(2,4,7-9). The ubiquitous nature of beta-oxidation, aldehyde/alcohol dehydrogenase and thioesterase enzymes has the potential to enable the efficient synthesis of these products in other industrial organisms.	[Dellomonaco, Clementina; Clomburg, James M.; Miller, Elliot N.; Gonzalez, Ramon] Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77005 USA; [Gonzalez, Ramon] Rice Univ, Dept Bioengn, Houston, TX 77005 USA	Rice University; Rice University	Gonzalez, R (corresponding author), Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77005 USA.	Ramon.Gonzalez@rice.edu	Gonzalez, Ramon/B-1961-2010					Atsumi S, 2008, METAB ENG, V10, P305, DOI 10.1016/j.ymben.2007.08.003; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Bond-Watts BB, 2011, NAT CHEM BIOL, V7, P222, DOI [10.1038/nchembio.537, 10.1038/NCHEMBIO.537]; Campbell JW, 2003, MOL MICROBIOL, V47, P793, DOI 10.1046/j.1365-2958.2003.03341.x; Cho BK, 2006, MICROBIOL-SGM, V152, P2207, DOI 10.1099/mic.0.28912-0; CHO HS, 1993, J BIOL CHEM, V268, P9238; Cirino PC, 2006, BIOTECHNOL BIOENG, V95, P1167, DOI 10.1002/bit.21082; Clark D. P., 2005, ESCHERICHIA COLI SAL, P343; Dellomonaco C, 2010, APPL ENVIRON MICROB, V76, P5067, DOI 10.1128/AEM.00046-10; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; Dharmadi Y, 2005, J CHROMATOGR A, V1070, P89, DOI 10.1016/j.chroma.2005.02.075; DURRE P, 1987, APPL MICROBIOL BIOT, V26, P268; EICHLER K, 1994, MOL MICROBIOL, V13, P775, DOI 10.1111/j.1365-2958.1994.tb00470.x; EICHLER K, 1995, J BASIC MICROB, V35, P217, DOI 10.1002/jobm.3620350404; Eppler T, 1999, MOL MICROBIOL, V33, P1221, DOI 10.1046/j.1365-2958.1999.01570.x; FEIGENBAUM J, 1975, J BACTERIOL, V122, P407, DOI 10.1128/JB.122.2.407-411.1975; Feng Y, 2009, J BACTERIOL, V191, P6320, DOI 10.1128/JB.00835-09; Gonzalez R, 2002, BIOTECHNOL PROGR, V18, P6, DOI 10.1021/bp010121i; Haapalainen AM, 2006, TRENDS BIOCHEM SCI, V31, P64, DOI 10.1016/j.tibs.2005.11.011; Handke P, 2011, METAB ENG, V13, P28, DOI 10.1016/j.ymben.2010.10.007; HARTMANIS MGN, 1984, APPL ENVIRON MICROB, V47, P1277, DOI 10.1128/AEM.47.6.1277-1283.1984; Jarboe LR, 2011, APPL MICROBIOL BIOT, V89, P249, DOI 10.1007/s00253-010-2912-9; JENKINS LS, 1987, J BACTERIOL, V169, P42, DOI 10.1128/jb.169.1.42-52.1987; Lalman JA, 2004, J AM OIL CHEM SOC, V81, P105, DOI 10.1007/s11746-004-0866-y; Lee SY, 2008, BIOTECHNOL BIOENG, V101, P209, DOI 10.1002/bit.22003; Lennen RM, 2010, BIOTECHNOL BIOENG, V106, P193, DOI 10.1002/bit.22660; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Nie L, 2008, BIOCHEMISTRY-US, V47, P9618, DOI 10.1021/bi801074e; OSMAN YA, 1987, J BACTERIOL, V169, P3726, DOI 10.1128/jb.169.8.3726-3736.1987; Papagianni M, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-16; Poirier Y, 2006, BBA-MOL CELL RES, V1763, P1413, DOI 10.1016/j.bbamcr.2006.08.034; Sambrook JF., 2001, MOL CLONING LAB MANU; Shen CR, 2008, METAB ENG, V10, P312, DOI 10.1016/j.ymben.2008.08.001; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Walt A, 2002, J BACTERIOL, V184, P4044, DOI 10.1128/JB.184.14.4044-4047.2002; WIESENBORN DP, 1988, APPL ENVIRON MICROB, V54, P2717, DOI 10.1128/AEM.54.11.2717-2722.1988; YANG SY, 1990, J BIOL CHEM, V265, P10424; Yazdani SS, 2008, METAB ENG, V10, P340, DOI 10.1016/j.ymben.2008.08.005; Zhang KC, 2008, P NATL ACAD SCI USA, V105, P20653, DOI 10.1073/pnas.0807157106; Zhuang ZH, 2008, BIOCHEMISTRY-US, V47, P2789, DOI 10.1021/bi702334h	40	411	472	7	265	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2011	476	7360					355	U131		10.1038/nature10333	http://dx.doi.org/10.1038/nature10333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21832992				2022-12-01	WOS:000294206500043
J	Guillem, K; Bloem, B; Poorthuis, RB; Loos, M; Smit, AB; Maskos, U; Spijker, S; Mansvelder, HD				Guillem, Karine; Bloem, Bernard; Poorthuis, Rogier B.; Loos, Maarten; Smit, August B.; Maskos, Uwe; Spijker, Sabine; Mansvelder, Huibert D.			Nicotinic Acetylcholine Receptor beta 2 Subunits in the Medial Prefrontal Cortex Control Attention	SCIENCE			English	Article							REACTION-TIME-TASK; BASAL FOREBRAIN; INDUCED LESIONS; PERFORMANCE; RELEASE; RATS; ANTAGONIST; COGNITION; NEURONS; SYSTEMS	More than one-third of all people are estimated to experience mild to severe cognitive impairment as they age. Acetylcholine (ACh) levels in the brain diminish with aging, and nicotinic ACh receptor (nAChR) stimulation is known to enhance cognitive performance. The prefrontal cortex (PFC) is involved in a range of cognitive functions and is thought to mediate attentional focus. We found that mice carrying nAChR beta 2-subunit deletions have impaired attention performance. Efficient lentiviral vector-mediated reexpression of functional beta 2-subunit-containing nAChRs in PFC neurons of the prelimbic area (PrL) completely restored the attentional deficit but did not affect impulsive and motivational behavior. Our findings show that beta 2-subunit expression in the PrL PFC is sufficient for endogenous nAChR-mediated cholinergic regulation of attentional performance.	[Guillem, Karine; Bloem, Bernard; Poorthuis, Rogier B.; Mansvelder, Huibert D.] Vrije Univ Amsterdam, Dept Integrat Neurophysiol, CNCR, NL-1081 HV Amsterdam, Netherlands; [Loos, Maarten; Smit, August B.; Spijker, Sabine] Vrije Univ Amsterdam, Dept Mol & Cellular Neurobiol, CNCR, NL-1081 HV Amsterdam, Netherlands; [Maskos, Uwe] Inst Pasteur, Dept Neurosci, Unite Neurobiol Integrat Syst Cholinerg, F-75724 Paris 15, France; [Maskos, Uwe] CNRS, URA2182, F-75724 Paris 15, France	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Mansvelder, HD (corresponding author), Vrije Univ Amsterdam, Dept Integrat Neurophysiol, CNCR, Neurosci Campus Amsterdam, NL-1081 HV Amsterdam, Netherlands.	huibert.mansvelder@cncr.vu.nl	Guillem, Karine/D-8705-2014; Loos, Maarten/A-2768-2012; Spijker, Sabine/F-2300-2011; Smit, August B/E-8410-2011; Mansvelder, Huibert/N-6138-2018	Guillem, Karine/0000-0002-9623-3698; Loos, Maarten/0000-0003-1629-2928; Mansvelder, Huibert/0000-0003-1365-5340; Spijker, Sabine/0000-0002-6814-2019	EU [HEALTH-F2-2007-202088]; Netherlands Organization for Scientific Research [917.76.360, 912.06.148]; Neurobasic PharmaPhenomics; VU University board	EU(European Commission); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Neurobasic PharmaPhenomics; VU University board	We thank J. Staal and H. Lodder. U. M. and A. B. S. received funding from the EU Seventh Framework Programme "Neurocypres" (HEALTH-F2-2007-202088); H. D. M., from the Netherlands Organization for Scientific Research (917.76.360 and 912.06.148), Neurobasic PharmaPhenomics, and the VU University board.	Avale ME, 2011, FASEB J, V25, P2145, DOI 10.1096/fj.10-178558; Couey JJ, 2007, NEURON, V54, P73, DOI 10.1016/j.neuron.2007.03.006; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; Dalley JW, 2004, CEREB CORTEX, V14, P922, DOI 10.1093/cercor/bhh052; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Granon S, 2003, P NATL ACAD SCI USA, V100, P9596, DOI 10.1073/pnas.1533498100; Hahn B, 2003, NEUROPHARMACOLOGY, V44, P1054, DOI 10.1016/S0028-3908(03)00099-6; Howe WM, 2010, NEUROPSYCHOPHARMACOL, V35, P1391, DOI 10.1038/npp.2010.9; Kassam SM, 2008, J NEUROSCI, V28, P8756, DOI 10.1523/JNEUROSCI.2645-08.2008; Lambe EK, 2003, NEUROPSYCHOPHARMACOL, V28, P216, DOI 10.1038/sj.npp.1300032; Maruki K, 2003, NEUROSCI LETT, V351, P95, DOI 10.1016/j.neulet.2003.07.012; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MUIR JL, 1995, PSYCHOPHARMACOLOGY, V118, P82; Muir JL, 1996, BEHAV BRAIN RES, V82, P31, DOI 10.1016/S0166-4328(97)81106-0; Parikh V, 2007, NEURON, V56, P141, DOI 10.1016/j.neuron.2007.08.025; Parikh V, 2010, J NEUROSCI, V30, P3518, DOI 10.1523/JNEUROSCI.5712-09.2010; Poorthuis RB, 2009, BIOCHEM PHARMACOL, V78, P668, DOI 10.1016/j.bcp.2009.04.031; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Sarter M, 2009, NAT REV NEUROSCI, V10, P383, DOI 10.1038/nrn2635; Schliebs R, 2011, BEHAV BRAIN RES, V221, P555, DOI 10.1016/j.bbr.2010.11.058; Steriade M, 2004, PROG BRAIN RES, V145, P179, DOI 10.1016/S0079-6123(03)45013-9; STOLERMAN P, 1995, MED RES REV, V15, P47; Woolf NJ, 2011, BEHAV BRAIN RES, V221, P488, DOI 10.1016/j.bbr.2009.12.046	27	136	140	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 12	2011	333	6044					888	891		10.1126/science.1207079	http://dx.doi.org/10.1126/science.1207079			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21836018				2022-12-01	WOS:000293785400044
J	Hou, FJ; Sun, LJ; Zheng, H; Skaug, B; Jiang, QX; Chen, ZJJ				Hou, Fajian; Sun, Lijun; Zheng, Hui; Skaug, Brian; Jiang, Qiu-Xing; Chen, Zhijian J.			MAVS Forms Functional Prion-like Aggregates to Activate and Propagate Antiviral Innate Immune Response	CELL			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; RIG-I; ADAPTER PROTEIN; APLYSIA CPEB; RECOGNITION; VIRUS; PHOSPHORYLATION; INFLAMMATION; INHERITANCE	In response to viral infection, RIG-I-like RNA helicases bind to viral RNA and activate the mitochondrial protein MAVS, which in turn activates the transcription factors IRF3 and NF-kappa B to induce type I interferons. We have previously shown that RIG-I binds to unanchored lysine-63 (K63) polyubiquitin chains and that this binding is important for MAVS activation; however, the mechanism underlying MAVS activation is not understood. Here, we show that viral infection induces the formation of very large MAVS aggregates, which potently activate IRF3 in the cytosol. We find that a fraction of recombinant MAVS protein forms fibrils that are capable of activating IRF3. Remarkably, the MAVS fibrils behave like prions and effectively convert endogenous MAVS into functional aggregates. We also show that, in the presence of K63 ubiquitin chains, RIG-I catalyzes the conversion of MAVS on the mitochondrial membrane to prion-like aggregates. These results suggest that a prion-like conformational switch of MAVS activates and propagates the antiviral signaling cascade.	[Hou, Fajian; Sun, Lijun; Skaug, Brian; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Zheng, Hui; Jiang, Qiu-Xing] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Sun, Lijun; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZJJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	zhijian.chen@utsouthwestern.edu	Jiang, Qiu-Xing/AAI-8579-2020; Chen, Zhijian/C-6039-2012; zheng, Hui/I-3573-2013; Sun, Lijun/ABD-4470-2021; Jiang, Qiu-Xing/ABF-1143-2021; Skaug, Brian/AAD-6152-2022	Chen, Zhijian/0000-0002-8475-8251; zheng, Hui/0000-0002-2504-9092; Skaug, Brian/0000-0002-6689-4655	NIH [RO1-GM63692, R01-GM88745, GM007062]; Welch Foundation [I-1389, I-1684]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007062, R01GM093271, R01GM063692, R01GM088745] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Xiaomo Jiang for the MDA5 plasmids. This work was supported by grants from NIH (RO1-GM63692) and the Welch Foundation (I-1389). H.Z. was supported by a Welch Foundation grant (I-1684) and partially by a EUREKA grant from NIH (R01-GM88745 to Q.-X.J.). B. S is supported by an NIH predoctoral training grant (GM007062). Z.J.C. is an Investigator of Howard Hughes Medical Institute.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Halfmann R, 2010, SCIENCE, V330, P629, DOI 10.1126/science.1191081; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; McWhirter SM, 2005, CELL, V122, P645, DOI 10.1016/j.cell.2005.08.026; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Onoguchi K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001012; Panne D, 2007, J BIOL CHEM, V282, P22816, DOI 10.1074/jbc.M703019200; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Potter JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-11; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rehwinkel J, 2010, SCIENCE, V327, P284, DOI 10.1126/science.1185068; Ronald PC, 2010, SCIENCE, V330, P1061, DOI 10.1126/science.1189468; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Stanker LH, 2010, J IMMUNOL, V185, P729, DOI 10.4049/jimmunol.0902930; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tuite MF, 2010, NAT REV MOL CELL BIO, V11, P823, DOI 10.1038/nrm3007; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2002, J INTERF CYTOK RES, V22, P73, DOI 10.1089/107999002753452674; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zeng WW, 2009, MOL CELL, V36, P315, DOI 10.1016/j.molcel.2009.09.037	35	810	833	6	136	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 5	2011	146	3					448	461		10.1016/j.cell.2011.06.041	http://dx.doi.org/10.1016/j.cell.2011.06.041			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	803GT	21782231	Bronze, Green Accepted			2022-12-01	WOS:000293570500018
J	Rolfe, A; Sheikh, A				Rolfe, Alexandra; Sheikh, Aziz			10-MINUTE CONSULTATION Measles, mumps, and rubella vaccination in a child with suspected egg allergy	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, Allergy & Resp Res Grp, Edinburgh EH8 9DX, Midlothian, Scotland	University of Edinburgh	Sheikh, A (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Allergy & Resp Res Grp, Edinburgh EH8 9DX, Midlothian, Scotland.	Aziz.Sheikh@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056				[Anonymous], 2011, NICE CLIN GUID 116 F; Clark AT, 2010, CLIN EXP ALLERGY, V40, P1116, DOI 10.1111/j.1365-2222.2010.03557.x; Kelso JM, 2009, ANN ALLERG ASTHMA IM, V103, P1; Lack G, 2008, NEW ENGL J MED, V359, P1252, DOI 10.1056/NEJMcp0800871	4	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 3	2011	343								d4536	10.1136/bmj.d4536	http://dx.doi.org/10.1136/bmj.d4536			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805NN	21816740	Green Submitted			2022-12-01	WOS:000293734700004
J	Dolmans, GH; Werker, PM; Hennies, HC; Furniss, D; Festen, EA; Franke, L; Becker, K; van der Vlies, P; Wolffenbuttel, BH; Tinschert, S; Toliat, MR; Nothnagel, M; Franke, A; Klopp, N; Wichmann, HE; Nurnberg, P; Giele, H; Ophoff, RA; Wijmenga, C				Dolmans, Guido H.; Werker, Paul M.; Hennies, Hans C.; Furniss, Dominic; Festen, Eleonora A.; Franke, Lude; Becker, Kerstin; van der Vlies, Pieter; Wolffenbuttel, Bruce H.; Tinschert, Sigrid; Toliat, Mohammad R.; Nothnagel, Michael; Franke, Andre; Klopp, Norman; Wichmann, H-Erich; Nuernberg, Peter; Giele, Henk; Ophoff, Roel A.; Wijmenga, Cisca		Dutch Dupuytren Study Grp; German Dupuytren Study Grp; LifeLines Cohort Study; BSSH-GODD Consortium	Wnt Signaling and Dupuytren's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENETIC SUSCEPTIBILITY; CONTRACTURE; CATENIN; ASSOCIATION; VARIANTS	BACKGROUND Dupuytren's disease is a benign fibromatosis of the hands and fingers that leads to flexion contractures. We hypothesized that multiple genetic and environmental factors influence susceptibility to this disease and sought to identify susceptibility genes to better understand its pathogenesis. METHODS We conducted a genomewide association study of 960 Dutch persons with Dupuytren's disease and 3117 controls (the discovery set) to test for association between the disease and genetic markers. We tested the 35 single-nucleotide polymorphisms (SNPs) most strongly associated with Dupuytren's disease (P< 1x10-4) in the discovery set in three additional, independent case series comprising a total of 1365 affected persons and 8445 controls from Germany, the United Kingdom, and the Netherlands. RESULTS Initially, we observed a significant genomewide association between Dupuytren's disease and 8 SNPs at three loci. Tests of replication and joint analysis of all data from 2325 patients with Dupuytren's disease and 11,562 controls yielded an association with 11 SNPs from nine different loci (P< 5.0x10(-8)). Six of these loci contain genes known to be involved in the Wnt-signaling pathway: WNT4 (rs7524102) (P = 2.8x10(-9); odds ratio, 1.28), SFRP4 (rs16879765) (P = 5.6x10-39; odds ratio, 1.98), WNT2 (rs4730775) (P = 3.0x10(-8); odds ratio, 0.83), RSPO2 (rs611744) (P = 7.9x10(-15); odds ratio, 0.75), SULF1 (rs2912522) (P = 2.0x10(-13); odds ratio, 0.72), and WNT7B (rs6519955) (P = 3.2x10(-33); odds ratio, 1.54). CONCLUSIONS This study implicates nine different loci involved in genetic susceptibility to Dupuytren's disease. The fact that six of these nine loci harbor genes encoding proteins in the Wnt-signaling pathway suggests that aberrations in this pathway are key to the process of fibromatosis in Dupuytren's disease.	[Dolmans, Guido H.; Festen, Eleonora A.; Franke, Lude; van der Vlies, Pieter; Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Dolmans, Guido H.; Werker, Paul M.] Univ Med Ctr Groningen, Dept Plast Surg, NL-9700 RB Groningen, Netherlands; [Festen, Eleonora A.] Univ Med Ctr Groningen, Dept Gastroenterol, NL-9700 RB Groningen, Netherlands; [Wolffenbuttel, Bruce H.] Univ Med Ctr Groningen, Dept Endocrinol, NL-9700 RB Groningen, Netherlands; Univ Groningen, Groningen, Netherlands; [Ophoff, Roel A.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Ophoff, Roel A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Hennies, Hans C.; Becker, Kerstin; Toliat, Mohammad R.; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, Div Dermatogenet, Cologne, Germany; [Hennies, Hans C.; Nuernberg, Peter] Univ Cologne, Ctr Mol Med, Cologne, Germany; [Tinschert, Sigrid] Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Clin Genet, D-8027 Dresden, Germany; [Nothnagel, Michael] Univ Kiel, Inst Med Informat & Stat, Kiel, Germany; [Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Klopp, Norman; Wichmann, H-Erich] Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Furniss, Dominic; Giele, Henk] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Furniss, Dominic; Giele, Henk] John Radcliffe Hosp, Dept Plast & Reconstruct Surg, Oxford OX3 9DU, England; [Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Cologne; University of Cologne; Technische Universitat Dresden; University of Kiel; University of Kiel; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; University of Oxford; University of Oxford; University of California System; University of California Los Angeles	Wijmenga, C (corresponding author), Univ Med Ctr Groningen, Dept Genet, POB 30001, NL-9700 RB Groningen, Netherlands.	ophoff@ucla.edu; cisca.wijmenga@med.umcg.nl	Wijmenga, Cisca/AAE-7719-2019; Wolffenbuttel, Bruce/A-8419-2011; Wichmann, Heinz Erich/AAA-5695-2022; Furniss, Dominic/AAH-4447-2019; Franke, Lude/P-7036-2016	Wijmenga, Cisca/0000-0002-5635-1614; Wolffenbuttel, Bruce/0000-0001-9262-6921; Franke, Lude/0000-0002-5159-8802; Giele, Henk/0000-0003-2017-5193; Nothnagel, Michael/0000-0001-8305-7114	University Medical Center Groningen; University of Groningen, the Netherlands; German Ministry of Education and Research through the German National Genome Research Network; German Research Foundation Cluster of Excellence Inflammation at Interfaces; Academy of Medical Sciences; Wellcome Trust; Oxford University [MRF/2009/HT/1932]; Netherlands Organization of Scientific Research [NWO 175.010.2007.006]; Dutch government; Ministries of Economic Affairs, Education, Culture and Science, and Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces; Province of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; Helmholtz Center Munich; German Research Center for Environmental Health; Munich Center of Health Sciences; WTCCC [076113, 085475]	University Medical Center Groningen; University of Groningen, the Netherlands(Netherlands Government); German Ministry of Education and Research through the German National Genome Research Network; German Research Foundation Cluster of Excellence Inflammation at Interfaces; Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Wellcome Trust(Wellcome TrustEuropean Commission); Oxford University; Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch government; Ministries of Economic Affairs, Education, Culture and Science, and Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces; Province of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; Helmholtz Center Munich(Helmholtz Association); German Research Center for Environmental Health; Munich Center of Health Sciences; WTCCC	Supported by grants from the University Medical Center Groningen and the University of Groningen, the Netherlands, and in part by grants from the German Ministry of Education and Research through the German National Genome Research Network (NGFN-2 and NGFNplus) and the German Research Foundation Cluster of Excellence Inflammation at Interfaces; the Academy of Medical Sciences, Wellcome Trust Starter Grants for Clinical Lecturers, and the Oxford University Medical Research Fund (MRF/2009/HT/1932) (all to Dr. Furniss); data generated by the LifeLines Cohort Study, the KORA research platform, and the Wellcome Trust Case Control Consortium (WTCCC); a grant to the LifeLines Cohort Study from the Netherlands Organization of Scientific Research (NWO 175.010.2007.006); the Dutch government's Economic Structure Enhancing Fund; the Ministries of Economic Affairs, Education, Culture and Science, and Health, Welfare and Sports; the Northern Netherlands Collaboration of Provinces; the Province of Groningen; the Dutch Kidney Foundation; the Dutch Diabetes Research Foundation; the KORA research platform, initiated and financed by the Helmholtz Center Munich and the German Research Center for Environmental Health and supported by the Munich Center of Health Sciences as part of LMUinnovativ; and the WTCCC (awards 076113 and 085475).	Anthony Shawn G, 2008, Hand (N Y), V3, P87, DOI 10.1007/s11552-007-9076-9; Armstrong JR, 2000, J BONE JOINT SURG BR, V82B, P90, DOI 10.1302/0301-620X.82B1.9808; Bayat A, 2003, BRIT J PLAST SURG, V56, P328, DOI 10.1016/S0007-1226(03)00176-0; Bayat A, 2003, PLAST RECONSTR SURG, V111, P2133, DOI 10.1097/01.PRS.0000060531.98180.32; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Blank V, 1997, TRENDS BIOCHEM SCI, V22, P437, DOI 10.1016/S0968-0004(97)01105-5; Bowley E, 2007, J SURG RES, V138, P141, DOI 10.1016/j.jss.2006.07.026; Burge P, 1999, HAND CLIN, V15, P63; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Degreef I, 2009, SCAND J PLAST RECONS, V43, P36, DOI 10.1080/02844310802489806; Dias JJ, 2006, J HAND SURG-BRIT EUR, V31B, P514, DOI 10.1016/j.jhsb.2006.05.005; Dubois PCA, 2010, NAT GENET, V42, P465, DOI 10.1038/ng0510-465; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Eychene A, 2008, NAT REV CANCER, V8, P683, DOI 10.1038/nrc2460; Freeman SD, 2008, DEV BIOL, V320, P436, DOI 10.1016/j.ydbio.2008.05.554; Hindocha S, 2006, J HAND SURG-AM, V31A, P204, DOI 10.1016/j.jhsa.2005.09.018; Hindocha Sandip, 2009, Hand (N Y), V4, P256, DOI 10.1007/s11552-008-9160-9; Hu FZ, 2005, CLIN GENET, V68, P424, DOI 10.1111/j.1399-0004.2005.00504.x; Hurst LC, 2009, NEW ENGL J MED, V361, P968, DOI 10.1056/NEJMoa0810866; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Lam WL, 2010, J HAND SURG-EUR VOL, V35E, P312, DOI 10.1177/1753193410362848; Lee LC, 2006, J HAND SURG-AM, V31A, P211, DOI 10.1016/j.jhsa.2005.09.007; LUCK JV, 1959, J BONE JOINT SURG AM, V41, P635, DOI 10.2106/00004623-195941040-00008; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Mosakhani N, 2010, MODERN PATHOL, V23, P1544, DOI 10.1038/modpathol.2010.146; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Ross DC, 1999, HAND CLIN, V15, P53; Sahota AP, 2009, EXP CELL RES, V315, P2752, DOI 10.1016/j.yexcr.2009.06.029; Stolk RP, 2008, EUR J EPIDEMIOL, V23, P67, DOI 10.1007/s10654-007-9204-4; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Van Rijssen AL, 2006, J HAND SURG-BRIT EUR, V31B, P498, DOI 10.1016/j.jhsb.2006.03.174	32	139	139	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2011	365	4					307	317		10.1056/NEJMoa1101029	http://dx.doi.org/10.1056/NEJMoa1101029			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798AJ	21732829	Green Published			2022-12-01	WOS:000293172200009
J	Coolen, MJL				Coolen, Marco J. L.			7000 Years of Emiliania huxleyi Viruses in the Black Sea	SCIENCE			English	Article							GENOME SEQUENCE; SULFUR BACTERIA; SEDIMENTS; INFECTION; BLOOM	A 7000-year record of Coccolithovirus and its host, the calcifying haptophyte Emiliania huxleyi, was reconstructed on the basis of genetic signatures preserved in sediments underlying the Black Sea. The data show that the same virus and host populations can persist for centuries. Major changes in virus and host populations occurred during early sapropel deposition, similar to 5600 years ago, and throughout the formation of the coccolith-bearing sediments of Unit I during the past 2500 years, when the Black Sea experienced dramatic changes in hydrologic and nutrient regimes. Unit I saw a reoccurrence of the same host genotype thousands of years later in the presence of a different subset of viruses. Historical plankton virus populations can thus be included in paleoecological and paleoenvironmental studies.	Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Coolen, MJL (corresponding author), Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Woods Hole, MA 02543 USA.	mcoolen@whoi.edu	Coolen, Marco J. L./B-8263-2015	Coolen, Marco J. L./0000-0002-0417-920X	NSF [OCE 0602423, OCE 0825020]; Andrew W. Mellon Foundation	NSF(National Science Foundation (NSF)); Andrew W. Mellon Foundation	I thank C. Wuchter for suggestions for improving the manuscript, P. Dimitrov and D. Dimitrov for their expertise in Black Sea sedimentology, and T.-H. Yang and J. van de Giessen for analytical support. This research was supported by NSF grants OCE 0602423 and OCE 0825020 and a grant from the Andrew W. Mellon Foundation Endowed Fund for Innovative Research. PCR-obtained sequences encoding the coccolithoviral MCP and PGM genes have been deposited in GenBank as "environmental sequences" and are listed under accession numbers GU563596 to GU563628, GU584106 and GU584107, and HQ412623 to HQ412638.	Bird DF, 2001, MAR GEOL, V174, P227, DOI 10.1016/S0025-3227(00)00152-3; Coolen MJL, 2007, ENVIRON MICROBIOL, V9, P238, DOI 10.1111/j.1462-2920.2006.01134.x; Coolen MJL, 2009, EARTH PLANET SC LETT, V284, P610, DOI 10.1016/j.epsl.2009.05.029; Coolen MJL, 1998, APPL ENVIRON MICROB, V64, P4513; Coolen MJL, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001188; Frada M, 2008, P NATL ACAD SCI USA, V105, P15944, DOI 10.1073/pnas.0807707105; HAY BJ, 1991, DEEP-SEA RES, V38, pS1211; Huang YS, 2002, GEOLOGY, V30, P1103, DOI 10.1130/0091-7613(2002)030<1103:HIROPA>2.0.CO;2; Lawrence JE, 2002, LIMNOL OCEANOGR, V47, P545, DOI 10.4319/lo.2002.47.2.0545; Marret F, 2009, QUATERN INT, V197, P72, DOI 10.1016/j.quaint.2007.01.010; Martinez JM, 2007, APPL ENVIRON MICROB, V73, P554, DOI 10.1128/AEM.00864-06; Pope WH, 2007, J MOL BIOL, V368, P966, DOI 10.1016/j.jmb.2007.02.046; SCHAFER H, 2001, DENATURING GRADIENT, P425; Schroeder DC, 2003, APPL ENVIRON MICROB, V69, P2484, DOI 10.1128/AEM.69.5.2484-2490.2003; Suttle C.A., 2000, ECOLOGY CYANOBACTERI, DOI DOI 10.1007/0-306-46855-7_20; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; van der Meer MTJ, 2008, EARTH PLANET SC LETT, V267, P426, DOI 10.1016/j.epsl.2007.12.001; Vardi A, 2009, SCIENCE, V326, P861, DOI 10.1126/science.1177322; VOLKMAN JK, 1980, PHYTOCHEMISTRY, V19, P2619, DOI 10.1016/S0031-9422(00)83930-8; Wilson WH, 2005, SCIENCE, V309, P1090, DOI 10.1126/science.1113109; Winter C, 2004, APPL ENVIRON MICROB, V70, P804, DOI 10.1128/AEM.70.2.804-813.2004; Xu L, 2001, ORG GEOCHEM, V32, P633, DOI 10.1016/S0146-6380(01)00019-5	22	61	67	3	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2011	333	6041					451	452		10.1126/science.1200072	http://dx.doi.org/10.1126/science.1200072			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21778399				2022-12-01	WOS:000292959600045
J	Li, HJ; Haurigot, V; Doyon, Y; Li, TJ; Wong, SNY; Bhagwat, AS; Malani, N; Anguela, XM; Sharma, R; Ivanciu, L; Murphy, SL; Finn, JD; Khazi, FR; Zhou, SZ; Paschon, DE; Rebar, EJ; Bushman, FD; Gregory, PD; Holmes, MC; High, KA				Li, Hojun; Haurigot, Virginia; Doyon, Yannick; Li, Tianjian; Wong, Sunnie Y.; Bhagwat, Anand S.; Malani, Nirav; Anguela, Xavier M.; Sharma, Rajiv; Ivanciu, Lacramiora; Murphy, Samuel L.; Finn, Jonathan D.; Khazi, Fayaz R.; Zhou, Shangzhen; Paschon, David E.; Rebar, Edward J.; Bushman, Frederic D.; Gregory, Philip D.; Holmes, Michael C.; High, Katherine A.			In vivo genome editing restores haemostasis in a mouse model of haemophilia	NATURE			English	Article							ZINC-FINGER NUCLEASES; LEBERS CONGENITAL AMAUROSIS; GENE-THERAPY; FACTOR-IX; CHIMERIC NUCLEASES; CELLS; TRANSDUCTION; VECTOR; DISRUPTION; DEFICIENCY	Editing of the human genome to correct disease-causing mutations is a promising approach for the treatment of genetic disorders. Genome editing improves on simple gene-replacement strategies by effecting in situ correction of a mutant gene, thus restoring normal gene function under the control of endogenous regulatory elements and reducing risks associated with random insertion into the genome. Gene-specific targeting has historically been limited to mouse embryonic stem cells. The development of zinc finger nucleases (ZFNs) has permitted efficient genome editing in transformed and primary cells that were previously thought to be intractable to such genetic manipulation(1). In vitro, ZFNs have been shown to promote efficient genome editing via homology-directed repair by inducing a site-specific double-strand break (DSB) at a target locus(2-4), but it is unclear whether ZFNs can induce DSBs and stimulate genome editing at a clinically meaningful level in vivo. Here we show that ZFNs are able to induce DSBs efficiently when delivered directly to mouse liver and that, when co-delivered with an appropriately designed gene-targeting vector, they can stimulate gene replacement through both homology-directed and homology-independent targeted gene insertion at the ZFN-specified locus. The level of gene targeting achieved was sufficient to correct the prolonged clotting times in a mouse model of haemophilia B, and remained persistent after induced liver regeneration. Thus, ZFN-driven gene correction can be achieved in vivo, raising the possibility of genome editing as a viable strategy for the treatment of genetic disease.	[Li, Hojun; Haurigot, Virginia; Bhagwat, Anand S.; Anguela, Xavier M.; Sharma, Rajiv; Ivanciu, Lacramiora; Murphy, Samuel L.; Finn, Jonathan D.; Khazi, Fayaz R.; Zhou, Shangzhen; High, Katherine A.] Childrens Hosp Philadelphia, CTRB 5000, Div Hematol, Philadelphia, PA 19104 USA; [Doyon, Yannick; Li, Tianjian; Wong, Sunnie Y.; Paschon, David E.; Rebar, Edward J.; Gregory, Philip D.; Holmes, Michael C.] Sangamo BioSci, Point Richmond Tech Ctr, Richmond, CA 94804 USA; [Malani, Nirav; Bushman, Frederic D.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [High, Katherine A.] Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Sangamo Therapeutics, Inc.; University of Pennsylvania; Howard Hughes Medical Institute	High, KA (corresponding author), Childrens Hosp Philadelphia, CTRB 5000, Div Hematol, 3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	mholmes@sangamo.com; high@email.chop.edu	Anguela, Xavier/K-9594-2019; Huang, ZhiXin/H-5123-2017; Wilson, Matthew H/K-3193-2013; Anguela, Xavier M/D-3223-2013; High, Katherine A./AAB-9322-2020	Anguela, Xavier/0000-0003-2430-8598; Huang, ZhiXin/0000-0003-0705-1970; Anguela, Xavier M/0000-0003-2430-8598; Sharma, Rajiv/0000-0002-8147-5723; Gregory, Philip/0000-0001-9249-2468; Bushman, Frederic/0000-0003-4740-4056; Haurigot, Virginia A./0000-0002-9772-2565; High, Katherine/0000-0002-0805-6223; Doyon, Yannick/0000-0002-3889-9563	National Institutes of Health; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007150, P01HL064190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Institutes of Health and the Howard Hughes Medical Institute.	Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Ayuso E, 2010, GENE THER, V17, P503, DOI 10.1038/gt.2009.157; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Berry C, 2006, PLOS COMPUT BIOL, V2, P1450, DOI 10.1371/journal.pcbi.0020157; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; GREEN PM, 2004, HAEMOPHILIA B MUTATI; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Li HJ, 2011, BLOOD, V117, P3311, DOI 10.1182/blood-2010-08-302729; Lin HF, 1997, BLOOD, V90, P3962, DOI 10.1182/blood.V90.10.3962; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Miao CH, 2000, MOL THER, V1, P522, DOI 10.1006/mthe.2000.0075; Miller DG, 2004, NAT GENET, V36, P767, DOI 10.1038/ng1380; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Nakai H, 2003, NAT GENET, V34, P297, DOI 10.1038/ng1179; Nakai H, 2001, J VIROL, V75, P6969, DOI 10.1128/JVI.75.15.6969-6976.2001; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; POLLAK ES, 2001, METABOLIC MOL BASES, P4393; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; THOMPSON AR, 1994, HUM GENET, V94, P299; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	30	393	479	4	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2011	475	7355					217	U128		10.1038/nature10177	http://dx.doi.org/10.1038/nature10177			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21706032	Green Accepted			2022-12-01	WOS:000292690500048
J	Black, ME				Black, Mary E.			THE BIGGER PICTURE Choice: a tale of two hospitals	BRITISH MEDICAL JOURNAL			English	Editorial Material												drmaryblack@gmail.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 13	2011	343								d4421	10.1136/bmj.d4421	http://dx.doi.org/10.1136/bmj.d4421			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	794OE	21752858				2022-12-01	WOS:000292908900010
J	Goritz, C; Dias, DO; Tomilin, N; Barbacid, M; Shupliakov, O; Frisen, J				Goritz, Christian; Dias, David O.; Tomilin, Nikolay; Barbacid, Mariano; Shupliakov, Oleg; Frisen, Jonas			A Pericyte Origin of Spinal Cord Scar Tissue	SCIENCE			English	Article							BLOOD-BRAIN-BARRIER; COLLAGEN-PRODUCING CELLS; GLIAL SCAR; FIBROSIS; REGENERATION; FIBROBLASTS; MIGRATION; INJURY; REPAIR; MICE	There is limited regeneration of lost tissue after central nervous system injury, and the lesion is sealed with a scar. The role of the scar, which often is referred to as the glial scar because of its abundance of astrocytes, is complex and has been discussed for more than a century. Here we show that a specific pericyte subtype gives rise to scar-forming stromal cells, which outnumber astrocytes, in the injured spinal cord. Blocking the generation of progeny by this pericyte subtype results in failure to seal the injured tissue. The formation of connective tissue is common to many injuries and pathologies, and here we demonstrate a cellular origin of fibrosis.	[Goritz, Christian; Dias, David O.; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Tomilin, Nikolay; Shupliakov, Oleg] Karolinska Inst, Dept Neurosci, SE-17177 Stockholm, Sweden; [Barbacid, Mariano] Ctr Nacl Invest Oncol, Mol Oncol Programme, Madrid 28029, Spain	Karolinska Institutet; Karolinska Institutet	Frisen, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	jonas.frisen@ki.se	Tomilin, Nikolay V/B-4676-2014; Shupliakov, Oleg/R-9148-2016; Göritz, Christian/AAK-5348-2021	Tomilin, Nikolay V/0000-0002-5581-3848; Shupliakov, Oleg/0000-0001-5352-6848; Göritz, Christian/0000-0003-0799-766X; Oliveira Dias, David/0000-0002-2144-6621	Swedish Research Council; Swedish Cancer Society; Tobias Stiftelsen; Hjarnfonden; Knut och Alice Wallenbergs Stiftelse; Swedish Agency for Innovation Systems; European Research Council [ERC-AG/250297-RAS AHEAD]; Foundation for Science and Technology, Portuguese government [SFRH/BD/63164/2009]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Tobias Stiftelsen; Hjarnfonden; Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); Swedish Agency for Innovation Systems(Vinnova); European Research Council(European Research Council (ERC)European Commission); Foundation for Science and Technology, Portuguese government	We thank A. Simon and the Frisen and Shupliakov groups for valuable discussions. This study was supported by the Swedish Research Council, the Swedish Cancer Society, Tobias Stiftelsen, Hjarnfonden, Knut och Alice Wallenbergs Stiftelse, the Swedish Agency for Innovation Systems, and the European Research Council (ERC-AG/250297-RAS AHEAD). D. D. was supported by the Foundation for Science and Technology from the Portuguese government (SFRH/BD/63164/2009).	Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bondjers C, 2006, FASEB J, V20, P1703, DOI 10.1096/fj.05-4944fje; Camand E, 2004, EUR J NEUROSCI, V20, P1161, DOI 10.1111/j.1460-9568.2004.03558.x; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; Dore-Duffy P, 2008, CURR PHARM DESIGN, V14, P1581, DOI 10.2174/138161208784705469; Drosten M, 2010, EMBO J, V29, P1091, DOI 10.1038/emboj.2010.7; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Krenning G, 2010, J CELL PHYSIOL, V225, P631, DOI 10.1002/jcp.22322; KRIKORIAN JG, 1981, EXP NEUROL, V72, P698, DOI 10.1016/0014-4886(81)90018-2; Krueger M, 2010, GLIA, V58, P1, DOI 10.1002/glia.20898; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; MATTHEWS MA, 1979, NEUROPATH APPL NEURO, V5, P161, DOI 10.1111/j.1365-2990.1979.tb00617.x; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Shearer MC, 2001, CELL TISSUE RES, V305, P267, DOI 10.1007/s004410100384; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Slezak M, 2007, GLIA, V55, P1565, DOI 10.1002/glia.20570; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sundberg C, 1996, LAB INVEST, V74, P452; WINDLE WF, 1950, J COMP NEUROL, V93, P241, DOI 10.1002/cne.900930206; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9	30	547	559	7	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					238	242		10.1126/science.1203165	http://dx.doi.org/10.1126/science.1203165			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21737741				2022-12-01	WOS:000292502700054
J	Heller, RC; Kang, S; Lam, WM; Chen, S; Chan, CS; Bell, SP				Heller, Ryan C.; Kang, Sukhyun; Lam, Wendy M.; Chen, Shuyan; Chan, Clara S.; Bell, Stephen P.			Eukaryotic Origin-Dependent DNA Replication In Vitro Reveals Sequential Action of DDK and S-CDK Kinases	CELL			English	Article							CHROMATIN ASSOCIATION; COMPLEX-FORMATION; MCM2-7 HELICASE; ATP-HYDROLYSIS; INITIATION; SLD3; CDC45; MCM10; GINS; PHOSPHORYLATION	Proper eukaryotic DNA replication requires temporal separation of helicase loading from helicase activation and replisome assembly. Using an in vitro assay for eukaryotic origin-dependent replication initiation, we investigated the control of these events. After helicase loading, we found that the Dbf4-dependent Cdc7 kinase (DDK) but not S phase cyclin-dependent kinase (S-CDK) is required for the initial origin recruitment of Sld3 and the Cdc45 helicase-activating protein. Likewise, in vivo, DDK drives early-firing-origin recruitment of Cdc45 before activation of S-CDK. After S-CDK activation, a second helicase-activating protein (GINS) and the remainder of the replisome are recruited to the origin. Finally, recruitment of lagging but not leading strand DNA polymerases depends on Mcm10 and DNA unwinding. Our studies identify distinct roles for DDK and S-CDK during helicase activation and support a model in which the leading strand DNA polymerase is recruited prior to origin DNA unwinding and RNA primer synthesis.	[Heller, Ryan C.; Kang, Sukhyun; Lam, Wendy M.; Chen, Shuyan; Chan, Clara S.; Bell, Stephen P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Bell, SP (corresponding author), MIT, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	spbell@mit.edu		Bell, Stephen/0000-0002-2876-610X; Kang, Sukhyun/0000-0002-7567-0231	NIH [GM52339]; Damon Runyon Cancer Research Foundation (DRG) [1959-07]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052339] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation (DRG); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Amon, I. Cheeseman, D. MacAlpine, and T. Takara for comments on the manuscript. Rfa1 antibodies were a gift from S. Brill. We thank R. Sinapius and J. Randell for reagents and K. Galani and H. Blitzblau for help with microarrays. This work was supported by NIH grant GM52339 (S.P.B.). S.P.B., S.C., and S.K. are Howard Hughes Medical Institute employees. R.C.H. was a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation (DRG-# 1959-07).	Aparicio OM, 1999, P NATL ACAD SCI USA, V96, P9130, DOI 10.1073/pnas.96.16.9130; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Cadoret JC, 2010, CHROMOSOME RES, V18, P79, DOI 10.1007/s10577-009-9094-2; Cayrou C, 2010, CHROMOSOME RES, V18, P137, DOI 10.1007/s10577-009-9105-3; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Gambus A, 2011, J BIOL CHEM, V286, P11855, DOI 10.1074/jbc.M110.199521; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gregan J, 2003, MOL BIOL CELL, V14, P3876, DOI 10.1091/mbc.E03-02-0090; Homesley L, 2000, GENE DEV, V14, P913; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Jares P, 2000, GENE DEV, V14, P1528; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063; Kubota Y, 2003, GENE DEV, V17, P1141, DOI 10.1101/gad.1070003; LABIB K, 2010, GENE DEV, V24, P1028; Lopez-Mosqueda J, 2010, NATURE, V467, P479, DOI 10.1038/nature09377; Masumoto H, 2000, MOL CELL BIOL, V20, P2809, DOI 10.1128/MCB.20.8.2809-2817.2000; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; Nougarede R, 2000, MOL CELL BIOL, V20, P3795, DOI 10.1128/MCB.20.11.3795-3806.2000; Pasero P, 2002, METHOD ENZYMOL, V351, P184; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Remus D, 2009, CURR OPIN CELL BIOL, V21, P771, DOI 10.1016/j.ceb.2009.08.002; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Sawyer SL, 2004, J MOL BIOL, V340, P195, DOI 10.1016/j.jmb.2004.04.066; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Seki T, 2000, P NATL ACAD SCI USA, V97, P14115, DOI 10.1073/pnas.97.26.14115; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; STINCHCOMB DT, 1979, NATURE, V282, P39, DOI 10.1038/282039a0; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanaka TU, 1998, EMBO J, V17, P5182, DOI 10.1093/emboj/17.17.5182; Tsakraklides V, 2010, J BIOL CHEM, V285, P9437, DOI 10.1074/jbc.M109.072504; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Walter JC, 2000, J BIOL CHEM, V275, P39773, DOI 10.1074/jbc.M008107200; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Yabuuchi H, 2006, EMBO J, V25, P4663, DOI 10.1038/sj.emboj.7601347; Ying CY, 2005, EMBO J, V24, P4334, DOI 10.1038/sj.emboj.7600892; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zegerman P, 2010, NATURE, V467, P474, DOI 10.1038/nature09373; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	48	217	219	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 8	2011	146	1					80	91		10.1016/j.cell.2011.06.012	http://dx.doi.org/10.1016/j.cell.2011.06.012			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729781	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000292539300008
J	Qu, XH; Wen, JD; Lancaster, L; Noller, HF; Bustamante, C; Tinoco, I				Qu, Xiaohui; Wen, Jin-Der; Lancaster, Laura; Noller, Harry F.; Bustamante, Carlos; Tinoco, Ignacio, Jr.			The ribosome uses two active mechanisms to unwind messenger RNA during translation	NATURE			English	Article							SECONDARY STRUCTURE; SINGLE-MOLECULE; TRANSLOCATION; HELICASES; TIME; STABILITY; MOVEMENT; DYNAMICS; RECEPTOR	The ribosome translates the genetic information encoded in messenger RNA into protein. Folded structures in the coding region of an mRNA represent a kinetic barrier that lowers the peptide elongation rate, as the ribosome must disrupt structures it encounters in the mRNA at its entry site to allow translocation to the next codon. Such structures are exploited by the cell to create diverse strategies for translation regulation, such as programmed frameshifting(1,2), the modulation of protein expression levels-(3,4), ribosome localization(5) and co-translational protein folding(6). Although strand separation activity is inherent to the ribosome, requiring no exogenous helicases(7), its mechanism is still unknown. Here, using a single-molecule optical tweezers assay on mRNA hairpins, we find that the translation rate of identical codons at the decoding centre is greatly influenced by the GC content of folded structures at the mRNA entry site. Furthermore, force applied to the ends of the hairpin to favour its unfolding significantly speeds translation. Quantitative analysis of the force dependence of its helicase activity reveals that the ribosome, unlike previously studied helicases, uses two distinct active mechanisms to unwind mRNA structure: it destabilizes the helical junction at the mRNA entry site by biasing its thermal fluctuations towards the open state, increasing the probability of the ribosome translocating unhindered; and it mechanically pulls apart the mRNA single strands of the closed junction during the conformational changes that accompany ribosome translocation. The second of these mechanisms ensures a minimal basal rate of translation in the cell; specialized, mechanically stable structures are required to stall the ribosome temporarily(1,2). Our results establish a quantitative mechanical basis for understanding the mechanism of regulation of the elongation rate of translation by structured mRNAs.	[Qu, Xiaohui; Wen, Jin-Der; Bustamante, Carlos; Tinoco, Ignacio, Jr.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Qu, Xiaohui; Wen, Jin-Der; Bustamante, Carlos] Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA; [Qu, Xiaohui; Wen, Jin-Der; Bustamante, Carlos] Univ Calif Berkeley, QB3 Inst, Berkeley, CA 94720 USA; [Lancaster, Laura; Noller, Harry F.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Lancaster, Laura; Noller, Harry F.] Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Tinoco, I (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu; intinoco@lbl.gov	; Wen, Jin-Der/A-3159-2014	Bustamante, Carlos/0000-0002-2970-0073; Wen, Jin-Der/0000-0001-8317-4329; Qu, Xiaohui/0000-0001-7756-307X	National Institutes of Health; Human Frontiers Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM010840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank rnembers of the Tinoco and Bustamante labs for helpful discussions, especially S. B. Smith for his help with the optical tweezers, J. Moffitt for advice on data analysis arid C. Kaiser for suggestions. Our work was supported by grants from the National Institutes of Health (to IT., C.B. and H.F.N.) and the Human Frontiers Science Program (to I.T. and H.F.N).	Betterton MD, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011904; Chen G, 2009, P NATL ACAD SCI USA, V106, P12706, DOI 10.1073/pnas.0905046106; Cukras AR, 2003, MOL CELL, V12, P321, DOI 10.1016/S1097-2765(03)00275-2; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Giedroc DP, 2009, VIRUS RES, V139, P193, DOI 10.1016/j.virusres.2008.06.008; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Keller D, 2000, BIOPHYS J, V78, P541, DOI 10.1016/S0006-3495(00)76615-X; Kim S, 2010, J MOL BIOL, V395, P995, DOI 10.1016/j.jmb.2009.11.072; Lionnet T, 2007, P NATL ACAD SCI USA, V104, P19790, DOI 10.1073/pnas.0709793104; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Manosas M, 2010, NUCLEIC ACIDS RES, V38, P5518, DOI 10.1093/nar/gkq273; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Peske F, 2000, MOL CELL, V6, P501, DOI 10.1016/S1097-2765(00)00049-6; Rodnina MV, 2000, BIOL CHEM, V381, P377, DOI 10.1515/BC.2000.050; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Tinoco I, 2002, BIOPHYS CHEM, V101, P513, DOI 10.1016/S0301-4622(02)00177-1; Tinoco I, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025006; TSUCHIHASHI Z, 1991, NUCLEIC ACIDS RES, V19, P2457, DOI 10.1093/nar/19.9.2457; Uemura S, 2007, NATURE, V446, P454, DOI 10.1038/nature05625; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Young JC, 1996, EMBO J, V15, P172, DOI 10.1002/j.1460-2075.1996.tb00345.x; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	30	219	220	1	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					118	121		10.1038/nature10126	http://dx.doi.org/10.1038/nature10126			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21734708	Green Accepted			2022-12-01	WOS:000292461300057
J	Chiuve, SE; Fung, TT; Rexrode, KM; Spiegelman, D; Manson, JE; Stampfer, MJ; Albert, CM				Chiuve, Stephanie E.; Fung, Teresa T.; Rexrode, Kathryn M.; Spiegelman, Donna; Manson, JoAnn E.; Stampfer, Meir J.; Albert, Christine M.			Adherence to a Low-Risk, Healthy Lifestyle and Risk of Sudden Cardiac Death Among Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; POLYUNSATURATED FATTY-ACIDS; BODY-MASS INDEX; MEDITERRANEAN DIET; MYOCARDIAL-INFARCTION; PRIMARY PREVENTION; PROSPECTIVE COHORT; PHYSICAL-ACTIVITY; MORTALITY; TIME	Context Sudden cardiac death (SCD) accounts for more than half of all cardiac deaths; the majority of SCD events occur as the first manifestation of heart disease, especially among women. Primary preventive strategies are needed to reduce SCD incidence. Objective To estimate the degree to which adherence to a healthy lifestyle may lower the risk of SCD among women. Design, Setting, and Participants A prospective cohort study of 81 722 US women in the Nurses' Health Study from June 1984 to June 2010. Lifestyle factors were assessed via questionnaires every 2 to 4 years. A low-risk lifestyle was defined as not smoking, body mass index of less than 25, exercise duration of 30 minutes/day or longer, and top 40% of the alternate Mediterranean diet score, which emphasizes high intake of vegetables, fruits, nuts, legumes, whole grains, and fish and moderate intake of alcohol. Main Outcome Measure Sudden cardiac death (defined as death occurring within 1 hour after symptom onset without evidence of circulatory collapse). Results There were 321 cases of SCD during 26 years of follow-up. Women were a mean age of 72 years at the time of the SCD event. All 4 low-risk lifestyle factors were significantly and independently associated with a lower risk of SCD. The absolute risks of SCD were 22 cases/100 000 person-years among women with 0 low-risk factors, 17 cases/100 000 person-years with 1 low-risk factor, 18 cases/100 000 person-years with 2 low-risk factors, 13 cases/100 000 person-years with 3 low-risk factors, and 16 cases/100 000 person-years with 4 low-risk factors. Compared with women with 0 low-risk factors, the multivariable relative risk of SCD was 0.54 (95% confidence interval [CI], 0.34-0.86) for women with 1 low-risk factor, 0.41 (95% CI, 0.25-0.65) for 2 low-risk factors, 0.33 (95% CI, 0.20-0.54) for 3 low-risk factors, and 0.08 (95% CI, 0.03-0.23) for 4 low-risk factors. The proportion of SCD attributable to smoking, inactivity, overweight, and poor diet was 81%(95% CI, 52%-93%). Among women without clinically diagnosed coronary heart disease, the percentage of population attributable risk was 79% (95% CI, 40%-93%). Conclusion Adherence to a low-risk lifestyle is associated with a low risk of SCD.	[Chiuve, Stephanie E.; Albert, Christine M.] Brigham & Womens Hosp, Dept Med, Ctr Arrhythmia Prevent, Boston, MA 02115 USA; [Chiuve, Stephanie E.; Rexrode, Kathryn M.; Manson, JoAnn E.; Stampfer, Meir J.; Albert, Christine M.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; [Albert, Christine M.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Spiegelman, Donna; Stampfer, Meir J.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Chiuve, Stephanie E.; Fung, Teresa T.; Stampfer, Meir J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Chiuve, Stephanie E.; Fung, Teresa T.; Stampfer, Meir J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Spiegelman, Donna; Manson, JoAnn E.; Stampfer, Meir J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Fung, Teresa T.] Simmons Coll, Dept Nutr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Simmons University	Chiuve, SE (corresponding author), 900 Commonwealth Ave, Boston, MA 02215 USA.	schiuve@hsph.harvard.edu	Rexrode, Kathryn M/I-1177-2018	Chiuve, Stephanie/0000-0002-3524-8917; Albert, Christine/0000-0002-2081-1121; Rexrode, Kathryn/0000-0003-3387-8429	National Institutes of Health [CA 87969, HL 034594]; American Heart Association [K99 HL097068]; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL097068, R01HL034594] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by grants CA 87969 and HL 034594 from the National Institutes of Health. Dr Chiuve was supported in part by grant K99 HL097068 and a Clinical Research Program Award from the American Heart Association. Dr Albert was supported in part by an Established Investigator Award from the American Heart Association.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Ajani UA, 2004, ANN EPIDEMIOL, V14, P731, DOI 10.1016/j.annepidem.2003.10.008; Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; Albert CM, 1999, CIRCULATION, V100, P944, DOI 10.1161/01.CIR.100.9.944; Albert CM, 2003, CIRCULATION, V107, P2096, DOI 10.1161/01.CIR.0000065223.21530.11; Albert CM, 2002, ARCH INTERN MED, V162, P1382, DOI 10.1001/archinte.162.12.1382; Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; Chiuve SE, 2008, CIRCULATION, V118, P947, DOI 10.1161/CIRCULATIONAHA.108.781062; Chugh SS, 2009, J AM COLL CARDIOL, V54, P2006, DOI 10.1016/j.jacc.2009.07.038; Chugh SS, 2008, PROG CARDIOVASC DIS, V51, P213, DOI 10.1016/j.pcad.2008.06.003; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P48, DOI 10.1093/oxfordjournals.aje.a114223; COPELAND KT, 1977, AM J EPIDEMIOL, V105, P488, DOI 10.1093/oxfordjournals.aje.a112408; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Ford ES, 2009, ARCH INTERN MED, V169, P1355, DOI 10.1001/archinternmed.2009.237; Forman JP, 2009, JAMA-J AM MED ASSOC, V302, P401, DOI 10.1001/jama.2009.1060; Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736; Hildebrandt Mandy, 2006, BMC Med Res Methodol, V6, P32, DOI 10.1186/1471-2288-6-32; HINKLE LE, 1982, CIRCULATION, V65, P457, DOI 10.1161/01.CIR.65.3.457; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Jouven X, 1999, CIRCULATION, V99, P1978, DOI 10.1161/01.CIR.99.15.1978; KANNEL WB, 1975, CIRCULATION, V51, P606, DOI 10.1161/01.CIR.51.4.606; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Lemaitre RN, 1999, ARCH INTERN MED, V159, P686, DOI 10.1001/archinte.159.7.686; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; PETERS RW, 1995, J AM COLL CARDIOL, V26, P1287, DOI 10.1016/0735-1097(95)00328-2; Platz EA, 2000, CANCER CAUSE CONTROL, V11, P579, DOI 10.1023/A:1008999232442; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Roger VL, 2009, JAMA-J AM MED ASSOC, V302, P437, DOI 10.1001/jama.2009.1075; Schoenborn Charlotte A, 2010, Vital Health Stat 10, P1; SHEKELLE RB, 1982, AM J EPIDEMIOL, V115, P506, DOI 10.1093/oxfordjournals.aje.a113332; Shojania KG, 2003, JAMA-J AM MED ASSOC, V289, P2849, DOI 10.1001/jama.289.21.2849; SISCOVICK DS, 1995, JAMA-J AM MED ASSOC, V274, P1363, DOI 10.1001/jama.274.17.1363; SISCOVICK DS, 1986, AM J EPIDEMIOL, V123, P490, DOI 10.1093/oxfordjournals.aje.a114265; Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673; Spiegelman D, 2007, CANCER CAUSE CONTROL, V18, P571, DOI 10.1007/s10552-006-0090-y; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Stecker EC, 2006, J AM COLL CARDIOL, V47, P1161, DOI 10.1016/j.jacc.2005.11.045; US Department of Agriculture, 1963, COMP FOODS RAW PROC, V8; US Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; van Dam RM, 2008, BMJ-BRIT MED J, V337, pa1440, DOI [10.1136/bmj.a1440, DOI 10.1136/BMJ.A1440]; WACHOLDER S, 1994, AM J EPIDEMIOL, V140, P303, DOI 10.1093/oxfordjournals.aje.a117252; WANNAMETHEE G, 1995, CIRCULATION, V91, P1749, DOI 10.1161/01.CIR.91.6.1749; Whang W, 2006, JAMA-J AM MED ASSOC, V295, P1399, DOI 10.1001/jama.295.12.1399; Willett WC, 2010, AM J CLIN NUTR, V91, P829, DOI 10.3945/ajcn.2010.29347; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254	54	125	132	1	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2011	306	1					62	69		10.1001/jama.2011.907	http://dx.doi.org/10.1001/jama.2011.907			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	787LV	21730242	Bronze, Green Accepted			2022-12-01	WOS:000292378700021
J	Usherwood, JR; Stavrou, M; Lowe, JC; Roskilly, K; Wilson, AM				Usherwood, James R.; Stavrou, Marinos; Lowe, John C.; Roskilly, Kyle; Wilson, Alan M.			Flying in a flock comes at a cost in pigeons	NATURE			English	Article							VORTEX THEORY; FLIGHT; FREQUENCY; BIRDS; DRAG	Flying birds often form flocks, with social(1), navigational(2) and antipredator(3) implications. Further, flying in a flock can result in aerodynamic benefits, thus reducing power requirements(4), as demonstrated by a reduction in heart rate and wingbeat frequency in pelicans flying in a V-formation(5). But how general is an aerodynamic power reduction due to group-flight? V-formation flocks are limited to moderately steady flight in relatively large birds, and may represent a special case. What are the aerodynamic consequences of flying in the more usual 'cluster'(6,7) flock? Here we use data from innovative back-mounted Global Positioning System (GPS) and 6-degrees-of-freedom inertial sensors to show that pigeons (1) maintain powered, banked turns like aircraft, imposing dorsal accelerations of up to 2g, effectively doubling body weight and quadrupling induced power requirements; (2) increase flap frequency with increases in all conventional aerodynamic power requirements; and (3) increase flap frequency when flying near, particularly behind, other birds. Therefore, unlike V-formation pelicans, pigeons do not gain an aerodynamic advantage from flying in a flock. Indeed, the increased flap frequency, whether due to direct aerodynamic interactions or requirements for increased stability or control, suggests a considerable energetic cost to flight in a tight cluster flock.	[Usherwood, James R.; Stavrou, Marinos; Lowe, John C.; Roskilly, Kyle; Wilson, Alan M.] Univ London, Struct & Mot Lab, Royal Vet Coll, Hatfield AL9 7TA, Herts, England	University of London; University of London Royal Veterinary College	Usherwood, JR (corresponding author), Univ London, Struct & Mot Lab, Royal Vet Coll, Hatfield AL9 7TA, Herts, England.	jusherwood@rvc.ac.uk		Wilson, Alan/0000-0001-9914-3455	Wellcome Trust; Royal Society; BBSRC; EPSRC; EPSRC [EP/H013016/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H013016/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We would like to thank T. Hubel, H. Chapman, V. Unt and T. Demes for practical assistance, and The Wellcome Trust (J.R.U.), The Royal Society (A.M.W.), BBSRC (K.R.) and EPSRC for funding.	Bilo D., 1984, BIONA REP, V3, P87; Dell'Ariccia G, 2008, ANIM BEHAV, V76, P1165, DOI 10.1016/j.anbehav.2008.05.022; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P115, DOI 10.1098/rstb.1984.0053; Greene P R, 1979, Physiologist, V22, pS35; Hedrick TL, 2004, J EXP BIOL, V207, P1689, DOI 10.1242/jeb.00933; Hedrick TL, 2009, SCIENCE, V324, P252, DOI 10.1126/science.1168431; HEPPNER FH, 1974, BIRD BANDING, V45, P160, DOI 10.2307/4512025; HIGDON JJL, 1978, AM NAT, V112, P727, DOI 10.1086/283314; Lilienthal O., 2001, BIRDFLIGHT BASIS AVI; LISSAMAN PB, 1970, SCIENCE, V168, P1003, DOI 10.1126/science.168.3934.1003; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Pennycuick C.J., 1989, BIRD FLIGHT PERFORMA; Pennycuick CJ, 1996, J EXP BIOL, V199, P2757; POMEROY H, 1992, AUK, V109, P256; RAYNER JMV, 1979, J FLUID MECH, V91, P697, DOI 10.1017/S0022112079000410; Schmidt-Wellenburg CA, 2007, J COMP PHYSIOL B, V177, P327, DOI 10.1007/s00360-006-0132-5; Spedding GR, 2010, J AIRCRAFT, V47, P120, DOI 10.2514/1.44247; Tinbergen N., 1951, STUDY INSTINCT; Tobalske BW, 2003, NATURE, V421, P363, DOI 10.1038/nature01284; Usherwood JR, 2006, BIOL LETTERS, V2, P47, DOI 10.1098/rsbl.2005.0399; Usherwood JR, 2009, BIOINSPIR BIOMIM, V4, DOI 10.1088/1748-3182/4/1/015003; Usherwood JR, 2005, NATURE, V438, P753, DOI 10.1038/438753a; Weimerskirch H, 2001, NATURE, V413, P697, DOI 10.1038/35099670	23	81	86	2	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					494	497		10.1038/nature10164	http://dx.doi.org/10.1038/nature10164			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21697946	Green Accepted			2022-12-01	WOS:000291939700045
J	Agrawal, N; Frederick, MJ; Pickering, CR; Bettegowda, C; Chang, K; Li, RJ; Fakhry, C; Xie, TX; Zhang, JX; Wang, J; Zhang, NX; El-Naggar, AK; Jasser, SA; Weinstein, JN; Trevino, L; Drummond, JA; Muzny, DM; Wu, YQ; Wood, LD; Hruban, RH; Westra, WH; Koch, WM; Califano, JA; Gibbs, RA; Sidransky, D; Vogelstein, B; Velculescu, VE; Papadopoulos, N; Wheeler, DA; Kinzler, KW; Myers, JN				Agrawal, Nishant; Frederick, Mitchell J.; Pickering, Curtis R.; Bettegowda, Chetan; Chang, Kyle; Li, Ryan J.; Fakhry, Carole; Xie, Tong-Xin; Zhang, Jiexin; Wang, Jing; Zhang, Nianxiang; El-Naggar, Adel K.; Jasser, Samar A.; Weinstein, John N.; Trevino, Lisa; Drummond, Jennifer A.; Muzny, Donna M.; Wu, Yuanqing; Wood, Laura D.; Hruban, Ralph H.; Westra, William H.; Koch, Wayne M.; Califano, Joseph A.; Gibbs, Richard A.; Sidransky, David; Vogelstein, Bert; Velculescu, Victor E.; Papadopoulos, Nickolas; Wheeler, David A.; Kinzler, Kenneth W.; Myers, Jeffrey N.			Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1	SCIENCE			English	Article							HUMAN-PAPILLOMAVIRUS; TUMOR-SUPPRESSOR; PATHWAY; GENE; P53	Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide. To explore the genetic origins of this cancer, we used whole-exome sequencing and gene copy number analyses to study 32 primary tumors. Tumors from patients with a history of tobacco use had more mutations than did tumors from patients who did not use tobacco, and tumors that were negative for human papillomavirus (HPV) had more mutations than did HPV-positive tumors. Six of the genes that were mutated in multiple tumors were assessed in up to 88 additional HNSCCs. In addition to previously described mutations in TP53, CDKN2A, PIK3CA, and HRAS, we identified mutations in FBXW7 and NOTCH1. Nearly 40% of the 28 mutations identified in NOTCH1 were predicted to truncate the gene product, suggesting that NOTCH1 may function as a tumor suppressor gene rather than an oncogene in this tumor type.	[Agrawal, Nishant; Li, Ryan J.; Fakhry, Carole; Koch, Wayne M.; Califano, Joseph A.; Sidransky, David] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21287 USA; [Agrawal, Nishant; Bettegowda, Chetan; Vogelstein, Bert; Velculescu, Victor E.; Papadopoulos, Nickolas; Kinzler, Kenneth W.] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet, Baltimore, MD 21231 USA; [Agrawal, Nishant; Bettegowda, Chetan; Vogelstein, Bert; Velculescu, Victor E.; Papadopoulos, Nickolas; Kinzler, Kenneth W.] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA; [Frederick, Mitchell J.; Pickering, Curtis R.; Xie, Tong-Xin; Jasser, Samar A.; Myers, Jeffrey N.] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Bettegowda, Chetan] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21287 USA; [Chang, Kyle; Trevino, Lisa; Drummond, Jennifer A.; Muzny, Donna M.; Wu, Yuanqing; Gibbs, Richard A.; Wheeler, David A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Zhang, Jiexin; Wang, Jing; Zhang, Nianxiang; Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [El-Naggar, Adel K.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Wood, Laura D.; Hruban, Ralph H.; Westra, William H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21287 USA; [Califano, Joseph A.; Gibbs, Richard A.] Greater Baltimore Med Ctr, Milton J Dance Head & Neck Ctr, Baltimore, MD 21204 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; University of Texas System; UTMD Anderson Cancer Center; Johns Hopkins University; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Johns Hopkins University; Greater Baltimore Medical Center; Baylor College of Medicine	Agrawal, N (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 600 N Wolfe St, Baltimore, MD 21287 USA.	nagrawal@jhmi.edu; velculescu@jhmi.edu; kinzlke@jhmi.edu; jmyers@mdanderson.org	Wheeler, David A/M-9740-2018; Drummond, Jennifer/AAG-1654-2020; Wood, Laura/ABF-1531-2020; Papadopoulos, Nickolas/K-7272-2012; Velculescu, Victor/ABF-4846-2020	Wheeler, David A/0000-0002-9056-6299; Drummond, Jennifer/0000-0002-2612-5958; Velculescu, Victor/0000-0003-1195-438X; Pickering, Curtis/0000-0002-7942-728X; Chang, Kyle/0000-0001-5295-9676; Weinstein, John/0000-0001-9401-6908	National Institutes of Health (NIH)/National Institute of Dental and Craniofacial Research [RC2DE020957, RC2DE020958]; NIH [CA121113, CA43460, CA57345, CN43302, P50DE019032, 5P50CA09700708]; Cancer Prevention Research Institute of Texas [RP100233]; Cancer Center [CA16672]; AACR; Virginia and D. K. Ludwig Fund for Cancer Research; NIH/National Cancer Institute National Research Service [T32 CA009574]; GSK Translational Research Fellowship; NATIONAL CANCER INSTITUTE [P50CA097007, R01CA057345, T32CA009574, P30CA016672, R01CA043460, R37CA043460, R37CA057345, R01CA121113] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P50DE019032, R37DE012588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020958, RC2DE020957] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; Cancer Center; AACR; Virginia and D. K. Ludwig Fund for Cancer Research; NIH/National Cancer Institute National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GSK Translational Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank our patients for their courage and generosity. We thank N. Silliman, J. Ptak, M. Whalen, L. Dobbyn, J. Schaeffer, X. Li, O. Folawiyo, and Z. Khan for expert technical assistance. This work was supported by the National Institutes of Health (NIH)/National Institute of Dental and Craniofacial Research grants RC2DE020957, and RC2DE020958; NIH grants CA121113, CA43460, CA57345, and CN43302; NIH Specialized Program of Research Excellence grants P50DE019032 and 5P50CA09700708; Cancer Prevention Research Institute of Texas grant RP100233; Cancer Center Support grant CA16672; AACR Stand Up To Cancer-Dream Team Translational Cancer Research grant; and the Virginia and D. K. Ludwig Fund for Cancer Research. Under agreements between the Johns Hopkins University, Genzyme, Exact Sciences, Inostics, Qiagen, Invitrogen, and Personal Genome Diagnostics, N.P., B.V., K.W.K., and V.E.V are entitled to a share of the royalties received by the university on sales of products related to genes and technologies described in this manuscript. N.P., B.V., K.W.K., and V.E.V are co-founders of Inostics and Personal Genome Diagnostics, are members of their Scientific Advisory Boards, and own Inostics and Personal Genome Diagnostics stock, which is subject to certain restrictions under Johns Hopkins University policy. J.C. is the Director of Research of the Milton J. Dance Head and Neck Endowment. The terms of these arrangements are managed by the Johns Hopkins University in accordance with its conflict-of-interest policies. C.B. is a recipient of T32 CA009574 NIH/National Cancer Institute National Research Service Award. C.R.P. is a TRIUMPH Fellow and supported by the GSK Translational Research Fellowship. This paper is based on a web database application provided by Research Information Technology Systems (RITS) www.rits.onc.jhmi.edu/.	Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Aster JC, 1997, J BIOL CHEM, V272, P11336; Baldus CD, 2009, HAEMATOL-HEMATOL J, V94, P1383, DOI 10.3324/haematol.2008.005272; Balz V, 2003, CANCER RES, V63, P1188; BERENSON JR, 1989, ONCOGENE, V4, P1111; BRENNAN JA, 1995, NEW ENGL J MED, V332, P712, DOI 10.1056/NEJM199503163321104; Cohen LY, 2005, CELL DEATH DIFFER, V12, P243, DOI 10.1038/sj.cdd.4401568; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Hafkamp HC, 2003, INT J CANCER, V107, P394, DOI 10.1002/ijc.11389; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.3322/caac.20105]; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Klussmann JP, 2009, CLIN CANCER RES, V15, P1779, DOI 10.1158/1078-0432.CCR-08-1463; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Roy M, 2007, CURR OPIN GENET DEV, V17, P52, DOI 10.1016/j.gde.2006.12.001; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Westhoff B, 2009, P NATL ACAD SCI USA, V106, P22293, DOI 10.1073/pnas.0907781106	22	1243	1263	2	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2011	333	6046					1154	1157		10.1126/science.1206923	http://dx.doi.org/10.1126/science.1206923			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21798897	Green Accepted			2022-12-01	WOS:000294244300051
J	Penkman, KEH; Preece, RC; Bridgland, DR; Keen, DH; Meijer, T; Parfitt, SA; White, TS; Collins, MJ				Penkman, Kirsty E. H.; Preece, Richard C.; Bridgland, David R.; Keen, David H.; Meijer, Tom; Parfitt, Simon A.; White, Tom S.; Collins, Matthew J.			A chronological framework for the British Quaternary based on Bithynia opercula	NATURE			English	Article							PLEISTOCENE; MIDDLE; GEOCHRONOLOGY; OCCUPATION; FRACTION; BRITAIN; SYSTEMS; EUROPE; RECORD	Marine and ice-core records show that the Earth has experienced a succession of glacials and interglacials during the Quaternary (last similar to 2.6 million years), although it is often difficult to correlate fragmentary terrestrial records with specific cycles. Aminostratigraphy is a method potentially able to link terrestrial sequences to the marine isotope stages (MIS) of the deep-sea record(1,2). We have used new methods of extraction and analysis of amino acids, preserved within the calcitic opercula of the freshwater gastropod Bithynia, to provide the most comprehensive data set for the British Pleistocene based on a single dating technique. A total of 470 opercula from 74 sites spanning the entire Quaternary are ranked in order of relative age based on the extent of protein degradation, using aspartic acid/asparagine (Asx), glutamic acid/glutamine (Glx), serine (Ser), alanine (Ala) and valine (Val). This new aminostratigraphy is consistent with the stratigraphical relationships of stratotypes, sites with independent geochronology, biostratigraphy and terrace stratigraphy(3-6). The method corroborates the existence of four interglacial stages between the Anglian (MIS 12) and the Holocene in the terrestrial succession. It establishes human occupation of Britain in most interglacial stages after MIS 15, but supports the notion of human absence during the Last Interglacial (MIS 5e)(7). Suspicions that the treeless 'optimum of the Upton Warren interstadial' at Isleworth pre-dates MIS 3 are confirmed. This new aminostratigraphy provides a robust framework against which climatic, biostratigraphical and archaeological models can be tested.	[Penkman, Kirsty E. H.; Collins, Matthew J.] Univ York, BioArCh, Dept Archaeol, York YO10 5DD, N Yorkshire, England; [Penkman, Kirsty E. H.; Collins, Matthew J.] Univ York, Dept Chem, BioArCh, York YO10 5DD, N Yorkshire, England; [Preece, Richard C.; White, Tom S.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Bridgland, David R.] Univ Durham, Dept Geog, Durham DH1 3LE, England; [Keen, David H.] Univ Birmingham, Inst Archaeol & Antiqu, Birmingham B15 2TT, W Midlands, England; [Meijer, Tom] Netherlands Ctr Biodivers, Cainozo Mollusca, NL-2300 RA Leiden, Netherlands; [Parfitt, Simon A.] UCL, Inst Archaeol, London WC1H 0PY, England; [Parfitt, Simon A.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England	University of York - UK; University of York - UK; University of Cambridge; Durham University; University of Birmingham; Naturalis Biodiversity Center; University of London; University College London; Natural History Museum London	Penkman, KEH (corresponding author), Univ York, BioArCh, Dept Archaeol, York YO10 5DD, N Yorkshire, England.	kirsty.penkman@york.ac.uk	Collins, Matthew J/A-7534-2008; Penkman, Kirsty E/D-1952-2012; Collins, Matthew James/O-1095-2019; White, Tom/A-2474-2013	Collins, Matthew J/0000-0003-4226-5501; Penkman, Kirsty E/0000-0002-6226-9799; Collins, Matthew James/0000-0003-4226-5501; White, Tom/0000-0001-9056-7286	English Heritage, NERC; Wellcome Trust [GR076905MA]; Leverhulme Trust; Engineering and Physical Sciences Research Council [EP/I001514/1] Funding Source: researchfish; EPSRC [EP/I001514/1] Funding Source: UKRI	English Heritage, NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission); Leverhulme Trust(Leverhulme Trust); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank D. Maddy, P. Allen, N. Ashton, D. Bain, M. Bates, S. Boreham, D. Bowen, R. Briant, C. Buckingham, J. Clayden, G. R. Coope, A. Cruickshanks, P. Dark, B. Demarchi, M. Greenwood, D. Kaufman, T. van Kolfschoten, H. Langford, S. Lewis, R. Markham, D. Mayhew, H. Roe, J. Rose, D. Schreve, R. Scott, K. Scott, C. Stringer, R. Waghorne, M. Warren and F. Wenban-Smith for providing some of the material analysed and general discussion. C. Helmsley and J. Todd released material from the Natural History Museum, London, for destructive analysis. R. Allen provided technical support. G. Peeters gave permission to reproduce images of Bithynia. The analyses were funded by English Heritage, NERC and the Wellcome Trust (grant GR076905MA). This is a contribution to the Ancient Human Occupation of Britain (AHOB) project funded by the Leverhulme Trust.	Ashton N, 2002, ANTIQUITY, V76, P388, DOI 10.1017/S0003598X00090505; Boreham S, 2010, P GEOLOGIST ASSOC, V121, P393, DOI 10.1016/j.pgeola.2010.02.003; Bowen D.Q., 1999, REVISED CORRELATION; BOWEN DQ, 1989, NATURE, V340, P49, DOI 10.1038/340049a0; Bridgland D, 2004, J QUATERNARY SCI, V19, P203, DOI 10.1002/jqs.819; Bridgland D.R., 1994, GEOLOGICAL CONSERVAT; Bridgland DR, 2006, P GEOLOGIST ASSOC, V117, P281, DOI 10.1016/S0016-7878(06)80036-2; Bridgland DR, 2006, J QUATERNARY SCI, V21, P437, DOI 10.1002/jqs.1042; Bridgland DR, 2010, J QUATERNARY SCI, V25, P433, DOI 10.1002/jqs.1383; Bridgland DR, 2000, QUATERNARY SCI REV, V19, P1293, DOI 10.1016/S0277-3791(99)00095-5; COOPE GR, 1975, J ANIM ECOL, V44, P365, DOI 10.2307/3603; Gibbard P., 1994, PLEISTOCENE HIST LOW; Jansen E, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P433; Kaufman DS, 1998, QUATERNARY SCI REV, V17, P987, DOI 10.1016/S0277-3791(97)00086-3; Keen DH, 2001, QUATERNARY SCI REV, V20, P1657, DOI 10.1016/S0277-3791(01)00030-0; Lewis S. G., 2010, ANCIENT HUMAN OCCUPA, P125; Maddy D, 1998, J QUATERNARY SCI, V13, P205, DOI 10.1002/(SICI)1099-1417(199805/06)13:3<205::AID-JQS357>3.0.CO;2-N; MADDY D, 1991, J GEOL SOC LONDON, V148, P473, DOI 10.1144/gsjgs.148.3.0473; Meijer T, 2000, GEOL MIJNBOUW-N J G, V79, P241; MILLER GH, 1979, NATURE, V281, P539, DOI 10.1038/281539a0; Penkman KEH, 2007, QUATERNARY SCI REV, V26, P2958, DOI 10.1016/j.quascirev.2007.06.034; Penkman KEH, 2008, QUAT GEOCHRONOL, V3, P2, DOI 10.1016/j.quageo.2007.07.001; Penkman KEH, 2010, QUATERN INT, V228, P25, DOI 10.1016/j.quaint.2010.06.020; Preece RC, 2005, P GEOLOGIST ASSOC, V116, P363, DOI 10.1016/S0016-7878(05)80053-7; Preece RC, 2009, J QUATERNARY SCI, V24, P557, DOI 10.1002/jqs.1245; Schreve DC, 2001, QUATERNARY SCI REV, V20, P1693, DOI 10.1016/S0277-3791(01)00033-6; Sykes GA, 1995, ORG GEOCHEM, V23, P1059, DOI 10.1016/0146-6380(95)00086-0; von Koenigswald W., 1996, EARLY MIDDLE PLEISTO, P211; White M, 2003, CURR ANTHROPOL, V44, P598, DOI 10.1086/377653; White T., 2007, FOREST GENETICS	30	103	105	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2011	476	7361					446	449		10.1038/nature10305	http://dx.doi.org/10.1038/nature10305			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811KT	21804567	Green Accepted, Green Submitted			2022-12-01	WOS:000294209400035
J	Marrakchi, S; Guigue, P; Renshaw, BR; Puel, A; Pei, XY; Fraitag, S; Zribi, J; Bal, E; Cluzeau, C; Chrabieh, M; Towne, JE; Douangpanya, J; Pons, C; Mansour, S; Serre, V; Makni, H; Mahfoudh, N; Fakhfakh, F; Bodemer, C; Feingold, J; Hadj-Rabia, S; Favre, M; Genin, E; Sahbatou, M; Munnich, A; Casanova, JL; Sims, JE; Turki, H; Bachelez, H; Smahi, A				Marrakchi, Slaheddine; Guigue, Philippe; Renshaw, Blair R.; Puel, Anne; Pei, Xue-Yuan; Fraitag, Sylvie; Zribi, Jihen; Bal, Elodie; Cluzeau, Celine; Chrabieh, Maya; Towne, Jennifer E.; Douangpanya, Jason; Pons, Christian; Mansour, Sourour; Serre, Valerie; Makni, Hafedh; Mahfoudh, Nadia; Fakhfakh, Faiza; Bodemer, Christine; Feingold, Josue; Hadj-Rabia, Smail; Favre, Michel; Genin, Emmanuelle; Sahbatou, Mourad; Munnich, Arnold; Casanova, Jean-Laurent; Sims, John E.; Turki, Hamida; Bachelez, Herve; Smahi, Asma			Interleukin-36-Receptor Antagonist Deficiency and Generalized Pustular Psoriasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NF-KAPPA-B; AUTOINFLAMMATORY DISEASE; FAMILY; MEMBERS; IDENTIFICATION; PATHOGENESIS; ASSOCIATION; IMMUNITY; LOCUS	BACKGROUND Generalized pustular psoriasis is a life-threatening disease of unknown cause. It is characterized by sudden, repeated episodes of high-grade fever, generalized rash, and disseminated pustules, with hyperleukocytosis and elevated serum levels of C-reactive protein, which may be associated with plaque-type psoriasis. METHODS We performed homozygosity mapping and direct sequencing in nine Tunisian multiplex families with autosomal recessive generalized pustular psoriasis. We assessed the effect of mutations on protein expression and conformation, stability, and function. RESULTS We identified significant linkage to an interval of 1.2 megabases on chromosome 2q13-q14.1 and a homozygous missense mutation in IL36RN, encoding an interleukin-36-receptor antagonist (interleukin-36Ra), an antiinflammatory cytokine. This mutation predicts the substitution of a proline residue for leucine at amino acid position 27 (L27P). Homology-based structural modeling of human interleukin-36Ra suggests that the proline at position 27 affects both the stability of interleukin-36Ra and its interaction with its receptor, interleukin-1 receptor-like 2 (interleukin-1 receptor-related protein 2). Biochemical analyses showed that the L27P variant was poorly expressed and less potent than the nonvariant interleukin-36Ra in inhibiting a cytokine-induced response in an interleukin-8 reporter assay, leading to enhanced production of inflammatory cytokines (interleukin-8 in particular) by keratinocytes from the patients. CONCLUSIONS Aberrant interleukin-36Ra structure and function lead to unregulated secretion of inflammatory cytokines and generalized pustular psoriasis. (Funded by Agence Nationale de la Recherche and Societe Francaise de Dermatologie.)	[Marrakchi, Slaheddine; Zribi, Jihen; Makni, Hafedh; Mahfoudh, Nadia; Fakhfakh, Faiza; Turki, Hamida] Sfax Univ, Hedi Chaker Hosp, Dept Dermatol, Sfax, Tunisia; [Marrakchi, Slaheddine; Guigue, Philippe; Fraitag, Sylvie; Bal, Elodie; Cluzeau, Celine; Mansour, Sourour; Serre, Valerie; Bodemer, Christine; Feingold, Josue; Hadj-Rabia, Smail; Munnich, Arnold; Smahi, Asma] Sorbonne Paris Cite Univ Paris Descartes, Hop Necker Enfants Malades, Genet Lab, INSERM,Unit 781, Paris, France; [Puel, Anne; Chrabieh, Maya; Casanova, Jean-Laurent] Sorbonne Paris Cite Univ Paris Descartes, Hop Necker Enfants Malades, Lab Human Genet Infect Dis, INSERM,Unit 980, Paris, France; [Fraitag, Sylvie] Hop Necker Enfants Malad, Dept Pathol, Paris, France; [Pons, Christian; Favre, Michel] Inst Pasteur, Unite Genet Papillomavirus & Canc Humain, Paris, France; [Genin, Emmanuelle] Sorbonne Paris Cite Univ Paris Diderot, Inst Univ Hematol, INSERM, UMRS 946, Paris, France; [Bachelez, Herve] Sorbonne Paris Cite Univ Paris Diderot, Hop St Louis, AP HP, INSERM,Unit 976, Paris, France; [Sahbatou, Mourad] Ctr Etud Polymorphisme Humain, Fdn Jean Dausset, F-75010 Paris, France; [Renshaw, Blair R.; Towne, Jennifer E.; Douangpanya, Jason; Sims, John E.] Dept Inflammat Res, Seattle, WA USA; [Pei, Xue-Yuan] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Casanova, Jean-Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, New York, NY 10021 USA	Universite de Sfax; Hopital Hedi Chaker; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Foundation Jean Dausset-CEPH; University of Cambridge; Rockefeller University	Smahi, A (corresponding author), Hop Necker Enfants Malad, INSERM, U781, 149 Rue Sevres, F-75015 Paris, France.	asma.smahi@inserm.fr	Casanova, Jean-Laurent/I-3418-2017; Puel, Anne/H-7305-2017; Cluzeau, Celine/E-6873-2016; Smahi, Asma/J-4184-2017; Genin, Emmanuelle/C-4974-2013; chrabieh, maya/H-7370-2017	Puel, Anne/0000-0003-2603-0323; Cluzeau, Celine/0000-0002-7791-6223; Smahi, Asma/0000-0002-6002-0981; Genin, Emmanuelle/0000-0003-4117-2813; chrabieh, maya/0000-0003-0772-4805; Casanova, Jean-Laurent/0000-0002-7782-4169; Mansour, Sourour/0000-0003-1959-1341; Hadj-Rabia, Smail/0000-0001-6801-7106; Sims, John/0000-0002-5667-9185; bachelez, herve/0000-0003-3567-9095	Agence Nationale de la Recherche; Societe Francaise de Dermatologie	Agence Nationale de la Recherche(French National Research Agency (ANR)); Societe Francaise de Dermatologie	Supported by grants from the Agence Nationale de la Recherche and the Societe Francaise de Dermatologie.	Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Augey F, 2006, EUR J DERMATOL, V16, P669, DOI 10.1684/ejd.2006.0003; BAKER H, 1968, BRIT J DERMATOL, V80, P771, DOI 10.1111/j.1365-2133.1968.tb11947.x; Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Blumberg H, 2010, J IMMUNOL, V185, P4354, DOI 10.4049/jimmunol.1000313; Carrie A, 1999, NAT GENET, V23, P25, DOI 10.1038/12623; Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; Chang SE, 2003, INT J DERMATOL, V42, P754; Debets R, 2001, J IMMUNOL, V167, P1440, DOI 10.4049/jimmunol.167.3.1440; Dinarello C, 2010, NAT IMMUNOL, V11, P973, DOI 10.1038/ni1110-973; Dinarello CA, 2009, NEW ENGL J MED, V360, P2467, DOI 10.1056/NEJMe0811014; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dunn EF, 2003, BIOCHEMISTRY-US, V42, P10938, DOI 10.1021/bi0341197; Genin E, 2004, J MED GENET, V41, P445, DOI 10.1136/jmg.2003.017962; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; Henderson C, 2010, CLIN IMMUNOL, V135, P210, DOI 10.1016/j.clim.2010.02.013; HUBLER WR, 1984, ARCH DERMATOL, V120, P1174, DOI 10.1001/archderm.120.9.1174; Iizuka H, 2003, ARCH DERMATOL RES, V295, pS55, DOI 10.1007/s00403-002-0372-5; Kumar S, 2000, J BIOL CHEM, V275, P10308, DOI 10.1074/jbc.275.14.10308; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Muto M, 2003, ARCH DERMATOL RES, V295, pS60, DOI 10.1007/s00403-002-0373-4; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Naldi L, 2007, CLIN DERMATOL, V25, P510, DOI 10.1016/j.clindermatol.2007.08.003; Puel A, 2004, CURR OPIN IMMUNOL, V16, P34, DOI 10.1016/j.coi.2003.11.013; Reddy S, 2009, NEW ENGL J MED, V360, P2438, DOI 10.1056/NEJMoa0809568; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Smith DE, 2000, J BIOL CHEM, V275, P1169, DOI 10.1074/jbc.275.2.1169; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; TAKEMATSU H, 1992, ACTA DERM-VENEREOL, V72, P443; Taylor SL, 2002, GENOMICS, V79, P726, DOI 10.1006/geno.2002.6752; Towne JE, 2004, J BIOL CHEM, V279, P13677, DOI 10.1074/jbc.M400117200; ZELICKSON BD, 1991, ARCH DERMATOL, V127, P1339, DOI 10.1001/archderm.127.9.1339	33	603	647	0	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2011	365	7					620	628		10.1056/NEJMoa1013068	http://dx.doi.org/10.1056/NEJMoa1013068			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808ER	21848462				2022-12-01	WOS:000293960500009
J	Wainberg, MA; Zaharatos, GJ; Brenner, BG				Wainberg, Mark A.; Zaharatos, Gerasimos J.; Brenner, Bluma G.			MECHANISMS OF DISEASE Development of Antiretroviral Drug Resistance	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1 SUBTYPE-C; TO-CHILD TRANSMISSION; SINGLE-DOSE NEVIRAPINE; REVERSE-TRANSCRIPTASE INHIBITORS; NON-B SUBTYPES; VIROLOGICAL FAILURE; IN-VITRO; K65R RESISTANCE; SOUTHERN BRAZIL		[Wainberg, Mark A.; Zaharatos, Gerasimos J.; Brenner, Bluma G.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, AIDS Ctr, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University	Wainberg, MA (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst, AIDS Ctr, 3755 Cote St Catherine Rd, Montreal, PQ H3T 1E2, Canada.	mark.wainberg@mcgill.ca	Franzeck, Fabian C/B-5055-2011; Brenner, Bluma/I-8714-2019	Brenner, Bluma/0000-0002-2084-728X				Aghokeng AF, 2005, AIDS RES HUM RETROV, V21, P430, DOI 10.1089/aid.2005.21.430; Akouamba BS, 2005, EMERG INFECT DIS, V11, P1230, DOI 10.3201/eid1108.040877; Arien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594; Ayele W, 2010, AIDS RES HUM RETROV, V26, P805, DOI 10.1089/aid.2009.0152; Barth RE, 2008, AIDS, V22, P2210, DOI 10.1097/QAD.0b013e328313bf87; Brennan CA, 2007, AIDS RES HUM RETROV, V23, P1434, DOI 10.1089/aid.2007.0121; Brenner B, 2003, AIDS, V17, pF1, DOI 10.1097/00002030-200301030-00001; Brenner BG, 2006, AIDS, V20, pF9, DOI 10.1097/01.aids.0000232228.88511.0b; Brenner BG, 2011, J MED VIROL, V83, P751, DOI 10.1002/jmv.22047; Brenner Bluma G., 2009, HIV Therapy, V3, P583, DOI [10.2217/hiv.09.40, 10.2217/HIV.09.40]; Brenner BG, 2007, CURR OPIN HIV AIDS, V2, P94, DOI 10.1097/COH.0b013e32801682e2; Calazans A, 2005, J INFECT DIS, V191, P1961, DOI 10.1086/430002; Ceccherini-Silberstein F, 2009, AIDS REV, V11, P17; Chaix ML, 2006, J INFECT DIS, V193, P482, DOI 10.1086/499966; Charpentier C, 2008, HIV MED, V9, P765, DOI 10.1111/j.1468-1293.2008.00628.x; Charpentier C, 2011, ANTIMICROB AGENTS CH, V55, P1293, DOI 10.1128/AAC.00942-10; Clotet B, 2008, J ANTIMICROB CHEMOTH, V61, P13, DOI 10.1093/jac/dkm432; Coutsinos Dimitrios, 2010, Antiviral Chemistry & Chemotherapy, V20, P117, DOI 10.3851/IMP1443; Coutsinos D, 2009, J VIROL, V83, P2029, DOI 10.1128/JVI.01349-08; D'Aquila RT, 2011, AIDS RES HUM RETROV, V27, P201, DOI 10.1089/aid.2010.0077; Descamps D, 2005, JAIDS-J ACQ IMM DEF, V38, P545, DOI 10.1097/01.qai.0000155201.51232.2e; Descamps D, 1997, J VIROL, V71, P8893, DOI 10.1128/JVI.71.11.8893-8898.1997; Deshpande A, 2007, AIDS RES HUM RETROV, V23, P335, DOI 10.1089/aid.2006.0183; Deshpande A, 2010, AIDS RES HUM RETROV, V26, P343, DOI 10.1089/aid.2009.0217; Doualla-Bell F, 2006, ANTIMICROB AGENTS CH, V50, P4182, DOI 10.1128/AAC.00714-06; Doualla-Bell F, 2006, ANTIMICROB AGENTS CH, V50, P2210, DOI 10.1128/AAC.01447-05; Doualla-Bell F, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-25; Dumans AT, 2004, J INFECT DIS, V189, P1232, DOI 10.1086/382483; Eshleman SH, 2006, JAIDS-J ACQ IMM DEF, V42, P518, DOI 10.1097/01.qai.0000221676.22069.b8; Fleury HJ, 2006, AIDS RES HUM RETROV, V22, P357, DOI 10.1089/aid.2006.22.357; Flys T, 2005, J INFECT DIS, V192, P24, DOI 10.1086/430742; Flys TS, 2006, JAIDS-J ACQ IMM DEF, V42, P610, DOI 10.1097/01.qai.0000221686.67810.20; Fransen S, 2009, J VIROL, V83, P11440, DOI 10.1128/JVI.01168-09; Fransen S, 2009, ANTIMICROB AGENTS CH, V53, P4522, DOI 10.1128/AAC.00651-09; Garrido C, 2010, AIDS REV, V12, P243; Gonzalez LMF, 2004, ANTIMICROB AGENTS CH, V48, P3552, DOI 10.1128/AAC.48.9.3552-3555.2004; Gottlieb GS, 2009, CLIN INFECT DIS, V48, P476, DOI 10.1086/596504; Grossman Z, 2004, ANTIMICROB AGENTS CH, V48, P2159, DOI 10.1128/AAC.48.6.2159-2165.2004; Grossman Z, 2004, AIDS, V18, P909, DOI 10.1097/00002030-200404090-00008; Gupta RK, 2005, AIDS, V19, P1916, DOI 10.1097/01.aids.0000189860.36688.e5; Harrigan PR, 2008, AIDS, V22, P2501, DOI 10.1097/QAD.0b013e328318f16c; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Holguin A, 2008, CURR HIV RES, V6, P327, DOI 10.2174/157016208785132455; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Hsu LY, 2005, JAIDS-J ACQ IMM DEF, V38, P5, DOI 10.1097/00126334-200501010-00002; Invernizzi CF, 2009, J INFECT DIS, V200, P1202, DOI 10.1086/605894; Johnson JA, 2005, J INFECT DIS, V192, P16, DOI 10.1086/430741; Johnston KM, 2010, AIDS, V24, P1929, DOI 10.1097/QAD.0b013e32833af85d; Buzon MJ, 2010, AIDS, V24, P17, DOI 10.1097/QAD.0b013e328331c81e; Kantor R, 2005, PLOS MED, V2, P325, DOI 10.1371/journal.pmed.0020112; Kantor Rami, 2005, MedGenMed, V7, P71, DOI 10.1186/1758-2652-7-1-71; Kantor R, 2006, CURR OPIN INFECT DIS, V19, P594, DOI 10.1097/QCO.0b013e3280109122; Kinomoto M, 2005, CLIN INFECT DIS, V41, P243, DOI 10.1086/431197; Lai MT, 2010, ANTIMICROB AGENTS CH, V54, P4812, DOI 10.1128/AAC.00829-10; Li JF, 2011, J INFECT DIS, V203, P798, DOI 10.1093/infdis/jiq126; Lisovsky I, 2010, ANTIMICROB AGENTS CH, V54, P2878, DOI 10.1128/AAC.01828-09; Locateli D, 2007, J MED VIROL, V79, P1455, DOI 10.1002/jmv.20955; Loemba H, 2002, ANTIMICROB AGENTS CH, V46, P2087, DOI 10.1128/AAC.46.7.2087-2094.2002; Maiga AI, 2009, ANTIVIR THER, V14, P123; Malet I, 2008, ANTIMICROB AGENTS CH, V52, P1351, DOI 10.1128/AAC.01228-07; Marconi VC, 2008, CLIN INFECT DIS, V46, P1589, DOI 10.1086/587109; Martinez-Cajas JL, 2008, AIDS REV, V10, P212; Miller MD, 2007, AIDS, V21, P265, DOI 10.1097/QAD.0b013e32801199ee; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Novitsky V, 2007, AIDS RES HUM RETROV, V23, P868, DOI 10.1089/aid.2006.0298; Ntemgwa ML, 2009, ANTIMICROB AGENTS CH, V53, P3611, DOI 10.1128/AAC.00154-09; Orrell C, 2009, ANTIVIR THER, V14, P523; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Phillips AN, 2011, AIDS, V25, P843, DOI 10.1097/QAD.0b013e328344037a; Pillay V, 2008, AIDS RES HUM RETROV, V24, P1449, DOI 10.1089/aid.2008.0180; Poveda E, 2004, AIDS RES HUM RETROV, V20, P347, DOI 10.1089/088922204322996590; Quercia R, 2009, J VIROL, V83, P10245, DOI 10.1128/JVI.00894-09; Rajesh L, 2009, AIDS RES HUM RETROV, V25, P1179, DOI 10.1089/aid.2009.0110; REWARI BB, 2010, J ACQUIR IMMUNE 1001; Rey D, 2009, J ANTIMICROB CHEMOTH, V63, P380, DOI 10.1093/jac/dkn471; Richard N, 2004, AIDS RES HUM RETROV, V20, P355, DOI 10.1089/088922204323048104; Ross L, 2009, AIDS RES HUM RETROV, V25, P665, DOI 10.1089/aid.2008.0302; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Shah M, 2011, AIDS, V25, P1093, DOI 10.1097/QAD.0b013e32834670b9; Soares EAJM, 2005, AIDS, V19, pS81, DOI 10.1097/01.aids.0000191497.00928.e4; Soares EAJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000730; Soares EAJM, 2003, JAIDS-J ACQ IMM DEF, V34, P520, DOI 10.1097/00126334-200312150-00012; Soares RO, 2010, J MOL GRAPH MODEL, V29, P137, DOI 10.1016/j.jmgm.2010.05.007; Sprinz E, 2009, AIDS RES HUM RETROV, V25, P861, DOI 10.1089/aid.2009.0012; Sukasema C, 2008, INT J ANTIMICROB AG, V31, P277, DOI 10.1016/j.ijantimicag.2007.10.029; Sylla M, 2008, ANTIVIR THER, V13, P141; Tebit DM, 2008, JAIDS-J ACQ IMM DEF, V49, P17, DOI 10.1097/QAI.0b013e318182d2bc; Tebit DM, 2011, LANCET INFECT DIS, V11, P45, DOI 10.1016/S1473-3099(10)70186-9; Thomas TK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001015; Toni TD, 2005, AIDS RES HUM RETROV, V21, P1031, DOI 10.1089/aid.2005.21.1031; Tuaillon E, 2004, JAIDS-J ACQ IMM DEF, V37, P1543, DOI 10.1097/00126334-200412150-00001; Turner D, 2009, J MED VIROL, V81, P1509, DOI 10.1002/jmv.21567; van Oosterhout JJG, 2009, TROP MED INT HEALTH, V14, P856, DOI 10.1111/j.1365-3156.2009.02309.x; VANMAARSEVEEN N, 2006, ANTIRETROVIRAL RESIS, P19; Varghese V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010992; Velazquez-Campoy A, 2002, BIOCHEMISTRY-US, V41, P8613, DOI 10.1021/bi020160i; von Wyl V, 2008, CLIN INFECT DIS, V46, P1299, DOI 10.1086/528863; Xu HT, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-14; Zeh C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000430; ZOLFO M, 2010, AIDS RES HUM RE 1123	101	155	161	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2011	365	7					637	646		10.1056/NEJMra1004180	http://dx.doi.org/10.1056/NEJMra1004180			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808ER	21848464				2022-12-01	WOS:000293960500011
J	McEwen, AS; Ojha, L; Dundas, CM; Mattson, SS; Byrne, S; Wray, JJ; Cull, SC; Murchie, SL; Thomas, N; Gulick, VC				McEwen, Alfred S.; Ojha, Lujendra; Dundas, Colin M.; Mattson, Sarah S.; Byrne, Shane; Wray, James J.; Cull, Selby C.; Murchie, Scott L.; Thomas, Nicolas; Gulick, Virginia C.			Seasonal Flows on Warm Martian Slopes	SCIENCE			English	Article							MARS; STABILITY; EVAPORATION; STREAKS; BRINES; WET	Water probably flowed across ancient Mars, but whether it ever exists as a liquid on the surface today remains debatable. Recurring slope lineae (RSL) are narrow (0.5 to 5 meters), relatively dark markings on steep (25 degrees to 40 degrees) slopes; repeat images from the Mars Reconnaissance Orbiter High Resolution Imaging Science Experiment show them to appear and incrementally grow during warm seasons and fade in cold seasons. They extend downslope from bedrock outcrops, often associated with small channels, and hundreds of them form in some rare locations. RSL appear and lengthen in the late southern spring and summer from 48 degrees S to 32 degrees S latitudes favoring equator-facing slopes, which are times and places with peak surface temperatures from similar to 250 to 300 kelvin. Liquid brines near the surface might explain this activity, but the exact mechanism and source of water are not understood.	[McEwen, Alfred S.; Ojha, Lujendra; Mattson, Sarah S.; Byrne, Shane] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Dundas, Colin M.] US Geol Survey, Flagstaff, AZ 86001 USA; [Wray, James J.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Cull, Selby C.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Murchie, Scott L.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Thomas, Nicolas] Univ Bern, Inst Phys, Bern, Switzerland; [Gulick, Virginia C.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Gulick, Virginia C.] SETI Inst, Moffett Field, CA 94035 USA	University of Arizona; United States Department of the Interior; United States Geological Survey; Cornell University; Washington University (WUSTL); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Bern; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	McEwen, AS (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.	mcewen@lpl.arizona.edu	Wray, James J/B-8457-2008; Ojha, Lujendra/B-2805-2013; Byrne, Shane/B-8104-2012; Murchie, Scott L/E-8030-2015; Thomas, Nicolas/G-4693-2015	Wray, James J/0000-0001-5559-2179; Murchie, Scott L/0000-0002-1616-8751; Thomas, Nicolas/0000-0002-0146-0071; Dundas, Colin/0000-0003-2343-7224	NASA	NASA(National Aeronautics & Space Administration (NASA))	This research was supported by NASA's MRO project; we thank them along with the reviewers. All original data reported in this paper are tabulated in the SOM and archived by NASA's Planetary Data System.	Altheide T, 2009, EARTH PLANET SC LETT, V282, P69, DOI 10.1016/j.epsl.2009.03.002; Baratoux D, 2006, ICARUS, V183, P30, DOI 10.1016/j.icarus.2006.01.023; BRASS GW, 1980, ICARUS, V42, P20, DOI 10.1016/0019-1035(80)90237-7; Christensen PR, 2004, SPACE SCI REV, V110, P85, DOI 10.1023/B:SPAC.0000021008.16305.94; CLARK BC, 1978, ICARUS, V34, P645, DOI 10.1016/0019-1035(78)90052-0; Cull SC, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045269; Diniega S, 2010, GEOLOGY, V38, P1047, DOI 10.1130/G31287.1; Dundas CM, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041351; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Goldspiel JM, 2011, ICARUS, V211, P238, DOI 10.1016/j.icarus.2010.10.008; Hansen CJ, 2011, SCIENCE, V331, P575, DOI 10.1126/science.1197636; Hecht MH, 2009, SCIENCE, V325, P64, DOI 10.1126/science.1172466; Kereszturi A, 2010, ICARUS, V207, P149, DOI 10.1016/j.icarus.2009.10.012; King C. M., 2010, LUNAR PLANET SCI, V41, P1542; Kossacki KJ, 2010, ICARUS, V210, P83, DOI 10.1016/j.icarus.2010.06.029; Kreslavsky MA, 2009, ICARUS, V201, P517, DOI 10.1016/j.icarus.2009.01.026; Malin MC, 2006, SCIENCE, V314, P1573, DOI 10.1126/science.1135156; McEwen AS, 2010, ICARUS, V205, P2, DOI 10.1016/j.icarus.2009.04.023; Mellon MT, 2004, ICARUS, V169, P324, DOI 10.1016/j.icarus.2003.10.022; Mohlmann D, 2011, ICARUS, V212, P123, DOI 10.1016/j.icarus.2010.11.025; Murchie S, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002682; Osterloo MM, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2010JE003613; Renno NO, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003362; Sears DWG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023443; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; Stoker CR, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003421; Ulrich R, 2010, ASTROBIOLOGY, V10, P643, DOI 10.1089/ast.2010.0472; Wray JJ, 2009, GEOLOGY, V37, P1043, DOI 10.1130/G30331A.1; Zhang H, 2006, APPL OPTICS, V45, P8753, DOI 10.1364/AO.45.008753; Zorzano MP, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040315	31	323	328	1	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2011	333	6043					740	743		10.1126/science.1204816	http://dx.doi.org/10.1126/science.1204816			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817049				2022-12-01	WOS:000293512100038
J	Park, KT; Wu, W; Battaile, KP; Lovell, S; Holyoak, T; Lutkenhaus, J				Park, Kyung-Tae; Wu, Wei; Battaile, Kevin P.; Lovell, Scott; Holyoak, Todd; Lutkenhaus, Joe			The Min Oscillator Uses MinD-Dependent Conformational Changes in MinE to Spatially Regulate Cytokinesis	CELL			English	Article							TOPOLOGICAL SPECIFICITY FACTOR; DIVISION SITE SELECTION; TO-POLE OSCILLATION; ESCHERICHIA-COLI; CELL-DIVISION; PROPER PLACEMENT; MEMBRANE INTERACTION; PATTERN-FORMATION; INHIBITOR MINC; DATA QUALITY	In E. coli, MinD recruits MinE to the membrane, leading to a coupled oscillation required for spatial regulation of the cytokinetic Z ring. How these proteins interact, however, is not clear because the MinD-binding regions of MinE are sequestered within a six-stranded beta sheet and masked by N-terminal helices. minE mutations that restore interaction between some MinD and MinE mutants were isolated. These mutations alter the MinE structure leading to release of the MinD-binding regions and the N-terminal helices that bind the membrane. Crystallization of MinD-MinE complexes revealed a four-stranded beta sheet MinE dimer with the released beta strands (MinD-binding regions) converted to alpha helices bound to MinD dimers. These results identify the MinD-dependent conformational changes in MinE that convert it from a latent to an active form and lead to a model of how MinE persists at the MinD-membrane surface.	[Park, Kyung-Tae; Wu, Wei; Lutkenhaus, Joe] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA; [Holyoak, Todd] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Battaile, Kevin P.] APS Argonne Natl Lab, Hauptman Woodward Med Res Inst, IMCA CAT, Sect 17, Argonne, IL 60439 USA; [Lovell, Scott] Univ Kansas, Struct Biol Ctr, Lawrence, KS 66047 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Hauptman Woodward Medical Research Institute; United States Department of Energy (DOE); Argonne National Laboratory; University of Kansas	Lutkenhaus, J (corresponding author), Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA.	jlutkenh@kumc.edu		Battaile, Kevin/0000-0003-0833-3259	National Institutes of Health [GM29764]; Industrial Macromolecular Crystallography Association; Hauptman-Woodward Medical Research Institute; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NIH, National Center for Research Resources [P20 RR-17708]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029764, R37GM029764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Industrial Macromolecular Crystallography Association; Hauptman-Woodward Medical Research Institute; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NIH, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant GM29764 from the National Institutes of Health to J.L. We thank members of the lab for discussion and Alex Dajkovic for reading of the manuscript. Use of the IMCA-CAT beamline 17-ID at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. Use of the KU COBRE Protein Structure Laboratory was supported by NIH Grant Number P20 RR-17708 from the National Center for Research Resources.	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Arjunan Satya Nanda Vel, 2010, Syst Synth Biol, V4, P35, DOI 10.1007/s11693-009-9047-2; Barilla D, 2007, P NATL ACAD SCI USA, V104, P1811, DOI 10.1073/pnas.0607216104; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fu XL, 2001, P NATL ACAD SCI USA, V98, P980, DOI 10.1073/pnas.031549298; Ghasriani H, 2010, P NATL ACAD SCI USA, V107, P18416, DOI 10.1073/pnas.1007141107; Hale CA, 2001, EMBO J, V20, P1563, DOI 10.1093/emboj/20.7.1563; Hsieh CW, 2010, MOL MICROBIOL, V75, P499, DOI 10.1111/j.1365-2958.2009.07006.x; Hu ZL, 2003, MOL MICROBIOL, V47, P345, DOI 10.1046/j.1365-2958.2003.03321.x; Hu ZL, 2003, J BACTERIOL, V185, P196, DOI 10.1128/JB.185.1.196-203.2003; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Ivanov V, 2010, P NATL ACAD SCI USA, V107, P8071, DOI 10.1073/pnas.0911036107; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Kang GB, 2010, MOL MICROBIOL, V76, P1222, DOI 10.1111/j.1365-2958.2010.07160.x; King GF, 2000, NAT STRUCT BIOL, V7, P1013, DOI 10.1038/80917; Kruse K, 2007, MOL MICROBIOL, V63, P1279, DOI 10.1111/j.1365-2958.2007.05607.x; Lackner LL, 2003, J BACTERIOL, V185, P735, DOI 10.1128/JB.185.3.735-749.2003; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Loose M, 2011, NAT STRUCT MOL BIOL, V18, P577, DOI 10.1038/nsmb.2037; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Ma LY, 2004, MOL MICROBIOL, V54, P99, DOI 10.1111/j.1365-2958.2004.04265.x; Ma LY, 2003, J BACTERIOL, V185, P4948, DOI 10.1128/JB.185.16.4948-4955.2003; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Meinhardt H, 2001, P NATL ACAD SCI USA, V98, P14202, DOI 10.1073/pnas.251216598; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; PICHOFF S, 1995, MOL MICROBIOL, V18, P321, DOI 10.1111/j.1365-2958.1995.mmi_18020321.x; Raskin DM, 1999, J BACTERIOL, V181, P6419, DOI 10.1128/JB.181.20.6419-6424.1999; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; Szeto TH, 2003, J BIOL CHEM, V278, P40050, DOI 10.1074/jbc.M306876200; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wu W, 2011, MOL MICROBIOL, V79, P1515, DOI 10.1111/j.1365-2958.2010.07536.x; Zhang Y, 1998, MOL MICROBIOL, V30, P265, DOI 10.1046/j.1365-2958.1998.01059.x; ZHAO CR, 1995, P NATL ACAD SCI USA, V92, P4313, DOI 10.1073/pnas.92.10.4313; Zhou HJ, 2005, J BACTERIOL, V187, P2846, DOI 10.1128/JB.187.8.2846-2857.2005	39	108	110	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 5	2011	146	3					396	407		10.1016/j.cell.2011.06.042	http://dx.doi.org/10.1016/j.cell.2011.06.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	803GT	21816275	Green Published, Bronze, Green Accepted			2022-12-01	WOS:000293570500014
J	Wang, L; Gural, A; Sun, XJ; Zhao, XY; Perna, F; Huang, G; Hatlen, MA; Vu, L; Liu, F; Xu, HM; Asai, T; Xu, H; Deblasio, T; Menendez, S; Voza, F; Jiang, YW; Cole, PA; Zhang, JS; Melnick, A; Roeder, RG; Nimer, SD				Wang, Lan; Gural, Alexander; Sun, Xiao-Jian; Zhao, Xinyang; Perna, Fabiana; Huang, Gang; Hatlen, Megan A.; Vu, Ly; Liu, Fan; Xu, Haiming; Asai, Takashi; Xu, Hao; Deblasio, Tony; Menendez, Silvia; Voza, Francesca; Jiang, Yanwen; Cole, Philip A.; Zhang, Jinsong; Melnick, Ari; Roeder, Robert G.; Nimer, Stephen D.			The Leukemogenicity of AML1-ETO Is Dependent on Site-Specific Lysine Acetylation	SCIENCE			English	Article							HEMATOPOIETIC STEM-CELLS; FUSION PROTEIN; MYELOID-LEUKEMIA; DNA-BINDING; SELF-RENEWAL; T(8/21); DOMAIN; DIFFERENTIATION; TRANSCRIPTION; INHIBITOR	The chromosomal translocations found in acute myelogenous leukemia (AML) generate oncogenic fusion transcription factors with aberrant transcriptional regulatory properties. Although therapeutic targeting of most leukemia fusion proteins remains elusive, the posttranslational modifications that control their function could be targetable. We found that AML1-ETO, the fusion protein generated by the t(8;21) translocation, is acetylated by the transcriptional coactivator p300 in leukemia cells isolated from t(8;21) AML patients, and that this acetylation is essential for its self-renewal-promoting effects in human cord blood CD34(+) cells and its leukemogenicity in mouse models. Inhibition of p300 abrogates the acetylation of AML1-ETO and impairs its ability to promote leukemic transformation. Thus, lysine acetyltransferases represent a potential therapeutic target in AML.	[Wang, Lan; Gural, Alexander; Zhao, Xinyang; Perna, Fabiana; Huang, Gang; Hatlen, Megan A.; Vu, Ly; Liu, Fan; Xu, Haiming; Asai, Takashi; Xu, Hao; Deblasio, Tony; Menendez, Silvia; Voza, Francesca; Nimer, Stephen D.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Mol Pharmacol & Chem Program, New York, NY 10065 USA; [Sun, Xiao-Jian; Roeder, Robert G.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA; [Jiang, Yanwen; Melnick, Ari] Weill Cornell Med Coll, Dept Med, Div Hematol Oncol, New York, NY 10065 USA; [Cole, Philip A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Zhang, Jinsong] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45267 USA	Memorial Sloan Kettering Cancer Center; Rockefeller University; Cornell University; Johns Hopkins University; University System of Ohio; University of Cincinnati	Nimer, SD (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Mol Pharmacol & Chem Program, New York, NY 10065 USA.	nimers@mskcc.org	Xu, Haiming/A-2238-2014; Sun, Xiao-Jian/D-1560-2011; Melnick, Ari/AAA-5763-2020	Sun, Xiao-Jian/0000-0001-8826-4614; Zhang, Jinsong/0000-0002-8798-7316; Perna, Fabiana/0000-0002-3744-8672; Vu, Ly/0000-0002-1682-7702; Zhao, Xinyang/0000-0001-6677-7072	Leukemia Lymphoma Society; Empire State Stem Cell Scholar award; Clinical Scholars award; Starr Foundation; NIH [GM62437]; Gabrielle's Angel Foundation; Acylin Therapeutics Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062437, R37GM062437] Funding Source: NIH RePORTER	Leukemia Lymphoma Society(Leukemia and Lymphoma Society); Empire State Stem Cell Scholar award; Clinical Scholars award; Starr Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabrielle's Angel Foundation; Acylin Therapeutics Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Nimer lab for thoughtful suggestions and comments; D. J. Meyers for the HAT inhibitors; E. Chuang for help with manuscript preparation; E. Dolezal for help with patient samples; K. Debeer for help with graphic design; M. E. Figueroa for help with data analysis; S. Pereira Mendez for technical assistance; and the MSKCC Animal Core Facility, Flow Cytometry Core Facility, and Anti-tumor Assessment Core Facility for their help. P.A.C. is a cofounder, paid consultant, and shareholder of Acylin Therapeutics Inc., which is developing p300 HAT inhibitors. P.A.C. and Johns Hopkins University hold a patent on HAT inhibitors that has been licensed to Acylin Therapeutics Inc. Supported by a Leukemia Lymphoma Society SCOR grant (S.D.N., R.G.R.), a Leukemia Lymphoma Society fellowship (L.W.), an Empire State Stem Cell Scholar award (L.W.), a Clinical Scholars award (F.L.), a Starr Foundation grant (X.-J.S., R.G.R., S.D.N.), NIH grant GM62437 (P.A.C.), and the Gabrielle's Angel Foundation. The microarray data have been submitted to the National Center for Biotechnology Information Gene Expression Omnibus (GEO) GSE28317.	Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006; BREEMS DA, 1994, LEUKEMIA, V8, P1095; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Jankovic V, 2007, P NATL ACAD SCI USA, V104, P1260, DOI 10.1073/pnas.0607894104; Kitabayashi I, 1998, EMBO J, V17, P2994, DOI 10.1093/emboj/17.11.2994; Klampfer L, 1996, P NATL ACAD SCI USA, V93, P14059, DOI 10.1073/pnas.93.24.14059; Kwok C, 2009, P NATL ACAD SCI USA, V106, P2853, DOI 10.1073/pnas.0810558106; Liu YZ, 2006, CANCER CELL, V9, P249, DOI 10.1016/j.ccr.2006.03.012; Mannari D, 2010, LEUKEMIA, V24, P891, DOI 10.1038/leu.2009.288; Minucci S, 2001, ONCOGENE, V20, P3110, DOI 10.1038/sj.onc.1204336; Mulloy JC, 2002, BLOOD, V99, P15, DOI 10.1182/blood.V99.1.15; Nimer SD, 2004, ONCOGENE, V23, P4249, DOI 10.1038/sj.onc.1207673; Okumura AJ, 2008, BLOOD, V112, P1392, DOI 10.1182/blood-2007-11-124735; Pabst T, 2001, NAT MED, V7, P444, DOI 10.1038/86515; Park S, 2009, BLOOD, V113, P3558, DOI 10.1182/blood-2008-06-161307; Rhoades KL, 1996, P NATL ACAD SCI USA, V93, P11895, DOI 10.1073/pnas.93.21.11895; Vangala RK, 2003, BLOOD, V101, P270, DOI 10.1182/blood-2002-04-1288; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Wang L, 2007, CELL DEATH DIFFER, V14, P306, DOI 10.1038/sj.cdd.4401996; Wang L, 2009, BLOOD CELL MOL DIS, V43, P30, DOI 10.1016/j.bcmd.2009.03.005; Wildonger J, 2005, DEVELOPMENT, V132, P2263, DOI 10.1242/dev.01824; Wilson A, 2009, CURR OPIN GENET DEV, V19, P461, DOI 10.1016/j.gde.2009.08.005; Yamaguchi Y, 2004, J BIOL CHEM, V279, P15630, DOI 10.1074/jbc.M400355200; Yan M, 2006, NAT MED, V12, P945, DOI 10.1038/nm1443; Yan M, 2009, BLOOD, V113, P883, DOI 10.1182/blood-2008-04-153742; Zhang JS, 2004, SCIENCE, V305, P1286, DOI 10.1126/science.1097937; Zhao X, 2008, GENE DEV, V22, P640, DOI 10.1101/gad.1632608; Zheng YJ, 2005, J AM CHEM SOC, V127, P17182, DOI 10.1021/ja0558544	29	152	159	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2011	333	6043					765	769		10.1126/science.1201662	http://dx.doi.org/10.1126/science.1201662			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21764752	Green Accepted			2022-12-01	WOS:000293512100046
J	Tan, YH; Luo, ZQ				Tan, Yunhao; Luo, Zhao-Qing			Legionella pneumophila SidD is a deAMPylase that modifies Rab1	NATURE			English	Article							EFFECTOR PROTEIN DRRA; AMPYLATION; SYSTEM; PHOSPHATASE; BINDING; FAMILY	Legionella pneumophila actively modulates host vesicle trafficking pathways to facilitate its intracellular replication with effectors translocated by the Dot/Icm type IV secretion system (T4SS)(1). The SidM/DrrA protein functions by locking the small GTPase Rab1 into an active form by its guanine nucleotide exchange factor (GEF) and AMPylation activity(2-4). Here we demonstrate that the L. pneumophila protein SidD preferably deAMPylates Rab1. We found that the deAMPylation activity of SidD could suppress the toxicity of SidM to yeast and is required to release Rab1 from bacterial phagosomes efficiently. A molecular mechanism for the temporal control of Rab1 activity in different phases of L. pneumophila infection is thus established. These observations indicate that AMPylation-mediated signal transduction is a reversible process regulated by specific enzymes.	[Tan, Yunhao; Luo, Zhao-Qing] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Luo, ZQ (corresponding author), Purdue Univ, Dept Biol Sci, 915 W State St, W Lafayette, IN 47907 USA.	luoz@purdue.edu	YAN, JING/J-7233-2015; Tan, Yunhao/K-7442-2016	Tan, Yunhao/0000-0002-5516-4980; Luo, Zhao-Qing/0000-0001-8890-6621	NIH-NIAID [R01AI069344, K02AI085403, R21AI092043]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI092043, K02AI085403, R01AI069344] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Isberg for the antibody against SidM and A. Aronson and A. Tao for critical reading of the manuscript and for discussions. This work was supported by NIH-NIAID grants R01AI069344, K02AI085403 and R21AI092043 (Z.-Q.L).	Belyi Y, 2008, J BACTERIOL, V190, P3026, DOI 10.1128/JB.01798-07; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Brombacher E, 2009, J BIOL CHEM, V284, P4846, DOI 10.1074/jbc.M807505200; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Conover GM, 2003, MOL MICROBIOL, V48, P305, DOI 10.1046/j.1365-2958.2003.03400.x; Ensminger AW, 2009, CURR OPIN MICROBIOL, V12, P67, DOI 10.1016/j.mib.2008.12.004; Fan HY, 1996, GENETICS, V142, P749; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818; Kubori T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001216; Liu YC, 2008, P NATL ACAD SCI USA, V105, P9385, DOI 10.1073/pnas.0801055105; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Rantanen MK, 2007, FEBS J, V274, P3128, DOI 10.1111/j.1742-4658.2007.05845.x; Roy CR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.262pe14; Schlicker C, 2008, J MOL BIOL, V376, P570, DOI 10.1016/j.jmb.2007.11.097; Seabra MC, 2004, CURR OPIN CELL BIOL, V16, P451, DOI 10.1016/j.ceb.2004.06.014; Shen XH, 2009, CELL MICROBIOL, V11, P911, DOI 10.1111/j.1462-5822.2009.01301.x; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Woolery AR, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00113; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Xu L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000822; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638	29	164	169	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2011	475	7357					506	U102		10.1038/nature10307	http://dx.doi.org/10.1038/nature10307			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21734656	Green Accepted			2022-12-01	WOS:000293167900042
J	Heaphy, CM; de Wilde, RF; Jiao, YC; Klein, AP; Edil, BH; Shi, CJ; Bettegowda, C; Rodriguez, FJ; Eberhart, CG; Hebbar, S; Offerhaus, GJ; McLendon, R; Rasheed, BA; He, YP; Yan, H; Bigner, DD; Oba-Shinjo, SM; Marie, SKN; Riggins, GJ; Kinzler, KW; Vogelstein, B; Hruban, RH; Maitra, A; Papadopoulos, N; Meeker, AK				Heaphy, Christopher M.; de Wilde, Roeland F.; Jiao, Yuchen; Klein, Alison P.; Edil, Barish H.; Shi, Chanjuan; Bettegowda, Chetan; Rodriguez, Fausto J.; Eberhart, Charles G.; Hebbar, Sachidanand; Offerhaus, G. Johan; McLendon, Roger; Rasheed, B. Ahmed; He, Yiping; Yan, Hai; Bigner, Darell D.; Oba-Shinjo, Sueli Mieko; Marie, Suely Kazue Nagahashi; Riggins, Gregory J.; Kinzler, Kenneth W.; Vogelstein, Bert; Hruban, Ralph H.; Maitra, Anirban; Papadopoulos, Nickolas; Meeker, Alan K.			Altered Telomeres in Tumors with ATRX and DAXX Mutations	SCIENCE			English	Article							CELLS; H3.3		[Heaphy, Christopher M.; de Wilde, Roeland F.; Klein, Alison P.; Rodriguez, Fausto J.; Eberhart, Charles G.; Hebbar, Sachidanand; Hruban, Ralph H.; Maitra, Anirban; Meeker, Alan K.] Johns Hopkins Med Inst, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine		npapado1@jhmi.edu; ameeker1@jhmi.edu	jiao, yuchen/H-6313-2011; Papadopoulos, Nickolas/K-7272-2012; Marie, Suely Kazue Nagahashi/D-1870-2012; Oba-Shinjo, Sueli M./C-4017-2012	Marie, Suely Kazue Nagahashi/0000-0003-4419-7928; Oba-Shinjo, Sueli M./0000-0002-1650-5973; Heaphy, Christopher/0000-0003-4264-1810; Jiao, Yuchen/0000-0001-7917-8810	Caring for Carcinoid Foundation; NATIONAL CANCER INSTITUTE [R37CA011898, R01CA113669, R01CA121113, P50CA062924, R01CA140316, P01CA134292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055089, P50NS020023] Funding Source: NIH RePORTER	Caring for Carcinoid Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	N.P., K.W.K., and B.V. are Founding Scientific Advisors of Personal Genome Diagnostics, Incorporated, a company focused on the identification of genetic alterations in human cancer for diagnostic and therapeutic purposes. N.P., K. W. K., and B. V. are members of the Scientific Advisory Board of Inostics, a company that is developing technologies for the molecular diagnosis of cancer. N.P., B. V., and K. W. K. also own stock in Inostics. The authors are entitled to a share of the royalties received by the university on sales of products related to genes described in this manuscript. The terms of these arrangements are being managed by the university in accordance with their conflict-of-interest policies. Johns Hopkins University has filed a patent application relating to the use of DAXX and ATRX mutations as diagnostic markers. Financial support came from the Caring for Carcinoid Foundation.	Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Elsaesser SJ, 2010, COLD SH Q B, V75, P27, DOI 10.1101/sqb.2010.75.008; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; Wong LH, 2009, GENOME RES, V19, P404, DOI 10.1101/gr.084947.108; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Yeager TR, 1999, CANCER RES, V59, P4175	11	705	728	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2011	333	6041					425	425		10.1126/science.1207313	http://dx.doi.org/10.1126/science.1207313			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21719641	Green Accepted			2022-12-01	WOS:000292959600036
J	Hessa, T; Sharma, A; Mariappan, M; Eshleman, HD; Gutierrez, E; Hegde, RS				Hessa, Tara; Sharma, Ajay; Mariappan, Malaiyalam; Eshleman, Heather D.; Gutierrez, Erik; Hegde, Ramanujan S.			Protein targeting and degradation are coupled for elimination of mislocalized proteins	NATURE			English	Article							SIGNAL RECOGNITION PARTICLE; CYTOSOLIC PRION PROTEIN; QUALITY-CONTROL PATHWAY; ENDOPLASMIC-RETICULUM; TRANSLOCATION CHANNEL; MEMBRANE; NEURODEGENERATION; ER; CONTRIBUTES; SEQUENCE	A substantial proportion of the genome encodes membrane proteins that are delivered to the endoplasmic reticulum by dedicated targeting pathways(1). Membrane proteins that fail targeting must be rapidly degraded to avoid aggregation and disruption of cytosolic protein homeostasis(2,3). The mechanisms of mislocalized protein (MLP) degradation are unknown. Here we reconstitute MLP degradation in vitro to identify factors involved in this pathway. We find that nascent membrane proteins tethered to ribosomes are not substrates for ubiquitination unless they are released into the cytosol. Their inappropriate release results in capture by the Bag6 complex, a recently identified ribosome-associating chaperone(4). Bag6-complex-mediated capture depends on the presence of unprocessed or non-inserted hydrophobic domains that distinguish MLPs from potential cytosolic proteins. A subset of these Bag6 complex 'clients' are transferred to TRC40 for insertion into the membrane, whereas the remainder are rapidly ubiquitinated. Depletion of the Bag6 complex selectively impairs the efficient ubiquitination of MLPs. Thus, by its presence on ribosomes that are synthesizing nascent membrane proteins, the Bag6 complex links targeting and ubiquitination pathways. We propose that such coupling allows the fast tracking of MLPs for degradation without futile engagement of the cytosolic folding machinery.	[Hessa, Tara; Sharma, Ajay; Mariappan, Malaiyalam; Eshleman, Heather D.; Gutierrez, Erik; Hegde, Ramanujan S.] NICHHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Gutierrez, Erik] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University	Hegde, RS (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	hegde.science@gmail.com	mariappan, malaiyalam/K-9024-2012	Hegde, Ramanujan/0000-0001-8338-852X	National Institutes of Health; Wenner-Gren Foundations; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD008861, ZIAHD008860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wenner-Gren Foundations; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We are grateful to E. Whiteman and X. Li for carrying out the initial experiments for parts of this project, S. W. Kang, S. Shao, and Z. Zhang for discussions, P. Sengupta, J. Magadan, and C. Ott for constructs, J. Taunton and J. Garrison for cotransin, S. Shao for comments on the manuscript, and Y. Ye for discussions and sharing results before publication. This work was supported by the Intramural Research Program of the National Institutes of Health (R. S. H.) and a postdoctoral fellowship from The Wenner-Gren Foundations (T.H.).	Ashok A, 2008, MOL BIOL CELL, V19, P3463, DOI 10.1091/mbc.E08-01-0087; Berndt U, 2009, P NATL ACAD SCI USA, V106, P1398, DOI 10.1073/pnas.0808584106; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Chakrabarti O, 2009, CELL, V137, P1136, DOI 10.1016/j.cell.2009.03.042; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Emerman AB, 2010, MOL BIOL CELL, V21, P4325, DOI 10.1091/mbc.E10-09-0742; Ernst R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000605; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Garrison JL, 2005, NATURE, V436, P285, DOI 10.1038/nature03821; GILMORE R, 1982, J CELL BIOL, V95, P463, DOI 10.1083/jcb.95.2.463; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Kim SJ, 2002, MOL BIOL CELL, V13, P3775, DOI 10.1091/mbc.E02-05-0293; Kim SJ, 2002, DEV CELL, V2, P207, DOI 10.1016/S1534-5807(01)00120-4; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; Lehner B, 2004, GENOMICS, V83, P153, DOI 10.1016/S0888-7543(03)00235-0; Levine CG, 2005, MOL BIOL CELL, V16, P279, DOI 10.1091/mbc.e04-06-0508; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; Magadan JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000869; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Minami R, 2010, J CELL BIOL, V190, P637, DOI 10.1083/jcb.200908092; Nillegoda NB, 2010, MOL BIOL CELL, V21, P2102, DOI 10.1091/mbc.E10-02-0098; Orsi A, 2006, J BIOL CHEM, V281, P30431, DOI 10.1074/jbc.M605320200; Park SH, 2007, MOL BIOL CELL, V18, P153, DOI 10.1091/mbc.E06-04-0338; Rane NS, 2008, DEV CELL, V15, P359, DOI 10.1016/j.devcel.2008.06.015; Rane NS, 2010, J CELL BIOL, V188, P515, DOI 10.1083/jcb.200911115; Rane NS, 2004, EMBO J, V23, P4550, DOI 10.1038/sj.emboj.7600462; Sharma A, 2010, METHODS MOL BIOL, V619, P339, DOI 10.1007/978-1-60327-412-8_20; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Wu MM, 2000, CHEM BIOL, V7, P197, DOI 10.1016/S1074-5521(00)00088-0	38	175	176	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2011	475	7356					394	U154		10.1038/nature10181	http://dx.doi.org/10.1038/nature10181			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21743475	Green Accepted			2022-12-01	WOS:000292911200046
J	Gesquiere, LR; Learn, NH; Simao, MCM; Onyango, PO; Alberts, SC; Altmann, J				Gesquiere, Laurence R.; Learn, Niki H.; Simao, M. Carolina M.; Onyango, Patrick O.; Alberts, Susan C.; Altmann, Jeanne			Life at the Top: Rank and Stress in Wild Male Baboons	SCIENCE			English	Article							REPRODUCTIVE SUCCESS; DOMINANCE RANK; CORTISOL; INSTABILITY; HYPOTHESIS; PATTERNS; BEHAVIOR	In social hierarchies, dominant individuals experience reproductive and health benefits, but the costs of social dominance remain a topic of debate. Prevailing hypotheses predict that higher-ranking males experience higher testosterone and glucocorticoid (stress hormone) levels than lower-ranking males when hierarchies are unstable but not otherwise. In this long-term study of rank-related stress in a natural population of savannah baboons (Papio cynocephalus), high-ranking males had higher testosterone and lower glucocorticoid levels than other males, regardless of hierarchy stability. The singular exception was for the highest-ranking (alpha) males, who exhibited both high testosterone and high glucocorticoid levels. In particular, alpha males exhibited much higher stress hormone levels than second-ranking (beta) males, suggesting that being at the very top may be more costly than previously thought.	[Gesquiere, Laurence R.; Learn, Niki H.; Simao, M. Carolina M.; Onyango, Patrick O.; Altmann, Jeanne] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Alberts, Susan C.] Duke Univ, Dept Biol, Durham, NC USA; [Alberts, Susan C.; Altmann, Jeanne] Natl Museums Kenya, Inst Primate Res, Nairobi, Kenya; [Altmann, Jeanne] Univ Nairobi, Dept Vet Anat & Physiol, Nairobi 00100, Kenya	Princeton University; Duke University; University of Nairobi	Gesquiere, LR (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	lgesquie@princeton.edu	Onyango, Patrick/AGG-7442-2022		NSF [IOB-0322781, BCS-0323596]; NIH [R03 MH65294]; National Institute on Aging [P30 AG024361, P01 AG031719, R01-AG034513]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH065294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034513, P30AG024361, P01AG031719] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by NSF (grants IOB-0322781 and BCS-0323596), NIH (grant R03 MH65294), and National Institute on Aging (grants P30 AG024361, P01 AG031719, and R01-AG034513). Thanks to the Kenya Wildlife Services; Amboseli-Longido pastoralist communities; the Amboseli research team, particularly R. S. Mututua, S. Sayialel, J. K. Warutere, T. Wango, and V. K. Oudu; S. Mukherjee, G. Rodriguez, and J. Tung for advice on analysis; and J. Beehner, N. Goldman, C. Markham, J. Silk, and B. Singer for comments on previous drafts of this paper. All protocols were noninvasive and were approved in Kenya (Ministry of Education, Science, and Technology document 13/001/C351 Vol. II) and the United States (Princeton University Institutional Animal Care and Use Committee document 1689). Data are available in the Dryad database (http://dx.doi.org/10.5061/dryad.j850j).	Abbott DH, 2003, HORM BEHAV, V43, P67, DOI 10.1016/S0018-506X(02)00037-5; Alberts SC, 2003, ANIM BEHAV, V65, P821, DOI 10.1006/anbe.2003.2106; Alberts SC, 1996, ANIM BEHAV, V51, P1269, DOI 10.1006/anbe.1996.0131; Alberts SC, 2006, ANIM BEHAV, V72, P1177, DOI 10.1016/j.anbehav.2006.05.001; Bercovitch FB, 2002, ANNU REV ANTHROPOL, V31, P45, DOI 10.1146/annurev.anthro.31.040202.105553; Bergman TJ, 2005, ANIM BEHAV, V70, P703, DOI 10.1016/j.anbehav.2004.12.017; Cheney D. L., 2006, SPRINGER SERIES DEV, P147; Cheney DL, 2009, ADV STUD BEHAV, V39, P1, DOI 10.1016/S0065-3454(09)39001-4; Clutton-Brock T.H., 1988, P1; COWLISHAW G, 1991, ANIM BEHAV, V41, P1045, DOI 10.1016/S0003-3472(05)80642-6; Creel S, 2001, TRENDS ECOL EVOL, V16, P491, DOI 10.1016/S0169-5347(01)02227-3; Dixson A.F., 1998, PRIMATE SEXUALITY CO; ELLIS L, 1995, ETHOL SOCIOBIOL, V16, P257, DOI 10.1016/0162-3095(95)00050-U; Gesquiere LR, 2011, AM J PHYS ANTHROPOL, V144, P169, DOI 10.1002/ajpa.21374; HAUSFATER G, 1976, NATURE, V262, P688, DOI 10.1038/262688a0; Johnson S. E., 2006, SPRINGER SERIES DEV, P177; Rodriguez-Llanes JM, 2009, ANIM BEHAV, V78, P643, DOI 10.1016/j.anbehav.2009.06.012; MICHAEL RP, 1993, AM J PRIMATOL, V30, P213, DOI 10.1002/ajp.1350300306; Mills SC, 2009, AM NAT, V173, P475, DOI 10.1086/597222; Muehlenbein MP, 2006, AM J PHYS ANTHROPOL, V130, P546, DOI 10.1002/ajpa.20391; Muller MN, 2004, BEHAV ECOL SOCIOBIOL, V55, P332, DOI 10.1007/s00265-003-0713-1; Nelson R. J., 2005, INTRO BEHAV ENDOCRIN, P3; Pusey A, 1997, SCIENCE, V277, P828, DOI 10.1126/science.277.5327.828; RASMUSSEN KLR, 1985, BEHAV ECOL SOCIOBIOL, V17, P161; Roberts ML, 2004, ANIM BEHAV, V68, P227, DOI 10.1016/j.anbehav.2004.05.001; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; SAPOLSKY RM, 1983, AM J PRIMATOL, V5, P365, DOI 10.1002/ajp.1350050406; SAPOLSKY RM, 1992, PSYCHONEUROENDOCRINO, V17, P701, DOI 10.1016/0306-4530(92)90029-7; Setchell JM, 2010, HORM BEHAV, V58, P720, DOI 10.1016/j.yhbeh.2010.07.004; Wingfield JC, 2003, J NEUROENDOCRINOL, V15, P711, DOI 10.1046/j.1365-2826.2003.01033.x; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134	31	207	209	4	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2011	333	6040					357	360		10.1126/science.1207120	http://dx.doi.org/10.1126/science.1207120			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21764751	Green Accepted			2022-12-01	WOS:000292732000047
J	Herbert, MR				Herbert, Martha R.			SHANK3, the Synapse, and Autism	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Herbert, Martha R.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Herbert, Martha R.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Herbert, MR (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.							Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Gauthier J, 2010, P NATL ACAD SCI USA, V107, P7863, DOI 10.1073/pnas.0906232107; Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001; Huett A, 2009, EXP CELL RES, V315, P2001, DOI 10.1016/j.yexcr.2009.04.003; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965	5	37	38	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2011	365	2					173	175		10.1056/NEJMcibr1104261	http://dx.doi.org/10.1056/NEJMcibr1104261			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791SP	21751912				2022-12-01	WOS:000292685500017
J	Stead, W				Stead, Wendy			The Gift of Perspective	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Stead, Wendy] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care,Div Infect Dis, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Stead, W (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care,Div Infect Dis, Boston, MA 02215 USA.	wstead@bidmc.harvard.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2011	306	2					136	136		10.1001/jama.2011.914	http://dx.doi.org/10.1001/jama.2011.914			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791CO	21750284				2022-12-01	WOS:000292639400001
J	Heianza, Y; Hara, S; Arase, Y; Saito, K; Fujiwara, K; Tsuji, H; Kodama, S; Hsieh, SD; Mori, Y; Shimano, H; Yamada, N; Kosaka, K; Sone, H				Heianza, Yoriko; Hara, Shigeko; Arase, Yasuji; Saito, Kazumi; Fujiwara, Kazuya; Tsuji, Hiroshi; Kodama, Satoru; Hsieh, Shiun Dong; Mori, Yasumichi; Shimano, Hitoshi; Yamada, Nobuhiro; Kosaka, Kinori; Sone, Hirohito			HbA(1c) 5.7-6.4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study	LANCET			English	Article							GLYCATED HEMOGLOBIN; CARDIOVASCULAR RISK; INSULIN SENSITIVITY; CUT-POINTS; A1C; IMPACT; PREVALENCE; TOLERANCE; SECRETION; PEOPLE	Background The clinical relevance of the diagnostic criteria for prediabetes to prediction of progression to diabetes has been little studied. We aimed to compare the prevalence of prediabetes when assessed by the new glycated haemoglobin A(1c) (HbA(1c)) 5.7-6.4% criterion or by impaired fasting glucose, and assessed differences in progression rate to diabetes between these two criteria for prediabetes in a Japanese population. Methods Our longitudinal cohort study included 4670 men and 1571 women aged 24-82 years without diabetes at baseline (diabetes was defined as fasting plasma glucose >= 7.0 mmol/L, self-reported clinician-diagnosed diabetes, or HbA(1c) >= 6.5%) who attended Toranomon Hospital (Tokyo, Japan) for a routine health check between 1997 and 2003. Participants with a baseline diagnosis of prediabetes according to impaired fasting glucose (fasting plasma glucose 5.6-6.9 mmol/L) or HbA(1c) 5.7-6.4%, or both, were divided into four groups on the basis of baseline diagnosis of prediabetes. Rate of progression to diabetes was assessed annually. Findings Mean follow-up was 4.7 (SD 0.7) years. 412 (7%) of 6241 participants were diagnosed with prediabetes on the basis of the HbA(1c) 5.7-6.4% criterion. Screening by HbA(1c) alone missed 1270 (61%) of the 2092 prediabetic individuals diagnosed by a combination of impaired fasting glucose and HbA(1c) 5.7-6.4%. Overall cumulative probability of progression to diabetes did not differ significantly between participants with prediabetes discordantly diagnosed by either HbA(1c) or impaired fasting glucose alone (incidence was 7% for HbA(1c) alone [n=412 individuals and 30 incident cases] and 9% for impaired fasting glucose alone [n=1270,108 cases]; log-rank test, p=0.3317). Multivariate-adjusted hazard ratios for incident diabetes were 6.16 (95% CI 4.33-8.77) for those diagnosed with prediabetes by impaired fasting glucose alone and 6.00 (3.76-9.56) for diagnosis by HbA(1c) alone, and were substantially increased to 31.9 (22.6-45.0) for diagnosis by both impaired fasting glucose and HbA(1c) compared with normoglycaemic individuals. Interpretation Diagnosis of prediabetes by both the new HbA(1c) criterion and impaired fasting glucose identified individuals with an increased risk of progression to diabetes. Although the new HbA(1c) criterion identified fewer individuals at high risk than did impaired fasting glucose, the predictive value for progression to diabetes assessed by HbA(1c) 5.7-6.4% was similar to that assessed by impaired fasting glucose alone. The two tests used together could efficiently target people who are most likely to develop diabetes and allow for early intervention.	[Heianza, Yoriko; Hara, Shigeko; Arase, Yasuji; Saito, Kazumi; Tsuji, Hiroshi; Kodama, Satoru; Hsieh, Shiun Dong; Kosaka, Kinori; Sone, Hirohito] Toranomon Gen Hosp, Hlth Management Ctr, Tokyo 1058470, Japan; [Heianza, Yoriko; Saito, Kazumi; Fujiwara, Kazuya; Kodama, Satoru; Shimano, Hitoshi; Yamada, Nobuhiro; Sone, Hirohito] Univ Tsukuba, Inst Clin Med, Dept Internal Med, Ibaraki, Japan; [Hara, Shigeko; Arase, Yasuji; Tsuji, Hiroshi; Hsieh, Shiun Dong; Mori, Yasumichi; Kosaka, Kinori] Toranomon Gen Hosp, Okinaka Mem Inst Med Res, Tokyo 1058470, Japan	Toranomon Hospital; University of Tsukuba; Toranomon Hospital	Sone, H (corresponding author), Toranomon Gen Hosp, Hlth Management Ctr, Tokyo 1058470, Japan.	hsone@md.tsukuba.ac.jp	Shimano, Hitoshi/AAI-5648-2020; Heianza, Yoriko/M-5716-2017; Shimano, Hitoshi/V-1761-2019; Sone, Hirohito/ABC-9346-2021	Heianza, Yoriko/0000-0002-0957-9309; Shimano, Hitoshi/0000-0002-5562-5572; Sone, Hirohito/0000-0003-1263-2817	Japan Society for the Promotion of Science; Ministry of Health Labor and Welfare, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	Japan Society for the Promotion of Science; Ministry of Health Labor and Welfare, Japan.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Cederberg H, 2010, DIABETES CARE, V33, P2077, DOI 10.2337/dc10-0262; Chamnan P, 2011, DIABETES CARE, V34, P950, DOI 10.2337/dc09-2326; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Christensen DL, 2010, DIABETES CARE, V33, P580, DOI 10.2337/dc09-1843; Droumaguet C, 2006, DIABETES CARE, V29, P1619, DOI 10.2337/dc05-2525; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Harano T, 1999, Rinsho Byori, V47, P215; Heianza Y, 2011, DIABETOLOGIA, V54, P762, DOI 10.1007/s00125-010-2029-9; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lorenzo C, 2010, DIABETES CARE, V33, P2104, DOI 10.2337/dc10-0679; Mann DM, 2010, DIABETES CARE, V33, P2190, DOI 10.2337/dc10-0752; Mohan V, 2010, DIABETES CARE, V33, P515, DOI 10.2337/dc09-1694; Mostafa SA, 2010, DIABETES RES CLIN PR, V90, P100, DOI 10.1016/j.diabres.2010.06.008; Mukai N, 2009, DIABETES CARE, V32, P2288, DOI 10.2337/dc09-0896; Nakagami T, 2010, DIABETES RES CLIN PR, V87, P126, DOI 10.1016/j.diabres.2009.11.001; *NAT DIAB INF CLEA, SICKL CELL TRAIT OTH; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Nichols GA, 2007, DIABETES CARE, V30, P228, DOI 10.2337/dc06-1392; Olson DE, 2010, DIABETES CARE, V33, P2184, DOI 10.2337/dc10-0433; Seino Y., 2010, Journal of the Japan Diabetes Society, V53, P450, DOI 10.1111/j.2040-1124.2010.00074.x; Selvin E, 2011, DIABETES CARE, V34, P84, DOI 10.2337/dc10-1235; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; van 't Riet E, 2010, DIABETES CARE, V33, P61, DOI 10.2337/dc09-0677; Waki K, 2005, DIABETIC MED, V22, P323, DOI 10.1111/j.1464-5491.2004.01403.x; Wang WY, 2011, DIABETES CARE, V34, P363, DOI 10.2337/dc10-1680; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang XP, 2010, DIABETES CARE, V33, P1665, DOI 10.2337/dc09-1939	30	167	171	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2011	378	9786					147	155		10.1016/S0140-6736(11)60472-8	http://dx.doi.org/10.1016/S0140-6736(11)60472-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	795CJ	21705064				2022-12-01	WOS:000292948800031
J	Viviani, D; Charlet, A; van den Burg, E; Robinet, C; Hurni, N; Abatis, M; Magara, F; Stoop, R				Viviani, Daniele; Charlet, Alexandre; van den Burg, Erwin; Robinet, Camille; Hurni, Nicolas; Abatis, Marios; Magara, Fulvio; Stoop, Ron			Oxytocin Selectively Gates Fear Responses Through Distinct Outputs from the Central Amygdala	SCIENCE			English	Article							RAT CENTRAL NUCLEUS; CONDITIONED FEAR; NEURONS; POPULATIONS; BRAIN	Central amygdala (CeA) projections to hypothalamic and brain stem nuclei regulate the behavioral and physiological expression of fear, but it is unknown whether these different aspects of the fear response can be separately regulated by the CeA. We combined fluorescent retrograde tracing of CeA projections to nuclei that modulate fear-related freezing or cardiovascular responses with in vitro electrophysiological recordings and with in vivo monitoring of related behavioral and physiological parameters. CeA projections emerged from separate neuronal populations with different electrophysiological characteristics and different response properties to oxytocin. In vivo, oxytocin decreased freezing responses in fear-conditioned rats without affecting the cardiovascular response. Thus, neuropeptidergic signaling can modulate the CeA outputs through separate neuronal circuits and thereby individually steer the various aspects of the fear response.	[Viviani, Daniele; Charlet, Alexandre; van den Burg, Erwin; Robinet, Camille; Hurni, Nicolas; Abatis, Marios; Magara, Fulvio; Stoop, Ron] Univ Lausanne, Lausanne Univ Hosp Ctr, Dept Psychiat, Ctr Psychiat Neurosci, CH-1015 Lausanne, Switzerland; [Stoop, Ron] Univ Lausanne, Dept Physiol, CH-1015 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Stoop, R (corresponding author), Univ Lausanne, Lausanne Univ Hosp Ctr, Dept Psychiat, Ctr Psychiat Neurosci, CH-1015 Lausanne, Switzerland.	rstoop@unil.ch	Charlet, Alexandre/D-5179-2016	Charlet, Alexandre/0000-0003-4837-3706	Swiss National Science Foundation [3100A0-116462]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank E. Welker for outstanding scientific advice; H. Markram and R. Perin for expert help with multiple patch recordings; R. Daniel and D. Rainnie for feedback on the manuscript; and O. Bussard, V. Martin, N. Pochon and L. Bonsignore for technical support. Supported by Swiss National Science Foundation grant 3100A0-116462.	Bisetti A, 2006, NEUROSCIENCE, V142, P999, DOI 10.1016/j.neuroscience.2006.07.018; Bosch OJ, 2005, J NEUROSCI, V25, P6807, DOI 10.1523/JNEUROSCI.1342-05.2005; Champagne FA, 2006, BIOL PSYCHIAT, V59, P1227, DOI 10.1016/j.biopsych.2005.10.016; Chieng BCH, 2006, J COMP NEUROL, V497, P910, DOI 10.1002/cne.21025; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; DAVIS M, 1992, P255; Day HEW, 1999, J COMP NEUROL, V413, P113; Dumont EC, 2002, EUR J NEUROSCI, V15, P545, DOI 10.1046/j.0953-816x.2001.01879.x; GOMEZ TMD, 1995, BRAIN RES, V689, P21, DOI 10.1016/0006-8993(95)00525-U; Gozzi A, 2010, NEURON, V67, P656, DOI 10.1016/j.neuron.2010.07.008; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; KATZ LC, 1984, NATURE, V310, P498, DOI 10.1038/310498a0; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Loewy AD., 1990, CENTRAL REGULATION A, P88; McCarthy MM, 1996, PHYSIOL BEHAV, V60, P1209, DOI 10.1016/S0031-9384(96)00212-0; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Porges SW, 2003, ANN NY ACAD SCI, V1008, P31, DOI 10.1196/annals.1301.004; Rainville P, 2006, INT J PSYCHOPHYSIOL, V61, P5, DOI 10.1016/j.ijpsycho.2005.10.024; Sajdyk TJ, 2004, NEUROPEPTIDES, V38, P225, DOI 10.1016/j.npep.2004.05.006; Sansone Randy A, 2009, Psychiatry (Edgmont), V6, P33; SCHWABER JS, 1982, J NEUROSCI, V2, P1424, DOI 10.1523/jneurosci.02-10-01424.1982; Tye KM, 2008, NATURE, V453, P1253, DOI 10.1038/nature06963; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Vianna EPM, 2006, INT J PSYCHOPHYSIOL, V61, P70, DOI 10.1016/j.ijpsycho.2005.10.019; Waldherr M, 2007, P NATL ACAD SCI USA, V104, P16681, DOI 10.1073/pnas.0705860104; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	28	261	264	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 1	2011	333	6038					104	107		10.1126/science.1201043	http://dx.doi.org/10.1126/science.1201043			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719680				2022-12-01	WOS:000292255400060
J	Hrecka, K; Hao, CL; Gierszewska, M; Swanson, SK; Kesik-Brodacka, M; Srivastava, S; Florens, L; Washburn, MP; Skowronski, J				Hrecka, Kasia; Hao, Caili; Gierszewska, Magda; Swanson, Selene K.; Kesik-Brodacka, Malgorzata; Srivastava, Smita; Florens, Laurence; Washburn, Michael P.; Skowronski, Jacek			Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein	NATURE			English	Article							AICARDI-GOUTIERES SYNDROME; UBIQUITIN LIGASE; INNATE; GENE; ASSOCIATION; USURPS; CELLS	Macrophages and dendritic cells have key roles in viral infections, providing virus reservoirs that frequently resist antiviral therapies and linking innate virus detection to antiviral adaptive immune responses(1,2). Human immunodeficiency virus 1 (HIV-1) fails to transduce dendritic cells and has a reduced ability to transduce macrophages, due to an as yet uncharacterized mechanism that inhibits infection by interfering with efficient synthesis of viral complementary DNA(3,4). In contrast, HIV-2 and related simian immunodeficiency viruses (SIVsm/mac) transduce myeloid cells efficiently owing to their virion-associated Vpx accessory proteins, which counteract the restrictive mechanism(5,6). Here we show that the inhibition of HIV-1 infection in macrophages involves the cellular SAM domain HD domain-containing protein 1 (SAMHD1). Vpx relieves the inhibition of lentivirus infection in macrophages by loading SAMHD1 onto the CRL4(DCAF1) E3 ubiquitin ligase, leading to highly efficient proteasome-dependent degradation of the protein. Mutations in SAMHD1 cause Aicardi-Goutieres syndrome, a disease that produces a phenotype that mimics the effects of a congenital viral infection(7,8). Failure to dispose of endogenous nucleic acid debris in Aicardi-Goutieres syndrome results in inappropriate triggering of innate immune responses via cytosolic nucleic acids sensors(9,10). Thus, our findings show that macrophages are defended from HIV-1 infection by a mechanism that prevents an unwanted interferon response triggered by self nucleic acids, and uncover an intricate relationship between innate immune mechanisms that control response to self and to retroviral pathogens.	[Hrecka, Kasia; Hao, Caili; Kesik-Brodacka, Malgorzata; Skowronski, Jacek] Case Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Hrecka, Kasia; Gierszewska, Magda; Srivastava, Smita; Skowronski, Jacek] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Swanson, Selene K.; Florens, Laurence; Washburn, Michael P.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Washburn, Michael P.] Univ Kansas, Dept Pathol & Lab Med, Med Ctr, Kansas City, KS 66160 USA	Case Western Reserve University; Cold Spring Harbor Laboratory; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Skowronski, J (corresponding author), Case Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.	jacek.skowronski@case.edu	Kęsik-Brodacka, Małgorzata/ABG-7355-2021	Florens, Laurence/0000-0002-9310-6650; Washburn, Michael/0000-0001-7568-2585	NIH [R01 AI077459, R21 AI084694]; Case CFAR developmental funds; Stowers Institute for Medical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077459, R21AI084694] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case CFAR developmental funds; Stowers Institute for Medical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Karn, McDonald and Bernstein laboratories, C. Carlin, R. Asaad, M. Reuter and A. Valentin-Torres, for reagents and help at various stages of this project. We acknowledge the excellent assistance of C. Wang with fluorescence microscopy. We also thank M. Emerman and N. Manel for HIV-2 Rod proviral constructs, F. Kirchhoff for the SIVmac 239-GFP proviral clone, M. Lederman and D. McDonald for discussions, J. Karn and M. Greenberg for discussions and comments on the manuscript. We are grateful to L. Van Aelst and D. Littman for advice, discussions and critical reading of the manuscript. This work in the J. S. laboratory was supported by NIH grants R01 AI077459 and R21 AI084694 and by Case CFAR developmental funds. S. K. S., L. F. and M. P. W. are supported by The Stowers Institute for Medical Research.	Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Bergamaschi A, 2009, J VIROL, V83, P4854, DOI 10.1128/JVI.00187-09; Blankson JN, 2002, ANNU REV MED, V53, P557, DOI 10.1146/annurev.med.53.082901.104024; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Florens Laurence, 2006, V328, P159; GIBBS JS, 1995, J VIROL, V69, P2378, DOI 10.1128/JVI.69.4.2378-2383.1995; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; GUYADER M, 1989, EMBO J, V8, P1169, DOI 10.1002/j.1460-2075.1989.tb03488.x; Hirsch VM, 1998, NAT MED, V4, P1401, DOI 10.1038/3992; HORTON R, 1994, VIROLOGY, V199, P453, DOI 10.1006/viro.1994.1144; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Kaushik R, 2009, CELL HOST MICROBE, V6, P68, DOI 10.1016/j.chom.2009.05.022; Kewalramani VN, 1996, VIROLOGY, V218, P159, DOI 10.1006/viro.1996.0176; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; Pick E, 2007, MOL CELL BIOL, V27, P4708, DOI 10.1128/MCB.02432-06; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Yamashita M, 2007, PLOS PATHOG, V3, P1502, DOI 10.1371/journal.ppat.0030156; Yamashita M, 2009, J VIROL, V83, P9835, DOI 10.1128/JVI.01084-09; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; YU XF, 1991, J VIROL, V65, P5088, DOI 10.1128/JVI.65.9.5088-5091.1991; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999	30	877	904	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2011	474	7353					658	U137		10.1038/nature10195	http://dx.doi.org/10.1038/nature10195			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21720370	Green Accepted			2022-12-01	WOS:000292204300043
J	Tamura, Y; Itoh, K; Sesaki, H				Tamura, Yasushi; Itoh, Kie; Sesaki, Hiromi			SnapShot: Mitochondrial Dynamics	CELL			English	Editorial Material							FISSION; FUSION; MECHANISMS; MITOPHAGY		[Tamura, Yasushi; Itoh, Kie; Sesaki, Hiromi] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Tamura, Y (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA.		Yasushi, TAMURA/I-7122-2014; Tamura, Yasushi/H-8270-2017; Tamura, Yasushi/A-9997-2013	Tamura, Yasushi/0000-0002-8462-0607; 	NIGMS NIH HHS [R01 GM089853, GM89853, R01 GM089853-02] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089853] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Campello S, 2010, EMBO REP, V11, P678, DOI 10.1038/embor.2010.115; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Hoppins S, 2009, BBA-MOL CELL RES, V1793, P20, DOI 10.1016/j.bbamcr.2008.07.005; KAGEYAMA Y, 2011, CURR OPIN CELL BIOL; Kuroiwa T, 2010, P JPN ACAD B-PHYS, V86, P455, DOI 10.2183/pjab.86.455; McBride H, 2010, CURR BIOL, V20, pR274, DOI 10.1016/j.cub.2010.02.011; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Westermann B, 2010, SEMIN CELL DEV BIOL, V21, P542, DOI 10.1016/j.semcdb.2009.12.003; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	10	42	43	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 24	2011	145	7							1158.e1	10.1016/j.cell.2011.06.018	http://dx.doi.org/10.1016/j.cell.2011.06.018			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703455	Green Accepted, Bronze			2022-12-01	WOS:000292025700021
J	Fairley, P				Fairley, Peter			Next generation biofuels	NATURE			English	Editorial Material																			0	128	134	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S2	S5		10.1038/474S02a	http://dx.doi.org/10.1038/474S02a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697838	Bronze			2022-12-01	WOS:000291939700001
J	Savage, N				Savage, Neil			The scum solution	NATURE			English	Editorial Material																			0	43	45	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S15	S16		10.1038/474S015a	http://dx.doi.org/10.1038/474S015a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697835	Bronze			2022-12-01	WOS:000291939700005
J	Cornes, O				Cornes, Ollie			Commentary: Living with CFS/ME	BRITISH MEDICAL JOURNAL			English	Editorial Material												ollie@cornes.org						ALTER HJ, 2010, BLOOD PRODUCTS ADVIS; 2009, NY TIMES        1015	2	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 22	2011	342								d3836	10.1136/bmj.d3836	http://dx.doi.org/10.1136/bmj.d3836			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AT	21697227				2022-12-01	WOS:000292200500009
J	Paolicelli, RC; Bolasco, G; Pagani, F; Maggi, L; Scianni, M; Panzanelli, P; Giustetto, M; Ferreira, TA; Guiducci, E; Dumas, L; Ragozzino, D; Gross, CT				Paolicelli, Rosa C.; Bolasco, Giulia; Pagani, Francesca; Maggi, Laura; Scianni, Maria; Panzanelli, Patrizia; Giustetto, Maurizio; Ferreira, Tiago Alves; Guiducci, Eva; Dumas, Laura; Ragozzino, Davide; Gross, Cornelius T.			Synaptic Pruning by Microglia Is Necessary for Normal Brain Development	SCIENCE			English	Article							IN-VIVO; FRACTALKINE RECEPTOR; TARGETED DELETION; RAT HIPPOCAMPUS; CELLS; REVEALS; ELIMINATION; PARENCHYMA; DEATH; FATE	Microglia are highly motile phagocytic cells that infiltrate and take up residence in the developing brain, where they are thought to provide a surveillance and scavenging function. However, although microglia have been shown to engulf and clear damaged cellular debris after brain insult, it remains less clear what role microglia play in the uninjured brain. Here, we show that microglia actively engulf synaptic material and play a major role in synaptic pruning during postnatal development in mice. These findings link microglia surveillance to synaptic maturation and suggest that deficits in microglia function may contribute to synaptic abnormalities seen in some neurodevelopmental disorders.	[Paolicelli, Rosa C.; Bolasco, Giulia; Ferreira, Tiago Alves; Guiducci, Eva; Dumas, Laura; Gross, Cornelius T.] European Mol Biol Lab, Mouse Biol Unit, I-00015 Monterotondo, Italy; [Pagani, Francesca; Maggi, Laura; Scianni, Maria; Ragozzino, Davide] Univ Rome, Inst Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Pagani, Francesca; Maggi, Laura; Scianni, Maria; Ragozzino, Davide] Univ Rome, Dept Human Physiol & Pharmacol, Ctr Excellence BEMM, I-00185 Rome, Italy; [Panzanelli, Patrizia; Giustetto, Maurizio] Univ Turin, Dept Anat Pharmacol & Forens Med, I-10124 Turin, Italy; [Giustetto, Maurizio] Natl Inst Neurosci, I-10126 Turin, Italy	European Molecular Biology Laboratory (EMBL); Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome; University of Turin	Gross, CT (corresponding author), European Mol Biol Lab, Mouse Biol Unit, Via Ramarini 32, I-00015 Monterotondo, Italy.	gross@embl.it	maggi, laura/H-2535-2012; Panzanelli, Patrizia/AAE-7773-2022; giustetto, maurizio/D-6606-2011; ragozzino, davide/K-6521-2016; Ferreira, Tiago/AFM-8050-2022	maggi, laura/0000-0002-0566-0433; giustetto, maurizio/0000-0003-1323-4060; ragozzino, davide/0000-0002-3290-7665; Paolicelli, Rosa Chiara/0000-0001-6851-0849; Panzanelli, Patrizia/0000-0002-5127-2757; Ferreira, Tiago/0000-0001-6866-1540	EMBL; Foundation Cenci Bolognetti	EMBL; Foundation Cenci Bolognetti	We thank R. Mellwig, U. Haselmann, and C. Antony at the EMBL Electron Microscopy Core Facility; F. Zonfrillo for expert mouse husbandry; the EMBL Transgenic Facility for help in rederiving mouse lines; J. Griesbach and M. Al Banchaabouchi for help in videoscoring; W. Fouquet at Leica Microsystems, Mannheim, Germany, for access to the STED microscope and microscopy expertise; and A. Pinto, F. Peri, P. Heppenstall, and M. Jechlinger for critical discussions. This work was supported by funds from EMBL to C.T.G and R.C.P. and Foundation Cenci Bolognetti to F.P., L.M., M.S., and D.R. R.C.P. carried out and analyzed all fluorescent imaging experiments except a portion of the microglia morphological analyses that were carried out by T.A.F., L.D., and E.G. Electron microscopy was carried out and analyzed by G.B., P.P., and M.G. Electrophysiological experiments were designed, carried out, and analyzed by M.S., F.P., L.M., and D.R. C.T.G conceived the projects and wrote the manuscript with input from R.C.P. and D.R.	Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Checchin D, 2006, INVEST OPHTH VIS SCI, V47, P3595, DOI 10.1167/iovs.05-1522; Chu YX, 2010, P NATL ACAD SCI USA, V107, P7975, DOI 10.1073/pnas.0913449107; Cruz-Martin A, 2010, J NEUROSCI, V30, P7793, DOI 10.1523/JNEUROSCI.0577-10.2010; Dalmau I, 1998, HIPPOCAMPUS, V8, P458, DOI 10.1002/(SICI)1098-1063(1998)8:5<458::AID-HIPO6>3.0.CO;2-N; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Haskell CA, 2001, J CLIN INVEST, V108, P679, DOI 10.1172/JCI12976; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; Imaizumi Tadaatsu, 2004, J Atheroscler Thromb, V11, P15; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Klioueva IA, 2001, PHYSIOL BEHAV, V72, P421, DOI 10.1016/S0031-9384(00)00425-X; Liang KJ, 2009, INVEST OPHTH VIS SCI, V50, P4444, DOI 10.1167/iovs.08-3357; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Mody M, 2001, P NATL ACAD SCI USA, V98, P8862, DOI 10.1073/pnas.141244998; Monier A, 2006, J COMP NEUROL, V499, P565, DOI 10.1002/cne.21123; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Ruitenberg MJ, 2008, J NEUROIMMUNOL, V205, P80, DOI 10.1016/j.jneuroim.2008.09.010; Schafer DP, 2010, BIOCHEM SOC T, V38, P476, DOI 10.1042/BST0380476; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; WAGNER JJ, 1995, J NEUROSCI, V15, P1577; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wakselman S, 2008, J NEUROSCI, V28, P8138, DOI 10.1523/JNEUROSCI.1006-08.2008	29	2196	2242	13	300	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 9	2011	333	6048					1456	1458		10.1126/science.1202529	http://dx.doi.org/10.1126/science.1202529			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817KU	21778362				2022-12-01	WOS:000294672200045
J	Kutateladze, TG				Kutateladze, Tatiana G.			SnapShot: Histone Readers	CELL			English	Editorial Material							CHROMATIN MODIFICATIONS; BINDING MODULES; LANGUAGE; CODE		Univ Colorado, Dept Pharmacol, Sch Med, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Kutateladze, TG (corresponding author), Univ Colorado, Dept Pharmacol, Sch Med, Aurora, CO 80045 USA.			Kutateladze, Tatiana/0000-0001-7375-6990	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096863] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM096863] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2	9	20	20	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 2	2011	146	5							842.e1	10.1016/j.cell.2011.08.022	http://dx.doi.org/10.1016/j.cell.2011.08.022			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21884941	Green Accepted, Bronze			2022-12-01	WOS:000294477500024
J	Possemato, R; Marks, KM; Shaul, YD; Pacold, ME; Kim, D; Birsoy, K; Sethumadhavan, S; Woo, HK; Jang, HG; Jha, AK; Chen, WW; Barrett, FG; Stransky, N; Tsun, ZY; Cowley, GS; Barretina, J; Kalaany, NY; Hsu, PP; Ottina, K; Chan, AM; Yuan, B; Garraway, LA; Root, DE; Mino-Kenudson, M; Brachtel, EF; Driggers, EM; Sabatini, DM				Possemato, Richard; Marks, Kevin M.; Shaul, Yoav D.; Pacold, Michael E.; Kim, Dohoon; Birsoy, Kivanc; Sethumadhavan, Shalini; Woo, Hin-Koon; Jang, Hyun G.; Jha, Abhishek K.; Chen, Walter W.; Barrett, Francesca G.; Stransky, Nicolas; Tsun, Zhi-Yang; Cowley, Glenn S.; Barretina, Jordi; Kalaany, Nada Y.; Hsu, Peggy P.; Ottina, Kathleen; Chan, Albert M.; Yuan, Bingbing; Garraway, Levi A.; Root, David E.; Mino-Kenudson, Mari; Brachtel, Elena F.; Driggers, Edward M.; Sabatini, David M.			Functional genomics reveal that the serine synthesis pathway is essential in breast cancer	NATURE			English	Article							GENE-EXPRESSION SIGNATURE; NEOPLASTIC RAT-TISSUES; EMBRYONIC STEM-CELLS; XENOGRAFT MODEL; METABOLISM; IDENTIFICATION; DEHYDROGENASE; ACTIVATION; SCREEN; TUMORS	Cancer cells adapt their metabolic processes to drive macromolecular biosynthesis for rapid cell growth and proliferation(1,2). RNA interference (RNAi)-based loss-of-function screening has proven powerful for the identification of new and interesting cancer targets, and recent studies have used this technology in vivo to identify novel tumour suppressor genes(3). Here we developed a method for identifying novel cancer targets via negative-selection RNAi screening using a human breast cancer xenograft model at an orthotopic site in the mouse. Using this method, we screened a set of metabolic genes associated with aggressive breast cancer and stemness to identify those required for in vivo tumorigenesis. Among the genes identified, phosphoglycerate dehydrogenase (PHGDH) is in a genomic region of recurrent copy number gain in breast cancer and PHGDH protein levels are elevated in 70% of oestrogen receptor (ER)-negative breast cancers. PHGDH catalyses the first step in the serine biosynthesis pathway, and breast cancer cells with high PHGDH expression have increased serine synthesis flux. Suppression of PHGDH in cell lines with elevated PHGDH expression, but not in those without, causes a strong decrease in cell proliferation and a reduction in serine synthesis. We find that PHGDH suppression does not affect intracellular serine levels, but causes a drop in the levels of alpha-ketoglutarate, another output of the pathway and a tricarboxylic acid (TCA) cycle intermediate. In cells with high PHGDH expression, the serine synthesis pathway contributes approximately 50% of the total anaplerotic flux of glutamine into the TCA cycle. These results reveal that certain breast cancers are dependent on increased serine pathway flux caused by PHGDH overexpression and demonstrate the utility of in vivo negative-selection RNAi screens for finding potential anticancer targets.	[Possemato, Richard; Shaul, Yoav D.; Pacold, Michael E.; Kim, Dohoon; Birsoy, Kivanc; Chen, Walter W.; Barrett, Francesca G.; Tsun, Zhi-Yang; Kalaany, Nada Y.; Hsu, Peggy P.; Ottina, Kathleen; Chan, Albert M.; Yuan, Bingbing; Sabatini, David M.] Nine Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Possemato, Richard; Shaul, Yoav D.; Pacold, Michael E.; Kim, Dohoon; Birsoy, Kivanc; Chen, Walter W.; Tsun, Zhi-Yang; Kalaany, Nada Y.; Hsu, Peggy P.; Ottina, Kathleen; Chan, Albert M.; Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Possemato, Richard; Shaul, Yoav D.; Pacold, Michael E.; Kim, Dohoon; Birsoy, Kivanc; Chen, Walter W.; Stransky, Nicolas; Cowley, Glenn S.; Barretina, Jordi; Kalaany, Nada Y.; Hsu, Peggy P.; Ottina, Kathleen; Chan, Albert M.; Garraway, Levi A.; Root, David E.; Sabatini, David M.] MIT, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Possemato, Richard; Shaul, Yoav D.; Pacold, Michael E.; Kim, Dohoon; Birsoy, Kivanc; Chen, Walter W.; Barrett, Francesca G.; Stransky, Nicolas; Tsun, Zhi-Yang; Cowley, Glenn S.; Barretina, Jordi; Kalaany, Nada Y.; Hsu, Peggy P.; Ottina, Kathleen; Chan, Albert M.; Garraway, Levi A.; Root, David E.; Sabatini, David M.] Broad Inst Harvard, Cambridge, MA 02142 USA; [Shaul, Yoav D.; Pacold, Michael E.; Kim, Dohoon; Birsoy, Kivanc; Chen, Walter W.; Tsun, Zhi-Yang; Kalaany, Nada Y.; Hsu, Peggy P.; Ottina, Kathleen; Chan, Albert M.; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Marks, Kevin M.; Sethumadhavan, Shalini; Woo, Hin-Koon; Jha, Abhishek K.; Driggers, Edward M.] Agios Pharmaceut, Cambridge, MA 02139 USA; [Pacold, Michael E.] Brigham & Womens Hosp, Harvard Radiat Oncol Program, Boston, MA 02114 USA; [Barretina, Jordi; Garraway, Levi A.] Dept Med Oncol, Boston, MA 02115 USA; [Barretina, Jordi; Garraway, Levi A.] Ctr Canc Genome Discovery, Dana Farber Canc Inst, Boston, MA 02115 USA; [Barretina, Jordi; Garraway, Levi A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Mino-Kenudson, Mari; Brachtel, Elena F.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Mino-Kenudson, Mari; Brachtel, Elena F.] Harvard Univ, Sch Med, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Agios Pharmaceuticals; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Sabatini, DM (corresponding author), Nine Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu	Shaul, Yoav/AAY-7011-2020; ravegnini, gloria/K-1330-2016; Barretina, Jordi/A-7192-2013	ravegnini, gloria/0000-0002-7774-402X; Barretina, Jordi/0000-0002-3478-4080; /0000-0002-1446-7256; Kalaany, Nada/0000-0001-7489-1035; Jha, Abhishek/0000-0001-9161-0450; Chen, Walter/0000-0002-7752-9581; Possemato, Richard/0000-0002-2401-0030	S. G. Komen for the Cure; Life Science Research Foundation; Keck Foundation; David H. Koch Institute for Integrative Cancer Research at MIT; Alexander and Margaret Stewart Trust; NIH [CA103866]; NATIONAL CANCER INSTITUTE [R01CA129105, R01CA103866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	S. G. Komen for the Cure; Life Science Research Foundation; Keck Foundation(W.M. Keck Foundation); David H. Koch Institute for Integrative Cancer Research at MIT; Alexander and Margaret Stewart Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the D. M. S. laboratory, M. Kwon, B. Luo and F. Reinhardt for assistance. This research is supported by fellowships from S. G. Komen for the Cure to R. P. and the Life Science Research Foundation to Y.D.S. and grants from the Keck Foundation, the David H. Koch Institute for Integrative Cancer Research at MIT, The Alexander and Margaret Stewart Trust Fund, and NIH Grant CA103866 to D. M. S. D. M. S. is an investigator of the Howard Hughes Medical Institute.	Achouri Y, 1997, BIOCHEM J, V323, P365, DOI 10.1042/bj3230365; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bric A, 2009, CANCER CELL, V16, P324, DOI 10.1016/j.ccr.2009.08.015; Buescher JM, 2010, ANAL CHEM, V82, P4403, DOI 10.1021/ac100101d; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; KNOX WE, 1969, ARCH BIOCHEM BIOPHYS, V132, P397, DOI 10.1016/0003-9861(69)90381-6; LUND K, 1985, ARCH BIOCHEM BIOPHYS, V237, P186, DOI 10.1016/0003-9861(85)90268-1; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; MILLER FR, 1993, J NATL CANCER I, V85, P1725, DOI 10.1093/jnci/85.21.1725; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Pollari S, 2011, BREAST CANCER RES TR, V125, P421, DOI 10.1007/s10549-010-0848-5; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; SNELL K, 1984, ADV ENZYME REGUL, V22, P325, DOI 10.1016/0065-2571(84)90021-9; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; WALSH DA, 1965, BIOCHEMISTRY-US, V4, P1076, DOI 10.1021/bi00882a015; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701	26	1057	1090	6	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 18	2011	476	7360					346	U119		10.1038/nature10350	http://dx.doi.org/10.1038/nature10350			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21760589	Green Accepted, Bronze, Green Submitted, Green Published			2022-12-01	WOS:000294206500041
J	Corti, D; Voss, J; Gamblin, SJ; Codoni, G; Macagno, A; Jarrossay, D; Vachieri, SG; Pinna, D; Minola, A; Vanzetta, F; Silacci, C; Fernandez-Rodriguez, BM; Agatic, G; Bianchi, S; Giacchetto-Sasselli, I; Calder, L; Sallusto, F; Collins, P; Haire, LF; Temperton, N; Langedijk, JPM; Skehel, JJ; Lanzavecchia, A				Corti, Davide; Voss, Jarrod; Gamblin, Steven J.; Codoni, Giosiana; Macagno, Annalisa; Jarrossay, David; Vachieri, Sebastien G.; Pinna, Debora; Minola, Andrea; Vanzetta, Fabrizia; Silacci, Chiara; Fernandez-Rodriguez, Blanca M.; Agatic, Gloria; Bianchi, Siro; Giacchetto-Sasselli, Isabella; Calder, Lesley; Sallusto, Federica; Collins, Patrick; Haire, Lesley F.; Temperton, Nigel; Langedijk, Johannes P. M.; Skehel, John J.; Lanzavecchia, Antonio			A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins	SCIENCE			English	Article							MEMBRANE-FUSION; RECEPTOR-BINDING; MONOCLONAL-ANTIBODIES; VIRUS HEMAGGLUTININ; B-CELLS; COMPLEX; SEQUENCES; SUBTYPES; EPITOPE; SITE	The isolation of broadly neutralizing antibodies against influenza A viruses has been a long-sought goal for therapeutic approaches and vaccine design. Using a single-cell culture method for screening large numbers of human plasma cells, we isolated a neutralizing monoclonal antibody that recognized the hemagglutinin (HA) glycoprotein of all 16 subtypes and neutralized both group 1 and group 2 influenza A viruses. Passive transfer of this antibody conferred protection to mice and ferrets. Complexes with HAs from the group 1 H1 and the group 2 H3 subtypes analyzed by x-ray crystallography showed that the antibody bound to a conserved epitope in the F subdomain. This antibody may be used for passive protection and to inform vaccine design because of its broad specificity and neutralization potency.	[Voss, Jarrod; Gamblin, Steven J.; Vachieri, Sebastien G.; Calder, Lesley; Collins, Patrick; Haire, Lesley F.; Skehel, John J.] Natl Inst Med Res, MRC, London NW7 1AA, England; [Corti, Davide; Vanzetta, Fabrizia; Agatic, Gloria; Bianchi, Siro] Humabs BioMed SA, CH-6500 Bellinzona, Switzerland; [Corti, Davide; Codoni, Giosiana; Macagno, Annalisa; Jarrossay, David; Pinna, Debora; Minola, Andrea; Silacci, Chiara; Fernandez-Rodriguez, Blanca M.; Giacchetto-Sasselli, Isabella; Sallusto, Federica; Lanzavecchia, Antonio] Inst Res Biomed, CH-6500 Bellinzona, Switzerland; [Temperton, Nigel] Univ Kent, Sch Pharm, Viral Pseudotype Unit, Chatham ME4 4TB, Kent, England; [Langedijk, Johannes P. M.] Pepscan Therapeut BV, NL-8243 RC Lelystad, Netherlands; [Lanzavecchia, Antonio] ETH, Inst Microbiol, CH-8032 Zurich, Switzerland	MRC National Institute for Medical Research; Universita della Svizzera Italiana; University of Kent; Pepscan Therapeutics B.V.; Swiss Federal Institutes of Technology Domain; ETH Zurich	Skehel, JJ (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	skeheljj@nimr.mrc.ac.uk; lanzavecchia@irb.unisi.ch	Temperton, Nigel James/K-5158-2013; Temperton, Nigel James/M-1164-2019	Temperton, Nigel James/0000-0002-7978-3815; Temperton, Nigel James/0000-0002-7978-3815; Zatta, Fabrizia/0000-0003-4945-8058; Bianchi, Siro/0000-0002-5100-8905	European Research Council [250348 IMMUNExplore]; Swiss National Science Foundation [31003A-126027]; Human Frontier Science Program [RGP9/2007]; U.K. Medical Research Council; Wellcome Trust; Helmut Horten Foundation; Medical Research Council [G0600369, MC_U117584222] Funding Source: researchfish; MRC [G0600369, MC_U117584222] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Human Frontier Science Program(Human Frontier Science Program); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Helmut Horten Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the European Research Council (grant 250348 IMMUNExplore), the Swiss National Science Foundation (31003A-126027), the Human Frontier Science Program (RGP9/2007), the U.K. Medical Research Council, and the Wellcome Trust. A. L. is supported by the Helmut Horten Foundation. We gratefully acknowledge Diamond for access to synchrotron time. We thank M. Nussenzweig and H. Wardemann for providing reagents for antibody cloning and expression, A. Ritchie at BioFocus for supervising the FI6-H1 structural work, K. Harrod at Lovelace Research Respiratory Institute for supervising the ferret study, E. Soethout at the National Institute for Public Health and the Environment (Netherlands) for providing the H3N2 HK-x31 virus, and W. J. Rutter and L. Varani for critical reading and comments. A. L. is the scientific founder and acting chief scientific officer of Humabs BioMed SA. A. L. and F. S. hold shares in Humabs BioMed SA. The Institute for Research in Biomedicine has two pending patent applications: PCT/IB/2009/007375 (Methods for producing antibodies from plasma cells, A. L. and D. J.) and PCT/US2009/051851 (Neutralizing anti-influenza virus antibodies and uses thereof, A. L.). J. P. M. L. has a patent application on the use of helical peptides for epitope mapping, EP 11160745.3 (Helical peptide libraries for lead identification and interaction site mapping). Antibody sequences for all described FI6 variants are available in fig. S1. Nucleotide sequences for the antibodies described have been deposited in GenBank (accession numbers JN234430, JN234431, JN234432, JN234433, JN234434, JN234435, JN234436, JN234437, JN234438, JN234439, JN234440, JN234441, JN234442, JN234443, JN234444, JN234445, JN234446, JN234447, JN234448). The FI6 and FI6v3 antibodies can be obtained for research purposes under a material transfer agreement.	Barbey-Martin C, 2002, VIROLOGY, V294, P70, DOI 10.1006/viro.2001.1320; Bottcher-Friebertshauser E, 2010, J VIROL, V84, P5605, DOI 10.1128/JVI.00140-10; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Calder LJ, 2010, P NATL ACAD SCI USA, V107, P10685, DOI 10.1073/pnas.1002123107; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; CUSACK S, 1985, J MOL BIOL, V186, P565, DOI 10.1016/0022-2836(85)90131-7; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fleury D, 1999, NAT STRUCT BIOL, V6, P530, DOI 10.1038/9299; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; Garten W, 1999, TRENDS MICROBIOL, V7, P99, DOI 10.1016/S0966-842X(99)01460-2; GODLEY L, 1992, CELL, V68, P635, DOI 10.1016/0092-8674(92)90140-8; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Knossow M, 2006, IMMUNOLOGY, V119, P1, DOI 10.1111/j.1365-2567.2006.02421.x; Langedijk JPM, 2011, ANAL BIOCHEM, V417, P149, DOI 10.1016/j.ab.2011.06.002; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Rossman JS, 2011, VIROLOGY, V411, P229, DOI 10.1016/j.virol.2010.12.003; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Russell RJ, 2004, VIROLOGY, V325, P287, DOI 10.1016/j.virol.2004.04.040; Russell RJ, 2008, P NATL ACAD SCI USA, V105, P17736, DOI 10.1073/pnas.0807142105; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; WATOWICH SJ, 1994, STRUCTURE, V2, P719, DOI 10.1016/S0969-2126(00)00073-3; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350	33	866	977	3	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2011	333	6044					850	856		10.1126/science.1205669	http://dx.doi.org/10.1126/science.1205669			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21798894				2022-12-01	WOS:000293785400033
J	Panizza, S; Mendoza, MA; Berlinger, M; Huang, LZ; Nicolas, A; Shirahige, K; Klein, F				Panizza, Silvia; Mendoza, Marco A.; Berlinger, Marc; Huang, Lingzhi; Nicolas, Alain; Shirahige, Katsuhiko; Klein, Franz			Spo11-Accessory Proteins Link Double-Strand Break Sites to the Chromosome Axis in Early Meiotic Recombination	CELL			English	Article							ANAPHASE-PROMOTING COMPLEX; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL INTERACTIONS; SYNAPTONEMAL COMPLEXES; CHIASMA FORMATION; DNA-REPLICATION; YEAST; INITIATION; MEIOSIS; SPO11	Meiotic recombination between homologous chromosomes initiates via programmed DNA double-strand breaks (DSBs), generated by complexes comprising Spo11 transesterase plus accessory proteins. DSBs arise concomitantly with the development of axial chromosome structures, where the coalescence of axis sites produces linear arrays of chromatin loops. Recombining DNA sequences map to loops, but are ultimately tethered to the underlying axis. How and when such tethering occurs is currently unclear. Using ChIPchip in yeast, we show that Spo11-accessory proteins Rec114, Mer2, and Mei4 stably interact with chromosome axis sequences, upon phosphorylation of Mer2 by S phase Cdk. This axis tethering requires meiotic axis components (Red1/Hop1) and is modulated in a domain-specific fashion by cohesin. Loss of Rec114, Mer2, and Mei4 binding correlates with loss of DSBs. Our results strongly suggest that hot-spot sequences become tethered to axis sites by the DSB machinery prior to DSB formation.	[Panizza, Silvia; Mendoza, Marco A.; Berlinger, Marc; Huang, Lingzhi; Klein, Franz] Univ Vienna, Dept Chromosome Biol, Max F Perutz Labs, A-1030 Vienna, Austria; [Nicolas, Alain] Univ Paris 06, CNRS, UMR3244, Inst Curie,Ctr Rech, F-75248 Paris 05, France; [Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Lab Genome Struct & Funct,Bunkyo Ku, Tokyo 1130032, Japan	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Universite Paris Cite; University of Tokyo	Klein, F (corresponding author), Univ Vienna, Dept Chromosome Biol, Max F Perutz Labs, Dr Bohr Gasse 1, A-1030 Vienna, Austria.	franz.klein@univie.ac.at		Shirahige, Katsuhiko/0000-0002-7862-1144; Panizza, Silvia/0000-0002-2435-5485; Klein, Franz/0000-0001-7204-1432; Mendoza-Parra, Marco Antonio/0000-0002-1809-1727	Austrian Science Foundation [F34, P18847]; MEXT; JST	Austrian Science Foundation(Austrian Science Fund (FWF)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST(Japan Science & Technology Agency (JST))	We would like to thank Y. Katou and S. Mori-Uehara for initial help with ChIPchip, B. Huttel for advice, and M. and A. Matzke for sharing the Affymetrix facility. Thanks to I. Tamir and D. Chen for important advice with bioinformatics. We thank N. Uematsu for the Rec114-myc13 construct, N. Hollingsworth, S. Keeney, K. Nasmyth, and T. F. Wang for plasmids, strains, and antibodies, B. Byers for early foundational input and N. Kleckner for valuable, critical comments on the manuscript. We are grateful to B. Wohlrab and C. Zierhut for making Zip1 and Hop1 antibody and to M. Madalinsky for Rec114 peptide synthesis. We are indebted to G. Ammerer and the Verein zur Forderung der Genomforschung for generously supplying most of the microarrays used in this study. This work was funded by SFB grant F34 and P18847 of the Austrian Science Foundation to F. K. and by aGrant-in-Aid for Scientific Research (S) from the MEXT and Strategic International Cooperative Program from JST to K. S.	Anderson LK, 1997, P NATL ACAD SCI USA, V94, P6868, DOI 10.1073/pnas.94.13.6868; Arora C, 2004, MOL CELL, V13, P549, DOI 10.1016/S1097-2765(04)00063-2; Bardhan A, 2010, MOL BIOL CELL, V21, P1799, DOI 10.1091/mbc.E09-05-0392; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Blitzblau HG, 2007, CURR BIOL, V17, P2003, DOI 10.1016/j.cub.2007.10.066; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Carballo JA, 2008, CELL, V132, P758, DOI 10.1016/j.cell.2008.01.035; CARPENTER ATC, 1987, BIOESSAYS, V6, P232, DOI 10.1002/bies.950060510; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; Dekker J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r116; Dirick L, 1998, SCIENCE, V281, P1854, DOI 10.1126/science.281.5384.1854; Fan QQ, 1997, GENETICS, V145, P661; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; GILLIES CB, 1979, GENETICS, V91, P1; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Henderson KA, 2006, CELL, V125, P1321, DOI 10.1016/j.cell.2006.04.039; Hochwagen A, 2005, CELL, V122, P861, DOI 10.1016/j.cell.2005.07.010; Hunter N., 2007, HOMOLOGOUS RECOMBINA, P1; Jessop L, 2005, GENETICS, V169, P1353, DOI 10.1534/genetics.104.036509; Jones GH, 2006, CELL, V126, P246, DOI 10.1016/j.cell.2006.07.010; Joshi N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000557; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; Katis VL, 2010, DEV CELL, V18, P397, DOI 10.1016/j.devcel.2010.01.014; Katou Y, 2006, METHOD ENZYMOL, V409, P389, DOI 10.1016/S0076-6879(05)09023-3; Kee K, 2002, GENETICS, V160, P111; Kee K, 2004, EMBO J, V23, P1815, DOI 10.1038/sj.emboj.7600184; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kim KP, 2010, CELL, V143, P924, DOI 10.1016/j.cell.2010.11.015; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Kugou K, 2009, MOL BIOL CELL, V20, P3064, DOI 10.1091/mbc.E08-12-1223; Kumar R, 2010, GENE DEV, V24, P1266, DOI 10.1101/gad.571710; Li J, 2006, GENETICS, V173, P1969, DOI 10.1534/genetics.106.058768; Lichten Michael, 2008, V3, P165, DOI 10.1007/7050_2008_040; Lorenz A, 2006, CHROMOSOMA, V115, P330, DOI 10.1007/s00412-006-0053-9; Maleki S, 2007, CHROMOSOMA, V116, P471, DOI 10.1007/s00412-007-0111-y; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Mendoza MA, 2009, METHODS MOL BIOL, V557, P267, DOI 10.1007/978-1-59745-527-5_17; Mets DG, 2009, CELL, V139, P73, DOI 10.1016/j.cell.2009.07.035; Mieczkowski PA, 2007, P NATL ACAD SCI USA, V104, P3955, DOI 10.1073/pnas.0700412104; Murakami H, 2008, GENE DEV, V22, P286, DOI 10.1101/gad.1642308; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; Nasmyth K, 2005, PHILOS T R SOC B, V360, P483, DOI 10.1098/rstb.2004.1604; Niu HY, 2005, MOL BIOL CELL, V16, P5804, DOI 10.1091/mbc.E05-05-0465; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Penkner AM, 2005, CELL, V120, P789, DOI 10.1016/j.cell.2005.01.017; Prieler S, 2005, GENE DEV, V19, P255, DOI 10.1101/gad.321105; Robine N, 2007, MOL CELL BIOL, V27, P1868, DOI 10.1128/MCB.02063-06; Sasanuma H, 2007, NUCLEIC ACIDS RES, V35, P1119, DOI 10.1093/nar/gkl1162; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; STACK SM, 1986, AM J BOT, V73, P264, DOI 10.2307/2444181; Stuart D, 1998, GENE DEV, V12, P2698, DOI 10.1101/gad.12.17.2698; Tarsounas M, 1999, J CELL BIOL, V147, P207, DOI 10.1083/jcb.147.2.207; Wan LH, 2004, MOL BIOL CELL, V15, P11, DOI 10.1091/mbc.E03-07-0499; WU TC, 1995, GENETICS, V140, P55; XU LH, 1995, EMBO J, V14, P5115, DOI 10.1002/j.1460-2075.1995.tb00194.x; Yamashita K, 2004, P NATL ACAD SCI USA, V101, P11380, DOI 10.1073/pnas.0400078101; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	68	223	225	2	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 5	2011	146	3					372	383		10.1016/j.cell.2011.07.003	http://dx.doi.org/10.1016/j.cell.2011.07.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	803GT	21816273	Bronze			2022-12-01	WOS:000293570500012
J	Berardi, MJ; Shih, WM; Harrison, SC; Chou, JJ				Berardi, Marcelo J.; Shih, William M.; Harrison, Stephen C.; Chou, James J.			Mitochondrial uncoupling protein 2 structure determined by NMR molecular fragment searching	NATURE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; DIPOLAR COUPLINGS; INDUCED ALIGNMENT; ADP/ATP CARRIER; SECRETION; UCP2; ADP	Mitochondrial uncoupling protein 2 (UCP2) is an integral membrane protein in the mitochondrial anion carrier protein family, the members of which facilitate the transport of small molecules across the mitochondrial inner membrane(1,2). When the mitochondrial respiratory complex pumps protons from the mitochondrial matrix to the intermembrane space, it builds up an electrochemical potential(2). A fraction of this electrochemical potential is dissipated as heat, in a process involving leakage of protons back to the matrix(2). This leakage, or 'uncoupling' of the proton electrochemical potential, is mediated primarily by uncoupling proteins(2). However, the mechanism of UCP-mediated proton translocation across the lipid bilayer is unknown. Here we describe a solution-NMR method for structural characterization of UCP2. The method, which overcomes some of the challenges associated with membrane-protein structure determination(3), combines orientation restraints derived from NMR residual dipolar couplings (RDCs) and semiquantitative distance restraints from paramagnetic relaxation enhancement (PRE) measurements. The local and secondary structures of the protein were determined by piecing together molecular fragments from the Protein Data Bank that best fit experimental RDCs from samples weakly aligned in a DNA nanotube liquid crystal. The RDCs also determine the relative orientation of the secondary structural segments, and the PRE restraints provide their spatial arrangement in the tertiary fold. UCP2 closely resembles the bovine ADP/ATP carrier (the only carrier protein of known structure(4)), but the relative orientations of the helical segments are different, resulting in a wider opening on the matrix side of the inner membrane. Moreover, the nitroxide-labelled GDP binds inside the channel and seems to be closer to transmembrane helices 1-4. We believe that this biophysical approach can be applied to other membrane proteins and, in particular, to other mitochondrial carriers, not only for structure determination but also to characterize various conformational states of these proteins linked to substrate transport.	[Berardi, Marcelo J.; Harrison, Stephen C.; Chou, James J.] Harvard Univ, Jack & Eileen Connors Struct Biol Lab, Sch Med, Boston, MA 02115 USA; [Berardi, Marcelo J.; Shih, William M.; Harrison, Stephen C.; Chou, James J.] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Boston, MA 02115 USA; [Shih, William M.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Shih, William M.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02138 USA; [Harrison, Stephen C.] Harvard Univ, Howard Hughes Med Inst, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Chou, JJ (corresponding author), Harvard Univ, Jack & Eileen Connors Struct Biol Lab, Sch Med, Boston, MA 02115 USA.	chou@cmcd.hms.harvard.edu	Chou, James J/N-9840-2013; Chou, James/AAD-6230-2022	Chou, James J/0000-0002-4442-0344; Chou, James/0000-0002-4442-0344	NIH [1U54GM094608, 1DP2OD004641]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094608] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004641] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank K. Oxenoid and R. Sounier for discussions, M. McClintock for help with DNA nanotube preparation, I. Stokes-Rees and P. Sliz for help with computations, and N. Voigt for help with figures. The work was supported by NIH grants 1U54GM094608 (to J.J.C.) and 1DP2OD004641 (to W. M. S.). S. C. H. is an Investigator at the Howard Hughes Medical Institute.	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; AQUILA H, 1985, EMBO J, V4, P2369, DOI 10.1002/j.1460-2075.1985.tb03941.x; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Chou JJ, 2000, J BIOMOL NMR, V18, P101, DOI 10.1023/A:1008358318863; Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610; Dehez F, 2008, J AM CHEM SOC, V130, P12725, DOI 10.1021/ja8033087; Delaglio F, 2000, J AM CHEM SOC, V122, P2142, DOI 10.1021/ja993603n; Diao J, 2008, P NATL ACAD SCI USA, V105, P12057, DOI 10.1073/pnas.0710434105; Douglas SM, 2007, P NATL ACAD SCI USA, V104, P6644, DOI 10.1073/pnas.0700930104; Gautier A, 2010, NAT STRUCT MOL BIOL, V17, P768, DOI 10.1038/nsmb.1807; Harper ME, 2002, FASEB J, V16, P1550, DOI 10.1096/fj.02-0541com; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Jaroniec CP, 2004, J BIOMOL NMR, V30, P181, DOI 10.1023/B:JNMR.0000048946.71249.2f; JONES TA, 1986, EMBO J, V5, P819, DOI 10.1002/j.1460-2075.1986.tb04287.x; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kontaxis G, 2000, J MAGN RESON, V143, P184, DOI 10.1006/jmre.1999.1979; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Kunji ERS, 2010, CURR OPIN STRUC BIOL, V20, P440, DOI 10.1016/j.sbi.2010.06.004; Kuszewski J, 1997, J MAGN RESON, V125, P171, DOI 10.1006/jmre.1997.1116; Losonczi JA, 1999, J MAGN RESON, V138, P334, DOI 10.1006/jmre.1999.1754; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Palmieri F, 2006, BBA-BIOENERGETICS, V1757, P1249, DOI 10.1016/j.bbabio.2006.05.023; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Salzmann M, 1999, J BIOMOL NMR, V15, P181, DOI 10.1023/A:1008358030477; Samudio I, 2009, CANCER RES, V69, P2163, DOI 10.1158/0008-5472.CAN-08-3722; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Tate CG, 2010, CURR OPIN STRUC BIOL, V20, P399, DOI 10.1016/j.sbi.2010.07.002; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Van Horn WD, 2009, SCIENCE, V324, P1726, DOI 10.1126/science.1171716; Wang JF, 2009, NAT STRUCT MOL BIOL, V16, P1267, DOI 10.1038/nsmb.1707; Wang Y, 2008, P NATL ACAD SCI USA, V105, P9598, DOI 10.1073/pnas.0801786105; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6; Zhou YP, 2008, MOL CELL, V31, P896, DOI 10.1016/j.molcel.2008.08.028; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	37	310	317	1	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2011	476	7358					109	113		10.1038/nature10257	http://dx.doi.org/10.1038/nature10257			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NR	21785437	Green Accepted			2022-12-01	WOS:000293447300040
J	Mukhtar, MS; Carvunis, AR; Dreze, M; Epple, P; Steinbrenner, J; Moore, J; Tasan, M; Galli, M; Hao, T; Nishimura, MT; Pevzner, SJ; Donovan, SE; Ghamsari, L; Santhanam, B; Romero, V; Poulin, MM; Gebreab, F; Gutierrez, BJ; Tam, S; Monachello, D; Boxem, M; Harbort, CJ; McDonald, N; Gai, LT; Chen, HM; He, YJ; Vandenhaute, J; Roth, FP; Hill, DE; Ecker, JR; Vidal, M; Beynon, J; Braun, P; Dangl, JL				Mukhtar, M. Shahid; Carvunis, Anne-Ruxandra; Dreze, Matija; Epple, Petra; Steinbrenner, Jens; Moore, Jonathan; Tasan, Murat; Galli, Mary; Hao, Tong; Nishimura, Marc T.; Pevzner, Samuel J.; Donovan, Susan E.; Ghamsari, Lila; Santhanam, Balaji; Romero, Viviana; Poulin, Matthew M.; Gebreab, Fana; Gutierrez, Bryan J.; Tam, Stanley; Monachello, Dario; Boxem, Mike; Harbort, Christopher J.; McDonald, Nathan; Gai, Lantian; Chen, Huaming; He, Yijian; Vandenhaute, Jean; Roth, Frederick P.; Hill, David E.; Ecker, Joseph R.; Vidal, Marc; Beynon, Jim; Braun, Pascal; Dangl, Jeffery L.		European Union Effectoromics Conso	Independently Evolved Virulence Effectors Converge onto Hubs in a Plant Immune System Network	SCIENCE			English	Article							DISEASE RESISTANCE; ARMS-RACE; ARABIDOPSIS; VIRUS	Plants generate effective responses to infection by recognizing both conserved and variable pathogen-encoded molecules. Pathogens deploy virulence effector proteins into host cells, where they interact physically with host proteins to modulate defense. We generated an interaction network of plant-pathogen effectors from two pathogens spanning the eukaryote-eubacteria divergence, three classes of Arabidopsis immune system proteins, and similar to 8000 other Arabidopsis proteins. We noted convergence of effectors onto highly interconnected host proteins and indirect, rather than direct, connections between effectors and plant immune receptors. We demonstrated plant immune system functions for 15 of 17 tested host proteins that interact with effectors from both pathogens. Thus, pathogens from different kingdoms deploy independently evolved virulence proteins that interact with a limited set of highly connected cellular hubs to facilitate their diverse life-cycle strategies.	[Carvunis, Anne-Ruxandra; Dreze, Matija; Hao, Tong; Pevzner, Samuel J.; Ghamsari, Lila; Santhanam, Balaji; Romero, Viviana; Poulin, Matthew M.; Gebreab, Fana; Gutierrez, Bryan J.; Tam, Stanley; Monachello, Dario; Roth, Frederick P.; Hill, David E.; Vidal, Marc; Braun, Pascal] Dana Farber Canc Inst, Ctr Canc Syst Biol CCSB, Boston, MA 02215 USA; [Carvunis, Anne-Ruxandra; Dreze, Matija; Hao, Tong; Pevzner, Samuel J.; Ghamsari, Lila; Santhanam, Balaji; Romero, Viviana; Poulin, Matthew M.; Gebreab, Fana; Gutierrez, Bryan J.; Tam, Stanley; Monachello, Dario; Roth, Frederick P.; Hill, David E.; Vidal, Marc; Braun, Pascal] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Mukhtar, M. Shahid; Epple, Petra; Nishimura, Marc T.; Harbort, Christopher J.; McDonald, Nathan; He, Yijian; Dangl, Jeffery L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Carvunis, Anne-Ruxandra; Dreze, Matija; Hao, Tong; Pevzner, Samuel J.; Ghamsari, Lila; Santhanam, Balaji; Romero, Viviana; Poulin, Matthew M.; Gebreab, Fana; Gutierrez, Bryan J.; Tam, Stanley; Hill, David E.; Vidal, Marc; Braun, Pascal] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Carvunis, Anne-Ruxandra] CNRS, Computat & Math Biol Grp, TIMC IMAG, UMR5525, F-38706 La Tronche, France; [Carvunis, Anne-Ruxandra] Univ Grenoble, Fac Med, F-38706 La Tronche, France; [Dreze, Matija; Vandenhaute, Jean] Fac Univ Notre Dame Paix, Unite Rech Biol Mol, B-5000 Namur, Wallonia Brusse, Belgium; [Steinbrenner, Jens; Donovan, Susan E.] Univ Warwick, Sch Life Sci, Wellesbourne CV35, Warwick, England; [Moore, Jonathan] Univ Warwick, Warwick Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England; [Tasan, Murat] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Galli, Mary; Gai, Lantian; Chen, Huaming; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Pevzner, Samuel J.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; Boston Univ, Sch Med, Boston, MA 02118 USA; [Monachello, Dario] Univ Evry Val Essonne European Res Lab UEVE ERL, CNRS, Inst Natl Rech Agron INRA, Unite Mixte Rech Genom Vegetale URGV,UM, F-91057 Evry, France; [Boxem, Mike] Univ Utrecht, NL-3584 CH Utrecht, Netherlands; [Roth, Frederick P.] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Boston, MA 02115 USA; [Ecker, Joseph R.] Salk Inst Biol Studies, Biol Lab, La Jolla, CA 92037 USA; [Dangl, Jeffery L.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Dangl, Jeffery L.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Dangl, Jeffery L.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite de Franche-Comte; University of Namur; University of Warwick; University of Warwick; Harvard University; Harvard Medical School; Salk Institute; Boston University; Boston University; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Utrecht University; Harvard University; Harvard Medical School; Salk Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Vidal, M (corresponding author), Dana Farber Canc Inst, Ctr Canc Syst Biol CCSB, Boston, MA 02215 USA.	marc_vidal@dfci.harvard.edu; jim.beynon@warwick.ac.uk; pascal_braun@dfci.harvard.edu; dangl@email.unc.edu	Ecker, Joseph R/B-9144-2008; Moore, Jonathan D/D-1796-2013; Cabral, Adriana/AAX-3284-2021; Braun, Pascal/B-9669-2013; Dreze, Matija/AAZ-3293-2020; Boxem, Mike/B-8857-2011; Harbort, Christopher/AAJ-7642-2020; Van den Ackerveken, Guido/B-8568-2011; Roth, Frederick P/H-6308-2011; Hill, David E/B-6617-2011	Ecker, Joseph R/0000-0001-5799-5895; Moore, Jonathan D/0000-0002-5486-0407; Braun, Pascal/0000-0003-2012-6746; Van den Ackerveken, Guido/0000-0002-0183-8978; Yatusevich, Ruslan/0000-0001-5382-4079; Nishimura, Marc Tad/0000-0003-4666-6900; /0000-0001-7002-8488; Mukhtar, Shahid/0000-0002-1104-6931; Roth, Frederick/0000-0002-6628-649X; Carvunis, Anne-Ruxandra/0000-0002-6474-6413; Harbort, CJ/0000-0002-2564-8941; McDonald, Nathan/0000-0003-2716-3881; Chen, Huaming/0000-0001-5289-7882; Steinbrenner, Jens/0000-0003-1008-2268	NIH [GM-066025, P50-HG004233]; NSF [2010 0929410, 0703905, 0520253, 0313578, 0726408]; U.S. Department of Energy (DOE) [FG02-95ER20187]; U.K. Biotechnology and Biological Sciences Research Council [E024815, F005806, G015066]; European Commission [LSHG-CT-2006-037704]; European Research Area in Plant Genomics; Biotechnology and Biological Sciences Research Council [BB/E024815/1, BB/G015066/1] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066025] Funding Source: NIH RePORTER; BBSRC [BB/E024815/1, BB/G015066/1] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); U.K. Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Area in Plant Genomics; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by NIH GM-066025, NSF 2010 0929410, and U.S. Department of Energy (DOE) FG02-95ER20187 to J.L.D.; U.K. Biotechnology and Biological Sciences Research Council E024815, F005806 and G015066 to J.B.; NSF 0703905 to M. V., J.R.E., D. E. H.; NIH P50-HG004233 to M. V.; and NSF 0520253, 0313578 and 0726408 to J.R.E. D. M. was supported by AGRONOMICS LSHG-CT-2006-037704 from Sixth Framework Programme of the European Commission to C. Lurin. We acknowledge that the NSF funded the Arabidopsis Biological Research Center and the Salk Institute Genomic Analysis Laboratory (SIGnAL) projects for seeds and clones, respectively. We thank L. Baxter (Warwick Systems Biology, UK) for Arabidopsis/Papaya ortholog identification; B. Charloteaux (Center of Cancer Systems Biology, Boston, USA) for assisting in some bioinformatics analyses; B. Kemmerling (University of Tuebingen, Germany) for several RLK clones not contained in SIGnAL; and C. Somerville and Y. Gu (University of California, Berkeley, USA), T. Mengiste (Purdue University, USA), and X.-W. Deng (Yale University, USA) for seeds. The EU Effectoromics Consortium was funded by the European Research Area in Plant Genomics and includes A. Cabral and G. van den Ackerveken (Utrecht University, The Netherlands); J. Bator, R. Yatusevich, S. Katou and J. Parker (Max Planck Institute for Plant Breeding Research, Cologne, Germany); G. Fabro and J. Jones (The Sainsbury Laboratory, Norwich, UK); and M. Coates and T. Payne (University of Warwick, Warwick, UK). M. V. is a Chercheur Qualifie Honoraire from the Fonds de la Recherche Scientifique (FRS-FNRS, Wallonia-Brussels Federation, Belgium). Binary interaction data are supplied in table S2 in SOM. Homozygous mutant seed stocks noted in Figure 4 are available from the Arabidopsis Biological Resource Center (ABRC). Author contributions are listed in the SOM.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; Cusick ME, 2009, NAT METHODS, V6, P39, DOI [10.1038/NMETH.1284, 10.1038/nmeth.1284]; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dreze M, 2010, METHOD ENZYMOL, V470, P281, DOI 10.1016/S0076-6879(10)70012-4; Dyer MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012089; Gusmaroli G, 2007, PLANT CELL, V19, P564, DOI 10.1105/tpc.106.047571; Holub EB, 2001, NAT REV GENET, V2, P516, DOI 10.1038/35080508; Jaillais Y, 2010, NAT STRUCT MOL BIOL, V17, P642, DOI 10.1038/nsmb0610-642; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Lewis JD, 2009, SEMIN CELL DEV BIOL, V20, P1055, DOI 10.1016/j.semcdb.2009.06.003; Lozano-Duran R, 2011, PLANT CELL, V23, P1014, DOI 10.1105/tpc.110.080267; Lukasik E, 2009, CURR OPIN PLANT BIOL, V12, P427, DOI 10.1016/j.pbi.2009.03.001; Peng ZY, 2009, NUCLEIC ACIDS RES, V37, pD975, DOI 10.1093/nar/gkn873; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Tan XP, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-56; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang PF, 2005, PLANT PHYSIOL, V138, P27, DOI 10.1104/pp.105.060376; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	33	576	592	5	249	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2011	333	6042					596	601		10.1126/science.1203659	http://dx.doi.org/10.1126/science.1203659			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21798943	Green Submitted, Green Accepted			2022-12-01	WOS:000293222400053
J	Liu, CL; Yang, XV; Wu, JJ; Kuei, C; Mani, NS; Zhang, L; Yu, JX; Sutton, SW; Qin, N; Banie, H; Karlsson, L; Sun, SQ; Lovenberg, TW				Liu, Changlu; Yang, Xia V.; Wu, Jiejun; Kuei, Chester; Mani, Neelakandha S.; Zhang, Li; Yu, Jingxue; Sutton, Steven W.; Qin, Ning; Banie, Homayon; Karlsson, Lars; Sun, Siquan; Lovenberg, Timothy W.			Oxysterols direct B-cell migration through EBI2	NATURE			English	Article							CHOLESTEROL-METABOLISM; NUCLEAR RECEPTOR; IDENTIFICATION; ACTIVATION; CATALYZES; RESPONSES; MOUSE	EBI2 (also called GPR183) is an orphan G-protein-coupled receptor that is highly expressed in spleen and upregulated upon Epstein-Barr-virus infection(1). Recent studies indicated that this receptor controls follicular B-cell migration and T-cell-dependent antibody production(2-6). Oxysterols elicit profound effects on immune and inflammatory responses as well as on cholesterol metabolism(7-9). The biological effects of oxysterols have largely been credited to the activation of nuclear hormone receptors(10,11). Here we isolate oxysterols from porcine spleen extracts and show that they are endogenous ligands for EBI2. The most potent ligand and activator is 7 alpha,25-dihydroxycholesterol (OHC), with a dissociation constant of 450 pM for EBI2. In vitro, 7 alpha,25-OHC stimulated the migration of EBI2-expressing mouse B and T cells with half-maximum effective concentration values around 500 pM, but had no effect on EBI2-deficient cells. In vivo, EBI2-deficient B cells or normal B cells desensitized by 7 alpha,25-OHC pre-treatment showed reduced homing to follicular areas of the spleen. Blocking the synthesis of 7 alpha,25-OHC in vivo with clotrimazole, a CYP7B1 inhibitor, reduced the content of 7 alpha,25-OHC in the mouse spleen and promoted the migration of adoptively transferred pre-activated B cells to the T/B boundary (the boundary between the T-zone and B-zone in the spleen follicle), mimicking the phenotype of pre-activated B cells from EBI2-deficient mice. Our results show an unexpected causal link between EBI2, an orphan G-protein-coupled receptor controlling B-cell migration, and the known immunological effects of certain oxysterols, thus uncovering a previously unknown role for this class of molecules.	[Liu, Changlu; Yang, Xia V.; Wu, Jiejun; Kuei, Chester; Mani, Neelakandha S.; Zhang, Li; Yu, Jingxue; Sutton, Steven W.; Qin, Ning; Banie, Homayon; Karlsson, Lars; Sun, Siquan; Lovenberg, Timothy W.] Johnson & Johnson Pharmaceut Res & Dev LLC, San Diego, CA 92121 USA	Johnson & Johnson; Johnson & Johnson USA	Liu, CL (corresponding author), Johnson & Johnson Pharmaceut Res & Dev LLC, 3210 Merryfield Row, San Diego, CA 92121 USA.	cliu9@its.jnj.com	Yang, Xia V/F-6911-2011	Zhang, Li/0000-0001-6656-6064				Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; BIRKENBACH M, 1993, J VIROL, V67, P2209, DOI 10.1128/JVI.67.4.2209-2220.1993; Bjorkhem I, 2002, ARTERIOSCL THROM VAS, V22, P734, DOI 10.1161/01.ATV.0000013312.32196.49; CALI JJ, 1991, J BIOL CHEM, V266, P7774; Chan TD, 2010, IMMUNOL REV, V237, P90, DOI 10.1111/j.1600-065X.2010.00942.x; Diczfalusy U, 2009, J LIPID RES, V50, P2258, DOI 10.1194/jlr.M900107-JLR200; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; HANNEDOUCHE S, 2011, NATURE, DOI DOI 10.1038/10280; Jin LH, 2010, MOL ENDOCRINOL, V24, P923, DOI 10.1210/me.2009-0507; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; Kesteman N, 2008, J LEUKOCYTE BIOL, V83, P640, DOI 10.1189/jlb.0807578; Kumar BS, 2011, ANAL BIOCHEM, V408, P242, DOI 10.1016/j.ab.2010.09.031; Li DS, 2000, STEROIDS, V65, P529, DOI 10.1016/S0039-128X(00)00131-8; Liu CL, 2003, J BIOL CHEM, V278, P50754, DOI 10.1074/jbc.M308995200; Lund EG, 1998, J BIOL CHEM, V273, P34316, DOI 10.1074/jbc.273.51.34316; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Paila YD, 2010, SUBCELL BIOCHEM, V51, P439, DOI 10.1007/978-90-481-8622-8_16; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Pereira JP, 2010, INT IMMUNOL, V22, P413, DOI 10.1093/intimm/dxq047; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Rose KA, 1997, P NATL ACAD SCI USA, V94, P4925, DOI 10.1073/pnas.94.10.4925; Russell DW, 2000, BBA-MOL CELL BIOL L, V1529, P126, DOI 10.1016/S1388-1981(00)00142-6; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; SMITH LL, 1987, CHEM PHYS LIPIDS, V44, P87, DOI 10.1016/0009-3084(87)90046-6; St'astna E, 2010, STEROIDS, V75, P721, DOI 10.1016/j.steroids.2010.04.010; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Zhao CY, 2010, J ENDOCRINOL, V204, P233, DOI 10.1677/JOE-09-0271	29	247	253	4	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2011	475	7357					519	U121		10.1038/nature10226	http://dx.doi.org/10.1038/nature10226			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21796211				2022-12-01	WOS:000293167900045
J	Hack, M; Schluchter, M; Andreias, L; Margevicius, S; Taylor, HG; Drotar, D; Cuttler, L				Hack, Maureen; Schluchter, Mark; Andreias, Laura; Margevicius, Seunghee; Taylor, H. Gerry; Drotar, Dennis; Cuttler, Leona			Change in Prevalence of Chronic Conditions Between Childhood and Adolescence Among Extremely Low-Birth-Weight Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-CARE NEEDS; CHRONIC LUNG-DISEASE; BODY-MASS INDEX; IDENTIFYING CHILDREN; FOLLOW-UP; FUNCTIONAL LIMITATIONS; 12-YEAR-OLD CHILDREN; EXTREMELY PRETERM; YOUNG ADULTHOOD; PREMATURE BIRTH	Context Extremely low-birth-weight (ELBW) children have high rates of chronic conditions during childhood. Information on their trajectory of health during adolescence is needed for health care planning. Objective To examine changes in the rates of chronic conditions between the ages of 8 and 14 years among ELBW children compared with normal-birth-weight (NBW) controls. Design, Setting, and Participants Cohort study conducted from 2004 through 2009 of 181 ELBW children (weight < 1 kg) and 115 NBW controls of similar sociodemographic status born from 1992 through 1995 in Cleveland, Ohio. Main Outcome Measures Rates of chronic conditions overall (measured with the revised Questionnaire for Identifying Children With Chronic Conditions) and rates of asthma and obesity. Results The overall rates of chronic conditions did not change significantly between the ages of 8 and 14 years among ELBW children (75% at age 8 years vs 74% at age 14 years) or NBW controls (37% at age 8 years vs 47% at age 14 years). In generalized estimating equations logistic regression adjusting for sociodemographic status, sex, and race, ELBW children continued to have a higher rate of chronic conditions than NBW controls at age 14 years (74% vs 47%, respectively, adjusted odds ratio [AOR], 2.8 [95% confidence interval {CI}, 1.7 to 4.6]). Rates of asthma requiring medication did not change between the ages of 8 and 14 years among ELBW children (23% at both ages) but increased among NBW controls from 8% at age 8 years to 17% at age 14 years (P=.002). Differences in rates of asthma between ELBW and NBW children were no longer significant at the age of 14 years (23% vs 17%, respectively; AOR, 1.5 [95% CI, 0.8 to 2.8]). Mean z scores for body mass index increased in ELBW children from 0.06 at age 8 years to 0.38 at age 14 years (P<.001) and rates of obesity increased from 12% at age 8 years to 19% at age 14 years (P=.02). However, the scores and rates did not change among NBW controls such that at the age of 14 years the differences between ELBW and NBW children in mean z scores for body mass index (0.38 vs 0.56, respectively; adjusted mean difference -0.2 [95% CI, -0.5 to 0.1]) or rates of obesity (19% vs 20%, respectively; AOR, 1.1 [95% CI, 0.6 to 2.0]) were not significant. Conclusions Among ELBW children, rates of overall chronic conditions and asthma did not change between the ages of 8 and 14 years but the rate of obesity increased. Compared with NBW controls, the rates of chronic conditions were higher but there were no significant differences in the rates of asthma or obesity. JAMA. 2011;306(4): 394-401 www.jama.com	[Hack, Maureen; Andreias, Laura; Taylor, H. Gerry; Cuttler, Leona] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Schluchter, Mark; Margevicius, Seunghee] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Drotar, Dennis] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA	Case Western Reserve University; Case Western Reserve University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Hack, M (corresponding author), Univ Hosp Cleveland, Case Med Ctr, Rainbow Babies & Childrens Hosp, 11100 Euclid Ave, Cleveland, OH 44106 USA.	mxh7@case.edu			National Institutes of Health [R01 HD 39756, M01 RR000, ULI RR024989]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039756] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by grants R01 HD 39756, M01 RR000, and ULI RR024989 from the National Institutes of Health. Part of the salaries of Drs Hack, Schluchter, Taylor, and Andreias and Ms Margivicius was funded by the National Institutes of Health grants.	Akinbami LJ, 2009, PEDIATRICS, V123, pS131, DOI 10.1542/peds.2008-2233C; Anderson P, 2003, JAMA-J AM MED ASSOC, V289, P3264, DOI 10.1001/jama.289.24.3264; [Anonymous], [No title captured]; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Barton M, 2010, PEDIATRICS, V125, P361, DOI 10.1542/peds.2009-2037; Bethell CD, 2008, MATERN CHILD HLTH J, V12, P1, DOI 10.1007/s10995-007-0220-5; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Bloom Barbara, 2009, Vital Health Stat 10, P1; Breslau N, 2004, PEDIATRICS, V114, P1035, DOI 10.1542/peds.2004-0069; Data Resource Center for Child and Adolescent Health supported by Cooperative Agreement from the U.S. Department of Health and Human Services HRaSA Maternal and Child Health Bureau, CHILD AD HLTH MEAS I; Doyle LW, 1999, PEDIATR PULM, V27, P185, DOI 10.1002/(SICI)1099-0496(199903)27:3<185::AID-PPUL6>3.0.CO;2-0; Doyle LW, 2003, PEDIATRICS, V112, P565, DOI 10.1542/peds.112.3.565; Doyle LW, 2001, ARCH DIS CHILD-FETAL, V85, pF159, DOI 10.1136/fn.85.3.F159; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Farooqi A, 2006, PEDIATRICS, V118, pE1466, DOI 10.1542/peds.2006-1070; Fawke J, 2010, AM J RESP CRIT CARE, V182, P237, DOI 10.1164/rccm.200912-1806OC; FEUER EJ, 1989, BIOMETRICS, V45, P629, DOI 10.2307/2531505; Gaddlin PO, 2007, ACTA PAEDIATR, V96, P499, DOI 10.1111/j.1651-2227.2007.00183.x; Hack M, 2005, JAMA-J AM MED ASSOC, V294, P318, DOI 10.1001/jama.294.3.318; Hack M, 2003, PEDIATRICS, V112, pE30, DOI 10.1542/peds.112.1.e30; Halvorsen T, 2005, PEDIAT ALLERG IMM-UK, V16, P487, DOI 10.1111/j.1399-3038.2005.00314.x; Koumbourlis AC, 1996, PEDIATR PULM, V21, P28, DOI 10.1002/(SICI)1099-0496(199601)21:1<28::AID-PPUL5>3.0.CO;2-M; Mai XM, 2003, PEDIATR ALLERGY IMMU, V14, P184, DOI 10.1034/j.1399-3038.2003.00045.x; McPherson M, 1998, PEDIATRICS, V102, P137, DOI 10.1542/peds.102.1.137; Newacheck PW, 2005, ARCH PEDIAT ADOL MED, V159, P10, DOI 10.1001/archpedi.159.1.10; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Perrin JM, 2007, JAMA-J AM MED ASSOC, V297, P2755, DOI 10.1001/jama.297.24.2755; Saigal S, 2001, PEDIATRICS, V108, P407, DOI 10.1542/peds.108.2.407; Saigal S, 2006, PEDIATR RES, V60, P751, DOI 10.1203/01.pdr.0000246201.93662.8e; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Stein REK, 1997, PEDIATRICS, V99, P513, DOI 10.1542/peds.99.4.513; Stein REK, 2000, ARCH PEDIAT ADOL MED, V154, P447, DOI 10.1001/archpedi.154.5.447; Stein REK, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.4.e61; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Subbarao P, 2009, CAN MED ASSOC J, V181, pE181, DOI 10.1503/cmaj.080612; Taylor HG, 2004, J INT NEUROPSYCH SOC, V10, P149, DOI 10.1017/S1355617704102038; Van Cleave J, 2010, JAMA-J AM MED ASSOC, V303, P623, DOI 10.1001/jama.2010.104; van der Lee JH, 2007, JAMA-J AM MED ASSOC, V297, P2741, DOI 10.1001/jama.297.24.2741; *WHO, 1999, INT CLASS FUNCT DIS; Wise PH, 2007, CRITICAL ANAL CARE C	40	41	47	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2011	306	4					394	401		10.1001/jama.2011.1025	http://dx.doi.org/10.1001/jama.2011.1025			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	797KL	21791688	Bronze, Green Accepted			2022-12-01	WOS:000293125800025
J	Wollmann, P; Cui, S; Viswanathan, R; Berninghausen, O; Wells, MN; Moldt, M; Witte, G; Butryn, A; Wendler, P; Beckmann, R; Auble, DT; Hopfner, KP				Wollmann, Petra; Cui, Sheng; Viswanathan, Ramya; Berninghausen, Otto; Wells, Melissa N.; Moldt, Manuela; Witte, Gregor; Butryn, Agata; Wendler, Petra; Beckmann, Roland; Auble, David T.; Hopfner, Karl-Peter			Structure and mechanism of the Swi2/Snf2 remodeller Mot1 in complex with its substrate TBP	NATURE			English	Article							TATA-BINDING PROTEIN; RNA-POLYMERASE-II; PREINITIATION COMPLEX; DNA; TRANSCRIPTION; CHROMATIN; SOFTWARE; PROMOTER; SYSTEM; NC2	Swi2/Snf2-type ATPases regulate genome-associated processes such as transcription, replication and repair by catalysing the disruption, assembly or remodelling of nucleosomes or other protein-DNA complexes(1,2). It has been suggested that ATP-driven motor activity along DNA disrupts target protein-DNA interactions in the remodelling reaction(3-5). However, the complex and highly specific remodelling reactions are poorly understood, mostly because of a lack of high-resolution structural information about how remodellers bind to their substrate proteins. Mot1 (modifier of transcription 1 in Saccharomyces cerevisiae, denoted BTAF1 in humans) is a Swi2/Snf2 enzyme that specifically displaces the TATA box binding protein (TBP) from the promoter DNA and regulates transcription globally by generating a highly dynamic TBP pool in the cell(6,7). As a Swi2/Snf2 enzyme that functions as a single polypeptide and interacts with a relatively simple substrate, Mot1 offers an ideal system from which to gain a better understanding of this important enzyme family. To reveal how Mot1 specifically disrupts TBP-DNA complexes, we combined crystal and electron microscopy structures of Mot1-TBP from Encephalitozoon cuni-culi with biochemical studies. Here we show that Mot1 wraps around TBP and seems to act like a bottle opener: a spring-like array of 16 HEAT(huntingtin, elongation factor 3, protein phosphatase 2A and lipid kinase TOR) repeats grips the DNA-distal side of TBP via loop insertions, and the Swi2/Snf2 domain binds to upstream DNA, positioned to weaken the TBP-DNA interaction by DNA translocation. A 'latch' subsequently blocks the DNA-binding groove of TBP, acting as a chaperone to prevent DNA re-association and ensure efficient promoter clearance. This work shows how a remodelling enzyme can combine both motor and chaperone activities to achieve functional specificity using a conserved Swi2/Snf2 translocase.	[Wollmann, Petra; Cui, Sheng; Berninghausen, Otto; Moldt, Manuela; Witte, Gregor; Butryn, Agata; Wendler, Petra; Beckmann, Roland; Hopfner, Karl-Peter] Univ Munich, Dept Biochem, D-81377 Munich, Germany; [Wollmann, Petra; Witte, Gregor; Hopfner, Karl-Peter] Gene Ctr Munich, Munich Ctr Adv Photon, D-81377 Munich, Germany; [Viswanathan, Ramya; Wells, Melissa N.; Auble, David T.] Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Witte, Gregor; Beckmann, Roland; Hopfner, Karl-Peter] Gene Ctr Munich, Ctr Integrated Prot Sci, D-81377 Munich, Germany	University of Munich; University of Munich; University of Virginia; University of Munich	Hopfner, KP (corresponding author), Univ Munich, Dept Biochem, Feodor Lynen Str 25, D-81377 Munich, Germany.	auble@virginia.edu; hopfner@lmb.uni-muenchen.de	Sheng, CUI/M-6405-2013; Witte, Gregor/B-4635-2011; Viswanathan, Ramya/L-5935-2019; Wendler, Petra/X-5799-2019; Wendler, Petra/C-9056-2014; Cui, Sheng/AAQ-1721-2020; Hopfner, Karl-Peter/B-6864-2014	Sheng, CUI/0000-0001-6329-3582; Witte, Gregor/0000-0003-0313-0962; Wendler, Petra/0000-0002-8285-2199; Hopfner, Karl-Peter/0000-0002-4528-8357; Butryn, Agata/0000-0002-5227-4770	German Research Council [SFB 646, SFB/TR5]; Excellence Initiative (Center for Integrated Protein Science, Munich); DFG [WE4628/1]; NIH [GM55763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055763, T32GM008136] Funding Source: NIH RePORTER	German Research Council(German Research Foundation (DFG)); Excellence Initiative (Center for Integrated Protein Science, Munich); DFG(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Max-Planck Crystallization Facility Martinsried. We thank M. Lucas, A. Schele, C. Ungewickell, J. Goetzl and Y. Hiruma for help with experimentation. We thank J.-P. Armache and M. Turk for help with electron microscopy data. We are grateful to G. Miller and S. Hahn for advice. We thank the staff at the SLS and ESRF for help with data collection. We thank P. Cramer and members of the Hopfner and Auble laboratories for discussions and comments on the manuscript. This work was supported by the German Research Council (SFB 646 and SFB/TR5) and Excellence Initiative (Center for Integrated Protein Science, Munich) to K.-P. H. and R. B., by DFG grant WE4628/1 to P. Wendler and by NIH grant GM55763 to D.T.A.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Auble DT, 2009, TRENDS BIOCHEM SCI, V34, P49, DOI 10.1016/j.tibs.2008.10.008; AUBLE DT, 1993, GENE DEV, V7, P844, DOI 10.1101/gad.7.5.844; Auble DT, 1997, MOL CELL BIOL, V17, P4842, DOI 10.1128/MCB.17.8.4842; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Chen HT, 2003, MOL CELL, V12, P437, DOI 10.1016/S1097-2765(03)00306-X; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Darst RP, 2003, J BIOL CHEM, V278, P13216, DOI 10.1074/jbc.M211445200; Darst RP, 2001, EMBO J, V20, P2028, DOI 10.1093/emboj/20.8.2028; Dasgupta A, 2002, P NATL ACAD SCI USA, V99, P2666, DOI 10.1073/pnas.052397899; de Graaf P, 2010, J CELL SCI, V123, P2663, DOI 10.1242/jcs.064097; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gangaraju VK, 2009, MOL CELL, V35, P58, DOI 10.1016/j.molcel.2009.05.013; Geisberg JV, 2004, MOL CELL, V14, P479, DOI 10.1016/j.molcel.2004.05.003; Gkikopoulos T, 2009, MOL CELL BIOL, V29, P4057, DOI 10.1128/MCB.00400-09; Hsu JY, 2008, GENE DEV, V22, P2353, DOI 10.1101/gad.1681808; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kagawa R, 2004, EMBO J, V23, P2734, DOI 10.1038/sj.emboj.7600293; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; Klejman MP, 2004, MOL CELL BIOL, V24, P10072, DOI 10.1128/MCB.24.22.10072-10082.2004; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller G, 2006, NAT STRUCT MOL BIOL, V13, P603, DOI 10.1038/nsmb1117; Mohibullah N, 2008, GENE DEV, V22, P2994, DOI 10.1101/gad.1724408; Pereira LA, 2004, J BIOL CHEM, V279, P21802, DOI 10.1074/jbc.M313519200; Pereira LA, 2001, MOL CELL BIOL, V21, P7523, DOI 10.1128/MCB.21.21.7523-7534.2001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POON D, 1994, J BIOL CHEM, V269, P23135; Pugh BF, 2000, GENE, V255, P1, DOI 10.1016/S0378-1119(00)00288-2; Racki LR, 2009, NATURE, V462, P1016, DOI 10.1038/nature08621; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Schluesche P, 2007, NAT STRUCT MOL BIOL, V14, P1196, DOI 10.1038/nsmb1328; Sprouse RO, 2006, EMBO J, V25, P1492, DOI 10.1038/sj.emboj.7601050; TIMMERS HTM, 1992, P NATL ACAD SCI USA, V89, P8140, DOI 10.1073/pnas.89.17.8140; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; van Werven FJ, 2008, GENE DEV, V22, P2359, DOI 10.1101/gad.1682308; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004	44	56	56	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 21	2011	475	7356					403	U168		10.1038/nature10215	http://dx.doi.org/10.1038/nature10215			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21734658	Green Accepted			2022-12-01	WOS:000292911200048
J	Jones, SB; Simmons, B; Mastracchio, A; MacMillan, DWC				Jones, Spencer B.; Simmons, Bryon; Mastracchio, Anthony; MacMillan, David W. C.			Collective synthesis of natural products by means of organocascade catalysis	NATURE			English	Article							INDOLE ALKALOIDS; ASPIDOSPERMA ALKALOIDS; CASCADE CATALYSIS; (+)-ASPIDOSPERMIDINE; (-)-STRYCHNINE; DERIVATIVES; CYCLIZATION; KOPSININE; OXIDATION	Organic chemists are now able to synthesize small quantities of almost any known natural product, given sufficient time, resources and effort. However, translation of the academic successes in total synthesis to the large-scale construction of complex natural products and the development of large collections of biologically relevant molecules present significant challenges to synthetic chemists. Here we show that the application of two nature-inspired techniques, namely organocascade catalysis and collective natural product synthesis, can facilitate the preparation of useful quantities of a range of structurally diverse natural products from a common molecular scaffold. The power of this concept has been demonstrated through the expedient, asymmetric total syntheses of six well-known alkaloid natural products: strychnine, aspidospermidine, vincadifformine, akuammicine, kopsanone and kopsinine.	[Jones, Spencer B.; Simmons, Bryon; Mastracchio, Anthony; MacMillan, David W. C.] Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA	Princeton University	MacMillan, DWC (corresponding author), Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA.	dmacmill@princeton.edu			NIHGMS [R01 GM078201-05]; Bristol-Myers Squibb; Merck; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078201] Funding Source: NIH RePORTER	NIHGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Bristol-Myers Squibb(Bristol-Myers Squibb); Merck(Merck & Company); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support was provided by NIHGMS (R01 GM078201-05) and gifts from Merck, Bristol-Myers Squibb and Abbott. S.B.J. and B. S. thank Bristol-Myers Squibb and Merck, respectively, for graduate fellowships.	ANET FAL, 1953, CHEM IND-LONDON, P245; Bandarage UK, 1999, TETRAHEDRON, V55, P9405, DOI 10.1016/S0040-4020(99)00513-X; Bonjoch J, 2000, CHEM REV, V100, P3455, DOI 10.1021/cr9902547; Cho HK, 2010, B KOREAN CHEM SOC, V31, P3382, DOI 10.5012/bkcs.2010.31.11.3382; COREY EJ, 1991, TETRAHEDRON LETT, V32, P7517, DOI 10.1016/0040-4039(91)80522-8; Dewick P. M., 2008, MED NATURAL PRODUCTS; GALLAGHER T, 1983, J AM CHEM SOC, V105, P2086, DOI 10.1021/ja00345a081; GATTA F, 1987, J HETEROCYCLIC CHEM, V24, P1183, DOI 10.1002/jhet.5570240449; Gnecco D, 2003, ARKIVOC, P185, DOI 10.3998/ark.5550190.0004.b19; Grondal C, 2010, NAT CHEM, V2, P167, DOI [10.1038/NCHEM.539, 10.1038/nchem.539]; Hajicek J, 2004, COLLECT CZECH CHEM C, V69, P1681, DOI 10.1135/cccc20041681; Huang Y, 2005, J AM CHEM SOC, V127, P15051, DOI 10.1021/ja055545d; Jeffery T, 1996, TETRAHEDRON, V52, P10113, DOI 10.1016/0040-4020(96)00547-9; Jones SB, 2009, J AM CHEM SOC, V131, P13606, DOI 10.1021/ja906472m; KNIGHT SD, 1993, J AM CHEM SOC, V115, P9293, DOI 10.1021/ja00073a057; Kobayashi S, 1999, TETRAHEDRON LETT, V40, P1519, DOI 10.1016/S0040-4039(98)02667-7; Kozmin SA, 2002, J AM CHEM SOC, V124, P4628, DOI 10.1021/ja017863s; KUEHNE ME, 1985, J ORG CHEM, V50, P4790, DOI 10.1021/jo00224a027; KUEHNE ME, 1995, SYNLETT, P557; Kuehne ME, 1998, J ORG CHEM, V63, P2172, DOI 10.1021/jo971838g; KUMP C, 1966, HELV CHIM ACTA, V49, P1237, DOI 10.1002/hlca.19660490403; MAGNUS P, 1985, J CHEM SOC CHEM COMM, P184, DOI 10.1039/c39850000184; Magnus P, 2000, TETRAHEDRON LETT, V41, P2077, DOI 10.1016/S0040-4039(00)00118-0; Marino JP, 2002, J AM CHEM SOC, V124, P13398, DOI 10.1021/ja026357f; Martin DBC, 2011, CHEM SCI, V2, P649, DOI 10.1039/c1sc00009h; Mori M, 2003, J AM CHEM SOC, V125, P9801, DOI 10.1021/ja029382u; Oestreich M., 2009, MIZOROKI HECK REACTI; OGAWA M, 1987, TETRAHEDRON LETT, V28, P3985, DOI 10.1016/S0040-4039(00)96438-4; PRASHAD M, 1995, SYNTHETIC COMMUN, V25, P95, DOI 10.1080/00397919508010793; Reed J. W, 2007, WAY SYNTHESIS EVOLUT; Simmons B, 2009, ANGEW CHEM INT EDIT, V48, P4349, DOI 10.1002/anie.200900220; Sirasani G, 2010, J ORG CHEM, V75, P3529, DOI 10.1021/jo100516g; Sole D, 2003, J ORG CHEM, V68, P5746, DOI 10.1021/jo034299q; Sole D, 1999, ANGEW CHEM INT EDIT, V38, P395, DOI 10.1002/(SICI)1521-3773(19990201)38:3<395::AID-ANIE395>3.0.CO;2-5; THOMAS PJ, 1978, J CHEM SOC P2, V11, P1130; Va P, 2010, J AM CHEM SOC, V132, P8489, DOI 10.1021/ja1027748; Walji AM, 2007, SYNLETT, P1477, DOI 10.1055/s-2007-980382; WENKERT E, 1988, J ORG CHEM, V53, P4875, DOI 10.1021/jo00255a044	38	529	531	10	297	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2011	475	7355					183	188		10.1038/nature10232	http://dx.doi.org/10.1038/nature10232			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21753848	Green Accepted			2022-12-01	WOS:000292690500041
J	Takahashi, H; Parmely, TJ; Sato, S; Tomomori-Sato, C; Banks, CAS; Kong, SE; Szutorisz, H; Swanson, SK; Martin-Brown, S; Washburn, MP; Florens, L; Seidel, CW; Lin, CQ; Smith, ER; Shilatifard, A; Conaway, RC; Conaway, JW				Takahashi, Hidehisa; Parmely, Tari J.; Sato, Shigeo; Tomomori-Sato, Chieri; Banks, Charles A. S.; Kong, Stephanie E.; Szutorisz, Henrietta; Swanson, Selene K.; Martin-Brown, Skylar; Washburn, Michael P.; Florens, Laurence; Seidel, Chris W.; Lin, Chengqi; Smith, Edwin R.; Shilatifard, Ali; Conaway, Ronald C.; Conaway, Joan W.			Human Mediator Subunit MED26 Functions as a Docking Site for Transcription Elongation Factors	CELL			English	Article							RNA-POLYMERASE-II; CARBOXYL-TERMINAL-DOMAIN; P-TEFB KINASE; HEAT-SHOCK; FACTOR ELL; HIV-1 TAT; COMPLEX; PROMOTER; ACTIVATION; BINDING	Promoter-proximal pausing by initiated RNA polymerase II (Pol II) and regulated release of paused polymerase into productive elongation has emerged as a major mechanism of transcription activation. Reactivation of paused Pol II correlates with recruitment of super-elongation complexes (SECs) containing ELL/EAF family members, P-TEFb, and other proteins, but the mechanism of their recruitment is an unanswered question. Here, we present evidence for a role of human Mediator subunit MED26 in this process. We identify in the conserved N-terminal domain of MED26 overlapping docking sites for SEC and a second ELL/EAF-containing complex, as well as general initiation factor TFIID. In addition, we present evidence consistent with the model that MED26 can function as a molecular switch that interacts first with TFIID in the Pol II initiation complex and then exchanges TFIID for complexes containing ELL/EAF and P-TEFb to facilitate transition of Pol II into the elongation stage of transcription.	[Takahashi, Hidehisa; Parmely, Tari J.; Sato, Shigeo; Tomomori-Sato, Chieri; Banks, Charles A. S.; Kong, Stephanie E.; Szutorisz, Henrietta; Swanson, Selene K.; Martin-Brown, Skylar; Washburn, Michael P.; Florens, Laurence; Seidel, Chris W.; Lin, Chengqi; Smith, Edwin R.; Shilatifard, Ali; Conaway, Ronald C.; Conaway, Joan W.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Conaway, Ronald C.; Conaway, Joan W.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Conaway, JW (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	jlc@stowers.org	Hidehisa, Takahashi/E-2175-2012	Tomomori-Sato, Chieri/0000-0002-2543-293X; Banks, Charles/0000-0002-0404-2940; Washburn, Michael/0000-0001-7568-2585; Conaway, Joan/0000-0002-2786-0663; Lin, Chengqi/0000-0002-2121-584X; Florens, Laurence/0000-0002-9310-6650	Stowers Institute; NIGMS, NIH [GM41628]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041628, R01GM041628] Funding Source: NIH RePORTER	Stowers Institute; NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Suganuma for helpful discussions, M. Thirman for a generous gift of the anti-EAF1 antibody, K. Zueckert-Gaudenz and A. Peak for help with microarray experiments, and M. Katt and V. Neubauer for tissue culture. C.L. is a PhD thesis student registered with the Open University. This work was supported by funds from the Stowers Institute and by Grant GM41628 from NIGMS, NIH to J.W.C. and R.C.C.	Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Andrau JC, 2006, MOL CELL, V22, P179, DOI 10.1016/j.molcel.2006.03.023; Balamotis MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.1164302; Banks CAS, 2007, J BIOL CHEM, V282, P5761, DOI 10.1074/jbc.M610393200; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Belakavadi M, 2010, MOL CELL BIOL, V30, P2437, DOI 10.1128/MCB.01541-09; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Booth V, 2000, J BIOL CHEM, V275, P31266, DOI 10.1074/jbc.M002595200; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Byun JS, 2009, P NATL ACAD SCI USA, V106, P19292, DOI 10.1073/pnas.0905469106; Cai G, 2010, NAT STRUCT MOL BIOL, V17, P273, DOI 10.1038/nsmb.1757; Cai Y, 2007, NAT STRUCT MOL BIOL, V14, P872, DOI 10.1038/nsmb1276; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Johnson KM, 2002, GENE DEV, V16, P1852, DOI 10.1101/gad.995702; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kim YK, 2002, MOL CELL BIOL, V22, P4622, DOI 10.1128/MCB.22.13.4622-4637.2002; Kininis M, 2009, MOL CELL BIOL, V29, P1123, DOI 10.1128/MCB.00841-08; KOLESKE AJ, 1994, NATURE, V368, P466, DOI 10.1038/368466a0; Kong SE, 2005, P NATL ACAD SCI USA, V102, P10094, DOI 10.1073/pnas.0503017102; Lariviere L, 2006, NAT STRUCT MOL BIOL, V13, P895, DOI 10.1038/nsmb1143; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; Lis JT, 2000, GENE DEV, V14, P792; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Martincic K, 2009, NAT IMMUNOL, V10, P1102, DOI 10.1038/ni.1786; Mittler G, 2001, EMBO REP, V2, P808, DOI 10.1093/embo-reports/kve186; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; Montanuy I, 2008, J BIOL CHEM, V283, P7368, DOI 10.1074/jbc.M706243200; Mueller D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000249; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Naar AM, 2002, GENE DEV, V16, P1339, DOI 10.1101/gad.987602; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Park JM, 2001, MOL CELL, V8, P9, DOI 10.1016/S1097-2765(01)00296-9; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; SERIZAWA H, 1992, P NATL ACAD SCI USA, V89, P7476, DOI 10.1073/pnas.89.16.7476; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Shilatifard A, 1997, J BIOL CHEM, V272, P22355, DOI 10.1074/jbc.272.35.22355; Smith ER, 2008, P NATL ACAD SCI USA, V105, P8575, DOI 10.1073/pnas.0804379105; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Taatjes DJ, 2002, SCIENCE, V295, P1058, DOI 10.1126/science.1065249; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Takahashi H, 2009, J BIOL CHEM, V284, P32405, DOI 10.1074/jbc.M109.017954; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zhu XF, 2006, MOL CELL, V22, P169, DOI 10.1016/j.molcel.2006.03.032	61	234	247	1	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 8	2011	146	1					92	104		10.1016/j.cell.2011.06.005	http://dx.doi.org/10.1016/j.cell.2011.06.005			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729782	Bronze, Green Accepted			2022-12-01	WOS:000292539300009
J	Greene, JA; Kesselheim, AS				Greene, Jeremy A.; Kesselheim, Aaron S.			Why Do the Same Drugs Look Different? Pills, Trade Dress, and Public Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COLOR; PLACEBO; LITERACY		[Greene, Jeremy A.; Kesselheim, Aaron S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Greene, JA (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	greene@fas.harvard.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018465] Funding Source: NIH RePORTER	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		[Anonymous], 2010, CBS 60 MINUTES  1229; Berman Adrienne, 2004, J Med Syst, V28, P9, DOI 10.1023/B:JOMS.0000021518.60670.10; Cardenas-Valladolid J, 2010, DRUG AGING, V27, P641, DOI 10.2165/11537320-000000000-00000; CARPENTER D, B HIST MED IN PRESS; Cutler C, 2011, BIOL BLOOD MARROW TR, V17, P285, DOI 10.1016/j.bbmt.2010.11.006; Davit BM, 2009, ANN PHARMACOTHER, V43, P1583, DOI 10.1345/aph.1M141; deCraen AJM, 1996, BRIT MED J, V313, P1624, DOI 10.1136/bmj.313.7072.1624; Donohue JM, 2007, NEW ENGL J MED, V357, P673, DOI 10.1056/NEJMsa070502; FACCHINETTI NJ, 1982, AM J PUBLIC HEALTH, V72, P468, DOI 10.2105/AJPH.72.5.468; Frank RG, 2007, NEW ENGL J MED, V357, P1993, DOI 10.1056/NEJMp078193; Fritsch David, 2006, INTELLECTUAL PROPERT, V47, P171; Generic Pharmaceutical Association, FACTS GLANC; Gray S, NHS EVIDENCE RESP; Greene JeremyA., 2007, PRESCRIBING NUMBERS; Greenslit Nathan, 2002, Mol Interv, V2, P342, DOI 10.1124/mi.2.6.342; HARRINGTON A, 1997, PLACEBO EFFECT; Hellier Elizabeth, 2010, J Patient Saf, V6, P158; HORN CR, 1986, LANCET, V1, P165; HUSKISSON EC, 1974, BMJ-BRIT MED J, V4, P196, DOI 10.1136/bmj.4.5938.196; JACOBS KW, 1979, PERCEPT MOTOR SKILL, V49, P367, DOI 10.2466/pms.1979.49.2.367; Kenagy JW, 2001, AM J HEALTH-SYST PH, V58, P2033, DOI 10.1093/ajhp/58.21.2033; Kesselheim AS, 2008, JAMA-J AM MED ASSOC, V300, P2514, DOI 10.1001/jama.2008.758; Khan A, 2010, PSYCHOPHARMACOLOGY, V211, P113, DOI 10.1007/s00213-010-1874-z; Kirsche ML, 2005, DRUG STORE NEWS 0822; Kohn L, 2000, ERR IS HUMAN BUILDIN; Krieg M, 1967, BLACK MARKET MED; Lambert BL, 2005, DRUG SAFETY, V28, P495, DOI 10.2165/00002018-200528060-00003; Levinthal BR, 2008, J GEN INTERN MED, V23, P1172, DOI 10.1007/s11606-008-0612-2; LUCCHELLI PE, 1978, EUR J CLIN PHARMACOL, V13, P153, DOI 10.1007/BF00609760; Matheson Julia Anne, 2009, MED MARKET MEDIA, V44, P55; NEWMAN SJ, 1994, U CHICAGO LAW REV, V61, P1595, DOI 10.2307/1600127; Ngoh LN, 2009, J AM PHARM ASSOC, V49, pE132, DOI 10.1331/JAPhA.2009.07075; Sabate E., 2003, ADHERENCE LONG TERM; Schiff Gordon, 2004, J Med Syst, V28, P1, DOI 10.1023/B:JOMS.0000021517.51673.f3; Shrank WH, 2010, HEALTH AFFAIR, V29, P1383, DOI 10.1377/hlthaff.2009.0424; Stinson Nina, 1982, INDIANA LAW REV, V15, P733; Waber RL, 2008, JAMA-J AM MED ASSOC, V299, P1016, DOI 10.1001/jama.299.9.1016; Wolf MS, 2011, ARCH INTERN MED, V171, P300, DOI 10.1001/archinternmed.2011.39	38	55	55	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2011	365	1					83	89		10.1056/NEJMhle1101722	http://dx.doi.org/10.1056/NEJMhle1101722			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	788QL	21732842				2022-12-01	WOS:000292459400016
J	Shimamoto, Y; Maeda, YT; Ishiwata, S; Libchaber, AJ; Kapoor, TM				Shimamoto, Yuta; Maeda, Yusuke T.; Ishiwata, Shin'ichi; Libchaber, Albert J.; Kapoor, Tarun M.			Insights into the Micromechanical Properties of the Metaphase Spindle	CELL			English	Article							MITOTIC SPINDLE; MICROTUBULE DYNAMICS; CELL-DIVISION; MECHANICAL-PROPERTIES; TUBULIN; KINESIN; LENGTH; MOTOR; ORGANIZATION; CHROMOSOMES	The microtubule-based metaphase spindle is subjected to forces that act in diverse orientations and over a wide range of timescales. Currently, we cannot explain how this dynamic structure generates and responds to forces while maintaining overall stability, as we have a poor understanding of its micromechanical properties. Here, we combine the use of force-calibrated needles, high-resolution microscopy, and biochemical perturbations to analyze the vertebrate metaphase spindle's timescale- and orientation-dependent viscoelastic properties. We find that spindle viscosity depends on microtubule crosslinking and density. Spindle elasticity can be linked to kinetochore and nonkinetochore microtubule rigidity, and also to spindle pole organization by kinesin-5 and dynein. These data suggest a quantitative model for the micromechanics of this cytoskeletal architecture and provide insight into how structural and functional stability is maintained in the face of forces, such as those that control spindle size and position, and can result from deformations associated with chromosome movement.	[Shimamoto, Yuta; Kapoor, Tarun M.] Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10065 USA; [Maeda, Yusuke T.; Libchaber, Albert J.] Rockefeller Univ, Lab Expt Condensed Matter Phys, New York, NY 10065 USA; [Ishiwata, Shin'ichi] Waseda Univ, Fac Sci & Engn, Dept Phys, Shinjuku Ku, Tokyo 1698555, Japan	Rockefeller University; Rockefeller University; Waseda University	Kapoor, TM (corresponding author), Rockefeller Univ, Lab Chem & Cell Biol, 1230 York Ave, New York, NY 10065 USA.	kapoor@rockefeller.edu	Shimamoto, Yuta/AAH-3281-2019	Shimamoto, Yuta/0000-0003-0935-2793	National Institutes of Health/National Institute of General Medical Sciences [GM065933]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065933] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22227005, 21000011] Funding Source: KAKEN	National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	T.M.K. acknowledges support from the National Institutes of Health/National Institute of General Medical Sciences (GM065933). We also thank the Uehara memorial foundation (Y.S.) and the Japan Society for the Promotion of Science (Y.S. and Y.T.M.).	ALEXANDER SP, 1991, J CELL BIOL, V113, P805, DOI 10.1083/jcb.113.4.805; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Burbank KS, 2006, J CELL BIOL, V175, P369, DOI 10.1083/jcb.200511112; Chakravarty A, 2004, MOL BIOL CELL, V15, P2116, DOI 10.1091/mbc.E03-08-0579; Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; Desai A, 1999, METHOD CELL BIOL, V61, P385; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Dumont S, 2009, CURR BIOL, V19, P1086, DOI 10.1016/j.cub.2009.05.056; EVANS RM, 2009, SOFT MATTER PHYS, V80; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Gaetz J, 2004, J CELL BIOL, V166, P465, DOI 10.1083/jcb.200404015; Gardel ML, 2008, METHOD CELL BIOL, V89, P487, DOI 10.1016/S0091-679X(08)00619-5; Gatlin JC, 2010, J CELL BIOL, V188, P481, DOI 10.1083/jcb.200907110; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Goshima G, 2010, ANNU REV CELL DEV BI, V26, P21, DOI 10.1146/annurev-cellbio-100109-104006; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Houghtaling BR, 2009, P NATL ACAD SCI USA, V106, P15338, DOI 10.1073/pnas.0902317106; Howard J., 2001, MECH MOTOR PROTEINS; Hughes SE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000348; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; Itabashi T, 2009, NAT METHODS, V6, P167, DOI [10.1038/nmeth.1297, 10.1038/NMETH.1297]; Janmey PA, 2007, METHOD CELL BIOL, V83, P3, DOI 10.1016/S0091-679X(07)83001-9; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; KISHINO A, 1988, NATURE, V334, P74, DOI 10.1038/334074a0; Kwok BH, 2007, CURR OPIN CELL BIOL, V19, P36, DOI 10.1016/j.ceb.2006.12.003; LESLIE RJ, 1984, CELL, V36, P717, DOI 10.1016/0092-8674(84)90352-0; LIN Y, 1971, J CELL BIOL, V49, P468; McIntosh J R, 1975, Soc Gen Physiol Ser, V30, P31; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mitchison TJ, 2005, MOL BIOL CELL, V16, P3064, DOI 10.1091/mbc.E05-02-0174; Mogilner A, 2010, J CELL SCI, V123, P3435, DOI 10.1242/jcs.062208; Nedelec F, 2001, METH MOL B, V164, P213; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; NICKLAS RB, 1983, J CELL BIOL, V97, P542, DOI 10.1083/jcb.97.2.542; NICKLAS RB, 1965, J CELL BIOL, V25, P119, DOI 10.1083/jcb.25.1.119; Ohi R, 2007, CURR BIOL, V17, P953, DOI 10.1016/j.cub.2007.04.057; SALMON ED, 1984, J CELL BIOL, V99, P2165, DOI 10.1083/jcb.99.6.2165; SATO M, 1988, J CELL BIOL, V106, P1205, DOI 10.1083/jcb.106.4.1205; SAWIN KE, 1991, J CELL BIOL, V112, P941, DOI 10.1083/jcb.112.5.941; TAWADA K, 1991, J THEOR BIOL, V150, P193, DOI 10.1016/S0022-5193(05)80331-5; Tirnauer JS, 2004, MOL BIOL CELL, V15, P1776, DOI 10.1091/mbc.E03-11-0824; Valentine MT, 2004, BIOPHYS J, V86, P4004, DOI 10.1529/biophysj.103.037812; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Waters JC, 1996, J CELL SCI, V109, P2823; Wittmann T, 1999, METHOD CELL BIOL, V61, P137; Yang G, 2007, NAT CELL BIOL, V9, P1233, DOI 10.1038/ncb1643; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721	50	75	75	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 24	2011	145	7					1062	1074		10.1016/j.cell.2011.05.038	http://dx.doi.org/10.1016/j.cell.2011.05.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703450	Green Accepted, Bronze			2022-12-01	WOS:000292025700013
J	Jacquemont, S; Reymond, A; Zufferey, F; Harewood, L; Walters, RG; Kutalik, Z; Martinet, D; Shen, YP; Valsesia, A; Beckmann, ND; Thorleifsson, G; Belfiore, M; Bouquillon, S; Campion, D; de Leeuw, N; de Vries, BBA; Esko, T; Fernandez, BA; Fernandez-Aranda, F; Fernandez-Real, JM; Gratacos, M; Guilmatre, A; Hoyer, J; Jarvelin, MR; Kooy, RF; Kurg, A; Le Caignec, C; Mannik, K; Platt, OS; Sanlaville, D; Van Haelst, MM; Gomez, SV; Walha, F; Wu, BL; Yu, YG; Aboura, A; Addor, MC; Alembik, Y; Antonarakis, SE; Arveiler, B; Barth, M; Bednarek, N; Bena, F; Bergmann, S; Beri, M; Bernardini, L; Blaumeiser, B; Bonneau, D; Bottani, A; Boute, O; Brunner, HG; Cailley, D; Callier, P; Chiesa, J; Chrast, J; Coin, L; Coutton, C; Cuisset, JM; Cuvellier, JC; David, A; de Freminville, B; Delobel, B; Delrue, MA; Demeer, B; Descamps, D; Didelot, G; Dieterich, K; Disciglio, V; Doco-Fenzy, M; Drunat, S; Duban-Bedu, B; Dubourg, C; Moustafa, JSE; Elliott, P; Faas, BHW; Faivre, L; Faudet, A; Fellmann, F; Ferrarini, A; Fisher, R; Flori, E; Forer, L; Gaillard, D; Gerard, M; Gieger, C; Gimelli, S; Gimelli, G; Grabe, HJ; Guichet, A; Guillin, O; Hartikainen, AL; Heron, D; Hippolyte, L; Holder, M; Homuth, G; Isidor, B; Jaillard, S; Jaros, Z; Jimenez-Murcia, S; Helas, GJ; Jonveaux, P; Kaksonen, S; Keren, B; Kloss-Brandstatter, A; Knoers, NVAM; Koolen, DA; Kroisel, PM; Kronenberg, F; Labalme, A; Landais, E; Lapi, E; Layet, V; Legallic, S; Leheup, B; Leube, B; Lewis, S; Lucas, J; MacDermot, KD; Magnusson, P; Marshall, C; Mathieu-Dramard, M; McCarthy, MI; Meitinger, T; Mencarelli, MA; Merla, G; Moerman, A; Mooser, V; Morice-Picard, F; Mucciolo, M; Nauck, M; Ndiaye, NC; Nordgren, A; Pasquier, L; Petit, F; Pfundt, R; Plessis, G; Rajcan-Separovic, E; Ramelli, GP; Rauch, A; Ravazzolo, R; Reis, A; Renieri, A; Richart, C; Ried, JS; Rieubland, C; Roberts, W; Roetzer, KM; Rooryck, C; Rossi, M; Saemundsen, E; Satre, V; Schurmann, C; Sigurdsson, E; Stavropoulos, DJ; Stefansson, H; Tengstrom, C; Thorsteinsdottir, U; Tinahones, FJ; Touraine, R; Vallee, L; van Binsbergen, E; Van der Aa, N; Vincent-Delorme, C; Visvikis-Siest, S; Vollenweider, P; Volzke, H; Vulto-van Silfhout, AT; Waeber, G; Wallgren-Pettersson, C; Witwicki, RM; Zwolinksi, S; Andrieux, J; Estivill, X; Gusella, JF; Gustafsson, O; Metspalu, A; Scherer, SW; Stefansson, K; Blakemore, AIF; Beckmann, JS; Froguel, P				Jacquemont, Sebastien; Reymond, Alexandre; Zufferey, Flore; Harewood, Louise; Walters, Robin G.; Kutalik, Zoltan; Martinet, Danielle; Shen, Yiping; Valsesia, Armand; Beckmann, Noam D.; Thorleifsson, Gudmar; Belfiore, Marco; Bouquillon, Sonia; Campion, Dominique; de Leeuw, Nicole; de Vries, Bert B. A.; Esko, Tonu; Fernandez, Bridget A.; Fernandez-Aranda, Fernando; Manuel Fernandez-Real, Jose; Gratacos, Monica; Guilmatre, Audrey; Hoyer, Juliane; Jarvelin, Marjo-Riitta; Kooy, R. Frank; Kurg, Ants; Le Caignec, Cedric; Maennik, Katrin; Platt, Orah S.; Sanlaville, Damien; Van Haelst, Mieke M.; Villatoro Gomez, Sergi; Walha, Faida; Wu, Bai-lin; Yu, Yongguo; Aboura, Azzedine; Addor, Marie-Claude; Alembik, Yves; Antonarakis, Stylianos E.; Arveiler, Benoit; Barth, Magalie; Bednarek, Nathalie; Bena, Frederique; Bergmann, Sven; Beri, Mylene; Bernardini, Laura; Blaumeiser, Bettina; Bonneau, Dominique; Bottani, Armand; Boute, Odile; Brunner, Han G.; Cailley, Dorothee; Callier, Patrick; Chiesa, Jean; Chrast, Jacqueline; Coin, Lachlan; Coutton, Charles; Cuisset, Jean-Marie; Cuvellier, Jean-Christophe; David, Albert; de Freminville, Benedicte; Delobel, Bruno; Delrue, Marie-Ange; Demeer, Benedicte; Descamps, Dominique; Didelot, Gerard; Dieterich, Klaus; Disciglio, Vittoria; Doco-Fenzy, Martine; Drunat, Severine; Duban-Bedu, Benedicte; Dubourg, Christele; Moustafa, Julia S. El-Sayed; Elliott, Paul; Faas, Brigitte H. W.; Faivre, Laurence; Faudet, Anne; Fellmann, Florence; Ferrarini, Alessandra; Fisher, Richard; Flori, Elisabeth; Forer, Lukas; Gaillard, Dominique; Gerard, Marion; Gieger, Christian; Gimelli, Stefania; Gimelli, Giorgio; Grabe, Hans J.; Guichet, Agnes; Guillin, Olivier; Hartikainen, Anna-Liisa; Heron, Delphine; Hippolyte, Loyse; Holder, Muriel; Homuth, Georg; Isidor, Bertrand; Jaillard, Sylvie; Jaros, Zdenek; Jimenez-Murcia, Susana; Helas, Geraldine Joly; Jonveaux, Philippe; Kaksonen, Satu; Keren, Boris; Kloss-Brandstaetter, Anita; Knoers, Nine V. A. M.; Koolen, David A.; Kroisel, Peter M.; Kronenberg, Florian; Labalme, Audrey; Landais, Emilie; Lapi, Elisabetta; Layet, Valerie; Legallic, Solenn; Leheup, Bruno; Leube, Barbara; Lewis, Suzanne; Lucas, Josette; MacDermot, Kay D.; Magnusson, Pall; Marshall, Christian; Mathieu-Dramard, Michele; McCarthy, Mark I.; Meitinger, Thomas; Mencarelli, Maria Antonietta; Merla, Giuseppe; Moerman, Alexandre; Mooser, Vincent; Morice-Picard, Fanny; Mucciolo, Mafalda; Nauck, Matthias; Ndiaye, Ndeye Coumba; Nordgren, Ann; Pasquier, Laurent; Petit, Florence; Pfundt, Rolph; Plessis, Ghislaine; Rajcan-Separovic, Evica; Ramelli, Gian Paolo; Rauch, Anita; Ravazzolo, Roberto; Reis, Andre; Renieri, Alessandra; Richart, Cristobal; Ried, Janina S.; Rieubland, Claudine; Roberts, Wendy; Roetzer, Katharina M.; Rooryck, Caroline; Rossi, Massimiliano; Saemundsen, Evald; Satre, Veronique; Schurmann, Claudia; Sigurdsson, Engilbert; Stavropoulos, Dimitri J.; Stefansson, Hreinn; Tengstrom, Carola; Thorsteinsdottir, Unnur; Tinahones, Francisco J.; Touraine, Renaud; Vallee, Louis; van Binsbergen, Ellen; Van der Aa, Nathalie; Vincent-Delorme, Catherine; Visvikis-Siest, Sophie; Vollenweider, Peter; Voelzke, Henry; Vulto-van Silfhout, Anneke T.; Waeber, Gerard; Wallgren-Pettersson, Carina; Witwicki, Robert M.; Zwolinksi, Simon; Andrieux, Joris; Estivill, Xavier; Gusella, James F.; Gustafsson, Omar; Metspalu, Andres; Scherer, Stephen W.; Stefansson, Kari; Blakemore, Alexandra I. F.; Beckmann, Jacques S.; Froguel, Philippe			Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus	NATURE			English	Article							COPY NUMBER VARIATION; BODY-MASS INDEX; DEPENDENT PROBE AMPLIFICATION; CIRCULAR BINARY SEGMENTATION; TIME QUANTITATIVE PCR; HIDDEN-MARKOV MODEL; SNP GENOTYPING DATA; FAILURE-TO-THRIVE; RELATIVE QUANTIFICATION; METABOLIC SYNDROME	Both obesity and being underweight have been associated with increased mortality(1,2). Underweight, defined as a body mass index (BMI) <= 18.5 kg per m(2) in adults and <= -2 standard deviations from the mean in children, is the main sign of a series of heterogeneous clinical conditions including failure to thrive(3-5), feeding and eating disorder and/or anorexia nervosa(6,7). In contrast to obesity, few genetic variants underlying these clinical conditions have been reported(8,9). We previously showed that hemizygosity of a similar to 600-kilobase (kb) region on the short arm of chromosome 16 causes a highly penetrant form of obesity that is often associated with hyperphagia and intellectual disabilities(10). Here we show that the corresponding reciprocal duplication is associated with being underweight. We identified 138 duplication carriers (including 132 novel cases and 108 unrelated carriers) from individuals clinically referred for developmental or intellectual disabilities (DD/ID) or psychiatric disorders, or recruited from population-based cohorts. These carriers show significantly reduced postnatal weight and BMI. Half of the boys younger than five years are underweight with a probable diagnosis of failure to thrive, whereas adult duplication carriers have an 8.3-fold increased risk of being clinically underweight. We observe a trend towards increased severity in males, as well as a depletion of male carriers among non-medically ascertained cases. These features are associated with an unusually high frequency of selective and restrictive eating behaviours and a significant reduction in head circumference. Each of the observed phenotypes is the converse of one reported in carriers of deletions at this locus. The phenotypes correlate with changes in transcript levels for genes mapping within the duplication but not in flanking regions. The reciprocal impact of these 16p11.2 copy-number variants indicates that severe obesity and being underweight could have mirror aetiologies, possibly through contrasting effects on energy balance.	[Jacquemont, Sebastien; Zufferey, Flore; Martinet, Danielle; Beckmann, Noam D.; Belfiore, Marco; Addor, Marie-Claude; Fellmann, Florence; Ferrarini, Alessandra; Hippolyte, Loyse; Beckmann, Jacques S.] CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Reymond, Alexandre; Harewood, Louise; Walha, Faida; Chrast, Jacqueline; Didelot, Gerard; Witwicki, Robert M.] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Walters, Robin G.; Van Haelst, Mieke M.; Coin, Lachlan; Moustafa, Julia S. El-Sayed; Blakemore, Alexandra I. F.; Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Dept Genom Common Dis, London W12 0NN, England; [Kutalik, Zoltan; Valsesia, Armand; Bergmann, Sven; Beckmann, Jacques S.] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Kutalik, Zoltan; Valsesia, Armand; Bergmann, Sven] Univ Lausanne, Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Shen, Yiping; Platt, Orah S.; Wu, Bai-lin; Yu, Yongguo] Childrens Hosp Boston, Boston, MA 02115 USA; [Shen, Yiping; Gusella, James F.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Valsesia, Armand] Univ Lausanne, Ludwig Inst Canc Res, CH-1015 Lausanne, Switzerland; [Thorleifsson, Gudmar; Stefansson, Hreinn; Thorsteinsdottir, Unnur; Gustafsson, Omar; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Bouquillon, Sonia; Andrieux, Joris] CHRU Lille, Hop Jeanne de Flandre, Med Genet Lab, F-59000 Lille, France; [Campion, Dominique; Guilmatre, Audrey; Guillin, Olivier; Legallic, Solenn] Univ Rouen, INSERM U614, F-76000 Rouen, France; [Campion, Dominique; Guilmatre, Audrey; Guillin, Olivier; Legallic, Solenn] Ctr Hosp Rouvray, F-76000 Rouen, France; [de Leeuw, Nicole; de Vries, Bert B. A.; Brunner, Han G.; Faas, Brigitte H. W.; Koolen, David A.; Pfundt, Rolph; Vulto-van Silfhout, Anneke T.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [de Leeuw, Nicole; de Vries, Bert B. A.; Brunner, Han G.; Faas, Brigitte H. W.; Koolen, David A.; Pfundt, Rolph; Vulto-van Silfhout, Anneke T.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Disorders, NL-6500 HB Nijmegen, Netherlands; [Esko, Tonu; Kurg, Ants; Maennik, Katrin; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Esko, Tonu; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [Fernandez, Bridget A.] Mem Univ Newfoundland, Discipline Genet & Med, St John, NF A1B 3V6, Canada; [Fernandez-Aranda, Fernando; Jimenez-Murcia, Susana] Univ Hosp Bellvitge IDIBELL, Ciber Fisiopatol Obesidad & Nutr CIBEROBN, Dept Psychiat, Barcelona 08907, Spain; [Manuel Fernandez-Real, Jose] Hosp Univ Girona Dr Josep Trueta, Dept Diabet Endocrinol & Nutr, Ciber Fisiopatol Obesidad & Nutr CIBEROBN, Inst Invest Biomed Girona,Inst Salud Carlos III, Girona 17007, Spain; [Gratacos, Monica; Villatoro Gomez, Sergi; Estivill, Xavier] CIBER Epidemiol & Salud Publ CIBERESP, Ctr Genom Regulat CRG UPF, Genes & Dis Program, Barcelona 08003, Catalonia, Spain; [Hoyer, Juliane; Reis, Andre] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London W2 1PG, England; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Child & Adolescent Hlth, Oulu 90101, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, FIN-90570 Oulu, Finland; [Jarvelin, Marjo-Riitta] 90014 Univ Oulu, Univ Oulu, Bioctr Oulu, Oulu, Finland; [Kooy, R. Frank; Blaumeiser, Bettina; Van der Aa, Nathalie] Univ Antwerp, Dept Med Genet, B-2650 Antwerp, Belgium; [Kooy, R. Frank; Blaumeiser, Bettina; Van der Aa, Nathalie] Univ Antwerp Hosp, B-2650 Antwerp, Belgium; [Le Caignec, Cedric; David, Albert; Isidor, Bertrand] CHU Nantes, Serv Genet Med, Nantes, France; [Sanlaville, Damien; Labalme, Audrey; Rossi, Massimiliano] CHU Lyon, Hosp Civils Lyon, Serv Cytogenet Constitut, F-69000 Lyon, France; [Sanlaville, Damien; Labalme, Audrey; Rossi, Massimiliano] UCBL1, TIGER Team, Neurosci Res Ctr, F-69000 Lyon, France; [Van Haelst, Mieke M.; Knoers, Nine V. A. M.; van Binsbergen, Ellen] Univ Med Ctr, Dept Med Genet, NL-3584 EA Utrecht, Netherlands; [Wu, Bai-lin] Fudan Univ, Childrens Hosp, Shanghai 200032, Peoples R China; [Wu, Bai-lin] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Yu, Yongguo] Shanghai Childrens Med Ctr, Shanghai 200127, Peoples R China; [Aboura, Azzedine; Drunat, Severine; Gerard, Marion] Robert DEBRE Univ Hosp, APHP, Dept Genet, F-75019 Paris, France; [Alembik, Yves; Flori, Elisabeth] CHU Strasbourg, Hop Hautepierre, Serv Genet Med, F-67000 Strasbourg, France; [Antonarakis, Stylianos E.; Bena, Frederique; Bottani, Armand; Gimelli, Stefania] Univ Hosp Geneva, Serv Genet Med, CH-1205 Geneva, Switzerland; [Arveiler, Benoit; Delrue, Marie-Ange; Morice-Picard, Fanny; Rooryck, Caroline] Univ Bordeaux 2, Lab Malad Rares Genet & Metab, F-33076 Bordeaux, France; [Arveiler, Benoit; Cailley, Dorothee; Delrue, Marie-Ange; Morice-Picard, Fanny; Rooryck, Caroline] CHU Bordeaux, Serv Genet Med, F-33076 Bordeaux, France; [Barth, Magalie; Bonneau, Dominique; Guichet, Agnes] CHU Angers, Serv Genet, F-49933 Angers, France; [Bednarek, Nathalie] CHU Hop Alix de Champagne, Serv Pediat, F-51100 Reims, France; [Beri, Mylene; Jonveaux, Philippe] CHU Nancy, Genet Lab, F-54511 Vandoeuvre Les Nancy, France; [Bernardini, Laura] IRCCS Casa Sollievo della Sofferenza Hosp, Mendel Lab, I-71013 San Giovanni Rotondo, Italy; [Boute, Odile; Holder, Muriel; Moerman, Alexandre; Petit, Florence] CHRU Lille, Hop Jeanne de Flandre, Serv Genet Clin, F-59037 Lille, France; [Chiesa, Jean] CHU Caremeau, Lab Cytogenet, F-30029 Nimes, France; [Coutton, Charles; Satre, Veronique] CHU Grenoble, Lab Genet Chromosom, F-38043 Grenoble, France; [Cuisset, Jean-Marie; Cuvellier, Jean-Christophe; Vallee, Louis] CHRU Lille, Hop Roger Salengro, Serv Neurol Pediat, F-59037 Lille, France; [de Freminville, Benedicte; Touraine, Renaud] CHU St Etienne, Serv Genet, CHU Hop Nord, F-42055 St Etienne, France; [Delobel, Bruno; Duban-Bedu, Benedicte] GHICL, Hop St Vincent de Paul, Ctr Genet Chromosom, F-59160 Lille, France; [Demeer, Benedicte; Mathieu-Dramard, Michele] CHRU Amiens, Serv Genet Med, F-80000 Amiens, France; [Descamps, Dominique] Ctr Hosp Bethune, F-62408 Bethune, France; [Dieterich, Klaus] CHU Grenoble, Serv Genet Clin, F-38043 Grenoble, France; [Disciglio, Vittoria; Mencarelli, Maria Antonietta; Mucciolo, Mafalda; Renieri, Alessandra] Univ Siena, Dept Biotechnol, I-53100 Siena, Italy; [Doco-Fenzy, Martine; Gaillard, Dominique; Landais, Emilie] CHU REIMS, IFR 53, HMB, Serv Genet, F-51092 Reims, France; [Dubourg, Christele; Jaillard, Sylvie] Univ Rennes 1, IFR GFAS 140, UMR CNRS 6061, F-35043 Rennes, France; [Dubourg, Christele] CHU, Serv Genet Mol, F-35033 Rennes, France; [Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London W2 1PG, England; [Faivre, Laurence] CHU Dijon, Ctr Genet, F-21079 Dijon, France; [Faudet, Anne; Keren, Boris] APHP GH Pitie Salpetriere, Dept Genet & Cytogenet, F-75013 Paris, France; [Fisher, Richard; Zwolinksi, Simon] Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 4EP, Tyne & Wear, England; [Forer, Lukas; Kloss-Brandstaetter, Anita; Kronenberg, Florian] Innsbruck Med Univ, Div Genet Epidemiol, Dept Med Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria; [Gieger, Christian; Ried, Janina S.] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Genet Epidemiol, D-85764 Neuherberg, Germany; [Gimelli, Giorgio] G Gaslini Inst Children, Lab Citogenet, I-16147 Genoa, Italy; [Grabe, Hans J.] Ernst Moritz Arndt Univ Greifswald, Dept Psychiat & Psychotherapy, D-17475 Greifswald, Germany; [Grabe, Hans J.] Ernst Moritz Arndt Univ Greifswald, Dept Psychiat & Psychotherapy, D-18437 Stralsund, Germany; [Hartikainen, Anna-Liisa] Univ Oulu, Dept Obstet & Gynecol, Inst Clin Med, FIN-90570 Oulu, Finland; [Heron, Delphine] Univ Paris 06, Embryol AP HP, F-75005 Paris, France; [Heron, Delphine] Hop La Pitie Salpetriere, Dept Genet Cytogenet, F-75013 Paris, France; [Homuth, Georg; Schurmann, Claudia] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, D-17487 Greifswald, Germany; [Jaillard, Sylvie; Lucas, Josette] CHU Rennes, Lab Cytogenet & Biol Cellulaire, F-35033 Rennes, France; [Jaros, Zdenek] Landesklinikum Waldviertel Zwettl, Abt Kinder & Jugendheilkunde, A-3910 Zwettl, Austria; [Helas, Geraldine Joly] CHU Rouen, Dept Genet, F-76183 Rouen, France; [Kaksonen, Satu] Habilitat Unit Folkhalsan, SF-00250 Helsinki, Finland; [Knoers, Nine V. A. M.] Univ Med Ctr, Dept Human Genet, NL-3584 EA Utrecht, Netherlands; [Kroisel, Peter M.; Roetzer, Katharina M.] Med Univ Graz, Inst Human Genet, A-8010 Graz, Austria; [Layet, Valerie] Childrens Hosp Anna Meyer, Med Genet Unit, I-50139 Florence, Italy; [Layet, Valerie] Grp Hosp Havre, Unite Genet, F-76600 Le Havre, France; [Leheup, Bruno] CHU Nancy, Serv Med Infantile & Genet Clin 3, F-54511 Vandoeuvre Les Nancy, France; [Leheup, Bruno] Univ Lorraine UHP Nancy, PRES, F-54511 Vandoeuvre Les Nancy, France; [Leube, Barbara] Heinrich Heine Univ Hosp Duesseldorf, Inst Human Genet & Anthropol, D-40001 Dusseldorf, Germany; [Lewis, Suzanne] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Lewis, Suzanne] Child & Family Res Inst, Vancouver, BC V6H 3N1, Canada; [MacDermot, Kay D.] Northwick Pk & St Marks Hosp, NW Thames Reg Genet Serv, Harrow HA1 3UJ, Middx, England; [Magnusson, Pall] Landspitali Univ Hosp, IS-105 Reykjavik, Iceland; [Marshall, Christian] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1X8, Canada; [McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LJ, England; [Meitinger, Thomas] German Res Ctr Environm Hlth, Hemholtz Ctr Munich, Inst Human Genet, D-85764 Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, D-85764 Neuherberg, Germany; [Merla, Giuseppe] IRCCS Casa Sollievo della Sofferenza Hosp, Med Genet Unit, I-71013 San Giovanni Rotondo, Italy; [Mooser, Vincent] GlaxoSmithKline R&D, Genet, King Of Prussia, PA 19406 USA; [Nauck, Matthias] Ernst Moritz Arndt Univ Greifswald, Inst Clin Chem & Lab Med, D-17475 Greifswald, Germany; [Ndiaye, Ndeye Coumba; Visvikis-Siest, Sophie] Univ Henri Poincare, Cardiovasc Genet Res Unit, EA4373, F-54000 Nancy, France; [Nordgren, Ann] Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Pasquier, Laurent] CLAD Ouest, Serv Genet, F-35203 Rennes 2, France; [Plessis, Ghislaine] CHU Clemenceau, Serv Genet, F-14033 Caen, France; [Rajcan-Separovic, Evica] Univ British Columbia, Dept Pathol, Vancouver, BC V5Z 4H4, Canada; [Rajcan-Separovic, Evica] Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; [Ramelli, Gian Paolo] Osped San Giovanni Bellinzona, Div Pediat, CH-6500 Bellinzona, Switzerland; [Rauch, Anita] Univ Zurich, Inst Med Genet, CH-8603 Schwerzenbach, Switzerland; [Ravazzolo, Roberto] Univ Genoa, Dept Pediat, I-16126 Genoa, Italy; [Ravazzolo, Roberto] Univ Genoa, G Gaslini Inst, CEBR, I-16126 Genoa, Italy; [Richart, Cristobal] Univ Rovira & Virgili, Univ Hosp Juan XXIII, Ciber Fisiopatol Obesidad & Nutr CIBEROBN, Dept Internal Med,Inst Salud Carlos III, Tarragona 43005, Spain; [Rieubland, Claudine] Univ Bern, Inselspital, Dept Paediat, Div Human Genet, CH-3010 Bern, Switzerland; [Roberts, Wendy] Hosp Sick Children, Autism Res Unit, Toronto, ON M5G 1X8, Canada; [Saemundsen, Evald] State Diagnost & Counseling Ctr, IS-200 Kopavogur, Iceland; [Sigurdsson, Engilbert] Landspitali Univ Hosp, IS-101 Reykjavik, Iceland; [Stavropoulos, Dimitri J.] Hosp Sick Children, Dept Pediat Lab Med, Toronto, ON M5G 1X8, Canada; [Tengstrom, Carola] Rinnekoti Res Fdn, Genet Serv, SF-02980 Espoo, Finland; [Thorsteinsdottir, Unnur] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Tinahones, Francisco J.] Clin Hosp Virgen de la Victoria, Ciber Fisiopatol Obesidad & Nutr CIBEROBN, Dept Endocrinol & Nutr, Inst Salud Carlos III, Malaga 29010, Spain; [Vincent-Delorme, Catherine] CH Arras CHRU Lille, Ctr Malad Rares, F-59000 Lille, France; [Vollenweider, Peter; Waeber, Gerard] CHU Vaudois, Dept Internal Med, CH-1011 Lausanne, Switzerland; [Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, D-17475 Greifswald, Germany; [Wallgren-Pettersson, Carina] Univ Helsinki, Dept Med Genet, Helsinki 00251, Finland; [Wallgren-Pettersson, Carina] Folkhalsan Inst Genet, Helsinki 00251, Finland; [Gustafsson, Omar] Oslo Univ Hosp, Dept Psychiat, N-0407 Oslo, Norway; [Scherer, Stephen W.] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1L7, Canada; [Froguel, Philippe] Inst Pasteur, Inst Biol, CNRS 8090, F-59800 Lille, France; [Disciglio, Vittoria] Azienda Osped Univ Senese, UOC Genet Med, Siena, Italy; [Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-81675 Munich, Germany	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Imperial College London; University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Ludwig Institute for Cancer Research; University of Lausanne; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Radboud University Nijmegen; Radboud University Nijmegen; University of Tartu; University of Tartu; Memorial University Newfoundland; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Erlangen Nuremberg; Imperial College London; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; University of Antwerp; University of Antwerp; Nantes Universite; CHU de Nantes; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Utrecht University; Utrecht University Medical Center; Fudan University; Fudan University; Shanghai Jiao Tong University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Geneva; UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU de Reims; CHU de Nancy; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Universite de Lille - ISITE; CHU Lille; Universite de Montpellier; CHU de Nimes; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite de Lille - ISITE; CHU Lille; CHU de St Etienne; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); University of Siena; CHU de Reims; Universite de Reims Champagne-Ardenne; Universite de Rennes 1; CHU Rennes; Imperial College London; CHU Dijon Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Newcastle University - UK; Medical University of Innsbruck; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Genoa; IRCCS Istituto Giannina Gaslini; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; University of Oulu; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Ernst Moritz Arndt Universitat Greifswald; CHU Rennes; CHU de Rouen; Utrecht University; Utrecht University Medical Center; Medical University of Graz; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; CHU de Nancy; Universite de Lorraine; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of British Columbia; Child & Family Research Institute; Imperial College London; Landspitali National University Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; IRCCS Casa Sollievo Della Sofferenza; GlaxoSmithKline; Ernst Moritz Arndt Universitat Greifswald; Universite de Lorraine; Karolinska Institutet; CHU de Caen NORMANDIE; University of British Columbia; Child & Family Research Institute; Regional Hospital of Bellinzona & Valleys, San Giovanni; University of Zurich; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Universitat Rovira i Virgili; University of Bern; University Hospital of Bern; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Landspitali National University Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Iceland; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Ernst Moritz Arndt Universitat Greifswald; University of Helsinki; University of Oslo; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; University of Siena; University Hospital of Siena; Technical University of Munich	Beckmann, JS (corresponding author), CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland.	Jacques.Beckmann@chuv.ch	de Leeuw, N./L-4480-2015; Kurg, Ants/AAM-1292-2020; Rossi, Massimiliano/AAO-5615-2020; Nordgren, Ann C/N-4057-2013; merla, giuseppe/K-4627-2012; Scherer, Stephen/B-3785-2013; Antonarakis, Stylianos E/N-8866-2014; Jacquemont, Sebastien/AAS-5060-2021; Colaus, PsyColaus/K-6607-2013; Isidor, Bertrand/AAJ-3456-2021; Pasquier, Laurent/AAN-4081-2020; FROGUEL, Philippe/O-6799-2017; Kurg, Ants/J-2616-2015; Brunner, Han/C-9928-2013; Stefansson, Kari/AAE-7187-2019; Estivill, Xavier/A-3125-2013; Forer, Lukas/AAX-9577-2021; Isidor, Bertrand/L-2435-2015; Sanlaville, Damien/M-4716-2014; Tinahones, Francisco José/AAB-2882-2020; RICHART, CRISTOBAL C/S-9158-2017; Meitinger, Thomas/O-1318-2015; Arveiler, Benoit/M-3721-2014; COUTTON, Charles/G-2859-2014; Touraine, Renaud/AAV-1605-2020; Faas, Brigitte/L-4301-2015; Estivill, Xavier/E-2957-2012; Walters, Robin G/E-6069-2010; Coin, Lachlan JM/A-9001-2014; MORICE-PICARD, Fanny/M-5125-2014; Fernández-Real, Jose Manuel/AGH-3599-2022; Beckmann, Jacques Simon/A-9772-2008; Kooy, Frank/F-5276-2014; ROORYCK, Caroline/M-4565-2014; Bonneau, Dominique/K-6110-2015; Sigurdsson, Engilbert/D-2486-2014; Reis, André/D-2309-2009; DISCIGLIO, VITTORIA/K-3376-2018; Nordgren, Ann/AAQ-9142-2021; jaillard, sylvie/L-9314-2015; AT, Vulto-van Silfhout/H-4199-2015; Bernardini, Laura/H-5360-2016; Fernandez-Aranda, Fernando/L-9762-2014; dieterich, klaus/R-8418-2019; Blakemore, Alexandra I F/D-2253-2009; Koolen, D.A./L-4448-2015; Mucciolo, Mafalda/AAB-8222-2019; Renieri, Alessandra/K-5950-2016; Mencarelli, Maria Antonietta/AAC-5615-2022; Kronenberg, Florian/B-1736-2008; Rauch, Anita/C-5568-2014; Valsesia, Armand/F-1724-2010; FERNANDEZ-ARANDA, FERNANDO/AGY-1597-2022; Pfundt, Rolph/L-4576-2015; Le Caignec, Cedric/K-8467-2015; Visvikis-Siest, Sophie/H-2324-2014; Coin, Lachlan/O-4976-2019; JIMENEZ-MURCIA, SUSANA/L-9786-2014; Schurmann, Claudia/L-1204-2016; Forer, Lukas/ABE-6007-2020; SATRE, Veronique/G-2864-2014; McCarthy, Mark/M-3763-2015	Kurg, Ants/0000-0002-0829-1987; Rossi, Massimiliano/0000-0002-5797-8152; Nordgren, Ann C/0000-0003-3285-4281; merla, giuseppe/0000-0001-5078-928X; Scherer, Stephen/0000-0002-8326-1999; Antonarakis, Stylianos E/0000-0001-8907-5823; Jacquemont, Sebastien/0000-0001-6838-8767; Isidor, Bertrand/0000-0001-6480-126X; Pasquier, Laurent/0000-0003-3985-1286; FROGUEL, Philippe/0000-0003-2972-0784; Estivill, Xavier/0000-0002-0723-2256; Forer, Lukas/0000-0003-2139-7329; Isidor, Bertrand/0000-0001-6480-126X; Sanlaville, Damien/0000-0001-9939-2849; RICHART, CRISTOBAL C/0000-0003-0852-6739; Walters, Robin G/0000-0002-9179-0321; Coin, Lachlan JM/0000-0002-4300-455X; Fernández-Real, Jose Manuel/0000-0002-7442-9323; Beckmann, Jacques Simon/0000-0002-9741-1900; Kooy, Frank/0000-0003-2024-0485; Sigurdsson, Engilbert/0000-0001-9404-7982; Reis, André/0000-0002-6301-6363; DISCIGLIO, VITTORIA/0000-0002-3518-9224; Nordgren, Ann/0000-0003-3285-4281; jaillard, sylvie/0000-0002-0593-0261; Bernardini, Laura/0000-0002-3554-2817; Fernandez-Aranda, Fernando/0000-0002-2968-9898; dieterich, klaus/0000-0002-4362-4062; Blakemore, Alexandra I F/0000-0003-0661-564X; Mucciolo, Mafalda/0000-0003-2228-8271; Renieri, Alessandra/0000-0002-0846-9220; Mencarelli, Maria Antonietta/0000-0001-5131-3718; Kronenberg, Florian/0000-0003-2229-1120; Rauch, Anita/0000-0003-2930-3163; FERNANDEZ-ARANDA, FERNANDO/0000-0002-2968-9898; Le Caignec, Cedric/0000-0002-0598-653X; Visvikis-Siest, Sophie/0000-0001-8104-8425; Coin, Lachlan/0000-0002-4300-455X; JIMENEZ-MURCIA, SUSANA/0000-0002-3596-8033; Schurmann, Claudia/0000-0003-4158-9192; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Faivre, Laurence/0000-0001-9770-444X; Rajcan-Separovic, Evica/0000-0002-4528-7135; Bergmann, Sven/0000-0002-6785-9034; Waeber, Gerard/0000-0003-4193-788X; Elliott, Paul/0000-0002-7511-5684; Esko, Tonu/0000-0003-1982-6569; Gieger, Christian/0000-0001-6986-9554; Harewood, Louise/0000-0002-6398-6714; Rooryck, Caroline/0000-0002-9789-3591; SATRE, Veronique/0000-0001-7852-8591; Valsesia, Armand/0000-0003-0746-9664; Coutton, Charles/0000-0002-8873-8098; Reymond, Alexandre/0000-0003-1030-8327; petit, florence/0000-0002-1368-1023; Kloss-Brandstatter, Anita/0000-0002-0873-6704; Tinahones, Francisco J/0000-0001-6871-4403; yu, yongguo/0000-0002-4472-0910; El-Sayed Moustafa, Julia Sarah/0000-0001-6963-6654; McCarthy, Mark/0000-0002-4393-0510; Fellmann, Florence/0000-0003-3156-4768; Bonneau, Dominique/0000-0002-6886-0969; Stefansson, Hreinn/0000-0002-9331-6666; Lewis, Suzanne/0000-0002-6300-5381; Meitinger, Thomas/0000-0002-8838-8403	Leenaards Foundation; Jerome Lejeune Foundation; Telethon Action Suisse Foundation; Swiss National Science Foundation; European Commission [037627, QLG1-CT-2000-01643]; Ludwig Institute for Cancer Research; Swiss Institute of Bioinformatics; Imperial College Department of Medicine; Comprehensive Biomedical Research Centre; Imperial College Healthcare NHS Trust; National Institute for Health Research; Wellcome Trust; Medical Research Council; Instituto de Salud Carlos III (ISCIII)-FIS; German Mental Retardation Network; German Federal Ministry of Education and Research [NGFNplus 01GS08160]; European Union [PI081714, PS09/01778, 201413, 245536, HEALTH-2007-2.2.1-10-223423]; Belgian National Fund for Scientific Research, Flanders; Dutch Organisation for Health Research and Development (ZON-MW) [917-86-319]; Hersenstichting Nederland (B.B.A.d.V.); Chinese National Natural Science Foundation [81000346]; Simons Foundation Autism Research Initiative; Autism Speaks; NIH [GM061354, MH071425]; Oesterreichische Nationalbank (OENB) [13059]; Children's Tumor Foundation; Harvard Medical School; Fudan University; Chinese National '973' project on Population and Health [2010CB529601]; Science and Technology Council of Shanghai [09JC1402400]; Michael Smith Foundation for Health; CIHR [MOP 74502]; Estonian Government [SF0180142s08, SF0180026s09, SF0180027s10]; Helmholtz Zentrum Munich; State of Bavaria; German National Genome Research Network [01GS0823]; German Federal Ministry of Education and Research (BMBF); Munich Center of Health Sciences (MC Health, LMUinnovativ); Genome Canada; McLaughlin Centre; Academy of Finland [104781, 120315, 129269, 1114194]; University Hospital Oulu; Biocenter; University of Oulu, Finland [75617]; NHLBI [5R01HL087679-02, 1RL1MH083268-01]; NIH/NIMH [5R01MH63706:02]; ENGAGE project; Medical Research Council, UK [G0500539, G0600705]; Academy of Finland; Biocentrum Helsinki;  [SAF2008-02278];  [HEALTH-F4-2007-201413]; Diabetes UK [08/0003775] Funding Source: researchfish; Medical Research Council [G0600705, G0801056B, G0801056] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063706, RL1MH083268, R01MH071425] Funding Source: NIH RePORTER; MRC [G0600705, G0801056] Funding Source: UKRI	Leenaards Foundation; Jerome Lejeune Foundation; Telethon Action Suisse Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Ludwig Institute for Cancer Research; Swiss Institute of Bioinformatics; Imperial College Department of Medicine; Comprehensive Biomedical Research Centre; Imperial College Healthcare NHS Trust; National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Instituto de Salud Carlos III (ISCIII)-FIS(Instituto de Salud Carlos III); German Mental Retardation Network; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); Belgian National Fund for Scientific Research, Flanders(Fonds de la Recherche Scientifique - FNRS); Dutch Organisation for Health Research and Development (ZON-MW)(Netherlands Organization for Health Research and Development); Hersenstichting Nederland (B.B.A.d.V.); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Simons Foundation Autism Research Initiative; Autism Speaks; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oesterreichische Nationalbank (OENB); Children's Tumor Foundation; Harvard Medical School; Fudan University; Chinese National '973' project on Population and Health(National Basic Research Program of China); Science and Technology Council of Shanghai; Michael Smith Foundation for Health(Michael Smith Foundation for Health Research); CIHR(Canadian Institutes of Health Research (CIHR)); Estonian Government; Helmholtz Zentrum Munich; State of Bavaria; German National Genome Research Network; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Munich Center of Health Sciences (MC Health, LMUinnovativ); Genome Canada(Genome Canada); McLaughlin Centre; Academy of Finland(Academy of Finland); University Hospital Oulu; Biocenter; University of Oulu, Finland; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ENGAGE project(General Electric); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Finland(Academy of Finland); Biocentrum Helsinki; ; ; Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the Vital-IT high-performance computing centre of the Swiss Institute of Bioinformatics. S.J. is recipient of a bourse de releve academique de la Faculte de Biologie et Medecine de l'Universite de Lausanne. This work was supported by the Leenaards Foundation Prize (S.J., D. M. and A. Reymond), the Jerome Lejeune Foundation (A. Reymond), the Telethon Action Suisse Foundation (A. Reymond), the Swiss National Science Foundation (A. Reymond, J.S.B., S. B. and S. E. A.), a Swiss National Science Foundation Sinergia grant (S.J., D. M., S. B., J.S.B. and A. Reymond), the European Commission an EU ploidy Integrated Project grant 037627 (A. Reymond, S. B., X. E., H. G. B. and S. E. A.), the Ludwig Institute for Cancer Research (A. V.), the Swiss Institute of Bioinformatics (S. B. and Z.K.), an Imperial College Department of Medicine PhD studentship (J.S.E.-S.M), the Comprehensive Biomedical Research Centre, Imperial College Healthcare NHS Trust, and the National Institute for Health Research (P. E.), the Wellcome Trust and the Medical Research Council (A. I. F. B. and P. F.), the Instituto de Salud Carlos III (ISCIII)-FIS, the German Mental Retardation Network funded through a grant of the German Federal Ministry of Education and Research (NGFNplus 01GS08160) (A. Reis), European Union-FEDER (PI081714, PS09/01778) (F. F. A., M. G. and X. E.), SAF2008-02278 (C. R.), the Belgian National Fund for Scientific Research, Flanders (N.V.A. and R. F. K.), the Dutch Organisation for Health Research and Development (ZON-MW grant 917-86-319) and Hersenstichting Nederland (B.B.A.d.V.), grant 81000346 from the Chinese National Natural Science Foundation (Y.G.Y.), the Simons Foundation Autism Research Initiative, Autism Speaks and NIH grant GM061354 (J.F.G.), and Oesterreichische Nationalbank (OENB) grant 13059 (A.K.-B.). Y.S. holds a Young Investigator Award from the Children's Tumor Foundation and a Catalyst Award from Harvard Medical School. B. L. W. holds a Fudan Scholar Research Award from Fudan University, a grant from Chinese National '973' project on Population and Health (2010CB529601) and a grant from the Science and Technology Council of Shanghai (09JC1402400). E. R. S. and S. L., recipients of the Michael Smith Foundation for Health Research Scholar award, acknowledge the CIHR MOP 74502 operational grant. The Estonian Genome Center of the University of Tartu (EGCUT) received support from the EU Centre of Excellence in Genomics and FP7 grants 201413 and 245536, and from Estonian Government SF0180142s08, SF0180026s09 and SF0180027s10 (A. M., K. M. and A. K.). D. S. thanks the Direction Generale de l'Organisation des Soins from the French Ministry of Health for their support in the development of several array-CGH platforms, and the Centres Labellises Anomalies du Development in France. The Helmholtz Zentrum Munich and the State of Bavaria financed the KORA study, also supported by the German National Genome Research Network (NGFN-2 and NGFN Plus: 01GS0823), the German Federal Ministry of Education and Research (BMBF), and the Munich Center of Health Sciences (MC Health, LMUinnovativ). CIBEROBN and CIBERESP are initiatives of ISCIII (Spain). S. W. S. holds the GlaxoSmithKline-Canadian Institutes of Health Chair in Genetics and Genomics at the University of Toronto and the Hospital for Sick Children, and is supported by Genome Canada and the McLaughlin Centre. Funding for deCODE came in part from NIH grant MH071425 (K. S.), EU grant HEALTH-2007-2.2.1-10-223423 (Project PsychCNV) and EU grant IMI-JU-NewMeds.; NFBC1966 received financial supportfrom the Academy of Finland (project grants 104781, 120315, 129269, 1114194, Center of Excellence in Complex Disease Genetics and SALVE), University Hospital Oulu, Biocenter, University of Oulu, Finland (75617), the European Commission (EURO-BLCS, Framework 5 award QLG1-CT-2000-01643), NHLBI grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01), NIH/NIMH (5R01MH63706:02), ENGAGE project and grant agreement HEALTH-F4-2007-201413, and the Medical Research Council, UK (G0500539, G0600705, PrevMetSyn/SALVE). The DNA extractions, sample quality controls, biobank up-keeping and aliquotting was performed in the National Public Health Institute, Biomedicum Helsinki, Finland and supported financially by the Academy of Finland and Biocentrum Helsinki. We thank M. Hass, Z. Jaros, M. Jussila, M. Koiranen, P. Rantakallio, M. C. Rudolf, V. Soo, O. Tornwall, S. Vaara, T. Ylitalo and the French DHOS national CGH network for their help, as well as all participating patients and clinicians. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, P39; [Anonymous], [No title captured]; Baxter PS, 2009, PEDIATRICS, V124, P590, DOI 10.1542/peds.2008-2784; Bengtsson H, 2008, BIOINFORMATICS, V24, P759, DOI 10.1093/bioinformatics/btn016; Bengtsson H, 2009, BIOINFORMATICS, V25, P861, DOI 10.1093/bioinformatics/btp074; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Bravender T, 2010, EUR EAT DISORD REV, V18, P79, DOI 10.1002/erv.994; Bunyan DJ, 2004, BRIT J CANCER, V91, P1155, DOI 10.1038/sj.bjc.6602121; Coin LJM, 2010, NAT METHODS, V7, P541, DOI [10.1038/NMETH.1466, 10.1038/nmeth.1466]; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Corbett SS, 2004, J CHILD PSYCHOL PSYC, V45, P641, DOI 10.1111/j.1469-7610.2004.00253.x; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; Crespi B, 2010, P NATL ACAD SCI USA, V107, P1736, DOI 10.1073/pnas.0906080106; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; de Onis M, 2004, JAMA-J AM MED ASSOC, V291, P2600, DOI 10.1001/jama.291.21.2600; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2007, J NUTR, V137, P144, DOI 10.1093/jn/137.1.144; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Fernandez L, 2005, CLIN GENET, V68, P373, DOI 10.1111/j.1399-0004.2005.00493.x; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Fredriks M., 1997, GROWTH DIAGRAMS 1997, P233; Girirajan S, 2010, HUM MOL GENET, V19, pR176, DOI 10.1093/hmg/ddq366; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Huang Jing, 2004, Human Genomics, V1, P287; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Li YF, 2008, OBESITY, V16, P1809, DOI 10.1038/oby.2008.296; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marioni JC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r228; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Mei ZG, 2002, AM J CLIN NUTR, V75, P978, DOI 10.1093/ajcn/75.6.978; Mei ZG, 2008, J PEDIATR-US, V153, P622, DOI 10.1016/j.jpeds.2008.05.048; Merla G, 2006, AM J HUM GENET, V79, P332, DOI 10.1086/506371; Molina J, 2008, HUM MOL GENET, V17, P2486, DOI 10.1093/hmg/ddn148; MORRIS JA, 1988, BRIT MED J, V296, P1313, DOI 10.1136/bmj.296.6632.1313; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Olsen EM, 2007, ARCH DIS CHILD, V92, P109, DOI 10.1136/adc.2005.080333; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Prader A, 1989, Helv Paediatr Acta Suppl, V52, P1; Pramyothin P, 2010, CURR OPIN ENDOCRINOL, V17, P460, DOI 10.1097/MED.0b013e32833de61c; Ricard G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000543; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; Rudolf MCJ, 2005, ARCH DIS CHILD, V90, P925, DOI 10.1136/adc.2004.050179; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Scherag S, 2010, EUR CHILD ADOLES PSY, V19, P211, DOI 10.1007/s00787-009-0085-9; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Sempe M., 1979, AUXOLOGIE METHODE SE; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Slater HR, 2003, J MED GENET, V40, P907, DOI 10.1136/jmg.40.12.907; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang K, 2011, MOL PSYCHIATR, V16, P949, DOI 10.1038/mp.2010.107; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	61	302	309	2	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 6	2011	478	7367					97	U111		10.1038/nature10406	http://dx.doi.org/10.1038/nature10406			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21881559	Green Submitted, Green Accepted			2022-12-01	WOS:000295575400042
J	Jobs, E; Ingelsson, E; Riserus, U; Nerpin, E; Jobs, M; Sundstrom, J; Basu, S; Larsson, A; Lind, L; Arnlov, J				Jobs, Elisabeth; Ingelsson, Erik; Riserus, Ulf; Nerpin, Elisabet; Jobs, Magnus; Sundstrom, Johan; Basu, Samar; Larsson, Anders; Lind, Lars; Arnlov, Johan			Association Between Serum Cathepsin S and Mortality in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CYSTATIN-C; TUMOR INVASION; ADIPOSE-TISSUE; EXPRESSION; ATHEROSCLEROSIS; CYSTEINE; PROGRESSION; PROTEASES; CHOLESTEROL; DEFICIENCY	Context Experimental data suggest that cathepsin S, a cysteine protease, is involved in the complex pathways leading to cardiovascular disease and cancer. However, prospective data concerning a potential association between circulating cathepsin S levels and mortality are lacking. Objective To investigate associations between circulating cathepsin S levels and mortality in 2 independent cohorts of elderly men and women. Design, Setting, and Participants Prospective study using 2 community-based cohorts, the Uppsala Longitudinal Study of Adult Men (ULSAM; n=1009; mean age: 71 years; baseline period: 1991-1995; median follow-up: 12.6 years; end of follow-up: 2006) and the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS; n=987; 50% women; mean age: 70 years; baseline period: 2001-2004; median follow-up: 7.9 years; end of follow-up: 2010). Serum samples were used to measure cathepsin S. Main Outcome Measure Total mortality. Results During follow-up, 413 participants died in the ULSAM cohort (incidence rate: 3.59/100 person-years at risk) and 100 participants died in the PIVUS cohort (incidence rate: 1.32/100 person-years at risk). In multivariable Cox regression models adjusted for age, systolic blood pressure, diabetes, smoking status, body mass index, total cholesterol, high-density lipoprotein cholesterol, antihypertensive treatment, lipid-lowering treatment, and history of cardiovascular disease, higher serum cathepsin S was associated with an increased risk for mortality (ULSAM cohort: hazard ratio [HR] for 1-unit increase of cathepsin S, 1.04 [95% CI, 1.01-1.06], P=.009; PIVUS cohort: HR for 1-unit increase of cathepsin S, 1.03 [95% CI, 1.00-1.07], P=.04). In the ULSAM cohort, serum cathepsin S also was associated with cardiovascular mortality (131 deaths; HR for quintile 5 vs quintiles 1-4, 1.62 [95% CI, 1.11-2.37]; P=.01) and cancer mortality (148 deaths; HR for 1-unit increase of cathepsin S, 1.05 [95% CI, 1.01-1.10]; P=.01). Conclusions Among elderly individuals in 2 independent cohorts, higher serum cathepsin S levels were associated with increased mortality risk. Additional research is needed to delineate the role of cathepsin S and whether its measurement might have clinical utility. JAMA. 2011;306(10):1113-1121 www.jama.com	[Jobs, Elisabeth; Ingelsson, Erik; Nerpin, Elisabet; Arnlov, Johan] Uppsala Univ, Dept Publ Hlth & Caring Sci, Sect Geriatr, Uppsala, Sweden; [Riserus, Ulf] Uppsala Univ, Sect Clin Nutr & Metab, Uppsala, Sweden; [Basu, Samar] Uppsala Univ, Sect Oxidat Stress & Inflammat, Uppsala, Sweden; [Sundstrom, Johan; Larsson, Anders; Lind, Lars] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Ingelsson, Erik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Jobs, Elisabeth; Nerpin, Elisabet; Jobs, Magnus; Arnlov, Johan] Dalarna Univ, Sch Hlth & Social Studies, Falun, Sweden; [Basu, Samar] Univ Auvergne, Fac Pharm, Lab Biochem Mol Biol & Nutr, Dauvergne, France	Uppsala University; Uppsala University; Uppsala University; Uppsala University; Karolinska Institutet; Dalarna University; Universite Clermont Auvergne (UCA)	Arnlov, J (corresponding author), Uppsala Sci Pk, SE-75185 Uppsala, Sweden.	johan.arnlov@pubcare.uu.se	Sundstrom, Johan/R-2139-2019; Ärnlöv, Johan/AAF-2746-2019; Sundström, Johan/A-6286-2009	Sundstrom, Johan/0000-0003-2247-8454; Ärnlöv, Johan/0000-0002-6933-4637; Sundström, Johan/0000-0003-2247-8454	Swedish Research Council [2006-6555]; Swedish Heart-Lung Foundation; Thureus Foundation; Dalarna University; Uppsala University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Thureus Foundation; Dalarna University; Uppsala University	This study was supported by grant 2006-6555 from the Swedish Research Council and by funding from the Swedish Heart-Lung Foundation, the Thureus Foundation, Dalarna University, and Uppsala University.	Aoki T, 2008, STROKE, V39, P2603, DOI 10.1161/STROKEAHA.107.513648; Bengtsson E, 2008, FRONT BIOSCI, V13, P5780; Burden RE, 2008, MOL CANCER THER, V7, P538, DOI 10.1158/1535-7163.MCT-07-0528; Burden RE, 2009, CLIN CANCER RES, V15, P6042, DOI 10.1158/1078-0432.CCR-09-1262; Byberg L, 1998, ARTERIOSCL THROM VAS, V18, P258, DOI 10.1161/01.ATV.18.2.258; Chan LLY, 2010, J LEUKOCYTE BIOL, V88, P303, DOI 10.1189/jlb.1009659; Chen JC, 2010, J MED CHEM, V53, P4545, DOI [10.1021/jm100089c, 10.1021/jm100089e]; Cheng Xian-Wu, 2008, Zhonghua Xinxueguanbing Zazhi, V36, P51; Chrysant SG, 2010, WORLD J CARDIOL, V2, P43, DOI 10.4330/wjc.v2.i3.43; de Nooijer R, 2009, ARTERIOSCL THROM VAS, V29, P188, DOI 10.1161/ATVBAHA.108.181578; Fernandez PL, 2001, INT J CANCER, V95, P51, DOI 10.1002/1097-0215(20010120)95:1<51::AID-IJC1009>3.0.CO;2-J; Flannery T, 2003, AM J PATHOL, V163, P175, DOI 10.1016/S0002-9440(10)63641-3; Flannery T, 2006, INT J CANCER, V119, P854, DOI 10.1002/ijc.21911; Geraghty P, 2007, J BIOL CHEM, V282, P33389, DOI 10.1074/jbc.M706884200; Gupta S, 2008, EXPERT OPIN THER TAR, V12, P291, DOI 10.1517/14728222.12.3.291; Ingelsson E, 2008, EUR J CLIN INVEST, V38, P502, DOI 10.1111/j.1365-2362.2008.01962.x; Jobs E, 2010, J CLIN ENDOCR METAB, V95, P4460, DOI 10.1210/jc.2010-0328; Jormsjo S, 2002, AM J PATHOL, V161, P939, DOI 10.1016/S0002-9440(10)64254-X; Kitamura H, 2005, IMMUNITY, V23, P491, DOI 10.1016/j.immuni.2005.09.010; Kos J, 2001, BRIT J CANCER, V85, P1193, DOI 10.1054/bjoc.2001.2057; Lee-Dutra A, 2011, EXPERT OPIN THER PAT, V21, P311, DOI 10.1517/13543776.2011.553800; Lind L, 2005, ARTERIOSCL THROM VAS, V25, P2368, DOI 10.1161/01.ATV.0000184769.22061.da; Lindstedt L, 2003, BIOCHEM BIOPH RES CO, V312, P1019, DOI 10.1016/j.bbrc.2003.11.020; Liu JA, 2004, ARTERIOSCL THROM VAS, V24, P1359, DOI 10.1161/01.ATV.0000134530.27208.41; Liu J, 2006, ATHEROSCLEROSIS, V186, P411, DOI 10.1016/j.atherosclerosis.2005.08.001; Liuzzo JP, 1999, MOL MED, V5, P320, DOI 10.1007/BF03402068; Martin SL, 2010, PEDIATR PULM, V45, P860, DOI 10.1002/ppul.21274; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; Naour N, 2010, J CLIN ENDOCR METAB, V95, P1861, DOI 10.1210/jc.2009-1894; Ovchinnikova O, 2009, AM J PATHOL, V174, P693, DOI 10.2353/ajpath.2009.080561; Pan JH, 2004, CIRCULATION, V109, P3149, DOI 10.1161/01.CIR.0000134704.84454.D2; Rodgers KJ, 2006, ARTERIOSCL THROM VAS, V26, P851, DOI 10.1161/01.ATV.0000203526.75772.4b; Schwarz G, 2002, J INVEST DERMATOL, V119, P44, DOI 10.1046/j.1523-1747.2002.01800.x; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Spielmann N, 2008, CLIN GENET, V74, P155, DOI 10.1111/j.1399-0004.2008.01043.x; Sukhova GK, 2003, J CLIN INVEST, V111, P897, DOI 10.1172/JCI200314915; Sukhova GK, 1998, J CLIN INVEST, V102, P576, DOI 10.1172/JCI181; Taleb S, 2006, J CLIN ENDOCR METAB, V91, P1042, DOI 10.1210/jc.2005-1601; Taleb S, 2005, FASEB J, V19, P1540, DOI 10.1096/fj.05-3673fje; Taleb S, 2006, ENDOCRINOLOGY, V147, P4950, DOI 10.1210/en.2006-0386; Urbonaviciene G, 2011, ATHEROSCLEROSIS, V216, P440, DOI 10.1016/j.atherosclerosis.2011.02.016; Wang B, 2006, J BIOL CHEM, V281, P6020, DOI 10.1074/jbc.M509134200; Ward C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012543; Williams AS, 2009, PULM PHARMACOL THER, V22, P27, DOI 10.1016/j.pupt.2008.11.002; Wu CK, 2010, J AM COLL CARDIOL, V56, P1930, DOI 10.1016/j.jacc.2010.04.069; Yang YX, 2010, J PROTEOME RES, V9, P6801, DOI 10.1021/pr101027g; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	47	60	61	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2011	306	10					1113	1121		10.1001/jama.2011.1246	http://dx.doi.org/10.1001/jama.2011.1246			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819DS	21878432	Bronze			2022-12-01	WOS:000294806200025
J	Star, B; Nederbragt, AJ; Jentoft, S; Grimholt, U; Malmstrom, M; Gregers, TF; Rounge, TB; Paulsen, J; Solbakken, MH; Sharma, A; Wetten, OF; Lanzen, A; Winer, R; Knight, J; Vogel, JH; Aken, B; Andersen, O; Lagesen, K; Tooming-Klunderud, A; Edvardsen, RB; Tina, KG; Espelund, M; Nepal, C; Previti, C; Karlsen, BO; Moum, T; Skage, M; Berg, PR; Gjoen, T; Kuhl, H; Thorsen, J; Malde, K; Reinhardt, R; Du, L; Johansen, SD; Searle, S; Lien, S; Nilsen, F; Jonassen, I; Omholt, SW; Stenseth, NC; Jakobsen, KS				Star, Bastiaan; Nederbragt, Alexander J.; Jentoft, Sissel; Grimholt, Unni; Malmstrom, Martin; Gregers, Tone F.; Rounge, Trine B.; Paulsen, Jonas; Solbakken, Monica H.; Sharma, Animesh; Wetten, Ola F.; Lanzen, Anders; Winer, Roger; Knight, James; Vogel, Jan-Hinnerk; Aken, Bronwen; Andersen, Oivind; Lagesen, Karin; Tooming-Klunderud, Ave; Edvardsen, Rolf B.; Tina, Kirubakaran G.; Espelund, Mari; Nepal, Chirag; Previti, Christopher; Karlsen, Bard Ove; Moum, Truls; Skage, Morten; Berg, Paul R.; Gjoen, Tor; Kuhl, Heiner; Thorsen, Jim; Malde, Ketil; Reinhardt, Richard; Du, Lei; Johansen, Steinar D.; Searle, Steve; Lien, Sigbjorn; Nilsen, Frank; Jonassen, Inge; Omholt, Stig W.; Stenseth, Nils Chr.; Jakobsen, Kjetill S.			The genome sequence of Atlantic cod reveals a unique immune system	NATURE			English	Article							MHC CLASS-I; OXYGEN-BINDING PROPERTIES; GADUS-MORHUA L.; GENES; POLYMORPHISM; TEMPERATURE; NEUTROPHILS; EXPRESSION; SELECTION; GENOTYPES	Atlantic cod (Gadus morhua) is a large, cold-adapted teleost that sustains long-standing commercial fisheries and incipient aquaculture(1,2). Here we present the genome sequence of Atlantic cod, showing evidence for complex thermal adaptations in its haemoglobin gene cluster and an unusual immune architecture compared to other sequenced vertebrates. The genome assembly was obtained exclusively by 454 sequencing of shotgun and paired-end libraries, and automated annotation identified 22,154 genes. The major histocompatibility complex (MHC) II is a conserved feature of the adaptive immune system of jawed vertebrates(3,4), but we show that Atlantic cod has lost the genes for MHC II, CD4 and invariant chain (Ii) that are essential for the function of this pathway. Nevertheless, Atlantic cod is not exceptionally susceptible to disease under natural conditions(5). We find a highly expanded number of MHC I genes and a unique composition of its Toll-like receptor (TLR) families. This indicates how the Atlantic cod immune system has evolved compensatory mechanisms in both adaptive and innate immunity in the absence of MHC II. These observations affect fundamental assumptions about the evolution of the adaptive immune system and its components in vertebrates.	[Star, Bastiaan; Nederbragt, Alexander J.; Jentoft, Sissel; Grimholt, Unni; Malmstrom, Martin; Rounge, Trine B.; Paulsen, Jonas; Solbakken, Monica H.; Lagesen, Karin; Tooming-Klunderud, Ave; Tina, Kirubakaran G.; Espelund, Mari; Skage, Morten; Berg, Paul R.; Omholt, Stig W.; Stenseth, Nils Chr.; Jakobsen, Kjetill S.] Univ Oslo, Dept Biol, CEES, N-0316 Oslo, Norway; [Gregers, Tone F.] Univ Oslo, Dept Mol Biosci, Ctr Immune Regulat, N-0316 Oslo, Norway; [Paulsen, Jonas] Oslo Univ Hosp, Inst Med Informat, Bioinformat Core Facil, N-0310 Oslo, Norway; [Sharma, Animesh; Nepal, Chirag; Jonassen, Inge] Univ Bergen, Dept Informat, N-5020 Bergen, Norway; [Wetten, Ola F.] Hedmark Univ Coll, Dept Nat Sci & Technol, N-2306 Bedriftsenteret, Hamar, Norway; [Wetten, Ola F.] Univ Life Sci, Dept Anim & Aquacultural Sci, N-1432 As, Norway; [Lanzen, Anders] Univ Bergen, Ctr Geobiol, Dept Biol, N-5020 Bergen, Norway; [Lanzen, Anders; Nepal, Chirag; Previti, Christopher; Jonassen, Inge] Uni Res AS, Uni Comp, Computat Biol Unit, N-5020 Bergen, Norway; [Winer, Roger; Knight, James; Du, Lei] 454 Life Sci, Branford, CT 06405 USA; [Vogel, Jan-Hinnerk; Aken, Bronwen; Searle, Steve] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Andersen, Oivind] Nofima Marine, N-1430 As, Norway; [Edvardsen, Rolf B.; Malde, Ketil] Inst Marine Res, N-5817 Bergen, Norway; [Tina, Kirubakaran G.; Lien, Sigbjorn; Omholt, Stig W.] Norwegian Univ Life Sci, Ctr Integrat Genet, CIGENE, Dept Anim & Aquacultural Sci, N-1432 As, Norway; [Karlsen, Bard Ove; Moum, Truls; Johansen, Steinar D.] Univ Nordland, Fac Biosci & Aquaculture, N-8049 Bodo, Norway; [Gjoen, Tor] Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, N-0316 Oslo, Norway; [Kuhl, Heiner; Reinhardt, Richard] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Thorsen, Jim] Sch Vet Sci, Inst Basic Sci & Aquat Med, N-0033 Oslo, Norway; [Johansen, Steinar D.] Univ Tromso, Fac Hlth Sci, Dept Med Biol, N-9037 Tromso, Norway	University of Oslo; University of Oslo; University of Oslo; University of Bergen; Inland Norway University of Applied Sciences; Norwegian University of Life Sciences; University of Bergen; University of Bergen; Wellcome Trust Sanger Institute; Nofima; Institute of Marine Research - Norway; Norwegian University of Life Sciences; Nord University; University of Oslo; Max Planck Society; UiT The Arctic University of Tromso	Jakobsen, KS (corresponding author), Univ Oslo, Dept Biol, CEES, POB 1066, N-0316 Oslo, Norway.	k.s.jakobsen@bio.uio.no	Lanzén, Anders/F-3818-2016; Jonassen, Inge/AAC-7035-2020; Nepal, Chirag/K-5866-2019; Gjoen, Tor/F-2740-2013; wenji, huang/F-4860-2015; Berg, Paul/A-3648-2011; Kuhl, Heiner/L-2737-2019; Berg, Paul Ragnar/Q-1584-2019; M, Ketil/AAH-5604-2020; Vogel, Jan-Hinnerk/C-4582-2013; Lanzén, Anders/AAG-5048-2019; Stenseth, Nils Chr./G-5212-2016	Lanzén, Anders/0000-0002-7138-6364; Gjoen, Tor/0000-0003-4040-5793; Berg, Paul/0000-0002-4974-8509; Berg, Paul Ragnar/0000-0002-4974-8509; Lanzén, Anders/0000-0002-7138-6364; Stenseth, Nils Chr./0000-0002-1591-5399; Aken, Bronwen/0000-0002-3032-4095; Hongro Solbakken, Monica/0000-0002-9677-403X; Jonassen, Inge/0000-0003-4110-0748; Nederbragt, Lex/0000-0001-5539-0999; Edvardsen, Rolf/0000-0001-8430-8042; Rounge, Trine/0000-0003-2677-2722; Nepal, Chirag/0000-0001-8402-3805; Moum, Truls/0000-0002-0651-6863; Grimholt, Unni/0000-0002-0202-8061; Reinhardt, Richard/0000-0001-9376-2132; Star, Bastiaan/0000-0003-0235-9810; Lagesen, Karin/0000-0003-1329-9032; Jentoft, Sissel/0000-0001-8707-531X	Research Council of Norway	Research Council of Norway(Research Council of Norway)	This work was supported by a grant from the Research Council of Norway (FUGE program) to K.S.J. The authors wish to thank the following people and organizations: the 454 Life Science Sequencing Center (Branford, USA); the 454 and Illumina nodes of the Norwegian Sequencing Centre (University of Oslo); M. Egholm (formerly 454 Life Science); the Norwegian Metacenter for Computational Science (Notur) and the Norwegian Storage Infrastructure (Norstore); the Research Computing Services group, especially B.-H. Mevik, at the Center for Information Technology (University of Oslo); B. Walenz (Celera); the Canadian Cod Genomics and Broodstock Development Consortium; P. Olsvik, K. Lie and E. Holen at the Norwegian National Institute of Nutrition and Seafood Research (NIFES); J. Gaup and H. Bakke (CEES, University of Oslo); M. Kent (CIGENE, Norwegian University of Life Sciences); S. Bowman (Genome Atlantic); the FUGE bioinformatics platforms group, especially S. Grindhaug; I. Sandlie and O. B. Landsverk (Centre for Immune Regulation, University of Oslo); and Roche Norway.	Amigorena S, 2010, CURR OPIN IMMUNOL, V22, P109, DOI 10.1016/j.coi.2010.01.022; Andersen O, 2009, P ROY SOC B-BIOL SCI, V276, P833, DOI 10.1098/rspb.2008.1529; Borza T, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-51; Brix O, 2004, COMP BIOCHEM PHYS A, V138, P241, DOI 10.1016/j.cbpb.2004.04.004; Dijkstra JM, 2007, IMMUNOGENETICS, V59, P305, DOI 10.1007/s00251-007-0198-6; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Gamperl AK, 2009, PHYSIOL BIOCHEM ZOOL, V82, P483, DOI 10.1086/603636; Hubert S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-191; Johansen SD, 2009, NEW BIOTECHNOL, V25, P263, DOI 10.1016/j.nbt.2009.03.014; Jozsef L, 2006, J IMMUNOL, V176, P1195, DOI 10.4049/jimmunol.176.2.1195; KAUFMAN J, 1995, IMMUNOL REV, V143, P63, DOI 10.1111/j.1600-065X.1995.tb00670.x; Kurlansky M., 1998, COD BIOGRAPHY FISH C; Landsverk OJB, 2009, SCAND J IMMUNOL, V70, P184, DOI 10.1111/j.1365-3083.2009.02301.x; Litman GW, 2010, NAT REV IMMUNOL, V10, P543, DOI 10.1038/nri2807; Magnadottir B, 2009, COMP BIOCHEM PHYS B, V154, P309, DOI 10.1016/j.cbpb.2009.07.005; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Miller KM, 2002, IMMUNOGENETICS, V53, P941, DOI 10.1007/s00251-001-0398-4; Overland HS, 2010, FISH SHELLFISH IMMUN, V28, P193, DOI 10.1016/j.fsi.2009.10.021; Persson AC, 1999, IMMUNOGENETICS, V50, P49, DOI 10.1007/s002510050685; Petersen MF, 2003, J EXP BIOL, V206, P359, DOI 10.1242/jeb.00111; Pilstrom L, 2005, FISHERIES SCI, V71, P961, DOI 10.1111/j.1444-2906.2005.01052.x; Rebl A, 2010, VET IMMUNOL IMMUNOP, V134, P139, DOI 10.1016/j.vetimm.2009.09.021; Ronneseth A, 2007, FISH SHELLFISH IMMUN, V23, P493, DOI 10.1016/j.fsi.2006.08.017; SICK K, 1961, NATURE, V192, P894, DOI 10.1038/192894a0; Solem ST, 2006, DEV COMP IMMUNOL, V30, P57, DOI 10.1016/j.dci.2005.06.007; Stenseth NC, 2009, NATURE, V457, P803, DOI 10.1038/457803a; Tournefier A, 1998, IMMUNOL REV, V166, P259, DOI 10.1111/j.1600-065X.1998.tb01268.x; Weber RE, 2004, RESP PHYSIOL NEUROBI, V144, P141, DOI 10.1016/j.resp.2004.04.018; Wetten OF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-315	30	528	556	3	187	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 8	2011	477	7363					207	210		10.1038/nature10342	http://dx.doi.org/10.1038/nature10342			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816MC	21832995	Green Published, hybrid, Green Accepted			2022-12-01	WOS:000294603900035
J	Rinkevich, Y; Lindau, P; Ueno, H; Longaker, MT; Weissman, IL				Rinkevich, Yuval; Lindau, Paul; Ueno, Hiroo; Longaker, Michael T.; Weissman, Irving L.			Germ-layer and lineage-restricted stem/progenitors regenerate the mouse digit tip	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; REGULATORY ELEMENTS; BLOOD-CELLS; MICE; LIMB; EXPRESSION; SKIN; RECOMBINATION; ENDOTHELIUM; PRECURSORS	The regrowth of amputated limbs and the distal tips of digits represent models of tissue regeneration in amphibians, fish and mice. For decades it had been assumed that limb regeneration derived from the blastema, an undifferentiated pluripotent cell population thought to be derived from mature cells via dedifferentiation. Here we show that a wide range of tissue stem/progenitor cells contribute towards the restoration of the mouse distal digit. Genetic fate mapping and clonal analysis of individual cells revealed that these stem cells are lineage restricted, mimicking digit growth during development. Transplantation of cyan-fluorescent-protein-expressing haematopoietic stem cells, and parabiosis between genetically marked mice, confirmed that the stem/progenitor cells are tissue resident, including the cells involved in angiogenesis. These results, combined with those from appendage regeneration in other vertebrate subphyla, collectively demonstrate that tissue stem cells rather than pluripotent blastema cells are an evolutionarily conserved cellular mode for limb regeneration after amputation.	[Rinkevich, Yuval; Lindau, Paul; Ueno, Hiroo; Longaker, Michael T.; Weissman, Irving L.] Stanford Univ, Sch Med, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Longaker, Michael T.] Stanford Univ, Sch Med, Dept Surg Plast & Reconstruct Surg, Hagey Lab Pediat Regenerat Med, Stanford, CA 94305 USA; [Weissman, Irving L.] Stanford Univ, Ludwig Ctr Canc Stem Cell Res, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Rinkevich, Y (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Lorry I Lokey Res Bldg, Stanford, CA 94028 USA.	ryuval@stanford.edu	Rinkevich, Yuval/B-7854-2018; Rinkevich, Yuval/B-7647-2018	Rinkevich, Yuval/0000-0001-6290-7271; Rinkevich, Yuval/0000-0002-9022-7668	California Institute of Regenerative Medicine [RC1 00354]; Smith Family Trust; Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; Human Frontier Science Program (HFSP); Machiah Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099999, U01HL099995] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Smith Family Trust; Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; Human Frontier Science Program (HFSP)(Human Frontier Science Program); Machiah Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank A. Mosley for assistance with animal care and parabiosis experiments; A. Sweet-Cordero for providing Sox9Cre and Prx1Cre mice; R. Schweitzer for providing ScxCre mice; and L. Luo for providing mTmG reporter mice. We thank D. Montoro for assistance with histochemical stains and G. Paz for assistance with figure preparations. This work was supported in part by a grant from the California Institute of Regenerative Medicine (RC1 00354) and from the Smith Family Trust (to I.L.W.), the Oak Foundation and the Hagey Laboratory for Pediatric Regenerative Medicine (to M.T.L.). Y.R. is supported by a Human Frontier Science Program (HFSP) Long Term Fellowship, and the Machiah Foundation Fellowship.	Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Alvarado AS, 2000, BIOESSAYS, V22, P578, DOI 10.1002/(SICI)1521-1878(200006)22:6<578::AID-BIES11>3.0.CO;2-#; BORGENS RB, 1982, SCIENCE, V217, P747, DOI 10.1126/science.7100922; Bratincsak A, 2007, STEM CELLS, V25, P2820, DOI 10.1634/stemcells.2007-0301; Brockes JP, 2005, SCIENCE, V310, P1919, DOI 10.1126/science.1115200; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Christen B, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-5; Djouad F, 2009, NAT REV RHEUMATOL, V5, P392, DOI 10.1038/nrrheum.2009.104; Faustman DL, 2006, SCIENCE, V314, DOI 10.1126/science.1129811; Fernando WA, 2011, DEV BIOL, V350, P301, DOI 10.1016/j.ydbio.2010.11.035; Forde A, 2002, GENESIS, V33, P191, DOI 10.1002/gene.10117; Forsberg EC, 2006, STEM CELL REV, V2, P23, DOI 10.1385/SCR:2:1:23; Gargioli C, 2004, DEVELOPMENT, V131, P2669, DOI 10.1242/dev.01155; Hamrick MW, 2001, EVOL DEV, V3, P355, DOI 10.1046/j.1525-142X.2001.01032.x; Han M, 2008, DEV BIOL, V315, P125, DOI 10.1016/j.ydbio.2007.12.025; ILLINGWORTH CM, 1974, J PEDIATR SURG, V9, P853, DOI 10.1016/S0022-3468(74)80220-4; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Kimmel RA, 2000, GENE DEV, V14, P1377; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; LIVERSAGE RA, 1991, HIST REGENERATION RE; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Monvoisin A, 2006, DEV DYNAM, V235, P3413, DOI 10.1002/dvdy.20982; Morgan T.H., 1901, REGENERATION, DOI 10.5962/bhl.title.1114; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; NEUFELD DA, 1993, PROG CLIN BIOL RES, V383, P243; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; Purhonen S, 2008, P NATL ACAD SCI USA, V105, P6620, DOI 10.1073/pnas.0710516105; REGINELLI AD, 1995, DEVELOPMENT, V121, P1065; RINKEVICH B, 1995, P NATL ACAD SCI USA, V92, P7695, DOI 10.1073/pnas.92.17.7695; Rinkevich Y, 2007, PLOS BIOL, V5, P900, DOI 10.1371/journal.pbio.0050071; ROSENTHAL LJ, 1979, PEDIATRICS, V64, P1; Said S, 2004, ANAT REC PART A, V278A, P443, DOI 10.1002/ar.a.20034; SCHOTTE OE, 1959, BIOL BULL, V117, P546, DOI 10.2307/1538866; Tamura K, 2010, DEV GROWTH DIFFER, V52, P89, DOI 10.1111/j.1440-169X.2009.01144.x; Tsonis PA, 2008, CURR STEM CELL RES T, V3, P53, DOI 10.2174/157488808783489408; Tu S, 2011, DEV CELL, V20, P725, DOI 10.1016/j.devcel.2011.04.013; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; VIDAL P, 1993, J HAND SURG-BRIT EUR, V18B, P230, DOI 10.1016/0266-7681(93)90116-W; Voskoboynik A, 2007, FASEB J, V21, P1335, DOI 10.1096/fj.06-7337com; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Zaidi N, 2007, ANN NY ACAD SCI, V1117, P62, DOI 10.1196/annals.1402.074	46	279	284	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 25	2011	476	7361					409	U53		10.1038/nature10346	http://dx.doi.org/10.1038/nature10346			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811KT	21866153	Green Accepted			2022-12-01	WOS:000294209400027
J	Moynihan, R				Moynihan, Ray			DISEASE MARKERS Surrogates under scrutiny: fallible correlations, fatal consequences	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PREVENTION; ARTICLES		Univ Newcastle, Callaghan, NSW 2308, Australia	University of Newcastle	Moynihan, R (corresponding author), Univ Newcastle, Callaghan, NSW 2308, Australia.	Ray.Moynihan@newcastle.edu.au	Moynihan, Ray/ABC-3010-2020					[Anonymous], 1989, NEW ENGL J MED, V321, P406; [Anonymous], 2010, THERAPEUTICS LETT, V77; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bossuyt PMM, 2011, JAMA-J AM MED ASSOC, V305, P2229, DOI 10.1001/jama.2011.729; Deckers JW, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1048; DeLaet CEDH, 1997, BRIT MED J, V315, P221, DOI 10.1136/bmj.315.7102.221; Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524; Greene JeremyA., 2007, PRESCRIBING NUMBERS; Heath I, 2007, BRIT MED J, V335, P1075, DOI 10.1136/bmj.39377.387373.AD; Inst Med, 2010, EVALUATION OF BIOMARKERS AND SURROGATE ENDPOINTS IN CHRONIC DISEASE, P1; Ioannidis JPA, 2011, JAMA-J AM MED ASSOC, V305, P2200, DOI 10.1001/jama.2011.713; Jarvinen TLN, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2175; Montori V, 2007, BMJ-BRIT MED J, V334, P882, DOI 10.1136/bmj.39169.447488.94; Moore TJ, 1995, DEADLY MED; Moynihan R, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2548; NIH Consensus Development Conference Management of Hepatitis B, 2008, NIH CONS DEV C MAN H; Press release, 2011, NIH NEWS        0526; Preventing Alzheimer's disease and cognitive declin, 2010, PREVENTING ALZHEIMER; Rose J, 2003, QUAL MANAG HEALTH CA, V17, P27; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Shaughnessy AF, 2003, BRIT MED J, V327, P266, DOI 10.1136/bmj.327.7409.266; Starfield B, 2008, J EPIDEMIOL COMMUN H, V62, P580, DOI 10.1136/jech.2007.071027; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4; Yudkin JS, 2011, LANCET, V377, P1220, DOI 10.1016/S0140-6736(10)61112-9	24	24	24	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 15	2011	343								d5160	10.1136/bmj.d5160	http://dx.doi.org/10.1136/bmj.d5160			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811KK	21844159	Green Submitted			2022-12-01	WOS:000294208300003
J	Bhopal, R; Macfarlane, GJ; Smith, WC; West, R				Bhopal, Raj; Macfarlane, Gary J.; Smith, William Cairns; West, Robert		Management Executive Comm XIX Worl	What is the future of epidemiology?	LANCET			English	Editorial Material									[Smith, William Cairns] Univ Aberdeen, Dept Publ Hlth, Aberdeen AB25 2ZD, Scotland; [Bhopal, Raj] Univ Edinburgh, Edinburgh Ethn & Hlth Res Grp, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Macfarlane, Gary J.] Univ Aberdeen, Epidemiol Grp, Inst Appl Hlth Sci, Aberdeen AB25 2ZD, Scotland; [West, Robert] Cardiff Univ, Wales Heart Res Inst, Cardiff, S Glam, Wales	University of Aberdeen; University of Edinburgh; University of Aberdeen; Cardiff University	Smith, WC (corresponding author), Univ Aberdeen, Dept Publ Hlth, Aberdeen AB25 2ZD, Scotland.	w.c.s.smith@abdn.ac.uk	Macfarlane, Gary J/I-9521-2014	Macfarlane, Gary J/0000-0003-2322-3314				*INT EP ASS, 2011, INT EP ASS 19 WORLD; *WHO COLL CTR U PI, SUP EP INT GLOB HLTH; World Health Organization, 2010, 1 WHO	3	9	9	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 6	2011	378	9790					464	465		10.1016/S0140-6736(11)61147-1	http://dx.doi.org/10.1016/S0140-6736(11)61147-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	809SO	21821173				2022-12-01	WOS:000294077200007
J	Goldstein, DB				Goldstein, David B.			Growth of genome screening needs debate	NATURE			English	Editorial Material							RARE		Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC 27708 USA	Duke University	Goldstein, DB (corresponding author), Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC 27708 USA.	d.goldstein@duke.edu	Goldstein, David/AAY-8125-2020					Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Fan HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010439; Heinzen EL, 2010, AM J HUM GENET, V86, P707, DOI 10.1016/j.ajhg.2010.03.018; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Merikangas AK, 2009, TRENDS GENET, V25, P536, DOI 10.1016/j.tig.2009.10.006; Potter S., 2010, DESIGNER GENES NEW E; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Zhu QQ, 2011, AM J HUM GENET, V88, P458, DOI 10.1016/j.ajhg.2011.03.008	10	9	9	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2011	476	7358					27	28		10.1038/476027a	http://dx.doi.org/10.1038/476027a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	801NR	21814258				2022-12-01	WOS:000293447300013
J	Kozlowski, S; Woodcock, J; Midthun, K; Sherman, RB				Kozlowski, Steven; Woodcock, Janet; Midthun, Karen; Sherman, Rachel Behrman			Developing the Nation's Biosimilars Program	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kozlowski, Steven; Woodcock, Janet; Sherman, Rachel Behrman] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Midthun, Karen] Ctr Biol Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Kozlowski, S (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							European Medicenes Agency, 2005, GUID SIM BIOL MED PR; European Medicines Agency, 2010, GUID SIM BI IN PRESS; Fed. Trade CoMM'n, 2009, EMERGING HLTH CARE I; Woodcock J, 2007, NAT REV DRUG DISCOV, V6, P437, DOI 10.1038/nrd2307	4	144	148	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2011	365	5					385	388		10.1056/NEJMp1107285	http://dx.doi.org/10.1056/NEJMp1107285			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	801NW	21812668				2022-12-01	WOS:000293447800001
J	Savin, T; Kurpios, NA; Shyer, AE; Florescu, P; Liang, HY; Mahadevan, L; Tabin, CJ				Savin, Thierry; Kurpios, Natasza A.; Shyer, Amy E.; Florescu, Patricia; Liang, Haiyi; Mahadevan, L.; Tabin, Clifford J.			On the growth and form of the gut	NATURE			English	Article								The developing vertebrate gut tube forms a reproducible looped pattern as it grows into the body cavity. Here we use developmental experiments to eliminate alternative models and show that gut looping morphogenesis is driven by the homogeneous and isotropic forces that arise from the relative growth between the gut tube and the anchoring dorsal mesenteric sheet, tissues that grow at different rates. A simple physical mimic, using a differentially strained composite of a pliable rubber tube and a soft latex sheet is consistent with this mechanism and produces similar patterns. We devise a mathematical theory and a computational model for the number, size and shape of intestinal loops based solely on the measurable geometry, elasticity and relative growth of the tissues. The predictions of our theory are quantitatively consistent with observations of intestinal loops at different stages of development in the chick embryo. Our model also accounts for the qualitative and quantitative variation in the distinct gut looping patterns seen in a variety of species including quail, finch and mouse, illuminating how the simple macroscopic mechanics of differential growth drives the morphology of the developing gut.	[Savin, Thierry; Florescu, Patricia; Liang, Haiyi; Mahadevan, L.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Kurpios, Natasza A.; Shyer, Amy E.; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Mahadevan, L.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Mahadevan, L.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Kavli Inst Bionano Sci & Technol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard University	Mahadevan, L (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	lm@seas.harvard.edu	liang, haiyi/Q-3422-2019; Liang, Haiyi/B-2969-2008	liang, haiyi/0000-0001-7458-8036; Liang, Haiyi/0000-0001-7458-8036; Savin, Thierry/0000-0002-3956-7077	Harvard NSF MRSEC; MacArthur Foundation; NIH [RO1 HD047360]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD047360] Funding Source: NIH RePORTER	Harvard NSF MRSEC; MacArthur Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank R. Prum for pointing out to us the literature on avian intestines, and the Harvard NSF MRSEC, the MacArthur Foundation (L.M.) and NIH RO1 HD047360 (C.J.T.) for support.	Beddard F. E., 1898, STRUCTURE CLASSIFICA; BELOUSSOV LV, 1994, INT REV CYTOL, V150, P1; Davis NM, 2008, DEV CELL, V15, P134, DOI 10.1016/j.devcel.2008.05.001; Forgacs G, 2005, BIOLOGICAL PHYSICS OF THE DEVELOPING EMBRYO, P1, DOI 10.1017/CBO9780511755576; Fung Y C, 2004, BIOMECHANICS MECH PR, P242; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Hamburger H, 1951, J MORPHOL, V88, P49; Hecksher-Sorensen J, 2004, DEVELOPMENT, V131, P4665, DOI 10.1242/dev.01364; His W., 1880, ANATOMIE MENSCHLICHE; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; Kleinman R. E., 2008, WALKERS PEDIAT GASTR, P207; Kurpios NA, 2008, P NATL ACAD SCI USA, V105, P8499, DOI 10.1073/pnas.0803578105; Liang HY, 2009, P NATL ACAD SCI USA, V106, P22049, DOI 10.1073/pnas.0911954106; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Mitchell C. P., 1896, P ZOOL SOC LOND, V64, P136; Salazar-Ciudad I, 2010, NATURE, V464, P583, DOI 10.1038/nature08838; Schoenwolf G., 2008, LARSENS HUMAN EMBRYO; Taber LA, 2001, ANNU REV BIOMED ENG, V3, P1, DOI 10.1146/annurev.bioeng.3.1.1; Thompson DW., 1917, GROWTH FORM, DOI [10.5962/bhl.title.11332, DOI 10.5962/BHL.TITLE.11332]	20	313	320	6	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 4	2011	476	7358					57	+		10.1038/nature10277	http://dx.doi.org/10.1038/nature10277			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NR	21814276	Green Accepted			2022-12-01	WOS:000293447300028
J	Mellars, P; French, JC				Mellars, Paul; French, Jennifer C.			Tenfold Population Increase in Western Europe at the Neandertal-to-Modern Human Transition	SCIENCE			English	Article							MODERN HUMAN COLONIZATION; EXTINCTION; AURIGNACIAN; CONTEXT; FRANCE	European Neandertals were replaced by modern human populations from Africa similar to 40,000 years ago. Archaeological evidence from the best-documented region of Europe shows that during this replacement human populations increased by one order of magnitude, suggesting that numerical supremacy alone may have been a critical factor in facilitating this replacement.	[Mellars, Paul; French, Jennifer C.] Univ Cambridge, Dept Archaeol, Cambridge CB2 3DZ, England	University of Cambridge	Mellars, P (corresponding author), Univ Cambridge, Dept Archaeol, Cambridge CB2 3DZ, England.	pam59@cam.ac.uk		French, Jennifer Clair/0000-0001-5947-6669	British Academy; Arts and Humanities Research Council; St. John's College, Cambridge	British Academy; Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); St. John's College, Cambridge	We thank S. Bohndiek, K. Boyle, L. Bourguinon, J.-P. Chadelle, L. Chiotti, P.-Y. Demars, H. Dibble, T. Higham, S. Kuhn, S. McPherron, P. Nigst, S. Shennan, R. White, and E. Zubrow for useful discussions and provision of data; D. Kemp for preparing the illustrations; and the British Academy, the Arts and Humanities Research Council, and St. John's College, Cambridge, for research funding.	Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Bailey Shara E., 2005, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V17, P115; Banks WE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003972; Bar-Yosef O, 2010, J HUM EVOL, V59, P586, DOI 10.1016/j.jhevol.2010.06.009; BARYOSEF O, 2006, DEFINITION AURIGNACI; Bocquet-Appel JP, 2000, ANTIQUITY, V74, P544, DOI 10.1017/S0003598X00059901; Bocquet-Appel JP, 2000, J ARCHAEOL SCI, V27, P551, DOI 10.1006/jasc.1999.0471; BORDES F, 1968, OLD STONE AGE; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Churchill SE, 2000, YEARB PHYS ANTHROPOL, V43, P61; Conard N.J., 2006, NEANDERTHALS MODERN; d'Errico F, 1998, CURR ANTHROPOL, V39, pS1, DOI 10.1086/204689; d'Errico F, 2003, QUATERNARY SCI REV, V22, P769, DOI 10.1016/S0277-3791(03)00009-X; Davis W, 2003, MACDONALD I MONOGRAP; de Sonneville-Bordes D, 1960, PALEOLITHIQUE SUPERI; Demars, 1996, PREHISTOIRE EUROPEEN, V8, P3; Demars PY, 2008, ANTHROPOLOGIE, V112, P157, DOI 10.1016/j.anthro.2008.02.001; Fabre V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005151; Finlayson C, 2006, NATURE, V443, P850, DOI 10.1038/nature05195; Gamble Clive., 1986, PALAEOLITHIC SETTLEM; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; HARROLD FB, 1989, HUMAN REVOLUTION, P677; Hawks J, 2008, RECENT ADVANCES IN PALAEODEMOGRAPHY, P9, DOI 10.1007/978-1-4020-6424-1_1; Higham T, 2010, P NATL ACAD SCI USA, V107, P20234, DOI 10.1073/pnas.1007963107; Hockett B, 2005, QUATERN INT, V137, P21, DOI 10.1016/j.quaint.2004.11.017; Klein R., 2009, HUMAN CAREER; Marean C.W., 2005, TOOLS SYMBOLS EARLY, V333, pe371; Mellars P, 2005, EVOL ANTHROPOL, V14, P12, DOI 10.1002/evan.20037; Mellars P, 2004, NATURE, V432, P461, DOI 10.1038/nature03103; MELLARS P, 1989, CURR ANTHROPOL, V30, P349, DOI 10.1086/203755; Mellars P, 1998, NEANDERTALS AND MODERN HUMANS IN WESTERN ASIA, P493; Mellars P., 1996, NEANDERTHAL LEGACY A; Mellars P.A., 1991, CAMB ARCHAEOL J, V1, P269; MELLARS PA, 1987, CURR ANTHROPOL, V28, P128, DOI 10.1086/203504; Mellars PA, 1985, PREHISTORIC HUNTER G, P271; Mellars P, 2006, EVOL ANTHROPOL, V15, P167, DOI 10.1002/evan.20103; Nigst PR, 2006, NEANDERTHALS MODERN, P269; O'Connell J. F., 2006, NEANDERTHALS MODERN, P43; Pelegrin J., 2009, NEANDERTALIENS BIOL, P283; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Richards MP, 2001, P NATL ACAD SCI USA, V98, P6528, DOI 10.1073/pnas.111155298; Soressi M, 2007, J HUM EVOL, V52, P455, DOI 10.1016/j.jhevol.2006.11.006; Soressi M., 2002, THESIS U BORDEAUX; Svoboda J.A., 2006, NEANDERTALS MODERN H, P233; VALLADAS H, 1986, NATURE, V322, P452, DOI 10.1038/322452a0; Vandermeersch B., 2009, NEANDERTALIENS BIOL, P109; ZUBROW E, 1989, HUMAN REVOLUTION, P212	47	121	125	2	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2011	333	6042					623	627		10.1126/science.1206930	http://dx.doi.org/10.1126/science.1206930			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	798PI	21798948				2022-12-01	WOS:000293222400060
J	Denham, BE				Denham, Bryan E.			Dietary Supplements-Regulatory Issues and Implications for Public Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Clemson Univ, Dept Commun Studies, Clemson, SC 29634 USA	Clemson University	Denham, BE (corresponding author), Clemson Univ, Dept Commun Studies, 412 Strode Tower, Clemson, SC 29634 USA.	bdenham@clemson.edu						Hill J.A., 2006, J FOOD L POL, V2, P361; *NAT CTR COMPL ALT, RES RES DIET HERB SU; US Food & Drug Administration, CURR GOOD MAN PRACT; *US GOV ACC OFF, 2009, PUBL US GOV ACC OFF; *US GOV ACC OFF, 2010, PUBL US GOV ACC OFF; *US GOV ACC OFF, 1993, PUBL US GOV ACC OFF	6	37	37	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2011	306	4					428	429		10.1001/jama.2011.982	http://dx.doi.org/10.1001/jama.2011.982			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	797KL	21730229				2022-12-01	WOS:000293125800029
J	Shiwani, MH				Shiwani, Muhammad Hanif			PERSONAL VIEW Surgical meshes containing animal products should be labelled	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Shiwani, Muhammad Hanif] Barnsley Gen Hosp, Barnsley, England; [Shiwani, Muhammad Hanif] Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Shiwani, MH (corresponding author), Barnsley Gen Hosp, Barnsley, England.	mhshiwani@gmail.com							0	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 27	2011	343								d4625	10.1136/bmj.d4625	http://dx.doi.org/10.1136/bmj.d4625			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801LS	21795240				2022-12-01	WOS:000293441000002
J	Shirey, SB; Richardson, SH				Shirey, Steven B.; Richardson, Stephen H.			Start of the Wilson Cycle at 3 Ga Shown by Diamonds from Subcontinental Mantle	SCIENCE			English	Article							BILLION YEARS AGO; RE-OS ISOTOPES; LITHOSPHERIC MANTLE; KAAPVAAL CRATON; PILBARA CRATON; SUBDUCTION; CRUST; DELAMINATION; CONSTRAINTS; INCLUSIONS	Mineral inclusions encapsulated in diamonds are the oldest, deepest, and most pristine samples of Earth's mantle. They provide age and chemical information over a period of 3.5 billion years-a span that includes continental crustal growth, atmospheric evolution, and the initiation of plate tectonics. We compiled isotopic and bulk chemical data of silicate and sulfide inclusions and found that a compositional change occurred 3.0 billion years ago (Ga). Before 3.2 Ga, only diamonds with peridotitic compositions formed, whereas after 3.0 Ga, eclogitic diamonds became prevalent. We suggest that this resulted from the capture of eclogite and diamond-forming fluids in subcontinental mantle via subduction and continental collision, marking the onset of the Wilson cycle of plate tectonics.	[Shirey, Steven B.] Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA; [Richardson, Stephen H.] Univ Cape Town, Dept Geol Sci, ZA-7701 Rondebosch, South Africa	Carnegie Institution for Science; University of Cape Town	Shirey, SB (corresponding author), Carnegie Inst Washington, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	shirey@dtm.ciw.edu; steve.richardson@uct.ac.za			NASA [NNA09DA81A]; NSF [EAR-1049992]; National Research Foundation (South Africa) [IFR73219]	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); National Research Foundation (South Africa)(National Research Foundation - South Africa)	We thank S. Aulbach, D. Bowen, G. Duke, D. Foustoukos, E. Gaillou, J. Harris, W. Nelson, D. Pearson, S. Solomon, M. Van Kranendonk, and two anonymous reviewers for helpful discussions. Supported by NASA Astrobiology grant NNA09DA81A (S. B. S.), NSF grant EAR-1049992 (S. B. S.), and National Research Foundation (South Africa) grant IFR73219 (S.H.R.)	Aulbach S, 2011, CONTRIB MINERAL PETR, V161, P947, DOI 10.1007/s00410-010-0573-4; Aulbach S, 2009, LITHOS, V112, P747, DOI 10.1016/j.lithos.2009.03.048; Bedard JH, 2006, GEOCHIM COSMOCHIM AC, V70, P1188, DOI 10.1016/j.gca.2005.11.008; Bleeker W, 2003, LITHOS, V71, P99, DOI 10.1016/j.lithos.2003.07.003; Bowring SA, 1999, CONTRIB MINERAL PETR, V134, P3, DOI 10.1007/s004100050465; BURKE K, 1976, TECTONOPHYSICS, V33, P287, DOI 10.1016/0040-1951(76)90149-9; Burke K, 2011, ANNU REV EARTH PL SC, V39, P1, DOI 10.1146/annurev-earth-040809-152521; Burov E, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041535; Chen CW, 2009, SCIENCE, V326, P1089, DOI 10.1126/science.1178477; Creighton S, 2010, CONTRIB MINERAL PETR, V159, P645, DOI 10.1007/s00410-009-0446-x; Furnes H, 2007, SCIENCE, V315, P1704, DOI 10.1126/science.1139170; Gurney JJ, 2010, ECON GEOL, V105, P689, DOI 10.2113/gsecongeo.105.3.689; Harvey J, 2006, EARTH PLANET SC LETT, V244, P606, DOI 10.1016/j.epsl.2006.02.031; Helmstaedt HH, 2010, CAN MINERAL, V48, P1385, DOI 10.3749/canmin.48.5.1385; Hoffman P.F., 1980, GEOLOGICAL ASS CANAD, V20, P523; Kamber BS, 2002, CONTRIB MINERAL PETR, V144, P38, DOI 10.1007/s00410-002-0374-5; Lloyd F.E., 1975, PHYS CHEM EARTH, V9, P389, DOI DOI 10.1016/0079-1946(75)90030-0; Menzies M., 1986, MANTLE METASOMATISM; MORGAN JW, 1986, J GEOPHYS RES-SOLID, V91, P2375, DOI 10.1029/JB091iB12p12375; Moser DE, 2001, SCIENCE, V291, P465, DOI 10.1126/science.291.5503.465; Nutman AP, 2006, ELEMENTS, V2, P223, DOI 10.2113/gselements.2.4.223; O'Neil J, 2011, J PETROL, V52, P985, DOI 10.1093/petrology/egr014; PEARSON DG, 1999, APPL RADIOGENIC ISOT, V12, P143; Richardson SH, 2001, EARTH PLANET SC LETT, V191, P257, DOI 10.1016/S0012-821X(01)00419-8; RICHARDSON SH, 1984, NATURE, V310, P198, DOI 10.1038/310198a0; Schmitz MD, 2004, EARTH PLANET SC LETT, V222, P363, DOI 10.1016/j.epsl.2004.03.036; Shirey SB, 2001, GEOPHYS RES LETT, V28, P2509, DOI 10.1029/2000GL012589; Stachel T, 2005, ELEMENTS, V1, P73, DOI 10.2113/gselements.1.2.73; Ueda K, 2008, PHYS EARTH PLANET IN, V171, P296, DOI 10.1016/j.pepi.2008.06.032; Van Kranendonk MJ, 2007, TERRA NOVA, V19, P1, DOI 10.1111/j.1365-3121.2006.00723.x; Van Kranendonk MJ, 2010, PRECAMBRIAN RES, V177, P145, DOI 10.1016/j.precamres.2009.11.007; Westerlund KJ, 2006, CONTRIB MINERAL PETR, V152, P275, DOI 10.1007/s00410-006-0101-8; WILSON JT, 1968, P AM PHILOS SOC, V112, P309; Zegers TE, 2001, GEOLOGY, V29, P1083, DOI 10.1130/0091-7613(2001)029<1083:MACFBC>2.0.CO;2	34	364	377	3	179	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2011	333	6041					434	436		10.1126/science.1206275	http://dx.doi.org/10.1126/science.1206275			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21778395				2022-12-01	WOS:000292959600039
J	Urban, LE; McCrory, MA; Dallal, GE; Das, SK; Saltzman, E; Weber, JL; Roberts, SB				Urban, Lorien E.; McCrory, Megan A.; Dallal, Gerard E.; Das, Sai Krupa; Saltzman, Edward; Weber, Judith L.; Roberts, Susan B.			Accuracy of Stated Energy Contents of Restaurant Foods	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WEIGHT-LOSS; US ADULTS; CONSUMPTION; OBESITY; TRENDS; PREVALENCE; OVERWEIGHT; AMERICA; CHOICES; IMPACT	Context National recommendations for the prevention and treatment of obesity emphasize reducing energy intake. Foods purchased in restaurants provide approximately 35% of the daily energy intake in US individuals but the accuracy of the energy contents listed for these foods is unknown. Objective To examine the accuracy of stated energy contents of foods purchased in restaurants. Design and Setting A validated bomb calorimetry technique was used to measure dietary energy in food from 42 restaurants, comprising 269 total food items and 242 unique foods. The restaurants and foods were randomly selected from quick-serve and sit-down restaurants in Massachusetts, Arkansas, and Indiana between January and June 2010. Main Outcome Measure The difference between restaurant-stated and laboratory-measured energy contents, which were corrected for standard metabolizable energy conversion factors. Results The absolute stated energy contents were not significantly different from the absolute measured energy contents overall (difference of 10 kcal/portion; 95% confidence interval [CI], -15 to 34 kcal/portion; P =. 52); however, the stated energy contents of individual foods were variable relative to the measured energy contents. Of the 269 food items, 50 (19%) contained measured energy contents of at least 100 kcal/portion more than the stated energy contents. Of the 10% of foods with the highest excess energy in the initial sampling, 13 of 17 were available for a second sampling. In the first analysis, these foods contained average measured energy contents of 289 kcal/portion (95% CI, 186 to 392 kcal/portion) more than the stated energy contents; in the second analysis, these foods contained average measured energy contents of 258 kcal/portion (95% CI, 154 to 361 kcal/portion) more than the stated energy contents (P < .001 for each vs 0 kcal/portion difference). In addition, foods with lower stated energy contents contained higher measured energy contents than stated, while foods with higher stated energy contents contained lower measured energy contents (P < .001). Conclusions Stated energy contents of restaurant foods were accurate overall. However, there was substantial inaccuracy for some individual foods, with understated energy contents for those with lower energy contents.	[Roberts, Susan B.] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Energy Metab Lab, Boston, MA 02111 USA; [McCrory, Megan A.] Purdue Univ, Dept Foods & Nutr, Dept Psychol Sci, W Lafayette, IN 47907 USA; [McCrory, Megan A.] Purdue Univ, Ingest Behav Res Ctr, W Lafayette, IN 47907 USA; [Weber, Judith L.] Univ Arkansas Med Sci, Dept Pediat, Coll Med, Little Rock, AR 72205 USA	Tufts University; United States Department of Agriculture (USDA); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Arkansas System; University of Arkansas Medical Sciences	Roberts, SB (corresponding author), Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Energy Metab Lab, 711 Washington St, Boston, MA 02111 USA.	susan.roberts@tufts.edu			GSK Consumer Healthcare; US Department of Agriculture [58-1950-0-014]; Tufts University; Purdue University; Arkansas Children's Hospital Research Institute; Arkansas Biosciences Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069772] Funding Source: NIH RePORTER	GSK Consumer Healthcare; US Department of Agriculture(United States Department of Agriculture (USDA)); Tufts University; Purdue University; Arkansas Children's Hospital Research Institute; Arkansas Biosciences Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All authors have completed and submitted the ICMJE Form for Disclosure ported that her institution received money from GSK Consumer Healthcare to conduct investigator-initiated research on dietary macronutrient composition interactions with orlistat effects on appetite and related variables; and money was paid to her institution (Department of Foods and Nutrition, Purdue University) for the corporate affiliates program in which interested parties, mostly food manufacturers or suppliers thereof, pay an annual fee to learn about recent research and discuss topical nutrition-related issues such as the 2010 Dietary Guidelines. No other authors reported disclosures.; This work was supported by the US Department of Agriculture agreement No. 58-1950-0-014 with Tufts University, by internal department research funds from Purdue University, and by the Arkansas Children's Hospital Research Institute and the Arkansas Biosciences Institute.	Ahuja JKC, 2008, J FOOD COMPOS ANAL, V21, pS119, DOI 10.1016/j.jfca.2007.05.005; Bowman SA, 2004, J AM COLL NUTR, V23, P163, DOI 10.1080/07315724.2004.10719357; Burke LE, 2011, J AM DIET ASSOC, V111, P92, DOI 10.1016/j.jada.2010.10.008; Butte NF, 2003, SCIENCE, V301; Duffey KJ, 2007, AM J CLIN NUTR, V85, P201, DOI 10.1093/ajcn/85.1.201; *EC RES SERV, DIET QUAL FOOD CONS; Economic Research Service, US PER CAP LOSS ADJ; Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Hall KD, 2008, INT J OBESITY, V32, P573, DOI 10.1038/sj.ijo.0803720; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Jakicic JM, 2001, MED SCI SPORT EXER, V33, P2145, DOI 10.1097/00005768-200112000-00026; Johnson CM, 2010, ARCH INTERN MED, V170, P732, DOI 10.1001/archinternmed.2010.72; Kant AK, 2004, PREV MED, V38, P243, DOI 10.1016/j.ypmed.2003.10.004; Katan MB, 2010, JAMA-J AM MED ASSOC, V303, P65, DOI 10.1001/jama.2009.1912; Levene H., 1960, CONTRIBUTIONS PROBAB, P278, DOI DOI 10.1137/1003016; Ludwig DS, 2009, JAMA-J AM MED ASSOC, V302, P434, DOI 10.1001/jama.2009.1045; McCrory MA, 1999, OBES RES, V7, P564, DOI 10.1002/j.1550-8528.1999.tb00715.x; Merrill AL, 1973, HDB USDA, V74; Natl. Cent. Health Stat, 2007, HLTH US 2007; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Pulos E, 2010, AM J PUBLIC HEALTH, V100, P1035, DOI 10.2105/AJPH.2009.174839; Roberto CA, 2010, AM J PUBLIC HEALTH, V100, P312, DOI 10.2105/AJPH.2009.160226; Root AD, 2004, INT J FOOD SCI NUTR, V55, P449, DOI 10.1080/09637480400010415; *SAS I INC, 2004, SAS STAT 9 1 US GUID, P4773; Technomic Information Services, 2008, DINN OCC CONS TREND; Urban LE, 2010, J AM DIET ASSOC, V110, P116, DOI 10.1016/j.jada.2009.10.003; US Department of Agriculture & US Department of Health and Human Services, 2010, DIET GUID AM 2010; *USDA, 2007, AW HOM PERC SEL NUTR; Wadden TA, 2003, ENDOCRIN METAB CLIN, V32, P981, DOI 10.1016/S0889-8529(03)00072-0; Wing R. R., 2002, Handbook of obesity treatment, P301; RESTAURANTS I MAGAZI	33	44	44	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2011	306	3					287	293		10.1001/jama.2011.993	http://dx.doi.org/10.1001/jama.2011.993			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794BS	21771989	Bronze, Green Accepted			2022-12-01	WOS:000292870500021
J	D'Agostino, RB				D'Agostino, Ralph B., Sr.			Changing End Points in Breast-Cancer Drug Approval - The Avastin Story	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PACLITAXEL		Boston Univ, Dept Math & Stat, Boston, MA 02215 USA	Boston University	D'Agostino, RB (corresponding author), Boston Univ, Dept Math & Stat, Boston, MA 02215 USA.							*FDA ONC DRUG ADV, 2010, JUL 20 M; *FDA ONC DRUGS ADV, 2007, DEC 5 M; Muggia FM, 2000, J CLIN ONCOL, V18, P106, DOI 10.1200/JCO.2000.18.1.106; Panageas KS, 2007, J NATL CANCER I, V99, P428, DOI 10.1093/jnci/djk091; Sledge GW, 2003, J CLIN ONCOL, V21, P588, DOI 10.1200/JCO.2003.08.013	5	65	67	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2011	365	2								10.1056/nejmp1106984	http://dx.doi.org/10.1056/nejmp1106984			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	791SP	21707384				2022-12-01	WOS:000292685500005
J	Facciabene, A; Peng, XH; Hagemann, IS; Balint, K; Barchetti, A; Wang, LP; Gimotty, PA; Gilks, CB; Lal, P; Zhang, L; Coukos, G				Facciabene, Andrea; Peng, Xiaohui; Hagemann, Ian S.; Balint, Klara; Barchetti, Andrea; Wang, Li-Ping; Gimotty, Phyllis A.; Gilks, C. Blake; Lal, Priti; Zhang, Lin; Coukos, George			Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T-reg cells	NATURE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OVARIAN-CANCER; SUPPRESSOR-CELLS; DENDRITIC CELLS; IMMUNE THERAPY; B RECEPTOR; RECRUITMENT; CCR10; VEGF; EXPRESSION	Although immune mechanisms can suppress tumour growth(1,2), tumours establish potent, overlapping mechanisms that mediate immune evasion(3-6). Emerging evidence suggests a link between angiogenesis and the tolerance of tumours to immune mechanisms(7-10). Hypoxia, a condition that is known to drive angiogenesis in tumours, results in the release of damage-associated pattern molecules, which can trigger the rejection of tumours by the immune system(11). Thus, the counter-activation of tolerance mechanisms at the site of tumour hypoxia would be a crucial condition for maintaining the immunological escape of tumours. However, a direct link between tumour hypoxia and tolerance through the recruitment of regulatory cells has not been established. We proposed that tumour hypoxia induces the expression of chemotactic factors that promote tolerance. Here we show that tumour hypoxia promotes the recruitment of regulatory T (T-reg) cells through induction of expression of the chemokine CC-chemokine ligand 28 (CCL28), which, in turn, promotes tumour tolerance and angiogenesis. Thus, peripheral immune tolerance and angiogenesis programs are closely connected and cooperate to sustain tumour growth.	[Facciabene, Andrea; Peng, Xiaohui; Balint, Klara; Barchetti, Andrea; Zhang, Lin; Coukos, George] Univ Penn, Ovarian Canc Res Ctr, Philadelphia, PA 19104 USA; [Hagemann, Ian S.; Wang, Li-Ping; Lal, Priti] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Gimotty, Phyllis A.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Gilks, C. Blake] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of British Columbia	Coukos, G (corresponding author), Univ Penn, Ovarian Canc Res Ctr, Philadelphia, PA 19104 USA.	gcks@mail.med.upenn.edu	duan, hf/F-9166-2011; Gimotty, Phyllis/GWZ-4136-2022; Balint, Klara/ABB-8816-2021; Hagemann, Ian/ABB-2854-2021; Zhang, Lin/K-8478-2012; Coukos, George/ABG-7389-2020	Gimotty, Phyllis/0000-0002-3850-9799; Hagemann, Ian/0000-0002-3855-9745; Coukos, George/0000-0001-8813-7367	National Institutes of Health [R01-CA116779]; National Cancer Institute [P01-CA83638]; Ovarian Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA116779, P50CA083638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ovarian Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant R01-CA116779; National Cancer Institute Ovarian SPORE grant P01-CA83638; and the Ovarian Cancer Research Fund. We thank M. Celeste Simon and S. Evans for generous help with the hypoxia studies; M. Feldman and the University of Pennsylvania Tumor Tissue & Biospecimen Bank for tumour processing; and G. Danet-Desnoyers and the University of Pennsylvania Xenograft Core Facility for NSG mice.	Ben-Shoshan J, 2008, EUR J IMMUNOL, V38, P2412, DOI 10.1002/eji.200838318; Bergeron M, 1999, NEUROSCIENCE, V89, P1357, DOI 10.1016/S0306-4522(98)00377-7; Bertozzi CC, 2006, IN VITRO CELL DEV-AN, V42, P58; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Buckanovich RJ, 2008, NAT MED, V14, P28, DOI 10.1038/nm1699; Buckanovich RJ, 2007, J CLIN ONCOL, V25, P852, DOI 10.1200/JCO.2006.08.8583; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Curiel TJ, 2004, CANCER RES, V64, P5535, DOI 10.1158/0008-5472.CAN-04-1272; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Daponte A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-335; Eksteen B, 2006, J IMMUNOL, V177, P593, DOI 10.4049/jimmunol.177.1.593; Elia L, 2007, CANCER GENE THER, V14, P201, DOI 10.1038/sj.cgt.7701004; Feng NG, 2006, J IMMUNOL, V176, P5749, DOI 10.4049/jimmunol.176.10.5749; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kandalaft LE, 2009, CLIN CANCER RES, V15, P4521, DOI 10.1158/1078-0432.CCR-08-0543; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Lazarus NH, 2003, J IMMUNOL, V170, P3799, DOI 10.4049/jimmunol.170.7.3799; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Lee YH, 1999, EUR J CANCER, V35, P1089, DOI 10.1016/S0959-8049(99)00073-8; Li B, 2006, CLIN CANCER RES, V12, P6808, DOI 10.1158/1078-0432.CCR-06-1558; Lotfi R, 2007, J IMMUNOTHER, V30, P16, DOI 10.1097/01.cji.0000211324.53396.f6; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Nagaraj S, 2007, ADV EXP MED BIOL, V601, P213; Ohta A, 2006, P NATL ACAD SCI USA, V103, P13132, DOI 10.1073/pnas.0605251103; Osada T, 2008, CANCER IMMUNOL IMMUN, V57, P1115, DOI 10.1007/s00262-007-0441-x; Pan JL, 2000, J IMMUNOL, V165, P2943, DOI 10.4049/jimmunol.165.6.2943; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Shimogai R, 2008, INT J GYNECOL CANCER, V18, P499, DOI 10.1111/j.1525-1438.2007.01055.x; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Wang W, 2000, J BIOL CHEM, V275, P22313, DOI 10.1074/jbc.M001461200; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhang L, 2002, AM J PATHOL, V161, P2295, DOI 10.1016/S0002-9440(10)64505-1; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	37	822	868	5	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2011	475	7355					226	U141		10.1038/nature10169	http://dx.doi.org/10.1038/nature10169			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21753853				2022-12-01	WOS:000292690500050
J	Snyder, KA; Pearse, W				Snyder, Karrie Ann; Pearse, William			Discussing Fertility Preservation Options With Patients With Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Snyder, Karrie Ann] Northwestern Univ, Dept Sociol, Evanston, IL 60208 USA; [Pearse, William] Rosalind Franklin Univ, N Chicago, IL USA	Northwestern University; Rosalind Franklin University Medical & Science	Snyder, KA (corresponding author), Northwestern Univ, Dept Sociol, 1810 Chicago Ave, Evanston, IL 60208 USA.	karrie-snyder@northwestern.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [RL1HD058296] Funding Source: NIH RePORTER; NICHD NIH HHS [RL1 HD058296-04] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Kohler TS, 2011, J ASSIST REPROD GEN, V28, P269, DOI 10.1007/s10815-010-9504-6; Lee SJ, 2006, J CLIN ONCOL, V24, P2917, DOI 10.1200/JCO.2006.06.5888; Quinn Gwendolyn P, 2007, J Cancer Surviv, V1, P146, DOI 10.1007/s11764-007-0019-9; Quinn GP, 2009, J CLIN ONCOL, V27, P5952, DOI 10.1200/JCO.2009.23.0250; RIEKER PP, 1990, J CLIN ONCOL, V8, P347, DOI 10.1200/JCO.1990.8.2.347; Robertson JA, 2005, FERTIL STERIL, V83, P1622, DOI 10.1016/j.fertnstert.2005.03.013; Schover LR, 2002, J CLIN ONCOL, V20, P1890, DOI 10.1200/JCO.2002.07.174; SCHOVER LR, 2005, J NATL CANC I MONOGR, V34, P2, DOI DOI 10.1093/JNCIMONOGRAPHS/LGI010; Woodruff TK, 2010, CANCER TREAT RES, V156, P1, DOI 10.1007/978-1-4419-6518-9; Woodruff TK, 2007, CANC TREATMENT RES, V138	10	22	22	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2011	306	2					202	203		10.1001/jama.2011.973	http://dx.doi.org/10.1001/jama.2011.973			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791CO	21750299				2022-12-01	WOS:000292639400029
J	Amit, R; Garcia, HG; Phillips, R; Fraser, SE				Amit, Roee; Garcia, Hernan G.; Phillips, Rob; Fraser, Scott E.			Building Enhancers from the Ground Up: A Synthetic Biology Approach	CELL			English	Article							TET REPRESSOR; RNA-POLYMERASE; TRANSCRIPTIONAL REGULATION; THERMODYNAMIC ANALYSIS; GENE-REGULATION; TOGGLE SWITCH; IN-VIVO; EXPRESSION; PROMOTER; BINDING	A challenge of the synthetic biology approach is to use our understanding of a system to recreate a biological function with specific properties. We have applied this framework to bacterial enhancers, combining a driver, transcription factor binding sites, and a poised polymerase to create synthetic modular enhancers. Our findings suggest that enhancer-based transcriptional control depends critically and quantitatively on DNA looping, leading to complex regulatory effects when the enhancer cassettes contain additional transcription factor binding sites for TetR, a bacterial transcription factor. We show through a systematic interplay of experiment and thermodynamic modeling that the level of gene expression can be modulated to convert a variable inducer concentration input into discrete or step-like output expression levels. Finally, using a different DNA-binding protein (TraR), we show that the regulatory output is not a particular feature of the specific DNA-binding protein used for the enhancer but a general property of synthetic bacterial enhancers.	[Amit, Roee; Phillips, Rob; Fraser, Scott E.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Garcia, Hernan G.] CALTECH, Dept Phys, Pasadena, CA 91125 USA; [Amit, Roee; Phillips, Rob; Fraser, Scott E.] CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology	Amit, R (corresponding author), Technion Israel Inst Technol, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel.	roeeamit@technion.ac.il	Fraser, Scott/Y-3406-2019	Fraser, Scott/0000-0002-5377-0223; Garcia, Hernan G./0000-0002-5212-3649	NIH [ARRA R01 GM085286-01S, R01 GM085286, DP1 OD000217]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085286] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000217] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would especially like to thank Prof. Frances H. Arnold for providing lab space and the forum to conduct thorough discussions as this project was evolving. We would also like to thank Eric H. Davidson for important early discussions and Alex J. Ninfa for plasmids and strains. R.A. was supported by a NIH Ruth L. Kirschstein fellowship, a Caltech CBCD grant, and the NIH through award NIH ARRA R01 GM085286-01S. R.P. and H.G.G. gratefully acknowledge awards NIH ARRA R01 GM085286-01S, R01 GM085286, and the NIH Director's PIONEER Award DP1 OD000217.	Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Atkinson MR, 2002, MOL MICROBIOL, V46, P1247, DOI 10.1046/j.1365-2958.2002.03211.x; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Becker NA, 2005, J MOL BIOL, V349, P716, DOI 10.1016/j.jmb.2005.04.035; Bintu L, 2005, CURR OPIN GENET DEV, V15, P125, DOI 10.1016/j.gde.2005.02.006; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Buck M, 2000, J BACTERIOL, V182, P4129, DOI 10.1128/JB.182.15.4129-4136.2000; Davidson E.H., 2006, REGULATORY GENOME; Davidson EH, 2001, GENOMIC REGULATORY S; DRIEVER W, 1989, NATURE, V340, P363, DOI 10.1038/340363a0; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Garcia HG, 2011, P NATL ACAD SCI USA, V108, P12173, DOI 10.1073/pnas.1015616108; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Hervas AB, 2009, J BACTERIOL, V191, P6123, DOI 10.1128/JB.00744-09; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; HILLEN W, 1984, J MOL BIOL, V172, P185, DOI 10.1016/S0022-2836(84)80037-6; Huo YX, 2006, MOL MICROBIOL, V59, P168, DOI 10.1111/j.1365-2958.2005.04943.x; JOUNG JK, 1993, P NATL ACAD SCI USA, V90, P3083, DOI 10.1073/pnas.90.7.3083; Kuhlman T, 2007, P NATL ACAD SCI USA, V104, P6043, DOI 10.1073/pnas.0606717104; LAW SM, 1993, J MOL BIOL, V230, P161, DOI 10.1006/jmbi.1993.1133; Lederer T, 1995, ANAL BIOCHEM, V232, P190, DOI 10.1006/abio.1995.0006; Lederer T, 1996, BIOCHEMISTRY-US, V35, P7439, DOI 10.1021/bi952683e; LEE DH, 1989, P NATL ACAD SCI USA, V86, P476, DOI 10.1073/pnas.86.2.476; Long T, 2009, PLOS BIOL, V7, P640, DOI 10.1371/journal.pbio.1000068; MAGASANIK B, 1993, J CELL BIOCHEM, V51, P34, DOI 10.1002/jcb.240510108; Mukherji S, 2009, NAT REV GENET, V10, P859, DOI 10.1038/nrg2697; Muller J, 1996, J MOL BIOL, V257, P21, DOI 10.1006/jmbi.1996.0143; Ninfa AJ, 2000, TRENDS MICROBIOL, V8, P172, DOI 10.1016/S0966-842X(00)01709-1; NINFA AJ, 1987, CELL, V50, P1039, DOI 10.1016/0092-8674(87)90170-X; Orth P, 2000, NAT STRUCT BIOL, V7, P215; Phillips R, 2009, PHYS BIOL CELL; Qin YP, 2009, MOL MICROBIOL, V74, P330, DOI 10.1111/j.1365-2958.2009.06865.x; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rappas M, 2007, CURR OPIN STRUC BIOL, V17, P110, DOI 10.1016/j.sbi.2006.11.002; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Schulz A, 2000, J MOL BIOL, V300, P709, DOI 10.1006/jmbi.2000.3921; SU W, 1990, P NATL ACAD SCI USA, V87, P5504, DOI 10.1073/pnas.87.14.5504	38	40	40	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 8	2011	146	1					105	118		10.1016/j.cell.2011.06.024	http://dx.doi.org/10.1016/j.cell.2011.06.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729783	Green Accepted, Bronze			2022-12-01	WOS:000292539300010
J	Sim, MS; Bosak, T; Ono, S				Sim, Min Sub; Bosak, Tanja; Ono, Shuhei			Large Sulfur Isotope Fractionation Does Not Require Disproportionation	SCIENCE			English	Article							MICROBIAL SULFATE REDUCTION; ATMOSPHERIC OXYGEN; EVOLUTION; SEDIMENTS; OCEAN; BIOSPHERE; SULFIDE; BURIAL; CARBON; PYRITE	The composition of sulfur isotopes in sedimentary sulfides and sulfates traces the sulfur cycle throughout Earth's history. In particular, depletions of sulfur-34 ((34)S) in sulfide relative to sulfate exceeding 47 per mil (parts per thousand) often serve as a proxy for the disproportionation of intermediate sulfur species in addition to sulfate reduction. Here, we demonstrate that a pure, actively growing culture of a marine sulfate-reducing bacterium can deplete (34)S by up to 66 parts per thousand during sulfate reduction alone and in the absence of an extracellular oxidative sulfur cycle. Therefore, similar magnitudes of sulfur isotope fractionation in sedimentary rocks do not unambiguously record the presence of other sulfur-based metabolisms or the stepwise oxygenation of Earth's surface environment during the Proterozoic.	[Sim, Min Sub; Bosak, Tanja; Ono, Shuhei] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Sim, MS (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	mssim@mit.edu		Sim, Min Sub/0000-0002-3491-9002	NASA Astrobiology Institute [NNA08CN84A]	NASA Astrobiology Institute	We thank W. Olszewski, K. Donovan, S. Templer, J. Seewald, S. Sylva, B. Weiss, L. Kump, J. Grabenstatter, B. Bannon, P. Hedman, and Y. J. Joo. This work was partially supported by NASA Astrobiology Institute (#NNA08CN84A).	Berner RA, 1998, SCIENCE, V282, P1426, DOI 10.1126/science.282.5393.1426; Brunner B, 2005, GEOCHIM COSMOCHIM AC, V69, P4759, DOI 10.1016/j.gca.2005.04.015; CANFIELD DE, 1994, SCIENCE, V266, P1973, DOI 10.1126/science.11540246; Canfield DE, 1996, NATURE, V382, P127, DOI 10.1038/382127a0; Canfield DE, 2010, GEOLOGY, V38, P415, DOI 10.1130/G30723.1; Canfield DE, 2009, P NATL ACAD SCI USA, V106, P8123, DOI 10.1073/pnas.0902037106; D'Hondt S, 2002, SCIENCE, V295, P2067, DOI 10.1126/science.1064878; Farquhar J, 2003, GEOBIOLOGY, V1, P27, DOI 10.1046/j.1472-4669.2003.00007.x; Fike DA, 2006, NATURE, V444, P744, DOI 10.1038/nature05345; GARRELS RM, 1981, P NATL ACAD SCI USA, V78, P4652, DOI 10.1073/pnas.78.8.4652; Hayes J.M., 1992, PROTEROZOIC BIOSPHER, P129; Hurtgen MT, 2005, GEOLOGY, V33, P41, DOI 10.1130/G20923.1; Johnston DT, 2007, GEOCHIM COSMOCHIM AC, V71, P3929, DOI 10.1016/j.gca.2007.05.008; Johnston DT, 2005, SCIENCE, V310, P1477, DOI 10.1126/science.1117824; JORGENSEN BB, 1990, SCIENCE, V249, P152, DOI 10.1126/science.249.4965.152; Jorgensen BB, 2007, NAT REV MICROBIOL, V5, P770, DOI 10.1038/nrmicro1745; Kah LC, 2004, NATURE, V431, P834, DOI 10.1038/nature02974; Li XN, 2010, GEOCHIM COSMOCHIM AC, V74, P6764, DOI 10.1016/j.gca.2010.08.020; MOPPER K, 1980, MAR CHEM, V10, P55, DOI 10.1016/0304-4203(80)90058-4; NORTHROP DB, 1981, ANNU REV BIOCHEM, V50, P103, DOI 10.1146/annurev.bi.50.070181.000535; Otake T, 2008, CHEM GEOL, V249, P357, DOI 10.1016/j.chemgeo.2008.01.020; Parnell J, 2010, NATURE, V468, P290, DOI 10.1038/nature09538; PETERSON BJ, 1986, ECOLOGY, V67, P865, DOI 10.2307/1939809; REES CE, 1973, GEOCHIM COSMOCHIM AC, V37, P1141, DOI 10.1016/0016-7037(73)90052-5; ROSS GM, 1995, PRECAMBRIAN RES, V73, P71, DOI 10.1016/0301-9268(94)00072-Y; Rudnicki MD, 2001, GEOCHIM COSMOCHIM AC, V65, P777, DOI 10.1016/S0016-7037(00)00579-2; Sim MS, 2011, GEOCHIM COSMOCHIM AC, V75, P4244, DOI 10.1016/j.gca.2011.05.021; STAMS JM, 1983, ARCH MICROBIOL, V136, P54; Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535; Wortmann UG, 2001, GEOLOGY, V29, P647, DOI 10.1130/0091-7613(2001)029<0647:HDBIES>2.0.CO;2; Wu NP, 2010, GEOCHIM COSMOCHIM AC, V74, P2053, DOI 10.1016/j.gca.2009.12.012; Zerkle AL, 2010, GEOCHIM COSMOCHIM AC, V74, P4953, DOI 10.1016/j.gca.2010.06.015	32	392	402	2	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 1	2011	333	6038					74	77		10.1126/science.1205103	http://dx.doi.org/10.1126/science.1205103			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719675				2022-12-01	WOS:000292255400051
J	Friedman, JR; Lackner, LL; West, M; DiBenedetto, JR; Nunnari, J; Voeltz, GK				Friedman, Jonathan R.; Lackner, Laura L.; West, Matthew; DiBenedetto, Jared R.; Nunnari, Jodi; Voeltz, Gia K.			ER Tubules Mark Sites of Mitochondrial Division	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; MAMMALIAN-CELLS; MEMBRANE; FISSION; RECRUITMENT; DYNAMICS; DNM1P; DRP1; MFF	Mitochondrial structure and distribution are regulated by division and fusion events. Mitochondrial division is regulated by Dnm1/Drp1, a dynamin-related protein that forms helices around mitochondria to mediate fission. Little is known about what determines sites of mitochondrial fission within the mitochondrial network. The endoplasmic reticulum (ER) and mitochondria exhibit tightly coupled dynamics and have extensive contacts. We tested whether ER plays a role in mitochondrial division. We found that mitochondrial division occurred at positions where ER tubules contacted mitochondria and mediated constriction before Drp1 recruitment. Thus, ER tubules may play an active role in defining the position of mitochondrial division sites.	[Friedman, Jonathan R.; West, Matthew; DiBenedetto, Jared R.; Voeltz, Gia K.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Lackner, Laura L.; Nunnari, Jodi] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	University of Colorado System; University of Colorado Boulder; University of California System; University of California Davis	Voeltz, GK (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	gia.voeltz@colorado.edu	Friedman, Jonathan/GWV-4047-2022	Friedman, Jonathan/0000-0001-8155-2429	NIH [R01 GM083977, GM08759, R01 GM062942]; Searle Scholar award; American Heart Innovative Research Grant; Biological Sciences Initiative; University of Colorado; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759, R01GM062942, R01GM083977] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholar award; American Heart Innovative Research Grant; Biological Sciences Initiative; University of Colorado; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by NIH grant R01 GM083977 and a Searle Scholar award (to G.K.V.), NIH training grant GM08759 (to J.R.F.), NIH grant R01 GM062942 and an American Heart Innovative Research Grant (to J.N.), and grants from the Biological Sciences Initiative (BURST grant) and the Undergraduate Research Opportunity Program at the University of Colorado (to J.R.D.). We thank the Boulder 3D Electron Microscopy facility for shared equipment and helpful suggestions.	Cho DH, 2010, CELL MOL LIFE SCI, V67, P3435, DOI 10.1007/s00018-010-0435-2; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; Friedman JR, 2010, J CELL BIOL, V190, P363, DOI 10.1083/jcb.200911024; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lackner LL, 2009, BBA-MOL BASIS DIS, V1792, P1138, DOI 10.1016/j.bbadis.2008.11.011; Legesse-Miller A, 2003, MOL BIOL CELL, V14, P1953, DOI 10.1091/mbc.E02-10-0657; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; West M, 2011, J CELL BIOL, V193, P333, DOI 10.1083/jcb.201011039; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Yoon Y, 2011, ANTIOXID REDOX SIGN, V14, P439, DOI 10.1089/ars.2010.3286	18	1199	1228	5	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 21	2011	334	6054					358	362		10.1126/science.1207385	http://dx.doi.org/10.1126/science.1207385			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	21885730	Green Accepted			2022-12-01	WOS:000296052500048
J	Barry, CL; Huskamp, HA				Barry, Colleen L.; Huskamp, Haiden A.			Moving beyond Parity - Mental Health and Addiction Care under the ACA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Barry, Colleen L.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Huskamp, Haiden A.] Harvard Univ, Sch Med, Boston, MA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Harvard Medical School	Barry, CL (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.				NIDA NIH HHS [R01 DA026414] Funding Source: Medline; NIMH NIH HHS [R01 MH080797] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026414] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Alakeson V, 2010, HEALTH AFFAIR, V29, P867, DOI 10.1377/hlthaff.2010.0080; Colton Craig W, 2006, Prev Chronic Dis, V3, pA42; Garfield RL, 2011, AM J PSYCHIAT, V168, P486, DOI 10.1176/appi.ajp.2010.10060792; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Mojtabai R, 2007, PSYCHIAT SERV, V58, P1261, DOI 10.1176/appi.ps.58.10.1261	5	144	144	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2011	365	11					973	975		10.1056/NEJMp1108649	http://dx.doi.org/10.1056/NEJMp1108649			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	819UR	21848453	Green Accepted			2022-12-01	WOS:000294857300001
J	Carette, JE; Raaben, M; Wong, AC; Herbert, AS; Obernosterer, G; Mulherkar, N; Kuehne, AI; Kranzusch, PJ; Griffin, AM; Ruthel, G; Dal Cin, P; Dye, JM; Whelan, SP; Chandran, K; Brummelkamp, TR				Carette, Jan E.; Raaben, Matthijs; Wong, Anthony C.; Herbert, Andrew S.; Obernosterer, Gregor; Mulherkar, Nirupama; Kuehne, Ana I.; Kranzusch, Philip J.; Griffin, April M.; Ruthel, Gordon; Dal Cin, Paola; Dye, John M.; Whelan, Sean P.; Chandran, Kartik; Brummelkamp, Thijn R.			Ebola virus entry requires the cholesterol transporter Niemann-Pick C1	NATURE			English	Article							VESICULAR STOMATITIS-VIRUS; HEMORRHAGIC-FEVER; ZAIRE-EBOLAVIRUS; HUMAN-CELLS; IDENTIFICATION; GENE; GLYCOPROTEIN; MECHANISM; RECEPTOR; ANTIBODY	Infections by the Ebola and Marburg filoviruses cause a rapidly fatal haemorrhagic fever in humans for which no approved antivirals are available(1). Filovirus entry is mediated by the viral spike glycoprotein (GP), which attaches viral particles to the cell surface, delivers them to endosomes and catalyses fusion between viral and endosomal membranes(2). Additional host factors in the endosomal compartment are probably required for viral membrane fusion; however, despite considerable efforts, these critical host factors have defied molecular identification(3-5). Here we describe a genome-wide haploid genetic screen in human cells to identify host factors required for Ebola virus entry. Our screen uncovered 67 mutations disrupting all six members of the homotypic fusion and vacuole protein-sorting (HOPS) multisubunit tethering complex, which is involved in the fusion of endosomes to lysosomes(6), and 39 independent mutations that disrupt the endo/lysosomal cholesterol transporter protein Niemann-Pick C1 (NPC1)(7). Cells defective for the HOPS complex or NPC1 function, including primary fibroblasts derived from human Niemann-Pick type C1 disease patients, are resistant to infection by Ebola virus and Marburg virus, but remain fully susceptible to a suite of unrelated viruses. We show that membrane fusion mediated by filovirus glycoproteins and viral escape from the vesicular compartment require the NPC1 protein, independent of its known function in cholesterol transport. Our findings uncover unique features of the entry pathway used by filoviruses and indicate potential antiviral strategies to combat these deadly agents.	[Carette, Jan E.; Obernosterer, Gregor; Brummelkamp, Thijn R.] Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; [Raaben, Matthijs; Kranzusch, Philip J.; Griffin, April M.; Whelan, Sean P.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Wong, Anthony C.; Mulherkar, Nirupama; Chandran, Kartik] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Herbert, Andrew S.; Kuehne, Ana I.; Ruthel, Gordon; Dye, John M.] USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Dal Cin, Paola] Ctr Adv Mol Diagnost, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Harvard Medical School; Yeshiva University; Albert Einstein College of Medicine	Brummelkamp, TR (corresponding author), Netherlands Canc Inst, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	John.M.Dye1@us.army.mil; sean_whelan@hms.harvard.edu; kartik.chandran@einstein.yu.edu; t.brummelkamp@nki.nl	Ruthel, Gordon/GYU-9133-2022	Raaben, Matthijs/0000-0001-5989-289X; Ruthel, Gordon/0000-0001-9193-5589; Dye, John/0000-0002-0883-5016; Whelan, Sean/0000-0003-1564-8590; Carette, Jan/0000-0002-5187-8070	NIH [R01 AI088027, AI081842, U54 AI057159, R21 HG004938]; DTRA Project [CBM.VAXPLAT.05.10.RD.005]; Whitehead Fellows Program; Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award; NIH at the Albert Einstein College of Medicine [T32 GM007288, T32 AI070117]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088027, U54AI057159, R56AI081842, T32AI070117, R01AI081842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DTRA Project; Whitehead Fellows Program; Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award(Burroughs Wellcome Fund); NIH at the Albert Einstein College of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank M. Kielian, H. Ploegh, V. Prasad and D. Sabatini for critical reading of the manuscript and valuable advice; C. Guimaraes, V. Blomen and T. Peterson for suggestions; M. Bogyo for providing the CTSB/CATL activity probe (GB111); T.-Y. Chang for the gift of NPC1-null CHO cells; D. Lyles for the antibody to VSV M; M. Nibert for providing reovirus; J. de la Torre for providing rVSV-GP-BDV; J. Wojcechowskyj for providing RVF; E. Muhlberger for providing Ebola cDNA; and M. Ericsson for support with electron microscopy. This research was supported by NIH grants R01 AI088027 (K. C.), AI081842 and U54 AI057159 (NERCE-BEID) (S. P. W.), and R21 HG004938 (T. R. B.), and by the DTRA Project, CBM.VAXPLAT.05.10.RD.005 (J. M. D.). T. R. B. was additionally supported by the Whitehead Fellows Program. S. P. W. is a recipient of a Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award. A. C. W. was additionally supported by NIH-funded training programs T32 GM007288 and T32 AI070117 at the Albert Einstein College of Medicine. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the US Army.	Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Blum G, 2005, NAT CHEM BIOL, V1, P203, DOI 10.1038/nchembio728; Bray M, 1998, J INFECT DIS, V178, P651, DOI 10.1086/515386; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Carette JE, 2010, BLOOD, V115, P4039, DOI 10.1182/blood-2009-07-231845; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Cruz JC, 2000, J BIOL CHEM, V275, P4013, DOI 10.1074/jbc.275.6.4013; Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394; Dell'Angelica EC, 2004, CURR OPIN CELL BIOL, V16, P458, DOI 10.1016/j.ceb.2004.05.001; Ebert DH, 2002, J BIOL CHEM, V277, P24609, DOI 10.1074/jbc.M201107200; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Geisbert TW, 2003, AM J PATHOL, V163, P2347, DOI 10.1016/S0002-9440(10)63591-2; Geisbert TW, 2003, AM J PATHOL, V163, P2371, DOI 10.1016/S0002-9440(10)63592-4; Goldman SDB, 2010, J BIOL CHEM, V285, P4983, DOI 10.1074/jbc.M109.037622; Kondratowicz AS, 2011, P NATL ACAD SCI USA, V108, P8426, DOI 10.1073/pnas.1019030108; Kranzusch PJ, 2010, P NATL ACAD SCI USA, V107, P20069, DOI 10.1073/pnas.1007152107; Kuhn JH, 2006, J BIOL CHEM, V281, P15951, DOI 10.1074/jbc.M601796200; Lee JE, 2009, FUTURE VIROL, V4, P621, DOI 10.2217/FVL.09.56; LEFRANCOIS L, 1982, VIROLOGY, V121, P157, DOI 10.1016/0042-6822(82)90125-8; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Maruyama T, 1999, J VIROL, V73, P6024, DOI 10.1128/JVI.73.7.6024-6030.1999; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Muhlberger E, 1999, J VIROL, V73, P2333; Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Nickerson DP, 2009, CURR OPIN CELL BIOL, V21, P543, DOI 10.1016/j.ceb.2009.05.007; PENTCHEV PG, 1986, J BIOL CHEM, V261, P2772; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; RODRIGUEZLAFRASSE C, 1990, BIOCHIM BIOPHYS ACTA, V1043, P123, DOI 10.1016/0005-2760(90)90284-5; Saeed MF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001110; Sbrissa D, 2007, J BIOL CHEM, V282, P23878, DOI 10.1074/jbc.M611678200; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; Takada A, 2001, J VIROL, V75, P2324, DOI 10.1128/JVI.75.5.2324-2330.2001; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tang YY, 2009, J VIROL, V83, P7982, DOI 10.1128/JVI.00259-09; Tiede S, 2005, NAT MED, V11, P1109, DOI 10.1038/nm1305; Warfield KL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-108; Whelan SPJ, 2000, J VIROL, V74, P8268, DOI 10.1128/JVI.74.18.8268-8276.2000; WHELAN SPJ, 1995, P NATL ACAD SCI USA, V92, P8388, DOI 10.1073/pnas.92.18.8388; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664; Wong AC, 2010, J VIROL, V84, P163, DOI 10.1128/JVI.01832-09; Wool-Lewis RJ, 1998, J VIROL, V72, P3155, DOI 10.1128/JVI.72.4.3155-3160.1998	49	847	896	6	265	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2011	477	7364					340	U115		10.1038/nature10348	http://dx.doi.org/10.1038/nature10348			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819TD	21866103	Green Accepted			2022-12-01	WOS:000294852400033
J	Guttman, M; Donaghey, J; Carey, BW; Garber, M; Grenier, JK; Munson, G; Young, G; Lucas, AB; Ach, R; Bruhn, L; Yang, XP; Amit, I; Meissner, A; Regev, A; Rinn, JL; Root, DE; Lander, ES				Guttman, Mitchell; Donaghey, Julie; Carey, Bryce W.; Garber, Manuel; Grenier, Jennifer K.; Munson, Glen; Young, Geneva; Lucas, Anne Bergstrom; Ach, Robert; Bruhn, Laurakay; Yang, Xiaoping; Amit, Ido; Meissner, Alexander; Regev, Aviv; Rinn, John L.; Root, David E.; Lander, Eric S.			lincRNAs act in the circuitry controlling pluripotency and differentiation	NATURE			English	Article							EMBRYONIC STEM-CELLS; LONG NONCODING RNAS; SELF-RENEWAL; GENE-EXPRESSION; DEVELOPMENTAL REGULATORS; CHROMATIN-STRUCTURE; VISCERAL ENDODERM; MOUSE EMBRYO; XIST RNA; ES CELLS	Although thousands of large intergenic non-coding RNAs (lincRNAs) have been identified in mammals, few have been functionally characterized, leading to debate about their biological role. To address this, we performed loss-of-function studies on most lincRNAs expressed in mouse embryonic stem (ES) cells and characterized the effects on gene expression. Here we show that knockdown of lincRNAs has major consequences on gene expression patterns, comparable to knockdown of well-known ES cell regulators. Notably, lincRNAs primarily affect gene expression in trans. Knockdown of dozens of lincRNAs causes either exit from the pluripotent state or upregulation of lineage commitment programs. We integrate lincRNAs into the molecular circuitry of ES cells and show that lincRNA genes are regulated by key transcription factors and that lincRNA transcripts bind to multiple chromatin regulatory proteins to affect shared gene expression programs. Together, the results demonstrate that lincRNAs have key roles in the circuitry controlling ES cell state.	[Guttman, Mitchell; Donaghey, Julie; Garber, Manuel; Grenier, Jennifer K.; Munson, Glen; Young, Geneva; Yang, Xiaoping; Amit, Ido; Meissner, Alexander; Regev, Aviv; Rinn, John L.; Root, David E.; Lander, Eric S.] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Guttman, Mitchell; Carey, Bryce W.; Regev, Aviv; Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Carey, Bryce W.] Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; [Lucas, Anne Bergstrom; Ach, Robert; Bruhn, Laurakay] Agilent Technol, Genom Res & Dev, Santa Clara, CA 95051 USA; [Meissner, Alexander; Rinn, John L.] Harvard Univ, Cambridge, MA 02138 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Agilent Technologies; Harvard University; Harvard University; Harvard Medical School	Guttman, M (corresponding author), Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA.	mguttman@mit.edu; lander@broadinstitute.org		Rinn, John/0000-0002-7231-7539	NHGRI, a Center for Excellence for Genomic Science; Merkin Foundation for Stem Cell Research; Broad Institute of MIT; Broad Institute of Harvard; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	NHGRI, a Center for Excellence for Genomic Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Merkin Foundation for Stem Cell Research; Broad Institute of MIT; Broad Institute of Harvard; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank D. Rivera, T. Green, T. Bhimdi, G. Verstappen, C. Surka, S. Silver, A. Brown, D. Lam and O. Ram for technical help; C. Gifford, S. Markoulaki and R. Jaenisch for providing cell lines used in this study; P. Tsang, B. Curry, A. Tsalenko and Agilent Technologies for microarray and technical help; B. Challis and Active Motif for antibodies; G. Geiss, R. Boykin and Nanostring technologies for technical help; E. Wang and C. Burge for help with RNA immunoprecipitation experiments and helpful discussions; P. Gupta, A. Gnirke, J. Cassady, E. Lieberman-Aiden, M. Cabili and M. Thompson for discussions and ideas; and L. Gaffney for assistance with figures. M. Guttman is a Vertex scholar. This work was funded by NHGRI, a Center for Excellence for Genomic Science, the Merkin Foundation for Stem Cell Research, and funds from the Broad Institute of MIT and Harvard.	Aiba K, 2006, STEM CELLS, V24, P889, DOI 10.1634/stemcells.2005-0332; Aiba K, 2009, DNA RES, V16, P73, DOI 10.1093/dnares/dsn035; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Dejosez M, 2008, CELL, V133, P1162, DOI 10.1016/j.cell.2008.05.047; Dey BK, 2008, MOL CELL BIOL, V28, P5312, DOI 10.1128/MCB.00128-08; Ebisuya M, 2008, NAT CELL BIOL, V10, P1106, DOI 10.1038/ncb1771; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Koerner MV, 2009, DEVELOPMENT, V136, P1771, DOI 10.1242/dev.030403; Koziol MJ, 2010, CURR OPIN GENET DEV, V20, P142, DOI 10.1016/j.gde.2010.03.003; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Langmead B, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r83; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Meissner Alexander, 2009, V482, P3, DOI 10.1007/978-1-59745-060-7_1; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Sherwood RI, 2007, DEV BIOL, V304, P541, DOI 10.1016/j.ydbio.2007.01.011; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang Z, 2009, METHODS, V48, P287, DOI 10.1016/j.ymeth.2009.02.021; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yuan P, 2009, GENE DEV, V23, P2507, DOI 10.1101/gad.1831909; Zappulla DC, 2004, P NATL ACAD SCI USA, V101, P10024, DOI 10.1073/pnas.0403641101; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	72	1491	1599	3	236	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2011	477	7364					295	U60		10.1038/nature10398	http://dx.doi.org/10.1038/nature10398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819TD	21874018	Green Accepted, Green Submitted			2022-12-01	WOS:000294852400023
J	Panatier, A; Vallee, J; Haber, M; Murai, KK; Lacaille, JC; Robitaille, R				Panatier, Aude; Vallee, Joanne; Haber, Michael; Murai, Keith K.; Lacaille, Jean-Claude; Robitaille, Richard			Astrocytes Are Endogenous Regulators of Basal Transmission at Central Synapses	CELL			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM POTENTIATION; GLIAL-CELLS; HIPPOCAMPAL ASTROCYTES; RAT HIPPOCAMPUS; SYNAPTIC-TRANSMISSION; DENDRITIC SPINES; D-SERINE; IN-SITU; CALCIUM OSCILLATIONS	Basal synaptic transmission involves the release of neurotransmitters at individual synapses in response to a single action potential. Recent discoveries show that astrocytes modulate the activity of neuronal networks upon sustained and intense synaptic activity. However, their ability to regulate basal synaptic transmission remains ill defined and controversial. Here, we show that astrocytes in the hippocampal CA1 region detect synaptic activity induced by single-synaptic stimulation. Astrocyte activation occurs at functional compartments found along astrocytic processes and involves metabotropic glutamate subtype 5 receptors. In response, astrocytes increase basal synaptic transmission, as revealed by the blockade of their activity with a Ca(2+) chelator. Astrocytic modulation of basal synaptic transmission is mediated by the release of purines and the activation of presynaptic A(2A) receptors by adenosine. Our work uncovers an essential role for astrocytes in the regulation of elementary synaptic communication and provides insight into fundamental aspects of brain function.	[Panatier, Aude; Vallee, Joanne; Lacaille, Jean-Claude; Robitaille, Richard] Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada; [Panatier, Aude; Vallee, Joanne; Lacaille, Jean-Claude; Robitaille, Richard] Univ Montreal, Grp Rech Syst Nerveux Cent, Montreal, PQ H3C 3J7, Canada; [Haber, Michael; Murai, Keith K.] McGill Univ, Ctr Res Neurosci, Dept Neurol & Neurosurg, Res Inst,Hlth Ctr,Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada	Universite de Montreal; Universite de Montreal; McGill University	Lacaille, JC (corresponding author), Univ Montreal, Dept Physiol, POB 6128,Stn Ctr Ville, Montreal, PQ H3C 3J7, Canada.	jean-claude.lacaille@umontreal.ca; richard.robitaille@umontreal.ca		Panatier, Aude/0000-0002-6107-4463; Robitaille, Richard/0000-0001-6628-0146	NSERC Discovery Group; FRSQ (Groupe de recherche sur le Systeme Nerveux Central); CIHR [MOP-14137, MOP-10848]	NSERC Discovery Group; FRSQ (Groupe de recherche sur le Systeme Nerveux Central)(Fonds de la Recherche en Sante du Quebec); CIHR(Canadian Institutes of Health Research (CIHR))	We thank Dr. A. Serrano for helpful discussions and suggestions; Dr. J. Boehm for helpful comments on different versions of the manuscript; and Dr. K.M. Harris for her comments, discussion and for reading different versions of the manuscript. We also thank Ms. Pierrette Fournel for her technical support. This work was supported by grants from NSERC Discovery Group; by an infrastructure grant from FRSQ (Groupe de recherche sur le Systeme Nerveux Central) to J.-C.L. and R.R.; and by the CIHR main operating fund to R.R. (MOP-14137) and J.-C.L. (MOP-10848). A.P. was a Long-Term Fellow of the Human Frontier Science Program Organization; R.R. was a Chercheur-National of the FRSQ; K.K.M. held the Canada Research Chair in Molecular Control of Synaptic Structure (Tier II); and J.-C.L. held the Canada Research Chair in Cellular and Molecular Neurophysiology (Tier I).	Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 2002, J NEUROSCI, V22, P2443, DOI 10.1523/JNEUROSCI.22-07-02443.2002; Ayala JE, 2008, NEUROPHARMACOLOGY, V54, P804, DOI 10.1016/j.neuropharm.2007.12.009; Belair EL, 2010, J PHYSIOL-LONDON, V588, P1039, DOI 10.1113/jphysiol.2009.178988; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Bushong EA, 2004, INT J DEV NEUROSCI, V22, P73, DOI 10.1016/j.ijdevneu.2003.12.008; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cai ZH, 2000, GLIA, V29, P70, DOI 10.1002/(SICI)1098-1136(20000101)29:1<70::AID-GLIA7>3.0.CO;2-V; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Cunha RA, 2001, NEUROCHEM INT, V38, P107, DOI 10.1016/S0197-0186(00)00034-6; D'Ascenzo M, 2007, P NATL ACAD SCI USA, V104, P1995, DOI 10.1073/pnas.0609408104; Diogenes MJ, 2007, HIPPOCAMPUS, V17, P577, DOI 10.1002/hipo.20294; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Goldberg JH, 2003, NEURON, V40, P807, DOI 10.1016/S0896-6273(03)00714-1; Gordon GRJ, 2009, NEURON, V64, P391, DOI 10.1016/j.neuron.2009.10.021; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Haber M, 2006, J NEUROSCI, V26, P8881, DOI 10.1523/JNEUROSCI.1302-06.2006; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Hama K, 2004, J NEUROCYTOL, V33, P277, DOI 10.1023/B:NEUR.0000044189.08240.a2; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Holbro N, 2009, P NATL ACAD SCI USA, V106, P15055, DOI 10.1073/pnas.0905110106; Honsek SD, 2012, HIPPOCAMPUS, V22, P29, DOI 10.1002/hipo.20843; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Latour I, 2001, HIPPOCAMPUS, V11, P132, DOI 10.1002/hipo.1031; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Matsui K, 2005, J NEUROSCI, V25, P7538, DOI 10.1523/JNEUROSCI.1927-05.2005; Matsui K, 2004, J NEUROSCI, V24, P8932, DOI 10.1523/JNEUROSCI.2650-04.2004; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Matthias K, 2003, J NEUROSCI, V23, P1750; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pasti L, 1997, J NEUROSCI, V17, P7817; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Porter JT, 1996, J NEUROSCI, V16, P5073; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; Rebola N, 2005, NEUROSCIENCE, V133, P79, DOI 10.1016/j.neuroscience.2005.01.054; Reid CA, 2001, J NEUROSCI, V21, P2206, DOI 10.1523/JNEUROSCI.21-07-02206.2001; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; Serrano A, 2008, GLIA, V56, P1648, DOI 10.1002/glia.20717; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006; Smith MA, 2003, J PHYSIOL-LONDON, V548, P245, DOI 10.1113/jphysiol.2002.036376; Tartaglia N, 2001, J BIOL CHEM, V276, P37585, DOI 10.1074/jbc.M101683200; Todd KJ, 2010, J NEUROSCI, V30, P11870, DOI 10.1523/JNEUROSCI.3165-10.2010; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Witcher MR, 2007, GLIA, V55, P13, DOI 10.1002/glia.20415; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Zhang Q, 2004, P NATL ACAD SCI USA, V101, P9441, DOI 10.1073/pnas.0401960101	54	396	400	1	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 2	2011	146	5					785	798		10.1016/j.cell.2011.07.022	http://dx.doi.org/10.1016/j.cell.2011.07.022			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21855979	Bronze			2022-12-01	WOS:000294477500018
J	Rausenberger, J; Tscheuschler, A; Nordmeier, W; Wust, F; Timmer, J; Schafer, E; Fleck, C; Hiltbrunner, A				Rausenberger, Julia; Tscheuschler, Anke; Nordmeier, Wiebke; Wuest, Florian; Timmer, Jens; Schaefer, Eberhard; Fleck, Christian; Hiltbrunner, Andreas			Photoconversion and Nuclear Trafficking Cycles Determine Phytochrome A's Response Profile to Far-Red Light	CELL			English	Article							HIGH-IRRADIANCE RESPONSE; SINAPIS-ALBA L; ARABIDOPSIS PHYTOCHROMES; ELONGATED HYPOCOTYL1; A PHOTORECEPTOR; FHY1; PHOTOMORPHOGENESIS; ACCUMULATION; SEEDLINGS; PROTEINS	Phytochrome A (phyA) is the only photoreceptor in plants, initiating responses in far-red light and, as such, essential for survival in canopy shade. Although the absorption and the ratio of active versus total phyA are maximal in red light, far-red light is the most efficient trigger of phyA-dependent responses. Using a joint experimental-theoretical approach, we unravel the mechanism underlying this shift of the phyA action peak from red to far-red light and show that it relies on specific molecular interactions rather than on intrinsic changes to phyA's spectral properties. According to our model, the dissociation rate of the phyA-FHY1/FHL nuclear import complex is a principle determinant of the phyA action peak. The findings suggest how higher plants acquired the ability to sense far-red light from an ancestral photoreceptor tuned to respond to red light.	[Rausenberger, Julia; Fleck, Christian] Univ Freiburg, Ctr Biol Syst Anal ZBSA, D-79104 Freiburg, Germany; [Rausenberger, Julia; Tscheuschler, Anke; Wuest, Florian; Schaefer, Eberhard] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Timmer, Jens] Univ Freiburg, Freiburg Inst Adv Studies FRIAS, D-79104 Freiburg, Germany; [Timmer, Jens; Schaefer, Eberhard] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Nordmeier, Wiebke; Hiltbrunner, Andreas] Univ Tubingen, Ctr Plant Mol Biol ZMBP, D-72076 Tubingen, Germany; [Timmer, Jens] Linkoping Univ, Dept Clin & Expt Med, SE-58183 Linkoping, Sweden	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Eberhard Karls University of Tubingen; Linkoping University	Fleck, C (corresponding author), Univ Freiburg, Ctr Biol Syst Anal ZBSA, D-79104 Freiburg, Germany.	christian.fleck@fdm.uni-freiburg.de; andreas.hiltbrunner@zmbp.uni-tuebingen.de	Fleck, Christian/D-1620-2012	Fleck, Christian/0000-0002-6371-4495; Hiltbrunner, Andreas/0000-0003-0438-5297; Wust, Florian/0000-0002-9941-5550	DFG [SFB592, GRK1305, EXC294]; BMBF-Freiburg Initiative in Systems Biology (FRISYS) [0313921]	DFG(German Research Foundation (DFG)); BMBF-Freiburg Initiative in Systems Biology (FRISYS)(Federal Ministry of Education & Research (BMBF))	We are grateful to Dr. M. Zeidler and the ABRC for providing fhy1-3 and fhl-1 seeds. We thank Prof. J. Paszkowski for the kind gift of the pWCO35 plasmid, Dr. S. Kircher for support for FRAP/FLIP analyses, M. Krenz and C. Konig for technical assistance, and Prof. C. Fankhauser and Prof. R. Ulm for critically reading the manuscript. This work was supported by grants from the DFG to E.S. (SFB592) and to E.S. and J.T. (GRK1305, EXC294) and the BMBF-Freiburg Initiative in Systems Biology 0313921 (FRISYS) to C.F., J.T., and E.S.	Bae G, 2008, ANNU REV PLANT BIOL, V59, P281, DOI 10.1146/annurev.arplant.59.032607.092859; Casal JJ, 2003, PHOTOCH PHOTOBIO SCI, V2, P625, DOI 10.1039/b300094j; Clodong S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100128; Debrieux D, 2010, PLANT MOL BIOL, V73, P687, DOI 10.1007/s11103-010-9649-9; Desnos T, 2001, GENE DEV, V15, P2980, DOI 10.1101/gad.205401; Devlin PF, 2007, J EXP BOT, V58, P3071, DOI 10.1093/jxb/erm251; Dieterle M, 2001, GENE DEV, V15, P939, DOI 10.1101/gad.197201; Eichenberg K, 2000, FEBS LETT, V470, P107, DOI 10.1016/S0014-5793(00)01301-6; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Genoud T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000143; HARTMANN KM, 1967, Z NATURFORSCH PT B, VB 22, P1172, DOI 10.1515/znb-1967-1117; Hennig L, 1999, PLANT PHYSIOL, V121, P571, DOI 10.1104/pp.121.2.571; Hennig L, 2000, PLANT CELL ENVIRON, V23, P727, DOI 10.1046/j.1365-3040.2000.00587.x; Hiltbrunner A, 2005, CURR BIOL, V15, P2125, DOI 10.1016/j.cub.2005.10.042; Hiltbrunner A, 2006, PLANT CELL PHYSIOL, V47, P1023, DOI 10.1093/pcp/pcj087; Hu W, 2009, MOL PLANT, V2, P166, DOI 10.1093/mp/ssn086; Kim L, 2000, PLANT J, V22, P125, DOI 10.1046/j.1365-313x.2000.00729.x; Mancinelli Alberto L., 1994, P211; Mathews S, 2005, J HERED, V96, P197, DOI 10.1093/jhered/esi032; MOHR H, 1957, PLANTA, V49, P389, DOI 10.1007/BF01947483; Oyama T, 1997, GENE DEV, V11, P2983, DOI 10.1101/gad.11.22.2983; QUAIL PH, 1994, PLANT CELL, V6, P468, DOI 10.1105/tpc.6.4.468; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rosler J, 2007, P NATL ACAD SCI USA, V104, P10737, DOI 10.1073/pnas.0703855104; SCHAFER E, 1974, J MATH BIOL, V1, P9, DOI 10.1007/BF02339485; SCHAFER E, 1975, J MATH BIOL, V2, P41, DOI 10.1007/BF00276015; SCHAFER E, 1975, PHOTOCHEM PHOTOBIOL, V22, P193, DOI 10.1111/j.1751-1097.1975.tb06736.x; Shen YP, 2009, PLANT CELL, V21, P494, DOI 10.1105/tpc.108.061259; Shinomura T, 1996, P NATL ACAD SCI USA, V93, P8129, DOI 10.1073/pnas.93.15.8129; Shinomura T, 2000, PLANT PHYSIOL, V122, P147, DOI 10.1104/pp.122.1.147; Sorokina Oxana, 2009, J Biol Eng, V3, P15, DOI 10.1186/1754-1611-3-15; Su YS, 2007, PLANT CELL, V19, P2124, DOI 10.1105/tpc.107.051516; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; WHITELAM GC, 1993, PLANT CELL, V5, P757, DOI 10.1105/tpc.5.7.757; Yang SW, 2009, PLANT CELL, V21, P1341, DOI 10.1105/tpc.109.067215; Zeidler M, 2001, PLANT CELL PHYSIOL, V42, P1193, DOI 10.1093/pcp/pce177; Zhou QQ, 2005, PLANT J, V43, P356, DOI 10.1111/j.1365-313X.2005.02453.x	37	113	121	2	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 2	2011	146	5					813	825		10.1016/j.cell.2011.07.023	http://dx.doi.org/10.1016/j.cell.2011.07.023			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21884939	Bronze			2022-12-01	WOS:000294477500020
J	Angel, A; Song, J; Dean, C; Howard, M				Angel, Andrew; Song, Jie; Dean, Caroline; Howard, Martin			A Polycomb-based switch underlying quantitative epigenetic memory	NATURE			English	Article							ARABIDOPSIS-THALIANA; VERNALIZATION; CHROMATIN; PROTEIN; FLC; METHYLATION; INFORMATION; PROPAGATION; INHERITANCE; REPRESSOR	The conserved Polycomb repressive complex 2 (PRC2) generates trimethylation of histone 3 lysine 27 (H3K27me3)(1,2), a modification associated with stable epigenetic silencing(3,4). Much is known about PRC2-induced silencing but key questions remain concerning its nucleation and stability. Vernalization, the perception and memory of winter in plants, is a classic epigenetic process that, in Arabidopsis, involves PRC2-based silencing of the floral repressor FLC(5,6). The slow dynamics of vernalization, taking place over weeks in the cold, generate a level of stable silencing of FLC in the subsequent warm that depends quantitatively on the length of the prior cold. These features make vernalization an ideal experimental system to investigate both the maintenance of epigenetic states and the switching between them. Here, using mathematical modelling, chromatin immunoprecipitation and an FLC:GUS reporter assay, we show that the quantitative nature of vernalization is generated by H3K27me3-mediated FLC silencing in the warm in a subpopulation of cells whose number depends on the length of the prior cold. During the cold, H3K27me3 levels progressively increase at a tightly localized nucleation region within FLC. At the end of the cold, numerical simulations predict that such a nucleation region is capable of switching the bistable epigenetic state of an individual locus, with the probability of overall FLC coverage by silencing H3K27me3 marks depending on the length of cold exposure. Thus, the model predicts a bistable pattern of FLC gene expression in individual cells, a prediction we verify using the FLC: GUS reporter system. Our proposed switching mechanism, involving the local nucleation of an opposing histone modification, is likely to be widely relevant in epigenetic reprogramming.	[Song, Jie; Dean, Caroline] John Innes Ctr, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; [Angel, Andrew; Howard, Martin] John Innes Ctr, Dept Computat & Syst Biol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Dean, C (corresponding author), John Innes Ctr, Dept Cell & Dev Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	caroline.dean@jic.ac.uk; martin.howard@jic.ac.uk	Howard, Martin/C-3629-2016	Howard, Martin/0000-0001-7670-0781; Dean, Caroline/0000-0002-6555-3525	European Research Council; Biotechnology and Biological Sciences Research Council; Royal Society; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0637, BBS/E/J/000CA369, BB/C519670/1] Funding Source: researchfish; BBSRC [BBS/E/J/000CA369, BBS/E/J/000C0637] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank all members of the C. D. and M. H. groups for discussions. We also thank S. Costa for suggestions to improve the FLC:GUS imagery and V. Grieneisen, S. Maree, R. Morris, S. Swiezewski and P. Wigge for comments on the manuscript. This research was supported by an Advanced Investigator European Research Council grant and the Core Strategic Grant from the Biotechnology and Biological Sciences Research Council to the John Innes Centre. M. H. also acknowledges support from The Royal Society.	Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; BURN JE, 1993, P NATL ACAD SCI USA, V90, P287, DOI 10.1073/pnas.90.1.287; David-Rus D, 2009, J THEOR BIOL, V258, P112, DOI 10.1016/j.jtbi.2008.12.021; De Lucia F, 2008, P NATL ACAD SCI USA, V105, P16831, DOI 10.1073/pnas.0808687105; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; Finnegan EJ, 2007, CURR BIOL, V17, P1978, DOI 10.1016/j.cub.2007.10.026; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Grandjean O, 2004, PLANT CELL, V16, P74, DOI 10.1105/tpc.017962; Greb T, 2007, CURR BIOL, V17, P73, DOI 10.1016/j.cub.2006.11.052; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Kaufman PD, 2010, CURR OPIN CELL BIOL, V22, P284, DOI 10.1016/j.ceb.2010.02.002; Kelemen JZ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000332; LEE I, 1994, PLANT J, V6, P903, DOI 10.1046/j.1365-313X.1994.6060903.x; Levy YY, 2002, SCIENCE, V297, P243, DOI 10.1126/science.1072147; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Mukhopadhyaya S, 2010, BIOSYSTEMS, V102, P49, DOI 10.1016/j.biosystems.2010.07.012; PIERIK RLM, 1970, CELLULAR MOL ASPECTS, P409; Reddy GV, 2004, DEVELOPMENT, V131, P4225, DOI 10.1242/dev.01261; Salazar JD, 2008, ACTA HORTIC, V803, P187, DOI 10.17660/ActaHortic.2008.803.24; Sedighi M, 2007, PHYS BIOL, V4, P246, DOI 10.1088/1478-3975/4/4/002; Sheldon CC, 2008, P NATL ACAD SCI USA, V105, P2214, DOI 10.1073/pnas.0711453105; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Turner BM, 2007, NAT CELL BIOL, V9, P2, DOI 10.1038/ncb0107-2; Wood CC, 2006, P NATL ACAD SCI USA, V103, P14631, DOI 10.1073/pnas.0606385103; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129	30	295	295	4	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 4	2011	476	7358					105	+		10.1038/nature10241	http://dx.doi.org/10.1038/nature10241			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NR	21785438				2022-12-01	WOS:000293447300039
J	Sokol, DK				Sokol, Daniel K.			ETHICS MAN Bariatric surgery and justice in an imperfect world	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Sokol, DK (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	daniel.sokol@talk21.com						Beckett Samuel, 2010, WAITING GODOT; Dyer C, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4894; WAGNER A, PUBLIC PURSE STAYS C	3	3	3	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 2	2011	343								d4944	10.1136/bmj.d4944	http://dx.doi.org/10.1136/bmj.d4944			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	805NM	21810883				2022-12-01	WOS:000293734600007
J	Glaeser, E				Glaeser, Edward			Cities, Productivity, and Quality of Life	SCIENCE			English	Editorial Material							AGGLOMERATION; WEALTH	Technological changes and improved electronic communications seem, paradoxically, to be making cities more, rather than less, important. There is a strong correlation between urbanization and economic development across countries, and within-country evidence suggests that productivity rises in dense agglomerations. But urban economic advantages are often offset by the perennial urban curses of crime, congestion and contagious disease. The past history of the developed world suggests that these problems require more capable governments that use a combination of economic and engineering solutions. Though the scope of urban challenges can make remaining rural seem attractive, agrarian poverty has typically also been quite costly.	[Glaeser, Edward] Harvard Univ, Dept Econ, Sch Arts & Sci, Cambridge, MA 02138 USA; [Glaeser, Edward] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 01238 USA	Harvard University; Harvard University	Glaeser, E (corresponding author), Harvard Univ, Dept Econ, Sch Arts & Sci, Cambridge, MA 02138 USA.	eglaeser@harvard.edu						[Anonymous], NATL VITAL STAT REPO; ARIAS E, 2010, NAT VIT STAT REP, V58; Bloom DE, 2008, SCIENCE, V319, P772, DOI 10.1126/science.1153057; Combes P.-P., 2010, AGGLOMERATION EC, P15; Cutler David M., 2006, CORRUPTION REFORM LE, P153, DOI DOI 10.7208/CHICAGO/9780226299594.003.0006; Duranton Gilles, 2009, 15376 NAT BUR EC RES; Ellison G, 2010, AM ECON REV, V100, P1195, DOI 10.1257/aer.100.3.1195; Glaeser E, 2011, TRIUMPH CITY; Glaeser EL, 2010, J URBAN ECON, V67, P404, DOI 10.1016/j.jue.2009.11.006; Glaeser EL, 2009, J ECON LIT, V47, P983, DOI 10.1257/jel.47.4.983; Glaeser EL, 2001, J LABOR ECON, V19, P316, DOI 10.1086/319563; JAFFE AB, 1993, Q J ECON, V108, P577, DOI 10.2307/2118401; *NY CIT DEP HLTH M, 2008, SUMM VIT STAT 2008; *NY CIT DEP HLTH M, 1961, SUMM VIT STAT 1961; Rosenthal SS, 2003, REV ECON STAT, V85, P377, DOI 10.1162/003465303765299882; United Nations Population Fund, 2007, STAT WORLDS POP 2007; United Nations Statistics Division, 2008, DEM YB 2008; United Nations Statistics Division, NAT ACC MAIN AGGR DA; Zheng S., 2009, 15621 NAT BUR EC RES	19	118	126	6	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2011	333	6042					592	594		10.1126/science.1209264	http://dx.doi.org/10.1126/science.1209264			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	798PI	21798941				2022-12-01	WOS:000293222400051
J	Bute, J; Waller, D				Bute, Jennifer; Waller, Derek			A PATIENT'S JOURNEY Dementia with cardiac problems	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Waller, Derek] Southampton Gen Hosp, Southampton SO16 6YD, Hants, England	University of Southampton	Bute, J (corresponding author), 47 Hapil Close, Sandford BS25 AA, Winscombe, England.	jennifer@kreativity.org							0	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 22	2011	343								d4278	10.1136/bmj.d4278	http://dx.doi.org/10.1136/bmj.d4278			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	797ZK	21784881	Green Submitted, Bronze			2022-12-01	WOS:000293169000001
J	Hirose, S; Benabentos, R; Ho, HI; Kuspa, A; Shaulsky, G				Hirose, Shigenori; Benabentos, Rocio; Ho, Hsing-I; Kuspa, Adam; Shaulsky, Gad			Self-Recognition in Social Amoebae Is Mediated by Allelic Pairs of Tiger Genes	SCIENCE			English	Article							CELL-CELL ADHESION; DICTYOSTELIUM DEVELOPMENT; LAGC; GBF	Free-living cells of the social amoebae Dictyostelium discoideum can aggregate and develop into multicellular fruiting bodies in which many die altruistically as they become stalk cells that support the surviving spores. Dictyostelium cells exhibit kin discrimination-a potential defense against cheaters, which sporulate without contributing to the stalk. Kin discrimination depends on strain relatedness, and the polymorphic genes tgrB1 and tgrC1 are potential components of that mechanism. Here, we demonstrate a direct role for these genes in kin discrimination. We show that a matching pair of tgrB1 and tgrC1 alleles is necessary and sufficient for attractive self-recognition, which is mediated by differential cell-cell adhesion. We propose that TgrB1 and TgrC1 proteins mediate this adhesion through direct binding. This system is a genetically tractable ancient model of eukaryotic self-recognition.	[Hirose, Shigenori; Kuspa, Adam] Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Benabentos, Rocio; Kuspa, Adam; Shaulsky, Gad] Baylor Coll Med, Cell & Mol Biol Grad Program, Houston, TX 77030 USA; [Benabentos, Rocio; Ho, Hsing-I; Kuspa, Adam; Shaulsky, Gad] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Kuspa, A (corresponding author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	akuspa@bcm.edu; gadi@bcm.edu		Shaulsky, Gad/0000-0002-0532-0551; Kuspa, Adam/0000-0002-9156-149X	NIH [R01 GM084992]; National Research Service from the NIH [F31 GM086131]; NSF [2006042535]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084992, F31GM086131] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service from the NIH; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Wang and W. J. Cordill for useful discussions. This work was supported by grant no. R01 GM084992 from the NIH. R. B. was supported by National Research Service Award grant F31 GM086131 from the NIH and by an NSF fellowship 2006042535.	Benabentos R, 2009, CURR BIOL, V19, P567, DOI 10.1016/j.cub.2009.02.037; Boehm T, 2006, CELL, V125, P845, DOI 10.1016/j.cell.2006.05.017; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; BRAR SK, 1993, J BIOL CHEM, V268, P24902; De Tomaso AW, 2005, NATURE, V438, P454, DOI 10.1038/nature04150; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Iranfar N, 2006, DEV BIOL, V290, P460, DOI 10.1016/j.ydbio.2005.11.035; Kessin RH., 2001, DICTYOSTELIUM EVOLUT; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Ostrowski EA, 2008, PLOS BIOL, V6, P2376, DOI 10.1371/journal.pbio.0060287; Rosa SFP, 2010, CURR BIOL, V20, P1122, DOI 10.1016/j.cub.2010.04.050; Rosengarten RD, 2011, MOL BIOL EVOL, V28, P933, DOI 10.1093/molbev/msq282; Shaulsky G, 2007, CURR BIOL, V17, pR684, DOI 10.1016/j.cub.2007.06.024; Siu CH, 2004, SEMIN CELL DEV BIOL, V15, P633, DOI 10.1016/j.semcdb.2004.09.004; Sukumaran S, 1998, DEV BIOL, V200, P16, DOI 10.1006/dbio.1998.8934; Wang J, 2000, DEV BIOL, V227, P734, DOI 10.1006/dbio.2000.9881	16	92	95	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2011	333	6041					467	470		10.1126/science.1203903	http://dx.doi.org/10.1126/science.1203903			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21700835	Green Accepted			2022-12-01	WOS:000292959600050
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA Press repeats journal's hype over acupuncture	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SHAM ACUPUNCTURE					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2011, DAILY MASH      0531; [Anonymous], 2011, DAILY TELEGRAPH 0530; [Anonymous], 2011, DAILY MIRROR    0505; Assefi NP, 2005, ANN INTERN MED, V143, P10, DOI 10.7326/0003-4819-143-1-200507050-00005; Moffet HH, 2009, J ALTERN COMPLEM MED, V15, P213, DOI 10.1089/acm.2008.0356; Paterson C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X572689; Tulder MW VA, 2000, COCHRANE DB SYST REV, V2	7	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 20	2011	343								d4606	10.1136/bmj.d4606	http://dx.doi.org/10.1136/bmj.d4606			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	797ZH	21775397				2022-12-01	WOS:000293168700013
J	Taniguchi, K; Maeda, R; Ando, T; Okumura, T; Nakazawa, N; Hatori, R; Nakamura, M; Hozumi, S; Fujiwara, H; Matsuno, K				Taniguchi, Kiichiro; Maeda, Reo; Ando, Tadashi; Okumura, Takashi; Nakazawa, Naotaka; Hatori, Ryo; Nakamura, Mitsutoshi; Hozumi, Shunya; Fujiwara, Hiroo; Matsuno, Kenji			Chirality in Planar Cell Shape Contributes to Left-Right Asymmetric Epithelial Morphogenesis	SCIENCE			English	Article							UNCONVENTIONAL MYOSIN; DROSOPHILA; DETERMINES; POLARITY; CADHERIN; AXIS	Some organs in animals display left-right (LR) asymmetry. To better understand LR asymmetric morphogenesis in Drosophila, we studied LR directional rotation of the hindgut epithelial tube. Hindgut epithelial cells adopt a LR asymmetric (chiral) cell shape within their plane, and we refer to this cell behavior as planar cell-shape chirality (PCC). Drosophila E-cadherin (DE-Cad) is distributed to cell boundaries with LR asymmetry, which is responsible for the PCC formation. Myosin ID switches the LR polarity found in PCC and in DE-Cad distribution, which coincides with the direction of rotation. An in silico simulation showed that PCC is sufficient to induce the directional rotation of this tissue. Thus, the intrinsic chirality of epithelial cells in vivo is an underlying mechanism for LR asymmetric tissue morphogenesis.	[Taniguchi, Kiichiro; Maeda, Reo; Ando, Tadashi; Okumura, Takashi; Nakazawa, Naotaka; Hatori, Ryo; Nakamura, Mitsutoshi; Hozumi, Shunya; Fujiwara, Hiroo; Matsuno, Kenji] Tokyo Univ Sci, Dept Biol Sci & Technol, Chiba 2788510, Japan; [Matsuno, Kenji] Tokyo Univ Sci, Res Inst Sci & Technol, Chiba 2788510, Japan	Tokyo University of Science; Tokyo University of Science	Taniguchi, K (corresponding author), Tokyo Univ Sci, Dept Biol Sci & Technol, 2641 Yamazaki, Chiba 2788510, Japan.	matsuno@rs.noda.tus.ac.jp	Hozumi, Shunya/Q-8610-2019; Taniguchi, Kiichiro/ACL-8906-2022	Taniguchi, Kiichiro/0000-0003-2321-7280; Nakamura, Mitsutoshi/0000-0001-7879-3176; Maeda, Reo/0000-0002-2727-3012; Hatori, Ryo/0000-0003-2224-5802; Nakazawa, Naotaka/0000-0002-8695-4344				CAMPOSORTEGA JA, 1987, EMBRYONIC DEV DROSOP; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Hashimoto M, 2010, NAT CELL BIOL, V12, P170, DOI 10.1038/ncb2020; Hozumi S, 2006, NATURE, V440, P798, DOI 10.1038/nature04625; Langevin J, 2005, DEV CELL, V9, P365, DOI 10.1016/j.devcel.2005.07.013; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Pohl C, 2010, DEV CELL, V19, P402, DOI 10.1016/j.devcel.2010.08.014; Speder P, 2006, NATURE, V440, P803, DOI 10.1038/nature04623; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Xu JS, 2007, P NATL ACAD SCI USA, V104, P9296, DOI 10.1073/pnas.0703153104	11	130	130	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2011	333	6040					339	341		10.1126/science.1200940	http://dx.doi.org/10.1126/science.1200940			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21764746				2022-12-01	WOS:000292732000042
J	Lind, M; Bounias, I; Olsson, M; Gudbjornsdottir, S; Svensson, AM; Rosengren, A				Lind, Marcus; Bounias, Ioannis; Olsson, Marita; Gudbjornsdottir, Soffia; Svensson, Ann-Marie; Rosengren, Annika			Glycaemic control and incidence of heart failure in 20 985 patients with type 1 diabetes: an observational study	LANCET			English	Article							RISK-FACTORS; DISEASE; PREVALENCE; MORTALITY; REGISTER; SWEDEN; MEN	Background Poor glycaemic control is associated with microvascular and macrovascular complications in type 1 diabetes, but whether glycaemic control is associated with heart failure in such patients is not known. We aimed to assess this association in a large cohort of patients with type 1 diabetes identified from the Swedish national diabetes registry. Methods We identified all patients (aged >= 18 years) with type 1 diabetes and no known heart failure who were registered in the national diabetes registry between January, 1998, and December, 2003. These patients were followed up until hospital admission for heart failure, death, or end of follow-up on Dec 31, 2009. We calculated incidence categorised by glycated haemoglobin A(1c) (HbA(1c)) values, and we assessed the association between patients' characteristics, including HbA(1c), and heart failure. Findings In a cohort of 20 985 patients with mean age of 38.6 years (SD 13.3) at baseline, 635 patients (3%) were admitted to hospital with a primary or secondary diagnosis of heart failure during a median follow-up of 9.0 years (IQR 7.3-11.0), with an incidence of 3.38 events per 1000 patient-years (95% CI 3.12-3.65). Incidence increased monotonically with HbA(1c), with a range of 1.42-5.20 per 1000 patient-years between patients in the lowest (<6.5%) and highest (>= 10.5%) categories of HbA(1c). In a Cox regression analysis, with adjustment for age, sex, duration of diabetes, cardiovascular risk factors, and baseline or intervening acute myocardial infarction and other comorbidities, the hazard ratio for development of heart failure was 3.98 (95% CI 2.23-7.14) in patients with HbA(1c) of 10.5% or higher compared with a reference group of patients with HbA(1c) of less than 6.5%. Risk of heart failure increased with age and duration of diabetes. Other modifiable factors associated with increased risk of heart failure were smoking, high systolic blood pressure, and raised body-mass index. In a subgroup of 18 281 patients (87%) with data for blood lipids, higher HDL cholesterol was associated with lower risk of heart failure, but there was no association with LDL cholesterol. Interpretation The positive association between HbA(1c) and risk of heart failure in fairly young patients with type 1 diabetes indicates a potential for prevention of heart failure with improved glycaemic control.	[Lind, Marcus] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Emergency & Cardiovasc Med, Gothenburg, Sweden; [Lind, Marcus; Bounias, Ioannis] NU Hosp Org, Dept Med, Uddevalla, Sweden; [Olsson, Marita] Chalmers Univ Technol, Dept Math Sci, S-41296 Gothenburg, Sweden; [Gudbjornsdottir, Soffia] Univ Gothenburg, Sahlgrenska Univ Hosp, Inst Med, Dept Med, Gothenburg, Sweden; [Svensson, Ann-Marie] Ctr Registers Reg Vastra Gotaland, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; NU Hospital Group; Voestalpine AG; Chalmers University of Technology; Sahlgrenska University Hospital; University of Gothenburg	Lind, M (corresponding author), Uddevalla Cent Hosp, Dept Med, S-45180 Uddevalla, Sweden.	lind.marcus@telia.com	Lind, Marcus/GRJ-4946-2022; Lind, Marcus/AAI-6733-2021		AstzaZeneca; Novo Nordisk Scandinavia; Swedish Heart and Lung Foundation; Swedish Research Council; Abbot Scandinavia	AstzaZeneca; Novo Nordisk Scandinavia(Novo Nordisk); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Abbot Scandinavia	AstzaZeneca, Novo Nordisk Scandinavia, Swedish Heart and Lung Foundation, and Swedish Research Council.; M L has received honoraria or served as consultant for Bayer, Eli Lilly, Novartis, Novo Nordisk Scandinavia, Medtronic Pfizer, and Sanofi-Aventis; and has been a member of an advisory board for Novo Nordisk Scandinavia. ML's institution (NU-Hospital Organisation) has received grants from AstraZeneca and Novo Nordisk Scandinavia related to studies of risk factors and diabetic complications, which were not drug specific, and from Abbot Scandinavia for assessments of continuous glucose monitoring. All other authors declare that they have no conflicts of interest.	Asif M, 2000, P NATL ACAD SCI USA, V97, P2809, DOI 10.1073/pnas.040558497; Avendano GF, 1999, DIABETES, V48, P1443, DOI 10.2337/diabetes.48.7.1443; Bauters C, 2003, CARDIOVASC DIABETOL, V2, DOI 10.1186/1475-2840-2-1; CLELAND JG, 1995, EUR HEART J, V16, P741; Di Cori A, 2007, AM J CARDIOL, V99, P84, DOI 10.1016/j.amjcard.2006.07.063; Eeg-Olofsson K, 2010, DIABETES CARE, V33, P1640, DOI 10.2337/dc10-0398; FRASER GE, 1995, AM J CARDIOL, V75, P141, DOI 10.1016/S0002-9149(00)80063-6; Gul K, 2009, EUR J ECHOCARDIOGR, V10, P841, DOI 10.1093/ejechocard/jep086; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; Ingelsson E, 2005, EUR J HEART FAIL, V7, P787, DOI 10.1016/j.ejheart.2004.12.007; Iribarren C, 2001, CIRCULATION, V103, P2668; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Laing SP, 2003, DIABETOLOGIA, V46, P760, DOI 10.1007/s00125-003-1116-6; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nichols GA, 2001, DIABETES CARE, V24, P1614, DOI 10.2337/diacare.24.9.1614; Rosen M, 2000, J INTERN MED, V248, P159, DOI 10.1046/j.1365-2796.2000.00716.x; Schaufelberger M, 2007, EUR HEART J, V28, P212, DOI 10.1093/eurheartj/ehl435; Shafazand M, 2009, EUR HEART J, V30, P671, DOI 10.1093/eurheartj/ehn541; Soedamah-Muthu SS, 2004, DIABETES CARE, V27, P530, DOI 10.2337/diacare.27.2.530; Steine K, 2007, EUR J HEART FAIL, V9, P1044, DOI 10.1016/j.ejheart.2007.07.013; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wilhelmsen L, 2001, J INTERN MED, V249, P253, DOI 10.1046/j.1365-2796.2001.00801.x; Yazici D, 2013, ACTA DIABETOL, V50, P155, DOI 10.1007/s00592-010-0235-z	25	178	180	1	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2011	378	9786					140	146		10.1016/S0140-6736(11)60471-6	http://dx.doi.org/10.1016/S0140-6736(11)60471-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	795CJ	21705065				2022-12-01	WOS:000292948800030
J	Block, BA; Jonsen, ID; Jorgensen, SJ; Winship, AJ; Shaffer, SA; Bograd, SJ; Hazen, EL; Foley, DG; Breed, GA; Harrison, AL; Ganong, JE; Swithenbank, A; Castleton, M; Dewar, H; Mate, BR; Shillinger, GL; Schaefer, KM; Benson, SR; Weise, MJ; Henry, RW; Costa, DP				Block, B. A.; Jonsen, I. D.; Jorgensen, S. J.; Winship, A. J.; Shaffer, S. A.; Bograd, S. J.; Hazen, E. L.; Foley, D. G.; Breed, G. A.; Harrison, A. -L.; Ganong, J. E.; Swithenbank, A.; Castleton, M.; Dewar, H.; Mate, B. R.; Shillinger, G. L.; Schaefer, K. M.; Benson, S. R.; Weise, M. J.; Henry, R. W.; Costa, D. P.			Tracking apex marine predator movements in a dynamic ocean	NATURE			English	Article							PACIFIC-OCEAN; BLUEFIN TUNA; MORTALITY; HABITAT; SHARKS; FISH; POPULATION; RESOURCES; MIGRATION; TURTLES	Pelagic marine predators face unprecedented challenges and uncertain futures. Overexploitation and climate variability impact the abundance and distribution of top predators in ocean ecosystems(1-4). Improved understanding of ecological patterns, evolutionary constraints and ecosystem function is critical for preventing extinctions, loss of biodiversity and disruption of ecosystem services. Recent advances in electronic tagging techniques have provided the capacity to observe the movements and long-distance migrations of animals in relation to ocean processes across a range of ecological scales(5,6). Tagging of Pacific Predators, a field programme of the Census of Marine Life, deployed 4,306 tags on 23 species in the North Pacific Ocean, resulting in a tracking data set of unprecedented scale and species diversity that covers 265,386 tracking days from 2000 to 2009. Here we report migration pathways, link ocean features to multispecies hotspots and illustrate niche partitioning within and among congener guilds. Our results indicate that the California Current large marine ecosystem and the North Pacific transition zone attract and retain a diverse assemblage of marine vertebrates. Within the California Current large marine ecosystem, several predator guilds seasonally undertake north-south migrations that may be driven by oceanic processes, species-specific thermal tolerances and shifts in prey distributions. We identify critical habitats across multinational boundaries and show that top predators exploit their environment in predictable ways, providing the foundation for spatial management of large marine ecosystems.	[Block, B. A.; Jorgensen, S. J.; Ganong, J. E.; Swithenbank, A.; Castleton, M.; Shillinger, G. L.] Stanford Univ, Hopkins Marine Stn, Dept Biol, Pacific Grove, CA 93950 USA; [Jonsen, I. D.; Winship, A. J.; Breed, G. A.] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada; [Shaffer, S. A.] San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA; [Bograd, S. J.; Hazen, E. L.; Foley, D. G.] NOAA, SW Fisheries Sci Ctr, Div Environm Res, Pacific Grove, CA 93950 USA; [Breed, G. A.; Harrison, A. -L.; Weise, M. J.; Henry, R. W.; Costa, D. P.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Long Marine Lab, Santa Cruz, CA 95060 USA; [Dewar, H.] NOAA, SW Fisheries Sci Ctr, Fisheries Res Div, La Jolla, CA 92037 USA; [Mate, B. R.] Oregon State Univ, Hatfield Marine Sci Ctr, Newport, OR 97365 USA; [Schaefer, K. M.] Interamer Trop Tuna Commiss, La Jolla, CA 92037 USA; [Benson, S. R.] NOAA, SW Fisheries Sci Ctr, Protected Resources Div, La Jolla, CA 92037 USA	Stanford University; Dalhousie University; California State University System; San Jose State University; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Santa Cruz; National Oceanic Atmospheric Admin (NOAA) - USA; Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA	Block, BA (corresponding author), Stanford Univ, Hopkins Marine Stn, Dept Biol, Pacific Grove, CA 93950 USA.	bblock@stanford.edu	Shaffer, Scott A/D-5015-2009; Hazen, Elliott/G-4149-2014; Bograd, Steven/AAA-4824-2021; Costa, Daniel/E-2616-2013	Shaffer, Scott A/0000-0002-7751-5059; Hazen, Elliott/0000-0002-0412-7178; Jonsen, Ian/0000-0001-5423-6076; Costa, Daniel/0000-0002-0233-5782; Harrison, Autumn-Lynn/0000-0002-6213-1765	Sloan Foundation; Packard Foundation; Moore Foundation; Office of Naval Research; NOAA; E&P Sound and Marine Life JIP under the OGP; Monterey Bay Aquarium Foundation	Sloan Foundation(Alfred P. Sloan Foundation); Packard Foundation(The David & Lucile Packard Foundation); Moore Foundation(Gordon and Betty Moore Foundation); Office of Naval Research(Office of Naval Research); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); E&P Sound and Marine Life JIP under the OGP; Monterey Bay Aquarium Foundation	This manuscript is the culmination of a Census of Marine Life cross project synthesis between TOPP and Future of Marine Animal Populations (FMAP). Funding for this work was provided by the Sloan Foundation's Census of Marine Life programme. TOPP research was funded by the Sloan, Packard and Moore foundations. FMAP was funded by the Sloan Foundation. Electronic tagging and tracking in TOPP was also supported by the Office of Naval Research, the NOAA, the E&P Sound and Marine Life JIP under contract from the OGP, and the Monterey Bay Aquarium Foundation. We thank the TOPP scientific teams and all those who supported animal tagging efforts, R. Kochevar and D. Kohrs for their dedication and their effort on behalf of the Census of Marine Life. We are grateful to the numerous captains and crews who provided ship time and logistical support and to the US Fish and Wildlife Service in Hawaii for further logistical support. We thank the Mexican authorities and collaborating TOPP partners (O. Sosa-Nishizki) for permitting and assisting in research in their waters. All animal research was conducted in accordance with IACUC protocols from Stanford University and the University of California.	Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; Berman-Kowalewski M, 2010, AQUAT MAMM, V36, P59, DOI 10.1578/AM.36.1.2010.59; Campana SE, 2002, N AM J FISH MANAGE, V22, P106, DOI 10.1577/1548-8675(2002)022<0106:PDOTPI>2.0.CO;2; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Costa DP, 2010, INTEGR COMP BIOL, V50, P1018, DOI 10.1093/icb/icq054; Halpern BS, 2009, CONSERV LETT, V2, P138, DOI 10.1111/j.1755-263X.2009.00058.x; Hays GC, 2003, MAR ECOL PROG SER, V262, P305, DOI 10.3354/meps262305; Heupel MR, 2002, CAN J FISH AQUAT SCI, V59, P624, DOI 10.1139/F02-036; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; Kurota H, 2009, CAN J FISH AQUAT SCI, V66, P321, DOI 10.1139/F08-197; Lewison RL, 2003, ECOL APPL, V13, P743, DOI 10.1890/1051-0761(2003)013[0743:EFBAEO]2.0.CO;2; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Peckham SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001041; PICES, 2004, PICES SPEC PUBL, V1; Polovina JJ, 2001, PROG OCEANOGR, V49, P469, DOI 10.1016/S0079-6611(01)00036-2; Prince ED, 2006, FISH OCEANOGR, V15, P451, DOI 10.1111/j.1365-2419.2005.00393.x; Robinson Robert A., 2009, Endangered Species Research, V7, P87, DOI 10.3354/esr00095; Scheffer M, 2005, TRENDS ECOL EVOL, V20, P579, DOI 10.1016/j.tree.2005.08.018; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Shiels HA, 2011, P ROY SOC B-BIOL SCI, V278, P18, DOI 10.1098/rspb.2010.1274; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Sibert J, 2006, SCIENCE, V314, P1773, DOI 10.1126/science.1135347; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; STEELE JH, 1994, PHILOS T ROY SOC B, V343, P5, DOI 10.1098/rstb.1994.0001; Swain DP, 2008, CAN J FISH AQUAT SCI, V65, P2315, DOI 10.1139/F08-175; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Weng KC, 2005, SCIENCE, V310, P104, DOI 10.1126/science.1114616; Whitehead H, 2008, ECOL LETT, V11, P1198, DOI 10.1111/j.1461-0248.2008.01234.x; Wood S., 2006, GEN ADDITIVE MODELS	30	850	866	9	586	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 7	2011	475	7354					86	90		10.1038/nature10082	http://dx.doi.org/10.1038/nature10082			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21697831				2022-12-01	WOS:000292461300050
J	Heath, I				Heath, Iona			LIFE AND DEATH Seeming virtuous on chronic diseases	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Coll Gen Practitioners, London, England		Heath, I (corresponding author), Royal Coll Gen Practitioners, London, England.	iona.heath22@yahoo.co.uk							0	9	9	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 6	2011	343								d4239	10.1136/bmj.d4239	http://dx.doi.org/10.1136/bmj.d4239			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791SD	21734169				2022-12-01	WOS:000292684100009
J	Hawkes, N				Hawkes, Nigel			MEDICAL RESEARCH Dangers of research into chronic fatigue syndrome	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						[Anonymous], 2011, LANCET, V377, P1808; NICE, CHRON FAT SYNDR MYAL; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018; White PD, 2011, LANCET, V377, P823, DOI 10.1016/S0140-6736(11)60096-2	4	15	15	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 22	2011	342								d3780	10.1136/bmj.d3780	http://dx.doi.org/10.1136/bmj.d3780			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AT	21697226				2022-12-01	WOS:000292200500006
J	Zuber, J; Shi, JW; Wang, E; Rappaport, AR; Herrmann, H; Sison, EA; Magoon, D; Qi, J; Blatt, K; Wunderlich, M; Taylor, MJ; Johns, C; Chicas, A; Mulloy, JC; Kogan, SC; Brown, P; Valent, P; Bradner, JE; Lowe, SW; Vakoc, CR				Zuber, Johannes; Shi, Junwei; Wang, Eric; Rappaport, Amy R.; Herrmann, Harald; Sison, Edward A.; Magoon, Daniel; Qi, Jun; Blatt, Katharina; Wunderlich, Mark; Taylor, Meredith J.; Johns, Christopher; Chicas, Agustin; Mulloy, James C.; Kogan, Scott C.; Brown, Patrick; Valent, Peter; Bradner, James E.; Lowe, Scott W.; Vakoc, Christopher R.			RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia	NATURE			English	Article							TRANSCRIPTIONAL PROGRAM; H3K79 METHYLATION; STEM-CELLS; IN-VIVO; C-MYC; CLASSIFICATION; LEUKEMOGENESIS; EXPRESSION; MLL-AF9; INHIBITION	Epigenetic pathways can regulate gene expression by controlling and interpreting chromatin modifications. Cancer cells are characterized by altered epigenetic landscapes, and commonly exploit the chromatin regulatory machinery to enforce oncogenic gene expression programs(1). Although chromatin alterations are, in principle, reversible and often amenable to drug intervention, the promise of targeting such pathways therapeutically has been limited by an incomplete understanding of cancer-specific dependencies on epigenetic regulators. Here we describe a non-biased approach to probe epigenetic vulnerabilities in acute myeloid leukaemia (AML), an aggressive haematopoietic malignancy that is often associated with aberrant chromatin states(2). By screening a custom library of small hairpin RNAs (shRNAs) targeting known chromatin regulators in a genetically defined AML mouse model, we identify the protein bromodomain-containing 4 (Brd4) as being critically required for disease maintenance. Suppression of Brd4 using shRNAs or the small-molecule inhibitor JQ1 led to robust antileukaemic effects in vitro and in vivo, accompanied by terminal myeloid differentiation and elimination of leukaemia stem cells. Similar sensitivities were observed in a variety of human AML cell lines and primary patient samples, revealing that JQ1 has broad activity in diverse AML subtypes. The effects of Brd4 suppression are, at least in part, due to its role in sustaining Myc expression to promote aberrant self-renewal, which implicates JQ1 as a pharmacological means to suppress MYC in cancer. Our results establish small-molecule inhibition of Brd4 as a promising therapeutic strategy in AML and, potentially, other cancers, and highlight the utility of RNA interference (RNAi) screening for revealing epigenetic vulnerabilities that can be exploited for direct pharmacological intervention.	[Lowe, Scott W.; Vakoc, Christopher R.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Zuber, Johannes] Res Inst Mol Pathol IMP, A-1030 Vienna, Austria; [Shi, Junwei] SUNY Stony Brook, Mol & Cellular Biol Program, Stony Brook, NY 11794 USA; [Rappaport, Amy R.; Lowe, Scott W.] Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Sison, Edward A.; Magoon, Daniel; Brown, Patrick] Johns Hopkins Univ, Sch Med, Div Pediat Oncol, Baltimore, MD 21231 USA; [Qi, Jun; Bradner, James E.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Blatt, Katharina; Valent, Peter] Med Univ Vienna, Div Hematol & Hemostaseol, Dept Internal Med 1, A-1090 Vienna, Austria; [Wunderlich, Mark; Mulloy, James C.] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Kogan, Scott C.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Cold Spring Harbor Laboratory; Johns Hopkins University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Medical University of Vienna; Cincinnati Children's Hospital Medical Center; University of California System; University of California San Francisco	Vakoc, CR (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	lowe@cshl.edu; vakoc@cshl.edu	Clovis, Jeff/C-1020-2009; Hermann, Harald/E-7073-2018; Zuber, Johannes/E-7517-2011; Test, PV/U-9451-2019; Valent, Peter/B-8533-2016; Test, Test/Y-7921-2019; Gamperl, Susi/V-2715-2019	Hermann, Harald/0000-0002-5095-4641; Zuber, Johannes/0000-0001-8810-6835; Valent, Peter/0000-0003-0456-5095; Gamperl, Susi/0000-0003-0456-5095; Kogan, Scott/0000-0002-2395-8479; Wang, Eric/0000-0001-7865-6702; Vakoc, Christopher/0000-0002-1158-7180	Don Monti Memorial Research Foundation; Laurie Strauss Leukemia Foundation; German Research Foundation (DFG); CSHL; NIH; Barbara McClintock fellowship; Damon-Runyon Cancer Research Foundation; Smith Family Foundation; Damon Runyon-Lilly Clinical Investigator Award; Leukemia and Lymphoma Society (LLS); Leukemia and Lymphoma Society of America; National Cancer Institute; Howard Hughes Medical Institute; CSHL President's Council; SASS Foundation for Medical Research; NATIONAL CANCER INSTITUTE [K08CA128972] Funding Source: NIH RePORTER	Don Monti Memorial Research Foundation; Laurie Strauss Leukemia Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); CSHL; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barbara McClintock fellowship; Damon-Runyon Cancer Research Foundation; Smith Family Foundation; Damon Runyon-Lilly Clinical Investigator Award; Leukemia and Lymphoma Society (LLS)(Leukemia and Lymphoma Society); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); CSHL President's Council; SASS Foundation for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank B. Ma, S. Muller and M. Weissenboeck for technical assistance; J. Simon, E. Earl and L. Bianco for support with mouse work; C. dos Santos for assistance with LSK FACS analysis; S. Hearn for microscopy support; G. Hannon, K. Chang, and E. Hodges for shRNA technology support; A. Gordon and M. Hammell for bioinformatics support; L. Dow for assistance with mouse pathology sample preparation; and G. Blobel for comments on the manuscript. We thank the Don Monti Memorial Research Foundation and Laurie Strauss Leukemia Foundation for research support. J.Z. was supported by a research fellowship from the German Research Foundation (DFG) and by the Andrew Seligson Memorial Clinical Fellowship at CSHL; A. R. R. was supported by an NIH traineeship and the Barbara McClintock fellowship; J. E. B and J. Q. are supported by the Damon-Runyon Cancer Research Foundation and Smith Family Foundation. P. B. is supported by a Damon Runyon-Lilly Clinical Investigator Award and a Leukemia and Lymphoma Society (LLS) Translational Research Program Grant, and is an LLS Scholar in Clinical Research. S. W. L. is supported by a Specialized Center of Research (SCOR) grant from the Leukemia and Lymphoma Society of America, a Cancer Target Discovery and Development (CTD2) grant from the National Cancer Institute, and by the Howard Hughes Medical Institute; C. R. V., J. S. and E. W. are supported by the CSHL President's Council and the SASS Foundation for Medical Research.	BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; BENNETT JM, 1985, ANN INTERN MED, V103, P620, DOI 10.7326/0003-4819-103-4-620; Chen JJ, 2010, NAT REV CANCER, V10, P23, DOI 10.1038/nrc2765; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; French CA, 2003, CANCER RES, V63, P304; Gilliland D Gary, 2004, Hematology Am Soc Hematol Educ Program, P80; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Schmidt M, 2000, MOL CELL BIOL, V20, P1970, DOI 10.1128/MCB.20.6.1970-1981.2000; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor James, 2007, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1005s19; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Wang JX, 1998, P NATL ACAD SCI USA, V95, P10860, DOI 10.1073/pnas.95.18.10860; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wong P, 2010, CANCER RES, V70, P3833, DOI 10.1158/0008-5472.CAN-09-3268; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Wunderlich Mark, 2009, V538, P263, DOI 10.1007/978-1-59745-418-6_13; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297; ZUBER J, GENES DEV IN PRESS, DOI DOI 10.1101/GAD.1726911; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720; Zuber J, 2009, GENE DEV, V23, P877, DOI 10.1101/gad.1771409	42	1367	1504	1	267	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 27	2011	478	7370					524	U124		10.1038/nature10334	http://dx.doi.org/10.1038/nature10334			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	21814200	Green Accepted			2022-12-01	WOS:000296194200045
J	O'Keefe, FR; Chiappe, LM				O'Keefe, F. R.; Chiappe, L. M.			Viviparity and K-Selected Life History in a Mesozoic Marine Plesiosaur (Reptilia, Sauropterygia)	SCIENCE			English	Article							EMBRYOS; BIRTH	Viviparity is known in several clades of Mesozoic aquatic reptiles, but evidence for it is lacking in the Plesiosauria. Here, we report a Late Cretaceous plesiosaur fossil consisting of a fetus preserved within an adult of the same taxon. We interpret this occurrence as a gravid female and unborn young and hence as definitive evidence for plesiosaur viviparity. Quantitative analysis indicates that plesiosaurs gave birth to large, probably single progeny. The combination of viviparity, large offspring size, and small brood number differs markedly from the pattern seen in other marine reptiles but does resemble the K-selected strategy of all extant marine mammals and a few extant lizards. Plesiosaurs may have shared other life history traits with these clades, such as sociality and maternal care.	[O'Keefe, F. R.] Marshall Univ, Dept Biol Sci, Huntington, WV 25755 USA; [Chiappe, L. M.] Nat Hist Museum Los Angeles Cty, Dinosaur Inst, Los Angeles, CA 90007 USA	Marshall University	O'Keefe, FR (corresponding author), Marshall Univ, Dept Biol Sci, Huntington, WV 25755 USA.	okeefef@marshall.edu		Chiappe, Luis/0000-0001-9661-0601	NSF [EPS-1003907]	NSF(National Science Foundation (NSF))	The fossil described here (LACM 129639) is reposited in the vertebrate paleontology collections of the Los Angeles County Museum and is currently on display in the public gallery. Metric data from the specimen is listed in tables S1 and S2. We thank Phil Fraley Productions for the skilled preparation and mounting of the fossil that made this study possible. B. Kear provided access to unpublished Leptocleidus data. Thanks to R. Cripps for the mount photograph in Fig. 1 and to D. Trankina for Fig. 1 line art. Many thanks to S. Abramowicz for the life reconstruction art, Fig. 3, and work on other figures. J. Long provided valuable feedback on an early version of this manuscript. This material is based on work supported by the NSF under award no. EPS-1003907.	Andrews R.M., 1982, Biology of Reptilia, V13, P273; Boness DJ, 2002, MARINE MAMMAL BIOLOGY: AN EVOLUTIONARY APPROACH, P278; Bottcher R., 1990, STUTTGARTER BEITRA B, V164, P1; Brown D.S., 1981, Bulletin of the British Museum (Natural History) Geology, V35, P253; BULL CM, 1993, J HERPETOL, V27, P489, DOI 10.2307/1564848; Caldwell MW, 2001, P ROY SOC B-BIOL SCI, V268, P2397, DOI 10.1098/rspb.2001.1796; Chapple DG, 2003, HERPETOL MONOGR, V17, P145, DOI 10.1655/0733-1347(2003)017[0145:ELABIT]2.0.CO;2; Cheng YN, 2009, J VERTEBR PALEONTOL, V29, P401, DOI 10.1671/039.029.0230; Cheng YN, 2004, NATURE, V432, P383, DOI 10.1038/nature03050; Delfino M, 2010, SEMIN CELL DEV BIOL, V21, P432, DOI 10.1016/j.semcdb.2009.11.007; ESTES JA, 1979, J FISH RES BOARD CAN, V36, P1009, DOI 10.1139/f79-140; Everhart M. J., 2005, OCEANS KANSAS NATURA; Everhart Michael J., 2004, Mosasaur, V7, P41; Hill RV, 2005, SYST BIOL, V54, P530, DOI 10.1080/10635150590950326; Ji Q, 2010, NATURWISSENSCHAFTEN, V97, P423, DOI 10.1007/s00114-010-0654-2; Kear BP, 2007, J PALEONTOL, V81, P154, DOI 10.1666/0022-3360(2007)81[154:AJPPRS]2.0.CO;2; Lin K., 1998, FIELDIANA GEOLOGY, V39, P1, DOI 10.5962/bhl.title.5174; O'Keefe ER, 2004, J VERTEBR PALEONTOL, V24, P326; O'Keefe FR, 2009, J VERTEBR PALEONTOL, V29, P1306, DOI 10.1671/039.029.0403; O'Keefe FR, 1999, PALEOBIOLOGY, V25, P504, DOI 10.1017/S0094837300020352; Parker F., 1983, P435; Perrin W.F., 1984, Reports of the International Whaling Commission Special Issue, P97; Renesto S, 2003, J VERTEBR PALEONTOL, V23, P957, DOI 10.1671/1840-21; RIEPPEL O, 1994, J HERPETOL, V28, P145, DOI 10.2307/1564613; SANDER PM, 1988, SCIENCE, V239, P780, DOI 10.1126/science.3340859; Seeley H. G., 1896, ANN REP YORKSHIRE PH, V1895; Shine R., 1988, BIOL REPTILIA, V16, P275; Storrs Glenn W., 1999, University of Kansas Paleontological Contributions New Series, V10-11, P1; TAYLOR MA, 1986, NATURE, V319, P179, DOI 10.1038/319179a0; THULBORN RA, 1982, PALAEONTOLOGY, V25, P351	30	63	67	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2011	333	6044					870	873		10.1126/science.1205689	http://dx.doi.org/10.1126/science.1205689			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21836013				2022-12-01	WOS:000293785400038
J	Kai, FM; Tyler, SC; Randerson, JT; Blake, DR				Kai, Fuu Ming; Tyler, Stanley C.; Randerson, James T.; Blake, Donald R.			Reduced methane growth rate explained by decreased Northern Hemisphere microbial sources	NATURE			English	Article							ATMOSPHERIC METHANE; WATER MANAGEMENT; RICE FIELDS; EMISSIONS; BUDGET; CHINA; MODEL; GAS	Atmospheric methane(CH4) increased through much of the twentieth century, but this trend gradually weakened until a stable state was temporarily reached around the turn of the millennium(1,2), after which levels increased once more(3). The reasons for the slowdown are incompletely understood, with past work identifying changes in fossil fuel, wetland and agricultural sources and hydroxyl (OH) sinks as important causal factors(1,4-8). Here we show that the late-twentieth century changes in the CH4 growth rates are best explained by reduced microbial sources in the Northern Hemisphere. Our results, based on synchronous time series of atmospheric CH4 mixing and C-13/C-12 ratios and a two-box atmospheric model, indicate that the evolution of the mixing ratio requires no significant change in Southern Hemisphere sources between 1984 and 2005. Observed changes in the interhemispheric difference of C-13 effectively exclude reduced fossil fuel emissions as the primary cause of the slowdown. The C-13 observations are consistent with long-term reductions in agricultural emissions or another microbial source within the Northern Hemisphere. Approximately half (51 +/- 18%) of the decrease in Northern Hemisphere CH4 emissions can be explained by reduced emissions from rice agriculture in Asia over the past three decades associated with increases in fertilizer application(9) and reductions in water use(10,11).	[Kai, Fuu Ming; Tyler, Stanley C.; Randerson, James T.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Blake, Donald R.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Kai, FM (corresponding author), Singapore MIT Alliance Res & Technol, S16-05-08,3 Sci Dr 2, Singapore 117543, Singapore.	fmkai@smart.mit.edu	Randerson, James/Y-2550-2019; Kai, Fuu Ming/AAE-8903-2021; Kai, Fuu Ming/C-3890-2013	Randerson, James/0000-0001-6559-7387; Kai, Fuu Ming/0000-0002-4126-3515; Blake, Donald/0000-0002-8283-5014	NASA [NGT5-30409, NNX08AF64G]; NSF [ATM 9871077, ATM-0628637, AGS-1021776]; Div Atmospheric & Geospace Sciences [1021613] Funding Source: National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the many researchers associated with the laboratories referred to as NOAA, NIWA, UW and UCI who took part in collecting and measuring many thousands of air samples over the years. We also thank P. Bousquet for detailed comments on earlier drafts that improved the manuscript. This work has been funded by NASA grants to S. C. T. (NGT5-30409) and J.T.R. (NNX08AF64G), NSF grants to S. C. T. (ATM 9871077) and J.T.R. (ATM-0628637 and AGS-1021776), and additional support from the W. M. Keck Foundation.	[Anonymous], 2008, WAT US STAT; Bloom AA, 2010, SCIENCE, V327, P322, DOI 10.1126/science.1175176; Bousquet P, 2006, NATURE, V443, P439, DOI 10.1038/nature05132; Cicerone RJ, 1988, GLOBAL BIOGEOCHEM CY, V2, P299, DOI 10.1029/GB002i004p00299; Dlugokencky EJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039780; Dlugokencky EJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018126; Dlugokencky EJ, 1998, NATURE, V393, P447, DOI 10.1038/30934; Etheridge DM, 1998, J GEOPHYS RES-ATMOS, V103, P15979, DOI 10.1029/98JD00923; Ferretti DF, 2005, SCIENCE, V309, P1714, DOI 10.1126/science.1115193; Fiore AM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026199; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Frolking S, 2004, GLOBAL CHANGE BIOL, V10, P1180, DOI 10.1111/j.1529-8817.2003.00798.x; Huang Y, 1998, GLOBAL CHANGE BIOL, V4, P247, DOI 10.1046/j.1365-2486.1998.00129.x; International Rice Research Institute, 2008, WORLD RIC STAT; Kai FM, 2010, J INTEGR ENVIRON SCI, V7, P49, DOI 10.1080/1943815X.2010.492227; Khalil MAK, 2000, ATMOSPHERIC METHANE, P98; Lassey KR, 2007, ATMOS CHEM PHYS, V7, P2119, DOI 10.5194/acp-7-2119-2007; Lassey KR, 2007, AGR FOREST METEOROL, V142, P120, DOI 10.1016/j.agrformet.2006.03.028; Li CS, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015370; Lowe DC, 1997, GEOPHYS RES LETT, V24, P857, DOI 10.1029/97GL00830; Quay P, 1999, GLOBAL BIOGEOCHEM CY, V13, P445, DOI 10.1029/1998GB900006; Simpson IJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027330; Tans PP, 1997, GLOBAL BIOGEOCHEM CY, V11, P77, DOI 10.1029/96GB03940; Tyler SC, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007231; United States Environmental Protection Agency (EPA), 2006, GLOB ANTHR NONCO2 GR; van Aardenne JA, 2001, GLOBAL BIOGEOCHEM CY, V15, P909, DOI 10.1029/2000GB001265; van der Gon HD, 1999, GLOBAL BIOGEOCHEM CY, V13, P1053, DOI 10.1029/1999GB900048; Wassmann R, 2000, NUTR CYCL AGROECOSYS, V58, P23, DOI 10.1023/A:1009874014903; Worthy DEJ, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011239; Zhuang Q, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002239	30	122	123	6	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2011	476	7359					194	197		10.1038/nature10259	http://dx.doi.org/10.1038/nature10259			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21833086	Green Published			2022-12-01	WOS:000293731900033
J	Yaffe, K; Laffan, AM; Harrison, SL; Redline, S; Spira, AP; Ensrud, KE; Ancoli-Israel, S; Stone, KL				Yaffe, Kristine; Laffan, Alison M.; Harrison, Stephanie Litwack; Redline, Susan; Spira, Adam P.; Ensrud, Kristine E.; Ancoli-Israel, Sonia; Stone, Katie L.			Sleep-Disordered Breathing, Hypoxia, and Risk of Mild Cognitive Impairment and Dementia in Older Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINI-MENTAL-STATE; HEART HEALTH; CARDIOVASCULAR-DISEASE; INTERMITTENT HYPOXIA; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; NOCTURNAL HYPOXIA; ANIMAL-MODELS; APNEA; FRAGMENTATION	Context Sleep-disordered breathing (characterized by recurrent arousals from sleep and intermittent hypoxemia) is common among older adults. Cross-sectional studies have linked sleep-disordered breathing to poor cognition; however, it remains unclear whether sleep-disordered breathing precedes cognitive impairment in older adults. Objectives To determine the prospective relationship between sleep-disordered breathing and cognitive impairment and to investigate potential mechanisms of this association. Design, Setting, and Participants Prospective sleep and cognition study of 298 women without dementia (mean [SD] age: 82.3 [3.2] years) who had overnight polysomnography measured between January 2002 and April 2004 in a substudy of the Study of Osteoporotic Fractures. Sleep-disordered breathing was defined as an apnea-hypopnea index of 15 or more events per hour of sleep. Multivariate logistic regression was used to determine the independent association of sleep-disordered breathing with risk of mild cognitive impairment or dementia, adjusting for age, race, body mass index, education level, smoking status, presence of diabetes, presence of hypertension, medication use (antidepressants, benzodiazepines, or nonbenzodiazepine anxiolytics), and baseline cognitive scores. Measures of hypoxia, sleep fragmentation, and sleep duration were investigated as underlying mechanisms for this relationship. Main Outcome Measures Adjudicated cognitive status (normal, dementia, or mild cognitive impairment) based on data collected between November 2006 and September 2008. Results Compared with the 193 women without sleep-disordered breathing, the 105 women (35.2%) with sleep-disordered breathing were more likely to develop mild cognitive impairment or dementia (31.1% [n=60] vs 44.8% [n=47]; adjusted odds ratio [AOR], 1.85; 95% confidence interval [CI], 1.11-3.08). Elevated oxygen desaturation index (>= 15 events/hour) and high percentage of sleep time (>7%) in apnea or hypopnea (both measures of disordered breathing) were associated with risk of developing mild cognitive impairment or dementia (AOR, 1.71 [95% CI, 1.04-2.83] and AOR, 2.04 [95% CI, 1.10-3.78], respectively). Measures of sleep fragmentation (arousal index and wake after sleep onset) or sleep duration (total sleep time) were not associated with risk of cognitive impairment. Conclusion Among older women, those with sleep-disordered breathing compared with those without sleep-disordered breathing had an increased risk of developing cognitive impairment. JAMA. 2011;306(6):613-619 www.jama.com	[Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94121 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94121 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94121 USA; [Yaffe, Kristine] San Francisco VA Med Ctr, San Francisco, CA USA; [Laffan, Alison M.; Harrison, Stephanie Litwack; Stone, Katie L.] Calif Pacific Med Ctr, San Francisco Coordinating Ctr, San Francisco, CA USA; [Redline, Susan] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Sleep Med, Boston, MA 02115 USA; [Redline, Susan] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02115 USA; [Spira, Adam P.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Ensrud, Kristine E.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Ensrud, Kristine E.] Univ Minnesota, Dept Epidemiol, Minneapolis, MN 55455 USA; [Ensrud, Kristine E.] Univ Minnesota, Dept Community Hlth, Minneapolis, MN 55455 USA; [Ensrud, Kristine E.] Vet Affairs Med Ctr, Minneapolis, MN USA; [Ancoli-Israel, Sonia] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; California Pacific Medical Center; California Pacific Medical Center Research Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of California System; University of California San Diego	Yaffe, K (corresponding author), Univ Calif San Francisco, Dept Psychiat, Box 181,4150 Clement St, San Francisco, CA 94121 USA.	kristine.yaffe@ucsf.edu		Spira, Adam/0000-0003-1507-0995; Ensrud, Kristine/0000-0002-9069-3036	National Institutes of Health; Alzheimer Association; Department of Defense; American Health Assistance Foundation; Beeson Scientific; Japan Geriatrics Society; Wake Forest University; State of California Department of Human Services; National Institute on Aging [AG05407, AR35582, AG05394, AR35584, AR35583, R01 AG005407, R01 AG027576-22, 2 R01 AG005394-22A1, 2 R01 AG027574-22A1, AG026720, K24AG031155, AG08415]; NIA [1K01AG033195]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035583, R01AR035582, R01AR035584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG033195, R01AG008415, R01AG026720, R01AG027576, R01AG005394, R01AG027574, R01AG005407, K24AG031155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); Department of Defense(United States Department of Defense); American Health Assistance Foundation; Beeson Scientific; Japan Geriatrics Society; Wake Forest University; State of California Department of Human Services; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Yaffe reported that she is a consultant for Novartis Inc; serves on data and safety monitoring boards for Pfizer, Medivation, and the National Institute of Mental Health; is a board member for Beeson Scientific Advisory; has grants pending with the National Institutes of Health, the Alzheimer Association, the Department of Defense, and the American Health Assistance Foundation; and has received funding for expenses unrelated to the activites listed from the Alzheimer Association, the National Institutes of Health, Beeson Scientific, Japan Geriatrics Society, Wake Forest University, and the State of California Department of Human Services. Dr Laffan reported that she received salary support and was reimbursed for travel to professional society meetings from the National Institutes of Health. Dr Redline reported that her institution received a California Pacific Medical Center subcontract via a National Institutes of Health grant; she is a board member for the American Academy of Sleep Medicine; her institution has received an endowment for a professorship in sleep medicine from Dr Peter Farrell, CEO of RosMed Inc; and has multiple grants pending with the National Institutes of Health on sleep apnea. Dr Spira reported that he has received honoraria as a clinical editor for the International Journal of Sleep and Wakefulness-Primary Care, which receives pharmaceutical industry support. Dr Ancoli-Israel reported that she is a consultant for Johnson & Johnson, Merck, Purdue Pharma LP, sanofi-aventis, and Pfizer and has grants pending with the National Institutes of Health. No other disclosures were reported.; The Study of Osteoporotic Fractures is supported by funding from the National Institutes of Health. The National Institute on Aging provided support for this study under grants AG05407, AR35582, AG05394, AR35584, AR35583, R01 AG005407, R01 AG027576-22, 2 R01 AG005394-22A1, and 2 R01 AG027574-22A1, AG05407, AR35582, AG05394, AR35584, AR35583, AG026720. In addition, this study was supported by National Institute on Aging grant AG026720. Dr Yaffe is supported in part by National Institute on Aging grant K24AG031155. Dr Spira is supported by a Mentored Research Scientist Development Award (NIA 1K01AG033195). Dr Ancoli-Israel is supported by National Institute on Aging grant AG08415.	Aloia MS, 2004, J INT NEUROPSYCH SOC, V10, P772, DOI 10.1017/S1355617704105134; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890423349; Ancoli-Israel S, 2008, J AM GERIATR SOC, V56, P2076, DOI 10.1111/j.1532-5415.2008.01934.x; ANCOLIISRAEL S, 1991, SLEEP, V14, P486, DOI 10.1093/sleep/14.6.486; ANCOLIISRAEL S, 1991, J AM GERIATR SOC, V39, P258, DOI 10.1111/j.1532-5415.1991.tb01647.x; Born J, 2011, PSYCHOL RES; Canessa N, 2011, AM J RESP CRIT CARE, V183, P1419, DOI 10.1164/rccm.201005-0693OC; Cooke JR, 2009, J CLIN SLEEP MED, V5, P305; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Dealberto MJ, 1996, J AM GERIATR SOC, V44, P1287, DOI 10.1111/j.1532-5415.1996.tb01397.x; Delis D.C., 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Dematteis M, 2009, ILAR J, V50, P262, DOI 10.1093/ilar.50.3.262; Drager LF, 2010, BEST PRACT RES CL EN, V24, P843, DOI 10.1016/j.beem.2010.08.011; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Foley DJ, 2003, SLEEP, V26, P596, DOI 10.1093/sleep/26.5.596; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ghegan MD, 2006, LARYNGOSCOPE, V116, P859, DOI 10.1097/01.mlg.0000214866.32050.2e; Iber C, 2004, SLEEP, V27, P536, DOI 10.1093/sleep/27.3.536; Ip MSM, 2002, AM J RESP CRIT CARE, V165, P670, DOI 10.1164/ajrccm.165.5.2103001; JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742; Kingshott RN, 2000, J SLEEP RES, V9, P353, DOI 10.1046/j.1365-2869.2000.00223.x; McDowell I, 1997, J CLIN EPIDEMIOL, V50, P377, DOI 10.1016/S0895-4356(97)00060-7; PAHOR M, 1994, EUR J EPIDEMIOL, V10, P405, DOI 10.1007/BF01719664; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Punjabi NM, 2004, AM J EPIDEMIOL, V160, P521, DOI 10.1093/aje/kwh261; Quan SF, 2002, SLEEP, V25, P843; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Reitan R.M., 1985, REITAN NEUROPSYCHOLO, V4; Row BW, 2007, ADV EXP MED BIOL, V618, P51; Sforza E, 2010, SLEEP, V33, P515, DOI 10.1093/sleep/33.4.515; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; Spira AP, 2008, J AM GERIATR SOC, V56, P45, DOI 10.1111/j.1532-5415.2007.01506.x; Spreen O., 1998, COMPENDIUM NEUROPSYC; Stepanski EJ, 2002, SLEEP, V25, P268, DOI 10.1093/sleep/25.3.268; SULLIVAN CE, 1981, LANCET, V1, P862; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Thomas RJ, 2007, SLEEP, V30, P1195, DOI 10.1093/sleep/30.9.1195; van Beek AHEA, 2008, J CEREBR BLOOD F MET, V28, P1071, DOI 10.1038/jcbfm.2008.13; Wechsler D., 1988, WECHSLER ADULT INTEL; Weiss MD, 2009, SLEEP MED, V10, P739, DOI 10.1016/j.sleep.2008.07.013; Yaffe K, 2011, ARCH NEUROL-CHICAGO, V68, P631, DOI 10.1001/archneurol.2011.82; Young T, 2000, SLEEP, V23, pS122	43	665	688	2	83	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 10	2011	306	6					613	619		10.1001/jama.2011.1115	http://dx.doi.org/10.1001/jama.2011.1115			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	804XD	21828324	Green Accepted			2022-12-01	WOS:000293687300022
J	Zhang, MZ; Zhang, RP; He, MG; Liang, WL; Li, XF; She, LB; Yang, YL; MacKenzie, G; Silver, JD; Ellwein, L; Moore, B; Congdon, N				Zhang, Mingzhi; Zhang, Riping; He, Mingguang; Liang, Wanling; Li, Xiaofeng; She, Lingbing; Yang, Yunli; MacKenzie, Graeme; Silver, Joshua D.; Ellwein, Leon; Moore, Bruce; Congdon, Nathan			Self correction of refractive error among young people in rural China: results of cross sectional investigation	BRITISH MEDICAL JOURNAL			English	Article							LOW-RESOURCE COUNTRIES; VISUAL IMPAIRMENT; SCHOOL-CHILDREN; SECONDARY SCHOOLCHILDREN; SOUTHERN CHINA; X-PRES; POPULATION; TEACHERS; DISTRICT; STUDENTS	Objective To compare outcomes between adjustable spectacles and conventional methods for refraction in young people. Design Cross sectional study. Setting Rural southern China. Participants 648 young people aged 12-18 (mean 14.9 (SD 0.98)), with uncorrected visual acuity <= 6/12 in either eye. Interventions All participants underwent self refraction without cycloplegia (paralysis of near focusing ability with topical eye drops), automated refraction without cycloplegia, and subjective refraction by an ophthalmologist with cycloplegia. Main outcome measures Uncorrected and corrected vision, improvement of vision (lines on a chart), and refractive error. Results Among the participants, 59% (384) were girls, 44% (288) wore spectacles, and 61% (393/648) had 2.00 dioptres or more of myopia in the right eye. All completed self refraction. The proportion with visual acuity >= 6/7.5 in the better eye was 5.2% (95% confidence interval 3.6% to 6.9%) for uncorrected vision, 30.2% (25.7% to 34.8%) for currently worn spectacles, 96.9% (95.5% to 98.3%) for self refraction, 98.4% (97.4% to 99.5%) for automated refraction, and 99.1% (98.3% to 99.9%) for subjective refraction (P=0.033 for self refraction v automated refraction, P=0.001 for self refraction v subjective refraction). Improvements over uncorrected vision in the better eye with self refraction and subjective refraction were within one line on the eye chart in 98% of participants. In logistic regression models, failure to achieve maximum recorded visual acuity of 6/7.5 in right eyes with self refraction was associated with greater absolute value of myopia/hyperopia (P<0.001), greater astigmatism (P=0.001), and not having previously worn spectacles (P=0.002), but not age or sex. Significant inaccuracies in power (>= 1.00 dioptre) were less common in right eyes with self refraction than with automated refraction (5% v 11%, P<0.001). Conclusions Though visual acuity was slightly worse with self refraction than automated or subjective refraction, acuity was excellent in nearly all these young people with inadequately corrected refractive error at baseline. Inaccurate power was less common with self refraction than automated refraction. Self refraction could decrease the requirement for scarce trained personnel, expensive devices, and cycloplegia in children's vision programmes in rural China.	[He, Mingguang; Congdon, Nathan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab, Ophthalmol Grp, Guangzhou 510060, Guangdong, Peoples R China; [He, Mingguang; Congdon, Nathan] Sun Yat Sen Univ, Div Prevent Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China; [Zhang, Mingzhi] Joint Shantou Int Eye Ctr, Refract Serv, Shantou, Peoples R China; [MacKenzie, Graeme] Adlens, Oxford OX2 8AH, England; [MacKenzie, Graeme] John Radcliffe Hosp, Nuffield Lab Ophthalmol, Oxford OX3 9DU, England; [Silver, Joshua D.] Univ Oxford St Catherines Coll, Ctr Vis Dev World, Oxford OX1 3UJ, England; [Ellwein, Leon] NEI, Bethesda, MD 20892 USA; [Moore, Bruce] New England Coll Optometry, Boston, MA USA	Sun Yat Sen University; Sun Yat Sen University; University of Oxford; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Congdon, N (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab, Ophthalmol Grp, 54 Xianlie S Rd, Guangzhou 510060, Guangdong, Peoples R China.	ncongdon1@gmail.com	He, Mingguang/AAY-5239-2020	He, Mingguang/0000-0002-6912-2810	Imperial College of Science, Technology and Medicine under the World Bank	Imperial College of Science, Technology and Medicine under the World Bank	This study was funded by grant to the Nuffield Laboratory of Ophthalmology (University of Oxford) from the Partnership for Child Development, (Imperial College of Science, Technology and Medicine) under the World Bank's FY2009 Development Grant Facility (DGF) Window 1. The adjustable spectacles used in this study were provided free of charge by Adaptive Eyecare. The study sponsor played no role in study design and the collection, analysis, and interpretation of data and the writing of the article and the decision to submit it for publication.	*AM AC OPHTH, 2011, PREF PRACT PATT AMBL; BERGER IB, 1993, OPTOMETRY VISION SCI, V70, P332, DOI 10.1097/00006324-199304000-00013; Bourne RRA, 2004, INVEST OPHTH VIS SCI, V45, P410, DOI 10.1167/iovs.03-0129; Congdon N, 2008, ARCH OPHTHALMOL-CHIC, V126, P1717, DOI 10.1001/archopht.126.12.1717; Congdon N, 2008, INVEST OPHTH VIS SCI, V49, P2888, DOI 10.1167/iovs.07-1160; Dandona R, 2002, INVEST OPHTH VIS SCI, V43, P615; Donovan L, 2008, BRIT J OPHTHALMOL, V92, P294, DOI 10.1136/bjo.2007.121699; Douali MG, 2004, OPHTHAL PHYSL OPT, V24, P234, DOI 10.1111/j.1475-1313.2004.00198.x; Esteso P, 2007, INVEST OPHTH VIS SCI, V48, P4949, DOI 10.1167/iovs.07-0052; Fotedar R, 2007, AM J OPHTHALMOL, V144, P307, DOI 10.1016/j.ajo.2007.03.041; Gilbert C, 2007, EYE, V21, P1338, DOI 10.1038/sj.eye.6702841; Goh PP, 2005, OPHTHALMOLOGY, V112, P678, DOI 10.1016/j.ophtha.2004.10.048; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; He MG, 2007, OPHTHALMOLOGY, V114, P374, DOI 10.1016/j.ophtha.2006.08.020; He MG, 2011, OPHTHALMOLOGY, V118, P1162, DOI 10.1016/j.ophtha.2010.10.003; Holguin AMC, 2006, INVEST OPHTH VIS SCI, V47, P925, DOI 10.1167/iovs.05-0895; Leone JF, 2010, ARCH OPHTHALMOL-CHIC, V128, P894, DOI 10.1001/archophthalmol.2010.134; Li LP, 2010, ARCH OPHTHALMOL-CHIC, V128, P759, DOI 10.1001/archophthalmol.2010.73; Maul E, 2000, AM J OPHTHALMOL, V129, P445, DOI 10.1016/S0002-9394(99)00454-7; Murthy GVS, 2002, INVEST OPHTH VIS SCI, V43, P623; Naidoo KS, 2003, INVEST OPHTH VIS SCI, V44, P3764, DOI 10.1167/iovs.03-0283; Odedra N, 2008, OPHTHAL EPIDEMIOL, V15, P410, DOI 10.1080/09286580802399094; Pokharel GP, 2000, AM J OPHTHALMOL, V129, P436, DOI 10.1016/S0002-9394(99)00453-5; Ramke J, 2008, CLIN EXP OPHTHALMOL, V36, P339, DOI 10.1111/j.1442-9071.2008.01768.x; RENGSTORFF RH, 1982, AM J OPTOM PHYS OPT, V59, P162; Sharma A, 2008, ARCH OPHTHALMOL-CHIC, V126, P1434, DOI 10.1001/archopht.126.10.1434; Smith K, 2010, OPTOMETRY VISION SCI, V87, pE176, DOI 10.1097/OPX.0b013e3181cf86d6; *UN ED SCI CULT OR, ED ALL PROGR; World Health Organization, 2011, GLOB SCH HLTH IN; World Health Organization, 2000, EL AV VIS DIS DUE RE; Zeng YF, 2009, OPHTHALMOLOGY, V116, P1839, DOI 10.1016/j.ophtha.2009.04.004; Zhang MZ, 2009, INVEST OPHTH VIS SCI, V50, P2011, DOI 10.1167/iovs.08-2849; Zhao JL, 2000, AM J OPHTHALMOL, V129, P427, DOI 10.1016/S0002-9394(99)00452-3	33	19	22	0	16	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 9	2011	343								d4767	10.1136/bmj.d4767	http://dx.doi.org/10.1136/bmj.d4767			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808CX	21828207	Green Published, hybrid			2022-12-01	WOS:000293954000001
J	Hannedouche, S; Zhang, J; Yi, TS; Shen, WJ; Nguyen, D; Pereira, JP; Guerini, D; Baumgarten, BU; Roggo, S; Wen, B; Knochenmuss, R; Noel, S; Gessier, F; Kelly, LM; Vanek, M; Laurent, S; Preuss, I; Miault, C; Christen, I; Karuna, R; Li, W; Koo, DI; Suply, T; Schmedt, C; Peters, EC; Falchetto, R; Katopodis, A; Spanka, C; Roy, MO; Detheux, M; Chen, YA; Schultz, PG; Cho, CY; Seuwen, K; Cyster, JG; Sailer, AW				Hannedouche, Sebastien; Zhang, Juan; Yi, Tangsheng; Shen, Weijun; Nguyen, Deborah; Pereira, Joao P.; Guerini, Danilo; Baumgarten, Birgit U.; Roggo, Silvio; Wen, Ben; Knochenmuss, Richard; Noel, Sophie; Gessier, Francois; Kelly, Lisa M.; Vanek, Mirka; Laurent, Stephane; Preuss, Inga; Miault, Charlotte; Christen, Isabelle; Karuna, Ratna; Li, Wei; Koo, Dong-In; Suply, Thomas; Schmedt, Christian; Peters, Eric C.; Falchetto, Rocco; Katopodis, Andreas; Spanka, Carsten; Roy, Marie-Odile; Detheux, Michel; Chen, Yu Alice; Schultz, Peter G.; Cho, Charles Y.; Seuwen, Klaus; Cyster, Jason G.; Sailer, Andreas W.			Oxysterols direct immune cell migration via EBI2	NATURE			English	Article							DENDRITIC CELLS; CHOLESTEROL; EXPRESSION; MACROPHAGES; ENZYMES	Epstein-Barr virus-induced gene 2 (EBI2, also known as GPR183) is a G-protein-coupled receptor that is required for humoral immune responses; polymorphisms in the receptor have been associated with inflammatory autoimmune diseases(1-3). The natural ligand for EBI2 has been unknown. Here we describe the identification of 7 alpha,25-dihydroxycholesterol (also called 7 alpha,25-OHC or 5-cholesten-3 beta,7 alpha,25-triol) as a potent and selective agonist of EBI2. Functional activation of human EBI2 by 7 alpha,25-OHC and closely related oxysterols was verified by monitoring second messenger readouts and saturable, high-affinity radioligand binding. Furthermore, we find that 7 alpha,25-OHC and closely related oxysterols act as chemoattractants for immune cells expressing EBI2 by directing cell migration in vitro and in vivo. A critical enzyme required for the generation of 7 alpha,25-OHC is cholesterol 25-hydroxylase (CH25H)(4). Similar to EBI2 receptor knockout mice, mice deficient in CH25H fail to position activated B cells within the spleen to the outer follicle and mount a reduced plasma cell response after an immune challenge. This demonstrates that CH25H generates EBI2 biological activity in vivo and indicates that the EBI2-oxysterol signalling pathway has an important role in the adaptive immune response.	[Zhang, Juan; Guerini, Danilo; Baumgarten, Birgit U.; Roggo, Silvio; Knochenmuss, Richard; Gessier, Francois; Vanek, Mirka; Laurent, Stephane; Preuss, Inga; Miault, Charlotte; Christen, Isabelle; Karuna, Ratna; Suply, Thomas; Falchetto, Rocco; Katopodis, Andreas; Spanka, Carsten; Seuwen, Klaus; Sailer, Andreas W.] Novartis Inst BioMed Res, CH-4056 Basel, Switzerland; [Hannedouche, Sebastien; Noel, Sophie; Roy, Marie-Odile; Detheux, Michel] Euroscreen SA, B-6041 Gosselies, Belgium; [Yi, Tangsheng; Pereira, Joao P.; Kelly, Lisa M.; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Yi, Tangsheng; Pereira, Joao P.; Kelly, Lisa M.; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Shen, Weijun; Nguyen, Deborah; Wen, Ben; Li, Wei; Schmedt, Christian; Peters, Eric C.; Chen, Yu Alice; Schultz, Peter G.; Cho, Charles Y.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Shen, Weijun; Koo, Dong-In] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Novartis; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Novartis; Scripps Research Institute	Sailer, AW (corresponding author), Novartis Inst BioMed Res, CH-4056 Basel, Switzerland.	andreas.sailer@novartis.com	kelly, Lisa/GWU-9804-2022; Karuna, Ratna/F-3653-2011; yi, tangsheng/E-5014-2011; Peters, Eric/W-2739-2019; Sailer, Andreas/M-9913-2016	Nguyen, Deborah/0000-0002-1694-0617; Pereira, Joao/0000-0002-5694-4938; Sailer, Andreas/0000-0002-9015-7946; Karuna, Ratna/0000-0003-0508-2490; Hannedouche, Sebastien/0000-0001-5909-242X; Shen, Weijun/0000-0001-8388-729X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040098] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI040098] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Diczfalusy U, 2009, J LIPID RES, V50, P2258, DOI 10.1194/jlr.M900107-JLR200; Dulos J, 2005, ARTHRITIS RHEUM-US, V52, P770, DOI 10.1002/art.20950; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; GAUWERKY CE, 1988, ONCOGENE, V2, P431; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Honda A, 2011, J LIPID RES, V52, P1509, DOI 10.1194/jlr.M014084; Lathe R, 2002, STEROIDS, V67, P967, DOI 10.1016/S0039-128X(02)00044-2; Li DS, 2000, STEROIDS, V65, P529, DOI 10.1016/S0039-128X(00)00131-8; Li XB, 2007, J LIPID RES, V48, P2587, DOI 10.1194/jlr.M700301-JLR200; LIU C, 2011, NATURE, DOI DOI 10.1038/10226; LUND E, 1993, BIOCHIM BIOPHYS ACTA, V1166, P177, DOI 10.1016/0005-2760(93)90094-P; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; REED JC, 1993, LEUKEMIA LYMPHOMA, V10, P157, DOI 10.3109/10428199309145877; Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Russell DW, 2000, BBA-MOL CELL BIOL L, V1529, P126, DOI 10.1016/S1388-1981(00)00142-6; Wang JH, 2006, BIOCHEM BIOPH RES CO, V345, P720, DOI 10.1016/j.bbrc.2006.04.156	21	305	315	5	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2011	475	7357					524	527		10.1038/nature10280	http://dx.doi.org/10.1038/nature10280			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21796212	Green Accepted			2022-12-01	WOS:000293167900046
J	Qian, L; Winfree, E; Bruck, J				Qian, Lulu; Winfree, Erik; Bruck, Jehoshua			Neural network computation with DNA strand displacement cascades	NATURE			English	Article							ASSOCIATIVE MEMORY; CHEMICAL-KINETICS; CIRCUITS; LOGIC; DEPTH	The impressive capabilities of the mammalian brain-ranging from perception, pattern recognition and memory formation to decision making and motor activity control-have inspired their re-creation in a wide range of artificial intelligence systems for applications such as face recognition, anomaly detection, medical diagnosis and robotic vehicle control(1). Yet before neuron-based brains evolved, complex biomolecular circuits provided individual cells with the 'intelligent' behaviour required for survival(2). However, the study of how molecules can 'think' has not produced an equal variety of computational models and applications of artificial chemical systems. Although biomolecular systems have been hypothesized to carry out neural-network-like computations in vivo(3,2,4) and the synthesis of artificial chemical analogues has been proposed theoretically(5-9), experimental work(10-13) has so far fallen short of fully implementing even a single neuron. Here, building on the richness of DNA computing(14) and strand displacement circuitry(15), we show how molecular systems can exhibit autonomous brain-like behaviours. Using a simple DNA gate architecture(16) that allows experimental scale-up of multilayer digital circuits(17), we systematically transform arbitrary linear threshold circuits(18) (an artificial neural network model) into DNA strand displacement cascades that function as small neural networks. Our approach even allows us to implement a Hopfield associative memory(19) with four fully connected artificial neurons that, after training in silico, remembers four single-stranded DNA patterns and recalls the most similar one when presented with an incomplete pattern. Our results suggest that DNA strand displacement cascades could be used to endow autonomous chemical systems with the capability of recognizing patterns of molecular events, making decisions and responding to the environment.	[Qian, Lulu; Winfree, Erik; Bruck, Jehoshua] CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Winfree, E (corresponding author), CALTECH, Pasadena, CA 91125 USA.	winfree@caltech.edu	Winfree, Erik/L-4002-2013	Winfree, Erik/0000-0002-5899-7523; Bruck, Jehoshua/0000-0001-8474-0812	NSF [0728703, 0832824]; HFSP award [RGY0074/2006-C]	NSF(National Science Foundation (NSF)); HFSP award	We thank P. Rothemund, P. Yin, D. Woods, D. Soloveichik and N. Dabby for comments on the manuscript. We also thank R. Murray for the use of experimental facilities. This work was supported by the NSF (grant nos 0728703 and 0832824 (The Molecular Programming Project)) and by HFSP award no. RGY0074/2006-C.	ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; AMARI S, 1989, NEURAL NETWORKS, V2, P451, DOI 10.1016/0893-6080(89)90043-9; BAUM EB, 1995, SCIENCE, V268, P583, DOI 10.1126/science.7725109; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Fernando CT, 2009, J R SOC INTERFACE, V6, P463, DOI 10.1098/rsif.2008.0344; HAJNAL A, 1993, J COMPUT SYST SCI, V46, P129, DOI 10.1016/0022-0000(93)90001-D; HJELMFELT A, 1991, P NATL ACAD SCI USA, V88, P10983, DOI 10.1073/pnas.88.24.10983; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Kautz W, 1961, IRE T ELECT COMPUTER, VEC-10, P371; Kim J., 2004, ADV NEURAL INFORM PR, V17, P681; Kim J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.119; LAPLANTE JP, 1995, J PHYS CHEM-US, V99, P10063, DOI 10.1021/j100025a001; Lederman H, 2006, BIOCHEMISTRY-US, V45, P1194, DOI 10.1021/bi051871u; Lim HW, 2010, BIOSYSTEMS, V100, P1, DOI 10.1016/j.biosystems.2009.12.001; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02459570; Mills A. P.  Jr, 2001, Soft Computing, V5, P10, DOI 10.1007/s005000000061; Mills AP, 1999, BIOSYSTEMS, V52, P175, DOI 10.1016/S0303-2647(99)00044-1; MJOLSNESS E, 1991, J THEOR BIOL, V152, P429, DOI 10.1016/S0022-5193(05)80391-1; Muller D. E., 1963, SWITCHING THEORY SPA, P289; MUROGA S, 1971, THRESHOLD LOGIC ITS, V18; Pei RJ, 2010, NAT NANOTECHNOL, V5, P773, DOI [10.1038/nnano.2010.194, 10.1038/NNANO.2010.194]; Qian L, 2011, J R SOC INTERFACE, V8, P1281, DOI 10.1098/rsif.2010.0729; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Rojas R., 1996, SYSTEMATIC INTRO, DOI [10.1007/978-3-642-61068-4{\_}7, DOI 10.1007/978-3-642-61068-4]; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Simmel FC, 2007, NANOMEDICINE-UK, V2, P817, DOI 10.2217/17435889.2.6.817; Soloveichik D, 2010, P NATL ACAD SCI USA, V107, P5393, DOI 10.1073/pnas.0909380107; WEGENER I, 1991, THEOR COMPUT SCI, V85, P155, DOI 10.1016/0304-3975(91)90052-4; Zhang DY, 2011, LECT NOTES COMPUT SC, V6518, P176, DOI 10.1007/978-3-642-18305-8_16; Zhang DY, 2011, NAT CHEM, V3, P103, DOI [10.1038/nchem.957, 10.1038/NCHEM.957]	31	633	668	20	601	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 21	2011	475	7356					368	372		10.1038/nature10262	http://dx.doi.org/10.1038/nature10262			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21776082				2022-12-01	WOS:000292911200040
J	Smith, LK; Budd, JLS; Field, DJ; Draper, ES				Smith, Lucy K.; Budd, Judith L. S.; Field, David J.; Draper, Elizabeth S.			Socioeconomic inequalities in outcome of pregnancy and neonatal mortality associated with congenital anomalies: population based study	BRITISH MEDICAL JOURNAL			English	Article							PRENATAL-DIAGNOSIS; PAKISTANI WOMEN; TERMINATION; ATTITUDES; ENGLAND; EUROPE; RATES; OFFER; UK	Objectives To investigate socioeconomic inequalities in outcome of pregnancy and neonatal mortality associated with congenital anomalies. Design Retrospective population based registry study. Setting East Midlands and South Yorkshire regions of England (representing about 10% of births in England and Wales). Participants All registered cases of nine selected congenital anomalies with poor prognostic outcome audited as part of the United Kingdom's fetal anomaly screening programme with an end of pregnancy date between 1 January 1998 and 31 December 2007. Main outcome measures Socioeconomic variation in the risk of selected congenital anomalies; outcome of pregnancy; incidence of live birth and neonatal mortality over time. Deprivation measured with the index of multiple deprivation 2004 at super output area level. Results There were 1579 fetuses registered with one of the nine selected congenital anomalies. There was no evidence of variation in the overall risk of these anomalies with deprivation (rate ratio for the most deprived 10th with the least deprived 10th: 1.05, 95% confidence interval 0.89 to 1.23). The rate ratio varied with type of anomaly and maternal age (deprivation rate ratio adjusted for maternal age: 1.43 (1.17 to 1.74) for non-chromosomal anomalies; 0.85 (0.63 to 1.15) for chromosomal anomalies). Of the nine anomalies, 86% were detected in the antenatal period, and there was no evidence that this varied with deprivation (rate ratio 0.99, 0.84 to 1.17). The rate of termination after antenatal diagnosis of a congenital anomaly was lower in the most deprived areas compared with the least deprived areas (63% v 79%; rate ratio 0.80, 0.65 to 0.97). Consequently there were significant socioeconomic inequalities in the rate of live birth and neonatal mortality associated with the presence of any of these nine anomalies. Compared with the least deprived areas, the most deprived areas had a 61% higher rate of live births (1.61, 1.21 to 2.15) and a 98% higher neonatal mortality rate (1.98, 1.20 to 3.27) associated with a congenital anomaly. Conclusions Antenatal screening for congenital anomalies has reduced neonatal mortality through termination of pregnancy. Socioeconomic variation in decisions regarding termination of pregnancy after antenatal detection, however, has resulted in wide socioeconomic inequalities in liveborn infants with a congenital anomaly and subsequent neonatal mortality.	[Smith, Lucy K.; Budd, Judith L. S.; Field, David J.; Draper, Elizabeth S.] Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England	University of Leicester	Smith, LK (corresponding author), Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England.	lks1@leicester.ac.uk	Smith, Lucy K/S-6593-2019; Draper, Elizabeth/S-6874-2019; Draper, Elizabeth S/I-6304-2018; Smith, Lucy K/I-6300-2018	Smith, Lucy K/0000-0001-9470-0793; Draper, Elizabeth/0000-0001-9340-8176; Draper, Elizabeth S/0000-0001-9340-8176; Smith, Lucy K/0000-0001-9470-0793	NIHR; UK Department of Health's National Institute of Health Research [RM62G0225]; National Institute for Health Research [RP-PG-0407-10029] Funding Source: researchfish	NIHR(National Institute for Health Research (NIHR)); UK Department of Health's National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank members of the NIHR programme grant team: Brad Manktelow, Elaine Boyle, and Julie Faulkes (University of Leicester) for helpful advice and comments throughout the study and Shona Golightly and Anna Springett (Centre for Maternal and Child Enquiries) for help with information on neonatal and infant deaths. We thank all NHS staff who notify cases to the EMSYCAR, Rosemary Pridding and Laura Berry for clerical support, and Martin Perkins for IT support.; This study was funded by UK Department of Health's National Institute of Health Research (RM62G0225). EMSYCAR is funded by the primary care trust in the areas covered by the register. The sponsors had no input in the design, the conduct, the analysis, or the interpretation of the study, and did not influence the manuscript preparation.	Ahmed S, 2006, PRENATAL DIAG, V26, P248, DOI 10.1002/pd.1391; Ahmed Shenaz, 2008, J Genet Couns, V17, P560, DOI 10.1007/s10897-008-9176-x; Alderdice F, 2008, PUBLIC HEALTH, V122, P42, DOI 10.1016/j.puhe.2007.05.004; Arif MO, 2008, PRENATAL DIAG, V28, P1149, DOI 10.1002/pd.2144; Davidson N, 2005, PAEDIATR PERINAT EP, V19, P50, DOI 10.1111/j.1365-3016.2004.00620.x; Dolk H, 2009, LANCET, V374, P378, DOI 10.1016/S0140-6736(09)61411-2; Gagnon A, 2009, J OBSTET GYNAECOL CA, V31, P875, DOI 10.1016/S1701-2163(16)34307-9; Garne E, 2005, ULTRASOUND OBST GYN, V25, P6, DOI 10.1002/uog.1784; Hewison J, 2007, PRENATAL DIAG, V27, P419, DOI 10.1002/pd.1701; Kirwan D, 2010, NHS FETAL ANOMALY SC; Liu SL, 2002, JAMA-J AM MED ASSOC, V287, P1561, DOI 10.1001/jama.287.12.1561; Lumley T, 2006, UW BIOSTATISTICS WOR; Neasham D, 2001, PAEDIATR PERINAT EP, V15, P364, DOI 10.1046/j.1365-3016.2001.0379a.x; Noble M, 2004, INDICES DEPRIVATION; Oakley Laura, 2009, Health Stat Q, P22; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; Olesen C, 2009, SCAND J PUBLIC HEALT, V37, P246, DOI 10.1177/1403494808100938; Rauch ER, 2005, AM J OBSTET GYNECOL, V193, P1492, DOI 10.1016/j.ajog.2005.02.099; Rowe RE, 2004, PUBLIC HEALTH, V118, P177, DOI 10.1016/j.puhe.2003.08.004; Schechtman KB, 2002, OBSTET GYNECOL, V99, P216, DOI 10.1016/S0029-7844(01)01673-8; SMALLWOOD S, 2004, POPUL TRENDS, V20, P6; Smith LK, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6654; van der Pal-de Bruin KM, 2002, PRENATAL DIAG, V22, P966, DOI 10.1002/pd.442; Vrijheid M, 2000, ARCH DIS CHILD, V82, P349, DOI 10.1136/adc.82.5.349; Zeitlin J, 2008, PEDIATRICS, V121, pE936, DOI 10.1542/peds.2007-1620; Zyblewski SC, 2009, PEDIATR CARDIOL, V30, P1105, DOI 10.1007/s00246-009-9514-2	26	47	49	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 19	2011	343								d4306	10.1136/bmj.d4306	http://dx.doi.org/10.1136/bmj.d4306			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	797ZG	21771825	Green Submitted, Green Published, hybrid			2022-12-01	WOS:000293168500010
J	McCartney, M				McCartney, Margaret			The scam of integrative medicine	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 13	2011	343								d4446	10.1136/bmj.d4446	http://dx.doi.org/10.1136/bmj.d4446			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	794OE	21752859				2022-12-01	WOS:000292908900017
J	Goetz, JG; Minguet, S; Navarro-Lerida, I; Lazcano, JJ; Samaniego, R; Calvo, E; Tello, M; Osteso-Ibanez, T; Pellinen, T; Echarri, A; Cerezo, A; Klein-Szanto, AJP; Garcia, R; Keely, PJ; Sanchez-Mateos, P; Cukierman, E; Del Pozo, MA				Goetz, Jacky G.; Minguet, Susana; Navarro-Lerida, Inmaculada; Jose Lazcano, Juan; Samaniego, Rafael; Calvo, Enrique; Tello, Marta; Osteso-Ibanez, Teresa; Pellinen, Teijo; Echarri, Asier; Cerezo, Ana; Klein-Szanto, Andres J. P.; Garcia, Ricardo; Keely, Patricia J.; Sanchez-Mateos, Paloma; Cukierman, Edna; Del Pozo, Miguel A.			Biomechanical Remodeling of the Microenvironment by Stromal Caveolin-1 Favors Tumor Invasion and Metastasis	CELL			English	Article							CELL-MIGRATION; RHO; CANCER; MORPHOGENESIS; FIBROBLASTS; PROGRESSION; EXPRESSION; DEFECTS; ABSENCE; GROWTH	Mechanotransduction is a key determinant of tissue homeostasis and tumor progression. It is driven by intercellular adhesions, cell contractility, and forces generated within the microenvironment and is dependent on extracellular matrix composition, organization, and compliance. We show that caveolin-1 (Cav1) favors cell elongation in three-dimensional cultures and promotes Rho- and force-dependent contraction, matrix alignment, and microenvironment stiffening through regulation of p190RhoGAP. In turn, microenvironment remodeling by Cav1 fibroblasts forces cell elongation. Cav1-deficient mice have disorganized stromal tissue architecture. Stroma associated with human carcinomas and melanoma metastases is enriched in Cav1-expressing carcinoma-associated fibroblasts (CAFs). Cav1 expression in breast CAFs correlates with low survival, and Cav1 depletion in CAFs decreases CAF contractility. Consistently, fibroblast expression of Cav1, through p190RhoGAP regulation, favors directional migration and invasiveness of carcinoma cells in vitro. In vivo, stromal Cav1 remodels peri- and intratumoral microenvironments to facilitate tumor invasion, correlating with increased metastatic potency. Thus, Cav1 modulates tissue responses through force-dependent architectural regulation of the microenvironment.	[Calvo, Enrique] CNIC, Prote Unit, Madrid 28029, Spain; [Samaniego, Rafael; Sanchez-Mateos, Paloma] Hosp Gen Univ Gregorio Maranon, Unidad Microscopi Confocal, Lab Inmunooncol, Madrid 28007, Spain; [Tello, Marta; Garcia, Ricardo] CSIC, Forcetool Grp, Inst Microelect Madrid, Tres Cantos 28760, Spain; [Keely, Patricia J.] Univ Wisconsin, Dept Pharmacol, Mol Biol Lab, Madison, WI 53706 USA; [Klein-Szanto, Andres J. P.; Cukierman, Edna] Canc Biol Program, Philadelphia, PA 19111 USA; [Goetz, Jacky G.; Minguet, Susana; Navarro-Lerida, Inmaculada; Jose Lazcano, Juan; Osteso-Ibanez, Teresa; Pellinen, Teijo; Echarri, Asier; Cerezo, Ana; Del Pozo, Miguel A.] CNIC, Integrin Signaling Lab, Dept Vasc Biol & Inflammat, Madrid 28029, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); General University Gregorio Maranon Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Microelectronica de Madrid (IMM); University of Wisconsin System; University of Wisconsin Madison; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Goetz, JG (corresponding author), Inst Genet & Mol & Cellular Biol, F-67404 Illkirch Graffenstaden, France.	jgoetz@igbmc.fr; madelpozo@cnic.es	Sanchez-Mateos, Paloma/E-8931-2013; Garcia, Ricardo/B-3124-2013; Echarri, Asier/J-5333-2016; cukierman, edna/AAU-8932-2020; Cukierman, Edna/A-3951-2013; Osteso, Teresa/AAD-6364-2021; Samaniego, Rafa/ABE-3558-2021; del Pozo, Miguel Angel/L-2861-2014; GOETZ, Jacky/AAT-1746-2021; Cerezo, Ana/F-4403-2011	Garcia, Ricardo/0000-0002-7115-1928; Echarri, Asier/0000-0002-7314-8087; cukierman, edna/0000-0002-1452-9576; del Pozo, Miguel Angel/0000-0001-9077-391X; GOETZ, Jacky/0000-0003-2842-8116; Sanchez-Mateos, Paloma/0000-0001-6589-4445; Cerezo Montemayor, Ana/0000-0003-0275-0844; Samaniego, Rafael/0000-0002-3081-7332; Navarro-Lerida, Inmaculada/0000-0001-9994-8069; Minguet, Susana/0000-0001-8211-5538; Microelectronica de Madrid, Instituto de/0000-0003-4211-9045; Osteso-Ibanez, Teresa/0000-0003-4247-8734	MICINN (Spanish Ministry of Science and Innovation) [SAF2008-02100, RTICC RD06/0020/1033, CSD2009-00016, SAF2010-1602, MAT2009-08650, CSD2010-00024]; EMBO; European Heads of Research Councils; ESF; NIH/NCI [CA113451]; MICINN; Pro-CNIC Foundation; NATIONAL CANCER INSTITUTE [R01CA114462, R01CA142833, R01CA113451] Funding Source: NIH RePORTER	MICINN (Spanish Ministry of Science and Innovation)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EMBO(European Molecular Biology Organization (EMBO)); European Heads of Research Councils; ESF(European Commission); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Pro-CNIC Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Wethank J. Massague and R. Gomis for luciferase-expressing TCs; F. Sirotnak, M. Kolonin, and A. Schrum for E0771 cells; M. Morente, the CNIO Tumor Bank, and the Spanish National Tumor Bank Network for colon carcinoma TMA; the CNIC Viral Vector Unit for lentivirus; P. Martin and R. Mota for intravenous injection; I. Trevino for help with immunohistochemistry; K. Devarajan for breast TMA statistical analysis; V. Gupta, R. Castello-Cros, and D. Bassi for renal and breast CAF harvesting and immunohistochemistry; A. Alfranca for luciferase vector and advice; M. Montoya for advice on SHG and helpful discussion; F. Sanchez-Cabo for help with statistical analysis; A. U. for brainstorming; X. Bustelo, I.R. Nabi, G. Scita, and P.P. di Fiore for critical reading of the manuscript; and S. Bartlett for editing. This work was supported by grants from the MICINN (Spanish Ministry of Science and Innovation) to M.A.D.P. (SAF2008-02100, RTICC RD06/0020/1033, and CSD2009-00016), P.S.-M. (SAF2010-1602), and R.G. (MAT2009-08650 and CSD2010-00024); by EMBO Young Investigator Programme to M.A.D.P., and by the European Heads of Research Councils and the ESF through a European Young Investigator (EURYI) award to M.A.D.P.; and by NIH/NCI CA113451 and FCCC Kidney Keystone Program grants to E.C. J.G.G. and T.P. are CNIC postdoctoral fellows. S.M. and A.E. are Ramon y Cajal fellows. A.C. is a AECC (Spanish Association against Cancer) fellow. The CNIC is supported by the MICINN and the Pro-CNIC Foundation.	Amatangelo MD, 2005, AM J PATHOL, V167, P475, DOI 10.1016/S0002-9440(10)62991-4; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bustos RI, 2008, CURR BIOL, V18, P1606, DOI 10.1016/j.cub.2008.09.019; Cerezo A, 2009, MOL CELL BIOL, V29, P5046, DOI 10.1128/MCB.00315-09; Chang SH, 2009, AM J PATHOL, V175, P1768, DOI 10.2353/ajpath.2009.090171; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2009, SCIENCE, V324, P208, DOI 10.1126/science.1170107; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Goetz JG, 2008, CANCER METAST REV, V27, P715, DOI 10.1007/s10555-008-9160-9; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Gonzalez-Munoz E, 2009, ENDOCRINOLOGY, V150, P3493, DOI 10.1210/en.2008-1520; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Gratton JP, 2003, CANCER CELL, V4, P31, DOI 10.1016/S1535-6108(03)00168-5; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Mammoto A, 2007, J CELL SCI, V120, P456, DOI 10.1242/jcs.03353; Mammoto T, 2007, J BIOL CHEM, V282, P23910, DOI 10.1074/jbc.M702169200; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Razani B, 2001, J BIOL CHEM, V276, P38121; Ronnov-Jessen L, 2009, TRENDS MOL MED, V15, P5, DOI 10.1016/j.molmed.2008.11.001; Sloan EK, 2009, AM J PATHOL, V174, P2035, DOI 10.2353/ajpath.2009.080924; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Williams TM, 2006, AM J PATHOL, V169, P1784, DOI 10.2353/ajpath.2006.060590; Witkiewicz AK, 2008, CELL CYCLE, V7, P3021, DOI 10.4161/cc.7.19.6719; Witkiewicz AK, 2009, AM J PATHOL, V174, P2023, DOI 10.2353/ajpath.2009.080873; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yang G, 2008, EXP MOL PATHOL, V84, P131, DOI 10.1016/j.yexmp.2007.08.004; Zhao XH, 2007, J CELL SCI, V120, P1801, DOI 10.1242/jcs.001586; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	44	492	502	5	114	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 8	2011	146	1					148	163		10.1016/j.cell.2011.05.040	http://dx.doi.org/10.1016/j.cell.2011.05.040			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729786	Green Accepted, Bronze			2022-12-01	WOS:000292539300013
J	Chowdhury, BA; Seymour, SM; Levenson, MS				Chowdhury, Badrul A.; Seymour, Sally M.; Levenson, Mark S.			Assessing the Safety of Adding LABAs to Inhaled Corticosteroids for Treating Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACTING BETA-AGONISTS		[Chowdhury, Badrul A.; Seymour, Sally M.] US FDA, Ctr Drug Evaluat & Res, Div Pulm Allergy & Rheumatol Prod, Off New Drugs, Silver Spring, MD USA; [Levenson, Mark S.] US FDA, Ctr Drug Evaluat & Res, Off Biostat, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Chowdhury, BA (corresponding author), US FDA, Ctr Drug Evaluat & Res, Div Pulm Allergy & Rheumatol Prod, Off New Drugs, Silver Spring, MD USA.							Chowdhury BA, 2010, NEW ENGL J MED, V362, P1169, DOI 10.1056/NEJMp1002074; Drazen JM, 2009, NEW ENGL J MED, V360, P1671, DOI 10.1056/NEJMe0902057; *FDA, 2010, MARCH 10 11 2010 JOI; Fleming TR, 2008, NEW ENGL J MED, V359, P1400, DOI 10.1056/NEJMe0807372; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15	5	84	87	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2011	364	26					2473	2475		10.1056/NEJMp1104375	http://dx.doi.org/10.1056/NEJMp1104375			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	785AM	21714647				2022-12-01	WOS:000292199800001
J	Choi, J; Wang, DY; Kundu, S; Choliy, Y; Emge, TJ; Krogh-Jespersen, K; Goldman, AS				Choi, Jongwook; Wang, David Y.; Kundu, Sabuj; Choliy, Yuriy; Emge, Thomas J.; Krogh-Jespersen, Karsten; Goldman, Alan S.			Net Oxidative Addition of C(sp(3))-F Bonds to Iridium via Initial C-H Bond Activation	SCIENCE			English	Article							TRANSITION-METAL-COMPLEXES; REDUCTIVE ELIMINATION; FLUORINE; REACTIVITY; CHEMISTRY; MECHANISM; HYDROGEN	Carbon-fluorine bonds are the strongest known single bonds to carbon and as a consequence can prove very hard to cleave. Alhough vinyl and aryl C-F bonds can undergo oxidative addition to transition metal complexes, this reaction has appeared inoperable with aliphatic substrates. We report the addition of C(sp(3))-F bonds (including alkyl-F) to an iridium center via the initial, reversible cleavage of a C-H bond. These results suggest a distinct strategy for the development of catalysts and promoters to make and break C-F bonds, which are of strong interest in the context of both pharmaceutical and environmental chemistry.	[Choi, Jongwook; Wang, David Y.; Kundu, Sabuj; Choliy, Yuriy; Emge, Thomas J.; Krogh-Jespersen, Karsten; Goldman, Alan S.] Rutgers State Univ, Dept Chem & Chem Biol, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick	Krogh-Jespersen, K (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, New Brunswick, NJ 08903 USA.	krogh@rutchem.rutgers.edu; alan.goldman@rutgers.edu	Goldman, Alan/D-9521-2011	Goldman, Alan/0000-0002-2774-710X	NSF [CHE-0719307, CHE-0650456]	NSF(National Science Foundation (NSF))	We thank the NSF (grant CHE-0719307) for support of this work. R. Kondrat (University of California, Riverside) is thanked for obtaining LIFDI spectra and for related discussion. Analytical data were obtained from the Center for Enabling New Technologies Through Catalysis Elemental Analysis Facility at the University of Rochester, funded by NSF CHE-0650456. Metrical parameters for the structure of 4b are available free of charge from the Cambridge Crystallographic Data Centre under reference CCDC-823748.	Amii H, 2009, CHEM REV, V109, P2119, DOI 10.1021/cr800388c; Bourgeois CJ, 2006, ORGANOMETALLICS, V25, P3474, DOI 10.1021/om060267s; BROTHERS PJ, 1988, CHEM REV, V88, P1293, DOI 10.1021/cr00089a014; Cho EJ, 2010, SCIENCE, V328, P1679, DOI 10.1126/science.1190524; Choi J, 2009, J AM CHEM SOC, V131, P15627, DOI 10.1021/ja906930u; COLLMAN JP, 1968, ACCOUNTS CHEM RES, V1, P136, DOI 10.1021/ar50005a002; Cooper AC, 1997, ORGANOMETALLICS, V16, P505, DOI 10.1021/om9605488; de Meijere A., 2004, METAL CATALYZED CROS, DOI 10.1002/9783527619535; Douvris C, 2008, SCIENCE, V321, P1188, DOI 10.1126/science.1159979; Dransfield TA, 2010, J FLUORINE CHEM, V131, P1213, DOI 10.1016/j.jfluchem.2010.05.008; Fawcett J, 2010, DALTON T, V39, P5827, DOI 10.1039/c0dt00066c; Furuya T, 2010, J AM CHEM SOC, V132, P3793, DOI 10.1021/ja909371t; Gomez-Benitez V., 2003, REV SOC QUIM MEX, V47, P124; HALPERN J, 1970, ACCOUNTS CHEM RES, V3, P386, DOI 10.1021/ar50035a004; Hartwig J.F., 2010, ORGANOTRANSITION MET; Huang DJ, 2000, J AM CHEM SOC, V122, P8916, DOI 10.1021/ja001646u; Hughes RP, 2005, J AM CHEM SOC, V127, P15020, DOI 10.1021/ja055166k; Hughes RP, 2009, EUR J INORG CHEM, P4591, DOI 10.1002/ejic.200900816; Jasim NA, 2000, J AM CHEM SOC, V122, P8685, DOI 10.1021/ja0010913; Kanzelberger M, 2000, J AM CHEM SOC, V122, P11017, DOI 10.1021/ja001626s; KIPLINGER JL, 1994, CHEM REV, V94, P373, DOI 10.1021/cr00026a005; Kraft BM, 2010, J FLUORINE CHEM, V131, P1122, DOI 10.1016/j.jfluchem.2010.05.003; McCulloch A, 2003, J FLUORINE CHEM, V123, P21, DOI 10.1016/S0022-1139(03)00105-2; MCMILLEN DF, 1982, ANNU REV PHYS CHEM, V33, P493, DOI 10.1146/annurev.pc.33.100182.002425; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Northcutt TO, 2001, J AM CHEM SOC, V123, P7257, DOI 10.1021/ja003944x; Parkin G, 2009, ACCOUNTS CHEM RES, V42, P315, DOI 10.1021/ar800156h; Perutz RN., 2007, COMPREHENSIVE ORGANO, P725; RACHIDI IE, 1990, NEW J CHEM, V14, P671; Rybtchinski B, 1996, J AM CHEM SOC, V118, P12406, DOI 10.1021/ja962253r; STILLE JK, 1977, ACCOUNTS CHEM RES, V10, P434, DOI 10.1021/ar50120a002; Torrens H, 2005, COORDIN CHEM REV, V249, P1957, DOI 10.1016/j.ccr.2005.01.025; Veltheer JE, 1995, J AM CHEM SOC, V117, P12478, DOI 10.1021/ja00155a012; Vetter AJ, 2009, J AM CHEM SOC, V131, P10742, DOI 10.1021/ja9002316; Vigalok A, 2008, CHEM-EUR J, V14, P5102, DOI 10.1002/chem.200701738; Watson DA, 2009, SCIENCE, V325, P1661, DOI 10.1126/science.1178239; Werkema EL, 2005, J AM CHEM SOC, V127, P7781, DOI 10.1021/ja0504800	37	133	133	7	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 24	2011	332	6037					1545	1548		10.1126/science.1200514	http://dx.doi.org/10.1126/science.1200514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	782EE	21700870				2022-12-01	WOS:000291990000041
J	Su, H; Cheng, YF; Oswald, R; Behrendt, T; Trebs, I; Meixner, FX; Andreae, MO; Cheng, P; Zhang, Y; Poschl, U				Su, Hang; Cheng, Yafang; Oswald, Robert; Behrendt, Thomas; Trebs, Ivonne; Meixner, Franz X.; Andreae, Meinrat O.; Cheng, Peng; Zhang, Yuanhang; Poeschl, Ulrich			Soil Nitrite as a Source of Atmospheric HONO and OH Radicals	SCIENCE			English	Article							NITROUS-ACID; HUMIC-ACID; OXIDE; DEPOSITION; EXCHANGE; DIOXIDE; FOREST; SOOT	Hydroxyl radicals (OH) are a key species in atmospheric photochemistry. In the lower atmosphere, up to similar to 30% of the primary OH radical production is attributed to the photolysis of nitrous acid (HONO), and field observations suggest a large missing source of HONO. We show that soil nitrite can release HONO and explain the reported strength and diurnal variation of the missing source. Fertilized soils with low pH appear to be particularly strong sources of HONO and OH. Thus, agricultural activities and land-use changes may strongly influence the oxidizing capacity of the atmosphere. Because of the widespread occurrence of nitrite-producing microbes, the release of HONO from soil may also be important in natural environments, including forests and boreal regions.	[Su, Hang; Oswald, Robert; Behrendt, Thomas; Trebs, Ivonne; Meixner, Franz X.; Andreae, Meinrat O.; Poeschl, Ulrich] Max Planck Inst Chem, Biogeochem Dept, D-55020 Mainz, Germany; [Cheng, Yafang; Cheng, Peng; Zhang, Yuanhang] Peking Univ, Coll Environm Sci & Engn, SKJ Lab Environm Simulat & Pollut Control, Beijing 100871, Peoples R China; [Cheng, Yafang] Univ Iowa, Ctr Global & Reg Environm Res, Iowa City, IA 52242 USA; [Meixner, Franz X.] Univ Zimbabwe, Dept Phys, Harare, Zimbabwe	Max Planck Society; Peking University; University of Iowa; University of Zimbabwe	Su, H (corresponding author), Max Planck Inst Chem, Biogeochem Dept, D-55020 Mainz, Germany.	h.su@mpic.de; yafang.cheng@gmail.com; u.poschl@mpic.de	Zhang, Yuanhang/F-7038-2011; Pöschl, Ulrich/A-6263-2010; Andreae, Meinrat O./B-1068-2008; Cheng, Yafang/F-9362-2010; Trebs, Ivonne/L-9125-2013; Su, Hang/A-6226-2010; cheng, peng/F-1006-2019	Pöschl, Ulrich/0000-0003-1412-3557; Andreae, Meinrat O./0000-0003-1968-7925; Cheng, Yafang/0000-0003-4912-9879; Su, Hang/0000-0003-4889-1669; cheng, peng/0000-0002-0806-9593; Trebs, Ivonne/0000-0001-5966-4942	Max Planck Society; European Commission [036833-2, 265148]	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Max Planck Society and the European Commission under the projects EUCAARI (grant no. 036833-2) and PEGASOS (grant no. 265148). We gratefully acknowledge X. G. Chi, S. S. Gunthe, M. Shiraiwa, and N. Knothe for comments and discussions.	Acker K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024643; Ammann M, 1998, NATURE, V395, P157, DOI 10.1038/25965; BURNS LC, 1995, SOIL BIOL BIOCHEM, V27, P47, DOI 10.1016/0038-0717(94)00130-S; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; CHAPMAN HD, 1952, SOIL SCI SOC AM PRO, V16, P276, DOI 10.2136/sssaj1952.03615995001600030014x; Cleemput O., 1995, NUTR CYCL AGROECOSYS, V45, P81; De Jeu R. A. M., 2002, P SOC PHOTO-OPT INS, V2002, P184; Dibb JE, 2002, ATMOS ENVIRON, V36, P2501, DOI 10.1016/S1352-2310(02)00130-9; Finlayson-Pitts BJ, 2003, PHYS CHEM CHEM PHYS, V5, P223, DOI 10.1039/b208564j; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Kleffmann J, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022524; Kleffmann J, 2007, CHEMPHYSCHEM, V8, P1137, DOI 10.1002/cphc.200700016; Lammel G, 1996, CHEM SOC REV, V25, P361, DOI 10.1039/cs9962500361; Ludwig J, 2001, BIOGEOCHEMISTRY, V52, P225, DOI 10.1023/A:1006424330555; Monge ME, 2010, P NATL ACAD SCI USA, V107, P6605, DOI 10.1073/pnas.0908341107; O'Connor G.A., 2001, SOIL SCI, DOI [10.1097/00010694-198006000-00010, DOI 10.1097/00010694-198006000-00010]; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; Ren X, 2010, ATMOS CHEM PHYS, V10, P6283, DOI 10.5194/acp-10-6283-2010; Ren XR, 2003, ATMOS ENVIRON, V37, P3639, DOI 10.1016/S1352-2310(03)00459-X; Seinfeld J. H, 2006, ATMOSPHERIC CHEM PHY; Sorgel M, 2011, ATMOS CHEM PHYS, V11, P841, DOI 10.5194/acp-11-841-2011; Stemmler K, 2007, ATMOS CHEM PHYS, V7, P4237, DOI 10.5194/acp-7-4237-2007; Stemmler K, 2006, NATURE, V440, P195, DOI 10.1038/nature04603; Stutz J, 2010, ATMOS ENVIRON, V44, P4090, DOI 10.1016/j.atmosenv.2009.02.003; Su H, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009060; Trebs I, 2006, ATMOS CHEM PHYS, V6, P447, DOI 10.5194/acp-6-447-2006; Venterea RT, 2000, GLOBAL CHANGE BIOL, V6, P303, DOI 10.1046/j.1365-2486.2000.00309.x; Zhang N, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038999	28	316	336	17	521	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2011	333	6049					1616	1618		10.1126/science.1207687	http://dx.doi.org/10.1126/science.1207687			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21852453				2022-12-01	WOS:000294900900039
J	Efremov, RG; Sazanov, LA				Efremov, Rouslan G.; Sazanov, Leonid A.			Structure of the membrane domain of respiratory complex I	NATURE			English	Article							NADH-QUINONE OXIDOREDUCTASE; ESCHERICHIA-COLI NDH-1; UBIQUINONE OXIDOREDUCTASE; PROTON TRANSLOCATION; CRYSTAL-STRUCTURE; SUBUNIT; MODEL; RESIDUES; SENSITIVITY; ANTIPORTER	Complex I is the first and largest enzyme of the respiratory chain, coupling electron transfer between NADH and ubiquinone to the translocation of four protons across the membrane. It has a central role in cellular energy production and has been implicated in many human neurodegenerative diseases. The L-shaped enzyme consists of hydrophilic and membrane domains. Previously, we determined the structure of the hydrophilic domain. Here we report the crystal structure of the Esherichia coli complex I membrane domain at 3.0 angstrom resolution. It includes six subunits, NuoL, NuoM, NuoN, NuoA, NuoJ and NuoK, with 55 transmembrane helices. The fold of the homologous antiporter-like subunits L, M and N is novel, with two inverted structural repeats of five transmembrane helices arranged, unusually, face-to-back. Each repeat includes a discontinuous transmembrane helix and forms half of a channel across the membrane. A network of conserved polar residues connects the two half-channels, completing the proton translocation pathway. Unexpectedly, lysines rather than carboxylate residues act as the main elements of the proton pump in these subunits. The fourth probable proton-translocation channel is at the interface of subunits N, K, J and A. The structure indicates that proton translocation in complex I, uniquely, involves coordinated conformational changes in six symmetrical structural elements.	[Efremov, Rouslan G.; Sazanov, Leonid A.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England		Sazanov, LA (corresponding author), MRC, Mitochondrial Biol Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	sazanov@mrc-mbu.cam.ac.uk	Efremov, Rouslan/P-9085-2015; Sazanov, Leonid A/ABF-2125-2021	Efremov, Rouslan/0000-0001-7516-8658; Sazanov, Leonid A/0000-0002-0977-7989	Medical Research Council; Medical Research Council [MC_U105674180] Funding Source: researchfish; MRC [MC_U105674180] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council. We thank the ESRF and the SLS for provision of synchrotron radiation facilities. Weare grateful to the staff of beamlines ID29 (ESRF) and X06SA (SLS) for assistance.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Amarneh B, 2003, BIOCHEMISTRY-US, V42, P4800, DOI 10.1021/bi0340346; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Baranova EA, 2007, J MOL BIOL, V366, P140, DOI 10.1016/j.jmb.2006.11.026; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cooley RB, 2010, J MOL BIOL, V404, P232, DOI 10.1016/j.jmb.2010.09.034; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Euro L, 2008, BBA-BIOENERGETICS, V1777, P1166, DOI 10.1016/j.bbabio.2008.06.001; FEARNLEY IM, 1992, BIOCHIM BIOPHYS ACTA, V1140, P105, DOI 10.1016/0005-2728(92)90001-I; Fisher N, 2000, J MOL BIOL, V296, P1153, DOI 10.1006/jmbi.2000.3509; Friedrich T, 2001, J BIOENERG BIOMEMBR, V33, P169, DOI 10.1023/A:1010722717257; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kao MC, 2005, BIOCHEMISTRY-US, V44, P9545, DOI 10.1021/bi050708w; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; Kervinen M, 2004, BIOCHEMISTRY-US, V43, P773, DOI 10.1021/bi0355903; KRISHNAMOORTHY G, 1988, J BIOL CHEM, V263, P17566; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEIF H, 1995, EUR J BIOCHEM, V230, P538, DOI 10.1111/j.1432-1033.1995.tb20594.x; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; Mathiesen C, 2003, FEBS LETT, V549, P7, DOI 10.1016/S0014-5793(03)00767-1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017420; Morino M, 2010, J BIOL CHEM, V285, P30942, DOI 10.1074/jbc.M110.118661; Nakamaru-Ogiso E, 2003, BIOCHEMISTRY-US, V42, P746, DOI 10.1021/bi0269660; Nakamaru-Ogiso E, 2010, J BIOL CHEM, V285, P39070, DOI 10.1074/jbc.M110.157826; Ohnishi ST, 2010, BBA-BIOENERGETICS, V1797, P1891, DOI 10.1016/j.bbabio.2010.06.010; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Ohnishi T, 2010, FEBS LETT, V584, P4131, DOI 10.1016/j.febslet.2010.08.039; Patsi J, 2008, BIOCHEM J, V409, P129, DOI 10.1042/BJ20070866; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2003, J BIOL CHEM, V278, P19483, DOI 10.1074/jbc.M208959200; Sazanov LA, 2007, BIOCHEMISTRY-US, V46, P2275, DOI 10.1021/bi602508x; Schapira AHV, 1998, BBA-BIOENERGETICS, V1364, P261, DOI 10.1016/S0005-2728(98)00032-2; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Steimle S, 2011, BIOCHEMISTRY-US, V50, P3386, DOI 10.1021/bi200264q; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200; Treberg JR, 2011, J BIOL CHEM, V286, P17579, DOI 10.1074/jbc.M111.227751; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vik SB, 2011, FEBS LETT, V585, P1180, DOI 10.1016/j.febslet.2011.03.029; Vinothkumar KR, 2010, Q REV BIOPHYS, V43, P65, DOI 10.1017/S0033583510000041; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpps.20, 10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Yip CY, 2011, J BIOL CHEM, V286, P5023, DOI 10.1074/jbc.M110.194993	60	280	282	3	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2011	476	7361					414	U62		10.1038/nature10330	http://dx.doi.org/10.1038/nature10330			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811KT	21822288				2022-12-01	WOS:000294209400028
J	Gardner, MK; Charlebois, BD; Janosi, IM; Howard, J; Hunt, AJ; Odde, DJ				Gardner, Melissa K.; Charlebois, Blake D.; Janosi, Imre M.; Howard, Jonathon; Hunt, Alan J.; Odde, David J.			Rapid Microtubule Self-Assembly Kinetics	CELL			English	Article							REAL-TIME OBSERVATIONS; DYNAMIC INSTABILITY; LIVING CELLS; PROTEIN; TUBULIN; GROWTH; ENDS; ELONGATION; RESOLUTION; XMAP215	Microtubule assembly is vital for many fundamental cellular processes. Current models for microtubule assembly kinetics assume that the subunit dissociation rate from a microtubule tip is independent of free subunit concentration. Total-Internal-Reflection-Fluorescence (TIRF) microscopy experiments and data from a laser tweezers assay that measures in vitro microtubule assembly with nanometer resolution, provides evidence that the subunit dissociation rate from a microtubule tip increases as the free subunit concentration increases. These data are consistent with a two-dimensional model for microtubule assembly, and are explained by a shift in microtubule tip structure from a relatively blunt shape at low free concentrations to relatively tapered at high free concentrations. We find that because both the association and the dissociation rates increase at higher free subunit concentrations, the kinetics of microtubule assembly are an order-of magnitude higher than currently estimated in the literature.	[Charlebois, Blake D.; Hunt, Alan J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Gardner, Melissa K.; Odde, David J.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Gardner, Melissa K.; Howard, Jonathon] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Gardner, Melissa K.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Janosi, Imre M.] Eotvos Lorand Univ, Dept Phys Complex Syst, Budapest, Hungary	University of Michigan System; University of Michigan; University of Minnesota System; University of Minnesota Twin Cities; Max Planck Society; University of Minnesota System; University of Minnesota Twin Cities; Eotvos Lorand University	Hunt, AJ (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	ajhunt@umich.edu; oddex002@umn.edu	Howard, Jonathon/D-4229-2011; Jánosi, Imre M./H-4096-2017; Odde, David/AAY-1720-2020; Howard, Jonathon/J-7492-2016; Odde, David/H-4925-2011	Howard, Jonathon/0000-0003-0086-1196; Jánosi, Imre M./0000-0002-3705-5748; Odde, David/0000-0001-7731-2799; Howard, Jonathon/0000-0003-0086-1196; 	National Institutes of Health (NIH) [GM076177, GM071522]; National Science Foundation (NSF) [615568]; Whitaker International Scholar Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071522, R01GM076177] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Whitaker International Scholar Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dominique Seetapun and Dr. Chris Gell for technical assistance. We thank Aleksey Demchouk for providing the microtubule tip tracking code. The LLC-PK1 alpha strain was kindly provided by Dr. Pat Wadsworth. This work was supported by National Institutes of Health (NIH) GM076177 to A.J.H. and D.J.O, NIH GM071522 to D.J.O, and National Science Foundation (NSF) 615568 to D.J.O. M. K. G. was supported in part by a Whitaker International Scholar Fellowship. The collaboration was supported by the Institute for Mathematics and Its Applications (IMA) at the University of Minnesota.	Bakhoum SF, 2009, CURR BIOL, V19, P1937, DOI 10.1016/j.cub.2009.09.055; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Cannon MJ, 2004, ANAL BIOCHEM, V328, P67, DOI 10.1016/j.ab.2004.01.014; CASSIMERIS L, 1988, J CELL BIOL, V107, P2223, DOI 10.1083/jcb.107.6.2223; Charlebois BD, 2010, METHOD CELL BIOL, V95, P207, DOI 10.1016/S0091-679X(10)95012-7; Charrasse S, 1998, J CELL SCI, V111, P1371; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Demchouk AO, 2011, CELL MOL BIOENG, V4, P192, DOI 10.1007/s12195-010-0155-6; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Gardner MK, 2008, CELL, V135, P894, DOI 10.1016/j.cell.2008.09.046; HILL TL, 1986, BIOPHYS J, V49, P1017, DOI 10.1016/S0006-3495(86)83730-4; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MITCHISON TJ, 1987, CELL BIOPHYS, V11, P35, DOI 10.1007/BF02797111; MURPHY DB, 1977, J MOL BIOL, V117, P33, DOI 10.1016/0022-2836(77)90021-3; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; OOSAWA F, 1970, J THEOR BIOL, V27, P69, DOI 10.1016/0022-5193(70)90129-3; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; PRYER NK, 1992, J CELL SCI, V103, P965; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; Schek HT, 2007, CURR BIOL, V17, P1445, DOI 10.1016/j.cub.2007.07.011; SHELDEN E, 1993, J CELL BIOL, V120, P935, DOI 10.1083/jcb.120.4.935; SKELLAM JG, 1946, J ROY STAT SOC A STA, V109, P296, DOI 10.2307/2981372; Stiffler LA, 1999, DEVELOPMENT, V126, P5505; Stukalin EB, 2004, J CHEM PHYS, V121, P1097, DOI 10.1063/1.1759316; VanBuren V, 2005, BIOPHYS J, V89, P2911, DOI 10.1529/biophysj.105.060913; VanBuren V, 2002, P NATL ACAD SCI USA, V99, P6035, DOI 10.1073/pnas.092504999; VASQUEZ RJ, 1994, J CELL BIOL, V127, P985, DOI 10.1083/jcb.127.4.985; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601	33	150	151	1	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 19	2011	146	4					582	592		10.1016/j.cell.2011.06.053	http://dx.doi.org/10.1016/j.cell.2011.06.053			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21854983	Green Accepted, Bronze			2022-12-01	WOS:000294043600013
J	Ward, JW; Averhoff, FM; Koh, HK				Ward, John W.; Averhoff, Francisco M.; Koh, Howard K.			World Hepatitis Day: a new era for hepatitis control	LANCET			English	Editorial Material									[Ward, John W.; Averhoff, Francisco M.] Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA 30333 USA; [Ward, John W.; Averhoff, Francisco M.; Koh, Howard K.] US Dept Hlth & Human Serv, Off Secretary, Washington, DC 20201 USA	Centers for Disease Control & Prevention - USA	Ward, JW (corresponding author), Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA 30333 USA.	jward@cdc.gov						Blumberg BS, 2002, HEPATITIS B HUNT KIL; *CDCP, 2011, 2009 AD VACC COV NHI; Dumolard L., 2008, Morbidity and Mortality Weekly Report, V57, P1249; *GAVI ALL, 2011, HEP B VACC; Hauri AM, 2004, INT J STD AIDS, V15, P7, DOI 10.1258/095646204322637182; Hu DJ., 2010, ATLAS SEXUALLY TRANS, P203; Jensen DM, 2011, NEW ENGL J MED, V364, P1272, DOI 10.1056/NEJMe1100829; OraSure Technologies Inc., 2011, ORAQUICK HCV RAP ANT; US Department of Health Human Services, 2011, COMB SIL EP VIR HEP; WHO, 2010, VIR HEP REP SECR; World Health Organization (WHO), 2011, IMM SURV ASS MON; Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6; 2006, C RECORD MAKING SAFE	13	8	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 13	2011	378	9791					552	553		10.1016/S0140-6736(11)60839-8	http://dx.doi.org/10.1016/S0140-6736(11)60839-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	812UX	21802132				2022-12-01	WOS:000294319500009
J	Hu, YL; Lee, CC; Ribbe, MW				Hu, Yilin; Lee, Chi Chung; Ribbe, Markus W.			Extending the Carbon Chain: Hydrocarbon Formation Catalyzed by Vanadium/Molybdenum Nitrogenases	SCIENCE			English	Article							FISCHER-TROPSCH SYNTHESIS; AZOTOBACTER-VINELANDII; VANADIUM NITROGENASE; D2O; MECHANISM; PROTEIN	In a small-scale reaction, vanadium-dependent nitrogenase has previously been shown to catalyze reductive catenation of carbon monoxide (CO) to ethylene, ethane, propylene, and propane. Here, we report the identification of additional hydrocarbon products [alpha-butylene, n-butane, and methane (CH4)] in a scaled-up reaction featuring 20 milligrams of vanadium-iron protein, the catalytic component of vanadium nitrogenase. Additionally, we show that the more common molybdenum-dependent nitrogenase can generate the same hydrocarbons from CO, although CH4 was not detected. The identification of CO as a substrate for both molybdenum-and vanadium-nitrogenases strengthens the hypothesis that CO reduction is an evolutionary relic of the function of the nitrogenase family. Moreover, the comparison between the CO-reducing capacities of the two nitrogenases suggests that the identity of heterometal at the active cofactor site affects the efficiency and product distribution of this reaction.	[Hu, Yilin; Lee, Chi Chung; Ribbe, Markus W.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Hu, YL (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	yilinh@uci.edu; mribbe@uci.edu			Herman Frasch Foundation [617-HF07]; NIH [GM 67626]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067626] Funding Source: NIH RePORTER	Herman Frasch Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. C. Rees and N. Dalleska of the California Institute of Technology (Pasadena, CA) for help with the GC-MS analysis. This work was supported by Herman Frasch Foundation grant 617-HF07 (M.W.R.) and NIH grant GM 67626 (M.W.R.).	Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; BURGESS BK, 1980, BIOCHIM BIOPHYS ACTA, V614, P196, DOI 10.1016/0005-2744(80)90180-1; CARNAHAN EM, 1993, ACCOUNTS CHEM RES, V26, P90, DOI 10.1021/ar00027a003; CASSMAN M, 1974, ARCH BIOCHEM BIOPHYS, V165, P60, DOI 10.1016/0003-9861(74)90141-6; Churchill DG, 2003, J AM CHEM SOC, V125, P1403, DOI 10.1021/ja027670k; Hales B J, 1990, Adv Inorg Biochem, V8, P165; KARSTEN WE, 1995, J AM CHEM SOC, V117, P5914, DOI 10.1021/ja00127a002; Khodadadi AA, 1996, CAN J CHEM ENG, V74, P695, DOI 10.1002/cjce.5450740520; Kurtz KA, 1997, J AM CHEM SOC, V119, P1155, DOI 10.1021/ja962783n; Lee CC, 2011, ANGEW CHEM INT EDIT, V50, P5545, DOI 10.1002/anie.201100869; Lee CC, 2010, SCIENCE, V329, P642, DOI 10.1126/science.1191455; Lee CC, 2009, P NATL ACAD SCI USA, V106, P9209, DOI 10.1073/pnas.0904408106; MORGAN TV, 1990, BIOCHEMISTRY-US, V29, P3077, DOI 10.1021/bi00464a026; ROFERDEPOORTER CK, 1981, CHEM REV, V81, P447, DOI 10.1021/cr00045a002; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; Sheu SY, 2008, J PHYS CHEM A, V112, P797, DOI 10.1021/jp0771668; Yang ZY, 2011, J BIOL CHEM, V286, P19417, DOI 10.1074/jbc.M111.229344	17	165	165	3	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2011	333	6043					753	755		10.1126/science.1206883	http://dx.doi.org/10.1126/science.1206883			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817053	Green Accepted			2022-12-01	WOS:000293512100042
J	Poelwijk, FJ; de Vos, MGJ; Tans, SJ				Poelwijk, Frank J.; de Vos, Marjon G. J.; Tans, Sander J.			Tradeoffs and Optimality in the Evolution of Gene Regulation	CELL			English	Article							LAC REPRESSOR; PHENOTYPIC PLASTICITY; ESCHERICHIA-COLI; EXPRESSION	Cellular regulation is believed to evolve in response to environmental variability. However, this has been difficult to test directly. Here, we show that a gene regulation system evolves to the optimal regulatory response when challenged with variable environments. We engineered a genetic module subject to regulation by the lac repressor (LacI) in E. coli, whose expression is beneficial in one environmental condition and detrimental in another. Measured tradeoffs in fitness between environments predict the competition between regulatory phenotypes. We show that regulatory evolution in adverse environments is delayed at specific boundaries in the phenotype space of the regulatory LacI protein. Once this constraint is relieved by mutation, adaptation proceeds toward the optimum, yielding LacI with an altered allosteric mechanism that enables an opposite response to its regulatory ligand IPTG. Our results indicate that regulatory evolution can be understood in terms of tradeoff optimization theory.	[Poelwijk, Frank J.; de Vos, Marjon G. J.; Tans, Sander J.] AMOLF Inst, NL-1098 XG Amsterdam, Netherlands	AMOLF	Tans, SJ (corresponding author), AMOLF Inst, Sci Pk 104, NL-1098 XG Amsterdam, Netherlands.	tans@amolf.nl	Tans, Sander/AAS-2901-2020	Poelwijk, Frank/0000-0002-5696-4357; de Vos, Marjon GJ/0000-0003-0601-908X	Nederlandse Organisatie voor Wetenschappelijke Onderzoek (NWO)	Nederlandse Organisatie voor Wetenschappelijke Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO))	We thank Kathleen S. Matthews for kindly providing the BLIM cells and pTara plasmid for our expression of the lac repressors. We thank Kim Renders and Roland Dries for technical assistance and Bertus Beaumont, Tom Shimizu, Ron Milo, and members of the Tans and ten Wolde groups for critical reading of the manuscript. We thank Walraj Gosal and other members of the Ranganathan lab for help with lac repressor purification. This work is part of the research program of the Stichting voor Fundamenteel Onderzoek der Materie (FOM), which is financially supported by the Nederlandse Organisatie voor Wetenschappelijke Onderzoek (NWO).	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Benner SA, 2005, NAT REV GENET, V6, P533, DOI 10.1038/nrg1637; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CHAMNESS GC, 1970, J MOL BIOL, V53, P561, DOI 10.1016/0022-2836(70)90084-7; CHOI KY, 1992, J BACTERIOL, V174, P6207, DOI 10.1128/JB.174.19.6207-6214.1992; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Cooper TF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040035; DeWitt T., 2004, PHENOTYPIC PLASTICIT, DOI DOI 10.1007/s10071-016-1007-0; Flynn TC, 2003, PROTEIN SCI, V12, P2523, DOI 10.1110/ps.03188303; GAY P, 1985, J BACTERIOL, V164, P918, DOI 10.1128/JB.164.2.918-921.1985; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Isalan M, 2008, NATURE, V452, P840, DOI 10.1038/nature06847; LEVINS RICHARD, 1968; Lunzer M, 2005, SCIENCE, V310, P499, DOI 10.1126/science.1115649; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; MADAN BM, 2003, NUCLEIC ACIDS RES, V31, P1234, DOI DOI 10.1093/NAR/GKG210; MILLER JH, 1979, J MOL BIOL, V131, P223, DOI 10.1016/0022-2836(79)90074-3; Miller SP, 2006, SCIENCE, V314, P458, DOI 10.1126/science.1133479; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; PFAHL M, 1976, J MOL BIOL, V106, P857, DOI 10.1016/0022-2836(76)90269-2; PIGLIUCCI M, 2001, SYN ECO EVO, pR13; Poelwijk FJ, 2007, NATURE, V445, P383, DOI 10.1038/nature05451; ROFF DA, 2001, LIFE HIST EVOLUTION; Sawaragi Y., 1985, THEORY MULTIOBJECTIV; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Scheiner SM, 2002, J EVOLUTION BIOL, V15, P889, DOI 10.1046/j.1420-9101.2002.00468.x; SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425; Suckow J, 1996, J MOL BIOL, V261, P509, DOI 10.1006/jmbi.1996.0479; Suiter AM, 2003, P NATL ACAD SCI USA, V100, P12782, DOI 10.1073/pnas.2134994100; True JR, 2002, ANNU REV CELL DEV BI, V18, P53, DOI 10.1146/annurev.cellbio.18.020402.140619; vanTienderen PH, 1997, EVOLUTION, V51, P1372, DOI [10.1111/j.1558-5646.1997.tb01460.x, 10.2307/2411189]; VASI F, 1994, AM NAT, V144, P432, DOI 10.1086/285685; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103; Wycuff DR, 2000, ANAL BIOCHEM, V277, P67, DOI 10.1006/abio.1999.4385; Zhan HL, 2010, BIOCHEMISTRY-US, V49, P8636, DOI 10.1021/bi101106x	41	83	85	2	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 5	2011	146	3					462	470		10.1016/j.cell.2011.06.035	http://dx.doi.org/10.1016/j.cell.2011.06.035			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	803GT	21802129	Green Submitted, Bronze			2022-12-01	WOS:000293570500019
J	Matson, CK; Murphy, MW; Sarver, AL; Griswold, MD; Bardwell, VJ; Zarkower, D				Matson, Clinton K.; Murphy, Mark W.; Sarver, Aaron L.; Griswold, Michael D.; Bardwell, Vivian J.; Zarkower, David			DMRT1 prevents female reprogramming in the postnatal mammalian testis	NATURE			English	Article							DM-DOMAIN GENE; SEX DETERMINATION; OVARIAN FAILURE; FOXL2; DIFFERENTIATION; EXPRESSION; MOUSE; SOX9	Sex in mammals is determined in the fetal gonad by the presence or absence of the Y chromosome gene Sry, which controls whether bipotential precursor cells differentiate into testicular Sertoli cells or ovarian granulosa cells(1). This pivotal decision in a single gonadal cell type ultimately controls sexual differentiation throughout the body. Sex determination can be viewed as a battle for primacy in the fetal gonad between a male regulatory gene network in which Sry activates Sox9 and a female network involving WNT/beta-catenin signalling(2). In females the primary sex-determining decision is not final: loss of the FOXL2 transcription factor in adult granulosa cells can reprogram granulosa cells into Sertoli cells(2). Here we show that sexual fate is also surprisingly labile in the testis: loss of the DMRT1 transcription factor(3) in mouse Sertoli cells, even in adults, activates Foxl2 and reprograms Sertoli cells into granulosa cells. In this environment, theca cells form, oestrogen is produced and germ cells appear feminized. Thus Dmrt1 is essential to maintain mammalian testis determination, and competing regulatory networks maintain gonadal sex long after the fetal choice between male and female. Dmrt1 and Foxl2 are conserved throughout vertebrates(4,5) and Dmrt1-related sexual regulators are conserved throughout metazoans(3). Antagonism between Dmrt1 and Foxl2 for control of gonadal sex may therefore extend beyond mammals. Reprogramming due to loss of Dmrt1 also may help explain the aetiology of human syndromes linked to DMRT1, including disorders of sexual differentiation(6) and testicular cancer(7).	[Matson, Clinton K.; Murphy, Mark W.; Bardwell, Vivian J.; Zarkower, David] Univ Minnesota, Ctr Dev Biol, Minneapolis, MN 55455 USA; [Matson, Clinton K.; Murphy, Mark W.; Bardwell, Vivian J.; Zarkower, David] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Matson, Clinton K.; Bardwell, Vivian J.; Zarkower, David] Univ Minnesota, Mol Cellular Dev Biol & Genet Grad Program, Minneapolis, MN 55455 USA; [Sarver, Aaron L.; Bardwell, Vivian J.; Zarkower, David] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Griswold, Michael D.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Washington State University	Zarkower, D (corresponding author), Univ Minnesota, Ctr Dev Biol, Minneapolis, MN 55455 USA.	bardw001@umn.edu; zarko001@umn.edu			NIH [GM59152]; Minnesota Medical Foundation; NSF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD010808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059152] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Medical Foundation; NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Treier for helpful discussion, K. Hatzi, A. Minkina, A. Peterson, the University of Minnesota Mouse Genetics Laboratory and C. Small for technical assistance, J. Dean, R. Veitia and K.-i. Morohashi for antibodies, D. Greenstein and A. M. Weber-Main for comments on the manuscript, C. Manivel for histology expertise, M. Steffes and D. Gabrielson for oestradiol analysis, and the University of Minnesota Supercomputing Institute for computational resources. This work was funded by the NIH (GM59152), the Minnesota Medical Foundation, and a predoctoral fellowship from the NSF (to C.K.M.).	Barrionuevo F, 2009, DEV BIOL, V327, P301, DOI 10.1016/j.ydbio.2008.12.011; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; Chang H, 2008, DEVELOPMENT, V135, P1875, DOI 10.1242/dev.018572; Cocquet J, 2005, GENOMICS, V85, P531, DOI 10.1016/j.ygeno.2005.01.007; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Duggavathi R, 2008, GENE DEV, V22, P1871, DOI 10.1101/gad.472008; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fahrioglu U, 2007, SEX DEV, V1, P42, DOI 10.1159/000096238; Kim S, 2007, DEV BIOL, V307, P314, DOI 10.1016/j.ydbio.2007.04.046; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Krentz AD, 2009, P NATL ACAD SCI USA, V106, P22323, DOI 10.1073/pnas.0905431106; Loffler KA, 2003, ENDOCRINOLOGY, V144, P3237, DOI 10.1210/en.2002-0095; Matson CK, 2010, DEV CELL, V19, P612, DOI 10.1016/j.devcel.2010.09.010; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Murphy MW, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-58; Murphy MW, 2010, P NATL ACAD SCI USA, V107, P13360, DOI 10.1073/pnas.1006243107; Orisaka M, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-9; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Raymond CS, 1999, DEV BIOL, V215, P208, DOI 10.1006/dbio.1999.9461; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Tannour-Louet M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015392; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yoshimoto S, 2008, P NATL ACAD SCI USA, V105, P2469, DOI 10.1073/pnas.0712244105	31	400	421	2	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2011	476	7358					101	+		10.1038/nature10239	http://dx.doi.org/10.1038/nature10239			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NR	21775990	Green Accepted			2022-12-01	WOS:000293447300038
J	Liu, X; Bushnell, DA; Silva, DA; Huang, XH; Kornberg, RD				Liu, Xin; Bushnell, David A.; Silva, Daniel-Adriano; Huang, Xuhui; Kornberg, Roger D.			Initiation Complex Structure and Promoter Proofreading	SCIENCE			English	Article							RNA-POLYMERASE-II; START SITE UTILIZATION; TRANSCRIPTION INITIATION; ABORTIVE INITIATION; ELONGATION COMPLEX; IN-VITRO; MECHANISM; STEPS; TFIIB; PREINITIATION	The initiation of transcription by RNA polymerase II is a multistage process. X-ray crystal structures of transcription complexes containing short RNAs reveal three structural states: one with 2- and 3-nucleotide RNAs, in which only the 3'-end of the RNA is detectable; a second state with 4- and 5-nucleotide RNAs, with an RNA-DNA hybrid in a grossly distorted conformation; and a third state with RNAs of 6 nucleotides and longer, essentially the same as a stable elongating complex. The transition from the first to the second state correlates with a markedly reduced frequency of abortive initiation. The transition from the second to the third state correlates with partial "bubble collapse" and promoter escape. Polymerase structure is permissive for abortive initiation, thereby setting a lower limit on polymerase-promoter complex lifetime and allowing the dissociation of nonspecific complexes. Abortive initiation may be viewed as promoter proofreading, and the structural transitions as checkpoints for promoter control.	[Liu, Xin; Bushnell, David A.; Kornberg, Roger D.] Stanford Univ, Dept Struct Biol, Sch Med, Stanford, CA 94305 USA; [Silva, Daniel-Adriano; Huang, Xuhui] Hong Kong Univ Sci & Technol, Dept Chem, Kowloon, Hong Kong, Peoples R China	Stanford University; Hong Kong University of Science & Technology	Kornberg, RD (corresponding author), Stanford Univ, Dept Struct Biol, Sch Med, Stanford, CA 94305 USA.	kornberg@stanford.edu	Huang, Xuhui/ABE-3207-2021	Huang, Xuhui/0000-0002-7119-9358; Silva Manzano, Daniel/0000-0002-3195-9009	NIH [GM049985, AI21144]; Jane Coffin Childs Memorial Fund; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources; National Institute of General Medical Sciences; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036659, R01GM049985] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund; Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grants GM049985 and AI21144 (R. D. K.) and by a Jane Coffin Childs Memorial Fund fellowship (X. L.). Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory, a national user facility operated by Stanford University on behalf of the U. S. Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357. Computing resources were provided by Dawning TC5000 supercomputing cluster, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences. Coordinates and structure factors have been deposited at the Protein Data Bank under accession codes 3RZO, 3RZD, 3S14, 3S15, 3S16, 3S17, 3S1M, 3S1N, 3S2H, 3S2D, 3S1Q, and 3S1R (see table S2).	Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; CAI H, 1987, J BIOL CHEM, V262, P298; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Domecq C, 2010, PROTEIN EXPRES PURIF, V69, P83, DOI 10.1016/j.pep.2009.06.016; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Keene RG, 1999, J BIOL CHEM, V274, P11526, DOI 10.1074/jbc.274.17.11526; Kennedy WP, 2007, J MOL BIOL, V370, P256, DOI 10.1016/j.jmb.2007.03.041; Khaperskyy DA, 2008, MOL CELL BIOL, V28, P3757, DOI 10.1128/MCB.02272-07; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Kugel JF, 2002, MOL CELL BIOL, V22, P762, DOI 10.1128/MCB.22.3.762-773.2002; Kugel JF, 2000, J BIOL CHEM, V275, P40483, DOI 10.1074/jbc.M006401200; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; LUSE DS, 1987, J BIOL CHEM, V262, P289; Majovski RC, 2005, J BIOL CHEM, V280, P34917, DOI 10.1074/jbc.M502932200; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Pal M, 2002, MOL CELL BIOL, V22, P30, DOI 10.1128/MCB.22.1.30-40.2002; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Yan M, 1997, EMBO J, V16, P7457, DOI 10.1093/emboj/16.24.7457; Yan M, 1999, J BIOL CHEM, V274, P34819, DOI 10.1074/jbc.274.49.34819	24	46	47	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2011	333	6042					633	637		10.1126/science.1206629	http://dx.doi.org/10.1126/science.1206629			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21798951	Green Accepted			2022-12-01	WOS:000293222400063
J	Eagle, RA; Tutken, T; Martin, TS; Tripati, AK; Fricke, HC; Connely, M; Cifelli, RL; Eiler, JM				Eagle, Robert A.; Tuetken, Thomas; Martin, Taylor S.; Tripati, Aradhna K.; Fricke, Henry C.; Connely, Melissa; Cifelli, Richard L.; Eiler, John M.			Dinosaur Body Temperatures Determined from Isotopic (C-13-O-18) Ordering in Fossil Biominerals	SCIENCE			English	Article							ENDOTHERMY; GROWTH; THERMOREGULATION; HISTOLOGY; EVOLUTION	The nature of the physiology and thermal regulation of the nonavian dinosaurs is the subject of debate. Previously, arguments have been made for both endothermic and ectothermic metabolisms on the basis of differing methodologies. We used clumped isotope thermometry to determine body temperatures from the fossilized teeth of large Jurassic sauropods. Our data indicate body temperatures of 36 degrees to 38 degrees C, which are similar to those of most modern mammals. This temperature range is 4 degrees to 7 degrees C lower than predicted by a model that showed scaling of dinosaur body temperature with mass, which could indicate that sauropods had mechanisms to prevent excessively high body temperatures being reached because of their gigantic size.	[Eagle, Robert A.; Martin, Taylor S.; Eiler, John M.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Eagle, Robert A.; Tripati, Aradhna K.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; [Tuetken, Thomas] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, D-53115 Bonn, Germany; [Tripati, Aradhna K.] Univ Calif Los Angeles, Inst Environm & Sustainabil, Inst Geophys & Planetary Phys, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA; [Fricke, Henry C.] Colorado Coll, Dept Geol, Colorado Springs, CO 80903 USA; [Connely, Melissa] Casper Coll, Tate Geol Museum, Casper, WY 82601 USA; [Cifelli, Richard L.] Univ Oklahoma, Oklahoma Museum Nat Hist, Norman, OK 73019 USA; [Cifelli, Richard L.] Univ Oklahoma, Dept Zool, Norman, OK 73019 USA	California Institute of Technology; University of California System; University of California Los Angeles; University of Bonn; University of California System; University of California Los Angeles; Colorado College; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Eagle, RA (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	rob.eagle@gmail.com	Martin, Taylor/AAJ-8728-2020; Tripati, Aradhna/C-9419-2011; Tütken, Thomas/E-4988-2010; Eagle, Robert/A-2679-2011	Martin, Taylor/0000-0002-6242-6782; Tripati, Aradhna/0000-0002-1695-1754; Eagle, Robert/0000-0003-0304-6111; Tutken, Thomas/0000-0002-2590-8600	National Science Foundation [EAR-1024929, EAR-0949191]; Deutsche Forschungsgemeinschaft (DFG) [TU 148/2-1, TU 148/4-1]; Division of Physical Sciences at UCLA	National Science Foundation(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Division of Physical Sciences at UCLA	R.A.E. and J.M.E. are funded by National Science Foundation grant EAR-1024929. T. T. is funded by Deutsche Forschungsgemeinschaft (DFG) grants TU 148/2-1 and TU 148/4-1. A. K. T. is supported by the Division of Physical Sciences at UCLA and National Science Foundation grant EAR-0949191. We thank the Utah Museum of Natural History, the Oklahoma Museum of Natural History, the Berlin Museum fur Naturkunde, the Aathal Dinosaurier Museum, D. Chure at Dinosaur National Monument, and the Wyoming Dinosaur International Society for the provision of specimens for analysis. We thank D. Schwarz-Wings for specimen identification and D. Goodreau for curatorial assistance. We also thank the stable isotope laboratories at Tubingen and Lyon for conducting phosphate delta<SUP>18</SUP>O measurements. Lastly, thanks to J. Gillooly for provision of published data. This is contribution number 113 of the DFG Research Unit 533 "Biology of the Sauropod Dinosaurs: The Evolution of Gigantism." R. A. E. designed the project and experiments, performed the experiments, analyzed the data, and wrote the manuscript. J. M. E. and A. K. T. assisted with experimental design and data interpretation. Clumped isotope analyses were conducted in the lab of J. M. E. T. T. provided samples for the study, conducted phosphate oxygen isotope analysis, and assisted with data interpretation. T. S. M. assisted with isotope measurements and petrographic analyses. H. C. F., M. C., and R. L. C. provided samples for analysis and insights into the provenance of samples and data interpretation.	Alexander RM, 1998, PALAEONTOLOGY, V41, P1231; Amiot R, 2006, EARTH PLANET SC LETT, V246, P41, DOI 10.1016/j.epsl.2006.04.018; [Anonymous], 1980, COLD LOOK WARM BLOOD; BAKKER RT, 1972, NATURE, V238, P81, DOI 10.1038/238081a0; BAKKER RT, 1980, COLD LOOK WARM BLOOD, P351; BARRICK RE, 1994, SCIENCE, V265, P222, DOI 10.1126/science.265.5169.222; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; Chinsamy A, 2004, DINOSAURIA, 2ND EDITION, P643; Clarke A, 2008, FUNCT ECOL, V22, P58, DOI 10.1111/j.1365-2435.2007.01341.x; COLBERT EH, 1993, AM J SCI, V293A, P1, DOI 10.2475/ajs.293.A.1; Dennis KJ, 2010, GEOCHIM COSMOCHIM AC, V74, P4110, DOI 10.1016/j.gca.2010.04.005; DUNHAM AE, 1989, GEOL S AM S, V238, P1; Eagle RA, 2010, P NATL ACAD SCI USA, V107, P10377, DOI 10.1073/pnas.0911115107; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Farlow J.O., 1990, P43; Fricke HC, 2000, GEOLOGY, V28, P799, DOI 10.1130/0091-7613(2000)028<0799:MTMLAT>2.3.CO;2; Fricke HC, 2008, PALAEOGEOGR PALAEOCL, V266, P13, DOI 10.1016/j.palaeo.2008.03.030; Ghosh P, 2006, GEOCHIM COSMOCHIM AC, V70, P1439, DOI 10.1016/j.gca.2005.11.014; Gillooly JF, 2006, PLOS BIOL, V4, P1467, DOI 10.1371/journal.pbio.0040248; Klein N, 2008, PALEOBIOLOGY, V34, P247, DOI 10.1666/0094-8373(2008)034[0247:OSITLB]2.0.CO;2; Kohn MJ, 2002, REV MINERAL GEOCHEM, V48, P455, DOI 10.2138/rmg.2002.48.12; O'Connor MP, 1999, PALEOBIOLOGY, V25, P341, DOI 10.1017/S0094837300021321; Padian K, 2004, DINOSAURIA, 2ND EDITION, P660; PALADINO FV, 1990, NATURE, V344, P858, DOI 10.1038/344858a0; Pontzer H, 2009, PLOS ONE, V4, pA127, DOI 10.1371/journal.pone.0007783; Ricqles A. de, 1974, EVOL THEORY, V1, P51; Ruben John, 1997, P505; RUSSELL LORE S., 1965, J PALEONTOL, V39, P497; Sander PM, 2008, SCIENCE, V322, P200, DOI 10.1126/science.1160904; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Seebacher F, 1999, J EXP BIOL, V202, P77; Seebacher F, 2003, PHYSIOL BIOCHEM ZOOL, V76, P348, DOI 10.1086/375426; Seebacher F, 2003, PALEOBIOLOGY, V29, P105, DOI 10.1666/0094-8373(2003)029<0105:DBTTOO>2.0.CO;2; Spotila J.R., 1991, Modern Geology, V16, P203; Wedel MJ, 2003, PALEOBIOLOGY, V29, P243, DOI 10.1666/0094-8373(2003)029<0243:VPASAT>2.0.CO;2	36	106	111	2	156	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2011	333	6041					443	445		10.1126/science.1206196	http://dx.doi.org/10.1126/science.1206196			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21700837				2022-12-01	WOS:000292959600042
J	Bejar, R; Stevenson, K; Abdel-Wahab, O; Galili, N; Nilsson, B; Garcia-Manero, G; Kantarjian, H; Raza, A; Levine, RL; Neuberg, D; Ebert, BL				Bejar, Rafael; Stevenson, Kristen; Abdel-Wahab, Omar; Galili, Naomi; Nilsson, Bjoern; Garcia-Manero, Guillermo; Kantarjian, Hagop; Raza, Azra; Levine, Ross L.; Neuberg, Donna; Ebert, Benjamin L.			Clinical Effect of Point Mutations in Myelodysplastic Syndromes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROGNOSTIC SCORING SYSTEM; TP53 MUTATIONS; OF-FUNCTION; GENE; RISK; CBL; EPIDEMIOLOGY; LEUKEMIA; RUNX1; IDH1	BACKGROUND Myelodysplastic syndromes are clinically heterogeneous disorders characterized by clonal hematopoiesis, impaired differentiation, peripheral-blood cytopenias, and a risk of progression to acute myeloid leukemia. Somatic mutations may influence the clinical phenotype but are not included in current prognostic scoring systems. METHODS We used a combination of genomic approaches, including next-generation sequencing and mass spectrometry-based genotyping, to identify mutations in samples of bone marrow aspirate from 439 patients with myelodysplastic syndromes. We then examined whether the mutation status for each gene was associated with clinical variables, including specific cytopenias, the proportion of blasts, and overall survival. RESULTS We identified somatic mutations in 18 genes, including two, ETV6 and GNAS, that have not been reported to be mutated in patients with myelodysplastic syndromes. A total of 51% of all patients had at least one point mutation, including 52% of the patients with normal cytogenetics. Mutations in RUNX1, TP53, and NRAS were most strongly associated with severe thrombocytopenia (P < 0.001 for all comparisons) and an increased proportion of bone marrow blasts (P < 0.006 for all comparisons). In a multivariable Cox regression model, the presence of mutations in five genes retained independent prognostic significance: TP53 (hazard ratio for death from any cause, 2.48; 95% confidence interval [CI], 1.60 to 3.84), EZH2 (hazard ratio, 2.13; 95% CI, 1.36 to 3.33), ETV6 (hazard ratio, 2.04; 95% CI, 1.08 to 3.86), RUNX1 (hazard ratio, 1.47; 95% CI, 1.01 to 2.15), and ASXL1 (hazard ratio, 1.38; 95% CI, 1.00 to 1.89). CONCLUSIONS Somatic point mutations are common in myelodysplastic syndromes and are associated with specific clinical features. Mutations in TP53, EZH2, ETV6, RUNX1, and ASXL1 are predictors of poor overall survival in patients with myelodysplastic syndromes, independently of established risk factors. (Funded by the National Institutes of Health and others.)	[Bejar, Rafael; Nilsson, Bjoern; Ebert, Benjamin L.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Bejar, Rafael; Nilsson, Bjoern; Ebert, Benjamin L.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Bejar, Rafael; Ebert, Benjamin L.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Stevenson, Kristen; Neuberg, Donna] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Leukemia Serv, Dept Med, New York, NY 10021 USA; [Galili, Naomi; Raza, Azra] Columbia Univ, New York Presbyterian Hosp, Med Ctr, Dept Hematol, New York, NY USA; [Garcia-Manero, Guillermo; Kantarjian, Hagop] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Columbia University; NewYork-Presbyterian Hospital; University of Texas System; UTMD Anderson Cancer Center	Ebert, BL (corresponding author), Brigham & Womens Hosp, Karp Res Bldg,CHRB 05-211,1 Blackfan Cir, Boston, MA 02115 USA.	bebert@partners.org	levine, ross/AAE-7658-2019	Abdel-Wahab, Omar/0000-0002-3907-6171; Bejar, Rafael/0000-0002-5603-4598	National Institutes of Health (NIH) [5R01 HL082945, P01 CA108631, T32 HL007623]; Starr Cancer Consortium; Burroughs-Wellcome Fund; Huber-Foster Fellowship; NATIONAL CANCER INSTITUTE [P01CA108631] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082945, T32HL007623] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; Burroughs-Wellcome Fund(Burroughs Wellcome Fund); Huber-Foster Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Institutes of Health (NIH) (5R01 HL082945 and P01 CA108631), the Starr Cancer Consortium, and the Burroughs-Wellcome Fund (Career Awards for Medical Scientists) (all to Dr. Ebert) and a grant from the NIH (T32 HL007623) and a Huber-Foster Fellowship (both to Dr. Bejar).	Badalian-Very G, 2010, BLOOD, V116, P1919, DOI 10.1182/blood-2010-04-279083; Bejar R, 2011, J CLIN ONCOL, V29, P504, DOI 10.1200/JCO.2010.31.1175; Chen CY, 2007, BRIT J HAEMATOL, V139, P405, DOI 10.1111/j.1365-2141.2007.06811.x; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Fisher CL, 2010, BLOOD, V115, P38, DOI 10.1182/blood-2009-07-230698; Garcia-Manero G, 2008, LEUKEMIA, V22, P538, DOI 10.1038/sj.leu.2405070; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Haase D, 2007, BLOOD, V110, P4385, DOI 10.1182/blood-2007-03-082404; Horiike S, 2003, LEUKEMIA LYMPHOMA, V44, P915, DOI 10.1080/1042819031000067620; Kalfa N, 2006, J UROLOGY, V176, P891, DOI 10.1016/j.juro.2006.04.023; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; KANEKO H, 1995, BLOOD, V85, P2189, DOI 10.1182/blood.V85.8.2189.bloodjournal8582189; Kita-Sasai Y, 2001, BRIT J HAEMATOL, V115, P309, DOI 10.1046/j.1365-2141.2001.03073.x; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kosmider O, 2010, LEUKEMIA, V24, P1094, DOI 10.1038/leu.2010.52; Kosmider O, 2009, BLOOD, V114, P3285, DOI 10.1182/blood-2009-04-215814; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Malcovati L, 2007, J CLIN ONCOL, V25, P3503, DOI 10.1200/JCO.2006.08.5696; Odero MD, 2002, GENE CHROMOSOME CANC, V35, P11, DOI 10.1002/gcc.10090; Padua RA, 1998, LEUKEMIA, V12, P887, DOI 10.1038/sj.leu.2401044; PAQUETTE RL, 1993, BLOOD, V82, P590, DOI 10.1182/blood.V82.2.590.bloodjournal822590; Pardanani A, 2010, LEUKEMIA, V24, P1370, DOI 10.1038/leu.2010.98; Pedersen-Bjergaard J, 2008, LEUKEMIA, V22, P240, DOI 10.1038/sj.leu.2405078; Rocquain J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-401; Rollison DE, 2008, BLOOD, V112, P45, DOI 10.1182/blood-2008-01-134858; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Sekeres MA, 2010, HEMATOL ONCOL CLIN N, V24, P287, DOI 10.1016/j.hoc.2010.02.011; Sekeres MA, 2008, JNCI-J NATL CANCER I, V100, DOI 10.1093/jnci/djn349; Silva FPG, 2008, LEUKEMIA, V22, P1639, DOI 10.1038/leu.2008.34; Smith AE, 2010, BLOOD, V116, P3923, DOI 10.1182/blood-2010-03-274704; Steensma DP, 2005, EUR J HAEMATOL, V74, P47, DOI 10.1111/j.1600-0609.2004.00363.x; SUAREZ HG, 1991, ONCOGENE, V6, P677; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	36	1125	1178	3	73	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2011	364	26					2496	2506		10.1056/NEJMoa1013343	http://dx.doi.org/10.1056/NEJMoa1013343			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	785AM	21714648	Green Accepted			2022-12-01	WOS:000292199800005
J	Ezratty, EJ; Stokes, N; Chai, S; Shah, AS; Williams, SE; Fuchs, E				Ezratty, Ellen J.; Stokes, Nicole; Chai, Sophia; Shah, Alok S.; Williams, Scott E.; Fuchs, Elaine			A Role for the Primary Cilium in Notch Signaling and Epidermal Differentiation during Skin Development	CELL			English	Article							HAIR FOLLICLE MORPHOGENESIS; INTRAFLAGELLAR TRANSPORT; TERMINAL DIFFERENTIATION; CONDITIONAL ABLATION; KIDNEY-DISEASE; KIF3A SUBUNIT; CELL-DIVISION; STEM-CELLS; KINESIN-II; HEDGEHOG	Ciliogenesis precedes lineage-determining signaling in skin development. To understand why, we performed shRNA-mediated knockdown of seven intraflagellar transport proteins (IFTs) and conditional ablation of Ift-88 and Kif3a during embryogenesis. In both cultured keratinocytes and embryonic epidermis, all of these eliminated cilia, and many (not Kif3a) caused hyperproliferation. Surprisingly and independent of proliferation, ciliary mutants displayed defects in Notch signaling and commitment of progenitors to differentiate. Notch receptors and Notch-processing enzymes colocalized with cilia in wild-type epidermal cells. Moreover, differentiation defects in ciliary mutants were cell autonomous and rescued by activated Notch (NICD). By contrast, Shh signaling was neither operative nor required for epidermal ciliogenesis, Notch signaling, or differentiation. Rather, Shh signaling defects in ciliary mutants occurred later, arresting hair follicle morphogenesis in the skin. These findings unveil temporally and spatially distinct functions for primary cilia at the nexus of signaling, proliferation, and differentiation.	[Ezratty, Ellen J.; Stokes, Nicole; Chai, Sophia; Shah, Alok S.; Williams, Scott E.; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Williams, Scott/0000-0001-9975-7334	National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR027883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank L. Goldstein (UCSD) for Kif3 fl/fl mice and Q. Zhang (University of Iowa) for Ift88 fl/fl mice; D. Oristan and L. Polak for their expertise and assistance in the mouse facility; A. North and the RU Bioimaging Resource Center for assistance with image acquisition; and M. Schober, D. Devenport, C. Luxenburg, M. Kadaja, and other Fuchs laboratory members for helpful discussions and critical reading of the manuscript. E.J.E. is a Jane Coffin Childs postdoctoral fellow, A. S. S. is a Marie Josee and Henry Kravis postdoctoral fellow, S. E. W. is an American Cancer Society postdoctoral fellow, and E. F. is an investigator in the Howard Hughes Medical Institute. This work was supported by a grant from the National Institutes of Health.	Baldari CT, 2010, CURR OPIN CELL BIOL, V22, P75, DOI 10.1016/j.ceb.2009.10.010; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Bershteyn M, 2010, DEV CELL, V19, P270, DOI 10.1016/j.devcel.2010.07.009; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chakrabarti A, 1998, CELL TISSUE RES, V293, P453, DOI 10.1007/s004410051137; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; Croyle MJ, 2011, DEVELOPMENT, V138, P1675, DOI 10.1242/dev.060210; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; ELOFSSON R, 1984, J ULTRA MOL STRUCT R, V87, P212, DOI 10.1016/S0022-5320(84)80061-1; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; FUCHS E, 1992, P NATL ACAD SCI USA, V89, P6906, DOI 10.1073/pnas.89.15.6906; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Gao J, 2008, GENE DEV, V22, P2111, DOI 10.1101/gad.1689908; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gritli-Linde A, 2007, DEV CELL, V12, P99, DOI 10.1016/j.devcel.2006.12.006; Han YG, 2010, CURR OPIN NEUROBIOL, V20, P58, DOI 10.1016/j.conb.2009.12.002; Haraguchi K, 2006, J BIOL CHEM, V281, P4094, DOI 10.1074/jbc.M507028200; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Jaulin F, 2010, J CELL BIOL, V190, P443, DOI 10.1083/jcb.201006044; Jonassen JA, 2008, J CELL BIOL, V183, P377, DOI 10.1083/jcb.200808137; KENNEDY JR, 1968, J ULTRA MOL STRUCT R, V22, P530, DOI 10.1016/S0022-5320(68)90039-7; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lechler T, 2007, J CELL BIOL, V176, P147, DOI 10.1083/jcb.200609109; Lehman JM, 2009, J INVEST DERMATOL, V129, P438, DOI 10.1038/jid.2008.279; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Lowell S, 2000, CURR BIOL, V10, P491, DOI 10.1016/S0960-9822(00)00451-6; Luxenburg C, 2011, NAT CELL BIOL, V13, P203, DOI 10.1038/ncb2163; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Moriyama M, 2008, DEV CELL, V14, P594, DOI 10.1016/j.devcel.2008.01.017; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Okuyama R, 2004, DEV CELL, V6, P551, DOI 10.1016/S1534-5807(04)00098-X; Oro AE, 2003, DEV BIOL, V255, P238, DOI 10.1016/S0012-1606(02)00042-8; Pan JM, 2007, CELL, V129, P1255, DOI 10.1016/j.cell.2007.06.018; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Santos N, 2010, DEV CELL, V19, P5, DOI 10.1016/j.devcel.2010.07.001; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Taulman PD, 2001, MOL BIOL CELL, V12, P589, DOI 10.1091/mbc.12.3.589; Tien AC, 2009, J CELL BIOL, V184, P621, DOI 10.1083/jcb.200811141; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Wang X, 2008, J CELL BIOL, V183, P37, DOI 10.1083/jcb.200804030; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744	60	216	221	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 24	2011	145	7					1129	1141		10.1016/j.cell.2011.05.030	http://dx.doi.org/10.1016/j.cell.2011.05.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703454	Green Accepted, Bronze			2022-12-01	WOS:000292025700018
J	Latham, JA; Chosed, RJ; Wang, SZ; Dent, SYR				Latham, John A.; Chosed, Renee J.; Wang, Shanzhi; Dent, Sharon Y. R.			Chromatin Signaling to Kinetochores: Transregulation of Dam1 Methylation by Histone H2B Ubiquitination	CELL			English	Article							RNA-POLYMERASE-II; REGULATES H3 METHYLATION; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; CHROMOSOME SEGREGATION; PAF1 COMPLEX; TRANSCRIPTIONAL ELONGATION; LYSINE-4 METHYLATION; PROTEIN INTERACTIONS; GENE-EXPRESSION	Histone H3K4 trimethylation by the Set1/MLL family of proteins provides a hallmark for transcriptional activity from yeast to humans. In S. cerevisiae, H3K4 methylation is mediated by the Set1-containing COMPASS complex and is regulated in trans by prior ubiquitination of histone H2BK123. All of the events that regulate H2BK123ub and H3K4me are thought to occur at gene promoters. Here we report that this pathway is indispensable for methylation of the only other known substrate of Set1, K233 in Dam1, at kinetochores. Deletion of RAD6, BRE1, or Paf1 complex members abolishes Dam1 methylation, as does mutation of H2BK123. Our results demonstrate that Set1-mediated methylation is regulated by a general pathway regardless of substrate that is composed of transcriptional regulatory factors functioning independently of transcription. Moreover, our data identify a node of regulatory crosstalk in trans between a histone modification and modification on a nonhistone protein, demonstrating that changing chromatin states can signal functional changes in other essential cellular proteins and machineries.	[Latham, John A.; Wang, Shanzhi; Dent, Sharon Y. R.] Univ Texas MD Anderson Canc Ctr, Program Genes & Dev, Smithville, TX 78957 USA; [Latham, John A.; Chosed, Renee J.; Dent, Sharon Y. R.] Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Smithville, TX 78957 USA; [Latham, John A.; Chosed, Renee J.; Dent, Sharon Y. R.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA; [Wang, Shanzhi] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Dent, SYR (corresponding author), Univ Texas MD Anderson Canc Ctr, Program Genes & Dev, Smithville, TX 78957 USA.	sroth@mdanderson.org	Dent, Sharon YR/F-1746-2011	Dent, Sharon YR/0000-0002-4824-3269; Chosed, Renee/0000-0002-0442-0833	American Legion Auxiliary; Odyssey Program; Theodore N. Law Endowment for Scientific Achievement at the University of Texas M.D. Anderson Cancer Center; NIH [GM51189]; Robert A. Welch Foundation [G1371]; Cancer Center Support [NCI CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051189] Funding Source: NIH RePORTER	American Legion Auxiliary; Odyssey Program; Theodore N. Law Endowment for Scientific Achievement at the University of Texas M.D. Anderson Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Cancer Center Support; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	J.A.L. was supported in part by a fellowship by the American Legion Auxiliary. Funding for R.J.C. as an Odyssey Fellow was supported by the Odyssey Program and the Theodore N. Law Endowment for Scientific Achievement at the University of Texas M.D. Anderson Cancer Center. Aspects of this work were supported by NIH grant GM51189 and a grant from the Robert A. Welch Foundation (G1371) to S.Y.R.D. DNA sequencing for this project was done in the UTMDACC DNA Analysis Facility, supported by Cancer Center Support Grant NCI CA16672. We thank the members of the Dent lab, especially Andria Schibler, Rebecca Lewis, Jill Butler, and Marenda Wilson-Pham for their suggestions as well as Fred Winston, Mitch Smith, and Kevin Morano for insightful comments. We are also grateful to Drs. Ambro van Hoof, Mary Ann Osley, Sue Biggins, Brian Strahl, and Peter Nagy for generously providing yeast strains, plasmids, and antibodies.	Adelman K, 2006, MOL CELL BIOL, V26, P250, DOI 10.1128/MCB.26.1.250-260.2006; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Basrai MA, 1996, MOL CELL BIOL, V16, P2838; Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Betz JL, 2002, MOL GENET GENOMICS, V268, P272, DOI 10.1007/s00438-002-0752-8; Bouck DC, 2005, P NATL ACAD SCI USA, V102, P5408, DOI 10.1073/pnas.0405925102; CHAN CSM, 1993, GENETICS, V135, P677; Chaudhary K, 2007, ONCOGENE, V26, P7499, DOI 10.1038/sj.onc.1210582; Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cheng HL, 2004, MOL CELL BIOL, V24, P2932, DOI 10.1128/MCB.24.7.2932-2943.2004; CISMOWSKI MJ, 1995, MOL CELL BIOL, V15, P2983; Crotti LB, 2004, EMBO J, V23, P1804, DOI 10.1038/sj.emboj.7600161; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Dichtl E, 2004, RNA, V10, P965, DOI 10.1261/rna.7090104; DOHENY KF, 1993, CELL, V73, P761, DOI 10.1016/0092-8674(93)90255-O; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Emanuele MJ, 2007, CELL, V130, P893, DOI 10.1016/j.cell.2007.07.023; Emre NCT, 2005, MOL CELL, V17, P585, DOI 10.1016/j.molcel.2005.01.007; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Foreman PK, 1996, GENETICS, V144, P1387; FRANCISCO L, 1994, CELL MOL BIOL RES, V40, P207; Furuyama T, 2009, CELL, V138, P104, DOI 10.1016/j.cell.2009.04.049; Glinsky GV, 2006, CELL CYCLE, V5, P1208, DOI 10.4161/cc.5.11.2796; Hanisch A, 2006, EMBO J, V25, P5504, DOI 10.1038/sj.emboj.7601426; Hemmerich P, 2000, P NATL ACAD SCI USA, V97, P12583, DOI 10.1073/pnas.97.23.12583; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Janke C, 2002, EMBO J, V21, P181, DOI 10.1093/emboj/21.1.181; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kim J, 2009, J BIOL CHEM, V284, P20582, DOI 10.1074/jbc.M109.017442; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li YM, 2002, GENE DEV, V16, P183, DOI 10.1101/gad.959402; Liu ZX, 2009, MOL BIOL CELL, V20, P757, DOI 10.1091/mbc.E08-09-0983; Lyakhovich A, 2004, ONCOGENE, V23, P3097, DOI 10.1038/sj.onc.1207449; McCleland ML, 2003, GENE DEV, V17, P101, DOI 10.1101/gad.1040903; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Milne TA, 2010, MOL CELL, V38, P853, DOI 10.1016/j.molcel.2010.05.011; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Moniaux N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007077; Mueller JE, 2006, GENETICS, V173, P557, DOI 10.1534/genetics.106.055400; Muntean AG, 2010, CANCER CELL, V17, P609, DOI 10.1016/j.ccr.2010.04.012; Nakanishi S, 2009, J CELL BIOL, V186, P371, DOI 10.1083/jcb.200906005; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Ooi CE, 1996, EMBO J, V15, P3515, DOI 10.1002/j.1460-2075.1996.tb00720.x; Porter SE, 2002, EUKARYOT CELL, V1, P830, DOI 10.1128/EC.1.5.830-842.2002; Qian C, 2006, CELL MOL LIFE SCI, V63, P2755, DOI 10.1007/s00018-006-6274-5; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Shang C, 2003, MOL BIOL CELL, V14, P3342, DOI 10.1091/mbc.E02-11-0765; Shekhar MPV, 2002, CANCER RES, V62, P2115; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tenney K, 2005, J CELL BIOCHEM, V95, P429, DOI 10.1002/jcb.20421; VALAY JG, 1995, J MOL BIOL, V249, P535, DOI 10.1006/jmbi.1995.0316; Vitaliano-Prunier A, 2008, NAT CELL BIOL, V10, P1365, DOI 10.1038/ncb1796; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Zhang K, 2005, CELL, V122, P723, DOI 10.1016/j.cell.2005.06.021; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	79	51	52	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 2	2011	146	5					709	719		10.1016/j.cell.2011.07.025	http://dx.doi.org/10.1016/j.cell.2011.07.025			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21884933	Bronze, Green Accepted			2022-12-01	WOS:000294477500012
J	Sankaran, VG; Xu, J; Byron, R; Greisman, HA; Fisher, C; Weatherall, DJ; Sabath, DE; Groudine, M; Orkin, SH; Premawardhena, A; Bender, MA				Sankaran, Vijay G.; Xu, Jian; Byron, Rachel; Greisman, Harvey A.; Fisher, Chris; Weatherall, David J.; Sabath, Daniel E.; Groudine, Mark; Orkin, Stuart H.; Premawardhena, Anuja; Bender, M. A.			A Functional Element Necessary for Fetal Hemoglobin Silencing	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DELTA-BETA-THALASSEMIA; GAMMA-GLOBIN GENE; SICKLE-CELL-DISEASE; FACTOR KLF1 CAUSES; HEREDITARY PERSISTENCE; SRI-LANKA; BCL11A; EXPRESSION; DELETION; SEQUENCES	Background An improved understanding of the regulation of the fetal hemoglobin genes holds promise for the development of targeted therapeutic approaches for fetal hemoglobin induction in the beta-hemoglobinopathies. Although recent studies have uncovered trans-acting factors necessary for this regulation, limited insight has been gained into the cis-regulatory elements involved. Methods We identified three families with unusual patterns of hemoglobin expression, suggestive of deletions in the locus of the beta-globin gene (beta-globin locus). We performed array comparative genomic hybridization to map these deletions and confirmed breakpoints by means of polymerase-chain-reaction assays and DNA sequencing. We compared these deletions, along with previously mapped deletions, and studied the trans-acting factors binding to these sites in the beta-globin locus by using chromatin immunoprecipitation. Results We found a new (delta beta)(0)-thalassemia deletion and a rare hereditary persistence of fetal hemoglobin deletion with identical downstream breakpoints. Comparison of the two deletions resulted in the identification of a small intergenic region required for gamma-globin (fetal hemoglobin) gene silencing. We mapped a Kurdish beta(0)-thalassemia deletion, which retains the required intergenic region, deletes other surrounding sequences, and maintains fetal hemoglobin silencing. By comparing these deletions and other previously mapped deletions, we elucidated a 3.5-kb intergenic region near the 5' end of the delta-globin gene that is necessary for gamma-globin silencing. We found that a critical fetal hemoglobin silencing factor, BCL11A, and its partners bind within this region in the chromatin of adult erythroid cells. Conclusions By studying three families with unusual deletions in the beta-globin locus, we identified an intergenic region near the delta-globin gene that is necessary for fetal hemoglobin silencing. (Funded by the National Institutes of Health and others.)	[Sankaran, Vijay G.; Xu, Jian; Orkin, Stuart H.] Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Xu, Jian; Orkin, Stuart H.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Sankaran, Vijay G.] Broad Inst, Cambridge, MA USA; [Byron, Rachel; Groudine, Mark; Bender, M. A.] Fred Hutchinson Canc Ctr, Seattle, WA 98109 USA; [Greisman, Harvey A.; Sabath, Daniel E.; Bender, M. A.] Univ Washington, Seattle, WA 98195 USA; [Fisher, Chris; Weatherall, David J.] Weatherall Inst Mol Med, Oxford, England; [Premawardhena, Anuja] Univ Kelaniya, Ragama Gampaha, Sri Lanka	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Oxford; University Kelaniya	Sankaran, VG (corresponding author), Childrens Hosp, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	sankaran@broadinstitute.org; mbender@fhcrc.org	Premawardhena, Anuja/GLN-5388-2022	Premawardhena, Anuja/0000-0003-0605-9081	Cooley's Anemia Foundation; National Institutes of Health [DK44746, HL032259]; Howard Hughes Medical Institute; Wellcome Trust; March of Dimes; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065440, R01HL032259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044746, R37DK044746] Funding Source: NIH RePORTER	Cooley's Anemia Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Wellcome Trust(Wellcome TrustEuropean Commission); March of Dimes(March of Dimes); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the Cooley's Anemia Foundation (to Dr. Sankaran), the National Institutes of Health (DK44746, to Drs. Bender and Groudine, and HL032259, to Dr. Orkin), the Howard Hughes Medical Institute (to Drs. Xu and Orkin), and the Wellcome Trust and March of Dimes (to Dr. Weatherall).	ANAGNOU NP, 1995, J BIOL CHEM, V270, P10256, DOI 10.1074/jbc.270.17.10256; Arnaud L, 2010, AM J HUM GENET, V87, P721, DOI 10.1016/j.ajhg.2010.10.010; Bauer DE, 2011, CURR OPIN PEDIATR, V23, P1, DOI 10.1097/MOP.0b013e3283420fd0; Benz EJ, 2005, NEW ENGL J MED, V352, P524; Benz EJ, 2004, NEW ENGL J MED, V351, P1490, DOI 10.1056/NEJMp048198; BOLLEKENS JA, 1991, HEMATOL ONCOL CLIN N, V5, P399, DOI 10.1016/S0889-8588(18)30422-2; Borg J, 2010, NAT GENET, V42, P801, DOI 10.1038/ng.630; Bottardi S, 2009, MOL CELL BIOL, V29, P1526, DOI 10.1128/MCB.01523-08; Bradner JE, 2010, P NATL ACAD SCI USA, V107, P12617, DOI 10.1073/pnas.1006774107; Calzolari R, 1999, EMBO J, V18, P949, DOI 10.1093/emboj/18.4.949; Chakalova L, 2005, BLOOD, V105, P2154, DOI 10.1182/blood-2003-11-4069; de Silva S, 2000, LANCET, V355, P786, DOI 10.1016/S0140-6736(99)08246-X; Gaensler KML, 2003, P NATL ACAD SCI USA, V100, P3374, DOI 10.1073/pnas.0634132100; Galarneau G, 2010, NAT GENET, V42, P1049, DOI 10.1038/ng.707; Giardine B, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9479; HENTHORN PS, 1986, P NATL ACAD SCI USA, V83, P5194, DOI 10.1073/pnas.83.14.5194; HUISMAN THJ, 1974, ANN NY ACAD SCI, V232, P107, DOI 10.1111/j.1749-6632.1974.tb20576.x; Joly P, 2009, BLOOD CELL MOL DIS, V43, P53, DOI 10.1016/j.bcmd.2009.01.017; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; ONER C, 1995, BRIT J HAEMATOL, V89, P306, DOI 10.1111/j.1365-2141.1995.tb03305.x; Premawardhena A, 2005, LANCET, V366, P1467, DOI 10.1016/S0140-6736(05)67396-5; Sankaran VG, 2010, NEW ENGL J MED, V363, P2258, DOI 10.1056/NEJMcibr1010767; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Thein SL, 2009, HUM MOL GENET, V18, pR216, DOI 10.1093/hmg/ddp401; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Weatherall D.J., 2001, THALASSAEMIA SYNDROM, Vfourth; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	30	132	137	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2011	365	9					807	814		10.1056/NEJMoa1103070	http://dx.doi.org/10.1056/NEJMoa1103070			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813YC	21879898	Bronze, Green Accepted			2022-12-01	WOS:000294405200007
J	Bosch, X				Bosch, Xavier			Systemic Lupus Erythematosus and the Neutrophil	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Barcelona, Dept Internal Med, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Bosch, X (corresponding author), Univ Barcelona, Dept Internal Med, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain.							Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Lahita RG, 2011, SYSTEMIC LUPUS ERYTHEMATOSUS, 5TH EDITION, P1; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Obermoser G, 2010, LUPUS, V19, P1012, DOI 10.1177/0961203310371161; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450	5	72	77	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2011	365	8					758	760		10.1056/NEJMcibr1107085	http://dx.doi.org/10.1056/NEJMcibr1107085			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811JM	21864171				2022-12-01	WOS:000294205300016
J	Hashiyama, K; Hayashi, Y; Kobayashi, S				Hashiyama, Kazuya; Hayashi, Yoshiki; Kobayashi, Satoru			Drosophila Sex lethal Gene Initiates Female Development in Germline Progenitors	SCIENCE			English	Article							INTERSTITIAL-CELLS; SOMATIC-CELLS; EXPRESSION; SXL; MELANOGASTER; TRANSCRIPTION; MECHANISMS; DIMORPHISM; PROTEINS; IDENTITY	Sex determination in the Drosophila germ line is regulated by both the sex of the surrounding soma and cell-autonomous cues. How primordial germ cells (PGCs) initiate sexual development via cell-autonomous mechanisms is unclear. Here, we demonstrate that, in Drosophila, the Sex lethal (Sxl) gene acts autonomously in PGCs to induce female development. Sxl is transiently expressed in PGCs during their migration to the gonads; this expression, which was detected only in XX PGCs, is necessary for PGCs to assume a female fate. Ectopic expression of Sxl in XY PGCs was sufficient to induce them to enter oogenesis and produce functional eggs when transplanted into an XX host. Our data provide powerful evidence that Sxl initiates female germline fate during sexual development.	[Hashiyama, Kazuya; Hayashi, Yoshiki; Kobayashi, Satoru] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Natl Inst Basic Biol, Higashiyama Ku, Okazaki, Aichi 4448787, Japan; [Hayashi, Yoshiki; Kobayashi, Satoru] Grad Univ Adv Studies, Dept Basic Biol, Sch Life Sci, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan	Kobayashi, S (corresponding author), Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Natl Inst Basic Biol, Higashiyama Ku, Okazaki, Aichi 4448787, Japan.	skob@nibb.ac.jp		Hayashi, Yoshiki/0000-0002-8966-8730	Ministry of Education, Culture, Sports, Science and Technology (Japan); Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank the researchers who provided us with flies and antibodies and members of our laboratory for their valuable comments. We also thank the Drosophila Genetic Resource Center (Kyoto), the Bloomington and Vienna Drosophila RNAi Stock Centers, and the Developmental Studies Hybridoma Bank for fly stocks and antibodies. This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (Japan) to S. K. and a Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science to K.H.	BERNSTEIN M, 1995, GENETICS, V139, P631; BOPP D, 1991, GENE DEV, V5, P403, DOI 10.1101/gad.5.3.403; Camara N, 2008, CURR TOP DEV BIOL, V83, P65, DOI 10.1016/S0070-2153(08)00403-1; CAMPBELL RD, 1985, J EXP ZOOL, V234, P451, DOI 10.1002/jez.1402340312; Casper A, 2006, DEVELOPMENT, V133, P2783, DOI 10.1242/dev.02415; Casper AL, 2009, DEVELOPMENT, V136, P3821, DOI 10.1242/dev.042374; DeFalco T, 2009, ANNU REV CELL DEV BI, V25, P457, DOI 10.1146/annurev.cellbio.042308.13350; Deshpande G, 1999, CELL, V99, P271, DOI 10.1016/S0092-8674(00)81658-X; Durcova-Hills G, 2008, CURR TOP DEV BIOL, V83, P185, DOI [10.1016/S0070-2153(08)00406-7, 10.1016/S0070-2153(09)00406-7]; Hashiyama K, 2009, GENE EXPR PATTERNS, V9, P50, DOI 10.1016/j.gep.2008.08.001; Hempel LU, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-113; Hempel LU, 2008, CURR TOP DEV BIOL, V83, P109, DOI 10.1016/S0070-2153(08)00404-3; Horabin JI, 2005, DEVELOPMENT, V132, P4801, DOI 10.1242/dev.02054; Huang L, 2005, DEV BIOL, V280, P407, DOI 10.1016/j.ydbio.2005.02.006; KEYES LN, 1992, CELL, V68, P933, DOI 10.1016/0092-8674(92)90036-C; LITTLEFIELD CL, 1984, DEV BIOL, V102, P426, DOI 10.1016/0012-1606(84)90207-0; MARSH JL, 1978, NATURE, V272, P249, DOI 10.1038/272249a0; Mattox W, 1996, GENETICS, V143, P303; Murray SM, 2010, CURR OPIN CELL BIOL, V22, P722, DOI 10.1016/j.ceb.2010.09.006; Oliver B, 2002, INT REV CYTOL, V219, P1; Penalva LOF, 2003, MICROBIOL MOL BIOL R, V67, P343, DOI 10.1128/MMBR.67.3.343-359.2003; Salz HK, 2010, FLY, V4, P60, DOI 10.4161/fly.4.1.11277; Sanchez L, 2008, INT J DEV BIOL, V52, P837, DOI 10.1387/ijdb.072396ls; SCHUPBACH T, 1982, DEV BIOL, V89, P117, DOI 10.1016/0012-1606(82)90300-1; Shigenobu S, 2006, P NATL ACAD SCI USA, V103, P13728, DOI 10.1073/pnas.0603767103; STEINMANNZWICKY M, 1994, DEV GENET, V15, P265, DOI 10.1002/dvg.1020150308; STEINMANNZWICKY M, 1989, CELL, V57, P157, DOI 10.1016/0092-8674(89)90181-5; Van Doren M, 1998, CURR BIOL, V8, P243; Wawersik M, 2005, NATURE, V436, P563, DOI 10.1038/nature03849; Wawersik M, 2006, CELL CYCLE, V5, P1385, DOI 10.4161/cc.5.13.2905	30	44	46	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 12	2011	333	6044					885	888		10.1126/science.1208146	http://dx.doi.org/10.1126/science.1208146			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21737698				2022-12-01	WOS:000293785400043
J	Yuan, J; Cheng, KCC; Johnson, RL; Huang, RL; Pattaradilokrat, S; Liu, AN; Guha, R; Fidock, DA; Inglese, J; Wellems, TE; Austin, CP; Su, XZ				Yuan, Jing; Cheng, Ken Chih-Chien; Johnson, Ronald L.; Huang, Ruili; Pattaradilokrat, Sittiporn; Liu, Anna; Guha, Rajarshi; Fidock, David A.; Inglese, James; Wellems, Thomas E.; Austin, Christopher P.; Su, Xin-zhuan			Chemical Genomic Profiling for Antimalarial Therapies, Response Signatures, and Molecular Targets	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; IN-VITRO ACTIVITY; DRUG-RESISTANCE; CHLOROQUINE RESISTANCE; DIGESTIVE VACUOLE; ARTEMISININ; GENE; SUSCEPTIBILITY; AMODIAQUINE; DIVERSITY	Malaria remains a devastating disease largely because of widespread drug resistance. New drugs and a better understanding of the mechanisms of drug action and resistance are essential for fulfilling the promise of eradicating malaria. Using high-throughput chemical screening and genome-wide association analysis, we identified 32 highly active compounds and genetic loci associated with differential chemical phenotypes (DCPs), defined as greater than or equal to fivefold differences in half-maximum inhibitor concentration (IC50) between parasite lines. Chromosomal loci associated with 49 DCPs were confirmed by linkage analysis and tests of genetically modified parasites, including three genes that were linked to 96% of the DCPs. Drugs whose responses mapped to wild-type or mutant pfcrt alleles were tested in combination in vitro and in vivo, which yielded promising new leads for antimalarial treatments.	[Cheng, Ken Chih-Chien; Johnson, Ronald L.; Huang, Ruili; Guha, Rajarshi; Inglese, James; Austin, Christopher P.] NHGRI, NIH Chem Genom Ctr, NIH, Bethesda, MD 20895 USA; [Yuan, Jing; Pattaradilokrat, Sittiporn; Liu, Anna; Wellems, Thomas E.; Su, Xin-zhuan] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; [Fidock, David A.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Fidock, David A.] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Columbia University; Columbia University	Austin, CP (corresponding author), NHGRI, NIH Chem Genom Ctr, NIH, Bethesda, MD 20895 USA.	austinc@mail.nih.gov; xsu@niaid.nih.gov		Su, Xinzhuan/0000-0003-3246-3248; Yuan, Jing/0000-0002-8907-9143; Pattaradilokrat, Sittiporn/0000-0002-1516-1961; Fidock, David/0000-0001-6753-8938	Division of Intramural Research at the National Institute of Allergy and Infectious Diseases (NIAID); National Human Genome Research Institute; NIH; Burroughs Wellcome Fund [R01 AI50234]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG200319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI050234, ZIAAI000483, R01AI050234] Funding Source: NIH RePORTER	Division of Intramural Research at the National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the Division of Intramural Research at the National Institute of Allergy and Infectious Diseases (NIAID), the National Human Genome Research Institute, and the Director's Challenge Award Program, all at NIH. Funding for the studies from D.A.F. was provided by R01 AI50234 and the Burroughs Wellcome Fund.	BASCO LK, 1993, AM J TROP MED HYG, V49, P301, DOI 10.4269/ajtmh.1993.49.301; Billups SJ, 1998, ANN PHARMACOTHER, V32, P659, DOI 10.1345/aph.17323; Bonnet M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-192; Brockman A, 2000, T ROY SOC TROP MED H, V94, P537, DOI 10.1016/S0035-9203(00)90080-4; Burgess SJ, 2010, J MED CHEM, V53, P6477, DOI 10.1021/jm1006484; Chong CR, 2006, NAT CHEM BIOL, V2, P415, DOI 10.1038/nchembio806; COWMAN AF, 1991, J CELL BIOL, V113, P1033, DOI 10.1083/jcb.113.5.1033; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Ferdig MT, 2004, MOL MICROBIOL, V52, P985, DOI 10.1111/j.1365-2958.2004.04035.x; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; GERSHON P, 1986, T ROY SOC TROP MED H, V80, P753, DOI 10.1016/0035-9203(86)90376-7; Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099; Hayton K, 2008, CURR GENET, V54, P223, DOI 10.1007/s00294-008-0214-x; Huang R, 2008, CHEM RES TOXICOL, V21, P659, DOI 10.1021/tx700365e; Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Kato N, 2008, NAT CHEM BIOL, V4, P347, DOI 10.1038/nchembio.87; Kazzim OJ, 2006, ANN TROP MED PARASIT, V100, P579, DOI 10.1179/136485906X118477; KYLE DE, 1993, AM J TROP MED HYG, V48, P126, DOI 10.4269/ajtmh.1993.48.126; Lell B, 2002, ANTIMICROB AGENTS CH, V46, P2315, DOI 10.1128/AAC.46.8.2315-2320.2002; Mu JB, 2010, NAT GENET, V42, P268, DOI 10.1038/ng.528; Mungthin M, 2010, AM J TROP MED HYG, V83, P1005, DOI 10.4269/ajtmh.2010.10-0339; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Patel JJ, 2010, MOL MICROBIOL, V78, P770, DOI 10.1111/j.1365-2958.2010.07366.x; Randic M, 1997, J CHEM INF COMP SCI, V37, P672, DOI 10.1021/ci960174t; Rathod PK, 1997, P NATL ACAD SCI USA, V94, P9389, DOI 10.1073/pnas.94.17.9389; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Sa JM, 2009, P NATL ACAD SCI USA, V106, P18883, DOI 10.1073/pnas.0911317106; Seed J, 2005, CRIT REV TOXICOL, V35, P663, DOI 10.1080/10408440591007133; Singh N, 2000, ACTA TROP, V77, P185, DOI 10.1016/S0001-706X(00)00133-9; Sowunmi A, 2003, ANN TROP MED PARASIT, V97, P103, DOI 10.1179/000349803235001516; Weisman JL, 2006, CHEM BIOL DRUG DES, V67, P409, DOI 10.1111/j.1747-0285.2006.00391.x; Wellems TE, 2004, NAT MED, V10, P1169, DOI 10.1038/nm1104-1169; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; White NJ, 1996, PARASITOL TODAY, V12, P399, DOI 10.1016/0169-4758(96)10055-7; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; Yuan J, 2009, NAT CHEM BIOL, V5, P765, DOI 10.1038/nchembio.215	39	109	113	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 5	2011	333	6043					724	729		10.1126/science.1205216	http://dx.doi.org/10.1126/science.1205216			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817045	Green Accepted			2022-12-01	WOS:000293512100034
J	Baur, LA				Baur, Louise A.			The art of medicine Changing perceptions of obesity-recollections of a paediatrician	LANCET			English	Editorial Material									[Baur, Louise A.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Baur, Louise A.] Univ Sydney, Sydney Med Sch, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Baur, Louise A.] Childrens Hosp Westmead, Westmead, NSW 2145, Australia	University of Sydney; University of Sydney; University of Sydney	Baur, LA (corresponding author), Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia.	louiseb3@chw.edu.au	Baur, Louise/AAE-3413-2021	Baur, Louise/0000-0002-4521-9482					0	3	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG-SEP	2011	378	9793					762	763		10.1016/S0140-6736(11)61365-2	http://dx.doi.org/10.1016/S0140-6736(11)61365-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816FY	21877330				2022-12-01	WOS:000294585300017
J	King, MS; Eisenberg, R; Newman, JH; Tolle, JJ; Harrell, FE; Nian, H; Ninan, M; Lambright, ES; Sheller, JR; Johnson, JE; Miller, RF				King, Matthew S.; Eisenberg, Rosana; Newman, John H.; Tolle, James J.; Harrell, Frank E., Jr.; Nian, Hui; Ninan, Mathew; Lambright, Eric S.; Sheller, James R.; Johnson, Joyce E.; Miller, Robert F.			Constrictive Bronchiolitis in Soldiers Returning from Iraq and Afghanistan	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GULF-WAR VETERANS; US MILITARY PERSONNEL; HEALTH-STATUS; PERSIAN-GULF; OBLITERANS; EXPOSURE; DYSPNEA	Background In this descriptive case series, 80 soldiers from Fort Campbell, Kentucky, with inhalational exposures during service in Iraq and Afghanistan were evaluated for dyspnea on exertion that prevented them from meeting the U. S. Army's standards for physical fitness. Methods The soldiers underwent extensive evaluation of their medical and exposure history, physical examination, pulmonary-function testing, and high-resolution computed tomography (CT). A total of 49 soldiers underwent thoracoscopic lung biopsy after noninvasive evaluation did not provide an explanation for their symptoms. Data on cardiopulmonary-exercise and pulmonary-function testing were compared with data obtained from historical military control subjects. Results Among the soldiers who were referred for evaluation, a history of inhalational exposure to a 2003 sulfur-mine fire in Iraq was common but not universal. Of the 49 soldiers who underwent lung biopsy, all biopsy samples were abnormal, with 38 soldiers having changes that were diagnostic of constrictive bronchiolitis. In the remaining 11 soldiers, diagnoses other than constrictive bronchiolitis that could explain the presenting dyspnea were established. All soldiers with constrictive bronchiolitis had normal results on chest radiography, but about one quarter were found to have mosaic air trapping or centrilobular nodules on chest CT. The results of pulmonary-function and cardiopulmonary-exercise testing were generally within normal population limits but were inferior to those of the military control subjects. Conclusions In 49 previously healthy soldiers with unexplained exertional dyspnea and diminished exercise tolerance after deployment, an analysis of biopsy samples showed diffuse constrictive bronchiolitis, which was possibly associated with inhalational exposure, in 38 soldiers.	[Miller, Robert F.] Vanderbilt Univ, Med Ctr, Dept Med, Med Ctr E 6134, Nashville, TN 37232 USA; [King, Matthew S.] Meharry Med Coll, Div Pulm & Crit Care Med, Nashville, TN 37208 USA; [Eisenberg, Rosana; Johnson, Joyce E.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Lambright, Eric S.] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37232 USA; [Harrell, Frank E., Jr.; Nian, Hui] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37232 USA; [Ninan, Mathew] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Memphis, TN 38163 USA	Vanderbilt University; Meharry Medical College; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Tennessee System; University of Tennessee Health Science Center	Miller, RF (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Med Ctr E 6134, Nashville, TN 37232 USA.				National Center for Research Resources, National Institutes of Health [UL1-RR024975]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024978, KL2RR024977, UL1RR024975] Funding Source: NIH RePORTER	National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported in part by a Clinical and Translational Science Award (UL1-RR024975) to Vanderbilt University Medical Center from the National Center for Research Resources, National Institutes of Health.	ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; BOSWELL RT, 1995, J OCCUP ENVIRON MED, V37, P850, DOI 10.1097/00043764-199507000-00015; BREATNACH E, 1982, CLIN RADIOL, V33, P657, DOI 10.1016/S0009-9260(82)80395-4; Coker WJ, 1999, BMJ-BRIT MED J, V318, P290, DOI 10.1136/bmj.318.7179.290; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; Devakonda A, 2010, CHEST, V137, P938, DOI 10.1378/chest.09-0800; de Mello GCF, 2010, RESPIRATION, V79, P322, DOI 10.1159/000235722; Kelsall HL, 2004, THORAX, V59, P897, DOI 10.1136/thx.2003.017103; Kreiss K, 2002, NEW ENGL J MED, V347, P330, DOI 10.1056/NEJMoa020300; Lee ES, 2000, RADIOLOGY, V216, P472, DOI 10.1148/radiology.216.2.r00au21472; MCLOUD TC, 1986, RADIOLOGY, V159, P1; Medinger AE, 1998, CHEST, V113, P612, DOI 10.1378/chest.113.3.612; Morris MJ, 2002, MIL MED, V167, P281; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Schwartz DA, 1997, JAMA-J AM MED ASSOC, V277, P238, DOI 10.1001/jama.277.3.238; SCHWARZ MI, 2003, INTERSTITIAL LUNG DI, P796; Shorr AF, 2004, JAMA-J AM MED ASSOC, V292, P2997, DOI 10.1001/jama.292.24.2997; Smith B, 2009, AM J EPIDEMIOL, V170, P1433, DOI 10.1093/aje/kwp287; Szema AM, 2008, J ALLERGY CLIN IMMUN, V121, pS230, DOI 10.1016/j.jaci.2007.12.909; Szema AM, 2010, ALLERGY ASTHMA PROC, V31, pE67, DOI 10.2500/aap.2010.31.3383; Tanaka N, 2004, J COMPUT ASSIST TOMO, V28, P351, DOI 10.1097/00004728-200405000-00009; Visscher Daniel W, 2006, Proc Am Thorac Soc, V3, P41, DOI 10.1513/pats.200512-124JH; WRIGHT JL, 1992, AM REV RESPIR DIS, V146, P240, DOI 10.1164/ajrccm/146.1.240; WRIGHT JL, 1984, HUM PATHOL, V15, P68, DOI 10.1016/S0046-8177(84)80332-9; ARMY PHYS FITNESS TE	25	165	167	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2011	365	3					222	230		10.1056/NEJMoa1101388	http://dx.doi.org/10.1056/NEJMoa1101388			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794QI	21774710	Green Accepted			2022-12-01	WOS:000292915500006
J	Payandeh, J; Scheuer, T; Zheng, N; Catterall, WA				Payandeh, Jian; Scheuer, Todd; Zheng, Ning; Catterall, William A.			The crystal structure of a voltage-gated sodium channel	NATURE			English	Article							MOLECULAR DETERMINANTS; IONIC SELECTIVITY; NA+ CHANNELS; LOCAL-ANESTHETICS; POTASSIUM CHANNEL; SKELETAL-MUSCLE; K+ SELECTIVITY; BLOCK; CA2+; PROTEINS	Voltage-gated sodium (Na-V) channels initiate electrical signalling in excitable cells and are the molecular targets for drugs and disease mutations, but the structural basis for their voltage-dependent activation, ion selectivity and drug block is unknown. Here we report the crystal structure of a voltage-gated Na+ channel from Arcobacter butzleri (NavAb) captured in a closed-pore conformation with four activated voltage sensors at 2.7 angstrom resolution. The arginine gating charges make multiple hydrophilic interactions within the voltage sensor, including unanticipated hydrogen bonds to the protein backbone. Comparisons to previous open-pore potassium channel structures indicate that the voltage-sensor domains and the S4-S5 linkers dilate the central pore by pivoting together around a hinge at the base of the pore module. The NavAb selectivity filter is short, similar to 4.6 angstrom wide, and water filled, with four acidic side chains surrounding the narrowest part of the ion conduction pathway. This unique structure presents a high-field-strength anionic coordination site, which confers Na+ selectivity through partial dehydration via direct interaction with glutamate side chains. Fenestrations in the sides of the pore module are unexpectedly penetrated by fatty acyl chains that extend into the central cavity, and these portals are large enough for the entry of small, hydrophobic pore-blocking drugs. This structure provides the template for understanding electrical signalling in excitable cells and the actions of drugs used for pain, epilepsy and cardiac arrhythmia at the atomic level.	[Payandeh, Jian; Scheuer, Todd; Zheng, Ning; Catterall, William A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Zheng, Ning] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zheng, N (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	nzheng@uw.edu; wcatt@uw.edu	Tuluc, Petronel/C-2527-2011		Canadian Institutes of Health Research; National Institutes of Health [R01 NS15751, U01 NS058039]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058039, R01NS015751] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B. Hille for comments on a draft of the manuscript and members of the N.Z. and W.A.C. groups for their support throughout this project. We are grateful to investigators who provided genomic DNA and the beamline staff at the Advanced Light Source (BL8.2.1 and BL8.2.2) for their assistance during data collection. J.P. acknowledges support from a Canadian Institutes of Health Research fellowship and the encouragement of E. Payandeh. This work was supported by grants from the National Institutes of Health (R01 NS15751 and U01 NS058039 to W. A. C.) and by the Howard Hughes Medical Institute (N.Z.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alam A, 2009, NAT STRUCT MOL BIOL, V16, P35, DOI 10.1038/nsmb.1537; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bezanilla F, 2006, BIOL RES, V39, P425, DOI 10.4067/S0716-97602006000300005; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.bi.55.070186.004513; CATTERALL WA, 1987, TRENDS PHARMACOL SCI, V8, P57, DOI 10.1016/0165-6147(87)90011-3; Catterall WA, 2010, NEURON, V67, P915, DOI 10.1016/j.neuron.2010.08.021; Chaptal V, 2010, J STRUCT BIOL, V171, P82, DOI 10.1016/j.jsb.2010.02.005; Chen XH, 1996, J GEN PHYSIOL, V108, P363, DOI 10.1085/jgp.108.5.363; Cronin CN, 2007, PROTEIN SCI, V16, P2023, DOI 10.1110/ps.072931407; CURTIS BM, 1986, BIOCHEMISTRY-US, V25, P3077, DOI 10.1021/bi00359a002; DeCaen PG, 2009, P NATL ACAD SCI USA, V106, P22498, DOI 10.1073/pnas.0912307106; DeCaen PG, 2008, P NATL ACAD SCI USA, V105, P15142, DOI 10.1073/pnas.0806486105; DELANO WL, 2002, PYMOLMOLECULAR VIEWE; Delmas P, 2005, NEURON, V47, P179, DOI 10.1016/j.neuron.2005.07.001; Doi M, 2001, ACTA CRYSTALLOGR D, V57, P628, DOI 10.1107/S0907444901002797; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; EISENMAN G, 1983, J MEMBRANE BIOL, V76, P197, DOI 10.1007/BF01870364; ELLINOR PT, 1995, NEURON, V15, P1121, DOI 10.1016/0896-6273(95)90100-0; Faham S, 2005, PROTEIN SCI, V14, P836, DOI 10.1110/ps.041167605; Faham S, 2002, J MOL BIOL, V316, P1, DOI 10.1006/jmbi.2001.5295; Favre I, 1996, BIOPHYS J, V71, P3110, DOI 10.1016/S0006-3495(96)79505-X; FELLER DJ, 1985, J BIOL CHEM, V260, P1542; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; HILLE B, 1975, J GEN PHYSIOL, V66, P535, DOI 10.1085/jgp.66.5.535; HILLE B, 1971, J GEN PHYSIOL, V58, P599, DOI 10.1085/jgp.58.6.599; HILLE B, 1972, J GEN PHYSIOL, V59, P637, DOI 10.1085/jgp.59.6.637; Hille B., 2001, ION CHANNELS EXCITAB, V3; Hockerman GH, 1997, ANNU REV PHARMACOL, V37, P361, DOI 10.1146/annurev.pharmtox.37.1.361; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Jogini V, 2005, J MOL BIOL, V354, P272, DOI 10.1016/j.jmb.2005.09.031; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Koishi R, 2004, J BIOL CHEM, V279, P9532, DOI 10.1074/jbc.M313100200; Koth CMM, 2009, ADV PROTEIN CHEM STR, V76, P43, DOI 10.1016/S1876-1623(08)76002-4; Kuzmenkin A, 2004, J GEN PHYSIOL, V124, P349, DOI 10.1085/jgp.200409139; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lee SY, 2009, PLOS BIOL, V7, P676, DOI 10.1371/journal.pbio.1000047; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; MCCLESKEY EW, 1985, P NATL ACAD SCI USA, V82, P7149, DOI 10.1073/pnas.82.20.7149; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; MORELLO RS, 1984, J PHARMACOL EXP THER, V230, P156; NODA M, 1989, FEBS LETT, V259, P213, DOI 10.1016/0014-5793(89)81531-5; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; Otwinowski Z, 1997, PROCESSING XRAY DIFF, V276; Petrek M, 2007, STRUCTURE, V15, P1357, DOI 10.1016/j.str.2007.10.007; Phillips K, 1997, J MOL BIOL, V273, P171, DOI 10.1006/jmbi.1997.1292; Ragsdale DS, 1996, P NATL ACAD SCI USA, V93, P9270, DOI 10.1073/pnas.93.17.9270; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Ryan DP, 2010, NEURON, V68, P282, DOI 10.1016/j.neuron.2010.10.008; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103; Ye S, 2010, NAT STRUCT MOL BIOL, V17, P1019, DOI 10.1038/nsmb.1865; YU FH, 2004, SCI STKE; Yue LX, 2002, J GEN PHYSIOL, V120, P845, DOI 10.1085/jgp.20028699; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; Zhao Y, 2004, P NATL ACAD SCI USA, V101, P17873, DOI 10.1073/pnas.0408270101; Zhao Y, 2004, NEURON, V41, P859, DOI 10.1016/S0896-6273(04)00116-3	66	1016	1036	14	482	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2011	475	7356					353	U104		10.1038/nature10238	http://dx.doi.org/10.1038/nature10238			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21743477	Green Accepted			2022-12-01	WOS:000292911200037
J	Li, F; Martienssen, R; Cande, WZ				Li, Fei; Martienssen, Rob; Cande, W. Zacheus			Coordination of DNA replication and histone modification by the Rik1-Dos2 complex	NATURE			English	Article							FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; POLYMERASE-EPSILON; RNA INTERFERENCE; S-PHASE; HETEROCHROMATIN FORMATION; CHROMOSOMAL REPLICATION; EPIGENETIC INHERITANCE; CELL-CYCLE; CHROMATIN	Histone modification marks have an important role in many chromatin processes(1,2). During DNA replication, both heterochromatin and euchromatin are disrupted ahead of the replication fork and are then reassembled into their original epigenetic states behind the fork(3,4). How histone marks are accurately inherited from generation to generation is still poorly understood. In fission yeast (Schizosaccharomyces pombe), RNA interference (RNAi)-mediated histone methylation is cell cycle regulated. Centromeric repeats are transiently transcribed in the S phase of the cell cycle and are processed into short interfering RNAs (siRNAs) by the complexes RITS (RNA-induced initiation of transcriptional gene silencing) and RDRC (RNA-directed RNA polymerase complex)(5-7). The small RNAs together with silencing factors-including Dos1 (also known as Clr8 and Raf1), Dos2 (also known as Clr7 and Raf2), Rik1 and Lid2-promote heterochromatic methylation of histone H3 at lysine 9 (H3K9) by a histone methyltransferase, Clr4 (refs 8-13). The methylation of H3K9 provides a binding site for Swi6, a structural and functional homologue of metazoan heterochromatin protein 1 (HP1)(14). Here we characterize a silencing complex in fission yeast that contains Dos2, Rik1, Mms19 and Cdc20 (the catalytic subunit of DNA polymerase-e). This complex regulates RNA polymerase II (RNA Pol II) activity in heterochromatin and is required for DNA replication and heterochromatin assembly. Our findings provide a molecular link between DNA replication and histone methylation, shedding light on how epigenetic marks are transmitted during each cell cycle.	[Li, Fei] NYU, Dept Biol, New York, NY 10003 USA; [Martienssen, Rob] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Cande, W. Zacheus] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	New York University; Cold Spring Harbor Laboratory; University of California System; University of California Berkeley	Li, F (corresponding author), NYU, Dept Biol, New York, NY 10003 USA.	fl43@nyu.edu		Li, Fei/0000-0002-1206-9684	National Institutes of Health [RO1GM076396]; Direct For Biological Sciences [1025830] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Allshire, P. Nurse, G. D'Urso and the Japan Yeast Genetic Resource Center for strains, E. Osborne and C. Hale for comments on the manuscript, Cold Spring Harbor Laboratory for mass spectrometry analysis, and members of the Cande and Li laboratories for their support and discussions. This work was supported by a grant from the National Institutes of Health (RO1GM076396) to W.Z.C. and R.M.	Allis C. D., 2006, EPIGENETICS; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; DUrso G, 1997, P NATL ACAD SCI USA, V94, P12491, DOI 10.1073/pnas.94.23.12491; Feng WY, 2001, MOL CELL BIOL, V21, P4495, DOI 10.1128/MCB.21.14.4495-4504.2001; Finnegan EJ, 2007, CURR BIOL, V17, P1978, DOI 10.1016/j.cub.2007.10.026; Fuss J, 2002, J BIOL CHEM, V277, P8658, DOI 10.1074/jbc.M110615200; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Hong Eun-Jin Erica, 2005, RNA Biol, V2, P106, DOI 10.4161/rna.2.3.2131; Horn PJ, 2005, GENE DEV, V19, P1705, DOI 10.1101/gad.1328005; Ito S, 2010, MOL CELL, V39, P632, DOI 10.1016/j.molcel.2010.07.029; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kirchmaier AL, 2001, SCIENCE, V291, P646, DOI 10.1126/science.291.5504.646; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lauder S, 1996, MOL CELL BIOL, V16, P6783; Li F, 2005, CURR BIOL, V15, P1448, DOI 10.1016/j.cub.2005.07.021; Li F, 2008, CELL, V135, P272, DOI 10.1016/j.cell.2008.08.036; Li YC, 2001, SCIENCE, V291, P650, DOI 10.1126/science.291.5504.650; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nakayama J, 2001, EMBO J, V20, P2857, DOI 10.1093/emboj/20.11.2857; Natsume T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002221; Pidoux A, 2004, METHODS, V33, P252, DOI 10.1016/j.ymeth.2003.11.021; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; SMITH JG, 1995, MOL CELL BIOL, V15, P5165; Thon G, 2005, GENETICS, V171, P1583, DOI 10.1534/genetics.105.048298; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wallace J, 2005, CHROMOSOMA, V114, P389, DOI 10.1007/s00412-005-0024-6; White SA, 2008, CURR TOP MICROBIOL, V320, P157; Wu XY, 2001, J BIOL CHEM, V276, P23962, DOI 10.1074/jbc.M101041200; Yin HB, 2009, PLANT CELL, V21, P386, DOI 10.1105/tpc.108.061549	32	85	85	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					244	U2562		10.1038/nature10161	http://dx.doi.org/10.1038/nature10161			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21725325	Green Submitted, Green Accepted			2022-12-01	WOS:000292690500054
J	Fidler, DP; Gostin, LO				Fidler, David P.; Gostin, Lawrence O.			The WHO Pandemic Influenza Preparedness Framework: A Milestone in Global Governance for Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Fidler, David P.] Indiana Univ, Maurer Sch Law, Bloomington, IN 47405 USA	Georgetown University; Indiana University System; Indiana University Bloomington	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				[Anonymous], WHA645 WHO; Fidler DP, 2008, EMERG INFECT DIS, V14, P88, DOI 10.3201/eid1401.070700; Fidler DP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000247; Holbrooke R, 2008, WASHINGTON POST 0810; Mack A., 2010, DOMESTIC INT IMPACTS; Secretariat of the Convention on Biological Diversity, 2011, NAG PROT ACC GEN RES; WHO, 2007, WHA6028 WHO; World Health Organization, DOC OP END WORK GROU; World Health Organization, DOC INT M PAND INFL; World Health Organization, 2011, PIPOEWG34 WHO	10	53	54	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2011	306	2					200	201		10.1001/jama.2011.960	http://dx.doi.org/10.1001/jama.2011.960			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791CO	21750298				2022-12-01	WOS:000292639400028
J	Kowey, PR				Kowey, Peter R.			The Silent Majority	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LIABILITY; REFORM		[Kowey, Peter R.] Main Line Hlth Syst, Lankenau Med Ctr, Wynnewood, PA USA; [Kowey, Peter R.] Main Line Hlth Syst, Inst Med Res, Wynnewood, PA USA; [Kowey, Peter R.] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA	Lankenau Medical Center; Jefferson University	Kowey, PR (corresponding author), Main Line Hlth Syst, Lankenau Med Ctr, Wynnewood, PA USA.	koweyp@mlhs.org						Alpert JS, 2011, AM J MED, V124, P187, DOI 10.1016/j.amjmed.2010.10.010; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; Dove JT, 2010, J AM COLL CARDIOL, V55, P2801, DOI 10.1016/j.jacc.2010.03.028; *GOV ACC OFF, 2003, MED MALPR IMPL RIS P; Mello MM, 2009, NEW ENGL J MED, V361, P1, DOI 10.1056/NEJMp0903765; Shanafelt TD, 2011, ARCH SURG-CHICAGO, V146, P54, DOI 10.1001/archsurg.2010.292; Tu JV, 1997, NEW ENGL J MED, V336, P1500, DOI 10.1056/NEJM199705223362106	7	2	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2011	306	1					18	19		10.1001/jama.2011.904	http://dx.doi.org/10.1001/jama.2011.904			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	787LV	21730231				2022-12-01	WOS:000292378700001
J	Abi-Rached, L; Jobin, MJ; Kulkarni, S; McWhinnie, A; Dalva, K; Gragert, L; Babrzadeh, F; Gharizadeh, B; Luo, M; Plummer, FA; Kimani, J; Carrington, M; Middleton, D; Rajalingam, R; Beksac, M; Marsh, SGE; Maiers, M; Guethlein, LA; Tavoularis, S; Little, AM; Green, RE; Norman, PJ; Parham, P				Abi-Rached, Laurent; Jobin, Matthew J.; Kulkarni, Subhash; McWhinnie, Alasdair; Dalva, Klara; Gragert, Loren; Babrzadeh, Farbod; Gharizadeh, Baback; Luo, Ma; Plummer, Francis A.; Kimani, Joshua; Carrington, Mary; Middleton, Derek; Rajalingam, Raja; Beksac, Meral; Marsh, Steven G. E.; Maiers, Martin; Guethlein, Lisbeth A.; Tavoularis, Sofia; Little, Ann-Margaret; Green, Richard E.; Norman, Paul J.; Parham, Peter			The Shaping of Modern Human Immune Systems by Multiregional Admixture with Archaic Humans	SCIENCE			English	Article							HLA-B ALLELES; HAPLOTYPE MAP; MHC; HISTORY; POLYMORPHISM; POPULATION; DIVERSITY; EVOLUTION; MIGRATION; SELECTION	Whole genome comparisons identified introgression from archaic to modern humans. Our analysis of highly polymorphic human leukocyte antigen (HLA) class I, vital immune system components subject to strong balancing selection, shows how modern humans acquired the HLA-B*73 allele in west Asia through admixture with archaic humans called Denisovans, a likely sister group to the Neandertals. Virtual genotyping of Denisovan and Neandertal genomes identified archaic HLA haplotypes carrying functionally distinctive alleles that have introgressed into modern Eurasian and Oceanian populations. These alleles, of which several encode unique or strong ligands for natural killer cell receptors, now represent more than half the HLA alleles of modern Eurasians and also appear to have been later introduced into Africans. Thus, adaptive introgression of archaic alleles has significantly shaped modern human immune systems.	[Abi-Rached, Laurent; Kulkarni, Subhash; Guethlein, Lisbeth A.; Norman, Paul J.; Parham, Peter] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Abi-Rached, Laurent; Kulkarni, Subhash; Guethlein, Lisbeth A.; Norman, Paul J.; Parham, Peter] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Jobin, Matthew J.] Santa Clara Univ, Dept Anthropol, Santa Clara, CA 95050 USA; [Jobin, Matthew J.] Stanford Univ, Dept Anthropol, Stanford, CA 94305 USA; [McWhinnie, Alasdair; Marsh, Steven G. E.; Little, Ann-Margaret] Royal Free Hosp, Anthony Nolan Res Inst, London NW3 2QG, England; [Dalva, Klara; Beksac, Meral] Ankara Univ, Dept Hematol, TR-06520 Ankara, Turkey; [Gragert, Loren; Maiers, Martin] Natl Marrow Donor Program, Minneapolis, MN 55413 USA; [Babrzadeh, Farbod; Gharizadeh, Baback] Stanford Univ, Sch Med, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Luo, Ma; Plummer, Francis A.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB R3E 3R2, Canada; [Luo, Ma; Plummer, Francis A.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3E 0J9, Canada; [Kimani, Joshua] Univ Nairobi, Dept Med Microbiol, Nairobi 00202, Kenya; [Carrington, Mary] NCI, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick Inc, Frederick, MD 21702 USA; [Carrington, Mary] Ragon Inst MGH MIT & Harvard, Boston, MA 02129 USA; [Middleton, Derek] Univ Liverpool, Royal Liverpool Univ Hosp, Sch Infect & Host Def, Div Immunol, Liverpool L7 8XP, Merseyside, England; [Rajalingam, Raja] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, UCLA Immunogenet Ctr, Los Angeles, CA 90095 USA; [Marsh, Steven G. E.; Little, Ann-Margaret] UCL, UCL Canc Inst, London WC1E 6BT, England; [Tavoularis, Sofia] Canadian Blood Serv, Head Off, HLA Lab, Ottawa, ON K1G 4J5, Canada; [Green, Richard E.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA	Stanford University; Stanford University; Santa Clara University; Stanford University; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Ankara University; National Marrow Donor Program; Stanford University; Public Health Agency of Canada; University of Manitoba; University of Nairobi; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of London; University College London; Canadian Blood Services; University of California System; University of California Santa Cruz	Parham, P (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	peropa@stanford.edu	Beksac, Meral/D-6411-2013; Abi-Rached, Laurent/H-7236-2012; dalva, klara/AAN-7704-2020; Kulkarni, Subhash/I-4159-2017	Beksac, Meral/0000-0003-1797-8657; dalva, klara/0000-0001-6917-6870; Kulkarni, Subhash/0000-0002-2298-0623; Norman, Paul/0000-0001-8370-7703; Maiers, Martin/0000-0002-0198-2064	NIH [AI031168]; Yerkes Center [RR000165]; NSF [CNS-0619926, TG-DBS100006]; National Cancer Institute (NCI), NIH [HHSN261200800001E]; NCI, NIH, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010792] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yerkes Center; NSF(National Science Foundation (NSF)); National Cancer Institute (NCI), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI, NIH, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank individual investigators and the Bone Marrow Donors Worldwide (BMDW) organization for kindly providing HLA class I typing data, as well as bone marrow registries from Australia, Austria, Belgium, Canada, Cyprus, Czech Republic, France, Ireland, Israel, Italy, Lithuania, Norway, Poland, Portugal, Singapore, Spain, Sweden, Switzerland, Turkey, United Kingdom, and United States for contributing typing data through BMDW. We thank E. Watkin for technical support. We are indebted to the large genome sequencing centers for early access to the gorilla genome data. We used sequence reads generated at the Wellcome Trust Sanger Institute as part of the gorilla reference genome sequencing project. These data can be obtained from the National Center for Biotechnology Information (NCBI) Trace Archive (www.ncbi.nlm.nih.gov/Traces). We also used reads generated by Washington University School of Medicine; these data were produced by the Genome Institute at Washington University School of Medicine in St. Louis and can be obtained from the NCBI Trace Archive (www.ncbi.nlm.nih.gov/Traces/). Funded by NIH grant AI031168, Yerkes Center base grant RR000165, NSF awards (CNS-0619926, TG-DBS100006), by federal funds from the National Cancer Institute (NCI), NIH (contract HHSN261200800001E), and by the Intramural Research Program of the NCI, NIH, Center for Cancer Research. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U. S. government. Sequence data have been deposited in GenBank under accession nos. JF974053 to 70.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; BELICH MP, 1992, NATURE, V357, P326, DOI 10.1038/357326a0; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Castric V, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000168; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; DECAMPOSLIMA PO, 1993, SCIENCE, V260, P98, DOI 10.1126/science.7682013; DeGiorgio M, 2009, P NATL ACAD SCI USA, V106, P16057, DOI 10.1073/pnas.0903341106; Ferrer-Admetlla A, 2008, J IMMUNOL, V181, P1315, DOI 10.4049/jimmunol.181.2.1315; Gibbons A, 2011, SCIENCE, V331, P392, DOI 10.1126/science.331.6016.392; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Graef T, 2009, J EXP MED, V206, P2557, DOI 10.1084/jem.20091010; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hansasuta P, 2004, EUR J IMMUNOL, V34, P1673, DOI 10.1002/eji.200425089; Jobin MJ, 2008, BIOINFORMATICS, V24, P2936, DOI 10.1093/bioinformatics/btn540; Moesta AK, 2008, J IMMUNOL, V180, P3969, DOI 10.4049/jimmunol.180.6.3969; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; Norman PJ, 2007, NAT GENET, V39, P1092, DOI 10.1038/ng2111; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; PARHAM P, 1994, TISSUE ANTIGENS, V43, P302, DOI 10.1111/j.1399-0039.1994.tb02344.x; PETZLERLER ML, 1993, TISSUE ANTIGENS, V41, P227; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Robinson J, 2011, NUCLEIC ACIDS RES, V39, pD1171, DOI 10.1093/nar/gkq998; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; VILCHES C, 1994, IMMUNOGENETICS, V40, P166, DOI 10.1007/BF00188185; VILCHES C, 1994, IMMUNOGENETICS, V40, P313, DOI 10.1007/BF00189983; WATKINS DI, 1992, NATURE, V357, P329, DOI 10.1038/357329a0; Yawata M, 2008, BLOOD, V112, P2369, DOI 10.1182/blood-2008-03-143727; Yotova V, 2011, MOL BIOL EVOL, V28, P1957, DOI 10.1093/molbev/msr024	30	319	327	8	246	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 7	2011	334	6052					89	94		10.1126/science.1209202	http://dx.doi.org/10.1126/science.1209202			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829KW	21868630	Green Accepted, Green Submitted			2022-12-01	WOS:000295580300046
J	Curfman, GD; Redberg, RF				Curfman, Gregory D.; Redberg, Rita F.			Medical Devices - Balancing Regulation and Innovation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		*BRIT HIP SOC BRIT, 2011, UPD GUID LARG DIAM M; Centers for Disease Control and Prevention, 2009, NAT HOSP DISCH SURV; Challoner DR, 2011, NEW ENGL J MED, V365, P977, DOI 10.1056/NEJMp1109150; Institute of Medicine, 2011, MED DEV PUBL HLTH FD	4	94	98	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2011	365	11					975	977		10.1056/NEJMp1109094	http://dx.doi.org/10.1056/NEJMp1109094			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	819UR	21830959				2022-12-01	WOS:000294857300002
J	Mukherjee, S; Liu, XY; Arasaki, K; McDonough, J; Galan, JE; Roy, CR				Mukherjee, Shaeri; Liu, Xiaoyun; Arasaki, Kohei; McDonough, Justin; Galan, Jorge E.; Roy, Craig R.			Modulation of Rab GTPase function by a protein phosphocholine transferase	NATURE			English	Article							LEGIONELLA-PNEUMOPHILA; IDENTIFICATION; AMPYLATION; DOMAIN; DRRA; DISPLACEMENT	The intracellular pathogen Legionella pneumophila modulates the activity of host GTPases to direct the transport and assembly of the membrane-bound compartment in which it resides(1-6). In vitro studies have indicated that the Legionella protein DrrA post-translationally modifies the GTPase Rab1 by a process called AMPylation(7). Here we used mass spectrometry to investigate post-translational modifications to Rab1 that occur during infection of host cells by Legionella. Consistent with in vitro studies, DrrA-mediated AMPylation of a conserved tyrosine residue in the switch II region of Rab1 was detected during infection. In addition, a modification to an adjacent serine residue in Rab1 was discovered, which was independent of DrrA. The Legionella effector protein AnkX was required for this modification. Biochemical studies determined that AnkX directly mediates the covalent attachment of a phosphocholine moiety to Rab1. This phosphocholine transferase activity used CDP-choline as a substrate and required a conserved histidine residue located in the FIC domain of the AnkX protein. During infection, AnkX modified both Rab1 and Rab35, which explains how this protein modulates membrane transport through both the endocytic and exocytic pathways of the host cell. Thus, phosphocholination of Rab GTPases represents a mechanism by which bacterial FIC-domain-containing proteins can alter host-cell functions.	[Mukherjee, Shaeri; Liu, Xiaoyun; Arasaki, Kohei; McDonough, Justin; Galan, Jorge E.; Roy, Craig R.] Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA	Yale University	Roy, CR (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, 295 Congress Ave, New Haven, CT 06536 USA.	craig.roy@yale.edu		Roy, Craig/0000-0003-4490-440X	Anna Fuller Fellowship; National Institutes of Health (NIH) [F32 AI082927, R01-AI064559, R01-AI048770]; Northeast Biodefense Center [U54-AI057158-Lipkin]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064559, F32AI082927, U54AI057158, R01AI041699, R01AI048770] Funding Source: NIH RePORTER	Anna Fuller Fellowship; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeast Biodefense Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Gulcicek and K. Stone at the Yale Keck Proteomic Facility for advice and providing the high-resolution MS/MS analysis, K. Reinish and X. Wu for providing purified connecdenn, L. Lucast and P. De Camilli for assistance with lipid analysis, X. Pan for assistance in constructing AnkX plasmids, A. Hubber for technical assistance and H. Newton for editorial assistance. This work was supported by an Anna Fuller Fellowship (S.M.), National Institutes of Health (NIH) Grants F32 AI082927 (J.M.), and NIH grants R01-AI064559, R01-AI048770 and Northeast Biodefense Center Grant U54-AI057158-Lipkin (C.R.R.).	Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Arasaki K, 2010, TRAFFIC, V11, P587, DOI 10.1111/j.1600-0854.2010.01050.x; BERGER KH, 1994, MOL MICROBIOL, V14, P809, DOI 10.1111/j.1365-2958.1994.tb01317.x; Brombacher E, 2009, J BIOL CHEM, V284, P4846, DOI 10.1074/jbc.M807505200; Chen C, 2010, P NATL ACAD SCI USA, V107, P21755, DOI 10.1073/pnas.1010485107; Grabitzki J, 2008, MOL BIOCHEM PARASIT, V161, P101, DOI 10.1016/j.molbiopara.2008.06.014; GROSS ML, 1994, J AM SOC MASS SPECTR, V5, P57, DOI 10.1016/1044-0305(94)85036-4; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818; Li ZY, 2008, J LIPID RES, V49, P1187, DOI 10.1194/jlr.R700019-JLR200; Lovell TM, 2007, J MOL ENDOCRINOL, V39, P189, DOI 10.1677/JME-07-0007; Machner MP, 2007, SCIENCE, V318, P974, DOI 10.1126/science.1149121; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Ninio S, 2007, TRENDS MICROBIOL, V15, P372, DOI 10.1016/j.tim.2007.06.006; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Roy CR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.262pe14; Schoebel S, 2009, MOL CELL, V36, P1060, DOI 10.1016/j.molcel.2009.11.014; Suh HY, 2010, EMBO J, V29, P496, DOI 10.1038/emboj.2009.347; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Yarbrough ML, 2009, NAT CHEM BIOL, V5, P378, DOI 10.1038/nchembio0609-378; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Zhu YQ, 2010, P NATL ACAD SCI USA, V107, P4699, DOI 10.1073/pnas.0914231107; Zuckman DM, 1999, MOL MICROBIOL, V32, P990, DOI 10.1046/j.1365-2958.1999.01410.x	27	219	233	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2011	477	7362					103	U122		10.1038/nature10335	http://dx.doi.org/10.1038/nature10335			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813XT	21822290	Green Accepted, Green Submitted			2022-12-01	WOS:000294404300040
J	de Lau, W; Barker, N; Low, TY; Koo, BK; Li, VSW; Teunissen, H; Kujala, P; Haegebarth, A; Peters, PJ; van de Wetering, M; Stange, DE; van Es, JE; Guardavaccaro, D; Schasfoort, RBM; Mohri, Y; Nishimori, K; Mohammed, S; Heck, AJR; Clevers, H				de Lau, Wim; Barker, Nick; Low, Teck Y.; Koo, Bon-Kyoung; Li, Vivian S. W.; Teunissen, Hans; Kujala, Pekka; Haegebarth, Andrea; Peters, Peter J.; van de Wetering, Marc; Stange, Daniel E.; van Es, Johan E.; Guardavaccaro, Daniele; Schasfoort, Richard B. M.; Mohri, Yasuaki; Nishimori, Katsuhiko; Mohammed, Shabaz; Heck, Albert J. R.; Clevers, Hans			Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling	NATURE			English	Article							PANETH CELL-DIFFERENTIATION; STEM-CELLS; SMALL-INTESTINE; PEPTIDE IDENTIFICATION; HAIR FOLLICLE; REPORTER GENE; NULL MICE; IN-VITRO; EXPRESSION; R-SPONDIN1	The adult stem cell marker Lgr5 and its relative Lgr4 are often co-expressed in Wnt-driven proliferative compartments. We find that conditional deletion of both genes in the mouse gut impairs Wnt target gene expression and results in the rapid demise of intestinal crypts, thus phenocopying Wnt pathway inhibition. Mass spectrometry demonstrates that Lgr4 and Lgr5 associate with the Frizzled/Lrp Wnt receptor complex. Each of the four R-spondins, secreted Wnt pathway agonists, can bind to Lgr4, -5 and -6. In HEK293 cells, RSPO1 enhances canonical WNT signals initiated by WNT3A. Removal of LGR4 does not affect WNT3A signalling, but abrogates the RSPO1-mediated signal enhancement, a phenomenon rescued by re-expression of LGR4, -5 or -6. Genetic deletion of Lgr4/5 in mouse intestinal crypt cultures phenocopies withdrawal of Rspo1 and can be rescued by Wnt pathway activation. Lgr5 homologues are facultative Wnt receptor components that mediate Wnt signal enhancement by soluble R-spondin proteins. These results will guide future studies towards the application of R-spondins for regenerative purposes of tissues expressing Lgr5 homologues.	[de Lau, Wim; Barker, Nick; Koo, Bon-Kyoung; Li, Vivian S. W.; Teunissen, Hans; Haegebarth, Andrea; van de Wetering, Marc; Stange, Daniel E.; van Es, Johan E.; Guardavaccaro, Daniele; Clevers, Hans] Univ Med Ctr, NL-3584 CX Utrecht, Netherlands; [de Lau, Wim; Barker, Nick; Koo, Bon-Kyoung; Li, Vivian S. W.; Teunissen, Hans; Haegebarth, Andrea; van de Wetering, Marc; Stange, Daniel E.; van Es, Johan E.; Guardavaccaro, Daniele; Clevers, Hans] Hubrecht Inst, NL-3584 CX Utrecht, Netherlands; [Low, Teck Y.; Mohammed, Shabaz; Heck, Albert J. R.] Univ Utrecht, Biomol Mass Spectrometry & Prote Grp, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Low, Teck Y.; Mohammed, Shabaz; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Kujala, Pekka; Peters, Peter J.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Schasfoort, Richard B. M.] Univ Twente, Med Cell Biophys MIRA Inst, NL-7500 AE Enschede, Netherlands; [Mohri, Yasuaki; Nishimori, Katsuhiko] Tohoku Univ, Sendai, Miyagi 9818555, Japan	Utrecht University; Utrecht University Medical Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University; Netherlands Cancer Institute; University of Twente; Tohoku University	Clevers, H (corresponding author), Univ Med Ctr, NL-3584 CX Utrecht, Netherlands.	h.clevers@hubrecht.eu	Barker, Nick/AAS-2774-2020; Stange, Daniel E/O-1837-2015; Low, Teck Yew/J-4403-2014; Low, Teck Yew/Q-5946-2019; Barker, Nick/A-5535-2011; Mohammed, Shabaz/D-1042-2010; Heck, Albert/D-7098-2011; van+Es, Johan/ABD-5411-2021; Koo, Bon-Kyoung/V-5219-2017; Mohammed, Shabaz/AAY-6313-2020; Barker, Nick/AAE-9833-2021	Stange, Daniel E/0000-0003-4246-2230; Low, Teck Yew/0000-0001-7878-7534; Low, Teck Yew/0000-0001-7878-7534; Mohammed, Shabaz/0000-0003-2640-9560; Heck, Albert/0000-0002-2405-4404; Koo, Bon-Kyoung/0000-0002-4134-8033; Mohammed, Shabaz/0000-0003-2640-9560; Barker, Nick/0000-0003-3566-4475; Li, Vivian/0000-0003-2041-0085; Schasfoort, Richard/0000-0003-1601-3853; Guardavaccaro, Daniele/0000-0002-4517-1765				Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Flanagan CA, 2005, MOL PHARMACOL, V68, P1, DOI 10.1124/mol.105.014183; Frese CK, 2011, J PROTEOME RES, V10, P2377, DOI 10.1021/pr1011729; Garcia MI, 2009, DEV BIOL, V331, P58, DOI 10.1016/j.ydbio.2009.04.020; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Ireland H, 2005, DEV DYNAM, V233, P1332, DOI 10.1002/dvdy.20446; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kato S, 2007, FEBS LETT, V581, P4685, DOI 10.1016/j.febslet.2007.08.064; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Morita H, 2004, MOL CELL BIOL, V24, P9736, DOI 10.1128/MCB.24.22.9736-9743.2004; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Ng SS, 2009, J BIOL CHEM, V284, P35308, DOI 10.1074/jbc.M109.078261; Ohkawara B, 2011, DEV CELL, V20, P303, DOI 10.1016/j.devcel.2011.01.006; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Raijmakers R, 2008, MOL CELL PROTEOMICS, V7, P1755, DOI 10.1074/mcp.M800093-MCP200; ROBINE S, 1993, J BIOL CHEM, V268, P11426; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Van Schoore G, 2005, HISTOCHEM CELL BIOL, V124, P35, DOI 10.1007/s00418-005-0002-3; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Zhao JS, 2007, GASTROENTEROLOGY, V132, P1331, DOI 10.1053/j.gastro.2007.02.001	42	852	899	4	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2011	476	7360					293	U57		10.1038/nature10337	http://dx.doi.org/10.1038/nature10337			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21727895				2022-12-01	WOS:000294206500030
J	Vidan, MT; Sanchez, E; Gracia, Y; Maranon, E; Vaquero, J; Serra, JA				Vidan, Maria T.; Sanchez, Elisabet; Gracia, Yassira; Maranon, Eugenio; Vaquero, Javier; Serra, Jose A.			Causes and Effects of Surgical Delay in Patients With Hip Fracture A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							PROXIMAL FEMORAL FRACTURES; TIME-TO-SURGERY; ELDERLY-PATIENTS; OPERATIVE DELAY; OLDER PATIENTS; MORTALITY; MORBIDITY; OUTCOMES; IMPACT; FEMUR	Background: The clinical effect of surgical delay in older patients with hip fracture is controversial. Discrepancies among study findings may be due to confounding that is caused by the reason for the delay or a differential effect on patient risk subgroups. Objective: To assess the effect of surgical delay on hospital outcomes according to the cause of delay. Design: Prospective cohort study. Setting: A hip fracture unit in a university hospital in Spain. Patients: 2250 consecutive elderly patients with hip fracture. Measurements: Time to surgery, reasons for surgical delay, adjusted in-hospital death, and risk for complications. Results: Median time to surgery was 72 hours. Lack of operating room availability (60.7%) and acute medical problems (33.1%) were the main reasons for delays longer than 48 hours. Overall, rates of hospital death and complications were 4.35% and 45.9%, respectively, but were 13.7% and 74.2% in clinically unstable patients. Longer delays were associated with higher mortality rates and rates of medical complications. After adjustment for age, dementia, chronic comorbid conditions, and functionality, this association did not persist for delays of 120 hours or less but did persist for delays longer than 120 hours (P = 0.002 for overall time effect on death and 0.002 for complications). The risks were attenuated after adjustment for the presence of acute medical conditions as the cause of the delay (P = 0.06 for time effect on mortality and 0.31 on medical complications). Risk for urinary tract infection remained elevated (odds ratio, 1.54 [95% CI, 0.99 to 2.44]). No interaction between delay and age, dementia, or functional status was found. Limitation: This was a single-center study without postdischarge follow-up. Conclusion: The reported association between late surgery and higher morbidity and mortality in patients with hip fracture is mostly explained by medical reasons for surgical delay, although some association between very delayed surgery and worse outcomes persists.	[Vidan, Maria T.] Hosp Gen Univ Gregorio Maranon, Dept Geriatr Med, Dr Esquerdo 46, Madrid 28007, Spain	General University Gregorio Maranon Hospital	Vidan, MT (corresponding author), Hosp Gen Univ Gregorio Maranon, Dept Geriatr Med, Dr Esquerdo 46, Madrid 28007, Spain.	mvidan.hgugm@salud.madrid.org		Serra Rexach, Jose A./0000-0003-1698-0624	Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III, Ministry of Science and Innovation, Spain [INT 09/078]	Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III, Ministry of Science and Innovation, Spain	Dr. Vidan was partially supported by a Program for research intensification grant of the Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III, Ministry of Science and Innovation, Spain (INT 09/078).	[Anonymous], 2010, SCOTTISH HIP FRACTUR; Bottle A, 2006, BMJ-BRIT MED J, V332, P947, DOI 10.1136/bmj.38790.468519.55; Elliott J, 2003, J CLIN EPIDEMIOL, V56, P788, DOI 10.1016/S0895-4356(03)00129-X; Fleisher Lee A, 2009, Cleve Clin J Med, V76 Suppl 4, pS9, DOI 10.3949/ccjm.76.s4.02; Franzo A, 2006, BRIT MED J, V332, P1093, DOI 10.1136/bmj.332.7549.1093-a; Friedman SM, 2009, ARCH INTERN MED, V169, P1712, DOI 10.1001/archinternmed.2009.321; Gdalevich M, 2004, ARCH ORTHOP TRAUM SU, V124, P334, DOI 10.1007/s00402-004-0662-9; Grimes JP, 2002, AM J MED, V112, P702, DOI 10.1016/S0002-9343(02)01119-1; Hamlet W P, 1997, Am J Orthop (Belle Mead NJ), V26, P621; HOLDEN MK, 1984, PHYS THER, V64, P35, DOI 10.1093/ptj/64.1.35; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Khan SK, 2009, INJURY, V40, P692, DOI 10.1016/j.injury.2009.01.010; Lyons AR, 1997, AM J MED, V103, P51; Majumdar SR, 2006, MED CARE, V44, P552, DOI 10.1097/01.mlr.0000215812.13720.2e; Moran CG, 2005, J BONE JOINT SURG AM, V87A, P483, DOI 10.2106/JBJS.D.01796; New Zealand Guidelines Group, 2003, AC MAN IMM REH HIP F, pa; Novack V, 2007, INT J QUAL HEALTH C, V19, P170, DOI 10.1093/intqhc/mzm003; Orosz GM, 2004, JAMA-J AM MED ASSOC, V291, P1738, DOI 10.1001/jama.291.14.1738; Orosz GM, 2002, J AM GERIATR SOC, V50, P1336, DOI 10.1046/j.1532-5415.2002.50353.x; PARKER MJ, 1992, J BONE JOINT SURG BR, V74, P203, DOI 10.1302/0301-620X.74B2.1544952; PEREZ JV, 1995, INJURY, V26, P237, DOI 10.1016/0020-1383(95)90008-L; Rae HC, 2007, ANZ J SURG, V77, P889, DOI 10.1111/j.1445-2197.2007.04267.x; ROGERS FB, 1995, J TRAUMA, V39, P261, DOI 10.1097/00005373-199508000-00012; Scottish Intercollegiate Guidelines Network, 2009, MAN HIP FRACT OLD PA; Siegmeth AW, 2005, J BONE JOINT SURG BR, V87B, P1123, DOI 10.1302/0301-620X.87B8; Simunovic N, 2010, CAN MED ASSOC J, V182, P1609, DOI 10.1503/cmaj.092220; Smektala R, 2000, ZBL CHIR, V125, P744, DOI 10.1055/s-2000-10657; Smektala R, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-171; Soderqvist A, 2009, GERONTOLOGY, V55, P496, DOI 10.1159/000230587; Vidan M, 2005, J AM GERIATR SOC, V53, P1476, DOI 10.1111/j.1532-5415.2005.53466.x; Weller I, 2005, J BONE JOINT SURG BR, V87B, P361, DOI 10.1302/0301-620X.87B3.15300; Zuckerman JD, 1996, NEW ENGL J MED, V334, P1519, DOI 10.1056/NEJM199606063342307; ZUCKERMAN JD, 1995, J BONE JOINT SURG AM, V77, P1551, DOI 10.2106/00004623-199510000-00010	34	131	140	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2011	155	4					226	+		10.7326/0003-4819-155-4-201108160-00006	http://dx.doi.org/10.7326/0003-4819-155-4-201108160-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	807KN	21844548				2022-12-01	WOS:000293896400003
J	von Kleist, L; Stahlschmidt, W; Bulut, H; Gromova, K; Puchkov, D; Robertson, MJ; MacGregor, KA; Tomlin, N; Pechstein, A; Chau, N; Chircop, M; Sakoff, J; von Kries, JP; Saenger, W; Krausslich, HG; Shupliakov, O; Robinson, PJ; McCluskey, A; Haucke, V				von Kleist, Lisa; Stahlschmidt, Wiebke; Bulut, Haydar; Gromova, Kira; Puchkov, Dmytro; Robertson, Mark J.; MacGregor, Kylie A.; Tomlin, Nikolay; Pechstein, Arndt; Ngoc Chau; Chircop, Megan; Sakoff, Jennette; von Kries, Jens Peter; Saenger, Wolfram; Kraeusslich, Hans-Georg; Shupliakov, Oleg; Robinson, Phillip J.; McCluskey, Adam; Haucke, Volker			Role of the Clathrin Terminal Domain in Regulating Coated Pit Dynamics Revealed by Small Molecule Inhibition	CELL			English	Article							MEDIATED ENDOCYTOSIS; PROTEINS; CELLS; ENTRY; ENDOSOMES; BIOLOGY; ACTIN; SITES	Clathrin-mediated endocytosis (CME) regulates many cell physiological processes such as the internalization of growth factors and receptors, entry of pathogens, and synaptic transmission. Within the endocytic network, clathrin functions as a central organizing platform for coated pit assembly and dissociation via its terminal domain (TD). We report the design and synthesis of two compounds named pitstops that selectively block endocytic ligand association with the clathrin TD as confirmed by X-ray crystallography. Pitstop-induced inhibition of clathrin TD function acutely interferes with receptor-mediated endocytosis, entry of HIV, and synaptic vesicle recycling. Endocytosis inhibition is caused by a dramatic increase in the lifetimes of clathrin coat components, including FCHo, clathrin, and dynamin, suggesting that the clathrin TD regulates coated pit dynamics. Pitstops provide new tools to address clathrin function in cell physiology with potential applications as inhibitors of virus and pathogen entry and as modulators of cell signaling.	[von Kleist, Lisa; Stahlschmidt, Wiebke; Bulut, Haydar; Gromova, Kira; Puchkov, Dmytro; Pechstein, Arndt; Saenger, Wolfram; Haucke, Volker] Free Univ Berlin, Inst Chem & Biochem & Neurocure Cluster Excellenc, D-14195 Berlin, Germany; [Robertson, Mark J.; MacGregor, Kylie A.; McCluskey, Adam] Univ Newcastle, Ctr Chem Biol, Callaghan, NSW 2308, Australia; [Tomlin, Nikolay; Pechstein, Arndt; Shupliakov, Oleg] Karolinska Inst, DBRM, Dept Neurosci, S-17117 Stockholm, Sweden; [Ngoc Chau; Chircop, Megan; Robinson, Phillip J.] Univ Sydney, Childrens Med Res Inst, Cell Signalling Unit, Sydney, NSW 2145, Australia; [Sakoff, Jennette] Calvary Mater Newcastle Hosp, Dept Med Oncol, Waratah, NSW 2298, Australia; [von Kries, Jens Peter; Haucke, Volker] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Kraeusslich, Hans-Georg] Heidelberg Univ, Dept Infect Dis, D-69120 Heidelberg, Germany	Free University of Berlin; University of Newcastle; Karolinska Institutet; Children's Medical Research Institute - Australia; University of Sydney; Calvary Mater Newcastle Hospital; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Ruprecht Karls University Heidelberg	Haucke, V (corresponding author), Free Univ Berlin, Inst Chem & Biochem & Neurocure Cluster Excellenc, D-14195 Berlin, Germany.	volker.haucke@fu-berlin.de	Sakoff, Jennette/AAU-6469-2021; Robertson, Mark/E-9173-2014; Shupliakov, Oleg/R-9148-2016; Robinson, Phillip J/G-4008-2011; Tomilin, Nikolay V/B-4676-2014; McCluskey, Adam/F-1894-2011	Sakoff, Jennette/0000-0002-7009-5792; Robertson, Mark/0000-0002-2140-2717; Shupliakov, Oleg/0000-0001-5352-6848; Robinson, Phillip J/0000-0002-7878-0313; Tomilin, Nikolay V/0000-0002-5581-3848; McCluskey, Adam/0000-0001-7125-863X; Haucke, Volker/0000-0003-3119-6993; von Kleist, Lisa/0000-0001-9938-6510; Puchkov, Dmytro/0000-0001-8341-4847	Deutsche Forschungsgemeinschaft [FOR 806-HA2686/3-1, FOR 806-HA2686/3-2, SFB765/B4, Exc-257]; European Science Foundation [Euromembrane-HA2686/6-1]; Swedish Research Council [13473, 20587]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Science Foundation(European Science Foundation (ESF)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission)	We thank Drs. Gilbert Di Paolo, Ludger Johannes, and Oliver Daumke for critical comments and Drs. Harvey Mc Mahon, Ludger Johannes, Pietro De Camilli, Tom Sudhof, and Sven Carlsson for reagents. Cytotoxicity assays were conducted with help from Aimee Novelle, Swetha Perera, and Dr. Jayne Gilbert. This work was supported by grants from the Deutsche Forschungsgemeinschaft (FOR 806-HA2686/3-1,3-2; SFB765/B4 to V. H.; Exc-257), the European Science Foundation (Euromembrane-HA2686/6-1), and the Swedish Research Council (grants 13473 and 20587 to O.S.).	Bhattacharyya S, 2010, VIROLOGY, V401, P18, DOI 10.1016/j.virol.2010.02.015; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Boucrot E, 2006, EXP CELL RES, V312, P4036, DOI 10.1016/j.yexcr.2006.09.025; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Daecke J, 2005, J VIROL, V79, P1581, DOI 10.1128/JVI.79.3.1581-1594.2005; Dittman J, 2009, ANNU REV CELL DEV BI, V25, P133, DOI 10.1146/annurev.cellbio.042308.113302; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Goh LK, 2010, J CELL BIOL, V189, P871, DOI 10.1083/jcb.201001008; Heerssen H, 2008, CURR BIOL, V18, P401, DOI 10.1016/j.cub.2008.02.055; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; Hinrichsen L, 2006, P NATL ACAD SCI USA, V103, P8715, DOI 10.1073/pnas.0600312103; Hirst J, 2009, TRAFFIC, V10, P1696, DOI 10.1111/j.1600-0854.2009.00983.x; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Joshi S, 2010, MOL CANCER THER, V9, P1995, DOI 10.1158/1535-7163.MCT-10-0161; Knuehl C, 2006, TRAFFIC, V7, P1688, DOI 10.1111/j.1600-0854.2006.00499.x; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mettlen M, 2009, MOL BIOL CELL, V20, P3251, DOI 10.1091/mbc.E09-03-0256; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Pechstein A, 2010, P NATL ACAD SCI USA, V107, P4206, DOI 10.1073/pnas.0911073107; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; Saint-Pol A, 2004, DEV CELL, V6, P525, DOI 10.1016/S1534-5807(04)00100-5; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Slepnev VI, 2000, J BIOL CHEM, V275, P17583, DOI 10.1074/jbc.M910430199; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; Veiga E, 2007, CELL HOST MICROBE, V2, P340, DOI 10.1016/j.chom.2007.10.001	33	360	368	3	77	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 5	2011	146	3					471	484		10.1016/j.cell.2011.06.025	http://dx.doi.org/10.1016/j.cell.2011.06.025			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	803GT	21816279	Bronze			2022-12-01	WOS:000293570500020
J	Tang, N; Marshall, WF; McMahon, M; Metzger, RJ; Martin, GR				Tang, Nan; Marshall, Wallace F.; McMahon, Martin; Metzger, Ross J.; Martin, Gail R.			Control of Mitotic Spindle Angle by the RAS-Regulated ERK1/2 Pathway Determines Lung Tube Shape	SCIENCE			English	Article							PLANAR CELL POLARITY; ONCOGENIC K-RAS; BRANCHING MORPHOGENESIS; KIDNEY-DISEASE; SPROUTY GENES; MOUSE LUNG; IN-VIVO; ORIENTATION; DIVISION; PROGRESSION	During early lung development, airway tubes change shape. Tube length increases more than circumference as a large proportion of lung epithelial cells divide parallel to the airway longitudinal axis. We show that this bias is lost in mutants with increased extracellular signal-regulated kinase 1 (ERK1) and ERK2 activity, revealing a link between the ERK1/2 signaling pathway and the control of mitotic spindle orientation. Using a mathematical model, we demonstrate that change in airway shape can occur as a function of spindle angle distribution determined by ERK1/2 signaling, independent of effects on cell proliferation or cell size and shape. We identify sprouty genes, which encode negative regulators of fibroblast growth factor 10 (FGF10)-mediated RAS-regulated ERK1/2 signaling, as essential for controlling airway shape change during development through an effect on mitotic spindle orientation.	[Tang, Nan; Metzger, Ross J.; Martin, Gail R.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Marshall, Wallace F.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [McMahon, Martin] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94158 USA; [McMahon, Martin] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Metzger, RJ (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA.	ross.metzger@ucsf.edu; gail.r.martin@ucsf.edu	McMahon, Martin/L-3303-2013	McMahon, Martin/0000-0003-2812-1042; Tang, Nan/0000-0002-8284-3372	NIH [R01 CA131201, R01 GM077004, R01 CA78711, R01 DE17744, 5T32HL007185]; W. M. Keck Foundation; Sandler Foundation; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA131261, R01CA078711] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077004] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); Sandler Foundation; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to J. Licht and J. Zallen for insightful and helpful suggestions; B. Hann for technical advice; K. Thorn (Nikon Imaging Center at UCSF/QB3) for imaging assistance; and D. Hom, P. Ghatpande, C. Firkus, and E. Yu for technical assistance. We also thank members of the Martin, Metzger, and Marshall laboratories and M. Barna, P. Devine, U. Grieshammer, J. Jeong, O. Klein, M. Kumar, S. Luschnig, A. Mogilner, S. Rafelski, and S. Greenberg for helpful comments on the manuscript. This work was supported by NIH grants R01 CA131201 (to M.McM.), R01 GM077004 (to W. F. M), and R01 CA78711 and R01 DE17744 (to G. R. M.). W. F. M. was supported by the W. M. Keck Foundation; R. J. M. was supported by the UCSF Program for Breakthrough Biomedical Research, which is funded in part by the Sandler Foundation; N.T. was supported by an American Heart Association postdoctoral fellowship and NIH training grant 5T32HL007185.	Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Bellusci S, 1997, DEVELOPMENT, V124, P4867; Benazeraf B, 2010, NATURE, V466, P248, DOI 10.1038/nature09151; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Colvin JS, 2001, DEVELOPMENT, V128, P2095; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Furthauer M, 2001, DEVELOPMENT, V128, P2175; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Gros J, 2010, CURR BIOL, V20, P1993, DOI 10.1016/j.cub.2010.09.063; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Huxley J. S., 1936, Nature London, V137, P780, DOI 10.1038/137780b0; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Kieserman EK, 2009, J CELL SCI, V122, P2481, DOI 10.1242/jcs.042135; Klein OD, 2008, DEVELOPMENT, V135, P377, DOI 10.1242/dev.015081; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; Liu Y, 2004, CURR BIOL, V14, P897, DOI 10.1016/j.cub.2004.05.020; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Minowada G, 1999, DEVELOPMENT, V126, P4465; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Shaw AT, 2007, GENE DEV, V21, P694, DOI 10.1101/gad.1526207; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; WEIBEL ER, 1962, SCIENCE, V137, P577, DOI 10.1126/science.137.3530.577; Young A, 2009, ADV CANCER RES, V102, P1, DOI 10.1016/S0065-230X(09)02001-6	35	128	128	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2011	333	6040					342	345		10.1126/science.1204831	http://dx.doi.org/10.1126/science.1204831			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21764747	Green Accepted			2022-12-01	WOS:000292732000043
J	Alaynick, WA; Jessell, TM; Pfaff, SL				Alaynick, William A.; Jessell, Thomas M.; Pfaff, Samuel L.			Snapshot: Spinal Cord Development	CELL			English	Editorial Material							CIRCUITS; SPECIFICATION; NETWORKS		[Alaynick, William A.; Pfaff, Samuel L.] Salk Inst Biol Studies, HHMI, La Jolla, CA 92037 USA; [Jessell, Thomas M.] Columbia Univ, HHMI, New York, NY 10032 USA	Howard Hughes Medical Institute; Salk Institute; Columbia University; Howard Hughes Medical Institute	Alaynick, WA (corresponding author), Salk Inst Biol Studies, HHMI, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037116, P01NS031249, R37NS037116, R01NS054172] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS037116-08S1, R01 NS037116, R01 NS037116-08, R01 NS054172-05, R01 NS037116-03, R01 NS037116-07, R01 NS037116-10, R01 NS054172-01A2, P01 NS031249, R01 NS037116-04, P01 NS031249-16, P01 NS031249-17, R01 NS037116-07S1, P01 NS031249-14A1, R01 NS037116-05, R01 NS054172, R01 NS054172-02, P01 NS031249-15, R01 NS037116-04S1, P01 NS031249-18, R01 NS037116-06A1, R01 NS054172-03, R01 NS037116-09, R37 NS037116, R01 NS054172-04] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Goulding M, 2005, CURR OPIN NEUROBIOL, V15, P14, DOI 10.1016/j.conb.2005.01.017; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; Jankowska E, 2001, J PHYSIOL-LONDON, V533, P31, DOI 10.1111/j.1469-7793.2001.0031b.x; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Ladle DR, 2007, NEURON, V56, P270, DOI 10.1016/j.neuron.2007.09.026; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750	10	186	189	2	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 8	2011	146	1					178	U19		10.1016/j.cell.2011.06.038	http://dx.doi.org/10.1016/j.cell.2011.06.038			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729788	Bronze, Green Accepted			2022-12-01	WOS:000292539300015
J	He, FJ; MacGregor, GA				He, Feng J.; MacGregor, Graham A.			Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials	LANCET			English	Editorial Material							DIETARY SALT; DISEASE; PREVENTION		[He, Feng J.; MacGregor, Graham A.] Queen Mary Univ London, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, London EC1M 6BQ, England	University of London; Queen Mary University London	MacGregor, GA (corresponding author), Queen Mary Univ London, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, London EC1M 6BQ, England.	g.macgregor@qmul.ac.uk		He, Feng/0000-0003-2807-4119				[Anonymous], 2011, DAILY EXPRESS   0706; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Food Standards Agency, 2008, DIET SOD LEV SURV; He FJ, 2010, PROG CARDIOVASC DIS, V52, P363, DOI 10.1016/j.pcad.2009.12.006; He FJ, 2003, HYPERTENSION, V42, P1093, DOI 10.1161/01.HYP.0000102864.05174.E8; LAW MR, 1991, BMJ-BRIT MED J, V302, P811, DOI 10.1136/bmj.302.6780.811; National Institute for Health and Clinical Excellence, 2010, GUID PREV CARD DIS P; Paterna S, 2008, CLIN SCI, V114, P221, DOI 10.1042/CS20070193; Strazzullo Pasquale, 2009, BMJ, V339, pb4567, DOI 10.1136/bmj.b4567; Taylor RS, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003331.pub4; Taylor RS, 2011, AM J HYPERTENS, V24, P843, DOI 10.1038/ajh.2011.115	12	258	272	2	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2011	378	9789					380	382		10.1016/S0140-6736(11)61174-4	http://dx.doi.org/10.1016/S0140-6736(11)61174-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803XM	21803192				2022-12-01	WOS:000293615900007
J	Rosenthal, PJ				Rosenthal, Philip J.			Lessons from Sickle Cell Disease in the Treatment and Control of Malaria	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Rosenthal, PJ (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.							de Souza JB, 2010, PARASITOLOGY, V137, P755, DOI 10.1017/S0031182009991715; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Ferreira A, 2011, CELL, V145, P398, DOI 10.1016/j.cell.2011.03.049; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009	5	13	15	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2011	364	26					2549	2551		10.1056/NEJMcibr1105118	http://dx.doi.org/10.1056/NEJMcibr1105118			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	785AM	21714653				2022-12-01	WOS:000292199800015
J	Hachet, O; Berthelot-Grosjean, M; Kokkoris, K; Vincenzetti, V; Moosbrugger, J; Martin, SG				Hachet, Olivier; Berthelot-Grosjean, Martine; Kokkoris, Kyriakos; Vincenzetti, Vincent; Moosbrugger, Josselin; Martin, Sophie G.			A Phosphorylation Cycle Shapes Gradients of the DYRK Family Kinase Pom1 at the Plasma Membrane	CELL			English	Article							FISSION YEAST; CELL POLARITY; PROTEIN-KINASES; DIVISION PLANE; GROWTH; TEA1; DETERMINANTS; CYTOSKELETON; ACTIVATION; MITOSIS	Concentration gradients regulate many cell biological and developmental processes. In rod-shaped fission yeast cells, polar cortical gradients of the DYRK family kinase Pom1 couple cell length with mitotic commitment by inhibiting a mitotic inducer positioned at midcell. However, how Pom1 gradients are established is unknown. Here, we show that Tea4, which is normally deposited at cell tips by microtubules, is both necessary and, upon ectopic cortical localization, sufficient to recruit Pom1 to the cell cortex. Pom1 then moves laterally at the plasma membrane, which it binds through a basic region exhibiting direct lipid interaction. Pom1 autophosphorylates in this region to lower lipid affinity and promote membrane release. Tea4 triggers Pom1 plasma membrane association by promoting its dephosphorylation through the protein phosphatase 1 Dis2. We propose that local dephosphorylation induces Pom1 membrane association and nucleates a gradient shaped by the opposing actions of lateral diffusion and autophosphorylation-dependent membrane detachment.	[Hachet, Olivier; Berthelot-Grosjean, Martine; Kokkoris, Kyriakos; Vincenzetti, Vincent; Moosbrugger, Josselin; Martin, Sophie G.] Univ Lausanne, Fac Biol & Med, Dept Fundamental Microbiol, CH-1015 Lausanne, Switzerland	University of Lausanne	Martin, SG (corresponding author), Univ Lausanne, Fac Biol & Med, Dept Fundamental Microbiol, CH-1015 Lausanne, Switzerland.	sophie.martin@unil.ch		Martin, Sophie/0000-0002-5317-2557; Berthelot-Grosjean, Martine/0000-0002-7168-2622	Human Frontiers Science Program (HFSP) long-term fellowship [LT00595/2005-L]; Roche [67-2008]; Swiss National Science Foundation [PP00A-114936]; HFSP Career Development Award [CDA0016/2008]; European Research Council [260493]	Human Frontiers Science Program (HFSP) long-term fellowship(Human Frontier Science Program); Roche(Roche Holding); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); HFSP Career Development Award; European Research Council(European Research Council (ERC)European Commission)	We would like to thank Patrice Waridel and Manfredo Quadroni at the Protein Analysis Facility for the mass spectrometry, Philippe Kircher for technical help, Jurg Bahler, Iain Hagan, and Stuart MacNeill for strains and reagents, Yves Barral, Felipe Bendezu, and Richard Benton for comments on the manuscript, and all members of the lab for advice and discussion. O.H. was supported by a Human Frontiers Science Program (HFSP) long-term fellowship (LT00595/2005-L) and K. K. by a Roche research fellowship (67-2008). Research in S. G. M.'s laboratory is supported by a Swiss National Science Foundation Professorship grant (PP00A-114936), an HFSP Career Development Award (CDA0016/2008), and a European Research Council Starting Grant (260493). We also extend our thanks to the Center for Integrative Genomics at the University of Lausanne, where a large part of this work was conducted, for generous support.	Almonacid M, 2009, CURR BIOL, V19, P961, DOI 10.1016/j.cub.2009.04.024; Alvarez-Tabares I, 2007, J CELL SCI, V120, P3589, DOI 10.1242/jcs.007567; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bahler J, 2001, EMBO J, V20, P1064, DOI 10.1093/emboj/20.5.1064; Bicho CC, 2010, CURR BIOL, V20, P1752, DOI 10.1016/j.cub.2010.08.035; Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; Campbell LE, 2002, FEBS LETT, V510, P31, DOI 10.1016/S0014-5793(01)03221-5; Celton-Morizur S, 2006, J CELL SCI, V119, P4710, DOI 10.1242/jcs.03261; CHANG F, 2009, PERSPECT BIOL, V1; Fuller BG, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-5; GREENBERG ML, 1993, J MEMBRANE BIOL, V131, P115, DOI 10.1007/BF02791320; Himpel S, 2000, J BIOL CHEM, V275, P2431, DOI 10.1074/jbc.275.4.2431; Huang YY, 2007, DEV CELL, V12, P987, DOI 10.1016/j.devcel.2007.03.015; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Knaus M, 2005, EMBO J, V24, P3000, DOI 10.1038/sj.emboj.7600783; KOUKOU AI, 1990, J GEN MICROBIOL, V136, P1271, DOI 10.1099/00221287-136-7-1271; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Martin SG, 2005, DEV CELL, V8, P479, DOI 10.1016/j.devcel.2005.02.008; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; Morrell JL, 2004, J CELL SCI, V117, P5293, DOI 10.1242/jcs.01409; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Padte NN, 2006, CURR BIOL, V16, P2480, DOI 10.1016/j.cub.2006.11.024; Snaith HA, 2005, EMBO J, V24, P3690, DOI 10.1038/sj.emboj.7600838; Tatebe H, 2005, CURR BIOL, V15, P1006, DOI 10.1016/j.cub.2005.04.061; Tatebe H, 2008, CURR BIOL, V18, P322, DOI 10.1016/j.cub.2008.02.005; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; WARTLICK O, 2009, PERSPECT BIOL, V1	30	89	90	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 24	2011	145	7					1116	1128		10.1016/j.cell.2011.05.014	http://dx.doi.org/10.1016/j.cell.2011.05.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703453	Bronze, Green Published			2022-12-01	WOS:000292025700017
J	Kofoed, EM; Vance, RE				Kofoed, Eric M.; Vance, Russell E.			Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity	NATURE			English	Article							CELL-DEATH; CASPASE-1; ACTIVATION; FLAGELLIN; INTERLEUKIN-1-BETA; SECRETION; BIRC1E	Inflammasomes are a family of cytosolic multiprotein complexes that initiate innate immune responses to pathogenic microbes by activating the caspase 1 protease(1,2). Although genetic data support a critical role for inflammasomes in immune defence and inflammatory diseases(3), the molecular basis by which individual inflammasomes respond to specific stimuli remains poorly understood. The inflammasome that contains the NLRC4 (NLR family, CARD domain containing 4) protein was previously shown to be activated in response to two distinct bacterial proteins, flagellin(4,5) and PrgJ(6), a conserved component of pathogen-associated type III secretion systems. However, direct binding between NLRC4 and flagellin or PrgJ has never been demonstrated. A homologue of NLRC4, NAIP5 (NLR family, apoptosis inhibitory protein 5), has been implicated in activation of NLRC4 (refs 7-11), but is widely assumed to have only an auxiliary role(1,2), as NAIP5 is often dispensable for NLRC4 activation(7,8). However, Naip5 is a member of a small multigene family(12), raising the possibility of redundancy and functional specialization among Naip genes. Here we show in mice that different NAIP paralogues determine the specificity of the NLRC4 inflammasome for distinct bacterial ligands. In particular, we found that activation of endogenous NLRC4 by bacterial PrgJ requires NAIP2, a previously uncharacterized member of the NAIP gene family, whereas NAIP5 and NAIP6 activate NLRC4 specifically in response to bacterial flagellin. We dissected the biochemical mechanism underlying the requirement for NAIP proteins by use of a reconstituted NLRC4 inflammasome system. We found that NAIP proteins control ligand-dependent oligomerization of NLRC4 and that the NAIP2-NLRC4 complex physically associates with PrgJ but not flagellin, whereas NAIP5-NLRC4 associates with flagellin but not PrgJ. Our results identify NAIPs as immune sensor proteins and provide biochemical evidence for a simple receptor-ligand model for activation of the NAIP-NLRC4 inflammasomes.	[Kofoed, Eric M.; Vance, Russell E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Vance, RE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.	rvance@berkeley.edu			Burroughs Wellcome Fund; Cancer Research Institute; NIH [AI075039, AI080749, AI063302]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI063302, R01AI075039, R01AI080749] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Cancer Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work in R.E.V.'s laboratory is supported by Investigator Awards from the Burroughs Wellcome Fund and the Cancer Research Institute and by NIH grants AI075039, AI080749 and AI063302. We thank J. von Moltke, A. Kintzer and B. Krantz for provision of reagents; S. Mariathasan and V. Dixit for the gift of anti-NLRC4 antibodies and Nlrc4<SUP>-/-</SUP> mice; J. D. Sauer and D. Portnoy for development of Listeria strains to deliver PrgJ and FlaA; and E. Michelle Long and W. Dietrich for pCDNA3-NAIP constructs and anti-NAIP antibodies. We thank A. Roberts for her initial efforts to knock down NAIP2, M. Fontana for validating NAIP knockdowns, and J. von Moltke and members of the Barton and Vance laboratories for discussions.	Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Damiano JS, 2004, BIOCHEM J, V381, P213, DOI 10.1042/BJ20031506; Diez E, 2003, NAT GENET, V33, P55, DOI 10.1038/ng1065; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Growney JD, 2000, GENOME RES, V10, P1158, DOI 10.1101/gr.10.8.1158; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Lightfield KL, 2011, INFECT IMMUN, V79, P1606, DOI 10.1128/IAI.01187-10; Lu CF, 2005, BIOCHEM BIOPH RES CO, V331, P1114, DOI 10.1016/j.bbrc.2005.04.027; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Romanish MT, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030010; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Wright EK, 2003, CURR BIOL, V13, P27, DOI 10.1016/S0960-9822(02)01359-3; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	26	609	627	1	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2011	477	7366					592	U356		10.1038/nature10394	http://dx.doi.org/10.1038/nature10394			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21874021	Green Accepted			2022-12-01	WOS:000295320900040
J	McGrath, PT; Xu, YF; Ailion, M; Garrison, JL; Butcher, RA; Bargmann, CI				McGrath, Patrick T.; Xu, Yifan; Ailion, Michael; Garrison, Jennifer L.; Butcher, Rebecca A.; Bargmann, Cornelia I.			Parallel evolution of domesticated Caenorhabditis species targets pheromone receptor genes	NATURE			English	Article							ELEGANS DAUER LARVA; MOLECULAR EVOLUTION; COMPONENT; BEHAVIOR; NEURONS; FOOD	Evolution can follow predictable genetic trajectories(1), indicating that discrete environmental shifts can select for reproducible genetic changes(2-4). Conspecific individuals are an important feature of an animal's environment, and a potential source of selective pressures. Here we show that adaptation of two Caenorhabditis species to growth at high density, a feature common to domestic environments, occurs by reproducible genetic changes to pheromone receptor genes. Chemical communication through pheromones that accumulate during high-density growth causes young nematode larvae to enter the long-lived but non-reproductive dauer stage. Two strains of Caenorhabditis elegans grown at high density have independently acquired multigenic resistance to pheromone-induced dauer formation. In each strain, resistance to the pheromone ascaroside C3 results from a deletion that disrupts the adjacent chemoreceptor genes serpentine receptor class g (srg)-36 and -37. Through misexpression experiments, we show that these genes encode redundant G-protein-coupled receptors for ascaroside C3. Multigenic resistance to dauer formation has also arisen in high-density cultures of a different nematode species, Caenorhabditis briggsae, resulting in part from deletion of an srg gene paralogous to srg-36 and srg-37. These results demonstrate rapid remodelling of the chemoreceptor repertoire as an adaptation to specific environments, and indicate that parallel changes to a common genetic substrate can affect life-history traits across species.	[McGrath, Patrick T.; Xu, Yifan; Garrison, Jennifer L.; Bargmann, Cornelia I.] Rockefeller Univ, Lab Neural Circuits & Behav, Howard Hughes Med Inst, New York, NY 10065 USA; [Ailion, Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Butcher, Rebecca A.] Univ Florida, Dept Chem, Gainesville, FL 32611 USA	Howard Hughes Medical Institute; Rockefeller University; Utah System of Higher Education; University of Utah; State University System of Florida; University of Florida	Bargmann, CI (corresponding author), Rockefeller Univ, Lab Neural Circuits & Behav, Howard Hughes Med Inst, New York, NY 10065 USA.	cori@rockefeller.edu	Ailion, Michael/ABE-6210-2021	Ailion, Michael/0000-0002-8070-1362; Bargmann, Cornelia/0000-0002-8484-0618	Damon Runyon Fellowship; Medical Scientist Training Program (MSTP) [GM07739]; Paul and Daisy Soros Fellowship; National Institutes of Health (NIH) [K99 GM092859]; HHMI;  [R00GM87533]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739, K99GM092859, R00GM087533] Funding Source: NIH RePORTER	Damon Runyon Fellowship; Medical Scientist Training Program (MSTP); Paul and Daisy Soros Fellowship; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Lu for the LSJ2 strain, M. Rockman for a qgIR1(X,CB4856>N2) introgression strain, J. Ragains for ascaroside synthesis, H. Hang for assistance in purifying pheromones and S. Dewell, K. Foster, N. Ringstad, A. Bendesky, Y. Saheki, M. Zimmer, S. Crosson, E. Feinberg, E. Toro, M. Rockman and L. Kruglyak for comments and advice. P. T. M. was funded by a Damon Runyon Fellowship. Y. X. was supported by Medical Scientist Training Program (MSTP) grant GM07739 and a Paul and Daisy Soros Fellowship. J. L. G. was an HHMI fellow of the Helen Hay Whitney Foundation and is funded by National Institutes of Health (NIH) K99 GM092859. R. A. B. is supported by R00GM87533. C. I. B. is an investigator of the Howard Hughes Medical Institute. This work was supported by the HHMI.	BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Butcher RA, 2008, P NATL ACAD SCI USA, V105, P14288, DOI 10.1073/pnas.0806676105; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Butcher RA, 2009, ORG LETT, V11, P3100, DOI 10.1021/ol901011c; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Cutter AD, 2008, MOL BIOL EVOL, V25, P778, DOI 10.1093/molbev/msn024; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; FODOR A, 1983, NEMATOLOGICA, V29, P203, DOI 10.1163/187529283X00456; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; Hu P.J., 2007, DAUER, DOI [10.1895/wormbook.1.144.1, DOI 10.1895/WORMBOOK.1.144.1]; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kim K, 2009, SCIENCE, V326, P994, DOI 10.1126/science.1176331; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; McGrath PT, 2009, NEURON, V61, P692, DOI 10.1016/j.neuron.2009.02.012; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; Stiernagle Theresa, 2006, WormBook, P1; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768; Szewczyk NJ, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-19; Thomas JH, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-42; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Viney ME, 2003, DEV GROWTH DIFFER, V45, P389, DOI 10.1046/j.1440-169X.2003.00703.x; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Weber KP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013922; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1	36	159	166	1	58	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2011	477	7364					321	U92		10.1038/nature10378	http://dx.doi.org/10.1038/nature10378			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819TD	21849976	Green Accepted			2022-12-01	WOS:000294852400029
J	Gee, HY; Noh, SH; Tang, BL; Kim, KH; Lee, MG				Gee, Heon Yung; Noh, Shin Hye; Tang, Bor Luen; Kim, Kyung Hwan; Lee, Min Goo			Rescue of Delta F508-CFTR Trafficking via a GRASP-Dependent Unconventional Secretion Pathway	CELL			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOPLASMIC-RETICULUM; DYNAMIC REGULATION; BREFELDIN-A; PROTEIN; CFTR; MEMBRANE; STACKING; SURFACE; BINDS	The most prevalent disease-causing mutation of CFTR is the deletion of Phe508 (Delta F508), which leads to defects in conventional Golgi-mediated exocytosis and cell surface expression. We report that Delta F508-CFTR surface expression can be rescued in vitro and in vivo by directing it to an unconventional GRASP-dependent secretion pathway. An integrated molecular and physiological analysis indicates that mechanisms associated with ER stress induce cell surface trafficking of the ER core-glycosylated wild-type and Delta F508-CFTR via the GRASP-dependent pathway. Phosphorylation of a specific site of GRASP and the PDZ-based interaction between GRASP and CFTR are critical for this unconventional surface trafficking. Remarkably, transgenic expression of GRASP in Delta F508-CFTR mice restores CFTR function and rescues mouse survival without apparent toxicity. These findings provide insight into how unconventional protein secretion is activated, and offer a potential therapeutic strategy for the treatment of cystic fibrosis and perhaps diseases stemming from other misfolded proteins.	[Gee, Heon Yung; Noh, Shin Hye; Kim, Kyung Hwan; Lee, Min Goo] Yonsei Univ, Dept Pharmacol, Brain Korea Project Med Sci 21, Severance Biomed Sci Inst,Coll Med, Seoul 120752, South Korea; [Tang, Bor Luen] Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, Singapore 117597, Singapore	Yonsei University; Yonsei University Health System; National University of Singapore	Lee, MG (corresponding author), Yonsei Univ, Dept Pharmacol, Brain Korea Project Med Sci 21, Severance Biomed Sci Inst,Coll Med, Seoul 120752, South Korea.	mlee@yuhs.ac	Lee, Min Goo/AAS-4636-2020; Tang, Bor Luen/E-4548-2012; Lee, Min Goo/D-5635-2012; Gee, Heon Yung/K-7781-2019	Lee, Min Goo/0000-0001-7436-012X; Tang, Bor Luen/0000-0002-1925-636X; Lee, Min Goo/0000-0001-7436-012X; Gee, Heon Yung/0000-0002-8741-6177; Noh, Shin Hye/0000-0003-3118-9240	Ministry of Education, Science, and Technology, Korea [2011-0001178, 2011-0016484]; Ministry of Health and Welfare, Korea [A030001]; Ministry of Education of Singapore	Ministry of Education, Science, and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Health and Welfare, Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Ministry of Education of Singapore(Ministry of Education, Singapore)	We thank Shmuel Muallem, Hyun Woo Park, and Dong-Su Jang for helpful discussions and editorial assistance, and the Yonsei-Carl Zeiss Advanced Imaging Center, Yonsei Proteome Research Center, and the Mouse Division of Macrogen for technical assistance. This work was supported by grants 2011-0001178 and 2011-0016484 from the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology, Korea, and A030001 from the Korea Health 21 R&D Project, Ministry of Health and Welfare, Korea. B.L.T. is supported by an AcRF grant from the Ministry of Education of Singapore. H.Y.G. and S.H.N. performed the experiments, analyzed data, and wrote the paper. B.L.T. and K.H.K. assisted in performing experiments. M.G.L. designed and coordinated the study and wrote the paper.	Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Becq F, 2010, DRUGS, V70, P241, DOI 10.2165/11316160-000000000-00000; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Egan ME, 2002, NAT MED, V8, P485, DOI 10.1038/nm0502-485; Gee HY, 2010, J BIOL CHEM, V285, P35519, DOI 10.1074/jbc.M110.162438; Gee HY, 2009, GASTROENTEROLOGY, V137, P607, DOI 10.1053/j.gastro.2009.01.065; Han W, 2006, J BIOL CHEM, V281, P1461, DOI 10.1074/jbc.M509786200; Hatsuzawa K, 2006, MOL BIOL CELL, V17, P3964, DOI 10.1091/mbc.E05-12-1174; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Jesch SA, 2001, MOL BIOL CELL, V12, P1811, DOI 10.1091/mbc.12.6.1811; Kinseth MA, 2007, CELL, V130, P524, DOI 10.1016/j.cell.2007.06.029; Kunzelmann K, 2001, NEWS PHYSIOL SCI, V16, P167; Lee JH, 2007, J BIOL CHEM, V282, P10414, DOI 10.1074/jbc.M610857200; Luo Y, 2009, BIOCHEM J, V419, P211, DOI 10.1042/BJ20081869; Manjithaya R, 2011, TRENDS CELL BIOL, V21, P67, DOI 10.1016/j.tcb.2010.09.009; Manjithaya R, 2010, J CELL BIOL, V188, P537, DOI 10.1083/jcb.200911149; MILLER SG, 1992, J CELL BIOL, V118, P267, DOI 10.1083/jcb.118.2.267; Namkung W, 2005, GASTROENTEROLOGY, V129, P1979, DOI 10.1053/j.gastro.2005.08.049; Pahl HL, 1999, PHYSIOL REV, V79, P683, DOI 10.1152/physrev.1999.79.3.683; Park HW, 2010, GASTROENTEROLOGY, V139, P620, DOI 10.1053/j.gastro.2010.04.004; Quinton Paul M., 1999, Physiological Reviews, V79, pS3; Rennolds J, 2008, BIOCHEM BIOPH RES CO, V366, P1025, DOI 10.1016/j.bbrc.2007.12.065; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roxo-Rosa M, 2006, P NATL ACAD SCI USA, V103, P17891, DOI 10.1073/pnas.0608312103; Russell C, 2010, TRAFFIC, V11, P303, DOI 10.1111/j.1600-0854.2009.01026.x; Schotman H, 2008, DEV CELL, V14, P171, DOI 10.1016/j.devcel.2007.12.006; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Tang BL, 2011, TRAFFIC, V12, P364, DOI 10.1111/j.1600-0854.2011.01161.x; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wiseman RL, 2010, CELL, V140, P590, DOI 10.1016/j.cell.2010.02.006; Yoo JS, 2002, J BIOL CHEM, V277, P11401, DOI 10.1074/jbc.M110263200; ZEIHER BG, 1995, J CLIN INVEST, V96, P2051, DOI 10.1172/JCI118253; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848	39	216	222	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 2	2011	146	5					746	760		10.1016/j.cell.2011.07.021	http://dx.doi.org/10.1016/j.cell.2011.07.021			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21884936	Bronze			2022-12-01	WOS:000294477500015
J	Bartels, T; Choi, JG; Selkoe, DJ				Bartels, Tim; Choi, Joanna G.; Selkoe, Dennis J.			alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation	NATURE			English	Article							PARKINSONS-DISEASE; BINDING; NEURODEGENERATION; MUTATIONS; COMPLEXES; PROTEINS	Parkinson's disease is the second most common neurodegenerative disorder(1,2). Growing evidence indicates a causative role of misfolded forms of the protein alpha-synuclein in the pathogenesis of Parkinson's disease(3,4). Intraneuronal aggregates of alpha-synuclein occur in Lewy bodies and Lewy neurites(5), the cytopathological hallmarks of Parkinson's disease and related disorders called synucleinopathies(4). alpha-Synuclein has long been defined as a 'natively unfolded' monomer of about 14 kDa (ref. 6) that is believed to acquire alpha-helical secondary structure only upon binding to lipid vesicles(7). This concept derives from the widespread use of recombinant bacterial expression protocols for in vitro studies, and of overexpression, sample heating and/or denaturing gels for cell culture and tissue studies. In contrast, we report that endogenous alpha-synuclein isolated and analysed under non-denaturing conditions from neuronal and non-neuronal cell lines, brain tissue and living human cells occurs in large part as a folded tetramer of about 58 kDa. Several methods, including analytical ultracentrifugation, scanning transmission electron microscopy and in vitro cell crosslinking confirmed the occurrence of the tetramer. Native, cell-derived alpha-synuclein showed alpha-helical structure without lipid addition and had much greater lipid-binding capacity than the recombinant alpha-synuclein studied heretofore. Whereas recombinantly expressed monomers readily aggregated intoamyloid-like fibrilsin vitro, native human tetramers underwent little or no amyloid-like aggregation. On the basis of these findings, we propose that destabilization of the helically folded tetramer precedes alpha-synuclein misfolding and aggregation in Parkinson's disease and other human synucleinopathies, and that small molecules that stabilize the physiological tetramer could reduce alpha-synuclein pathogenicity.	[Bartels, Tim; Choi, Joanna G.; Selkoe, Dennis J.] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Bartels, Tim; Choi, Joanna G.; Selkoe, Dennis J.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Selkoe, DJ (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	dselkoe@rics.bwh.harvard.edu	Bartels, Tim/AAD-6128-2021	Bartels, Tim/0000-0002-4071-5612	NIH [NS051318, NS038375]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038375, R01NS051318] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Mass measurements were carried out at the Brookhaven National Laboratory STEM facility, a user facility supported by the US Department of Energy. We are grateful to D. Walker and J. Anderson (Elan Pharmaceuticals) for conducting mass spectrometry of our purified alpha-synuclein samples and for comments. We thank X. Simon and I. Perovic (Brandeis University) for their assistance with the AUC and phosphate analyses. Supported by NIH grants NS051318 and NS038375 (D.J.S.). We thank our colleagues at the Center for Neurologic Diseases for many discussions.	Beyer K, 2007, CELL BIOCHEM BIOPHYS, V47, P285, DOI 10.1007/s12013-007-0014-9; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Connelly S, 2010, CURR OPIN STRUC BIOL, V20, P54, DOI 10.1016/j.sbi.2009.12.009; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; DeTure M, 2000, BRAIN RES, V853, P5, DOI 10.1016/S0006-8993(99)02124-1; Gupta A, 2008, ANN NEUROL, V64, pS3, DOI 10.1002/ana.21573; Klucken J, 2006, FASEB J, V20, P2050, DOI 10.1096/fj.05-5422com; Ko LW, 2008, J NEUROPATH EXP NEUR, V67, P1084, DOI 10.1097/NEN.0b013e31818c3618; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; McLean PJ, 2000, J BIOL CHEM, V275, P8812, DOI 10.1074/jbc.275.12.8812; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Quintas A, 1999, J BIOL CHEM, V274, P32943, DOI 10.1074/jbc.274.46.32943; Scherzer CR, 2008, P NATL ACAD SCI USA, V105, P10907, DOI 10.1073/pnas.0802437105; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Smith DP, 2008, BIOCHEMISTRY-US, V47, P1425, DOI 10.1021/bi701522m; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tong JC, 2010, BRAIN, V133, P172, DOI 10.1093/brain/awp282; Tsika E, 2010, J NEUROSCI, V30, P3409, DOI 10.1523/JNEUROSCI.4977-09.2010; Wall JS, 2008, METHOD ENZYMOL, V436, P487, DOI 10.1016/S0076-6879(08)36027-3; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Wittig I, 2005, PROTEOMICS, V5, P4338, DOI 10.1002/pmic.200500081	24	849	860	11	293	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2011	477	7362					107	U123		10.1038/nature10324	http://dx.doi.org/10.1038/nature10324			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813XT	21841800	Green Accepted			2022-12-01	WOS:000294404300041
J	Vader, G; Blitzblau, HG; Tame, MA; Falk, JE; Curtin, L; Hochwagen, A				Vader, Gerben; Blitzblau, Hannah G.; Tame, Mihoko A.; Falk, Jill E.; Curtin, Lisa; Hochwagen, Andreas			Protection of repetitive DNA borders from self-induced meiotic instability	NATURE			English	Article							DOUBLE-STRAND-BREAK; SACCHAROMYCES-CEREVISIAE; RECOMBINATION INITIATION; HISTONE DEACETYLASE; BUDDING YEAST; PROTEIN; GENE; REPLICATION; METABOLISM; MECHANISMS	DNA double strand breaks (DSBs) in repetitive sequences are a potent source of genomic instability, owing to the possibility of non-allelic homologous recombination (NAHR). Repetitive sequences are especially at risk during meiosis, when numerous programmed DSBs are introduced into the genome to initiate meiotic recombination(1). In the repetitive ribosomal DNA (rDNA) array of the budding yeast Saccharomyces cerevisiae, meiotic DSB formation is prevented in part through Sir2-dependent heterochromatin formation(2,3). Here we show that the edges of the rDNA array are exceptionally susceptible to meiotic DSBs, revealing an inherent heterogeneity in the rDNA array. We find that this localized DSB susceptibility necessitates a border-specific protection system consisting of the meiotic ATPase Pch2 and the origin recognition complex subunit Orc1. Upon disruption of these factors, DSB formation and recombination increased specifically in the outermost rDNA repeats, leading to NAHR and rDNA instability. Notably, the Sir2-dependent heterochromatin of the rDNA itself was responsible for the induction of DSBs at the rDNA borders in pch2 Delta cells. Thus, although the activity of Sir2 globally prevents meiotic DSBs in the rDNA, it creates a highly permissive environment for DSB formation at the junctions between heterochromatin and euchromatin. Heterochromatinized repetitive DNA arrays are abundant in most eukaryotic genomes. Our data define the borders of such chromatin domains as distinct high-risk regions for meiotic NAHR, the protection of which may be a universal requirement to prevent meiotic genome rearrangements that are associated with genomic diseases and birth defects.	[Vader, Gerben; Blitzblau, Hannah G.; Tame, Mihoko A.; Falk, Jill E.; Curtin, Lisa; Hochwagen, Andreas] Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; [Curtin, Lisa] Somerville High Sch, Somerville, MA 02143 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Hochwagen, A (corresponding author), NYU, Dept Biol, 100 Washington Sq E, New York, NY 10003 USA.	andi@nyu.edu		Vader, Gerben/0000-0001-5729-0991; Falk, Jill/0000-0003-2910-9803; Hochwagen, Andreas/0000-0002-6184-443X	NIH [GM088248]; Netherlands Organisation for Scientific Research [NWO Rubicon-825.08.009, NWO VENI-016.111.004]; HHMI [52005879]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088248] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. P. Bell, A. Shinohara, N. Hunter, N. Hollingsworth and F. Klein for sharing reagents and data. We thank I. Cheeseman, M. Gehring and V. Subramanian for discussions and critical reading of the manuscript. This work was supported by NIH grant GM088248 to A.H. and by fellowships from the Netherlands Organisation for Scientific Research (NWO Rubicon-825.08.009 and NWO VENI-016.111.004) to G.V.; L.C. was supported by an HHMI Institutional Undergraduate Education Grant to MIT (grant 52005879).	Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Arora C, 2004, MOL CELL, V13, P549, DOI 10.1016/S1097-2765(04)00063-2; Bell SP, 2002, GENE DEV, V16, P659, DOI 10.1101/gad.969602; BELL SP, 1995, CELL, V83, P563, DOI 10.1016/0092-8674(95)90096-9; Blitzblau HG, 2007, CURR BIOL, V17, P2003, DOI 10.1016/j.cub.2007.10.066; Blitzblau HG, 2011, METHODS MOL BIOL, V745, P47, DOI 10.1007/978-1-61779-129-1_4; Borner GV, 2008, P NATL ACAD SCI USA, V105, P3327, DOI 10.1073/pnas.0711864105; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; CHERNOFF YO, 1994, EMBO J, V13, P906, DOI 10.1002/j.1460-2075.1994.tb06334.x; Coelho PSR, 2002, GENE DEV, V16, P2755, DOI 10.1101/gad.1035002; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Gibson DG, 2006, GENES CELLS, V11, P557, DOI 10.1111/j.1365-2443.2006.00967.x; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hoang ML, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001228; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; James P, 1996, GENETICS, V144, P1425; Keeney S, 2006, BIOCHEM SOC T, V34, P523, DOI 10.1042/BST0340523; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Kobayashi T, 2006, GENES GENET SYST, V81, P155, DOI 10.1266/ggs.81.155; LOIDL J, 1991, CHROMOSOMA, V100, P221, DOI 10.1007/BF00344155; Mieczkowski PA, 2007, P NATL ACAD SCI USA, V104, P3955, DOI 10.1073/pnas.0700412104; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Peoples TL, 2002, GENE DEV, V16, P1682, DOI 10.1101/gad.983802; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; San-Segundo PA, 1999, CELL, V97, P313, DOI 10.1016/S0092-8674(00)80741-2; Sasaki M, 2010, NAT REV MOL CELL BIO, V11, P182, DOI 10.1038/nrm2849; Vader G, 2010, CURR BIOL, V20, pR879, DOI 10.1016/j.cub.2010.09.037; Wu HY, 2006, CURR BIOL, V16, P2473, DOI 10.1016/j.cub.2006.10.069	30	70	70	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2011	477	7362					115	U141		10.1038/nature10331	http://dx.doi.org/10.1038/nature10331			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813XT	21822291	Green Accepted			2022-12-01	WOS:000294404300043
J	Kleykamp, BA; Heishman, SJ				Kleykamp, Bethea A.; Heishman, Stephen J.			The Older Smoker	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SMOKING-CESSATION; UNITED-STATES; ADULTS		[Kleykamp, Bethea A.] NIDA, Intramural Res Program, Nicotine Psychopharmacol Sect, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Kleykamp, BA (corresponding author), NIDA, Intramural Res Program, Nicotine Psychopharmacol Sect, NIH, 251 Bayview Blvd,Ste 200, Baltimore, MD 21224 USA.	annie.kleykamp@nih.gov			Intramural NIH HHS [ZIA DA000483-08] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000483, ZIADA000484] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Almeida OP, 2011, NEUROIMAGE, V55, P1480, DOI 10.1016/j.neuroimage.2011.01.063; Brega AG, 2008, AGE AGEING, V37, P521, DOI 10.1093/ageing/afn121; Fiore M, 2008, TREATING TOBACCO USE, P1; Han B, 2009, ADDICTION, V104, P88, DOI 10.1111/j.1360-0443.2008.02411.x; Hughes JR, 2007, NICOTINE TOB RES, V9, P315, DOI 10.1080/14622200701188919; Husten C G, 1997, Tob Control, V6, P175, DOI 10.1136/tc.6.3.175; Molander L, 2001, CLIN PHARMACOL THER, V69, P57, DOI 10.1067/mcp.2001.113181; Ossip-Klein D J, 1999, Nicotine Tob Res, V1, P299, DOI 10.1080/14622299050011421; Thorne S. L., 2008, Morbidity and Mortality Weekly Report, V57, P1221; Vincent G, NEXT 4 DECADES OLDER	10	22	22	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 24	2011	306	8					876	877		10.1001/jama.2011.1221	http://dx.doi.org/10.1001/jama.2011.1221			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	810VY	21862749	Green Accepted			2022-12-01	WOS:000294157300027
J	Cavallaro, E; Date, K; Medus, C; Meyer, S; Miller, B; Kim, C; Nowicki, S; Cosgrove, S; Sweat, D; Phan, Q; Flint, J; Daly, ER; Adams, J; Hyytia-Trees, E; Gerner-Smidt, P; Hoekstra, RM; Schwensohn, C; Langer, A; Sodha, SV; Rogers, MC; Angulo, FJ; Tauxe, RV; Williams, IT; Behravesh, CB				Cavallaro, Elizabeth; Date, Kashmira; Medus, Carlota; Meyer, Stephanie; Miller, Benjamin; Kim, Clara; Nowicki, Scott; Cosgrove, Shaun; Sweat, David; Phan, Quyen; Flint, James; Daly, Elizabeth R.; Adams, Jennifer; Hyytia-Trees, Eija; Gerner-Smidt, Peter; Hoekstra, Robert M.; Schwensohn, Colin; Langer, Adam; Sodha, Samir V.; Rogers, Michael C.; Angulo, Frederick J.; Tauxe, Robert V.; Williams, Ian T.; Behravesh, Casey Barton		Salmonella Typhimurium Outbreak	Salmonella Typhimurium Infections Associated with Peanut Products	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OUTBREAK; BUTTER	BACKGROUND Contaminated food ingredients can affect multiple products, each distributed through various channels and consumed in multiple settings. Beginning in November 2008, we investigated a nationwide outbreak of salmonella infections. METHODS A case was defined as laboratory-confirmed infection with the outbreak strain of Salmonella Typhimurium occurring between September 1, 2008, and April 20, 2009. We conducted two case-control studies, product "trace-back," and environmental investigations. RESULTS Among 714 case patients identified in 46 states, 166 (23%) were hospitalized and 9 (1%) died. In study 1, illness was associated with eating any peanut butter (matched odds ratio, 2.5; 95% confidence interval [CI], 1.3 to 5.3), peanut butter-containing products (matched odds ratio, 2.2; 95% CI, 1.1 to 4.7), and frozen chicken products (matched odds ratio, 4.6; 95% CI, 1.7 to 14.7). Investigations of focal clusters and single cases associated with nine institutions identified a single institutional brand of peanut butter (here called brand X) distributed to all facilities. In study 2, illness was associated with eating peanut butter outside the home (matched odds ratio, 3.9; 95% CI, 1.6 to 10.0) and two brands of peanut butter crackers (brand A: matched odds ratio, 17.2; 95% CI, 6.9 to 51.5; brand B: matched odds ratio, 3.6; 95% CI, 1.3 to 9.8). Both cracker brands were made from brand X peanut paste. The outbreak strain was isolated from brand X peanut butter, brand A crackers, and 15 other products. A total of 3918 peanut butter-containing products were recalled between January 10 and April 29, 2009. CONCLUSIONS Contaminated peanut butter and peanut products caused a nationwide salmonellosis outbreak. Ingredient-driven outbreaks are challenging to detect and may lead to widespread contamination of numerous food products.	[Cavallaro, Elizabeth; Date, Kashmira; Adams, Jennifer; Hyytia-Trees, Eija; Gerner-Smidt, Peter; Hoekstra, Robert M.; Schwensohn, Colin; Langer, Adam; Sodha, Samir V.; Angulo, Frederick J.; Tauxe, Robert V.; Williams, Ian T.; Behravesh, Casey Barton] Ctr Dis Control & Prevent, Program Off Sci Educ & Profess Dev, Natl Ctr Emerging & Zoonot Infect Dis, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30333 USA; [Cavallaro, Elizabeth; Date, Kashmira; Kim, Clara] Ctr Dis Control & Prevent, Program Off Sci Educ & Profess Dev, Epidem Intelligence Serv, Atlanta, GA USA; [Medus, Carlota; Meyer, Stephanie] Minnesota Dept Hlth, St Paul, MN USA; [Miller, Benjamin] Minnesota Dept Agr, St Paul, MN USA; [Kim, Clara; Nowicki, Scott] Ohio Dept Hlth, Columbus, OH USA; [Cosgrove, Shaun] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Sweat, David] N Carolina Div Publ Hlth, Raleigh, NC USA; [Phan, Quyen] Connecticut Dept Publ Hlth, Hartford, CT USA; [Flint, James] Publ Hlth Agcy Canada, Ottawa, ON, Canada; [Daly, Elizabeth R.] New Hampshire Dept Hlth & Human Serv, Concord, NH USA; [Rogers, Michael C.] US FDA, Silver Spring, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Minnesota Department of Health (MHD); Colorado Department of Public Health & Environment; Public Health Agency of Canada; US Food & Drug Administration (FDA)	Cavallaro, E (corresponding author), Ctr Dis Control & Prevent, Program Off Sci Educ & Profess Dev, Natl Ctr Emerging & Zoonot Infect Dis, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30333 USA.	ecavallaro@cdc.gov	Trees, Eija/AAY-7538-2020; Daly, Elizabeth/ABC-1577-2021; BARTON BEHRAVESH, Casey/HDL-8040-2022; Langer, Adam Justin/P-1188-2019	Trees, Eija/0000-0001-6694-2445; Daly, Elizabeth/0000-0003-3468-5151; BARTON BEHRAVESH, Casey/0000-0003-2270-5573; Langer, Adam Justin/0000-0001-5980-3359; Miller, Benjamin/0000-0003-1647-0122; Hoekstra, Robert Michael/0000-0002-0340-8015				[Anonymous], 2009, MMWR-MORBID MORTAL W, V58, P85; Behravesh CB, 2011, NEW ENGL J MED, V364, P918, DOI 10.1056/NEJMoa1005741; Burnett SL, 2000, J APPL MICROBIOL, V89, P472, DOI 10.1046/j.1365-2672.2000.01138.x; *CDCP, 2007, FOODB OUTBR DUE CONF; *CDCP, 2008, INV INF OUTBR SALM T; *CONAGRA FOODS, PET PAN PEAN BUTT FR; Council to Improve Foodborne Outbreak Response (CIFOR), 2009, GUID FOODB DIS OUTBR; DOLYLE M, 2009, US PEAN C AM ISL FL; FIALKOW G, CANNED GOOD SHELF LI; *FOOD DRUG ADM, 2009, REP DEP HLTH HUM SER; *FOOD DRUG ADM, 2009, RES CONS IND; *FOOD DRUG ADM, 2009, PEAN BUTT OTH PEAN C; *FOOD DRUG ADM, 2009, FDAS INV WESTC FRUIT; *FOOD DRUG ADM, 2009, NEW APPR TARG SPECT; *FOOD DRUG ADM, 1998, BACT AN MAN BAM SALM; *FOODNET, 2006, POP SURV DAT; Grimont PAD, 2007, ANTIGENIC FORMULAE S; Lehmacher A, 1995, EPIDEMIOL INFECT, V115, P501, DOI 10.1017/S0950268800058660; Ma L, 2009, J FOOD PROTECT, V72, P1596, DOI 10.4315/0362-028X-72.8.1596; Park EJ, 2008, J FOOD SCI, V73, pM82, DOI 10.1111/j.1750-3841.2007.00638.x; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI 10.3201/eid1701.091101p2; Shachar D, 2006, J FOOD PROTECT, V69, P2687, DOI 10.4315/0362-028X-69.11.2687; Sotir MJ, 2010, PEDIATR INFECT DIS J, V29, P284, DOI 10.1097/01.inf.0000369241.58743.90; Sotir MJ, 2009, PEDIATR INFECT DIS J, V28, P1041, DOI 10.1097/INF.0b013e3181af6218; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; 2007, MMWR MORB MORTAL WKL, V21, P521; 2009, THOMASNET NEWS  0311	28	74	76	2	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2011	365	7					601	610		10.1056/NEJMoa1011208	http://dx.doi.org/10.1056/NEJMoa1011208			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808ER	21848461				2022-12-01	WOS:000293960500007
J	Shinzato, C; Shoguchi, E; Kawashima, T; Hamada, M; Hisata, K; Tanaka, M; Fujie, M; Fujiwara, M; Koyanagi, R; Ikuta, T; Fujiyama, A; Miller, DJ; Satoh, N				Shinzato, Chuya; Shoguchi, Eiichi; Kawashima, Takeshi; Hamada, Mayuko; Hisata, Kanako; Tanaka, Makiko; Fujie, Manabu; Fujiwara, Mayuki; Koyanagi, Ryo; Ikuta, Tetsuro; Fujiyama, Asao; Miller, David J.; Satoh, Nori			Using the Acropora digitifera genome to understand coral responses to environmental change	NATURE			English	Article							IMMUNE GENE REPERTOIRE; CLIMATE-CHANGE; REVEALS; COMPLEXITY; BIOSYNTHESIS; ALIGNMENTS; MECHANISMS; EVOLUTION; SEQUENCE; DATABASE	Despite the enormous ecological and economic importance of coral reefs, the keystone organisms in their establishment, the scleractinian corals, increasingly face a range of anthropogenic challenges including ocean acidification and seawater temperature rise(1-4). To understand better the molecular mechanisms underlying coral biology, here we decoded the approximately 420-megabase genome of Acropora digitifera using next-generation sequencing technology. This genome contains approximately 23,700 gene models. Molecular phylogenetics indicate that the coral and the sea anemone Nematostella vectensis diverged approximately 500 million years ago, considerably earlier than the time over which modern corals are represented in the fossil record (similar to 240 million years ago)(5). Despite the long evolutionary history of the endosymbiosis, no evidence was found for horizontal transfer of genes from symbiont to host. However, unlike several other corals, Acropora seems to lack an enzyme essential for cysteine biosynthesis, implying dependency of this coral on its symbionts for this amino acid. Corals inhabit environments where they are frequently exposed to high levels of solar radiation, and analysis of the Acropora genome data indicates that the coral host can independently carry out de novo synthesis of mycosporine-like amino acids, which are potent ultraviolet-protective compounds. In addition, the coral innate immunity repertoire is notably more complex than that of the sea anemone, indicating that some of these genes may have roles in symbiosis or coloniality. A number of genes with putative roles in calcification were identified, and several of these are restricted to corals. The coral genome provides a platform for understanding the molecular basis of symbiosis and responses to environmental changes.	[Shinzato, Chuya; Shoguchi, Eiichi; Kawashima, Takeshi; Hamada, Mayuko; Hisata, Kanako; Tanaka, Makiko; Fujiwara, Mayuki; Koyanagi, Ryo; Ikuta, Tetsuro; Satoh, Nori] Okinawa Inst Sci & Technol Promot Corp, Marine Genom Unit, Okinawa 9040412, Japan; [Fujiyama, Asao] Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; [Fujie, Manabu] Okinawa Inst Sci & Technol Promot Corp, DNA Sequencing Ctr Sect, Okinawa 9040412, Japan; [Miller, David J.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Miller, David J.] James Cook Univ, Sch Pharm & Mol Sci, Townsville, Qld 4811, Australia	Okinawa Institute of Science & Technology Graduate University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Okinawa Institute of Science & Technology Graduate University; James Cook University; James Cook University	Satoh, N (corresponding author), Okinawa Inst Sci & Technol Promot Corp, Marine Genom Unit, Okinawa 9040412, Japan.	norisky@oist.jp	Shinzato, Chuya/G-2958-2015; Kawashima, Takeshi/M-4510-2015; Satoh, Nori/C-4123-2009	Satoh, Nori/0000-0002-4480-3572; Koyanagi, Ryo/0000-0002-9694-0288	IT Section of OIST; Human Genome Center, University of Tokyo; MEXT; JSPS, Japan; Grants-in-Aid for Scientific Research [20121002] Funding Source: KAKEN	IT Section of OIST; Human Genome Center, University of Tokyo; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We acknowledge A. Iguchi, K. Sakai and all other staff members of the Sesoko Station, Tropical Biosphere Research Center, University of the Ryukyus for their help in collection and maintenance of the coral, M. Hidaka and V. Weis for suggestions, Y. Yokoyama, T. Usami and other staff members of our Unit for sequencing, and S. Brenner, R. Baughman and T. Ichikawa for their support. D. Rokhsar and J. Chapman are acknowledged for suggestions on sequence assembly and gene prediction. The super-computing was supported by the IT Section of OIST and the Human Genome Center, University of Tokyo. This work was supported in part by Grants-in-Aids from MEXT and JSPS, Japan.	Balskus EP, 2010, SCIENCE, V329, P1653, DOI 10.1126/science.1193637; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Davies D.C., 2007, FLOW CYTOMETRY PRINC; Dayarian A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-345; Dunn SR, 2007, P ROY SOC B-BIOL SCI, V274, P3079, DOI 10.1098/rspb.2007.0711; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fujiyama A, 2002, SCIENCE, V295, P131, DOI 10.1126/science.1065199; Fukuda I, 2003, BIOCHEM BIOPH RES CO, V304, P11, DOI 10.1016/S0006-291X(03)00527-8; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Hemmrich G, 2008, BIOESSAYS, V30, P1010, DOI 10.1002/bies.20813; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Huang SF, 2008, GENOME RES, V18, P1112, DOI 10.1101/gr.069674.107; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jackson DJ, 2007, SCIENCE, V316, P1893, DOI 10.1126/science.1141560; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leister D, 2004, TRENDS GENET, V20, P116, DOI 10.1016/j.tig.2004.01.007; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; Miller DJ, 2005, TRENDS GENET, V21, P536, DOI 10.1016/j.tig.2005.08.002; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rastogi RP, 2010, J IND MICROBIOL BIOT, V37, P537, DOI 10.1007/s10295-010-0718-5; Sarashina Isao, 2006, Paleontological Research, V10, P311; Shick JM, 2002, ANNU REV PHYSIOL, V64, P223, DOI 10.1146/annurev.physiol.64.081501.155802; Shoguchi E, 2006, GENOME RES, V16, P297, DOI 10.1101/gr.4156606; Smit A., 1996, REPEATMASKER OPEN 3; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Stanley GD, 2001, SCIENCE, V291, P1913, DOI 10.1126/science.1056632; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Wilkinson C., 2004, STATUS CORAL REEFS W; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	44	564	578	21	361	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2011	476	7360					320	U82		10.1038/nature10249	http://dx.doi.org/10.1038/nature10249			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21785439	hybrid, Green Accepted			2022-12-01	WOS:000294206500035
J	Mills, EJ; Bakanda, C; Birungi, J; Chan, K; Ford, N; Cooper, CL; Nachega, JB; Dybul, M; Hogg, RS				Mills, Edward J.; Bakanda, Celestin; Birungi, Josephine; Chan, Keith; Ford, Nathan; Cooper, Curtis L.; Nachega, Jean B.; Dybul, Mark; Hogg, Robert S.			Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low-Income Countries: A Cohort Analysis From Uganda	ANNALS OF INTERNAL MEDICINE			English	Article							HIV-INFECTED INDIVIDUALS; SUB-SAHARAN AFRICA; FOLLOW-UP; IMMUNOLOGICAL OUTCOMES; SOUTHERN AFRICA; PATIENTS LOST; MEN MATTER; MORTALITY; CARE; TUBERCULOSIS	Background: Little is known about the effect of combination anti-retroviral therapy (cART) on life expectancy in sub-Saharan Africa. Objective: To estimate life expectancy of patients once they initiate cART in Uganda. Design: Prospective cohort study. Setting: Public sector HIV and AIDS disease-management program in Uganda. Patients: 22 315 eligible patients initiated cART during the study period, of whom 1943 were considered to have died. Measurements: All-cause mortality rates were calculated and abridged life tables were constructed and stratified by sex and baseline CD4 cell count status to estimate life expectancies for patients receiving cART. The average number of years remaining to be lived by patients who received cART at varying age categories was estimated. Results: After adjustment for loss to follow-up, crude mortality rates (deaths per 1000 person-years) ranged from 26.9 (95% CI, 25.4 to 28.5) in women to 43.9 (CI, 40.7 to 47.0) in men. For patients with a baseline CD4 cell count less than 0.050 X 10(9) cells/L, the mortality rate was 67.3 (CI, 62.1 to 72.9) deaths per 1000 person-years, whereas among persons with a baseline CD4 cell count of 0.250 X 10(9) cells/L or more, the mortality rate was 19.1 (CI, 16.0 to 22.7) deaths per 1000 person-years. Life expectancy at age 20 years for the overall cohort was 26.7 (CI, 25.0 to 28.4) additional years and at age 35 years was 27.9 (CI, 26.7 to 29.1) additional years. Life expectancy increased substantially with increasing baseline CD4 cell count. Similar trends are observed for older age groups. Limitations: A small (6.4%) proportion of patients were lost to follow-up, and it was imputed that 30% of these patients had died. Few patients with a CD4 cell count greater than 0.250 X 10(9) cells/L initiated cART. Conclusion: Ugandan patients receiving cART can expect an almost normal life expectancy, although there is considerable variability among subgroups of patients.	[Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON K1N 6X1, Canada; AIDS Support Org, Kampala, Uganda; British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; Med Sans Frontieres, Geneva, Switzerland; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa; Univ Stellenbosch, Cape Town, South Africa; Ottawa Hosp, Ottawa, ON, Canada; Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC USA	University of Ottawa; B.C. Centre for Excellence in HIV/AIDS; Doctors Without Borders; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Cape Town; Stellenbosch University; University of Ottawa; Ottawa Hospital Research Institute; Simon Fraser University; Georgetown University	Mills, EJ (corresponding author), Univ Ottawa, Fac Hlth Sci, 43 Templeton, Ottawa, ON K1N 6X1, Canada.		Hogg, Robert S/B-2783-2012; Cooper, Curtis/M-9320-2019	Hogg, Robert S/0000-0003-3463-5488; Nachega, Jean/0000-0002-2862-4443	Canadian Institutes of Health Research; Canada Research Chair; National Institutes of Health; European Developing Country Clinical Trials Partnership	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Developing Country Clinical Trials Partnership	By the Canadian Institutes of Health Research. Dr. Mills is supported by a Canada Research Chair award. Dr. Nachega is supported by National Institutes of Health operating grants and the European Developing Country Clinical Trials Partnership Fellowship award. Dr. Hogg is a member of the Antiretroviral Cohort Collaboration, and he led the Antiretroviral Cohort Collaboration's high-income nation evaluation of life expectancy.	Allison P.D., 2010, SURVIVAL ANAL USING; Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; [Anonymous], 2011, WHO GLOB HLTH OBS 20; Bakanda C, 2011, INT J EPIDEMIOL; Bakanda C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019261; Bakanda C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016279; Bakanda C, 2011, AIDS, V25, P701, DOI 10.1097/QAD.0b013e3283437ed7; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; CHIANG CL, 1972, J AM STAT ASSOC, V67, P538, DOI 10.2307/2284435; Chiang CL, 1968, LIFE TABLE ITS CONST, P189; Cooper CL, 2009, INT J INFECT DIS, V13, P302, DOI 10.1016/j.ijid.2008.06.042; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Eayres D, 2004, J EPIDEMIOL COMMUN H, V58, P243, DOI 10.1136/jech.2003.009654; Fang CT, 2007, QJM-INT J MED, V100, P97, DOI 10.1093/qjmed/hcl141; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Harries AD, 2006, LANCET, V367, P1817, DOI 10.1016/S0140-6736(06)68799-0; Hecht R, 2006, PLOS MED, V3, P1992, DOI 10.1371/journal.pmed.0030455; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; Katabira Elly T., 2009, NATL ANTIRETROVIRAL; Kiboneka A, 2008, AIDS, V22, P2493, DOI 10.1097/QAD.0b013e328318f148; Kiboneka A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b201; Kuwane B, 2009, LANCET, V374, P1329, DOI 10.1016/S0140-6736(09)61823-7; Leisegang R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000189; Lima VD, 2007, AIDS, V21, P685, DOI 10.1097/QAD.0b013e32802ef30c; Madhavan S, 2009, POP STUD-J DEMOG, V63, P37, DOI 10.1080/00324720802592784; McGuire AL, 2005, HIV MED, V6, P57, DOI 10.1111/j.1468-1293.2005.00266.x; Mills EJ, 2011, AIDS, V25, P851, DOI 10.1097/QAD.0b013e32834564e9; Mills EJ, 2009, LANCET, V374, P275, DOI 10.1016/S0140-6736(09)61348-9; Muga R, 2007, AIDS, V21, P2521, DOI 10.1097/QAD.0b013e3282f1c933; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Mugyenyi P, 2009, LANCET, V374, P292, DOI 10.1016/S0140-6736(09)61365-9; Muula AS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-63; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; Rawat R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-316; ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143; Rosen S, 2007, PLOS MED, V8, P267; Tam LWY, 2007, HIV MED, V8, P267, DOI 10.1111/j.1468-1293.2007.00463.x; WHO, WHO ANT THER HIV INF; Williams T, 2011, CALCULATING LIFE EXP	43	297	306	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2011	155	4					209	+		10.7326/0003-4819-155-4-201108160-00358	http://dx.doi.org/10.7326/0003-4819-155-4-201108160-00358			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	807KN	21768555				2022-12-01	WOS:000293896400001
J	Kaan, HYK; Hackney, DD; Kozielski, F				Kaan, Hung Yi Kristal; Hackney, David D.; Kozielski, Frank			The Structure of the Kinesin-1 Motor-Tail Complex Reveals the Mechanism of Autoinhibition	SCIENCE			English	Article							DIMERIC KINESIN; MOTILITY; PROTEIN; DOMAIN; HEAD; SITE	When not transporting cargo, kinesin-1 is autoinhibited by binding of a tail region to the motor domains, but the mechanism of inhibition is unclear. We report the crystal structure of a motor domain dimer in complex with its tail domain at 2.2 angstroms and compare it with a structure of the motor domain alone at 2.7 angstroms. These structures indicate that neither an induced conformational change nor steric blocking is the cause of inhibition. Instead, the tail cross-links the motor domains at a second position, in addition to the coiled coil. This "double lockdown," by cross-linking at two positions, prevents the movement of the motor domains that is needed to undock the neck linker and release adenosine diphosphate. This autoinhibition mechanism could extend to some other kinesins.	[Kaan, Hung Yi Kristal; Kozielski, Frank] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Hackney, David D.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Beatson Institute; Carnegie Mellon University	Kozielski, F (corresponding author), Beatson Inst Canc Res, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	f.kozielski@beatson.gla.ac.uk			Agency for Science, Technology, and Research (A*STAR, Singapore); Cancer Research UK; NIH [NS058848]; NSF [MCB-0615549]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058848] Funding Source: NIH RePORTER	Agency for Science, Technology, and Research (A*STAR, Singapore)(Agency for Science Technology & Research (A*STAR)); Cancer Research UK(Cancer Research UK); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Flot of the European Synchrotron Radiation Facility and European Molecular Biology Laboratory-Grenoble, and M. Muller of Swiss Light Source for assistance and support in using beamlines ID23-2 and PXI, respectively. We also thank E. Dodson for valuable crystallography advice, O. Rath for data collection, V. Ulaganathan for useful discussion, Y. Yeo and M. Kim for assistance in cloning and preparation of mutant kinesin motor domains, and A. Snyder for assistance in preparation of the tail fusion peptide. H. Y. K. K. holds a National Science Scholarship, financed by Agency for Science, Technology, and Research (A*STAR, Singapore), and this publication contains part of her doctoral thesis. We thank Cancer Research UK, NIH (NS058848) and NSF (MCB-0615549) for financial support. Coordinates and structure factor files for the dimer and dimer-tail complex have been deposited in the Protein Data Bank under accession numbers 2Y5W and 2Y65, respectively. The authors declare no competing financial interests.	Cheng JQ, 1998, BIOCHEMISTRY-US, V37, P5288, DOI 10.1021/bi972742j; Dietrich KA, 2008, P NATL ACAD SCI USA, V105, P8938, DOI 10.1073/pnas.0803575105; Endow SA, 2010, J CELL SCI, V123, P3420, DOI 10.1242/jcs.064113; Hackney DD, 2009, BIOCHEMISTRY-US, V48, P3448, DOI 10.1021/bi8022575; Hackney DD, 2000, NAT CELL BIOL, V2, P257, DOI 10.1038/35010525; Hahlen K, 2006, J BIOL CHEM, V281, P18868, DOI 10.1074/jbc.M508019200; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hwang W, 2008, STRUCTURE, V16, P62, DOI 10.1016/j.str.2007.11.008; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Kull FJ, 2002, J CELL SCI, V115, P15; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Sindelar CV, 2010, P NATL ACAD SCI USA, V107, P4111, DOI 10.1073/pnas.0911208107; Stock MF, 1999, J BIOL CHEM, V274, P14617, DOI 10.1074/jbc.274.21.14617; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782	15	103	106	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 12	2011	333	6044					883	885		10.1126/science.1204824	http://dx.doi.org/10.1126/science.1204824			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21836017	Green Accepted			2022-12-01	WOS:000293785400042
J	Caiazzo, M; Dell'Anno, MT; Dvoretskova, E; Lazarevic, D; Taverna, S; Leo, D; Sotnikova, TD; Menegon, A; Roncaglia, P; Colciago, G; Russo, G; Carninci, P; Pezzoli, G; Gainetdinov, RR; Gustincich, S; Dityatev, A; Broccoli, V				Caiazzo, Massimiliano; Dell'Anno, Maria Teresa; Dvoretskova, Elena; Lazarevic, Dejan; Taverna, Stefano; Leo, Damiana; Sotnikova, Tatyana D.; Menegon, Andrea; Roncaglia, Paola; Colciago, Giorgia; Russo, Giovanni; Carninci, Piero; Pezzoli, Gianni; Gainetdinov, Raul R.; Gustincich, Stefano; Dityatev, Alexander; Broccoli, Vania			Direct generation of functional dopaminergic neurons from mouse and human fibroblasts	NATURE			English	Article							EMBRYONIC STEM-CELLS; EXPRESSION; TRANSPLANTATION	Transplantation of dopaminergic neurons can potentially improve the clinical outcome of Parkinson's disease, a neurological disorder resulting from degeneration of mesencephalic dopaminergic neurons(1,2). In particular, transplantation of embryonic-stem-cell-derived dopaminergic neurons has been shown to be efficient in restoring motor symptoms in conditions of dopamine deficiency(3,4). However, the use of pluripotent-derived cells might lead to the development of tumours if not properly controlled(5). Here we identified a minimal set of three transcription factors-Mash1 (also known as Ascl1), Nurr1 (also known as Nr4a2) and Lmx1a-that are able to generate directly functional dopaminergic neurons from mouse and human fibroblasts without reverting to a progenitor cell stage. Induced dopaminergic (iDA) cells release dopamine and show spontaneous electrical activity organized in regular spikes consistent with the pacemaker activity featured by brain dopaminergic neurons. The three factors were able to elicit dopaminergic neuronal conversion in prenatal and adult fibroblasts from healthy donors and Parkinson's disease patients. Direct generation of iDA cells from somatic cells might have significant implications for understanding critical processes for neuronal development, in vitro disease modelling and cell replacement therapies.	[Caiazzo, Massimiliano; Dell'Anno, Maria Teresa; Colciago, Giorgia; Broccoli, Vania] Ist Sci San Raffaele, Stem Cells & Neurogenesis Unit, Div Neurosci, I-20132 Milan, Italy; [Dvoretskova, Elena; Taverna, Stefano; Leo, Damiana; Sotnikova, Tatyana D.; Russo, Giovanni; Pezzoli, Gianni; Gainetdinov, Raul R.; Dityatev, Alexander] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, I-16163 Genoa, Italy; [Lazarevic, Dejan] CBM Srl, I-34149 Trieste, Italy; [Lazarevic, Dejan; Roncaglia, Paola; Gustincich, Stefano] Int Sch Adv Studies SISSA, Neurobiol Sect, I-34136 Trieste, Italy; [Menegon, Andrea] Ist Sci San Raffaele, Expt Imaging Ctr, Adv Light & Electron Microscopy Bioimaging Ctr, I-20132 Milan, Italy; [Carninci, Piero] RIKEN Yokohama Inst, Omics Sci Ctr, Tsurumi Ku, Kanagawa 2300045, Japan; [Pezzoli, Gianni] Ist Clin Perfezionamento, Parkinson Inst, I-20126 Milan, Italy; [Gustincich, Stefano] Giovanni Armenise Harvard Fdn Lab, I-34136 Trieste, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Istituto Italiano di Tecnologia - IIT; International School for Advanced Studies (SISSA); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; RIKEN	Broccoli, V (corresponding author), Ist Sci San Raffaele, Stem Cells & Neurogenesis Unit, Div Neurosci, I-20132 Milan, Italy.	broccoli.vania@hsr.it	Sotnikova, Tatyana D/T-9992-2017; Taverna, Stefano/AAN-1938-2020; Carninci, Piero/K-1568-2014; menegon, andrea/AAN-3736-2020; Caiazzo, Massimiliano/C-1722-2016; Gainetdinov, Raul R/G-5875-2011; Dityatev, Alexander/A-4034-2008; Broccoli, Vania/K-3464-2016; Lazarevic, Dejan/AAN-1861-2020; Colciago, Giorgia/AAN-2698-2020	Taverna, Stefano/0000-0003-1871-8662; Carninci, Piero/0000-0001-7202-7243; menegon, andrea/0000-0002-2396-756X; Caiazzo, Massimiliano/0000-0002-8975-3257; Gainetdinov, Raul R/0000-0003-2951-6038; Dityatev, Alexander/0000-0002-0472-0553; Broccoli, Vania/0000-0003-4050-0926; Colciago, Giorgia/0000-0003-0476-8861; lazarevic, dejan/0000-0003-4527-290X; Gustincich, Stefano/0000-0002-2749-2514; Pezzoli, Gianni/0000-0003-4665-6710; Leo, Damiana/0000-0001-9219-5498; Dell'Anno, Maria Teresa/0000-0003-1825-671X; Roncaglia, Paola/0000-0002-2825-0621	Fondazione Grigioni per il Morbo di Parkinson [FGBRCVNI10310-001-V.B.]; Eranet Neuron; Cariplo Foundation; Ministry of Health; Italian Institute of Technology; Fondazione Telethon Funding Source: Custom	Fondazione Grigioni per il Morbo di Parkinson; Eranet Neuron; Cariplo Foundation(Fondazione Cariplo); Ministry of Health; Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT); Fondazione Telethon(Fondazione Telethon)	We are thankful to D. Bonanomi, S.-L. Ang, S. El Mestikawy, M. P. Smidt, M. German and F. Valtorta for providing valuable antibodies. We thank A. Sessa and V. B. laboratory members for helpful discussion. M. Wernig is acknowledged for providing the iN-inducing lentiviral vectors. We are thankful to S. Nicolis for sharing Sox2<SUP>beta-geo</SUP> mice. L. Muzio, C. Laterza and G. Martino are acknowledged for the generation of Sox2<SUP>beta-geo</SUP> induced pluripotent stem cells. M. Bacigaluppi is acknowledged for advice on stereological countings. We thank the "Cell Line and DNA Biobank" (G. Gaslini Institute) and "Human Genetic Bank of Patients affected by Parkinson Disease and parkinsonism" (Parkinson Institute of Milan) of the Telethon Genetic Biobank Network for human fibroblast samples. This study was supported by the "Fondazione Grigioni per il Morbo di Parkinson" (grant no. FGBRCVNI10310-001-V.B.), Eranet Neuron (V. B.), Cariplo Foundation (V. B.), Ministry of Health (Giovani ricercatori Award) (V. B.) and Italian Institute of Technology (V.B., A.D., S.G., T.S., R.G.).	Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Ang SL, 2006, DEVELOPMENT, V133, P3499, DOI 10.1242/dev.02501; Bacigaluppi M, 2009, BRAIN, V132, P2239, DOI 10.1093/brain/awp174; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Biagioli M, 2009, P NATL ACAD SCI USA, V106, P15454, DOI 10.1073/pnas.0813216106; Broccoli V, 1999, NATURE, V401, P164, DOI 10.1038/43670; Colasante G, 2008, J NEUROSCI, V28, P10674, DOI 10.1523/JNEUROSCI.1283-08.2008; GRACE AA, 1984, J NEUROSCI, V4, P2866; GRACE AA, 1989, J NEUROSCI, V9, P3463; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Lindvall Olle, 2004, NeuroRx, V1, P382; Menegon A, 2006, J NEUROSCI, V26, P11670, DOI 10.1523/JNEUROSCI.3321-06.2006; Mundroff M. L., 2002, CURR PROTOC NEUROSCI; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Perlmann T, 2004, CELL TISSUE RES, V318, P45, DOI 10.1007/s00441-004-0974-7; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Politis M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000976; Pothos E, 1996, J NEUROCHEM, V66, P629; Pothos EN, 1998, J NEUROSCI, V18, P4106; Pruszak J., 2009, CURR PROTOC STEM CEL; Sawamoto K, 2001, P NATL ACAD SCI USA, V98, P6423, DOI 10.1073/pnas.111152398; Simeone A, 2005, TRENDS NEUROSCI, V28, P62, DOI 10.1016/j.tins.2004.11.007; Sironi F, 2008, PARKINSONISM RELAT D, V14, P326, DOI 10.1016/j.parkreldis.2007.10.003; Sironi F, 2010, PARKINSONISM RELAT D, V16, P228, DOI 10.1016/j.parkreldis.2009.09.008; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Smyth G.K., 2004, STAT APPL GENET MOL, V3, pArticl, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Staal RGW, 2004, NAT NEUROSCI, V7, P341, DOI 10.1038/nn1205; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Zappone MV, 2000, DEVELOPMENT, V127, P2367	36	728	772	4	195	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2011	476	7359					224	U151		10.1038/nature10284	http://dx.doi.org/10.1038/nature10284			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21725324				2022-12-01	WOS:000293731900040
J	Wu, YH; Vendome, J; Shapiro, L; Ben-Shaul, A; Honig, B				Wu, Yinghao; Vendome, Jeremie; Shapiro, Lawrence; Ben-Shaul, Avinoam; Honig, Barry			Transforming binding affinities from three dimensions to two with application to cadherin clustering	NATURE			English	Article							CELL-ADHESION MOLECULES; SPECIFICITY; MACROMOLECULES; CD2	Membrane-bound receptors often form large assemblies resulting from binding to soluble ligands, cell-surface molecules on other cells and extracellular matrix proteins(1). For example, the association of membrane proteins with proteins on different cells (trans-interactions) can drive the oligomerization of proteins on the same cell(2) (cis-interactions). A central problem in understanding the molecular basis of such phenomena is that equilibrium constants are generally measured in three-dimensional solution and are thus difficult to relate to the two-dimensional environment of a membrane surface. Here we present a theoretical treatment that converts three-dimensional affinities to two dimensions, accounting directly for the structure and dynamics of the membrane-bound molecules. Using a multiscale simulation approach, we apply the theory to explain the formation of ordered, junction-like clusters by classical cadherin adhesion proteins. The approach features atomic-scale molecular dynamics simulations to determine interdomain flexibility, Monte Carlo simulations of multidomain motion and lattice simulations of junction formation(3). A finding of general relevance is that changes in interdomain motion on trans-binding have a crucial role in driving the lateral, cis-, clustering of adhesion receptors.	[Ben-Shaul, Avinoam] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel; [Ben-Shaul, Avinoam] Hebrew Univ Jerusalem, Fritz Haber Res Ctr, IL-91904 Jerusalem, Israel; [Wu, Yinghao; Vendome, Jeremie; Shapiro, Lawrence; Honig, Barry] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Wu, Yinghao; Vendome, Jeremie; Honig, Barry] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Wu, Yinghao; Vendome, Jeremie; Honig, Barry] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Shapiro, Lawrence] Columbia Univ, Edward S Harkness Eye Inst, New York, NY 10032 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University	Ben-Shaul, A (corresponding author), Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.	abs@fh.huji.ac.il; bh6@columbia.edu	Shapiro, Lawrence/AAE-7172-2019; Califano, Andrea/F-7239-2012		National Science Foundation [MCB-0918535]; National Institutes of Health [R01 GM062270-07]; US-Israel Binational Science Foundation [2006-401]; Israel Science Foundation (ISF) [1448/10, 695/06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062270] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation (ISF)(Israel Science Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation grant MCB-0918535 (to B. H.) and National Institutes of Health grant R01 GM062270-07 (to L. S.). The financial support of the US-Israel Binational Science Foundation (grant no. 2006-401, to A.B.-S., B. H. and L. S.) and the Israel Science Foundation (ISF 1448/10 and 695/06) (to A.B.-S.) is acknowledged. We thank E. Sackmann for an email exchange concerning membrane fluctuations.	Aplin AE, 1999, CURR OPIN CELL BIOL, V11, P737, DOI 10.1016/S0955-0674(99)00045-9; Aricescu AR, 2007, CURR OPIN CELL BIOL, V19, P543, DOI 10.1016/j.ceb.2007.09.010; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; BELL GI, 1984, BIOPHYS J, V45, P1051, DOI 10.1016/S0006-3495(84)84252-6; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Chen CP, 2005, P NATL ACAD SCI USA, V102, P8531, DOI 10.1073/pnas.0503319102; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; Dustin ML, 1996, J CELL BIOL, V132, P465, DOI 10.1083/jcb.132.3.465; Dustin ML, 2001, ANNU REV CELL DEV BI, V17, P133, DOI 10.1146/annurev.cellbio.17.1.133; Gov NS, 2005, BIOPHYS J, V88, P1859, DOI 10.1529/biophysj.104.045328; Harrison OJ, 2011, STRUCTURE, V19, P244, DOI 10.1016/j.str.2010.11.016; HILL TL, 1987, INTRO STAT THERMODYN, P147; Hong S, 2010, P NATL ACAD SCI USA, V107, P3528, DOI 10.1073/pnas.0911027107; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Katsamba P, 2009, P NATL ACAD SCI USA, V106, P11594, DOI 10.1073/pnas.0905349106; Li GH, 2002, BIOPHYS J, V83, P2457, DOI 10.1016/S0006-3495(02)75257-0; Milstein O, 2008, J BIOL CHEM, V283, P34414, DOI 10.1074/jbc.M804756200; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Tama F, 2000, PROTEINS, V41, P1; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wu YH, 2010, P NATL ACAD SCI USA, V107, P17592, DOI 10.1073/pnas.1011247107; ZILKER A, 1987, J PHYS-PARIS, V48, P2139, DOI 10.1051/jphys:0198700480120213900	23	164	168	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2011	475	7357					510	U107		10.1038/nature10183	http://dx.doi.org/10.1038/nature10183			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21796210	Green Accepted			2022-12-01	WOS:000293167900043
J	Beatty, PH; Good, AG				Beatty, Perrin H.; Good, Allen G.			Future Prospects for Cereals That Fix Nitrogen	SCIENCE			English	Editorial Material							IRON-MOLYBDENUM COFACTOR; BACTERIA; PROTEINS; SULFUR; RICE		[Beatty, Perrin H.; Good, Allen G.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada	University of Alberta	Beatty, PH (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada.	allen.good@ualberta.ca	Good, Allen G/A-2644-2014; Beatty, Perrin H./H-6487-2019	Good, Allen G/0000-0003-4256-355X; Beatty, Perrin H./0000-0002-9240-447X				Burrill TJ, 1917, AGR EXP STATION B, V202, P113; Charpentier M, 2010, CURR OPIN PLANT BIOL, V13, P556, DOI 10.1016/j.pbi.2010.08.003; Curatti L, 2007, P NATL ACAD SCI USA, V104, P17626, DOI 10.1073/pnas.0703050104; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Joseph SJ, 2003, APPL ENVIRON MICROB, V69, P7210, DOI 10.1128/AEM.69.12.7210-7215.2003; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Madsen LH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1009; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; MERRICK M, 1984, TRENDS BIOTECHNOL, V2, P162, DOI 10.1016/0167-7799(84)90034-9; Muraki N, 2010, NATURE, V465, P110, DOI 10.1038/nature08950; Oldroyd GED, 2009, SCIENCE, V324, P753, DOI 10.1126/science.1171644; Rubio LM, 2008, ANNU REV MICROBIOL, V62, P93, DOI 10.1146/annurev.micro.62.081307.162737; Stoltzfus JR, 1997, PLANT SOIL, V194, P25, DOI 10.1023/A:1004298921641; Yanni YG, 2010, PLANT SOIL, V336, P129, DOI 10.1007/s11104-010-0454-7	14	125	132	6	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2011	333	6041					416	417		10.1126/science.1209467	http://dx.doi.org/10.1126/science.1209467			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	795FR	21778391				2022-12-01	WOS:000292959600034
J	Russell, AB; Hood, RD; Bui, NK; LeRoux, M; Vollmer, W; Mougous, JD				Russell, Alistair B.; Hood, Rachel D.; Bui, Nhat Khai; LeRoux, Michele; Vollmer, Waldemar; Mougous, Joseph D.			Type VI secretion delivers bacteriolytic effectors to target cells	NATURE			English	Article							COMPLETE GENOME SEQUENCE; PSEUDOMONAS-AERUGINOSA; STRUCTURAL FEATURES; PROTEIN; SYSTEM; GENE; CATALOG; TOXIN	Peptidoglycan is the major structural constituent of the bacterial cell wall, forming a meshwork outside the cytoplasmic membrane that maintains cell shape and prevents lysis. In Gram-negative bacteria, peptidoglycan is located in the periplasm, where it is protected from exogenous lytic enzymes by the outer membrane. Here we show that the type VI secretion system of Pseudomonas aeruginosa breaches this barrier to deliver two effector proteins, Tse1 and Tse3, to the periplasm of recipient cells. In this compartment, the effectors hydrolyse peptidoglycan, thereby providing a fitness advantage for P. aeruginosa cells in competition with other bacteria. To protect itself from lysis by Tse1 and Tse3, P. aeruginosa uses specific periplasmically localized immunity proteins. The requirement for these immunity proteins depends on intercellular self-intoxication through an active type VI secretion system, indicating a mechanism for export whereby effectors do not access donor cell periplasm in transit.	[Russell, Alistair B.; Hood, Rachel D.; Mougous, Joseph D.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Bui, Nhat Khai; Vollmer, Waldemar] Newcastle Univ, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [LeRoux, Michele] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Newcastle University - UK; University of Washington; University of Washington Seattle	Mougous, JD (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	mougous@u.washington.edu		LeRoux, Michele/0000-0003-2075-4208; Russell, Alistair/0000-0002-5342-2309	National Institutes of Health [RO1 AI080609]; European Commission; National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080609] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Singh, E. Nester, H. Kulasekara, N. Salama, E. P. Greenberg, L. Ramakrishnan and members of the Mougous laboratory for discussions and critical reading of the manuscript, the Harwood laboratory for use of their microscope, and J. Gray of the Pinnacle Laboratory of Newcastle University for MS analysis. This work was supported by the National Institutes of Health (J. D. M.; RO1 AI080609) and the European Commission within the DIVINOCELL programme (W. V.). A. B. R was supported by a Graduate Research Fellowship from the National Science Foundation.	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Brook I, 1999, CRIT REV MICROBIOL, V25, P155, DOI 10.1080/10408419991299211; BROTZ H, 1995, ANTIMICROB AGENTS CH, V39, P714, DOI 10.1128/AAC.39.3.714; Bui NK, 2009, J BACTERIOL, V191, P494, DOI 10.1128/JB.00608-08; Cardona ST, 2005, PLASMID, V54, P219, DOI 10.1016/j.plasmid.2005.03.004; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gjodsbol Kristine, 2006, Int Wound J, V3, P225, DOI 10.1111/j.1742-481X.2006.00159.x; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Grundling A, 2006, J BACTERIOL, V188, P2463, DOI 10.1128/JB.188.7.2463-2472.2006; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Hsu FS, 2009, MOL MICROBIOL, V72, P1111, DOI 10.1111/j.1365-2958.2009.06701.x; Imperi F, 2009, PROTEOMICS, V9, P1901, DOI 10.1002/pmic.200800618; Iwase T, 2010, NATURE, V465, P346, DOI 10.1038/nature09074; Kanamaru S, 2009, P NATL ACAD SCI USA, V106, P4067, DOI 10.1073/pnas.0901205106; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; LEI SP, 1987, J BACTERIOL, V169, P4379, DOI 10.1128/jb.169.9.4379-4383.1987; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; LIU J, 1990, P NATL ACAD SCI USA, V87, P4028, DOI 10.1073/pnas.87.11.4028; MORTENSEN JE, 1995, INFECT CONT HOSP EP, V16, P30; Mougous JD, 2004, NAT STRUCT MOL BIOL, V11, P721, DOI 10.1038/nsmb802; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rakhuba DV, 2010, POL J MICROBIOL, V59, P145, DOI 10.33073/pjm-2010-023; Reid G, 2001, TRENDS MICROBIOL, V9, P424, DOI 10.1016/S0966-842X(01)02132-1; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Vollmer W, 1997, J BACTERIOL, V179, P1580, DOI 10.1128/jb.179.5.1580-1583.1997; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; WATT SR, 1994, FEMS MICROBIOL LETT, V124, P113, DOI 10.1111/j.1574-6968.1994.tb07270.x; WOOD PM, 1978, FEBS LETT, V92, P214, DOI 10.1016/0014-5793(78)80757-1	48	443	452	4	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2011	475	7356					343	U92		10.1038/nature10244	http://dx.doi.org/10.1038/nature10244			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21776080	Green Accepted			2022-12-01	WOS:000292911200035
J	Kamerow, D				Kamerow, Douglas			YANKEE DOODLING The pros and cons of generic drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												dkamerow@rti.org	Mendoza, Elvia/A-9361-2012	Kamerow, Douglas/0000-0001-7000-9957				Briesacher BA, 2009, AM J MANAG CARE, V15, P450; Emery J, 2010, BMJ; Ferner RE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2548; Greene JA, 2011, NEW ENGL J MED, V365, P83, DOI 10.1056/NEJMhle1101722; Hellier Elizabeth, 2010, J Patient Saf, V6, P158; Kaiser Family Foundation, 2010, US HLTH CAR COSTS; Mishori R, 2011, WASHINGTON POST 0712, pE1; Shrank WH, 2011, AM J MED, V124, P309, DOI 10.1016/j.amjmed.2010.11.020; Tanne JH, 2003, BRIT MED J, V327, P565, DOI 10.1136/bmj.327.7414.565	9	5	5	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 20	2011	343								d4584	10.1136/bmj.d4584	http://dx.doi.org/10.1136/bmj.d4584			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	797ZH	21775394				2022-12-01	WOS:000293168700009
J	Sokol, DK				Sokol, Daniel K.			ETHICS MAN The medical ethics of the battlefield	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Sokol, DK (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	daniel.sokol@talk21.com						CHARLTON J, 1990, MILITARY QUOTATION B, P144; Kondro W, 2007, CAN MED ASSOC J, V177, P134, DOI 10.1503/cmaj.070852; PATTERSON K, TALK ME MY FATHER FR; US Department of Defence, 2004, EM WAR SURG	4	9	9	1	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 20	2011	343								d3877	10.1136/bmj.d3877	http://dx.doi.org/10.1136/bmj.d3877			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	797ZH	21775391				2022-12-01	WOS:000293168700002
J	Schouten, EJ; Jahn, A; Midiani, D; Makombe, SD; Mnthambala, A; Chirwa, Z; Harries, AD; van Oosterhout, JJ; Meguid, T; Ben-Smith, A; Zachariah, R; Lynen, L; Zolfo, M; Van Damme, W; Gilks, CF; Atun, R; Shawa, M; Chimbwandira, F				Schouten, Erik J.; Jahn, Andreas; Midiani, Dalitso; Makombe, Simon D.; Mnthambala, Austin; Chirwa, Zengani; Harries, Anthony D.; van Oosterhout, Joep J.; Meguid, Tarek; Ben-Smith, Anne; Zachariah, Rony; Lynen, Lutgarde; Zolfo, Maria; Van Damme, Wim; Gilks, Charles F.; Atun, Rifat; Shawa, Mary; Chimbwandira, Frank			Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach	LANCET			English	Editorial Material							ANTIRETROVIRAL THERAPY; INITIATION; SETTINGS; AFRICA; COHORT		[Schouten, Erik J.; Jahn, Andreas; Midiani, Dalitso; Makombe, Simon D.; Mnthambala, Austin; Chirwa, Zengani; Chimbwandira, Frank] Minist Hlth, Dept HIV & AIDS, Lilongwe, Malawi; [Schouten, Erik J.] Management Sci Hlth, Lilongwe, Malawi; [Jahn, Andreas; Chirwa, Zengani] ITECH Malawi, Seattle, WA USA; [Jahn, Andreas; Chirwa, Zengani] Univ Washington, Seattle, WA 98195 USA; [Harries, Anthony D.] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony D.] London Sch Hyg & Trop Med, London WC1, England; [van Oosterhout, Joep J.] Coll Med, Blantyre, Malawi; [Meguid, Tarek] Kamuzu Cent Hosp, Lilongwe, Malawi; [Ben-Smith, Anne] Maame Akua, Lilongwe, Malawi; [Zachariah, Rony] Med Sans Frontieres Operat Res Unit, Luxembourg, Luxembourg; [Lynen, Lutgarde; Zolfo, Maria; Van Damme, Wim] Inst Trop Med, B-2000 Antwerp, Belgium; [Gilks, Charles F.] UNAIDS, New Delhi, India; [Gilks, Charles F.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, Sch Business, London, England; [Atun, Rifat] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Shawa, Mary] Off President & Cabinet, Lilongwe, Malawi	University of Washington; University of Washington Seattle; University of London; London School of Hygiene & Tropical Medicine; University of Malawi; Institute of Tropical Medicine (ITM); Imperial College London; Imperial College London	Schouten, EJ (corresponding author), Minist Hlth, Dept HIV & AIDS, POB 30377, Lilongwe, Malawi.	eschouten@msh.org	Lynen, Lutgarde/AAT-9180-2020; Atun, Rifat/AAH-5537-2021; Zolfo, Maria/B-9787-2015; Lynen, Lutgarde/A-1212-2014; Van Damme, Wim/F-7404-2011; Jahn, Andreas/ABB-7796-2020; Gilks, Charles/B-4184-2012	Lynen, Lutgarde/0000-0001-7183-4895; Zolfo, Maria/0000-0001-9756-9380; Lynen, Lutgarde/0000-0001-7183-4895; Van Damme, Wim/0000-0002-6344-3007; Jahn, Andreas/0000-0003-4645-1600; Gilks, Charles/0000-0002-8953-3123; zachariah, rony/0000-0002-2915-9328; Atun, Rifat/0000-0002-1531-5983				[Anonymous], 2010, ANTIRETROVIRAL THERA; [Anonymous], 2009, LANCET, V373, P1352; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Ford N, 2010, AIDS, V24, P1461, DOI 10.1097/QAD.0b013e32833a2a14; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hargrove JW, 2010, AIDS, V24, pF11, DOI 10.1097/QAD.0b013e328335749d; Harries AD, 2006, LANCET, V367, P1870, DOI 10.1016/S0140-6736(06)68809-0; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; *MIN HLTH HIV UN M, ANT THER; Mofenson LM, 2010, CLIN INFECT DIS, V50, pS130, DOI 10.1086/651484; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Myer L, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000229; National Statistics Office and ORC Macro, 2005, MAL DEM HLTH SURV 20; Sutcliffe S, 2002, JAIDS-J ACQ IMM DEF, V31, P90, DOI 10.1097/00126334-200209010-00012; *UNAIDS, 09 AIDS EP UPD NOV 2; *WHO, 2009, WORLD HLTH STAT 2009; World Health Organization UNAIDS and UNICEF, 2010, UN ACC SCAL PRIOR HI; World Health Organization (WHO), 2010, ANT DRUGS TREAT PREG; CAMPAIGN ACCESS ESSE	22	193	193	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 16	2011	378	9787					282	284		10.1016/S0140-6736(10)62303-3	http://dx.doi.org/10.1016/S0140-6736(10)62303-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	798JD	21763940				2022-12-01	WOS:000293201100036
J	Xu, X; Pan, SK; Cheng, SF; Zhang, B; Mu, DS; Ni, PX; Zhang, GY; Yang, S; Li, RQ; Wang, J; Orjeda, G; Guzman, F; Torres, M; Lozano, R; Ponce, O; Martinez, D; De la Cruz, G; Chakrabarti, SK; Patil, VU; Skryabin, KG; Kuznetsov, BB; Ravin, NV; Kolganova, TV; Beletsky, AV; Mardanov, AV; Di Genova, A; Bolser, DM; Martin, DMA; Li, GC; Yang, Y; Kuang, HH; Hu, Q; Xiong, XY; Bishop, GJ; Sagredo, B; Mejia, N; Zagorski, W; Gromadka, R; Gawor, J; Szczesny, P; Huang, SW; Zhang, ZH; Liang, CB; He, J; Li, Y; He, Y; Xu, JF; Zhang, YJ; Xie, BY; Du, YC; Qu, DY; Bonierbale, M; Ghislain, M; Herrera, MD; Giuliano, G; Pietrella, M; Perrotta, G; Facella, P; O'Brien, K; Feingold, SE; Barreiro, LE; Massa, GA; Diambra, L; Whitty, BR; Vaillancourt, B; Lin, HN; Massa, A; Geoffroy, M; Lundback, S; DellaPenna, D; Buell, CR; Sharma, SK; Marshall, DF; Waugh, R; Bryan, GJ; Destefanis, M; Nagy, I; Milbourne, D; Thomson, SJ; Fiers, M; Jacobs, JME; Nielsen, KL; Sonderkaer, M; Iovene, M; Torres, GA; Jiang, JM; Veilleux, RE; Bachem, CWB; de Boer, J; Borm, T; Kloosterman, B; van Eck, H; Datema, E; Hekkert, BTL; Goverse, A; van Ham, RCHJ; Visser, RGF				Xu, Xun; Pan, Shengkai; Cheng, Shifeng; Zhang, Bo; Mu, Desheng; Ni, Peixiang; Zhang, Gengyun; Yang, Shuang; Li, Ruiqiang; Wang, Jun; Orjeda, Gisella; Guzman, Frank; Torres, Michael; Lozano, Roberto; Ponce, Olga; Martinez, Diana; De la Cruz, German; Chakrabarti, S. K.; Patil, Virupaksh U.; Skryabin, Konstantin G.; Kuznetsov, Boris B.; Ravin, Nikolai V.; Kolganova, Tatjana V.; Beletsky, Alexey V.; Mardanov, Andrei V.; Di Genova, Alex; Bolser, Daniel M.; Martin, David M. A.; Li, Guangcun; Yang, Yu; Kuang, Hanhui; Hu, Qun; Xiong, Xingyao; Bishop, Gerard J.; Sagredo, Boris; Mejia, Nilo; Zagorski, Wlodzimierz; Gromadka, Robert; Gawor, Jan; Szczesny, Pawel; Huang, Sanwen; Zhang, Zhonghua; Liang, Chunbo; He, Jun; Li, Ying; He, Ying; Xu, Jianfei; Zhang, Youjun; Xie, Binyan; Du, Yongchen; Qu, Dongyu; Bonierbale, Merideth; Ghislain, Marc; del Rosario Herrera, Maria; Giuliano, Giovanni; Pietrella, Marco; Perrotta, Gaetano; Facella, Paolo; O'Brien, Kimberly; Feingold, Sergio E.; Barreiro, Leandro E.; Massa, Gabriela A.; Diambra, Luis; Whitty, Brett R.; Vaillancourt, Brieanne; Lin, Haining; Massa, AliciaN.; Geoffroy, Michael; Lundback, Steven; DellaPenna, Dean; Buell, C. Robin; Sharma, Sanjeev Kumar; Marshall, David F.; Waugh, Robbie; Bryan, Glenn J.; Destefanis, Marialaura; Nagy, Istvan; Milbourne, Dan; Thomson, Susan J.; Fiers, Mark; Jacobs, Jeanne M. E.; Nielsen, Kare L.; Sonderkaer, Mads; Iovene, Marina; Torres, Giovana A.; Jiang, Jiming; Veilleux, Richard E.; Bachem, Christian W. B.; de Boer, Jan; Borm, Theo; Kloosterman, Bjorn; van Eck, Herman; Datema, Erwin; Hekkert, Bas Te Lintel; Goverse, Aska; van Ham, Roeland C. H. J.; Visser, Richard G. F.		Potato Genome Sequencing Consortiu	Genome sequence and analysis of the tuber crop potato	NATURE			English	Article							EUKARYOTIC GENOMES; RESISTANCE GENES; IN-VITRO; RNA-SEQ; SOLANUM; TOOL; IDENTIFICATION; ELEMENTS; REVEALS; MAIZE	Potato (Solanum tuberosum L.) is the world's most important non-grain food crop and is central to global food security. It is clonally propagated, highly heterozygous, autotetraploid, and suffers acute inbreeding depression. Here we use a homozygous doubled-monoploid potato clone to sequence and assemble 86% of the 844-megabase genome. We predict 39,031 protein-coding genes and present evidence for at least two genome duplication events indicative of a palaeopolyploid origin. As the first genome sequence of an asterid, the potato genome reveals 2,642 genes specific to this large angiosperm clade. We also sequenced a heterozygous diploid clone and show that gene presence/absence variants and other potentially deleterious mutations occur frequently and are a likely cause of inbreeding depression. Gene family expansion, tissue-specific expression and recruitment of genes to new pathways contributed to the evolution of tuber development. The potato genome sequence provides a platform for genetic improvement of this vital crop.	[Huang, Sanwen; Zhang, Zhonghua; Liang, Chunbo; He, Jun; Li, Ying; He, Ying; Xu, Jianfei; Zhang, Youjun; Xie, Binyan; Du, Yongchen; Qu, Dongyu] Chinese Acad Agr Sci, Key Lab Hort Crops Genet Improvement, Sino Dutch Joint Lab Hort Genom, Inst Vegetables & Flowers,Minist Agr, Beijing 100081, Peoples R China; [Xu, Xun; Pan, Shengkai; Cheng, Shifeng; Zhang, Bo; Mu, Desheng; Ni, Peixiang; Zhang, Gengyun; Yang, Shuang; Li, Ruiqiang; Wang, Jun] Chinese Minist Agr, Key Lab Genom, BGI Shenzhen, Shenzhen 518083, Peoples R China; [Orjeda, Gisella; Guzman, Frank; Torres, Michael; Lozano, Roberto; Ponce, Olga; Martinez, Diana; De la Cruz, German] Cayetano Heredia Univ, Genom Res Unit, Lima 13, Peru; [Orjeda, Gisella; Guzman, Frank; Torres, Michael; Lozano, Roberto; Ponce, Olga; Martinez, Diana; De la Cruz, German] San Cristobal Huamanga Univ, Biotechnol & Plant Genet Lab, Ayacucho, Peru; [Chakrabarti, S. K.; Patil, Virupaksh U.] Cent Potato Res Inst, Shimla 171001, Himachal Prades, India; [Skryabin, Konstantin G.; Kuznetsov, Boris B.; Ravin, Nikolai V.; Kolganova, Tatjana V.; Beletsky, Alexey V.; Mardanov, Andrei V.] Ctr Bioengn RAS, Moscow 117312, Russia; [Di Genova, Alex] Univ Chile, UMI CNRS 2807, Ctr Genome Regulat, CGR CMM, Santiago, Chile; [Di Genova, Alex] Univ Chile, UMI CNRS 2807, Ctr Math Modeling, Santiago, Chile; [Bolser, Daniel M.; Martin, David M. A.] Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland; [Li, Guangcun; Yang, Yu] Shandong Acad Agr Sci, High Technol Res Ctr, Jinan 250100, Peoples R China; [Kuang, Hanhui; Hu, Qun] Huazhong Agr Univ, Minist Educ, Coll Hort & Forestry, Dept Vegetable Crops,Key Lab Hort Biol, Wuhan 430070, Peoples R China; [Xiong, Xingyao] Hunan Agr Univ, Coll Hort & Landscape, Changsha 410128, Hunan, Peoples R China; [Bishop, Gerard J.] Univ London Imperial Coll Sci Technol & Med, Div Biol, London SW7 1AZ, England; [Sagredo, Boris; Mejia, Nilo] Inst Invest Agropecuarias, Sector Los Choapinos, Rengo 2940000, Region Libertad, Chile; [Zagorski, Wlodzimierz; Gromadka, Robert; Gawor, Jan; Szczesny, Pawel] PAS, DNA Sequencing & Oligonucleotides Synth Lab, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; [Bonierbale, Merideth; Ghislain, Marc; del Rosario Herrera, Maria] Int Potato Ctr, Lima 12, Peru; [Giuliano, Giovanni; Pietrella, Marco; Perrotta, Gaetano; Facella, Paolo] Italian Natl Agcy New Technol, Energy & Sustainable Dev ENEA, Casaccia Res Ctr, I-00123 Rome, Italy; [Giuliano, Giovanni; Pietrella, Marco; Perrotta, Gaetano; Facella, Paolo] Trisaia Res Ctr, I-75026 Rotondella, Matera, Italy; [O'Brien, Kimberly] J Craig Venter Inst, Rockville, MD 20850 USA; [Feingold, Sergio E.; Barreiro, Leandro E.; Massa, Gabriela A.] INTA, Estn Expt Agropecuaria Balcarce, Lab Agrobiotecnol, RA-7620 Balcarce, Argentina; [Diambra, Luis] Univ Nacl LaPlata, CREG, Lab Biol Sistemas, RA-1888 La Plata, Argentina; [Vaillancourt, Brieanne; Lin, Haining; Massa, AliciaN.; Geoffroy, Michael; Lundback, Steven; DellaPenna, Dean; Buell, C. Robin] Michigan State Univ, E Lansing, MI 48824 USA; [Sharma, Sanjeev Kumar; Marshall, David F.; Waugh, Robbie; Bryan, Glenn J.] Scottish Crop Res Inst, Genet Programme, Dundee DD2 5DA, Scotland; [Destefanis, Marialaura; Nagy, Istvan; Milbourne, Dan] Teagasc Crops Res Ctr, Oak Pk, Carlow, Ireland; [Thomson, Susan J.; Fiers, Mark; Jacobs, Jeanne M. E.] New Zealand Inst Plant & Food Res Ltd, Christchurch 8140, New Zealand; [Nielsen, Kare L.; Sonderkaer, Mads] Aalborg Univ, AAU, Dept Biotechnol Chem & Environm Engn, DK-9000 Aalborg, Denmark; [Iovene, Marina; Torres, Giovana A.; Jiang, Jiming] Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; [Veilleux, Richard E.] Virginia Polytech Inst & State Univ, Dept Hort, Blacksburg, VA 24061 USA; [Bachem, Christian W. B.; de Boer, Jan; Borm, Theo; Kloosterman, Bjorn; Visser, Richard G. F.] Univ Wageningen & Res Ctr, Dept Plant Sci, Lab Plant Breeding, NL-6708 PB Wageningen, Netherlands; [Goverse, Aska; van Ham, Roeland C. H. J.; Visser, Richard G. F.] Ctr BioSyst Genom, NL-6708 PB Wageningen, Netherlands; [Goverse, Aska] Univ Wageningen & Res Ctr, Dept Plant Sci, Nematol Lab, NL-6708 PB Wageningen, Netherlands	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Ministry of Agriculture & Rural Affairs; Beijing Genomics Institute (BGI); Ministry of Agriculture & Rural Affairs; Universidad Peruana Cayetano Heredia; Universidad Nacional De San Cristobal De Huamanga; Indian Council of Agricultural Research (ICAR); ICAR - Central Potato Research Institute; Research Center of Biotechnology RAS; Russian Academy of Sciences; Universidad de Chile; Universidad de Chile; University of Dundee; Shandong Academy of Agricultural Sciences; Huazhong Agricultural University; Hunan Agricultural University; Imperial College London; Instituto de Investigacion Agropecuaria (INIA); Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; CGIAR; International Potato Center (CIP); Italian National Agency New Technical Energy & Sustainable Economics Development; J. Craig Venter Institute; Instituto Nacional de Tecnologia Agropecuaria (INTA); National University of La Plata; Michigan State University; James Hutton Institute; Teagasc; New Zealand Institute for Plant & Food Research Ltd; Aalborg University; University of Wisconsin System; University of Wisconsin Madison; Virginia Polytechnic Institute & State University; Wageningen University & Research; Centre for BioSystems Genomics; Wageningen University & Research	Huang, SW (corresponding author), Chinese Acad Agr Sci, Key Lab Hort Crops Genet Improvement, Sino Dutch Joint Lab Hort Genom, Inst Vegetables & Flowers,Minist Agr, Beijing 100081, Peoples R China.	huangsanwen@caas.net.cn; buell@msu.edu; Richard.Visser@wur.nl	Huang, Sanwen/ABE-9053-2020; Bolser, Dan/AAE-3087-2019; Whitty, Brett/P-3231-2019; Martin, David/C-2984-2009; Ravin, Nikolai V/C-5907-2014; Pietrella, Marco/ABE-3613-2020; Massa, Gabriela/ABF-7533-2021; Jiang, Jiming/V-6060-2019; Beletsky, Alexey/AAA-5366-2019; Xu, Xun/AAI-6763-2020; Patil, Virupaksh/AAH-5133-2021; van Eck, Herman/C-5940-2008; Kolganova, Tatyana/E-1587-2014; Mardanov, Andrey/S-2294-2016; Marshall, David F/F-2471-2011; He, Jun/ABC-9997-2021; Visser, Richard GF/B-3423-2012; Giuliano, Giovanni/A-2701-2012; L, Diambra/F-6319-2015; Guzman, Frank L/H-1271-2014; MARTINEZ, DIANA/P-2887-2018; Nielsen, Kåre Lehmann L/A-1181-2013; Guzman, Fanny fg/K-5592-2013; Zhang, Youjun/AAY-7948-2020; Torres, Giovana/AAN-5637-2020; Wang, Jun/A-7261-2013; Torres, Giovana A/J-7989-2012; Sharma, Sanjeev Kumar/H-8147-2013; Iovene, Marina/J-5593-2015; Fiers, Mark WEJ/E-6755-2010; Jiang, Jiming/A-9614-2009; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Huang, Sanwen/0000-0002-8547-5309; Bolser, Dan/0000-0002-3991-0859; Whitty, Brett/0000-0001-5776-5424; Jiang, Jiming/0000-0002-6435-6140; Beletsky, Alexey/0000-0002-7611-2354; Xu, Xun/0000-0002-5338-5173; van Eck, Herman/0000-0002-6530-0616; Mardanov, Andrey/0000-0002-8245-8757; Marshall, David F/0000-0001-9309-2570; He, Jun/0000-0003-3733-0241; Visser, Richard GF/0000-0002-0213-4016; Giuliano, Giovanni/0000-0002-2486-0510; L, Diambra/0000-0001-8052-4880; Guzman, Frank L/0000-0002-5048-4213; MARTINEZ, DIANA/0000-0003-1115-5967; Nielsen, Kåre Lehmann L/0000-0002-5598-4401; Guzman, Fanny fg/0000-0003-1537-0904; Zhang, Youjun/0000-0003-3508-6695; Torres, Giovana/0000-0002-3740-8689; Torres, Giovana A/0000-0002-3740-8689; Iovene, Marina/0000-0002-5992-8677; Fiers, Mark WEJ/0000-0001-5694-2409; Jiang, Jiming/0000-0002-6435-6140; Buell, C Robin/0000-0002-6727-4677; Vaillancourt, Brieanne/0000-0002-6795-5173; Zhang, Bo/0000-0001-8890-8416; Sonderkaer, Mads/0000-0002-9309-7459; Ravin, Nikolai/0000-0002-1456-1832; Feingold, Sergio/0000-0002-7107-4651; Orjeda, Gisella/0000-0003-3013-5523; Bachem, Christian/0000-0002-3077-6833; Gawor, Jan/0000-0003-3800-2557; Di Genova, Alex/0000-0002-3120-9283; Massa, Gabriela Alejandra/0000-0002-9028-1330; Milbourne, Dan/0000-0002-8323-6195; Sharma, Sanjeev Kumar/0000-0002-3273-0708; Wang, Jun/0000-0002-8540-8931; Ponce, Olga Patricia/0000-0001-9454-5797; Lozano, Roberto/0000-0003-0760-4977; Pietrella, Marco/0000-0002-8789-6860; Perrotta, Gaetano/0000-0003-2037-1063; zhang, zhonghua/0000-0002-1034-227X; Jacobs, Jeanne/0000-0002-1047-1039; Wang, Jun/0000-0002-2113-5874; Chakrabarti, Swarup Kumar/0000-0001-5566-3264; Bryan, Glenn/0000-0002-7752-5740; Szczesny, Pawel/0000-0001-8442-0157; Thomson, Susan/0000-0001-7127-9414; Martin, David/0000-0002-8732-204X; Gromadka, Robert/0000-0002-9941-6692	EU [APOPHYS EU-QLRT-2001-01849]; US Department of Agriculture National Institute of Food and Agriculture [2008-55300-04757, 2009-85606-05673]; "863'' National High Tech Research Development Program in China [2006AA100107]; "973'' National Key Basic Research Program in China [2006CB101904, 2007CB815703, 2007CB815705, 2009CB119000]; Board of Wageningen University and Research Centre; CAPES Brazilian Ministry of Education; Chinese Academy of Agricultural Sciences; Chinese Ministry of Agriculture; Chinese Ministry of Finance [1251610601001]; Chinese Ministry of Science and Technology [2007DFB30080]; China Postdoctoral Science Foundation [20070420446]; CONICET (Argentina); DAFF Research Stimulus Fund [07-567]; CONICYT-Chile [PBCT-PSD-03]; Danish Council for Strategic Research Programme Commission on Health, Food and Welfare [2101-07-0116]; Danish Council for Strategic Research Programme Commission on Strategic Growth Technologies [2106-07-0021]; FINCyT [099-FINCyT-EQUIP-2009, 076-FINCyT-PIN-2008]; Prestamo BID [1663/OC-PE]; Fund for Economic Structural Support (FES); HarvestPlus Challenge Program; Indian Council of Agricultural Research; INIA-Ministry of Agriculture of Chile; Instituto Nacional de Innovacion Agraria-Ministry of Agriculture of Peru; Instituto Nacional de Tecnologia Agropecuaria (INTA); Italian Ministry of Research (Special Fund for Basic Research); International Potato Center; LBMG of Center for Genome Regulation and Center for Mathematical Modeling; Universidad de Chile [UMI 2807 CNRS]; Ministry of Education and Science of Russia [02.552.11.7073]; National Nature Science Foundation of China [30671319, 30725008, 30890032, 30971995]; Natural Science Foundation of Shandong Province in China [Y2006D21]; Netherlands Technology Foundation (STW); Netherlands Genomics Initiative (NGI); Netherlands Ministries of Economic Affairs (EZ) and Agriculture (LNV); New Zealand Institute for Crop & Food Research Ltd Strategic Science Initiative; Perez Guerrero Fund; Peruvian Ministry of Agriculture-Technical Secretariat of coordination; CGIAR; Peruvian National Council of Science and Technology (CONCYTEC); Polish Ministry of Science and Higher Education [47/PGS/2006/01]; Programa Cooperativo para el Desarrollo Tecnologico Agroalimentario y Agroindustrial del Cono Sur (PROCISUR); Project Programa Bicentenario de Ciencia y Tecnologia - Conicyt; PBCT - Conicyt [PSD-03]; Russian Foundation for Basic Research [09-04-12275]; Secretaria de Ciencia y Tecnologia (SECyT) actual Ministerio de Ciencia y Tecnologia (MINCyT), Argentina; Shenzhen Municipal Government of China [CXB200903110066A, ZYC200903240077A, ZYC200903240076A]; Solexa project [272-07-0196]; Inter-American Council for Integral Development (FEMCIDI); Teagasc; Teagasc Walsh Fellowship Scheme; New Zealand Institute for Plant & Food Research Ltd; Scottish Government Rural and Environment Research and Analysis Directorate (RERAD); Department for Environment, Food and Rural Affairs (DEFRA; Agriculture and Horticulture Development Board - Potato Council; UK Biotechnology and Biological Sciences Research Council [BB/F012640]; US National Science Foundation [DBI-0604907/DBI-0834044]; Virginia Agricultural Experiment Station USDA [135853]; Wellcome Trust [WT 083481]; BBSRC [BB/F013280/1, BB/F012640/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F012640/1, BB/F013280/1] Funding Source: researchfish	EU(European Commission); US Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); "863'' National High Tech Research Development Program in China(National High Technology Research and Development Program of China); "973'' National Key Basic Research Program in China(National Basic Research Program of China); Board of Wageningen University and Research Centre; CAPES Brazilian Ministry of Education(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Chinese Academy of Agricultural Sciences; Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs); Chinese Ministry of Finance; Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); DAFF Research Stimulus Fund; CONICYT-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Danish Council for Strategic Research Programme Commission on Health, Food and Welfare; Danish Council for Strategic Research Programme Commission on Strategic Growth Technologies; FINCyT; Prestamo BID; Fund for Economic Structural Support (FES); HarvestPlus Challenge Program; Indian Council of Agricultural Research(Indian Council of Agricultural Research (ICAR)); INIA-Ministry of Agriculture of Chile; Instituto Nacional de Innovacion Agraria-Ministry of Agriculture of Peru; Instituto Nacional de Tecnologia Agropecuaria (INTA); Italian Ministry of Research (Special Fund for Basic Research)(Ministry of Education, Universities and Research (MIUR)); International Potato Center(CGIAR); LBMG of Center for Genome Regulation and Center for Mathematical Modeling; Universidad de Chile; Ministry of Education and Science of Russia(Ministry of Education and Science, Russian Federation); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province in China(Natural Science Foundation of Shandong Province); Netherlands Technology Foundation (STW)(Technologiestichting STW); Netherlands Genomics Initiative (NGI); Netherlands Ministries of Economic Affairs (EZ) and Agriculture (LNV); New Zealand Institute for Crop & Food Research Ltd Strategic Science Initiative; Perez Guerrero Fund; Peruvian Ministry of Agriculture-Technical Secretariat of coordination; CGIAR(CGIAR); Peruvian National Council of Science and Technology (CONCYTEC); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Programa Cooperativo para el Desarrollo Tecnologico Agroalimentario y Agroindustrial del Cono Sur (PROCISUR); Project Programa Bicentenario de Ciencia y Tecnologia - Conicyt; PBCT - Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/PBCT); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Secretaria de Ciencia y Tecnologia (SECyT) actual Ministerio de Ciencia y Tecnologia (MINCyT), Argentina(Secretaria de Ciencia y Tecnologia (SECYT)); Shenzhen Municipal Government of China; Solexa project; Inter-American Council for Integral Development (FEMCIDI); Teagasc; Teagasc Walsh Fellowship Scheme; New Zealand Institute for Plant & Food Research Ltd; Scottish Government Rural and Environment Research and Analysis Directorate (RERAD); Department for Environment, Food and Rural Affairs (DEFRA(Department for Environment, Food & Rural Affairs (DEFRA)); Agriculture and Horticulture Development Board - Potato Council; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); US National Science Foundation(National Science Foundation (NSF)); Virginia Agricultural Experiment Station USDA; Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We acknowledge the assistance of W. Amoros, B. Babinska, R. V. Baslerov, B. K. Bumazhkin, M. F. Carboni, T. Conner, J. Coombs, L. Daddiego, J. M. D'Ambrosio, G. Diretto, S. B. Divito, D. Douches, M. Filipiak, G. Gianese, R. Hutten, E. Jacobsen, E. Kalinska, S. Kamoun, D. Kells, H. Kossowska, L. Lopez, M. Magallanes-Lundback, T. Miranda, P. S. Naik, A. N. Panteleeva, D. Pattanayak, E. O. Patutina, M. Portantier, S. Rawat, R. Simon, B. P. Singh, B. Singh, W. Stiekema, M. V. Sukhacheva and C. Town in providing plant material, generating data, annotation, analyses, and discussions. We are indebted to additional faculty and staff of the BGI-Shenzhen, J Craig Venter Institute, and MSU Research Technology Support Facility who contributed to this project. Background and preliminary data were provided by the Centre for BioSystems Genomics (CBSG), EU-project (APOPHYS EU-QLRT-2001-01849) and US Department of Agriculture National Institute of Food and Agriculture SolCAP project (2008-55300-04757 and 2009-85606-05673). We acknowledge the funding made available by the "863'' National High Tech Research Development Program in China (2006AA100107), "973'' National Key Basic Research Program in China (2006CB101904, 2007CB815703, 2007CB815705, 2009CB119000), Board of Wageningen University and Research Centre, CAPES Brazilian Ministry of Education, Chinese Academy of Agricultural Sciences (seed grant to S. H.), Chinese Ministry of Agriculture (The "948'' Program), Chinese Ministry of Finance (1251610601001), Chinese Ministry of Science and Technology (2007DFB30080), China Postdoctoral Science Foundation (20070420446 to Z.Z.), CONICET (Argentina), DAFF Research Stimulus Fund (07-567), CONICYT-Chile (PBCT-PSD-03), Danish Council for Strategic Research Programme Commission on Health, Food and Welfare (2101-07-0116), Danish Council for Strategic Research Programme Commission on Strategic Growth Technologies (Grant 2106-07-0021), FINCyT ((099-FINCyT-EQUIP-2009)/(076-FINCyT-PIN-2008), Prestamo BID no. 1663/OC-PE, FONDAP and BASAL-CMM), Fund for Economic Structural Support (FES), HarvestPlus Challenge Program, Indian Council of Agricultural Research, INIA-Ministry of Agriculture of Chile, Instituto Nacional de Innovacion Agraria-Ministry of Agriculture of Peru, Instituto Nacional de Tecnologia Agropecuaria (INTA), Italian Ministry of Research (Special Fund for Basic Research), International Potato Center (CIP-CGIAR core funds), LBMG of Center for Genome Regulation and Center for Mathematical Modeling, Universidad de Chile (UMI 2807 CNRS), Ministry of Education and Science of Russia (contract 02.552.11.; 7073), National Nature Science Foundation of China (30671319, 30725008, 30890032, 30971995), Natural Science Foundation of Shandong Province in China (Y2006D21), Netherlands Technology Foundation (STW), Netherlands Genomics Initiative (NGI), Netherlands Ministries of Economic Affairs (EZ) and Agriculture (LNV), New Zealand Institute for Crop & Food Research Ltd Strategic Science Initiative, Perez Guerrero Fund, Peruvian Ministry of Agriculture-Technical Secretariat of coordination with the CGIAR, Peruvian National Council of Science and Technology (CONCYTEC), Polish Ministry of Science and Higher Education (47/PGS/2006/01), Programa Cooperativo para el Desarrollo Tecnologico Agroalimentario y Agroindustrial del Cono Sur (PROCISUR), Project Programa Bicentenario de Ciencia y Tecnologia - Conicyt, PBCT - Conicyt PSD-03, Russian Foundation for Basic Research (09-04-12275), Secretaria de Ciencia y Tecnologia (SECyT) actual Ministerio de Ciencia y Tecnologia (MINCyT),Argentina, Shenzhen Municipal Government of China (CXB200903110066A, ZYC200903240077A, ZYC200903240076A), Solexa project (272-07-0196), Special Multilateral Fund of the Inter-American Council for Integral Development (FEMCIDI), Teagasc, Teagasc Walsh Fellowship Scheme, The New Zealand Institute for Plant & Food Research Ltd Capability Fund, UK Potato Genome Sequencing grant (Scottish Government Rural and Environment Research and Analysis Directorate (RERAD), Department for Environment, Food and Rural Affairs (DEFRA), Agriculture and Horticulture Development Board - Potato Council), UK Biotechnology and Biological Sciences Research Council (Grant BB/F012640), US National Science Foundation Plant Genome Research Program (DBI-0604907/DBI-0834044), Virginia Agricultural Experiment Station USDA Hatch Funds (135853), and Wellcome Trust Strategic award (WT 083481).	Albach DC, 2001, SYST BOT, V26, P242; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [DOI 10.1007/BF02672069, 10.1007/BF02672069]; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Ballvora A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-112; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Borm T. J., 2008, THESIS WAGENINGEN U; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burlingame B, 2009, J FOOD COMPOS ANAL, V22, P494, DOI 10.1016/j.jfca.2009.09.001; Chaisson M, 2004, BIOINFORMATICS, V20, P2067, DOI 10.1093/bioinformatics/bth205; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Chen N., 2004, CURR PROTOC BIOINFOR, V25, P4101; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Fettke J, 2010, NEW PHYTOL, V185, P663, DOI 10.1111/j.1469-8137.2009.03126.x; Glaczinski H, 2002, POTATO RES, V45, P163, DOI 10.1007/BF02736112; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Haynes FL, 1972, PROSPECTS POTATO DEV, P100; Hijmans RJ, 2001, AM J POTATO RES, V78, P403, DOI 10.1007/BF02896371; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jiang ZS, 2008, GENOME RES, V18, P1362, DOI 10.1101/gr.078477.108; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kohler A, 2008, PLANT MOL BIOL, V66, P619, DOI 10.1007/s11103-008-9293-9; Kuang H, 2004, PLANT CELL, V16, P2870, DOI 10.1105/tpc.104.025502; Kuang HH, 2009, GENOME RES, V19, P42, DOI [10.1101/gr.07816.108, 10.1101/gr.078196.108]; Kuang HH, 2005, PLANT J, V44, P37, DOI 10.1111/j.1365-313X.2005.02506.x; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Mun JH, 2009, MOL GENET GENOMICS, V282, P617, DOI 10.1007/s00438-009-0492-0; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Paz MM, 1999, PLANT BREEDING, V118, P53, DOI 10.1046/j.1439-0523.1999.118001053.x; Peters SA, 2009, PLANT J, V58, P857, DOI 10.1111/j.1365-313X.2009.03822.x; Porter BW, 2009, MOL GENET GENOMICS, V281, P609, DOI 10.1007/s00438-009-0434-x; PRAT S, 1990, FEBS LETT, V268, P334, DOI 10.1016/0014-5793(90)81281-R; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sanseverino W, 2010, NUCLEIC ACIDS RES, V38, pD814, DOI 10.1093/nar/gkp978; Shannon JC, 1996, PLANT PHYSIOL, V110, P835, DOI 10.1104/pp.110.3.835; Simillion C, 2008, BIOINFORMATICS, V24, P127, DOI 10.1093/bioinformatics/btm449; Sonnewald U, 2001, TRENDS PLANT SCI, V6, P333, DOI 10.1016/S1360-1385(01)02020-9; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Tang XM, 2009, CHROMOSOME RES, V17, P899, DOI 10.1007/s10577-009-9077-3; Tauberger E, 2000, PLANT J, V23, P43, DOI 10.1046/j.1365-313x.2000.00783.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van der Vossen E., 2010, WHOLE GENOME PROFILI; van Os H, 2006, GENETICS, V173, P1075, DOI 10.1534/genetics.106.055871; VanOoijen J. W., 2006, JOINMAP; Visser RGF, 2009, AM J POTATO RES, V86, P417, DOI 10.1007/s12230-009-9097-8; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928	57	1294	1425	21	569	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					189	U94		10.1038/nature10158	http://dx.doi.org/10.1038/nature10158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21743474	hybrid, Green Submitted, Green Published			2022-12-01	WOS:000292690500042
J	McCartney, M				McCartney, Margaret			HEALTH MARKETING Waterlogged?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							WATER; DRINK; RISK					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Bennett Jill A, 2004, J Gerontol Nurs, V30, P22; BIRCH LL, 1989, PHYSIOL BEHAV, V45, P387, DOI 10.1016/0031-9384(89)90145-5; Brander Nickie, 2003, Nurs Times, V99, P50; British Bottled Water Producers, WAT VIT STAT IND DAT; Hebert LA, 2003, AM J KIDNEY DIS, V41, P962, DOI 10.1016/S0272-6386(03)00193-8; *HYRDR HLTH, WE DONT DRINK EN WAT; Manz F, 2007, J AM COLL NUTR, V26, p535S, DOI 10.1080/07315724.2007.10719655; Muckelbauer R, 2009, PEDIATRICS, V123, pE661, DOI 10.1542/peds.2008-2186; Negoianu D, 2008, J AM SOC NEPHROL, V19, P1041, DOI 10.1681/ASN.2008030274; *NHS CHOIC, 8 TIPS HLTH LIV; Petraccia L, 2006, CLIN NUTR, V25, P377, DOI 10.1016/j.clnu.2005.10.002; Rogers PJ, 2001, APPETITE, V36, P57, DOI 10.1006/appe.2000.0374; Strippoli GFM, 2011, NEPHROLOGY, V16, P326, DOI 10.1111/j.1440-1797.2010.01415.x; Valtin H, 2002, AM J PHYSIOL-REG I, V283, pR993, DOI 10.1152/ajpregu.00365.2002; 2000, BBC NEWS        0427	15	15	16	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 12	2011	343								d4280	10.1136/bmj.d4280	http://dx.doi.org/10.1136/bmj.d4280			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	794NX	21750074				2022-12-01	WOS:000292908200004
J	Willeit, P; Willeit, J; Kloss-Brandstatter, A; Kronenberg, F; Kiechl, S				Willeit, Peter; Willeit, Johann; Kloss-Brandstaetter, Anita; Kronenberg, Florian; Kiechl, Stefan			Fifteen-Year Follow-up of Association Between Telomere Length and Incident Cancer and Cancer Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Willeit, Peter] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Willeit, Johann; Kiechl, Stefan] Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria; [Kloss-Brandstaetter, Anita; Kronenberg, Florian] Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Innsbruck, Austria	University of Cambridge; Medical University of Innsbruck; Medical University of Innsbruck	Willeit, P (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England.	stefan.kiechl@i-med.ac.at	Willeit, Peter/HCI-7091-2022; Kronenberg, Florian/B-1736-2008	Willeit, Peter/0000-0002-1866-7159; Kronenberg, Florian/0000-0003-2229-1120; Kloss-Brandstatter, Anita/0000-0002-0873-6704	British Heart Foundation [RG/08/014/24067] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008612; Houben JMJ, 2011, J GERONTOL A-BIOL, V66, P38, DOI 10.1093/gerona/glq164; Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Wood AM, 2009, STAT MED, V28, P1067, DOI 10.1002/sim.3530	6	74	75	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2011	306	1					42	44		10.1001/jama.2011.901	http://dx.doi.org/10.1001/jama.2011.901			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	787LV	21730239	Bronze			2022-12-01	WOS:000292378700018
J	Donlea, JM; Thimgan, MS; Suzuki, Y; Gottschalk, L; Shaw, PJ				Donlea, Jeffrey M.; Thimgan, Matthew S.; Suzuki, Yasuko; Gottschalk, Laura; Shaw, Paul J.			Inducing Sleep by Remote Control Facilitates Memory Consolidation in Drosophila	SCIENCE			English	Article							VISUAL-PATTERN MEMORY; CENTRAL COMPLEX; NEURONS; BRAIN; DEPRIVATION; PLASTICITY; BEHAVIOR; NEUROPEPTIDES; MELANOGASTER; WAKEFULNESS	Sleep is believed to play an important role in memory consolidation. We induced sleep on demand by expressing the temperature-gated nonspecific cation channel Transient receptor potential cation channel (UAS-TrpA1) in neurons, including those with projections to the dorsal fan-shaped body (FB). When the temperature was raised to 31 degrees C, flies entered a quiescent state that meets the criteria for identifying sleep. When sleep was induced for 4 hours after a massed-training protocol for courtship conditioning that is not capable of inducing long-term memory (LTM) by itself, flies develop an LTM. Activating the dorsal FB in the absence of sleep did not result in the formation of LTM after massed training.	[Donlea, Jeffrey M.; Thimgan, Matthew S.; Suzuki, Yasuko; Gottschalk, Laura; Shaw, Paul J.] Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Shaw, PJ (corresponding author), Washington Univ, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	shawp@pcg.wustl.edu			NIH [R01-NS051305-01A1, NS057105, T32GM008151, 5F31NS063514-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS063514, R01NS051305, P30NS057105] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Taghert, E. Herzog, P. Gray, L. Seugnet, A. Diantonio, W. Vanderheyden, and B. van Swinderen for discussions. This work was supported by NIH grants R01-NS051305-01A1, NS057105, T32GM008151, and 5F31NS063514-02.	Al-Anzi B, 2010, CURR BIOL, V20, P969, DOI 10.1016/j.cub.2010.04.039; Andretic R, 2005, METHOD ENZYMOL, V393, P759, DOI 10.1016/S0076-6879(05)93040-1; Appelbaum L, 2010, NEURON, V68, P87, DOI 10.1016/j.neuron.2010.09.006; BERGMANN BM, 1989, SLEEP, V12, P5, DOI 10.1093/sleep/12.1.5; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; GAILEY DA, 1985, GENETICS, V111, P795; GAILEY DA, 1982, GENETICS, V102, P771; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Kahsai L, 2011, J COMP NEUROL, V519, P290, DOI 10.1002/cne.22520; Kahsai L, 2010, J EXP BIOL, V213, P2256, DOI 10.1242/jeb.043190; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Luan HJ, 2006, J NEUROSCI, V26, P573, DOI 10.1523/JNEUROSCI.3916-05.2006; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Pan YF, 2009, LEARN MEMORY, V16, P289, DOI 10.1101/lm.1331809; Rechtschaffen A, 1998, PERSPECT BIOL MED, V41, P359, DOI 10.1353/pbm.1998.0051; Seugnet L, 2008, CURR BIOL, V18, P1110, DOI 10.1016/j.cub.2008.07.028; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Walker MP, 2005, NEUROSCIENCE, V133, P911, DOI 10.1016/j.neuroscience.2005.04.007; Wang ZP, 2008, LEARN MEMORY, V15, P133, DOI 10.1101/lm.873008; Winther AME, 2006, MOL CELL NEUROSCI, V31, P399, DOI 10.1016/j.mcn.2005.10.010; Young JM, 2010, J COMP NEUROL, V518, P1500, DOI 10.1002/cne.22284	33	221	223	2	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 24	2011	332	6037					1571	1576		10.1126/science.1202249	http://dx.doi.org/10.1126/science.1202249			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700877	Green Accepted			2022-12-01	WOS:000291990000049
J	Liu, W; Wen, WY; Wei, ZY; Yu, J; Ye, F; Liu, CH; Hardie, RC; Zhang, MJ				Liu, Wei; Wen, Wenyu; Wei, Zhiyi; Yu, Jiang; Ye, Fei; Liu, Che-Hsiung; Hardie, Roger C.; Zhang, Mingjie			The INAD Scaffold Is a Dynamic, Redox-Regulated Modulator of Signaling in the Drosophila Eye	CELL			English	Article							PROTEIN-KINASE-C; PDZ-DOMAIN PROTEIN; PHOTORECEPTOR CELLS; LIGHT ADAPTATION; RETINAL DEGENERATION; VISUAL TRANSDUCTION; PHOSPHOLIPASE-C; TARGET BINDING; TRP CHANNELS; CA2+ CHANNEL	INAD is a scaffolding protein that regulates signaling in Drosophila photoreceptors. One of its PDZ domains, PDZ5, cycles between reduced and oxidized forms in response to light, but it is unclear how light affects its redox potential. Through biochemical and structural studies, we show that the redox potential of PDZ5 is allosterically regulated by its interaction with another INAD domain, PDZ4. Whereas isolated PDZ5 is stable in the oxidized state, formation of a PDZ45 "supramodule'' locks PDZ5 in the reduced state by raising the redox potential of its Cys606/Cys645 disulfide bond by similar to 330 mV. Acidification, potentially mediated via light and PLC beta-mediated hydrolysis of PIP(2), disrupts the interaction between PDZ4 and PDZ5, leading to PDZ5 oxidation and dissociation from the TRP Ca(2+) channel, a key component of fly visual signaling. These results show that scaffolding proteins can actively modulate the intrinsic redox potentials of their disulfide bonds to exert regulatory roles in signaling.	[Liu, Wei; Wei, Zhiyi; Yu, Jiang; Ye, Fei; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Div Life Sci, Mol Neurosci Ctr, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Wei, Zhiyi] Hong Kong Univ Sci & Technol, Inst Adv Studies, Kowloon, Hong Kong, Peoples R China; [Wen, Wenyu] Fudan Univ, Dept Chem, Shanghai 200032, Peoples R China; [Wen, Wenyu] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Liu, Che-Hsiung; Hardie, Roger C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Fudan University; Fudan University; University of Cambridge	Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Mol Neurosci Ctr, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China.	mzhang@ust.hk	Wei, Zhiyi/N-9995-2019; Wei, Zhiyi/C-4315-2014; Yu, Jiang/C-6980-2012; Wei, Zhiyi/B-5001-2010	Wei, Zhiyi/0000-0002-4446-6502; Wei, Zhiyi/0000-0002-4446-6502; Wei, Zhiyi/0000-0002-4446-6502; Liu, Wei/0000-0001-8250-2562; Zhang, Mingjie/0000-0001-9404-0190; Hardie, Roger/0000-0001-5531-3264	Research Grants Council of Hong Kong [663808, 664009, 660709, 663610, CA07/08.SC01, HKUST6/CRF/10, SEG_HKUST06, AoE/B-15/01-II]; National Major Basic Research Program of China [2009CB918600]; Natural Science Foundation of China [30970574]; Shanghai Rising-Star Program [10QA1400700]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G006865/1]; Biotechnology and Biological Sciences Research Council [BB/G006865/1] Funding Source: researchfish; BBSRC [BB/G006865/1] Funding Source: UKRI	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); National Major Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Drs. Quan Hao and Qun Liu for X-ray data collection, Dr. Zhenguo Wu and Dr. Yarui Diao for help in the protein kinase assays, and Mr. Anthony Zhang for critical reading of the manuscript. This work was supported by grants from the Research Grants Council of Hong Kong to M.Z. (663808, 664009, 660709, 663610, CA07/08.SC01, HKUST6/CRF/10, SEG_HKUST06, and AoE/B-15/01-II); the National Major Basic Research Program of China (2009CB918600), the Natural Science Foundation of China (30970574), and the Shanghai Rising-Star Program (10QA1400700) to W. W.; and BB/G006865/1 from the Biotechnology and Biological Sciences Research Council (BBSRC) to R.C.H.	Adamski FM, 1998, J BIOL CHEM, V273, P17713, DOI 10.1074/jbc.273.28.17713; Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Feng W, 2003, NAT STRUCT BIOL, V10, P972, DOI 10.1038/nsb992; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Fox GC, 2007, NATURE, V447, P487, DOI 10.1038/nature05804; Gu YC, 2005, CURR BIOL, V15, P1228, DOI 10.1016/j.cub.2005.05.058; Hardie RC, 2002, NEURON, V36, P689, DOI 10.1016/S0896-6273(02)01048-6; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; HARDIE RC, 2008, SENSES COMPREHENSIVE, V1, P77; Huang JH, 2010, CURR BIOL, V20, P189, DOI 10.1016/j.cub.2009.12.019; Huber A, 1996, J BIOL CHEM, V271, P11710, DOI 10.1074/jbc.271.20.11710; Huber A, 1996, EMBO J, V15, P7036, DOI 10.1002/j.1460-2075.1996.tb01095.x; Huber A, 2001, EUR J NEUROSCI, V14, P769, DOI 10.1046/j.0953-816x.2001.01704.x; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Juusola M, 2001, J GEN PHYSIOL, V117, P3, DOI 10.1085/jgp.117.1.3; Keese MA, 1999, FEBS LETT, V447, P135, DOI 10.1016/S0014-5793(99)00296-3; Kemble DJ, 2009, P NATL ACAD SCI USA, V106, P5070, DOI 10.1073/pnas.0806117106; Kimple ME, 2001, EMBO J, V20, P4414, DOI 10.1093/emboj/20.16.4414; Li HS, 2000, J CELL BIOL, V150, P1411, DOI 10.1083/jcb.150.6.1411; Liu CH, 2008, NEURON, V59, P778, DOI 10.1016/j.neuron.2008.07.007; Long JF, 2005, NAT STRUCT MOL BIOL, V12, P722, DOI 10.1038/nsmb958; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; Long JF, 2008, J MOL BIOL, V375, P1457, DOI 10.1016/j.jmb.2007.11.088; Mishra P, 2007, CELL, V131, P80, DOI 10.1016/j.cell.2007.07.037; Montell C, 2005, J PHYSIOL-LONDON, V567, P45, DOI 10.1113/jphysiol.2005.092551; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; Montell C, 2003, CELL CALCIUM, V33, P409, DOI 10.1016/S0143-4160(03)00053-8; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Peng L, 2008, J NEUROCHEM, V104, P1526, DOI 10.1111/j.1471-4159.2007.05096.x; Popescu DC, 2006, J NEUROSCI, V26, P8570, DOI 10.1523/JNEUROSCI.1478-06.2006; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Scott K, 1997, CELL, V91, P375, DOI 10.1016/S0092-8674(00)80421-3; Shieh BH, 1996, NEURON, V16, P991, DOI 10.1016/S0896-6273(00)80122-1; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; Tsunoda S, 1999, CELL CALCIUM, V26, P165, DOI 10.1054/ceca.1999.0070; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; van Huizen R, 1998, EMBO J, V17, P2285, DOI 10.1093/emboj/17.8.2285; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Xu XZS, 1998, J CELL BIOL, V142, P545, DOI 10.1083/jcb.142.2.545; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; Zhang MJ, 2003, ACCOUNTS CHEM RES, V36, P530, DOI 10.1021/ar020210b	48	50	55	1	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 24	2011	145	7					1088	1101		10.1016/j.cell.2011.05.015	http://dx.doi.org/10.1016/j.cell.2011.05.015			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703451	Bronze			2022-12-01	WOS:000292025700015
J	Decramer, M				Decramer, Marc		European Resp Roadmap Initiative	The European Respiratory Roadmap	LANCET			English	Editorial Material									[Decramer, Marc; European Resp Roadmap Initiative] Katholieke Univ Leuven, Div Resp, B-3000 Louvain, Belgium	KU Leuven	Decramer, M (corresponding author), Katholieke Univ Leuven, Div Resp, B-3000 Louvain, Belgium.	Marc.Decramer@uzleuven.be		Nicod, Laurent P/0000-0002-0905-916X				[Anonymous], 2011, SMOK FREE LEG EU; Christensen CM, 2000, HARVARD BUS REV, V78, P102; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; *EUR COMM, 2009, SURV TOB AN REP; Gerkens S, 2010, HEALT SYST TRANSIT, V12, P1; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; K Neubauer, 2010, INVESTING EUROPES HL; Kamel N, 2008, EUR RESPIR J, V31, P924, DOI 10.1183/09031936.00033208; Kane RL, 2007, MED CARE, V45, P1195, DOI 10.1097/MLR.0b013e3181468ca3; La Parra D, 2008, AGEING SOC, V28, P85, DOI 10.1017/S0144686X07006563; Loddenkemper R, 2008, EUR RESPIR J, V32, P538, DOI 10.1183/09031936.00090908; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; World Health Organization, WORLD HLTH STAT 2008	13	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2011	378	9805					1765	1767		10.1016/S0140-6736(11)60619-3	http://dx.doi.org/10.1016/S0140-6736(11)60619-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	851IS	21703674				2022-12-01	WOS:000297262300010
J	Welz, PS; Wullaert, A; Vlantis, K; Kondylis, V; Fernandez-Majada, V; Ermolaeva, M; Kirsch, P; Sterner-Kock, A; van Loo, G; Pasparakis, M				Welz, Patrick-Simon; Wullaert, Andy; Vlantis, Katerina; Kondylis, Vangelis; Fernandez-Majada, Vanesa; Ermolaeva, Maria; Kirsch, Petra; Sterner-Kock, Anja; van Loo, Geert; Pasparakis, Manolis			FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation	NATURE			English	Article							NEMO/IKK-GAMMA; DEFICIENT MICE; TNF-ALPHA; B-CELL; DEATH; REGULATOR; APOPTOSIS; DELETION; IMMUNITY; RIP3	Intestinal immune homeostasis depends on a tightly regulated cross talk between commensal bacteria, mucosal immune cells and intestinal epithelial cells (IECs)(1-4). Epithelial barrier disruption is considered to be a potential cause of inflammatory bowel disease; however, the mechanisms regulating intestinal epithelial integrity are poorly understood(1,5). Here we show that mice with IEC-specific knockout of FADD (FADD(IEC-KO)), an adaptor protein required for death-receptor-induced apoptosis(6), spontaneously developed epithelial cell necrosis, loss of Paneth cells, enteritis and severe erosive colitis. Genetic deficiency in RIP3, a critical regulator of programmed necrosis(7-9), prevented the development of spontaneous pathology in both the small intestine and colon of FADD(IEC-KO) mice, demonstrating that intestinal inflammation is triggered by RIP3-dependent death of FADD-deficient IECs. Epithelial-specific inhibition of CYLD, a deubiquitinase that regulates cellular necrosis(10), prevented colitis development in FADD(IEC-KO) but not in NEMOIEC-KO mice(11), showing that different mechanisms mediated death of colonic epithelial cells in these two models. In FADD(IEC-KO) mice, TNF deficiency ameliorated colon inflammation, whereas MYD88 deficiency and also elimination of the microbiota prevented colon inflammation, indicating that bacteria-mediated Toll-like-receptor signalling drives colitis by inducing the expression of TNF and other cytokines. However, neither CYLD, TNF or MYD88 deficiency nor elimination of the microbiota could prevent Paneth cell loss and enteritis in FADD(IEC-KO) mice, showing that different mechanisms drive RIP3-dependent necrosis of FADD-deficient IECs in the small and large bowel. Therefore, by inhibiting RIP3-mediated IEC necrosis, FADD preserves epithelial barrier integrity and antibacterial defence, maintains homeostasis and prevents chronic intestinal inflammation. Collectively, these results show that mechanisms preventing RIP3-mediated epithelial cell death are critical for the maintenance of intestinal homeostasis and indicate that programmed necrosis of IECs might be implicated in the pathogenesis of inflammatory bowel disease, in which Paneth cell and barrier defects are thought to contribute to intestinal inflammation.	[Welz, Patrick-Simon; Wullaert, Andy; Vlantis, Katerina; Kondylis, Vangelis; Fernandez-Majada, Vanesa; Ermolaeva, Maria; Pasparakis, Manolis] Univ Cologne, Ctr Mol Med CMMC, Inst Genet, D-50674 Cologne, Germany; [Kirsch, Petra] Univ Ulm, Tierforschungszentrum, D-89081 Ulm, Germany; [Sterner-Kock, Anja] Univ Cologne, Uniklin Koln, Ctr Med Expt, D-50931 Cologne, Germany; [van Loo, Geert] Univ Ghent VIB, Dept Mol Biomed Res, B-9052 Ghent, Belgium; [van Loo, Geert] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium	University of Cologne; Ulm University; University of Cologne; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Pasparakis, M (corresponding author), Univ Cologne, Ctr Mol Med CMMC, Inst Genet, Zulpicher Str 47A, D-50674 Cologne, Germany.	Pasparakis@uni-koeln.de	Pasparakis, Manolis/N-4350-2019; Pasparakis, Manolis/H-9292-2017; , van Loo Geert/AAD-1220-2019; Wullaert, Andy/R-1924-2019; Kondylis, Vangelis/S-6276-2019; Wullaert, Andy/D-2975-2018; van Loo, Geert/C-1505-2009; Welz, Patrick-Simon/F-3856-2016; Fernandez Majada, Vanesa/K-8564-2017	Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966; , van Loo Geert/0000-0002-8427-4775; Wullaert, Andy/0000-0001-5012-654X; Wullaert, Andy/0000-0001-5012-654X; Welz, Patrick-Simon/0000-0001-8370-625X; Fernandez Majada, Vanesa/0000-0003-4287-5086; Kondylis, Vangelis/0000-0002-6970-8731	Deutsche Forschungsgemeinschaft [SFB670, SFB829]; European Commission (EC) [223151, 223404]; EMBO; 'Group-IDMRP' of Ghent University; International Graduate School in Genetics and Functional Genomics at the University of Cologne	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission (EC)(European CommissionEuropean Commission Joint Research Centre); EMBO(European Molecular Biology Organization (EMBO)); 'Group-IDMRP' of Ghent University; International Graduate School in Genetics and Functional Genomics at the University of Cologne	We thank C. Uthoff-Hachenberg, J. Pfeiffer, E. Mahlberg, D. Beier, J. Buchholz, B. Huelser, B. Wolff, E. Merkel and S. Schmidt for technical support. We also thank V. Dixit and K. Newton for providing Ripk3<SUP>-/-</SUP> mice and R. Massoumi for providing anti-CYLD antibody. This work was funded by grants from the Deutsche Forschungsgemeinschaft (SFB670, SFB829, CECAD) and European Commission FP7 program grants 'INFLA-CARE' and 'Masterswitch' (EC contract numbers 223151 and 223404 respectively) to M. P. V. F.-M. was supported by a long-term EMBO fellowship, G. v. L. was supported by 'Group-IDMRP' of Ghent University and P.-S.W. was supported by a fellowship from the International Graduate School in Genetics and Functional Genomics at the University of Cologne.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; DOURMASHKIN RR, 1983, HUM PATHOL, V14, P643, DOI 10.1016/S0046-8177(83)80207-X; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kollias G, 2005, SEMIN ARTHRITIS RHEU, V34, P3, DOI 10.1016/j.semarthrit.2005.01.002; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Mc Guire C, 2010, J IMMUNOL, V185, P7646, DOI 10.4049/jimmunol.1000930; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Osborn SL, 2010, P NATL ACAD SCI USA, V107, P13034, DOI 10.1073/pnas.1005997107; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Peyrin-Biroulet L, 2010, Minerva Gastroenterol Dietol, V56, P233; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Ukena SN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001308; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681	36	443	463	4	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2011	477	7364					330	U102		10.1038/nature10273	http://dx.doi.org/10.1038/nature10273			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819TD	21804564				2022-12-01	WOS:000294852400031
J	Mechanic, RE				Mechanic, Robert E.			Opportunities and Challenges for Episode-Based Payment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02453 USA	Brandeis University	Mechanic, RE (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02453 USA.							Casale AS, 2007, ANN SURG, V246, P613, DOI 10.1097/SLA.0b013e318155a996; de Brantes F, 2009, NEW ENGL J MED, V361, P1033, DOI 10.1056/NEJMp0906121; Hussey PS, 2009, HEALTH AFFAIR, V28, P1406, DOI 10.1377/hlthaff.28.5.1406; Mechanic RE, 2009, HEALTH AFFAIR, V28, pW262, DOI 10.1377/hlthaff.28.2.w262	4	57	57	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2011	365	9					777	779		10.1056/NEJMp1105963	http://dx.doi.org/10.1056/NEJMp1105963			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	813YC	21864162				2022-12-01	WOS:000294405200001
J	Sigal, A; Kim, JT; Balazs, AB; Dekel, E; Mayo, A; Milo, R; Baltimore, D				Sigal, Alex; Kim, Jocelyn T.; Balazs, Alejandro B.; Dekel, Erez; Mayo, Avi; Milo, Ron; Baltimore, David			Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LYMPHOID-TISSUE; TARGET-CELLS; INFECTION; DYNAMICS; RECOMBINATION; LYMPHOCYTES; RESERVOIRS; VIREMIA; HAART	Latency and ongoing replication(1) have both been proposed to explain the drug-insensitive human immunodeficiency virus (HIV) reservoir maintained during antiretroviral therapy. Here we explore a novel mechanism for ongoing HIV replication in the face of antiretroviral drugs. We propose a model whereby multiple infections(2,3) per cell lead to reduced sensitivity to drugs without requiring drug-resistant mutations, and experimentally validate the model using multiple infections per cell by cell-free HIV in the presence of the drug tenofovir. We then examine the drug sensitivity of cell-to-cell spread of HIV(4-7), a mode of HIV transmission that can lead to multiple infection events per target cell(8-10). Infections originating from cell-free virus decrease strongly in the presence of antiretrovirals tenofovir and efavirenz whereas infections involving cell-to-cell spread are markedly less sensitive to the drugs. The reduction in sensitivity is sufficient to keep multiple rounds of infection from terminating in the presence of drugs. We examine replication from cell-to-cell spread in the presence of clinical drug concentrations using a stochastic infection model and find that replication is intermittent, without substantial accumulation of mutations. If cell-to-cell spread has the same properties in vivo, it may have adverse consequences for the immune system(11-13), lead to therapy failure in individuals with risk factors(14), and potentially contribute to viral persistence and hence be a barrier to curing HIV infection.	[Sigal, Alex; Kim, Jocelyn T.; Balazs, Alejandro B.; Baltimore, David] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Kim, Jocelyn T.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90095 USA; [Dekel, Erez; Mayo, Avi] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Milo, Ron] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel	California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Weizmann Institute of Science; Weizmann Institute of Science	Baltimore, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	baltimo@caltech.edu	mayo, avi/N-3756-2019; MAYO, AVI E/K-1736-2012; Sigal, Alex/GWC-7488-2022; Milo, Hilla/C-8767-2016	mayo, avi/0000-0002-4479-3423; Sigal, Alex/0000-0001-8571-2004; Balazs, Alejandro/0000-0002-1767-3944; Kim, Jocelyn/0000-0001-7040-5773; Milo, Ron/0000-0003-1641-2299	Human Frontier Science Program [LT00946]; UCLA [T32 AI089398]; amfAR Postdoctoral Research Fellowship [107756-47-RFVA]; Bill & Melinda Gates Foundation; National Institutes of Health [HHSN266200500035C]; National Institute of Allergy and Infectious Diseases; UCLA CFAR Virology Core Lab [P01-AI-28697]; UCSF-GIVI CFAR [P30-AI-27763]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089398] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); UCLA; amfAR Postdoctoral Research Fellowship; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UCLA CFAR Virology Core Lab; UCSF-GIVI CFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. K. Chen, A. Del Portillo, J. T. Schiffer, L. Corey, and G. Lustig for discussions. A.S. was supported by the Human Frontier Science Program Long Term Fellowship LT00946. J.T.K. was supported by the UCLA STAR fellowship and T32 AI089398. A.B.B. was supported by the amfAR Postdoctoral Research Fellowship 107756-47-RFVA. This work was supported by the Bill & Melinda Gates Foundation and by the National Institutes of Health (HHSN266200500035C) and a contract from the National Institute of Allergy and Infectious Diseases. We acknowledge the support of the UCLA CFAR Virology Core Lab (P01-AI-28697) and the UCSF-GIVI CFAR (P30-AI-27763).	Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Chen BK, 1996, J VIROL, V70, P6044, DOI 10.1128/JVI.70.9.6044-6053.1996; Chun TW, 2011, J INFECT DIS, V204, P135, DOI 10.1093/infdis/jir208; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Cu-Uvin S, 2010, AIDS, V24, P2486, DOI 10.1097/QAD.0b013e32833e5043; Dang Q, 2004, P NATL ACAD SCI USA, V101, P632, DOI 10.1073/pnas.0307636100; Del Portillo A, 2011, J VIROL, V85, P7169, DOI 10.1128/JVI.00231-11; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Dixit NM, 2005, P NATL ACAD SCI USA, V102, P8198, DOI 10.1073/pnas.0407498102; Dixit NM, 2004, J VIROL, V78, P8942, DOI 10.1128/JVI.78.16.8942-8945.2004; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Frenkel LM, 2003, J VIROL, V77, P5721, DOI 10.1128/JVI.77.10.5721-5730.2003; Gratton S, 2000, P NATL ACAD SCI USA, V97, P14566, DOI 10.1073/pnas.97.26.14566; Grossman Z, 1999, NAT MED, V5, P1099, DOI 10.1038/13410; Jung A, 2002, NATURE, V418, P144, DOI 10.1038/418144a; Kieffer TL, 2004, J INFECT DIS, V189, P1452, DOI 10.1086/382488; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Martin N, 2010, J VIROL, V84, P3516, DOI 10.1128/JVI.02651-09; Mathias AA, 2007, JAIDS-J ACQ IMM DEF, V46, P167, DOI 10.1097/QAI.0b013e3181427835; North TW, 2010, J VIROL, V84, P2913, DOI 10.1128/JVI.02356-09; Nowak M. A, 2000, VIRUS DYNAMICS; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Ribeiro RM, 2010, J VIROL, V84, P6096, DOI 10.1128/JVI.00127-10; Rong LB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000533; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Wu Y, 2007, CURR HIV RES, V5, P394	30	367	371	3	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2011	477	7362					95	U100		10.1038/nature10347	http://dx.doi.org/10.1038/nature10347			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813XT	21849975				2022-12-01	WOS:000294404300038
J	Gandhi, TK; Zuccotti, G; Lee, TH				Gandhi, Tejal K.; Zuccotti, Gianna; Lee, Thomas H.			Incomplete Care - On the Trail of Flaws in the System	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gandhi, Tejal K.] Partners HealthCare Syst, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA	Partners Healthcare System; Harvard University; Harvard Medical School	Gandhi, TK (corresponding author), Partners HealthCare Syst, Boston, MA USA.							[Anonymous], 2010, MMWR MORB MORTAL WKL, V59, P1102; Pang J, 2010, J GEN INTERN MED, V25, P216; Shojania KG, 2010, CAN MED ASSOC J, V182, pE216, DOI 10.1503/cmaj.090578; Sumaraju V, 2001, INFECT DIS CLIN N AM, V15, P551, DOI 10.1016/S0891-5520(05)70159-8; Turchin A, 2010, P AMIA 2010 ANN S WA, P1282	5	18	18	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2011	365	6					486	488		10.1056/NEJMp1106313	http://dx.doi.org/10.1056/NEJMp1106313			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	805MW	21830964				2022-12-01	WOS:000293732100003
J	Li, FY; Chaigne-Delalande, B; Kanellopoulou, C; Davis, JC; Matthews, HF; Douek, DC; Cohen, JI; Uzel, G; Su, HC; Lenardo, MJ				Li, Feng-Yen; Chaigne-Delalande, Benjamin; Kanellopoulou, Chrysi; Davis, Jeremiah C.; Matthews, Helen F.; Douek, Daniel C.; Cohen, Jeffrey I.; Uzel, Gulbu; Su, Helen C.; Lenardo, Michael J.			Second messenger role for Mg2+ revealed by human T-cell immunodeficiency	NATURE			English	Article							ACQUIRED-IMMUNODEFICIENCY; SIGNAL-TRANSDUCTION; HIV-INFECTION; MAGNESIUM; ACTIVATION; CALCIUM; LYMPHOCYTOPENIA; RECEPTOR; DEFICIENCY; IDENTIFICATION	The magnesium ion, Mg2+, is essential for all life as a cofactor for ATP, polyphosphates such as DNA and RNA, and metabolic enzymes, but whether it plays a part in intracellular signalling (as Ca2+ does) is unknown. Here we identify mutations in the magnesium transporter gene, MAGT1, in a novel X-linked human immunodeficiency characterized by CD4 lymphopenia, severe chronic viral infections, and defective T-lymphocyte activation. We demonstrate that a rapid transient Mg2+ influx is induced by antigen receptor stimulation in normal T cells and by growth factor stimulation in non-lymphoid cells. MAGT1 deficiency abrogates the Mg2+ influx, leading to impaired responses to antigen receptor engagement, including defective activation of phospholipase C gamma 1 and a markedly impaired Ca2+ influx in T cells but not B cells. These observations reveal a role for Mg2+ as an intracellular second messenger coupling cell-surface receptor activation to intracellular effectors and identify MAGT1 as a possible target for novel therapeutics.	[Li, Feng-Yen; Chaigne-Delalande, Benjamin; Kanellopoulou, Chrysi; Matthews, Helen F.; Lenardo, Michael J.] NIAID, Mol Dev Sect, Lymphocyte Mol Genet Unit, Immunol Lab,NIH, Bethesda, MD 20892 USA; [Li, Feng-Yen] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Davis, Jeremiah C.; Su, Helen C.] NIAID, Human Immunol Dis Unit, Host Def Lab, NIH, Bethesda, MD 20892 USA; [Douek, Daniel C.] NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Cohen, Jeffrey I.] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [Uzel, Gulbu] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Li, FY (corresponding author), NIAID, Mol Dev Sect, Lymphocyte Mol Genet Unit, Immunol Lab,NIH, Bethesda, MD 20892 USA.	lenardo@nih.gov	Su, Helen C/H-9541-2015	Su, Helen C/0000-0002-5582-9110	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000913, ZIAAI000769, ZIAAI001059] Funding Source: NIH RePORTER	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Zheng, A. Weiss, R. Germain, R. Siegel, F. Wolf and P. Schwartzberg for critically reading the manuscript; F. Wolf for advice on magnesium assessments; L. Zheng, C. Lowell and A. Weiss for advice on experiments and data; H. Jing for making HVS lines from patient cells; P. Chen for assistance with plasmid DNA preparation; N. Sandler for flow cytometry assistance; A. Snow and H. Jing for assistance with genomic DNA library preparation for Solexa sequencing; J. Almenara and Illumina staff for Solexa assistance; D. Killilea for assistance with MS-ICP data interpretation; and A. Irani for referring the patients. F.-Y.L. is in the Medical Scientist Training Program at the University of California-San Francisco and thanks K. Shannon and J. Toutolmin for support and encouragement. This work was supported by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health.	ABBOUD CN, 1985, J CELL PHYSIOL, V122, P64, DOI 10.1002/jcp.1041220111; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; Cakmak I, 2008, PHYSIOL PLANTARUM, V133, P692, DOI 10.1111/j.1399-3054.2007.01042.x; Centers for Disease Control (CDC), 1992, MMWR Morb Mortal Wkly Rep, V41, P541; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Cossu F, 2010, ITAL J PEDIATR, V36, DOI 10.1186/1824-7288-36-76; Cowan JA, 2002, BIOMETALS, V15, P225, DOI 10.1023/A:1016022730880; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; FAUCI AS, 1993, NEW ENGL J MED, V328, P429, DOI 10.1056/NEJM199302113280610; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Filipovich AH, 2010, BLOOD, V116, P3398, DOI 10.1182/blood-2010-03-275909; FLYNN A, 1984, J NUTR, V114, P2034, DOI 10.1093/jn/114.11.2034; Freier S, 1998, ARCH DIS CHILD, V78, P371, DOI 10.1136/adc.78.4.371; Fu GP, 2010, J EXP MED, V207, P309, DOI 10.1084/jem.20090880; Gasser A, 2006, J BIOL CHEM, V281, P16906, DOI 10.1074/jbc.M601347200; Goytain A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-48; GRUBBS RD, 1987, MAGNESIUM, V6, P113; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Junge S, 2007, EUR J IMMUNOL, V37, P3270, DOI 10.1002/eji.200636976; Killilea DW, 2008, P NATL ACAD SCI USA, V105, P5768, DOI 10.1073/pnas.0712401105; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Kohler S, 2009, BLOOD, V113, P769, DOI 10.1182/blood-2008-02-139154; LAURENCE J, 1992, LANCET, V340, P273, DOI 10.1016/0140-6736(92)92359-N; Lin SA, 2001, PEDIATR HEMAT ONCOL, V18, P153, DOI 10.1080/088800101300003008; LOBATO MN, 1995, PEDIATR INFECT DIS J, V14, P527, DOI 10.1097/00006454-199506000-00011; MODIANO JF, 1988, J CELL PHYSIOL, V135, P451, DOI 10.1002/jcp.1041350312; Murphy E, 2000, CIRC RES, V86, P245, DOI 10.1161/01.RES.86.3.245; Nel AE, 2002, J ALLERGY CLIN IMMUN, V109, P758, DOI 10.1067/mai.2002.124259; NG LL, 1991, CLIN SCI, V80, P539, DOI 10.1042/cs0800539; Notarangelo LD, 2010, J ALLERGY CLIN IMMUN, V125, pS182, DOI 10.1016/j.jaci.2009.07.053; Permyakov EA, 2009, J INORG BIOCHEM, V103, P77, DOI 10.1016/j.jinorgbio.2008.09.006; Peterson EJ, 1999, CLIN EXP RHEUMATOL, V17, P107; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Quamme GA, 2010, AM J PHYSIOL-CELL PH, V298, pC407, DOI 10.1152/ajpcell.00124.2009; RIJKERS GT, 1993, BIOCHEM J, V289, P373, DOI 10.1042/bj2890373; Romani AMP, 2007, FRONT BIOSCI-LANDMRK, V12, P308, DOI 10.2741/2066; Sabbagh F, 2008, TRANSPL IMMUNOL, V20, P83, DOI 10.1016/j.trim.2008.07.005; SMITH DK, 1993, NEW ENGL J MED, V328, P373, DOI 10.1056/NEJM199302113280601; SUTHERLAND EW, 1972, SCIENCE, V177, P401, DOI 10.1126/science.177.4047.401; Takaya J, 2000, MAGNESIUM RES, V13, P139; Weber K, 2008, MOL THER, V16, P698, DOI 10.1038/mt.2008.6; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wengler GS, 1997, LIFE SCI, V61, P1405, DOI 10.1016/S0024-3205(97)00686-3; WHITNEY RB, 1972, J IMMUNOL, V108, P1179; Xie ZJ, 2010, BIOCHEM BIOPH RES CO, V399, P425, DOI 10.1016/j.bbrc.2010.07.098; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506; Zhou H, 2009, P NATL ACAD SCI USA, V106, P15750, DOI 10.1073/pnas.0908332106	51	353	364	3	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2011	475	7357					471	U63		10.1038/nature10246	http://dx.doi.org/10.1038/nature10246			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21796205	Green Accepted			2022-12-01	WOS:000293167900034
J	Delebecque, CJ; Lindner, AB; Silver, PA; Aldaye, FA				Delebecque, Camille J.; Lindner, Ariel B.; Silver, Pamela A.; Aldaye, Faisal A.			Organization of Intracellular Reactions with Rationally Designed RNA Assemblies	SCIENCE			English	Article							DNA	The rules of nucleic acid base-pairing have been used to construct nanoscale architectures and organize biomolecules, but little has been done to apply this technology in vivo. We designed and assembled multidimensional RNA structures and used them as scaffolds for the spatial organization of bacterial metabolism. Engineered RNA modules were assembled into discrete, one-dimensional, and two-dimensional scaffolds with distinct protein-docking sites and used to control the spatial organization of a hydrogen-producing pathway. We increased hydrogen output as a function of scaffold architecture. Rationally designed RNA assemblies can thus be used to construct functional architectures in vivo.	[Delebecque, Camille J.; Lindner, Ariel B.] INSERM, U1001, F-75015 Paris, France; [Delebecque, Camille J.; Silver, Pamela A.; Aldaye, Faisal A.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Delebecque, Camille J.; Silver, Pamela A.; Aldaye, Faisal A.] Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Delebecque, Camille J.; Lindner, Ariel B.] Paris Descartes Univ, Fac Med, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Harvard University; Harvard Medical School; UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte	Lindner, AB (corresponding author), INSERM, U1001, F-75015 Paris, France.	ariel.lindner@inserm.fr; pamela_silver@hms.harvard.edu	Lindner, Ariel B/I-8503-2016; Lindner, Ariel/K-9247-2019	Lindner, Ariel B/0000-0001-5015-6511; Lindner, Ariel/0000-0001-5015-6511	Enerbio-Tuck Foundation; Institut Francais du Petrole Energies Nouvelles; Agence Nationale de la Recherche France; Institut National de la Sante et de la Recherche Medicale-Institut National de Recherche en Informatique et en Automatique projet d'envergure; Axa Foundation Chair on Longevity; Natural Sciences and Engineering Research Council of Canada; Wyss Institute for Biologically Inspired Engineering	Enerbio-Tuck Foundation; Institut Francais du Petrole Energies Nouvelles; Agence Nationale de la Recherche France(French National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale-Institut National de Recherche en Informatique et en Automatique projet d'envergure; Axa Foundation Chair on Longevity; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Wyss Institute for Biologically Inspired Engineering	This work was supported by from the Enerbio-Tuck Foundation and the Institut Francais du Petrole Energies Nouvelles (to C.J.D.); Agence Nationale de la Recherche France, Institut National de la Sante et de la Recherche Medicale-Institut National de Recherche en Informatique et en Automatique projet d'envergure, and Axa Foundation Chair on Longevity (to A. B. L.); Natural Sciences and Engineering Research Council of Canada (to F. A. A.); and the Wyss Institute for Biologically Inspired Engineering. We thank the Harvard Medical School Electron Microscopy Center for assistance in electron microscopy, and we thank the reviewers for their insight.	Barstow B, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-7; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Cayrol B, 2009, J AM CHEM SOC, V131, P17270, DOI 10.1021/ja906076e; Diestra E, 2009, J STRUCT BIOL, V165, P157, DOI 10.1016/j.jsb.2008.11.009; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Guo PX, 2010, NAT NANOTECHNOL, V5, P833, DOI 10.1038/NNANO.2010.231; Isaacs FJ, 2006, NAT BIOTECHNOL, V24, P545, DOI 10.1038/nbt1208; Jaeger L, 2006, CURR OPIN STRUC BIOL, V16, P531, DOI 10.1016/j.sbi.2006.07.001; Lin C, 2009, BIOCHEMISTRY-US, V48, P1663, DOI 10.1021/bi802324w; Lin CX, 2008, P NATL ACAD SCI USA, V105, P17626, DOI 10.1073/pnas.0805416105; Liu HP, 2006, ANGEW CHEM INT EDIT, V45, P1942, DOI 10.1002/anie.200504022; Liu HP, 2005, BIOMACROMOLECULES, V6, P2943, DOI 10.1021/bm050632j; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Savage DF, 2010, SCIENCE, V327, P1258, DOI 10.1126/science.1186090; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yin P, 2008, NATURE, V451, P318, DOI 10.1038/nature06451	19	453	488	7	278	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2011	333	6041					470	474		10.1126/science.1206938	http://dx.doi.org/10.1126/science.1206938			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21700839				2022-12-01	WOS:000292959600051
J	Imasaki, T; Calero, G; Cai, G; Tsai, KL; Yamada, K; Cardelli, F; Erdjument-Bromage, H; Tempst, P; Berger, I; Kornberg, GL; Asturias, FJ; Kornberg, RD; Takagi, Y				Imasaki, Tsuyoshi; Calero, Guillermo; Cai, Gang; Tsai, Kuang-Lei; Yamada, Kentaro; Cardelli, Francesco; Erdjument-Bromage, Hediye; Tempst, Paul; Berger, Imre; Kornberg, Guy Lorch; Asturias, Francisco J.; Kornberg, Roger D.; Takagi, Yuichiro			Architecture of the Mediator head module	NATURE			English	Article							RNA-POLYMERASE-II; REPEAT DOMAIN; COMPLEX; YEAST; PROTEIN; INITIATION; SUBUNIT; BINDING; SYSTEM; CTD	Mediator is a key regulator of eukaryotic transcription(1), connecting activators and repressors bound to regulatory DNA elements with RNA polymerase II1-4 (Pol II). In the yeast Saccharomyces cerevisiae, Mediator comprises 25 subunits with a total mass of more than one megadalton (refs 5, 6) and is organized into three modules, called head, middle/arm and tail(7-9). Our understanding of Mediator assembly and its role in regulating transcription has been impeded so far by limited structural information. Here we report the crystal structure of the essential Mediator head module (seven subunits, with a mass of 223 kilodaltons) at a resolution of 4.3 angstroms. Our structure reveals three distinct domains, with the integrity of the complex centred on a bundle of ten helices from five different head subunits. An intricate pattern of interactions within this helical bundle ensures the stable assembly of the head subunits and provides the binding sites for general transcription factors and Pol II. Our structural and functional data suggest that the head module juxtaposes transcription factor IIH and the carboxy-terminal domain of the largest subunit of Pol II, thereby facilitating phosphorylation of the carboxy-terminal domain of Pol II. Our results reveal architectural principles underlying the role of Mediator in the regulation of gene expression.	[Imasaki, Tsuyoshi; Yamada, Kentaro; Cardelli, Francesco; Takagi, Yuichiro] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Calero, Guillermo; Kornberg, Guy Lorch; Kornberg, Roger D.] Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94350 USA; [Cai, Gang; Tsai, Kuang-Lei; Asturias, Francisco J.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Erdjument-Bromage, Hediye; Tempst, Paul] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; [Berger, Imre] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France	Indiana University System; Indiana University Bloomington; Stanford University; Scripps Research Institute; Memorial Sloan Kettering Cancer Center; European Molecular Biology Laboratory (EMBL)	Takagi, Y (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	ytakagi@iupui.edu	Cai, Gang/B-1103-2012; Cai, Gang/AAA-4439-2020	Cai, Gang/0000-0001-8622-3907; Cai, Gang/0000-0001-8622-3907; Tempst, Paul/0000-0002-6680-3987; Imasaki, Tsuyoshi/0000-0001-5462-1820; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Berger, Imre/0000-0001-7518-9045	NCI [Y1-CO-1020]; NIGMS [Y1-GM-1104]; US National Science Foundation [MCB 0843026]; American Heart Association [0735395N]; Human Frontier Science Program; NIH [Y1-CO-1020, Y1-GM-1104, R01 GM67167, GM36659]; NCI Cancer Center [P30 CA08748]; European Commission; DOE [DE-AC02-06CH11357, DE-AC02-05CH11231]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036659, R01GM067167, R37GM036659] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Commission(European CommissionEuropean Commission Joint Research Centre); DOE(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Messerle for providing the Ta<INF>6</INF>Br<INF>14</INF> metal cluster, T. Hurley for reading the manuscript, M. Georgiadis for discussions, C. Kaplan for his advice on yeast genetics, T. Earnest for giving us beam time and L. Fabrizio for assisting with the N-terminal sequence analysis. We thank the CCP4 summer school, funded by the NCI (Y1-CO-1020), and NIGMS (Y1-GM-1104) for their assistance with the twinning data analysis. Y.T. thanks the instructors on 'The X-Ray Methods Course' at Cold Spring Harbor Laboratory. This work was supported by US National Science Foundation grant MCB 0843026 (Y.T.); the American Heart Association 0735395N (Y.T.); a Human Frontier Science Program long-term fellowship (T.I.); NIH grants R01 GM67167 (F.J.A.) and GM36659 (R.D.K.); NCI Cancer Center Support Grant P30 CA08748 (to the MSKCC Microchemistry and Proteomics Core Laboratory); and the European Commission Framework Program 7 projects INSTRUCT and P-CUBE (I.B.). X-ray data were collected at the GM/CA-CAT at the Advanced Photon Source, Argonne National Laboratory. GM/CA-CAT is funded by the NIH (Y1-CO-1020 and Y1-GM-1104) and the Advanced Photon Source is supported by the DOE (DE-AC02-06CH11357). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, supported by the DOE and the NIH, and at the Advanced Light Source, supported by the DOE (DE-AC02-05CH11231).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Boube M, 2002, CELL, V110, P143, DOI 10.1016/S0092-8674(02)00830-9; Brignole EJ, 2009, NAT STRUCT MOL BIOL, V16, P190, DOI 10.1038/nsmb.1532; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cai G, 2010, NAT STRUCT MOL BIOL, V17, P273, DOI 10.1038/nsmb.1757; Cai G, 2009, STRUCTURE, V17, P559, DOI 10.1016/j.str.2009.01.016; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P750, DOI 10.1107/S0907444997016247; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Kang JS, 2001, J BIOL CHEM, V276, P42003, DOI 10.1074/jbc.M105961200; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; KOLESKE AJ, 1992, CELL, V69, P883, DOI 10.1016/0092-8674(92)90298-Q; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Lariviere L, 2006, NAT STRUCT MOL BIOL, V13, P895, DOI 10.1038/nsmb1143; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; NONET ML, 1989, GENETICS, V123, P715; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAYNE JM, 1989, J BIOL CHEM, V264, P19621; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sogaard TMM, 2007, J BIOL CHEM, V282, P14113, DOI 10.1074/jbc.M701345200; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; STOFFLER G, 1983, ULTRASTRUCTURE MACRO, P409; Svejstrup JQ, 1997, P NATL ACAD SCI USA, V94, P6075, DOI 10.1073/pnas.94.12.6075; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Takagi Y, 2006, MOL CELL, V23, P355, DOI 10.1016/j.molcel.2006.06.007; Tempst Paul, 1994, Methods (Orlando), V6, P248, DOI 10.1006/meth.1994.1027; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; THOMPSON CM, 1995, P NATL ACAD SCI USA, V92, P4587, DOI 10.1073/pnas.92.10.4587; TISCHENDORF GW, 1974, MOL GEN GENET, V134, P187, DOI 10.1007/BF00267715	42	89	95	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					240	U45		10.1038/nature10162	http://dx.doi.org/10.1038/nature10162			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21725323	Green Accepted			2022-12-01	WOS:000292690500053
J	Cortellino, S; Xu, JF; Sannai, M; Moore, R; Caretti, E; Cigliano, A; Le Coz, M; Devarajan, K; Wessels, A; Soprano, D; Abramowitz, LK; Bartolomei, MS; Rambow, F; Bassi, MR; Bruno, T; Fanciulli, M; Renner, C; Klein-Szanto, AJ; Matsumoto, Y; Kobi, D; Davidson, I; Alberti, C; Larue, L; Bellacosa, A				Cortellino, Salvatore; Xu, Jinfei; Sannai, Mara; Moore, Robert; Caretti, Elena; Cigliano, Antonio; Le Coz, Madeleine; Devarajan, Karthik; Wessels, Andy; Soprano, Dianne; Abramowitz, Lara K.; Bartolomei, Marisa S.; Rambow, Florian; Bassi, Maria Rosaria; Bruno, Tiziana; Fanciulli, Maurizio; Renner, Catherine; Klein-Szanto, Andres J.; Matsumoto, Yoshihiro; Kobi, Dominique; Davidson, Irwin; Alberti, Christophe; Larue, Lionel; Bellacosa, Alfonso			Thymine DNA Glycosylase Is Essential for Active DNA Demethylation by Linked Deamination-Base Excision Repair	CELL			English	Article							MAMMALIAN DEVELOPMENT; EMBRYONIC LETHALITY; CANCER EPIGENETICS; PATERNAL GENOME; AID DEFICIENCY; METHYLATION; TRANSCRIPTION; 5-METHYLCYTOSINE; ACTIVATION; RECEPTORS	DNA methylation is a major epigenetic mechanism for gene silencing. Whereas methyltransferases mediate cytosine methylation, it is less clear how unmethylated regions in mammalian genomes are protected from de novo methylation and whether an active demethylating activity is involved. Here, we show that either knockout or catalytic inactivation of the DNA repair enzyme thymine DNA glycosylase (TDG) leads to embryonic lethality in mice. TDG is necessary for recruiting p300 to retinoic acid (RA)-regulated promoters, protection of CpG islands from hypermethylation, and active demethylation of tissue-specific developmentally and hormonally regulated promoters and enhancers. TDG interacts with the deaminase AID and the damage response protein GADD45a. These findings highlight a dual role for TDG in promoting proper epigenetic states during development and suggest a two-step mechanism for DNA demethylation in mammals, whereby 5-methylcytosine and 5-hydroxymethylcytosine are first deaminated by AID to thymine and 5-hydroxymethyluracil, respectively, followed by TDG-mediated thymine and 5-hydroxymethyluracil excision repair.	[Cortellino, Salvatore; Xu, Jinfei; Sannai, Mara; Moore, Robert; Caretti, Elena; Cigliano, Antonio; Le Coz, Madeleine; Bassi, Maria Rosaria; Bellacosa, Alfonso] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Cortellino, Salvatore; Xu, Jinfei; Sannai, Mara; Moore, Robert; Caretti, Elena; Cigliano, Antonio; Le Coz, Madeleine; Bassi, Maria Rosaria; Bellacosa, Alfonso] Fox Chase Canc Ctr, Epigenet & Progenitor Cells Keystone Program, Philadelphia, PA 19111 USA; [Devarajan, Karthik] Fox Chase Canc Ctr, Dept Biostat, Philadelphia, PA 19111 USA; [Renner, Catherine; Klein-Szanto, Andres J.] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA; [Wessels, Andy] Med Univ S Carolina, Dept Cell Biol & Anat, Charleston, SC 29425 USA; [Soprano, Dianne] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Abramowitz, Lara K.; Bartolomei, Marisa S.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Rambow, Florian; Alberti, Christophe; Larue, Lionel] Inst Curie, Ctr Rech, F-91405 Orsay, France; [Rambow, Florian; Alberti, Christophe; Larue, Lionel] CNRS, INSERM, U1021, UMR3347, F-91405 Orsay, France; [Bruno, Tiziana; Fanciulli, Maurizio] Regina Elena Canc Ctr, I-00158 Rome, Italy; [Matsumoto, Yoshihiro] E Stroudsburg Univ, Dept Biol Sci, E Stroudsburg, PA 18301 USA; [Kobi, Dominique; Davidson, Irwin] CNRS INSERM ULP, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center; Medical University of South Carolina; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Pennsylvania State System of Higher Education (PASSHE); East Stroudsburg University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Bellacosa, A (corresponding author), Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA.	alfonso.bellacosa@fccc.edu	Larue, Lionel/I-6532-2016; bruno, tiziana/AAC-4913-2022; Cortellino, Salvatore/AAH-8857-2019; fanciulli, maurizio/ABH-6745-2020; Cigliano, Antonio/J-4660-2017; Cortellino, Salvatore/GPW-6929-2022; Larue, Lionel/F-7355-2013; cigliano, antonio/J-1836-2015	bruno, tiziana/0000-0003-0352-4523; Cigliano, Antonio/0000-0002-6408-3613; Matsumoto, Yoshihiro/0000-0001-6580-7188; Davidson, Irwin/0000-0001-5533-1171; Bassi, Maria Rosaria/0000-0001-6736-6152; rambow, florian/0000-0002-9727-8986; CORTELLINO, Salvatore/0000-0001-8331-3800; Le Coz, Madeleine/0000-0003-4932-1342	NIH [CA78412, CA06927, DK067558, T32GM008216]; Commonwealth of Pennsylvania; Italian Association for Cancer Research (AIRC); American-Italian Cancer Foundation; Epigenetics and Progenitor Cells Keystone Program Fellowship; NATIONAL CANCER INSTITUTE [P30CA006927, R29CA078412, R01CA078412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008216] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); American-Italian Cancer Foundation; Epigenetics and Progenitor Cells Keystone Program Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. F. De Angelis, H.-Y. Fan, R. Katz, O. Segatto, K. Zaret, and R. Zhang for critical reading of the manuscript; Drs. P. K. Cooper, F. Roegiers, and K. Soprano for comments and advice; G. Albergo, K. Brewer, C. Garnier, B. Lurie, and M. Oliver for mouse genotyping; Dr. Z.P. Zhang for help with CAT assays; Dr. J. Kulkosky, A. Kowalski, T. Stulkivska, and W. Schroeder for Crabp2 and Oct4 methylation analysis; Dr. M. Xu for the targeting plasmid (with permission from Dr. G. Martin); Dr. A.J. Furnace for recombinant GADD45a; Dr. K. Sugasawa for anti-TDG antibody; Drs. L. Bagella and P.L. Puri for p300 reporters; Drs. S. Peri and Y. Zhou for ingenuity pathway analysis; Dr. F. Alt for AID cDNA; Dr. N. Davidson for Apobec-1 cDNA; Dr. W. Cui for human Oct4::EGFP reporter; Drs. C. Niehrs and A. Schafer for advice on transfected plasmid recovery; Dr. J. Thorvaldsen for advice on bisulfite modification of PGC DNA; and R. Sonlin for secretarial assistance. We thank the following core facilities at the Fox Chase Cancer Center: Genotyping, Cell Culture, Transgenic and Knock-out, Laboratory Animal, and Fannie E. Rippel Biotechnology Facility. Y.M. would like to thank Dr. Alan Tomkinson for providing hospitality to conduct some of the experiments in his laboratory. This study was supported by NIH grants CA78412, CA06927, and DK067558; an appropriation from the Commonwealth of Pennsylvania to the Fox Chase Cancer Center; and the Italian Association for Cancer Research (AIRC). S.C. was supported, in part, by an American-Italian Cancer Foundation Post-Doctoral Research Fellowship. M.L.C. was supported by an Epigenetics and Progenitor Cells Keystone Program Fellowship. L.K.A. was supported by NIH training grant T32GM008216. A. B. would like to dedicate this article to the memory of his father Pancrazio who taught him the importance of hard work, perseverance and dedication.	Baker D, 2002, CHEM RES TOXICOL, V15, P33, DOI 10.1021/tx010113b; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; Carrier F, 1999, MOL CELL BIOL, V19, P1673; Chen DS, 2003, J BIOL CHEM, V278, P38586, DOI 10.1074/jbc.M304286200; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2003, P NATL ACAD SCI USA, V100, P15071, DOI 10.1073/pnas.2334585100; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hardeland U, 2000, J BIOL CHEM, V275, P33449, DOI 10.1074/jbc.M005095200; Haushalter KA, 1999, CURR BIOL, V9, P174, DOI 10.1016/S0960-9822(99)80087-6; Howard JH, 2009, CANCER BIOL THER, V8, P94, DOI 10.4161/cbt.8.1.7469; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Kass SU, 1997, CURR BIOL, V7, P157, DOI 10.1016/S0960-9822(97)70086-1; Kim MS, 2009, NATURE, V461, P1007, DOI 10.1038/nature08456; Kress C, 2006, P NATL ACAD SCI USA, V103, P11112, DOI 10.1073/pnas.0601793103; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li YQ, 2007, NUCLEIC ACIDS RES, V35, P390, DOI 10.1093/nar/gkl1052; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Missero C, 2001, J BIOL CHEM, V276, P33569, DOI 10.1074/jbc.M104963200; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Niehrs C, 2009, DIFFERENTIATION, V77, P1, DOI 10.1016/j.diff.2008.09.004; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Pantoja C, 2005, CANCER RES, V65, P26; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Reese KJ, 2006, CYTOGENET GENOME RES, V113, P153, DOI 10.1159/000090827; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Schmitz KM, 2009, MOL CELL, V33, P344, DOI 10.1016/j.molcel.2009.01.015; Siegfried Z, 1997, CURR BIOL, V7, pR305, DOI 10.1016/S0960-9822(06)00144-8; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tanaka Y, 2000, MECH DEVELOP, V95, P133, DOI 10.1016/S0925-4773(00)00360-9; Thomassin H, 2001, EMBO J, V20, P1974, DOI 10.1093/emboj/20.8.1974; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Um S, 1998, J BIOL CHEM, V273, P20728, DOI 10.1074/jbc.273.33.20728; Vermot J, 2003, P NATL ACAD SCI USA, V100, P1763, DOI 10.1073/pnas.0437920100; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xu J, 2007, P NATL ACAD SCI USA, V104, P12377, DOI 10.1073/pnas.0704579104; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Yi YW, 2000, BIOCHEM BIOPH RES CO, V272, P193; Zhu B, 2000, P NATL ACAD SCI USA, V97, P5135, DOI 10.1073/pnas.100107597	62	580	610	1	132	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 8	2011	146	1					67	79		10.1016/j.cell.2011.06.020	http://dx.doi.org/10.1016/j.cell.2011.06.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21722948	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000292539300007
J	Pfeffer, MA; Bowler, MB				Pfeffer, Marc A.; Bowler, Marianne B.			Access to Safety Data - Stockholders versus Prescribers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Pfeffer, Marc A.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Pfeffer, Marc A.] Harvard Univ, Sch Med, Boston, MA USA; [Bowler, Marianne B.] US Dist Court, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Pfeffer, MA (corresponding author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA.							BREYER STEPHEN, 2010, MAKING OUR DEMOCRACY; Curfman GD, 2006, NEW ENGL J MED, V354, P1193, DOI 10.1056/NEJMe068054; *FOOD DRUG ADM, SENT IN NAT STRAT MO	3	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2011	365	1					1	3		10.1056/NEJMp1104699	http://dx.doi.org/10.1056/NEJMp1104699			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	788QL	21714642				2022-12-01	WOS:000292459400001
J	Kim, N; Huang, SYN; Williams, JS; Li, YC; Clark, AB; Cho, JE; Kunkel, TA; Pommier, Y; Jinks-Robertson, S				Kim, Nayun; Huang, Shar-yin N.; Williams, Jessica S.; Li, Yue C.; Clark, Alan B.; Cho, Jang-Eun; Kunkel, Thomas A.; Pommier, Yves; Jinks-Robertson, Sue			Mutagenic Processing of Ribonucleotides in DNA by Yeast Topoisomerase I	SCIENCE			English	Article							MISMATCH REPAIR PROTEINS; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION; CAMPTOTHECIN; INSTABILITY; ANTICANCER; SEQUENCE; H2	The ribonuclease (RNase) H class of enzymes degrades the RNA component of RNA:DNA hybrids and is important in nucleic acid metabolism. RNase H2 is specialized to remove single ribonucleotides [ribonucleoside monophosphates (rNMPs)] from duplex DNA, and its absence in budding yeast has been associated with the accumulation of deletions within short tandem repeats. Here, we demonstrate that rNMP-associated deletion formation requires the activity of Top1, a topoisomerase that relaxes supercoils by reversibly nicking duplex DNA. The reported studies extend the role of Top1 to include the processing of rNMPs in genomic DNA into irreversible single-strand breaks, an activity that can have distinct mutagenic consequences and may be relevant to human disease.	[Kim, Nayun; Li, Yue C.; Cho, Jang-Eun; Jinks-Robertson, Sue] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Huang, Shar-yin N.; Pommier, Yves] NCI, Lab Mol Pharmacol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Williams, Jessica S.; Clark, Alan B.; Kunkel, Thomas A.] NIEHS, Lab Mol Genet, NIH, Res Triangle Pk, NC 27709 USA; [Williams, Jessica S.; Clark, Alan B.; Kunkel, Thomas A.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	Duke University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Jinks-Robertson, S (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	sue.robertson@duke.edu	Kunkel, Thomas A./D-5088-2019	Kunkel, Thomas A./0000-0002-9900-1788	NIH [R01 GM38464, R01 GM93197]; Center for Cancer Research, National Cancer Institute, NIH; Division of Intramural Research of the NIH, National Institute of Environmental Health Sciences [Z01 ES065070, Z01 ES065089]; NATIONAL CANCER INSTITUTE [ZIABC006161, ZIABC006150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES065070] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research, National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Division of Intramural Research of the NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	S.J.-R. was supported by NIH grants R01 GM38464 and R01 GM93197; Y.P. was supported by the Intramural Program, Center for Cancer Research, National Cancer Institute, NIH; and T.A.K. was supported by Projects Z01 ES065070 and Z01 ES065089 from the Division of Intramural Research of the NIH, National Institute of Environmental Health Sciences.	Chen JJZ, 2000, NUCLEIC ACIDS RES, V28, P3649, DOI 10.1093/nar/28.18.3649; Clark AB, 2011, DNA REPAIR, V10, P476, DOI 10.1016/j.dnarep.2011.02.001; Clark AB, 2010, CELL CYCLE, V9, P4422, DOI 10.4161/cc.9.22.14052; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Greene CN, 1997, MOL CELL BIOL, V17, P2844, DOI 10.1128/MCB.17.5.2844; Harfe BD, 1999, MOL CELL BIOL, V19, P4766; HSIANG YH, 1988, CANCER RES, V48, P1722; JAXEL C, 1991, J BIOL CHEM, V266, P20418; Jeong HS, 2004, NUCLEIC ACIDS RES, V32, P407, DOI 10.1093/nar/gkh209; Lippert MJ, 2011, P NATL ACAD SCI USA, V108, P698, DOI 10.1073/pnas.1012363108; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/nchembio.424, 10.1038/NCHEMBIO.424]; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; PORTER SE, 1989, MOL CELL BIOL, V9, P541, DOI 10.1128/MCB.9.2.541; Sekiguchi J, 1997, MOL CELL, V1, P89, DOI 10.1016/S1097-2765(00)80010-6; Takahashi T, 2011, P NATL ACAD SCI USA, V108, P692, DOI 10.1073/pnas.1012582108; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831	17	219	219	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 24	2011	332	6037					1561	1564		10.1126/science.1205016	http://dx.doi.org/10.1126/science.1205016			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700875	Green Accepted			2022-12-01	WOS:000291990000046
J	Lynd, LR; Woods, J				Lynd, Lee R.; Woods, Jeremy			A new hope for Africa	NATURE			English	Editorial Material									[Lynd, Lee R.] Dartmouth Coll Thayer Sch Engn, Hanover, NH USA; [Woods, Jeremy] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Dartmouth College; Imperial College London	Lynd, LR (corresponding author), Dartmouth Coll Thayer Sch Engn, Hanover, NH USA.	lee.r.lynd@Dartmouth.edu; Jeremy.woods@imperial.ac.uk	Lynd, Lee R/N-1260-2013	Lynd, Lee R/0000-0002-5642-668X; Woods, Jeremy/0000-0002-1542-8144					0	37	39	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S20	S21		10.1038/474S020a	http://dx.doi.org/10.1038/474S020a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697839	Bronze, Green Submitted			2022-12-01	WOS:000291939700008
J	Mello, MM; Messing, NA				Mello, Michelle M.; Messing, Noah A.			Restrictions on the Use of Prescribing Data for Drug Promotion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PHYSICIANS; 1ST-AMENDMENT		[Mello, Michelle M.] Harvard Univ, Sch Med, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Messing, Noah A.] Yale Univ, Sch Law, New Haven, CT 06520 USA	Harvard University; Harvard Medical School; Yale University	Mello, MM (corresponding author), Harvard Univ, Sch Med, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	mmello@hsph.harvard.edu						*AM MED ASS, AMA PROGR HELPS PROT; Campo Katia, 2005, Health Mark Q, V22, P73; Caudill TS, 1996, ARCH FAM MED, V5, P201, DOI 10.1001/archfami.5.4.201; CHREN MM, 1994, JAMA-J AM MED ASSOC, V271, P684, DOI 10.1001/jama.271.9.684; Curfman GD, 2011, NEW ENGL J MED, V364, P2053, DOI 10.1056/NEJMe1104460; Grande D, 2007, ANN INTERN MED, V146, P751, DOI 10.7326/0003-4819-146-10-200705150-00010; Grande D, 2009, NEW ENGL J MED, V360, P747, DOI 10.1056/NEJMp0810410; Greene JA, 2007, ANN INTERN MED, V146, P742, DOI 10.7326/0003-4819-146-10-200705150-00008; Kesselheim AS, 2008, NEW ENGL J MED, V358, P1727, DOI 10.1056/NEJMsb0708920; Orentlicher D, 2010, J LAW MED ETHICS, V38, P74, DOI 10.1111/j.1748-720X.2010.00468.x; PEAY MY, 1988, SOC SCI MED, V26, P1183, DOI 10.1016/0277-9536(88)90149-9; Post R, 2009, NEW ENGL J MED, V360, P745, DOI 10.1056/NEJMp0810339; Steinbrook R, 2006, NEW ENGL J MED, V354, P2745, DOI 10.1056/NEJMp068125; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; 2004, INT M AMA HOUS DEL D, P140	15	16	17	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 29	2011	365	13					1248	1254		10.1056/NEJMhle1107678	http://dx.doi.org/10.1056/NEJMhle1107678			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	825YO	21812664				2022-12-01	WOS:000295318400016
J	Bouvignies, G; Vallurupalli, P; Hansen, DF; Correia, BE; Lange, O; Bah, A; Vernon, RM; Dahlquist, FW; Baker, D; Kay, LE				Bouvignies, Guillaume; Vallurupalli, Pramodh; Hansen, D. Flemming; Correia, Bruno E.; Lange, Oliver; Bah, Alaji; Vernon, Robert M.; Dahlquist, Frederick W.; Baker, David; Kay, Lewis E.			Solution structure of a minor and transiently formed state of a T4 lysozyme mutant	NATURE			English	Article							RELAXATION DISPERSION NMR; EXCITED PROTEIN STATES; NUCLEAR-MAGNETIC-RESONANCE; CHEMICAL-SHIFTS; HETERONUCLEAR CORRELATION; SPECTROSCOPY; EXCHANGE; FLEXIBILITY; ANGLES; RESOLUTION	Proteins are inherently plastic molecules, whose function often critically depends on excursions between different molecular conformations (conformers)(1-3). However, a rigorous understanding of the relation between a protein's structure, dynamics and function remains elusive. This is because many of the conformers on its energy landscape are only transiently formed and marginally populated (less than a few per cent of the total number of molecules), so that they cannot be individually characterized by most biophysical tools. Here we study a lysozyme mutant from phage T4 that binds hydrophobic molecules(4) and populates an excited state transiently (about 1 ms) to about 3% at 25 degrees C (ref. 5). We show that such binding occurs only via the ground state, and present the atomic-level model of the 'invisible', excited state obtained using a combined strategy of relaxation-dispersion NMR (ref. 6) and CS-Rosetta(7) model building that rationalizes this observation. The model was tested using structure-based design calculations identifying point mutants predicted to stabilize the excited state relative to the ground state. In this way a pair of mutations were introduced, inverting the relative populations of the ground and excited states and altering function. Our results suggest a mechanism for the evolution of a protein's function by changing the delicate balance between the states on its energy landscape. More generally, they show that our approach can generate and validate models of excited protein states.	[Bouvignies, Guillaume; Vallurupalli, Pramodh; Hansen, D. Flemming; Kay, Lewis E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Bouvignies, Guillaume; Vallurupalli, Pramodh; Hansen, D. Flemming; Kay, Lewis E.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Bouvignies, Guillaume; Vallurupalli, Pramodh; Hansen, D. Flemming; Kay, Lewis E.] Univ Toronto, Dept Chem, Toronto, ON M5S 1A8, Canada; [Correia, Bruno E.; Lange, Oliver; Vernon, Robert M.; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Correia, Bruno E.] Inst Gulbenkian Ciencias, Program Computat Biol, P-2780156 Oeiras, Portugal; [Bah, Alaji; Vernon, Robert M.; Kay, Lewis E.] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Dahlquist, Frederick W.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	University of Toronto; University of Toronto; University of Toronto; University of Washington; University of Washington Seattle; Instituto Gulbenkian de Ciencia; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of California System; University of California Santa Barbara	Kay, LE (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	kay@pound.med.utoronto.ca	Lange, Oliver/K-5749-2012; Bouvignies, Guillaume/C-1009-2008; Baker, David/K-8941-2012	Lange, Oliver/0000-0002-4018-7020; Bouvignies, Guillaume/0000-0003-4398-0320; Baker, David/0000-0001-7896-6217; Hansen, Dennis Flemming/0000-0003-0891-220X	European Molecular Biology Organization; Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092802] Funding Source: NIH RePORTER	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Forman-Kay for providing laboratory space, and J. Forman-Kay and T. Alber for discussions. G.B. acknowledges The European Molecular Biology Organization and The Canadian Institutes of Health Research (CIHR) for postdoctoral fellowships. L.E.K. holds a Canada Research Chair in Biochemistry. This work was supported by the CIHR and the Natural Sciences and Engineering Research Council of Canada, with computations performed on the GPC supercomputer at the SciNet HPC Consortium.	Baase WA, 2010, PROTEIN SCI, V19, P631, DOI 10.1002/pro.344; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Bouvignies G, 2010, J BIOMOL NMR, V47, P135, DOI 10.1007/s10858-010-9418-8; Cavalli A, 2007, P NATL ACAD SCI USA, V104, P9615, DOI 10.1073/pnas.0610313104; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; ERIKSSON AE, 1992, NATURE, V355, P371, DOI 10.1038/355371a0; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Feher VA, 1996, NAT STRUCT BIOL, V3, P516, DOI 10.1038/nsb0696-516; Fersht A, 1999, STRUCTURE MECH PROTE; Goddard T. D., 2006, SPARKY 3; Hansen DF, 2008, J BIOMOL NMR, V41, P113, DOI 10.1007/s10858-008-9251-5; Hansen DF, 2008, J AM CHEM SOC, V130, P2667, DOI 10.1021/ja078337p; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Hu JS, 1997, J AM CHEM SOC, V119, P1803, DOI 10.1021/ja963625z; Hu JS, 1997, J AM CHEM SOC, V119, P6360, DOI 10.1021/ja970067v; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655; Korzhnev DM, 2008, ACCOUNTS CHEM RES, V41, P442, DOI 10.1021/ar700189y; Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723; Liu LJ, 2009, J MOL BIOL, V385, P595, DOI 10.1016/j.jmb.2008.10.086; Loken Chris, 2010, Journal of Physics: Conference Series, V256, DOI 10.1088/1742-6596/256/1/012026; Lundstrom P, 2009, NAT PROTOC, V4, P1641, DOI 10.1038/nprot.2009.118; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; MONTELIONE GT, 1989, J AM CHEM SOC, V111, P3096, DOI 10.1021/ja00190a072; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Mulder FAA, 2000, BIOCHEMISTRY-US, V39, P12614, DOI 10.1021/bi001351t; NICHOLSON H, 1992, BIOPOLYMERS, V32, P1431, DOI 10.1002/bip.360321103; Orekhov VY, 2004, J AM CHEM SOC, V126, P1886, DOI 10.1021/ja038620y; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Press W., 1992, NUMERICAL RECIPES, V2nd; Religa TL, 2010, SCIENCE, V328, P98, DOI 10.1126/science.1184991; Rodriguez JC, 2004, J BIOMOL NMR, V30, P155, DOI 10.1023/B:JNMR.0000048857.44219.c3; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Skrynnikov NR, 2002, J AM CHEM SOC, V124, P12352, DOI 10.1021/ja0207089; Sprangers R, 2005, P NATL ACAD SCI USA, V102, P16678, DOI 10.1073/pnas.0507370102; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Vallurupalli P, 2008, P NATL ACAD SCI USA, V105, P11766, DOI 10.1073/pnas.0804221105; Vallurupalli P, 2007, P NATL ACAD SCI USA, V104, P18473, DOI 10.1073/pnas.0708296104; Vallurupalli P, 2009, J BIOMOL NMR, V45, P45, DOI 10.1007/s10858-009-9310-6; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050	51	219	222	1	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2011	477	7362					111	U134		10.1038/nature10349	http://dx.doi.org/10.1038/nature10349			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813XT	21857680	Green Accepted			2022-12-01	WOS:000294404300042
J	Kane, GC; Karon, BL; Mahoney, DW; Redfield, MM; Roger, VL; Burnett, JC; Jacobsen, SJ; Rodeheffer, RJ				Kane, Garvan C.; Karon, Barry L.; Mahoney, Douglas W.; Redfield, Margaret M.; Roger, Veronique L.; Burnett, John C., Jr.; Jacobsen, Steven J.; Rodeheffer, Richard J.			Progression of Left Ventricular Diastolic Dysfunction and Risk of Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRESERVED EJECTION FRACTION; CARDIOVASCULAR-DISEASE ENTERPRISES; BRAIN NATRIURETIC PEPTIDE; DOPPLER-ECHOCARDIOGRAPHY; MAJOR SHAREHOLDERS; POPULATION; COMMUNITY; PREVALENCE; ARTERIAL; AGE	Context Heart failure incidence increases with advancing age, and approximately half of patients with heart failure have preserved left ventricular ejection fraction. Although diastolic dysfunction plays a role in heart failure with preserved ejection fraction, little is known about age-dependent longitudinal changes in diastolic function in community populations. Objective To measure changes in diastolic function over time and to determine the relationship between diastolic dysfunction and the risk of subsequent heart failure. Design, Setting, and Participants Population-based cohort of participants enrolled in the Olmsted County Heart Function Study. Randomly selected participants 45 years or older (N=2042) underwent clinical evaluation, medical record abstraction, and echocardiography (examination 1 [1997-2000]). Diastolic left ventricular function was graded as normal, mild, moderate, or severe by validated Doppler techniques. After 4 years, participants were invited to return for examination 2 (2001-2004). The cohort of participants returning for examination 2 (n=1402 of 1960 surviving [72%]) then underwent follow-up for ascertainment of new-onset heart failure (2004-2010). Main Outcome Measures Change in diastolic function grade and incident heart failure. Results During the 4 (SD, 0.3) years between examinations 1 and 2, diastolic dysfunction prevalence increased from 23.8% (95% confidence interval [CI], 21.2%-26.4%) to 39.2% (95% CI, 36.3%-42.2%) (P<.001). Diastolic function grade worsened in 23.4% (95% CI, 20.9%-26.0%) of participants, was unchanged in 67.8% (95% CI, 64.8%-70.6%), and improved in 8.8% (95% CI, 7.1%-10.5%). Worsened diastolic dysfunction was associated with age 65 years or older (odds ratio, 2.85 [95% CI, 1.77-4.72]). During 6.3 (SD, 2.3) years of additional follow-up, heart failure occurred in 2.6% (95% CI, 1.4%-3.8%), 7.8% (95% CI, 5.8%-13.0%), and 12.2% (95% CI, 8.5%-18.4%) of persons whose diastolic function normalized or remained normal, remained or progressed to mild dysfunction, or remained or progressed to moderate or severe dysfunction, respectively (P<.001). Diastolic dysfunction was associated with incident heart failure after adjustment for age, hypertension, diabetes, and coronary artery disease (hazard ratio, 1.81 [95% CI, 1.01-3.48]). Conclusions In a population-based cohort undergoing 4 years of follow-up, prevalence of diastolic dysfunction increased. Diastolic dysfunction was associated with development of heart failure during 6 years of subsequent follow-up. JAMA. 2011;306(8):856-863 www.jama.com	[Kane, Garvan C.; Karon, Barry L.; Redfield, Margaret M.; Roger, Veronique L.; Burnett, John C., Jr.; Rodeheffer, Richard J.] Mayo Clin, Div Cardiovasc Dis, Dept Internal Med, Rochester, MN 55905 USA; [Mahoney, Douglas W.; Roger, Veronique L.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Sch Med, Rochester, MN 55905 USA; [Jacobsen, Steven J.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Jacobsen, Steven J.] So Calif Permanente Med Grp, Los Angeles, CA 90027 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Southern California; Kaiser Permanente; Southern California Permanente Medical Group (SCPMG); Permanente Medical Groups	Rodeheffer, RJ (corresponding author), Mayo Clin, Div Cardiovasc Dis, Dept Internal Med, 200 1st St SW, Rochester, MN 55905 USA.	rodeheffer.richard@mayo.edu	Roger, Veronique/AAV-5951-2020	Jacobsen, Steven/0000-0002-8174-8533	National Heart, Lung, and Blood Institute [R0155502]; National Institutes of Health (NIH) National Center for Research Resources [1UL 1RR024150, UL RR024150]; Mayo Foundation; NIH [HL-R01-55502, AR-36582, HL63281]; National Institute on Aging [R01-AG034676]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024150] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055502, R01HL063281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034676] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health (NIH) National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Mayo Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Heart, Lung, and Blood Institute grant R0155502, grant 1UL 1RR024150 from the National Institutes of Health (NIH) National Center for Research Resources, and the Mayo Foundation. The research was supported by NIH HL-R01-55502 (Dr Rodeheffer), NIH AR-36582 (Dr Jacobsen), and NIH HL63281 (Redfield). The project was supported by NIH/National Center for Research Resources (NCRR) Clinical and Translational Science Awards Grant UL RR024150 and by the Rochester Epidemiology Project, grant R01-AG034676 from the National Institute on Aging, and the Mayo Foundation.	Abhayaratna WP, 2006, HEART, V92, P1259, DOI 10.1136/hrt.2005.080150; Abhayaratna WP, 2006, AM J CARDIOL, V98, P1387, DOI 10.1016/j.amjcard.2006.06.035; Ammar KA, 2007, CIRCULATION, V115, P1563, DOI 10.1161/CIRCULATIONAHA.106.666818; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Borlaug Barry A, 2008, Heart Fail Clin, V4, P23, DOI 10.1016/j.hfc.2007.10.001; Borlaug BA, 2009, J AM COLL CARDIOL, V54, P410, DOI 10.1016/j.jacc.2009.05.013; Chantler PD, 2008, J APPL PHYSIOL, V105, P1342, DOI 10.1152/japplphysiol.90600.2008; Cheng S, 2009, CIRC-CARDIOVASC IMAG, V2, P191, DOI 10.1161/CIRCIMAGING.108.819938; Davies MK, 2001, LANCET, V358, P439, DOI 10.1016/S0140-6736(01)05620-3; GERSTENBLITH G, 1977, CIRCULATION, V56, P273, DOI 10.1161/01.CIR.56.2.273; Grewal J, 2009, JAMA-J AM MED ASSOC, V301, P286, DOI 10.1001/jama.2008.1022; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Hurrell DG, 1997, J AM COLL CARDIOL, V30, P459, DOI 10.1016/S0735-1097(97)00184-8; Jacobsen SJ, 2004, ANN EPIDEMIOL, V14, P579, DOI 10.1016/j.annepidem.2003.11.001; Kass DA, 2004, CIRC RES, V94, P1533, DOI 10.1161/01.RES.0000129254.25507.d6; Kass DA, 2005, HYPERTENSION, V46, P185, DOI 10.1161/01.HYP.0000168053.34306.d4; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lakatta EG, 2003, CIRCULATION, V107, P346, DOI 10.1161/01.CIR.0000048893.62841.F7; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; McKie PM, 2006, HYPERTENSION, V47, P874, DOI 10.1161/01.HYP.0000216794.24161.8c; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; Munagala VK, 2003, J AM SOC ECHOCARDIOG, V16, P1049, DOI 10.1016/S0894-7317(03)00516-9; Nishimura RA, 1997, J AM COLL CARDIOL, V30, P8, DOI 10.1016/S0735-1097(97)00144-7; Okura Y, 2007, CIRC J, V71, P1013, DOI 10.1253/circj.71.1013; Ommen SR, 2000, CIRCULATION, V102, P1788; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Pritchett AM, 2005, J AM COLL CARDIOL, V45, P87, DOI 10.1016/j.jacc.2004.09.054; Redfield MM, 2004, NEW ENGL J MED, V350, P1930, DOI 10.1056/NEJMp048064; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Redfield MM, 2005, CIRCULATION, V112, P2254, DOI 10.1161/CIRCULATIONAHA.105.541078; Redfield MM, 2002, NEW ENGL J MED, V347, P1442, DOI 10.1056/NEJMe020115; Redfield MM, 2004, CIRCULATION, V109, P3176, DOI 10.1161/01.CIR.0000130845.38133.8F; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; RODEHEFFER RJ, 1993, MAYO CLIN PROC, V68, P1143, DOI 10.1016/S0025-6196(12)60063-9; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Senni M, 1999, ARCH INTERN MED, V159, P29, DOI 10.1001/archinte.159.1.29; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566; Zile MR, 2001, CIRCULATION, V104, P779, DOI 10.1161/hc3201.094226; 1998, ARCH INTERN MED, V158, P573	43	461	471	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 24	2011	306	8					856	863		10.1001/jama.2011.1201	http://dx.doi.org/10.1001/jama.2011.1201			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	810VY	21862747	Green Accepted, Bronze			2022-12-01	WOS:000294157300023
J	Kitajima, TS; Ohsugi, M; Ellenberg, J				Kitajima, Tomoya S.; Ohsugi, Miho; Ellenberg, Jan			Complete Kinetochore Tracking Reveals Error-Prone Homologous Chromosome Biorientation in Mammalian Oocytes	CELL			English	Article							SPINDLE ASSEMBLY CHECKPOINT; MOUSE OOCYTES; MEIOSIS-I; MICROTUBULE ATTACHMENT; METAPHASE PLATE; TISSUE-CELLS; AURORA-B; SEGREGATION; NONDISJUNCTION; CONGRESSION	Chromosomes must establish stable biorientation prior to anaphase to achieve faithful segregation during cell division. The detailed process by which chromosomes are bioriented and how biorientation is coordinated with spindle assembly and chromosome congression remain unclear. Here, we provide complete 3D kinetochore-tracking datasets throughout cell division by high-resolution imaging of meiosis I in live mouse oocytes. We show that in acentrosomal oocytes, chromosome congression forms an intermediate chromosome configuration, the prometaphase belt, which precedes biorientation. Chromosomes then invade the elongating spindle center to form the metaphase plate and start biorienting. Close to 90% of all chromosomes undergo one or more rounds of error correction of their kinetochore-microtubule attachments before achieving correct biorientation. This process depends on Aurora kinase activity. Our analysis reveals the error-prone nature of homologous chromosome biorientation, providing a possible explanation for the high incidence of aneuploid eggs observed in mammals, including humans.	[Kitajima, Tomoya S.; Ellenberg, Jan] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Ohsugi, Miho] Univ Tokyo, Inst Med Sci, Dept Canc Biol, Div Oncol,Minato Ku, Tokyo 1088639, Japan; [Ohsugi, Miho] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	European Molecular Biology Laboratory (EMBL); University of Tokyo; Japan Science & Technology Agency (JST)	Ellenberg, J (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	jan.ellenberg@embl.de	Ohsugi, Miho/AAY-9339-2020; Ellenberg, Jan/I-4688-2014; Holt, Janet E/B-2415-2013; Kitajima, Tomoya/A-7049-2016	Ohsugi, Miho/0000-0003-0288-3428; Ellenberg, Jan/0000-0001-5909-701X; Kitajima, Tomoya/0000-0002-6486-7143	HFSP; JSPS; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology, Japan; German Research Council; European Commission (DFG) within the MitoSys consortium [EL-246/4-1, SPP1384, FP7/2007-2013-241548]	HFSP(Human Frontier Science Program); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); German Research Council(German Research Foundation (DFG)); European Commission (DFG) within the MitoSys consortium	We thank Alexey Khodjakov for communicating unpublished results; Yoshinori Watanabe for providing mouse CENP-C cDNA and discussion; Andrea Musacchio for providing human Mad2 cDNA; Melina Schuh, Kota Miura, Sebastien Huet, Annelie Wunsche, Thomas Walter, and the members of the Ellenberg lab for advice and discussion; the members of EMBL Laboratory Animal Resources, especially Klaus Schmitt, Silke Brohn, and Angela Burro, for excellent support. This work was supported by HFSP Long-Term Fellowships and JSPS Postdoctoral Fellowships for Research Abroad (to T. S. K.), Grants-in-aid from the Japan Science and Technology Agency and the Ministry of Education, Culture, Sports, Science and Technology, Japan (to M.O.), and the German Research Council as well as the European Commission (DFG EL-246/4-1 within the SPP1384; FP7/2007-2013-241548 within the MitoSys consortium, both to J.E.).	Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; Brunet S, 1999, J CELL BIOL, V146, P1, DOI 10.1083/jcb.146.1.1; Cai S, 2009, NAT CELL BIOL, V11, P832, DOI 10.1038/ncb1890; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; Chiang T, 2010, CURR BIOL, V20, P1522, DOI 10.1016/j.cub.2010.06.069; Cimini D, 2003, J CELL SCI, V116, P4213, DOI 10.1242/jcs.00716; Dernburg AF, 1996, CELL, V86, P135, DOI 10.1016/S0092-8674(00)80084-7; Foley EA, 2009, NAT CELL BIOL, V11, P787, DOI 10.1038/ncb1902; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HASSOLD T, 1995, AM J HUM GENET, V57, P867; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hodges CA, 2005, NAT GENET, V37, P1351, DOI 10.1038/ng1672; Homer HA, 2005, GENE DEV, V19, P202, DOI 10.1101/gad.328105; Jaffe LA, 2004, METHOD CELL BIOL, V74, P219; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Karpen GH, 1996, SCIENCE, V273, P118, DOI 10.1126/science.273.5271.118; Kemp B, 2004, GENE DEV, V18, P1946, DOI 10.1101/gad.1227304; Koehler KE, 1996, NAT GENET, V14, P406, DOI 10.1038/ng1296-406; Kops GJPL, 2010, CELL MOL LIFE SCI, V67, P2145, DOI 10.1007/s00018-010-0321-y; Lacefield S, 2007, NAT GENET, V39, P1273, DOI 10.1038/ng2120; Lamb NE, 1997, HUM MOL GENET, V6, P1391, DOI 10.1093/hmg/6.9.1391; Lane SIR, 2010, REPRODUCTION, V140, P521, DOI 10.1530/REP-10-0223; Levesque AA, 2001, J CELL BIOL, V154, P1135, DOI 10.1083/jcb.200106093; Li M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007701; Lipp JJ, 2007, J CELL SCI, V120, P1245, DOI 10.1242/jcs.03425; Lister LM, 2010, CURR BIOL, V20, P1511, DOI 10.1016/j.cub.2010.08.023; Magidson V, 2011, CELL, V146, P555, DOI 10.1016/j.cell.2011.07.012; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Manandhar G, 2005, BIOL REPROD, V72, P2, DOI 10.1095/biolreprod.104.031245; McGulnness BE, 2009, CURR BIOL, V19, P369, DOI 10.1016/j.cub.2009.01.064; Nezi LG, 2009, CURR OPIN CELL BIOL, V21, P785, DOI 10.1016/j.ceb.2009.09.007; Ohsugi M, 2008, CELL, V132, P771, DOI 10.1016/j.cell.2008.01.029; Rabut G, 2004, J MICROSC-OXFORD, V216, P131, DOI 10.1111/j.0022-2720.2004.01404.x; Ross LO, 1996, P NATL ACAD SCI USA, V93, P4979, DOI 10.1073/pnas.93.10.4979; Salmon ED, 2005, PHILOS T R SOC B, V360, P553, DOI 10.1098/rstb.2004.1610; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Sharif B, 2010, J CELL SCI, V123, P4292, DOI 10.1242/jcs.067447; Tsurumi C, 2004, J CELL BIOL, V167, P1037, DOI 10.1083/jcb.200405165; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Wassmann K, 2003, CURR BIOL, V13, P1596, DOI 10.1016/j.cub.2003.08.052; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; Wignall SM, 2009, NAT CELL BIOL, V11, P839, DOI 10.1038/ncb1891; Wollman R, 2005, CURR BIOL, V15, P828, DOI 10.1016/j.cub.2005.03.019; Yang KT, 2010, MOL BIOL CELL, V21, P2371, DOI 10.1091/mbc.E10-02-0170; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013	47	216	219	1	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 19	2011	146	4					568	581		10.1016/j.cell.2011.07.031	http://dx.doi.org/10.1016/j.cell.2011.07.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21854982	Bronze			2022-12-01	WOS:000294043600012
J	Yunker, PJ; Still, T; Lohr, MA; Yodh, AG				Yunker, Peter J.; Still, Tim; Lohr, Matthew A.; Yodh, A.G.			Suppression of the coffee-ring effect by shape-dependent capillary interactions	NATURE			English	Article							AIR-WATER-INTERFACE; ELLIPSOIDAL PARTICLES; PATTERN-FORMATION; EVAPORATION; DROPLETS; DROPS	When a drop of liquid dries on a solid surface, its suspended particulate matter is deposited in ring-like fashion. This phenomenon, known as the coffee-ring effect(1-3), is familiar to anyone who has observed a drop of coffee dry. During the drying process, drop edges become pinned to the substrate, and capillary flow outward from the centre of the drop brings suspended particles to the edge as evaporation proceeds. After evaporation, suspended particles are left highly concentrated along the original drop edge. The coffee-ring effect is manifested in systems with diverse constituents, ranging from large colloids(1,4,5) to nanoparticles(6) and individual molecules(7). In fact-despite the many practical applications for uniform coatings in printing(8), biology(9,10) and complex assembly(11)-the ubiquitous nature of the effect has made it difficult to avoid(6,12-16). Here we show experimentally that the shape of the suspended particles is important and can be used to eliminate the coffee-ring effect: ellipsoidal particles are deposited uniformly during evaporation. The anisotropic shape of the particles significantly deforms interfaces, producing strong interparticle apillary interactions(17-23). Thus, after the ellipsoids are carried to the air-water interface by the same outward flow that causes the coffee-ring effect for spheres, strong long-ranged interparticle attractions between ellipsoids lead to the formation of loosely packed or arrested structures on the air-water interface(17,18,21,24). These structures prevent the suspended particles from reaching the drop edge and ensure uniform deposition. Interestingly, under appropriate conditions, suspensions of spheres mixed with a small number of ellipsoids also produce uniform deposition. Thus, particle shape provides a convenient parameter to control the deposition of particles, without modification of particle or solvent chemistry.	Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; CNRS Rhodia Univ Pennsylvania, Complex Assemblies Soft Matter, UMI 3254, Bristol, PA 19007 USA	University of Pennsylvania; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Yunker, PJ (corresponding author), Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA.	pyunker@sas.upenn.edu		Yunker, Peter/0000-0001-8471-4171				Bigioni TP, 2006, NAT MATER, V5, P265, DOI 10.1038/nmat1611; Bowden N, 2001, LANGMUIR, V17, P1757, DOI 10.1021/la001447o; Brown ABD, 2000, PHYS REV E, V62, P951, DOI 10.1103/PhysRevE.62.951; Champion JA, 2007, P NATL ACAD SCI USA, V104, P11901, DOI 10.1073/pnas.0705326104; DANOV KD, 2010, COLLOID INTERFACE SC, V154, P91; de Gans BJ, 2004, ADV MATER, V16, P203, DOI 10.1002/adma.200300385; Deegan RD, 2000, PHYS REV E, V62, P756, DOI 10.1103/PhysRevE.62.756; Deegan RD, 2000, PHYS REV E, V61, P475, DOI 10.1103/PhysRevE.61.475; Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827; DENKOV ND, 1993, NATURE, V361, P26, DOI 10.1038/361026a0; Dugas V, 2005, LANGMUIR, V21, P9130, DOI 10.1021/la050764y; Dugas V, 2004, SENSOR ACTUAT B-CHEM, V101, P112, DOI 10.1016/j.snb.2004.02.041; Fournier JB, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031601; HO CC, 1993, COLLOID POLYM SCI, V271, P469, DOI 10.1007/BF00657391; Hu H, 2006, J PHYS CHEM B, V110, P7090, DOI 10.1021/jp0609232; Hu H, 2002, J PHYS CHEM B, V106, P1334, DOI 10.1021/jp0118322; Kajiya T, 2009, J PHYS CHEM B, V113, P15460, DOI 10.1021/jp9077757; Kaya D, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3493687; Lehle H, 2008, EUR PHYS J E, V26, P151, DOI 10.1140/epje/i2007-10314-1; Lewandowski EP, 2009, SOFT MATTER, V5, P886, DOI 10.1039/b812257a; Loudet JC, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018301; Madivala B, 2009, SOFT MATTER, V5, P1717, DOI 10.1039/b816680c; Madivala B, 2009, LANGMUIR, V25, P2718, DOI 10.1021/la803554u; Nguyen VX, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.164501; PARK BJ, 2011, ATTRACTIVE INTERACTI; Park BJ, 2010, SOFT MATTER, V6, P485, DOI 10.1039/b919629c; Park J, 2006, LANGMUIR, V22, P3506, DOI 10.1021/la053450j; Stamou D, 2000, PHYS REV E, V62, P5263, DOI 10.1103/PhysRevE.62.5263; Weon BM, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.015305	29	1104	1127	40	1168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2011	476	7360					308	311		10.1038/nature10344	http://dx.doi.org/10.1038/nature10344			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21850105				2022-12-01	WOS:000294206500047
J	Sawcer, S; Hellenthal, G; Pirinen, M; Spencer, CCA; Patsopoulos, NA; Moutsianas, L; Dilthey, A; Su, Z; Freeman, C; Hunt, SE; Edkins, S; Gray, E; Booth, DR; Potter, SC; Goris, A; Band, G; Oturai, AB; Strange, A; Saarela, J; Bellenguez, C; Fontaine, B; Gillman, M; Hemmer, B; Gwilliam, R; Zipp, F; Jayakumar, A; Martin, R; Leslie, S; Hawkins, S; Giannoulatou, E; D'alfonso, S; Blackburn, H; Boneschi, FM; Liddle, J; Harbo, HF; Perez, ML; Spurkland, A; Waller, MJ; Mycko, MP; Ricketts, M; Comabella, M; Hammond, N; Kockum, I; McCann, OT; Ban, M; Whittaker, P; Kemppinen, A; Weston, P; Hawkins, C; Widaa, S; Zajicek, J; Dronov, S; Robertson, N; Bumpstead, SJ; Barcellos, LF; Ravindrarajah, R; Abraham, R; Alfredsson, L; Ardlie, K; Aubin, C; Baker, A; Baker, K; Baranzini, SE; Bergamaschi, L; Bergamaschi, R; Bernstein, A; Berthele, A; Boggild, M; Bradfield, JP; Brassat, D; Broadley, SA; Buck, D; Butzkueven, H; Capra, R; Carroll, WM; Cavalla, P; Celius, EG; Cepok, S; Chiavacci, R; Clerget-Darpoux, F; Clysters, K; Comi, G; Cossburn, M; Cournu-Rebeix, I; Cox, MB; Cozen, W; Cree, BAC; Cross, AH; Cusi, D; Daly, MJ; Davis, E; de Bakker, PIW; Debouverie, M; D'hooghe, MB; Dixon, K; Dobosi, R; Dubois, B; Ellinghaus, D; Elovaara, I; Esposito, F; Fontenille, C; Foote, S; Franke, A; Galimberti, D; Ghezzi, A; Glessner, J; Gomez, R; Gout, O; Graham, C; Grant, SFA; Guerini, FR; Hakonarson, H; Hall, P; Hamsten, A; Hartung, HP; Heard, RN; Heath, S; Hobart, J; Hoshi, M; Infante-Duarte, C; Ingram, G; Ingram, W; Islam, T; Jagodic, M; Kabesch, M; Kermode, AG; Kilpatrick, TJ; Kim, C; Klopp, N; Koivisto, K; Larsson, M; Lathrop, M; Lechner-Scott, JS; Leone, MA; Leppa, V; Liljedahl, U; Bomfim, IL; Lincoln, RR; Link, J; Liu, JJ; Lorentzen, AR; Lupoli, S; Macciardi, F; Mack, T; Marriott, M; Martinelli, V; Mason, D; McCauley, JL; Mentch, F; Mero, IL; Mihalova, T; Montalban, X; Mottershead, J; Myhr, KM; Naldi, P; Ollier, W; Page, A; Palotie, A; Pelletier, J; Piccio, L; Pickersgill, T; Piehl, F; Pobywajlo, S; Quach, HL; Ramsay, PP; Reunanen, M; Reynolds, R; Rioux, J; Rodegher, M; Roesner, S; Rubio, JP; Ruckert, IM; Salvetti, M; Salvi, E; Santaniello, A; Schaefer, CA; Schreiber, S; Schulze, C; Scott, RJ; Sellebjerg, F; Selmaj, KW; Sexton, D; Shen, L; Simms-Acuna, B; Skidmore, S; Sleiman, PMA; Smestad, C; Sorensen, PS; Sondergaard, HB; Stankovich, J; Strange, RC; Sulonen, AM; Sundqvist, E; Syvanen, AC; Taddeo, F; Taylor, B; Blackwell, JM; Tienari, P; Bramon, E; Tourbah, A; Brown, MA; Tronczynska, E; Casas, JP; Tubridy, N; Corvin, A; Vickery, J; Jankowski, J; Villoslada, P; Markus, HS; Wang, K; Mathew, CG; Wason, J; Palmer, CNA; Wichmann, HE; Plomin, R; Willoughby, E; Rautanen, A; Winkelmann, J; Wittig, M; Trembath, RC; Yaouanq, J; Viswanathan, AC; Zhang, HT; Wood, NW; Zuvich, R; Deloukas, P; Langford, C; Duncanson, A; Oksenberg, JR; Pericak-Vance, MA; Haines, JL; Olsson, T; Hillert, J; Ivinson, AJ; De Jager, PL; Peltonen, L; Stewart, GJ; Hafler, DA; Hauser, SL; McVean, G; Donnelly, P; Compston, A				Sawcer, Stephen; Hellenthal, Garrett; Pirinen, Matti; Spencer, Chris C. A.; Patsopoulos, Nikolaos A.; Moutsianas, Loukas; Dilthey, Alexander; Su, Zhan; Freeman, Colin; Hunt, Sarah E.; Edkins, Sarah; Gray, Emma; Booth, David R.; Potter, Simon C.; Goris, An; Band, Gavin; Oturai, Annette Bang; Strange, Amy; Saarela, Janna; Bellenguez, Celine; Fontaine, Bertrand; Gillman, Matthew; Hemmer, Bernhard; Gwilliam, Rhian; Zipp, Frauke; Jayakumar, Alagurevathi; Martin, Roland; Leslie, Stephen; Hawkins, Stanley; Giannoulatou, Eleni; D'alfonso, Sandra; Blackburn, Hannah; Boneschi, Filippo Martinelli; Liddle, Jennifer; Harbo, Hanne F.; Perez, Marc L.; Spurkland, Anne; Waller, Matthew J.; Mycko, Marcin P.; Ricketts, Michelle; Comabella, Manuel; Hammond, Naomi; Kockum, Ingrid; McCann, Owen T.; Ban, Maria; Whittaker, Pamela; Kemppinen, Anu; Weston, Paul; Hawkins, Clive; Widaa, Sara; Zajicek, John; Dronov, Serge; Robertson, Neil; Bumpstead, Suzannah J.; Barcellos, Lisa F.; Ravindrarajah, Rathi; Abraham, Roby; Alfredsson, Lars; Ardlie, Kristin; Aubin, Cristin; Baker, Amie; Baker, Katharine; Baranzini, Sergio E.; Bergamaschi, Laura; Bergamaschi, Roberto; Bernstein, Allan; Berthele, Achim; Boggild, Mike; Bradfield, Jonathan P.; Brassat, David; Broadley, Simon A.; Buck, Dorothea; Butzkueven, Helmut; Capra, Ruggero; Carroll, William M.; Cavalla, Paola; Celius, Elisabeth G.; Cepok, Sabine; Chiavacci, Rosetta; Clerget-Darpoux, Francoise; Clysters, Katleen; Comi, Giancarlo; Cossburn, Mark; Cournu-Rebeix, Isabelle; Cox, Mathew B.; Cozen, Wendy; Cree, Bruce A. C.; Cross, Anne H.; Cusi, Daniele; Daly, Mark J.; Davis, Emma; de Bakker, Paul I. W.; Debouverie, Marc; D'hooghe, Marie Beatrice; Dixon, Katherine; Dobosi, Rita; Dubois, Benedicte; Ellinghaus, David; Elovaara, Irina; Esposito, Federica; Fontenille, Claire; Foote, Simon; Franke, Andre; Galimberti, Daniela; Ghezzi, Angelo; Glessner, Joseph; Gomez, Refujia; Gout, Olivier; Graham, Colin; Grant, Struan F. A.; Guerini, Franca Rosa; Hakonarson, Hakon; Hall, Per; Hamsten, Anders; Hartung, Hans-Peter; Heard, Rob N.; Heath, Simon; Hobart, Jeremy; Hoshi, Muna; Infante-Duarte, Carmen; Ingram, Gillian; Ingram, Wendy; Islam, Talat; Jagodic, Maja; Kabesch, Michael; Kermode, Allan G.; Kilpatrick, Trevor J.; Kim, Cecilia; Klopp, Norman; Koivisto, Keijo; Larsson, Malin; Lathrop, Mark; Lechner-Scott, Jeannette S.; Leone, Maurizio A.; Leppa, Virpi; Liljedahl, Ulrika; Bomfim, Izaura Lima; Lincoln, Robin R.; Link, Jenny; Liu, Jianjun; Lorentzen, Aslaug R.; Lupoli, Sara; Macciardi, Fabio; Mack, Thomas; Marriott, Mark; Martinelli, Vittorio; Mason, Deborah; McCauley, Jacob L.; Mentch, Frank; Mero, Inger-Lise; Mihalova, Tania; Montalban, Xavier; Mottershead, John; Myhr, Kjell-Morten; Naldi, Paola; Ollier, William; Page, Alison; Palotie, Aarno; Pelletier, Jean; Piccio, Laura; Pickersgill, Trevor; Piehl, Fredrik; Pobywajlo, Susan; Quach, Hong L.; Ramsay, Patricia P.; Reunanen, Mauri; Reynolds, Richard; Rioux, Johnd.; Rodegher, Mariaemma; Roesner, Sabine; Rubio, Justin P.; Rueckert, Ina-Maria; Salvetti, Marco; Salvi, Erika; Santaniello, Adam; Schaefer, Catherine A.; Schreiber, Stefan; Schulze, Christian; Scott, Rodney J.; Sellebjerg, Finn; Selmaj, Krzysztof W.; Sexton, David; Shen, Ling; Simms-Acuna, Brigid; Skidmore, Sheila; Sleiman, Patrick M. A.; Smestad, Cathrine; Sorensen, Per Soelberg; Sondergaard, Helle Bach; Stankovich, Jim; Strange, Richard C.; Sulonen, Anna-Maija; Sundqvist, Emilie; Syvaenen, Ann-Christine; Taddeo, Francesca; Taylor, Bruce; Blackwell, Jenefer M.; Tienari, Pentti; Bramon, Elvira; Tourbah, Ayman; Brown, Matthew A.; Tronczynska, Ewa; Casas, Juan P.; Tubridy, Niall; Corvin, Aiden; Vickery, Jane; Jankowski, Janusz; Villoslada, Pablo; Markus, Hugh S.; Wang, Kai; Mathew, Christopher G.; Wason, James; Palmer, Colin N. A.; Wichmann, H-Erich; Plomin, Robert; Willoughby, Ernest; Rautanen, Anna; Winkelmann, Juliane; Wittig, Michael; Trembath, Richard C.; Yaouanq, Jacqueline; Viswanathan, Ananth C.; Zhang, Haitao; Wood, Nicholas W.; Zuvich, Rebecca; Deloukas, Panos; Langford, Cordelia; Duncanson, Audrey; Oksenberg, Jorge R.; Pericak-Vance, Margaret A.; Haines, Jonathan L.; Olsson, Tomas; Hillert, Jan; Ivinson, Adrian J.; De Jager, Philip L.; Peltonen, Leena; Stewart, Graeme J.; Hafler, David A.; Hauser, Stephen L.; McVean, Gil; Donnelly, Peter; Compston, Alastair		Int Multiple Sclerosis Genetics Co; Wellcome Trust Case Control Consor	Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis	NATURE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; HETEROGENEITY; HAPLOTYPES; VARIANTS; ALLELES	Multiple sclerosis is a common disease of the central nervous system in which the interplay between inflammatory and neurodegenerative processes typically results in intermittent neurological disturbance followed by progressive accumulation of disability(1). Epidemiological studies have shown that genetic factors are primarily responsible for the substantially increased frequency of the disease seen in the relatives of affected individuals(2,3), and systematic attempts to identify linkage in multiplex families have confirmed that variation within the major histocompatibility complex (MHC) exerts the greatest individual effect on risk(4). Modestly powered genome-wide association studies (GWAS)(5-10) have enabled more than 20 additional risk loci to be identified and have shown that multiple variants exerting modest individual effects have a key role in disease susceptibility(11). Most of the genetic architecture underlying susceptibility to the disease remains to be defined and is anticipated to require the analysis of sample sizes that are beyond the numbers currently available to individual research groups. In a collaborative GWAS involving 9,772 cases of European descent collected by 23 research groups working in 15 different countries, we have replicated almost all of the previously suggested associations and identified at least a further 29 novel susceptibility loci. Within the MHC we have refined the identity of the HLA-DRB1 risk alleles and confirmed that variation in the HLA-A gene underlies the independent protective effect attributable to the class I region. Immunologically relevant genes are significantly overrepresented among those mapping close to the identified loci and particularly implicate T-helper-cell differentiation in the pathogenesis of multiple sclerosis.	[Sawcer, Stephen; Ban, Maria; Kemppinen, Anu; Baker, Amie; Skidmore, Sheila; Compston, Alastair] Univ Cambridge, Dept Clin Neurosci, Addenbrookes Hosp, Cambridge CB2 0QQ, England; [Hellenthal, Garrett; Pirinen, Matti; Spencer, Chris C. A.; Su, Zhan; Freeman, Colin; Band, Gavin; Strange, Amy; Bellenguez, Celine; Giannoulatou, Eleni; Rautanen, Anna; McVean, Gil; Donnelly, Peter] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Patsopoulos, Nikolaos A.; de Bakker, Paul I. W.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet,Dept Med, Boston, MA 02115 USA; [Patsopoulos, Nikolaos A.; Ardlie, Kristin; Aubin, Cristin; Daly, Mark J.; de Bakker, Paul I. W.; De Jager, Philip L.; Hafler, David A.] Broad Inst Harvard Univ & Massachusetts Inst Tech, Cambridge, MA 02142 USA; [Patsopoulos, Nikolaos A.; Pobywajlo, Susan; De Jager, Philip L.] Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, Boston, MA 02115 USA; [Moutsianas, Loukas; Dilthey, Alexander; Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Hunt, Sarah E.; Edkins, Sarah; Gray, Emma; Potter, Simon C.; Gillman, Matthew; Gwilliam, Rhian; Jayakumar, Alagurevathi; Blackburn, Hannah; Liddle, Jennifer; Perez, Marc L.; Waller, Matthew J.; Ricketts, Michelle; Hammond, Naomi; McCann, Owen T.; Whittaker, Pamela; Weston, Paul; Widaa, Sara; Dronov, Serge; Bumpstead, Suzannah J.; Ravindrarajah, Rathi; Palotie, Aarno; Deloukas, Panos; Langford, Cordelia] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Booth, David R.; Heard, Rob N.; Stewart, Graeme J.] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2145, Australia; [Goris, An; Clysters, Katleen; Dobosi, Rita; Dubois, Benedicte] Katholieke Univ Leuven, Sect Expt Neurol, Lab Neuroimmunol, B-3000 Louvain, Belgium; [Oturai, Annette Bang; Sellebjerg, Finn; Sorensen, Per Soelberg; Sondergaard, Helle Bach] Rigshosp, Copenhagen Univ Hosp, Dept Neurol, Danish Multiple Sclerosis Ctr, DK-2100 Copenhagen, Denmark; [Saarela, Janna; Leppa, Virpi; Palotie, Aarno; Sulonen, Anna-Maija] Univ Helsinki, Inst Mol Med Finland FIMM, FIN-00290 Helsinki, Finland; [Fontaine, Bertrand; Cournu-Rebeix, Isabelle; Fontenille, Claire] UPMC, AP HP, INSERM UMR S CRICM 975, Dept Neurol Pitie Salpetriere, F-75013 Paris, France; [Hemmer, Bernhard; Berthele, Achim; Buck, Dorothea; Cepok, Sabine; Hoshi, Muna; Winkelmann, Juliane] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-81675 Munich, Germany; [Zipp, Frauke] Johannes Gutenberg Univ Mainz, Univ Med Mainz, Dept Neurol, D-55131 Mainz, Germany; [Zipp, Frauke; Martin, Roland] Max Delbrueck Ctr Mol Med, D-13092 Berlin, Germany; [Roesner, Sabine] Ctr Mol Neurobiol, Inst Neuroimmunol & Clin MS Res Inims, D-20251 Hamburg, Germany; [Leslie, Stephen] Univ Oxford, Dept Clin Pharmacol, Oxford OX3 7DQ, England; [Hawkins, Stanley] Queens Univ Belfast, Belfast BT7 1NN, Antrim, North Ireland; [D'alfonso, Sandra; Bergamaschi, Laura] Univ Piemonte Orientale, Dept Med Sci, I-28100 Novara, Italy; [D'alfonso, Sandra; Bergamaschi, Laura] Univ Piemonte Orientale, IRCAD, I-28100 Novara, Italy; [Boneschi, Filippo Martinelli; Comi, Giancarlo; Esposito, Federica; Martinelli, Vittorio; Rodegher, Mariaemma] Ist Sci San Raffaele, Dept Neurol, Inst Expt Neurol INSPE, Div Neurosci, I-20132 Milan, Italy; [Harbo, Hanne F.; Celius, Elisabeth G.; Mero, Inger-Lise; Smestad, Cathrine] Oslo Univ Hosp, Dept Neurol, N-0407 Oslo, Norway; [Harbo, Hanne F.; Lorentzen, Aslaug R.] Univ Oslo, Dept Neurol, N-0318 Oslo, Norway; [Spurkland, Anne] Univ Oslo, Inst Basal Med Sci, N-0317 Oslo, Norway; [Mycko, Marcin P.; Selmaj, Krzysztof W.; Tronczynska, Ewa] Med Univ Lodz, Lab Neuroimmunol, Dept Neurol, PL-90153 Lodz, Poland; [Comabella, Manuel; Montalban, Xavier] Vall dHebron Univ Hosp, Multiple Sclerosis Ctr Catalonia CEM Cat, Clin Neuroinmunol Unit, Barcelona 08035, Spain; [Kockum, Ingrid; Jagodic, Maja; Bomfim, Izaura Lima; Link, Jenny; Piehl, Fredrik; Sundqvist, Emilie; Olsson, Tomas; Hillert, Jan] Karolinska Inst, Karolinska Univ Hosp, Ctr Mol Med CMM, Dept Clin Neurosci, SE-17176 Stockholm, Sweden; [Hawkins, Clive; Abraham, Roby; Mihalova, Tania; Strange, Richard C.] Keele Univ, Sch Med, Stoke On Trent ST4 7NY, Staffs, England; [Zajicek, John; Hobart, Jeremy; Ingram, Wendy; Vickery, Jane] Univ Exeter, Peninsula Coll Med & Dent, Plymouth PL6 8BX, Devon, England; [Zajicek, John; Hobart, Jeremy; Ingram, Wendy; Vickery, Jane] Univ Plymouth, Clin Neurol Res Grp, Plymouth PL6 8BX, Devon, England; [Robertson, Neil; Baker, Katharine; Cossburn, Mark; Ingram, Gillian; Pickersgill, Trevor] Univ Wales Hosp, Dept Neurol, Cardiff CF14 4XW, S Glam, Wales; [Barcellos, Lisa F.; Quach, Hong L.; Ramsay, Patricia P.] Univ Calif Berkeley, Genet Epidemiol & Genom Lab, Div Epidemiol, Sch Publ Hlth, Berkeley, CA 94720 USA; [Barcellos, Lisa F.; Bernstein, Allan; Schaefer, Catherine A.; Shen, Ling; Simms-Acuna, Brigid] Kaiser Permanente No Calif Div Res, Oakland, CA 94612 USA; [Alfredsson, Lars] Karolinska Inst, Inst Expt Med, S-17177 Stockholm, Sweden; [Baranzini, Sergio E.; Cree, Bruce A. C.; Gomez, Refujia; Lincoln, Robin R.; Santaniello, Adam; Oksenberg, Jorge R.; Hauser, Stephen L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Bergamaschi, Roberto] IRCCS, Neurol Inst C Mondino, I-27100 Pavia, Italy; [Boggild, Mike] Walton Ctr Neurol & Neurosurg, Liverpool L7 9LJ, Merseyside, England; [Bradfield, Jonathan P.; Chiavacci, Rosetta; Glessner, Joseph; Grant, Struan F. A.; Hakonarson, Hakon; Kim, Cecilia; Mentch, Frank; Sleiman, Patrick M. A.; Wang, Kai; Zhang, Haitao] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Brassat, David] INSERM, U1043, F-31059 Toulouse, France; [Brassat, David] Hop Purpan, F-31059 Toulouse, France; [Broadley, Simon A.] Griffith Univ, Sch Med, Gold Coast, Qld 4222, Australia; [Butzkueven, Helmut; Kilpatrick, Trevor J.; Marriott, Mark; Rubio, Justin P.] Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic 3010, Australia; [Butzkueven, Helmut; Kilpatrick, Trevor J.; Marriott, Mark; Tubridy, Niall] Royal Melbourne Hosp, Parkville, Vic 3050, Australia; [Butzkueven, Helmut] Monash Univ, Box Hill Hosp, Clayton, Vic 3800, Australia; [Butzkueven, Helmut] Univ Melbourne, Dept Med, RMH Cluster, Melbourne, Vic 3010, Australia; [Capra, Ruggero] Osped Civili Brescia, Dept Neurol, Multiple Sclerosis Ctr, I-25018 Brescia, Italy; [Carroll, William M.; Kermode, Allan G.] Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Perth, WA 6009, Australia; [Cavalla, Paola] Univ Turin, AOU San Giovanni Battista, Dept Neurosci, I-10126 Turin, Italy; [Clerget-Darpoux, Francoise] Univ Paris 11, INSERM, U669, F-94800 Villejuif, France; [Cox, Mathew B.; Lechner-Scott, Jeannette S.; Scott, Rodney J.] Univ Newcastle, Callaghan, NSW 2308, Australia; [Cozen, Wendy; Islam, Talat; Mack, Thomas] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA; [Cross, Anne H.; Piccio, Laura] Washington Univ, Dept Neurol, St Louis, MO 63110 USA; [Cusi, Daniele; Lupoli, Sara; Macciardi, Fabio; Salvi, Erika] Univ Milan, Filarete Fdn, AO San Paolo, Dept Med Surg & Dent, I-20139 Milan, Italy; [Daly, Mark J.; Ivinson, Adrian J.; De Jager, Philip L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Daly, Mark J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Davis, Emma; Dixon, Katherine; Ollier, William] Univ Manchester, UK DNA Banking Network, Ctr Integrated Genom Med Res, Manchester M13 9PT, Lancs, England; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Div Biomed Genet, Dept Med Genet, NL-3508 GA Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Debouverie, Marc] Hop Cent, Serv Neurol, F-54035 Nancy, France; [D'hooghe, Marie Beatrice] Natl Multiple Sclerosis Ctr, B-1820 Melsbroek, Belgium; [Ellinghaus, David; Franke, Andre; Schreiber, Stefan; Wittig, Michael] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Elovaara, Irina] Tampere Univ Hosp, Dept Neurol, FIN-33014 Tampere, Finland; [Elovaara, Irina] Univ Tampere, Sch Med, Tampere 33014, Finland; [Foote, Simon; Stankovich, Jim; Taylor, Bruce] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas 7000, Australia; [Galimberti, Daniela] Univ Milan, Fdn Ca Granda, Ctr Dino Ferrari, Dept Neurol Sci,Osped Maggiore Policlin, I-20122 Milan, Italy; [Ghezzi, Angelo] Osped Gallarate, Ctr Studi Sclerosi Multipla, I-21013 Gallarate, VA, Italy; [Gout, Olivier] Fdn Ophtalmol Adolphe de Rothschild, Serv Neurol, F-75019 Paris, France; [Graham, Colin] Belfast Hlth & Social Care Trust, City Hosp, Belfast BT9 7AB, Antrim, North Ireland; [Grant, Struan F. A.; Hakonarson, Hakon; Sleiman, Patrick M. A.; Wang, Kai; Zhang, Haitao] Childrens Hosp Philadelphia, Div Genet, Philadelphia, PA 19104 USA; [Grant, Struan F. A.; Hakonarson, Hakon] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Guerini, Franca Rosa] Don C Gnocchi Fdn IRCCS, Lab Mol Med & Biotechnol, I-20148 Milan, Italy; [Hall, Per] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Hamsten, Anders; Larsson, Malin] Karolinska Inst, Karolinska Univ, Dept Med Solna, Atherosclerosis Res Unit, S-17176 Stockholm, Sweden; [Hartung, Hans-Peter] Univ Dusseldorf, Dept Neurol, D-40225 Dusseldorf, Germany; [Heath, Simon; Lathrop, Mark] Commissariat Energie Atom, Inst Genom, Ctr Natl Genotypage, F-91057 Evry, France; [Infante-Duarte, Carmen] Univ Med Berlin, Charite, Expt & Clin Res Ctr, D-13125 Berlin, Germany; [Infante-Duarte, Carmen] Max Delbrueck Ctr Mol Med, D-13125 Berlin, Germany; [Kabesch, Michael] Hannover Med Sch, Dept Paediat Pneumol Allergy & Neonatol, D-30625 Hannover, Germany; [Kilpatrick, Trevor J.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic 3010, Australia; [Klopp, Norman; Rueckert, Ina-Maria; Wichmann, H-Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, D-85764 Munich, Germany; [Koivisto, Keijo] Seinajoki Cent Hosp, Seinajoki 60220, Finland; [Lechner-Scott, Jeannette S.] John Hunter Hosp, Hunter Med Res Inst, New Lambton, NSW 2305, Australia; [Leone, Maurizio A.; Naldi, Paola] Maggiore della Carita Hosp, SCDU Neurol, I-28100 Novara, Italy; [Leppa, Virpi; Sulonen, Anna-Maija] Natl Inst Hlth & Welf, Unit Publ Hlth Genom, Helsinki 00290, Finland; [Liljedahl, Ulrika; Syvaenen, Ann-Christine] Uppsala Univ, Dept Med Sci, Mol Med & Sci Life Lab, Univ Hosp,Res Dept 2, S-75185 Uppsala, Sweden; [Liu, Jianjun] Genome Inst Singapore, Singapore 138672, Singapore; [Lorentzen, Aslaug R.; Mero, Inger-Lise] Oslo Univ Hosp, Inst Immunol, N-0027 Oslo, Norway; [Lupoli, Sara] Ist Sci San Raffaele, Inst Expt Neurol INSPE, I-20132 Milan, Italy; [Macciardi, Fabio] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92617 USA; [Mason, Deborah] Univ Otago, Christchurch Sch Med, Christchurch 8041, New Zealand; [McCauley, Jacob L.; Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [McCauley, Jacob L.; Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, Dept Human Genet, Dr John T Macdonald Fdn, Miami, FL 33136 USA; [Mottershead, John] Hope Hosp, Greater Manchester Ctr Clin Neurosci, Salford M6 8HD, Lancs, England; [Mottershead, John] Dunedin Publ Hosp, Dept Neurol, Otago 9016, New Zealand; [Myhr, Kjell-Morten] Haukeland Hosp, Dept Neurol, Norwegian Multiple Sclerosis Competence Ctr, N-5021 Bergen, Norway; [Myhr, Kjell-Morten] Univ Bergen, Dept Clin Med, N-5021 Bergen, Norway; [Page, Alison] Derriford Hosp, Dept Neurol, Plymouth Hosp NHS Trust, Plymouth PL6 8DH, Devon, England; [Palotie, Aarno] Univ Helsinki, Dept Med Genet, Helsinki 00014, Finland; [Palotie, Aarno] Univ Cent Hosp, Helsinki 00014, Finland; [Palotie, Aarno] Broad Inst MIT & Harvard, Program Med & Populat Genet & Genet Anal Platform, Cambridge, MA 02142 USA; [Pelletier, Jean] Hop La Timone, Serv Neurol, Pole Neurosci Clin, F-13005 Marseille, France; [Reunanen, Mauri] Oulu Univ Hosp, Dept Neurol, Oulu 90029, Finland; [Reynolds, Richard] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Wolfson Neurosci Labs, UK MS Tissue Bank, London W12 0NN, England; [Rioux, Johnd.] Univ Montreal, Montreal, PQ H1T 1C8, Canada; [Rioux, Johnd.] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Salvetti, Marco] Univ Roma La Sapienza, Ctr Expt Neurol Therapy CENTERS, I-00189 Rome, Italy; [Salvi, Erika; Taddeo, Francesca] KOS Genet Srl, I-20123 Milan, Italy; [Schreiber, Stefan] Univ Kiel, Univ Hosp, Dept Gen Internal Med, D-24105 Kiel, Germany; [Schulze, Christian] Ctr Mol Neurobiol, D-20251 Hamburg, Germany; [Sexton, David; Zuvich, Rebecca; Haines, Jonathan L.] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN 37232 USA; [Blackwell, Jenefer M.] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Subiaco, WA 6008, Australia; [Blackwell, Jenefer M.] Univ Cambridge, Sch Clin Med, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Tienari, Pentti] Univ Helsinki, Cent Hosp, Dept Neurol, FIN-00290 Helsinki, Finland; [Blackwell, Jenefer M.; Tienari, Pentti] Univ Helsinki, Biomedicum, Mol Neurol Programme, FIN-00290 Helsinki, Finland; [Bramon, Elvira] Kings Coll London, Inst Psychiat, Biomed Res Ctr Mental Hlth, Div Psychol Med & Psychiat, London SE5 8AF, England; [Bramon, Elvira] S London & Maudsley NHS Fdn Trust, London SE5 8AF, England; [Tourbah, Ayman] Univ Reims, Serv Neurol, F-51100 Reims, France; [Tourbah, Ayman] Univ Reims, Fac Med Reims, F-51100 Reims, France; [Brown, Matthew A.] Univ Queensland, Brisbane, Qld 4102, Australia; [Brown, Matthew A.] Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld 4102, Australia; [Casas, Juan P.] Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; [Tubridy, Niall] St Vincents Univ Hosp, Dublin 4, Ireland; [Corvin, Aiden] Trinity Coll Dublin, Inst Mol Med, Neuropsychiat Genet Res Grp, Dublin 2, Eire, Ireland; [Jankowski, Janusz] Barts & London Queen Marys Sch Med & Dent, Ctr Gastroenterol, London E1 2AT, England; [Villoslada, Pablo] Hosp Clin Barcelona, Inst Biomed Res August Pi Sunyer IDIBAPS, Dept Neurosci, Barcelona 08036, Spain; [Markus, Hugh S.] St Georges Univ London, London SW17 0RE, England; [Mathew, Christopher G.; Trembath, Richard C.] Kings Coll London, Guys Hosp, Sch Med, Dept Med & Mol Genet, London SE1 9RT, England; [Wason, James] Med Res Council Biostat Unit, Cambridge CB2 0SR, England; [Palmer, Colin N. A.] Univ Dundee, Inst Biomed Res, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, D-81377 Munich, Germany; [Wichmann, H-Erich] Klinikum Grosshadern, D-81377 Munich, Germany; [Plomin, Robert] Kings Coll London, Social Genet & Dev Psychiat Ctr, Inst Psychiat, London SE5 8AF, England; [Willoughby, Ernest] Auckland City Hosp, Dept Neurol, Auckland 1010, New Zealand; [Winkelmann, Juliane] Tech Univ Munich, Inst Humangenet, D-81675 Munich, Germany; [Winkelmann, Juliane] Helmholtz Zentrum Munchen, Inst Humangenet, D-85764 Munich, Germany; [Wittig, Michael] Univ Kiel, Popgen Biobank, D-24105 Kiel, Germany; [Yaouanq, Jacqueline] CHU Pontchaillou, F-35033 Rennes, France; [Viswanathan, Ananth C.] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr Ophthalmol, London EC1V 2PD, England; [Viswanathan, Ananth C.] UCL Inst Ophthalmol, London EC1V 2PD, England; [Wood, Nicholas W.] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Duncanson, Audrey] Wellcome Trust Res Labs, London NW1 2BE, England; [Ivinson, Adrian J.] Harvard Univ, Sch Med, Harvard NeuroDiscovery Ctr, Boston, MA 02115 USA; [Hafler, David A.] Yale Univ, Sch Med, Dept Neurol & Immunol, New Haven, CT 06520 USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; University of Oxford; Wellcome Trust Sanger Institute; University of Sydney; Westmead Institute for Medical Research; KU Leuven; Rigshospitalet; University of Copenhagen; University of Helsinki; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Technical University of Munich; Johannes Gutenberg University of Mainz; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Oxford; Queens University Belfast; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Oslo; University of Oslo; University of Oslo; Medical University Lodz; Hospital Universitari Vall d'Hebron; Karolinska Institutet; Karolinska University Hospital; Keele University; University of Exeter; University of Plymouth; University of Plymouth; Cardiff University; University of California System; University of California Berkeley; Kaiser Permanente; Karolinska Institutet; University of California System; University of California San Francisco; IRCCS Fondazione Casimiro Mondino; University of Pavia; Walton Centre; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Griffith University; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Melbourne Hospital; Box Hill Hospital; Monash University; University of Melbourne; Hospital Spedali Civili Brescia; University of Western Australia; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Newcastle; University of Southern California; Washington University (WUSTL); University of Milan; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Manchester; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; CHU de Nancy; University of Kiel; Tampere University; Tampere University Hospital; Tampere University; University of Tasmania; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Belfast City Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; IRCCS Fondazione Don Carlo Gnocchi Onlus; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Heinrich Heine University Dusseldorf; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Hannover Medical School; University of Melbourne; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Seinajoki Central Hospital; Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle; Finland National Institute for Health & Welfare; Uppsala University; Uppsala University Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Oslo; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of California System; University of California Irvine; University of Otago; University of Miami; University of Miami; University of Bergen; Haukeland University Hospital; University of Bergen; Derriford Hospital; University of Plymouth; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Oulu; Imperial College London; Universite de Montreal; Universite de Montreal; Sapienza University Rome; University of Kiel; Schleswig Holstein University Hospital; Vanderbilt University; Telethon Kids Institute; University of Western Australia; University of Cambridge; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of London; King's College London; South London & Maudsley NHS Trust; Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne; University of Queensland; University of Queensland; University of London; London School of Hygiene & Tropical Medicine; University College Dublin; Saint Vincent's University Hospital; Trinity College Dublin; University of London; Queen Mary University London; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; St Georges University London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; MRC Biostatistics Unit; University of Dundee; University of Munich; University of Munich; University of London; King's College London; Auckland City Hospital; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Kiel; CHU Rennes; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; University College London; Harvard University; Harvard Medical School; Yale University	Compston, A (corresponding author), Univ Cambridge, Dept Clin Neurosci, Addenbrookes Hosp, BOX 165,Hills Rd, Cambridge CB2 0QQ, England.	donnelly@well.ox.ac.uk; alastair.compston@medschl.cam.ac.uk	Baranzini, Sergio/A-9422-2013; Salvi, Erika/C-1033-2015; Jankowski, Janusz/H-2706-2012; Villoslada, Pablo/AAF-9547-2019; Brown, Matthew A/E-5749-2010; Scott, Rodney J/B-2827-2013; Boneschi, Filippo Martinelli/H-8592-2012; Mycko, Marcin Przemyslaw/S-9386-2016; Rioux, John D/A-9599-2015; Ellinghaus, David/ABC-3610-2020; Esposito, Federica/K-6537-2016; Montalban, Xavier/J-5938-2016; , Talat/AAV-6834-2020; Kockum, Ingrid/O-8781-2018; Bergamaschi, Laura/ABE-1175-2020; Deloukas, Panos/B-2922-2013; Franke, Andre/B-2151-2010; Blackwell, Jenefer M/H-3015-2015; Mathew, Christopher G/G-3434-2015; Bramon, Elvira/A-9463-2011; Celius, Elisabeth Gulowsen/S-1387-2019; Macciardi, Fabio/N-3768-2014; Villoslada, Pablo/O-1757-2019; Kabesch, Michael/AAB-5701-2020; Goris, An/L-5852-2019; Wichmann, Heinz Erich/AAA-5695-2022; D'hooghe, Marie BGJ/G-3423-2013; Foote, Simon J/F-2802-2013; Hemmer, Bernhard/GPX-8451-2022; Palmer, Colin NA/C-7053-2008; Cree, Bruce C/AAV-6109-2020; Martinelli, Vittorio/AAN-7240-2020; Tienari, Pentti J/A-4893-2012; Galimberti, Daniela/N-7209-2019; Hemmer, Bernhard/AAT-8388-2021; de Bakker, Paul IW/B-8730-2009; Lima Bomfim, Izaura/J-3462-2012; ghezzi, angelo/AAJ-9606-2020; Heath, Simon C/J-4138-2012; Guerini, Franca R./G-8055-2012; Piccio, Laura/AAE-1706-2020; Belllenguez, Céline/Y-3183-2018; Wood, Nicholas W/C-2505-2009; Leone, Maurizio A./J-4130-2016; Goris, An/F-2943-2010; Piehl, Fredrik/E-3451-2013; Alfredsson, Lars/AAC-9007-2019; Haines, Jonathan/C-3374-2012; Schulze, Christian/AGJ-7744-2022; Salvetti, Marco/K-3836-2016; Bellenguez, Céline/X-4004-2019; Myhr, Kjell-Morten/H-1528-2018; Saarela, Janna S/E-5369-2014; Brassat, David/L-2173-2014; Kermode, Allan/G-3568-2019; Liu, Jianjun/AAK-4989-2020; Hauser, Stephen L/J-2978-2016; Spurkland, Anne/L-3369-2019; Ellinghaus, David/G-4467-2012; Zipp, Frauke/C-9968-2015; Daly, Mark J/B-2453-2017; D'Alfonso, Sandra/K-7295-2014; Link, Jenny/J-1629-2012; Plomin, Robert/B-8911-2008; Salvi, Erika/AAA-1415-2019; Kabesch, Michael/GZM-1583-2022; Clerget-Darpoux, Francoise/I-4825-2017; Dubois, Benedicte/A-4338-2019	Baranzini, Sergio/0000-0003-0067-194X; Salvi, Erika/0000-0002-2724-2291; Jankowski, Janusz/0000-0003-2130-9181; Brown, Matthew A/0000-0003-0538-8211; Scott, Rodney J/0000-0001-7724-3404; Rioux, John D/0000-0001-7560-8326; Ellinghaus, David/0000-0002-4332-6110; Esposito, Federica/0000-0003-2550-0805; Montalban, Xavier/0000-0002-0098-9918; , Talat/0000-0002-2837-865X; Kockum, Ingrid/0000-0002-0867-4726; Deloukas, Panos/0000-0001-9251-070X; Franke, Andre/0000-0003-1530-5811; Mathew, Christopher G/0000-0003-4178-1838; Celius, Elisabeth Gulowsen/0000-0002-9127-6488; Macciardi, Fabio/0000-0003-0537-4266; Villoslada, Pablo/0000-0002-8735-6119; Goris, An/0000-0002-1276-6682; Hemmer, Bernhard/0000-0001-5985-6784; Palmer, Colin NA/0000-0002-6415-6560; Cree, Bruce C/0000-0001-7689-2533; Galimberti, Daniela/0000-0002-9284-5953; de Bakker, Paul IW/0000-0001-7735-7858; Heath, Simon C/0000-0002-9550-0897; Guerini, Franca R./0000-0001-9461-5927; Piccio, Laura/0000-0002-8760-109X; Belllenguez, Céline/0000-0002-1240-7874; Wood, Nicholas W/0000-0002-9500-3348; Leone, Maurizio A./0000-0002-6339-5738; Goris, An/0000-0002-1276-6682; Alfredsson, Lars/0000-0003-1688-6697; Haines, Jonathan/0000-0002-4351-4728; Schulze, Christian/0000-0001-9442-7141; Bellenguez, Céline/0000-0002-1240-7874; Myhr, Kjell-Morten/0000-0002-0980-510X; Kermode, Allan/0000-0002-4476-4016; Liu, Jianjun/0000-0002-3255-3019; Spurkland, Anne/0000-0003-4421-0766; Zipp, Frauke/0000-0002-1231-1928; Daly, Mark J/0000-0002-0949-8752; D'Alfonso, Sandra/0000-0002-3983-9925; Salvi, Erika/0000-0002-2724-2291; Patsopoulos, Nikolaos/0000-0003-3757-8941; RUBIO, JUSTIN/0000-0003-3750-917X; Clerget-Darpoux, Francoise/0000-0003-4816-6619; martinelli boneschi, filippo/0000-0002-9955-1368; Martin, Roland/0000-0002-0982-1329; Butzkueven, Helmut/0000-0003-3940-8727; Potter, Simon/0000-0003-4208-4102; Sondergaard, Helle Bach/0000-0001-9435-0658; Pirinen, Matti/0000-0002-1664-1350; Murray, Dianna/0000-0003-3481-825X; Rapa, Anna/0000-0002-5523-5224; Selmaj, Krzysztof/0000-0003-1213-7218; Sorensen, Per Soelberg/0000-0002-2818-3780; Grant, Struan/0000-0003-2025-5302; Infante Duarte, Carmen/0000-0003-3005-351X; Olsson, Tomas/0000-0002-2938-1877; D'hooghe, Marie/0000-0002-0917-4176; Cavalla, Paola/0000-0003-4589-4864; McVean, Gil/0000-0002-5012-4162; Gillman, Matthew S./0000-0002-2340-6930; Trembath, Richard/0000-0003-0550-3400; Saarela, Janna/0000-0002-0853-6219; Comabella Lopez, Manuel/0000-0002-2373-6657; Cross, Anne/0000-0003-0829-7569; Wason, James/0000-0002-4691-126X; Winkelmann, Juliane/0000-0003-2667-9691; Band, Gavin/0000-0002-1710-9024; Gomez, Refujia/0000-0003-0730-8019; Foote, Simon/0000-0002-9142-2107; Sellebjerg, Finn/0000-0002-1333-9623; Schulze, Christian/0000-0002-1442-1987; Lima Bomfim, Izaura/0000-0003-0890-3872; Sulonen, Anna-Maija/0000-0002-5518-1975; Corvin, Aiden/0000-0001-6717-4089; Kilpatrick, Trevor/0000-0003-3999-085X; Mycko, Marcin/0000-0002-2226-1784; Glessner, Joseph/0000-0001-5131-2811; Stankovich, Jim/0000-0001-9344-7749; Lechner-Scott, Jeannette/0000-0002-3850-447X; Giannoulatou, Eleni/0000-0002-7084-6736; Palotie, Aarno/0000-0002-2527-5874; Hunt, Sarah/0000-0002-8350-1235; Plomin, Robert/0000-0002-0756-3629; Walters, James/0000-0002-6980-4053; Link, Jenny/0000-0002-6134-9404; Leppa, Virpi/0000-0003-2942-2656; Dubois, Benedicte/0000-0003-0604-8702; Bramon, Elvira/0000-0003-1369-5983	Wellcome Trust [085475/B/08/Z, 085475/Z/08/Z, 075491/Z/04/Z, 068545/Z/02]; National Institutes of Health [AI076544, NS032830, NS049477, NS19142, NS049510, NS26799, NS43559, NS067305, CA104021, RR020092, RR024992, K23N/S048869]; US National Multiple Sclerosis Society [RG 4201-A-1]; Nancy Davis Foundation; Cambridge NIHR Biomedical Research Centre; UK Medical Research Council [G0700061, G0000934]; Multiple Sclerosis Society of Great Britain and Northern Ireland [898/08]; Wolfson Royal Society; Peter Doherty fellowship; Lagrange Fellowship; Harry Weaver Neuroscience Scholarships; Australian National Health and Medical Research Council (NHMRC); Australian Research Council; JHH Charitable Trust; Multiple Sclerosis Research Australia; Health Research Council New Zealand; National MS Society of New Zealand; Wetenschappelijk Onderzoek Multiple Sclerose; Bayer Chair on Fundamental Genetic Research; Biogen Idec Chair Translational Research in Multiple Sclerosis; FWO-Vlaanderen; Belgian Neurological Society; Danish Multiple Sclerosis Society; Neuropromise EU [LSHM-CT-2005-018637]; Center of Excellence for Disease Genetics of the Academy of Finland; Sigrid Juselius Foundation; Helsinki University Central Hospital Research Foundation; Bundesministerium fur Bildung und Technologie (KKNMS consortium Control MS); Deutsche Forschungsgemeinschaft; Institut National de la Sante et de la Recherche Medicale (INSERM); Association pour la Recherche sur la Sclerose En Plaques (ARSEP); Association Francaise contre les Myopathies (AFM); Italian Foundation for Multiple Sclerosis [2002/R/40, 2005/R/10, 2008/R/11, 2008/R/15]; Italian Ministry of Health [Giovani Ricercatori 2007-D.lgs 502/92]; Regione Piemonte [2003, 2004, 2008, 2009]; CRT Foundation; Turin; Moorfields/UCL Institute of Ophthalmology NIHR Biomedical Research Centre; Norwegian MS Register and Biobank; Research Council of Norway; South-Eastern and Western Norway regional Health Authories; Ulleval University Hospital Scientific Advisory Council; Haukeland University Hospital; Amici Centro Sclerosi Multipla del San Raffaele (ACESM); Association of British Neurologists; Spanish Ministry of Health [FISPI060117]; Bibbi and Niels Jensens Foundation; Montel Williams foundation; Hjarnfonden and Swedish medical research council [8691]; Stockholm County Council [562183]; Swedish Council for Working life and Social Research; Gemeinnutzige Hertie Stiftung; Northern California Kaiser Permanente members and Polpharma Foundation; Washington University Institute of Clinical and Translational Sciences-Brain, Behavioral and Performance Unit; German Ministry of Education and Research; Helmholtz Zentrum Munchen-National Research Center; German National Genome Research Network (NGFN); LMUinnovativ; Knut and Alice Wallenberg Foundation; Children's Hospital of Philadelphia; Agency for Science & Technology and Research of Singapore; Susan G. Komen Breast Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA104021] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992, C06RR020092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049510, R01NS043559, R01NS032830, R01NS067305, R01NS026799, R01NS019142, R01NS049477] Funding Source: NIH RePORTER; MRC [MC_EX_G0800860, G19/2, G0700061, G0901310, G0100594, G0901461] Funding Source: UKRI; Medical Research Council [G19/2, G0400017, G9817803B, G0700061, G0901461, G0100594, G0801418B, MC_EX_G0800860, G0901310] Funding Source: researchfish; National Institute for Health Research [PDA/02/06/016, NF-SI-0507-10379] Funding Source: researchfish; Parkinson&quot;s UK [J-0804] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Multiple Sclerosis Society(National Multiple Sclerosis Society); Nancy Davis Foundation; Cambridge NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Multiple Sclerosis Society of Great Britain and Northern Ireland; Wolfson Royal Society(Royal Society of London); Peter Doherty fellowship; Lagrange Fellowship; Harry Weaver Neuroscience Scholarships; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); JHH Charitable Trust; Multiple Sclerosis Research Australia; Health Research Council New Zealand(Health Research Council of New Zealand); National MS Society of New Zealand; Wetenschappelijk Onderzoek Multiple Sclerose; Bayer Chair on Fundamental Genetic Research; Biogen Idec Chair Translational Research in Multiple Sclerosis; FWO-Vlaanderen(FWO); Belgian Neurological Society; Danish Multiple Sclerosis Society; Neuropromise EU; Center of Excellence for Disease Genetics of the Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki University Central Hospital Research Foundation; Bundesministerium fur Bildung und Technologie (KKNMS consortium Control MS)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association pour la Recherche sur la Sclerose En Plaques (ARSEP); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Italian Foundation for Multiple Sclerosis; Italian Ministry of Health(Ministry of Health, Italy); Regione Piemonte(Regione Piemonte); CRT Foundation; Turin; Moorfields/UCL Institute of Ophthalmology NIHR Biomedical Research Centre; Norwegian MS Register and Biobank; Research Council of Norway(Research Council of Norway); South-Eastern and Western Norway regional Health Authories; Ulleval University Hospital Scientific Advisory Council; Haukeland University Hospital; Amici Centro Sclerosi Multipla del San Raffaele (ACESM); Association of British Neurologists; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Bibbi and Niels Jensens Foundation; Montel Williams foundation; Hjarnfonden and Swedish medical research council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stockholm County Council(Stockholm County Council); Swedish Council for Working life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Gemeinnutzige Hertie Stiftung; Northern California Kaiser Permanente members and Polpharma Foundation; Washington University Institute of Clinical and Translational Sciences-Brain, Behavioral and Performance Unit; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Helmholtz Zentrum Munchen-National Research Center; German National Genome Research Network (NGFN); LMUinnovativ; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Children's Hospital of Philadelphia; Agency for Science & Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK)	The principal funding for this study was provided by the Wellcome Trust (085475/B/08/Z, 085475/Z/08/Z, 075491/Z/04/Z and 068545/Z/02). The work was also supported by National Institutes of Health (AI076544, NS032830, NS049477, NS19142, NS049510, NS26799, NS43559, NS067305, CA104021, RR020092, RR024992 and K23N/S048869), US National Multiple Sclerosis Society (RG 4201-A-1), Nancy Davis Foundation, Cambridge NIHR Biomedical Research Centre, UK Medical Research Council (G0700061, G0000934), Multiple Sclerosis Society of Great Britain and Northern Ireland (898/08), Wolfson Royal Society Merit Award, Peter Doherty fellowship, Lagrange Fellowship, Harry Weaver Neuroscience Scholarships, Australian National Health and Medical Research Council (NHMRC), Australian Research Council Linkage Program Grant, JHH Charitable Trust Fund, Multiple Sclerosis Research Australia, Health Research Council New Zealand, National MS Society of New Zealand, Wetenschappelijk Onderzoek Multiple Sclerose, Bayer Chair on Fundamental Genetic Research regarding the Neuroimmunological Aspects of Multiple Sclerosis, Biogen Idec Chair Translational Research in Multiple Sclerosis, FWO-Vlaanderen, Belgian Neurological Society, Danish Multiple Sclerosis Society, Neuropromise EU grant (LSHM-CT-2005-018637), Center of Excellence for Disease Genetics of the Academy of Finland, Sigrid Juselius Foundation, Helsinki University Central Hospital Research Foundation, Bundesministerium fur Bildung und Technologie (KKNMS consortium Control MS), Deutsche Forschungsgemeinschaft, Institut National de la Sante et de la Recherche Medicale (INSERM), Association pour la Recherche sur la Sclerose En Plaques (ARSEP), Association Francaise contre les Myopathies (AFM), Italian Foundation for Multiple Sclerosis (FISM grants 2002/R/40, 2005/R/10, 2008/R/11 and 2008/R/15), Italian Ministry of Health (grant Giovani Ricercatori 2007-D.lgs 502/92), Regione Piemonte (grants 2003, 2004, 2008, 2009), CRT Foundation, Turin, Moorfields/UCL Institute of Ophthalmology NIHR Biomedical Research Centre, Norwegian MS Register and Biobank, Research Council of Norway, South-Eastern and Western Norway regional Health Authories, Ulleval University Hospital Scientific Advisory Council, Haukeland University Hospital, Amici Centro Sclerosi Multipla del San Raffaele (ACESM), Association of British Neurologists, Spanish Ministry of Health (FISPI060117), Bibbi and Niels Jensens Foundation, Montel Williams foundation, Hjarnfonden and Swedish medical research council (8691), Stockholm County Council (562183), Swedish Council for Working life and Social Research, Gemeinnutzige Hertie Stiftung, Northern California Kaiser Permanente members and Polpharma Foundation, and Washington University Institute of Clinical and Translational Sciences-Brain, Behavioral and Performance Unit. We acknowledge use of data from the British 1958 Birth Cohort, the UK National Blood Service, the popgen biobank, the KORA and MONICA Augsburg studies, the Accelerated Cure Project, the Brigham & Women's Hospital PhenoGenetic Project, the Swedish CAD project, the Norwegian Bone Marrow Donor Registry, the Children's Hospital of Philadelphia (CHOP), the Swedish Breast Cancer study, BRC-REFGENSEP (Pitie-Salpetriere Centre d'Investigation Clinique (CIC) and Genethon) and HYPERGENES (HEALTH-F4-2007-201550).; Projects received support from the German Ministry of Education and Research, the Helmholtz Zentrum Munchen-National Research Center, the German National Genome Research Network (NGFN), the LMUinnovativ, the Knut and Alice Wallenberg Foundation, the Cener for Applied Genomics from the Children's Hospital of Philadelphia Development Award, the Agency for Science & Technology and Research of Singapore, and the Susan G. Komen Breast Cancer Foundation. We thank S. Bertrand, J. Bryant, S. L. Clark, L. Collimedaglia, G. Coniglio, J. S. Conquer, B. Colombo, T. Dibling, G. Eckstein, J. C. Eldred, G. Fischer, S. Gamble, P. Gregersen, R. Guerrero, C. Hind, P. Lichtner, L. Moiola, H. Mousavi, R. Naismith, R. J. Parks, R. Pearson, V. Pilato, M. Radaelli, E. Scarpini, C. R. Stribling, T. Strom, S. Taylor, D. Vukcevic and A. Wilk for their help and support. Detailed acknowledgements are available in Supplementary Information. This manuscript is dedicated to the memory of L. Peltonen, a member of both the IMSGC and the WTCCC2, in recognition of her contributions to, and her leadership in, human genetics.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Barcellos LF, 2006, HUM MOL GENET, V15, P2813, DOI 10.1093/hmg/ddl223; Bielekova B, 2009, ARCH NEUROL-CHICAGO, V66, P483, DOI 10.1001/archneurol.2009.50; Brynedal B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000664; Bush WS, 2010, AM J HUM GENET, V86, P621, DOI 10.1016/j.ajhg.2010.02.027; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dyment DA, 2006, J NEUROL NEUROSUR PS, V77, P258, DOI 10.1136/jnnp.2005.063008; Dyment DA, 2005, HUM MOL GENET, V14, P2019, DOI 10.1093/hmg/ddi206; Field J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013454; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hemminki K, 2009, NEUROGENETICS, V10, P5, DOI 10.1007/s10048-008-0156-y; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Masterman T, 2000, ANN NEUROL, V48, P211, DOI 10.1002/1531-8249(200008)48:2<211::AID-ANA11>3.3.CO;2-I; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Pierrot-Deseilligny C, 2010, BRAIN, V133, P1869, DOI 10.1093/brain/awq147; Sanna S, 2010, NAT GENET, V42, P495, DOI 10.1038/ng.584; Sawcer S, 2005, AM J HUM GENET, V77, P454; Spencer CCA, 2011, HUM MOL GENET, V20, P345, DOI 10.1093/hmg/ddq469; Steinman L, 2009, NAT REV IMMUNOL, V9, P440, DOI 10.1038/nri2548; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Su Z, 2009, STAT SCI, V24, P430, DOI 10.1214/09-STS311	26	1906	1940	10	459	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 11	2011	476	7359					214	219		10.1038/nature10251	http://dx.doi.org/10.1038/nature10251			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21833088	Green Accepted, Green Submitted			2022-12-01	WOS:000293731900038
J	Salmena, L; Poliseno, L; Tay, Y; Kats, L; Pandolfi, PP				Salmena, Leonardo; Poliseno, Laura; Tay, Yvonne; Kats, Lev; Pandolfi, Pier Paolo			A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?	CELL			English	Article							NONCODING RNAS; UNTRANSLATED REGION; MICRORNA SPONGES; DOWN-REGULATION; MESSENGER-RNAS; GENE; EXPRESSION; GENOME; PSEUDOGENES; REVEALS	Here, we present a unifying hypothesis about how messenger RNAs, transcribed pseudogenes, and long noncoding RNAs "talk" to each other using microRNA response elements (MREs) as letters of a new language. We propose that this "competing endogenous RNA" (ceRNA) activity forms a large-scale regulatory network across the transcriptome, greatly expanding the functional genetic information in the human genome and playing important roles in pathological conditions, such as cancer.	[Salmena, Leonardo; Poliseno, Laura; Tay, Yvonne; Kats, Lev; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr,Dept Med, Canc Genet Program,Beth Israel Deaconess Canc Ctr, Boston, MA 02215 USA; [Salmena, Leonardo; Poliseno, Laura; Tay, Yvonne; Kats, Lev; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr,Dept Pathol, Canc Genet Program,Beth Israel Deaconess Canc Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Pandolfi, PP (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr,Dept Med, Canc Genet Program,Beth Israel Deaconess Canc Ctr, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu	Kats, Lev/AAW-3252-2021; Poliseno, Laura/B-5711-2012	Kats, Lev/0000-0001-8742-8138; Pandolfi, Pier Paolo/0000-0002-5352-5295; Poliseno, Laura/0000-0001-6557-955X; Salmena, Leonardo/0000-0003-4023-658X	Canadian Institutes of Health Research; Human Frontier Science Program; Istituto Toscano Tumori; American Italian Cancer Foundation; Leukemia & Lymphoma Society; NHMRC; NIH [R01 CA-82328-09]; NATIONAL CANCER INSTITUTE [R01CA082328] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Human Frontier Science Program(Human Frontier Science Program); Istituto Toscano Tumori; American Italian Cancer Foundation; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all Pandolfi lab members for critical discussions. L. S. was supported by fellowships from the Canadian Institutes of Health Research and the Human Frontier Science Program. L. P. was supported by fellowships from the Istituto Toscano Tumori and the American Italian Cancer Foundation. Y.T. is supported by a Special Fellow Award from The Leukemia & Lymphoma Society. L. K. is supported by a NHMRC Overseas Biomedical Postdoctoral Fellowship. This work was supported by NIH grant R01 CA-82328-09 awarded to P. P. P.	Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Balasubramanian S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r2; Baltimore D, 2001, NATURE, V409, P814, DOI 10.1038/35057267; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brown BD, 2007, BLOOD, V110, P4144, DOI 10.1182/blood-2007-03-078493; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Costa FF, 2008, GENE, V410, P9, DOI 10.1016/j.gene.2007.12.008; D'Errico Ilenia, 2004, Briefings in Functional Genomics & Proteomics, V3, P157, DOI 10.1093/bfgp/3.2.157; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/nmeth.1277, 10.1038/NMETH.1277]; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Jeyapalan Z, 2011, NUCLEIC ACIDS RES, V39, P3026, DOI 10.1093/nar/gkq1003; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Lee DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013599; Lee DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004527; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mercer TR, 2011, NUCLEIC ACIDS RES, V39, P2393, DOI 10.1093/nar/gkq1158; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Panzitt K, 2007, GASTROENTEROLOGY, V132, P330, DOI 10.1053/j.gastro.2006.08.026; Pink RC, 2011, RNA, V17, P792, DOI 10.1261/rna.2658311; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; RASTINEJAD F, 1993, CELL, V72, P903, DOI 10.1016/0092-8674(93)90579-F; RASTINEJAD F, 1993, CELL, V75, P1107, DOI 10.1016/0092-8674(93)90320-P; Scaglioni PP, 2007, CURR TOP MICROBIOL, V313, P85; Seitz H, 2009, CURR BIOL, V19, P870, DOI 10.1016/j.cub.2009.03.059; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Venables JP, 2009, NAT STRUCT MOL BIOL, V16, P670, DOI 10.1038/nsmb.1608; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285	50	4528	4772	30	370	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 5	2011	146	3					353	358		10.1016/j.cell.2011.07.014	http://dx.doi.org/10.1016/j.cell.2011.07.014			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	803GT	21802130	Bronze, Green Accepted			2022-12-01	WOS:000293570500010
J	Weiler, R; Ingram, M; Wolman, R				Weiler, Richard; Ingram, Michael; Wolman, Roger			10-MINUTE CONSULTATION Osgood-Schlatter disease	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Weiler, Richard] Homerton Univ Hosp NHS Fdn Trust, London E9 6SR, England; [Ingram, Michael] Red House Grp, Radlett, Herts, England; [Wolman, Roger] Royal Natl Orthopaed Hosp, Stanmore HA7 4LP, Middx, England	University of London; University College London; Royal National Orthopaedic Hospital NHS Trust	Weiler, R (corresponding author), Homerton Univ Hosp NHS Fdn Trust, London E9 6SR, England.	rweiler@doctors.org.uk						Australian Acute Musculoskeletal Pain Guidelines Group, 2004, EV BAS MAN AC MUSC P; de Lucena GL, 2011, AM J SPORT MED, V39, P415, DOI 10.1177/0363546510383835; Gholve PA, 2007, CURR OPIN PEDIATR, V19, P44, DOI 10.1097/MOP.0b013e328013dbea; KUJALA UM, 1985, AM J SPORT MED, V13, P236, DOI 10.1177/036354658501300404; Pihlajamaki HK, 2010, J BONE JOINT SURG AM, V92A, P258, DOI 10.2106/JBJS.J.00450	5	8	9	0	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 1	2011	343								d4534	10.1136/bmj.d4534	http://dx.doi.org/10.1136/bmj.d4534			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805NK	21807772				2022-12-01	WOS:000293734400001
J	Barton, P; Andronis, L; Briggs, A; McPherson, K; Capewell, S				Barton, Pelham; Andronis, Lazaros; Briggs, Andrew; McPherson, Klim; Capewell, Simon			Effectiveness and cost effectiveness of cardiovascular disease prevention in whole populations: modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS; HEALTH; MORTALITY; CHOLESTEROL; REDUCTION; PROFILE; DECLINE; WALES; SALT	Objective To estimate the potential cost effectiveness of a population-wide risk factor reduction programme aimed at preventing cardiovascular disease. Design Economic modelling analysis. Setting England and Wales. Population Entire population. Model Spreadsheet model to quantify the reduction in cardiovascular disease over a decade, assuming the benefits apply consistently for men and women across age and risk groups. Main outcome measures Cardiovascular events avoided, quality adjusted life years gained, and savings in healthcare costs for a given effectiveness; estimates of how much it would be worth spending to achieve a specific outcome. Results A programme across the entire population of England and Wales (about 50 million people) that reduced cardiovascular events by just 1% would result in savings to the health service worth at least 30m pound ((sic)34m; $48m) a year compared with no additional intervention. Reducing mean cholesterol concentrations or blood pressure levels in the population by 5% (as already achieved by similar interventions in some other countries) would result in annual savings worth at least 80m pound to 100m pound. Legislation or other measures to reduce dietary salt intake by 3 g/day (current mean intake approximately 8.5 g/day) would prevent approximately 30 000 cardiovascular events, with savings worth at least 40m pound a year. Legislation to reduce intake of industrial trans fatty acid by approximately 0.5% of total energy content might gain around 570 000 life years and generate NHS savings worth at least 230m pound a year. Conclusions Any intervention that achieved even a modest population-wide reduction in any major cardiovascular risk factor would produce a net cost saving to the NHS, as well as improving health. Given the conservative assumptions used in this model, the true benefits would probably be greater.	[Barton, Pelham; Andronis, Lazaros] Univ Birmingham, Hlth Econ Unit, Birmingham B15 2TT, W Midlands, England; [Briggs, Andrew] Univ Glasgow, Glasgow, Lanark, Scotland; [Capewell, Simon] Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England	University of Birmingham; University of Glasgow; University of Liverpool	Barton, P (corresponding author), Univ Birmingham, Hlth Econ Unit, Publ Hlth Bldg, Birmingham B15 2TT, W Midlands, England.	p.m.barton@bham.ac.uk	Briggs, Andrew/ABA-9009-2020	Briggs, Andrew/0000-0002-0777-1997	NICE; West Midlands Health Technology Assessment Collaboration (WMHTAC); Peninsula Technology Appraisal Group (PenTAG); Medical Research Council [G0900847] Funding Source: researchfish; MRC [G0900847] Funding Source: UKRI	NICE; West Midlands Health Technology Assessment Collaboration (WMHTAC); Peninsula Technology Appraisal Group (PenTAG); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	PB and LA were funded by NICE. KMcP, AB, and SC were all members of the NICE Programme Development Group on cardiovascular disease prevention in populations. However, the conclusions do not necessarily reflect official NICE views. West Midlands Health Technology Assessment Collaboration (WMHTAC) and Peninsula Technology Appraisal Group (PenTAG) were funded to provide support to the NICE Centre for Public Health Excellence (CPHE).	Abelson P., 2001, RETURNS INVESTMENT P; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; [Anonymous], PREV HLTH AM INV DIS; Aspelund T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013957; Barton P, 2009, PREVENTION CARDIOVAS; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Bjorck L, 2009, EUR HEART J, V30, P1046, DOI 10.1093/eurheartj/ehn554; British Heart Foundation, 2011, HEART STAT; Capewell S, 2008, MODELLING UK BURDEN; Capewell S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000320; Capewell S, 2010, B WORLD HEALTH ORGAN, V88, P120, DOI 10.2471/BLT.08.057885; Catford J, 2009, HEALTH PROMOT INT, V24, P1, DOI 10.1093/heapro/dap003; Collins GS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2442; Curtis L., 2010, UNIT COSTS HLTH SOCI; Daviglus ML, 1998, NEW ENGL J MED, V339, P1122, DOI 10.1056/NEJM199810153391606; Department of Health, 2008, PUTT PREV 1 VASC CHE; Food Standards Agency, 2007, LOW INC DIET NUTR SU; Food Standards Agency, 2008, DIET SOD LEV SURV; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; Institute of Medicine, 2010, PROM CARD HLTH DEV W; KRISTIANSEN IS, 1991, BRIT MED J, V302, P1119, DOI 10.1136/bmj.302.6785.1119; Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274; Luengo-Fernandez R, 2006, HEART, V92, P1384, DOI 10.1136/hrt.2005.072173; Mozaffarian D, 2009, EUR J CLIN NUTR, V63, pS5, DOI 10.1038/sj.ejcn.1602973; Mozaffarian D, 2010, BRIT MED J, V340, pc1826; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; National Institute for Health and Clinical Excellence, 2010, PREV CARD DIS POP LE; Office for National Statistics, 2010, POP EST UK ENGL WAL; Smith-Spangler CM, 2010, ANN INTERN MED, V4819, P152; Stender S, 2006, ATHEROSCLEROSIS SUPP, V7, P47, DOI 10.1016/j.atherosclerosissup.2006.04.011; Strategy Unit, 2008, FOOD MATT STRAT 21 C; Tudor-Smith C, 1998, BRIT MED J, V316, P818, DOI 10.1136/bmj.316.7134.818; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Veerman L., 2010, ASSESSING COST EFFEC; Wanless D., 2004, SECURING GOOD HLTH W; Ward S, 2011, STATINS PREVENTION C; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	40	133	135	1	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 28	2011	343								d4044	10.1136/bmj.d4044	http://dx.doi.org/10.1136/bmj.d4044			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801LT	21798967	hybrid, Green Accepted, Green Published, Green Submitted			2022-12-01	WOS:000293441100002
J	Tugwell, P; Singh, JA; Wells, GA				Tugwell, Peter; Singh, Jasvinder A.; Wells, George A.			THERAPEUTICS Biologicals for rheumatoid arthritis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MODIFYING ANTIRHEUMATIC DRUGS; EULAR RECOMMENDATIONS; DISEASE; SAFETY; MANAGEMENT; INFLIXIMAB; AGENTS	This is one of a series of occasional articles on therapeutics for common or serious conditions, covering new drugs and old drugs with important new indications or concerns. The series advisers are Robin Ferner, honorary professor of clinical pharmacology, University of Birmingham and Birmingham City Hospital, and Philip Routledge, professor of clinical pharmacology, Cardiff University. To suggest a topic for this series, please email us at practice@bmj.com.	[Tugwell, Peter] Univ Ottawa, Dept Med, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada; [Tugwell, Peter] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON K1N 6N5, Canada; [Singh, Jasvinder A.] Birmingham VA Med Ctr, Dept Med, Birmingham, AL 35294 USA; [Singh, Jasvinder A.] Univ Alabama Birmingham, Birmingham, AL 35294 USA; [Wells, George A.] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Wells, George A.] Univ Ottawa, Inst Heart, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Birmingham; University of Ottawa; University of Ottawa; University of Ottawa Heart Institute	Tugwell, P (corresponding author), Univ Ottawa, Dept Med, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada.	tugwell.bb@uottawa.ca	Singh, Jasvinder/R-6172-2019; Tugwell, Peter/AFD-8076-2022	Singh, Jasvinder/0000-0003-3485-0006; Tugwell, Peter/0000-0001-5062-0556	Canadian Institutes of Health Research (CIHR); Takeda; Savient; Wyeth; Amgen; URL Pharma; Novartis; Bristol-Myers Squibb	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Takeda(Takeda Pharmaceutical Company Ltd); Savient; Wyeth(Wyeth); Amgen(Amgen); URL Pharma; Novartis(Novartis); Bristol-Myers Squibb(Bristol-Myers Squibb)	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work. PT received honorariums for quality of life consultancy with Bristol-Myers Squibb; chairs data safety monitoring boards for Chelsea Therapeutics and UCB, mandated for the Food and Drug Administration; is a member of the executive of OMERACT, an organisation that develops outcome measures in rheumatology and receives "arms length" funding from 36 companies; co-chaired an industry board of six companies (Abbott, Bristol-Myers Squibb, Merck, Roche, Schering Plough, UCB) for a biologicals registry of the Ontario Rheumatology Association, the Ontario Biologics Research Initiative (an arms-length registry that independently collects information, supported by a grant from the Canadian Institutes of Health Research (CIHR) matched by funding from these drug companies); and receives an honorarium from the CIHR grant. JAS has received speaker honorariums from Abbott, research and travel grants from Takeda, Savient, Wyeth, and Amgen, and consultant fees from URL Pharma, Takeda, Savient, and Novartis; he is a member of the executive of OMERACT. GAW received honorariums for consultancy with Novartis, Bristol-Myers Squibb, and Abbott; a grant from Bristol-Myers Squibb; and speaker honorariums from Abbott; he is a member of the executive of OMERACT and of the Scientific Committee for the Ontario Biologics Research Initiative.	Bucher C, 2005, GUT, V54, P732; Clinicaltrials.gov, RHEUM ARTHR COMP ACT; Delabaye I, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3058; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Fransen J, 2005, CLIN EXP RHEUMATOL, V23, pS93; Gaujoux-Viala C, 2010, ANN RHEUM DIS, V69, P1004, DOI 10.1136/ard.2009.127225; Gea-Banacloche JC, 2010, SEMIN HEMATOL, V47, P187, DOI 10.1053/j.seminhematol.2010.01.002; Graudal N, 2010, ARTHRITIS RHEUM-US, V62, P2852, DOI 10.1002/art.27592; Katchamart W, 2010, COCHRANE DB SYST REV, V4; Kievit W, 2011, RHEUMATOLOGY, V50, P196, DOI 10.1093/rheumatology/keq325; Maxwell L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007277.pub2; Mertens M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005121.pub3; National Institute for Health and Clinical Excellence, 2010, RHEUM ARTHR; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; Schoels M, 2010, ANN RHEUM DIS, V69, P995, DOI 10.1136/ard.2009.126714; Simon LS, 2009, J RHEUMATOL, V36, P2110, DOI 10.3899/jrheum.090590; Singh JA, 2010, COCHRANE DB SYST REV, V10; Singh JA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007848.pub2; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Smolen JS, 2010, ANN RHEUM DIS, V69, P1058, DOI 10.1136/ard.2009.114652; Solomon DH, 2006, ARTHRITIS RHEUM-US, V54, P3790, DOI 10.1002/art.22255; van der Velde G, 2011, ARTHRIT CARE RES, V63, P65, DOI 10.1002/acr.20338; Vandenbroucke JP, 2004, BRIT MED J, V329, P2, DOI 10.1136/bmj.329.7456.2	23	14	14	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 28	2011	343								d4027	10.1136/bmj.d4027	http://dx.doi.org/10.1136/bmj.d4027			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801LT	21798970				2022-12-01	WOS:000293441100001
J	Watts, G				Watts, Geoff			REGENERATIVE MEDICINE Will medicine ever be able to halt the process of ageing?	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						*A4M, WHAT IS ANT MED; *AM AC ANT MED, GLOB ANT PROD MARK R; de Grey A., 2007, ENDING AGEING REJUVE; Hayflick L, 2004, J GERONTOL A-BIOL, V59, P573, DOI 10.1093/gerona/59.6.B573; *SENS FDN, RES THEM	5	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 25	2011	343								d4119	10.1136/bmj.d4119	http://dx.doi.org/10.1136/bmj.d4119			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	801LM	21788257				2022-12-01	WOS:000293440400001
J	Amlacher, S; Sarges, P; Flemming, D; van Noort, V; Kunze, R; Devos, DP; Arumugam, M; Bork, P; Hurt, E				Amlacher, Stefan; Sarges, Phillip; Flemming, Dirk; van Noort, Vera; Kunze, Ruth; Devos, Damien P.; Arumugam, Manimozhiyan; Bork, Peer; Hurt, Ed			Insight into Structure and Assembly of the Nuclear Pore Complex by Utilizing the Genome of a Eukaryotic Thermophile	CELL			English	Article							OPEN READING FRAMES; MOLECULAR ARCHITECTURE; ELECTRON-MICROSCOPY; BASE COMPOSITION; NEW-GENERATION; YEAST; NUCLEOPORINS; MEMBRANE; EXPORT; TEMPERATURE	Despite decades of research, the structure and assembly of the nuclear pore complex (NPC), which is composed of similar to 30 nucleoporins (Nups), remain elusive. Here, we report the genome of the thermophilic fungus Chaetomium thermophilum (ct) and identify the complete repertoire of Nups therein. The thermophilic proteins show improved properties for structural and biochemical studies compared to their mesophilic counterparts, and purified ctNups enabled the reconstitution of the inner pore ring module that spans the width of the NPC from the anchoring membrane to the central transport channel. This module is composed of two large Nups, Nup192 and Nup170, which are flexibly bridged by short linear motifs made up of linker Nups, Nic96 and Nup53. This assembly illustrates how Nup interactions can generate structural plasticity within the NPC scaffold. Our findings therefore demonstrate the utility of the genome of a thermophilic eukaryote for studying complex molecular machines.	[van Noort, Vera; Devos, Damien P.; Arumugam, Manimozhiyan; Bork, Peer] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Amlacher, Stefan; Sarges, Phillip; Flemming, Dirk; Kunze, Ruth; Hurt, Ed] Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg	Bork, P (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	bork@embl.de; ed.hurt@bzh.uni-heidelberg.de	Arumugam, Manimozhiyan/E-1211-2011; Ed Hurt, Dr./AAE-8874-2019; devos, damien/ABH-5348-2020; van Noort, Vera/E-1053-2011; Bork, Peer/F-1813-2013; Flemming, Dirk/AAP-3274-2021; Arumugam, Manimozhiyan/AAJ-2394-2020; van Noort, Vera/GWZ-9038-2022	Arumugam, Manimozhiyan/0000-0002-0886-9101; Ed Hurt, Dr./0000-0002-4535-8255; van Noort, Vera/0000-0002-8436-6602; Bork, Peer/0000-0002-2627-833X; Arumugam, Manimozhiyan/0000-0002-0886-9101; Devos, Damien/0000-0002-9453-4753	Deutsche Forschungsgemeinschaft [SFB 638/B2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Eurofins MWG Operon, in particular Dr. Georg Gradl, for a very competent cooperation in the DNA sequencing project. We thank Christian von Mering for help using the eggNOG pipeline and Sheila Lutz for initial help in setting up blast searches using the C. thermophilum genomic sequence. We thank Andrea Hellwig (Prof. Hilmar Bading, Department of Neurobiology, University of Heidelberg) for performing thin-section electron microscopy. E.H. is recipient of grants from the Deutsche Forschungsgemeinschaft (SFB 638/B2).	Al-Samarrai TH, 2000, LETT APPL MICROBIOL, V30, P53, DOI 10.1046/j.1472-765x.2000.00664.x; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Belgareh N, 1998, MOL BIOL CELL, V9, P3475, DOI 10.1091/mbc.9.12.3475; Boussau B, 2008, NATURE, V456, P942, DOI 10.1038/nature07393; Brohawn SG, 2008, SCIENCE, V322, P1369, DOI 10.1126/science.1165886; Brohawn SG, 2009, NAT STRUCT MOL BIOL, V16, P1173, DOI 10.1038/nsmb.1713; Cook AG, 2009, NATURE, V461, P60, DOI 10.1038/nature08394; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009; De Souza CPC, 2004, CURR BIOL, V14, P1973, DOI 10.1016/j.cub.2004.10.050; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Dilworth DJ, 2001, J CELL BIOL, V153, P1465, DOI 10.1083/jcb.153.7.1465; Dong XH, 2009, NAT STRUCT MOL BIOL, V16, P558, DOI 10.1038/nsmb.1586; Doye V, 1997, CURR OPIN CELL BIOL, V9, P401, DOI 10.1016/S0955-0674(97)80014-2; Fahrenkrog B, 2000, MOL BIOL CELL, V11, P3885, DOI 10.1091/mbc.11.11.3885; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Flemming D, 2010, NAT STRUCT MOL BIOL, V17, P775, DOI 10.1038/nsmb.1811; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; GRANDI P, 1993, EMBO J, V12, P3061, DOI 10.1002/j.1460-2075.1993.tb05975.x; Hakulinen N, 2003, EUR J BIOCHEM, V270, P1399, DOI 10.1046/j.1432-1033.2003.03496.x; Handa N, 2006, J MOL BIOL, V363, P114, DOI 10.1016/j.jmb.2006.07.089; Hawryluk-Gara LA, 2005, MOL BIOL CELL, V16, P2382, DOI 10.1091/mbc.E04-10-0857; Hickey DA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-117; Hsia KC, 2007, CELL, V131, P1313, DOI 10.1016/j.cell.2007.11.038; Hurwitz ME, 1998, P NATL ACAD SCI USA, V95, P11241, DOI 10.1073/pnas.95.19.11241; James P, 1996, GENETICS, V144, P1425; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kosova B, 1999, J BIOL CHEM, V274, P22646, DOI 10.1074/jbc.274.32.22646; Lambros RJ, 2003, EXTREMOPHILES, V7, P443, DOI 10.1007/s00792-003-0353-4; LATOUCHE CJ, 1948, NATURE, V161, P320; Leksa NC, 2009, STRUCTURE, V17, P1082, DOI 10.1016/j.str.2009.06.003; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Lin FH, 2007, EXTREMOPHILES, V11, P9, DOI 10.1007/s00792-006-0005-6; Lu DV, 2009, BIOINFORMATICS, V25, P1587, DOI 10.1093/bioinformatics/btp273; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lutzmann M, 2005, J BIOL CHEM, V280, P18442, DOI 10.1074/jbc.M412787200; Makio T, 2009, J CELL BIOL, V185, P459, DOI 10.1083/jcb.200810029; Marelli M, 1998, J CELL BIOL, V143, P1813, DOI 10.1083/jcb.143.7.1813; Marelli M, 2001, J CELL BIOL, V153, P709, DOI 10.1083/jcb.153.4.709; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MARMUR J, 1962, J MOL BIOL, V5, P109, DOI 10.1016/S0022-2836(62)80066-7; Melo F, 2002, PROTEIN SCI, V11, P430, DOI 10.1002/pro.110430; Miller BR, 2000, MOL BIOL CELL, V11, P3381, DOI 10.1091/mbc.11.10.3381; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Nagy V, 2009, P NATL ACAD SCI USA, V106, P17693, DOI 10.1073/pnas.0909373106; Nehrbass U, 1996, J CELL BIOL, V133, P1153, DOI 10.1083/jcb.133.6.1153; Onischenko E, 2009, J CELL BIOL, V185, P475, DOI 10.1083/jcb.200810030; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roca MG, 2010, EUKARYOT CELL, V9, P1171, DOI 10.1128/EC.00329-09; Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; RUTHERFORD K, 2000, ARTEMIS SEQUENCE VIS, V16, P944; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schrader N, 2008, MOL CELL, V29, P46, DOI 10.1016/j.molcel.2007.10.022; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Stelter P, 2007, NAT CELL BIOL, V9, P788, DOI 10.1038/ncb1604; Tcheperegine SE, 1999, J BIOL CHEM, V274, P5252, DOI 10.1074/jbc.274.8.5252; Theerthagiri G, 2010, J CELL BIOL, V189, P1129, DOI 10.1083/jcb.200912045; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Zeldovich KB, 2007, PLOS COMPUT BIOL, V3, P62, DOI 10.1371/journal.pcbi.0030005	71	192	267	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 22	2011	146	2					277	289		10.1016/j.cell.2011.06.039	http://dx.doi.org/10.1016/j.cell.2011.06.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	795XS	21784248	Bronze			2022-12-01	WOS:000293013000010
J	Darnell, JC; Van Driesche, SJ; Zhang, CL; Hung, KYS; Mele, A; Fraser, CE; Stone, EF; Chen, C; Fak, JJ; Chi, SW; Licatalosi, DD; Richter, JD; Darnell, RB				Darnell, Jennifer C.; Van Driesche, Sarah J.; Zhang, Chaolin; Hung, Ka Ying Sharon; Mele, Aldo; Fraser, Claire E.; Stone, Elizabeth F.; Chen, Cynthia; Fak, John J.; Chi, Sung Wook; Licatalosi, Donny D.; Richter, Joel D.; Darnell, Robert B.			FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism	CELL			English	Article							X MENTAL-RETARDATION; LOCAL PROTEIN-SYNTHESIS; DEPENDENT TRANSLATION; INHIBITS TRANSLATION; KNOCKOUT MICE; MOUSE MODEL; PLASTICITY; POLYRIBOSOMES; MEMORY; INITIATION	FMRP loss of function causes Fragile X syndrome (FXS) and autistic features. FMRP is a polyribosome-associated neuronal RNA-binding protein, suggesting that it plays a key role in regulating neuronal translation, but there has been little consensus regarding either its RNA targets or mechanism of action. Here, we use high-throughput sequencing of RNAs isolated by crosslinking immunoprecipitation (HITS-CLIP) to identify FMRP interactions with mouse brain polyribosomal mRNAs. FMRP interacts with the coding region of transcripts encoding pre- and postsynaptic proteins and transcripts implicated in autism spectrum disorders (ASD). We developed a brain polyribosome-programmed translation system, revealing that FMRP reversibly stalls ribosomes specifically on its target mRNAs. Our results suggest that loss of a translational brake on the synthesis of a subset of synaptic proteins contributes to FXS. In addition, they provide insight into the molecular basis of the cognitive and allied defects in FXS and ASD and suggest multiple targets for clinical intervention.	[Darnell, Jennifer C.; Van Driesche, Sarah J.; Zhang, Chaolin; Hung, Ka Ying Sharon; Mele, Aldo; Fraser, Claire E.; Stone, Elizabeth F.; Chen, Cynthia; Fak, John J.; Chi, Sung Wook; Licatalosi, Donny D.; Darnell, Robert B.] Rockefeller Univ, Mol Neurooncol Lab, New York, NY 10065 USA; [Darnell, Robert B.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Richter, Joel D.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; University of Massachusetts System; University of Massachusetts Worcester	Darnell, JC (corresponding author), Rockefeller Univ, Mol Neurooncol Lab, New York, NY 10065 USA.	darneje@rockefeller.edu; darnelr@rockefeller.edu	Hung, Ka Ying Sharon/AAI-1685-2021; Darnell, Robert B/B-9022-2008	Hung, Ka Ying Sharon/0000-0002-4084-6030; Darnell, Robert B/0000-0002-5134-8088; Stone, Elizabeth/0000-0002-4148-7957	NIH [HD40647, AG30323, GM46779, HD37267, GM95713, NS34389, NS40955]; NSF [MSTP-GM07749]; Rockefeller University Hospital CTSA [UL1 RR024143]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040647] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037267, R37HD037267] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM095713, K99GM095713, R01GM046779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034389, R01NS040955, R56NS034389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030323] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Rockefeller University Hospital CTSA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Pelletier for providing hippuristanol, E. Khandjian for anti-FXR1P antibody, N. Heintz for the transgenic mice expressing tagged ribosomal protein EGFP-rpL10a, and the members of the Darnell laboratory for advice and suggestions throughout the course of this work. We are grateful to E. Sphicas and K. Uryu for help with electron microscopy, and Xuning Wang and Scott Dewell for help with bioinformatics and high-throughput sequencing. This work was supported by the NIH (HD40647 to J.C.D., AG30323, GM46779, and HD37267 to J.D.R., GM95713 to C.Z., and NS34389 and NS40955 to R.B.D.), an NSF grant to S.J.V., MSTP-GM07749 to C.E.F., and the Rockefeller University Hospital CTSA Grant UL1 RR024143. R.B.D. is an Investigator of the Howard Hughes Medical Institute.	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Abul-Husn NS, 2009, PROTEOMICS, V9, P3303, DOI 10.1002/pmic.200800767; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Beaulieu MA, 2000, BIOCHEM BIOPH RES CO, V275, P608, DOI 10.1006/bbrc.2000.3313; Braat AK, 2004, DEV CELL, V7, P125, DOI 10.1016/j.devcel.2004.06.009; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Christie SB, 2009, J NEUROSCI, V29, P1514, DOI 10.1523/JNEUROSCI.3937-08.2009; Clark IE, 2000, CURR BIOL, V10, P1311, DOI 10.1016/S0960-9822(00)00754-5; Conrad B, 2007, ANNU REV GENOM HUM G, V8, P17, DOI 10.1146/annurev.genom.8.021307.110233; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Croning MDR, 2009, NUCLEIC ACIDS RES, V37, pD846, DOI 10.1093/nar/gkn700; Darnell JC, 2005, GENES BRAIN BEHAV, V4, P341, DOI 10.1111/j.1601-183X.2005.00144.x; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Darnell JC, 2009, HUM MOL GENET, V18, P3164, DOI 10.1093/hmg/ddp255; Darnell RB, 2010, WIRES RNA, V1, P266, DOI 10.1002/wrna.31; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; Feng Y, 1997, J NEUROSCI, V17, P1539; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Gatto CL, 2009, MOL NEUROBIOL, V39, P107, DOI 10.1007/s12035-009-8057-0; Hagerman R.J., 2002, FRAGILE X SYNDROME D; Harlow EG, 2010, NEURON, V65, P385, DOI 10.1016/j.neuron.2010.01.024; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hernandez RN, 2009, AM J MED GENET A, V149A, P1125, DOI 10.1002/ajmg.a.32848; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Khandjian EW, 2004, P NATL ACAD SCI USA, V101, P13357, DOI 10.1073/pnas.0405398101; Khandjian EW, 1996, NAT GENET, V12, P91, DOI 10.1038/ng0196-91; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pfeiffer BE, 2009, NEUROSCIENTIST, V15, P549, DOI 10.1177/1073858409333075; Pilpel Y, 2009, J PHYSIOL-LONDON, V587, P787, DOI 10.1113/jphysiol.2008.160929; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Price TJ, 2007, J NEUROSCI, V27, P13958, DOI 10.1523/JNEUROSCI.4383-07.2007; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; Siomi MC, 1996, MOL CELL BIOL, V16, P3825; Stefani G, 2004, J NEUROSCI, V24, P7272, DOI 10.1523/JNEUROSCI.2306-04.2004; Sutton MA, 2007, NEURON, V55, P648, DOI 10.1016/j.neuron.2007.07.030; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Symons FJ, 2003, AM J MED GENET A, V118A, P115, DOI 10.1002/ajmg.a.10078; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zang JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000758; Zukin RS, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.014.2009	72	1330	1355	0	140	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 22	2011	146	2					247	261		10.1016/j.cell.2011.06.013	http://dx.doi.org/10.1016/j.cell.2011.06.013			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	795XS	21784246	Green Accepted, Bronze			2022-12-01	WOS:000293013000008
J	Hechinger, RF; Lafferty, KD; Dobson, AP; Brown, JH; Kuris, AM				Hechinger, Ryan F.; Lafferty, Kevin D.; Dobson, Andy P.; Brown, James H.; Kuris, Armand M.			A Common Scaling Rule for Abundance, Energetics, and Production of Parasitic and Free-Living Species	SCIENCE			English	Article							POPULATION ENERGY-USE; BODY-SIZE; FOOD WEBS; EQUIVALENCE RULE; METABOLIC-RATE; DENSITY; MASS; ECOLOGY; TEMPERATURE; COMMUNITIES	The metabolic theory of ecology uses the scaling of metabolism with body size and temperature to explain the causes and consequences of species abundance. However, the theory and its empirical tests have never simultaneously examined parasites alongside free-living species. This is unfortunate because parasites represent at least half of species diversity. We show that metabolic scaling theory could not account for the abundance of parasitic or free-living species in three estuarine food webs until accounting for trophic dynamics. Analyses then revealed that the abundance of all species uniformly scaled with body mass to the -3/4 power. This result indicates "production equivalence," where biomass production within trophic levels is invariant of body size across all species and functional groups: invertebrate or vertebrate, ectothermic or endothermic, and free-living or parasitic.	[Hechinger, Ryan F.; Lafferty, Kevin D.] Univ Calif Santa Barbara, Inst Marine Sci, US Geol Survey, Western Ecol Res Ctr, Santa Barbara, CA 93106 USA; [Hechinger, Ryan F.; Lafferty, Kevin D.; Kuris, Armand M.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Dobson, Andy P.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Dobson, Andy P.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Brown, James H.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	United States Department of the Interior; United States Geological Survey; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Princeton University; The Santa Fe Institute; University of New Mexico	Hechinger, RF (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, US Geol Survey, Western Ecol Res Ctr, Santa Barbara, CA 93106 USA.	hechinger@lifesci.ucsb.edu	Lafferty, Kevin D./B-3888-2009	Hechinger, Ryan/0000-0002-6633-253X	NSF/NIH [DEB-0224565]; CA Sea Grant [R/OPCENV-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018754] Funding Source: NIH RePORTER	NSF/NIH(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CA Sea Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank S. Sokolow, J. McLaughlin, J. Childress, and J. Damuth for discussion or comments on the manuscript. Supported by NSF/NIH EID grant DEB-0224565 and by CA Sea Grant R/OPCENV-01. The analyses in this manuscript used data published in Hechinger et al. (25), available at Ecological Archives (accession no. E092-066).	Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; Arneberg P, 1998, AM NAT, V151, P497, DOI 10.1086/286136; BAIRD D, 1991, PHILOS T R SOC B, V333, P15, DOI 10.1098/rstb.1991.0058; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brown JH, 2003, P NATL ACAD SCI USA, V100, P1467, DOI 10.1073/pnas.0630310100; CALOW P, 1983, PARASITOLOGY, V86, P197, DOI 10.1017/S0031182000050897; Cohen JE, 2003, P NATL ACAD SCI USA, V100, P1781, DOI 10.1073/pnas.232715699; Cyr H, 1997, OIKOS, V79, P333, DOI 10.2307/3546017; Cyr H, 2000, SFI S SCI C, P267; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; DAMUTH J, 1987, BIOL J LINN SOC, V31, P193, DOI 10.1111/j.1095-8312.1987.tb01990.x; de Meeus T, 2002, TRENDS PARASITOL, V18, P247, DOI 10.1016/S1471-4922(02)02269-9; Dobson A, 2008, P NATL ACAD SCI USA, V105, P11482, DOI 10.1073/pnas.0803232105; Ernest SKM, 2003, ECOL LETT, V6, P990, DOI 10.1046/j.1461-0248.2003.00526.x; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Hechinger R. F., 2011, Ecology, V92, P791, DOI 10.1890/10-1383.1; HEMMINGSEN AXEL M., 1960, REPTS STENO HOSP COPENHAGEN, V9, P7; Jennings S, 2003, ECOL LETT, V6, P971, DOI 10.1046/j.1461-0248.2003.00529.x; KLEIBER MAX, 1932, HILGARDIA, V6, P315; KOZLOVSKY DG, 1968, ECOLOGY, V49, P48, DOI 10.2307/1933560; Kuris AM, 2008, NATURE, V454, P515, DOI 10.1038/nature06970; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; McGill BJ, 2008, AM NAT, V172, P88, DOI 10.1086/588044; Meehan TD, 2006, ECOLOGY, V87, P1650, DOI 10.1890/0012-9658(2006)87[1650:EUAAAI]2.0.CO;2; Morand S, 2002, EVOL ECOL RES, V4, P951; NEE S, 1991, NATURE, V351, P312, DOI 10.1038/351312a0; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Price P.W., 1980, EVOLUTIONARY BIOL PA; Reuman DC, 2008, ECOL LETT, V11, P1216, DOI 10.1111/j.1461-0248.2008.01236.x; Reuman DC, 2009, ADV ECOL RES, V41, P1, DOI 10.1016/S0065-2504(09)00401-2; ROBINSON WR, 1983, CAN J ZOOL, V61, P281, DOI 10.1139/z83-037	31	85	87	0	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2011	333	6041					445	448		10.1126/science.1204337	http://dx.doi.org/10.1126/science.1204337			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21778398	Green Accepted			2022-12-01	WOS:000292959600043
J	Seeley, RJ; Sandoval, DA				Seeley, Randy J.; Sandoval, Darleen A.			NEUROSCIENCE Weight loss through smoking	NATURE			English	Editorial Material									[Seeley, Randy J.; Sandoval, Darleen A.] Univ Cincinnati, Metab Dis Inst, Cincinnati, OH 45237 USA	University System of Ohio; University of Cincinnati	Seeley, RJ (corresponding author), Univ Cincinnati, Metab Dis Inst, Cincinnati, OH 45237 USA.	randy.seeley@uc.edu		Seeley, Randy/0000-0002-3721-5625				Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Greenfield JR, 2009, NEW ENGL J MED, V360, P44, DOI 10.1056/NEJMoa0803085; Huang H, 2011, J NEUROPHYSIOL, V106, P1191, DOI 10.1152/jn.00740.2010; Mineur YS, 2011, SCIENCE, V332, P1330, DOI 10.1126/science.1201889; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106	6	28	30	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					176	177		10.1038/475176a	http://dx.doi.org/10.1038/475176a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21753841				2022-12-01	WOS:000292690500035
J	Hampton, T				Hampton, Tracy			Data Mining Approach Shows Promise in Detecting Unexpected Drug Interactions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	5	5	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2011	306	2					144	144		10.1001/jama.2011.918	http://dx.doi.org/10.1001/jama.2011.918			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791CO	21750287				2022-12-01	WOS:000292639400004
J	Simon, A; Warszawski, J; Kariyawasam, D; Le Chenadec, J; Benhammou, V; Czernichow, P; Foissac, F; Laborde, K; Treluyer, JM; Firtion, G; Layouni, I; Munzer, M; Bavoux, F; Polak, M; Blanche, S				Simon, Albane; Warszawski, Josiane; Kariyawasam, Dulanjalee; Le Chenadec, Jerome; Benhammou, Valerie; Czernichow, Paul; Foissac, Frantz; Laborde, Kathleen; Treluyer, Jean-Marc; Firtion, Ghislaine; Layouni, Incs; Munzer, Martine; Bavoux, Francoise; Polak, Michel; Blanche, Stephane		ANRS French Perinatal Cohort Study	Association of Prenatal and Postnatal Exposure to Lopinavir-Ritonavir and Adrenal Dysfunction Among Uninfected Infants of HIV-Infected Mothers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PARTIAL ALDOSTERONE RESISTANCE; LOPINAVIR/RITONAVIR; PHARMACOKINETICS; INSUFFICIENCY; HYPERPLASIA; BIRTH; AGE; INHIBITORS; PREGNANCY; CHILDREN	Context Lopinavir-ritonavir is a human immunodeficiency virus 1 (HIV-1) protease inhibitor boosted by ritonavir, a cytochrome p450 inhibitor. A warning about its tolerance in premature newborns was recently released, and transient elevation of 17-hydroxyprogesterone (17OHP) was noted in 2 newborns treated with lopinavir-ritonavir in France. Objective To evaluate adrenal function in newborns postnatally treated with lopinavir-ritonavir. Design, Setting, and Participants Retrospective cross-sectional analysis of the database from the national screening for congenital adrenal hyperplasia (CAH) and the French Perinatal Cohort. Comparison of HIV-1-uninfected newborns postnatally treated with lopinavir-ritonavir and controls treated with standard zidovudine. Main Outcome Measures Plasma 17OHP and dehydroepiandrosterone-sulfate (DHEA-S) concentrations during the first week of treatment. Clinical and biological symptoms compatible with adrenal deficiency. Results Of 50 HIV-1-uninfected newborns who received lopinavir-ritonavir at birth for a median of 30 days (interquartile range [IQR], 25-33), 7 (14%) had elevated 17OHP levels greater than 16.5 ng/mL for term infants (>23.1 ng/mL for preterm) on days 1 to 6 vs 0 of 108 controls having elevated levels. The median 17OHP concentration for 42 term newborns treated with lopinavir-ritonavir was 9.9 ng/mL (IQR, 3.9-14.1 ng/mL) vs 3.7 ng/mL (IQR, 2.6-5.3 ng/mL) for 93 term controls (P < .001). The difference observed in median 17OHP values between treated newborns and controls was higher in children also exposed in utero (11.5 ng/mL vs 3.7 ng/mL; P < .001) than not exposed in utero (6.9 ng/mL vs 3.3 ng/mL; P =. 03). The median DHEA-S concentration among 18 term newborns treated with lopinavir-ritonavir was 9242 ng/mL (IQR, 1347-25 986 ng/mL) compared with 484 ng/mL (IQR, 218-1308 ng/mL) among 17 term controls (P < .001). The 17OHP and DHEA-S concentrations were positively correlated (r = 0.53; P =. 001). All term newborns treated with lopinavir-ritonavir were asymptomatic, although 3 premature newborns experienced life-threatening symptoms compatible with adrenal insufficiency, including hyponatremia and hyperkalemia with, in 1 case, cardiogenic shock. All symptoms resolved following completion of the lopinavir-ritonavir treatment. Conclusion Among newborn children of HIV-1-infected mothers exposed in utero to lopinavir-ritonavir, postnatal treatment with a lopinavir-ritonavir-based regimen, compared with a zidovudine-based regimen, was associated with transient adrenal dysfunction.	[Blanche, Stephane] Hop Necker Enfants Malad, AP HP, Unite Immunol Hematol Pediat, F-75015 Paris, France; [Simon, Albane; Kariyawasam, Dulanjalee; Polak, Michel] Assoc Francaise Depistage & Prevent Handicaps Enf, Unite Endocrinol Pediat, Paris, France; [Foissac, Frantz; Treluyer, Jean-Marc] Hop Necker Enfants Malad, AP HP, Paris Ctr, Unite Rech Clin, F-75015 Paris, France; [Laborde, Kathleen] Hop Necker Enfants Malad, AP HP, Lab Explorat Fonct, F-75015 Paris, France; [Polak, Michel] Hop Necker Enfants Malad, AP HP, INSERM, U845, F-75015 Paris, France; [Foissac, Frantz; Treluyer, Jean-Marc; Blanche, Stephane] EA 3620, Paris, France; [Simon, Albane; Kariyawasam, Dulanjalee; Polak, Michel] Univ Paris 05, Paris, France; [Warszawski, Josiane; Le Chenadec, Jerome; Benhammou, Valerie] Equipe VIH & IST, INSERM, CESP U1018, Le Kremlin Bicetre, France; [Warszawski, Josiane] Univ & Fac Med Paris Sud, Le Kremlin Bicetre, France; [Warszawski, Josiane] Hop Bicetre, AP HP, Serv Epidemiol & Sante Publ, Le Kremlin Bicetre, France; [Firtion, Ghislaine] Hop Cochin Port Royal, AP HP, Serv Neonatol, Creteil, France; [Layouni, Incs] Hop Intercommunal Creteil, Serv Neonatol, Creteil, France; [Munzer, Martine] Ctr Hosp Univ Reims, Serv Pediat, Reims, France; [Bavoux, Francoise] Hop Cochin St Vincent Paul, AP HP, Unite Pharmacovigilance Pediat, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; CHU de Reims; Universite de Reims Champagne-Ardenne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Blanche, S (corresponding author), Hop Necker Enfants Malad, AP HP, Unite Immunol Hematol Pediat, 149 Rue Sevres, F-75015 Paris, France.	stephane.blanche@nck.aphp.fr	kariyawasam, dulanjalee/AAH-1867-2021; Foix-L'Hélias, Laurence/AAH-4933-2019; treluyer, Jean-Marc/F-8036-2010; Matheron, Sophie/D-7420-2017	Foix-L'Hélias, Laurence/0000-0002-5699-4839; Matheron, Sophie/0000-0001-7879-6553	Abbott Laboratories; Pfizer; IPSEN; Sandoz-SAS Laboratories	Abbott Laboratories(Abbott Laboratories); Pfizer(Pfizer); IPSEN(Ipsen); Sandoz-SAS Laboratories(Randox Laboratories)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Warszawski reported having obtained a research grant from Abbott Laboratories for another study concerning lopinavir-ritonavir in children. Dr Polak reported having received support for educational presentations and grant support from Pfizer, IPSEN, and Sandoz-SAS Laboratories. Dr Blanche reported having received support for travel to meetings from Abbott Laboratories and honoraria for lectures and for development of educational presentations from Astellas, Boehringer Ingelheim, GlaxoSmithKline, and Tibotec Laboratories. No other disclosures were reported.r This study was supported by the French Agence Nationale de Recherche sur le SIDA (ANRS) and Agence Francaise de Securite Sanitaire et des Produits de Sante (AFSSAPS).	[Anonymous], KAL LOP RIT LAB CHAN; [Anonymous], PRISE CHARGE MED PER; Beal B., 1992, NONMEM USERS GUIDE; Benhammou V, 2008, AIDS, V22, P2165, DOI 10.1097/QAD.0b013e328311d18b; BLANCHE S, 1989, NEW ENGL J MED, V320, P1643, DOI 10.1056/NEJM198906223202502; Bornstein SR, 2009, NEW ENGL J MED, V360, P2328, DOI 10.1056/NEJMra0804635; Cavarzere P, 2009, EUR J ENDOCRINOL, V161, P285, DOI 10.1530/EJE-09-0145; Chadwick EG, 2008, AIDS, V22, P249, DOI 10.1097/QAD.0b013e3282f2be1d; Chadwick EG, 2009, PEDIATR INFECT DIS J, V28, P215, DOI 10.1097/INF.0b013e31818cc053; Chiappini E, 2009, CLIN INFECT DIS, V49, P1618, DOI 10.1086/644774; Coovadia H, 2009, CURR OPIN HIV AIDS, V4, P319, DOI 10.1097/COH.0b013e32832a9a17; Croxtall JD, 2010, DRUGS, V70, P1885, DOI 10.2165/11204950-000000000-00000; DEPERETTI E, 1978, J CLIN ENDOCR METAB, V47, P572, DOI 10.1210/jcem-47-3-572; DHONDT JL, 1986, J INHERIT METAB DIS, V9, P147, DOI 10.1007/BF01800869; Fernandez EF, 2009, J PERINATOL, V29, pS44, DOI 10.1038/jp.2009.24; Foisy MM, 2008, HIV MED, V9, P389, DOI 10.1111/j.1468-1293.2008.00579.x; Forest MG, 2003, DIAGNOSTICS ENDOCRIN, P372; Gingelmaier A, 2006, AIDS, V20, P1737, DOI 10.1097/01.aids.0000242820.67001.2c; Haile-Selassie H, HIV MED, DOI [10.1111/j.1468-1293.2010.00902, DOI 10.1111/J.1468-1293.2010.00902]; Jullien V, 2006, ANTIMICROB AGENTS CH, V50, P3548, DOI 10.1128/AAC.00943-05; Lopriore E, 2007, AIDS, V21, P2564, DOI 10.1097/QAD.0b013e3282f12060; Lyall E G, 2001, HIV Med, V2, P314, DOI 10.1046/j.1464-2662.2001.00082.x; Martinerie L, 2009, PEDIATR RES, V66, P323, DOI 10.1203/PDR.0b013e3181b1bbec; Martinerie L, 2009, ENDOCRINOLOGY, V150, P4414, DOI 10.1210/en.2008-1498; McArthur MA, 2009, PEDIATR INFECT DIS J, V28, P1127, DOI 10.1097/INF.0b013e3181acd17e; Neary N, 2010, CURR OPIN ENDOCRINOL, V17, P217, DOI 10.1097/MED.0b013e328338f608; Nielsen KN, 2011, 18 C RETR OPP INF CR; Ozturk IC, 2000, MOL DIAGN, V5, P47, DOI 10.2165/00066982-200005010-00011; Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, REC US ANT DRUGS PRE; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Urien S, 2011, BRIT J CLIN PHARMACO, V71, P956, DOI 10.1111/j.1365-2125.2011.03926.x; Watterberg Kristi L, 2004, Semin Neonatol, V9, P13, DOI 10.1016/j.siny.2003.08.003; White PC, 2009, NAT REV ENDOCRINOL, V5, P490, DOI 10.1038/nrendo.2009.148; Yeh RF, 2009, ANTIMICROB AGENTS CH, V53, P2367, DOI 10.1128/AAC.01523-08	34	62	62	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2011	306	1					70	78		10.1001/jama.2011.915	http://dx.doi.org/10.1001/jama.2011.915			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	787LV	21730243	Bronze			2022-12-01	WOS:000292378700022
J	Chow, EJ; Mueller, BA; Baker, KS; Cushing-Haugen, KL; Flowers, MED; Martin, PJ; Friedman, DL; Lee, SJ				Chow, Eric J.; Mueller, Beth A.; Baker, K. Scott; Cushing-Haugen, Kara L.; Flowers, Mary E. D.; Martin, Paul J.; Friedman, Debra L.; Lee, Stephanie J.			Cardiovascular Hospitalizations and Mortality Among Recipients of Hematopoietic Stem Cell Transplantation	ANNALS OF INTERNAL MEDICINE			English	Article							LONG-TERM SURVIVORS; BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; ADMINISTRATIVE DATA; EUROPEAN-GROUP; VASCULAR ENDOTHELIUM; METABOLIC SYNDROME; KIDNEY-DISEASE; HEART-FAILURE; UNITED-STATES	Background: Hematopoietic stem cell transplantation (HSCT) is increasingly used to treat multiple malignant and nonmalignant conditions. The risk for cardiovascular disease after the procedure has not been well-described. Objective: To compare rates and hazards of cardiovascular-related hospitalization and death among persons who were still alive at least 2 years after HSCT with those in a population-based sample. Design: Retrospective cohort study. Setting: Comprehensive cancer center. Patients: 1491 patients who had survived 2 years or longer after HSCT received between 1985 and 2006, and frequency-matched persons who were randomly selected from drivers' license files in the state of Washington. Measurements: Cardiovascular hospitalizations and death, as determined from statewide hospital discharge records and death registries in Washington. Results: Compared with the general population, transplant recipients experienced increased cardiovascular death (adjusted incidence rate difference, 3.6 per 1000 person-years [95% CI, 1.7 to 5.5]). Recipients also had an increased cumulative incidence of ischemic heart disease, cardiomyopathy or heart failure, stroke, vascular diseases, and rhythm disorders and an increased incidence of related conditions that predispose toward more serious cardiovascular disease (hypertension, renal disease, dyslipidemia, and diabetes). No consistent differences in hazards were observed after total-body irradiation or receipt of an allogeneic versus an autologous graft, aside from an increased rate of hypertension among recipients of allogeneic grafts. Disease relapse after transplantation was associated with an increased hazard of cardiovascular death (hazard ratio, 2.3 [CI, 1.1 to 4.8]). Limitation: All patients received HSCT at a single institution, and no information was available on pretransplantation treatment and lifestyle factors that may influence risk for cardiovascular disease. Conclusion: Increased rates of cardiovascular disease should be taken into account when caring for patients who have received HSCT. Future efforts should be directed toward improved screening and controlling of factors that predispose toward cardiovascular disease.	[Chow, Eric J.] Seattle Childrens Hosp, Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Washington, Seattle, WA 98195 USA; Vanderbilt Univ, Nashville, TN USA; Vanderbilt Ingram Canc Ctr, Nashville, TN USA	Fred Hutchinson Cancer Center; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Vanderbilt University; Vanderbilt University	Chow, EJ (corresponding author), Seattle Childrens Hosp, Fred Hutchinson Canc Res Ctr, POB 19024,M4-C308, Seattle, WA 98109 USA.	ericchow@u.washington.edu	Chow, Eric/GWV-1056-2022; Chow, Eric/AAU-8380-2021	Chow, Eric/0000-0001-7712-961X; Chow, Eric/0000-0001-7712-961X	American Society for Blood and Marrow Transplantation; Leukemia and Lymphoma Society; Seattle Children's Research Institute; NATIONAL CANCER INSTITUTE [U54CA091408] Funding Source: NIH RePORTER	American Society for Blood and Marrow Transplantation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Seattle Children's Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Primary Funding Source: The American Society for Blood and Marrow Transplantation, the Leukemia and Lymphoma Society, and the Seattle Children's Research Institute.	Annaloro C, 2008, BONE MARROW TRANSPL, V41, P797, DOI 10.1038/sj.bmt.1705972; Armenian SH, 2008, J CLIN ONCOL, V26, P5537, DOI 10.1200/JCO.2008.17.7428; Baker KS, 2007, BLOOD, V109, P1765, DOI 10.1182/blood-2006-05-022335; Bhatia S, 2005, BLOOD, V105, P4215, DOI 10.1182/blood-2005-01-0035; Bhatia S, 2007, BLOOD, V110, P3784, DOI 10.1182/blood-2007-03-082933; Biedermann BC, 2008, BEST PRACT RES CL HA, V21, P129, DOI 10.1016/j.beha.2008.02.003; Centers for Disease Control and Prevention, GROWTH CHARTS; CHAO NJ, 2008, THOMAS HEMATOPOIETIC, P1257, DOI DOI 10.1016/J.BEHA.2008.02.002; Chow EJ, 2010, BIOL BLOOD MARROW TR, V16, P1674, DOI 10.1016/j.bbmt.2010.05.016; GIANNI L, 2008, BLOOD, V26, P3777; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; Gooley TA, 2010, NEW ENGL J MED, V363, P2091, DOI 10.1056/NEJMoa1004383; Herman AA, 1997, PAEDIATR PERINAT EP, V11, P5, DOI 10.1046/j.1365-3016.11.s1.11.x; Hingorani S, 2007, BONE MARROW TRANSPL, V39, P223, DOI 10.1038/sj.bmt.1705573; Hoffmeister PA, 2004, J PEDIAT HEMATOL ONC, V26, P81, DOI 10.1097/00043426-200402000-00003; HOROWITZ MM, 2008, THOMAS HEMATOPOIETIC, P15; IVES DG, 2009, MED CARE, V57, P133; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Lee DS, 2005, MED CARE, V43, P182, DOI 10.1097/00005650-200502000-00012; Majhail NS, 2009, BONE MARROW TRANSPL, V43, P49, DOI 10.1038/bmt.2008.263; Martin PJ, 2010, J CLIN ONCOL, V28, P1011, DOI 10.1200/JCO.2009.25.6693; Meacham LR, 2010, CANCER EPIDEM BIOMAR, V19, P170, DOI 10.1158/1055-9965.EPI-09-0555; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; *OFF FIN MAN STAT, AG SEX RAC HISP OR; *OFF FIN MAN STAT, MIGR, DOI DOI 10.1016/J.ANNEPIDEM.2003.09.016; Powell H, 2001, J CLIN EPIDEMIOL, V54, P687, DOI 10.1016/S0895-4356(00)00364-4; Quan H, 2004, MED CARE, V42, P801, DOI 10.1097/01.mlr.0000132391.59713.0d; Rizzo JD, 2006, BIOL BLOOD MARROW TR, V12, P138, DOI 10.1016/j.bbmt.2005.09.012; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Saydah SH, 2004, ANN EPIDEMIOL, V14, P507, DOI 10.1016/j.annepidem.2003.09.016; Schmitz N, 2006, BLOOD, V108, P4288, DOI 10.1182/blood-2006-05-024042; Shankar SM, 2007, CANCER EPIDEM BIOMAR, V16, P834, DOI 10.1158/1055-9965.EPI-06-0714; Socie G, 2003, BLOOD, V101, P3373, DOI 10.1182/blood-2002-07-2231; SUN CL, 2010, CIRCULATION, V116, P3129; Taskinen M, 2000, LANCET, V356, P993, DOI 10.1016/S0140-6736(00)02717-3; Tichelli A, 2008, BEST PRACT RES CL HA, V21, P139, DOI 10.1016/j.beha.2008.02.002; Tichelli A, 2008, HAEMATOL-HEMATOL J, V93, P1203, DOI 10.3324/haematol.12949; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; Yeh ETH, 2004, CIRCULATION, V109, P3122, DOI 10.1161/01.CIR.0000133187.74800.B9	40	131	134	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2011	155	1					21	+		10.7326/0003-4819-155-1-201107050-00004	http://dx.doi.org/10.7326/0003-4819-155-1-201107050-00004			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	788MA	21727290				2022-12-01	WOS:000292447800003
J	Makinen, N; Mehine, M; Tolvanen, J; Kaasinen, E; Li, YL; Lehtonen, HJ; Gentile, M; Yan, J; Enge, M; Taipale, M; Aavikko, M; Katainen, R; Virolainen, E; Bohling, T; Koski, TA; Launonen, V; Sjoberg, J; Taipale, J; Vahteristo, P; Aaltonen, LA				Makinen, Netta; Mehine, Miika; Tolvanen, Jaana; Kaasinen, Eevi; Li, Yilong; Lehtonen, Heli J.; Gentile, Massimiliano; Yan, Jian; Enge, Martin; Taipale, Minna; Aavikko, Mervi; Katainen, Riku; Virolainen, Elina; Bohling, Tom; Koski, Taru A.; Launonen, Virpi; Sjoberg, Jari; Taipale, Jussi; Vahteristo, Pia; Aaltonen, Lauri A.			MED12, the Mediator Complex Subunit 12 Gene, Is Mutated at High Frequency in Uterine Leiomyomas	SCIENCE			English	Article							FG SYNDROME; MEDIATOR; ETIOLOGY; FEATURES; COMPLEX	Uterine leiomyomas, or fibroids, are benign tumors that affect millions of women worldwide and that can cause considerable morbidity. To study the genetic basis of this tumor type, we examined 18 uterine leiomyomas derived from 17 different patients by exome sequencing and identified tumor-specific mutations in the mediator complex subunit 12 (MED12) gene in 10. Through analysis of 207 additional tumors, we determined that MED12 is altered in 70% (159 of 225) of tumors from a total of 80 patients. The Mediator complex is a 26-subunit transcriptional regulator that bridges DNA regulatory sequences to the RNA polymerase II initiation complex. All mutations resided in exon 2, suggesting that aberrant function of this region of MED12 contributes to tumorigenesis.	[Makinen, Netta; Mehine, Miika; Tolvanen, Jaana; Kaasinen, Eevi; Li, Yilong; Lehtonen, Heli J.; Taipale, Minna; Aavikko, Mervi; Katainen, Riku; Koski, Taru A.; Launonen, Virpi; Taipale, Jussi; Vahteristo, Pia; Aaltonen, Lauri A.] Univ Helsinki, Genome Scale Biol Res Program, Dept Med Genet, FIN-00014 Helsinki, Finland; [Gentile, Massimiliano] Ctr Sci Ltd, Espoo 02101, Finland; [Yan, Jian; Enge, Martin; Taipale, Minna; Taipale, Jussi] Karolinska Inst, Sci Life Lab, Dept Biosci & Nutr, S-14183 Stockholm, Sweden; [Virolainen, Elina; Bohling, Tom] Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland; [Bohling, Tom] Helsinki Univ Cent Hosp, Lab Hosp Dist Helsinki & Uusimaa, Helsinki 00029, Finland; [Sjoberg, Jari] Helsinki Univ Cent Hosp, Dept Obstet & Gynecol, Helsinki 00029, Finland	University of Helsinki; Karolinska Institutet; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital	Aaltonen, LA (corresponding author), Univ Helsinki, Genome Scale Biol Res Program, Dept Med Genet, FIN-00014 Helsinki, Finland.	lauri.aaltonen@helsinki.fi	Gentile, Massimo/R-3270-2016; Katainen, Riku/GYR-0921-2022; Yan, Jian/B-2631-2018; Aaltonen, Lauri/A-5375-2010; Enge, Martin/GYQ-5073-2022; Kaukomaa, Jaana/G-1040-2016	Gentile, Massimo/0000-0002-5256-0726; Yan, Jian/0000-0002-1267-2870; Aaltonen, Lauri/0000-0001-6839-4286; Kaukomaa, Jaana/0000-0003-1183-4943; Taipale, Minna/0000-0002-1905-2551; Makinen, Netta/0000-0003-0104-7794; Katainen, Riku/0000-0003-4575-4239; Kaasinen, Eevi/0000-0002-1333-8049; Enge, Martin/0000-0001-8748-8931	Academy of Finland (Center of Excellence in Translational Genome-Scale Biology) [6302352, 1124270, 212901, 214323]; European Commission [2005-518200]; GENICA Genomic Instability in Cancer and Precancer [201630]; Sigrid Juselius Foundation; Cancer Society of Finland	Academy of Finland (Center of Excellence in Translational Genome-Scale Biology)(Academy of Finland); European Commission(European CommissionEuropean Commission Joint Research Centre); GENICA Genomic Instability in Cancer and Precancer; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Society of Finland	We thank S. Nieminen, I.-L. Svedberg, M. Kuris, and I. Vuoristo for technical assistance. This work was supported by grants from the Academy of Finland (Center of Excellence in Translational Genome-Scale Biology grant 6302352, and grants 1124270, 212901, and 214323), European Commission Projects TCAC in Cancer (project number 2005-518200) and GENICA Genomic Instability in Cancer and Precancer (project number 201630), Sigrid Juselius Foundation, and the Cancer Society of Finland. Primer sequences are provided in the Supporting Online Material. The gene expression data presented have been deposited in the Gene Expression Omnibus database (www.ncbi.nlm.nih.gov/geo) and are accessible with the accession number GSE30673.	Akoulitchev S, 2000, NATURE, V407, P102, DOI 10.1038/35024111; Borggrefe T, 2002, J BIOL CHEM, V277, P44202, DOI 10.1074/jbc.M207195200; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Chen GL, 2007, BLOOD, V110, P1410, DOI 10.1182/blood-2006-09-018655; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Elmlund H, 2006, P NATL ACAD SCI USA, V103, P15788, DOI 10.1073/pnas.0607483103; Graham JM, 2010, AM J MED GENET C, V154C, P477, DOI 10.1002/ajmg.c.30284; Harper PS, 2011, HUM GENET, V130, P169, DOI 10.1007/s00439-011-1013-x; Hennig Y, 1996, MOL HUM REPROD, V2, P277, DOI 10.1093/molehr/2.4.277; Jacoby VL, 2009, OBSTET GYNECOL, V114, P1041, DOI 10.1097/AOG.0b013e3181b9d222; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Okolo S, 2008, BEST PRACT RES CL OB, V22, P571, DOI 10.1016/j.bpobgyn.2008.04.002; Parker WH, 2007, FERTIL STERIL, V87, P725, DOI 10.1016/j.fertnstert.2007.01.093; Rocha PP, 2010, DEVELOPMENT, V137, P2723, DOI 10.1242/dev.053660; Rump P, 2011, CLIN GENET, V79, P183, DOI 10.1111/j.1399-0004.2010.01449.x; Schwartz CE, 2007, J MED GENET, V44, P472, DOI 10.1136/jmg.2006.048637; Stewart EA, 2001, LANCET, V357, P293, DOI 10.1016/S0140-6736(00)03622-9; Taatjes DJ, 2002, SCIENCE, V295, P1058, DOI 10.1126/science.1065249; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Velagaleti GVN, 2010, CANCER GENET CYTOGEN, V202, P11, DOI 10.1016/j.cancergencyto.2010.06.002; Wallach EE, 2004, OBSTET GYNECOL, V104, P393, DOI 10.1097/01.AOG.0000136079.62513.39; Zhou HY, 2006, MOL CELL BIOL, V26, P8667, DOI 10.1128/MCB.00443-06	24	413	433	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2011	334	6053					252	255		10.1126/science.1208930	http://dx.doi.org/10.1126/science.1208930			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21868628				2022-12-01	WOS:000295833600054
J	Lovibond, K; Jowett, S; Barton, P; Caulfield, M; Heneghan, C; Hobbs, FDR; Hodgkinson, J; Mant, J; Martin, U; Williams, B; Wonderling, D; McManus, RJ				Lovibond, Kate; Jowett, Sue; Barton, Pelham; Caulfield, Mark; Heneghan, Carl; Hobbs, F. D. Richard; Hodgkinson, James; Mant, Jonathan; Martin, Una; Williams, Bryan; Wonderling, David; McManus, Richard J.			Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study	LANCET			English	Article							TARGET ORGAN DAMAGE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; GENERAL-POPULATION; HYPERTENSION; HOME; MORTALITY; STROKE; RISK; GUIDELINES	Background The diagnosis of hypertension has traditionally been based on blood-pressure measurements in the clinic, but home and ambulatory measurements better correlate with cardiovascular outcome, and ambulatory monitoring is more accurate than both clinic and home monitoring in diagnosing hypertension. We aimed to compare the cost-effectiveness of different diagnostic strategies for hypertension. Methods We did a Markov model-based probabilistic cost-effectiveness analysis. We used a hypothetical primary-care population aged 40 years or older with a screening blood-pressure measurement greater than 140/90 mm Hg and risk-factor prevalence equivalent to the general population. We compared three diagnostic strategies-further blood pressure measurement in the clinic, at home, and with an ambulatory monitor-in terms of lifetime costs, quality-adjusted life years, and cost-effectiveness. Findings Ambulatory monitoring was the most cost-effective strategy for the diagnosis of hypertension for men and women of all ages. It was cost-saving for all groups (from -56 pound [95% CI -105 to -10] in men aged 75 years to -323 pound [-389 to -222] in women aged 40 years) and resulted in more quality-adjusted life years for men and women older than 50 years (from 0.006 [0.000 to 0.015] for women aged 60 years to 0.022 [0.012 to 0.035] for men aged 70 years). This finding was robust when assessed with a wide range of deterministic sensitivity analyses around the base case, but was sensitive if home monitoring was judged to have equal test performance to ambulatory monitoring or if treatment was judged effective irrespective of whether an individual was hypertensive. Interpretation Ambulatory monitoring as a diagnostic strategy for hypertension after an initial raised reading in the clinic would reduce misdiagnosis and save costs. Additional costs from ambulatory monitoring are counterbalanced by cost savings from better targeted treatment. Ambulatory monitoring is recommended for most patients before the start of antihypertensive drugs.	[Martin, Una; McManus, Richard J.] Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England; [Lovibond, Kate; Wonderling, David] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Caulfield, Mark] Queen Mary Univ London, Barts London Sch Med & Dent, William Harvey Res Inst, London, England; [Caulfield, Mark] Queen Mary Univ London, Barts London Sch Med & Dent, NIHR Cardiovasc Biomed Res Unit, London, England; [Heneghan, Carl; Hobbs, F. D. Richard] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Mant, Jonathan] Univ Cambridge, Gen Practice & Primary Care Res Unit, Cambridge, England; [Williams, Bryan] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Williams, Bryan] Glenfield Hosp, Leicester NIHR Biomed Res Unit Cardiovasc Dis, Leicester, Leics, England	University of Birmingham; Royal College of Physicians; University of London; Queen Mary University London; University of London; Queen Mary University London; University of Oxford; University of Cambridge; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	McManus, RJ (corresponding author), Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England.	s.jowett@bham.ac.uk; r.j.mcmanus@bham.ac.uk	Hodgkinson, James/AAY-3410-2020; Hug, Balthasar L./G-1568-2010; Jowett, Sue/AAO-4198-2021	Hodgkinson, James/0000-0002-7583-5278; Jowett, Sue/0000-0001-8936-3745; Caulfield, Mark/0000-0001-9295-3594; Wonderling, David/0000-0003-0315-6273; Williams, Bryan/0000-0002-8094-1841; Mant, Jonathan/0000-0002-9531-0268; hobbs, richard/0000-0001-7976-7172	Microlife; BpTRU; National Institute for Health and Clinical Excellence; National Institute for Health Research (NIHR) [RP-PG-0407-10347]; National Institute for Health Research [NF-SI-0509-10222, CDF/01/017] Funding Source: researchfish	Microlife; BpTRU; National Institute for Health and Clinical Excellence; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	FDRH has received research support in terms of blood pressure devices from Microlife and BpTRU. All other authors declare that they have no conflicts of interest.; The National Clinical Guideline Centre (KL and DW) is funded by the National Institute for Health and Clinical Excellence. The views expressed in this publication are those of the authors and not necessarily those of the Institute. This article presents independent research commissioned by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0407-10347). The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. RJM was funded by an NIHR Career Development Fellowship. BW and FDRH are NIHR senior investigators.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Asayama K, 2005, EUR HEART J, V26, P2026, DOI 10.1093/eurheartj/ehi330; Bobrie G, 2001, ARCH INTERN MED, V161, P2205, DOI 10.1001/archinte.161.18.2205; Briggs A, 2006, DECISION MODELLING H, P77; British Hypertension Society, VAL DEV SUIT HOM US; Bronnum-Hansen H, 2001, J CLIN EPIDEMIOL, V54, P1244, DOI 10.1016/S0895-4356(01)00405-X; Bronnum-Hansen H, 2001, STROKE, V32, P2131, DOI 10.1161/hs0901.094253; Craig R MJ., 2006, JOINT HLTH SURVEYS U; DENNIS M, 1990, STROKE, V21, P848, DOI 10.1161/01.STR.21.6.848; *DEP HLTH, 2004, HLTH SURV ENGL 2003; Dolan E, 2005, HYPERTENSION, V46, P156, DOI 10.1161/01.HYP.0000170138.56903.7a; Ewald B, 2002, MED J AUSTRALIA, V176, P580, DOI 10.5694/j.1326-5377.2002.tb04588.x; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fravel MA, 2008, PHARMACOTHERAPY, V28, P1341, DOI 10.1592/phco.28.11.1341; Fukunaga H, 2008, J HYPERTENS, V26, P685, DOI 10.1097/HJH.0b013e3282f42285; Hansen TW, 2005, HYPERTENSION, V45, P499, DOI 10.1161/01.HYP.0000160402.39597.3b; Hodgkinson J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3621; Imai, 1996, Blood Press Monit, V1, P251; Information Centre for Health and Social Care, QUAL OUTC FRAM 2006; JOHNSTON ME, 1984, J CHRON DIS, V37, P417, DOI 10.1016/0021-9681(84)90025-0; Joint Formulary Committee, 2010, BRIT NAT FORM 60; Koehler E, 2009, AM STAT, V63, P155, DOI 10.1198/tast.2009.0030; Krakoff LR, 2006, HYPERTENSION, V47, P29, DOI 10.1161/01.HYP.0000197195.84725.66; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Little P, 2002, BMJ-BRIT MED J, V325, P254, DOI 10.1136/bmj.325.7358.254; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Mule G, 2002, J CARDIOVASC RISK, V9, P123, DOI 10.1097/00043798-200204000-00008; *NAT COLL CTR CHRO, 2006, HYP MAN AD PRIM CAR; National Centre for Social Research and University College London, 2010, DEP EP PUBL HLTH HLT; National Clinical Guideline Centre for Acute and Chronic Conditions, STABL ANG DRAFT FULL; National Institute for Health and Clinical Excellence (NICE), 2009, GUID METH TECHN APPR; National Institute for Health and Clinical Excellence (NICE), 2008, CARD RISK ASS MOD BL; [NICE (NICE) NIfHaCE], 2008, SOC VAL JUDG PRINC D; NICE, 2017, HYP IMPR BLOOD PRESS; NICE, 2011, CLIN GUID 127 HYP UP; NICE, 2010, CLOP MOD REL DIS PRE; Office for National Statistics (ONS), ENGL WAL INT LIF TAB; Office for National Statistics (ONS), MORT STAT DEATHS REG; Ohkubo T, 1998, J HYPERTENS, V16, P971, DOI 10.1097/00004872-199816070-00010; Ohkubo T, 2000, J HYPERTENS, V18, P847, DOI 10.1097/00004872-200018070-00005; Palmer S, 2002, COST EFFECTIVENESS M; Personal Social Services Research Unit, UN COSTS HLTH SOC CA; Phillips LS, 2001, ANN INTERN MED, V135, P825, DOI 10.7326/0003-4819-135-9-200111060-00012; PIERDOMENICO SD, 1995, EUR HEART J, V16, P692, DOI 10.1093/oxfordjournals.eurheartj.a060975; Redon J, 1998, HYPERTENSION, V31, P712, DOI 10.1161/01.HYP.31.2.712; Rosengren A, 1998, J INTERN MED, V244, P495, DOI 10.1111/j.1365-2796.1998.00394.x; Staessen JA, 1999, JAMA-J AM MED ASSOC, V282, P539, DOI 10.1001/jama.282.6.539; Stergiou GS, 2005, AM J HYPERTENS, V18, P772, DOI 10.1016/j.amjhyper.2005.01.003; The Department of Health, NHS REF COSTS 2008 0; The NHS Information Centre Prescribing Support Unit, 2009, PRESCR COST AN ENGL; TRAZZI S, 1991, J HYPERTENS, V9, P115, DOI 10.1097/00004872-199102000-00003; Tsunoda S, 2002, HYPERTENS RES, V25, P167, DOI 10.1291/hypres.25.167; *US DEP HHS, 7 REP JOINT NAT COMM; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; Verdecchia P, 2001, BLOOD PRESS MONIT, V6, P323, DOI 10.1097/00126097-200112000-00011; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Ward S, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11140; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683; Youman P, 2003, PHARMACOECONOMICS, V21, P43, DOI 10.2165/00019053-200321001-00005	61	228	240	1	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 1	2011	378	9798					1219	1230		10.1016/S0140-6736(11)61184-7	http://dx.doi.org/10.1016/S0140-6736(11)61184-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831IO	21868086				2022-12-01	WOS:000295723600024
J	Kario, K; Nishizawa, M; Hoshide, S; Shimpo, M; Ishibashi, Y; Kunii, O; Shibuya, K				Kario, Kazuomi; Nishizawa, Masafumi; Hoshide, Satoshi; Shimpo, Masahisa; Ishibashi, Yukishige; Kunii, Osamu; Shibuya, Kenji			Development of a disaster cardiovascular prevention network	LANCET			English	Editorial Material							EARTHQUAKE; HEART; STRESS		[Kario, Kazuomi; Nishizawa, Masafumi; Hoshide, Satoshi; Shimpo, Masahisa] Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, Shimotsuke, Tochigi 3290498, Japan; [Nishizawa, Masafumi] Shizugawa Hosp, Dept Med, Shizugawa, Japan; [Ishibashi, Yukishige] Ishibashi Clin, Tokyo, Japan; [Ishibashi, Yukishige] Primary Care All Team, Tokyo, Japan; [Kunii, Osamu] United Nations Childrens Fund, Somalia Support Ctr, Nairobi, Kenya; [Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan	Jichi Medical University; University of Tokyo	Kario, K (corresponding author), Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	kkario@jichi.ac.jp		Shibuya, Kenji/0000-0003-2528-7530				[Anonymous], 2011, LANCET, V377, P968, DOI 10.1016/S0140-6736(11)60368-1; Inui A, 1998, ARCH INTERN MED, V158, P274, DOI 10.1001/archinte.158.3.274; [Japanese Ministry of Health Labour and Welfare Ministry of Education Culture Sports Science and Technology], 2011, STAT SURV RES DIS AF; Kario K, 1997, J AM GERIATR SOC, V45, P610, DOI 10.1111/j.1532-5415.1997.tb03096.x; Kario K, 1997, J AM COLL CARDIOL, V29, P926, DOI 10.1016/S0735-1097(97)00002-8; Kario K, 2003, HYPERTENS RES, V26, P355, DOI 10.1291/hypres.26.355; Kario K., 2005, JMAJ - Japan Medical Association Journal, V48, P363; Kario K, 1998, J AM GERIATR SOC, V46, P537, DOI 10.1111/j.1532-5415.1998.tb02485.x; McCurry J, 2011, LANCET, V378, P15, DOI 10.1016/S0140-6736(11)61002-7; Mokdad Ali H, 2005, Prev Chronic Dis, V2 Spec no, pA04; Pickering T G, 2001, Curr Hypertens Rep, V3, P249, DOI 10.1007/s11906-001-0047-1; Shibuya K, 2011, LANCET, V378, P1265, DOI 10.1016/S0140-6736(11)61098-2	12	26	26	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 24	2011	378	9797					1125	1127		10.1016/S0140-6736(11)61187-2	http://dx.doi.org/10.1016/S0140-6736(11)61187-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829RH	21885110				2022-12-01	WOS:000295601500008
J	Scheid, JF; Mouquet, H; Ueberheide, B; Diskin, R; Klein, F; Oliveira, TYK; Pietzsch, J; Fenyo, D; Abadir, A; Velinzon, K; Hurley, A; Myung, S; Boulad, F; Poignard, P; Burton, DR; Pereyra, F; Ho, DD; Walker, BD; Seaman, MS; Bjorkman, PJ; Chait, BT; Nussenzweig, MC				Scheid, Johannes F.; Mouquet, Hugo; Ueberheide, Beatrix; Diskin, Ron; Klein, Florian; Oliveira, Thiago Y. K.; Pietzsch, John; Fenyo, David; Abadir, Alexander; Velinzon, Klara; Hurley, Arlene; Myung, Sunnie; Boulad, Farid; Poignard, Pascal; Burton, Dennis R.; Pereyra, Florencia; Ho, David D.; Walker, Bruce D.; Seaman, Michael S.; Bjorkman, Pamela J.; Chait, Brian T.; Nussenzweig, Michel C.			Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; MEMORY B-CELLS; NEUTRALIZING ANTIBODIES; TYPE-1 GP120; ENVELOPE GLYCOPROTEIN; EPITOPE; RECEPTOR; GP41; INDIVIDUALS	Passive transfer of broadly neutralizing HIV antibodies can prevent infection, which suggests that vaccines that elicit such antibodies would be protective. Thus far, however, few broadly neutralizing HIV antibodies that occur naturally have been characterized. To determine whether these antibodies are part of a larger group of related molecules, we cloned 576 new HIV antibodies from four unrelated individuals. All four individuals produced expanded clones of potent broadly neutralizing CD4-binding-site antibodies that mimic binding to CD4. Despite extensive hypermutation, the new antibodies shared a consensus sequence of 68 immunoglobulin H (IgH) chain amino acids and arise independently from two related IgH genes. Comparison of the crystal structure of one of the antibodies to the broadly neutralizing antibody VRC01 revealed conservation of the contacts to the HIV spike.	[Scheid, Johannes F.; Mouquet, Hugo; Klein, Florian; Oliveira, Thiago Y. K.; Pietzsch, John; Abadir, Alexander; Velinzon, Klara; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Scheid, Johannes F.] Charite, D-10117 Berlin, Germany; [Ueberheide, Beatrix; Fenyo, David; Myung, Sunnie; Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10065 USA; [Diskin, Ron; Bjorkman, Pamela J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Pietzsch, John] Free Univ Berlin, Dept Biol Chem & Pharm, D-14195 Berlin, Germany; [Hurley, Arlene] Rockefeller Univ, Rockefeller Univ Hosp, New York, NY 10065 USA; [Boulad, Farid] Mem Sloan Kettering Canc Ctr, Bone Marrow Transplant Serv, New York, NY 10065 USA; [Poignard, Pascal; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Poignard, Pascal; Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Poignard, Pascal] Int AIDS Vaccine Initiat, New York, NY 10028 USA; [Burton, Dennis R.; Pereyra, Florencia; Walker, Bruce D.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02129 USA; [Pereyra, Florencia; Walker, Bruce D.] Massachusetts Gen Hosp, Partners AIDS Res Ctr, Charlestown, MA 02129 USA; [Pereyra, Florencia; Walker, Bruce D.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Ho, David D.; Walker, Bruce D.; Bjorkman, Pamela J.; Nussenzweig, Michel C.] Howard Hughes Med Inst, New York, NY 10065 USA; Aaron Diamond AIDS Res Ctr, New York, NY 10065 USA; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Rockefeller University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Rockefeller University; California Institute of Technology; Free University of Berlin; Rockefeller University; Memorial Sloan Kettering Cancer Center; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; International AIDS Vaccine Initiative; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Massachusetts General Hospital; Harvard University; Howard Hughes Medical Institute; Harvard University; Beth Israel Deaconess Medical Center	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussen@mail.rockefeller.edu	poignard, pascal/AAB-4613-2020; Oliveira, Thiago Y/HGA-3848-2022; Nussenzweig, Michel/AAE-7292-2019; Mouquet, Hugo/M-2750-2014; poignard, pascal/N-6678-2013; Oliveira, Thiago Y/ABF-5186-2020	Oliveira, Thiago Y/0000-0002-2654-0879; Mouquet, Hugo/0000-0002-4230-610X; Oliveira, Thiago Y/0000-0002-2654-0879; Poignard, Pascal/0000-0002-0021-7192; Fenyo, David/0000-0001-5049-3825; Ueberheide, Beatrix/0000-0003-2512-0204	NIH [P01 AI081677, RR00862, RR022220]; Bill & Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery/Comprehensive Antibody-Vaccine Immune Monitoring Consortium [38619s, 38660]; Gordon and Betty Moore Foundation; Stanford Synchrotron Radiation Lightsource; German Research Foundation (Deutsche Forschungsgemeinschaft) [KL 2389/1-1]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862, U54RR022220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033292, P01AI081677, P30AI060354] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery/Comprehensive Antibody-Vaccine Immune Monitoring Consortium; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Stanford Synchrotron Radiation Lightsource; German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The data reported in this paper are tabulated in the supporting online material, and the coordinates for the 3BNC60 Fab as well as the antibody sequences have been deposited in the Protein Data Bank and the European Molecular Biology Laboratory-European Bioinformatics Institute database [accession codes: 3RPI (3BNC60 coordinates), HE584535 to HE584554 (antibody sequences)]. We thank the HIV-positive donors for their support. We thank M. Jankovic for discussions and help with cloning of HIV envelope constructs; R. Wyatt for the plasmid of YU2-gp140; J. Mascola for the plasmid of 2CC-core and YU2-gp120 mutants; and M. Connors for access to patient NIH45; C. Gaebler, M. Warncke, P. M. Marcovecchio, and H. Gao for help with protein expression; K. Moss for patient coordination. We thank F. McCutchan, G. Shaw, B. Hahn, J. Baalwa, D. Montefiori, F. Gao, M. Thomson, J. Overbaugh, R. Swanstrom, L. Morris, J. Kim, L. Zhang, D. Ellenberger, and C. Williamson for contributing the HIV-1 Envelope plasmids used in our neutralization panel. We thank M. Simek, F. Priddy, and all the study participants and research staff at each of the International AIDS Vaccine Initiative (IAVI) Protocol G project; clinical and site team members; and all of the Protocol G clinical investigators, specifically, G. Miiro, A. Pozniak, D. McPhee, O. Manigart, E. Karita, A. Inwoley, W. Jaoko, J. DeHovitz, L.-G. Bekker, P. Pitisuttithum, R. Paris, J. Serwanga, and S. Allen for samples from one broadly neutralizing serum donor from Protocol G. We thank L. Walker for providing data on the neutralizing specificity of the Protocol G donor. In connection with this work, M.C.N. and J. F. S. have a pending patent application with the U. S. Patent and Trademark Office, patent number U. S. 61/486,960, entitled "Human Immunodeficiency Virus Neutralizing Antibodies and Methods of Use Thereof." The reagents are available with a Materials Transfer Agreement. The work was supported by NIH grants P01 AI081677, RR00862, and RR022220, and by the Bill & Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery/Comprehensive Antibody-Vaccine Immune Monitoring Consortium, grant numbers 38619s and 38660. We thank the Molecular Observatory at Caltech (supported by the Gordon and Betty Moore Foundation) and the Stanford Synchrotron Radiation Lightsource. F. K. was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, KL 2389/1-1). M.C.N., P. J. B, and B. D. W. are Howard Hughes Medical Institute Investigators.	BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Dey B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000445; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Dorner T, 2007, IMMUNITY, V27, P384, DOI 10.1016/j.immuni.2007.09.002; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; MCCLURE MO, 1987, NATURE, V330, P487, DOI 10.1038/330487a0; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Moore JP, 1996, J VIROL, V70, P1863, DOI 10.1128/JVI.70.3.1863-1872.1996; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; OLSHEVSKY U, 1990, J VIROL, V64, P5701, DOI 10.1128/JVI.64.12.5701-5707.1990; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Pietzsch J, 2010, J EXP MED, V207, P1995, DOI 10.1084/jem.20101176; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; THALI M, 1991, J VIROL, V65, P6188, DOI 10.1128/JVI.65.11.6188-6193.1991; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yang XZ, 2000, J VIROL, V74, P5716, DOI 10.1128/JVI.74.12.5716-5725.2000; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zwick MB, 2001, J VIROL, V75, P12198, DOI 10.1128/JVI.75.24.12198-12208.2001; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	36	846	927	3	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2011	333	6049					1633	1637		10.1126/science.1207227	http://dx.doi.org/10.1126/science.1207227			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21764753	Green Submitted, Green Accepted			2022-12-01	WOS:000294900900044
J	Thomas, C; Moraga, I; Levin, D; Krutzik, PO; Podoplelova, Y; Trejo, A; Lee, C; Yarden, G; Vleck, SE; Glenn, JS; Nolan, GP; Piehler, J; Schreiber, G; Garcia, KC				Thomas, Christoph; Moraga, Ignacio; Levin, Doron; Krutzik, Peter O.; Podoplelova, Yulia; Trejo, Angelica; Lee, Choongho; Yarden, Ganit; Vleck, Susan E.; Glenn, Jeffrey S.; Nolan, Garry P.; Piehler, Jacob; Schreiber, Gideon; Garcia, K. Christopher			Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons	CELL			English	Article							CRYSTAL-STRUCTURE; MUTATIONAL ANALYSIS; COMPLEX REVEALS; BINDING-SITE; AFFINITY; IFNAR1; IFN-ALPHA-2; MUTANT; ALPHA; GAMMA	Type I Interferons (IFNs) are important cytokines for innate immunity against viruses and cancer. Sixteen human type I IFN variants signal through the same cell-surface receptors, IFNAR1 and IFNAR2, yet they can evoke markedly different physiological effects. The crystal structures of two human type I IFN ternary signaling complexes containing IFN alpha 2 and IFN omega reveal recognition modes and heterotrimeric architectures that are unique among the cytokine receptor superfamily but conserved between different type I IFNs. Receptor-ligand cross-reactivity is enabled by conserved receptor-ligand "anchor points" interspersed among ligand-specific interactions that "tune" the relative IFN-binding affinities, in an apparent extracellular "ligand proofreading" mechanism that modulates biological activity. Functional differences between IFNs are linked to their respective receptor recognition chemistries, in concert with a ligand-induced conformational change in IFNAR1, that collectively control signal initiation and complex stability, ultimately regulating differential STAT phosphorylation profiles, receptor internalization rates, and downstream gene expression patterns.	[Thomas, Christoph; Moraga, Ignacio; Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Thomas, Christoph; Moraga, Ignacio; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Krutzik, Peter O.; Trejo, Angelica; Nolan, Garry P.] Stanford Univ, Sch Med, Baxter Lab Stem Cell Biol, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Lee, Choongho; Vleck, Susan E.; Glenn, Jeffrey S.] Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Dept Med, Stanford, CA 94305 USA; [Levin, Doron; Yarden, Ganit; Schreiber, Gideon] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Podoplelova, Yulia; Piehler, Jacob] Univ Osnabruck, Div Biophys, D-49076 Osnabruck, Germany	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Weizmann Institute of Science; University Osnabruck	Garcia, KC (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	kcgarcia@stanford.edu	Lee, Choongho/AAZ-9876-2020; Nolan, Garry/AAE-7903-2019	Thomas, Christoph/0000-0001-7441-1089; Moraga, Ignacio/0000-0001-9909-0701; Nolan, Garry/0000-0002-8862-9043	International Human Frontier Science Program Organization; European Community [223608];  [NIH-RO1-AI51321];  [NIH-RO1-AI087917]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI051321, R01AI051321, R01AI087917] Funding Source: NIH RePORTER	International Human Frontier Science Program Organization(Human Frontier Science Program); European Community(European Commission); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Natalia Goriatcheva for expert technical assistance, the staff at SSRL and ALS for their assistance, and David Canner for preparing the Proteopedia pages. K. C. G. is an Investigator of the Howard Hughes Medical Institute. This work was also supported by NIH-RO1-AI51321 (K. C. G.) and NIH-RO1-AI087917 (J.S.G.), C. T. is supported by a long-term postdoctoral fellowship of the International Human Frontier Science Program Organization. G. S. and J.P. are supported by the European Community's FP7/2007-2013 under GA no. 223608 (IFNaction).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bleicher L, 2008, FEBS LETT, V582, P2985, DOI 10.1016/j.febslet.2008.07.046; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P419, DOI 10.1016/S0952-7915(00)00111-4; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Cajean-Feroldi C, 2004, BIOCHEMISTRY-US, V43, P12498, DOI 10.1021/bi049111r; Chill JH, 2003, STRUCTURE, V11, P791, DOI 10.1016/S0969-2126(03)00120-5; Cho NJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000331; Coelho LFL, 2005, P NATL ACAD SCI USA, V102, P11917, DOI 10.1073/pnas.0502188102; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; GABORIAUD C, 1990, FEBS LETT, V269, P1, DOI 10.1016/0014-5793(90)81103-U; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Horton HM, 1999, CANCER RES, V59, P4064; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Jaitin DA, 2006, MOL CELL BIOL, V26, P1888, DOI 10.1128/MCB.26.5.1888-1897.2006; Jaks E, 2007, J MOL BIOL, V366, P525, DOI 10.1016/j.jmb.2006.11.053; Jones BC, 2008, STRUCTURE, V16, P1333, DOI 10.1016/j.str.2008.06.005; Josephson K, 2001, IMMUNITY, V15, P35, DOI 10.1016/S1074-7613(01)00169-8; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kalie E, 2008, J BIOL CHEM, V283, P32925, DOI 10.1074/jbc.M806019200; Kalie E, 2007, J BIOL CHEM, V282, P11602, DOI 10.1074/jbc.M610115200; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Lamken P, 2005, J MOL BIOL, V350, P476, DOI 10.1016/j.jmb.2005.05.008; Levin D, 2011, MOL CELL BIOL, V31, P3252, DOI 10.1128/MCB.05251-11; Li ZL, 2008, J MOL BIOL, V377, P715, DOI 10.1016/j.jmb.2007.12.005; Marijanovic Z, 2007, BIOCHEM J, V407, P141, DOI 10.1042/BJ20070605; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miknis ZJ, 2010, J MOL BIOL, V404, P650, DOI 10.1016/j.jmb.2010.09.068; Moraga I, 2009, MOL CELL BIOL, V29, P4778, DOI 10.1128/MCB.01808-08; Nudelman I, 2010, BIOCHEMISTRY-US, V49, P5117, DOI 10.1021/bi100041f; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Piehler J, 2000, J BIOL CHEM, V275, P40425, DOI 10.1074/jbc.M006854200; Quadt-Akabayov SR, 2006, PROTEIN SCI, V15, P2656, DOI 10.1110/ps.062283006; Radhakrishnan R, 1996, STRUCTURE, V4, P1453, DOI 10.1016/S0969-2126(96)00152-9; Roisman LC, 2005, J MOL BIOL, V353, P271, DOI 10.1016/j.jmb.2005.08.042; Roisman LC, 2001, P NATL ACAD SCI USA, V98, P13231, DOI 10.1073/pnas.221290398; Schindler C, 2008, SEMIN CELL DEV BIOL, V19, P311, DOI 10.1016/j.semcdb.2008.08.010; Strunk JJ, 2008, J MOL BIOL, V377, P725, DOI 10.1016/j.jmb.2008.01.017; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WALTER MR, 1995, NATURE, V376, P230, DOI 10.1038/376230a0; Walter MR, 2004, ADV PROTEIN CHEM, V68, P171; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Zdanov A, 2010, CYTOKINE GROWTH F R, V21, P325, DOI 10.1016/j.cytogfr.2010.08.003	45	250	261	3	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 19	2011	146	4					621	632		10.1016/j.cell.2011.06.048	http://dx.doi.org/10.1016/j.cell.2011.06.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21854986	Green Accepted, Bronze			2022-12-01	WOS:000294043600016
J	Tse, D; Takeuchi, T; Kakeyama, M; Kajii, Y; Okuno, H; Tohyama, C; Bito, H; Morris, RGM				Tse, Dorothy; Takeuchi, Tomonori; Kakeyama, Masaki; Kajii, Yasushi; Okuno, Hiroyuki; Tohyama, Chiharu; Bito, Haruhiko; Morris, Richard G. M.			Schema-Dependent Gene Activation and Memory Encoding in Neocortex	SCIENCE			English	Article							LONG-TERM-MEMORY; SPATIAL MEMORY; ASSOCIATIVE MEMORY; EPISODIC MEMORY; RAT HIPPOCAMPUS; CONSOLIDATION; EXPRESSION; PLASTICITY; EXPERIENCE; NEURONS	When new learning occurs against the background of established prior knowledge, relevant new information can be assimilated into a schema and thereby expand the knowledge base. An animal model of this important component of memory consolidation reveals that systems memory consolidation can be very fast. In experiments with rats, we found that the hippocampal-dependent learning of new paired associates is associated with a striking up-regulation of immediate early genes in the prelimbic region of the medial prefrontal cortex, and that pharmacological interventions targeted at that area can prevent both new learning and the recall of remotely and even recently consolidated information. These findings challenge the concept of distinct fast (hippocampal) and slow (cortical) learning systems, and shed new light on the neural mechanisms of memory assimilation into schemas.	[Tse, Dorothy; Takeuchi, Tomonori; Morris, Richard G. M.] Univ Edinburgh, Ctr Cognit & Neural Syst, Edinburgh EH8 9JZ, Midlothian, Scotland; [Kakeyama, Masaki; Tohyama, Chiharu] Univ Tokyo, Grad Sch Med, Lab Environm Hlth Sci, Ctr Dis Biol & Integrat Med,Bunkyo Ku, Tokyo 1130033, Japan; [Kajii, Yasushi] Mitsubishi Tanabe Pharma Corp, Pharmacol Res Labs 1, Aoba Ku, Yokohama, Kanagawa 2270033, Japan; [Okuno, Hiroyuki; Bito, Haruhiko] Univ Tokyo, Grad Sch Med, Dept Neurochem, Bunkyo Ku, Tokyo 1130033, Japan	University of Edinburgh; University of Tokyo; Mitsubishi Tanabe Pharma Corporation; University of Tokyo	Morris, RGM (corresponding author), Univ Edinburgh, Ctr Cognit & Neural Syst, Edinburgh EH8 9JZ, Midlothian, Scotland.	r.g.m.morris@ed.ac.uk	Tohyama, Chiharu/AAI-5598-2020; Bito, Haruhiko/A-8635-2008; Takeuchi, Tomonori/P-5988-2016; Morris, Richard G M/C-9982-2013	Tohyama, Chiharu/0000-0003-1061-6872; Takeuchi, Tomonori/0000-0002-9981-4260; OKUNO, HIROYUKI/0000-0001-6237-6503; MORRIS, Richard G M/0000-0001-8661-1520; Bito, Haruhiko/0000-0001-6315-9594; Kakeyama, Masaki/0000-0001-9063-9673; Tse, Dorothy/0000-0003-2263-8139	Mitsubishi Tanabe Pharmaceutical Company; UK Medical Research Council; Uehara Foundation; Astellas Foundation; SRPBS-Ministry of Education, Culture, Sports, Science and Technology (MEXT); CREST-Japan Science and Technology Agency; Ministry of Health, Labour and Welfare of Japan; Medical Research Council [G0700447, G0700704B] Funding Source: researchfish; MRC [G0700447] Funding Source: UKRI	Mitsubishi Tanabe Pharmaceutical Company; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Uehara Foundation(Uehara Memorial Foundation); Astellas Foundation(Astellas Pharmaceuticals); SRPBS-Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST-Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by grants from the Mitsubishi Tanabe Pharmaceutical Company, the UK Medical Research Council (R. G. M. M.), the Uehara and Astellas Foundations (T. T.), SRPBS-Ministry of Education, Culture, Sports, Science and Technology (MEXT) (C. T.), CREST-Japan Science and Technology Agency (H.O., H. B.), and grants-in-aid from MEXT (M. K., H.O., H. B.) and Ministry of Health, Labour and Welfare of Japan (M. K., H. B.). We thank B. Bontempi, S. Alaux-Cantin, M. Ginger, G. Poirier, P. Spooner, and J. Tulloch for technical advice, and S.-H. Wang for scientific discussion.	ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; [Anonymous], REMEMBERING; Barker GRI, 2008, J NEUROSCI, V28, P2837, DOI 10.1523/JNEUROSCI.4447-07.2008; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Bethus I, 2010, J NEUROSCI, V30, P1610, DOI 10.1523/JNEUROSCI.2721-09.2010; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Bransford J.D., 1979, HUMAN COGNITION LEAR; Day M, 2003, NATURE, V424, P205, DOI 10.1038/nature01769; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Dudai Y, 2000, BRAIN, PERCEPTION, MEMORY, P149; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Griffiths D, 1999, TRENDS COGN SCI, V3, P74, DOI 10.1016/S1364-6613(98)01272-8; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Harris JA, 1999, P NATL ACAD SCI USA, V96, P7587, DOI 10.1073/pnas.96.13.7587; Hasselmo ME, 2010, BEHAV BRAIN RES, V215, P261, DOI 10.1016/j.bbr.2009.12.010; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Komorowski RW, 2009, J NEUROSCI, V29, P9918, DOI 10.1523/JNEUROSCI.1378-09.2009; Kuhl BA, 2010, NAT NEUROSCI, V13, P501, DOI 10.1038/nn.2498; Laroche S, 2000, HIPPOCAMPUS, V10, P438; Lesburgueres E, 2011, SCIENCE, V331, P924, DOI 10.1126/science.1196164; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Miyashita T, 2009, J NEUROSCI, V29, P898, DOI 10.1523/JNEUROSCI.4588-08.2009; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Osada T, 2008, PHILOS T R SOC B, V363, P2187, DOI 10.1098/rstb.2008.2271; Restivo L, 2009, J NEUROSCI, V29, P8206, DOI 10.1523/JNEUROSCI.0966-09.2009; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Squire L.R., 1987, MEMORY BRAIN; STAUBLI U, 1989, BEHAV NEUROSCI, V103, P54, DOI 10.1037/0735-7044.103.1.54; Sweatt JD, 2003, MECH MEMORY; TEYLER TJ, 1986, BEHAV NEUROSCI, V100, P147, DOI 10.1037/0735-7044.100.2.147; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; van Kesteren MTR, 2010, J NEUROSCI, V30, P15888, DOI 10.1523/JNEUROSCI.2674-10.2010; van Kesteren MTR, 2010, P NATL ACAD SCI USA, V107, P7550, DOI 10.1073/pnas.0914892107; Vazdarjanova A, 2002, J NEUROSCI, V22, P10067; Winocur G, 2005, NAT NEUROSCI, V8, P273, DOI 10.1038/nn1401	44	361	364	0	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 12	2011	333	6044					891	895		10.1126/science.1205274	http://dx.doi.org/10.1126/science.1205274			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21737703				2022-12-01	WOS:000293785400045
J	Cappuccio, FP; Capewell, S; Lincoln, P; McPherson, K				Cappuccio, Francesco P.; Capewell, Simon; Lincoln, Paul; McPherson, Klim			Policy options to reduce population salt intake	BRITISH MEDICAL JOURNAL			English	Editorial Material							BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; RANDOMIZED-TRIALS; SODIUM-CHLORIDE; PUBLIC-HEALTH; METAANALYSIS; FOOD		[Cappuccio, Francesco P.] Univ Warwick, Warwick Med Sch, WHO Collaborating Ctr Nutr, WHO Collaborating Ctr, Coventry CV2 2DX, W Midlands, England; [Capewell, Simon] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Lincoln, Paul] Natl Heart Forum, London, England; [McPherson, Klim] Univ Oxford, Oxford, England	University of Warwick; World Health Organization; University of Liverpool; University of Oxford	Cappuccio, FP (corresponding author), Univ Warwick, Warwick Med Sch, WHO Collaborating Ctr Nutr, WHO Collaborating Ctr, Coventry CV2 2DX, W Midlands, England.	f.p.cappuccio@warwick.ac.uk	Cappuccio, Francesco Paolo/ABF-1094-2020	Cappuccio, Francesco Paolo/0000-0002-7842-5493				Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; BLAIS CA, 1986, AM J CLIN NUTR, V44, P232, DOI 10.1093/ajcn/44.2.232; Cappuccio FP, 2007, BMJ-BRIT MED J, V334, P859, DOI 10.1136/bmj.39175.364954.BE; FORTE JG, 1989, J HUM HYPERTENS, V3, P179; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; He FJ, 2003, HYPERTENSION, V42, P1093, DOI 10.1161/01.HYP.0000102864.05174.E8; Karppanen H, 2006, PROG CARDIOVASC DIS, V49, P59, DOI 10.1016/j.pcad.2006.07.001; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Malik VS, 2006, AM J CLIN NUTR, V84, P274; National Institute for Health and Clinical Excellence, 2010, PREV CARD DIS POP LE; Sasaki N., 1979, PROPHYLACTIC APPROAC, P467; Sharma LL, 2010, AM J PUBLIC HEALTH, V100, P240, DOI 10.2105/AJPH.2009.160960; Strazzullo P, 2011, J HYPERTENS, V29, P829, DOI 10.1097/HJH.0b013e3283459568; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Takahashi Y, 2006, J HYPERTENS, V24, P451, DOI 10.1097/01.hjh.0000209980.36359.16; TEOW BH, 1985, CLIN EXP HYPERTENS A, V7, P1681, DOI 10.3109/10641968509073618; Turnbull F, 2003, LANCET, V362, P1527; Webster JL, 2011, J HYPERTENS, V29, P1043, DOI 10.1097/HJH.0b013e328345ed83	19	86	90	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 11	2011	343								d4995	10.1136/bmj.d4995	http://dx.doi.org/10.1136/bmj.d4995			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	808DP	21835876	Green Submitted			2022-12-01	WOS:000293956900003
J	Armstrong, JB; Schindler, DE				Armstrong, Jonathan B.; Schindler, Daniel E.			Excess digestive capacity in predators reflects a life of feast and famine	NATURE			English	Article							BIOENERGETICS MODEL; FISHES; RUN	A central challenge for predators is achieving positive energy balance when prey are spatially and temporally heterogeneous. Ecological heterogeneity produces evolutionary trade-offs in the physiological design of predators; this is because the ability to capitalize on pulses of food abundance requires high capacity for food-processing, yet maintaining such capacity imposes energetic costs that are taxing during periods of food scarcity(1,2). Recent advances in physiology show that when variation in foraging opportunities is predictable, animals may adjust energetic tradeoffs by rapidly modulating their digestive system to track variation in foraging opportunities(1). However, it is increasingly recognized that foraging opportunities for animals are unpredictable(3), which should favour animals that maintain a capacity for food-processing that exceeds average levels of consumption (loads)(2,4). Despite this basic principle of quantitative evolutionary design, estimates of digestive load: capacity ratios in wild animals are virtually nonexistent(1). Here we provide an extensive assessment of load: capacity ratios for the digestive systems of predators in the wild, compiling 639 estimates across 38 species of fish. We found that piscine predators typically maintain the physiological capacity to feed at daily rates 2-3 times higher than what they experience on average. A numerical simulation of the trade-off between food-processing capacity and metabolic cost suggests that the observed level of physiological opportunism is profitable only if predator-prey encounters, and thus predator energy budgets, are far more variable in nature than currently assumed.	[Armstrong, Jonathan B.; Schindler, Daniel E.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Armstrong, JB (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Box 355020, Seattle, WA 98195 USA.	Jonny99@uw.edu			Gordon and Betty Moore Foundation; US National Science Foundation; University of Washington School of Aquatic and Fishery Sciences; Directorate For Geosciences [1114918] Funding Source: National Science Foundation	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); US National Science Foundation(National Science Foundation (NSF)); University of Washington School of Aquatic and Fishery Sciences(University of Washington); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank T. Essington, R. Huey, T. Reed, A. Walters, V. Sturtevant and A. Armstrong for comments on this manuscript. We also thank the following people for contributing to this project: J. Kitchell, O. Jensen, E. Ward, D. Beauchamp, B. Chasco, A. Farrell, P. Bisson and J. Kershner. This work was supported by the Gordon and Betty Moore Foundation, the US National Science Foundation and the University of Washington School of Aquatic and Fishery Sciences.	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1997, FISH BIOEN 3 0; Armstrong JB, 2010, ECOLOGY, V91, P1445, DOI 10.1890/09-0790.1; Arrington DA, 2002, ECOLOGY, V83, P2145, DOI 10.2307/3072046; BEAUCHAMP DA, 1989, T AM FISH SOC, V118, P597, DOI 10.1577/1548-8659(1989)118<0597:COABMF>2.3.CO;2; BRECK JE, 1993, T AM FISH SOC, V122, P902, DOI 10.1577/1548-8659(1993)122<0902:FTAPFA>2.3.CO;2; Brodin Anders, 2007, P221; De Angelis D., 1992, INDIVIDUAL BASED MOD, DOI 10.1201/9781351073462; Diamond J, 2002, J PHYSIOL-LONDON, V542, P337, DOI 10.1113/jphysiol.2002.018366; Dupont-Prinet A, 2010, J EXP BIOL, V213, P1143, DOI 10.1242/jeb.037812; ELLIOTT JM, 1978, J ANIM ECOL, V47, P977, DOI 10.2307/3682; Essington TE, 2000, CAN J FISH AQUAT SCI, V57, P548, DOI 10.1139/cjfas-57-3-548; Farrell A. P., 2001, COMP BIOCH PHYSL A, V128, P549, DOI DOI 10.1016/S1095-6433(00)00335-4; GANS C, 1979, EVOLUTION, V33, P227, DOI 10.1111/j.1558-5646.1979.tb04677.x; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; Huey RB, 2001, ECOLOGY, V82, P1; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Jeschke JM, 2007, OECOLOGIA, V152, P357, DOI 10.1007/s00442-006-0654-2; Kauffman MJ, 2007, ECOL LETT, V10, P690, DOI 10.1111/j.1461-0248.2007.01059.x; Kersten M, 1996, FUNCT ECOL, V10, P440, DOI 10.2307/2389936; KITCHELL JF, 1977, J FISH RES BOARD CAN, V34, P1922, DOI 10.1139/f77-258; KITCHELL JF, 1994, J FISH BIOL, V45, P209, DOI 10.1006/jfbi.1994.1224; Klaassen M, 1997, PHYSIOL ZOOL, V70, P125, DOI 10.1086/639556; Multivariate Density Estimation, 1992, MULTIVARIATE DENSITY, DOI [10.1002/9780470316849, DOI 10.1002/9780470316849]; Piersma T., 2011, FLEXIBLE PHENOTYPE; RICE JA, 1984, ECOLOGY, V65, P732, DOI 10.2307/1938045; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Schindler DE, 1997, ECOLOGY, V78, P1816; SECOR SM, 1994, AM J PHYSIOL, V266, pG695, DOI 10.1152/ajpgi.1994.266.4.G695; Stevens ED, 2000, J FISH BIOL, V56, P191, DOI 10.1111/j.1095-8649.2000.tb02094.x; Walters C.J., 2004, FISHERIES ECOLOGY MA; WEIBEL ER, 1991, P NATL ACAD SCI USA, V88, P10357, DOI 10.1073/pnas.88.22.10357; WEINER J, 1992, TRENDS ECOL EVOL, V7, P384, DOI 10.1016/0169-5347(92)90009-Z; Yang LH, 2008, ECOLOGY, V89, P621, DOI 10.1890/07-0175.1; [No title captured]	36	111	112	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2011	476	7358					84	+		10.1038/nature10240	http://dx.doi.org/10.1038/nature10240			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NR	21734659				2022-12-01	WOS:000293447300034
J	Pritt, BS; Sloan, LM; Johnson, DKH; Munderloh, UG; Paskewitz, SM; McElroy, KM; McFadden, JD; Binnicker, MJ; Neitzel, DF; Liu, GP; Nicholson, WL; Nelson, CM; Franson, JJ; Martin, SA; Cunningham, SA; Steward, CR; Bogumill, K; Bjorgaard, ME; Davis, JP; McQuiston, JH; Warshauer, DM; Wilhelm, MP; Patel, R; Trivedi, VA; Eremeeva, ME				Pritt, Bobbi S.; Sloan, Lynne M.; Johnson, Diep K. Hoang; Munderloh, Ulrike G.; Paskewitz, Susan M.; McElroy, Kristina M.; McFadden, Jevon D.; Binnicker, Matthew J.; Neitzel, David F.; Liu, Gongping; Nicholson, William L.; Nelson, Curtis M.; Franson, Joni J.; Martin, Scott A.; Cunningham, Scott A.; Steward, Christopher R.; Bogumill, Kay; Bjorgaard, Mary E.; Davis, Jeffrey P.; McQuiston, Jennifer H.; Warshauer, David M.; Wilhelm, Mark P.; Patel, Robin; Trivedi, Vipul A.; Eremeeva, Marina E.			Emergence of a New Pathogenic Ehrlichia Species, Wisconsin and Minnesota, 2009	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANAPLASMA-PHAGOCYTOPHILUM; AGENT; TICKS; IDENTIFICATION; CHAFFEENSIS; EPIDEMIOLOGY; HUMANS; MURIS; ASSAY	BACKGROUND Ehrlichiosis is a clinically important, emerging zoonosis. Only Ehrlichia chaffeensis and E. ewingii have been thought to cause ehrlichiosis in humans in the United States. Patients with suspected ehrlichiosis routinely undergo testing to ensure proper diagnosis and to ascertain the cause. Methods We used molecular methods, culturing, and serologic testing to diagnose and ascertain the cause of cases of ehrlichiosis. RESULTS On testing, four cases of ehrlichiosis in Minnesota or Wisconsin were found not to be from E. chaffeensis or E. ewingii and instead to be caused by a newly discovered ehrlichia species. All patients had fever, malaise, headache, and lymphopenia; three had thrombocytopenia; and two had elevated liver-enzyme levels. All recovered after receiving doxycycline treatment. At least 17 of 697 Ixodes scapularis ticks collected in Minnesota or Wisconsin were positive for the same ehrlichia species on polymerase-chain-reaction testing. Genetic analyses revealed that this new ehrlichia species is closely related to E. muris. CONCLUSIONS We report a new ehrlichia species in Minnesota and Wisconsin and provide supportive clinical, epidemiologic, culture, DNA-sequence, and vector data. Physicians need to be aware of this newly discovered close relative of E. muris to ensure appropriate testing, treatment, and regional surveillance.	[Pritt, Bobbi S.] Mayo Clin, Div Clin Microbiol, Rochester, MN 55905 USA; [Munderloh, Ulrike G.; Nelson, Curtis M.] Univ Minnesota, St Paul, MN 55108 USA; [Neitzel, David F.; Liu, Gongping] Minnesota Dept Hlth, St Paul, MN USA; [Johnson, Diep K. Hoang; McFadden, Jevon D.; Steward, Christopher R.; Davis, Jeffrey P.] Wisconsin Div Publ Hlth, Madison, WI USA; [Paskewitz, Susan M.] Univ Wisconsin, Madison, WI 53706 USA; [Franson, Joni J.; Martin, Scott A.; Trivedi, Vipul A.] Mayo Clin Hlth Syst, Eau Claire, WI USA; [Bogumill, Kay] Eau Claire City Cty Hlth Dept, Eau Claire, WI USA; [Bjorgaard, Mary E.] Dept Hlth & Human Serv, Siren, WI USA; [Warshauer, David M.] Univ Wisconsin, Wisconsin State Lab Hyg, Madison, WI 53706 USA; [McFadden, Jevon D.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; [Nicholson, William L.; McQuiston, Jennifer H.; Eremeeva, Marina E.] Ctr Dis Control & Prevent, Rickettsial Zoonoses Branch, Atlanta, GA USA	Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; Minnesota Department of Health (MHD); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Pritt, BS (corresponding author), Mayo Clin, Div Clin Microbiol, Hilton 470-B,200 1st St, Rochester, MN 55905 USA.	pritt.bobbi@mayo.edu	Cunningham, Scott A/ABC-6171-2020	Cunningham, Scott/0000-0002-7589-1712; Pritt, Bobbi/0000-0003-0261-1326	National Institutes of Health [R01 AI042792]; Centers for Disease Control and Prevention;  [5U50C1000483-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institutes of Health and the Centers for Disease Control and Prevention.; Supported in part by a grant from the National Institutes of Health (R01 AI042792, to Dr. Munderloh) and a cooperative agreement with the CDC (5U50C1000483-03, to Mr. Neitzel).	Alekseev AN, 2001, J CLIN MICROBIOL, V39, P2237, DOI 10.1128/JCM.39.6.2237-2242.2001; ANDERSON BE, 1991, J CLIN MICROBIOL, V29, P2838, DOI 10.1128/JCM.29.12.2838-2842.1991; Bell CA, 2005, DIAGN MICR INFEC DIS, V53, P301, DOI 10.1016/j.diagmicrobio.2005.06.019; Buller RS, 1999, NEW ENGL J MED, V341, P148, DOI 10.1056/NEJM199907153410303; Cao WC, 2000, J CLIN MICROBIOL, V38, P2778, DOI 10.1128/JCM.38.7.2778-2780.2000; CHEN SM, 1994, J CLIN MICROBIOL, V32, P589, DOI 10.1128/JCM.32.3.589-595.1994; Childs JE, 2003, ANNU REV ENTOMOL, V48, P307, DOI 10.1146/annurev.ento.48.091801.112728; Demma LJ, 2005, AM J TROP MED HYG, V73, P400, DOI 10.4269/ajtmh.2005.73.400; Dumler JS, 2001, INT J SYST EVOL MICR, V51, P2145, DOI 10.1099/00207713-51-6-2145; Eremeeva ME, 2007, VECTOR-BORNE ZOONOT, V7, P426, DOI 10.1089/vbz.2007.0112; Eremeeva ME, 2007, NEW ENGL J MED, V356, P2381, DOI 10.1056/NEJMoa065987; Ismail N, 2010, CLIN LAB MED, V30, P261, DOI 10.1016/j.cll.2009.10.004; Kawahara M, 1999, J CLIN MICROBIOL, V37, P1123, DOI 10.1128/JCM.37.4.1123-1129.1999; Munderloh UG, 2009, ANN NY ACAD SCI, V1166, P112, DOI 10.1111/j.1749-6632.2009.04520.x; Nefedova V. V., 2008, Vestnik Rossiiskoi Akademii Meditsinskikh Nauk, P47; Nelson CM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-364; Nicholson WL, 1997, J CLIN MICROBIOL, V35, P1510, DOI 10.1128/JCM.35.6.1510-1516.1997; Olano JP, 2003, CLIN DIAGN LAB IMMUN, V10, P891, DOI 10.1128/CDLI.10.5.891-896.2003; Perez M, 1996, J CLIN MICROBIOL, V34, P2133, DOI 10.1128/JCM.34.9.2133-2139.1996; Rar VA, 2005, EMERG INFECT DIS, V11, P1708, DOI 10.3201/eid1111.041195; Spitalska E, 2008, ACTA VIROL, V52, P175; Takano A, 2009, MICROBIOL IMMUNOL, V53, P101, DOI 10.1111/j.1348-0421.2008.00093.x; Tamamoto C, 2007, VET PARASITOL, V150, P370, DOI 10.1016/j.vetpar.2007.09.017; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Telford Iii Sam R, 2011, Open Microbiol J, V5, P18, DOI 10.2174/1874285801105010018	25	149	155	2	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2011	365	5					422	429		10.1056/NEJMoa1010493	http://dx.doi.org/10.1056/NEJMoa1010493			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801NW	21812671	Green Accepted			2022-12-01	WOS:000293447800006
J	Ray, RS; Corcoran, AE; Brust, RD; Kim, JC; Richerson, GB; Nattie, E; Dymecki, SM				Ray, Russell S.; Corcoran, Andrea E.; Brust, Rachael D.; Kim, Jun Chul; Richerson, George B.; Nattie, Eugene; Dymecki, Susan M.			Impaired Respiratory and Body Temperature Control Upon Acute Serotonergic Neuron Inhibition	SCIENCE			English	Article							MEDULLARY RAPHE NEURONS; INFANT-DEATH-SYNDROME; BRAIN-STEM; RETROTRAPEZOID NUCLEUS; K+ CHANNELS; CO2; CHEMORECEPTION; RAT; CHEMOSENSITIVITY; VENTILATION	Physiological homeostasis is essential for organism survival. Highly responsive neuronal networks are involved, but their constituent neurons are just beginning to be resolved. To query brain serotonergic neurons in homeostasis, we used a neuronal silencing tool, mouse RC::FPDi (based on the synthetic G protein-coupled receptor Di), designed for cell type-specific, ligand-inducible, and reversible suppression of action potential firing. In mice harboring Di-expressing serotonergic neurons, administration of the ligand clozapine-N-oxide (CNO) by systemic injection attenuated the chemoreflex that normally increases respiration in response to tissue carbon dioxide (CO2) elevation and acidosis. At the cellular level, CNO suppressed firing rate increases evoked by CO2 acidosis. Body thermoregulation at room temperature was also disrupted after CNO triggering of Di; core temperatures plummeted, then recovered. This work establishes that serotonergic neurons regulate life-sustaining respiratory and thermoregulatory networks, and demonstrates a noninvasive tool for mapping neuron function.	[Corcoran, Andrea E.; Nattie, Eugene] Dartmouth Med Sch, Dept Physiol & Neurobiol, Lebanon, NH 03756 USA; [Kim, Jun Chul] Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada; [Richerson, George B.] Univ Iowa Hosp & Clin, Dept Neurol, Iowa City, IA 52242 USA; [Ray, Russell S.; Brust, Rachael D.; Dymecki, Susan M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Dartmouth College; University of Toronto; University of Iowa; Harvard University; Harvard Medical School	Dymecki, SM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	dymecki@genetics.med.harvard.edu		Richerson, George/0000-0001-5696-1554; Brust, Rachael/0000-0001-5375-6731	NIH [F32HD063257-01A1, 5R21DA023643-02, 5R21MH083613-02, 5P01HD036379-13, 5R01HL028066-30, 5R01HD052772]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD036379, F32HD063257] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD052772] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH083613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS073276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023643] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by NIH grants F32HD063257-01A1 (R. R.), 5R21DA023643-02 (R. B., S. D.), 5R21MH083613-02 (R. R., J.C.K., S. D.), 5P01HD036379-13 (R. R., A. C., R. B., J.C.K., E.N., G. R., S. D.), 5R01HL028066-30 (A. C., E.N.), and 5R01HD052772 (G. R.). Clozapine-N-oxide used in some preliminary experiments was provided through the NIH Rapid Access to Intervention Development Program. We thank B. Roth for providing the Di-encoding cDNA; B. Roth, W. Regehr, C. Hull, B. Sabatini, and members of the Dymecki lab for helpful discussions; and Y. Wu and J. J. Mai for technical assistance. The authors declare no conflicts of interest.	Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Bonnavion P, 2010, J COMP NEUROL, V518, P2744, DOI 10.1002/cne.22331; Cano G, 2003, J COMP NEUROL, V460, P303, DOI 10.1002/cne.10643; Corcoran AE, 2009, RESP PHYSIOL NEUROBI, V168, P49, DOI 10.1016/j.resp.2009.04.014; Depuy SD, 2011, J NEUROSCI, V31, P1981, DOI 10.1523/JNEUROSCI.4639-10.2011; Dias MB, 2008, J APPL PHYSIOL, V105, P83, DOI 10.1152/japplphysiol.00120.2008; Dubreuil V, 2009, J NEUROSCI, V29, P14836, DOI 10.1523/JNEUROSCI.2623-09.2009; Duncan JR, 2010, JAMA-J AM MED ASSOC, V303, P430, DOI 10.1001/jama.2010.45; Dymecki SM, 2007, NEURON, V54, P17, DOI 10.1016/j.neuron.2007.03.009; ELAM M, 1981, BRAIN RES, V222, P373, DOI 10.1016/0006-8993(81)91040-4; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Gobbi G, 2007, EUR NEUROPSYCHOPHARM, V17, P328, DOI 10.1016/j.euroneuro.2006.07.004; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Guyenet PG, 2010, J COMP NEUROL, V518, P3883, DOI 10.1002/cne.22435; Haldine JS, 1905, J PHYSIOL-LONDON, V32, P225; HAYASHI F, 1991, RESP PHYSIOL, V84, P61, DOI 10.1016/0034-5687(91)90019-F; Hodges MR, 2008, J NEUROSCI, V28, P2495, DOI 10.1523/JNEUROSCI.4729-07.2008; Hodges MR, 2010, J APPL PHYSIOL, V108, P1425, DOI 10.1152/japplphysiol.01270.2009; INNIS RB, 1987, EUR J PHARMACOL, V143, P195, DOI 10.1016/0014-2999(87)90533-4; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Kety S S, 2001, Biogr Mem Natl Acad Sci, V79, P66; Kim JC, 2009, NEURON, V63, P305, DOI 10.1016/j.neuron.2009.07.010; Kinney HC, 2009, ANNU REV PATHOL-MECH, V4, P517, DOI 10.1146/annurev.pathol.4.110807.092322; LEUSEN IR, 1954, AM J PHYSIOL, V176, P39, DOI 10.1152/ajplegacy.1953.176.1.39; Li A, 2008, ADV EXP MED BIOL, V605, P371; Marina N, 2010, J NEUROSCI, V30, P12466, DOI 10.1523/JNEUROSCI.3141-10.2010; Mark MD, 2000, EUR J BIOCHEM, V267, P5830, DOI 10.1046/j.1432-1327.2000.01670.x; MITCHELL RA, 1963, J APPL PHYSIOL, V18, P523, DOI 10.1152/jappl.1963.18.3.523; Morrison SF, 2008, EXP PHYSIOL, V93, P773, DOI 10.1113/expphysiol.2007.041848; Nattie E, 2011, J APPL PHYSIOL, V110, P1, DOI 10.1152/japplphysiol.01061.2010; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; PENINGTON NJ, 1993, J PHYSIOL-LONDON, V469, P387, DOI 10.1113/jphysiol.1993.sp019819; Pineyro G, 1999, PHARMACOL REV, V51, P533; RICHERSON GB, 1995, J NEUROPHYSIOL, V73, P933, DOI 10.1152/jn.1995.73.3.933; Smith CA, 2006, J APPL PHYSIOL, V100, P13, DOI 10.1152/japplphysiol.00926.2005; St-John WM, 2000, RESP PHYSIOL, V123, P201, DOI 10.1016/S0034-5687(00)00177-8; STERNBACH H, 1991, AM J PSYCHIAT, V148, P705; Wang W, 1999, NEUROSCIENCE, V90, P1001, DOI 10.1016/S0306-4522(98)00505-3; Wang WG, 1998, J PHYSIOL-LONDON, V511, P433, DOI 10.1111/j.1469-7793.1998.433bh.x; Washburn CP, 2002, J NEUROSCI, V22, P1256, DOI 10.1523/JNEUROSCI.22-04-01256.2002; Wenker IC, 2010, J NEUROPHYSIOL, V104, P3042, DOI 10.1152/jn.00544.2010; Williams RH, 2007, P NATL ACAD SCI USA, V104, P10685, DOI 10.1073/pnas.0702676104	43	232	233	3	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2011	333	6042					637	642		10.1126/science.1205295	http://dx.doi.org/10.1126/science.1205295			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21798952	Green Accepted			2022-12-01	WOS:000293222400064
J	Rodriguez, LAG; Cea-Soriano, L; Martin-Merino, E; Johansson, S				Garcia Rodriguez, Luis A.; Cea-Soriano, Luca; Martin-Merino, Elisa; Johansson, Saga			Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SECONDARY PREVENTION; CORONARY; DISEASE; GUIDELINES; WITHDRAWAL; EVENTS	Objectives To evaluate the risk of myocardial infarction and death from coronary heart disease after discontinuation of low dose aspirin in primary care patients with a history of cardiovascular events. Design Nested case-control study. Setting The Health Improvement Network (THIN) database in the United Kingdom. Participants Individuals aged 50-84 with a first prescription for aspirin (75-300 mg/day) for secondary prevention of cardiovascular outcomes in 2000-7 (n=39 513). Main outcome measures Individuals were followed up for a mean of 3.2 years to identify cases of non-fatal myocardial infarction or death from coronary heart disease. A nested case-control analysis assessed the risk of these events in those who had stopped taking low dose aspirin compared with those who had continued treatment. Results There were 876 non-fatal myocardial infarctions and 346 deaths from coronary heart disease. Compared with current users, people who had recently stopped taking aspirin had a significantly increased risk of non-fatal myocardial infarction or death from coronary heart disease combined (rate ratio 1.43, 95% confidence interval 1.12 to 1.84) and non-fatal myocardial infarction alone (1.63, 1.23 to 2.14). There was no significant association between recently stopping low dose aspirin and the risk of death from coronary heart disease (1.07, 0.67 to 1.69). For every 1000 patients, over a period of one year there were about four more cases of non-fatal myocardial infarction among patients who discontinued treatment with low dose aspirin (recent discontinuers) compared with patients who continued treatment. Conclusions Individuals with a history of cardiovascular events who stop taking low dose aspirin are at increased risk of non-fatal myocardial infarction compared with those who continue treatment.	[Garcia Rodriguez, Luis A.; Cea-Soriano, Luca; Martin-Merino, Elisa] Spanish Ctr Pharmacoepidemiol Res CEIFE, Madrid 28004, Spain; [Johansson, Saga] AstraZeneca Res & Dev, Molndal, Sweden; [Johansson, Saga] Gothenburg Univ, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden	AstraZeneca; University of Gothenburg	Rodriguez, LAG (corresponding author), Spanish Ctr Pharmacoepidemiol Res CEIFE, Madrid 28004, Spain.	lagarcia@ceife.es	rodriguez, luis a garcia/B-1980-2010; Soriano, Lucia Cea/D-4380-2018	Soriano, Lucia Cea/0000-0002-7051-0730; Martin Merino, Elisa/0000-0002-3576-8605	AstraZeneca; AstraZeneca Research and Development Molndal	AstraZeneca(AstraZeneca); AstraZeneca Research and Development Molndal(AstraZeneca)	We thank Nesta Hughes and Catherine Hill, of Oxford PharmaGenesis, who provided writing support funded by AstraZeneca.; This study was funded by an unrestricted research grant from AstraZeneca Research and Development Molndal. The sponsors played no part in the design or conduct of the study.	ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bedson J, 2001, BRIT J GEN PRACT, V51, P1001; Biondi-Zoccai GGL, 2006, EUR HEART J, V27, P2667, DOI 10.1093/eurheartj/ehl334; Bjorklund L, 2009, INT J CLIN PRACT, V63, P468, DOI 10.1111/j.1742-1241.2008.01908.x; Campbell NC, 1998, BMJ-BRIT MED J, V316, P1430, DOI 10.1136/bmj.316.7142.1430; Collet JP, 2004, CIRCULATION, V110, P2361, DOI 10.1161/01.CIR.0000145171.89690.B4; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Ferrari E, 2005, J AM COLL CARDIOL, V45, P456, DOI 10.1016/j.jacc.2004.11.041; First Data Bank, 2010, MULTILEX PRIM CAR; Rodriguez LAG, 2009, CIRCULATION, V120, pS480; Rodriguez LAG, 2008, J AM COLL CARDIOL, V52, P1628, DOI 10.1016/j.jacc.2008.08.041; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Hoper S, 1998, FAM PRACT, V15, pS10; KROL WF, 1980, CIRCULATION, V62, P449; Lanas A, 2007, CURR MED RES OPIN, V23, P162, DOI 10.1185/030079907X162656; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Maulaz AB, 2005, ARCH NEUROL-CHICAGO, V62, P1217, DOI 10.1001/archneur.62.8.1217; Newby K, 2001, CIRCULATION, V103, P1727; Ng W, 2006, WORLD J GASTROENTERO, V12, P2923, DOI 10.3748/wjg.v12.i18.2923; PEARCE N, 1993, INT J EPIDEMIOL, V22, P1189, DOI 10.1093/ije/22.6.1189; Rodriguez LAG, 2004, CIRCULATION, V109, P3000, DOI 10.1161/01.CIR.0000132491.96623.04; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3; SLATTERY J, 1995, GUT, V37, P509, DOI 10.1136/gut.37.4.509; Smith SC, 2006, J AM COLL CARDIOL, V47, P2130, DOI 10.1016/j.jacc.2006.04.026; Stuart-Buttle C D, 1996, Proc AMIA Annu Fall Symp, P75; Sud A, 2005, ANN PHARMACOTHER, V39, P1792, DOI 10.1345/aph.1G249	27	92	95	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2011	343								d4094	10.1136/bmj.d4094	http://dx.doi.org/10.1136/bmj.d4094			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	797ZG	21771831	hybrid, Green Published, Green Submitted			2022-12-01	WOS:000293168500007
J	van Dijk, EL; Chen, CL; d'Aubenton-Carafa, Y; Gourvennec, S; Kwapisz, M; Roche, V; Bertrand, C; Silvain, M; Legoix-Ne, P; Loeillet, S; Nicolas, A; Thermes, C; Morillon, A				van Dijk, E. L.; Chen, C. L.; d'Aubenton-Carafa, Y.; Gourvennec, S.; Kwapisz, M.; Roche, V.; Bertrand, C.; Silvain, M.; Legoix-Ne, P.; Loeillet, S.; Nicolas, A.; Thermes, C.; Morillon, A.			XUTs are a class of Xrn1-sensitive antisense regulatory non-coding RNA in yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; PERVASIVE TRANSCRIPTION; BIDIRECTIONAL PROMOTERS; EUKARYOTIC GENOME; S. CEREVISIAE; METHYLATION; POLYMERASE; CHROMATIN; DECAY; XRN1	Non-coding (nc)RNAs are key players in numerous biological processes such as gene regulation, chromatin domain formation and genome stability(1,2). Large ncRNAs interact with histone modifiers' and are involved in cancer development(6), X-chromosome inactivation(7) and autosomal gene imprinting(8). However, despite recent evidence showing that pervasive transcription is more widespread than previously thought(9), only a few examples mediating gene regulation in eukaryotes have been described(10). In Saccharomyces cerevisiae, the bona-fide regulatory ncRNAs are destabilized by the Xrn1 5'-3' RNA exonudease(11,12) (also known as Kem1), but the genome-wide characterization of the entire regulatory ncRNA family remains elusive. Here, using strand-specific RNA sequencing (RNA-seq), we identify a novel class of 1,658 Xrn1-sensitive unstable transcripts (XUTs) in which 66% are antisense to open reading frames. These transcripts are polyadenylated and RNA polymerase II (RNAPII)-dependent. The majority of XUTs strongly accumulate in lithium-containing media, indicating that they might have a role in adaptive responses to changes in growth conditions. Notably, RNAP II chromatin immunoprecipitation followed by DNA sequencing (ChIP-seq) analysis of Xrn1-deficient strains revealed a significant decrease of RNAPII occupancy over 273 genes with antisense XUTs. These genes show an unusual bias for H3K4me3 marks and require the Set1 histone H3 lysine 4 methyl-transferase for silencing. Furthermore, abolishing H3K4me3 triggers the silencing of other genes with antisense XUTs, supporting a model in which H3K4me3 antagonizes antisense ncRNA repressive activity. Our results demonstrate that antisense ncRNA-mediated regulation is a general regulatory pathway for gene expression in S. cerevisiae.	[van Dijk, E. L.; Chen, C. L.; d'Aubenton-Carafa, Y.; Silvain, M.; Thermes, C.; Morillon, A.] CNRS, Ctr Genet Mol, UPR 3404, F-91198 Gif Sur Yvette, France; [Gourvennec, S.; Kwapisz, M.; Roche, V.; Bertrand, C.; Morillon, A.] Univ Paris 06, CNRS, UMR3244, Inst Curie,ncRNA,Ctr Rech, F-75248 Paris 05, France; [Legoix-Ne, P.] Inst Curie, NGS Platform, F-75248 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Morillon, A (corresponding author), CNRS, Ctr Genet Mol, UPR 3404, Ave Terrasse, F-91198 Gif Sur Yvette, France.	thermes@cgm.cnrs-gif.fr; antonin.morillon@curie.fr	Morillon, Antonin/M-4751-2017; Thermes, Claude/GNP-6416-2022; CHEN, Chunlong/D-7096-2011	Morillon, Antonin/0000-0002-0575-5264; Thermes, Claude/0000-0002-0023-5294; CHEN, Chunlong/0000-0002-4795-0295; Roche, Veronique/0000-0001-8064-0507	Canceropole Ile de France; ANR "REGULncRNA"; ERC "EPIncRNA"; FRM fellowship	Canceropole Ile de France(Region Ile-de-France); ANR "REGULncRNA"(French National Research Agency (ANR)); ERC "EPIncRNA"; FRM fellowship(Fondation pour la Recherche Medicale)	We thank B. Seraphin, L. Benard and J. O'Sullivan for support and advice; B. Dichtl for insights into lithium treatment data normalization; M. Wery and A. Taddei for helpful discussions: A. Johnson, T. Kouzarides and V. Geli for generous gift of plasmids and strains. Special thanks to M. Descrimes, C. Jubin and S. Lair for technical assistance. We thank L. Steinmetz and M. Chodder for sharing unpublished results. E.L.V.D. benefits from an FRM fellowship. This work has benefited from facilities and expertise of the IMAGIF sequencing platform (Centre de Recherche de Gif). This work was financially supported by the Canceropole Ile de France, the ANR "REGULncRNA" and ERC "EPIncRNA" starting grant.	Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Berretta J, 2008, GENE DEV, V22, P615, DOI 10.1101/gad.458008; Berretta J, 2009, EMBO REP, V10, P973, DOI 10.1038/embor.2009.181; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Camblong J, 2009, GENE DEV, V23, P1534, DOI 10.1101/gad.522509; Chernyakov I, 2008, GENE DEV, V22, P1369, DOI 10.1101/gad.1654308; Chow J, 2009, CURR OPIN CELL BIOL, V21, P359, DOI 10.1016/j.ceb.2009.04.012; Dichtl B, 1997, EMBO J, V16, P7184, DOI 10.1093/emboj/16.23.7184; Dichtl E, 2004, RNA, V10, P965, DOI 10.1261/rna.7090104; Fatica A, 2000, EMBO J, V19, P6218, DOI 10.1093/emboj/19.22.6218; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Johnson AW, 1997, MOL CELL BIOL, V17, P6122, DOI 10.1128/MCB.17.10.6122; Kirmizis A, 2007, NATURE, V449, P928, DOI 10.1038/nature06160; Long RM, 2003, MOL CELL, V11, P1126, DOI 10.1016/S1097-2765(03)00198-9; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Matsuda E, 2009, P NATL ACAD SCI USA, V106, P15657, DOI 10.1073/pnas.0908305106; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; NONET M, 1987, MOL CELL BIOL, V7, P1602, DOI 10.1128/MCB.7.5.1602; Pinskaya M, 2009, EPIGENETICS-US, V4, P302, DOI 10.4161/epi.4.5.9369; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Thompson DM, 2007, MOL CELL BIOL, V27, P92, DOI 10.1128/MCB.01023-06; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yassour M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r87; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468	35	257	259	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					114	U139		10.1038/nature10118	http://dx.doi.org/10.1038/nature10118			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21697827				2022-12-01	WOS:000292461300056
J	Sykes, SM; Lane, SW; Bullinger, L; Kalaitzidis, D; Yusuf, R; Saez, B; Ferraro, F; Mercier, F; Singh, H; Brumme, KM; Acharya, SS; Scholl, C; Tothova, Z; Attar, EC; Frohling, S; DePinho, RA; Armstrong, SA; Gilliland, DG; Scadden, DT				Sykes, Stephen M.; Lane, Steven W.; Bullinger, Lars; Kalaitzidis, Demetrios; Yusuf, Rushdia; Saez, Borja; Ferraro, Francesca; Mercier, Francois; Singh, Harshabad; Brumme, Kristina M.; Acharya, Sanket S.; Schoell, Claudia; Tothova, Zuzana; Attar, Eyal C.; Froehling, Stefan; DePinho, Ronald A.; Armstrong, Scott A.; Gilliland, D. Gary; Scadden, David T.			AKT/FOXO Signaling Enforces Reversible Differentiation Blockade in Myeloid Leukemias	CELL			English	Article							HEMATOPOIETIC STEM-CELLS; PROTEIN-KINASE-B; FORKHEAD TRANSCRIPTION FACTOR; JUN ACTIVATION DOMAIN; OXIDATIVE STRESS; AKT PHOSPHORYLATION; TUMOR SUPPRESSORS; INITIATING CELLS; INSULIN; FOXO	AKT activation is associated with many malignancies, where AKT acts, in part, by inhibiting FOXO tumor suppressors. We show a converse role for AKT/FOXOs in acute myeloid leukemia (AML). Rather than decreased FOXO activity, we observed that FOXOs are active in similar to 40% of AML patient samples regardless of genetic subtype. We also observe this activity in human MLL-AF9 leukemia allele-induced AML in mice, where either activation of Akt or compound deletion of FoxO1/3/4 reduced leukemic cell growth, with the latter markedly diminishing leukemia-initiating cell (LIC) function in vivo and improving animal survival. FOXO inhibition resulted in myeloid maturation and subsequent AML cell death. FOXO activation inversely correlated with JNK/c-JUN signaling, and leukemic cells resistant to FOXO inhibition responded to JNK inhibition. These data reveal a molecular role for AKT/FOXO and JNK/c-JUN in maintaining a differentiation blockade that can be targeted to inhibit leukemias with a range of genetic lesions.	[Sykes, Stephen M.; Yusuf, Rushdia; Saez, Borja; Ferraro, Francesca; Mercier, Francois; Singh, Harshabad; Acharya, Sanket S.; Attar, Eyal C.; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Sykes, Stephen M.; Yusuf, Rushdia; Saez, Borja; Ferraro, Francesca; Mercier, Francois; Singh, Harshabad; Acharya, Sanket S.; Attar, Eyal C.; Scadden, David T.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Sykes, Stephen M.; Yusuf, Rushdia; Saez, Borja; Ferraro, Francesca; Mercier, Francois; Acharya, Sanket S.; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Lane, Steven W.; Kalaitzidis, Demetrios; Brumme, Kristina M.; Armstrong, Scott A.] Harvard Univ, Sch Med, Div Hematol Oncol, Childrens Hosp Boston, Boston, MA 02115 USA; [Tothova, Zuzana] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Belfer Inst Appl Canc Sci, Dept Med Oncol, Boston, MA 02115 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Belfer Inst Appl Canc Sci, Dept Med, Boston, MA 02115 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet, Dana Farber Canc Inst, Boston, MA 02115 USA; [Bullinger, Lars; Schoell, Claudia; Froehling, Stefan] Univ Hosp Ulm, Dept Internal Med 3, D-89081 Ulm, Germany; [Gilliland, D. Gary] Merck Res Labs, N Wales, PA 19454 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Ulm University; Merck & Company	Scadden, DT (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	dscadden@mgh.harvard.edu	Bullinger, Lars/AAL-7965-2020; Lane, Steven/C-3215-2012; Saez, Borja/L-7411-2015	Lane, Steven/0000-0002-8050-6209; DePinho, Ronald/0000-0002-5625-577X; Bullinger, Lars/0000-0002-5890-5510; Saez, Borja/0000-0001-7908-7089	NHLBI [5T32HL007623-24, U01HL100402]; Deutsche Forschungsgemeinschaft [BU 1339/3-1]; Leukemia and Lymphoma Society; Alex Lemonade Stand Foundation; Chamber of Industry and Commerce of the Government of Spain; NCI [U01CA141508, CA140575]; NIH NHLBI [HL097794, HL097748, HL100402]; NIDDK [DK050234]; Ellison Foundation; Harvard Stem Cell Institute; NATIONAL CANCER INSTITUTE [R01CA140575, U01CA141508] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097748, T32HL007623, R01HL097794, U01HL100402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050234] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Alex Lemonade Stand Foundation; Chamber of Industry and Commerce of the Government of Spain; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Ellison Foundation(Lawrence Ellison Foundation); Harvard Stem Cell Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank Dr. Christine Ragu, Dr. Andrew Lane, and Dr. David Sykes for critically reading the manuscript and providing valuable suggestions. We would also like to thank Dr. Kira Gritsman and Dr. Michael Kharas for donating the MSCV-IRES-GFP-myr-Akt construct. We would also like to thank M. Milsom for donating the LoxP-STOP-LoxP-hCD34 expression plasmid. S.M.S. was supported by NHLBI 5T32HL007623-24. L.B. was supported by the Deutsche Forschungsgemeinschaft (Heisenberg-Stipendium BU 1339/3-1). R.Y. is supported by the Leukemia and Lymphoma Society and the Alex Lemonade Stand Foundation. B.S. is supported by the Chamber of Industry and Commerce of the Government of Spain. F.F. is supported by NHLBI U01HL100402. R.A.D. was supported by NCI U01CA141508. S.A.A. was supported by the Leukemia and Lymphoma Society and NCI CA140575. D.T.S. is supported by the NIH NHLBI HL097794, HL097748, and HL100402 and NIDDK DK050234, the Ellison Foundation, and the Harvard Stem Cell Institute. D.G.G. is a full-time employee of Merck & Company, Inc.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Arden KC, 2006, EXP GERONTOL, V41, P709, DOI 10.1016/j.exger.2006.05.015; Armstrong SA, 2003, SEMIN HEMATOL, V40, P268, DOI 10.1016/S0037-1963(03)00196-3; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dash A, 2001, BEST PRACT RES CL HA, V14, P49, DOI 10.1053/beha.2000.0115; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; delPeso L, 1997, SCIENCE, V278, P687; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Frohling S, 2005, J CLIN ONCOL, V23, P6285, DOI 10.1200/JCO.2005.05.010; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Gallay N, 2009, LEUKEMIA, V23, P1029, DOI 10.1038/leu.2008.395; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kharas MG, 2010, BLOOD, V115, P1406, DOI 10.1182/blood-2009-06-229443; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lee JY, 2010, CELL STEM CELL, V7, P593, DOI 10.1016/j.stem.2010.09.015; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Park S, 2010, HAEMATOL-HEMATOL J, V95, P819, DOI 10.3324/haematol.2009.013797; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Santamaria CM, 2009, LEUKEMIA RES, V33, P1706, DOI 10.1016/j.leukres.2009.04.024; Tamburini J, 2007, BLOOD, V110, P1025, DOI 10.1182/blood-2006-12-061283; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wang Z, 2008, NATURE, V455, P1205, DOI 10.1038/nature07284; Yalcin S, 2008, J BIOL CHEM, V283, P25692, DOI 10.1074/jbc.M800517200; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703	39	198	211	1	51	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 2	2011	146	5					697	708		10.1016/j.cell.2011.07.032	http://dx.doi.org/10.1016/j.cell.2011.07.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21884932	Green Accepted, Bronze			2022-12-01	WOS:000294477500011
J	Walker, S				Walker, Shaun			PUBLIC HEALTH Russia's alcohol problem	BRITISH MEDICAL JOURNAL			English	Editorial Material												s.walker@independent.co.uk						WHO, 2014, GLOB STAT REP ALC HL; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5	2	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 17	2011	343								d5240	10.1136/bmj.d5240	http://dx.doi.org/10.1136/bmj.d5240			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811LB	21849392				2022-12-01	WOS:000294210500007
J	Rosling, A; Cox, F; Cruz-Martinez, K; Ihrmark, K; Grelet, GA; Lindahl, BD; Menkis, A; James, TY				Rosling, Anna; Cox, Filipa; Cruz-Martinez, Karelyn; Ihrmark, Katarina; Grelet, Gwen-Aelle; Lindahl, Bjorn D.; Menkis, Audrius; James, Timothy Y.			Archaeorhizomycetes: Unearthing an Ancient Class of Ubiquitous Soil Fungi	SCIENCE			English	Article							ECTOMYCORRHIZAL; DIVERSITY; COMMUNITIES; EVOLUTION; TREE; BIODIVERSITY; ASCOMYCOTA	Estimates suggest that only one-tenth of the true fungal diversity has been described. Among numerous fungal lineages known only from environmental DNA sequences, Soil Clone Group 1 is the most ubiquitous. These globally distributed fungi may dominate below-ground fungal communities, but their placement in the fungal tree of life has been uncertain. Here, we report cultures of this group and describe the class, Archaeorhizomycetes, phylogenetically placed within subphylum Taphrinomycotina in the Ascomycota. Archaeorhizomycetes comprises hundreds of cryptically reproducing filamentous species that do not form recognizable mycorrhizal structures and have saprotrophic potential, yet are omnipresent in roots and rhizosphere soil and show ecosystem and host root habitat specificity.	[Rosling, Anna; Cruz-Martinez, Karelyn; Ihrmark, Katarina; Lindahl, Bjorn D.; Menkis, Audrius] SLU, Uppsala BioCtr, Dept Forest Mycol & Pathol, S-75007 Uppsala, Sweden; [Rosling, Anna] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Cox, Filipa] Univ London Imperial Coll Sci Technol & Med, Richmond TW9 3DS, Surrey, England; [Cox, Filipa] Royal Bot Gardens, Richmond TW9 3DS, Surrey, England; [Grelet, Gwen-Aelle] Univ Aberdeen, Aberdeen AB24 3UU, Scotland; [James, Timothy Y.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Grelet, Gwen-Aelle] James Hutton Inst, Aberdeen AB24 3UU, Scotland	Swedish University of Agricultural Sciences; Indiana University System; Indiana University Bloomington; Imperial College London; Royal Botanic Gardens, Kew; University of Aberdeen; University of Michigan System; University of Michigan; James Hutton Institute	Rosling, A (corresponding author), SLU, Uppsala BioCtr, Dept Forest Mycol & Pathol, Box 7026, S-75007 Uppsala, Sweden.	anna.rosling@slu.se; tyjames@umich.edu	Menkis, Audrius/AAE-5639-2020; Finlay, Roger D/B-4731-2009; Rosling, Anna/D-1984-2012; Lindahl, Björn D./AAH-4538-2019	Finlay, Roger D/0000-0002-3652-2930; Cox, Filipa/0000-0003-1405-7481; Menkis, Audrius/0000-0002-6545-8907; Rosling, Anna/0000-0002-7003-5941	Carl Trygger Foundation; FORMAS; Natural Environment Research Council UK [NE/C003128/1]; NERC [NE/H014098/1] Funding Source: UKRI; Natural Environment Research Council [NE/H014098/1, NE/C003128/1] Funding Source: researchfish	Carl Trygger Foundation; FORMAS(Swedish Research Council Formas); Natural Environment Research Council UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding from Carl Trygger Foundation, FORMAS, and Natural Environment Research Council UK (NE/C003128/1). We thank A. Taylor and R. Landweert for isolating Archaeorhizomyces finlayi. We thank S. Redhead for advice on the taxonomy and A. Piper for help with the Latin translation. The culture of A. finlayi is available at CBS (CBS 128710) and DNA sequences for Archaeorhizomyces have been deposited at the National Center for Biotechnology Information under accession numbers JF836020 to JF836030 and FN811925 (table S3).	Anderson IC, 2003, ENVIRON MICROBIOL, V5, P1121, DOI [10.1046/j.1462-2920.2003.00383.x, 10.1046/j.1462-2920.2003.00522.x]; Castro HF, 2010, APPL ENVIRON MICROB, V76, P999, DOI 10.1128/AEM.02874-09; Cox F, 2010, ECOL LETT, V13, P1103, DOI 10.1111/j.1461-0248.2010.01494.x; Deslippe JR, 2011, GLOBAL CHANGE BIOL, V17, P1625, DOI 10.1111/j.1365-2486.2010.02318.x; Grelet GA, 2010, NEW PHYTOL, V188, P210, DOI 10.1111/j.1469-8137.2010.03353.x; HAWKSWORTH DL, 1991, MYCOL RES, V95, P641, DOI 10.1016/S0953-7562(09)80810-1; Hibbett David S., 2011, Fungal Biology Reviews, V25, P38, DOI 10.1016/j.fbr.2011.01.001; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Kjoller R, 2009, FOREST ECOL MANAG, V257, P2217, DOI 10.1016/j.foreco.2009.02.038; Landvik S, 2003, MYCOL RES, V107, P1021, DOI 10.1017/S0953756203008219; Lindahl BD, 2007, NEW PHYTOL, V173, P611, DOI 10.1111/j.1469-8137.2006.01936.x; Liu Y, 2009, MOL BIOL EVOL, V26, P27, DOI 10.1093/molbev/msn221; Menkis A, 2005, MYCORRHIZA, V16, P33, DOI 10.1007/s00572-005-0011-z; Porter TM, 2008, MOL PHYLOGENET EVOL, V46, P635, DOI 10.1016/j.ympev.2007.10.002; REDHEAD SA, 1979, MYCOLOGIA, V71, P1248, DOI 10.2307/3759112; Rincon A, 2010, FOREST ECOL MANAG, V260, P361, DOI 10.1016/j.foreco.2010.04.028; Rosling A, 2003, NEW PHYTOL, V159, P775, DOI 10.1046/j.1469-8137.2003.00829.x; Schadt CW, 2003, SCIENCE, V301, P1359, DOI 10.1126/science.1086940; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; SMITH ML, 1992, NATURE, V356, P428, DOI 10.1038/356428a0; Sugiyama J, 2006, MYCOLOGIA, V98, P996, DOI 10.3852/mycologia.98.6.996; Tedersoo L, 2009, ENVIRON MICROBIOL, V11, P3166, DOI 10.1111/j.1462-2920.2009.02020.x; Urban A, 2008, MYCORRHIZA, V18, P339, DOI 10.1007/s00572-008-0189-y; Vandenkoornhuyse P, 2002, SCIENCE, V295, P2051, DOI 10.1126/science.295.5562.2051; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; White TM., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Zwickl D.J., 2006, GENETIC ALGORITHM AP	28	193	205	1	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2011	333	6044					876	879		10.1126/science.1206958	http://dx.doi.org/10.1126/science.1206958			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21836015				2022-12-01	WOS:000293785400040
J	Kanady, JS; Tsui, EY; Day, MW; Agapie, T				Kanady, Jacob S.; Tsui, Emily Y.; Day, Michael W.; Agapie, Theodor			A Synthetic Model of the Mn3Ca Subsite of the Oxygen-Evolving Complex in Photosystem II	SCIENCE			English	Article							WATER-OXIDIZING COMPLEX; CRYSTAL-STRUCTURE; MANGANESE COMPLEX; MN4CA CLUSTER; OXIDATION; RESOLUTION; CHEMISTRY; DIOXYGEN; COBALT; MN	Within photosynthetic organisms, the oxygen-evolving complex (OEC) of photosystem II generates dioxygen from water using a catalytic Mn4CaOn cluster (n varies with the mechanism and nature of the intermediate). We report here the rational synthesis of a [Mn3CaO4](6+) cubane that structurally models the trimanganese-calcium-cubane subsite of the OEC. Structural and electrochemical comparison between Mn3CaO4 and a related Mn4O4 cubane alongside characterization of an intermediate calcium-manganese multinuclear complex reveals potential roles of calcium in facilitating high oxidation states at manganese and in the assembly of the biological cluster.	[Kanady, Jacob S.; Tsui, Emily Y.; Day, Michael W.; Agapie, Theodor] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Agapie, T (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd,MC 127-72, Pasadena, CA 91125 USA.	agapie@caltech.edu		Tsui, Emily/0000-0001-6419-3954	California Institute of Technology; Rose Hill Foundation; NSF	California Institute of Technology; Rose Hill Foundation; NSF(National Science Foundation (NSF))	We thank California Institute of Technology, the Searle Scholars Program (T.A.), the Rose Hill Foundation (J.S.K.), and the NSF Graduate Research Fellowship Program (E.Y.T.) for funding. We also thank L. M. Henling for assistance with crystallography. The Bruker KAPPA APEXII x-ray diffractometer was purchased via an NSF Chemistry Research Instrumentation and Facilities: Departmental Multi-User Instrumentation award to Caltech (CHE-0639094). Crystallographic data have been deposited at the Cambridge Crystallographic Database Centre, and copies can be obtained on request, free of charge, by quoting the publication citation and the deposition numbers 817379 (3), 817683 (4), and 817924 (5).	ARJOMAND M, 1975, J CHEM SOC DALTON, P1055, DOI 10.1039/dt9750001055; Armstrong FA, 2008, PHILOS T R SOC B, V363, P1263, DOI 10.1098/rstb.2007.2223; Barber J, 2008, PHILOS T R SOC B, V363, P1129, DOI 10.1098/rstb.2007.2208; Bartlett JE, 2008, PHILOS T R SOC B, V363, P1253, DOI 10.1098/rstb.2007.2222; Cady CW, 2008, COORDIN CHEM REV, V252, P444, DOI 10.1016/j.ccr.2007.06.002; CHEN CG, 1995, BIOCHEMISTRY-US, V34, P13511, DOI 10.1021/bi00041a031; CHRISTOU G, 1989, ACCOUNTS CHEM RES, V22, P328, DOI 10.1021/ar00165a006; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; Dau H, 2008, PHILOS T R SOC B, V363, P1237, DOI 10.1098/rstb.2007.2220; Dismukes GC, 2009, ACCOUNTS CHEM RES, V42, P1935, DOI 10.1021/ar900249x; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Fukuzumi S, 2010, NAT CHEM, V2, P756, DOI [10.1038/nchem.731, 10.1038/NCHEM.731]; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hewitt IJ, 2006, CHEM COMMUN, P2650, DOI 10.1039/b518026k; Kanan MW, 2008, SCIENCE, V321, P1072, DOI 10.1126/science.1162018; Kanan MW, 2010, J AM CHEM SOC, V132, P13692, DOI 10.1021/ja1023767; Kotzabasaki V, 2011, INORG CHEM COMMUN, V14, P213, DOI 10.1016/j.inoche.2010.10.025; LEVASON W, 1974, COORDIN CHEM REV, V12, P151, DOI 10.1016/S0010-8545(00)82026-3; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; McEvoy JP, 2005, PHOTOCH PHOTOBIO SCI, V4, P940, DOI 10.1039/b506755c; Messinger J, 2004, PHYS CHEM CHEM PHYS, V6, P4764, DOI 10.1039/b406437b; Mishra A, 2005, CHEM COMMUN, P54, DOI 10.1039/b413680b; Mishra A, 2007, CHEM COMMUN, P1538, DOI 10.1039/b701355h; Mukhopadhyay S, 2004, CHEM REV, V104, P3981, DOI 10.1021/cr0206014; Mullins CS, 2008, COORDIN CHEM REV, V252, P416, DOI 10.1016/j.ccr.2007.07.021; Najafpour MM, 2010, ANGEW CHEM INT EDIT, V49, P2233, DOI 10.1002/anie.200906745; Nayak S, 2011, DALTON T, V40, P2699, DOI 10.1039/c0dt01463j; Park YJ, 2011, J AM CHEM SOC, V133, P9258, DOI 10.1021/ja203458d; Peloquin JM, 2000, J AM CHEM SOC, V122, P10926, DOI 10.1021/ja002104f; Symes MD, 2011, J AM CHEM SOC, V133, P5174, DOI 10.1021/ja110908v; TAMURA N, 1989, BIOCHIM BIOPHYS ACTA, V976, P173, DOI 10.1016/S0005-2728(89)80227-0; Tsui EY, 2011, CHEM COMMUN, V47, P4189, DOI 10.1039/c0cc05608a; Tsui EY, 2011, ANGEW CHEM INT EDIT, V50, P1668, DOI 10.1002/anie.201005232; Tyryshkin AM, 2006, BIOCHEMISTRY-US, V45, P12876, DOI 10.1021/bi061495t; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Yagi M, 2001, CHEM REV, V101, P21, DOI 10.1021/cr980108l; Yano J, 2008, INORG CHEM, V47, P1711, DOI 10.1021/ic7016837; Yano J, 2006, SCIENCE, V314, P821, DOI 10.1126/science.1128186; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	40	422	426	5	303	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2011	333	6043					733	736		10.1126/science.1206036	http://dx.doi.org/10.1126/science.1206036			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817047				2022-12-01	WOS:000293512100036
J	Delamothe, T				Delamothe, Tony			ON THE CONTRARY Very like a fish	BRITISH MEDICAL JOURNAL			English	Editorial Material												tdelamothe@bmj.com						Angell M, 2011, NEW YORK REV BO 0623; Angell M, 2011, NEW YORK REV BO 0714; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Tallis R., 2011, APING MANKIND NEUROM; Taylor J.B., 2008, JB TAYLORS STROKE IN; Taylor JillBolte., 2009, MY STROKE INSIGHT BR; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x	7	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 3	2011	343								d4918	10.1136/bmj.d4918	http://dx.doi.org/10.1136/bmj.d4918			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805NN	21816746				2022-12-01	WOS:000293734700009
J	Paige, JS; Wu, KY; Jaffrey, SR				Paige, Jeremy S.; Wu, Karen Y.; Jaffrey, Samie R.			RNA Mimics of Green Fluorescent Protein	SCIENCE			English	Article							LIVING CELLS; POLYMERASE; INHIBITORS; LIGANDS; DYES	Green fluorescent protein (GFP) and its derivatives have transformed the use and analysis of proteins for diverse applications. Like proteins, RNA has complex roles in cellular function and is increasingly used for various applications, but a comparable approach for fluorescently tagging RNA is lacking. Here, we describe the generation of RNA aptamers that bind fluorophores resembling the fluorophore in GFP. These RNA-fluorophore complexes create a palette that spans the visible spectrum. An RNA-fluorophore complex, termed Spinach, resembles enhanced GFP and emits a green fluorescence comparable in brightness with fluorescent proteins. Spinach is markedly resistant to photobleaching, and Spinach fusion RNAs can be imaged in living cells. These RNA mimics of GFP provide an approach for genetic encoding of fluorescent RNAs.	[Paige, Jeremy S.; Wu, Karen Y.; Jaffrey, Samie R.] Cornell Univ, Dept Pharmacol, Weill Med Coll, New York, NY 10065 USA; [Jaffrey, Samie R.] Cornell Univ, Triinst Program Chem Biol, Weill Med Coll, New York, NY 10065 USA	Cornell University; Cornell University	Jaffrey, SR (corresponding author), Cornell Univ, Dept Pharmacol, Weill Med Coll, New York, NY 10065 USA.	srj2003@med.cornell.edu		Jaffrey, Samie/0000-0003-3615-6958	McKnight Neuroscience Technology Innovation Award; Weill Cornell Medical College; National Institute of Neurological Disorders and Stroke [NS064516, T32CA062948]; NATIONAL CANCER INSTITUTE [T32CA062948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064516] Funding Source: NIH RePORTER	McKnight Neuroscience Technology Innovation Award; Weill Cornell Medical College; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. S. Cohen, A. Deglincerti, J. D. Warren, and S. C. Blanchard (Weill Cornell Medical College) and D. S. Tan (Sloan-Kettering Institute) for useful comments and suggestions; D. Engelke (University of Michigan) for providing plasmids containing the 5S sequence; and F. Dardel (Universite Paris Descartes) for providing plasmids containing the tRNA scaffold sequence. This work was supported by the McKnight Neuroscience Technology Innovation Award, Weill Cornell Medical College, and National Institute of Neurological Disorders and Stroke grant NS064516 (S.R.J.) and training grant T32CA062948 (J.S.P.).	Babendure JR, 2003, J AM CHEM SOC, V125, P14716, DOI 10.1021/ja037994o; Bell AF, 2000, BIOCHEMISTRY-US, V39, P4423, DOI 10.1021/bi992675o; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Constantin TP, 2008, ORG LETT, V10, P1561, DOI 10.1021/ol702920e; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; LIAO JC, 1994, P NATL ACAD SCI USA, V91, P2659, DOI 10.1073/pnas.91.7.2659; Meech SR, 2009, CHEM SOC REV, V38, P2922, DOI 10.1039/b820168b; Murdoch K, 2002, EUR J CELL BIOL, V81, P549, DOI 10.1078/0171-9335-00271; Niwa H, 1996, P NATL ACAD SCI USA, V93, P13617, DOI 10.1073/pnas.93.24.13617; Paul CP, 2003, MOL THER, V7, P237, DOI 10.1016/S1525-0016(02)00038-2; Ponchon L, 2007, NAT METHODS, V4, P571, DOI 10.1038/NMETH1058; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Szent-Gyorgyi C, 2008, NAT BIOTECHNOL, V26, P235, DOI 10.1038/nbt1368; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Tyagi S, 2009, NAT METHODS, V6, P331, DOI [10.1038/nmeth.1321, 10.1038/NMETH.1321]; WARD WW, 1982, BIOCHEMISTRY-US, V21, P4535, DOI 10.1021/bi00262a003; Wu LP, 2003, EUKARYOT CELL, V2, P256, DOI 10.1128/EC.2.2.256-264.2003; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	23	819	862	29	573	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2011	333	6042					642	646		10.1126/science.1207339	http://dx.doi.org/10.1126/science.1207339			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21798953	Green Accepted			2022-12-01	WOS:000293222400065
J	Moreau, K; Ravikumar, B; Renna, M; Puri, C; Rubinsztein, DC				Moreau, Kevin; Ravikumar, Brinda; Renna, Maurizio; Puri, Claudia; Rubinsztein, David C.			Autophagosome Precursor Maturation Requires Homotypic Fusion	CELL			English	Article							ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; MAMMALIAN-CELLS; V-SNARES; COMPLEX; PROTEIN; MECHANISMS; GOLGI; TRAFFICKING; PHAGOPHORE	Autophagy is a catabolic process in which lysosomes degrade intracytoplasmic contents transported in double-membraned autophagosomes. Autophagosomes are formed by the elongation and fusion of phagophores, which can be derived from preautophagosomal structures coming from the plasma membrane and other sites like the endoplasmic reticulum and mitochondria. The mechanisms by which preautophagosomal structures elongate their membranes and mature toward fully formed autophagosomes still remain unknown. Here, we show that the maturation of the early Atg16L1 precursors requires homotypic fusion, which is essential for subsequent autophagosome formation. Atg16L1 precursor homotypic fusion depends on the SNARE protein VAMP7 together with partner SNAREs. Atg16L1 precursor homotypic fusion is a critical event in the early phases of autophagy that couples membrane acquisition and autophagosome biogenesis, as this step regulates the size of the vesicles, which in turn appears to influence their subsequent maturation into LC3-positive autophagosomes.	[Moreau, Kevin; Ravikumar, Brinda; Renna, Maurizio; Puri, Claudia; Rubinsztein, David C.] Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 20Y, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital	Rubinsztein, DC (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Wellcome MRC Bldg,Hills Rd, Cambridge CB2 20Y, England.	dcr1000@hermes.cam.ac.uk	Rubinsztein, David C/C-3472-2011		Wellcome Trust; MRC; Cancer Research UK; Medical Research Council [G0600194] Funding Source: researchfish; MRC [G0600194] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful for funding from a Wellcome Trust Senior Clinical Research Fellowship (D.C.R.), an MRC Programme grant (D.C.R.), and Cancer Research UK (C.P.). We thank Tamotsu Yoshimori, Ramnik Xavier, Nicholas Ktistakis, Thierry Galli, Marc Coppolino, and Andrew Peden for reagents, Maike Lichtenberg for helpful assistance, and Paul Luzio and Lena Wartosch for helpful comments on the manuscript.	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Barysch SV, 2010, NAT PROTOC, V5, P1127, DOI 10.1038/nprot.2010.84; Bethani I, 2009, TRAFFIC, V10, P1543, DOI 10.1111/j.1600-0854.2009.00959.x; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Caplan S, 2001, J CELL BIOL, V154, P109, DOI 10.1083/jcb.200102142; Chaineau M, 2009, FEBS LETT, V583, P3817, DOI 10.1016/j.febslet.2009.10.026; Chaineau M, 2008, J BIOL CHEM, V283, P34365, DOI 10.1074/jbc.M804587200; Furuta N, 2010, MOL BIOL CELL, V21, P1001, DOI 10.1091/mbc.E09-08-0693; Gordon DE, 2010, TRAFFIC, V11, P1191, DOI 10.1111/j.1600-0854.2010.01087.x; Gordon DE, 2009, EMBO REP, V10, P851, DOI 10.1038/embor.2009.96; Guo ZH, 1998, CELL, V94, P537, DOI 10.1016/S0092-8674(00)81594-9; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Fader CM, 2009, BBA-MOL CELL RES, V1793, P1901, DOI 10.1016/j.bbamcr.2009.09.011; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; MONTECUCCO C, 1993, TRENDS BIOCHEM SCI, V18, P324, DOI 10.1016/0968-0004(93)90065-U; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Pocard T, 2007, J CELL SCI, V120, P3309, DOI 10.1242/jcs.007948; Proux-Gillardeaux V, 2005, TRAFFIC, V6, P366, DOI 10.1111/j.1600-0854.2005.00288.x; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Puri C, 2009, J BIOL CHEM, V284, P34998, DOI 10.1074/jbc.M109.012328; Randhawa VK, 2004, MOL BIOL CELL, V15, P5565, DOI 10.1091/mbc.E04-03-0266; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Ravikumar B, 2009, J CELL SCI, V122, P1707, DOI 10.1242/jcs.031773; Renna M, 2011, J CELL SCI, V124, P469, DOI 10.1242/jcs.076489; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Sarkar S, 2009, AUTOPHAGY, V5, P307, DOI 10.4161/auto.5.3.7664; Skalski M, 2005, BIOCHEM BIOPH RES CO, V335, P1199, DOI 10.1016/j.bbrc.2005.07.195; van der Vaart A, 2010, MOL BIOL CELL, V21, P2270, DOI 10.1091/mbc.E09-04-0345; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yen WL, 2010, J CELL BIOL, V188, P101, DOI 10.1083/jcb.200904075; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180	44	283	290	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 22	2011	146	2					303	317		10.1016/j.cell.2011.06.023	http://dx.doi.org/10.1016/j.cell.2011.06.023			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	795XS	21784250	Green Published, hybrid			2022-12-01	WOS:000293013000012
J	Montaner, JSG				Montaner, Julio S. G.			Treatment as prevention-a double hat-trick	LANCET			English	Editorial Material							ACTIVE ANTIRETROVIRAL THERAPY; HIV TRANSMISSION; ACCESS; EPIDEMIC; STRATEGY; GROWTH; CURB		[Montaner, Julio S. G.] Univ British Columbia, Fac Med, Div Aids, Vancouver, BC, Canada; [Montaner, Julio S. G.] St Pauls Hosp, BC Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Montaner, Julio S. G.] Providence Healthcare, Vancouver, BC, Canada	University of British Columbia; B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan	Montaner, JSG (corresponding author), Univ British Columbia, Fac Med, Div Aids, Vancouver, BC, Canada.	jmontaner@cfenet.ubc.ca	Montaner, Julio/K-7621-2012		CIHR Funding Source: Medline; NIDA NIH HHS [1DP1DA026182-01, DP1 DA026182] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026182] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		[Anonymous], 2011, LANCET, V377, P1719, DOI 10.1016/S0140-6736(11)60713-7; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Kirk G, 2011, 18 C RETR OPP INF BO, P484; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; *NAT I ALL INF DIS, 2011, TREAT HIV INF PEOPL; *NAT I ALL INF DIS, 2011, HPTN 052 STUD PREV S; Sturt AS, 2010, COCHRANE DB SYST REV, V3; Volkow ND, 2010, JAMA-J AM MED ASSOC, V303, P1423, DOI 10.1001/jama.2010.421; Wagner BG, 2010, AIDS, V24, P775, DOI 10.1097/QAD.0b013e3283366782; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649; 2011, INT TREATM PREV WORK	17	94	99	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 16	2011	378	9787					208	209		10.1016/S0140-6736(11)60821-0	http://dx.doi.org/10.1016/S0140-6736(11)60821-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	798JD	21763923				2022-12-01	WOS:000293201100008
J	Li, Y; Yin, J; Cai, XY; Temkin-Greener, H; Mukamel, DB				Li, Yue; Yin, Jun; Cai, Xueya; Temkin-Greener, Helena; Mukamel, Dana B.			Association of Race and Sites of Care With Pressure Ulcers in High-Risk Nursing Home Residents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINIMUM DATA SET; PAY-FOR-PERFORMANCE; RACIAL DISPARITIES; QUALITY; MANAGEMENT; US; PREVALENCE; ADJUSTMENT; FACILITIES; VALIDITY	Context A variety of nursing home quality improvement programs have been implemented during the last decade but their implications for racial disparities on quality are unknown. Objectives To determine the longitudinal trend of racial disparities in pressure ulcer prevalence among high-risk, long-term nursing home residents and to assess whether persistent disparities are related to where residents received care. Design, Setting, and Participants Observational cohort study of pressure ulcer rates in 2.1 million white and 346 808 black residents of 12 473 certified nursing homes in the United States that used the nursing home resident assessment; Online Survey, Certification, and Reporting files; and Area Resource Files for 2003 through 2008. Nursing homes were categorized according to their proportions of black residents. Main Outcome Measures Risk-adjusted racial disparities between and within sites of care and risk-adjusted odds of pressure ulcers in stages 2 through 4 for black and white residents receiving care in different nursing home facilities. Results Pressure ulcer rates decreased overall from 2003 through 2008 but black residents of nursing homes showed persistently higher pressure ulcer rates than white residents. In 2003, the pressure ulcer rate was 16.8% (95% confidence interval [CI], 16.6%-17.0%) for black nursing home residents compared with 11.4% (95% CI, 11.3%-11.5%) for white residents; in 2008, the rate was 14.6% (95% CI, 14.4%-14.8%) compared with 9.6%(95% CI, 9.5%-9.7%), respectively (P>.05 for trend of disparities). In nursing homes with the highest percentages of black residents (>= 35%), both black residents (unadjusted rate of 15.5% [95% CI, 15.2%-15.8%] in 2008; adjusted odds ratio [AOR], 1.59 [95% CI, 1.52-1.67]) and white residents (unadjusted rate of 12.1% [95% CI, 11.8%12.4%]; AOR, 1.33 [95% CI, 1.26-1.40]) had higher rates of pressure ulcers than nursing homes serving primarily white residents (concentration of black residents <5%), in which white residents had an unadjusted rate of 8.8% (95% CI, 8.7%-8.9%). Conclusions From 2003 through 2008, the prevalence of pressure ulcers among high-risk nursing home residents was higher among black residents than among white residents. This disparity was in part related to the site of nursing home care. JAMA. 2011;306(2):179-186	[Li, Yue; Cai, Xueya] Univ Iowa, Div Gen Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Yin, Jun; Cai, Xueya] Univ Iowa, Dept Biostat, Iowa City, IA 52242 USA; [Li, Yue; Cai, Xueya] Iowa City VA Med Ctr, Ctr Comprehens Access & Delivery Res Evaluat, Iowa City, IA USA; [Temkin-Greener, Helena] Univ Rochester, Med Ctr, Dept Community & Prevent Med, Rochester, NY 14642 USA; [Mukamel, Dana B.] Univ Calif Irvine, Dept Med, Hlth Policy Res Inst, Irvine, CA 92717 USA	University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Rochester; University of California System; University of California Irvine	Li, Y (corresponding author), Univ Iowa, Div Gen Internal Med, Carver Coll Med, 200 Hawkins Dr,Box C44-N GH, Iowa City, IA 52242 USA.	yue-li@uiowa.edu			National Institute on Aging [R01AG032264]; NATIONAL INSTITUTE ON AGING [R01AG032264] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by grant R01AG032264 from the National Institute on Aging.	*ABT ASS INC, 2006, QUAL MON MED GLOB PA; *ABT ASS INC, 2004, QUAL MEAS NAT PUBL R; Agency for Healthcare Research and Quality (AHRQ), 2009, NAT HEALTHC DISP REP; Allsworth JE, 2005, ETHNIC DIS, V15, P205; [Anonymous], 2003, ANAL PANEL DATA; Baier Rosa R, 2003, J Am Med Dir Assoc, V4, P291, DOI 10.1016/S1525-8610(04)70387-4; Baumgarten M, 2004, J AM GERIATR SOC, V52, P1293, DOI 10.1111/j.1532-5415.2004.52358.x; Berlowitz DR, 1996, ANN INTERN MED, V124, P557, DOI 10.7326/0003-4819-124-6-199603150-00003; Berlowitz DR, 2001, J AM GERIATR SOC, V49, P872, DOI 10.1046/j.1532-5415.2001.49176.x; BERLOWITZ DR, 1993, IMPROVING CARE NURSI; Bernabei R, 1998, JAMA-J AM MED ASSOC, V279, P1877, DOI 10.1001/jama.279.23.1877; BRANDEIS GH, 1990, JAMA-J AM MED ASSOC, V264, P2905, DOI 10.1001/jama.264.22.2905; Cai SB, 2010, MED CARE, V48, P233, DOI 10.1097/MLR.0b013e3181ca2810; Casalino LP, 2007, HEALTH AFFAIR, V26, pW405, DOI 10.1377/hlthaff.26.3.w405; Fennell ML, 2010, HEALTH AFFAIR, V29, P65, DOI 10.1377/hlthaff.2009.0003; *GEN ACC OFF, 2003, NURS HOM QUAL PREV S; Grabowski DC, 2003, J HEALTH ECON, V22, P1, DOI 10.1016/S0167-6296(02)00093-0; Harrington C, 2004, J HEALTH POLIT POLIC, V29, P43, DOI 10.1215/03616878-29-1-43; Harrington C, 2001, AM J PUBLIC HEALTH, V91, P1452, DOI 10.2105/AJPH.91.9.1452; Institute of Medicine, IMPR QUAL CAR NURS H; Jones Adrienne L, 2009, Vital Health Stat 13, P1; Konetzka RT, 2009, MED CARE RES REV, V66, P491, DOI 10.1177/1077558709331813; Lapane KL, 2005, J AM GERIATR SOC, V53, P1077, DOI 10.1111/j.1532-5415.2005.53338_5.x; Lawton MP, 1998, J AM GERIATR SOC, V46, P736, DOI 10.1111/j.1532-5415.1998.tb03809.x; Li Y, 2010, AM J PUBLIC HEALTH, V100, pS256, DOI 10.2105/AJPH.2009.173468; Mor V, 2004, MED CARE, V42, P50, DOI 10.1097/01.mlr.0000120104.01232.5e; Mor V, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-20; Mor V, 2004, MILBANK Q, V82, P227, DOI 10.1111/j.0887-378X.2004.00309.x; Mor V, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-78; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; Mukamel DB, 2008, HEALTH SERV RES, V43, P1244, DOI 10.1111/j.1475-6773.2007.00829.x; Mukamel DB, 2007, J GERONTOL B-PSYCHOL, V62, pS218, DOI 10.1093/geronb/62.4.S218; Rantz MJ, 2003, GERONTOLOGIST, V43, P248, DOI 10.1093/geront/43.2.248; Reddy M, 2008, JAMA-J AM MED ASSOC, V300, P2647, DOI 10.1001/jama.2008.778; Rollow W, 2006, ANN INTERN MED, V145, P342, DOI 10.7326/0003-4819-145-5-200609050-00134; Rosen Jules, 2006, Adv Skin Wound Care, V19, P262, DOI 10.1097/00129334-200606000-00011; Rosen J, 2006, J AM MED DIR ASSOC, V7, P141, DOI 10.1016/j.jamda.2005.08.003; Smith DB, 2007, HEALTH AFFAIR, V26, P1448, DOI 10.1377/hlthaff.26.5.1448; Stevenson DG, 2009, J AM GERIATR SOC, V57, P1678, DOI 10.1111/j.1532-5415.2009.02401.x; Werner R, 2010, HEALTH AFFAIR, V29, P1706, DOI 10.1377/hlthaff.2009.0556; Werner RM, 2010, MED CARE RES REV, V67, P364, DOI 10.1177/1077558709350885; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	42	69	69	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2011	306	2					179	186		10.1001/jama.2011.942	http://dx.doi.org/10.1001/jama.2011.942			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	791CO	21750295	Green Accepted, Bronze			2022-12-01	WOS:000292639400025
J	Chandra, FA; Buzi, G; Doyle, JC				Chandra, Fiona A.; Buzi, Gentian; Doyle, John C.			Glycolytic Oscillations and Limits on Robust Efficiency	SCIENCE			English	Article							YEAST; LIMITATIONS	Both engineering and evolution are constrained by trade-offs between efficiency and robustness, but theory that formalizes this fact is limited. For a simple two-state model of glycolysis, we explicitly derive analytic equations for hard trade-offs between robustness and efficiency with oscillations as an inevitable side effect. The model describes how the trade-offs arise from individual parameters, including the interplay of feedback control with autocatalysis of network products necessary to power and catalyze intermediate reactions. We then use control theory to prove that the essential features of these hard trade-off "laws" are universal and fundamental, in that they depend minimally on the details of this system and generalize to the robust efficiency of any autocatalytic network. The theory also suggests worst-case conditions that are consistent with initial experiments.	[Chandra, Fiona A.] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA; [Buzi, Gentian; Doyle, John C.] CALTECH, Dept Control & Dynam Syst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Chandra, FA (corresponding author), CALTECH, Dept Bioengn, Pasadena, CA 91125 USA.	fiona@caltech.edu		/0000-0001-8370-3374	NIH [R01GM078992A]; Institute of Collaborative Biotechnologies from the U.S. Army Research Office [KK4102, DAAD19-03-D-0004]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Collaborative Biotechnologies from the U.S. Army Research Office	The authors thank H. El-Samad and J. Stewart-Ornstein at the University of California, San Francisco, for their laboratory space and assistance; N. Pierce (Ray Deshaies' lab) for the green fluorescent protein library; O. Venturelli (Richard Murray's lab) for her help; and M. Csete for helpful feedback. Microscopy was performed at the Nikon Imaging Center at UCSF. Experimental data are available in SOM. This work is supported by the NIH (award R01GM078992A) and Institute of Collaborative Biotechnologies from the U.S. Army Research Office (subaward KK4102, prime award DAAD19-03-D-0004).	Alderson DL, 2010, IEEE T SYST MAN CY A, V40, P839, DOI 10.1109/TSMCA.2010.2048027; Astrom KJ., 2008, FEEDBACK SYSTEMS INT; BETZ A, 1965, ARCH BIOCHEM BIOPHYS, V109, P585, DOI 10.1016/0003-9861(65)90404-2; Bier M, 1996, BIOPHYS CHEM, V62, P15, DOI 10.1016/S0301-4622(96)02195-3; Buzi G, 2011, AUTOMATICA, V47, P1123, DOI 10.1016/j.automatica.2011.02.040; Chernyak BV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P240, DOI 10.1007/s10541-005-0106-3; Csete ME, 2002, SCIENCE, V295, P1664, DOI 10.1126/science.1069981; Doyle J., 1992, FEEDBACK CONTROL THE; GHOSH A, 1964, BIOCHEM BIOPH RES CO, V16, P174, DOI 10.1016/0006-291X(64)90357-2; Goldbeter A., 1996, BIOCH OSCILLATIONS C; Hynne R, 2001, BIOPHYS CHEM, V94, P121; Iglesias PA., 2010, CONTROL THEORY SYSTE; Lander AD, 2004, PLOS BIOL, V2, P712, DOI 10.1371/journal.pbio.0020164; Lestas I, 2010, NATURE, V467, P174, DOI 10.1038/nature09333; Martins NC, 2007, IEEE T AUTOMAT CONTR, V52, P56, DOI 10.1109/TAC.2006.887898; Poulsen AK, 2007, BIOPHYS CHEM, V125, P275, DOI 10.1016/j.bpc.2006.08.009; Richard P, 2003, FEMS MICROBIOL REV, V27, P547, DOI 10.1016/S0168-6445(03)00065-2; RICHTER PH, 1981, SCIENCE, V211, P715, DOI 10.1126/science.6450447; Sandberg H, 2011, IEEE T AUTOMAT CONTR, V56, P293, DOI 10.1109/TAC.2010.2056450; SELKOV E, 1975, EUR J BIOCHEM, V59, P151, DOI 10.1111/j.1432-1033.1975.tb02436.x; Stahlberg A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-170; TERMONIA Y, 1981, P NATL ACAD SCI-BIOL, V78, P2952, DOI 10.1073/pnas.78.5.2952; Teusink B, 1996, BBA-BIOENERGETICS, V1275, P204, DOI 10.1016/0005-2728(96)00026-6	23	133	135	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2011	333	6039					187	192		10.1126/science.1200705	http://dx.doi.org/10.1126/science.1200705			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21737735	Green Published			2022-12-01	WOS:000292502700040
J	Baker, M				Baker, Monya			TECHNOLOGY FEATURE Inside the minds of mice and men	NATURE			English	Editorial Material							MOUSE; BEHAVIORS; DEFECTS											Abazyan B, 2010, BIOL PSYCHIAT, V68, P1172, DOI 10.1016/j.biopsych.2010.09.022; Bissonette GB, 2008, J NEUROSCI, V28, P11124, DOI 10.1523/JNEUROSCI.2820-08.2008; Bussey TJ, 2012, NEUROPHARMACOLOGY, V62, P1191, DOI 10.1016/j.neuropharm.2011.04.011; Goulding EH, 2008, P NATL ACAD SCI USA, V105, P20575, DOI 10.1073/pnas.0809053106; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Krueger DD, 2011, ANNU REV MED, V62, P411, DOI 10.1146/annurev-med-061109-134644; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/nmeth.1455, 10.1038/NMETH.1455]; Lutz C. M., J CLIN INVE IN PRESS; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Spencer CM, 2011, AUTISM RES, V4, P40, DOI 10.1002/aur.168; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Yang M, 2011, AUTISM RES, V4, P17, DOI 10.1002/aur.163	12	49	49	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					123	128		10.1038/475123a	http://dx.doi.org/10.1038/475123a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21734709	Bronze			2022-12-01	WOS:000292461300061
J	van de Kamp, T; Vagovic, P; Baumbach, T; Riedel, A				van de Kamp, Thomas; Vagovic, Patrik; Baumbach, Tilo; Riedel, Alexander			A Biological Screw in a Beetle's Leg	SCIENCE			English	Article									[van de Kamp, Thomas; Riedel, Alexander] State Museum Nat Hist SMNK, D-76133 Karlsruhe, Germany; [van de Kamp, Thomas; Vagovic, Patrik; Baumbach, Tilo] Karlsruhe Inst Technol, ANKA Inst Synchrotron Radiat, D-76344 Eggenstein Leopoldshafen, Germany; [van de Kamp, Thomas] Univ Dusseldorf, Inst Zool 2, D-40225 Dusseldorf, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Heinrich Heine University Dusseldorf	Riedel, A (corresponding author), State Museum Nat Hist SMNK, D-76133 Karlsruhe, Germany.	riedel@smnk.de	Baumbach, Tilo Gerd/K-5355-2013; van de Kamp, Thomas/G-1440-2016; Vagovic, Patrik/H-1193-2013; Riedel, Alexander/V-2608-2019	van de Kamp, Thomas/0000-0001-7390-1318; Riedel, Alexander/0000-0002-8291-4425	German Research Foundation [RI 1817/3-1]	German Research Foundation(German Research Foundation (DFG))	We are grateful to F. Glaw encouraging us to prepare the initial manuscript, to S. Scharf for performing the segmentation of mu CT scans, and to D. Pelliccia for his assistance during the scans. M. Balke, O. Betz, and M. Spies kindly revised earlier drafts. The specimens examined are deposited at SMNK. The image data are stored at www. morphdbase. de?A_Riedel_20110523-M-4.1. This work was supported by grant RI 1817/3-1 from the German Research Foundation.	Betz O, 2007, J MICROSC-OXFORD, V227, P51, DOI 10.1111/j.1365-2818.2007.01785.x; Bogelsack G, 2000, THEOR BIOSCI, V119, P104, DOI 10.1078/1431-7613-00008; Chamorro-Lacayo ML, 2004, ZOOTAXA, P1; Frantsevich L, 2009, ARTHROPOD STRUCT DEV, V38, P16, DOI 10.1016/j.asd.2008.06.002; Larsen O., 1966, Opuscula Entomologica Suppl, V30, P1; Reuleaux F., 1900, LEHRBUCH KINEMATIK, V2, P723; Riedel A, 2010, ZOOL SCR, V39, P63, DOI 10.1111/j.1463-6409.2009.00404.x	7	39	40	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2011	333	6038					52	52		10.1126/science.1204245	http://dx.doi.org/10.1126/science.1204245			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719669				2022-12-01	WOS:000292255400044
J	Gilbert, N				Gilbert, Natasha			The seeds of an economy	NATURE			English	Editorial Material									Nature, London, England		Gilbert, N (corresponding author), Nature, London, England.								0	14	15	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S18	S19		10.1038/474S018a	http://dx.doi.org/10.1038/474S018a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697837	Bronze			2022-12-01	WOS:000291939700007
J	Balarajan, Y; Ramakrishnan, U; Ozaltin, E; Shankar, AH; Subramanian, SV				Balarajan, Yarlini; Ramakrishnan, Usha; Oezaltin, Emre; Shankar, Anuraj H.; Subramanian, S. V.			Anaemia in low-income and middle-income countries	LANCET			English	Review							IRON-DEFICIENCY ANEMIA; ROUTINE PROPHYLACTIC SUPPLEMENTATION; TRANSMITTED HELMINTH INFECTIONS; FOLIC-ACID; HEMOGLOBIN CONCENTRATION; FOLATE-DEFICIENCY; HIGH PREVALENCE; WHEAT-FLOUR; HEALTH; WOMEN	Anaemia affects a quarter of the global population, including 293 million (47%) children younger than 5 years and 468 million (30%) non-pregnant women. In addition to anaemia's adverse health consequences, the economic effect of anaemia on human capital results in the loss of billions of dollars annually. In this paper, we review the epidemiology, clinical assessment, pathophysiology, and consequences of anaemia in low-income and middle-income countries. Our analysis shows that anaemia is disproportionately concentrated in low socioeconomic groups, and that maternal anaemia is strongly associated with child anaemia. Anaemia has multifactorial causes involving complex interaction between nutrition, infectious diseases, and other factors, and this complexity presents a challenge to effectively address the population determinants of anaemia. Reduction of knowledge gaps in research and policy and improvement of the implementation of effective population-level strategies will help to alleviate the anaemia burden in low-resource settings.	[Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Balarajan, Yarlini; Oezaltin, Emre] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Shankar, Anuraj H.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Ramakrishnan, Usha] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Emory University; Rollins School Public Health	Subramanian, SV (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	svsubram@hsph.harvard.edu	Ramakrishnan, Usha/L-8921-2016; Shankar, Anuraj/U-3764-2018	Shankar, Anuraj/0000-0001-7268-6708				Abu-Saad K, 2010, EPIDEMIOL REV, V32, P5, DOI 10.1093/epirev/mxq001; Adetifa I, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006736.pub2; Albonico M, 1998, INT J EPIDEMIOL, V27, P530, DOI 10.1093/ije/27.3.530; Alderman H, 2009, FOOD NUTR BULL, V30, P265, DOI 10.1177/156482650903000308; Allen L, 2008, Med Trop (Mars), V68, P182; Allen LH, 2004, NUTR REV, V62, pS29, DOI 10.1111/j.1753-4887.2004.tb00069.x; Allen LH, 2002, J NUTR, V132, p813S, DOI 10.1093/jn/132.4.813S; Allen LH, 2000, AM J CLIN NUTR, V71, p1280S, DOI 10.1093/ajcn/71.5.1280s; Allen LH, 2009, AM J CLIN NUTR, V89, p693S, DOI 10.3945/ajcn.2008.26947A; ANDERSON RM, 1985, ADV PARASIT, V24, P1, DOI 10.1016/S0065-308X(08)60561-8; Antony AC, 2003, AM J CLIN NUTR, V78, P3, DOI 10.1093/ajcn/78.1.3; Antony AC, 2001, AM J CLIN NUTR, V74, P157; Baltussen R, 2004, J NUTR, V134, P2678, DOI 10.1093/jn/134.10.2678; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Beutler E, 2006, BLOOD, V107, P1747, DOI 10.1182/blood-2005-07-3046; Bhutta Z.A., 2010, GLOB HLTH WORKFORCE, V1, P61; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Bondevik GT, 2001, EUR J CLIN NUTR, V55, P856, DOI 10.1038/sj.ejcn.1601236; Bothwell TH, 2000, AM J CLIN NUTR, V72, p257S, DOI 10.1093/ajcn/72.1.257S; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Brooker S, 2000, ADV PARASIT, V47, P245, DOI 10.1016/S0065-308X(00)47011-9; Brooker S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000291; Brooker S, 2007, AM J TROP MED HYG, V77, P88, DOI 10.4269/ajtmh.2007.77.88; Brooker S, 2009, INT J PARASITOL, V39, P591, DOI 10.1016/j.ijpara.2008.10.014; Calis JCJ, 2008, AIDS, V22, P1099, DOI 10.1097/QAD.0b013e3282fa759f; Chalco Juan P, 2005, BMC Pediatr, V5, P46, DOI 10.1186/1471-2431-5-46; Chaparro CM, 2008, J NUTR, V138, P2529, DOI 10.1093/jn/138.12.2529; Colomer J, 1990, Paediatr Perinat Epidemiol, V4, P196, DOI 10.1111/j.1365-3016.1990.tb00638.x; Consensus Consensus Center, 2008, COP CONS 2008 RES; DALLMAN PR, 1978, AM J CLIN NUTR, V31, P377, DOI 10.1093/ajcn/31.3.377; de Pee S, 2002, J NUTR, V132, P2215, DOI 10.1093/jn/132.8.2215; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Duggan CMD, 2008, NUTR PEDIAT BASIC SC; Ezzati M., 2004, COMP QUANTIFICATION; Fiedler JL, 2008, INT J HEALTH PLAN M, V23, P373, DOI 10.1002/hpm.928; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; Fishman SM, 2000, PUBLIC HEALTH NUTR, V3, P125, DOI 10.1017/S1368980000000173; Friedman JF, 2005, TRENDS PARASITOL, V21, P386, DOI 10.1016/j.pt.2005.06.006; Ghosh S, 2009, J BIOSOC SCI, V41, P763, DOI 10.1017/S0021932009990149; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; GUILLEBAUD J, 1976, LANCET, V1, P387; Gulani A, 2007, BMJ-BRIT MED J, V334, P1095, DOI 10.1136/bmj.39150.510475.AE; Gwatkin DR, 2000, SOCIOECONOMIC DIFF E; Haas JD, 2001, J NUTR, V131, p676S, DOI 10.1093/jn/131.2.676S; Himes JH, 1997, AM J CLIN NUTR, V65, P831, DOI 10.1093/ajcn/65.3.831; Horton S, 2007, FOOD POLICY, V32, P141, DOI 10.1016/j.foodpol.2006.08.002; Horton S, 2003, FOOD POLICY, V28, P51, DOI 10.1016/S0306-9192(02)00070-2; Horton S, 2010, SCALING NUTR WHAT WI; Horton S, 2008, CHALLENGE PAPER HUNG; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Hotez PJ, 2004, NEW ENGL J MED, V351, P799, DOI 10.1056/NEJMra032492; Hurrell RF, 1999, BRIT J NUTR, V81, P289, DOI 10.1017/S0007114599000537; Hurrell R, 2010, FOOD NUTR BULL, V31, pS7, DOI 10.1177/15648265100311S102; JOHNSONSPEAR MA, 1994, AM J CLIN NUTR, V60, P117, DOI 10.1093/ajcn/60.1.117; Kalaivani K, 2009, INDIAN J MED RES, V130, P627; Khusun H, 1999, J NUTR, V129, P1669, DOI 10.1093/jn/129.9.1669; Klemm RDW, 2010, FOOD NUTR BULL, V31, pS47, DOI 10.1177/15648265100311S105; Lengeler C, 2004, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000363.PUB2; Lozoff B, 2003, PEDIATRICS, V112, P846; Lutter CK, 2008, J NUTR, V138, P2523, DOI 10.3945/jn.108.095406; Mason John, 2005, Food and Nutrition Bulletin, V26, P59; McCann JC, 2007, AM J CLIN NUTR, V85, P931, DOI 10.1093/ajcn/85.4.931; McGarvey ST, 1996, AM J TROP MED HYG, V54, P498, DOI 10.4269/ajtmh.1996.54.498; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Measure DHS, DEM HLTH SURV; Mei ZG, 2005, J NUTR, V135, P1974, DOI 10.1093/jn/135.8.1974; Meinzen-Derr JK, 2006, J NUTR, V136, P452, DOI 10.1093/jn/136.2.452; Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9; Meremikwu M, 2008, COCHRANE DB SYST REV, V2; Metz J, 2008, FOOD NUTR BULL, V29, pS74, DOI 10.1177/15648265080292S111; Micronutrient Initiative, 2009, INV FUT UN CALL ACT; Milman N, 2008, ANN HEMATOL, V87, P949, DOI 10.1007/s00277-008-0518-4; Milman N, 2006, ANN HEMATOL, V85, P559, DOI 10.1007/s00277-006-0108-2; Misra A, 2002, EUR J NUTR, V41, P68, DOI 10.1007/s003940200010; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; Modood-ul-Mannan, 1995, J Pak Med Assoc, V45, P187; Muhsen K, 2008, HELICOBACTER, V13, P323, DOI 10.1111/j.1523-5378.2008.00617.x; Ngnie-Teta I, 2009, PUBLIC HEALTH NUTR, V12, P1462, DOI 10.1017/S1368980008004400; Ojukwu J, 2009, COCHRANE DB SYST REV, V4; Pena-Rosas JP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004736.pub3; Prentice AM, 2008, J NUTR, V138, P2537, DOI 10.3945/jn.108.098806; Qu XH, 2010, WORLD J GASTROENTERO, V16, P886, DOI 10.3748/wjg.v16.i7.886; Ramakrishnan U, 2001, NUTR ANEMIAS; Rasmussen KM, 2001, J NUTR, V131, p590S, DOI 10.1093/jn/131.2.590S; Rutstein SO, 2003, GUIDE DHS STAT; Rutstein SO, 2004, 6 ORC MACR; Sari M, 2001, B WORLD HEALTH ORGAN, V79, P506; SAVAGE D, 1994, BRIT J HAEMATOL, V86, P844, DOI 10.1111/j.1365-2141.1994.tb04840.x; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Semba RD, 2008, NUTR HEALTH SER, P1, DOI 10.1007/978-1-59745-464-3; Semba RD, 2010, AM J CLIN NUTR, V92, P170, DOI 10.3945/ajcn.2010.29254; Shamah-Levy T, 2003, SALUD PUBLICA MEXICO, V45, pS499; Shankar A, 2008, LANCET, V371, P1223, DOI 10.1016/S0140-6736(08)60536-X; Sharman A, 2000, ANEMIA TESTING POPUL; Smith JL, 2010, TROP MED INT HEALTH, V15, P776, DOI 10.1111/j.1365-3156.2010.02542.x; Stabler SP, 2004, ANNU REV NUTR, V24, P299, DOI 10.1146/annurev.nutr.24.012003.132440; Stoltzfus RJ, 1997, LANCET, V349, P1764, DOI 10.1016/S0140-6736(96)12355-2; Stoltzfus RJ, 1999, J NUTR, V129, P1675, DOI 10.1093/jn/129.9.1675; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; Tielsch JM, 2006, LANCET, V367, P144, DOI 10.1016/S0140-6736(06)67963-4; Tolentino K, 2007, AM J TROP MED HYG, V77, P44, DOI 10.4269/ajtmh.2007.77.44; United Nations. Subcommittee on Nutrition International Food Policy Research Institute, 1992, 2 UN NUTR INT FOOD P; van den Broek NR, 2009, BJOG-INT J OBSTET GY, V116, P18, DOI 10.1111/j.1471-0528.2009.02333.x; Volberding Paul A, 2004, Clin Infect Dis, V38, P1454, DOI 10.1086/383031; Warrell D, 2003, OXFORD TXB MED; Weatherall DJ, 2010, BLOOD, V115, P4331, DOI 10.1182/blood-2010-01-251348; Weatherall DJ, 2008, CURR MOL MED, V8, P592, DOI 10.2174/156652408786241375; Weatherall DJ, 2001, B WORLD HEALTH ORGAN, V79, P704; WHO, 2005, HDB IMCI INT MAN CHI; WHO, 2008, WORLDW PREV AN 1993; WHO Centers for Disease Control and Prevention, 2004, ASS IR STAT POP REP; WHO UNICEF, 2010, COUNTD 2015 DEC REP; World Health Organization. Department of Reproductive Health and Research, 2006, PREGN CHILDB POSTP N; Xiong X, 2000, AM J PERINAT, V17, P137, DOI 10.1055/s-2000-9508; Yip R, 2002, J NUTR, V132, p827S, DOI 10.1093/jn/132.4.827S; Zhang QY, 2009, ANN EPIDEMIOL, V19, P793, DOI 10.1016/j.annepidem.2009.06.002; Zimmermann MB, 2008, BRIT J NUTR, V99, pS2, DOI 10.1017/S000711450800679X; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	119	557	578	3	78	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 17	2011	378	9809					2123	2135		10.1016/S0140-6736(10)62304-5	http://dx.doi.org/10.1016/S0140-6736(10)62304-5			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	865EL	21813172				2022-12-01	WOS:000298293600034
J	Ito, S; Shen, L; Dai, Q; Wu, SC; Collins, LB; Swenberg, JA; He, C; Zhang, Y				Ito, Shinsuke; Shen, Li; Dai, Qing; Wu, Susan C.; Collins, Leonard B.; Swenberg, James A.; He, Chuan; Zhang, Yi			Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine	SCIENCE			English	Article							ACTIVE DNA DEMETHYLATION; 5-HYDROXYMETHYLCYTOSINE	5-methylcytosine (5mC) in DNA plays an important role in gene expression, genomic imprinting, and suppression of transposable elements. 5mC can be converted to 5-hydroxymethylcytosine (5hmC) by the Tet (ten eleven translocation) proteins. Here, we show that, in addition to 5hmC, the Tet proteins can generate 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) from 5mC in an enzymatic activity-dependent manner. Furthermore, we reveal the presence of 5fC and 5caC in genomic DNA of mouse embryonic stem cells and mouse organs. The genomic content of 5hmC, 5fC, and 5caC can be increased or reduced through overexpression or depletion of Tet proteins. Thus, we identify two previously unknown cytosine derivatives in genomic DNA as the products of Tet proteins. Our study raises the possibility that DNA demethylation may occur through Tet-catalyzed oxidation followed by decarboxylation.	[Ito, Shinsuke; Shen, Li; Wu, Susan C.; Zhang, Yi] Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; [Ito, Shinsuke; Shen, Li; Wu, Susan C.; Zhang, Yi] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Ito, Shinsuke; Shen, Li; Wu, Susan C.; Swenberg, James A.; Zhang, Yi] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Dai, Qing; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Dai, Qing; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Collins, Leonard B.; Swenberg, James A.] Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Chicago; University of Chicago; University of North Carolina; University of North Carolina Chapel Hill	Zhang, Y (corresponding author), Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu	Dai, Qing/ABD-8444-2021	Collins, Leonard/0000-0002-7734-9708; Zhang, Yi/0000-0002-2789-0811	NIH [GM68804, GM071440, P42ES5948, P30ES10126]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES005948, P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071440, R01GM068804] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Q. Zhang for suggestion of the NaBH<INF>4</INF> experiment and C. X. Song for help in oligo purification. This work was supported by NIH grants GM68804 (Y.Z.), GM071440 (C. H.), and P42ES5948 and P30ES10126 (J.A.S.). S. I. is a research fellow of the Japan Society for the Promotion of Science. Y.Z. is an Investigator of the Howard Hughes Medical Institute.	Boysen G, 2010, J CHROMATOGR B, V878, P375, DOI 10.1016/j.jchromb.2009.12.004; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Dai Q, 2011, ORG LETT, V13, P3446, DOI 10.1021/ol201189n; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; HUANG LH, 1982, NUCLEIC ACIDS RES, V10, P1579, DOI 10.1093/nar/10.5.1579; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kukushkin VY, 1999, COORDIN CHEM REV, V181, P147, DOI 10.1016/S0010-8545(98)00215-X; Neidigh JW, 2009, CHEM RES TOXICOL, V22, P885, DOI 10.1021/tx8004482; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Smiley JA, 2005, BBA-GEN SUBJECTS, V1723, P256, DOI 10.1016/j.bbagen.2005.02.001; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; WILLIAMS A, 1981, ANAL BIOCHEM, V114, P173, DOI 10.1016/0003-2697(81)90470-X; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950	17	2313	2434	7	431	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2011	333	6047					1300	1303		10.1126/science.1210597	http://dx.doi.org/10.1126/science.1210597			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21778364	Green Submitted, Green Accepted			2022-12-01	WOS:000294406400057
J	Dhalla, IA; Persaud, N; Juurlink, DN				Dhalla, Irfan A.; Persaud, Navindra; Juurlink, David N.			Facing up to the prescription opioid crisis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHRONIC NONCANCER PAIN; PRACTICE GUIDELINE; NONMALIGNANT PAIN; MORTALITY; ANALGESICS; OXYCODONE; DEATHS; SAFETY		[Dhalla, Irfan A.; Juurlink, David N.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Dhalla, Irfan A.; Juurlink, David N.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Dhalla, Irfan A.] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Dhalla, Irfan A.; Persaud, Navindra] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Dhalla, Irfan A.; Juurlink, David N.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Persaud, Navindra] St Michaels Hosp, Dept Family & Community Med, Toronto, ON M5B 1W8, Canada; [Persaud, Navindra] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Juurlink, David N.] Sunnybrook Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Dhalla, IA (corresponding author), 30 Bond St, Toronto, ON M5B 1W8, Canada.	dhallai@smh.ca						Andersen S, 1996, BRIT J CLIN PRACT, V50, P324; [Anonymous], PHARM SALES 2010; Centers for Disease Control and Prevention, 2010, MMWR-MORBID MORTAL W, V59, P1026; Chou R, 2009, J PAIN, V10, P147, DOI 10.1016/j.jpain.2008.10.007; Dhalla IA, 2011, CAN FAM PHYSICIAN, V57, pE92; Dhalla IA, 2009, CAN MED ASSOC J, V181, P891, DOI 10.1503/cmaj.090784; Furlan AD, 2010, CAN MED ASSOC J, V182, P923, DOI 10.1503/cmaj.100187; Gomes T, 2011, ARCH INTERN MED, V171, P686, DOI 10.1001/archinternmed.2011.117; Hawton K, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2270; Noble M, 2008, J PAIN SYMPTOM MANAG, V35, P214, DOI 10.1016/j.jpainsymman.2007.03.015; Nuesch E., 2009, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003115.PUB3; Office for National Statistics, DEATHS REL DRUG POIS; Rintoul AC, 2011, INJURY PREV, V17, P254, DOI 10.1136/ip.2010.029611; Solomon DH, 2010, ARCH INTERN MED, V170, P1968, DOI 10.1001/archinternmed.2010.391; SOUMERAI SB, 1990, JAMA-J AM MED ASSOC, V263, P549, DOI 10.1001/jama.263.4.549; Spence D., 2010, BMJ-BRIT MED J, V340, pc2659; United nations, REP INT NARC CONTR B; United States General Accounting Office, 2003, OX AB DIV EFF ADDR P; US Department of Health and Human Services, 2009, WARN LETT EMBEDA MOR; US Department of Health and Human Services, 2004, WARN LETT DUR FENT T; Warner M, 1999, INCREASE FATAL POISO; Zee AV, 2009, AM J PUBLIC HEALTH, V99, P221, DOI 10.2105/AJPH.2007.131714	22	129	129	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 23	2011	343								d5142	10.1136/bmj.d5142	http://dx.doi.org/10.1136/bmj.d5142			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	813ZK	21862533	Green Submitted			2022-12-01	WOS:000294409600005
J	Li, FB; Ravetch, JV				Li, Fubin; Ravetch, Jeffrey V.			Inhibitory Fc gamma Receptor Engagement Drives Adjuvant and Anti-Tumor Activities of Agonistic CD40 Antibodies	SCIENCE			English	Article							MONOCLONAL-ANTIBODY; IN-VIVO; BREAST-CANCER; CELLS; POLYMORPHISMS; TRASTUZUMAB; LYMPHOMA; EFFICACY; THERAPY; BINDING	CD40, a member of the tumor necrosis factor receptor (TNFR) superfamily, is expressed on antigen-presenting cells (APCs) and is essential for immune activation. Although agonistic CD40 antibodies have been developed for immunotherapy, their clinical efficacy has been limited. We have found that coengagement of the Fc domain of agonistic CD40 monoclonal antibodies (mAbs) with the inhibitory Fc gamma receptor Fc gamma RIIB is required for immune activation. Direct comparison of mAbs to CD40 enhanced for activating Fc gamma R binding, hence capable of cytotoxicity, or for inhibitory Fc gamma RIIB binding, revealed that enhancing Fc gamma RIIB binding conferred immunostimulatory activity and considerably greater anti-tumor responses. This unexpected requirement for Fc gamma RIIB in enhancing CD40-mediated immune activation has direct implications for the design of agonistic antibodies to TNFR as therapeutics.	[Li, Fubin; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA	Rockefeller University	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA.	ravetch@rockefeller.edu	Li, Fubin/H-1285-2012; Ravetch, Jeffrey/Z-1596-2019	Ravetch, Jeffrey/0000-0003-2024-9041	NIH; Paralyzed Veterans of America research foundation [2757]; NATIONAL CANCER INSTITUTE [R01CA080757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI051573] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paralyzed Veterans of America research foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Anthony, A. Pincetic, and S. Bournazos for helpful discussion and comments on the manuscript; M. Nussenzweig, D. Robbiani, and S. Deroubaix for kindly providing B6BL cells; and P. Smith, B. Wang, L. Bozzacco, A. Kamphorst, K. Horiuchi, R. Peraza M. Kibe, I. Londono J. Carroll, J. Brown, and T. Shabaneh for excellent technical support. This work was performed with support from NIH grants to J. V. R. F. L. is supported in part by grant no. 2757 from the Paralyzed Veterans of America research foundation. J. V. R. is a paid consultant and member of the Scientific Advisory Board of Xencor, Inc. A patent has been filed (application no. 61424996) "Modulating adjuvant effect of agonistic TNFR monoclonal antibodies," which relates to modified antibodies, and associated methods and compositions, that both engage a receptor from the TNFR superfamily and enhance its ability to stimulate natural immunological responsiveness through coengagement of the inhibitory Fc receptor FcRIIB. The listed inventors are F.L. and J.V.R.	Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Chu SY, 2008, MOL IMMUNOL, V45, P3926, DOI 10.1016/j.molimm.2008.06.027; Chuntharapai A, 2001, J IMMUNOL, V166, P4891, DOI 10.4049/jimmunol.166.8.4891; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; French RR, 1999, NAT MED, V5, P548, DOI 10.1038/8426; HEATH AW, 1994, EUR J IMMUNOL, V24, P1828, DOI 10.1002/eji.1830240816; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Horton HM, 2011, J IMMUNOL, V186, P4223, DOI 10.4049/jimmunol.1003412; McKenzie SE, 1999, J IMMUNOL, V162, P4311; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tamura K, 2011, ANN ONCOL, V22, P1302, DOI 10.1093/annonc/mdq585; Wilson NS, 2011, CANCER CELL, V19, P101, DOI 10.1016/j.ccr.2010.11.012; Xu YY, 2003, J IMMUNOL, V171, P562, DOI 10.4049/jimmunol.171.2.562; Zhang ML, 2006, BLOOD, V108, P705, DOI 10.1182/blood-2005-11-4607	22	237	322	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 19	2011	333	6045					1030	1034		10.1126/science.1206954	http://dx.doi.org/10.1126/science.1206954			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808TD	21852502	Green Accepted			2022-12-01	WOS:000294000400059
J	Magidson, V; O'Connell, CB; Loncarek, J; Paul, R; Mogilner, A; Khodjakov, A				Magidson, Valentin; O'Connell, Christopher B.; Loncarek, Jadranka; Paul, Raja; Mogilner, Alex; Khodjakov, Alexey			The Spatial Arrangement of Chromosomes during Prometaphase Facilitates Spindle Assembly	CELL			English	Article							EGG EXTRACT SPINDLES; NEWT LUNG-CELLS; MITOTIC-SPINDLE; MICROTUBULE ATTACHMENT; ELECTRON-MICROSCOPY; CHROMOKINESIN KID; METAPHASE PLATE; MITOSIS; CONGRESSION; KINETOCHORES	Error-free chromosome segregation requires stable attachment of sister kinetochores to the opposite spindle poles (amphitelic attachment). Exactly how amphitelic attachments are achieved during spindle assembly remains elusive. We employed photoactivatable GFP and high-resolution live-cell confocal microscopy to visualize complete 3D movements of individual kinetochores throughout mitosis in non-transformed human cells. Combined with electron microscopy, molecular perturbations, and immunofluorescence analyses, this approach reveals unexpected details of chromosome behavior. Our data demonstrate that unstable lateral interactions between kinetochores and microtubules dominate during early prometaphase. These transient interactions lead to the reproducible arrangement of chromosomes in an equatorial ring on the surface of the nascent spindle. A computational model predicts that this toroidal distribution of chromosomes exposes kinetochores to a high density of microtubules which facilitates subsequent formation of amphitelic attachments. Thus, spindle formation involves a previously overlooked stage of chromosome prepositioning which promotes formation of amphitelic attachments.	[Magidson, Valentin; O'Connell, Christopher B.; Loncarek, Jadranka; Khodjakov, Alexey] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [Paul, Raja; Mogilner, Alex] Univ Calif Davis, Dept Math, Davis, CA 95616 USA; [Paul, Raja; Mogilner, Alex] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Khodjakov, Alexey] Rensselaer Polytech Inst, Troy, NY 12180 USA	State University of New York (SUNY) System; Wadsworth Center; University of California System; University of California Davis; University of California System; University of California Davis; Rensselaer Polytechnic Institute	Khodjakov, A (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA.	khodj@wadsworth.org		Loncarek, Jadranka/0000-0003-1879-5473; Magidson, Valentin/0000-0002-0780-9123	NIH [GM059363, GM068952]; Kirschstein National Research Service Award [GM077911]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM077911, R01GM068952, R01GM059363] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM059363 (A. K.) and GM068952 (A. M.) and a Kirschstein National Research Service Award GM077911 to C.B.O. We acknowledge use of the Wadsworth Center's electron microscopy core facility and the Ordway Research Institute's Flow Cytometry Core. A special thanks to Dr. Duane Compton (Dartmouth Medical School) for his generous donation of anti-KID serum. V. M., C.B.O., and A. K. designed the experiments. V. M., C.B.O., and J.L. performed the experiments. R. P. and A. M. developed the computational model. V. M. designed the MatLab tools to visualize and numerically analyze kinetochore/centrosome trajectories. All authors analyzed and interpreted the data. The manuscript was written primarily by C.B.O. and A. K. with significant input from V. M. and other authors.	Allison DC, 1999, J CELL BIOL, V145, P1, DOI 10.1083/jcb.145.1.1; Bakhoum SF, 2009, CURR BIOL, V19, P1937, DOI 10.1016/j.cub.2009.09.055; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Cahu J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003936; Cai S, 2009, NAT CELL BIOL, V11, P832, DOI 10.1038/ncb1890; CHALY N, 1988, J CELL SCI, V91, P325; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Goshima G, 2005, MOL BIOL CELL, V16, P3896, DOI 10.1091/mbc.E05-02-0118; Jaqaman K, 2010, J CELL BIOL, V188, P665, DOI 10.1083/jcb.200909005; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Khodjakov A, 1999, CELL MOTIL CYTOSKEL, V43, P179, DOI 10.1002/(SICI)1097-0169(1999)43:3<179::AID-CM1>3.3.CO;2-W; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Kitajima TS, 2011, CELL, V146, P568, DOI 10.1016/j.cell.2011.07.031; Lenart P, 2005, NATURE, V436, P812, DOI 10.1038/nature03810; Levesque AA, 2001, J CELL BIOL, V154, P1135, DOI 10.1083/jcb.200106093; MAGIDSON V, 2007, LASER MANIPULATIONS, P237; Maresca TJ, 2010, J CELL SCI, V123, P825, DOI 10.1242/jcs.064790; MOLEBAJER J, 1975, CYTOBIOS, V13, P117; MOSGOLLER W, 1991, HUM GENET, V88, P27, DOI 10.1007/BF00204924; NAGELE R, 1995, SCIENCE, V270, P1831, DOI 10.1126/science.270.5243.1831; Nezi LG, 2009, CURR OPIN CELL BIOL, V21, P785, DOI 10.1016/j.ceb.2009.09.007; O'Connell CB, 2009, J CELL BIOL, V187, P43, DOI 10.1083/jcb.200903076; Paul R, 2009, P NATL ACAD SCI USA, V106, P15708, DOI 10.1073/pnas.0908261106; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Rieder CL, 1999, METHOD CELL BIOL, V61, P297; RIEDER CL, 1994, J CELL BIOL, V124, P223, DOI 10.1083/jcb.124.3.223; RIEDER CL, 1986, J CELL BIOL, V103, P581, DOI 10.1083/jcb.103.2.581; ROOS UP, 1973, CHROMOSOMA, V40, P43, DOI 10.1007/BF00319836; Rosenblatt J, 2005, NAT CELL BIOL, V7, P219, DOI 10.1038/ncb0305-219; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Stumpff J, 2008, DEV CELL, V14, P252, DOI 10.1016/j.devcel.2007.11.014; Tokai N, 1996, EMBO J, V15, P457, DOI 10.1002/j.1460-2075.1996.tb00378.x; Tokai-Nishizumi N, 2005, MOL BIOL CELL, V16, P5455, DOI 10.1091/mbc.E05-03-0244; Toso A, 2009, J CELL BIOL, V184, P365, DOI 10.1083/jcb.200809055; Uetake Y, 2010, CURR BIOL, V20, P1666, DOI 10.1016/j.cub.2010.08.018; Uteng M, 2008, J CELL BIOL, V182, P715, DOI 10.1083/jcb.200801125; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Whitehead CM, 1996, CELL MOTIL CYTOSKEL, V35, P298, DOI 10.1002/(SICI)1097-0169(1996)35:4<298::AID-CM3>3.0.CO;2-3; Wollman R, 2005, CURR BIOL, V15, P828, DOI 10.1016/j.cub.2005.03.019; Yang Z, 2008, NAT CELL BIOL, V10, P748, DOI 10.1038/ncb1738	44	209	210	0	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 19	2011	146	4					555	567		10.1016/j.cell.2011.07.012	http://dx.doi.org/10.1016/j.cell.2011.07.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21854981	Bronze, Green Accepted			2022-12-01	WOS:000294043600011
J	Taoka, K; Ohki, I; Tsuji, H; Furuita, K; Hayashi, K; Yanase, T; Yamaguchi, M; Nakashima, C; Purwestri, YA; Tamaki, S; Ogaki, Y; Shimada, C; Nakagawa, A; Kojima, C; Shimamoto, K				Taoka, Ken-ichiro; Ohki, Izuru; Tsuji, Hiroyuki; Furuita, Kyoko; Hayashi, Kokoro; Yanase, Tomoko; Yamaguchi, Midori; Nakashima, Chika; Purwestri, Yekti Asih; Tamaki, Shojiro; Ogaki, Yuka; Shimada, Chihiro; Nakagawa, Atsushi; Kojima, Chojiro; Shimamoto, Ko			14-3-3 proteins act as intracellular receptors for rice Hd3a florigen	NATURE			English	Article							STRUCTURAL BASIS; SIGNALS; SYSTEM; GROWTH; FT; CRYSTALLOGRAPHY; AGROBACTERIUM; REGULATOR; REVEALS; VECTORS	'Florigen' was proposed 75 years ago(1) to be synthesized in the leaf and transported to the shoot apex, where it induces flowering. Only recently have genetic and biochemical studies established that florigen is encoded by FLOWERING LOCUS T (FT), a gene that is universally conserved in higher plants(2-4). Nonetheless, the exact function of florigen during floral induction remains poorly understood and receptors for florigen have not been identified. Here we show that the rice FT homologue Hd3a(5) interacts with 14-3-3 proteins in the apical cells of shoots, yielding a complex that translocates to the nucleus and binds to the Oryza sativa (Os)FD1 transcription factor, a rice homologue of Arabidopsis thaliana FD. The resultant ternary 'florigen activation complex' (FAC) induces transcription of OsMADS15, a homologue of A. thaliana APETALA1 (AP1), which leads to flowering. We have determined the 2.4 angstrom crystal structure of rice FAC, which provides a mechanistic basis for florigen function in flowering. Our results indicate that 14-3-3 proteins act as intracellular receptors for florigen in shoot apical cells, and offer new approaches to manipulate flowering in various crops and trees.	[Ohki, Izuru; Furuita, Kyoko; Hayashi, Kokoro; Kojima, Chojiro] Nara Inst Sci & Technol, Lab Biophys, Grad Sch Biol Sci, Nara 6300192, Japan; [Taoka, Ken-ichiro; Tsuji, Hiroyuki; Yanase, Tomoko; Yamaguchi, Midori; Nakashima, Chika; Purwestri, Yekti Asih; Tamaki, Shojiro; Ogaki, Yuka; Shimada, Chihiro; Shimamoto, Ko] Nara Inst Sci & Technol, Lab Plant Mol Genet, Grad Sch Biol Sci, Nara 6300192, Japan; [Nakagawa, Atsushi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Nara Institute of Science & Technology; Nara Institute of Science & Technology; Osaka University	Kojima, C (corresponding author), Nara Inst Sci & Technol, Lab Biophys, Grad Sch Biol Sci, 8916-5 Takayama, Nara 6300192, Japan.	kojima@protein.osaka-u.ac.jp; simamoto@bs.naist.jp	Ding, Cheng-Qiang/B-6287-2011; Ohki, Izuru/O-4816-2019; Nakagawa, Atsushi/D-4329-2009; Purwestri, Yekti Asih/AAK-2777-2021; Nakagawa, Atsushi/M-5731-2019; Kojima, Chojiro/AFV-4592-2022; Ohki, Izuru/C-7883-2013	Ohki, Izuru/0000-0002-0667-5936; Nakagawa, Atsushi/0000-0002-1700-7861; Purwestri, Yekti Asih/0000-0002-7032-9253; Nakagawa, Atsushi/0000-0002-1700-7861; Kojima, Chojiro/0000-0003-2723-8249; Tsuji, Hiroyuki/0000-0002-6444-559X; Furuita, Kyoko/0000-0002-9272-0026	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Global COE Program at NAIST; Bio-oriented Research Advancement Institution (BRAIN)	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program at NAIST; Bio-oriented Research Advancement Institution (BRAIN)	We thank Y. Takahashi for the anti-14-3-3 antibody and S. Takayama for the BiFC vectors. We are grateful to I. Smith for critical reading of the manuscript. We also thank N. Inada for FRET measurement; Y. Nishio, Y. Ohno, E. Kawano and M. Kanda for technical assistance; Y. Tamaki, Y. Konomi and J. Naritomi for rice transformation; M. Yoneyama, H. Kinoshita and A. Yasuba for sample preparation; J. Tsukamoto for mass spectroscopy analysis; H. Fukada for ITC measurement; K. Takeshita and Y. Hara for crystallization; and members of the Laboratory of Plant Molecular Genetics and the Laboratory of Biophysics at Nara Institute of Science and Technology (NAIST) for discussions. We thank beamline staff of BL41XU and BL44XU at SPring-8 and Photon Factory for data collection. We also thank Academia Sinica and National Synchrotron Radiation Research Center (Taiwan) for use of the MX225-HE detector at BL44XU. This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) through the Target Proteins Research Program, by the Global COE Program at NAIST, by Grants-in-Aid for Scientific Research to I.O., C. K. and K. S., by Grants-in-Aid for Scientific Research on Priority Areas to K. S. and by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry from Bio-oriented Research Advancement Institution (BRAIN) to H.T.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; [Anonymous], 2008, ROWLAND NMR TOOLKIT; Bartel PL, 1993, CELLULAR INTERACTION, P153; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cailachjan MC, 1936, CR ACAD SCI URSS, V12, P443; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delano D.W., 2002, PYMOL MOL GRAPHICS S; Goddard D. T., 2004, SPARKY 3; Hayashi K, 2008, PROTEIN EXPRES PURIF, V62, P120, DOI 10.1016/j.pep.2008.07.007; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Kaufmann K, 2010, SCIENCE, V328, P85, DOI 10.1126/science.1185244; Kawano Y, 2010, CELL HOST MICROBE, V7, P362, DOI 10.1016/j.chom.2010.04.010; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Komiya R, 2008, DEVELOPMENT, V135, P767, DOI 10.1242/dev.008631; Komiya R, 2009, DEVELOPMENT, V136, P3443, DOI 10.1242/dev.040170; Krieger U, 2010, NAT GENET, V42, P459, DOI 10.1038/ng.550; Kwaaitaal M, 2010, PLANT PHYSIOL, V152, P1135, DOI 10.1104/pp.109.151142; Kyozuka J, 1991, PLANT TISSUE CULT, V1, P1; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miki D, 2004, PLANT CELL PHYSIOL, V45, P490, DOI 10.1093/pcp/pch048; Muszynski MG, 2006, PLANT PHYSIOL, V142, P1523, DOI 10.1104/pp.106.088815; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Okano Y, 2008, PLANT J, V53, P65, DOI 10.1111/j.1365-313X.2007.03313.x; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pnueli L, 2001, PLANT CELL, V13, P2687, DOI 10.1105/tpc.13.12.2687; Purwestri YA, 2009, PLANT CELL PHYSIOL, V50, P429, DOI 10.1093/pcp/pcp012; Rovnyak D, 2004, J MAGN RESON, V170, P15, DOI 10.1016/j.jmr.2004.05.016; Schumacher MA, 2000, J BIOL CHEM, V275, P35242, DOI 10.1074/jbc.M007293200; Shalit A, 2009, P NATL ACAD SCI USA, V106, P8392, DOI 10.1073/pnas.0810810106; Shyu YJ, 2008, P NATL ACAD SCI USA, V105, P151, DOI 10.1073/pnas.0705181105; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zeevaart JAD, 2008, CURR OPIN PLANT BIOL, V11, P541, DOI 10.1016/j.pbi.2008.06.009	46	419	466	9	235	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 18	2011	476	7360					332	U97		10.1038/nature10272	http://dx.doi.org/10.1038/nature10272			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21804566				2022-12-01	WOS:000294206500038
J	Cheng, LY; Bailey, AP; Leevers, SJ; Ragan, TJ; Driscoll, PC; Gould, AP				Cheng, Louise Y.; Bailey, Andrew P.; Leevers, Sally J.; Ragan, Timothy J.; Driscoll, Paul C.; Gould, Alex P.			Anaplastic Lymphoma Kinase Spares Organ Growth during Nutrient Restriction in Drosophila	CELL			English	Article							RECEPTOR TYROSINE KINASE; ASYMMETRIC CELL-DIVISION; INSULIN-LIKE PEPTIDES; PHOSPHOINOSITIDE 3-KINASE; ACTIVATING MUTATIONS; SIGNALING PATHWAY; BRAIN-DEVELOPMENT; ALK KINASE; FAT-CELLS; LIFE-SPAN	Developing animals survive periods of starvation by protecting the growth of critical organs at the expense of other tissues. Here, we use Drosophila to explore the as yet unknown mechanisms regulating this privileged tissue growth. As in mammals, we observe in Drosophila that the CNS is more highly spared than other tissues during nutrient restriction (NR). We demonstrate that anaplastic lymphoma kinase (Alk) efficiently protects neural progenitor (neuroblast) growth against reductions in amino acids and insulin-like peptides during NR via two mechanisms. First, Alk suppresses the growth requirement for amino acid sensing via Slimfast/Rheb/TOR complex 1. And second, Alk, rather than insulin-like receptor, primarily activates PI3-kinase. Alk maintains PI3-kinase signaling during NR as its ligand, Jelly belly (Jeb), is constitutively expressed from a glial cell niche surrounding neuroblasts. Together, these findings identify a brain-sparing mechanism that shares some regulatory features with the starvation-resistant growth programs of mammalian tumors.	[Cheng, Louise Y.; Bailey, Andrew P.; Gould, Alex P.] Natl Inst Med Res, MRC, Div Dev Neurobiol, London NW7 1AA, England; [Ragan, Timothy J.; Driscoll, Paul C.] Natl Inst Med Res, MRC, Div Mol Struct, London NW7 1AA, England; [Leevers, Sally J.] Canc Res UK London Res Inst, London WC2A 3PX, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research; Cancer Research UK	Gould, AP (corresponding author), Natl Inst Med Res, MRC, Div Dev Neurobiol, Mill Hill, London NW7 1AA, England.	agould@nimr.mrc.ac.uk	Gould, Alex/M-5353-2019; Gould, Alex/A-7479-2010; Cheng, Louise/B-5112-2012; Ragan, Timothy/F-9251-2012	Gould, Alex/0000-0002-6875-6985; Gould, Alex/0000-0002-6875-6985; Driscoll, Paul/0000-0002-4124-6950; Bailey, Andrew/0000-0003-2143-1689; Cheng, Louise/0000-0001-9712-4082; Ragan, Timothy/0000-0002-6233-3375	Medical Research Council [U117584237]; Cancer Research UK; MRC [MC_U117533887, MC_U117584237] Funding Source: UKRI; Medical Research Council [MC_U117574559, MC_U117533887, MC_U117584237] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to Steve Cohen, Bruce Edgar, Ernst Hafen, Jean-Luc Imler, Pierre Leopold, Fumio Matsuzaki, Tom Neufeld, James Nowick, Ruth Palmer, Linda Partridge, Iris Salecker, Hugo Stocker, Gary Struhl, Nic Tapon, and Tian Xu and also to the Bloomington, Kyoto Drosophila Genetic Resource, and Vienna Drosophila RNAi Centers for fly stocks, antibodies, and chemicals. We also acknowledge Tom Frenkiel and the Biomedical NMR Centre, and Steve Morris, Ruth Palmer, Iris Salecker, Patricia Serpente, Rita Sousa-Nunes, Caroline Vincent, and Joe Weiss for advice and critical reading of the manuscript. L.Y.C., A.B., T.J.R., P.C.D., and A.P.G. are supported by the Medical Research Council (U117584237), and S.J.L. is supported by Cancer Research UK.	Bai RY, 2000, BLOOD, V96, P4319, DOI 10.1182/blood.V96.13.4319; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; BAKKER K., 1959, Entomologia Experimentalis et Applicata, V2, P171, DOI 10.1007/BF00302537; Bazigou E, 2007, CELL, V128, P961, DOI 10.1016/j.cell.2007.02.024; Beadle GW, 1938, BIOL BULL-US, V75, P447, DOI 10.2307/1537573; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Bowden ET, 2002, J BIOL CHEM, V277, P35862, DOI 10.1074/jbc.M203963200; Britton JS, 1998, DEVELOPMENT, V125, P2149; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003721; Calikoglu AS, 2001, PEDIATR RES, V49, P197, DOI 10.1203/00006450-200102000-00011; Caren H, 2008, BIOCHEM J, V416, P153, DOI 10.1042/BJ20081834; Chalhoub N, 2009, GENE DEV, V23, P1619, DOI 10.1101/gad.1799609; Chell JM, 2010, CELL, V143, P1161, DOI 10.1016/j.cell.2010.12.007; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Dann SG, 2006, FEBS LETT, V580, P2821, DOI 10.1016/j.febslet.2006.04.068; Delanoue R, 2010, DEV CELL, V18, P1012, DOI 10.1016/j.devcel.2010.05.007; DOBBING J, 1971, BIOL NEONATE, V19, P363, DOI 10.1159/000240430; Drysdale RA, 2005, NUCLEIC ACIDS RES, V33, pD390, DOI 10.1093/nar/gki046; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Egger B, 2008, PHILOS T R SOC B, V363, P39, DOI 10.1098/rstb.2006.2011; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Englund C, 2003, NATURE, V425, P512, DOI 10.1038/nature01950; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Grewal SS, 2009, INT J BIOCHEM CELL B, V41, P1006, DOI 10.1016/j.biocel.2008.10.010; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; GRUENWALD P, 1963, BIOL NEONATORUM, V5, P215; Gu TL, 2004, BLOOD, V103, P4622, DOI 10.1182/blood-2003-03-0820; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Hentges K, 1999, DEVELOPMENT, V126, P1601; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Kaneko K, 2010, CELL METAB, V12, P619, DOI 10.1016/j.cmet.2010.11.005; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Kockel L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000990; Lee G, 2007, BIOCHEM BIOPH RES CO, V357, P1154, DOI 10.1016/j.bbrc.2007.04.086; Lee HH, 2003, NATURE, V425, P507, DOI 10.1038/nature01916; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Liu W, 2009, J NEUROSCI RES, V87, P2821, DOI 10.1002/jnr.22129; Loren CE, 2003, EMBO REP, V4, P781, DOI 10.1038/sj.embor.embor897; Loren CE, 2001, GENES CELLS, V6, P531, DOI 10.1046/j.1365-2443.2001.00440.x; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Perez-Pinera P, 2007, J BIOL CHEM, V282, P28683, DOI 10.1074/jbc.M704505200; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Powers C, 2002, J BIOL CHEM, V277, P14153, DOI 10.1074/jbc.M112354200; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Randhawa R, 2005, MOL GENET METAB, V86, P84, DOI 10.1016/j.ymgme.2005.07.028; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; Shi P, 2009, BLOOD, V114, P360, DOI 10.1182/blood-2007-11-125658; Shingleton AW, 2007, BIOESSAYS, V29, P536, DOI 10.1002/bies.20584; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Slupianek A, 2001, CANCER RES, V61, P2194; Sousa-Nunes R, 2011, NATURE, V471, P508, DOI 10.1038/nature09867; Sousa-Nunes R, 2010, CURR OPIN NEUROBIOL, V20, P50, DOI 10.1016/j.conb.2009.12.005; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Stoica GE, 2002, J BIOL CHEM, V277, P35990, DOI 10.1074/jbc.M205749200; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Teleman AA, 2005, GENE DEV, V19, P1844, DOI 10.1101/gad.341505; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Weiss JB, 2001, CELL, V107, P387, DOI 10.1016/S0092-8674(01)00540-2; Wu MYW, 2007, EMBO J, V26, P371, DOI 10.1038/sj.emboj.7601487; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhong WM, 2008, CURR OPIN NEUROBIOL, V18, P4, DOI 10.1016/j.conb.2008.05.002; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Zou J, 2011, DEV CELL, V20, P97, DOI 10.1016/j.devcel.2010.11.020	85	153	156	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 5	2011	146	3					435	447		10.1016/j.cell.2011.06.040	http://dx.doi.org/10.1016/j.cell.2011.06.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	803GT	21816278	Bronze			2022-12-01	WOS:000293570500017
J	Su, JR; Beltrami, JF; Zaidi, AA; Weinstock, HS				Su, John R.; Beltrami, John F.; Zaidi, Akbar A.; Weinstock, Hillard S.			Primary and Secondary Syphilis Among Black and Hispanic Men Who Have Sex With Men: Case Report Data From 27 States	ANNALS OF INTERNAL MEDICINE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; HIV PREVENTION INTERVENTION; REPRODUCTIVE HEALTH; SOCIAL DETERMINANTS; UNITED-STATES; EPIDEMIOLOGY; ORIENTATION; NETWORKS; CONTEXT; RATES	Background: Until 2005, national-level data on the sex of sex partners that describe how primary and secondary syphilis affects men who have sex with men (MSM) of different races or ethnicities were not reported. Objective: To present data from 27 states comparing trends in primary and secondary syphilis among MSM of different races or ethnicities. Design: Review of case report data and regression analysis. Setting: Federal database of case reports in the National Electronic Telecommunications System for Surveillance. Participants: Men reported to be MSM. Measurements: Cases of primary and secondary syphilis per 100 000 males of matching race or ethnicity ("rates"), determined by using population data from the National Center for Health Statistics as the denominator to compare age and racial and ethnic differences. Results: For each year during 2005 to 2008, 27 states from all U. S. census regions reported data on the sex of sex partners for 70% or more of male cases of primary and secondary syphilis. Regression analysis revealed significantly different trends in rates of primary and secondary syphilis: Absolute increases in rates among black MSM and Hispanic MSM were, respectively, 8.0 times and 2.4 times the absolute increase in rate among white MSM. By region, rates among MSM increased 30% in the Midwest, 48% in the South, 73% in the Northeast, and 77% in the West. By age group, the largest absolute increase in rates occurred among MSM aged 20 to 29 years. Limitation: Results from 27 states may not be generalizable to the United States as a whole. Conclusion: Rates of primary and secondary syphilis disproportionately increased among black and Hispanic MSM (compared with white MSM) and among young MSM. Care providers should offer counseling about safer sexual practices and screening for syphilis and other sexually transmitted infections when caring for MSM.	[Su, John R.] Ctr Dis Control & Prevent, Div STD Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Su, JR (corresponding author), Ctr Dis Control & Prevent, Div STD Prevent, 1600 Clifton Rd,MS-E02, Atlanta, GA 30333 USA.	ezu2@cdc.gov			Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Centers for Disease Control and Prevention.	Adimora AA, 2005, J INFECT DIS, V191, pS115, DOI 10.1086/425280; Anderson John E, 2006, Adv Data, P1; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P269; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P77; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P681; [Anonymous], 2010, 2009 NATL SCH CLIMAT; Blas E, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P1; Bowen AM, 2007, HEALTH EDUC RES, V22, P120, DOI 10.1093/her/cyl057; Brindis CD, 2005, J ADOLESCENT HEALTH, V37, P155, DOI 10.1016/j.jadohealth.2004.09.015; Brookmeyer KA, 2009, J PRIM PREV, V30, P677, DOI 10.1007/s10935-009-0196-6; Brooks RA, 2005, AIDS PATIENT CARE ST, V19, P737, DOI 10.1089/apc.2005.19.737; Carpenter KM, 2010, AIDS BEHAV, V14, P549, DOI 10.1007/s10461-009-9578-2; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P773; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P853; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P117; Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P817; Centers for Disease Control and Prevention (CDCP), 2010, SEX TRANSM DIS SURV; D'Souza G, 2003, SEX TRANSM DIS, V30, P872, DOI 10.1097/01.OLQ.0000091144.72555.13; Dean HD, 2010, PUBLIC HEALTH REP, V125, P1, DOI 10.1177/00333549101250S401; Diaz E. M., 2009, SHARED DIFFERENCES E; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Garofalo R, 1998, PEDIATRICS, V101, P895, DOI 10.1542/peds.101.5.895; Gavin Lorrie, 2009, Morbidity and Mortality Weekly Report, V58, P1; Grossman AH, 1998, J HOMOSEXUAL, V35, P25, DOI 10.1300/J082v35n02_02; Hall-Baker Patsy A., 2011, Morbidity and Mortality Weekly Report, V58, P1; Heffelfinger JD, 2007, AM J PUBLIC HEALTH, V97, P1076, DOI 10.2105/AJPH.2005.070417; Hogben M, 2008, SEX TRANSM DIS, V35, pS13, DOI 10.1097/OLQ.0b013e31818d3cad; Holmes KK, 2008, SEXUALLY TRANSMITTED; Jones KT, 2008, AM J PUBLIC HEALTH, V98, P1043, DOI 10.2105/AJPH.2007.120337; Kimbrough LW, 2009, AM J PUBLIC HEALTH, V99, P1093, DOI 10.2105/AJPH.2008.139329; Lieb S, 2009, J URBAN HEALTH, V86, P887, DOI 10.1007/s11524-009-9401-4; McCullagh P, 2019, GEN LINEAR MODELS; Mosher William D, 2005, Adv Data, P1; Nakashima AK, 1996, SEX TRANSM DIS, V23, P16, DOI 10.1097/00007435-199601000-00006; O'Leary A, 2007, AIDS BEHAV, V11, P706, DOI 10.1007/s10461-006-9205-4; Peterman TA, 2005, SEX TRANSM DIS, V32, P144, DOI 10.1097/01.olq.0000156552.91788.25; Peterman TA, 2005, SEX TRANSM DIS, V32, pS4, DOI 10.1097/01.olq.0000180455.79024.e9; Rhodes SD, 2004, AIDS EDUC PREV, V16, P315, DOI 10.1521/aeap.16.4.315.40399; Rivers Ian, 2004, Crisis, V25, P169; *SAS I, 2009, SAS ONLINEDOC 9 2; Sifakis F, 2010, AIDS BEHAV, V14, P904, DOI 10.1007/s10461-007-9317-5; Silenzio VMB, 2007, AM J PUBLIC HEALTH, V97, P2017, DOI 10.2105/AJPH.2006.095943; St Lawrence JS, 2002, AM J PUBLIC HEALTH, V92, P1784, DOI 10.2105/AJPH.92.11.1784; Valentine JA, 2008, SEX TRANSM DIS, V35, pS23, DOI 10.1097/OLQ.0b013e31818d3cc7; Valleroy LA, 2000, JAMA-J AM MED ASSOC, V284, P198, DOI 10.1001/jama.284.2.198; Warner L, 2008, PLOS MED, V5, P919, DOI 10.1371/journal.pmed.0050135; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1	48	50	53	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 2	2011	155	3					145	+		10.7326/0003-4819-155-3-201108020-00004	http://dx.doi.org/10.7326/0003-4819-155-3-201108020-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	800DJ	21810707				2022-12-01	WOS:000293339600002
J	Korb, MA; Thakkar, U				Korb, Michele A.; Thakkar, Umesh			Facilitating Scientific Investigations and Training Data Scientists	SCIENCE			English	Editorial Material									[Korb, Michele A.] Calif State Univ Hayward, Dept Teacher Educ, Coll Educ & Allied Studies, Hayward, CA 94542 USA; [Thakkar, Umesh] Univ Illinois, Coordinated Sci Lab, Urbana, IL 61801 USA; [Thakkar, Umesh] Vet Hlth Adm, Off Publ Hlth, US Dept Vet Affairs, Washington, DC 20420 USA	California State University System; California State University East Bay; University of Illinois System; University of Illinois Urbana-Champaign; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Korb, MA (corresponding author), Calif State Univ Hayward, Dept Teacher Educ, Coll Educ & Allied Studies, Hayward, CA 94542 USA.	michele.korb@csueastbay.edu; uthakkar@illinois.edu						Alberts B, 2008, SCIENCE, V319, P1589, DOI 10.1126/science.1157518; HADLEY K, 2007, SCI CHILD, V45, P29; *NSF CYB COUNC, 2007, CYB VIS 21 CENT DISC; NSF Task Force on Cyberlearning, 2008, FOST LEARN NETW WORL; President's Council of Advisors on Science and Technology, 2010, PREP INSP K 12 ED SC; ROBINSON S, 2011, MICROSC TODAY, V19, P46; THAKKAR U, 2000, AM ED RES ASS ANN M; Wieman CE, 2008, SCIENCE, V322, P682, DOI 10.1126/science.1161948	8	1	1	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2011	333	6042					534	535		10.1126/science.1196981	http://dx.doi.org/10.1126/science.1196981			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21798922				2022-12-01	WOS:000293222400032
J	Soldner, F; Laganiere, J; Cheng, AW; Hockemeyer, D; Gao, Q; Alagappan, R; Khurana, V; Golbe, LI; Myers, RH; Lindquist, S; Zhang, L; Guschin, D; Fong, LK; Vu, BJ; Meng, XD; Urnov, FD; Rebar, EJ; Gregory, PD; Zhang, HS; Jaenisch, R				Soldner, Frank; Laganiere, Josee; Cheng, Albert W.; Hockemeyer, Dirk; Gao, Qing; Alagappan, Raaji; Khurana, Vikram; Golbe, Lawrence I.; Myers, Richard H.; Lindquist, Susan; Zhang, Lei; Guschin, Dmitry; Fong, Lauren K.; Vu, B. Joseph; Meng, Xiangdong; Urnov, Fyodor D.; Rebar, Edward J.; Gregory, Philip D.; Zhang, H. Steve; Jaenisch, Rudolf			Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point Mutations	CELL			English	Article							COPY NUMBER; HUMAN ESCS; GENOME; DISEASE; REPAIR; MODEL; OLIGODEOXYNUCLEOTIDES; PATHOGENESIS; GENES; IPSCS	Patient-specific induced pluripotent stem cells (iPSCs) derived from somatic cells provide a unique tool for the study of human disease, as well as a promising source for cell replacement therapies. One crucial limitation has been the inability to perform experiments under genetically defined conditions. This is particularly relevant for late age onset disorders in which in vitro phenotypes are predicted to be subtle and susceptible to significant effects of genetic background variations. By combining zinc finger nuclease (ZFN)-mediated genome editing and iPSC technology, we provide a generally applicable solution to this problem, generating sets of isogenic disease and control human pluripotent stem cells that differ exclusively at either of two susceptibility variants for Parkinson's disease by modifying the underlying point mutations in the a-synuclein gene. The robust capability to genetically correct disease-causing point mutations in patient-derived hiPSCs represents significant progress for basic biomedical research and an advance toward hiPSC-based cell replacement therapies.	[Soldner, Frank; Cheng, Albert W.; Hockemeyer, Dirk; Gao, Qing; Alagappan, Raaji; Khurana, Vikram; Lindquist, Susan; Jaenisch, Rudolf] Whitehead Inst, Cambridge, MA 02142 USA; [Lindquist, Susan; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA; [Cheng, Albert W.] MIT, Computat & Syst Biol Program, Cambridge, MA 02139 USA; [Laganiere, Josee; Zhang, Lei; Guschin, Dmitry; Fong, Lauren K.; Vu, B. Joseph; Meng, Xiangdong; Urnov, Fyodor D.; Rebar, Edward J.; Gregory, Philip D.; Zhang, H. Steve] Sangamo BioSci Inc, Pt Richmond Tech Ctr, Richmond, CA 94804 USA; [Khurana, Vikram] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Khurana, Vikram] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; [Myers, Richard H.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Golbe, Lawrence I.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurol, New Brunswick, NJ 08903 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Sangamo Therapeutics, Inc.; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Jaenisch, R (corresponding author), Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	Guschin, Dmitry/U-3731-2019; Guschin, Dmitry/O-7594-2018	Guschin, Dmitry/0000-0002-4184-0001; Guschin, Dmitry/0000-0002-4184-0001; Khurana, Vikram/0000-0002-4018-5527; Laganiere, Josee/0000-0003-0775-3331; Gregory, Philip/0000-0001-9249-2468; Cheng, Albert/0000-0003-2653-5743; Myers, Richard/0000-0002-8365-2674; Hockemeyer, Dirk/0000-0002-5598-5092	NIH [R01-CA084198, R37-HD045022]; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA084198, R01CA084198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076843] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Ping Xu and Tenzin Lungjangwa for technical support and Jessica Dausman, Kibibi Ganz, Ruth Flannery, and Dongdong Fu for their help with animal husbandry and processing of teratomas. We would like to thank Tom Volkert and Jeong-Ah Kwon of the Whitehead Genome Technology Core for their help with the CNV analysis; Nicki Watson of the W.M. Keck Microscopy Facility for help with confocal microscopy; and Patti Wisniewski and Chad Araneo of the Whitehead Institute FACS facility for their help with cell sorting. We thank Gladys Dulay for construction of ZFN vectors and Elo Leung for computational analysis for the off-target study. We thank all of the members of the Jaenisch lab for helpful discussions and comments on the manuscript. R.J. was supported by NIH grants R01-CA084198 and R37-HD045022. This research was supported, in part, by a Collaborative Innovation Award from the Howard Hughes Medical Institute. R.J. is an adviser to Stemgent and a cofounder of Fate Therapeutics. D.H. is a Merck Fellow of the Life Sciences Research Foundation. J.L., L.K.F., L.Z., F.D.U., P.D.G., H.S.Z., D.J., B.J.V., X.M., and E.J.R. are full-time employees of Sangamo BioSciences, Inc.	Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Daley GQ, 2008, CELL, V132, P544, DOI 10.1016/j.cell.2008.02.009; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93; Golbe LI, 1996, ANN NEUROL, V40, P767, DOI 10.1002/ana.410400513; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Radecke F, 2006, MOL THER, V14, P798, DOI 10.1016/j.ymthe.2006.06.008; Radecke S, 2010, MOL THER, V18, P743, DOI 10.1038/mt.2009.304; Rashid ST, 2010, J CLIN INVEST, V120, P3127, DOI 10.1172/JCI43122; Richardson C, 2000, MOL CELL BIOL, V20, P9068, DOI 10.1128/MCB.20.23.9068-9075.2000; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Schulz JB, 2008, J NEUROL, V255, P3, DOI 10.1007/s00415-008-5011-4; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Summers KM, 1996, HUM MUTAT, V7, P283; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Vogel G, 2010, SCIENCE, V330, P1172, DOI 10.1126/science.330.6008.1172; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	48	537	593	0	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 22	2011	146	2					318	331		10.1016/j.cell.2011.06.019	http://dx.doi.org/10.1016/j.cell.2011.06.019			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	795XS	21757228	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000293013000013
J	Zimmet, P; Alberti, KGMM; Rubino, F; Dixon, JB				Zimmet, Paul; Alberti, K. George M. M.; Rubino, Francesco; Dixon, John B.			IDF's view of bariatric surgery in type 2 diabetes	LANCET			English	Editorial Material							RISK-FACTORS; ASSOCIATION; MORTALITY; MELLITUS; WEIGHT; TRENDS		[Zimmet, Paul; Dixon, John B.] Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia; [Alberti, K. George M. M.] Univ London Imperial Coll Sci Technol & Med, London, England; [Rubino, Francesco] Weill Cornell Med Coll, New York, NY USA	Baker Heart and Diabetes Institute; Imperial College London; Cornell University	Zimmet, P (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia.	paul.zimmet@bakeridi.edu.au	Zimmet, Paul/H-7635-2013; Zimmet, Paul/O-8486-2019; Dixon, John B/A-5318-2011	Zimmet, Paul/0000-0003-0627-0776; Dixon, John B/0000-0001-5391-4082				[Anonymous], 1995, Diabetes, V44, P1249; Buchwald H, 2007, SURGERY, V142, P621, DOI 10.1016/j.surg.2007.07.018; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Colquitt J., 2009, COCHRANE DB SYST REV, V15, P1, DOI DOI 10.1002/14651858.CD003641.PUB3; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Dixon JB, 2011, DIABETIC MED, V28, P628, DOI 10.1111/j.1464-5491.2011.03306.x; Dixon JB, 2003, ARCH INTERN MED, V163, P2058, DOI 10.1001/archinte.163.17.2058; Liebl A, 2002, DIABETOLOGIA, V45, pS23, DOI 10.1007/s00125-002-0863-0; Meijer RI, 2011, ARCH SURG-CHICAGO, V146, P744, DOI 10.1001/archsurg.2011.134; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y; Norris SL, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004096.pub2, 10.1002/14651858.CD004095.pub2, 10.1002/14651858.CD005270]; Office of Health Economics, 2010, SHEDD POUNDS OB MAN; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Welbourn R, 2011, UK NATL BARIATRIC SU	16	38	42	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2011	378	9786					108	110		10.1016/S0140-6736(11)61027-1	http://dx.doi.org/10.1016/S0140-6736(11)61027-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	795CJ	21742162				2022-12-01	WOS:000292948800008
J	Xiao, T; Staub, W; Robles, E; Gosse, NJ; Cole, GJ; Baier, H				Xiao, Tong; Staub, Wendy; Robles, Estuardo; Gosse, Nathan J.; Cole, Gregory J.; Baier, Herwig			Assembly of Lamina-Specific Neuronal Connections by Slit Bound to Type IV Collagen	CELL			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; AXON GUIDANCE; OPTIC TECTUM; ROBO RECEPTORS; RETINAL AXONS; RETINOTECTAL PROJECTION; EMBRYONIC ZEBRAFISH; BASEMENT-MEMBRANE; LATERAL POSITION; EXPRESSION	The mechanisms that generate specific neuronal connections in the brain are under intense investigation. In zebrafish, retinal ganglion cells project their axons into at least six layers within the neuropil of the midbrain tectum. Each axon elaborates a single, planar arbor in one of the target layers and forms synapses onto the dendrites of tectal neurons. We show that the laminar specificity of retinotectal connections does not depend on self-sorting interactions among RGC axons. Rather, tectum-derived Slit1, signaling through axonal Robo2, guides neurites to their target layer. Genetic and biochemical studies indicate that Slit binds to Dragnet (Col4a5), a type IV Collagen, which forms the basement membrane on the surface of the tectum. We further show that radial glial endfeet are required for the basement-membrane anchoring of Slit. We propose that Slit1 signaling, perhaps in the form of a superficial-to-deep gradient, presents laminar positional cues to ingrowing retinal axons.	[Xiao, Tong; Staub, Wendy; Robles, Estuardo; Gosse, Nathan J.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, Program Neurosci, San Francisco, CA 94158 USA; [Xiao, Tong; Staub, Wendy; Robles, Estuardo; Gosse, Nathan J.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, Genet Program, San Francisco, CA 94158 USA; [Xiao, Tong; Staub, Wendy; Robles, Estuardo; Gosse, Nathan J.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, Program Dev Biol, San Francisco, CA 94158 USA; [Cole, Gregory J.] N Carolina Cent Univ, Julius L Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of North Carolina; North Carolina Central University	Baier, H (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18, D-82152 Martinsried, Germany.	herwig.baier@ucsf.edu		Robles, Estuardo/0000-0002-1202-2050	NIH [R01 EY013855, EY012406]; NATIONAL EYE INSTITUTE [R01EY013855, R01EY012406] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Hitoshi Okamoto, Marc Ekker, Chi-Bin Chien and members of our laboratory for reagents and fish lines. This work was funded by NIH R01 EY013855 and EY012406.	Arrenberg AB, 2009, P NATL ACAD SCI USA, V106, P17968, DOI 10.1073/pnas.0906252106; Baier H, 1996, DEVELOPMENT, V123, P415; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Campbell DS, 2007, NEURON, V55, P231, DOI 10.1016/j.neuron.2007.06.034; Chen Z, 2008, NEURON, V58, P325, DOI 10.1016/j.neuron.2008.02.016; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Dalkic E, 2006, DEV GENES EVOL, V216, P555, DOI 10.1007/s00427-006-0070-y; Davison JM, 2007, DEV BIOL, V304, P811, DOI 10.1016/j.ydbio.2007.01.033; Erskine L, 2000, J NEUROSCI, V20, P4975; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; Ghanem N, 2003, GENOME RES, V13, P533, DOI 10.1101/gr.716103; Goodhill GJ, 2003, NEURAL COMPUT, V15, P549, DOI 10.1162/089976603321192077; Gosse NJ, 2008, NATURE, V452, P892, DOI 10.1038/nature06816; Halfter W, 1998, J COMP NEUROL, V397, P105, DOI 10.1002/(SICI)1096-9861(19980720)397:1<105::AID-CNE8>3.0.CO;2-4; Halfter W, 2002, J NEUROSCI, V22, P6029; Haubst N, 2006, DEVELOPMENT, V133, P3245, DOI 10.1242/dev.02486; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hu HY, 2001, NAT NEUROSCI, V4, P695, DOI 10.1038/89482; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Huberman AD, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001743; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Hussain SA, 2006, J BIOL CHEM, V281, P39693, DOI 10.1074/jbc.M609384200; Hutson LD, 2002, NEURON, V33, P205, DOI 10.1016/S0896-6273(01)00579-7; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; Kay JN, 2005, DEVELOPMENT, V132, P2573, DOI 10.1242/dev.01831; Kay JN, 2001, NEURON, V30, P725, DOI 10.1016/S0896-6273(01)00312-9; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Lee JS, 2001, DEV DYNAM, V221, P216, DOI 10.1002/dvdy.1136; Lee JS, 2004, NEURON, V44, P947, DOI 10.1016/j.neuron.2004.11.029; Lemke G, 2005, ANNU REV CELL DEV BI, V21, P551, DOI 10.1146/annurev.cellbio.20.022403.093702; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Matsuoka RL, 2011, NATURE, V470, P259, DOI 10.1038/nature09675; May PJ, 2006, PROG BRAIN RES, V151, P321, DOI 10.1016/S0079-6123(05)51011-2; Nevin LM, 2011, DEVELOPMENT, V138, P2457, DOI 10.1242/dev.060335; Nevin LM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-126; Nevin LM, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-36; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Poggi L, 2005, J CELL BIOL, V171, P991, DOI 10.1083/jcb.200509098; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Rakic P, 2003, GLIA, V43, P19, DOI 10.1002/glia.10244; Robles E, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00001; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Scott EK, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.013.2009; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Spitzweck B, 2010, CELL, V140, P409, DOI 10.1016/j.cell.2010.01.002; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Van Vactor D, 2006, CURR OPIN NEUROBIOL, V16, P40, DOI 10.1016/j.conb.2006.01.011; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wang XM, 2008, NATURE, V455, P72, DOI 10.1038/nature07214; Xiao T, 2003, J NEUROSCI, V23, P4190; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; Xiao T, 2007, NAT NEUROSCI, V10, P1529, DOI 10.1038/nn2002; YAMAGATA M, 1995, DEVELOPMENT, V121, P189; YAMAGATA M, 1995, DEVELOPMENT, V121, P3763; Yebra M, 2003, DEV CELL, V5, P695, DOI 10.1016/S1534-5807(03)00330-7; Yeo SY, 2004, MECH DEVELOP, V121, P315, DOI 10.1016/j.mod.2004.03.006; Yeo SY, 2001, DEV BIOL, V230, P1, DOI 10.1006/dbio.2000.0105	60	75	75	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 8	2011	146	1					164	176		10.1016/j.cell.2011.06.016	http://dx.doi.org/10.1016/j.cell.2011.06.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729787	Green Accepted, Bronze			2022-12-01	WOS:000292539300014
J	Keown, P; Weich, S; Bhui, KS; Scott, J				Keown, Patrick; Weich, Scott; Bhui, Kamaldeep S.; Scott, Jan			Association between provision of mental illness beds and rate of involuntary admissions in the NHS in England 1988-2008: ecological study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIAL; PSYCHIATRIC ADMISSION; HEALTH-CARE; SERVICES; TEAM	Objective To examine the rise in the rate of involuntary admissions for mental illness in England that has occurred as community alternatives to hospital admission have been introduced. Design Ecological analysis. Setting England, 1988-2008. Data source Publicly available data on provision of beds for people with mental illness in the National Health Service from Hospital Activity Statistics and involuntary admission rates from the NHS Information Centre. Main outcome measures Association between annual changes in provision of mental illness beds in the NHS and involuntary admission rates, using cross correlation. Partial correlation coefficients were calculated and regression analysis carried out for the time lag (interval) over which the largest association between these variables was identified. Results The rate of involuntary admissions per annum in the NHS increased by more than 60%, whereas the provision of mental illness beds decreased by more than 60% over the same period; these changes seemed to be synchronous. The strongest association between these variables was observed when a time lag of one year was introduced, with bed reductions preceding increases in involuntary admissions (cross correlation -0.60, 95% confidence interval -1.06 to -0.15). This association increased in magnitude when analyses were restricted to civil (non-forensic) involuntary admissions and non-secure mental illness beds. Conclusion The annual reduction in provision of mental illness beds was associated with the rate of involuntary admissions over the short to medium term, with the closure of two mental illness beds leading to one additional involuntary admission in the subsequent year. This study provides a method for predicting rates of involuntary admissions and what may happen in the future if bed closures continue.	[Keown, Patrick] Queen Elizabeth Hosp, Tranwell Unit, Gateshead NE10 9R, Tyne & Wear, England; [Keown, Patrick; Scott, Jan] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Weich, Scott] Warwick Med Sch, Hlth Sci Res Inst, Coventry, W Midlands, England; [Bhui, Kamaldeep S.] Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, London, England	Newcastle University - UK; University of Warwick; University of London; Queen Mary University London	Keown, P (corresponding author), Queen Elizabeth Hosp, Tranwell Unit, Gateshead NE10 9R, Tyne & Wear, England.	patrick.keown@ncl.ac.uk	Scott, Jan/F-2966-2010; Bhui, Kamaldeep/AAX-2576-2020	Scott, Jan/0000-0002-7203-8601; Bhui, Kamaldeep/0000-0002-9205-2144; Weich, Scott/0000-0002-7552-7697	SDO grant	SDO grant	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years. All authors are applicants for an SDO grant pending review to build on these analyses.	Bennewith O, 2010, BRIT J PSYCHIAT, V196, P75, DOI 10.1192/bjp.bp.109.068890; Bhui K, 2003, BRIT J PSYCHIAT, V182, P105, DOI 10.1192/bjp.182.2.105; Bindman J, 2002, SOC PSYCH PSYCH EPID, V37, P341, DOI 10.1007/s00127-002-0558-3; Craig TK, 2004, BMJ-BRIT MED J, V329, P1067, DOI 10.1136/bmj.38246.594873.7C; Davidge M., 1993, SURVEY ENGLISH MENTA; Dean C, 1993, BRIT MED J, V307, P642; Department of Health, 1988, IN PAT FORM DET HOSP; Department of Health, 2009, BED AV OCC; Glover G, 2006, BRIT J PSYCHIAT, V189, P441, DOI 10.1192/bjp.bp.105.020362; Information Centre (2009m), 2009, INP FORM DET HOSP ME; Johnson S, 2005, BRIT MED J, V331, P599, DOI 10.1136/bmj.38519.678148.8F; Keown P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1837; NHSX, 2022, EL PRESCR MED ADM ME; Priebe S, 2005, BMJ-BRIT MED J, V330, P123, DOI 10.1136/bmj.38296.611215.AE; Rethink, 2005, FUT PERF OUTL ALT PA; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; VELLEMAN PF, 1980, J AM STAT ASSOC, V75, P609, DOI 10.2307/2287657; Wall S, 1999, BRIT MED J, V318, P1520, DOI 10.1136/bmj.318.7197.1520; Weich S, 2008, BRIT MED J, V337, P970; Weich S, 2010, SOC PSYCHIAT PSYCHIA	20	80	81	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2011	343								d3736	10.1136/bmj.d3736	http://dx.doi.org/10.1136/bmj.d3736			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791RV	21729994	hybrid, Green Published, Green Submitted			2022-12-01	WOS:000292683200001
J	Schousboe, JT; Kerlikowske, K; Loh, A; Cummings, SR				Schousboe, John T.; Kerlikowske, Karla; Loh, Andrew; Cummings, Steven R.			Personalizing Mammography by Breast Density and Other Risk Factors for Breast Cancer: Analysis of Health Benefits and Cost-Effectiveness	ANNALS OF INTERNAL MEDICINE			English	Article							CARCINOMA IN-SITU; NATURAL-HISTORY; FOLLOW-UP; MODEL; MORTALITY; WOMEN; STAGE; ACCURACY; THERAPY; STATES	Background: Current guidelines recommend mammography every 1 or 2 years starting at age 40 or 50 years, regardless of individual risk for breast cancer. Objective: To estimate the cost-effectiveness of mammography by age, breast density, history of breast biopsy, family history of breast cancer, and screening interval. Design: Markov microsimulation model. Data Sources: Surveillance, Epidemiology, and End Results program, Breast Cancer Surveillance Consortium, and the medical literature. Target Population: U. S. women aged 40 to 49, 50 to 59, 60 to 69, and 70 to 79 years with initial mammography at age 40 years and breast density of Breast Imaging Reporting and Data System (BI-RADS) categories 1 to 4. Time Horizon: Lifetime. Perspective: National health payer. Intervention: Mammography annually, biennially, or every 3 to 4 years or no mammography. Outcome Measures: Costs per quality-adjusted life-year (QALY) gained and number of women screened over 10 years to prevent 1 death from breast cancer. Results of Base-Case Analysis: Biennial mammography cost less than $100 000 per QALY gained for women aged 40 to 79 years with BI-RADS category 3 or 4 breast density or aged 50 to 69 years with category 2 density; women aged 60 to 79 years with category 1 density and either a family history of breast cancer or a previous breast biopsy; and all women aged 40 to 79 years with both a family history of breast cancer and a previous breast biopsy, regardless of breast density. Biennial mammography cost less than $50 000 per QALY gained for women aged 40 to 49 years with category 3 or 4 breast density and either a previous breast biopsy or a family history of breast cancer. Annual mammography was not cost-effective for any group, regardless of age or breast density. Results of Sensitivity Analysis: Mammography is expensive if the disutility of false-positive mammography results and the costs of detecting nonprogressive and nonlethal invasive cancer are considered. Limitation: Results are not applicable to carriers of BRCA1 or BRCA2 mutations. Conclusion: Mammography screening should be personalized on the basis of a woman's age, breast density, history of breast biopsy, family history of breast cancer, and beliefs about the potential benefit and harms of screening.	Pk Nicollet Hlth Serv, Minneapolis, MN USA; Univ Minnesota, Minneapolis, MN USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Calif Pacific Med Ctr, Res Inst, San Francisco Coordinating Ctr, San Francisco, CA USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; California Pacific Medical Center; California Pacific Medical Center Research Institute	Schousboe, JT (corresponding author), Pk Nicollet Inst, 3800 Pk Nicollet Blvd, Minneapolis, MN 55416 USA.	scho0600@umn.edu			Eli Lilly; Da Costa Family Foundation for Research in Breast Cancer Prevention of the California Pacific Medical Center; Breast Cancer Surveillance Consortium; National Cancer Institute BCSC [U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040]; NATIONAL CANCER INSTITUTE [U01CA086076, U01CA069976, U01CA070040, U01CA070013, U01CA063731, U01CA063740, U01CA063736, U01CA086082] Funding Source: NIH RePORTER	Eli Lilly(Eli Lilly); Da Costa Family Foundation for Research in Breast Cancer Prevention of the California Pacific Medical Center; Breast Cancer Surveillance Consortium; National Cancer Institute BCSC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Primary Funding Source: Eli Lilly, Da Costa Family Foundation for Research in Breast Cancer Prevention of the California Pacific Medical Center, and Breast Cancer Surveillance Consortium.r Grant Support: By an unrestricted grant from Eli Lilly and by the Da Costa Family Foundation for Research in Breast Cancer Prevention of the California Pacific Medical Center. Data collection for this work was supported by grants U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, and U01CA70040 from the National Cancer Institute BCSC. The collection of cancer incidence data used in this study was supported by several state public health departments and cancer registries throughout the United States; a full description of these sources can be found at http://breastscreening.cancer.gov/work/acknowledgement.html.	American Cancer Society, 2009, AM CANC SOC GUID EAR; Arias Elizabeth, 2006, Natl Vital Stat Rep, V54, P1; Arveux P, 2003, EUR J CANCER CARE, V12, P143, DOI 10.1046/j.1365-2354.2003.00373.x; Berg AO, 2002, ANN INTERN MED, V137, P344, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00011; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Breast Cancer Surveillance Consortium, 2004, NIH PUBL; Brett J, 2005, PSYCHO-ONCOLOGY, V14, P917, DOI 10.1002/pon.904; Bureau of Labor Statistics, 2009, CONS PRIC IND DET RE, V2009; Burstrom K, 2006, HEALTH POLICY, V76, P359, DOI 10.1016/j.healthpol.2005.06.011; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Centers for Medicare & Medicaid Services, 2008, 2009 PHYS FEE SCHED; Chiu SYH, 2010, CANCER EPIDEM BIOMAR, V19, P1219, DOI 10.1158/1055-9965.EPI-09-1028; Ciatto S, 2005, BREAST, V14, P269, DOI 10.1016/j.breast.2004.12.004; EDDY DM, 1989, ANN INTERN MED, V111, P389, DOI 10.7326/0003-4819-111-5-389; Erbas B, 2006, BREAST CANCER RES TR, V97, P135, DOI 10.1007/s10549-005-9101-z; Ernster VL, 2000, ARCH INTERN MED, V160, P953, DOI 10.1001/archinte.160.7.953; Ernster VL, 2002, J NATL CANCER I, V94, P1546; Garuz R, 1997, EUR J PUBLIC HEALTH, V7, P68, DOI 10.1093/eurpub/7.1.68; Gotzsche PC, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub2; HALL J, 1992, SOC SCI MED, V34, P993, DOI 10.1016/0277-9536(92)90130-I; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; KATTLOVE H, 1995, JAMA-J AM MED ASSOC, V273, P142, DOI 10.1001/jama.273.2.142; Kerlikowske K, 2003, JNCI-J NATL CANCER I, V95, P1692, DOI 10.1093/jnci/djg097; Kerlikowske K, 1998, J NATL CANCER I, V90, P1801, DOI 10.1093/jnci/90.23.1801; Kerlikowske K, 2007, J NATL CANCER I, V99, P386, DOI 10.1093/jnci/djk066; Lee CH, 2002, RADIOL CLIN N AM, V40, P395, DOI 10.1016/S0033-8389(01)00015-X; Lidgren M, 2007, QUAL LIFE RES, V16, P1073, DOI 10.1007/s11136-007-9202-8; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Olsen AH, 2009, BRIT J CANCER, V100, P1205, DOI 10.1038/sj.bjc.6604989; Plevritis SK, 2007, STAT MED, V26, P581, DOI 10.1002/sim.2550; Ries LA, 2006, SEER CANC STAT REV 1; Sirovich BE, 1999, SURG CLIN N AM, V79, P961, DOI 10.1016/S0039-6109(05)70056-6; Surveillance Epidemiology and End Results (SEER) Program, 2007, RES DAT 1973 2005; Szeto KL, 1996, HEALTH POLICY, V38, P101, DOI 10.1016/0168-8510(96)00843-3; TAPLIN SH, 1995, J NATL CANCER I, V87, P417, DOI 10.1093/jnci/87.6.417; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; Tosteson ANA, 2008, ANN INTERN MED, V148, P1, DOI 10.7326/0003-4819-148-1-200801010-00002; von Eschenbach AC, 2002, ONCOLOGIST, V7, P170, DOI 10.1634/theoncologist.7-3-170; Wang H, 2001, CANCER CAUSE CONTROL, V12, P39, DOI 10.1023/A:1008999403069; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C; Zahl PH, 2008, ARCH INTERN MED, V168, P2311, DOI 10.1001/archinte.168.21.2311	45	231	235	0	39	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2011	155	1					10	+		10.7326/0003-4819-155-1-201107050-00003	http://dx.doi.org/10.7326/0003-4819-155-1-201107050-00003			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	788MA	21727289	Green Accepted			2022-12-01	WOS:000292447800002
J	Marschner, K; Kollmann, K; Schweizer, M; Braulke, T; Pohl, S				Marschner, Katrin; Kollmann, Katrin; Schweizer, Michaela; Braulke, Thomas; Pohl, Sandra			A Key Enzyme in the Biogenesis of Lysosomes Is a Protease That Regulates Cholesterol Metabolism	SCIENCE			English	Article							ELEMENT-BINDING PROTEINS; UDP-N-ACETYLGLUCOSAMINE; SITE-1 PROTEASE; CLEAVAGE; CELLS; SUBUNIT; GLCNAC-1-PHOSPHOTRANSFERASE; PHOSPHOTRANSFERASE; IDENTIFICATION; CONVERTASE	Mucolipidosis II is a severe lysosomal storage disorder caused by defects in the alpha and beta subunits of the hexameric N-acetylglucosamine-1-phosphotransferase complex essential for the formation of the mannose 6-phosphate targeting signal on lysosomal enzymes. Cleavage of the membrane-bound alpha/beta-subunit precursor by an unknown protease is required for catalytic activity. Here we found that the alpha/beta-subunit precursor is cleaved by the site-1 protease (S1P) that activates sterol regulatory element-binding proteins in response to cholesterol deprivation. S1P-deficient cells failed to activate the alpha/beta-subunit precursor and exhibited a mucolipidosis II-like phenotype. Thus, S1P functions in the biogenesis of lysosomes, and lipid-independent phenotypes of S1P deficiency may be caused by lysosomal dysfunction.	[Marschner, Katrin; Kollmann, Katrin; Braulke, Thomas; Pohl, Sandra] Univ Med Ctr Hamburg Eppendorf, Childrens Hosp, Dept Biochem, Hamburg, Germany; [Schweizer, Michaela] Univ Hamburg, Ctr Mol Neurobiol, Dept Electron Microscopy, D-2000 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg	Braulke, T (corresponding author), Univ Med Ctr Hamburg Eppendorf, Childrens Hosp, Dept Biochem, Hamburg, Germany.	braulke@uke.uni-hamburg.de	Braulke, Thomas/AAV-9121-2020; Pohl, Sandra/AAF-1943-2020	Braulke, Thomas/0000-0002-2336-8532; Pohl, Sandra/0000-0001-7409-7042	Deutsche Forschungsgemeinschaft [SFB877/B3, GRK1459]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank J. L. Goldstein for providing SRD-12B and CHO-7 cells. Lipoprotein-poor newborn calf serum and human LDL for selection of SRD-12B cells were provided by J. Heeren. We also thank J. Brand and C. Raithore for technical assistance. We are grateful to J. Bonifacino for critical reading of the manuscript and comments, and to K. Duncan for help in editing the manuscript. T. Braulke and S. Muller-Loennies hold a patent on the single-chain antibody fragment for the detection of M6P-containing proteins (International Patent no. PTC/EP2009/060224 and U.S./PTC Application no. 13/057,844). This work was supported by the Deutsche Forschungsgemeinschaft (SFB877/B3, GRK1459).	Bao M, 1996, J BIOL CHEM, V271, P31437, DOI 10.1074/jbc.271.49.31437; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Elagoz A, 2002, J BIOL CHEM, V277, P11265, DOI 10.1074/jbc.M109011200; Hawkins JL, 2008, J PHARMACOL EXP THER, V326, P801, DOI 10.1124/jpet.108.139626; Kollmann K, 2010, EUR J CELL BIOL, V89, P117, DOI 10.1016/j.ejcb.2009.10.008; Kornfeld S., 2001, METABOLIC MOL BASES, P3421; Kudo M, 2006, J BIOL CHEM, V281, P11761, DOI 10.1074/jbc.M513717200; Kudo M, 2005, J BIOL CHEM, V280, P36141, DOI 10.1074/jbc.m509008200; Mullerr-Loennies S, 2010, AM J PATHOL, V177, P240, DOI 10.2353/ajpath.2010.090954; Paik KH, 2005, HUM MUTAT, V26, P308, DOI 10.1002/humu.20205; Patra D, 2007, J CELL BIOL, V179, P687, DOI 10.1083/jcb.200708092; Pohl S, 2010, J BIOL CHEM, V285, P23936, DOI 10.1074/jbc.M110.129684; Rawson RB, 1998, J BIOL CHEM, V273, P28261, DOI 10.1074/jbc.273.43.28261; Rojek JM, 2008, J VIROL, V82, P6045, DOI 10.1128/JVI.02392-07; Rojek JM, 2010, J VIROL, V84, P573, DOI 10.1128/JVI.01697-09; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; Saul RA, 2005, AM J MED GENET A, V135A, P328, DOI 10.1002/ajmg.a.30716; Schlombs K, 2003, P NATL ACAD SCI USA, V100, P14024, DOI 10.1073/pnas.2331794100; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 1999, P NATL ACAD SCI USA, V96, P1321, DOI 10.1073/pnas.96.4.1321; Stirling J, 2006, MOL BIOL CELL, V17, P413, DOI 10.1091/mbc.E05-06-0500; Tiede S, 2005, NAT MED, V11, P1109, DOI 10.1038/nm1305; Walkley SU, 2009, BBA-MOL CELL RES, V1793, P726, DOI 10.1016/j.bbamcr.2008.11.014	25	98	106	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 1	2011	333	6038					87	90		10.1126/science.1205677	http://dx.doi.org/10.1126/science.1205677			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719679				2022-12-01	WOS:000292255400055
J	Iheanacho, I				Iheanacho, Ike			DRUG TALES AND OTHER STORIES Death of the silent witness: patients' reporting of adverse drug reactions	BRITISH MEDICAL JOURNAL			English	Editorial Material									Drug & Therapeut Bulletin, London, England		Iheanacho, I (corresponding author), Drug & Therapeut Bulletin, London, England.	iiheanacho@bmjgroup.com							0	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 29	2011	342								d4042	10.1136/bmj.d4042	http://dx.doi.org/10.1136/bmj.d4042			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	788PZ	21715457				2022-12-01	WOS:000292458200007
J	Keck, JM; Jones, MH; Wong, CCL; Binkley, J; Chen, DC; Jaspersen, SL; Holinger, EP; Xu, T; Niepel, M; Rout, MP; Vogel, J; Sidow, A; Yates, JR; Winey, M				Keck, Jamie M.; Jones, Michele H.; Wong, Catherine C. L.; Binkley, Jonathan; Chen, Daici; Jaspersen, Sue L.; Holinger, Eric P.; Xu, Tao; Niepel, Mario; Rout, Michael P.; Vogel, Jackie; Sidow, Arend; Yates, John R., III; Winey, Mark			A Cell Cycle Phosphoproteome of the Yeast Centrosome	SCIENCE			English	Article							SPINDLE POLE BODY; BUDDING YEAST; PHOSPHORYLATION SITES; PROTEIN; DUPLICATION; KINASE; COMPLEX; CDK1	Centrosomes organize the bipolar mitotic spindle, and centrosomal defects cause chromosome instability. Protein phosphorylation modulates centrosome function, and we provide a comprehensive map of phosphorylation on intact yeast centrosomes (18 proteins). Mass spectrometry was used to identify 297 phosphorylation sites on centrosomes from different cell cycle stages. We observed different modes of phosphoregulation via specific protein kinases, phosphorylation site clustering, and conserved phosphorylated residues. Mutating all eight cyclin-dependent kinase (Cdk)-directed sites within the core component, Spc42, resulted in lethality and reduced centrosomal assembly. Alternatively, mutation of one conserved Cdk site within gamma-tubulin (Tub4-S360D) caused mitotic delay and aberrant anaphase spindle elongation. Our work establishes the extent and complexity of this prominent posttranslational modification in centrosome biology and provides specific examples of phosphorylation control in centrosome function.	[Keck, Jamie M.; Jones, Michele H.; Holinger, Eric P.; Winey, Mark] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Wong, Catherine C. L.; Xu, Tao; Yates, John R., III] Scripps Res Inst, Dept Chem Physiol, La Jolla, CA 92037 USA; [Binkley, Jonathan; Sidow, Arend] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Binkley, Jonathan; Sidow, Arend] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Chen, Daici; Vogel, Jackie] McGill Univ, Dept Biol, Montreal, PQ H3G 0B1, Canada; [Jaspersen, Sue L.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Jaspersen, Sue L.] Univ Kansas, Dept Mol & Integrat Physiol, Med Ctr, Kansas City, KS 66160 USA; [Niepel, Mario] Harvard Univ, Dept Syst Biol, Sch Med, Boston, MA 02115 USA; [Rout, Michael P.] Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10065 USA	University of Colorado System; University of Colorado Boulder; Scripps Research Institute; Stanford University; Stanford University; McGill University; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; Harvard University; Harvard Medical School; Rockefeller University	Winey, M (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, UCB 347, Boulder, CO 80309 USA.	mark.winey@colorado.edu	Niepel, Mario/G-5443-2011; Rout, Michael/Y-7090-2018; Chen, Daici/AAI-7285-2020	Niepel, Mario/0000-0003-1415-6295; Chen, Daici/0000-0002-8872-0592; Rout, Michael/0000-0003-2010-706X; Wong, Catherine CL/0000-0001-7270-980X	NIH [U54 RR022220, R01 GM062427, R01 HG003039, P41 RR011823, GM51312, F32 GM086038, T32 GM008759]; CIHR [MOP-64404]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823, U54RR022220] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051312, R01GM062427, F32GM086038, T32GM008759] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Pearson, A. Stemm-Wolf, and T. Su for comments on the manuscript; T. Davis and the Winey lab for helpful discussions; E. O'Toole for the electron micrograph; E. Nazarova for assisting with spindle dynamics analysis; M. Riffle for Yeast Resource Center assistance; and D. D'amours for the Cdc28 purification protocol. This work was supported by NIH U54 RR022220 and R01 GM062427 (M.P.R.), NIH R01 HG003039 (A.S.), NIH P41 RR011823 (J.R.Y. III, T.N. Davis, principal investigator), CIHR MOP-64404 (J.V.), and NIH GM51312 (M. W.). J.M.K. was supported by NIH F32 GM086038, and E.P.H. was supported by NIH T32 GM008759. Mass spectrometry data are provided at the Yeast Resource Center (www.yeastrc.org/pdr/pages/front.jsp).	Alvarado-Kristensson M, 2009, NAT CELL BIOL, V11, P1081, DOI 10.1038/ncb1921; Araki Y, 2010, J CELL BIOL, V189, P41, DOI 10.1083/jcb.200910027; Ba ANN, 2010, MOL BIOL EVOL, V27, P2027, DOI 10.1093/molbev/msq090; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Binkley J, 2010, GENOME RES, V20, P142, DOI 10.1101/gr.097121.109; Crasta K, 2008, NAT CELL BIOL, V10, P665, DOI 10.1038/ncb1729; Friedman DB, 2001, J BIOL CHEM, V276, P17958, DOI 10.1074/jbc.M010461200; Holinger EP, 2009, J BIOL CHEM, V284, P12949, DOI 10.1074/jbc.M900088200; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Jaspersen SL, 2004, ANNU REV CELL DEV BI, V20, P1, DOI 10.1146/annurev.cellbio.20.022003.114106; KAHANA JA, 1995, P NATL ACAD SCI USA, V92, P9707, DOI 10.1073/pnas.92.21.9707; Kimura M., 1983, NEUTRAL THEORY MOL E; Kollman JM, 2010, NATURE, V466, P879, DOI 10.1038/nature09207; Lu BW, 2007, ANAL CHEM, V79, P1301, DOI 10.1021/ac061334v; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Niepel M, 2005, J CELL BIOL, V170, P225, DOI 10.1083/jcb.200504140; Schweiger R, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-6; Snead JL, 2007, CHEM BIOL, V14, P1261, DOI 10.1016/j.chembiol.2007.09.011; Vinh DBN, 2002, MOL BIOL CELL, V13, P1144, DOI 10.1091/mbc.02-01-0607; Visintin R, 2001, MOL BIOL CELL, V12, P2961, DOI 10.1091/mbc.12.10.2961; Vogel J, 2001, DEV CELL, V1, P621, DOI 10.1016/S1534-5807(01)00073-9; Winey M, 2001, NAT CELL BIOL, V3, pE23, DOI 10.1038/35050663	23	77	81	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 24	2011	332	6037					1557	1561		10.1126/science.1205193	http://dx.doi.org/10.1126/science.1205193			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700874	Green Accepted			2022-12-01	WOS:000291990000045
J	Wang, X; Ouyang, H; Yamamoto, Y; Kumar, PA; Wei, TS; Dagher, R; Vincent, M; Lu, X; Bellizzi, AM; Ho, KY; Crum, CP; Xian, W; McKeon, F				Wang, Xia; Ouyang, Hong; Yamamoto, Yusuke; Kumar, Pooja Ashok; Wei, Tay Seok; Dagher, Rania; Vincent, Matthew; Lu, Xin; Bellizzi, Andrew M.; Ho, Khek Yu; Crum, Christopher P.; Xian, Wa; McKeon, Frank			Residual Embryonic Cells as Precursors of a Barrett's-like Metaplasia	CELL			English	Article							INFLAMMATORY-BOWEL-DISEASE; ESOPHAGEAL ADENOCARCINOMA; INTESTINAL METAPLASIA; SQUAMOUS EPITHELIUM; COLUMNAR EPITHELIUM; GENE-EXPRESSION; GASTRIC-CANCER; STEM-CELLS; DYSPLASIA; P63	Barrett's esophagus is an intestine-like metaplasia and precursor of esophageal adenocarcinoma. Triggered by gastroesophageal reflux disease, the origin of this metaplasia remains unknown. p63-deficient mice, which lack squamous epithelia, may model acid-reflux damage. We show here that p63 null embryos rapidly develop intestine-like metaplasia with gene expression profiles similar to Barrett's metaplasia. We track its source to a unique embryonic epithelium that is normally undermined and replaced by p63-expressing cells. Significantly, we show that a discrete population of these embryonic cells persists in adult mice and humans at the squamocolumnar junction, the source of Barrett's metaplasia. We show that upon programmed damage to the squamous epithelium, these embryonic cells migrate toward adjacent, specialized squamous cells in a process that may recapitulate early Barrett's. Our findings suggest that certain precancerous lesions, such as Barrett's, initiate not from genetic alterations but from competitive interactions between cell lineages driven by opportunity.	[Wei, Tay Seok; Xian, Wa] ASTAR, Inst Med Biol, Singapore 138648, Singapore; [Wang, Xia; Ouyang, Hong; McKeon, Frank] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Yamamoto, Yusuke; Kumar, Pooja Ashok; McKeon, Frank] ASTAR, Genome Inst Singapore, Singapore 138672, Singapore; [Dagher, Rania] Univ Strasbourg, Inst Sci & Ingn Supramol, F-67081 Strasbourg, France; [Vincent, Matthew] Multiclonal Therapeut Inc, Newburyport, MA 01833 USA; [Lu, Xin] Univ Oxford, Ludwig Canc Inst, Oxford OX3 7DQ, England; [Bellizzi, Andrew M.; Crum, Christopher P.; Xian, Wa] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ho, Khek Yu] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 119077, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Harvard University; Harvard Medical School; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Ludwig Institute for Cancer Research; University of Oxford; Harvard University; Brigham & Women's Hospital; National University of Singapore	Xian, W (corresponding author), ASTAR, Inst Med Biol, Singapore 138648, Singapore.	wa.xian@imb.a-star.edu.sg; mckeonf@gis.a-star.edu.sg	Kumar, Pooja Ashok/K-6762-2019	Bellizzi, Andrew/0000-0002-8264-6379; Kumar, Pooja/0000-0002-6589-2447; Lu, Xin/0000-0002-6587-1152; Ouyang, Hong/0000-0002-7622-7733	National Institutes of Health [RO1-GM083348, R21CA124688]; European Research Council; Agence de Nationale; Biomedical Research Council; National Medical Research Council, Singapore; Institute of Medical Biology; Genome Institute of Singapore of the Agency for Science, Technology, and Research, Singapore; NATIONAL CANCER INSTITUTE [R21CA124688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Agence de Nationale; Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institute of Medical Biology(Agency for Science Technology & Research (A*STAR)); Genome Institute of Singapore of the Agency for Science, Technology, and Research, Singapore; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Prof. Rod Bronson and the Rodent Pathology Core at Harvard Medical School for help with histology, the staff of the Nikon Imaging Center of the Harvard Medical School for their help with imaging, and Prof. Ed Cox of the Dana Farber Cancer Institute Microarray Facility. We thank Da-Kai Mu for assistance with genotyping. We thank Profs. Birgit Lane of the Institute of Medical Biology, Bernard Dallemagne of the IRCAD, University of Strasbourg, and Teh Ming of the National University of Singapore for helpful discussions. We thank all the members in the Xian-McKeon laboratory for helpful discussions and support and Profs. Edison Liu and Barbara Knowles for their critical review of the manuscript. This work was supported by grants from the National Institutes of Health (RO1-GM083348 and R21CA124688), the European Research Council, the Agence de Nationale, and the Biomedical Research Council and the National Medical Research Council, Singapore and intramural grants from the Institute of Medical Biology and the Genome Institute of Singapore of the Agency for Science, Technology, and Research, Singapore.	Antonioli DA, 1997, GASTROENTEROL CLIN N, V26, P495, DOI 10.1016/S0889-8553(05)70309-5; Badreddine RJ, 2010, NAT REV GASTRO HEPAT, V7, P369, DOI 10.1038/nrgastro.2010.78; Barr H, 1996, LANCET, V348, P584, DOI 10.1016/S0140-6736(96)03054-1; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; BLOT WJ, 1991, JAMA-J AM MED ASSOC, V265, P1287, DOI 10.1001/jama.265.10.1287; Botelho NK, 2010, CANCER BIOL THER, V10, P172, DOI 10.4161/cbt.10.2.12166; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Coad RA, 2005, J PATHOL, V206, P388, DOI 10.1002/path.1804; CORREA P, 1994, CANCER SURV, V20, P55; Daniely Y, 2004, AM J PHYSIOL-CELL PH, V287, pC171, DOI 10.1152/ajpcell.00226.2003; Dixon J, 2001, AM J GASTROENTEROL, V96, P2575, DOI 10.1111/j.1572-0241.2001.04159.x; Farraye FA, 2010, GASTROENTEROLOGY, V138, P746, DOI [10.1053/j.gastro.2009.12.035, 10.1053/j.gastro.2009.12.037]; Glickman JN, 2001, AM J SURG PATHOL, V25, P569, DOI 10.1097/00000478-200105000-00002; Goldenring JR, 2010, GASTROENTEROLOGY, V138, P2207, DOI 10.1053/j.gastro.2010.04.023; HAGGITT RC, 1994, HUM PATHOL, V25, P982, DOI 10.1016/0046-8177(94)90057-4; Ivanova A, 2005, GENESIS, V43, P129, DOI 10.1002/gene.20162; Jankowski JA, 1999, AM J PATHOL, V154, P965, DOI 10.1016/S0002-9440(10)65346-1; Kimchi ET, 2005, CANCER RES, V65, P3146, DOI 10.1158/0008-5472.CAN-04-2490; Kiran RP, 2010, ANN SURG, V252, P330, DOI 10.1097/SLA.0b013e3181e61e69; Leedham SJ, 2008, GUT, V57, P1041, DOI 10.1136/gut.2007.143339; LEVINE DS, 1989, LAB INVEST, V60, P418; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Mutoh H, 2002, BIOCHEM BIOPH RES CO, V294, P470, DOI 10.1016/S0006-291X(02)00480-1; NAEF AP, 1975, J THORAC CARDIOV SUR, V70, P826; Piazuelo MB, 2004, MODERN PATHOL, V17, P62, DOI 10.1038/modpathol.3800016; RASKIND WH, 1992, CANCER RES, V52, P2946; REID BJ, 1991, GASTROENTEROL CLIN N, V20, P817; Reid BJ, 2010, NAT REV CANCER, V10, P87, DOI 10.1038/nrc2773; SAGAR PM, 1995, BRIT J SURG, V82, P806, DOI 10.1002/bjs.1800820628; Schetter AJ, 2010, CARCINOGENESIS, V31, P37, DOI 10.1093/carcin/bgp272; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Souza RF, 2008, AM J PHYSIOL-GASTR L, V295, pG211, DOI 10.1152/ajpgi.90250.2008; SPECHLER SJ, 1986, NEW ENGL J MED, V315, P362, DOI 10.1056/NEJM198608073150605; Stairs DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003534; Strobel O, 2010, GASTROENTEROLOGY, V138, P1166, DOI 10.1053/j.gastro.2009.12.005; Suh E, 1996, MOL CELL BIOL, V16, P619; Tobey NA, 2007, AM J PHYSIOL-GASTR L, V293, pG264, DOI 10.1152/ajpgi.00047.2007; van Baal JWPM, 2008, SCAND J GASTROENTERO, V43, P132, DOI 10.1080/00365520701676575; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wang J, 2009, J GASTROENTEROL, V44, P897, DOI 10.1007/s00535-009-0082-2; Weimann A, 2010, VIRCHOWS ARCH, V457, P537, DOI 10.1007/s00428-010-0972-y; Wojcik SM, 2001, J CELL BIOL, V154, P619, DOI 10.1083/jcb.200102079; Wong P, 2003, J CELL BIOL, V163, P327, DOI 10.1083/jcb.200305032; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	45	244	251	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 24	2011	145	7					1023	1035		10.1016/j.cell.2011.05.026	http://dx.doi.org/10.1016/j.cell.2011.05.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703447	Green Accepted, Bronze			2022-12-01	WOS:000292025700010
J	Martin, J				Martin, Jeremy			Don't foul the water	NATURE			English	Editorial Material									[Martin, Jeremy] Union Concerned Scientists, Cambridge, MA USA		Martin, J (corresponding author), Union Concerned Scientists, Cambridge, MA USA.	JMartin@ucsusa.org						EPA, 2008, TECH REP; *USDA, 2010, FEEDGR YB	2	11	13	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S17	S17		10.1038/474S017a	http://dx.doi.org/10.1038/474S017a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697836	Bronze			2022-12-01	WOS:000291939700006
J	Kesselheim, AS; Rajkumar, R				Kesselheim, Aaron S.; Rajkumar, Rahul			Who Owns Federally Funded Research? The Supreme Court and the Bayh-Dole Act	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kesselheim, Aaron S.] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Kesselheim, Aaron S.; Rajkumar, Rahul] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA USA; [Rajkumar, Rahul] McKinsey & Co Inc, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Eisenberg RS, 1996, VA LAW REV, V82, P1663, DOI 10.2307/1073686; HAWKINSON JA, 2011, TECH            0610; Mello MM, 2005, NEW ENGL J MED, V352, P2202, DOI 10.1056/NEJMsa044115; Sampat BN, 2006, RES POLICY, V35, P772, DOI 10.1016/j.respol.2006.04.009	4	3	4	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 29	2011	365	13					1167	1169		10.1056/NEJMp1109168	http://dx.doi.org/10.1056/NEJMp1109168			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	825YO	21879888	Bronze			2022-12-01	WOS:000295318400002
J	Rasmussen, SGF; DeVree, BT; Zou, YZ; Kruse, AC; Chung, KY; Kobilka, TS; Thian, FS; Chae, PS; Pardon, E; Calinski, D; Mathiesen, JM; Shah, STA; Lyons, JA; Caffrey, M; Gellman, SH; Steyaert, J; Skiniotis, G; Weis, WI; Sunahara, RK; Kobilka, BK				Rasmussen, Soren G. F.; DeVree, Brian T.; Zou, Yaozhong; Kruse, Andrew C.; Chung, Ka Young; Kobilka, Tong Sun; Thian, Foon Sun; Chae, Pil Seok; Pardon, Els; Calinski, Diane; Mathiesen, Jesper M.; Shah, Syed T. A.; Lyons, Joseph A.; Caffrey, Martin; Gellman, Samuel H.; Steyaert, Jan; Skiniotis, Georgios; Weis, William I.; Sunahara, Roger K.; Kobilka, Brian K.			Crystal structure of the beta(2) adrenergic receptor-Gs protein complex	NATURE			English	Article							ADENYLATE-CYCLASE; BETA(2)-ADRENERGIC RECEPTOR; MEDIATED ACTIVATION; BINDING; CRYSTALLIZATION; RECONSTITUTION; INSIGHTS; AMINO	G protein-coupled receptors (GPCRs) are responsible for the majority of cellular responses to hormones and neurotransmitters as well as the senses of sight, olfaction and taste. The paradigm of GPCR signalling is the activation of a heterotrimeric GTP binding protein (G protein) by an agonist-occupied receptor. The beta(2) adrenergic receptor (beta(2)AR) activation of Gs, the stimulatory G protein for adenylyl cyclase, has long been a model system for GPCR signalling. Here we present the crystal structure of the active state ternary complex composed of agonist-occupied monomeric beta(2)AR and nucleotide-free Gs heterotrimer. The principal interactions between the beta(2)AR and Gs involve the amino-and carboxy-terminal a-helices of Gs, with conformational changes propagating to the nucleotide-binding pocket. The largest conformational changes in the beta(2)AR include a 14 angstrom outward movement at the cytoplasmic end of transmembrane segment 6 (TM6) and an alpha-helical extension of the cytoplasmic end of TM5. The most surprising observation is a major displacement of the alpha-helical domain of G alpha s relative to the Ras-like GTPase domain. This crystal structure represents the first high-resolution view of transmembrane signalling by a GPCR.	[Rasmussen, Soren G. F.; Zou, Yaozhong; Kruse, Andrew C.; Chung, Ka Young; Kobilka, Tong Sun; Thian, Foon Sun; Mathiesen, Jesper M.; Weis, William I.; Kobilka, Brian K.] Stanford Univ, Dept Mol & Cellular Biol, Sch Med, Stanford, CA 94305 USA; [Rasmussen, Soren G. F.] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark; [DeVree, Brian T.; Calinski, Diane; Sunahara, Roger K.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Chae, Pil Seok; Gellman, Samuel H.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Pardon, Els; Steyaert, Jan] Vrije Univ Brussel, VIB, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium; [Shah, Syed T. A.; Lyons, Joseph A.; Caffrey, Martin] Trinity Coll Dublin, Membrane Struct & Funct Biol Grp, Sch Med, Dublin 2, Ireland; [Shah, Syed T. A.; Lyons, Joseph A.; Caffrey, Martin] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland; [Skiniotis, Georgios] Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA; [Skiniotis, Georgios] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Weis, William I.] Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA	Stanford University; University of Copenhagen; University of Michigan System; University of Michigan; University of Wisconsin System; University of Wisconsin Madison; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Trinity College Dublin; Trinity College Dublin; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University	Kobilka, BK (corresponding author), Stanford Univ, Dept Mol & Cellular Biol, Sch Med, Stanford, CA 94305 USA.	sunahara@umich.edu; kobilka@stanford.edu	Shah, Syed Tasadaque Ali/AAB-4890-2021; Lyons, Joseph/AAA-2528-2020; Sunahara, Roger/AAJ-8667-2020; steyaert, jan/GQP-7811-2022; Weis, William I/G-1437-2011; DeVree, Brian T/F-6205-2011; Steyaert, Jan/H-4662-2011; Chung, Ka Young/AAO-7984-2020	Weis, William I/0000-0002-5583-6150; Steyaert, Jan/0000-0002-3825-874X; DeVree, Brian/0000-0003-0582-8125; Kobilka, Brian/0000-0001-5958-3990; Skiniotis, Georgios/0000-0003-0238-7846; Chung, Ka Young/0000-0001-9038-9571; Caffrey, Martin/0000-0002-2931-4551; Rasmussen, Soren/0000-0002-1853-1841	National Institutes of Health [NS028471, GM083118, GM56169, P01 GM75913, T32-GM008270, P60DK-20572, GM75915, P50GM073210, U54GM094599]; Science Foundation Ireland [07/IN.1/B1836]; FP7 COST Action [CM0902]; Mathers Foundation; Lundbeck Foundation; University of Michigan; Fund for Scientific Research of Flanders (FWO-Vlaanderen); Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB); Danish Council for Independent Research, Medical Sciences; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068603, U54GM094599, R01GM056169, P50GM073210, P01GM075913, T32GM008270, R01GM083118, R01GM075915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471, R37NS028471] Funding Source: NIH RePORTER; Lundbeck Foundation [R37-2009-3457, R19-2008-2113] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); FP7 COST Action; Mathers Foundation; Lundbeck Foundation(Lundbeckfonden); University of Michigan(University of Michigan System); Fund for Scientific Research of Flanders (FWO-Vlaanderen)(FWO); Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB); Danish Council for Independent Research, Medical Sciences(Det Frie Forskningsrad (DFF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Lundbeck Foundation(Lundbeckfonden)	We acknowledge support from National Institutes of Health Grants NS028471 (B. K. K.) and GM083118 (B. K. K. and R. K. S.), GM56169 (W. I. W.), P01 GM75913 (S. H. G), T32-GM008270 and P60DK-20572 (R. K. S.), GM75915, P50GM073210 and U54GM094599 (M. C.), Science Foundation Ireland (07/IN.1/B1836) and FP7 COST Action CM0902 (M. C.), the Mathers Foundation (B. K. K. and W. I. W.), the Lundbeck Foundation (Junior Group Leader Fellowship, S. G. F. R.), the University of Michigan Biomedical Sciences Scholars Program (R. K. S.), the Fund for Scientific Research of Flanders (FWO-Vlaanderen) and the Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB) (E. P. and J.S.), The Danish Council for Independent Research, Medical Sciences (J.M.M.). We thank D. Grayson and A. Coughlan for help with lipid synthesis.	Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Baltensperger K, 1996, J BIOL CHEM, V271, P1061, DOI 10.1074/jbc.271.2.1061; Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; BRANDT DR, 1983, BIOCHEMISTRY-US, V22, P4357, DOI 10.1021/bi00288a002; Breitwieser GE, 2004, CIRC RES, V94, P17, DOI 10.1161/01.RES.0000110420.68526.19; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; CERIONE RA, 1984, BIOCHEMISTRY-US, V23, P4519, DOI 10.1021/bi00315a003; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; DELEAN A, 1980, J BIOL CHEM, V255, P7108; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; Domanska K, 2011, P NATL ACAD SCI USA, V108, P1314, DOI 10.1073/pnas.1008560108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Jastrzebska B, 2010, BIOCHEM J, V428, P1, DOI 10.1042/BJ20100270; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; MARKBY DW, 1993, SCIENCE, V262, P1895, DOI 10.1126/science.8266082; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Misquitta LV, 2004, STRUCTURE, V12, P2113, DOI 10.1016/j.str.2004.09.020; MORO O, 1993, J BIOL CHEM, V268, P22273; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; ROSS EM, 1977, J BIOL CHEM, V252, P5761; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Swaminath G, 2002, MOL PHARMACOL, V61, P65, DOI 10.1124/mol.61.1.65; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104	48	2123	2174	13	666	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2011	477	7366					549	U311		10.1038/nature10361	http://dx.doi.org/10.1038/nature10361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21772288	Green Accepted, Green Published			2022-12-01	WOS:000295320900031
J	Santoro, AE; Buchwald, C; McIlvin, MR; Casciotti, KL				Santoro, Alyson E.; Buchwald, Carolyn; McIlvin, Matthew R.; Casciotti, Karen L.			Isotopic Signature of N2O Produced by Marine Ammonia-Oxidizing Archaea	SCIENCE			English	Article							NITROUS-OXIDE; NITRIFYING ARCHAEA; OXIDATION; NITRIFICATION; NITROSOMONAS; CONSTRAINTS; BACTERIA; BUDGET; NO2	The ocean is an important global source of nitrous oxide (N2O), a greenhouse gas that contributes to stratospheric ozone destruction. Bacterial nitrification and denitrification are thought to be the primary sources of marine N2O, but the isotopic signatures of N2O produced by these processes are not consistent with the marine contribution to the global N2O budget. Based on enrichment cultures, we report that archaeal ammonia oxidation also produces N2O. Natural-abundance stable isotope measurements indicate that the produced N2O had bulk delta N-15 and delta O-18 values higher than observed for ammonia-oxidizing bacteria but similar to the delta N-15 and delta O-18 values attributed to the oceanic N2O source to the atmosphere. Our results suggest that ammonia-oxidizing archaea may be largely responsible for the oceanic N2O source.	[Santoro, Alyson E.; McIlvin, Matthew R.; Casciotti, Karen L.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Buchwald, Carolyn] Massachusetts Inst Technol Woods Hole Oceanog Ins, Joint Program Chem Oceanog, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution; Massachusetts Institute of Technology (MIT)	Santoro, AE (corresponding author), Univ Maryland, Ctr Environm Sci, Horn Point Lab, Cambridge, MD 21613 USA.	asantoro@umces.edu; kcasciotti@stanford.edu	McIlvin, Matthew/ABB-4762-2020; Santoro, Alyson E/E-5686-2013	Santoro, Alyson E/0000-0003-2503-8219; Casciotti, Karen/0000-0002-5286-7795	Woods Hole Oceanographic Institution Ocean Life Institute; Woods Hole Oceanographic Institution; U.S. National Science Foundation [OCE-0526277, OCE-0961098]	Woods Hole Oceanographic Institution Ocean Life Institute; Woods Hole Oceanographic Institution; U.S. National Science Foundation(National Science Foundation (NSF))	We thank C. Wuchter, S. Sievert, and M. Johnson for assistance in the laboratory. We also thank C. Frame, L. Codispoti, and three anonymous reviewers for helpful discussions and feedback. Funding for this work was provided by the Woods Hole Oceanographic Institution Ocean Life Institute, a Woods Hole Oceanographic Institution Postdoctoral Scholar Fellowship to A. E. S., and U.S. National Science Foundation grants OCE-0526277 and OCE-0961098 to K. L. C. The 16S ribosomal RNA gene and amoA gene sequences for CN25 and CN75 have been deposited in GenBank under the accession nos. HQ338108, JF521547, and JF521548. The CN25 and CN75 strains are available by request from A.E.S.	ANDERSSON KK, 1983, FEBS LETT, V164, P236, DOI 10.1016/0014-5793(83)80292-0; Beman JM, 2008, ISME J, V2, P429, DOI 10.1038/ismej.2007.118; Casciotti KL, 2010, LIMNOL OCEANOGR, V55, P753, DOI 10.4319/lo.2009.55.2.0753; Casciotti KL, 2002, ANAL CHEM, V74, P4905, DOI 10.1021/ac020113w; CODISPOTI LA, 1985, MAR CHEM, V16, P277, DOI 10.1016/0304-4203(85)90051-9; Dore JE, 1998, NATURE, V396, P63, DOI 10.1038/23921; Dore JE, 2002, LIMNOL OCEANOGR, V47, P1595, DOI 10.4319/lo.2002.47.6.1595; DUA RD, 1979, FEBS LETT, V106, P401, DOI 10.1016/0014-5793(79)80541-4; ELKINS JW, 1978, NATURE, V275, P602, DOI 10.1038/275602a0; Frame CH, 2010, BIOGEOSCIENCES, V7, P2695, DOI 10.5194/bg-7-2695-2010; GOREAU TJ, 1980, APPL ENVIRON MICROB, V40, P526, DOI 10.1128/AEM.40.3.526-532.1980; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; KIM KR, 1993, SCIENCE, V262, P1855, DOI 10.1126/science.262.5141.1855; KIM KR, 1990, NATURE, V347, P58, DOI 10.1038/347058a0; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; Naqvi SWA, 1998, NATURE, V394, P462, DOI 10.1038/28828; Nevison CD, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002110; Ostrom N.E., 2000, CHEMOSPHERE GLOBAL C, V2, P281, DOI [DOI 10.1016/S1465-9972(00)00031-3, 10.1016/S1465-9972(00)00031-3]; Popp BN, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001806; Rahn T, 2000, GLOBAL BIOGEOCHEM CY, V14, P537, DOI 10.1029/1999GB900070; Santoro AE, 2011, ISME J, V5, P1796, DOI 10.1038/ismej.2011.58; Santoro AE, 2010, ENVIRON MICROBIOL, V12, P1989, DOI 10.1111/j.1462-2920.2010.02205.x; Solomon S., 2007, ADV CLIM CHANG RES; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103; Yoshida N, 2000, NATURE, V405, P330, DOI 10.1038/35012558; YOSHIDA N, 1988, NATURE, V335, P528, DOI 10.1038/335528a0	27	302	329	9	387	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2011	333	6047					1282	1285		10.1126/science.1208239	http://dx.doi.org/10.1126/science.1208239			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21798895				2022-12-01	WOS:000294406400052
J	Smith, ADM; Brown, CJ; Bulman, CM; Fulton, EA; Johnson, P; Kaplan, IC; Lozano-Montes, H; Mackinson, S; Marzloff, M; Shannon, LJ; Shin, YJ; Tam, J				Smith, Anthony D. M.; Brown, Christopher J.; Bulman, Catherine M.; Fulton, Elizabeth A.; Johnson, Penny; Kaplan, Isaac C.; Lozano-Montes, Hector; Mackinson, Steven; Marzloff, Martin; Shannon, Lynne J.; Shin, Yunne-Jai; Tam, Jorge			Impacts of Fishing Low-Trophic Level Species on Marine Ecosystems	SCIENCE			English	Article							FORAGE FISH; FOOD WEBS; FISHERIES; VARIABILITY; CONSEQUENCES; MANAGEMENT; ABUNDANCE; PATTERNS; ECOSIM; MODEL	Low-trophic level species account for more than 30% of global fisheries production and contribute substantially to global food security. We used a range of ecosystem models to explore the effects of fishing low-trophic level species on marine ecosystems, including marine mammals and seabirds, and on other commercially important species. In five well-studied ecosystems, we found that fishing these species at conventional maximum sustainable yield (MSY) levels can have large impacts on other parts of the ecosystem, particularly when they constitute a high proportion of the biomass in the ecosystem or are highly connected in the food web. Halving exploitation rates would result in much lower impacts on marine ecosystems while still achieving 80% of MSY.	[Smith, Anthony D. M.; Bulman, Catherine M.; Fulton, Elizabeth A.; Johnson, Penny; Marzloff, Martin] Commonwealth Sci & Ind Res Org, Hobart, Tas 7001, Australia; [Brown, Christopher J.] Univ Queensland, Sch Biol Sci, St Lucia, Qld 4072, Australia; [Brown, Christopher J.] Commonwealth Sci & Ind Res Org, Brisbane, Qld 4163, Australia; [Kaplan, Isaac C.] NOAA, NW Fisheries Sci Ctr, Natori, Miyagi 98112, Japan; [Lozano-Montes, Hector] Commonwealth Sci & Ind Res Org, Floreat, WA 6014, Australia; [Mackinson, Steven] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft NR33 0HT, Suffolk, England; [Marzloff, Martin] Univ Tasmania, Inst Marine & Antarct Studies, Sandy Bay, Tas 7005, Australia; [Shannon, Lynne J.; Shin, Yunne-Jai] Univ Cape Town, Marine Res MA RE Inst, ZA-7701 Rondebosch, South Africa; [Shannon, Lynne J.; Shin, Yunne-Jai] Univ Cape Town, Dept Zool, ZA-7701 Rondebosch, South Africa; [Shin, Yunne-Jai] Inst Rech Dev, UMR EME 212, F-34203 Sete, France; [Tam, Jorge] Inst Mar Peru, Callao, Peru	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); National Oceanic Atmospheric Admin (NOAA) - USA; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Centre for Environment Fisheries & Aquaculture Science; University of Tasmania; University of Cape Town; University of Cape Town; Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Instituto del Mar del Peru	Smith, ADM (corresponding author), Commonwealth Sci & Ind Res Org, Hobart, Tas 7001, Australia.	tony.d.smith@csiro.edu	Shin, Yunne-Jai/A-7575-2012; Shannon, Lynne J/A-1612-2015; Fulton, Beth/A-2871-2008; Lozano-Montes, Hector M/E-5034-2014; Brown, Christopher J/G-4287-2011; Marzloff, Martin/J-7186-2014; Marzloff, Martin/AAY-3833-2020; Fulton, Beth/AAJ-1398-2021; Bulman, Catherine M/A-9795-2012; Smith, Tony D/A-4017-2012	Shin, Yunne-Jai/0000-0002-7259-9265; Shannon, Lynne J/0000-0001-7842-0636; Fulton, Beth/0000-0002-5904-7917; Brown, Christopher J/0000-0002-7271-4091; Marzloff, Martin/0000-0002-8152-4273; Marzloff, Martin/0000-0002-8152-4273; Fulton, Beth/0000-0002-5904-7917; Bulman, Catherine M/0000-0002-8997-4615; Mackinson, Steven/0000-0002-0262-1180; Tam, Jorge/0000-0001-8224-4313	Marine Stewardship Council (MSC); Commonwealth Scientific and Industrial Research Organization (Australia); National Oceanographic and Atmospheric Administration (USA); Institut de Recherche pour le Developpement (France); Instituto del Mar del Peru (Peru); Gordon and Betty Moore Foundation; David and Lucile Packard Foundation; European Union (EU) [244966]; Department of Environment Food and Rural Affairs [M1202]; South African Research Chair Initiative; South African Department of Science and Technology; EU [212085]	Marine Stewardship Council (MSC); Commonwealth Scientific and Industrial Research Organization (Australia); National Oceanographic and Atmospheric Administration (USA)(National Oceanic Atmospheric Admin (NOAA) - USA); Institut de Recherche pour le Developpement (France); Instituto del Mar del Peru (Peru); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); European Union (EU)(CGIAREuropean Commission); Department of Environment Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); South African Research Chair Initiative; South African Department of Science and Technology; EU(European Commission)	This work was partly funded by the Marine Stewardship Council (MSC) to investigate "Developing best practice management for low trophic level fisheries: evaluation of harvest strategies." The authors also acknowledge funding from the Commonwealth Scientific and Industrial Research Organization (Australia), National Oceanographic and Atmospheric Administration (USA), Institut de Recherche pour le Developpement (France), and Instituto del Mar del Peru (Peru). I.C.K. (not funded by MSC) and E.A.F. acknowledge support from the Gordon and Betty Moore Foundation and the David and Lucile Packard Foundation. S.M. acknowledges support from European Union (EU) FP7 grant FACTS (Forage Fish Interactions), grant agreement 244966, and Department of Environment Food and Rural Affairs contract M1202. L.S. acknowledges the support of the South African Research Chair Initiative, funded through the South African Department of Science and Technology and administered by the South African National Research Foundation (NRF). Y.J.S. acknowledges support from EU FP7 project MEECE (Marine Ecosystem Evolution in a Changing Environment), grant agreement 212085. J. Field kindly provided the EcoSim model for the northern California current and advised on its use. C. de Moor provided information on management targets for sardines and anchovy in the Southern Benguela.	Ainley DG, 2009, FISH FISH, V10, P13, DOI 10.1111/j.1467-2979.2008.00293.x; Alder J, 2008, ANNU REV ENV RESOUR, V33, P153, DOI 10.1146/annurev.environ.33.020807.143204; Anderson SC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014735, 10.1371/journal.pone.0024368]; BARBER RT, 1983, SCIENCE, V222, P1203, DOI 10.1126/science.222.4629.1203; Branch TA, 2010, NATURE, V468, P431, DOI 10.1038/nature09528; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Constable AJ, 2000, ICES J MAR SCI, V57, P778, DOI 10.1006/jmsc.2000.0725; Crawford RJM, 2007, ICES J MAR SCI, V64, P570, DOI 10.1093/icesjms/fsm009; Cury P, 2000, ICES J MAR SCI, V57, P603, DOI 10.1006/jmsc.2000.0712; Frederiksen M, 2005, MAR ECOL PROG SER, V300, P201, DOI 10.3354/meps300201; Freon P, 2008, PROG OCEANOGR, V79, P401, DOI 10.1016/j.pocean.2008.10.011; Fulton EA, 2005, ICES J MAR SCI, V62, P540, DOI 10.1016/j.icesjms.2004.12.012; Fulton EA, 2004, ECOL MODEL, V173, P371, DOI 10.1016/j.ecolmodel.2003.09.024; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Greenstreet SPR, 2006, ICES J MAR SCI, V63, P1530, DOI 10.1016/j.icesjms.2006.05.009; Gross T, 2009, SCIENCE, V325, P747, DOI 10.1126/science.1173536; Jahncke J, 2004, FISH OCEANOGR, V13, P208, DOI 10.1111/j.1365-2419.2004.00283.x; Llope M, 2011, GLOBAL CHANGE BIOL, V17, P1251, DOI 10.1111/j.1365-2486.2010.02331.x; Lo N.C., 2009, ASSESSMENT PACIFIC S; MAY RM, 1979, SCIENCE, V205, P267, DOI 10.1126/science.205.4403.267; Merino G, 2010, J MARINE SYST, V81, P196, DOI 10.1016/j.jmarsys.2009.12.010; Montoya JM, 2009, ECOLOGY, V90, P2426, DOI 10.1890/08-0657.1; Santora JA, 2009, FISH OCEANOGR, V18, P20, DOI 10.1111/j.1365-2419.2008.00490.x; Shannon LJ, 2000, ICES J MAR SCI, V57, P720, DOI 10.1006/jmsc.2000.0716; Shin YJ, 2004, CAN J FISH AQUAT SCI, V61, P414, DOI 10.1139/F03-154; Tacon AGJ, 2009, AMBIO, V38, P294; Travers M, 2009, ECOL MODEL, V220, P3089, DOI 10.1016/j.ecolmodel.2009.08.016; Tyrrell MC, 2011, FISH RES, V108, P1, DOI 10.1016/j.fishres.2010.12.025; Walters C, 2000, ECOSYSTEMS, V3, P70, DOI 10.1007/s100210000011; Walters CJ, 2005, ICES J MAR SCI, V62, P558, DOI 10.1016/j.icesjms.2004.12.005; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	32	411	421	10	318	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 26	2011	333	6046					1147	1150		10.1126/science.1209395	http://dx.doi.org/10.1126/science.1209395			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21778363				2022-12-01	WOS:000294244300049
J	Seitan, VC; Hao, BT; Tachibana-Konwalski, K; Lavagnolli, T; Mira-Bontenbal, H; Brown, KE; Teng, G; Carroll, T; Terry, A; Horan, K; Marks, H; Adams, DJ; Schatz, DG; Aragon, L; Fisher, AG; Krangel, MS; Nasmyth, K; Merkenschlager, M				Seitan, Vlad C.; Hao, Bingtao; Tachibana-Konwalski, Kikue; Lavagnolli, Thais; Mira-Bontenbal, Hegias; Brown, Karen E.; Teng, Grace; Carroll, Tom; Terry, Anna; Horan, Katie; Marks, Hendrik; Adams, David J.; Schatz, David G.; Aragon, Luis; Fisher, Amanda G.; Krangel, Michael S.; Nasmyth, Kim; Merkenschlager, Matthias			A role for cohesin in T-cell-receptor rearrangement and thymocyte differentiation	NATURE			English	Article							ANTIGEN-RECEPTOR; CHROMATIN ARCHITECTURE; V(D)J RECOMBINATION; POSITIVE SELECTION; TRANSGENIC MICE; DAD1 GENES; TCR-ALPHA; ACCESSIBILITY; REGION; LOCUS	Cohesin enables post-replicative DNA repair and chromosome segregation by holding sister chromatids together from the time of DNA replication in S phase until mitosis(1). There is growing evidence that cohesin also forms long-range chromosomal cis-interactions(2-4) and may regulate gene expression(2-10) in association with CTCF8,9, mediator(4) or tissue-specific transcription factors(10). Human cohesinopathies such as Cornelia de Lange syndrome are thought to result from impaired non-canonical cohesin functions(7), but a clear distinction between the cell-division-related and cell-division-independent functions of cohesion-as exemplified in Drosophila(11-13)-has not been demonstrated in vertebrate systems. To address this, here we deleted the cohesin locus Rad21 in mouse thymocytes at a time in development when these cells stop cycling and rearrange their T-cell receptor (TCR) a locus (Tcra). Rad21-deficient thymocytes had a normal lifespan and retained the ability to differentiate, albeit with reduced efficiency. Loss of Rad21 led to defective chromatin architecture at the Tcra locus, where cohesion-binding sites flank the TEA promoter and the Ea enhancer, and demarcate Tcra from interspersed Tcrd elements and neighbouring housekeeping genes. Cohesin was required for long-range promoter-enhancer interactions, Tcra transcription, H3K4me3 histone modifications that recruit the recombination machinery(14,15) and Tcra rearrangement. Provision of pre-rearranged TCR transgenes largely rescued thymocyte differentiation, demonstrating that among thousands of potential target genes across the genome(4,8-10), defective Tcra rearrangement was limiting for the differentiation of cohesin-deficient thymocytes. These findings firmly establish a cell-division-independent role for cohesin in Tcra locus rearrangement and provide a comprehensive account of the mechanisms by which cohesin enables cellular differentiation in a well-characterized mammalian system.	[Seitan, Vlad C.; Lavagnolli, Thais; Mira-Bontenbal, Hegias; Brown, Karen E.; Terry, Anna; Fisher, Amanda G.; Merkenschlager, Matthias] Univ London Imperial Coll Sci Technol & Med, MRC, Clin Sci Ctr, Lymphocyte Dev Grp, London W12 0NN, England; [Seitan, Vlad C.; Aragon, Luis] Univ London Imperial Coll Sci Technol & Med, MRC, Clin Sci Ctr, Cell Cycle Grp, London W12 0NN, England; [Seitan, Vlad C.; Lavagnolli, Thais; Mira-Bontenbal, Hegias; Brown, Karen E.; Carroll, Tom; Terry, Anna; Aragon, Luis; Fisher, Amanda G.; Merkenschlager, Matthias] Univ London Imperial Coll Sci Technol & Med, MRC, Clin Sci Ctr, Epigenet Sect, London W12 0NN, England; [Hao, Bingtao; Krangel, Michael S.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Tachibana-Konwalski, Kikue; Nasmyth, Kim] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Teng, Grace; Schatz, David G.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Horan, Katie] Univ London Imperial Coll Sci Technol & Med, Cent Biol Serv, London W12 0NN, England; [Marks, Hendrik] Nijmegen Ctr Mol Life Sci, Dept Mol Biol, NL-6500 HB Nijmegen, Netherlands; [Adams, David J.] Wellcome Trust Genome Campus, Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Schatz, David G.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Imperial College London; Imperial College London; Imperial College London; Duke University; University of Oxford; Yale University; Imperial College London; Radboud University Nijmegen; Wellcome Trust Sanger Institute; Howard Hughes Medical Institute; Yale University	Krangel, MS (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC, Clin Sci Ctr, Lymphocyte Dev Grp, Du Cane Rd, London W12 0NN, England.	krang001@mc.duke.edu; kim.nasmyth@bioch.ox.ac.uk; matthias.merkenschlager@csc.mrc.ac.uk	Marks, Hendrik/E-2801-2012; hao, Bingtao/G-6648-2011; Schatz, David/A-6748-2013	Marks, Hendrik/0000-0002-4198-3731; hao, Bingtao/0000-0003-1997-9338; Schatz, David/0000-0002-5669-1176; Adams, David/0000-0001-9490-0306; Seitan, Vlad/0000-0002-4546-340X; Merkenschlager, Matthias/0000-0003-2889-3288; Terry, Anna/0000-0002-1946-8223; Nasmyth, Kim/0000-0001-7030-4403	Medical Research Council, UK; European Union; Boehringer Ingelheim Fonds; Wellcome Trust; National Institutes of Health; Medical Research Council [MC_U120027516, MC_U120081295] Funding Source: researchfish; MRC [MC_U120027516, MC_U120081295] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041052] Funding Source: NIH RePORTER	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Hadjur, D. Tough, L. Williams, Z. Webster, J. Godwin and H.-Y. Shih for help and advice, L. Game and M. Jones for high-throughput sequencing, A. Giess for sequence alignment, and J. Elliott and P. Hexley for cell sorting. Supported by the Medical Research Council, UK (V.S., T.L., H.M.-B., K.E.B., T.C., A.T., L.A., A.G.F., K.N., M.M.), the European Union FP6 integrated project HEROIC (H.M.), EU and the Marie Curie Research Training Network Chromatin Plasticity (H.M.-B.), the Boehringer Ingelheim Fonds (T.L.), the Wellcome Trust (D.J.A., K.N.) and the National Institutes of Health (B.H., M.S.K., G.T., D.G.S.). D.G.S. is an investigator of the Howard Hughes Medical Institute.	Abarrategui I, 2006, NAT IMMUNOL, V7, P1109, DOI 10.1038/ni1379; Abarrategui I, 2009, ADV EXP MED BIOL, V650, P93; BREKELMANS P, 1994, CELL IMMUNOL, V159, P331, DOI 10.1006/cimm.1994.1319; Degner SC, 2011, P NATL ACAD SCI USA, V108, P9566, DOI 10.1073/pnas.1019391108; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Desiderio S, 1996, CURR TOP MICROBIOL, V217, P45; DIAZ P, 1994, IMMUNITY, V1, P207, DOI 10.1016/1074-7613(94)90099-X; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Guo J, 2002, NAT IMMUNOL, V3, P469, DOI 10.1038/ni791; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Hagstrom KA, 2003, NAT REV GENET, V4, P520, DOI 10.1038/nrg1110; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; Jackson A, 2005, NAT IMMUNOL, V6, P189, DOI 10.1038/ni1157; Jhunjhunwala S, 2009, CELL, V138, P435, DOI 10.1016/j.cell.2009.07.016; Ji YH, 2010, CELL, V141, P419, DOI 10.1016/j.cell.2010.03.010; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; Krangel MS, 2009, CURR OPIN IMMUNOL, V21, P133, DOI 10.1016/j.coi.2009.03.009; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lee YN, 2009, P NATL ACAD SCI USA, V106, P17487, DOI 10.1073/pnas.0909723106; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Magdinier F, 2004, J BIOL CHEM, V279, P25381, DOI 10.1074/jbc.M403121200; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Pauli A, 2010, CURR BIOL, V20, P1787, DOI 10.1016/j.cub.2010.09.006; Rollins RA, 1999, GENETICS, V152, P577; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; Strachan T, 2005, CURR OPIN GENET DEV, V15, P258, DOI 10.1016/j.gde.2005.04.005; Toyoda Y, 2006, MOL BIOL CELL, V17, P2287, DOI 10.1091/mbc.E05-11-1089; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Zhong XP, 1999, J IMMUNOL, V163, P295	39	178	182	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2011	476	7361					467	U126		10.1038/nature10312	http://dx.doi.org/10.1038/nature10312			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811KT	21832993	Green Accepted, Green Submitted			2022-12-01	WOS:000294209400040
J	Bell, CM; Brener, SS; Gunraj, N; Huo, C; Bierman, AS; Scales, DC; Bajcar, J; Zwarenstein, M; Urbach, DR				Bell, Chaim M.; Brener, Stacey S.; Gunraj, Nadia; Huo, Cindy; Bierman, Arlene S.; Scales, Damon C.; Bajcar, Jana; Zwarenstein, Merrick; Urbach, David R.			Association of ICU or Hospital Admission With Unintentional Discontinuation of Medications for Chronic Diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVERSE DRUG EVENTS; LONG-TERM MEDICATION; INTENSIVE-CARE-UNIT; ELDERLY-PATIENTS; ANTIHYPERTENSIVE THERAPY; ATRIAL-FIBRILLATION; STATIN THERAPY; PATIENT SAFETY; CANADIANS USE; HEALTH-CARE	Context Patients discharged from acute care hospitals may be at risk for unintentional discontinuation of medications prescribed for chronic diseases. The intensive care unit (ICU) may pose an even greater risk because of the focus on acute events and the presence of multiple transitions in care. Objective To evaluate rates of potentially unintentional discontinuation of medications following hospital or ICU admission. Design, Setting, and Patients A population-based cohort study using administrative records from 1997 to 2009 of all hospitalizations and outpatient prescriptions in Ontario, Canada; it included 396 380 patients aged 66 years or older with continuous use of at least 1 of 5 evidence-based medication groups prescribed for long-term use: (1) statins, (2) antiplatelet/anticoagulant agents, (3) levothyroxine, (4) respiratory inhalers, and (5) gastric acid-suppressing drugs. Rates of medication discontinuation were compared across 3 groups: patients admitted to the ICU, patients hospitalized without ICU admission, and nonhospitalized patients (controls). Odds ratios (ORs) were calculated and adjusted for patient demographics, clinical factors, and health services use. Main Outcome Measures The primary outcome was failure to renew the prescription within 90 days after hospital discharge. Results Patients admitted to the hospital (n=187 912) were more likely to experience potentially unintentional discontinuation of medications than controls (n=208 468) across all medication groups examined. The adjusted ORs (AORs) ranged from 1.18 (95% CI, 1.14-1.23) for discontinuing levothyroxine in 12.3% of hospitalized patients (n=6831) vs 11.0% of controls (n=7114) to an AOR of 1.86 (95% CI, 1.771.97) for discontinuing antiplatelet/anticoagulant agents in 19.4% of hospitalized patients (n=5564) vs 11.8% of controls (n=2535). With ICU exposure, the AORs ranged from 1.48 (95% CI, 1.39-1.57) for discontinuing statins in 14.6% of ICU patients (n=1484) to an AOR of 2.31 (95% CI, 2.07-2.57) for discontinuing antiplatelet/anticoagulant agents in 22.8% of ICU patients (n=522) vs the control group. Admission to an ICU was associated with an additional risk of medication discontinuation in 4 of 5 medication groups vs hospitalizations without an ICU admission. One-year follow-up of patients who discontinued medications showed an elevated AOR for the secondary composite outcome of death, emergency department visit, or emergent hospitalization of 1.07 (95% CI, 1.03-1.11) in the statins group and of 1.10 (95% CI, 1.03-1.16) in the antiplatelet/anticoagulant agents group. Conclusions Patients prescribed medications for chronic diseases were at risk for potentially unintentional discontinuation after hospital admission. Admission to the ICU was generally associated with an even higher risk of medication discontinuation. JAMA. 2011;306(8):840-847 www.jama.com	[Bell, Chaim M.; Brener, Stacey S.] Univ Toronto, St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Bell, Chaim M.; Brener, Stacey S.; Bierman, Arlene S.; Zwarenstein, Merrick; Urbach, David R.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M5B 1W8, Canada; [Bell, Chaim M.; Brener, Stacey S.; Bierman, Arlene S.] Univ Toronto, Dept Med, Toronto, ON M5B 1W8, Canada; [Urbach, David R.] Univ Toronto, Dept Surg, Toronto, ON M5B 1W8, Canada; [Scales, Damon C.] Univ Toronto, Interdept Div Critical Care, Toronto, ON M5B 1W8, Canada; [Bierman, Arlene S.] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON M5B 1W8, Canada; [Bajcar, Jana] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON M5B 1W8, Canada; [Bell, Chaim M.] Univ Toronto, Ctr Patient Safety, Toronto, ON M5B 1W8, Canada; [Urbach, David R.] Univ Toronto, Univ Hlth Network, Toronto, ON M5B 1W8, Canada; [Bell, Chaim M.; Gunraj, Nadia; Huo, Cindy; Bierman, Arlene S.; Scales, Damon C.; Zwarenstein, Merrick; Urbach, David R.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Scales, Damon C.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada; [Bajcar, Jana] Sunnybrook Hlth Sci Ctr, Dept Pharm, Toronto, ON M4N 3M5, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Bell, CM (corresponding author), Univ Toronto, St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.	bellc@smh.toronto.on.ca	Zwarenstein, Merrick F/P-5210-2014; Bell, Chaim/C-4611-2015; Greiver, Michelle/N-8764-2015	Zwarenstein, Merrick F/0000-0003-0162-7027; Bell, Chaim/0000-0002-3778-9469; Greiver, Michelle/0000-0001-8957-0285	sanofi-aventis; AstraZeneca; Centre for Medical Technology Policy; Canadian Institutes of Health Research [67113]; Ontario Ministry of Health and Long-Term Care; Canadian Institutes of Health Research	sanofi-aventis(Sanofi-Aventis); AstraZeneca(AstraZeneca); Centre for Medical Technology Policy; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Bajcar reported that she has been a consultant to Merck Frosst Canada and AstraZeneca; has received payment from sanofi-aventis for lectures; and has received payment from AstraZeneca for manuscript preparation. Dr Zwarenstein reported that he has been consultant on trial design for Johnson & Johnson; and has received financial support from the Centre for Medical Technology Policy for teaching pragmatic trial design. No other disclosures were reported.; The study was funded by operating grant 67113 from the Canadian Institutes of Health Research. This study was supported by the Institute for Clinical Evaluative Sciences, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care. Drs Bell and Scales received funding as Canadian Institutes of Health Research New Investigators. Dr Bell now holds a Canadian Institutes of Health Research/Canadian Patient Safety Institute Chair in Patient Safety and Continuity of Care.	Avorn J, 1998, JAMA-J AM MED ASSOC, V279, P1458, DOI 10.1001/jama.279.18.1458; Bajcar Jana M, 2005, Res Social Adm Pharm, V1, P408; Bajcar JM, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-75; Ball C, 2003, BRIT MED J, V327, P1014, DOI 10.1136/bmj.327.7422.1014; Bauer TT, 2001, INTENS CARE MED, V27, P3, DOI 10.1007/PL00020870; Bell CM, 2006, J GEN INTERN MED, V21, P937, DOI 10.1007/BF02743141; Bell CM, 2006, ARCH INTERN MED, V166, P2525, DOI 10.1001/archinte.166.22.2525; Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Boockvar K, 2004, ARCH INTERN MED, V164, P545, DOI 10.1001/archinte.164.5.545; Brown JC, RAPID RESPONSE TEAMS; Calkins DR, 1997, ARCH INTERN MED, V157, P1026, DOI 10.1001/archinte.157.9.1026; COCHRANE RA, 1992, BRIT MED J, V305, P694, DOI 10.1136/bmj.305.6855.694; Coffey Maitreya, 2009, Healthc Q, V12 Spec No Patient, P102; Cook D, 1998, NEW ENGL J MED, V338, P791, DOI 10.1056/NEJM199803193381203; Cornish PL, 2005, ARCH INTERN MED, V165, P424, DOI 10.1001/archinte.165.4.424; DeVault KR, 1999, AM J GASTROENTEROL, V94, P1434; Etchells E, 2004, CAN MED ASSOC J, V170, P333; Fodor JG, 2000, CAN MED ASSOC J, V162, P1441; Ganz DA, 2000, J GEN INTERN MED, V15, P776, DOI 10.1046/j.1525-1497.2000.91022.x; Gillen D, 1999, GUT, V44, P468, DOI 10.1136/gut.44.4.468; Gleason KM, 2010, J GEN INTERN MED, V25, P441, DOI 10.1007/s11606-010-1256-6; Graves T, 1997, ARCH INTERN MED, V157, P2205, DOI 10.1001/archinte.157.19.2205; Green CJ, 1997, CAN J CARDIOL, V13, P811; GURWITZ JH, 1993, AM J PUBLIC HEALTH, V83, P711, DOI 10.2105/AJPH.83.5.711; Hajjar Emily R, 2007, Am J Geriatr Pharmacother, V5, P345, DOI 10.1016/j.amjopharm.2007.12.002; Harrington RA, 2004, CHEST, V126, p513S, DOI 10.1378/chest.126.3_suppl.513S; Hart RG, 2003, ANN INTERN MED, V138, P831, DOI 10.7326/0003-4819-138-10-200305200-00011; Himmel W, 1996, EUR J CLIN PHARMACOL, V50, P253, DOI 10.1007/s002280050103; Institute for Health Improvement, HOW TO GUID PREV ADV; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Juurlink D., 2006, CANADIAN I HLTH INFO; Katz SJ, 2002, HEALTH AFFAIR, V21, P19, DOI 10.1377/hlthaff.21.3.19; Katz SJ, 1998, HEALTH AFFAIR, V17, P225, DOI 10.1377/hlthaff.17.1.225; Kaushal R, 2001, ARCH PEDIAT ADOL MED, V155, P1002, DOI 10.1001/archpedi.155.9.1002; Kripalani S, 2007, J HOSP MED, V2, P314, DOI 10.1002/jhm.228; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Landefeld CS, 2003, ANN INTERN MED, V139, P421, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00008; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; MacLean DR, 1999, CAN J CARDIOL, V15, P434; Maslove DM, 2009, J GEN INTERN MED, V24, P995, DOI 10.1007/s11606-009-1053-2; MONANE M, 1994, ARCH INTERN MED, V154, P433, DOI 10.1001/archinte.154.4.433; Monane M, 1997, AM J HYPERTENS, V10, P697, DOI 10.1016/S0895-7061(97)00056-3; Moore C, 2003, J GEN INTERN MED, V18, P646, DOI 10.1046/j.1525-1497.2003.20722.x; O'Donnell Denis E, 2003, Can Respir J, V10 Suppl A, p11A; Perkins GD, 2006, AM J RESP CRIT CARE, V173, P281, DOI 10.1164/rccm.200508-1302OC; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; Racz M, 2005, J AM GERIATR SOC, V53, pS245, DOI 10.1111/j.1532-5415.2005.53350.x; Rudd P, 1998, AM J MANAG CARE, V4, P957; Schneeweiss S, 2002, J CLIN EPIDEMIOL, V55, P833, DOI 10.1016/S0895-4356(02)00437-7; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Schnipper JL, 2009, ARCH INTERN MED, V169, P771, DOI 10.1001/archinternmed.2009.51; Schnipper JL, 2006, ARCH INTERN MED, V166, P565, DOI 10.1001/archinte.166.5.565; SCHWARTZ D, 1962, AM J PUBLIC HEALTH N, V52, P2018, DOI 10.2105/AJPH.52.12.2018; Sibon I, 2004, NEUROLOGY, V62, P1187, DOI 10.1212/01.WNL.0000118288.04483.02; Tam VC, 2005, CAN MED ASSOC J, V173, P510, DOI 10.1503/cmaj.045311; Waldum HL, 1996, GUT, V39, P649, DOI 10.1136/gut.39.5.649	57	180	184	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 24	2011	306	8					840	847		10.1001/jama.2011.1206	http://dx.doi.org/10.1001/jama.2011.1206			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	810VY	21862745				2022-12-01	WOS:000294157300021
J	Sanghavi, DM				Sanghavi, Darshak M.			The art of medicine Unexpected life lessons from cardiac anatomy and physiology	LANCET			English	Editorial Material									Univ Massachusetts, Sch Med, Div Pediat Cardiol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Sanghavi, DM (corresponding author), Univ Massachusetts, Sch Med, Div Pediat Cardiol, Worcester, MA 01655 USA.	darshak.sanghavi@umassmemorial.org						MCRAE D, 2007, EVERY SECOND COUNTS; Miller GW, 2000, KING HEARTS TRUE STO; RUHLMAN M, 2003, WALK WATER MIRACLE S; Sacks O., 1995, ANTHR MARS	4	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 20	2011	378	9792					658	659		10.1016/S0140-6736(11)61322-6	http://dx.doi.org/10.1016/S0140-6736(11)61322-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	815EW	21866584				2022-12-01	WOS:000294509900014
J	Metcalf, CJE; Graham, AL; Huijben, S; Barclay, VC; Long, GH; Grenfell, BT; Read, AF; Bjornstad, ON				Metcalf, C. J. E.; Graham, A. L.; Huijben, S.; Barclay, V. C.; Long, G. H.; Grenfell, B. T.; Read, A. F.; Bjornstad, O. N.			Partitioning Regulatory Mechanisms of Within-Host Malaria Dynamics Using the Effective Propagation Number	SCIENCE			English	Article							BLOOD-STAGE MALARIA; PLASMODIUM-CHABAUDI; IMMUNE-RESPONSES; PARASITES; ALPHA(+)-THALASSEMIA; COMPETITION; CHILDREN; ANEMIA; MODEL; MICE	Immune clearance and resource limitation (via red blood cell depletion) shape the peaks and troughs of malaria parasitemia, which in turn affect disease severity and transmission. Quantitatively partitioning the relative roles of these effects through time is challenging. Using data from rodent malaria, we estimated the effective propagation number, which reflects the relative importance of contrasting within-host control mechanisms through time and is sensitive to the inoculating parasite dose. Our analysis showed that the capacity of innate responses to restrict initial parasite growth saturates with parasite dose and that experimentally enhanced innate immunity can affect parasite density indirectly via resource depletion. Such a statistical approach offers a tool to improve targeting of drugs or vaccines for human therapy by revealing the dynamics and interactions of within-host regulatory mechanisms.	[Metcalf, C. J. E.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Graham, A. L.; Grenfell, B. T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Huijben, S.; Barclay, V. C.; Read, A. F.; Bjornstad, O. N.] Penn State Univ, Ctr Infect Dis Dynam, State Coll, PA USA; [Long, G. H.] Univ Sheffield, Dept Anim & Plant Sci, Western Bank, Sheffield S10 2TN, S Yorkshire, England; [Grenfell, B. T.; Read, A. F.; Bjornstad, O. N.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	University of Oxford; Princeton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of Sheffield; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Metcalf, CJE (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	charlotte.metcalf@zoo.ox.ac.uk	Long, Gráinne H/B-3635-2012; Graham, Andrea L./P-7296-2019; Graham, Andrea L./A-8808-2010; Bjornstad, Ottar N/I-4518-2012; Graham, Andrea/GON-8450-2022; Huijben, Silvie/Q-3837-2019	Long, Gráinne H/0000-0001-5080-9885; Graham, Andrea L./0000-0002-6580-2755; Graham, Andrea L./0000-0002-6580-2755; Huijben, Silvie/0000-0002-3537-1915	Wellcome Trust; Darwin Trust of the University of Edinburgh; UK Biotechnology and Biological Sciences Research Council; National Institute of General Medical Sciences [R01GM089932]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089932] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Darwin Trust of the University of Edinburgh; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Our empirical work was funded by the Wellcome Trust (A.F.R., V.C.B., G.H.L.), the Darwin Trust of the University of Edinburgh (S.H.), and the UK Biotechnology and Biological Sciences Research Council (A.L.G., G.H.L.), and the theoretical work by the Bill and Melinda Gates Foundation (C.J.E.M., B.T.G., O.N.B.), the RAPIDD program of the Science and Technology Directorate (B.T.G., A.L.G., A.F.R.), and National Institute of General Medical Sciences grant R01GM089932 (B.G., O.N.B., A.F.R.). We thank N. Mideo and P. Klepac for extensive discussion. All authors discussed the results and implications and commented on the manuscript at all stages. C.J.E.M. and O.N.B. developed the statistical approach; A.F.R., V.B., and S.H. designed and performed the dose-dependent and CD4<SUP>+</SUP> T cell-depleted mice experiments; A.L.G. and G.H.L. designed and performed the innate immunity experiments. The authors declare no competing interests.	ANDERSON R M, 1991; ANTIA R, 1994, J THEOR BIOL, V168, P141, DOI 10.1006/jtbi.1994.1094; Antia R, 2008, P ROY SOC B-BIOL SCI, V275, P1449, DOI 10.1098/rspb.2008.0198; Baer K, 2007, PLOS PATHOG, V3, P1651, DOI 10.1371/journal.ppat.0030171; Ball CL, 2007, B MATH BIOL, V69, P2361, DOI 10.1007/s11538-007-9223-z; Barclay VC, 2008, P ROY SOC B-BIOL SCI, V275, P1171, DOI 10.1098/rspb.2007.1713; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; CARTER R, 1975, ANN TROP MED PARASIT, V69, P187, DOI 10.1080/00034983.1975.11687000; Chang KH, 2004, J INFECT DIS, V189, P735, DOI 10.1086/381458; Chao DL, 2004, IMMUNOL CELL BIOL, V82, P55, DOI 10.1111/j.1440-1711.2004.01207.x; Dietz K, 2006, AM J TROP MED HYG, V75, P46, DOI 10.4269/ajtmh.2006.75.46; GLYNN JR, 1995, PARASITOLOGY, V110, P7, DOI 10.1017/S0031182000080999; Handel A, 2010, J R SOC INTERFACE, V7, P35, DOI 10.1098/rsif.2009.0067; Haydon DT, 2003, P ROY SOC B-BIOL SCI, V270, P289, DOI 10.1098/rspb.2002.2203; HELLRIEGEL B, 1992, P ROY SOC B-BIOL SCI, V250, P249, DOI 10.1098/rspb.1992.0156; Hetzel C, 1996, PARASITOLOGY, V113, P25, DOI 10.1017/S0031182000066245; Huijben S, 2010, THESIS U EDINBURGH; JARRA W, 1989, PARASITOLOGY, V99, P157, DOI 10.1017/S0031182000058583; Killick-Kendrick R., 1978, RODENT MALARIA; Kochin BF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010444; Lamikanra AA, 2007, BLOOD, V110, P18, DOI 10.1182/blood-2006-09-018069; Long GH, 2006, PARASITOLOGY, V133, P673, DOI 10.1017/S003118200600117X; Long GH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-128; Lythgoe KA, 2007, P NATL ACAD SCI USA, V104, P8095, DOI 10.1073/pnas.0606206104; McQueen PG, 2004, P NATL ACAD SCI USA, V101, P9161, DOI 10.1073/pnas.0308256101; Mideo N, 2008, AM NAT, V172, pE214, DOI 10.1086/591684; Miller MR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000946; Mockenhaupt FP, 2004, BLOOD, V104, P2003, DOI 10.1182/blood-2003-11-4090; Molineaux L, 2002, T ROY SOC TROP MED H, V96, P205, DOI 10.1016/S0035-9203(02)90308-1; Molineaux L, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P221; Nowak M. A, 2000, VIRUS DYNAMICS; Othoro C, 1999, J INFECT DIS, V179, P279, DOI 10.1086/314548; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; Pilyugin SS, 2000, B MATH BIOL, V62, P869, DOI 10.1006/bulm.2000.0181; Ribeiro RM, 2010, J VIROL, V84, P6096, DOI 10.1128/JVI.00127-10; Russell MS, 2007, J IMMUNOL, V179, P211, DOI 10.4049/jimmunol.179.1.211; Saenz RA, 2010, J VIROL, V84, P3974, DOI 10.1128/JVI.02078-09; Savill NJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000416; Stephens R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001208; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Su Z, 2002, J INFECT DIS, V186, P1321, DOI 10.1086/344576; Walther M, 2006, J IMMUNOL, V177, P5736, DOI 10.4049/jimmunol.177.8.5736; Wambua S, 2006, BRIT J HAEMATOL, V133, P206, DOI 10.1111/j.1365-2141.2006.06006.x	43	59	59	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2011	333	6045					984	988		10.1126/science.1204588	http://dx.doi.org/10.1126/science.1204588			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808TD	21852493	Green Accepted			2022-12-01	WOS:000294000400047
J	Moazed, D				Moazed, Danesh			Mechanisms for the Inheritance of Chromatin States	CELL			English	Article							ORIGIN RECOGNITION COMPLEX; POLYCOMB RESPONSE ELEMENT; SILENCING PROTEIN SIR2; DNA-BINDING PROTEIN; ASSEMBLY FACTOR-I; SACCHAROMYCES-CEREVISIAE; TELOMERIC HETEROCHROMATIN; EPIGENETIC INHERITANCE; HISTONE H3; SIR2/SIR4 COMPLEX		Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Moazed, D (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Cell Biol, Boston, MA 02115 USA.	danesh@hms.harvard.edu			National Institutes of Health; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I thank the members of my laboratory and colleagues in the transcription and chromatin fields for discussion. Research in my lab is supported by the National Institutes of Health and the Howard Hughes Medical Institute.	Altaf M, 2007, MOL CELL, V28, P1002, DOI 10.1016/j.molcel.2007.12.002; APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Bayne EH, 2010, CELL, V140, P666, DOI 10.1016/j.cell.2010.01.038; Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; BELL SP, 1993, SCIENCE, V262, P1844, DOI 10.1126/science.8266072; BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5; Busturia A, 1997, DEVELOPMENT, V124, P4343; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Chan SWL, 2006, PLOS BIOL, V4, P1923, DOI 10.1371/journal.pbio.0040363; Cheng TH, 2000, GENE DEV, V14, P452; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; FOSS M, 1993, SCIENCE, V262, P1838, DOI 10.1126/science.8266071; Gardner KA, 1999, GENETICS, V151, P31; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; Gerace EL, 2010, MOL CELL, V39, P360, DOI 10.1016/j.molcel.2010.07.017; Gottschling DE, 2004, COLD SH Q B, V69, P507, DOI 10.1101/sqb.2004.69.507; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Guenther MG, 2010, SCIENCE, V329, P150, DOI 10.1126/science.1193995; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Hauenschild A, 2008, PLOS BIOL, V6, P2130, DOI 10.1371/journal.pbio.0060261; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hekimoglu B, 2009, RNA BIOL, V6, P129, DOI 10.4161/rna.6.2.8178; Hogga I, 2002, DEVELOPMENT, V129, P4915; HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230; Holmes SG, 1996, GENE DEV, V10, P1021, DOI 10.1101/gad.10.8.1021; Hoppe GJ, 2002, MOL CELL BIOL, V22, P4167, DOI 10.1128/MCB.22.12.4167-4180.2002; Iida T, 2008, MOL CELL, V31, P178, DOI 10.1016/j.molcel.2008.07.003; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; JACKSON V, 1985, BIOCHEMISTRY-US, V24, P6930, DOI 10.1021/bi00345a027; JACKSON V, 1974, BIOCHEMISTRY-US, V13, P3952, DOI 10.1021/bi00716a021; JOHNSON LM, 1992, EMBO J, V11, P2201, DOI 10.1002/j.1460-2075.1992.tb05279.x; Kaufman PD, 2010, CURR OPIN CELL BIOL, V22, P284, DOI 10.1016/j.ceb.2010.02.002; Kaufman PD, 1998, MOL CELL BIOL, V18, P4793, DOI 10.1128/MCB.18.8.4793; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; KAYNE PS, 1988, CELL, V55, P27, DOI 10.1016/0092-8674(88)90006-2; Klar AJS, 1998, TRENDS GENET, V14, P299, DOI 10.1016/S0168-9525(98)01535-2; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; Liou GG, 2005, CELL, V121, P515, DOI 10.1016/j.cell.2005.03.035; Luo KH, 2002, GENE DEV, V16, P1528, DOI 10.1101/gad.988802; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; MCNALLY FJ, 1991, MOL CELL BIOL, V11, P5648, DOI 10.1128/MCB.11.11.5648; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Moazed D, 1997, P NATL ACAD SCI USA, V94, P2186, DOI 10.1073/pnas.94.6.2186; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Muller HJ, 1930, J GENET, V22, P299, DOI 10.1007/BF02984195; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Onishi M, 2007, MOL CELL, V28, P1015, DOI 10.1016/j.molcel.2007.12.004; PILLUS L, 1989, CELL, V59, P637, DOI 10.1016/0092-8674(89)90009-3; Ptashne M, 1998, CURR BIOL, V8, pR812, DOI 10.1016/S0960-9822(07)00508-8; Ptashne M, 2001, GENES SIGNALS; Ptashne M, 2007, CURR BIOL, V17, pR233, DOI 10.1016/j.cub.2007.02.030; Radman-Livaja M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001075; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Rudner AD, 2005, MOL CELL BIOL, V25, P4514, DOI 10.1128/MCB.25.11.4514-4528.2005; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Rusche LN, 2002, MOL BIOL CELL, V13, P2207, DOI 10.1091/mbc.E02-03-0175; Schaefer CB, 2007, SCIENCE, V316, P398, DOI 10.1126/science.1137544; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Sengupta AK, 2004, DEVELOPMENT, V131, P1959, DOI 10.1242/dev.01084; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; Simmer F, 2010, EMBO REP, V11, P112, DOI 10.1038/embor.2009.273; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; SOGO JM, 1986, J MOL BIOL, V189, P189, DOI 10.1016/0022-2836(86)90390-6; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Triolo T, 1996, NATURE, V381, P251, DOI 10.1038/381251a0; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Xu EY, 2006, MOL CELL, V23, P219, DOI 10.1016/j.molcel.2006.05.035; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601; Zordan RE, 2006, P NATL ACAD SCI USA, V103, P12807, DOI 10.1073/pnas.0605138103	83	161	161	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 19	2011	146	4					510	518		10.1016/j.cell.2011.07.013	http://dx.doi.org/10.1016/j.cell.2011.07.013			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21854979	Green Accepted, Bronze			2022-12-01	WOS:000294043600007
J	Kuhlenkoetter, S; Wintermeyer, W; Rodnina, MV				Kuhlenkoetter, Stephan; Wintermeyer, Wolfgang; Rodnina, Marina V.			Different substrate-dependent transition states in the active site of the ribosome	NATURE			English	Article							PEPTIDE-BOND FORMATION; TRANSLATION TERMINATION; TRANSFERASE REACTION; RELEASE FACTORS; TRANSFER-RNA; 70S RIBOSOME; GGQ MOTIF; RF2; CATALYSIS; INSIGHTS	The active site of the ribosome, the peptidyl transferase centre, catalyses two reactions, namely, peptide bond formation between peptidyl-tRNA and aminoacyl-tRNA as well as the release-factor-dependent hydrolysis of peptidyl-tRNA. Unlike peptide bond formation, peptide release is strongly impaired by mutations of nucleotides within the active site, in particular by base exchanges at position A2602 (refs 1, 2). The 2'-OH group of A76 of the peptidyl-tRNA substrate seems to have a key role in peptide release(3). According to computational analysis(4), the 2'-OH may take part in a concerted 'proton shuttle' by which the leaving group is protonated, in analogy to similar current models of peptide bond formation(4-6). Here we report kinetic solvent isotope effects and proton inventories (reaction rates measured in buffers with increasing content of deuterated water, D(2)O) of the two reactions catalysed by the active site of the Escherichia coli ribosome. The transition state of the release factor 2 (RF2)-dependent hydrolysis reaction is characterized by the rate-limiting formation of a single strong hydrogen bond. This finding argues against a concerted proton shuttle in the transition state of the hydrolysis reaction. In comparison, the proton inventory for peptide bond formation indicates the rate-limiting formation of three hydrogen bonds with about equal contributions, consistent with a concerted eight-membered proton shuttle in the transition state(5). Thus, the ribosome supports different rate-limiting transition states for the two reactions that take place in the peptidyl transferase centre.	[Kuhlenkoetter, Stephan; Wintermeyer, Wolfgang; Rodnina, Marina V.] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	Max Planck Society	Rodnina, MV (corresponding author), Max Planck Inst Biophys Chem, Am Fassberg 11, D-37077 Gottingen, Germany.	rodnina@mpibpc.mpg.de	Rodnina, Marina V./AAD-4667-2019	Rodnina, Marina V./0000-0003-0105-3879; Wintermeyer, Wolfgang/0000-0001-5119-8481	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank H.-H. Limbach for discussions and advice. This work was supported by the Deutsche Forschungsgemeinschaft (M.V.R. and W.W.).	Amort M, 2007, NUCLEIC ACIDS RES, V35, P5130, DOI 10.1093/nar/gkm539; Beringer M, 2005, J BIOL CHEM, V280, P36065, DOI 10.1074/jbc.M507961200; Beringer M, 2003, RNA, V9, P919, DOI 10.1261/rna.5600503; Bieling P, 2006, NAT STRUCT MOL BIOL, V13, P423, DOI 10.1038/nsmb1091; Brunelle JL, 2008, RNA, V14, P1526, DOI 10.1261/rna.1057908; Dincbas-Renqvist V, 2000, EMBO J, V19, P6900, DOI 10.1093/emboj/19.24.6900; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; Huang KS, 2008, BIOCHEMISTRY-US, V47, P8822, DOI 10.1021/bi800299u; Jin H, 2010, P NATL ACAD SCI USA, V107, P8593, DOI 10.1073/pnas.1003995107; Katunin VI, 2002, MOL CELL, V10, P339, DOI 10.1016/S1097-2765(02)00566-X; Kingery DA, 2008, CHEM BIOL, V15, P493, DOI 10.1016/j.chembiol.2008.04.005; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Mora L, 2003, MOL MICROBIOL, V47, P267, DOI 10.1046/j.1365-2958.2003.03301.x; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Polacek N, 2003, MOL CELL, V11, P103, DOI 10.1016/S1097-2765(02)00825-0; Quinn D.M., 2006, ISOTOPE EFFECTS CHEM, P995; Rangelov MA, 2006, J AM CHEM SOC, V128, P4964, DOI 10.1021/ja060648x; Schmeing TM, 2005, MOL CELL, V20, P437, DOI 10.1016/j.molcel.2005.09.006; SCHOWEN KBJ, 1972, TRANSITION STATES BI, P225; Seila AC, 2005, BIOCHEMISTRY-US, V44, P4018, DOI 10.1021/bi047742f; Shaw JJ, 2007, MOL CELL, V28, P458, DOI 10.1016/j.molcel.2007.09.007; Sievers A, 2004, P NATL ACAD SCI USA, V101, P7897, DOI 10.1073/pnas.0402488101; Trobro S, 2006, BIOCHEMISTRY-US, V45, P7049, DOI 10.1021/bi0605383; Trobro S, 2009, BIOCHEMISTRY-US, V48, P11296, DOI 10.1021/bi9017297; Wallin G, 2010, P NATL ACAD SCI USA, V107, P1888, DOI 10.1073/pnas.0914192107; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8	29	61	61	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 18	2011	476	7360					351	U124		10.1038/nature10247	http://dx.doi.org/10.1038/nature10247			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21804565	Green Published			2022-12-01	WOS:000294206500042
J	Morgan, JA; LeCain, DR; Pendall, E; Blumenthal, DM; Kimball, BA; Carrillo, Y; Williams, DG; Heisler-White, J; Dijkstra, FA; West, M				Morgan, Jack A.; LeCain, Daniel R.; Pendall, Elise; Blumenthal, Dana M.; Kimball, Bruce A.; Carrillo, Yolima; Williams, David G.; Heisler-White, Jana; Dijkstra, Feike A.; West, Mark			C-4 grasses prosper as carbon dioxide eliminates desiccation in warmed semi-arid grassland	NATURE			English	Article							ATMOSPHERIC CO2; WATER RELATIONS; ELEVATED CO2; CLIMATE; NORTH; RESPONSES; ECOSYSTEM; DROUGHT; IMPACT; FUTURE	Global warming is predicted to induce desiccation in many world regions through increases in evaporative demand(1-3). Rising CO2 may counter that trend by improving plant water-use efficiency(4,5). However, it is not clear how important this CO2-enhanced water use efficiency might be in offsetting warming-induced desiccation because higher CO2 also leads to higher plant biomass, and therefore greater transpirational surface(2,6,7). Furthermore, although warming is predicted to favour warm-season, C-4 grasses, rising CO2 should favour C-3, or cool-season plants(8). Here we show in a semi-arid grassland that elevated CO2 can completely reverse the desiccating effects of moderate warming. Although enrichment of air to 600 p. p. m. v. CO2 increased soil water content (SWC), 1.5/3.0 degrees C day/night warming resulted in desiccation, such that combined CO2 enrichment and warming had no effect on SWC relative to control plots. As predicted, elevated CO2 favoured C-3 grasses and enhanced stand productivity, whereas warming favoured C-4 grasses. Combined warming and CO2 enrichment stimulated above-ground growth of C-4 grasses in 2 of 3 years when soil moisture most limited plant productivity. The results indicate that in a warmer, CO2-enriched world, both SWC and productivity in semi-arid grasslands may be higher than previously expected.	[Morgan, Jack A.; LeCain, Daniel R.; Blumenthal, Dana M.; Dijkstra, Feike A.; West, Mark] USDA ARS, Rangeland Resources Res Unit, Ft Collins, CO 80526 USA; [Morgan, Jack A.; LeCain, Daniel R.; Blumenthal, Dana M.; Dijkstra, Feike A.; West, Mark] USDA ARS, No Plains Area, Ft Collins, CO 80526 USA; [Pendall, Elise; Carrillo, Yolima; Williams, David G.; Heisler-White, Jana] Univ Wyoming, Dept Bot, Laramie, WY 82071 USA; [Pendall, Elise; Carrillo, Yolima; Williams, David G.; Heisler-White, Jana] Univ Wyoming, Program Ecol, Laramie, WY 82071 USA; [Kimball, Bruce A.] ARS, US Arid Land Agr Res Ctr, USDA, Maricopa, AZ 85238 USA; [Dijkstra, Feike A.] Univ Sydney, Fac Agr Food & Nat Resources, Sydney, NSW 2006, Australia	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Wyoming; University of Wyoming; United States Department of Agriculture (USDA); University of Sydney	Morgan, JA (corresponding author), USDA ARS, Rangeland Resources Res Unit, Ft Collins, CO 80526 USA.	jack.morgan@ars.usda.gov	Dijkstra, Feike A/H-2182-2012; Blumenthal, Dana M/J-3106-2012; Williams, David G/A-6407-2014; Pendall, Elise/AAF-5667-2020	Dijkstra, Feike A/0000-0002-6191-6018; Williams, David G/0000-0003-3627-5260; Pendall, Elise/0000-0002-1651-8969	US Department of Agriculture; US Department of Agriculture-Cooperative State Research, Education, and Extension Service [2008-35107-18655]; US Department of Energy's Office of Science (Biological and Environmental Research) through the Western Regional Center of the National Institute for Climatic Change Research at Northern Arizona University; National Science Foundation [1021559]; Direct For Biological Sciences [1027319, 0823405, 1021559] Funding Source: National Science Foundation	US Department of Agriculture(United States Department of Agriculture (USDA)); US Department of Agriculture-Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); US Department of Energy's Office of Science (Biological and Environmental Research) through the Western Regional Center of the National Institute for Climatic Change Research at Northern Arizona University(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank D. Smith for installation and operation of the PHACE experiment, E. Hardy for assistance in installation, A. Eden and C. Brooks for data collection and analysis, F. Miglietta for advice and help on installation of the FACE system, and R. Seager, A. Leakey, B. Cook and G. Wang for comments on the manuscript. The work was supported by the US Department of Agriculture-Agricultural Research Service Climate Change, Soils & Emissions Program, the US Department of Agriculture-Cooperative State Research, Education, and Extension Service Soil Processes Program (grant no. 2008-35107-18655), the US Department of Energy's Office of Science (Biological and Environmental Research) through the Western Regional Center of the National Institute for Climatic Change Research at Northern Arizona University, and the National Science Foundation (DEB no. 1021559). Mention of commercial products is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the USDA.	Asner GP, 2004, ANNU REV ENV RESOUR, V29, P261, DOI 10.1146/annurev.energy.29.062403.102142; Derner JD, 2007, RANGELAND ECOL MANAG, V60, P270, DOI 10.2111/1551-5028(2007)60[270:GMTPSC]2.0.CO;2; Dijkstra FA, 2010, NEW PHYTOL, V187, P426, DOI 10.1111/j.1469-8137.2010.03293.x; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; Epstein HE, 2002, J BIOGEOGR, V29, P875, DOI 10.1046/j.1365-2699.2002.00701.x; Frelich LE, 2010, FRONT ECOL ENVIRON, V8, P371, DOI 10.1890/080191; Hovenden MJ, 2008, NEW PHYTOL, V180, P143, DOI 10.1111/j.1469-8137.2008.02563.x; Kimball B. A., 2007, AGRONOMY MONOGRAPH, P627; Kimball BA, 2008, GLOBAL CHANGE BIOL, V14, P309, DOI 10.1111/j.1365-2486.2007.01486.x; Leakey ADB, 2009, P ROY SOC B-BIOL SCI, V276, P2333, DOI 10.1098/rspb.2008.1517; Lecain DR, 2003, ANN BOT-LONDON, V92, P41, DOI 10.1093/aob/mcg109; Luo YQ, 2009, GCB BIOENERGY, V1, P62, DOI 10.1111/j.1757-1707.2008.01005.x; MCNAUGHTON KG, 1991, AGR FOREST METEOROL, V54, P279, DOI 10.1016/0168-1923(91)90010-N; Miglietta F, 2001, NEW PHYTOL, V150, P465, DOI 10.1046/j.1469-8137.2001.00115.x; Milchunas DG, 2005, GLOBAL CHANGE BIOL, V11, P1837, DOI 10.1111/j.1365-2486.2005.001009.x; Morgan JA, 2004, OECOLOGIA, V140, P11, DOI 10.1007/s00442-004-1550-2; Morgan JA, 2007, P NATL ACAD SCI USA, V104, P14724, DOI 10.1073/pnas.0703427104; Noy-Meir I., 1973, Annual Review of Ecology and Systematics, V4, P25, DOI 10.1146/annurev.es.04.110173.000325; Piao SL, 2007, P NATL ACAD SCI USA, V104, P15242, DOI 10.1073/pnas.0707213104; Polley HW, 1997, J RANGE MANAGE, V50, P562, DOI 10.2307/4003450; Seager R, 2010, P NATL ACAD SCI USA, V107, P21277, DOI 10.1073/pnas.0910856107; Semmartin M, 2004, OIKOS, V107, P148, DOI 10.1111/j.0030-1299.2004.13153.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Suttie J. M., 2006, P1; Tieszen LL, 1997, ECOL APPL, V7, P59, DOI 10.2307/2269407; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; Wang GL, 2005, CLIM DYNAM, V25, P739, DOI 10.1007/s00382-005-0057-9; Woodhouse CA, 2010, P NATL ACAD SCI USA, V107, P21283, DOI 10.1073/pnas.0911197107	28	352	371	11	344	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 11	2011	476	7359					202	U101		10.1038/nature10274	http://dx.doi.org/10.1038/nature10274			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21814202				2022-12-01	WOS:000293731900035
J	Ruhl, M; Bonis, NR; Reichart, GJ; Damste, JSS; Kurschner, WM				Ruhl, Micha; Bonis, Nina R.; Reichart, Gert-Jan; Damste, Jaap S. Sinninghe; Kurschner, Wolfram M.			Atmospheric Carbon Injection Linked to End-Triassic Mass Extinction	SCIENCE			English	Article							CYCLE; OCEAN; ACIDIFICATION; BIODIVERSITY; TERRESTRIAL; CONSTRAINTS; ANGIOSPERMS; CONIFERS; RELEASE; METHANE	The end-Triassic mass extinction (similar to 201.4 million years ago), marked by terrestrial ecosystem turnover and up to similar to 50% loss in marine biodiversity, has been attributed to intensified volcanic activity during the break-up of Pangaea. Here, we present compound-specific carbon-isotope data of long-chain n-alkanes derived from waxes of land plants, showing a similar to 8.5 per mil negative excursion, coincident with the extinction interval. These data indicate strong carbon-13 depletion of the end-Triassic atmosphere, within only 10,000 to 20,000 years. The magnitude and rate of this carbon-cycle disruption can be explained by the injection of at least similar to 12 x 10(3) gigatons of isotopically depleted carbon as methane into the atmosphere. Concurrent vegetation changes reflect strong warming and an enhanced hydrological cycle. Hence, end-Triassic events are robustly linked to methane-derived massive carbon release and associated climate change.	[Ruhl, Micha; Bonis, Nina R.; Kurschner, Wolfram M.] Univ Utrecht, Fac Sci, Inst Environm Biol, NL-3584 CD Utrecht, Netherlands; [Ruhl, Micha] Univ Copenhagen, Nat Hist Museum Denmark, NordCEE, DK-1350 Copenhagen K, Denmark; [Bonis, Nina R.] Shell Global Solut Int BV, NL-2288 GS Rijswijk, Netherlands; [Reichart, Gert-Jan; Damste, Jaap S. Sinninghe] Univ Utrecht, Fac Geosci, Dept Earth Sci, NL-3508 TA Utrecht, Netherlands; [Damste, Jaap S. Sinninghe] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Organ Biogeochem, NL-1790 AB Den Burg, Netherlands; [Kurschner, Wolfram M.] Univ Oslo, Dept Geosci, N-0316 Oslo, Norway	Utrecht University; University of Copenhagen; Royal Dutch Shell; Utrecht University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Oslo	Ruhl, M (corresponding author), Univ Utrecht, Fac Sci, Inst Environm Biol, Budapestlaan 4, NL-3584 CD Utrecht, Netherlands.	micharuhl@gmail.com	Kürschner, Wolfram Michael/B-4724-2009; Opazo, Luis-Felipe/G-9586-2011; Damste, Jaap S Sinninghe/F-6128-2011; Reichart, Gert-Jan/N-6308-2018; Kürschner, Wolfram Michael/AAC-7769-2020	Kürschner, Wolfram Michael/0000-0001-6883-6486; Damste, Jaap S Sinninghe/0000-0002-8683-1854; Reichart, Gert-Jan/0000-0002-7256-2243; Kürschner, Wolfram Michael/0000-0001-6883-6486; Ruhl, Micha/0000-0001-8170-0399	Utrecht University	Utrecht University	We thank G. Nobbe for lab assistance with stable-isotope measurements, and H. Visscher and A. Sluijs for suggestions and comments during the initial drafting of the manuscript. We also thank H. Svensen and three anonymous reviewers for suggestions and comments during the review of this paper. W. M. K., M. R., and N.R.B. acknowledge funding from the Utrecht University High Potential program. This contribution is publication 20110601 of the Netherlands Research School of Sedimentary Geology.	Allen MR, 2009, NATURE, V458, P1163, DOI 10.1038/nature08019; Beerling DJ, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001637; Bonis NR, 2010, PALAEOGEOGR PALAEOCL, V290, P151, DOI 10.1016/j.palaeo.2009.06.016; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Deenen MHL, 2010, EARTH PLANET SC LETT, V291, P113, DOI 10.1016/j.epsl.2010.01.003; Dickens GR, 2003, EARTH PLANET SC LETT, V213, P169, DOI 10.1016/S0012-821X(03)00325-X; Hautmann M, 2008, NEUES JAHRB GEOL P-A, V249, P119, DOI 10.1127/0077-7749/2008/0249-0119; Hesselbo SP, 2002, GEOLOGY, V30, P251, DOI 10.1130/0091-7613(2002)030<0251:TAMEAT>2.0.CO;2; Kemp DB, 2005, NATURE, V437, P396, DOI 10.1038/nature04037; Marzoli A, 1999, SCIENCE, V284, P616, DOI 10.1126/science.284.5414.616; McElwain JC, 1999, SCIENCE, V285, P1386, DOI 10.1126/science.285.5432.1386; McElwain JC, 2009, SCIENCE, V324, P1554, DOI 10.1126/science.1171706; Olsen PE, 2002, SCIENCE, V296, P1305, DOI 10.1126/science.1065522; Pancost RD, 2004, MAR CHEM, V92, P239, DOI 10.1016/j.marchem.2004.06.029; Pedentchouk N, 2008, ORG GEOCHEM, V39, P1066, DOI 10.1016/j.orggeochem.2008.02.005; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; Ruhl M, 2011, GEOLOGY, V39, P431, DOI 10.1130/G31680.1; Ruhl M, 2010, EARTH PLANET SC LETT, V295, P262, DOI 10.1016/j.epsl.2010.04.008; Ruhl M, 2010, EARTH PLANET SC LETT, V292, P17, DOI 10.1016/j.epsl.2009.12.046; Ruhl M, 2009, EARTH PLANET SC LETT, V281, P169, DOI 10.1016/j.epsl.2009.02.020; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schaller MF, 2011, SCIENCE, V331, P1404, DOI 10.1126/science.1199011; Schoene B, 2010, GEOLOGY, V38, P387, DOI 10.1130/G30683.1; Schouten S, 2007, EARTH PLANET SC LETT, V258, P581, DOI 10.1016/j.epsl.2007.04.024; Sepkoski J. J., 1996, GLOBAL EVENTS EVENT, DOI DOI 10.1007/978-3-642-79634-0_4; Svensen H, 2004, NATURE, V429, P542, DOI 10.1038/nature02566; Svensen H, 2007, EARTH PLANET SC LETT, V256, P554, DOI 10.1016/j.epsl.2007.02.013; Svensen H, 2009, EARTH PLANET SC LETT, V277, P490, DOI 10.1016/j.epsl.2008.11.015; van de Schootbrugge B, 2009, NAT GEOSCI, V2, P589, DOI 10.1038/NGEO577; Von Hillebrandt A. V, 2007, INT SUBCOMMISSION JU, V34, P2; Ward PD, 2001, SCIENCE, V292, P1148, DOI 10.1126/science.1058574; Whiteside JH, 2010, P NATL ACAD SCI USA, V107, P6721, DOI 10.1073/pnas.1001706107; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004	33	147	150	3	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2011	333	6041					430	434		10.1126/science.1204255	http://dx.doi.org/10.1126/science.1204255			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21778394				2022-12-01	WOS:000292959600038
J	Wu, CC; Li, TK; Farh, L; Lin, LY; Lin, TS; Yu, YJ; Yen, TJ; Chiang, CW; Chan, NL				Wu, Chyuan-Chuan; Li, Tsai-Kun; Farh, Lynn; Lin, Li-Ying; Lin, Te-Sheng; Yu, Yu-Jen; Yen, Tien-Jui; Chiang, Chia-Wang; Chan, Nei-Li			Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide	SCIENCE			English	Article							DNA TOPOISOMERASE; CRYSTAL-STRUCTURE; CLEAVAGE; BETA; RESISTANCE; COMPLEX; TARGET; CANCER; IA; SUBSTITUENTS	Type II topoisomerases (TOP2s) resolve the topological problems of DNA by transiently cleaving both strands of a DNA duplex to form a cleavage complex through which another DNA segment can be transported. Several widely prescribed anticancer drugs increase the population of TOP2 cleavage complex, which leads to TOP2-mediated chromosome DNA breakage and death of cancer cells. We present the crystal structure of a large fragment of human TOP2 beta complexed to DNA and to the anticancer drug etoposide to reveal structural details of drug-induced stabilization of a cleavage complex. The interplay between the protein, the DNA, and the drug explains the structure-activity relations of etoposide derivatives and the molecular basis of drug-resistant mutations. The analysis of protein-drug interactions provides information applicable for developing an isoform-specific TOP2-targeting strategy.	[Wu, Chyuan-Chuan; Lin, Li-Ying; Lin, Te-Sheng; Yu, Yu-Jen; Yen, Tien-Jui; Chiang, Chia-Wang; Chan, Nei-Li] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei 100, Taiwan; [Li, Tsai-Kun] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 100, Taiwan; [Li, Tsai-Kun] Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 100, Taiwan; [Li, Tsai-Kun] Natl Taiwan Univ, Ctr Biotechnol, Taipei 106, Taiwan; [Farh, Lynn] Natl Pingtung Univ Educ, Dept Biol Chem, Pingtung 900, Taiwan; [Lin, Li-Ying; Lin, Te-Sheng; Chiang, Chia-Wang; Chan, Nei-Li] Natl Chung Hsing Univ, Coll Life Sci, Inst Biochem, Taichung 402, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Pingtung University; National Chung Hsing University	Chan, NL (corresponding author), Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei 100, Taiwan.	nlchan@ntu.edu.tw	Yen, Tien-Jui/AGF-8092-2022; Wu, Chyuan-Chuan/S-3997-2017	LI, TSAI-KUN/0000-0003-0393-2340; Wu, Chyuan-Chuan/0000-0002-7389-8777; CHAN, NEI-LI/0000-0003-0139-6513	National Science Council [99-2113-M-002-008-MY3, 99-2320-B-002-058-MY3, 100-2325-B-002-019]; National Taiwan University College of Medicine [99R311001]; National Health Research Institute [EX100-9939NI]	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University College of Medicine(National Taiwan University); National Health Research Institute(National Health Research Institutes - Taiwan)	Atomic coordinates and structure factors have been deposited in the Protein DataBank (PDB) under accession code 3QX3. This work was supported by the National Science Council (99-2113-M-002-008-MY3 to N.C.; 99-2320-B-002-058-MY3 and 100-2325-B-002-019 to T. L.), National Taiwan University College of Medicine (99R311001 to N.C. and T. L.), and National Health Research Institute (EX100-9939NI to T. L.). We thank T.-S. Hsieh for stimulating discussion, and critical reading and editing of the manuscript. Portions of this research were carried out at beamline BL13B1 of the National Synchrotron Radiation Research Center (Taiwan) and beamline SP12B2 of the SPring-8 (Japan). We thank the Protein Crystallography teams at both facilities for assistance during data collection. The National Taiwan University has applied for a patent concerning use of the hTOP2 beta<SUP>core</SUP>-DNA structure in drug development.	AUSTIN CA, 1995, J BIOL CHEM, V270, P15739, DOI 10.1074/jbc.270.26.15739; Azarova AM, 2007, P NATL ACAD SCI USA, V104, P11014, DOI 10.1073/pnas.0704002104; Bax BD, 2010, NATURE, V466, P935, DOI 10.1038/nature09197; BECK WT, 1993, ADV ENZYME REGUL, V33, P113; Bender RP, 2008, BIOCHEMISTRY-US, V47, P4501, DOI 10.1021/bi702019z; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; Bromberg KD, 2003, J BIOL CHEM, V278, P7406, DOI 10.1074/jbc.M212056200; Byl JAW, 2001, BIOCHEMISTRY-US, V40, P712, DOI 10.1021/bi0021838; Capranico G, 1998, BBA-GENE STRUCT EXPR, V1400, P185, DOI 10.1016/S0167-4781(98)00135-3; Changela A, 2001, NATURE, V411, P1077, DOI 10.1038/35082615; Collins TRL, 2009, NUCLEIC ACIDS RES, V37, P712, DOI 10.1093/nar/gkn1059; DARPA P, 1990, CANCER RES, V50, P6919; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; Dingemans AMC, 1998, BBA-GENE STRUCT EXPR, V1400, P275, DOI 10.1016/S0167-4781(98)00141-9; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gentry AC, 2011, BIOCHEMISTRY-US, V50, P3240, DOI 10.1021/bi200094z; Gilroy KL, 2006, NUCLEIC ACIDS RES, V34, P1597, DOI 10.1093/nar/gkl057; Haffner MC, 2010, NAT GENET, V42, P668, DOI 10.1038/ng.613; Jarvinen TAH, 2003, CYTOPATHOLOGY, V14, P309, DOI 10.1046/j.0956-5507.2003.00105.x; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Laponogov I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011338; Laponogov I, 2009, NAT STRUCT MOL BIOL, V16, P667, DOI 10.1038/nsmb.1604; Lee KH, 1999, J BIOMED SCI, V6, P236, DOI 10.1007/BF02253565; Leontiou C, 2006, MOL PHARMACOL, V69, P130, DOI 10.1124/mol.105.015933; Leontiou C, 2007, MOL PHARMACOL, V71, P1006, DOI 10.1124/mol.106.032953; Liu QY, 1999, P NATL ACAD SCI USA, V96, P881, DOI 10.1073/pnas.96.3.881; LONG BH, 1994, CANCER CHEMOTH PHARM, V34, pS26, DOI 10.1007/BF00684860; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Lyu YL, 2006, MOL CELL BIOL, V26, P7929, DOI 10.1128/MCB.00617-06; McClendon AK, 2007, MUTAT RES-FUND MOL M, V623, P83, DOI 10.1016/j.mrfmmm.2007.06.009; Meresse P, 2004, CURR MED CHEM, V11, P2443, DOI 10.2174/0929867043364531; Neto BAD, 2009, MOLECULES, V14, P1725, DOI 10.3390/molecules14051725; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; ROSS W, 1984, CANCER RES, V44, P5857; Ruiz J, 2003, J ANTIMICROB CHEMOTH, V51, P1109, DOI 10.1093/jac/dkg222; Schmidt BH, 2010, NATURE, V465, P641, DOI 10.1038/nature08974; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; SPITZNER JR, 1988, NUCLEIC ACIDS RES, V16, P5533, DOI 10.1093/nar/16.12.5533; Strumberg D, 1999, J BIOL CHEM, V274, P28246, DOI 10.1074/jbc.274.40.28246; VASSETZKY YS, 1995, BIOESSAYS, V17, P767, DOI 10.1002/bies.950170906; Wang J. C., 2009, UNTANGLING DOUBLE HE; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wilstermann AM, 2007, BIOCHEMISTRY-US, V46, P8217, DOI 10.1021/bi700272u; Wohlkonig A, 2010, NAT STRUCT MOL BIOL, V17, P1152, DOI 10.1038/nsmb.1892; Zhang ZT, 2011, P NATL ACAD SCI USA, V108, P6939, DOI 10.1073/pnas.1100300108; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	49	348	352	4	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2011	333	6041					459	462		10.1126/science.1204117	http://dx.doi.org/10.1126/science.1204117			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21778401				2022-12-01	WOS:000292959600048
J	Cobb, NK; Abrams, DB				Cobb, Nathan K.; Abrams, David B.			E-Cigarette or Drug-Delivery Device? Regulating Novel Nicotine Products	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cobb, Nathan K.; Abrams, David B.] Amer Legacy Fdn, Schroeder Inst Tobacco Res & Policy Studies, Washington, DC USA; [Cobb, Nathan K.] Georgetown Univ, Med Ctr, Div Pulm & Crit Care, Washington, DC 20007 USA; [Cobb, Nathan K.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Cobb, Nathan K.; Abrams, David B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA	Georgetown University; Georgetown University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Cobb, NK (corresponding author), Amer Legacy Fdn, Schroeder Inst Tobacco Res & Policy Studies, Washington, DC USA.		Abrams, David B/AAY-7699-2020	Abrams, David B/0000-0002-0868-4350; Cobb, Nathan/0000-0003-4210-226X				Cobb NK, 2010, AM J PUBLIC HEALTH, V100, P2340, DOI 10.2105/AJPH.2010.199281; Deyton LR, 2011, REGULATION E CIGARET; Eissenberg T, 2010, TOB CONTROL, V19, P87, DOI 10.1136/tc.2009.033498; Rose JE, 2011, EXP CLIN PSYCHOPHARM, V19, pIII, DOI 10.1037/a0021869; Rose JE, 2010, EXP CLIN PSYCHOPHARM, V18, P385, DOI 10.1037/a0020834; Trtchounian A, 2010, NICOTINE TOB RES, V12, P905, DOI 10.1093/ntr/ntq114	6	120	123	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2011	365	3					193	195		10.1056/NEJMp1105249	http://dx.doi.org/10.1056/NEJMp1105249			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	794QI	21774706				2022-12-01	WOS:000292915500001
J	Abrams, TE; Vaughan-Sarrazin, M; Fan, VS; Kaboli, PJ				Abrams, Thad E.; Vaughan-Sarrazin, Mary; Fan, Vincent S.; Kaboli, Peter J.			Geographic Isolation and the Risk for Chronic Obstructive Pulmonary Disease-Related Mortality	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; QUALITY-OF-LIFE; HOSPITAL MORTALITY; 30-DAY MORTALITY; FUEL COMBUSTION; HEART-FAILURE; BIOMASS SMOKE; HEALTH; VETERANS; CARE	Background: Little is known about the possible differences in outcomes between patients with chronic obstructive pulmonary disease (COPD) who live in rural areas and those who live in urban areas of the United States. Objective: To determine whether COPD-related mortality is higher in persons living in rural areas, and to assess whether hospital characteristics influence any observed associations. Design: Retrospective cohort study. Setting: 129 acute care Veterans Affairs hospitals. Patients: Hospitalized patients with a COPD exacerbation. Measurements: Patient rurality (primary exposure); 30-day mortality (primary outcome); and hospital volume and hospital rurality, defined as the mean proportion of hospital admissions coming from rural areas (secondary exposures). Results: 18 809 patients (71% of the study population) lived in urban areas, 5671 (21%) in rural areas, and 1919 (7%) in isolated rural areas. Mortality was increased in patients living in isolated rural areas compared with urban areas (5.0% vs. 3.8%; P = 0.002). The increase in mortality associated with living in an isolated rural area persisted after adjustment for patient characteristics and hospital rurality and volume (odds ratio [OR], 1.42 [95% CI, 1.07 to 1.89]; P = 0.016). Adjusted mortality did not seem to be higher in patients living in nonisolated rural areas (OR, 1.09 [CI, 0.90 to 1.32]; P = 0.47). Results were unchanged in analyses assessing the influence of an omitted confounder on estimates. Limitations: The study population was limited to mostly male inpatients who were veterans. Results were based on administrative data. Conclusion: Patients with COPD living in isolated rural areas of the United States seem to be at greater risk for COPD exacerbation-related mortality than those living in urban areas, independent of hospital rurality and volume. Mortality was not increased for patients living in nonisolated rural areas.	[Abrams, Thad E.] Iowa City Vet Affairs Healthcare Syst, Vet Rural Hlth Resource Center Cent Reg, Ctr Comprehens Access & Delivery Res & Evaluat, Iowa City Vet Affairs Med Ctr,Vet Hlth Adm Off Ru, Iowa City, IA 52246 USA; Univ Iowa, Iowa City, IA USA; Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA; Univ Washington, Seattle, WA 98195 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle	Abrams, TE (corresponding author), Iowa City Vet Affairs Healthcare Syst, Vet Rural Hlth Resource Center Cent Reg, Ctr Comprehens Access & Delivery Res & Evaluat, Iowa City Vet Affairs Med Ctr,Vet Hlth Adm Off Ru, 601 Highway 6 W,Mailstop 152, Iowa City, IA 52246 USA.	Thad-Abrams@va.gov		abrams, thad/0000-0003-0510-7803; Vaughan Sarrazin, Mary/0000-0001-8717-1061; Kaboli, Peter/0000-0003-0993-0952	Veterans Health Administration Office of Rural Health; Veterans Rural Health Resource Center-Central Region; Health Services Research and Development Service through the Center for Comprehensive Access and Delivery Research and Evaluation at the Iowa City Veterans Affairs Healthcare System, U. S. Department of Veterans Affairs [HFP 04-149]	Veterans Health Administration Office of Rural Health; Veterans Rural Health Resource Center-Central Region; Health Services Research and Development Service through the Center for Comprehensive Access and Delivery Research and Evaluation at the Iowa City Veterans Affairs Healthcare System, U. S. Department of Veterans Affairs(US Department of Veterans Affairs)	By the Veterans Health Administration Office of Rural Health, Veterans Rural Health Resource Center-Central Region, and the Health Services Research and Development Service, through the Center for Comprehensive Access and Delivery Research and Evaluation at the Iowa City Veterans Affairs Healthcare System, U. S. Department of Veterans Affairs (grant HFP 04-149).		0	32	32	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2011	155	2					80	+		10.7326/0003-4819-155-2-201107190-00003	http://dx.doi.org/10.7326/0003-4819-155-2-201107190-00003			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	793KW	21768581				2022-12-01	WOS:000292822000014
J	Gandy, S				Gandy, Sam			PERSPECTIVE Prevention is better than cure	NATURE			English	Editorial Material							ALZHEIMERS-DISEASE; COMPOUND-B		[Gandy, Sam] Mt Sinai Sch Med, Alzheimers Dis Res Ctr, New York, NY 10029 USA; [Gandy, Sam] James J Peters VA Med Ctr, New York, NY USA	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Gandy, S (corresponding author), Mt Sinai Sch Med, Alzheimers Dis Res Ctr, New York, NY 10029 USA.	samuel.gandy@mssm.edu			NIA NIH HHS [P50 AG005138] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P50AG005138] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Knight WD, 2011, BRAIN, V134, P293, DOI 10.1093/brain/awq310; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; TERRY RD, 1983, ANN NEUROL, V14, P497, DOI 10.1002/ana.410140502	7	30	31	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2011	475	7355					S15	S15		10.1038/475S15a	http://dx.doi.org/10.1038/475S15a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	791UA	21760576	Green Accepted, Bronze			2022-12-01	WOS:000292690500007
J	Edelson, M; Sharot, T; Dolan, RJ; Dudai, Y				Edelson, Micah; Sharot, Tali; Dolan, Raymond J.; Dudai, Yadin			Following the Crowd: Brain Substrates of Long-Term Memory Conformity	SCIENCE			English	Article							FALSE MEMORIES; AMYGDALA; COGNITION; PREDICTS; EMOTION; CORTEX; MONKEY	Human memory is strikingly susceptible to social influences, yet we know little about the underlying mechanisms. We examined how socially induced memory errors are generated in the brain by studying the memory of individuals exposed to recollections of others. Participants exhibited a strong tendency to conform to erroneous recollections of the group, producing both long-lasting and temporary errors, even when their initial memory was strong and accurate. Functional brain imaging revealed that social influence modified the neuronal representation of memory. Specifically, a particular brain signature of enhanced amygdala activity and enhanced amygdala-hippocampus connectivity predicted long-lasting but not temporary memory alterations. Our findings reveal how social manipulation can alter memory and extend the known functions of the amygdala to encompass socially mediated memory distortions.	[Edelson, Micah; Dudai, Yadin] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Sharot, Tali; Dolan, Raymond J.] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England	Weizmann Institute of Science; University of London; University College London	Edelson, M (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	micah.edelson@weizmann.ac.il		Edelson, Micah/0000-0001-6494-2871; Dolan, Ray/0000-0001-9356-761X	Weizmann Institute-UK; British Academy; Wellcome Trust; Nella and Leon Benoziyo Center for Neurological Diseases	Weizmann Institute-UK; British Academy; Wellcome Trust(Wellcome TrustEuropean Commission); Nella and Leon Benoziyo Center for Neurological Diseases	M.E. was supported by a Weizmann Institute-UK Grant. T.S. is supported by a British Academy Postdoctoral Fellowship. R.J.D is supported by a Wellcome Trust Program Grant. Y.D. is supported by the Nella and Leon Benoziyo Center for Neurological Diseases. We thank A. Ben-Yakov, J. G. Edelson, T. Fitzgerald, O. Furman, S. Fleming, D. Levi, M. Guitart-Masip, A. Mendelsohn, U. Nili, A. Pine, J. S. Winston, and N. Wright for helpful comments and the support teams of the Norman and Helen Asher Center for Brain Imaging at the Weizmann Institute and the Imaging Neuroscience & Theoretical Neurobiology unit in the Wellcome Trust Center for Neuroimaging.	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Aggleton JP., 2000, AMYGDALA FUNCTIONAL; ALLEN VL, 1965, ADV EXP SOC PSYCHOL, V2, P133; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; [Anonymous], REMEMBERING; Arndt J, 2010, J EXP PSYCHOL LEARN, V36, P66, DOI 10.1037/a0017394; Asch S. E., 1951, GROUPS LEADERSHIP ME, P39; Bickart KC, 2011, NAT NEUROSCI, V14, P163, DOI 10.1038/nn.2724; Boyd R., 1988, P29; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Dudai Y., 2002, MEMORY KEYWORDS CONC; Festinger L., 1957, THEOR COGNITIVE DIS, P99; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Howe ML, 2008, PSYCHOL BULL, V134, P768, DOI 10.1037/0033-2909.134.5.768; Klucharev V, 2009, NEURON, V61, P140, DOI 10.1016/j.neuron.2008.11.027; Kluver H, 1938, J PSYCHOL, V5, P33; Kuhl BA, 2007, NAT NEUROSCI, V10, P908, DOI 10.1038/nn1918; Levy BJ, 2002, TRENDS COGN SCI, V6, P299, DOI 10.1016/S1364-6613(02)01923-X; Loftus EF, 2005, LEARN MEMORY, V12, P361, DOI 10.1101/lm.94705; Meade ML, 2002, MEM COGNITION, V30, P995, DOI 10.3758/BF03194318; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P800, DOI 10.1162/0898929053747595; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Ochsner Kevin, 2006, SOC NEUROSCI-UK, P245; Okado Y, 2005, LEARN MEMORY, V12, P3, DOI 10.1101/lm.87605; Perkins HW, 2010, ADDICT BEHAV, V35, P866, DOI 10.1016/j.addbeh.2010.05.004; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; REYNA VF, 1995, LEARN INDIVID DIFFER, V7, P1, DOI 10.1016/1041-6080(95)90031-4; Reysen MB, 2005, MEMORY, V13, P87, DOI 10.1080/09658210344000602; Richardson MP, 2004, NAT NEUROSCI, V7, P278, DOI 10.1038/nn1190; Roediger HL, 2001, PSYCHON B REV, V8, P385, DOI 10.3758/BF03196177; Schacter D. L., 2001, 7 SINS MEMORY MIND F; Shaw JS, 1997, LAW HUMAN BEHAV, V21, P503, DOI 10.1023/A:1024875723399; Sherif M., 1936, PSYCHOL SOCIAL NORMS, V2nd; Smith E.R., 2007, SOC PSYCHOL-GERMANY, V3rd Ed.; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; Stefanacci L, 2002, J COMP NEUROL, V451, P301, DOI 10.1002/cne.10339; Wright DB, 2009, CURR DIR PSYCHOL SCI, V18, P174, DOI 10.1111/j.1467-8721.2009.01631.x	42	128	138	4	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2011	333	6038					108	111		10.1126/science.1203557	http://dx.doi.org/10.1126/science.1203557			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	785UF	21719681	Green Accepted, Green Published			2022-12-01	WOS:000292255400061
J	Thiele, P; Blair, S				Thiele, Pauline; Blair, Simon			A PATIENT'S JOURNEY Destined to die	BRITISH MEDICAL JOURNAL			English	Editorial Material												liam194@gmail.com							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 1	2011	343								d3625	10.1136/bmj.d3625	http://dx.doi.org/10.1136/bmj.d3625			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	788QD	21724563	Bronze			2022-12-01	WOS:000292458600001
J	Klassen, T; Davis, C; Goldman, A; Burgess, D; Chen, T; Wheeler, D; McPherson, J; Bourquin, T; Lewis, L; Villasana, D; Morgan, M; Muzny, D; Gibbs, R; Noebels, J				Klassen, Tara; Davis, Caleb; Goldman, Alica; Burgess, Dan; Chen, Tim; Wheeler, David; McPherson, John; Bourquin, Traci; Lewis, Lora; Villasana, Donna; Morgan, Margaret; Muzny, Donna; Gibbs, Richard; Noebels, Jeffrey			Exome Sequencing of Ion Channel Genes Reveals Complex Profiles Confounding Personal Risk Assessment in Epilepsy	CELL			English	Article							SEVERE MYOCLONIC EPILEPSY; ORGANIZATION; MUTATIONS; MODELS; CHANNELOPATHIES; SUSCEPTIBILITY; PREVALENCE; MECHANISMS; EVOLUTION; ALIGNMENT	Ion channel mutations are an important cause of rare Mendelian disorders affecting brain, heart, and other tissues. We performed parallel exome sequencing of 237 channel genes in a well-characterized human sample, comparing variant profiles of unaffected individuals to those with the most common neuronal excitability disorder, sporadic idiopathic epilepsy. Rare missense variation in known Mendelian disease genes is prevalent in both groups at similar complexity, revealing that even deleterious ion channel mutations confer uncertain risk to an individual depending on the other variants with which they are combined. Our findings indicate that variant discovery via large scale sequencing efforts is only a first step in illuminating the complex allelic architecture underlying personal disease risk. We propose that in silico modeling of channel variation in realistic cell and network models will be crucial to future strategies assessing mutation profile pathogenicity and drug response in individuals with a broad spectrum of excitability disorders.	[Klassen, Tara; Davis, Caleb; Goldman, Alica; Burgess, Dan; Chen, Tim; Noebels, Jeffrey] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Noebels, Jeffrey] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [McPherson, John; Gibbs, Richard; Noebels, Jeffrey] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Wheeler, David; McPherson, John; Bourquin, Traci; Lewis, Lora; Villasana, Donna; Morgan, Margaret; Muzny, Donna; Gibbs, Richard] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Noebels, J (corresponding author), Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA.	jnoebels@bcm.edu	Wheeler, David A/M-9740-2018; Sander-Effron, Samuel/AAX-2231-2020; McPherson, John D/D-2633-2017; Resource Center, NINDS Human Genetics/AGF-2474-2022	Wheeler, David A/0000-0002-9056-6299; McPherson, John D/0000-0001-8049-9347; Davis, Caleb/0000-0002-5125-0494; Noebels, Jeffrey/0000-0002-2887-0839	NIH [NS 049130]; National Human Genome Research Institute; Gillson Longenbaugh Foundation; Blue Bird Circle Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS047304, R01NS049130] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Gillson Longenbaugh Foundation; Blue Bird Circle Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Melissa Lambeth and Marsha Hill for assistance with clinical recruitment, the Human Genome Sequencing Center sequencing team, and Colleen Clancy and Luay Nakhleh for valuable discussion. The authors acknowledge the support NIH NS 049130 (J.N.), the National Human Genome Research Institute (R. G.), the Gillson Longenbaugh Foundation (J.N. and R. G.), and the Blue Bird Circle Foundation.	Ackerman MJ, 2004, HEART RHYTHM, V1, P600, DOI 10.1016/j.hrthm.2004.07.013; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Bayes A, 2009, NAT REV NEUROSCI, V10, P635, DOI 10.1038/nrn2701; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Bloodgood BL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000190; Bower James M, 2007, Methods Mol Biol, V401, P103, DOI 10.1007/978-1-59745-520-6_7; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Catterall WA, 2008, J NEUROSCI, V28, P11768, DOI 10.1523/JNEUROSCI.3901-08.2008; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Clancy CE, 1999, NATURE, V400, P566, DOI 10.1038/23034; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Demolombe S, 2005, CARDIOVASC RES, V67, P438, DOI 10.1016/j.cardiores.2005.04.021; Dougherty JD, 2010, NUCLEIC ACIDS RES, V38, P4218, DOI 10.1093/nar/gkq130; Drolet B, 2005, J CLIN INVEST, V115, P2209, DOI 10.1172/JCI23741; Dyhrfjeld-Johnsen J, 2007, J NEUROPHYSIOL, V97, P1566, DOI 10.1152/jn.00950.2006; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FRASER FC, 1976, TERATOLOGY, V14, P267, DOI 10.1002/tera.1420140302; Gargus JJ, 2003, AM J HUM GENET, V72, P785, DOI 10.1086/374317; Glasscock E, 2007, NAT NEUROSCI, V10, P1554, DOI 10.1038/nn1999; Goaillard JM, 2009, NAT NEUROSCI, V12, P1424, DOI 10.1038/nn.2404; Grashow R, 2009, P NATL ACAD SCI USA, V106, P11742, DOI 10.1073/pnas.0905614106; Gurkiewicz M, 2007, PLOS COMPUT BIOL, V3, P1633, DOI 10.1371/journal.pcbi.0030169; Harmar AJ, 2009, NUCLEIC ACIDS RES, V37, pD680, DOI 10.1093/nar/gkn728; Hawkins NA, 2011, NEUROBIOL DIS, V41, P655, DOI 10.1016/j.nbd.2010.11.016; Hiriart M, 2008, AM J PHYSIOL-ENDOC M, V295, pE1298, DOI 10.1152/ajpendo.90493.2008; Holmkvist J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005872; Huffaker SJ, 2009, NAT MED, V15, P509, DOI 10.1038/nm.1962; Jegla TJ, 2009, COMB CHEM HIGH T SCR, V12, P2, DOI 10.2174/138620709787047957; Kaczmarek LK, 2006, NAT REV NEUROSCI, V7, P761, DOI 10.1038/nrn1988; Kapplinger JD, 2009, HEART RHYTHM, V6, P1297, DOI 10.1016/j.hrthm.2009.05.021; Kellems AR, 2009, J COMPUT NEUROSCI, V27, P161, DOI 10.1007/s10827-008-0134-2; KNUDSON AG, 1975, P NATL ACAD SCI USA, V72, P5116, DOI 10.1073/pnas.72.12.5116; Liu G, 2003, NEUROPHARMACOLOGY, V44, P413, DOI 10.1016/S0028-3908(02)00400-8; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marder E, 2010, NEURON, V66, P161, DOI 10.1016/j.neuron.2010.04.022; Martin MS, 2007, HUM MOL GENET, V16, P2892, DOI 10.1093/hmg/ddm248; Matzke AJM, 2010, MOL PLANT, V3, P642, DOI 10.1093/mp/ssq013; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; Muller CS, 2010, P NATL ACAD SCI USA, V107, P14950, DOI 10.1073/pnas.1005940107; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Nusser Z, 2009, TRENDS NEUROSCI, V32, P267, DOI 10.1016/j.tins.2009.01.003; Ohmori I, 2006, EPILEPSIA, V47, P1636, DOI 10.1111/j.1528-1167.2006.00643.x; Okaty BW, 2009, J NEUROSCI, V29, P7040, DOI 10.1523/JNEUROSCI.0105-09.2009; Reid CA, 2009, PROG NEUROBIOL, V87, P41, DOI 10.1016/j.pneurobio.2008.09.016; Roepke TK, 2009, NAT MED, V15, P1186, DOI 10.1038/nm.2029; Rusconi R, 2007, J NEUROSCI, V27, P11037, DOI 10.1523/JNEUROSCI.3515-07.2007; Ryan DP, 2010, CELL, V140, P88, DOI 10.1016/j.cell.2009.12.024; Scheffer IE, 2007, BRAIN, V130, P100, DOI 10.1093/brain/awl272; Sheets MF, 2010, TRENDS CARDIOVAS MED, V20, P16, DOI 10.1016/j.tcm.2010.03.002; Singh NA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000649; Song I, 2004, J NEUROSCI, V24, P5249, DOI 10.1523/JNEUROSCI.5546-03.2004; Sontheimer H, 2008, EXP BIOL MED, V233, P779, DOI 10.3181/0711-MR-308; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Thomas EA, 2009, ARCH NEUROL-CHICAGO, V66, P1225, DOI 10.1001/archneurol.2009.219; Tobin AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006742; Toledo-Rodriguez M, 2005, TRENDS NEUROSCI, V28, P534, DOI 10.1016/j.tins.2005.08.001; Tomaselli GF, 2010, HEART RHYTHM, V7, P206, DOI 10.1016/j.hrthm.2009.10.029; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; Tsuji K, 2007, J MOL CELL CARDIOL, V42, P662, DOI 10.1016/j.yjmcc.2006.12.015; Tucker T, 2009, AM J HUM GENET, V85, P142, DOI 10.1016/j.ajhg.2009.06.022; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Winden KD, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.46; Wray NR, 2010, GENOME MED, V2, DOI 10.1186/gm131; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Xu J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002056; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754; Zhang JH, 2005, PLOS COMPUT BIOL, V1, P395, DOI 10.1371/journal.pcbi.0010053	75	227	231	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 24	2011	145	7					1036	1048		10.1016/j.cell.2011.05.025	http://dx.doi.org/10.1016/j.cell.2011.05.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703448	Bronze, Green Accepted			2022-12-01	WOS:000292025700011
J	Seong, KH; Li, D; Shimizu, H; Nakamura, R; Ishii, S				Seong, Ki-Hyeon; Li, Dong; Shimizu, Hideyuki; Nakamura, Ryoichi; Ishii, Shunsuke			Inheritance of Stress-Induced, ATF-2-Dependent Epigenetic Change	CELL			English	Article							POSITION-EFFECT VARIEGATION; DROSOPHILA-MELANOGASTER; TRANSPOSABLE ELEMENTS; RNA-POLYMERASE; GENE; P38; PARAMUTATION; ACTIVATION; EXPRESSION; RESPONSES	Atf1, the fission yeast homolog of activation transcription factor-2 (ATF-2), contributes to heterochromatin formation. However, the role of ATF-2 in chromatin assembly in higher organisms remains unknown. This study reveals that Drosophila ATF-2 (dATF-2) is required for heterochromatin assembly, whereas the stress-induced phosphorylation of dATF-2, via Mekk1-p38, disrupts heterochromatin. The dATF-2 protein colocalized with HP1, not only on heterochromatin but also at specific loci in euchromatin. Heat shock or osmotic stress induced phosphorylation of dATF-2 and resulted in its release from heterochromatin. This heterochromatic disruption was an epigenetic event that was transmitted to the next generation in a non-Mendelian fashion. When embryos were exposed to heat stress over multiple generations, the defective chromatin state was maintained over multiple successive generations, though it gradually returned to the normal state. The results suggest a mechanism by which the effects of stress are inherited epigenetically via the regulation of a tight chromatin structure.	[Seong, Ki-Hyeon; Li, Dong; Shimizu, Hideyuki; Nakamura, Ryoichi; Ishii, Shunsuke] RIKEN Tsukuba Inst, Mol Genet Lab, Tsukuba, Ibaraki 3050074, Japan	RIKEN	Ishii, S (corresponding author), RIKEN Tsukuba Inst, Mol Genet Lab, 3-1-1 Koyadai, Tsukuba, Ibaraki 3050074, Japan.	sishii@rtc.riken.jp	Ishii, Shunsuke/A-5271-2016	Ishii, Shunsuke/0000-0002-6530-2478; Seong, Ki-Hyeon/0000-0002-0606-8896; Li, Dong/0000-0002-7268-657X	Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research [23370079] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to Y. Iijima and T. Nomura for technical assistance, the staff of the Research Resources Center of the RIKEN Brain Science Institute for microarray analysis, L. L. Wallrath, the Exelixis collection at Harvard Medical School, T. Ide, T. Adachi-Yamada, and J. Eissenberg, and the Bloomington Stock Center for Drosophila strains. This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science, and Technology.	Alleman M, 2006, NATURE, V442, P295, DOI 10.1038/nature04884; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chandler VL, 2007, CELL, V128, P641, DOI 10.1016/j.cell.2007.02.007; Craig CR, 2004, EMBO REP, V5, P1058, DOI 10.1038/sj.embor.7400282; Gowen JW, 1933, SCIENCE, V77, P312, DOI 10.1126/science.77.1995.312; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Han SJ, 1998, J BIOL CHEM, V273, P369, DOI 10.1074/jbc.273.1.369; Inoue H, 2001, EMBO J, V20, P5421, DOI 10.1093/emboj/20.19.5421; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kavi HH, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-15; Kennerdell JR, 2002, GENE DEV, V16, P1884, DOI 10.1101/gad.990802; Khurana JS, 2010, J CELL BIOL, V191, P905, DOI 10.1083/jcb.201006034; Lloyd VK, 2003, GENOME, V46, P1104, DOI 10.1139/G03-070; Lu BY, 1996, EMBO J, V15, P1323, DOI 10.1002/j.1460-2075.1996.tb00474.x; MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x; Maekawa T, 2007, MOL CELL BIOL, V27, P1730, DOI 10.1128/MCB.01579-06; Maekawa T, 2010, EMBO J, V29, P184, DOI 10.1038/emboj.2009.318; Molinier J, 2006, NATURE, V442, P1046, DOI 10.1038/nature05022; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Okamura T, 2007, MOL BIOL CELL, V18, P1519, DOI 10.1091/mbc.E06-10-0909; RABINOW L, 1991, GENETICS, V129, P463; REUTER G, 1982, CHROMOSOMA, V85, P539, DOI 10.1007/BF00327349; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sano Y, 2005, MOL BIOL CELL, V16, P2934, DOI 10.1091/mbc.E04-11-1008; Shimizu H, 2008, MOL CELL BIOL, V28, P6278, DOI 10.1128/MCB.02242-07; SPOFFORD JB, 1976, GENETICS BIOL DROS C, V1, P955; TARTOF KD, 1984, CELL, V37, P869, DOI 10.1016/0092-8674(84)90422-7; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wagschal A, 2007, CSH PROTOC; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276	37	214	221	0	59	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 24	2011	145	7					1049	1061		10.1016/j.cell.2011.05.029	http://dx.doi.org/10.1016/j.cell.2011.05.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703449	Bronze			2022-12-01	WOS:000292025700012
